<html xmlns:ecco="http://owl.cs.manchester.ac.uk/diff">
   <head>
      <meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
      <title>ecco</title>
      <meta charset="utf-8">
      <link rel="stylesheet" href="css/style.css">
      <link rel="stylesheet" href="css/reveal.css"><script type="text/javascript" src="js/jquery-1.4.4.js"></script><script type="text/javascript" src="js/jquery-ui-1.8.12.custom.min.js"></script><script type="text/javascript" src="js/script.js"></script><script type="text/javascript" src="js/jquery.checkboxtree.js"></script><script type="text/javascript" src="js/jquery.reveal.js"></script><script type="text/javascript" src="js/jscript.js"></script></head>
   <body>
      <h1><br></h1>
      				[<a href="index.jsp">Back Home</a>]
      				
      <form action="getXml" method="post" class="inl">
         						[<a id="top3" target="_blank" href="EccoChangeSet_labels.xml">Source XML</a>]
         					
      </form><br><br><h2 style="display:inline;">Change Summary</h2>&nbsp;
      				[<a id="top1" href="javascript:;" onClick="showAll();$('#tree1').checkboxTree('expandAll');$('#tree2').checkboxTree('expandAll')">Show All</a> | 
      				<a id="top2" href="javascript:;" onClick="hideAll();$('#tree1').checkboxTree('collapseAll');$('#tree2').checkboxTree('collapseAll');">Hide All</a>] 
      				[<a id="genViewPerml" href="#" onclick="setPermalink();">Generate View Permalink</a>]
      				
      <div id="view-plink-modal" class="reveal-modal">
         <h3>view-permalink</h3><textarea id="view-plink" rows="3" cols="60" readonly="true" style="resize: none;"></textarea><br>
         					[<a href="javascript:;" onclick="select_all('view-plink');">Select all</a>]
         					<a class="close-reveal-modal">x</a></div><br><br><form action="output" method="post" name="GenSymTrigger"><input type="hidden" name="uuid" value="b46df4c9-4046-41d5-89e3-b49d51806148-lbl"><input type="button" name="gensyms" onClick="parent.location='index_labels.html'" value="Use Labels"> <input type="button" name="gensyms" onClick="parent.location='index_names.html'" value="Use Term Names"> <input type="button" name="gensyms" onClick="parent.location='index_gensyms.html'" value="Use GenSyms"></form>
      <table width="70%" style="table-layout:fixed;">
         <tr>
            <th class="topright"><input type="checkbox" name="removals" onClick="toggleGroup('removals')">  
               <h3 style="display:inline;">Removals (1038)</h3>
            </th>
            <th class="topleft"><input type="checkbox" name="additions" onClick="toggleGroup('additions')">  
               <h3 style="display:inline;">Additions (6465)</h3>
            </th>
         </tr>
         <tr>
            <td class="topright">
               <ul id="tree1">
                  <li>  <input type="checkbox" name="effRemsTrigger" onClick="toggleChanges('effRems','effRemsTrigger')">  
                     <h4 style="display:inline;">Effectual (300)</h4>  <img src="images/info_bubble.png" alt="" align="right" width="14" height="14" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Axioms that are in Ontology 1, not in Ontology 2, and are not entailed by Ontology 2');"><ul>
                        <li>  Weakenings (0)</li>
                        <li>  <input type="checkbox" name="effRems" onClick="toggleDiv('wkequiv','wkequivrt');">  <b>Modified Definitions (24)</b>  <img src="images/info_bubble.png" alt="" align="right" width="14" height="14" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Equivalence axioms that have been extended; if split into subsumptions then one was strengthened and the other weakened');"><ul style="display:none">
                              <li id="wkequivtrig"><img src="images/blank.png" alt="">  <input type="checkbox" name="effAdds" onClick="toggleDiv('wkequiv');">  <a href="#wkequiv">With Shared Terms (24)</a></li>
                              <li><img src="images/blank.png" alt="">&nbsp;&nbsp;With Retired Terms (0)
                              </li>
                           </ul>
                        </li>
                        <li id="retdesctrig"><img src="images/blank.png" alt="">  <input type="checkbox" name="effRems" onClick="toggleDiv('retdesc');">  <a href="#retdesc">Retired Descriptions (2)</a>  <img src="images/info_bubble.png" alt="" align="right" width="14" height="14" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Axioms describing retired terms, i.e., terms that no longer exist in Ontology 2');"></li>
                        <li>  <input type="checkbox" name="effRems" onClick="toggleDiv('rem','remrt');">  <b>Pure Removals (274)</b>  <img src="images/info_bubble.png" alt="" align="right" width="14" height="14" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Axioms with no co-relation with axioms in Ontology 2; typically related to hierachy changes');"><ul style="display:none">
                              <li id="remtrig"><img src="images/blank.png" alt="">  <input type="checkbox" name="effAdds" onClick="toggleDiv('rem');">  <a href="#rem">With Shared Terms (270)</a></li>
                              <li id="remrttrig"><img src="images/blank.png" alt="">  <input type="checkbox" name="effAdds" onClick="toggleDiv('remrt');">  <a href="#remrt">With Retired Terms (4)</a></li>
                           </ul>
                        </li><br></ul>
                  </li><br><li>  <input type="checkbox" name="ineffRemsTrigger" onClick="toggleChanges('ineffRems','ineffRemsTrigger')">  
                     <h4 style="display:inline;">Ineffectual (738)</h4>  <img src="images/info_bubble.png" alt="" align="right" width="14" height="14" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Axioms that are in Ontology 1, not in Ontology 2, but are entailed by Ontology 2, i.e., that have been removed but are still entailed');"><ul>
                        <li>  <input type="checkbox" name="ineffRems" onClick="toggleDiv('ravred','rst','rpsnovred');">  <b>Prospective Redundancy (737)</b>  <img src="images/info_bubble.png" alt="" align="right" width="14" height="14" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Axioms in Ontology 1 for which there are more constraining related axioms in Ontology 2');"><ul style="display:none">
                              <li><img src="images/blank.png" alt="">&nbsp;&nbsp;Reshuffle (0)
                              </li>
                              <li>  <input type="checkbox" name="ineffRems" onClick="toggleDiv('rst','rpsnovred');">  <b>Retired Prospective Redundancy (737)</b><b id="t1"></b>  
                                 <ul style="display:none">
                                    <li id="rsttrig"><img src="images/blank.png" alt="">  <input type="checkbox" name="ineffRems" onClick="toggleDiv('rst');">  <a href="#rst">Novel (61)</a></li>
                                    <li id="rpsnovredtrig"><img src="images/blank.png" alt="">  <input type="checkbox" name="ineffRems" onClick="toggleDiv('rpsnovred');">  <a href="#rpsnovred">Pseudo Novel (676)</a></li>
                                 </ul>
                              </li>
                           </ul>
                        </li>
                        <li><img src="images/blank.png" alt="">&nbsp;&nbsp;Rewritten (0)
                        </li>
                        <li id="rredtrig"><img src="images/blank.png" alt="">  <input type="checkbox" name="ineffRems" onClick="toggleDiv('rred')">  <a href="#rred">Redundant (1)</a>  <img src="images/info_bubble.png" alt="" align="right" width="14" height="14" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Axioms in Ontology 1 that are entailed by at least one shared axiom between Ontology 1 and 2');"></li>
                     </ul>
                  </li>
               </ul>
            </td>
            <td class="topleft" style="vertical-align:top">
               <ul id="tree2">
                  <li>  <input type="checkbox" name="effAddsTrigger" onClick="toggleChanges('effAdds','effAddsTrigger')">  
                     <h4 style="display:inline;">Effectual (6447)</h4>  <img src="images/info_bubble.png" alt="" align="right" width="14" height="14" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Axioms that are in Ontology 2, not in Ontology 1, and are not entailed by Ontology 1');"><ul>
                        <li>  <input type="checkbox" name="effAdds" onClick="toggleDiv('st','stnt');">  <b>Strengthenings (259)</b>  <img src="images/info_bubble.png" alt="" align="right" width="14" height="14" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Axioms that are more constraining than existing axioms in Ontology 1');"><ul style="display:none">
                              <li id="sttrig"><img src="images/blank.png" alt="">  <input type="checkbox" name="effAdds" onClick="toggleDiv('st');">  <a href="#st">With Shared Terms (224)</a></li>
                              <li id="stnttrig"><img src="images/blank.png" alt="">  <input type="checkbox" name="effAdds" onClick="toggleDiv('stnt');">  <a href="#stnt">With New Terms (35)</a></li>
                           </ul>
                        </li>
                        <li>  <input type="checkbox" name="effAdds" onClick="toggleDiv('stequiv','stequivnt');">  <b>Modified Definitions (25)</b>  <img src="images/info_bubble.png" alt="" align="right" width="14" height="14" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Equivalence axioms that have been extended; if split into subsumptions then one was strengthened and the other weakened');"><ul style="display:none">
                              <li id="stequivtrig"><img src="images/blank.png" alt="">  <input type="checkbox" name="effAdds" onClick="toggleDiv('stequiv');">  <a href="#aed">With Shared Terms (22)</a></li>
                              <li id="stequivnttrig"><img src="images/blank.png" alt="">  <input type="checkbox" name="effAdds" onClick="toggleDiv('stequivnt');">  <a href="#aednt">With New Terms (3)</a></li>
                           </ul>
                        </li>
                        <li id="newdesctrig"><img src="images/blank.png" alt="">  <input type="checkbox" name="effAdds" onClick="toggleDiv('newdesc');">  <a href="#newdesc">New Descriptions (5718)</a>  <img src="images/info_bubble.png" alt="" align="right" width="14" height="14" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Axioms describing newly created terms, i.e., terms that did not exist in Ontology 1');"></li>
                        <li>  <input type="checkbox" name="effAdds" onClick="toggleDiv('add','addnt');">  <b>Pure Additions (445)</b>  <img src="images/info_bubble.png" alt="" align="right" width="14" height="14" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Axioms with no co-relation with axioms in Ontology 1; typically related to hierachy changes');"><ul style="display:none">
                              <li id="addtrig"><img src="images/blank.png" alt="">  <input type="checkbox" name="effAdds" onClick="toggleDiv('add');">  <a href="#add">With Shared Terms (355)</a></li>
                              <li id="addnttrig"><img src="images/blank.png" alt="">  <input type="checkbox" name="effAdds" onClick="toggleDiv('addnt');">  <a href="#addnt">With New Terms (90)</a></li>
                           </ul>
                        </li>
                     </ul>
                  </li><br><li>  <input type="checkbox" name="ineffAddsTrigger" onClick="toggleChanges('ineffAdds','ineffAddsTrigger')">  
                     <h4 style="display:inline;">Ineffectual (18)</h4>  <img src="images/info_bubble.png" alt="" align="right" width="14" height="14" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Axioms that are in Ontology 2, not in Ontology 1, but are entailed by Ontology 1, i.e., that have been added but were already entailed');"><ul>
                        <li>  <input type="checkbox" name="ineffAdds" onClick="toggleDiv('aavred','apseudopred','aweak');">  <b>Retrospective Redundancy (16)</b>  <img src="images/info_bubble.png" alt="" align="right" width="14" height="14" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Axioms in Ontology 2 for which there are more constraining related axioms in Ontology 1');"><ul style="display:none">
                              <li><img src="images/blank.png" alt="">&nbsp;&nbsp;Reshuffle (0)
                              </li>
                              <li>  <input type="checkbox" name="ineffAdds" onClick="toggleDiv('aweak','apseudopred');">  <b>New Retrospective Redundancy (16)</b>  
                                 <ul style="display:none">
                                    <li id="aweaktrig"><img src="images/blank.png" alt="">  <input type="checkbox" name="ineffAdds" onClick="toggleDiv('aweak');">  <a href="#aweak">Novel (16)</a></li>
                                    <li><img src="images/blank.png" alt="">&nbsp;&nbsp;Pseudo Novel (0)
                                    </li>
                                 </ul>
                              </li>
                           </ul>
                        </li>
                        <li><img src="images/blank.png" alt="">&nbsp;&nbsp;Rewritten (0)
                        </li>
                        <li id="aredtrig"><img src="images/blank.png" alt="">  <input type="checkbox" name="ineffAdds" onClick="toggleDiv('ared')">  <a href="#ared">Redundant (2)</a>  <img src="images/info_bubble.png" alt="" align="right" width="14" height="14" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Axioms in Ontology 2 that are entailed by at least one shared axiom between Ontology 1 and 2');"></li>
                     </ul>
                  </li>
               </ul>
            </td>
         </tr>
         <tr>
            <td class="topright">[<a href="javascript:void(0);" id="tree1-expandAll">Expand All</a> | <a href="javascript:void(0);" id="tree1-collapseAll">Collapse All</a>]
            </td>
            <td class="topleft">[<a href="javascript:void(0);" id="tree2-expandAll">Expand All</a> | <a href="javascript:void(0);" id="tree2-collapseAll">Collapse All</a>]
            </td>
         </tr>
      </table>
      <table width="100%" style="table-layout:fixed;">
         <colgroup>
            <col>
            <col width="47.5%">
            <col width="47.5%">
         </colgroup>
         <tbody id="st" style="display:none">
            <tr class="withoutstyle">
               <td colspan="3">
                  <h4 style="display: inline-block;">Strengthenings with Shared Terms (224)</h4> [<a href="#">back to top</a>]
               </td>
            </tr>
            <tr>
               <th class="addition">ID</th>
               <th class="normaladd">Weaker Axiom in Ontology 1</th>
               <th class="addition">Strengthened Axiom in Ontology 2</th>
            </tr>
            <tr class="addition">
               <td>1</td>
               <td>ADAM17 wt Allele<span class="subclass"> SubClassOf </span>ADAM17 Gene. 
               </td>
               <td>ADAM17 wt Allele<span class="subclass"> EquivalentTo </span>ADAM17 Gene<br><span class="keyword"> and </span>(Gene_Found_In_Organism<span class="some"> some </span>Human)<br><span class="keyword"> and </span>(Gene_In_Chromosomal_Location<span class="some"> some </span>2p25).<br></td>
            </tr>
            <tr class="addition">
               <td>2</td>
               <td>Acinar Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Lung Adenocarcinoma. 
               </td>
               <td>Acinar Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Acinar Pattern).<br></td>
            </tr>
            <tr class="addition">
               <td>4</td>
               <td>Alcohol-Related Carcinoma<span class="subclass"> SubClassOf </span>Neoplasm by Cause. 
               </td>
               <td>Alcohol-Related Carcinoma<span class="subclass"> EquivalentTo </span>Behavior-Related Disorder<br><span class="keyword"> and </span>Carcinoma<br><span class="keyword"> and </span>Neoplasm by Cause<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Toxicity).<br></td>
            </tr>
            <tr class="addition">
               <td>5</td>
               <td>Alcohol-Related Esophageal Carcinoma<span class="subclass"> SubClassOf </span>Alcohol-Related Carcinoma. 
               </td>
               <td>Alcohol-Related Esophageal Carcinoma<span class="subclass"> EquivalentTo </span>Alcohol-Related Carcinoma<br><span class="keyword"> and </span>Esophageal Carcinoma.<br></td>
            </tr>
            <tr class="addition">
               <td>6</td>
               <td>Alcohol-Related Laryngeal Carcinoma<span class="subclass"> SubClassOf </span>Laryngeal Carcinoma. 
               </td>
               <td>Alcohol-Related Laryngeal Carcinoma<span class="subclass"> EquivalentTo </span>Alcohol-Related Carcinoma<br><span class="keyword"> and </span>Laryngeal Carcinoma.<br></td>
            </tr>
            <tr class="addition">
               <td>8</td>
               <td>Apocrine Breast Carcinoma<span class="subclass"> SubClassOf </span>Breast Adenocarcinoma. 
               </td>
               <td>Apocrine Breast Carcinoma<span class="subclass"> EquivalentTo </span>Apocrine Gland Carcinoma<br><span class="keyword"> and </span>Breast Adenocarcinoma.<br></td>
            </tr>
            <tr class="addition">
               <td>7</td>
               <td>Apocrine Breast Carcinoma In Situ<span class="subclass"> SubClassOf </span>Apocrine Breast Carcinoma. 
               </td>
               <td>Apocrine Breast Carcinoma In Situ<span class="subclass"> EquivalentTo </span>Apocrine Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Invasive Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>In Situ Lesion).<br></td>
            </tr>
            <tr class="addition">
               <td>9</td>
               <td>Asbestos-Related Lung Carcinoma<span class="subclass"> SubClassOf </span>Asbestos-Related Malignant Neoplasm. 
               </td>
               <td>Asbestos-Related Lung Carcinoma<span class="subclass"> EquivalentTo </span>Asbestos-Related Malignant Neoplasm<br><span class="keyword"> and </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis).<br></td>
            </tr>
            <tr class="addition">
               <td>10</td>
               <td>Basal-Like Subtype of Invasive Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>c-erbB2 Messenger RNA Overexpression. 
               </td>
               <td>Basal-Like Subtype of Invasive Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Breast Carcinoma by Gene Expression Profile<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>c-erbB2 Messenger RNA Overexpression).<br></td>
            </tr>
            <tr class="addition">
               <td>11</td>
               <td>Basaloid Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Finding<span class="some"> some </span>Comedo Necrosis. 
               </td>
               <td>Basaloid Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Basaloid Carcinoma<br><span class="keyword"> and </span>Large Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Comedo Necrosis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis).<br></td>
            </tr>
            <tr class="addition">
               <td>12</td>
               <td>Benign Lung Hilum Neoplasm<span class="subclass"> SubClassOf </span>Benign Lung Neoplasm. 
               </td>
               <td>Benign Lung Hilum Neoplasm<span class="subclass"> EquivalentTo </span>Benign Lung Neoplasm<br><span class="keyword"> and </span>Lung Hilum Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Hilar Area of the Lung).<br></td>
            </tr>
            <tr class="addition">
               <td>13</td>
               <td>Benign Tracheal Neoplasm<span class="subclass"> SubClassOf </span>Benign Respiratory Tract Neoplasm. 
               </td>
               <td>Benign Tracheal Neoplasm<span class="subclass"> EquivalentTo </span>Benign Respiratory Tract Neoplasm<br><span class="keyword"> and </span>Tracheal Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Trachea).<br></td>
            </tr>
            <tr class="addition">
               <td>14</td>
               <td>Bilateral Breast Carcinoma<span class="subclass"> SubClassOf </span>Bilateral Carcinoma. 
               </td>
               <td>Bilateral Breast Carcinoma<span class="subclass"> EquivalentTo </span>Bilateral Carcinoma<br><span class="keyword"> and </span>Breast Carcinoma.<br></td>
            </tr>
            <tr class="addition">
               <td>15</td>
               <td>Bilateral Carcinoma<span class="subclass"> SubClassOf </span>Carcinoma. 
               </td>
               <td>Bilateral Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Bilateral Mass).<br></td>
            </tr>
            <tr class="addition">
               <td>16</td>
               <td>Biphasic Pulmonary Blastoma<span class="subclass"> SubClassOf </span>Pulmonary Blastoma. 
               </td>
               <td>Biphasic Pulmonary Blastoma<span class="subclass"> EquivalentTo </span>Pulmonary Blastoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Biphasic Pattern)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Epithelial Component Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mesenchymal Component Present).<br></td>
            </tr>
            <tr class="addition">
               <td>17</td>
               <td>Breast Adenocarcinoma<span class="subclass"> SubClassOf </span>Breast Carcinoma. 
               </td>
               <td>Breast Adenocarcinoma<span class="subclass"> EquivalentTo </span>Adenocarcinoma<br><span class="keyword"> and </span>Breast Carcinoma.<br></td>
            </tr>
            <tr class="addition">
               <td>18</td>
               <td>Breast Adenocarcinoma with Squamous Metaplasia<span class="subclass"> SubClassOf </span>Adenocarcinoma with Squamous Metaplasia. 
               </td>
               <td>Breast Adenocarcinoma with Squamous Metaplasia<span class="subclass"> EquivalentTo </span>Adenocarcinoma with Squamous Metaplasia<br><span class="keyword"> and </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Metaplastic Breast Carcinoma.<br></td>
            </tr>
            <tr class="addition">
               <td>19</td>
               <td>Breast Carcinoma<span class="subclass"> SubClassOf </span>Common Carcinoma. 
               </td>
               <td>Breast Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>Common Carcinoma<br><span class="keyword"> and </span>Malignant Breast Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Mammary Epithelium)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Breast).<br></td>
            </tr>
            <tr class="addition">
               <td>20</td>
               <td>Breast Carcinoma with Chondroid Metaplasia<span class="subclass"> SubClassOf </span>Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma. 
               </td>
               <td>Breast Carcinoma with Chondroid Metaplasia<span class="subclass"> EquivalentTo </span>Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Cartilagenous Metaplasia).<br></td>
            </tr>
            <tr class="addition">
               <td>21</td>
               <td>Breast Carcinoma with Choriocarcinomatous Features<span class="subclass"> SubClassOf </span>Invasive Ductal Carcinoma, Not Otherwise Specified. 
               </td>
               <td>Breast Carcinoma with Choriocarcinomatous Features<span class="subclass"> EquivalentTo </span>Invasive Ductal Carcinoma, Not Otherwise Specified<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Human Chorionic Gonadotropin Positive Neoplastic Cells Present).<br></td>
            </tr>
            <tr class="addition">
               <td>22</td>
               <td>Breast Carcinoma with Osseous Metaplasia<span class="subclass"> SubClassOf </span>Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma. 
               </td>
               <td>Breast Carcinoma with Osseous Metaplasia<span class="subclass"> EquivalentTo </span>Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Osseous Metaplasia).<br></td>
            </tr>
            <tr class="addition">
               <td>23</td>
               <td>Breast Carcinoma with Osteoclastic Giant Cells<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma. 
               </td>
               <td>Breast Carcinoma with Osteoclastic Giant Cells<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Large Osteoclastic Giant Cell).<br></td>
            </tr>
            <tr class="addition">
               <td>24</td>
               <td>Breast Large Cell Neuroendocrine Carcinoma<span class="subclass"> SubClassOf </span>Large Cell Neuroendocrine Carcinoma. 
               </td>
               <td>Breast Large Cell Neuroendocrine Carcinoma<span class="subclass"> EquivalentTo </span>Breast Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Large Cell Neuroendocrine Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>High Mitotic Activity)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Necrotic Change).<br></td>
            </tr>
            <tr class="addition">
               <td>25</td>
               <td>Breast Melanoma<span class="subclass"> SubClassOf </span>Malignant Breast Neoplasm. 
               </td>
               <td>Breast Melanoma<span class="subclass"> EquivalentTo </span>Malignant Breast Neoplasm<br><span class="keyword"> and </span>Melanoma<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Mammary Gland Tissue)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Breast).<br></td>
            </tr>
            <tr class="addition">
               <td>26</td>
               <td>Breast Small Cell Carcinoma<span class="subclass"> SubClassOf </span>Breast Neuroendocrine Neoplasm. 
               </td>
               <td>Breast Small Cell Carcinoma<span class="subclass"> EquivalentTo </span>Breast Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Small Cell Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Neuroendocrine Small Cell).<br></td>
            </tr>
            <tr class="addition">
               <td>27</td>
               <td>Bronchogenic Carcinoma<span class="subclass"> SubClassOf </span>Lung Carcinoma. 
               </td>
               <td>Bronchogenic Carcinoma<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Bronchial Epithelial Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Bronchial Epithelium)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchus).<br></td>
            </tr>
            <tr class="addition">
               <td>28</td>
               <td>Carcinoid Tumor of the Breast<span class="subclass"> SubClassOf </span>Breast Neuroendocrine Neoplasm. 
               </td>
               <td>Carcinoid Tumor of the Breast<span class="subclass"> EquivalentTo </span>Breast Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Carcinoid Tumor<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Breast).<br></td>
            </tr>
            <tr class="addition">
               <td>30</td>
               <td>Combined Large Cell Lung Neuroendocrine Carcinoma<span class="subclass"> SubClassOf </span>Large Cell Lung Neuroendocrine Carcinoma. 
               </td>
               <td>Combined Large Cell Lung Neuroendocrine Carcinoma<span class="subclass"> EquivalentTo </span>Combined Lung Carcinoma<br><span class="keyword"> and </span>Large Cell Lung Neuroendocrine Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Adenocarcinoma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Epithelial Giant Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Epithelial Spindle Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Squamous Cell).<br></td>
            </tr>
            <tr class="addition">
               <td>31</td>
               <td>Combined Lung Carcinoma<span class="subclass"> SubClassOf </span>High Grade Lung Neuroendocrine Neoplasm. 
               </td>
               <td>Combined Lung Carcinoma<span class="subclass"> EquivalentTo </span>Complex Epithelial Neoplasm<br><span class="keyword"> and </span>High Grade Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Lung Carcinoma<br><span class="keyword"> and </span>Neuroendocrine Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mixed Cellular Population).<br></td>
            </tr>
            <tr class="addition">
               <td>3</td>
               <td>Combined Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Combined Small Cell Lung Carcinoma. 
               </td>
               <td>Combined Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Combined Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Adenocarcinoma Cell).<br></td>
            </tr>
            <tr class="addition">
               <td>105</td>
               <td>Combined Small Cell<br><span class="keyword"> and </span>Squamous Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Combined Small Cell Lung Carcinoma. 
               </td>
               <td>Combined Small Cell<br><span class="keyword"> and </span>Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Combined Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Squamous Cell).<br></td>
            </tr>
            <tr class="addition">
               <td>32</td>
               <td>Comedocarcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Comedo Necrosis. 
               </td>
               <td>Comedocarcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Comedo Necrosis).<br></td>
            </tr>
            <tr class="addition">
               <td>33</td>
               <td>Cribriform Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Cribriform Pattern. 
               </td>
               <td>Cribriform Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Cribriform Pattern).<br></td>
            </tr>
            <tr class="addition">
               <td>34</td>
               <td>Ductal Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q. 
               </td>
               <td>Ductal Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome Xq)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 22q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Calcification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CCND1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>c-erbB2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ERBB2 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>CDH1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Loss of E-cadherin Expression)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Ductal Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit).<br></td>
            </tr>
            <tr class="addition">
               <td>36</td>
               <td>Ductal Breast Carcinoma In Situ<br><span class="keyword"> and </span>Invasive Lobular Carcinoma<span class="subclass"> SubClassOf </span>Intraductal<br><span class="keyword"> and </span>Lobular Carcinoma. 
               </td>
               <td>Ductal Breast Carcinoma In Situ<br><span class="keyword"> and </span>Invasive Lobular Carcinoma<span class="subclass"> EquivalentTo </span>Intraductal<br><span class="keyword"> and </span>Lobular Carcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Ductal Breast Carcinoma in Situ)<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Invasive Lobular Breast Carcinoma).<br></td>
            </tr>
            <tr class="addition">
               <td>35</td>
               <td>Ductal Breast Carcinoma with Squamous Metaplasia<span class="subclass"> SubClassOf </span>Breast Adenocarcinoma with Squamous Metaplasia. 
               </td>
               <td>Ductal Breast Carcinoma with Squamous Metaplasia<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma with Squamous Metaplasia<br><span class="keyword"> and </span>Invasive Ductal Carcinoma, Not Otherwise Specified.<br></td>
            </tr>
            <tr class="addition">
               <td>37</td>
               <td>ERBB2 Overexpressing Subtype of Invasive Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome. 
               </td>
               <td>ERBB2 Overexpressing Subtype of Invasive Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Breast Carcinoma by Gene Expression Profile<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>c-erbB2 Messenger RNA Overexpression).<br></td>
            </tr>
            <tr class="addition">
               <td>38</td>
               <td>Epithelial Predominant Pulmonary Blastoma<span class="subclass"> SubClassOf </span>Pulmonary Blastoma. 
               </td>
               <td>Epithelial Predominant Pulmonary Blastoma<span class="subclass"> EquivalentTo </span>Pulmonary Blastoma<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Biphasic Pattern)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Epithelial Component Present).<br></td>
            </tr>
            <tr class="addition">
               <td>39</td>
               <td>FANCM wt Allele<span class="subclass"> SubClassOf </span>Gene_In_Chromosomal_Location<span class="some"> some </span>14q21.3. 
               </td>
               <td>FANCM wt Allele<span class="subclass"> EquivalentTo </span>FANCM Gene<br><span class="keyword"> and </span>(Gene_In_Chromosomal_Location<span class="some"> some </span>14q21.3).<br></td>
            </tr>
            <tr class="addition">
               <td>40</td>
               <td>Glycogen-Rich, Clear Cell Breast Carcinoma<span class="subclass"> SubClassOf </span>Breast Adenocarcinoma. 
               </td>
               <td>Glycogen-Rich, Clear Cell Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Clear Cell Adenocarcinoma<br><span class="keyword"> and </span>Glycogen-Rich Carcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Aggressive Clinical Course).<br></td>
            </tr>
            <tr class="addition">
               <td>41</td>
               <td>Grade 1 Invasive Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Grade<span class="some"> only </span>Grade 1. 
               </td>
               <td>Grade 1 Invasive Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Breast Carcinoma by Histologic Grade<br><span class="keyword"> and </span>(Disease_Is_Grade<span class="some"> only </span>Grade 1).<br></td>
            </tr>
            <tr class="addition">
               <td>42</td>
               <td>Grade 2 Invasive Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Grade<span class="some"> only </span>Grade 2. 
               </td>
               <td>Grade 2 Invasive Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Breast Carcinoma by Histologic Grade<br><span class="keyword"> and </span>(Disease_Is_Grade<span class="some"> only </span>Grade 2).<br></td>
            </tr>
            <tr class="addition">
               <td>43</td>
               <td>Grade 3 Invasive Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma by Histologic Grade. 
               </td>
               <td>Grade 3 Invasive Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Breast Carcinoma by Histologic Grade<br><span class="keyword"> and </span>(Disease_Is_Grade<span class="some"> only </span>Grade 3).<br></td>
            </tr>
            <tr class="addition">
               <td>44</td>
               <td>Hereditary Breast Carcinoma<span class="subclass"> SubClassOf </span>Hereditary Malignant Neoplasm. 
               </td>
               <td>Hereditary Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>Hereditary Malignant Neoplasm.<br></td>
            </tr>
            <tr class="addition">
               <td>45</td>
               <td>Hereditary Fallopian Tube Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRCA2 Gene Inactivation. 
               </td>
               <td>Hereditary Fallopian Tube Carcinoma<span class="subclass"> EquivalentTo </span>Fallopian Tube Carcinoma<br><span class="keyword"> and </span>Hereditary Malignant Neoplasm<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRCA1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRCA2 Gene Inactivation).<br></td>
            </tr>
            <tr class="addition">
               <td>46</td>
               <td>Hereditary Female Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRCA2 Gene Inactivation. 
               </td>
               <td>Hereditary Female Breast Carcinoma<span class="subclass"> EquivalentTo </span>Female Breast Carcinoma<br><span class="keyword"> and </span>Hereditary Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Basal-Like Subtype of Invasive Breast Carcinoma)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRCA1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRCA2 Gene Inactivation).<br></td>
            </tr>
            <tr class="addition">
               <td>47</td>
               <td>Hereditary Male Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Molecular_Abnormality<span class="some"> only </span>BRCA2 Gene Inactivation. 
               </td>
               <td>Hereditary Male Breast Carcinoma<span class="subclass"> EquivalentTo </span>Hereditary Breast Carcinoma<br><span class="keyword"> and </span>Male Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>BRCA2 Gene Inactivation).<br></td>
            </tr>
            <tr class="addition">
               <td>48</td>
               <td>High Grade Lung Neuroendocrine Neoplasm<span class="subclass"> SubClassOf </span>Lung Neuroendocrine Neoplasm. 
               </td>
               <td>High Grade Lung Neuroendocrine Neoplasm<span class="subclass"> EquivalentTo </span>Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>High Grade Lesion).<br></td>
            </tr>
            <tr class="addition">
               <td>50</td>
               <td>Inflammatory Breast Carcinoma<span class="subclass"> SubClassOf </span>Breast Adenocarcinoma. 
               </td>
               <td>Inflammatory Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Aggressive Clinical Course)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphoplasmacytic Infiltrate)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Edema)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Erythema)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphatic Spread)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Peau d'orange).<br></td>
            </tr>
            <tr class="addition">
               <td>51</td>
               <td>Intermediate Grade Lung Neuroendocrine Neoplasm<span class="subclass"> SubClassOf </span>Lung Neuroendocrine Neoplasm. 
               </td>
               <td>Intermediate Grade Lung Neuroendocrine Neoplasm<span class="subclass"> EquivalentTo </span>Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Intermediate Grade Lesion).<br></td>
            </tr>
            <tr class="addition">
               <td>52</td>
               <td>Intracystic Papillary Breast Carcinoma<span class="subclass"> SubClassOf </span>Intraductal Papillary Breast Carcinoma. 
               </td>
               <td>Intracystic Papillary Breast Carcinoma<span class="subclass"> EquivalentTo </span>Intraductal Papillary Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Cystic Change).<br></td>
            </tr>
            <tr class="addition">
               <td>53</td>
               <td>Intraductal Micropapillary Breast Carcinoma<span class="subclass"> SubClassOf </span>Intraductal Papillary Breast Carcinoma. 
               </td>
               <td>Intraductal Micropapillary Breast Carcinoma<span class="subclass"> EquivalentTo </span>Intraductal Papillary Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Micropapillary Pattern).<br></td>
            </tr>
            <tr class="addition">
               <td>54</td>
               <td>Intraductal Papillary Breast Carcinoma<span class="subclass"> SubClassOf </span>Papillary Breast Carcinoma. 
               </td>
               <td>Intraductal Papillary Breast Carcinoma<span class="subclass"> EquivalentTo </span>Intraductal Papillary Breast Neoplasm<br><span class="keyword"> and </span>Papillary Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome).<br></td>
            </tr>
            <tr class="addition">
               <td>55</td>
               <td>Intraductal<br><span class="keyword"> and </span>Lobular Carcinoma<span class="subclass"> SubClassOf </span>Mixed Lobular<br><span class="keyword"> and </span>Ductal Breast Carcinoma. 
               </td>
               <td>Intraductal<br><span class="keyword"> and </span>Lobular Carcinoma<span class="subclass"> EquivalentTo </span>Mixed Lobular<br><span class="keyword"> and </span>Ductal Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Ductal Breast Carcinoma in Situ).<br></td>
            </tr>
            <tr class="addition">
               <td>56</td>
               <td>Invasive Apocrine Breast Carcinoma<span class="subclass"> SubClassOf </span>Apocrine Breast Carcinoma. 
               </td>
               <td>Invasive Apocrine Breast Carcinoma<span class="subclass"> EquivalentTo </span>Apocrine Breast Carcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma.<br></td>
            </tr>
            <tr class="addition">
               <td>57</td>
               <td>Invasive Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Finding<span class="some"> some </span>Pain. 
               </td>
               <td>Invasive Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>Invasive Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Breast Lump)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pain).<br></td>
            </tr>
            <tr class="addition">
               <td>58</td>
               <td>Invasive Cribriform Breast Carcinoma<span class="subclass"> SubClassOf </span>Breast Adenocarcinoma. 
               </td>
               <td>Invasive Cribriform Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Cribriform Carcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma.<br></td>
            </tr>
            <tr class="addition">
               <td>59</td>
               <td>Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14). 
               </td>
               <td>Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> EquivalentTo </span>Ductal Breast Carcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>der(1;16)(q10;p10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(1)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(8)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cord-Like Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Solid Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Syncytial Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin E Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 12p).<br></td>
            </tr>
            <tr class="addition">
               <td>60</td>
               <td>Invasive Ductal<br><span class="keyword"> and </span>Invasive Lobular Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Ductal<br><span class="keyword"> and </span>Lobular Carcinoma. 
               </td>
               <td>Invasive Ductal<br><span class="keyword"> and </span>Invasive Lobular Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Ductal<br><span class="keyword"> and </span>Lobular Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Invasive Lobular Breast Carcinoma).<br></td>
            </tr>
            <tr class="addition">
               <td>61</td>
               <td>Invasive Ductal<br><span class="keyword"> and </span>Lobular Carcinoma<span class="subclass"> SubClassOf </span>Invasive Mixed Breast Carcinoma. 
               </td>
               <td>Invasive Ductal<br><span class="keyword"> and </span>Lobular Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Mixed Breast Carcinoma<br><span class="keyword"> and </span>Mixed Lobular<br><span class="keyword"> and </span>Ductal Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Invasive Ductal Carcinoma, Not Otherwise Specified).<br></td>
            </tr>
            <tr class="addition">
               <td>49</td>
               <td>Invasive Ductal<br><span class="keyword"> and </span>Lobular Carcinoma In Situ<span class="subclass"> SubClassOf </span>Invasive Ductal<br><span class="keyword"> and </span>Lobular Carcinoma. 
               </td>
               <td>Invasive Ductal<br><span class="keyword"> and </span>Lobular Carcinoma In Situ<span class="subclass"> EquivalentTo </span>Invasive Ductal<br><span class="keyword"> and </span>Lobular Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Lobular Breast Carcinoma In Situ).<br></td>
            </tr>
            <tr class="addition">
               <td>62</td>
               <td>Invasive Lobular Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma. 
               </td>
               <td>Invasive Lobular Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Lobular Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Single-File Linear Pattern).<br></td>
            </tr>
            <tr class="addition">
               <td>63</td>
               <td>Invasive Micropapillary Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Papillary Breast Carcinoma. 
               </td>
               <td>Invasive Micropapillary Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Papillary Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Micropapillary Pattern).<br></td>
            </tr>
            <tr class="addition">
               <td>64</td>
               <td>Invasive Mixed Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma. 
               </td>
               <td>Invasive Mixed Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mixed Cellular Population).<br></td>
            </tr>
            <tr class="addition">
               <td>65</td>
               <td>Invasive Papillary Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma. 
               </td>
               <td>Invasive Papillary Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Papillary Breast Carcinoma.<br></td>
            </tr>
            <tr class="addition">
               <td>66</td>
               <td>Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Large Cell Carcinoma. 
               </td>
               <td>Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Large Cell Carcinoma<br><span class="keyword"> and </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS Gene Mutation).<br></td>
            </tr>
            <tr class="addition">
               <td>67</td>
               <td>Large Cell Lung Carcinoma with Rhabdoid Phenotype<span class="subclass"> SubClassOf </span>Large Cell Lung Carcinoma. 
               </td>
               <td>Large Cell Lung Carcinoma with Rhabdoid Phenotype<span class="subclass"> EquivalentTo </span>Large Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Rhabdoid Cell).<br></td>
            </tr>
            <tr class="addition">
               <td>29</td>
               <td>Large Cell Lung Carcinoma, Clear Cell Variant<span class="subclass"> SubClassOf </span>Large Cell Lung Carcinoma. 
               </td>
               <td>Large Cell Lung Carcinoma, Clear Cell Variant<span class="subclass"> EquivalentTo </span>Large Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Clear Cell).<br></td>
            </tr>
            <tr class="addition">
               <td>68</td>
               <td>Lipid-Rich Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma. 
               </td>
               <td>Lipid-Rich Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Clear Cell Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Lipid-Rich Carcinoma.<br></td>
            </tr>
            <tr class="addition">
               <td>69</td>
               <td>Lobular Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CDH1 Gene Inactivation. 
               </td>
               <td>Lobular Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CDH1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Loss of E-cadherin Expression)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Mixed Cellular Population)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Lobular Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit).<br></td>
            </tr>
            <tr class="addition">
               <td>70</td>
               <td>Localized Carcinoma<span class="subclass"> SubClassOf </span>Carcinoma. 
               </td>
               <td>Localized Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Localized Disease).<br></td>
            </tr>
            <tr class="addition">
               <td>71</td>
               <td>Localized Extrahepatic Bile Duct Carcinoma<span class="subclass"> SubClassOf </span>Extrahepatic Bile Duct Carcinoma. 
               </td>
               <td>Localized Extrahepatic Bile Duct Carcinoma<span class="subclass"> EquivalentTo </span>Extrahepatic Bile Duct Carcinoma<br><span class="keyword"> and </span>Localized Carcinoma.<br></td>
            </tr>
            <tr class="addition">
               <td>72</td>
               <td>Localized Gallbladder Carcinoma<span class="subclass"> SubClassOf </span>Localized Carcinoma. 
               </td>
               <td>Localized Gallbladder Carcinoma<span class="subclass"> EquivalentTo </span>Gallbladder Carcinoma<br><span class="keyword"> and </span>Localized Carcinoma.<br></td>
            </tr>
            <tr class="addition">
               <td>73</td>
               <td>Low Grade Lung Neuroendocrine Neoplasm<span class="subclass"> SubClassOf </span>Lung Neuroendocrine Neoplasm. 
               </td>
               <td>Low Grade Lung Neuroendocrine Neoplasm<span class="subclass"> EquivalentTo </span>Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Low Grade Lesion).<br></td>
            </tr>
            <tr class="addition">
               <td>74</td>
               <td>Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q24-qter. 
               </td>
               <td>Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Non-Small Cell Adenocarcinoma<br><span class="keyword"> and </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q24-qter)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome Y)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>LKB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Loss of Chromosome 5q).<br></td>
            </tr>
            <tr class="addition">
               <td>75</td>
               <td>Lung Carcinoma<span class="subclass"> SubClassOf </span>Carcinoma. 
               </td>
               <td>Lung Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>Malignant Lung Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Lung).<br></td>
            </tr>
            <tr class="addition">
               <td>76</td>
               <td>Lung Carcinosarcoma<span class="subclass"> SubClassOf </span>Carcinosarcoma. 
               </td>
               <td>Lung Carcinosarcoma<span class="subclass"> EquivalentTo </span>Carcinosarcoma<br><span class="keyword"> and </span>Lung Sarcomatoid Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Spindle Cell).<br></td>
            </tr>
            <tr class="addition">
               <td>77</td>
               <td>Lung Clear Cell Adenocarcinoma<span class="subclass"> SubClassOf </span>Lung Adenocarcinoma. 
               </td>
               <td>Lung Clear Cell Adenocarcinoma<span class="subclass"> EquivalentTo </span>Clear Cell Adenocarcinoma<br><span class="keyword"> and </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis).<br></td>
            </tr>
            <tr class="addition">
               <td>78</td>
               <td>Lung Epithelial-Myoepithelial Carcinoma<span class="subclass"> SubClassOf </span>Epithelial-Myoepithelial Carcinoma. 
               </td>
               <td>Lung Epithelial-Myoepithelial Carcinoma<span class="subclass"> EquivalentTo </span>Epithelial-Myoepithelial Carcinoma<br><span class="keyword"> and </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchus).<br></td>
            </tr>
            <tr class="addition">
               <td>79</td>
               <td>Lung Hilum Carcinoma<span class="subclass"> SubClassOf </span>Lung Carcinoma. 
               </td>
               <td>Lung Hilum Carcinoma<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>Malignant Lung Hilum Neoplasm.<br></td>
            </tr>
            <tr class="addition">
               <td>80</td>
               <td>Lung Hilum Neoplasm<span class="subclass"> SubClassOf </span>Lung Neoplasm. 
               </td>
               <td>Lung Hilum Neoplasm<span class="subclass"> EquivalentTo </span>Lung Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Associated_Anatomic_Site<span class="some"> only </span>Hilar Area of the Lung).<br></td>
            </tr>
            <tr class="addition">
               <td>81</td>
               <td>Lung Melanoma<span class="subclass"> SubClassOf </span>Malignant Lung Neoplasm. 
               </td>
               <td>Lung Melanoma<span class="subclass"> EquivalentTo </span>Malignant Lung Neoplasm<br><span class="keyword"> and </span>Melanoma<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Lung Tissue)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Lung).<br></td>
            </tr>
            <tr class="addition">
               <td>82</td>
               <td>Lung Mucinous Adenocarcinoma<span class="subclass"> SubClassOf </span>Mucinous Adenocarcinoma. 
               </td>
               <td>Lung Mucinous Adenocarcinoma<span class="subclass"> EquivalentTo </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>Mucinous Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Well Differentiated Lesion).<br></td>
            </tr>
            <tr class="addition">
               <td>83</td>
               <td>Lung Neuroendocrine Neoplasm<span class="subclass"> SubClassOf </span>Neuroendocrine Neoplasm. 
               </td>
               <td>Lung Neuroendocrine Neoplasm<span class="subclass"> EquivalentTo </span>Malignant Lung Neoplasm<br><span class="keyword"> and </span>Neuroendocrine Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Neuroendocrine Cell)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Lung).<br></td>
            </tr>
            <tr class="addition">
               <td>84</td>
               <td>Lung Pleomorphic Carcinoma<span class="subclass"> SubClassOf </span>Lung Sarcomatoid Carcinoma. 
               </td>
               <td>Lung Pleomorphic Carcinoma<span class="subclass"> EquivalentTo </span>Lung Sarcomatoid Carcinoma<br><span class="keyword"> and </span>Pleomorphic Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Adenocarcinoma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Epithelial Giant Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Squamous Cell)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Spindle Cell).<br></td>
            </tr>
            <tr class="addition">
               <td>85</td>
               <td>Lung Sarcomatoid Carcinoma<span class="subclass"> SubClassOf </span>Non-Small Cell Lung Carcinoma. 
               </td>
               <td>Lung Sarcomatoid Carcinoma<span class="subclass"> EquivalentTo </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Sarcomatoid Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis).<br></td>
            </tr>
            <tr class="addition">
               <td>86</td>
               <td>Lung Signet Ring Cell Carcinoma<span class="subclass"> SubClassOf </span>Signet Ring Cell Carcinoma. 
               </td>
               <td>Lung Signet Ring Cell Carcinoma<span class="subclass"> EquivalentTo </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>Signet Ring Cell Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis).<br></td>
            </tr>
            <tr class="addition">
               <td>87</td>
               <td>Lung Spindle Cell Carcinoma<span class="subclass"> SubClassOf </span>Lung Sarcomatoid Carcinoma. 
               </td>
               <td>Lung Spindle Cell Carcinoma<span class="subclass"> EquivalentTo </span>Lung Sarcomatoid Carcinoma<br><span class="keyword"> and </span>(Disease_Excludes_Abnormal_Cell<span class="some"> only </span>Adenocarcinoma Cell)<br><span class="keyword"> and </span>(Disease_Excludes_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Giant Cell)<br><span class="keyword"> and </span>(Disease_Excludes_Abnormal_Cell<span class="some"> only </span>Malignant Squamous Cell)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Spindle Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphoplasmacytic Infiltrate).<br></td>
            </tr>
            <tr class="addition">
               <td>88</td>
               <td>Malignant Breast Adenomyoepithelioma<span class="subclass"> SubClassOf </span>Malignant Breast Neoplasm. 
               </td>
               <td>Malignant Breast Adenomyoepithelioma<span class="subclass"> EquivalentTo </span>Breast Adenomyoepithelioma<br><span class="keyword"> and </span>Malignant Breast Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Myoepithelial Cell)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Breast).<br></td>
            </tr>
            <tr class="addition">
               <td>89</td>
               <td>Malignant Breast Eccrine Spiradenoma<span class="subclass"> SubClassOf </span>Malignant Breast Neoplasm. 
               </td>
               <td>Malignant Breast Eccrine Spiradenoma<span class="subclass"> EquivalentTo </span>Malignant Breast Neoplasm<br><span class="keyword"> and </span>Malignant Eccrine Spiradenoma<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Breast).<br></td>
            </tr>
            <tr class="addition">
               <td>90</td>
               <td>Malignant Breast Myoepithelioma<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma. 
               </td>
               <td>Malignant Breast Myoepithelioma<span class="subclass"> EquivalentTo </span>Breast Myoepithelial Neoplasm<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Malignant Myoepithelioma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mitotic Activity).<br></td>
            </tr>
            <tr class="addition">
               <td>91</td>
               <td>Malignant Breast Neoplasm<span class="subclass"> SubClassOf </span>Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Cell. 
               </td>
               <td>Malignant Breast Neoplasm<span class="subclass"> EquivalentTo </span>Breast Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Cell).<br></td>
            </tr>
            <tr class="addition">
               <td>96</td>
               <td>Malignant Breast Phyllodes Tumor<span class="subclass"> SubClassOf </span>Malignant Breast Neoplasm. 
               </td>
               <td>Malignant Breast Phyllodes Tumor<span class="subclass"> EquivalentTo </span>Malignant Breast Neoplasm<br><span class="keyword"> and </span>Malignant Phyllodes Tumor<br><span class="keyword"> and </span>Breast Phyllodes Tumor<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cartilagenous Metaplasia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lipomatous Metaplasia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Osseous Metaplasia).<br></td>
            </tr>
            <tr class="addition">
               <td>92</td>
               <td>Malignant Chest Wall Neoplasm<span class="subclass"> SubClassOf </span>Chest Wall Neoplasm. 
               </td>
               <td>Malignant Chest Wall Neoplasm<span class="subclass"> EquivalentTo </span>Chest Wall Neoplasm<br><span class="keyword"> and </span>Malignant Thoracic Neoplasm.<br></td>
            </tr>
            <tr class="addition">
               <td>93</td>
               <td>Malignant Lung Hilum Neoplasm<span class="subclass"> SubClassOf </span>Lung Hilum Neoplasm. 
               </td>
               <td>Malignant Lung Hilum Neoplasm<span class="subclass"> EquivalentTo </span>Lung Hilum Neoplasm<br><span class="keyword"> and </span>Malignant Lung Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Hilar Area of the Lung).<br></td>
            </tr>
            <tr class="addition">
               <td>94</td>
               <td>Malignant Lung Neoplasm<span class="subclass"> SubClassOf </span>Malignant Respiratory Tract Neoplasm. 
               </td>
               <td>Malignant Lung Neoplasm<span class="subclass"> EquivalentTo </span>Lung Neoplasm<br><span class="keyword"> and </span>Malignant Respiratory Tract Neoplasm<br><span class="keyword"> and </span>Malignant Thoracic Neoplasm.<br></td>
            </tr>
            <tr class="addition">
               <td>95</td>
               <td>Malignant Nipple Neoplasm<span class="subclass"> SubClassOf </span>Malignant Breast Neoplasm. 
               </td>
               <td>Malignant Nipple Neoplasm<span class="subclass"> EquivalentTo </span>Malignant Breast Neoplasm<br><span class="keyword"> and </span>Nipple Neoplasm.<br></td>
            </tr>
            <tr class="addition">
               <td>97</td>
               <td>Malignant Respiratory Tract Neoplasm<span class="subclass"> SubClassOf </span>Respiratory Tract Neoplasm. 
               </td>
               <td>Malignant Respiratory Tract Neoplasm<span class="subclass"> EquivalentTo </span>Respiratory Tract Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Cell).<br></td>
            </tr>
            <tr class="addition">
               <td>98</td>
               <td>Malignant Tracheal Neoplasm<span class="subclass"> SubClassOf </span>Tracheal Neoplasm. 
               </td>
               <td>Malignant Tracheal Neoplasm<span class="subclass"> EquivalentTo </span>Malignant Respiratory Tract Neoplasm<br><span class="keyword"> and </span>Tracheal Neoplasm.<br></td>
            </tr>
            <tr class="addition">
               <td>99</td>
               <td>Metaplastic Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma. 
               </td>
               <td>Metaplastic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Metaplastic Carcinoma.<br></td>
            </tr>
            <tr class="addition">
               <td>100</td>
               <td>Metaplastic Carcinoma<span class="subclass"> SubClassOf </span>Carcinoma. 
               </td>
               <td>Metaplastic Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Metaplasia).<br></td>
            </tr>
            <tr class="addition">
               <td>101</td>
               <td>Metastatic Breast Carcinoid Tumor<span class="subclass"> SubClassOf </span>Carcinoid Tumor of the Breast. 
               </td>
               <td>Metastatic Breast Carcinoid Tumor<span class="subclass"> EquivalentTo </span>Carcinoid Tumor of the Breast<br><span class="keyword"> and </span>Metastatic Carcinoid Tumor.<br></td>
            </tr>
            <tr class="addition">
               <td>102</td>
               <td>Metastatic Signet Ring Cell Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Metastatic Lesion. 
               </td>
               <td>Metastatic Signet Ring Cell Breast Carcinoma<span class="subclass"> EquivalentTo </span>Signet Ring Cell Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Metastatic Lesion).<br></td>
            </tr>
            <tr class="addition">
               <td>103</td>
               <td>Microinvasive Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma. 
               </td>
               <td>Microinvasive Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Microinvasive Malignant Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Ductal Breast Carcinoma in Situ).<br></td>
            </tr>
            <tr class="addition">
               <td>104</td>
               <td>Mixed Lobular<br><span class="keyword"> and </span>Ductal Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Abnormal_Cell<span class="some"> only </span>Lobular Carcinoma Cell. 
               </td>
               <td>Mixed Lobular<br><span class="keyword"> and </span>Ductal Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CDH1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Loss of E-cadherin Expression)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Ductal Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Lobular Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Ductal Breast Carcinoma)<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Lobular Breast Carcinoma)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mixed Cellular Population)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit).<br></td>
            </tr>
            <tr class="addition">
               <td>106</td>
               <td>Mucinous Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma. 
               </td>
               <td>Mucinous Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Mucinous Adenocarcinoma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Round Adenocarcinoma Cell).<br></td>
            </tr>
            <tr class="addition">
               <td>107</td>
               <td>Nipple Duct Carcinoma<span class="subclass"> SubClassOf </span>Nipple Carcinoma. 
               </td>
               <td>Nipple Duct Carcinoma<span class="subclass"> EquivalentTo </span>Nipple Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Lactiferous Duct).<br></td>
            </tr>
            <tr class="addition">
               <td>108</td>
               <td>Non-Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_Excludes_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Small Cell. 
               </td>
               <td>Non-Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Common Carcinoma<br><span class="keyword"> and </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Small Cell).<br></td>
            </tr>
            <tr class="addition">
               <td>109</td>
               <td>Occult Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Large Cell Lung Carcinoma. 
               </td>
               <td>Occult Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Large Cell Lung Carcinoma<br><span class="keyword"> and </span>Occult Non-Small Cell Lung Carcinoma.<br></td>
            </tr>
            <tr class="addition">
               <td>110</td>
               <td>Occult Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Lung Adenocarcinoma. 
               </td>
               <td>Occult Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>Occult Non-Small Cell Lung Carcinoma.<br></td>
            </tr>
            <tr class="addition">
               <td>111</td>
               <td>Occult Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_Excludes_Finding<span class="some"> only </span>No Evidence of Radiologic Finding. 
               </td>
               <td>Occult Lung Carcinoma<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>No Evidence of Radiologic Finding).<br></td>
            </tr>
            <tr class="addition">
               <td>112</td>
               <td>Occult Non-Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Non-Small Cell Lung Carcinoma. 
               </td>
               <td>Occult Non-Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Occult Lung Carcinoma.<br></td>
            </tr>
            <tr class="addition">
               <td>113</td>
               <td>Occult Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Small Cell Lung Carcinoma. 
               </td>
               <td>Occult Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Occult Lung Carcinoma<br><span class="keyword"> and </span>Small Cell Lung Carcinoma.<br></td>
            </tr>
            <tr class="addition">
               <td>114</td>
               <td>Oncocytic Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma. 
               </td>
               <td>Oncocytic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Oxyphilic Adenocarcinoma.<br></td>
            </tr>
            <tr class="addition">
               <td>115</td>
               <td>Paget's Disease<br><span class="keyword"> and </span>Intraductal Carcinoma of the Breast<span class="subclass"> SubClassOf </span>Paget's Disease of the Breast without Invasive Carcinoma. 
               </td>
               <td>Paget's Disease<br><span class="keyword"> and </span>Intraductal Carcinoma of the Breast<span class="subclass"> EquivalentTo </span>Paget's Disease of the Breast without Invasive Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Ductal Breast Carcinoma in Situ).<br></td>
            </tr>
            <tr class="addition">
               <td>116</td>
               <td>Paget's Disease of the Breast<span class="subclass"> SubClassOf </span>Paget's Disease. 
               </td>
               <td>Paget's Disease of the Breast<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Paget's Disease<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Eczema)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Erythema).<br></td>
            </tr>
            <tr class="addition">
               <td>117</td>
               <td>Paget's Disease of the Breast with Invasive Ductal Carcinoma<span class="subclass"> SubClassOf </span>Paget's Disease of the Breast. 
               </td>
               <td>Paget's Disease of the Breast with Invasive Ductal Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Paget's Disease of the Breast<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Invasive Ductal Carcinoma, Not Otherwise Specified)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Invasive Lesion).<br></td>
            </tr>
            <tr class="addition">
               <td>118</td>
               <td>Paget's Disease of the Breast without Invasive Carcinoma<span class="subclass"> SubClassOf </span>Paget's Disease of the Breast. 
               </td>
               <td>Paget's Disease of the Breast without Invasive Carcinoma<span class="subclass"> EquivalentTo </span>Paget's Disease of the Breast<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Invasive Lesion).<br></td>
            </tr>
            <tr class="addition">
               <td>119</td>
               <td>Paget's Disease of the Nipple<span class="subclass"> SubClassOf </span>Paget's Disease of the Breast. 
               </td>
               <td>Paget's Disease of the Nipple<span class="subclass"> EquivalentTo </span>Nipple Carcinoma<br><span class="keyword"> and </span>Paget's Disease of the Breast.<br></td>
            </tr>
            <tr class="addition">
               <td>120</td>
               <td>Papillary Breast Carcinoma<span class="subclass"> SubClassOf </span>Papillary Adenocarcinoma. 
               </td>
               <td>Papillary Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Papillary Adenocarcinoma<br><span class="keyword"> and </span>Papillary Breast Neoplasm.<br></td>
            </tr>
            <tr class="addition">
               <td>121</td>
               <td>Papillary Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Lung Adenocarcinoma. 
               </td>
               <td>Papillary Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>Papillary Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis).<br></td>
            </tr>
            <tr class="addition">
               <td>122</td>
               <td>Pleomorphic Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Aneuploidy. 
               </td>
               <td>Pleomorphic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Grade 3 Invasive Breast Carcinoma<br><span class="keyword"> and </span>Invasive Ductal Carcinoma, Not Otherwise Specified<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Aneuploidy)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Giant Adenocarcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Pleomorphic Adenocarcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>High Mitotic Activity)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Necrotic Change).<br></td>
            </tr>
            <tr class="addition">
               <td>123</td>
               <td>Pleomorphic Carcinoma<span class="subclass"> SubClassOf </span>Sarcomatoid Carcinoma. 
               </td>
               <td>Pleomorphic Carcinoma<span class="subclass"> EquivalentTo </span>Sarcomatoid Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Spindle Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Nuclear Pleomorphism).<br></td>
            </tr>
            <tr class="addition">
               <td>124</td>
               <td>Pleuropulmonary Blastoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Associated_Disease<span class="some"> some </span>Cystic Nephroma. 
               </td>
               <td>Pleuropulmonary Blastoma<span class="subclass"> EquivalentTo </span>Blastoma<br><span class="keyword"> and </span>Malignant Lung<br><span class="keyword"> and </span>Pleural Neoplasm<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Colon Polyp)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Cystic Nephroma)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Ovarian Teratoma)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Chest Pain)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pneumothorax)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Respiratory Distress)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Thoracic Cavity).<br></td>
            </tr>
            <tr class="addition">
               <td>125</td>
               <td>Primary Breast Carcinoid Tumor<span class="subclass"> SubClassOf </span>Carcinoid Tumor of the Breast. 
               </td>
               <td>Primary Breast Carcinoid Tumor<span class="subclass"> EquivalentTo </span>Carcinoid Tumor of the Breast<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Primary Lesion).<br></td>
            </tr>
            <tr class="addition">
               <td>126</td>
               <td>Primary Carcinoma<span class="subclass"> SubClassOf </span>Carcinoma. 
               </td>
               <td>Primary Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Primary Lesion).<br></td>
            </tr>
            <tr class="addition">
               <td>127</td>
               <td>Primary Peritoneal Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>c-erbB2 Gene Amplification. 
               </td>
               <td>Primary Peritoneal Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>Malignant Peritoneal Neoplasm<br><span class="keyword"> and </span>Primary Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRCA1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>c-erbB2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Primary_Anatomic_Site<span class="some"> only </span>Ovary)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Peritoneum).<br></td>
            </tr>
            <tr class="addition">
               <td>128</td>
               <td>Primary Peritoneal Serous Adenocarcinoma<span class="subclass"> SubClassOf </span>Primary Peritoneal Carcinoma. 
               </td>
               <td>Primary Peritoneal Serous Adenocarcinoma<span class="subclass"> EquivalentTo </span>Primary Peritoneal Carcinoma<br><span class="keyword"> and </span>Serous Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Psammoma Body Formation).<br></td>
            </tr>
            <tr class="addition">
               <td>129</td>
               <td>Primary Serous Papillary Carcinoma of Peritoneum<span class="subclass"> SubClassOf </span>Serous Surface Papillary Carcinoma. 
               </td>
               <td>Primary Serous Papillary Carcinoma of Peritoneum<span class="subclass"> EquivalentTo </span>Primary Peritoneal Serous Adenocarcinoma<br><span class="keyword"> and </span>Serous Surface Papillary Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Papillary Pattern).<br></td>
            </tr>
            <tr class="addition">
               <td>130</td>
               <td>Pulmonary Sulcus Neoplasm<span class="subclass"> SubClassOf </span>Lung Neoplasm. 
               </td>
               <td>Pulmonary Sulcus Neoplasm<span class="subclass"> EquivalentTo </span>Lung Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Associated_Anatomic_Site<span class="some"> only </span>Apex of the Lung).<br></td>
            </tr>
            <tr class="addition">
               <td>131</td>
               <td>Recurrent Breast Cancer<span class="subclass"> SubClassOf </span>Recurrent Carcinoma. 
               </td>
               <td>Recurrent Breast Cancer<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>Recurrent Carcinoma.<br></td>
            </tr>
            <tr class="addition">
               <td>132</td>
               <td>Recurrent Inflammatory Breast Carcinoma<span class="subclass"> SubClassOf </span>Inflammatory Breast Carcinoma. 
               </td>
               <td>Recurrent Inflammatory Breast Carcinoma<span class="subclass"> EquivalentTo </span>Inflammatory Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Recurrent Disease).<br></td>
            </tr>
            <tr class="addition">
               <td>133</td>
               <td>Recurrent Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Recurrent Non-Small Cell Lung Cancer. 
               </td>
               <td>Recurrent Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Large Cell Lung Carcinoma<br><span class="keyword"> and </span>Recurrent Non-Small Cell Lung Cancer.<br></td>
            </tr>
            <tr class="addition">
               <td>134</td>
               <td>Recurrent Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Recurrent Non-Small Cell Lung Cancer. 
               </td>
               <td>Recurrent Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>Recurrent Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis).<br></td>
            </tr>
            <tr class="addition">
               <td>135</td>
               <td>Recurrent Lung Cancer<span class="subclass"> SubClassOf </span>Lung Carcinoma. 
               </td>
               <td>Recurrent Lung Cancer<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>Recurrent Carcinoma.<br></td>
            </tr>
            <tr class="addition">
               <td>136</td>
               <td>Recurrent Non-Small Cell Lung Cancer<span class="subclass"> SubClassOf </span>Non-Small Cell Lung Carcinoma. 
               </td>
               <td>Recurrent Non-Small Cell Lung Cancer<span class="subclass"> EquivalentTo </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Recurrent Lung Cancer.<br></td>
            </tr>
            <tr class="addition">
               <td>137</td>
               <td>Sebaceous Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma. 
               </td>
               <td>Sebaceous Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Sebaceous Carcinoma.<br></td>
            </tr>
            <tr class="addition">
               <td>138</td>
               <td>Signet Ring Cell Breast Carcinoma<span class="subclass"> SubClassOf </span>Signet Ring Cell Carcinoma. 
               </td>
               <td>Signet Ring Cell Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Signet Ring Cell Carcinoma.<br></td>
            </tr>
            <tr class="addition">
               <td>139</td>
               <td>Solid Carcinoma<span class="subclass"> SubClassOf </span>Carcinoma. 
               </td>
               <td>Solid Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Solid Growth Pattern).<br></td>
            </tr>
            <tr class="addition">
               <td>140</td>
               <td>Solid Lung Adenocarcinoma with Mucin Production<span class="subclass"> SubClassOf </span>Lung Adenocarcinoma. 
               </td>
               <td>Solid Lung Adenocarcinoma with Mucin Production<span class="subclass"> EquivalentTo </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>Mucin-Producing Adenocarcinoma<br><span class="keyword"> and </span>Solid Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis).<br></td>
            </tr>
            <tr class="addition">
               <td>141</td>
               <td>Sporadic Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q. 
               </td>
               <td>Sporadic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 16)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 22)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 6)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 18)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 7)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Non-Hereditary Lesion).<br></td>
            </tr>
            <tr class="addition">
               <td>210</td>
               <td>Stage I Breast Cancer<span class="subclass"> SubClassOf </span>Breast Carcinoma. 
               </td>
               <td>Stage I Breast Cancer<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage I).<br></td>
            </tr>
            <tr class="addition">
               <td>211</td>
               <td>Stage I Fallopian Tube Cancer<span class="subclass"> SubClassOf </span>Fallopian Tube Carcinoma. 
               </td>
               <td>Stage I Fallopian Tube Cancer<span class="subclass"> EquivalentTo </span>Fallopian Tube Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage I).<br></td>
            </tr>
            <tr class="addition">
               <td>212</td>
               <td>Stage I Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage I Non-Small Cell Lung Cancer. 
               </td>
               <td>Stage I Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Large Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage I Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis).<br></td>
            </tr>
            <tr class="addition">
               <td>213</td>
               <td>Stage I Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Stage I Non-Small Cell Lung Cancer. 
               </td>
               <td>Stage I Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>Stage I Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis).<br></td>
            </tr>
            <tr class="addition">
               <td>214</td>
               <td>Stage I Lung Cancer<span class="subclass"> SubClassOf </span>Lung Carcinoma. 
               </td>
               <td>Stage I Lung Cancer<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage I).<br></td>
            </tr>
            <tr class="addition">
               <td>215</td>
               <td>Stage I Non-Small Cell Lung Cancer<span class="subclass"> SubClassOf </span>Stage I Lung Cancer. 
               </td>
               <td>Stage I Non-Small Cell Lung Cancer<span class="subclass"> EquivalentTo </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage I Lung Cancer.<br></td>
            </tr>
            <tr class="addition">
               <td>216</td>
               <td>Stage I Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage I Lung Cancer. 
               </td>
               <td>Stage I Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Limited Stage Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage I Lung Cancer.<br></td>
            </tr>
            <tr class="addition">
               <td>142</td>
               <td>Stage IA Fallopian Tube Cancer<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IA. 
               </td>
               <td>Stage IA Fallopian Tube Cancer<span class="subclass"> EquivalentTo </span>Stage I Fallopian Tube Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IA).<br></td>
            </tr>
            <tr class="addition">
               <td>143</td>
               <td>Stage IA Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage IA Non-Small Cell Lung Carcinoma. 
               </td>
               <td>Stage IA Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IA Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage I Large Cell Lung Carcinoma.<br></td>
            </tr>
            <tr class="addition">
               <td>144</td>
               <td>Stage IA Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Stage I Lung Adenocarcinoma. 
               </td>
               <td>Stage IA Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Stage IA Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage I Lung Adenocarcinoma.<br></td>
            </tr>
            <tr class="addition">
               <td>145</td>
               <td>Stage IA Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage I Lung Cancer. 
               </td>
               <td>Stage IA Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage I Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IA).<br></td>
            </tr>
            <tr class="addition">
               <td>146</td>
               <td>Stage IA Non-Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage IA Lung Carcinoma. 
               </td>
               <td>Stage IA Non-Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IA Lung Carcinoma<br><span class="keyword"> and </span>Stage I Non-Small Cell Lung Cancer.<br></td>
            </tr>
            <tr class="addition">
               <td>147</td>
               <td>Stage IA Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage I Small Cell Lung Carcinoma. 
               </td>
               <td>Stage IA Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IA Lung Carcinoma<br><span class="keyword"> and </span>Stage I Small Cell Lung Carcinoma.<br></td>
            </tr>
            <tr class="addition">
               <td>148</td>
               <td>Stage IB Fallopian Tube Cancer<span class="subclass"> SubClassOf </span>Stage I Fallopian Tube Cancer. 
               </td>
               <td>Stage IB Fallopian Tube Cancer<span class="subclass"> EquivalentTo </span>Stage I Fallopian Tube Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IB).<br></td>
            </tr>
            <tr class="addition">
               <td>149</td>
               <td>Stage IB Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage IB Non-Small Cell Lung Carcinoma. 
               </td>
               <td>Stage IB Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IB Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage I Large Cell Lung Carcinoma.<br></td>
            </tr>
            <tr class="addition">
               <td>150</td>
               <td>Stage IB Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Stage I Lung Adenocarcinoma. 
               </td>
               <td>Stage IB Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Stage IB Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage I Lung Adenocarcinoma.<br></td>
            </tr>
            <tr class="addition">
               <td>151</td>
               <td>Stage IB Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IB. 
               </td>
               <td>Stage IB Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage I Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IB).<br></td>
            </tr>
            <tr class="addition">
               <td>152</td>
               <td>Stage IB Non-Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage I Non-Small Cell Lung Cancer. 
               </td>
               <td>Stage IB Non-Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IB Lung Carcinoma<br><span class="keyword"> and </span>Stage I Non-Small Cell Lung Cancer.<br></td>
            </tr>
            <tr class="addition">
               <td>153</td>
               <td>Stage IB Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage IB Lung Carcinoma. 
               </td>
               <td>Stage IB Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IB Lung Carcinoma<br><span class="keyword"> and </span>Stage I Small Cell Lung Carcinoma.<br></td>
            </tr>
            <tr class="addition">
               <td>154</td>
               <td>Stage IC Fallopian Tube Cancer<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IC. 
               </td>
               <td>Stage IC Fallopian Tube Cancer<span class="subclass"> EquivalentTo </span>Stage I Fallopian Tube Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IC).<br></td>
            </tr>
            <tr class="addition">
               <td>195</td>
               <td>Stage II Breast Cancer<span class="subclass"> SubClassOf </span>Breast Carcinoma. 
               </td>
               <td>Stage II Breast Cancer<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage II).<br></td>
            </tr>
            <tr class="addition">
               <td>196</td>
               <td>Stage II Fallopian Tube Cancer<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage II. 
               </td>
               <td>Stage II Fallopian Tube Cancer<span class="subclass"> EquivalentTo </span>Fallopian Tube Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage II).<br></td>
            </tr>
            <tr class="addition">
               <td>197</td>
               <td>Stage II Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Large Cell Lung Carcinoma. 
               </td>
               <td>Stage II Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Large Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage II Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis).<br></td>
            </tr>
            <tr class="addition">
               <td>198</td>
               <td>Stage II Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Lung Adenocarcinoma. 
               </td>
               <td>Stage II Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>Stage II Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis).<br></td>
            </tr>
            <tr class="addition">
               <td>199</td>
               <td>Stage II Lung Cancer<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage II. 
               </td>
               <td>Stage II Lung Cancer<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage II).<br></td>
            </tr>
            <tr class="addition">
               <td>200</td>
               <td>Stage II Non-Small Cell Lung Cancer<span class="subclass"> SubClassOf </span>Stage II Lung Cancer. 
               </td>
               <td>Stage II Non-Small Cell Lung Cancer<span class="subclass"> EquivalentTo </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage II Lung Cancer.<br></td>
            </tr>
            <tr class="addition">
               <td>201</td>
               <td>Stage II Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage II Lung Cancer. 
               </td>
               <td>Stage II Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Limited Stage Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage II Lung Cancer.<br></td>
            </tr>
            <tr class="addition">
               <td>155</td>
               <td>Stage IIA Breast Cancer<span class="subclass"> SubClassOf </span>Stage II Breast Cancer. 
               </td>
               <td>Stage IIA Breast Cancer<span class="subclass"> EquivalentTo </span>Stage II Breast Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIA).<br></td>
            </tr>
            <tr class="addition">
               <td>156</td>
               <td>Stage IIA Fallopian Tube Cancer<span class="subclass"> SubClassOf </span>Stage II Fallopian Tube Cancer. 
               </td>
               <td>Stage IIA Fallopian Tube Cancer<span class="subclass"> EquivalentTo </span>Stage II Fallopian Tube Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIA).<br></td>
            </tr>
            <tr class="addition">
               <td>157</td>
               <td>Stage IIA Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage IIA Non-Small Cell Lung Carcinoma. 
               </td>
               <td>Stage IIA Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIA Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage II Large Cell Lung Carcinoma.<br></td>
            </tr>
            <tr class="addition">
               <td>158</td>
               <td>Stage IIA Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Stage II Lung Adenocarcinoma. 
               </td>
               <td>Stage IIA Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Stage IIA Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage II Lung Adenocarcinoma.<br></td>
            </tr>
            <tr class="addition">
               <td>159</td>
               <td>Stage IIA Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IIA. 
               </td>
               <td>Stage IIA Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage II Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIA).<br></td>
            </tr>
            <tr class="addition">
               <td>160</td>
               <td>Stage IIA Non-Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage IIA Lung Carcinoma. 
               </td>
               <td>Stage IIA Non-Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIA Lung Carcinoma<br><span class="keyword"> and </span>Stage II Non-Small Cell Lung Cancer.<br></td>
            </tr>
            <tr class="addition">
               <td>161</td>
               <td>Stage IIA Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage IIA Lung Carcinoma. 
               </td>
               <td>Stage IIA Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIA Lung Carcinoma<br><span class="keyword"> and </span>Stage II Small Cell Lung Carcinoma.<br></td>
            </tr>
            <tr class="addition">
               <td>162</td>
               <td>Stage IIB Breast Cancer<span class="subclass"> SubClassOf </span>Stage II Breast Cancer. 
               </td>
               <td>Stage IIB Breast Cancer<span class="subclass"> EquivalentTo </span>Stage II Breast Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIB).<br></td>
            </tr>
            <tr class="addition">
               <td>163</td>
               <td>Stage IIB Fallopian Tube Cancer<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IIB. 
               </td>
               <td>Stage IIB Fallopian Tube Cancer<span class="subclass"> EquivalentTo </span>Stage II Fallopian Tube Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIB).<br></td>
            </tr>
            <tr class="addition">
               <td>164</td>
               <td>Stage IIB Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage II Large Cell Lung Carcinoma. 
               </td>
               <td>Stage IIB Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIB Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage II Large Cell Lung Carcinoma.<br></td>
            </tr>
            <tr class="addition">
               <td>165</td>
               <td>Stage IIB Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Stage II Lung Adenocarcinoma. 
               </td>
               <td>Stage IIB Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Stage IIB Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage II Lung Adenocarcinoma.<br></td>
            </tr>
            <tr class="addition">
               <td>166</td>
               <td>Stage IIB Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IIB. 
               </td>
               <td>Stage IIB Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage II Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIB).<br></td>
            </tr>
            <tr class="addition">
               <td>167</td>
               <td>Stage IIB Non-Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage IIB Lung Carcinoma. 
               </td>
               <td>Stage IIB Non-Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIB Lung Carcinoma<br><span class="keyword"> and </span>Stage II Non-Small Cell Lung Cancer.<br></td>
            </tr>
            <tr class="addition">
               <td>168</td>
               <td>Stage IIB Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage II Small Cell Lung Carcinoma. 
               </td>
               <td>Stage IIB Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIB Lung Carcinoma<br><span class="keyword"> and </span>Stage II Small Cell Lung Carcinoma.<br></td>
            </tr>
            <tr class="addition">
               <td>169</td>
               <td>Stage IIC Fallopian Tube Cancer<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IIC. 
               </td>
               <td>Stage IIC Fallopian Tube Cancer<span class="subclass"> EquivalentTo </span>Stage II Fallopian Tube Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIC).<br></td>
            </tr>
            <tr class="addition">
               <td>189</td>
               <td>Stage III Breast Cancer<span class="subclass"> SubClassOf </span>Breast Carcinoma. 
               </td>
               <td>Stage III Breast Cancer<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage III).<br></td>
            </tr>
            <tr class="addition">
               <td>190</td>
               <td>Stage III Fallopian Tube Cancer<span class="subclass"> SubClassOf </span>Fallopian Tube Carcinoma. 
               </td>
               <td>Stage III Fallopian Tube Cancer<span class="subclass"> EquivalentTo </span>Fallopian Tube Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage III).<br></td>
            </tr>
            <tr class="addition">
               <td>191</td>
               <td>Stage III Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Large Cell Lung Carcinoma. 
               </td>
               <td>Stage III Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Large Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage III Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis).<br></td>
            </tr>
            <tr class="addition">
               <td>192</td>
               <td>Stage III Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Stage III Non-Small Cell Lung Cancer. 
               </td>
               <td>Stage III Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>Stage III Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis).<br></td>
            </tr>
            <tr class="addition">
               <td>193</td>
               <td>Stage III Lung Cancer<span class="subclass"> SubClassOf </span>Lung Carcinoma. 
               </td>
               <td>Stage III Lung Cancer<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage III).<br></td>
            </tr>
            <tr class="addition">
               <td>194</td>
               <td>Stage III Non-Small Cell Lung Cancer<span class="subclass"> SubClassOf </span>Stage III Lung Cancer. 
               </td>
               <td>Stage III Non-Small Cell Lung Cancer<span class="subclass"> EquivalentTo </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage III Lung Cancer.<br></td>
            </tr>
            <tr class="addition">
               <td>170</td>
               <td>Stage IIIA Breast Cancer<span class="subclass"> SubClassOf </span>Stage III Breast Cancer. 
               </td>
               <td>Stage IIIA Breast Cancer<span class="subclass"> EquivalentTo </span>Stage III Breast Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIIA).<br></td>
            </tr>
            <tr class="addition">
               <td>171</td>
               <td>Stage IIIA Fallopian Tube Cancer<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IIIA. 
               </td>
               <td>Stage IIIA Fallopian Tube Cancer<span class="subclass"> EquivalentTo </span>Stage III Fallopian Tube Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIIA).<br></td>
            </tr>
            <tr class="addition">
               <td>172</td>
               <td>Stage IIIA Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage IIIA Non-Small Cell Lung Cancer. 
               </td>
               <td>Stage IIIA Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIIA Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>Stage III Large Cell Lung Carcinoma.<br></td>
            </tr>
            <tr class="addition">
               <td>173</td>
               <td>Stage IIIA Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Stage III Lung Adenocarcinoma. 
               </td>
               <td>Stage IIIA Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Stage IIIA Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>Stage III Lung Adenocarcinoma.<br></td>
            </tr>
            <tr class="addition">
               <td>174</td>
               <td>Stage IIIA Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage III Lung Cancer. 
               </td>
               <td>Stage IIIA Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage III Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIIA).<br></td>
            </tr>
            <tr class="addition">
               <td>175</td>
               <td>Stage IIIA Non-Small Cell Lung Cancer<span class="subclass"> SubClassOf </span>Stage IIIA Lung Carcinoma. 
               </td>
               <td>Stage IIIA Non-Small Cell Lung Cancer<span class="subclass"> EquivalentTo </span>Stage IIIA Lung Carcinoma<br><span class="keyword"> and </span>Stage III Non-Small Cell Lung Cancer.<br></td>
            </tr>
            <tr class="addition">
               <td>176</td>
               <td>Stage IIIA Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage III Small Cell Lung Carcinoma. 
               </td>
               <td>Stage IIIA Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Limited Stage Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage IIIA Lung Carcinoma<br><span class="keyword"> and </span>Stage III Small Cell Lung Carcinoma.<br></td>
            </tr>
            <tr class="addition">
               <td>177</td>
               <td>Stage IIIB Breast Cancer<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IIIB. 
               </td>
               <td>Stage IIIB Breast Cancer<span class="subclass"> EquivalentTo </span>Stage III Breast Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIIB).<br></td>
            </tr>
            <tr class="addition">
               <td>178</td>
               <td>Stage IIIB Fallopian Tube Cancer<span class="subclass"> SubClassOf </span>Stage III Fallopian Tube Cancer. 
               </td>
               <td>Stage IIIB Fallopian Tube Cancer<span class="subclass"> EquivalentTo </span>Stage III Fallopian Tube Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIIB).<br></td>
            </tr>
            <tr class="addition">
               <td>179</td>
               <td>Stage IIIB Inflammatory Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IIIB. 
               </td>
               <td>Stage IIIB Inflammatory Breast Carcinoma<span class="subclass"> EquivalentTo </span>Inflammatory Breast Carcinoma<br><span class="keyword"> and </span>Stage IIIB Breast Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIIB).<br></td>
            </tr>
            <tr class="addition">
               <td>180</td>
               <td>Stage IIIB Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage IIIB Non-Small Cell Lung Cancer. 
               </td>
               <td>Stage IIIB Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIIB Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>Stage III Large Cell Lung Carcinoma.<br></td>
            </tr>
            <tr class="addition">
               <td>181</td>
               <td>Stage IIIB Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Stage IIIB Non-Small Cell Lung Cancer. 
               </td>
               <td>Stage IIIB Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Stage IIIB Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>Stage III Lung Adenocarcinoma.<br></td>
            </tr>
            <tr class="addition">
               <td>182</td>
               <td>Stage IIIB Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage III Lung Cancer. 
               </td>
               <td>Stage IIIB Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage III Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIIB).<br></td>
            </tr>
            <tr class="addition">
               <td>183</td>
               <td>Stage IIIB Non-Small Cell Lung Cancer<span class="subclass"> SubClassOf </span>Stage IIIB Lung Carcinoma. 
               </td>
               <td>Stage IIIB Non-Small Cell Lung Cancer<span class="subclass"> EquivalentTo </span>Stage IIIB Lung Carcinoma<br><span class="keyword"> and </span>Stage III Non-Small Cell Lung Cancer.<br></td>
            </tr>
            <tr class="addition">
               <td>184</td>
               <td>Stage IIIB Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage IIIB Lung Carcinoma. 
               </td>
               <td>Stage IIIB Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIIB Lung Carcinoma<br><span class="keyword"> and </span>Stage III Small Cell Lung Carcinoma.<br></td>
            </tr>
            <tr class="addition">
               <td>185</td>
               <td>Stage IIIB Small Cell Lung Carcinoma with Pleural Effusion<span class="subclass"> SubClassOf </span>Stage IIIB Small Cell Lung Carcinoma. 
               </td>
               <td>Stage IIIB Small Cell Lung Carcinoma with Pleural Effusion<span class="subclass"> EquivalentTo </span>Extensive Stage Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage IIIB Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Pleural Effusion).<br></td>
            </tr>
            <tr class="addition">
               <td>186</td>
               <td>Stage IIIB Small Cell Lung Carcinoma without Pleural Effusion<span class="subclass"> SubClassOf </span>Limited Stage Small Cell Lung Carcinoma. 
               </td>
               <td>Stage IIIB Small Cell Lung Carcinoma without Pleural Effusion<span class="subclass"> EquivalentTo </span>Limited Stage Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage IIIB Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Pleural Effusion).<br></td>
            </tr>
            <tr class="addition">
               <td>187</td>
               <td>Stage IIIC Breast Cancer<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IIIC. 
               </td>
               <td>Stage IIIC Breast Cancer<span class="subclass"> EquivalentTo </span>Stage III Breast Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIIC).<br></td>
            </tr>
            <tr class="addition">
               <td>188</td>
               <td>Stage IIIC Fallopian Tube Cancer<span class="subclass"> SubClassOf </span>Stage III Fallopian Tube Cancer. 
               </td>
               <td>Stage IIIC Fallopian Tube Cancer<span class="subclass"> EquivalentTo </span>Stage III Fallopian Tube Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIIC).<br></td>
            </tr>
            <tr class="addition">
               <td>202</td>
               <td>Stage IV Breast Cancer<span class="subclass"> SubClassOf </span>Breast Carcinoma. 
               </td>
               <td>Stage IV Breast Cancer<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IV).<br></td>
            </tr>
            <tr class="addition">
               <td>203</td>
               <td>Stage IV Fallopian Tube Cancer<span class="subclass"> SubClassOf </span>Fallopian Tube Carcinoma. 
               </td>
               <td>Stage IV Fallopian Tube Cancer<span class="subclass"> EquivalentTo </span>Fallopian Tube Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IV).<br></td>
            </tr>
            <tr class="addition">
               <td>204</td>
               <td>Stage IV Inflammatory Breast Carcinoma<span class="subclass"> SubClassOf </span>Inflammatory Breast Carcinoma. 
               </td>
               <td>Stage IV Inflammatory Breast Carcinoma<span class="subclass"> EquivalentTo </span>Inflammatory Breast Carcinoma<br><span class="keyword"> and </span>Stage IV Breast Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IV).<br></td>
            </tr>
            <tr class="addition">
               <td>205</td>
               <td>Stage IV Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Large Cell Lung Carcinoma. 
               </td>
               <td>Stage IV Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Large Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage IV Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis).<br></td>
            </tr>
            <tr class="addition">
               <td>206</td>
               <td>Stage IV Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Lung Adenocarcinoma. 
               </td>
               <td>Stage IV Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>Stage IV Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis).<br></td>
            </tr>
            <tr class="addition">
               <td>207</td>
               <td>Stage IV Lung Cancer<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IV. 
               </td>
               <td>Stage IV Lung Cancer<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IV).<br></td>
            </tr>
            <tr class="addition">
               <td>208</td>
               <td>Stage IV Non-Small Cell Lung Cancer<span class="subclass"> SubClassOf </span>Non-Small Cell Lung Carcinoma. 
               </td>
               <td>Stage IV Non-Small Cell Lung Cancer<span class="subclass"> EquivalentTo </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage IV Lung Cancer.<br></td>
            </tr>
            <tr class="addition">
               <td>209</td>
               <td>Stage IV Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Extensive Stage Small Cell Lung Carcinoma. 
               </td>
               <td>Stage IV Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Extensive Stage Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage IV Lung Cancer.<br></td>
            </tr>
            <tr class="addition">
               <td>217</td>
               <td>Superior Sulcus Lung Carcinoma<span class="subclass"> SubClassOf </span>Malignant Superior Sulcus Neoplasm. 
               </td>
               <td>Superior Sulcus Lung Carcinoma<span class="subclass"> EquivalentTo </span>Bronchogenic Carcinoma<br><span class="keyword"> and </span>Malignant Superior Sulcus Neoplasm.<br></td>
            </tr>
            <tr class="addition">
               <td>218</td>
               <td>Tracheal Carcinoma<span class="subclass"> SubClassOf </span>Carcinoma. 
               </td>
               <td>Tracheal Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>Infrequent Neoplasm<br><span class="keyword"> and </span>Malignant Tracheal Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Tracheal Epithelium)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Trachea).<br></td>
            </tr>
            <tr class="addition">
               <td>219</td>
               <td>Tracheal Neoplasm<span class="subclass"> SubClassOf </span>Respiratory Tract Neoplasm. 
               </td>
               <td>Tracheal Neoplasm<span class="subclass"> EquivalentTo </span>Respiratory Tract Neoplasm<br><span class="keyword"> and </span>Tracheal Disorder.<br></td>
            </tr>
            <tr class="addition">
               <td>220</td>
               <td>Transplant-Related Lung Carcinoma<span class="subclass"> SubClassOf </span>Transplant-Related Carcinoma. 
               </td>
               <td>Transplant-Related Lung Carcinoma<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>Transplant-Related Carcinoma.<br></td>
            </tr>
            <tr class="addition">
               <td>221</td>
               <td>Tubular Breast Carcinoma<span class="subclass"> SubClassOf </span>Breast Adenocarcinoma. 
               </td>
               <td>Tubular Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Tubular Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11q ATM Gene Locus)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p FHIT Gene Locus)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Calcification)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>High Mitotic Activity)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Nuclear Pleomorphism)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Desmoplastic Stroma Formation).<br></td>
            </tr>
            <tr class="addition">
               <td>222</td>
               <td>Type I Pleuropulmonary Blastoma<span class="subclass"> SubClassOf </span>Pleuropulmonary Blastoma. 
               </td>
               <td>Type I Pleuropulmonary Blastoma<span class="subclass"> EquivalentTo </span>Pleuropulmonary Blastoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Small Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Cystic Change).<br></td>
            </tr>
            <tr class="addition">
               <td>223</td>
               <td>Undifferentiated Breast Carcinoma<span class="subclass"> SubClassOf </span>Undifferentiated Carcinoma. 
               </td>
               <td>Undifferentiated Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Undifferentiated Carcinoma.<br></td>
            </tr>
            <tr class="addition">
               <td>224</td>
               <td>Unilateral Breast Carcinoma<span class="subclass"> SubClassOf </span>Breast Carcinoma. 
               </td>
               <td>Unilateral Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Bilateral Disease).<br></td>
            </tr>
         </tbody>
         <tbody id="stnt" style="display:none">
            <tr class="withoutstyle">
               <td colspan="3"><a name="st"></a><h4 style="display: inline-block;">Strengthenings with New Terms (35)</h4> [<a href="#">back to top</a>]
               </td>
            </tr>
            <tr>
               <th class="addition">ID</th>
               <th class="normaladd">Weaker Axiom in Ontology 1</th>
               <th class="addition">Strengthened Axiom in Ontology 2</th>
            </tr>
            <tr class="addition">
               <td>225</td>
               <td>Acinic Cell Breast Carcinoma<span class="subclass"> SubClassOf </span>Breast Adenocarcinoma. 
               </td>
               <td>Acinic Cell Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Serous Adenocarcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Acinic Cell Differentiation).<br><i>New Terms: Acinic Cell Differentiation</i></td>
            </tr>
            <tr class="addition">
               <td>226</td>
               <td>Breast Adenocarcinoma with Spindle Cell Metaplasia<span class="subclass"> SubClassOf </span>Breast Adenocarcinoma. 
               </td>
               <td>Breast Adenocarcinoma with Spindle Cell Metaplasia<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Metaplastic Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Spindle Cell Metaplasia).<br><i>New Terms: Spindle Cell Metaplasia</i></td>
            </tr>
            <tr class="addition">
               <td>227</td>
               <td>Breast Carcinoma with Melanotic Features<span class="subclass"> SubClassOf </span>Invasive Ductal Carcinoma, Not Otherwise Specified. 
               </td>
               <td>Breast Carcinoma with Melanotic Features<span class="subclass"> EquivalentTo </span>Invasive Ductal Carcinoma, Not Otherwise Specified<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Melanoma Cells Present).<br><i>New Terms: Melanoma Cells Present</i></td>
            </tr>
            <tr class="addition">
               <td>228</td>
               <td>Bronchioloalveolar Carcinoma<span class="subclass"> SubClassOf </span>Lung Adenocarcinoma. 
               </td>
               <td>Bronchioloalveolar Carcinoma<span class="subclass"> EquivalentTo </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Stromal Invasion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lepidic Growth Pattern).<br><i>New Terms: Lepidic Growth Pattern</i></td>
            </tr>
            <tr class="addition">
               <td>229</td>
               <td>Combined Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Small Cell Lung Carcinoma. 
               </td>
               <td>Combined Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Combined Lung Carcinoma<br><span class="keyword"> and </span>Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Coin Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hoarseness).<br><i>New Terms: Coin Lesion</i></td>
            </tr>
            <tr class="addition">
               <td>230</td>
               <td>Extensive Stage Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Small Cell Lung Carcinoma. 
               </td>
               <td>Extensive Stage Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Coin Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hoarseness)<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Extensive Stage).<br><i>New Terms: Coin Lesion</i></td>
            </tr>
            <tr class="addition">
               <td>231</td>
               <td>Fetal Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Lung Adenocarcinoma. 
               </td>
               <td>Fetal Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Tubular Structures of Glycogen-Rich Non-Ciliated Cells Present).<br><i>New Terms: Tubular Structures of Glycogen-Rich Non-Ciliated Cells Present</i></td>
            </tr>
            <tr class="addition">
               <td>232</td>
               <td>Glycogen-Rich Carcinoma<span class="subclass"> SubClassOf </span>Carcinoma. 
               </td>
               <td>Glycogen-Rich Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Clear Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present).<br><i>New Terms: Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present</i></td>
            </tr>
            <tr class="addition">
               <td>233</td>
               <td>Invasive Ductal Breast Carcinoma with Predominant Intraductal Component<span class="subclass"> SubClassOf </span>Invasive Ductal Carcinoma, Not Otherwise Specified. 
               </td>
               <td>Invasive Ductal Breast Carcinoma with Predominant Intraductal Component<span class="subclass"> EquivalentTo </span>Invasive Ductal Carcinoma, Not Otherwise Specified<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Prominent Intraductal Component Present).<br><i>New Terms: Prominent Intraductal Component Present</i></td>
            </tr>
            <tr class="addition">
               <td>234</td>
               <td>Invasive Lobular Breast Carcinoma with Predominant In Situ Component<span class="subclass"> SubClassOf </span>Invasive Lobular Breast Carcinoma. 
               </td>
               <td>Invasive Lobular Breast Carcinoma with Predominant In Situ Component<span class="subclass"> EquivalentTo </span>Invasive Lobular Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Prominent In Situ Component Present).<br><i>New Terms: Prominent In Situ Component Present</i></td>
            </tr>
            <tr class="addition">
               <td>235</td>
               <td>Large Cell Lung Neuroendocrine Carcinoma<span class="subclass"> SubClassOf </span>High Grade Lung Neuroendocrine Neoplasm. 
               </td>
               <td>Large Cell Lung Neuroendocrine Carcinoma<span class="subclass"> EquivalentTo </span>High Grade Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Large Cell Lung Carcinoma<br><span class="keyword"> and </span>Large Cell Neuroendocrine Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>C-KIT Tyrosine Kinase Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>More than 10 Mitoses per 10HPF).<br><i>New Terms: More than 10 Mitoses per 10HPF</i></td>
            </tr>
            <tr class="addition">
               <td>236</td>
               <td>Limited Stage Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Limited Stage. 
               </td>
               <td>Limited Stage Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Coin Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hoarseness)<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Limited Stage).<br><i>New Terms: Coin Lesion</i></td>
            </tr>
            <tr class="addition">
               <td>237</td>
               <td>Lipid-Rich Carcinoma<span class="subclass"> SubClassOf </span>Carcinoma. 
               </td>
               <td>Lipid-Rich Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Clear Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present).<br><i>New Terms: Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present</i></td>
            </tr>
            <tr class="addition">
               <td>238</td>
               <td>Lung Adenocarcinoma, Mixed Subtype<span class="subclass"> SubClassOf </span>Lung Adenocarcinoma. 
               </td>
               <td>Lung Adenocarcinoma, Mixed Subtype<span class="subclass"> EquivalentTo </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Acinar Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lepidic Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Mild Cytologic Atypia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Moderate Cytologic Atypia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Moderately Differentiated Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Papillary Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Poorly Differentiated Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Severe Cytologic Atypia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Solid Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Well Differentiated Lesion).<br><i>New Terms: Lepidic Growth Pattern</i></td>
            </tr>
            <tr class="addition">
               <td>239</td>
               <td>Lung Atypical Carcinoid Tumor<span class="subclass"> SubClassOf </span>Intermediate Grade Lung Neuroendocrine Neoplasm. 
               </td>
               <td>Lung Atypical Carcinoid Tumor<span class="subclass"> EquivalentTo </span>Intermediate Grade Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Lung Carcinoid Tumor<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Necrotic Change)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Two to 10 Mitoses per 10HPF).<br><i>New Terms: Two to 10 Mitoses per 10HPF</i></td>
            </tr>
            <tr class="addition">
               <td>240</td>
               <td>Lung Carcinoid Tumor<span class="subclass"> SubClassOf </span>Lung Neuroendocrine Neoplasm. 
               </td>
               <td>Lung Carcinoid Tumor<span class="subclass"> EquivalentTo </span>Foregut Carcinoid Tumor<br><span class="keyword"> and </span>Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(11q))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Atypia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Calcification)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Nuclear Pleomorphism)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>More than 10 Mitoses per 10HPF)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Nodular Lesion)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchus).<br><i>New Terms: More than 10 Mitoses per 10HPF</i></td>
            </tr>
            <tr class="addition">
               <td>241</td>
               <td>Lung Mucinous Cystadenocarcinoma<span class="subclass"> SubClassOf </span>Lung Mucinous Adenocarcinoma. 
               </td>
               <td>Lung Mucinous Cystadenocarcinoma<span class="subclass"> EquivalentTo </span>Lung Mucinous Adenocarcinoma<br><span class="keyword"> and </span>Mucinous Cystadenocarcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Cystic Change)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Partially Encapsulated Mass).<br><i>New Terms: Partially Encapsulated Mass</i></td>
            </tr>
            <tr class="addition">
               <td>242</td>
               <td>Lung Typical Carcinoid Tumor<span class="subclass"> SubClassOf </span>Lung Carcinoid Tumor. 
               </td>
               <td>Lung Typical Carcinoid Tumor<span class="subclass"> EquivalentTo </span>Low Grade Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Lung Carcinoid Tumor<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Necrotic Change)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Less than 2 Mitoses per 10HPF).<br><i>New Terms: Less than 2 Mitoses per 10HPF</i></td>
            </tr>
            <tr class="addition">
               <td>243</td>
               <td>Malignant Superior Sulcus Neoplasm<span class="subclass"> SubClassOf </span>Pulmonary Sulcus Neoplasm. 
               </td>
               <td>Malignant Superior Sulcus Neoplasm<span class="subclass"> EquivalentTo </span>Malignant Lung Neoplasm<br><span class="keyword"> and </span>Pulmonary Sulcus Neoplasm<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Pancoast Syndrome)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Lung Tissue)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Apex of the Lung).<br><i>New Terms: Pancoast Syndrome</i></td>
            </tr>
            <tr class="addition">
               <td>244</td>
               <td>Medullary Breast Carcinoma<span class="subclass"> SubClassOf </span>Medullary Carcinoma. 
               </td>
               <td>Medullary Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Medullary Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 12p)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Glandular Pattern)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Round Adenocarcinoma Cell with Abundant Cytoplasm<br><span class="keyword"> and </span>Vesicular Nucleus)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>High Mitotic Activity)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphoplasmacytic Infiltrate)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Syncytial Pattern).<br><i>New Terms: Round Adenocarcinoma Cell with Abundant Cytoplasm and Vesicular Nucleus</i></td>
            </tr>
            <tr class="addition">
               <td>245</td>
               <td>Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma<span class="subclass"> SubClassOf </span>Metaplastic Breast Carcinoma. 
               </td>
               <td>Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Metaplastic Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mesenchymal Metaplasia).<br><i>New Terms: Mesenchymal Metaplasia</i></td>
            </tr>
            <tr class="addition">
               <td>246</td>
               <td>Mixed Mucinous<br><span class="keyword"> and </span>Non-Mucinous Bronchioloalveolar Carcinoma<span class="subclass"> SubClassOf </span>Bronchioloalveolar Carcinoma. 
               </td>
               <td>Mixed Mucinous<br><span class="keyword"> and </span>Non-Mucinous Bronchioloalveolar Carcinoma<span class="subclass"> EquivalentTo </span>Bronchioloalveolar Carcinoma<br><span class="keyword"> and </span>Mucin-Producing Adenocarcinoma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Mucin-Producing Tall Columnar Adenocarcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Clara Cell Differentiation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Type II Cell Differentiation).<br><i>New Terms: Type II Cell Differentiation, Mucin-Producing Tall Columnar Adenocarcinoma Cell, Clara
                     Cell Differentiation</i></td>
            </tr>
            <tr class="addition">
               <td>247</td>
               <td>Mucinous Bronchioloalveolar Carcinoma<span class="subclass"> SubClassOf </span>Bronchioloalveolar Carcinoma. 
               </td>
               <td>Mucinous Bronchioloalveolar Carcinoma<span class="subclass"> EquivalentTo </span>Bronchioloalveolar Carcinoma<br><span class="keyword"> and </span>Mucin-Producing Adenocarcinoma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Mucin-Producing Tall Columnar Adenocarcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mucoid Stroma Formation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Well Differentiated Lesion).<br><i>New Terms: Mucin-Producing Tall Columnar Adenocarcinoma Cell</i></td>
            </tr>
            <tr class="addition">
               <td>248</td>
               <td>Non-Mucinous Bronchioloalveolar Carcinoma<span class="subclass"> SubClassOf </span>Bronchioloalveolar Carcinoma. 
               </td>
               <td>Non-Mucinous Bronchioloalveolar Carcinoma<span class="subclass"> EquivalentTo </span>Bronchioloalveolar Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Clara Cell Differentiation)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Moderately Differentiated Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Type II Cell Differentiation)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Well Differentiated Lesion).<br><i>New Terms: Type II Cell Differentiation, Clara Cell Differentiation</i></td>
            </tr>
            <tr class="addition">
               <td>249</td>
               <td>Primary Carcinoma Unspecified Site<span class="subclass"> SubClassOf </span>Primary Carcinoma. 
               </td>
               <td>Primary Carcinoma Unspecified Site<span class="subclass"> EquivalentTo </span>Primary Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Primary Site Unspecified).<br><i>New Terms: Primary Site Unspecified</i></td>
            </tr>
            <tr class="addition">
               <td>250</td>
               <td>Pulmonary Blastoma<span class="subclass"> SubClassOf </span>Blastoma. 
               </td>
               <td>Pulmonary Blastoma<span class="subclass"> EquivalentTo </span>Blastoma<br><span class="keyword"> and </span>Lung Sarcomatoid Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CTNNB1 Gene Mutation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Tubular Structures of Glycogen-Rich Non-Ciliated Cells Present).<br><i>New Terms: Tubular Structures of Glycogen-Rich Non-Ciliated Cells Present</i></td>
            </tr>
            <tr class="addition">
               <td>251</td>
               <td>Recurrent Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Small Cell Lung Carcinoma. 
               </td>
               <td>Recurrent Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Recurrent Lung Cancer<br><span class="keyword"> and </span>Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Coin Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hoarseness).<br><i>New Terms: Coin Lesion</i></td>
            </tr>
            <tr class="addition">
               <td>252</td>
               <td>Secretory Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(12;15)(p13;q26). 
               </td>
               <td>Secretory Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(12;15)(p13;q26))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ETV6-NTRK3 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Adenocarcinoma Cell with Abundant Pale Staining Cytoplasm)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Compact Pattern)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Intracytoplasmic<br><span class="keyword"> and </span>Extracytoplasmic Eosinophilic Material Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Honeycombed Pattern)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Tubular Pattern)<br><span class="keyword"> and </span>(Disease_Is_Grade<span class="some"> only </span>Low Grade).<br><i>New Terms: Intracytoplasmic and Extracytoplasmic Eosinophilic Material Present, Adenocarcinoma
                     Cell with Abundant Pale Staining Cytoplasm</i></td>
            </tr>
            <tr class="addition">
               <td>253</td>
               <td>Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4. 
               </td>
               <td>Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>High Grade Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Lung Carcinoma<br><span class="keyword"> and </span>Small Cell Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Paraneoplastic Syndrome)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 18q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 5q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>C-KIT Tyrosine Kinase Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NMYC Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>More than 10 Mitoses per 10HPF)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchus).<br><i>New Terms: More than 10 Mitoses per 10HPF</i></td>
            </tr>
            <tr class="addition">
               <td>254</td>
               <td>Solid Papillary Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Papillary Breast Carcinoma. 
               </td>
               <td>Solid Papillary Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Papillary Breast Carcinoma<br><span class="keyword"> and </span>Solid Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Fibrotic Stroma with Finger-Like Projections Present).<br><i>New Terms: Fibrotic Stroma with Finger-Like Projections Present</i></td>
            </tr>
            <tr class="addition">
               <td>255</td>
               <td>Stage III Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage III Lung Cancer. 
               </td>
               <td>Stage III Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage III Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Coin Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hoarseness).<br><i>New Terms: Coin Lesion</i></td>
            </tr>
            <tr class="addition">
               <td>256</td>
               <td>Synchronous Bilateral Breast Carcinoma<span class="subclass"> SubClassOf </span>Bilateral Breast Carcinoma. 
               </td>
               <td>Synchronous Bilateral Breast Carcinoma<span class="subclass"> EquivalentTo </span>Bilateral Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Synchronous Lesion).<br><i>New Terms: Synchronous Lesion</i></td>
            </tr>
            <tr class="addition">
               <td>257</td>
               <td>Synchronous Multifocal Osteosarcoma<span class="subclass"> SubClassOf </span>Multifocal Osteosarcoma. 
               </td>
               <td>Synchronous Multifocal Osteosarcoma<span class="subclass"> EquivalentTo </span>Multifocal Osteosarcoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Synchronous Lesion).<br><i>New Terms: Synchronous Lesion</i></td>
            </tr>
            <tr class="addition">
               <td>259</td>
               <td>Type II Pleuropulmonary Blastoma<span class="subclass"> SubClassOf </span>Pleuropulmonary Blastoma. 
               </td>
               <td>Type II Pleuropulmonary Blastoma<span class="subclass"> EquivalentTo </span>Pleuropulmonary Blastoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Aggressive Clinical Course)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Small Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Sarcomatous Component Present).<br><i>New Terms: Sarcomatous Component Present</i></td>
            </tr>
            <tr class="addition">
               <td>258</td>
               <td>Type III Pleuropulmonary Blastoma<span class="subclass"> SubClassOf </span>Pleuropulmonary Blastoma. 
               </td>
               <td>Type III Pleuropulmonary Blastoma<span class="subclass"> EquivalentTo </span>Pleuropulmonary Blastoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Aggressive Clinical Course)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Sarcomatous Component Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Solid Growth Pattern).<br><i>New Terms: Sarcomatous Component Present</i></td>
            </tr>
         </tbody>
         <tbody id="newdesc" style="display:none">
            <tr class="withoutstyle">
               <td colspan="3">
                  <h4 style="display: inline-block;">New Descriptions (5718)</h4> [<a href="#">back to top</a>]
               </td>
            </tr>
            <tr>
               <th class="addition">ID</th>
               <th class="addition" colspan="2">New Description Axiom in Ontology 2</th>
            </tr>
            <tr class="addition">
               <td>260</td>
               <td colspan="2">AV Block First Degree Adverse Event<span class="subclass"> SubClassOf </span>Conduction Abnormality<br><span class="keyword"> and </span>Atrioventricular Heart Block Adverse Event. <br><i>New Terms: AV Block First Degree Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>262</td>
               <td colspan="2">AV Block Second Degree Mobitz<span class="subclass"> Type </span>I Adverse Event<span class="subclass"> SubClassOf </span>Conduction Abnormality<br><span class="keyword"> and </span>Atrioventricular Heart Block Adverse Event. <br><i>New Terms: AV Block Second Degree Mobitz Type I Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>261</td>
               <td colspan="2">AV Block Second Degree Mobitz<span class="subclass"> Type </span>II Adverse Event<span class="subclass"> SubClassOf </span>Conduction Abnormality<br><span class="keyword"> and </span>Atrioventricular Heart Block Adverse Event. <br><i>New Terms: AV Block Second Degree Mobitz Type II Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>263</td>
               <td colspan="2">AV Block Third Degree Adverse Event<span class="subclass"> SubClassOf </span>Conduction Abnormality<br><span class="keyword"> and </span>Atrioventricular Heart Block Adverse Event. <br><i>New Terms: AV Block Third Degree Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>264</td>
               <td colspan="2">Abdomen Fistula Adverse Event NOS<span class="subclass"> SubClassOf </span>Gastrointestinal Fistula Adverse Event. <br><i>New Terms: Abdomen Fistula Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>265</td>
               <td colspan="2">Abdomen Hemorrhage Adverse Event NOS<span class="subclass"> SubClassOf </span>Gastrointestinal Hemorrhage Adverse Event. <br><i>New Terms: Abdomen Hemorrhage Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>266</td>
               <td colspan="2">Abdomen Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Abdomen Infection NOS Adverse Event Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>267</td>
               <td colspan="2">Abdomen Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Abdomen Infection NOS Adverse Event with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>268</td>
               <td colspan="2">Abdomen Infection NOS Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Abdomen Infection NOS Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>269</td>
               <td colspan="2">Abdomen NOS Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Abdomen NOS Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>270</td>
               <td colspan="2">Abdomen Pain NOS Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Abdomen Pain NOS Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>271</td>
               <td colspan="2">Abdomen Soft Tissue Necrosis Adverse Event<span class="subclass"> SubClassOf </span>Soft Tissue Necrosis Adverse Event. <br><i>New Terms: Abdomen Soft Tissue Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>272</td>
               <td colspan="2">Abdominal Distension<br><span class="keyword"> or </span>Bloating Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Gastrointestinal System. <br><i>New Terms: Abdominal Distension or Bloating Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>273</td>
               <td colspan="2">Acinic Cell Differentiation<span class="subclass"> SubClassOf </span>Epithelial Differentiation. <br><i>New Terms: Acinic Cell Differentiation</i></td>
            </tr>
            <tr class="addition">
               <td>274</td>
               <td colspan="2">Acral Skin Nevus<span class="subclass"> SubClassOf </span>Melanocytic Nevus. <br><i>New Terms: Acral Skin Nevus</i></td>
            </tr>
            <tr class="addition">
               <td>275</td>
               <td colspan="2">Acute Vascular Leak Syndrome Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Vascular System. <br><i>New Terms: Acute Vascular Leak Syndrome Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>276</td>
               <td colspan="2">Adenocarcinoma Cell with Abundant Finely Vacuolated Cytoplasm<span class="subclass"> SubClassOf </span>Adenocarcinoma Cell. <br><i>New Terms: Adenocarcinoma Cell with Abundant Finely Vacuolated Cytoplasm</i></td>
            </tr>
            <tr class="addition">
               <td>277</td>
               <td colspan="2">Adenocarcinoma Cell with Abundant Pale Staining Cytoplasm<span class="subclass"> SubClassOf </span>Adenocarcinoma Cell. <br><i>New Terms: Adenocarcinoma Cell with Abundant Pale Staining Cytoplasm</i></td>
            </tr>
            <tr class="addition">
               <td>278</td>
               <td colspan="2">Adrenal Gland Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Adrenal Gland Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>279</td>
               <td colspan="2">Adrenal Insufficiency Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Endocrine System. <br><i>New Terms: Adrenal Insufficiency Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>280</td>
               <td colspan="2">Adult Respiratory Distress Syndrome Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Systems. <br><i>New Terms: Adult Respiratory Distress Syndrome Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>281</td>
               <td colspan="2">Adverse Event Associated with Dentures<br><span class="keyword"> or </span>Dental Prostheses<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Gastrointestinal System. <br><i>New Terms: Adverse Event Associated with Dentures or Dental Prostheses</i></td>
            </tr>
            <tr class="addition">
               <td>282</td>
               <td colspan="2">Adverse Event Associated with the Teeth<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Gastrointestinal System. <br><i>New Terms: Adverse Event Associated with the Teeth</i></td>
            </tr>
            <tr class="addition">
               <td>283</td>
               <td colspan="2">Agitation Adverse Event<span class="subclass"> SubClassOf </span>Mood Alteration Adverse Event. <br><i>New Terms: Agitation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>284</td>
               <td colspan="2">Alcohol Intolerance Antabuse-Like Syndrome Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Syndromes. <br><i>New Terms: Alcohol Intolerance Antabuse-Like Syndrome Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>285</td>
               <td colspan="2">Alkaline Phosphatase Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Metabolic<br><span class="keyword"> and </span>Laboratory Abnormalities. <br><i>New Terms: Alkaline Phosphatase Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>286</td>
               <td colspan="2">Allergic Reaction<br><span class="keyword"> and </span>Hypersensitivity Adverse Event Including Drug Fever<span class="subclass"> SubClassOf </span>Adverse Event Associated with Allergy<br><span class="keyword"> and </span>Immunology. <br><i>New Terms: Allergic Reaction and Hypersensitivity Adverse Event Including Drug Fever</i></td>
            </tr>
            <tr class="addition">
               <td>287</td>
               <td colspan="2">Allergic Rhinitis Adverse Event Including Sneezing Nasal Stuffiness Postnasal Drip<span class="subclass"> SubClassOf </span>Adverse Event Associated with Allergy<br><span class="keyword"> and </span>Immunology. <br><i>New Terms: Allergic Rhinitis Adverse Event Including Sneezing Nasal Stuffiness Postnasal Drip</i></td>
            </tr>
            <tr class="addition">
               <td>288</td>
               <td colspan="2">Alopecia Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Dermatology<br><span class="keyword"> and </span>Skin. <br><i>New Terms: Alopecia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>289</td>
               <td colspan="2">Alpha-2 Country Code<span class="subclass"> SubClassOf </span>Country Code. <br><i>New Terms: Alpha-2 Country Code</i></td>
            </tr>
            <tr class="addition">
               <td>290</td>
               <td colspan="2">Alpha-3 Country Code<span class="subclass"> SubClassOf </span>Country Code. <br><i>New Terms: Alpha-3 Country Code</i></td>
            </tr>
            <tr class="addition">
               <td>291</td>
               <td colspan="2">Alteration in Bone Age Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Growth<br><span class="keyword"> and </span>Development. <br><i>New Terms: Alteration in Bone Age Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>292</td>
               <td colspan="2">Amylase Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Metabolic<br><span class="keyword"> and </span>Laboratory Abnormalities. <br><i>New Terms: Amylase Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>293</td>
               <td colspan="2">Anal Incontinence Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Gastrointestinal System. <br><i>New Terms: Anal Incontinence Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>294</td>
               <td colspan="2">Anal Sphincter Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Anal Sphincter Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>295</td>
               <td colspan="2">Anal<br><span class="keyword"> or </span>Perianal Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Anal or Perianal Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>296</td>
               <td colspan="2">Anal<br><span class="keyword"> or </span>Perianal Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Anal or Perianal Infection Adverse Event with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>297</td>
               <td colspan="2">Anal<br><span class="keyword"> or </span>Perianal Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Anal or Perianal Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>298</td>
               <td colspan="2">Annual<span class="subclass"> SubClassOf </span>Temporal Qualifier. <br><i>New Terms: Annual</i></td>
            </tr>
            <tr class="addition">
               <td>299</td>
               <td colspan="2">Anorexia Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Gastrointestinal System. <br><i>New Terms: Anorexia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>300</td>
               <td colspan="2">Anus Fistula Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Fistula Adverse Event. <br><i>New Terms: Anus Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>301</td>
               <td colspan="2">Anus Hemorrhage Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Hemorrhage Adverse Event. <br><i>New Terms: Anus Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>302</td>
               <td colspan="2">Anus Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Anus Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>303</td>
               <td colspan="2">Anus Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Mucositis<br><span class="keyword"> and </span>Stomatitis Adverse Event by Clinical Examination Classification. <br><i>New Terms: Anus Mucositis or Stomatitis Adverse Event by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>304</td>
               <td colspan="2">Anus Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Mucositis<br><span class="keyword"> and </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> and </span>Symptomatic Classification. <br><i>New Terms: Anus Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>305</td>
               <td colspan="2">Anus Necrosis Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Necrosis Adverse Event. <br><i>New Terms: Anus Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>306</td>
               <td colspan="2">Anus Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Anus Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>307</td>
               <td colspan="2">Anus Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Stricture<br><span class="keyword"> and </span>Stenosis Adverse Event Including Anastomotic Stricture<br><span class="keyword"> and </span>Stenosis. <br><i>New Terms: Anus Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>308</td>
               <td colspan="2">Anus Ulcer Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Ulcer Adverse Event. <br><i>New Terms: Anus Ulcer Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>309</td>
               <td colspan="2">Anxiety Adverse Event<span class="subclass"> SubClassOf </span>Mood Alteration Adverse Event. <br><i>New Terms: Anxiety Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>310</td>
               <td colspan="2">Aorta Artery Injury Adverse Event<span class="subclass"> SubClassOf </span>Artery Injury Adverse Event. <br><i>New Terms: Aorta Artery Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>311</td>
               <td colspan="2">Aorta Artery Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Aorta Artery Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>312</td>
               <td colspan="2">Apnea Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Nervous System. <br><i>New Terms: Apnea Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>313</td>
               <td colspan="2">Appendix Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Appendix Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>314</td>
               <td colspan="2">Appendix Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Appendix Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>315</td>
               <td colspan="2">Appendix Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Appendix Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>316</td>
               <td colspan="2">Appendix Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Appendix Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>317</td>
               <td colspan="2">Appendix Perforation Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Perforation Adverse Event. <br><i>New Terms: Appendix Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>318</td>
               <td colspan="2">Arachidonic Acid Metabolism Pathway<span class="subclass"> SubClassOf </span>Metabolic Pathway. <br><i>New Terms: Arachidonic Acid Metabolism Pathway</i></td>
            </tr>
            <tr class="addition">
               <td>319</td>
               <td colspan="2">Arachnoiditis<br><span class="keyword"> and </span>Meningismus<br><span class="keyword"> and </span>Radiculitis Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Nervous System. <br><i>New Terms: Arachnoiditis and Meningismus and Radiculitis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>320</td>
               <td colspan="2">Artery Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Artery Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>321</td>
               <td colspan="2">Artery Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Artery Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>322</td>
               <td colspan="2">Artery Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Artery Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>323</td>
               <td colspan="2">Artery NOS Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Artery NOS Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>324</td>
               <td colspan="2">Asbestos Exposure<span class="subclass"> SubClassOf </span>Chemical Exposure. <br><i>New Terms: Asbestos Exposure</i></td>
            </tr>
            <tr class="addition">
               <td>325</td>
               <td colspan="2">Aspiration Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Systems. <br><i>New Terms: Aspiration Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>326</td>
               <td colspan="2">Asystole Adverse Event<span class="subclass"> SubClassOf </span>Conduction Abnormality<br><span class="keyword"> and </span>Atrioventricular Heart Block Adverse Event. <br><i>New Terms: Asystole Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>327</td>
               <td colspan="2">Ataxia Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Nervous System. <br><i>New Terms: Ataxia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>328</td>
               <td colspan="2">Atelectasis Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Systems. <br><i>New Terms: Atelectasis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>329</td>
               <td colspan="2">Atmosphere<span class="subclass"> SubClassOf </span>Unit of Pressure. <br><i>New Terms: Atmosphere</i></td>
            </tr>
            <tr class="addition">
               <td>330</td>
               <td colspan="2">Atmosphere<span class="subclass"> SubClassOf </span>Units for Vital Signs Results. <br><i>New Terms: Atmosphere</i></td>
            </tr>
            <tr class="addition">
               <td>331</td>
               <td colspan="2">Atrial Fibrillation Adverse Event<span class="subclass"> SubClassOf </span>Supraventricular<br><span class="keyword"> and </span>Nodal Arrhythmia Adverse Event. <br><i>New Terms: Atrial Fibrillation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>332</td>
               <td colspan="2">Atrial Flutter Adverse Event<span class="subclass"> SubClassOf </span>Supraventricular<br><span class="keyword"> and </span>Nodal Arrhythmia Adverse Event. <br><i>New Terms: Atrial Flutter Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>333</td>
               <td colspan="2">Atrial Tachycardia<br><span class="keyword"> or </span>Paroxysmal Atrial Tachycardia Adverse Event<span class="subclass"> SubClassOf </span>Supraventricular<br><span class="keyword"> and </span>Nodal Arrhythmia Adverse Event. <br><i>New Terms: Atrial Tachycardia or Paroxysmal Atrial Tachycardia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>334</td>
               <td colspan="2">Autoimmune Reaction Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Allergy<br><span class="keyword"> and </span>Immunology. <br><i>New Terms: Autoimmune Reaction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>335</td>
               <td colspan="2">Avascular Osteonecrosis Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Musculoskeletal System<br><span class="keyword"> and </span>Soft Tissue. <br><i>New Terms: Avascular Osteonecrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>336</td>
               <td colspan="2">Back Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Back Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>337</td>
               <td colspan="2">Bigeminy Adverse Event<span class="subclass"> SubClassOf </span>Ventricular Arrhythmia Adverse Event. <br><i>New Terms: Bigeminy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>338</td>
               <td colspan="2">Biliary Tree Common Bile Duct Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Biliary Tree Common Bile Duct Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>339</td>
               <td colspan="2">Biliary Tree Common Hepatic Duct Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Biliary Tree Common Hepatic Duct Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>340</td>
               <td colspan="2">Biliary Tree Fistula Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Fistula Adverse Event. <br><i>New Terms: Biliary Tree Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>341</td>
               <td colspan="2">Biliary Tree Hemorrhage Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Hemorrhage Adverse Event. <br><i>New Terms: Biliary Tree Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>342</td>
               <td colspan="2">Biliary Tree Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Biliary Tree Infection Adverse Event Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>343</td>
               <td colspan="2">Biliary Tree Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Biliary Tree Infection Adverse Event with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>344</td>
               <td colspan="2">Biliary Tree Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Biliary Tree Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>345</td>
               <td colspan="2">Biliary Tree Leak Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Leak Adverse Event Including Anastomotic Leak. <br><i>New Terms: Biliary Tree Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>346</td>
               <td colspan="2">Biliary Tree Left Hepatic Duct Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Biliary Tree Left Hepatic Duct Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>347</td>
               <td colspan="2">Biliary Tree NOS Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Biliary Tree NOS Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>348</td>
               <td colspan="2">Biliary Tree Perforation Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Perforation Adverse Event. <br><i>New Terms: Biliary Tree Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>349</td>
               <td colspan="2">Biliary Tree Right Hepatic Duct Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Biliary Tree Right Hepatic Duct Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>350</td>
               <td colspan="2">Biliary Tree Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Stricture<br><span class="keyword"> and </span>Stenosis Adverse Event Including Anastomotic Stricture<br><span class="keyword"> and </span>Stenosis. <br><i>New Terms: Biliary Tree Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>351</td>
               <td colspan="2">Bladder Fistula Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Fistula Adverse Event. <br><i>New Terms: Bladder Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>352</td>
               <td colspan="2">Bladder Hemorrhage Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Hemorrhage Adverse Event. <br><i>New Terms: Bladder Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>353</td>
               <td colspan="2">Bladder Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Bladder Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>354</td>
               <td colspan="2">Bladder Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Bladder Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>355</td>
               <td colspan="2">Bladder Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Bladder Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>356</td>
               <td colspan="2">Bladder Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Bladder Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>357</td>
               <td colspan="2">Bladder Leak Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Leak Adverse Event Including Anastomotic Leak. <br><i>New Terms: Bladder Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>358</td>
               <td colspan="2">Bladder Obstruction Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Obstruction Adverse Event. <br><i>New Terms: Bladder Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>359</td>
               <td colspan="2">Bladder Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Bladder Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>360</td>
               <td colspan="2">Bladder Perforation Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Perforation Adverse Event. <br><i>New Terms: Bladder Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>361</td>
               <td colspan="2">Bladder Spasm Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Kidney<br><span class="keyword"> and </span>Genitourinary System. <br><i>New Terms: Bladder Spasm Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>362</td>
               <td colspan="2">Bladder Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Stricture<br><span class="keyword"> and </span>Stenosis Adverse Event Including Anastomotic Stricture<br><span class="keyword"> and </span>Stenosis. <br><i>New Terms: Bladder Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>363</td>
               <td colspan="2">Blood Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Blood Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>364</td>
               <td colspan="2">Blood Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Blood Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>365</td>
               <td colspan="2">Blood Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Blood Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>367</td>
               <td colspan="2">Blood Pressure Finding<span class="subclass"> SubClassOf </span>Cardiovascular System Finding. <br><i>New Terms: Blood Pressure Finding</i></td>
            </tr>
            <tr class="addition">
               <td>366</td>
               <td colspan="2">Blood Pressure<span class="subclass"> SubClassOf </span>Personal Attribute. <br><i>New Terms: Blood Pressure</i></td>
            </tr>
            <tr class="addition">
               <td>368</td>
               <td colspan="2">Blurred Vision Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Ocular<br><span class="keyword"> and </span>Visual Systems. <br><i>New Terms: Blurred Vision Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>369</td>
               <td colspan="2">Board Eligible<span class="subclass"> SubClassOf </span>Personal Attribute. <br><i>New Terms: Board Eligible</i></td>
            </tr>
            <tr class="addition">
               <td>370</td>
               <td colspan="2">Bone Growth Limb Length Discrepancy Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Growth<br><span class="keyword"> and </span>Development. <br><i>New Terms: Bone Growth Limb Length Discrepancy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>371</td>
               <td colspan="2">Bone Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Bone Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>372</td>
               <td colspan="2">Bone Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Bone Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or 2
                     Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>373</td>
               <td colspan="2">Bone Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Bone Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>374</td>
               <td colspan="2">Bone Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Bone Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>375</td>
               <td colspan="2">Bone Marrow Cellularity Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Blood<br><span class="keyword"> and </span>Bone Marrow. <br><i>New Terms: Bone Marrow Cellularity Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>376</td>
               <td colspan="2">Bone Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Bone Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>377</td>
               <td colspan="2">Brachial Plexopathy Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Nervous System. <br><i>New Terms: Brachial Plexopathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>378</td>
               <td colspan="2">Brachial Plexus Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Brachial Plexus Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>379</td>
               <td colspan="2">Brain Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Brain Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>380</td>
               <td colspan="2">Brain Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Brain Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>381</td>
               <td colspan="2">Brain Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Brain Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>382</td>
               <td colspan="2">Brain Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Brain Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>383</td>
               <td colspan="2">Brain<br><span class="keyword"> and </span>Spinal Cord Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Brain and Spinal Cord Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>384</td>
               <td colspan="2">Brain<br><span class="keyword"> and </span>Spinal Cord Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Brain and Spinal Cord Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>385</td>
               <td colspan="2">Brain<br><span class="keyword"> and </span>Spinal Cord Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Brain and Spinal Cord Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>386</td>
               <td colspan="2">Breast Function<br><span class="keyword"> and </span>Lactation Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Sexual<br><span class="keyword"> and </span>Reproductive Function. <br><i>New Terms: Breast Function and Lactation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>387</td>
               <td colspan="2">Breast Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Breast Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>388</td>
               <td colspan="2">Breast Nevus<span class="subclass"> SubClassOf </span>Breast Neoplasm. <br><i>New Terms: Breast Nevus</i></td>
            </tr>
            <tr class="addition">
               <td>389</td>
               <td colspan="2">Breast Nevus<span class="subclass"> SubClassOf </span>Melanocytic Nevus. <br><i>New Terms: Breast Nevus</i></td>
            </tr>
            <tr class="addition">
               <td>390</td>
               <td colspan="2">Breast Nipple<br><span class="keyword"> and </span>Areolar Deformity Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Sexual<br><span class="keyword"> and </span>Reproductive Function. <br><i>New Terms: Breast Nipple and Areolar Deformity Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>391</td>
               <td colspan="2">Breast Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Breast Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>392</td>
               <td colspan="2">Breast Volume<br><span class="keyword"> and </span>Hypoplasia Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Sexual<br><span class="keyword"> and </span>Reproductive Function. <br><i>New Terms: Breast Volume and Hypoplasia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>393</td>
               <td colspan="2">Bronchopulmonary Hemorrhage Adverse Event NOS<span class="subclass"> SubClassOf </span>Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Hemorrhage Adverse Event. <br><i>New Terms: Bronchopulmonary Hemorrhage Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>394</td>
               <td colspan="2">Bronchospasm<br><span class="keyword"> and </span>Wheezing Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Systems. <br><i>New Terms: Bronchospasm and Wheezing Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>395</td>
               <td colspan="2">Bronchus Fistula Adverse Event<span class="subclass"> SubClassOf </span>Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Fistula Adverse Event. <br><i>New Terms: Bronchus Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>396</td>
               <td colspan="2">Bronchus Hemorrhage Adverse Event<span class="subclass"> SubClassOf </span>Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Hemorrhage Adverse Event. <br><i>New Terms: Bronchus Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>397</td>
               <td colspan="2">Bronchus Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Bronchus Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>398</td>
               <td colspan="2">Bronchus Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Bronchus Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>399</td>
               <td colspan="2">Bronchus Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Bronchus Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>400</td>
               <td colspan="2">Bronchus Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Bronchus Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>401</td>
               <td colspan="2">Bronchus Obstruction<br><span class="keyword"> and </span>Stenosis Adverse Event<span class="subclass"> SubClassOf </span>Airway Obstruction<br><span class="keyword"> and </span>Stenosis Adverse Event. <br><i>New Terms: Bronchus Obstruction and Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>402</td>
               <td colspan="2">Bruising in the Absence of Grade 3<br><span class="keyword"> or </span>Grade 4 Thrombocytopenia Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Dermatology<br><span class="keyword"> and </span>Skin. <br><i>New Terms: Bruising in the Absence of Grade 3 or Grade 4 Thrombocytopenia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>403</td>
               <td colspan="2">Burn Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Dermatology<br><span class="keyword"> and </span>Skin. <br><i>New Terms: Burn Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>404</td>
               <td colspan="2">Buttock Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Buttock Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>405</td>
               <td colspan="2">CA2 Term<span class="subclass"> Type </span>SubClassOf Term Type. <br><i>New Terms: CA2 Term Type</i></td>
            </tr>
            <tr class="addition">
               <td>406</td>
               <td colspan="2">CA3 Term<span class="subclass"> Type </span>SubClassOf Term Type. <br><i>New Terms: CA3 Term Type</i></td>
            </tr>
            <tr class="addition">
               <td>407</td>
               <td colspan="2">CAS Number<span class="subclass"> SubClassOf </span>Identifier. <br><i>New Terms: CAS Number</i></td>
            </tr>
            <tr class="addition">
               <td>408</td>
               <td colspan="2">CD4 Count Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Blood<br><span class="keyword"> and </span>Bone Marrow. <br><i>New Terms: CD4 Count Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>409</td>
               <td colspan="2">CNS Cerebrovascular Ischemia Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Nervous System. <br><i>New Terms: CNS Cerebrovascular Ischemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>410</td>
               <td colspan="2">CNS Necrosis<br><span class="keyword"> and </span>Cystic Progression Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Nervous System. <br><i>New Terms: CNS Necrosis and Cystic Progression Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>411</td>
               <td colspan="2">CNU Term<span class="subclass"> Type </span>SubClassOf Term Type. <br><i>New Terms: CNU Term Type</i></td>
            </tr>
            <tr class="addition">
               <td>412</td>
               <td colspan="2">CTCAE Grade 1 AV Block First Degree<span class="subclass"> SubClassOf </span>AV Block First Degree Adverse Event. <br><i>New Terms: CTCAE Grade 1 AV Block First Degree, AV Block First Degree Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>413</td>
               <td colspan="2">CTCAE Grade 1 AV Block Second Degree Mobitz<span class="subclass"> Type </span>I<span class="subclass"> SubClassOf </span>AV Block Second Degree Mobitz<span class="subclass"> Type </span>I Adverse Event. <br><i>New Terms: CTCAE Grade 1 AV Block Second Degree Mobitz Type I, AV Block Second Degree Mobitz
                     Type I Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>414</td>
               <td colspan="2">CTCAE Grade 1 AV Block Second Degree Mobitz<span class="subclass"> Type </span>II<span class="subclass"> SubClassOf </span>AV Block Second Degree Mobitz<span class="subclass"> Type </span>II Adverse Event. <br><i>New Terms: AV Block Second Degree Mobitz Type II Adverse Event, CTCAE Grade 1 AV Block Second
                     Degree Mobitz Type II</i></td>
            </tr>
            <tr class="addition">
               <td>415</td>
               <td colspan="2">CTCAE Grade 1 AV Block Third Degree<span class="subclass"> SubClassOf </span>AV Block Third Degree Adverse Event. <br><i>New Terms: CTCAE Grade 1 AV Block Third Degree, AV Block Third Degree Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>416</td>
               <td colspan="2">CTCAE Grade 1 Abdomen Fistula NOS<span class="subclass"> SubClassOf </span>Abdomen Fistula Adverse Event NOS. <br><i>New Terms: CTCAE Grade 1 Abdomen Fistula NOS, Abdomen Fistula Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>417</td>
               <td colspan="2">CTCAE Grade 1 Abdomen Hemorrhage NOS<span class="subclass"> SubClassOf </span>Abdomen Hemorrhage Adverse Event NOS. <br><i>New Terms: CTCAE Grade 1 Abdomen Hemorrhage NOS, Abdomen Hemorrhage Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>418</td>
               <td colspan="2">CTCAE Grade 1 Abdomen NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Abdomen NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: Abdomen NOS Intra-Operative Injury Adverse Event, CTCAE Grade 1 Abdomen NOS Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>419</td>
               <td colspan="2">CTCAE Grade 1 Abdomen Pain NOS<span class="subclass"> SubClassOf </span>Abdomen Pain NOS Adverse Event. <br><i>New Terms: CTCAE Grade 1 Abdomen Pain NOS, Abdomen Pain NOS Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>420</td>
               <td colspan="2">CTCAE Grade 1 Abdominal Distension<br><span class="keyword"> or </span>Bloating<span class="subclass"> SubClassOf </span>Abdominal Distension<br><span class="keyword"> or </span>Bloating Adverse Event. <br><i>New Terms: Abdominal Distension or Bloating Adverse Event, CTCAE Grade 1 Abdominal Distension
                     or Bloating</i></td>
            </tr>
            <tr class="addition">
               <td>421</td>
               <td colspan="2">CTCAE Grade 1 Adrenal Gland Intra-Operative Injury<span class="subclass"> SubClassOf </span>Adrenal Gland Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Adrenal Gland Intra-Operative Injury, Adrenal Gland Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>422</td>
               <td colspan="2">CTCAE Grade 1 Adrenal Insufficiency<span class="subclass"> SubClassOf </span>Adrenal Insufficiency Adverse Event. <br><i>New Terms: CTCAE Grade 1 Adrenal Insufficiency, Adrenal Insufficiency Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>423</td>
               <td colspan="2">CTCAE Grade 1 Agitation<span class="subclass"> SubClassOf </span>Agitation Adverse Event. <br><i>New Terms: Agitation Adverse Event, CTCAE Grade 1 Agitation</i></td>
            </tr>
            <tr class="addition">
               <td>424</td>
               <td colspan="2">CTCAE Grade 1 Alkaline phosphatase<span class="subclass"> SubClassOf </span>Alkaline Phosphatase Adverse Event. <br><i>New Terms: Alkaline Phosphatase Adverse Event, CTCAE Grade 1 Alkaline phosphatase</i></td>
            </tr>
            <tr class="addition">
               <td>425</td>
               <td colspan="2">CTCAE Grade 1 Allergic Reaction<br><span class="keyword"> and </span>Hypersensitivity Including Drug Fever<span class="subclass"> SubClassOf </span>Allergic Reaction<br><span class="keyword"> and </span>Hypersensitivity Adverse Event Including Drug Fever. <br><i>New Terms: CTCAE Grade 1 Allergic Reaction and Hypersensitivity Including Drug Fever, Allergic
                     Reaction and Hypersensitivity Adverse Event Including Drug Fever</i></td>
            </tr>
            <tr class="addition">
               <td>426</td>
               <td colspan="2">CTCAE Grade 1 Allergic Rhinitis Including Sneezing Nasal Stuffiness Postnasal Drip<span class="subclass"> SubClassOf </span>Allergic Rhinitis Adverse Event Including Sneezing Nasal Stuffiness Postnasal Drip. <br><i>New Terms: Allergic Rhinitis Adverse Event Including Sneezing Nasal Stuffiness Postnasal Drip,
                     CTCAE Grade 1 Allergic Rhinitis Including Sneezing Nasal Stuffiness Postnasal Drip</i></td>
            </tr>
            <tr class="addition">
               <td>427</td>
               <td colspan="2">CTCAE Grade 1 Alopecia<span class="subclass"> SubClassOf </span>Alopecia Adverse Event. <br><i>New Terms: Alopecia Adverse Event, CTCAE Grade 1 Alopecia</i></td>
            </tr>
            <tr class="addition">
               <td>428</td>
               <td colspan="2">CTCAE Grade 1 Amylase<span class="subclass"> SubClassOf </span>Amylase Adverse Event. <br><i>New Terms: Amylase Adverse Event, CTCAE Grade 1 Amylase</i></td>
            </tr>
            <tr class="addition">
               <td>429</td>
               <td colspan="2">CTCAE Grade 1 Anal Incontinence<span class="subclass"> SubClassOf </span>Anal Incontinence Adverse Event. <br><i>New Terms: CTCAE Grade 1 Anal Incontinence, Anal Incontinence Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>430</td>
               <td colspan="2">CTCAE Grade 1 Anal Sphincter Intra-Operative Injury<span class="subclass"> SubClassOf </span>Anal Sphincter Intra-Operative Injury Adverse Event. <br><i>New Terms: Anal Sphincter Intra-Operative Injury Adverse Event, CTCAE Grade 1 Anal Sphincter
                     Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>431</td>
               <td colspan="2">CTCAE Grade 1 Anorexia<span class="subclass"> SubClassOf </span>Anorexia Adverse Event. <br><i>New Terms: Anorexia Adverse Event, CTCAE Grade 1 Anorexia</i></td>
            </tr>
            <tr class="addition">
               <td>432</td>
               <td colspan="2">CTCAE Grade 1 Anus Fistula<span class="subclass"> SubClassOf </span>Anus Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 1 Anus Fistula, Anus Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>433</td>
               <td colspan="2">CTCAE Grade 1 Anus Hemorrhage<span class="subclass"> SubClassOf </span>Anus Hemorrhage Adverse Event. <br><i>New Terms: Anus Hemorrhage Adverse Event, CTCAE Grade 1 Anus Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>434</td>
               <td colspan="2">CTCAE Grade 1 Anus Intra-Operative Injury<span class="subclass"> SubClassOf </span>Anus Intra-Operative Injury Adverse Event. <br><i>New Terms: Anus Intra-Operative Injury Adverse Event, CTCAE Grade 1 Anus Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>435</td>
               <td colspan="2">CTCAE Grade 1 Anus Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Anus Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Clinical Examination Classification. <br><i>New Terms: Anus Mucositis or Stomatitis Adverse Event by Clinical Examination Classification,
                     CTCAE Grade 1 Anus Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>436</td>
               <td colspan="2">CTCAE Grade 1 Anus Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Anus Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: CTCAE Grade 1 Anus Mucositis or Stomatitis by Functional or Symptomatic Classification,
                     Anus Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>437</td>
               <td colspan="2">CTCAE Grade 1 Anus Pain<span class="subclass"> SubClassOf </span>Anus Pain Adverse Event. <br><i>New Terms: CTCAE Grade 1 Anus Pain, Anus Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>438</td>
               <td colspan="2">CTCAE Grade 1 Anus Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Anus Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 1 Anus Stricture or Stenosis, Anus Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>439</td>
               <td colspan="2">CTCAE Grade 1 Anus Ulcer<span class="subclass"> SubClassOf </span>Anus Ulcer Adverse Event. <br><i>New Terms: Anus Ulcer Adverse Event, CTCAE Grade 1 Anus Ulcer</i></td>
            </tr>
            <tr class="addition">
               <td>440</td>
               <td colspan="2">CTCAE Grade 1 Anxiety<span class="subclass"> SubClassOf </span>Anxiety Adverse Event. <br><i>New Terms: Anxiety Adverse Event, CTCAE Grade 1 Anxiety</i></td>
            </tr>
            <tr class="addition">
               <td>441</td>
               <td colspan="2">CTCAE Grade 1 Aorta Artery Injury<span class="subclass"> SubClassOf </span>Aorta Artery Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Aorta Artery Injury, Aorta Artery Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>442</td>
               <td colspan="2">CTCAE Grade 1 Aorta Artery Intra-Operative Injury<span class="subclass"> SubClassOf </span>Aorta Artery Intra-Operative Injury Adverse Event. <br><i>New Terms: Aorta Artery Intra-Operative Injury Adverse Event, CTCAE Grade 1 Aorta Artery Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>443</td>
               <td colspan="2">CTCAE Grade 1 Appendix Intra-Operative Injury<span class="subclass"> SubClassOf </span>Appendix Intra-Operative Injury Adverse Event. <br><i>New Terms: Appendix Intra-Operative Injury Adverse Event, CTCAE Grade 1 Appendix Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>444</td>
               <td colspan="2">CTCAE Grade 1 Appendix Perforation<span class="subclass"> SubClassOf </span>Appendix Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 1 Appendix Perforation, Appendix Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>445</td>
               <td colspan="2">CTCAE Grade 1 Arachnoiditis<br><span class="keyword"> and </span>Meningismus<br><span class="keyword"> and </span>Radiculitis<span class="subclass"> SubClassOf </span>Arachnoiditis<br><span class="keyword"> and </span>Meningismus<br><span class="keyword"> and </span>Radiculitis Adverse Event. <br><i>New Terms: CTCAE Grade 1 Arachnoiditis and Meningismus and Radiculitis, Arachnoiditis and Meningismus
                     and Radiculitis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>446</td>
               <td colspan="2">CTCAE Grade 1 Artery NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Artery NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: Artery NOS Intra-Operative Injury Adverse Event, CTCAE Grade 1 Artery NOS Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>447</td>
               <td colspan="2">CTCAE Grade 1 Aspiration<span class="subclass"> SubClassOf </span>Aspiration Adverse Event. <br><i>New Terms: Aspiration Adverse Event, CTCAE Grade 1 Aspiration</i></td>
            </tr>
            <tr class="addition">
               <td>448</td>
               <td colspan="2">CTCAE Grade 1 Associated with Dentures<br><span class="keyword"> or </span>Dental Prosthesis<span class="subclass"> SubClassOf </span>Adverse Event Associated with Dentures<br><span class="keyword"> or </span>Dental Prostheses. <br><i>New Terms: CTCAE Grade 1 Associated with Dentures or Dental Prosthesis, Adverse Event Associated
                     with Dentures or Dental Prostheses</i></td>
            </tr>
            <tr class="addition">
               <td>449</td>
               <td colspan="2">CTCAE Grade 1 Associated with the Teeth<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Teeth. <br><i>New Terms: Adverse Event Associated with the Teeth, CTCAE Grade 1 Associated with the Teeth</i></td>
            </tr>
            <tr class="addition">
               <td>450</td>
               <td colspan="2">CTCAE Grade 1 Asystole<span class="subclass"> SubClassOf </span>Asystole Adverse Event. <br><i>New Terms: Asystole Adverse Event, CTCAE Grade 1 Asystole</i></td>
            </tr>
            <tr class="addition">
               <td>451</td>
               <td colspan="2">CTCAE Grade 1 Ataxia<span class="subclass"> SubClassOf </span>Ataxia Adverse Event. <br><i>New Terms: CTCAE Grade 1 Ataxia, Ataxia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>452</td>
               <td colspan="2">CTCAE Grade 1 Atelectasis<span class="subclass"> SubClassOf </span>Atelectasis Adverse Event. <br><i>New Terms: Atelectasis Adverse Event, CTCAE Grade 1 Atelectasis</i></td>
            </tr>
            <tr class="addition">
               <td>453</td>
               <td colspan="2">CTCAE Grade 1 Atrial Fibrillation<span class="subclass"> SubClassOf </span>Atrial Fibrillation Adverse Event. <br><i>New Terms: CTCAE Grade 1 Atrial Fibrillation, Atrial Fibrillation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>454</td>
               <td colspan="2">CTCAE Grade 1 Atrial Flutter<span class="subclass"> SubClassOf </span>Atrial Flutter Adverse Event. <br><i>New Terms: Atrial Flutter Adverse Event, CTCAE Grade 1 Atrial Flutter</i></td>
            </tr>
            <tr class="addition">
               <td>455</td>
               <td colspan="2">CTCAE Grade 1 Atrial Tachycardia<br><span class="keyword"> or </span>Paroxysmal Atrial Tachycardia<span class="subclass"> SubClassOf </span>Atrial Tachycardia<br><span class="keyword"> or </span>Paroxysmal Atrial Tachycardia Adverse Event. <br><i>New Terms: CTCAE Grade 1 Atrial Tachycardia or Paroxysmal Atrial Tachycardia, Atrial Tachycardia
                     or Paroxysmal Atrial Tachycardia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>456</td>
               <td colspan="2">CTCAE Grade 1 Autoimmune Reaction<span class="subclass"> SubClassOf </span>Autoimmune Reaction Adverse Event. <br><i>New Terms: Autoimmune Reaction Adverse Event, CTCAE Grade 1 Autoimmune Reaction</i></td>
            </tr>
            <tr class="addition">
               <td>457</td>
               <td colspan="2">CTCAE Grade 1 Avascular Osteonecrosis<span class="subclass"> SubClassOf </span>Avascular Osteonecrosis Adverse Event. <br><i>New Terms: CTCAE Grade 1 Avascular Osteonecrosis, Avascular Osteonecrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>458</td>
               <td colspan="2">CTCAE Grade 1 Back Pain<span class="subclass"> SubClassOf </span>Back Pain Adverse Event. <br><i>New Terms: CTCAE Grade 1 Back Pain, Back Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>459</td>
               <td colspan="2">CTCAE Grade 1 Bigeminy<span class="subclass"> SubClassOf </span>Bigeminy Adverse Event. <br><i>New Terms: CTCAE Grade 1 Bigeminy, Bigeminy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>460</td>
               <td colspan="2">CTCAE Grade 1 Biliary Tree Common Bile Duct Intra-Operative Injury<span class="subclass"> SubClassOf </span>Biliary Tree Common Bile Duct Intra-Operative Injury Adverse Event. <br><i>New Terms: Biliary Tree Common Bile Duct Intra-Operative Injury Adverse Event, CTCAE Grade 1
                     Biliary Tree Common Bile Duct Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>461</td>
               <td colspan="2">CTCAE Grade 1 Biliary Tree Common Hepatic Duct Intra-Operative Injury<span class="subclass"> SubClassOf </span>Biliary Tree Common Hepatic Duct Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Biliary Tree Common Hepatic Duct Intra-Operative Injury, Biliary Tree
                     Common Hepatic Duct Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>462</td>
               <td colspan="2">CTCAE Grade 1 Biliary Tree Fistula<span class="subclass"> SubClassOf </span>Biliary Tree Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 1 Biliary Tree Fistula, Biliary Tree Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>463</td>
               <td colspan="2">CTCAE Grade 1 Biliary Tree Hemorrhage<span class="subclass"> SubClassOf </span>Biliary Tree Hemorrhage Adverse Event. <br><i>New Terms: Biliary Tree Hemorrhage Adverse Event, CTCAE Grade 1 Biliary Tree Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>464</td>
               <td colspan="2">CTCAE Grade 1 Biliary Tree Leak<span class="subclass"> SubClassOf </span>Biliary Tree Leak Adverse Event. <br><i>New Terms: CTCAE Grade 1 Biliary Tree Leak, Biliary Tree Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>465</td>
               <td colspan="2">CTCAE Grade 1 Biliary Tree Left Hepatic Duct Intra-Operative Injury<span class="subclass"> SubClassOf </span>Biliary Tree Left Hepatic Duct Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Biliary Tree Left Hepatic Duct Intra-Operative Injury, Biliary Tree
                     Left Hepatic Duct Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>466</td>
               <td colspan="2">CTCAE Grade 1 Biliary Tree NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Biliary Tree NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: Biliary Tree NOS Intra-Operative Injury Adverse Event, CTCAE Grade 1 Biliary Tree
                     NOS Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>467</td>
               <td colspan="2">CTCAE Grade 1 Biliary Tree Perforation<span class="subclass"> SubClassOf </span>Biliary Tree Perforation Adverse Event. <br><i>New Terms: Biliary Tree Perforation Adverse Event, CTCAE Grade 1 Biliary Tree Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>468</td>
               <td colspan="2">CTCAE Grade 1 Biliary Tree Right Hepatic Duct Intra-Operative Injury<span class="subclass"> SubClassOf </span>Biliary Tree Right Hepatic Duct Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Biliary Tree Right Hepatic Duct Intra-Operative Injury, Biliary Tree
                     Right Hepatic Duct Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>469</td>
               <td colspan="2">CTCAE Grade 1 Biliary Tree Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Biliary Tree Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Biliary Tree Stricture or Stenosis Adverse Event, CTCAE Grade 1 Biliary Tree Stricture
                     or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>470</td>
               <td colspan="2">CTCAE Grade 1 Bladder Fistula<span class="subclass"> SubClassOf </span>Bladder Fistula Adverse Event. <br><i>New Terms: Bladder Fistula Adverse Event, CTCAE Grade 1 Bladder Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>471</td>
               <td colspan="2">CTCAE Grade 1 Bladder Hemorrhage<span class="subclass"> SubClassOf </span>Bladder Hemorrhage Adverse Event. <br><i>New Terms: Bladder Hemorrhage Adverse Event, CTCAE Grade 1 Bladder Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>472</td>
               <td colspan="2">CTCAE Grade 1 Bladder Intra-Operative Injury<span class="subclass"> SubClassOf </span>Bladder Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Bladder Intra-Operative Injury, Bladder Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>473</td>
               <td colspan="2">CTCAE Grade 1 Bladder Leak<span class="subclass"> SubClassOf </span>Bladder Leak Adverse Event. <br><i>New Terms: Bladder Leak Adverse Event, CTCAE Grade 1 Bladder Leak</i></td>
            </tr>
            <tr class="addition">
               <td>474</td>
               <td colspan="2">CTCAE Grade 1 Bladder Obstruction<span class="subclass"> SubClassOf </span>Bladder Obstruction Adverse Event. <br><i>New Terms: Bladder Obstruction Adverse Event, CTCAE Grade 1 Bladder Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>475</td>
               <td colspan="2">CTCAE Grade 1 Bladder Pain<span class="subclass"> SubClassOf </span>Bladder Pain Adverse Event. <br><i>New Terms: Bladder Pain Adverse Event, CTCAE Grade 1 Bladder Pain</i></td>
            </tr>
            <tr class="addition">
               <td>476</td>
               <td colspan="2">CTCAE Grade 1 Bladder Perforation<span class="subclass"> SubClassOf </span>Bladder Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 1 Bladder Perforation, Bladder Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>477</td>
               <td colspan="2">CTCAE Grade 1 Bladder Spasms<span class="subclass"> SubClassOf </span>Bladder Spasm Adverse Event. <br><i>New Terms: Bladder Spasm Adverse Event, CTCAE Grade 1 Bladder Spasms</i></td>
            </tr>
            <tr class="addition">
               <td>478</td>
               <td colspan="2">CTCAE Grade 1 Bladder Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Bladder Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 1 Bladder Stricture or Stenosis, Bladder Stricture or Stenosis Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>479</td>
               <td colspan="2">CTCAE Grade 1 Blurred Vision<span class="subclass"> SubClassOf </span>Blurred Vision Adverse Event. <br><i>New Terms: CTCAE Grade 1 Blurred Vision, Blurred Vision Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>480</td>
               <td colspan="2">CTCAE Grade 1 Bone Growth Limb Length Discrepancy<span class="subclass"> SubClassOf </span>Bone Growth Limb Length Discrepancy Adverse Event. <br><i>New Terms: CTCAE Grade 1 Bone Growth Limb Length Discrepancy, Bone Growth Limb Length Discrepancy
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>481</td>
               <td colspan="2">CTCAE Grade 1 Bone Intra-Operative Injury<span class="subclass"> SubClassOf </span>Bone Intra-Operative Injury Adverse Event. <br><i>New Terms: Bone Intra-Operative Injury Adverse Event, CTCAE Grade 1 Bone Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>482</td>
               <td colspan="2">CTCAE Grade 1 Bone Marrow Cellularity<span class="subclass"> SubClassOf </span>Bone Marrow Cellularity Adverse Event. <br><i>New Terms: Bone Marrow Cellularity Adverse Event, CTCAE Grade 1 Bone Marrow Cellularity</i></td>
            </tr>
            <tr class="addition">
               <td>483</td>
               <td colspan="2">CTCAE Grade 1 Bone Pain<span class="subclass"> SubClassOf </span>Bone Pain Adverse Event. <br><i>New Terms: CTCAE Grade 1 Bone Pain, Bone Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>484</td>
               <td colspan="2">CTCAE Grade 1 Brachial Plexopathy<span class="subclass"> SubClassOf </span>Brachial Plexopathy Adverse Event. <br><i>New Terms: Brachial Plexopathy Adverse Event, CTCAE Grade 1 Brachial Plexopathy</i></td>
            </tr>
            <tr class="addition">
               <td>485</td>
               <td colspan="2">CTCAE Grade 1 Brachial Plexus Intra-Operative Injury<span class="subclass"> SubClassOf </span>Brachial Plexus Intra-Operative Injury Adverse Event. <br><i>New Terms: Brachial Plexus Intra-Operative Injury Adverse Event, CTCAE Grade 1 Brachial Plexus
                     Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>486</td>
               <td colspan="2">CTCAE Grade 1 Brain Intra-Operative Injury<span class="subclass"> SubClassOf </span>Brain Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Brain Intra-Operative Injury, Brain Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>487</td>
               <td colspan="2">CTCAE Grade 1 Breast Function<br><span class="keyword"> and </span>Lactation<span class="subclass"> SubClassOf </span>Breast Function<br><span class="keyword"> and </span>Lactation Adverse Event. <br><i>New Terms: Breast Function and Lactation Adverse Event, CTCAE Grade 1 Breast Function and Lactation</i></td>
            </tr>
            <tr class="addition">
               <td>488</td>
               <td colspan="2">CTCAE Grade 1 Breast Intra-Operative Injury<span class="subclass"> SubClassOf </span>Breast Intra-Operative Injury Adverse Event. <br><i>New Terms: Breast Intra-Operative Injury Adverse Event, CTCAE Grade 1 Breast Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>489</td>
               <td colspan="2">CTCAE Grade 1 Breast Nipple<br><span class="keyword"> and </span>Areolar Deformity<span class="subclass"> SubClassOf </span>Breast Nipple<br><span class="keyword"> and </span>Areolar Deformity Adverse Event. <br><i>New Terms: Breast Nipple and Areolar Deformity Adverse Event, CTCAE Grade 1 Breast Nipple and
                     Areolar Deformity</i></td>
            </tr>
            <tr class="addition">
               <td>490</td>
               <td colspan="2">CTCAE Grade 1 Breast Pain<span class="subclass"> SubClassOf </span>Breast Pain Adverse Event. <br><i>New Terms: Breast Pain Adverse Event, CTCAE Grade 1 Breast Pain</i></td>
            </tr>
            <tr class="addition">
               <td>491</td>
               <td colspan="2">CTCAE Grade 1 Breast Volume<br><span class="keyword"> and </span>Hypoplasia<span class="subclass"> SubClassOf </span>Breast Volume<br><span class="keyword"> and </span>Hypoplasia Adverse Event. <br><i>New Terms: CTCAE Grade 1 Breast Volume and Hypoplasia, Breast Volume and Hypoplasia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>492</td>
               <td colspan="2">CTCAE Grade 1 Bronchopulmonary Hemorrhage NOS<span class="subclass"> SubClassOf </span>Bronchopulmonary Hemorrhage Adverse Event NOS. <br><i>New Terms: CTCAE Grade 1 Bronchopulmonary Hemorrhage NOS, Bronchopulmonary Hemorrhage Adverse
                     Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>493</td>
               <td colspan="2">CTCAE Grade 1 Bronchospasm<br><span class="keyword"> and </span>Wheezing<span class="subclass"> SubClassOf </span>Bronchospasm<br><span class="keyword"> and </span>Wheezing Adverse Event. <br><i>New Terms: Bronchospasm and Wheezing Adverse Event, CTCAE Grade 1 Bronchospasm and Wheezing</i></td>
            </tr>
            <tr class="addition">
               <td>494</td>
               <td colspan="2">CTCAE Grade 1 Bronchus Fistula<span class="subclass"> SubClassOf </span>Bronchus Fistula Adverse Event. <br><i>New Terms: Bronchus Fistula Adverse Event, CTCAE Grade 1 Bronchus Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>495</td>
               <td colspan="2">CTCAE Grade 1 Bronchus Hemorrhage<span class="subclass"> SubClassOf </span>Bronchus Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 1 Bronchus Hemorrhage, Bronchus Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>496</td>
               <td colspan="2">CTCAE Grade 1 Bronchus Intra-Operative Injury<span class="subclass"> SubClassOf </span>Bronchus Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Bronchus Intra-Operative Injury, Bronchus Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>497</td>
               <td colspan="2">CTCAE Grade 1 Bronchus Obstruction<br><span class="keyword"> and </span>Stenosis<span class="subclass"> SubClassOf </span>Bronchus Obstruction<br><span class="keyword"> and </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 1 Bronchus Obstruction and Stenosis, Bronchus Obstruction and Stenosis
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>498</td>
               <td colspan="2">CTCAE Grade 1 Bruising in the Absence of Grade 3<br><span class="keyword"> or </span>Grade 4 Thrombocytopenia<span class="subclass"> SubClassOf </span>Bruising in the Absence of Grade 3<br><span class="keyword"> or </span>Grade 4 Thrombocytopenia Adverse Event. <br><i>New Terms: CTCAE Grade 1 Bruising in the Absence of Grade 3 or Grade 4 Thrombocytopenia, Bruising
                     in the Absence of Grade 3 or Grade 4 Thrombocytopenia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>499</td>
               <td colspan="2">CTCAE Grade 1 Burn<span class="subclass"> SubClassOf </span>Burn Adverse Event. <br><i>New Terms: Burn Adverse Event, CTCAE Grade 1 Burn</i></td>
            </tr>
            <tr class="addition">
               <td>500</td>
               <td colspan="2">CTCAE Grade 1 Buttock Pain<span class="subclass"> SubClassOf </span>Buttock Pain Adverse Event. <br><i>New Terms: CTCAE Grade 1 Buttock Pain, Buttock Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>501</td>
               <td colspan="2">CTCAE Grade 1 CD4 Count<span class="subclass"> SubClassOf </span>CD4 Count Adverse Event. <br><i>New Terms: CTCAE Grade 1 CD4 Count, CD4 Count Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>502</td>
               <td colspan="2">CTCAE Grade 1 CNS Necrosis<br><span class="keyword"> and </span>Cystic Progression<span class="subclass"> SubClassOf </span>CNS Necrosis<br><span class="keyword"> and </span>Cystic Progression Adverse Event. <br><i>New Terms: CNS Necrosis and Cystic Progression Adverse Event, CTCAE Grade 1 CNS Necrosis and
                     Cystic Progression</i></td>
            </tr>
            <tr class="addition">
               <td>503</td>
               <td colspan="2">CTCAE Grade 1 Carbon Monoxide Diffusion Capacity<span class="subclass"> SubClassOf </span>Carbon Monoxide Diffusion Capacity Adverse Event. <br><i>New Terms: Carbon Monoxide Diffusion Capacity Adverse Event, CTCAE Grade 1 Carbon Monoxide Diffusion
                     Capacity</i></td>
            </tr>
            <tr class="addition">
               <td>504</td>
               <td colspan="2">CTCAE Grade 1 Cardiac Ischemia<br><span class="keyword"> or </span>Infarction<span class="subclass"> SubClassOf </span>Cardiac Ischemia<br><span class="keyword"> or </span>Infarction Adverse Event. <br><i>New Terms: Cardiac Ischemia or Infarction Adverse Event, CTCAE Grade 1 Cardiac Ischemia or Infarction</i></td>
            </tr>
            <tr class="addition">
               <td>505</td>
               <td colspan="2">CTCAE Grade 1 Cardiac Troponin T<span class="subclass"> SubClassOf </span>Cardiac Troponin T Adverse Event. <br><i>New Terms: Cardiac Troponin T Adverse Event, CTCAE Grade 1 Cardiac Troponin T</i></td>
            </tr>
            <tr class="addition">
               <td>506</td>
               <td colspan="2">CTCAE Grade 1 Cardiac<br><span class="keyword"> and </span>Heart Pain<span class="subclass"> SubClassOf </span>Cardiac<br><span class="keyword"> and </span>Heart Pain Adverse Event. <br><i>New Terms: Cardiac and Heart Pain Adverse Event, CTCAE Grade 1 Cardiac and Heart Pain</i></td>
            </tr>
            <tr class="addition">
               <td>507</td>
               <td colspan="2">CTCAE Grade 1 Carotid Artery Injury<span class="subclass"> SubClassOf </span>Carotid Artery Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Carotid Artery Injury, Carotid Artery Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>508</td>
               <td colspan="2">CTCAE Grade 1 Carotid Artery Intra-Operative Injury<span class="subclass"> SubClassOf </span>Carotid Artery Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Carotid Artery Intra-Operative Injury, Carotid Artery Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>509</td>
               <td colspan="2">CTCAE Grade 1 Cartilage Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cartilage Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Cartilage Intra-Operative Injury, Cartilage Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>510</td>
               <td colspan="2">CTCAE Grade 1 Cataract<span class="subclass"> SubClassOf </span>Cataract Adverse Event. <br><i>New Terms: CTCAE Grade 1 Cataract, Cataract Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>511</td>
               <td colspan="2">CTCAE Grade 1 Cecum Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cecum Intra-Operative Injury Adverse Event. <br><i>New Terms: Cecum Intra-Operative Injury Adverse Event, CTCAE Grade 1 Cecum Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>512</td>
               <td colspan="2">CTCAE Grade 1 Cecum Obstruction<span class="subclass"> SubClassOf </span>Cecum Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 1 Cecum Obstruction, Cecum Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>513</td>
               <td colspan="2">CTCAE Grade 1 Cecum Perforation<span class="subclass"> SubClassOf </span>Cecum Perforation Adverse Event. <br><i>New Terms: Cecum Perforation Adverse Event, CTCAE Grade 1 Cecum Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>514</td>
               <td colspan="2">CTCAE Grade 1 Cecum Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Cecum Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Cecum Stricture or Stenosis Adverse Event, CTCAE Grade 1 Cecum Stricture or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>515</td>
               <td colspan="2">CTCAE Grade 1 Cecum Ulcer<span class="subclass"> SubClassOf </span>Cecum Ulcer Adverse Event. <br><i>New Terms: CTCAE Grade 1 Cecum Ulcer, Cecum Ulcer Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>516</td>
               <td colspan="2">CTCAE Grade 1 Cecum<br><span class="keyword"> or </span>Appendix Hemorrhage<span class="subclass"> SubClassOf </span>Cecum<br><span class="keyword"> or </span>Appendix Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 1 Cecum or Appendix Hemorrhage, Cecum or Appendix Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>517</td>
               <td colspan="2">CTCAE Grade 1 Central Nervous System Hemorrhage<span class="subclass"> SubClassOf </span>Central Nervous System Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 1 Central Nervous System Hemorrhage, Central Nervous System Hemorrhage
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>518</td>
               <td colspan="2">CTCAE Grade 1 Cerebral Artery Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cerebral Artery Intra-Operative Injury Adverse Event. <br><i>New Terms: Cerebral Artery Intra-Operative Injury Adverse Event, CTCAE Grade 1 Cerebral Artery
                     Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>519</td>
               <td colspan="2">CTCAE Grade 1 Cerebrospinal Fluid Leak<span class="subclass"> SubClassOf </span>Cerebrospinal Fluid Leak Adverse Event. <br><i>New Terms: CTCAE Grade 1 Cerebrospinal Fluid Leak, Cerebrospinal Fluid Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>520</td>
               <td colspan="2">CTCAE Grade 1 Cervical Spine<span class="subclass"> Range </span>of Motion<span class="subclass"> SubClassOf </span>Cervical Spine<span class="subclass"> Range </span>of Motion Adverse Event. <br><i>New Terms: CTCAE Grade 1 Cervical Spine Range of Motion, Cervical Spine Range of Motion Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>521</td>
               <td colspan="2">CTCAE Grade 1 Cervix Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cervix Intra-Operative Injury Adverse Event. <br><i>New Terms: Cervix Intra-Operative Injury Adverse Event, CTCAE Grade 1 Cervix Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>522</td>
               <td colspan="2">CTCAE Grade 1 Cheilitis<span class="subclass"> SubClassOf </span>Cheilitis Adverse Event. <br><i>New Terms: Cheilitis Adverse Event, CTCAE Grade 1 Cheilitis</i></td>
            </tr>
            <tr class="addition">
               <td>523</td>
               <td colspan="2">CTCAE Grade 1 Chemoradiation<span class="subclass"> SubClassOf </span>Rash<br><span class="keyword"> and </span>Dermatitis Adverse Event Associated with Chemoradiation. <br><i>New Terms: Rash and Dermatitis Adverse Event Associated with Chemoradiation, CTCAE Grade 1 Chemoradiation</i></td>
            </tr>
            <tr class="addition">
               <td>524</td>
               <td colspan="2">CTCAE Grade 1 Chest Wall Pain<span class="subclass"> SubClassOf </span>Chest Wall Pain Adverse Event. <br><i>New Terms: CTCAE Grade 1 Chest Wall Pain, Chest Wall Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>525</td>
               <td colspan="2">CTCAE Grade 1 Chest<br><span class="keyword"> and </span>Thorax Pain<span class="subclass"> SubClassOf </span>Chest<br><span class="keyword"> and </span>Thorax Pain NOS Adverse Event. <br><i>New Terms: Chest and Thorax Pain NOS Adverse Event, CTCAE Grade 1 Chest and Thorax Pain</i></td>
            </tr>
            <tr class="addition">
               <td>526</td>
               <td colspan="2">CTCAE Grade 1 Cholecystitis<span class="subclass"> SubClassOf </span>Cholecystitis Adverse Event. <br><i>New Terms: CTCAE Grade 1 Cholecystitis, Cholecystitis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>527</td>
               <td colspan="2">CTCAE Grade 1 Chyle<br><span class="keyword"> or </span>Lymph Leakage<span class="subclass"> SubClassOf </span>Chyle<br><span class="keyword"> or </span>Lymph Leakage Adverse Event. <br><i>New Terms: Chyle or Lymph Leakage Adverse Event, CTCAE Grade 1 Chyle or Lymph Leakage</i></td>
            </tr>
            <tr class="addition">
               <td>528</td>
               <td colspan="2">CTCAE Grade 1 Chylothorax<span class="subclass"> SubClassOf </span>Chylothorax Adverse Event. <br><i>New Terms: Chylothorax Adverse Event, CTCAE Grade 1 Chylothorax</i></td>
            </tr>
            <tr class="addition">
               <td>529</td>
               <td colspan="2">CTCAE Grade 1 Cognitive Disturbance<span class="subclass"> SubClassOf </span>Cognitive Disturbance Adverse Event. <br><i>New Terms: CTCAE Grade 1 Cognitive Disturbance, Cognitive Disturbance Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>530</td>
               <td colspan="2">CTCAE Grade 1 Colitis<span class="subclass"> SubClassOf </span>Colitis Adverse Event. <br><i>New Terms: CTCAE Grade 1 Colitis, Colitis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>531</td>
               <td colspan="2">CTCAE Grade 1 Colon Hemorrhage<span class="subclass"> SubClassOf </span>Colon Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 1 Colon Hemorrhage, Colon Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>532</td>
               <td colspan="2">CTCAE Grade 1 Colon Intra-Operative Injury<span class="subclass"> SubClassOf </span>Colon Intra-Operative Injury Adverse Event. <br><i>New Terms: Colon Intra-Operative Injury Adverse Event, CTCAE Grade 1 Colon Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>533</td>
               <td colspan="2">CTCAE Grade 1 Colon Obstruction<span class="subclass"> SubClassOf </span>Colon Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 1 Colon Obstruction, Colon Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>534</td>
               <td colspan="2">CTCAE Grade 1 Colon Perforation<span class="subclass"> SubClassOf </span>Colon Perforation Adverse Event. <br><i>New Terms: Colon Perforation Adverse Event, CTCAE Grade 1 Colon Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>535</td>
               <td colspan="2">CTCAE Grade 1 Colon Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Colon Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Colon Stricture or Stenosis Adverse Event, CTCAE Grade 1 Colon Stricture or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>536</td>
               <td colspan="2">CTCAE Grade 1 Colon Ulcer<span class="subclass"> SubClassOf </span>Colon Ulcer Adverse Event. <br><i>New Terms: CTCAE Grade 1 Colon Ulcer, Colon Ulcer Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>537</td>
               <td colspan="2">CTCAE Grade 1 Colon<br><span class="keyword"> or </span>Cecum<br><span class="keyword"> or </span>Appendix Fistula<span class="subclass"> SubClassOf </span>Colon<br><span class="keyword"> or </span>Cecum<br><span class="keyword"> or </span>Appendix Fistula Adverse Event. <br><i>New Terms: Colon or Cecum or Appendix Fistula Adverse Event, CTCAE Grade 1 Colon or Cecum or
                     Appendix Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>538</td>
               <td colspan="2">CTCAE Grade 1 Conduction Abnormality NOS<span class="subclass"> SubClassOf </span>Conduction Abnormality Adverse Event NOS. <br><i>New Terms: Conduction Abnormality Adverse Event NOS, CTCAE Grade 1 Conduction Abnormality NOS</i></td>
            </tr>
            <tr class="addition">
               <td>539</td>
               <td colspan="2">CTCAE Grade 1 Confusion<span class="subclass"> SubClassOf </span>Confusion Adverse Event. <br><i>New Terms: CTCAE Grade 1 Confusion, Confusion Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>540</td>
               <td colspan="2">CTCAE Grade 1 Conjunctiva Intra-Operative Injury<span class="subclass"> SubClassOf </span>Conjunctiva Intra-Operative Injury Adverse Event. <br><i>New Terms: Conjunctiva Intra-Operative Injury Adverse Event, CTCAE Grade 1 Conjunctiva Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>541</td>
               <td colspan="2">CTCAE Grade 1 Constipation<span class="subclass"> SubClassOf </span>Constipation Adverse Event. <br><i>New Terms: CTCAE Grade 1 Constipation, Constipation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>542</td>
               <td colspan="2">CTCAE Grade 1 Cornea Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cornea Intra-Operative Injury Adverse Event. <br><i>New Terms: Cornea Intra-Operative Injury Adverse Event, CTCAE Grade 1 Cornea Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>543</td>
               <td colspan="2">CTCAE Grade 1 Cough<span class="subclass"> SubClassOf </span>Cough Adverse Event. <br><i>New Terms: Cough Adverse Event, CTCAE Grade 1 Cough</i></td>
            </tr>
            <tr class="addition">
               <td>553</td>
               <td colspan="2">CTCAE Grade 1 Cranial Nerve I Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve I Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Cranial Nerve I Intra-Operative Injury, Cranial Nerve I Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>554</td>
               <td colspan="2">CTCAE Grade 1 Cranial Nerve I Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve I Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve I Neuropathy Adverse Event, CTCAE Grade 1 Cranial Nerve I Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>546</td>
               <td colspan="2">CTCAE Grade 1 Cranial Nerve II Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve II Intra-Operative Injury Adverse Event. <br><i>New Terms: Cranial Nerve II Intra-Operative Injury Adverse Event, CTCAE Grade 1 Cranial Nerve
                     II Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>547</td>
               <td colspan="2">CTCAE Grade 1 Cranial Nerve II Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve II Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 1 Cranial Nerve II Neuropathy, Cranial Nerve II Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>544</td>
               <td colspan="2">CTCAE Grade 1 Cranial Nerve III Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve III Intra-Operative Injury Adverse Event. <br><i>New Terms: Cranial Nerve III Intra-Operative Injury Adverse Event, CTCAE Grade 1 Cranial Nerve
                     III Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>545</td>
               <td colspan="2">CTCAE Grade 1 Cranial Nerve III Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve III Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve III Neuropathy Adverse Event, CTCAE Grade 1 Cranial Nerve III Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>548</td>
               <td colspan="2">CTCAE Grade 1 Cranial Nerve IV Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve IV Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Cranial Nerve IV Intra-Operative Injury, Cranial Nerve IV Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>549</td>
               <td colspan="2">CTCAE Grade 1 Cranial Nerve IV Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve IV Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve IV Neuropathy Adverse Event, CTCAE Grade 1 Cranial Nerve IV Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>550</td>
               <td colspan="2">CTCAE Grade 1 Cranial Nerve IX Motor Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve IX Motor Intra-Operative Injury Adverse Event. <br><i>New Terms: Cranial Nerve IX Motor Intra-Operative Injury Adverse Event, CTCAE Grade 1 Cranial
                     Nerve IX Motor Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>551</td>
               <td colspan="2">CTCAE Grade 1 Cranial Nerve IX Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve IX Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 1 Cranial Nerve IX Neuropathy, Cranial Nerve IX Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>552</td>
               <td colspan="2">CTCAE Grade 1 Cranial Nerve IX Sensory Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve IX Sensory Intra-Operative Injury Adverse Event. <br><i>New Terms: Cranial Nerve IX Sensory Intra-Operative Injury Adverse Event, CTCAE Grade 1 Cranial
                     Nerve IX Sensory Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>555</td>
               <td colspan="2">CTCAE Grade 1 Cranial Nerve Or Branch NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve Or Branch NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Cranial Nerve Or Branch NOS Intra-Operative Injury, Cranial Nerve Or
                     Branch NOS Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>563</td>
               <td colspan="2">CTCAE Grade 1 Cranial Nerve V Motor Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve V Motor Intra-Operative Injury Adverse Event. <br><i>New Terms: Cranial Nerve V Motor Intra-Operative Injury Adverse Event, CTCAE Grade 1 Cranial
                     Nerve V Motor Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>564</td>
               <td colspan="2">CTCAE Grade 1 Cranial Nerve V Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve V Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve V Neuropathy Adverse Event, CTCAE Grade 1 Cranial Nerve V Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>565</td>
               <td colspan="2">CTCAE Grade 1 Cranial Nerve V Sensory Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve V Sensory Intra-Operative Injury Adverse Event. <br><i>New Terms: Cranial Nerve V Sensory Intra-Operative Injury Adverse Event, CTCAE Grade 1 Cranial
                     Nerve V Sensory Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>561</td>
               <td colspan="2">CTCAE Grade 1 Cranial Nerve VI Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve VI Intra-Operative Injury Adverse Event. <br><i>New Terms: Cranial Nerve VI Intra-Operative Injury Adverse Event, CTCAE Grade 1 Cranial Nerve
                     VI Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>562</td>
               <td colspan="2">CTCAE Grade 1 Cranial Nerve VI Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve VI Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve VI Neuropathy Adverse Event, CTCAE Grade 1 Cranial Nerve VI Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>558</td>
               <td colspan="2">CTCAE Grade 1 Cranial Nerve VII Motor Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve VII Motor Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Cranial Nerve VII Motor Intra-Operative Injury, Cranial Nerve VII Motor
                     Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>559</td>
               <td colspan="2">CTCAE Grade 1 Cranial Nerve VII Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve VII Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve VII Neuropathy Adverse Event, CTCAE Grade 1 Cranial Nerve VII Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>560</td>
               <td colspan="2">CTCAE Grade 1 Cranial Nerve VII Sensory Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve VII Sensory Intra-Operative Injury Adverse Event. <br><i>New Terms: Cranial Nerve VII Sensory Intra-Operative Injury Adverse Event, CTCAE Grade 1 Cranial
                     Nerve VII Sensory Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>556</td>
               <td colspan="2">CTCAE Grade 1 Cranial Nerve VIII Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve VIII Intra-Operative Injury Adverse Event. <br><i>New Terms: Cranial Nerve VIII Intra-Operative Injury Adverse Event, CTCAE Grade 1 Cranial Nerve
                     VIII Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>557</td>
               <td colspan="2">CTCAE Grade 1 Cranial Nerve VIII Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve VIII Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 1 Cranial Nerve VIII Neuropathy, Cranial Nerve VIII Neuropathy Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>570</td>
               <td colspan="2">CTCAE Grade 1 Cranial Nerve X Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve X Intra-Operative Injury Adverse Event. <br><i>New Terms: Cranial Nerve X Intra-Operative Injury Adverse Event, CTCAE Grade 1 Cranial Nerve
                     X Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>571</td>
               <td colspan="2">CTCAE Grade 1 Cranial Nerve X Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve X Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve X Neuropathy Adverse Event, CTCAE Grade 1 Cranial Nerve X Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>568</td>
               <td colspan="2">CTCAE Grade 1 Cranial Nerve XI Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve XI Intra-Operative Injury Adverse Event. <br><i>New Terms: Cranial Nerve XI Intra-Operative Injury Adverse Event, CTCAE Grade 1 Cranial Nerve
                     XI Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>569</td>
               <td colspan="2">CTCAE Grade 1 Cranial Nerve XI Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve XI Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve XI Neuropathy Adverse Event, CTCAE Grade 1 Cranial Nerve XI Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>566</td>
               <td colspan="2">CTCAE Grade 1 Cranial Nerve XII Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve XII Intra-Operative Injury Adverse Event. <br><i>New Terms: Cranial Nerve XII Intra-Operative Injury Adverse Event, CTCAE Grade 1 Cranial Nerve
                     XII Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>567</td>
               <td colspan="2">CTCAE Grade 1 Cranial Nerve XII Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve XII Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve XII Neuropathy Adverse Event, CTCAE Grade 1 Cranial Nerve XII Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>572</td>
               <td colspan="2">CTCAE Grade 1 Creatine Phosphokinase<span class="subclass"> SubClassOf </span>Creatine Phosphokinase Adverse Event. <br><i>New Terms: Creatine Phosphokinase Adverse Event, CTCAE Grade 1 Creatine Phosphokinase</i></td>
            </tr>
            <tr class="addition">
               <td>573</td>
               <td colspan="2">CTCAE Grade 1 Creatinine<span class="subclass"> SubClassOf </span>Creatinine Adverse Event. <br><i>New Terms: Creatinine Adverse Event, CTCAE Grade 1 Creatinine</i></td>
            </tr>
            <tr class="addition">
               <td>574</td>
               <td colspan="2">CTCAE Grade 1 Cystitis<span class="subclass"> SubClassOf </span>Cystitis Adverse Event. <br><i>New Terms: Cystitis Adverse Event, CTCAE Grade 1 Cystitis</i></td>
            </tr>
            <tr class="addition">
               <td>575</td>
               <td colspan="2">CTCAE Grade 1 Cytokine Release Syndrome<br><span class="keyword"> or </span>Acute Infusion Reaction<span class="subclass"> SubClassOf </span>Cytokine Release Syndrome<br><span class="keyword"> or </span>Acute Infusion Reaction Adverse Event. <br><i>New Terms: Cytokine Release Syndrome or Acute Infusion Reaction Adverse Event, CTCAE Grade 1
                     Cytokine Release Syndrome or Acute Infusion Reaction</i></td>
            </tr>
            <tr class="addition">
               <td>576</td>
               <td colspan="2">CTCAE Grade 1 Dehydration<span class="subclass"> SubClassOf </span>Dehydration Adverse Event. <br><i>New Terms: CTCAE Grade 1 Dehydration, Dehydration Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>577</td>
               <td colspan="2">CTCAE Grade 1 Dental<br><span class="keyword"> and </span>Teeth<br><span class="keyword"> and </span>Peridontal Pain<span class="subclass"> SubClassOf </span>Dental<br><span class="keyword"> and </span>Teeth<br><span class="keyword"> and </span>Peridontal Pain Adverse Event. <br><i>New Terms: Dental and Teeth and Peridontal Pain Adverse Event, CTCAE Grade 1 Dental and Teeth
                     and Peridontal Pain</i></td>
            </tr>
            <tr class="addition">
               <td>578</td>
               <td colspan="2">CTCAE Grade 1 Depression<span class="subclass"> SubClassOf </span>Depression Adverse Event. <br><i>New Terms: CTCAE Grade 1 Depression, Depression Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>579</td>
               <td colspan="2">CTCAE Grade 1 Dermal Change Lymphedema<br><span class="keyword"> or </span>Phlebolymphedema<span class="subclass"> SubClassOf </span>Dermal Change Adverse Event Lymphedema<br><span class="keyword"> or </span>Phlebolymphedema. <br><i>New Terms: CTCAE Grade 1 Dermal Change Lymphedema or Phlebolymphedema, Dermal Change Adverse
                     Event Lymphedema or Phlebolymphedema</i></td>
            </tr>
            <tr class="addition">
               <td>580</td>
               <td colspan="2">CTCAE Grade 1 Diaphoresis<span class="subclass"> SubClassOf </span>Diaphoresis Adverse Event. <br><i>New Terms: Diaphoresis Adverse Event, CTCAE Grade 1 Diaphoresis</i></td>
            </tr>
            <tr class="addition">
               <td>581</td>
               <td colspan="2">CTCAE Grade 1 Diarrhea<span class="subclass"> SubClassOf </span>Diarrhea Adverse Event. <br><i>New Terms: Diarrhea Adverse Event, CTCAE Grade 1 Diarrhea</i></td>
            </tr>
            <tr class="addition">
               <td>582</td>
               <td colspan="2">CTCAE Grade 1 Dizziness<span class="subclass"> SubClassOf </span>Dizziness Adverse Event. <br><i>New Terms: CTCAE Grade 1 Dizziness, Dizziness Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>583</td>
               <td colspan="2">CTCAE Grade 1 Dry Eye Syndrome<span class="subclass"> SubClassOf </span>Dry Eye Syndrome Adverse Event. <br><i>New Terms: CTCAE Grade 1 Dry Eye Syndrome, Dry Eye Syndrome Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>584</td>
               <td colspan="2">CTCAE Grade 1 Dry Skin<span class="subclass"> SubClassOf </span>Dry Skin Adverse Event. <br><i>New Terms: CTCAE Grade 1 Dry Skin, Dry Skin Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>585</td>
               <td colspan="2">CTCAE Grade 1 Duodenum Fistula<span class="subclass"> SubClassOf </span>Duodenum Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 1 Duodenum Fistula, Duodenum Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>586</td>
               <td colspan="2">CTCAE Grade 1 Duodenum Hemorrhage<span class="subclass"> SubClassOf </span>Duodenum Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 1 Duodenum Hemorrhage, Duodenum Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>587</td>
               <td colspan="2">CTCAE Grade 1 Duodenum Intra-Operative Injury<span class="subclass"> SubClassOf </span>Duodenum Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Duodenum Intra-Operative Injury, Duodenum Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>588</td>
               <td colspan="2">CTCAE Grade 1 Duodenum Obstruction<span class="subclass"> SubClassOf </span>Duodenum Obstruction Adverse Event. <br><i>New Terms: Duodenum Obstruction Adverse Event, CTCAE Grade 1 Duodenum Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>589</td>
               <td colspan="2">CTCAE Grade 1 Duodenum Perforation<span class="subclass"> SubClassOf </span>Duodenum Perforation Adverse Event. <br><i>New Terms: Duodenum Perforation Adverse Event, CTCAE Grade 1 Duodenum Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>590</td>
               <td colspan="2">CTCAE Grade 1 Duodenum Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Duodenum Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 1 Duodenum Stricture or Stenosis, Duodenum Stricture or Stenosis Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>591</td>
               <td colspan="2">CTCAE Grade 1 Duodenum Ulcer<span class="subclass"> SubClassOf </span>Duodenum Ulcer Adverse Event. <br><i>New Terms: Duodenum Ulcer Adverse Event, CTCAE Grade 1 Duodenum Ulcer</i></td>
            </tr>
            <tr class="addition">
               <td>592</td>
               <td colspan="2">CTCAE Grade 1 Dysphagia<span class="subclass"> SubClassOf </span>Dysphagia Adverse Event. <br><i>New Terms: CTCAE Grade 1 Dysphagia, Dysphagia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>593</td>
               <td colspan="2">CTCAE Grade 1 Dyspnea<span class="subclass"> SubClassOf </span>Dyspnea Adverse Event. <br><i>New Terms: CTCAE Grade 1 Dyspnea, Dyspnea Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>594</td>
               <td colspan="2">CTCAE Grade 1 Edema of the Head<br><span class="keyword"> and </span>Neck<span class="subclass"> SubClassOf </span>Edema Adverse Event of the Head<br><span class="keyword"> and </span>Neck. <br><i>New Terms: CTCAE Grade 1 Edema of the Head and Neck, Edema Adverse Event of the Head and Neck</i></td>
            </tr>
            <tr class="addition">
               <td>595</td>
               <td colspan="2">CTCAE Grade 1 Edema of the Limb<span class="subclass"> SubClassOf </span>Edema Adverse Event of the Limb. <br><i>New Terms: CTCAE Grade 1 Edema of the Limb, Edema Adverse Event of the Limb</i></td>
            </tr>
            <tr class="addition">
               <td>596</td>
               <td colspan="2">CTCAE Grade 1 Edema of the Trunk<br><span class="keyword"> and </span>Genital Area<span class="subclass"> SubClassOf </span>Edema Adverse Event of the Trunk<br><span class="keyword"> and </span>Genital Area. <br><i>New Terms: CTCAE Grade 1 Edema of the Trunk and Genital Area, Edema Adverse Event of the Trunk
                     and Genital Area</i></td>
            </tr>
            <tr class="addition">
               <td>597</td>
               <td colspan="2">CTCAE Grade 1 Edema of the Viscera<span class="subclass"> SubClassOf </span>Edema Adverse Event of the Viscera. <br><i>New Terms: Edema Adverse Event of the Viscera, CTCAE Grade 1 Edema of the Viscera</i></td>
            </tr>
            <tr class="addition">
               <td>598</td>
               <td colspan="2">CTCAE Grade 1 Ejaculatory Dysfunction<span class="subclass"> SubClassOf </span>Ejaculatory Dysfunction Adverse Event. <br><i>New Terms: CTCAE Grade 1 Ejaculatory Dysfunction, Ejaculatory Dysfunction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>599</td>
               <td colspan="2">CTCAE Grade 1 Enteritis<span class="subclass"> SubClassOf </span>Enteritis Adverse Event. <br><i>New Terms: CTCAE Grade 1 Enteritis, Enteritis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>600</td>
               <td colspan="2">CTCAE Grade 1 Epiphora<span class="subclass"> SubClassOf </span>Epiphora Adverse Event. <br><i>New Terms: CTCAE Grade 1 Epiphora, Epiphora Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>601</td>
               <td colspan="2">CTCAE Grade 1 Erectile Dysfunction<span class="subclass"> SubClassOf </span>Erectile Dysfunction Adverse Event. <br><i>New Terms: Erectile Dysfunction Adverse Event, CTCAE Grade 1 Erectile Dysfunction</i></td>
            </tr>
            <tr class="addition">
               <td>602</td>
               <td colspan="2">CTCAE Grade 1 Esophageal Varices Hemorrhage<span class="subclass"> SubClassOf </span>Esophageal Varices Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 1 Esophageal Varices Hemorrhage, Esophageal Varices Hemorrhage Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>603</td>
               <td colspan="2">CTCAE Grade 1 Esophagitis<span class="subclass"> SubClassOf </span>Esophagitis Adverse Event. <br><i>New Terms: CTCAE Grade 1 Esophagitis, Esophagitis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>604</td>
               <td colspan="2">CTCAE Grade 1 Esophagus Fistula<span class="subclass"> SubClassOf </span>Esophagus Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 1 Esophagus Fistula, Esophagus Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>605</td>
               <td colspan="2">CTCAE Grade 1 Esophagus Hemorrhage<span class="subclass"> SubClassOf </span>Esophagus Hemorrhage Adverse Event. <br><i>New Terms: Esophagus Hemorrhage Adverse Event, CTCAE Grade 1 Esophagus Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>606</td>
               <td colspan="2">CTCAE Grade 1 Esophagus Intra-Operative Injury<span class="subclass"> SubClassOf </span>Esophagus Intra-Operative Injury Adverse Event. <br><i>New Terms: Esophagus Intra-Operative Injury Adverse Event, CTCAE Grade 1 Esophagus Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>607</td>
               <td colspan="2">CTCAE Grade 1 Esophagus Leak<span class="subclass"> SubClassOf </span>Esophagus Leak Adverse Event. <br><i>New Terms: CTCAE Grade 1 Esophagus Leak, Esophagus Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>608</td>
               <td colspan="2">CTCAE Grade 1 Esophagus Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Esophagus Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Clinical Examination Classification. <br><i>New Terms: Esophagus Mucositis or Stomatitis Adverse Event by Clinical Examination Classification,
                     CTCAE Grade 1 Esophagus Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>609</td>
               <td colspan="2">CTCAE Grade 1 Esophagus Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Esophagus Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: Esophagus Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification,
                     CTCAE Grade 1 Esophagus Mucositis or Stomatitis by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>610</td>
               <td colspan="2">CTCAE Grade 1 Esophagus Obstruction<span class="subclass"> SubClassOf </span>Esophagus Obstruction Adverse Event. <br><i>New Terms: Esophagus Obstruction Adverse Event, CTCAE Grade 1 Esophagus Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>611</td>
               <td colspan="2">CTCAE Grade 1 Esophagus Pain<span class="subclass"> SubClassOf </span>Esophagus Pain Adverse Event. <br><i>New Terms: Esophagus Pain Adverse Event, CTCAE Grade 1 Esophagus Pain</i></td>
            </tr>
            <tr class="addition">
               <td>612</td>
               <td colspan="2">CTCAE Grade 1 Esophagus Perforation<span class="subclass"> SubClassOf </span>Esophagus Perforation Adverse Event. <br><i>New Terms: Esophagus Perforation Adverse Event, CTCAE Grade 1 Esophagus Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>613</td>
               <td colspan="2">CTCAE Grade 1 Esophagus Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Esophagus Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Esophagus Stricture or Stenosis Adverse Event, CTCAE Grade 1 Esophagus Stricture or
                     Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>614</td>
               <td colspan="2">CTCAE Grade 1 Esophagus Ulcer<span class="subclass"> SubClassOf </span>Esophagus Ulcer Adverse Event. <br><i>New Terms: Esophagus Ulcer Adverse Event, CTCAE Grade 1 Esophagus Ulcer</i></td>
            </tr>
            <tr class="addition">
               <td>615</td>
               <td colspan="2">CTCAE Grade 1 Euphoria<span class="subclass"> SubClassOf </span>Euphoria Adverse Event. <br><i>New Terms: CTCAE Grade 1 Euphoria, Euphoria Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>616</td>
               <td colspan="2">CTCAE Grade 1 Exostosis<span class="subclass"> SubClassOf </span>Exostosis Adverse Event. <br><i>New Terms: CTCAE Grade 1 Exostosis, Exostosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>617</td>
               <td colspan="2">CTCAE Grade 1 External Ear Pain<span class="subclass"> SubClassOf </span>External Ear Pain Adverse Event. <br><i>New Terms: CTCAE Grade 1 External Ear Pain, External Ear Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>618</td>
               <td colspan="2">CTCAE Grade 1 Extraocular Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Extraocular Muscle Weakness Not Due to Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 1 Extraocular Muscle Weakness Not Due to Neuropathy, Extraocular Muscle
                     Weakness Not Due to Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>619</td>
               <td colspan="2">CTCAE Grade 1 Extrapyramidal<br><span class="keyword"> and </span>Involuntary Movement<br><span class="keyword"> and </span>Restlessness<span class="subclass"> SubClassOf </span>Extrapyramidal<br><span class="keyword"> and </span>Involuntary Movement<br><span class="keyword"> and </span>Restlessness Adverse Event. <br><i>New Terms: Extrapyramidal and Involuntary Movement and Restlessness Adverse Event, CTCAE Grade
                     1 Extrapyramidal and Involuntary Movement and Restlessness</i></td>
            </tr>
            <tr class="addition">
               <td>620</td>
               <td colspan="2">CTCAE Grade 1 Extremity Limb Pain<span class="subclass"> SubClassOf </span>Extremity Limb Pain Adverse Event. <br><i>New Terms: Extremity Limb Pain Adverse Event, CTCAE Grade 1 Extremity Limb Pain</i></td>
            </tr>
            <tr class="addition">
               <td>621</td>
               <td colspan="2">CTCAE Grade 1 Eye NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Eye NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: Eye NOS Intra-Operative Injury Adverse Event, CTCAE Grade 1 Eye NOS Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>622</td>
               <td colspan="2">CTCAE Grade 1 Eye Pain<span class="subclass"> SubClassOf </span>Eye Pain Adverse Event. <br><i>New Terms: CTCAE Grade 1 Eye Pain, Eye Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>623</td>
               <td colspan="2">CTCAE Grade 1 Eyelid Dysfunction<span class="subclass"> SubClassOf </span>Eyelid Dysfunction Adverse Event. <br><i>New Terms: CTCAE Grade 1 Eyelid Dysfunction, Eyelid Dysfunction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>624</td>
               <td colspan="2">CTCAE Grade 1 FEV1<span class="subclass"> SubClassOf </span>FEV1 Adverse Event. <br><i>New Terms: FEV1 Adverse Event, CTCAE Grade 1 FEV1</i></td>
            </tr>
            <tr class="addition">
               <td>625</td>
               <td colspan="2">CTCAE Grade 1 Face NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Face NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Face NOS Intra-Operative Injury, Face NOS Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>626</td>
               <td colspan="2">CTCAE Grade 1 Face Pain<span class="subclass"> SubClassOf </span>Face Pain Adverse Event. <br><i>New Terms: Face Pain Adverse Event, CTCAE Grade 1 Face Pain</i></td>
            </tr>
            <tr class="addition">
               <td>627</td>
               <td colspan="2">CTCAE Grade 1 Facial Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Facial Muscle Weakness Not Due to Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 1 Facial Muscle Weakness Not Due to Neuropathy, Facial Muscle Weakness
                     Not Due to Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>628</td>
               <td colspan="2">CTCAE Grade 1 Fallopian Tube Hemorrhage<span class="subclass"> SubClassOf </span>Fallopian Tube Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 1 Fallopian Tube Hemorrhage, Fallopian Tube Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>629</td>
               <td colspan="2">CTCAE Grade 1 Fallopian Tube Intra-Operative Injury<span class="subclass"> SubClassOf </span>Fallopian Tube Intra-Operative Injury Adverse Event. <br><i>New Terms: Fallopian Tube Intra-Operative Injury Adverse Event, CTCAE Grade 1 Fallopian Tube
                     Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>630</td>
               <td colspan="2">CTCAE Grade 1 Fallopian Tube Leak<span class="subclass"> SubClassOf </span>Fallopian Tube Leak Adverse Event. <br><i>New Terms: Fallopian Tube Leak Adverse Event, CTCAE Grade 1 Fallopian Tube Leak</i></td>
            </tr>
            <tr class="addition">
               <td>631</td>
               <td colspan="2">CTCAE Grade 1 Fallopian Tube Obstruction<span class="subclass"> SubClassOf </span>Fallopian Tube Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 1 Fallopian Tube Obstruction, Fallopian Tube Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>632</td>
               <td colspan="2">CTCAE Grade 1 Fallopian Tube Perforation<span class="subclass"> SubClassOf </span>Fallopian Tube Perforation Adverse Event. <br><i>New Terms: Fallopian Tube Perforation Adverse Event, CTCAE Grade 1 Fallopian Tube Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>633</td>
               <td colspan="2">CTCAE Grade 1 Fallopian Tube Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Fallopian Tube Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 1 Fallopian Tube Stricture or Stenosis, Fallopian Tube Stricture or Stenosis
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>634</td>
               <td colspan="2">CTCAE Grade 1 Fatigue<span class="subclass"> SubClassOf </span>Fatigue Adverse Event. <br><i>New Terms: CTCAE Grade 1 Fatigue, Fatigue Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>635</td>
               <td colspan="2">CTCAE Grade 1 Female Genital Tract Fistula<span class="subclass"> SubClassOf </span>Female Genital Tract Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 1 Female Genital Tract Fistula, Female Genital Tract Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>636</td>
               <td colspan="2">CTCAE Grade 1 Fever Without Neutropenia<span class="subclass"> SubClassOf </span>Fever Without Neutropenia Adverse Event. <br><i>New Terms: CTCAE Grade 1 Fever Without Neutropenia, Fever Without Neutropenia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>637</td>
               <td colspan="2">CTCAE Grade 1 Fibrinogen<span class="subclass"> SubClassOf </span>Fibrinogen Adverse Event. <br><i>New Terms: CTCAE Grade 1 Fibrinogen, Fibrinogen Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>638</td>
               <td colspan="2">CTCAE Grade 1 Fibrosis-Cosmesis<span class="subclass"> SubClassOf </span>Fibrosis-Cosmesis Adverse Event. <br><i>New Terms: Fibrosis-Cosmesis Adverse Event, CTCAE Grade 1 Fibrosis-Cosmesis</i></td>
            </tr>
            <tr class="addition">
               <td>639</td>
               <td colspan="2">CTCAE Grade 1 Fibrosis-Deep Connective Tissue<span class="subclass"> SubClassOf </span>Fibrosis-Deep Connective Tissue Adverse Event. <br><i>New Terms: Fibrosis-Deep Connective Tissue Adverse Event, CTCAE Grade 1 Fibrosis-Deep Connective
                     Tissue</i></td>
            </tr>
            <tr class="addition">
               <td>640</td>
               <td colspan="2">CTCAE Grade 1 Flashing Lights<br><span class="keyword"> and </span>Floaters in Vision<span class="subclass"> SubClassOf </span>Flashing Lights<br><span class="keyword"> and </span>Floaters in Vision Adverse Event. <br><i>New Terms: CTCAE Grade 1 Flashing Lights and Floaters in Vision, Flashing Lights and Floaters
                     in Vision Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>641</td>
               <td colspan="2">CTCAE Grade 1 Flatulence<span class="subclass"> SubClassOf </span>Flatulence Adverse Event. <br><i>New Terms: Flatulence Adverse Event, CTCAE Grade 1 Flatulence</i></td>
            </tr>
            <tr class="addition">
               <td>642</td>
               <td colspan="2">CTCAE Grade 1 Flu-Like Syndrome<span class="subclass"> SubClassOf </span>Flu-Like Syndrome Adverse Event. <br><i>New Terms: Flu-Like Syndrome Adverse Event, CTCAE Grade 1 Flu-Like Syndrome</i></td>
            </tr>
            <tr class="addition">
               <td>643</td>
               <td colspan="2">CTCAE Grade 1 Flushing<span class="subclass"> SubClassOf </span>Flushing Adverse Event. <br><i>New Terms: Flushing Adverse Event, CTCAE Grade 1 Flushing</i></td>
            </tr>
            <tr class="addition">
               <td>644</td>
               <td colspan="2">CTCAE Grade 1 Fracture<span class="subclass"> SubClassOf </span>Fracture Adverse Event. <br><i>New Terms: Fracture Adverse Event, CTCAE Grade 1 Fracture</i></td>
            </tr>
            <tr class="addition">
               <td>645</td>
               <td colspan="2">CTCAE Grade 1 Gallbladder Fistula<span class="subclass"> SubClassOf </span>Gallbladder Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 1 Gallbladder Fistula, Gallbladder Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>646</td>
               <td colspan="2">CTCAE Grade 1 Gallbladder Intra-Operative Injury<span class="subclass"> SubClassOf </span>Gallbladder Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Gallbladder Intra-Operative Injury, Gallbladder Intra-Operative Injury
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>647</td>
               <td colspan="2">CTCAE Grade 1 Gallbladder Obstruction<span class="subclass"> SubClassOf </span>Gallbladder Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 1 Gallbladder Obstruction, Gallbladder Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>648</td>
               <td colspan="2">CTCAE Grade 1 Gallbladder Pain<span class="subclass"> SubClassOf </span>Gallbladder Pain Adverse Event. <br><i>New Terms: Gallbladder Pain Adverse Event, CTCAE Grade 1 Gallbladder Pain</i></td>
            </tr>
            <tr class="addition">
               <td>649</td>
               <td colspan="2">CTCAE Grade 1 Gallbladder Perforation<span class="subclass"> SubClassOf </span>Gallbladder Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 1 Gallbladder Perforation, Gallbladder Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>650</td>
               <td colspan="2">CTCAE Grade 1 Gamma-Glutamyl Transpeptidase<span class="subclass"> SubClassOf </span>Gamma-Glutamyl Transpeptidase Adverse Event. <br><i>New Terms: CTCAE Grade 1 Gamma-Glutamyl Transpeptidase, Gamma-Glutamyl Transpeptidase Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>651</td>
               <td colspan="2">CTCAE Grade 1 Gastritis<span class="subclass"> SubClassOf </span>Gastritis Adverse Event. <br><i>New Terms: Gastritis Adverse Event, CTCAE Grade 1 Gastritis</i></td>
            </tr>
            <tr class="addition">
               <td>652</td>
               <td colspan="2">CTCAE Grade 1 Gastrointestinal Leak NOS<span class="subclass"> SubClassOf </span>Gastrointestinal Leak Adverse Event NOS. <br><i>New Terms: CTCAE Grade 1 Gastrointestinal Leak NOS, Gastrointestinal Leak Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>653</td>
               <td colspan="2">CTCAE Grade 1 Gastrointestinal Stoma Hemorrhage<span class="subclass"> SubClassOf </span>Gastrointestinal Stoma Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 1 Gastrointestinal Stoma Hemorrhage, Gastrointestinal Stoma Hemorrhage
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>654</td>
               <td colspan="2">CTCAE Grade 1 Gastrointestinal Stoma Intra-Operative Injury<span class="subclass"> SubClassOf </span>Gastointestinal Stoma Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Gastrointestinal Stoma Intra-Operative Injury, Gastointestinal Stoma
                     Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>655</td>
               <td colspan="2">CTCAE Grade 1 Gastrointestinal Stoma Leak<span class="subclass"> SubClassOf </span>Gastrointestinal Stoma Leak Adverse Event. <br><i>New Terms: Gastrointestinal Stoma Leak Adverse Event, CTCAE Grade 1 Gastrointestinal Stoma Leak</i></td>
            </tr>
            <tr class="addition">
               <td>656</td>
               <td colspan="2">CTCAE Grade 1 Genitourinary Stoma Hemorrhage<span class="subclass"> SubClassOf </span>Genitourinary Stoma Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 1 Genitourinary Stoma Hemorrhage, Genitourinary Stoma Hemorrhage Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>657</td>
               <td colspan="2">CTCAE Grade 1 Genitourinary Stoma Leak<span class="subclass"> SubClassOf </span>Genitourinary Stoma Leak Adverse Event. <br><i>New Terms: CTCAE Grade 1 Genitourinary Stoma Leak, Genitourinary Stoma Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>658</td>
               <td colspan="2">CTCAE Grade 1 Genitourinary Stoma Obstruction<span class="subclass"> SubClassOf </span>Genitourinary Stoma Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 1 Genitourinary Stoma Obstruction, Genitourinary Stoma Obstruction Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>659</td>
               <td colspan="2">CTCAE Grade 1 Genitourinary Stoma Prolapse<span class="subclass"> SubClassOf </span>Genitourinary Stoma Prolapse Adverse Event. <br><i>New Terms: CTCAE Grade 1 Genitourinary Stoma Prolapse, Genitourinary Stoma Prolapse Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>660</td>
               <td colspan="2">CTCAE Grade 1 Genitourinary Stoma Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Genitourinary Stoma Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Genitourinary Stoma Stricture or Stenosis Adverse Event, CTCAE Grade 1 Genitourinary
                     Stoma Stricture or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>661</td>
               <td colspan="2">CTCAE Grade 1 Gingiva Intra-Operative Injury<span class="subclass"> SubClassOf </span>Gingiva Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Gingiva Intra-Operative Injury, Gingiva Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>662</td>
               <td colspan="2">CTCAE Grade 1 Glaucoma<span class="subclass"> SubClassOf </span>Glaucoma Adverse Event. <br><i>New Terms: CTCAE Grade 1 Glaucoma, Glaucoma Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>663</td>
               <td colspan="2">CTCAE Grade 1 Glomerular Filtration Rate<span class="subclass"> SubClassOf </span>Glomerular Filtration Rate Adverse Event. <br><i>New Terms: CTCAE Grade 1 Glomerular Filtration Rate, Glomerular Filtration Rate Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>664</td>
               <td colspan="2">CTCAE Grade 1 Haptoglobin<span class="subclass"> SubClassOf </span>Haptoglobin Adverse Event. <br><i>New Terms: CTCAE Grade 1 Haptoglobin, Haptoglobin Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>665</td>
               <td colspan="2">CTCAE Grade 1 Head<br><span class="keyword"> and </span>Headache Pain<span class="subclass"> SubClassOf </span>Head<br><span class="keyword"> and </span>Headache Pain Adverse Event. <br><i>New Terms: Head and Headache Pain Adverse Event, CTCAE Grade 1 Head and Headache Pain</i></td>
            </tr>
            <tr class="addition">
               <td>666</td>
               <td colspan="2">CTCAE Grade 1 Hearing Patients with<br><span class="keyword"> or </span>without Baseline Audiogram<br><span class="keyword"> and </span>Enrolled in a Monitoring Program<span class="subclass"> SubClassOf </span>Hearing Adverse Event Patients with<br><span class="keyword"> or </span>without Baseline Audiogram<br><span class="keyword"> and </span>Enrolled in a Monitoring Program. <br><i>New Terms: CTCAE Grade 1 Hearing Patients with or without Baseline Audiogram and Enrolled in
                     a Monitoring Program, Hearing Adverse Event Patients with or without Baseline Audiogram
                     and Enrolled in a Monitoring Program</i></td>
            </tr>
            <tr class="addition">
               <td>667</td>
               <td colspan="2">CTCAE Grade 1 Heart Intra-Operative Injury<span class="subclass"> SubClassOf </span>Heart Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Heart Intra-Operative Injury, Heart Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>668</td>
               <td colspan="2">CTCAE Grade 1 Heartburn<br><span class="keyword"> or </span>Dyspepsia<span class="subclass"> SubClassOf </span>Heartburn<br><span class="keyword"> or </span>Dyspepsia. <br><i>New Terms: Heartburn or Dyspepsia, CTCAE Grade 1 Heartburn or Dyspepsia</i></td>
            </tr>
            <tr class="addition">
               <td>669</td>
               <td colspan="2">CTCAE Grade 1 Hematoma<span class="subclass"> SubClassOf </span>Hematoma Adverse Event. <br><i>New Terms: Hematoma Adverse Event, CTCAE Grade 1 Hematoma</i></td>
            </tr>
            <tr class="addition">
               <td>670</td>
               <td colspan="2">CTCAE Grade 1 Hemoglobin<span class="subclass"> SubClassOf </span>Hemoglobin Adverse Event. <br><i>New Terms: Hemoglobin Adverse Event, CTCAE Grade 1 Hemoglobin</i></td>
            </tr>
            <tr class="addition">
               <td>671</td>
               <td colspan="2">CTCAE Grade 1 Hemoglobinuria<span class="subclass"> SubClassOf </span>Hemoglobinuria Adverse Event. <br><i>New Terms: Hemoglobinuria Adverse Event, CTCAE Grade 1 Hemoglobinuria</i></td>
            </tr>
            <tr class="addition">
               <td>672</td>
               <td colspan="2">CTCAE Grade 1 Hemolysis<span class="subclass"> SubClassOf </span>Hemolysis Adverse Event. <br><i>New Terms: Hemolysis Adverse Event, CTCAE Grade 1 Hemolysis</i></td>
            </tr>
            <tr class="addition">
               <td>673</td>
               <td colspan="2">CTCAE Grade 1 Hemorrhoids<span class="subclass"> SubClassOf </span>Hemorrhoids Adverse Event. <br><i>New Terms: Hemorrhoids Adverse Event, CTCAE Grade 1 Hemorrhoids</i></td>
            </tr>
            <tr class="addition">
               <td>674</td>
               <td colspan="2">CTCAE Grade 1 Hepatic Artery Intra-Operative Injury<span class="subclass"> SubClassOf </span>Hepatic Artery Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Hepatic Artery Intra-Operative Injury, Hepatic Artery Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>675</td>
               <td colspan="2">CTCAE Grade 1 Hepatic Vein Intra-Operative Injury<span class="subclass"> SubClassOf </span>Hepatic Vein Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Hepatic Vein Intra-Operative Injury, Hepatic Vein Intra-Operative Injury
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>676</td>
               <td colspan="2">CTCAE Grade 1 Hiccoughs<span class="subclass"> SubClassOf </span>Hiccoughs Adverse Event. <br><i>New Terms: CTCAE Grade 1 Hiccoughs, Hiccoughs Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>677</td>
               <td colspan="2">CTCAE Grade 1 Hot Flashes<br><span class="keyword"> or </span>Flushes<span class="subclass"> SubClassOf </span>Hot Flashes<br><span class="keyword"> or </span>Flushes Adverse Event. <br><i>New Terms: Hot Flashes or Flushes Adverse Event, CTCAE Grade 1 Hot Flashes or Flushes</i></td>
            </tr>
            <tr class="addition">
               <td>678</td>
               <td colspan="2">CTCAE Grade 1 Hydrocephalus<span class="subclass"> SubClassOf </span>Hydrocephalus Adverse Event. <br><i>New Terms: Hydrocephalus Adverse Event, CTCAE Grade 1 Hydrocephalus</i></td>
            </tr>
            <tr class="addition">
               <td>679</td>
               <td colspan="2">CTCAE Grade 1 Hyperbilirubinemia<span class="subclass"> SubClassOf </span>Hyperbilirubinemia Adverse Event. <br><i>New Terms: CTCAE Grade 1 Hyperbilirubinemia, Hyperbilirubinemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>680</td>
               <td colspan="2">CTCAE Grade 1 Hyperpigmentation<span class="subclass"> SubClassOf </span>Hyperpigmentation Adverse Event. <br><i>New Terms: CTCAE Grade 1 Hyperpigmentation, Hyperpigmentation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>681</td>
               <td colspan="2">CTCAE Grade 1 Hypertension<span class="subclass"> SubClassOf </span>Hypertension Adverse Event. <br><i>New Terms: Hypertension Adverse Event, CTCAE Grade 1 Hypertension</i></td>
            </tr>
            <tr class="addition">
               <td>682</td>
               <td colspan="2">CTCAE Grade 1 Hypopigmentation<span class="subclass"> SubClassOf </span>Hypopigmentation Adverse Event. <br><i>New Terms: CTCAE Grade 1 Hypopigmentation, Hypopigmentation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>683</td>
               <td colspan="2">CTCAE Grade 1 Hypotension<span class="subclass"> SubClassOf </span>Hypotension Adverse Event. <br><i>New Terms: Hypotension Adverse Event, CTCAE Grade 1 Hypotension</i></td>
            </tr>
            <tr class="addition">
               <td>684</td>
               <td colspan="2">CTCAE Grade 1 Idioventricular Rhythm<span class="subclass"> SubClassOf </span>Idioventricular Rhythm Adverse Event. <br><i>New Terms: Idioventricular Rhythm Adverse Event, CTCAE Grade 1 Idioventricular Rhythm</i></td>
            </tr>
            <tr class="addition">
               <td>685</td>
               <td colspan="2">CTCAE Grade 1 Ileum Fistula<span class="subclass"> SubClassOf </span>Ileum Fistula Adverse Event. <br><i>New Terms: Ileum Fistula Adverse Event, CTCAE Grade 1 Ileum Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>686</td>
               <td colspan="2">CTCAE Grade 1 Ileum Hemorrhage<span class="subclass"> SubClassOf </span>Ileum Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 1 Ileum Hemorrhage, Ileum Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>687</td>
               <td colspan="2">CTCAE Grade 1 Ileum Intra-Operative Injury<span class="subclass"> SubClassOf </span>Ileum Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Ileum Intra-Operative Injury, Ileum Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>688</td>
               <td colspan="2">CTCAE Grade 1 Ileum Obstruction<span class="subclass"> SubClassOf </span>Ileum Obstruction Adverse Event. <br><i>New Terms: Ileum Obstruction Adverse Event, CTCAE Grade 1 Ileum Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>689</td>
               <td colspan="2">CTCAE Grade 1 Ileum Perforation<span class="subclass"> SubClassOf </span>Ileum Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 1 Ileum Perforation, Ileum Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>690</td>
               <td colspan="2">CTCAE Grade 1 Ileum Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Ileum Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Ileum Stricture or Stenosis Adverse Event, CTCAE Grade 1 Ileum Stricture or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>691</td>
               <td colspan="2">CTCAE Grade 1 Ileum Ulcer<span class="subclass"> SubClassOf </span>Ileum Ulcer Adverse Event. <br><i>New Terms: Ileum Ulcer Adverse Event, CTCAE Grade 1 Ileum Ulcer</i></td>
            </tr>
            <tr class="addition">
               <td>692</td>
               <td colspan="2">CTCAE Grade 1 Ileus<span class="subclass"> SubClassOf </span>Gastrointestinal Ileus Adverse Event. <br><i>New Terms: CTCAE Grade 1 Ileus, Gastrointestinal Ileus Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>693</td>
               <td colspan="2">CTCAE Grade 1 Induration<br><span class="keyword"> or </span>Fibrosis of the Skin<br><span class="keyword"> and </span>Subcutaneous Tissue<span class="subclass"> SubClassOf </span>Induration<br><span class="keyword"> or </span>Fibrosis of the Skin<br><span class="keyword"> and </span>Subcutaneous Tissue Adverse Event. <br><i>New Terms: Induration or Fibrosis of the Skin and Subcutaneous Tissue Adverse Event, CTCAE Grade
                     1 Induration or Fibrosis of the Skin and Subcutaneous Tissue</i></td>
            </tr>
            <tr class="addition">
               <td>694</td>
               <td colspan="2">CTCAE Grade 1 Infectious Colitis<span class="subclass"> SubClassOf </span>Infectious Colitis Adverse Event. <br><i>New Terms: Infectious Colitis Adverse Event, CTCAE Grade 1 Infectious Colitis</i></td>
            </tr>
            <tr class="addition">
               <td>695</td>
               <td colspan="2">CTCAE Grade 1 Inferior Vena Cava Intra-Operative Injury<span class="subclass"> SubClassOf </span>Inferior Vena Cava Intra-Operative Injury Adverse Event. <br><i>New Terms: Inferior Vena Cava Intra-Operative Injury Adverse Event, CTCAE Grade 1 Inferior Vena
                     Cava Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>696</td>
               <td colspan="2">CTCAE Grade 1 Inferior Vena Cava Vein Injury<span class="subclass"> SubClassOf </span>Inferior Vena Cava Vein Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Inferior Vena Cava Vein Injury, Inferior Vena Cava Vein Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>697</td>
               <td colspan="2">CTCAE Grade 1 Injection Site Reaction<br><span class="keyword"> or </span>Extravasation Changes<span class="subclass"> SubClassOf </span>Injection Site Reaction<br><span class="keyword"> or </span>Extravasation Changes Adverse Event. <br><i>New Terms: CTCAE Grade 1 Injection Site Reaction or Extravasation Changes, Injection Site Reaction
                     or Extravasation Changes Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>698</td>
               <td colspan="2">CTCAE Grade 1 Inner Ear Intra-Operative Injury<span class="subclass"> SubClassOf </span>Inner Ear Intra-Operative Injury Adverse Event. <br><i>New Terms: Inner Ear Intra-Operative Injury Adverse Event, CTCAE Grade 1 Inner Ear Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>699</td>
               <td colspan="2">CTCAE Grade 1 Insomnia<span class="subclass"> SubClassOf </span>Insomnia Adverse Event. <br><i>New Terms: Insomnia Adverse Event, CTCAE Grade 1 Insomnia</i></td>
            </tr>
            <tr class="addition">
               <td>700</td>
               <td colspan="2">CTCAE Grade 1 International Normalized Ratio of Prothrombin Time<span class="subclass"> SubClassOf </span>International Normalized Ratio of Prothrombin Time Adverse Event. <br><i>New Terms: CTCAE Grade 1 International Normalized Ratio of Prothrombin Time, International Normalized
                     Ratio of Prothrombin Time Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>701</td>
               <td colspan="2">CTCAE Grade 1 Intestine Pain<span class="subclass"> SubClassOf </span>Intestine Pain Adverse Event. <br><i>New Terms: CTCAE Grade 1 Intestine Pain, Intestine Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>702</td>
               <td colspan="2">CTCAE Grade 1 Irregular Menses<span class="subclass"> SubClassOf </span>Irregular Menses Adverse Event. <br><i>New Terms: CTCAE Grade 1 Irregular Menses, Irregular Menses Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>703</td>
               <td colspan="2">CTCAE Grade 1 Irritability in Children Less Than 3 Years of Age<span class="subclass"> SubClassOf </span>Irritability in Children Less Than 3 Years of Age Adverse Event. <br><i>New Terms: Irritability in Children Less Than 3 Years of Age Adverse Event, CTCAE Grade 1 Irritability
                     in Children Less Than 3 Years of Age</i></td>
            </tr>
            <tr class="addition">
               <td>704</td>
               <td colspan="2">CTCAE Grade 1 Jejunum Fistula<span class="subclass"> SubClassOf </span>Jejunum Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 1 Jejunum Fistula, Jejunum Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>705</td>
               <td colspan="2">CTCAE Grade 1 Jejunum Hemorrhage<span class="subclass"> SubClassOf </span>Jejunum Hemorrhage Adverse Event. <br><i>New Terms: Jejunum Hemorrhage Adverse Event, CTCAE Grade 1 Jejunum Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>706</td>
               <td colspan="2">CTCAE Grade 1 Jejunum Intra-Operative Injury<span class="subclass"> SubClassOf </span>Jejunum Intra-Operative Injury Adverse Event. <br><i>New Terms: Jejunum Intra-Operative Injury Adverse Event, CTCAE Grade 1 Jejunum Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>707</td>
               <td colspan="2">CTCAE Grade 1 Jejunum Obstruction<span class="subclass"> SubClassOf </span>Jejunum Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 1 Jejunum Obstruction, Jejunum Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>708</td>
               <td colspan="2">CTCAE Grade 1 Jejunum Perforation<span class="subclass"> SubClassOf </span>Jejunum Perforation Adverse Event. <br><i>New Terms: Jejunum Perforation Adverse Event, CTCAE Grade 1 Jejunum Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>709</td>
               <td colspan="2">CTCAE Grade 1 Jejunum Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Jejunum Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 1 Jejunum Stricture or Stenosis, Jejunum Stricture or Stenosis Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>710</td>
               <td colspan="2">CTCAE Grade 1 Jejunum Ulcer<span class="subclass"> SubClassOf </span>Jejunum Ulcer Adverse Event. <br><i>New Terms: CTCAE Grade 1 Jejunum Ulcer, Jejunum Ulcer Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>711</td>
               <td colspan="2">CTCAE Grade 1 Joint Effusion<span class="subclass"> SubClassOf </span>Joint Effusion Adverse Event. <br><i>New Terms: Joint Effusion Adverse Event, CTCAE Grade 1 Joint Effusion</i></td>
            </tr>
            <tr class="addition">
               <td>712</td>
               <td colspan="2">CTCAE Grade 1 Joint Function<span class="subclass"> SubClassOf </span>Joint Function Adverse Event. <br><i>New Terms: CTCAE Grade 1 Joint Function, Joint Function Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>713</td>
               <td colspan="2">CTCAE Grade 1 Joint Intra-Operative Injury<span class="subclass"> SubClassOf </span>Joint Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Joint Intra-Operative Injury, Joint Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>714</td>
               <td colspan="2">CTCAE Grade 1 Joint Pain<span class="subclass"> SubClassOf </span>Joint Pain Adverse Event. <br><i>New Terms: Joint Pain Adverse Event, CTCAE Grade 1 Joint Pain</i></td>
            </tr>
            <tr class="addition">
               <td>715</td>
               <td colspan="2">CTCAE Grade 1 Jugular Vein Injury<span class="subclass"> SubClassOf </span>Jugular Vein Injury Adverse Event. <br><i>New Terms: Jugular Vein Injury Adverse Event, CTCAE Grade 1 Jugular Vein Injury</i></td>
            </tr>
            <tr class="addition">
               <td>716</td>
               <td colspan="2">CTCAE Grade 1 Jugular Vein Intra-Operative Injury<span class="subclass"> SubClassOf </span>Jugular Vein Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Jugular Vein Intra-Operative Injury, Jugular Vein Intra-Operative Injury
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>717</td>
               <td colspan="2">CTCAE Grade 1 Keratitis<span class="subclass"> SubClassOf </span>Keratitis Adverse Event. <br><i>New Terms: Keratitis Adverse Event, CTCAE Grade 1 Keratitis</i></td>
            </tr>
            <tr class="addition">
               <td>718</td>
               <td colspan="2">CTCAE Grade 1 Kidney Fistula<span class="subclass"> SubClassOf </span>Kidney Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 1 Kidney Fistula, Kidney Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>719</td>
               <td colspan="2">CTCAE Grade 1 Kidney Hemorrhage<span class="subclass"> SubClassOf </span>Kidney Hemorrhage Adverse Event. <br><i>New Terms: Kidney Hemorrhage Adverse Event, CTCAE Grade 1 Kidney Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>720</td>
               <td colspan="2">CTCAE Grade 1 Kidney Intra-Operative Injury<span class="subclass"> SubClassOf </span>Kidney Intra-Operative Injury Adverse Event. <br><i>New Terms: Kidney Intra-Operative Injury Adverse Event, CTCAE Grade 1 Kidney Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>721</td>
               <td colspan="2">CTCAE Grade 1 Kidney Leak<span class="subclass"> SubClassOf </span>Kidney Leak Adverse Event. <br><i>New Terms: CTCAE Grade 1 Kidney Leak, Kidney Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>722</td>
               <td colspan="2">CTCAE Grade 1 Kidney Pain<span class="subclass"> SubClassOf </span>Kidney Pain Adverse Event. <br><i>New Terms: CTCAE Grade 1 Kidney Pain, Kidney Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>723</td>
               <td colspan="2">CTCAE Grade 1 Kidney Perforation<span class="subclass"> SubClassOf </span>Kidney Perforation Adverse Event. <br><i>New Terms: Kidney Perforation Adverse Event, CTCAE Grade 1 Kidney Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>724</td>
               <td colspan="2">CTCAE Grade 1 Large Bowel Leak<span class="subclass"> SubClassOf </span>Large Bowel Leak Adverse Event. <br><i>New Terms: CTCAE Grade 1 Large Bowel Leak, Large Bowel Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>725</td>
               <td colspan="2">CTCAE Grade 1 Large Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Large Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification. <br><i>New Terms: CTCAE Grade 1 Large Bowel Mucositis or Stomatitis by Clinical Examination Classification,
                     Large Bowel Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>726</td>
               <td colspan="2">CTCAE Grade 1 Large Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Large Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: Large Bowel Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification,
                     CTCAE Grade 1 Large Bowel Mucositis or Stomatitis by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>727</td>
               <td colspan="2">CTCAE Grade 1 Laryngeal Nerve Dysfunction<span class="subclass"> SubClassOf </span>Laryngeal Nerve Dysfunction Adverse Event. <br><i>New Terms: CTCAE Grade 1 Laryngeal Nerve Dysfunction, Laryngeal Nerve Dysfunction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>728</td>
               <td colspan="2">CTCAE Grade 1 Larynx Edema<span class="subclass"> SubClassOf </span>Larynx Edema Adverse Event. <br><i>New Terms: CTCAE Grade 1 Larynx Edema, Larynx Edema Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>729</td>
               <td colspan="2">CTCAE Grade 1 Larynx Fistula<span class="subclass"> SubClassOf </span>Larynx Fistula Adverse Event. <br><i>New Terms: Larynx Fistula Adverse Event, CTCAE Grade 1 Larynx Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>730</td>
               <td colspan="2">CTCAE Grade 1 Larynx Hemorrhage<span class="subclass"> SubClassOf </span>Larynx Hemorrhage Adverse Event. <br><i>New Terms: Larynx Hemorrhage Adverse Event, CTCAE Grade 1 Larynx Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>731</td>
               <td colspan="2">CTCAE Grade 1 Larynx Intra-Operative Injury<span class="subclass"> SubClassOf </span>Larynx Intra-Operative Injury Adverse Event. <br><i>New Terms: Larynx Intra-Operative Injury Adverse Event, CTCAE Grade 1 Larynx Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>732</td>
               <td colspan="2">CTCAE Grade 1 Larynx Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Larynx Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification. <br><i>New Terms: Larynx Mucositis or Stomatitis by Clinical Examination Classification, CTCAE Grade
                     1 Larynx Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>733</td>
               <td colspan="2">CTCAE Grade 1 Larynx Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Larynx Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: CTCAE Grade 1 Larynx Mucositis or Stomatitis by Functional or Symptomatic Classification,
                     Larynx Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>734</td>
               <td colspan="2">CTCAE Grade 1 Larynx Obstruction<br><span class="keyword"> and </span>Stenosis<span class="subclass"> SubClassOf </span>Larynx Obstruction<br><span class="keyword"> and </span>Stenosis Adverse Event. <br><i>New Terms: Larynx Obstruction and Stenosis Adverse Event, CTCAE Grade 1 Larynx Obstruction and
                     Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>735</td>
               <td colspan="2">CTCAE Grade 1 Larynx Pain<span class="subclass"> SubClassOf </span>Larynx Pain Adverse Event. <br><i>New Terms: CTCAE Grade 1 Larynx Pain, Larynx Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>737</td>
               <td colspan="2">CTCAE Grade 1 Left Ventricular Diastolic Dysfunction<span class="subclass"> SubClassOf </span>Left Ventricular Diastolic Dysfunction Adverse Event. <br><i>New Terms: Left Ventricular Diastolic Dysfunction Adverse Event, CTCAE Grade 1 Left Ventricular
                     Diastolic Dysfunction</i></td>
            </tr>
            <tr class="addition">
               <td>738</td>
               <td colspan="2">CTCAE Grade 1 Left Ventricular Systolic Dysfunction<span class="subclass"> SubClassOf </span>Left Ventricular Systolic Dysfunction Adverse Event. <br><i>New Terms: CTCAE Grade 1 Left Ventricular Systolic Dysfunction, Left Ventricular Systolic Dysfunction
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>736</td>
               <td colspan="2">CTCAE Grade 1 Left-Sided Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Left-Sided Muscle Weakness Not Due to Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 1 Left-Sided Muscle Weakness Not Due to Neuropathy, Left-Sided Muscle
                     Weakness Not Due to Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>739</td>
               <td colspan="2">CTCAE Grade 1 Lens Intra-Operative Injury<span class="subclass"> SubClassOf </span>Lens Intra-Operative Injury Adverse Event. <br><i>New Terms: Lens Intra-Operative Injury Adverse Event, CTCAE Grade 1 Lens Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>740</td>
               <td colspan="2">CTCAE Grade 1 Leukocytes<span class="subclass"> SubClassOf </span>Leukocytes Adverse Event. <br><i>New Terms: CTCAE Grade 1 Leukocytes, Leukocytes Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>741</td>
               <td colspan="2">CTCAE Grade 1 Leukoencephalopathy Radiographic Findings<span class="subclass"> SubClassOf </span>Leukoencephalopathy Radiographic Findings Adverse Event. <br><i>New Terms: Leukoencephalopathy Radiographic Findings Adverse Event, CTCAE Grade 1 Leukoencephalopathy
                     Radiographic Findings</i></td>
            </tr>
            <tr class="addition">
               <td>742</td>
               <td colspan="2">CTCAE Grade 1 Libido<span class="subclass"> SubClassOf </span>Libido Adverse Event. <br><i>New Terms: CTCAE Grade 1 Libido, Libido Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>743</td>
               <td colspan="2">CTCAE Grade 1 Ligament Intra-Operative Injury<span class="subclass"> SubClassOf </span>Ligament Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Ligament Intra-Operative Injury, Ligament Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>744</td>
               <td colspan="2">CTCAE Grade 1 Lingual Nerve Intra-Operative Injury<span class="subclass"> SubClassOf </span>Lingual Nerve Intra-Operative Injury Adverse Event. <br><i>New Terms: Lingual Nerve Intra-Operative Injury Adverse Event, CTCAE Grade 1 Lingual Nerve Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>745</td>
               <td colspan="2">CTCAE Grade 1 Lip Or Perioral Area Intra-Operative Injury<span class="subclass"> SubClassOf </span>Lip Or Perioral Area Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Lip Or Perioral Area Intra-Operative Injury, Lip Or Perioral Area Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>746</td>
               <td colspan="2">CTCAE Grade 1 Lip Pain<span class="subclass"> SubClassOf </span>Lip Pain Adverse Event. <br><i>New Terms: CTCAE Grade 1 Lip Pain, Lip Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>747</td>
               <td colspan="2">CTCAE Grade 1 Lipase<span class="subclass"> SubClassOf </span>Lipase Adverse Event. <br><i>New Terms: CTCAE Grade 1 Lipase, Lipase Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>748</td>
               <td colspan="2">CTCAE Grade 1 Liver Hemorrhage<span class="subclass"> SubClassOf </span>Liver Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 1 Liver Hemorrhage, Liver Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>749</td>
               <td colspan="2">CTCAE Grade 1 Liver Intra-Operative Injury<span class="subclass"> SubClassOf </span>Liver Intra-Operative Injury Adverse Event. <br><i>New Terms: Liver Intra-Operative Injury Adverse Event, CTCAE Grade 1 Liver Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>750</td>
               <td colspan="2">CTCAE Grade 1 Liver Pain<span class="subclass"> SubClassOf </span>Liver Pain Adverse Event. <br><i>New Terms: Liver Pain Adverse Event, CTCAE Grade 1 Liver Pain</i></td>
            </tr>
            <tr class="addition">
               <td>751</td>
               <td colspan="2">CTCAE Grade 1 Local Complication of Device<br><span class="keyword"> and </span>Prosthesis<span class="subclass"> SubClassOf </span>Local Complication of Device<br><span class="keyword"> and </span>Prosthesis Adverse Event. <br><i>New Terms: Local Complication of Device and Prosthesis Adverse Event, CTCAE Grade 1 Local Complication
                     of Device and Prosthesis</i></td>
            </tr>
            <tr class="addition">
               <td>752</td>
               <td colspan="2">CTCAE Grade 1 Low Serum Bicarbonate<span class="subclass"> SubClassOf </span>Low Serum Bicarbonate Adverse Event. <br><i>New Terms: CTCAE Grade 1 Low Serum Bicarbonate, Low Serum Bicarbonate Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>753</td>
               <td colspan="2">CTCAE Grade 1 Lower Extremity Artery Injury<span class="subclass"> SubClassOf </span>Lower Extremity Artery Injury Adverse Event. <br><i>New Terms: Lower Extremity Artery Injury Adverse Event, CTCAE Grade 1 Lower Extremity Artery
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>754</td>
               <td colspan="2">CTCAE Grade 1 Lower Extremity Artery Intra-Operative Injury<span class="subclass"> SubClassOf </span>Lower Extremity Artery Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Lower Extremity Artery Intra-Operative Injury, Lower Extremity Artery
                     Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>755</td>
               <td colspan="2">CTCAE Grade 1 Lower Extremity Gait<span class="subclass"> SubClassOf </span>Lower Extremity Gait Adverse Event. <br><i>New Terms: Lower Extremity Gait Adverse Event, CTCAE Grade 1 Lower Extremity Gait</i></td>
            </tr>
            <tr class="addition">
               <td>756</td>
               <td colspan="2">CTCAE Grade 1 Lower Extremity Intra-Operative Injury<span class="subclass"> SubClassOf </span>Lower Extremity Intra-Operative Injury Adverse Event. <br><i>New Terms: Lower Extremity Intra-Operative Injury Adverse Event, CTCAE Grade 1 Lower Extremity
                     Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>757</td>
               <td colspan="2">CTCAE Grade 1 Lower Extremity Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Lower Extremity Muscle Weakness Adverse Event Not Due to Neuropathy. <br><i>New Terms: CTCAE Grade 1 Lower Extremity Muscle Weakness Not Due to Neuropathy, Lower Extremity
                     Muscle Weakness Adverse Event Not Due to Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>758</td>
               <td colspan="2">CTCAE Grade 1 Lower Extremity Vein Injury<span class="subclass"> SubClassOf </span>Lower Extremity Vein Injury Adverse Event. <br><i>New Terms: Lower Extremity Vein Injury Adverse Event, CTCAE Grade 1 Lower Extremity Vein Injury</i></td>
            </tr>
            <tr class="addition">
               <td>759</td>
               <td colspan="2">CTCAE Grade 1 Lower Extremity Vein Intra-Operative Injury<span class="subclass"> SubClassOf </span>Lower Extremity Vein Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Lower Extremity Vein Intra-Operative Injury, Lower Extremity Vein Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>760</td>
               <td colspan="2">CTCAE Grade 1 Lower Gastrointestinal Hemorrhage NOS<span class="subclass"> SubClassOf </span>Lower Gastrointestinal Hemorrhage Adverse Event NOS. <br><i>New Terms: Lower Gastrointestinal Hemorrhage Adverse Event NOS, CTCAE Grade 1 Lower Gastrointestinal
                     Hemorrhage NOS</i></td>
            </tr>
            <tr class="addition">
               <td>761</td>
               <td colspan="2">CTCAE Grade 1 Lumbar Spine<span class="subclass"> Range </span>of Motion<span class="subclass"> SubClassOf </span>Lumbar Spine<span class="subclass"> Range </span>of Motion Adverse Event. <br><i>New Terms: Lumbar Spine Range of Motion Adverse Event, CTCAE Grade 1 Lumbar Spine Range of Motion</i></td>
            </tr>
            <tr class="addition">
               <td>762</td>
               <td colspan="2">CTCAE Grade 1 Lung Fistula<span class="subclass"> SubClassOf </span>Lung Fistula Adverse Event. <br><i>New Terms: Lung Fistula Adverse Event, CTCAE Grade 1 Lung Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>763</td>
               <td colspan="2">CTCAE Grade 1 Lung Hemorrhage<span class="subclass"> SubClassOf </span>Lung Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 1 Lung Hemorrhage, Lung Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>764</td>
               <td colspan="2">CTCAE Grade 1 Lung Intra-Operative Injury<span class="subclass"> SubClassOf </span>Lung Intra-Operative Injury Adverse Event. <br><i>New Terms: Lung Intra-Operative Injury Adverse Event, CTCAE Grade 1 Lung Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>765</td>
               <td colspan="2">CTCAE Grade 1 Lung Thoracic Nerve Intra-Operative Injury<span class="subclass"> SubClassOf </span>Lung Thoracic Nerve Intra-Operative Injury Adverse Event. <br><i>New Terms: Lung Thoracic Nerve Intra-Operative Injury Adverse Event, CTCAE Grade 1 Lung Thoracic
                     Nerve Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>766</td>
               <td colspan="2">CTCAE Grade 1 Lymph Node Pain<span class="subclass"> SubClassOf </span>Lymph Node Pain Adverse Event. <br><i>New Terms: Lymph Node Pain Adverse Event, CTCAE Grade 1 Lymph Node Pain</i></td>
            </tr>
            <tr class="addition">
               <td>767</td>
               <td colspan="2">CTCAE Grade 1 Lymphedema-Related Fibrosis<span class="subclass"> SubClassOf </span>Lymphedema-Related Fibrosis Adverse Event. <br><i>New Terms: Lymphedema-Related Fibrosis Adverse Event, CTCAE Grade 1 Lymphedema-Related Fibrosis</i></td>
            </tr>
            <tr class="addition">
               <td>768</td>
               <td colspan="2">CTCAE Grade 1 Lymphocele<span class="subclass"> SubClassOf </span>Lymphocele Adverse Event. <br><i>New Terms: CTCAE Grade 1 Lymphocele, Lymphocele Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>769</td>
               <td colspan="2">CTCAE Grade 1 Lymphopenia<span class="subclass"> SubClassOf </span>Lymphopenia Adverse Event. <br><i>New Terms: Lymphopenia Adverse Event, CTCAE Grade 1 Lymphopenia</i></td>
            </tr>
            <tr class="addition">
               <td>770</td>
               <td colspan="2">CTCAE Grade 1 Major Visceral Artery Intra-Operative Injury<span class="subclass"> SubClassOf </span>Major Visceral Artery Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Major Visceral Artery Intra-Operative Injury, Major Visceral Artery
                     Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>771</td>
               <td colspan="2">CTCAE Grade 1 Major Visceral Vein Intra-Operative Injury<span class="subclass"> SubClassOf </span>Major Visceral Vein Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Major Visceral Vein Intra-Operative Injury, Major Visceral Vein Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>772</td>
               <td colspan="2">CTCAE Grade 1 Mediastinum Hemorrhage<span class="subclass"> SubClassOf </span>Mediastinum Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 1 Mediastinum Hemorrhage, Mediastinum Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>773</td>
               <td colspan="2">CTCAE Grade 1 Mediastinum Intra-Operative Injury<span class="subclass"> SubClassOf </span>Mediastinum Intra-Operative Injury Adverse Event. <br><i>New Terms: Mediastinum Intra-Operative Injury Adverse Event, CTCAE Grade 1 Mediastinum Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>774</td>
               <td colspan="2">CTCAE Grade 1 Memory Impairment<span class="subclass"> SubClassOf </span>Memory Impairment Adverse Event. <br><i>New Terms: CTCAE Grade 1 Memory Impairment, Memory Impairment Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>775</td>
               <td colspan="2">CTCAE Grade 1 Meninges Intra-Operative Injury<span class="subclass"> SubClassOf </span>Meninges Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Meninges Intra-Operative Injury, Meninges Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>776</td>
               <td colspan="2">CTCAE Grade 1 Metabolic<br><span class="keyword"> or </span>Respiratory Acidosis<span class="subclass"> SubClassOf </span>Metabolic<br><span class="keyword"> or </span>Respiratory Acidosis Adverse Event. <br><i>New Terms: Metabolic or Respiratory Acidosis Adverse Event, CTCAE Grade 1 Metabolic or Respiratory
                     Acidosis</i></td>
            </tr>
            <tr class="addition">
               <td>777</td>
               <td colspan="2">CTCAE Grade 1 Metabolic<br><span class="keyword"> or </span>Respiratory Alkalosis<span class="subclass"> SubClassOf </span>Metabolic<br><span class="keyword"> or </span>Respiratory Alkalosis Adverse Event. <br><i>New Terms: CTCAE Grade 1 Metabolic or Respiratory Alkalosis, Metabolic or Respiratory Alkalosis
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>778</td>
               <td colspan="2">CTCAE Grade 1 Middle Ear Intra-Operative Injury<span class="subclass"> SubClassOf </span>Middle Ear Intra-Operative Injury Adverse Event. <br><i>New Terms: Middle Ear Intra-Operative Injury Adverse Event, CTCAE Grade 1 Middle Ear Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>779</td>
               <td colspan="2">CTCAE Grade 1 Middle Ear Pain<span class="subclass"> SubClassOf </span>Middle Ear Pain Adverse Event. <br><i>New Terms: Middle Ear Pain Adverse Event, CTCAE Grade 1 Middle Ear Pain</i></td>
            </tr>
            <tr class="addition">
               <td>780</td>
               <td colspan="2">CTCAE Grade 1 Motor Neuropathy<span class="subclass"> SubClassOf </span>Motor Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 1 Motor Neuropathy, Motor Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>781</td>
               <td colspan="2">CTCAE Grade 1 Muscle Intra-Operative Injury<span class="subclass"> SubClassOf </span>Muscle Intra-Operative Injury Adverse Event. <br><i>New Terms: Muscle Intra-Operative Injury Adverse Event, CTCAE Grade 1 Muscle Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>782</td>
               <td colspan="2">CTCAE Grade 1 Muscle Pain<span class="subclass"> SubClassOf </span>Muscle Pain Adverse Event. <br><i>New Terms: CTCAE Grade 1 Muscle Pain, Muscle Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>783</td>
               <td colspan="2">CTCAE Grade 1 Muscular<br><span class="keyword"> and </span>Skeletal Hypoplasia<span class="subclass"> SubClassOf </span>Muscular<br><span class="keyword"> and </span>Skeletal Hypoplasia Adverse Event. <br><i>New Terms: Muscular and Skeletal Hypoplasia Adverse Event, CTCAE Grade 1 Muscular and Skeletal
                     Hypoplasia</i></td>
            </tr>
            <tr class="addition">
               <td>784</td>
               <td colspan="2">CTCAE Grade 1 Myelitis<span class="subclass"> SubClassOf </span>Myelitis Adverse Event. <br><i>New Terms: CTCAE Grade 1 Myelitis, Myelitis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>785</td>
               <td colspan="2">CTCAE Grade 1 Myositis<span class="subclass"> SubClassOf </span>Myositis Adverse Event. <br><i>New Terms: Myositis Adverse Event, CTCAE Grade 1 Myositis</i></td>
            </tr>
            <tr class="addition">
               <td>786</td>
               <td colspan="2">CTCAE Grade 1 Nail Changes<span class="subclass"> SubClassOf </span>Nail Changes Adverse Event. <br><i>New Terms: Nail Changes Adverse Event, CTCAE Grade 1 Nail Changes</i></td>
            </tr>
            <tr class="addition">
               <td>787</td>
               <td colspan="2">CTCAE Grade 1 Nails Intra-Operative Injury<span class="subclass"> SubClassOf </span>Nails Intra-Operative Injury Adverse Event. <br><i>New Terms: Nails Intra-Operative Injury Adverse Event, CTCAE Grade 1 Nails Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>788</td>
               <td colspan="2">CTCAE Grade 1 Nasal Cavity Intra-Operative Injury<span class="subclass"> SubClassOf </span>Nasal Cavity Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Nasal Cavity Intra-Operative Injury, Nasal Cavity Intra-Operative Injury
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>789</td>
               <td colspan="2">CTCAE Grade 1 Nasal Cavity<br><span class="keyword"> and </span>Paranasal Sinus Reactions<span class="subclass"> SubClassOf </span>Nasal Cavity<br><span class="keyword"> and </span>Paranasal Sinus Reactions Adverse Event. <br><i>New Terms: CTCAE Grade 1 Nasal Cavity and Paranasal Sinus Reactions, Nasal Cavity and Paranasal
                     Sinus Reactions Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>790</td>
               <td colspan="2">CTCAE Grade 1 Nasopharynx Intra-Operative Injury<span class="subclass"> SubClassOf </span>Nasopharynx Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Nasopharynx Intra-Operative Injury, Nasopharynx Intra-Operative Injury
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>791</td>
               <td colspan="2">CTCAE Grade 1 Nausea<span class="subclass"> SubClassOf </span>Nausea Adverse Event. <br><i>New Terms: CTCAE Grade 1 Nausea, Nausea Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>792</td>
               <td colspan="2">CTCAE Grade 1 Neck NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Neck NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Neck NOS Intra-Operative Injury, Neck NOS Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>793</td>
               <td colspan="2">CTCAE Grade 1 Neck Pain<span class="subclass"> SubClassOf </span>Neck Pain Adverse Event. <br><i>New Terms: CTCAE Grade 1 Neck Pain, Neck Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>794</td>
               <td colspan="2">CTCAE Grade 1 Neuralgia<br><span class="keyword"> and </span>Peripheral Nerve Pain<span class="subclass"> SubClassOf </span>Neuralgia<br><span class="keyword"> and </span>Peripheral Nerve Pain Adverse Event. <br><i>New Terms: CTCAE Grade 1 Neuralgia and Peripheral Nerve Pain, Neuralgia and Peripheral Nerve
                     Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>795</td>
               <td colspan="2">CTCAE Grade 1 Neuroendocrine ACTH Deficiency<span class="subclass"> SubClassOf </span>Neuroendocrine ACTH Deficiency Adverse Event. <br><i>New Terms: CTCAE Grade 1 Neuroendocrine ACTH Deficiency, Neuroendocrine ACTH Deficiency Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>796</td>
               <td colspan="2">CTCAE Grade 1 Neuroendocrine ADH Secretion Abnormality<span class="subclass"> SubClassOf </span>Neuroendocrine ADH Secretion Abnormality Adverse Event. <br><i>New Terms: CTCAE Grade 1 Neuroendocrine ADH Secretion Abnormality, Neuroendocrine ADH Secretion
                     Abnormality Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>797</td>
               <td colspan="2">CTCAE Grade 1 Neuroendocrine Gonadotropin Secretion Abnormality<span class="subclass"> SubClassOf </span>Neuroendocrine Gonadotropin Secretion Abnormality Adverse Event. <br><i>New Terms: Neuroendocrine Gonadotropin Secretion Abnormality Adverse Event, CTCAE Grade 1 Neuroendocrine
                     Gonadotropin Secretion Abnormality</i></td>
            </tr>
            <tr class="addition">
               <td>798</td>
               <td colspan="2">CTCAE Grade 1 Neuroendocrine Growth Hormone Secretion Abnormality<span class="subclass"> SubClassOf </span>Neuroendocrine Growth Hormone Secretion Abnormality Adverse Event. <br><i>New Terms: CTCAE Grade 1 Neuroendocrine Growth Hormone Secretion Abnormality, Neuroendocrine
                     Growth Hormone Secretion Abnormality Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>799</td>
               <td colspan="2">CTCAE Grade 1 Neuroendocrine Prolactin Hormone Secretion Abnormality<span class="subclass"> SubClassOf </span>Neuroendocrine Prolactin Hormone Secretion Abnormality Adverse Event. <br><i>New Terms: CTCAE Grade 1 Neuroendocrine Prolactin Hormone Secretion Abnormality, Neuroendocrine
                     Prolactin Hormone Secretion Abnormality Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>800</td>
               <td colspan="2">CTCAE Grade 1 Neutrophils<br><span class="keyword"> and </span>Granulocytes<span class="subclass"> SubClassOf </span>Neutrophils<br><span class="keyword"> and </span>Granulocytes Adverse Event. <br><i>New Terms: CTCAE Grade 1 Neutrophils and Granulocytes, Neutrophils and Granulocytes Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>801</td>
               <td colspan="2">CTCAE Grade 1 Nodal<br><span class="keyword"> or </span>Junctional Rhythm<span class="subclass"> SubClassOf </span>Nodal<br><span class="keyword"> or </span>Junctional Rhythm Adverse Event. <br><i>New Terms: CTCAE Grade 1 Nodal or Junctional Rhythm, Nodal or Junctional Rhythm Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>802</td>
               <td colspan="2">CTCAE Grade 1 Non-Infectious Vaginal Discharge<span class="subclass"> SubClassOf </span>Non-Infectious Vaginal Discharge Adverse Event. <br><i>New Terms: Non-Infectious Vaginal Discharge Adverse Event, CTCAE Grade 1 Non-Infectious Vaginal
                     Discharge</i></td>
            </tr>
            <tr class="addition">
               <td>803</td>
               <td colspan="2">CTCAE Grade 1 Non-Infectious Wound Complication<span class="subclass"> SubClassOf </span>Non-Infectious Wound Complication Adverse Event. <br><i>New Terms: CTCAE Grade 1 Non-Infectious Wound Complication, Non-Infectious Wound Complication
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>804</td>
               <td colspan="2">CTCAE Grade 1 Non-Malignant Ascites<span class="subclass"> SubClassOf </span>Non-Malignant Ascites Adverse Event. <br><i>New Terms: CTCAE Grade 1 Non-Malignant Ascites, Non-Malignant Ascites Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>805</td>
               <td colspan="2">CTCAE Grade 1 Non-Malignant Pericardial Effusion<span class="subclass"> SubClassOf </span>Non-Malignant Pericardial Effusion Adverse Event. <br><i>New Terms: Non-Malignant Pericardial Effusion Adverse Event, CTCAE Grade 1 Non-Malignant Pericardial
                     Effusion</i></td>
            </tr>
            <tr class="addition">
               <td>806</td>
               <td colspan="2">CTCAE Grade 1 Non-Malignant Pleural Effusion<span class="subclass"> SubClassOf </span>Non-Malignant Pleural Effusion Adverse Event. <br><i>New Terms: CTCAE Grade 1 Non-Malignant Pleural Effusion, Non-Malignant Pleural Effusion Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>807</td>
               <td colspan="2">CTCAE Grade 1 Non-Septic Arthritis<span class="subclass"> SubClassOf </span>Non-Septic Arthritis Adverse Event. <br><i>New Terms: CTCAE Grade 1 Non-Septic Arthritis, Non-Septic Arthritis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>808</td>
               <td colspan="2">CTCAE Grade 1 Nose Hemorrhage<span class="subclass"> SubClassOf </span>Nose Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 1 Nose Hemorrhage, Nose Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>809</td>
               <td colspan="2">CTCAE Grade 1 Nose Intra-Operative Injury<span class="subclass"> SubClassOf </span>Nose Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Nose Intra-Operative Injury, Nose Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>810</td>
               <td colspan="2">CTCAE Grade 1 Nyctalopia<span class="subclass"> SubClassOf </span>Nyctalopia Adverse Event. <br><i>New Terms: CTCAE Grade 1 Nyctalopia, Nyctalopia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>811</td>
               <td colspan="2">CTCAE Grade 1 Nystagmus<span class="subclass"> SubClassOf </span>Nystagmus Adverse Event. <br><i>New Terms: CTCAE Grade 1 Nystagmus, Nystagmus Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>812</td>
               <td colspan="2">CTCAE Grade 1 Ocular Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Ocular Muscle Weakness Not Due to Neuropathy Adverse Event. <br><i>New Terms: Ocular Muscle Weakness Not Due to Neuropathy Adverse Event, CTCAE Grade 1 Ocular Muscle
                     Weakness Not Due to Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>813</td>
               <td colspan="2">CTCAE Grade 1 Ocular Surface Disease<span class="subclass"> SubClassOf </span>Ocular Surface Disease Adverse Event. <br><i>New Terms: CTCAE Grade 1 Ocular Surface Disease, Ocular Surface Disease Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>814</td>
               <td colspan="2">CTCAE Grade 1 Ophthalmoplegia<br><span class="keyword"> and </span>Diplopia<span class="subclass"> SubClassOf </span>Ophthalmoplegia<br><span class="keyword"> and </span>Diplopia Adverse Event. <br><i>New Terms: CTCAE Grade 1 Ophthalmoplegia and Diplopia, Ophthalmoplegia and Diplopia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>815</td>
               <td colspan="2">CTCAE Grade 1 Optic Disc Edema<span class="subclass"> SubClassOf </span>Optic Disc Edema Adverse Event. <br><i>New Terms: CTCAE Grade 1 Optic Disc Edema, Optic Disc Edema Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>816</td>
               <td colspan="2">CTCAE Grade 1 Oral Cavity GI Fistula<span class="subclass"> SubClassOf </span>Oral Cavity GI Fistula Adverse Event. <br><i>New Terms: Oral Cavity GI Fistula Adverse Event, CTCAE Grade 1 Oral Cavity GI Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>817</td>
               <td colspan="2">CTCAE Grade 1 Oral Cavity Hemorrhage<span class="subclass"> SubClassOf </span>Oral Cavity Adverse Event Hemorrhage. <br><i>New Terms: CTCAE Grade 1 Oral Cavity Hemorrhage, Oral Cavity Adverse Event Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>818</td>
               <td colspan="2">CTCAE Grade 1 Oral Cavity Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Oral Cavity Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification. <br><i>New Terms: CTCAE Grade 1 Oral Cavity Mucositis or Stomatitis by Clinical Examination Classification,
                     Oral Cavity Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>819</td>
               <td colspan="2">CTCAE Grade 1 Oral Cavity Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Oral Cavity Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: CTCAE Grade 1 Oral Cavity Mucositis or Stomatitis by Functional or Symptomatic Classification,
                     Oral Cavity Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>820</td>
               <td colspan="2">CTCAE Grade 1 Oral Cavity NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Oral Cavity NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Oral Cavity NOS Intra-Operative Injury, Oral Cavity NOS Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>821</td>
               <td colspan="2">CTCAE Grade 1 Oral Cavity Pain<span class="subclass"> SubClassOf </span>Oral Cavity Pain Adverse Event. <br><i>New Terms: CTCAE Grade 1 Oral Cavity Pain, Oral Cavity Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>822</td>
               <td colspan="2">CTCAE Grade 1 Oral Cavity Pulmonary Fistula<span class="subclass"> SubClassOf </span>Oral Cavity Pulmonary Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 1 Oral Cavity Pulmonary Fistula, Oral Cavity Pulmonary Fistula Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>823</td>
               <td colspan="2">CTCAE Grade 1 Oral Intra-Operative Injury<span class="subclass"> SubClassOf </span>Oral Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Oral Intra-Operative Injury, Oral Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>824</td>
               <td colspan="2">CTCAE Grade 1 Oral Pain of the Gums<span class="subclass"> SubClassOf </span>Oral Pain of the Gums Adverse Event. <br><i>New Terms: CTCAE Grade 1 Oral Pain of the Gums, Oral Pain of the Gums Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>825</td>
               <td colspan="2">CTCAE Grade 1 Orgasmic Dysfunction<span class="subclass"> SubClassOf </span>Orgasmic Dysfunction Adverse Event. <br><i>New Terms: CTCAE Grade 1 Orgasmic Dysfunction, Orgasmic Dysfunction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>826</td>
               <td colspan="2">CTCAE Grade 1 Osteoporosis<span class="subclass"> SubClassOf </span>Osteoporosis Adverse Event. <br><i>New Terms: Osteoporosis Adverse Event, CTCAE Grade 1 Osteoporosis</i></td>
            </tr>
            <tr class="addition">
               <td>827</td>
               <td colspan="2">CTCAE Grade 1 Other Allergy<br><span class="keyword"> and </span>Immunology<span class="subclass"> SubClassOf </span>Other Allergy<br><span class="keyword"> and </span>Immunology Adverse Event. <br><i>New Terms: CTCAE Grade 1 Other Allergy and Immunology, Other Allergy and Immunology Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>828</td>
               <td colspan="2">CTCAE Grade 1 Other Auditory<br><span class="keyword"> and </span>Ear<span class="subclass"> SubClassOf </span>Other Auditory<br><span class="keyword"> and </span>Ear Adverse Event. <br><i>New Terms: Other Auditory and Ear Adverse Event, CTCAE Grade 1 Other Auditory and Ear</i></td>
            </tr>
            <tr class="addition">
               <td>829</td>
               <td colspan="2">CTCAE Grade 1 Other Blood<br><span class="keyword"> and </span>Bone Marrow<span class="subclass"> SubClassOf </span>Other Blood<br><span class="keyword"> and </span>Bone Marrow Adverse Event. <br><i>New Terms: Other Blood and Bone Marrow Adverse Event, CTCAE Grade 1 Other Blood and Bone Marrow</i></td>
            </tr>
            <tr class="addition">
               <td>830</td>
               <td colspan="2">CTCAE Grade 1 Other Cardiac Arrhythmia<span class="subclass"> SubClassOf </span>Other Cardiac Arrhythmia Adverse Event. <br><i>New Terms: Other Cardiac Arrhythmia Adverse Event, CTCAE Grade 1 Other Cardiac Arrhythmia</i></td>
            </tr>
            <tr class="addition">
               <td>831</td>
               <td colspan="2">CTCAE Grade 1 Other Coagulation<span class="subclass"> SubClassOf </span>Other Coagulation Adverse Event. <br><i>New Terms: CTCAE Grade 1 Other Coagulation, Other Coagulation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>832</td>
               <td colspan="2">CTCAE Grade 1 Other Constitutional Symptoms<span class="subclass"> SubClassOf </span>Other Constitutional Symptoms Adverse Event. <br><i>New Terms: CTCAE Grade 1 Other Constitutional Symptoms, Other Constitutional Symptoms Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>833</td>
               <td colspan="2">CTCAE Grade 1 Other Dermatology<br><span class="keyword"> or </span>Skin<span class="subclass"> SubClassOf </span>Other Dermatology<br><span class="keyword"> or </span>Skin Adverse Event. <br><i>New Terms: CTCAE Grade 1 Other Dermatology or Skin, Other Dermatology or Skin Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>834</td>
               <td colspan="2">CTCAE Grade 1 Other Endocrine<span class="subclass"> SubClassOf </span>Other Endocrine Adverse Event. <br><i>New Terms: CTCAE Grade 1 Other Endocrine, Other Endocrine Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>835</td>
               <td colspan="2">CTCAE Grade 1 Other Gastrointestinal<span class="subclass"> SubClassOf </span>Other Gastrointestinal Adverse Event. <br><i>New Terms: Other Gastrointestinal Adverse Event, CTCAE Grade 1 Other Gastrointestinal</i></td>
            </tr>
            <tr class="addition">
               <td>836</td>
               <td colspan="2">CTCAE Grade 1 Other Growth<br><span class="keyword"> and </span>Development<span class="subclass"> SubClassOf </span>Other Growth<br><span class="keyword"> and </span>Development Adverse Event. <br><i>New Terms: Other Growth and Development Adverse Event, CTCAE Grade 1 Other Growth and Development</i></td>
            </tr>
            <tr class="addition">
               <td>837</td>
               <td colspan="2">CTCAE Grade 1 Other Heart in General<span class="subclass"> SubClassOf </span>Other Adverse Event Associated with the Heart in General. <br><i>New Terms: CTCAE Grade 1 Other Heart in General, Other Adverse Event Associated with the Heart
                     in General</i></td>
            </tr>
            <tr class="addition">
               <td>838</td>
               <td colspan="2">CTCAE Grade 1 Other Hemorrhage<br><span class="keyword"> and </span>Bleeding<span class="subclass"> SubClassOf </span>Other Hemorrhage<br><span class="keyword"> and </span>Bleeding Adverse Event. <br><i>New Terms: Other Hemorrhage and Bleeding Adverse Event, CTCAE Grade 1 Other Hemorrhage and Bleeding</i></td>
            </tr>
            <tr class="addition">
               <td>839</td>
               <td colspan="2">CTCAE Grade 1 Other Hepatobiliary<br><span class="keyword"> and </span>Pancreas<span class="subclass"> SubClassOf </span>Other Hepatobiliary<br><span class="keyword"> and </span>Pancreas Adverse Event. <br><i>New Terms: CTCAE Grade 1 Other Hepatobiliary and Pancreas, Other Hepatobiliary and Pancreas Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>840</td>
               <td colspan="2">CTCAE Grade 1 Other Infection<span class="subclass"> SubClassOf </span>Infection Other Adverse Event. <br><i>New Terms: CTCAE Grade 1 Other Infection, Infection Other Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>841</td>
               <td colspan="2">CTCAE Grade 1 Other Intra-Operative Injury<span class="subclass"> SubClassOf </span>Other Intra-Operative Injury Adverse Event. <br><i>New Terms: Other Intra-Operative Injury Adverse Event, CTCAE Grade 1 Other Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>842</td>
               <td colspan="2">CTCAE Grade 1 Other Lymphatics<span class="subclass"> SubClassOf </span>Other Lymphatics Adverse Event. <br><i>New Terms: CTCAE Grade 1 Other Lymphatics, Other Lymphatics Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>843</td>
               <td colspan="2">CTCAE Grade 1 Other Metabolic<br><span class="keyword"> and </span>Laboratory<span class="subclass"> SubClassOf </span>Other Metabolic<br><span class="keyword"> and </span>Laboratory Adverse Event. <br><i>New Terms: Other Metabolic and Laboratory Adverse Event, CTCAE Grade 1 Other Metabolic and Laboratory</i></td>
            </tr>
            <tr class="addition">
               <td>844</td>
               <td colspan="2">CTCAE Grade 1 Other Musculoskeletal<br><span class="keyword"> and </span>Soft Tissue<span class="subclass"> SubClassOf </span>Other Musculoskeletal<br><span class="keyword"> and </span>Soft Tissue Adverse Event. <br><i>New Terms: CTCAE Grade 1 Other Musculoskeletal and Soft Tissue, Other Musculoskeletal and Soft
                     Tissue Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>845</td>
               <td colspan="2">CTCAE Grade 1 Other NOS Artery Injury<span class="subclass"> SubClassOf </span>Other NOS Artery Injury Adverse Event. <br><i>New Terms: Other NOS Artery Injury Adverse Event, CTCAE Grade 1 Other NOS Artery Injury</i></td>
            </tr>
            <tr class="addition">
               <td>846</td>
               <td colspan="2">CTCAE Grade 1 Other NOS Vein Injury<span class="subclass"> SubClassOf </span>Other NOS Vein Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Other NOS Vein Injury, Other NOS Vein Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>847</td>
               <td colspan="2">CTCAE Grade 1 Other Neurology<span class="subclass"> SubClassOf </span>Other Neurology Adverse Event. <br><i>New Terms: CTCAE Grade 1 Other Neurology, Other Neurology Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>848</td>
               <td colspan="2">CTCAE Grade 1 Other Ocular<br><span class="keyword"> and </span>Visual<span class="subclass"> SubClassOf </span>Other Ocular<br><span class="keyword"> and </span>Visual Adverse Event. <br><i>New Terms: Other Ocular and Visual Adverse Event, CTCAE Grade 1 Other Ocular and Visual</i></td>
            </tr>
            <tr class="addition">
               <td>849</td>
               <td colspan="2">CTCAE Grade 1 Other Pain<span class="subclass"> SubClassOf </span>Other Pain Adverse Event. <br><i>New Terms: CTCAE Grade 1 Other Pain, Other Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>850</td>
               <td colspan="2">CTCAE Grade 1 Other Pulmonary<br><span class="keyword"> and </span>Upper Respiratory<span class="subclass"> SubClassOf </span>Other Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Adverse Event. <br><i>New Terms: CTCAE Grade 1 Other Pulmonary and Upper Respiratory, Other Pulmonary and Upper Respiratory
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>851</td>
               <td colspan="2">CTCAE Grade 1 Other Renal<br><span class="keyword"> or </span>Genitourinary<span class="subclass"> SubClassOf </span>Renal<br><span class="keyword"> or </span>Genitourinary Other Adverse Event. <br><i>New Terms: Renal or Genitourinary Other Adverse Event, CTCAE Grade 1 Other Renal or Genitourinary</i></td>
            </tr>
            <tr class="addition">
               <td>852</td>
               <td colspan="2">CTCAE Grade 1 Other Sexual Reproductive Function<span class="subclass"> SubClassOf </span>Other Sexual Reproductive Function Adverse Event. <br><i>New Terms: CTCAE Grade 1 Other Sexual Reproductive Function, Other Sexual Reproductive Function
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>853</td>
               <td colspan="2">CTCAE Grade 1 Other Syndromes<span class="subclass"> SubClassOf </span>Other Syndromes Adverse Event. <br><i>New Terms: Other Syndromes Adverse Event, CTCAE Grade 1 Other Syndromes</i></td>
            </tr>
            <tr class="addition">
               <td>854</td>
               <td colspan="2">CTCAE Grade 1 Other Vascular<span class="subclass"> SubClassOf </span>Other Vascular Adverse Event. <br><i>New Terms: CTCAE Grade 1 Other Vascular, Other Vascular Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>855</td>
               <td colspan="2">CTCAE Grade 1 Otitis External Ear Non Infectious<span class="subclass"> SubClassOf </span>Otitis Adverse Event External Ear Non Infectious. <br><i>New Terms: CTCAE Grade 1 Otitis External Ear Non Infectious, Otitis Adverse Event External Ear
                     Non Infectious</i></td>
            </tr>
            <tr class="addition">
               <td>856</td>
               <td colspan="2">CTCAE Grade 1 Otitis Middle Ear Non Infectious<span class="subclass"> SubClassOf </span>Otitis Adverse Event Middle Ear Non Infectious. <br><i>New Terms: CTCAE Grade 1 Otitis Middle Ear Non Infectious, Otitis Adverse Event Middle Ear Non
                     Infectious</i></td>
            </tr>
            <tr class="addition">
               <td>857</td>
               <td colspan="2">CTCAE Grade 1 Outer Ear NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Outer Ear NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: Outer Ear NOS Intra-Operative Injury Adverse Event, CTCAE Grade 1 Outer Ear NOS Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>858</td>
               <td colspan="2">CTCAE Grade 1 Outer Ear Pinna Intra-Operative Injury<span class="subclass"> SubClassOf </span>Outer Ear Pinna Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Outer Ear Pinna Intra-Operative Injury, Outer Ear Pinna Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>859</td>
               <td colspan="2">CTCAE Grade 1 Ovary Hemorrhage<span class="subclass"> SubClassOf </span>Ovary Hemorrhage Adverse Event. <br><i>New Terms: Ovary Hemorrhage Adverse Event, CTCAE Grade 1 Ovary Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>860</td>
               <td colspan="2">CTCAE Grade 1 Ovary Intra-Operative Injury<span class="subclass"> SubClassOf </span>Ovary Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Ovary Intra-Operative Injury, Ovary Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>861</td>
               <td colspan="2">CTCAE Grade 1 Ovary Perforation<span class="subclass"> SubClassOf </span>Ovary Perforation Adverse Event. <br><i>New Terms: Ovary Perforation Adverse Event, CTCAE Grade 1 Ovary Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>862</td>
               <td colspan="2">CTCAE Grade 1 Ovulatory Pain<span class="subclass"> SubClassOf </span>Ovulatory Pain Adverse Event. <br><i>New Terms: Ovulatory Pain Adverse Event, CTCAE Grade 1 Ovulatory Pain</i></td>
            </tr>
            <tr class="addition">
               <td>863</td>
               <td colspan="2">CTCAE Grade 1 PVCs<span class="subclass"> SubClassOf </span>Premature Ventricular Contraction Adverse Event. <br><i>New Terms: CTCAE Grade 1 PVCs, Premature Ventricular Contraction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>864</td>
               <td colspan="2">CTCAE Grade 1 Pain NOS<span class="subclass"> SubClassOf </span>Pain NOS Adverse Event. <br><i>New Terms: Pain NOS Adverse Event, CTCAE Grade 1 Pain NOS</i></td>
            </tr>
            <tr class="addition">
               <td>865</td>
               <td colspan="2">CTCAE Grade 1 Palpitations<span class="subclass"> SubClassOf </span>Palpitations Adverse Event. <br><i>New Terms: Palpitations Adverse Event, CTCAE Grade 1 Palpitations</i></td>
            </tr>
            <tr class="addition">
               <td>866</td>
               <td colspan="2">CTCAE Grade 1 Pancreas Fistula<span class="subclass"> SubClassOf </span>Pancreas Fistula Adverse Event. <br><i>New Terms: Pancreas Fistula Adverse Event, CTCAE Grade 1 Pancreas Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>867</td>
               <td colspan="2">CTCAE Grade 1 Pancreas Hemorrhage<span class="subclass"> SubClassOf </span>Pancreas Hemorrhage Adverse Event. <br><i>New Terms: Pancreas Hemorrhage Adverse Event, CTCAE Grade 1 Pancreas Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>868</td>
               <td colspan="2">CTCAE Grade 1 Pancreas Intra-Operative Injury<span class="subclass"> SubClassOf </span>Pancreas Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Pancreas Intra-Operative Injury, Pancreas Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>869</td>
               <td colspan="2">CTCAE Grade 1 Pancreas Leak<span class="subclass"> SubClassOf </span>Pancreas Leak Adverse Event. <br><i>New Terms: Pancreas Leak Adverse Event, CTCAE Grade 1 Pancreas Leak</i></td>
            </tr>
            <tr class="addition">
               <td>870</td>
               <td colspan="2">CTCAE Grade 1 Pancreas<br><span class="keyword"> or </span>Pancreatic Duct Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Pancreas<br><span class="keyword"> or </span>Pancreatic Duct Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 1 Pancreas or Pancreatic Duct Stricture or Stenosis, Pancreas or Pancreatic
                     Duct Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>871</td>
               <td colspan="2">CTCAE Grade 1 Pancreatic Duct Intra-Operative Injury<span class="subclass"> SubClassOf </span>Pancreatic Duct Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Pancreatic Duct Intra-Operative Injury, Pancreatic Duct Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>872</td>
               <td colspan="2">CTCAE Grade 1 Pancreatic Endocrine Glucose Intolerance<span class="subclass"> SubClassOf </span>Pancreatic Endocrine Glucose Intolerance Adverse Event. <br><i>New Terms: CTCAE Grade 1 Pancreatic Endocrine Glucose Intolerance, Pancreatic Endocrine Glucose
                     Intolerance Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>873</td>
               <td colspan="2">CTCAE Grade 1 Pancreatitis<span class="subclass"> SubClassOf </span>Pancreatitis Adverse Event. <br><i>New Terms: Pancreatitis Adverse Event, CTCAE Grade 1 Pancreatitis</i></td>
            </tr>
            <tr class="addition">
               <td>874</td>
               <td colspan="2">CTCAE Grade 1 Parathyroid Function Low<span class="subclass"> SubClassOf </span>Parathyroid Function Low Adverse Event. <br><i>New Terms: CTCAE Grade 1 Parathyroid Function Low, Parathyroid Function Low Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>875</td>
               <td colspan="2">CTCAE Grade 1 Parathyroid Intra-Operative Injury<span class="subclass"> SubClassOf </span>Parathyroid Intra-Operative Injury Adverse Event. <br><i>New Terms: Parathyroid Intra-Operative Injury Adverse Event, CTCAE Grade 1 Parathyroid Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>876</td>
               <td colspan="2">CTCAE Grade 1 Parotid Gland Intra-Operative Injury<span class="subclass"> SubClassOf </span>Parotid Gland Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Parotid Gland Intra-Operative Injury, Parotid Gland Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>877</td>
               <td colspan="2">CTCAE Grade 1 Partial Thromboplastin Time<span class="subclass"> SubClassOf </span>Partial Thromboplastin Time Adverse Event. <br><i>New Terms: Partial Thromboplastin Time Adverse Event, CTCAE Grade 1 Partial Thromboplastin Time</i></td>
            </tr>
            <tr class="addition">
               <td>878</td>
               <td colspan="2">CTCAE Grade 1 Patient Odor<span class="subclass"> SubClassOf </span>Patient Odor Adverse Event. <br><i>New Terms: CTCAE Grade 1 Patient Odor, Patient Odor Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>879</td>
               <td colspan="2">CTCAE Grade 1 Pelvic Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Pelvic Muscle Weakness Not Due to Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 1 Pelvic Muscle Weakness Not Due to Neuropathy, Pelvic Muscle Weakness
                     Not Due to Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>880</td>
               <td colspan="2">CTCAE Grade 1 Pelvis NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Pelvis Intra-Operative Injury Adverse Event. <br><i>New Terms: Pelvis Intra-Operative Injury Adverse Event, CTCAE Grade 1 Pelvis NOS Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>881</td>
               <td colspan="2">CTCAE Grade 1 Pelvis Pain<span class="subclass"> SubClassOf </span>Pelvis Pain Adverse Event. <br><i>New Terms: CTCAE Grade 1 Pelvis Pain, Pelvis Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>882</td>
               <td colspan="2">CTCAE Grade 1 Penis Intra-Operative Injury<span class="subclass"> SubClassOf </span>Penis Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Penis Intra-Operative Injury, Penis Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>883</td>
               <td colspan="2">CTCAE Grade 1 Penis Pain<span class="subclass"> SubClassOf </span>Penis Pain Adverse Event. <br><i>New Terms: CTCAE Grade 1 Penis Pain, Penis Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>884</td>
               <td colspan="2">CTCAE Grade 1 Pericarditis<span class="subclass"> SubClassOf </span>Pericarditis Adverse Event. <br><i>New Terms: Pericarditis Adverse Event, CTCAE Grade 1 Pericarditis</i></td>
            </tr>
            <tr class="addition">
               <td>885</td>
               <td colspan="2">CTCAE Grade 1 Pericardium Pain<span class="subclass"> SubClassOf </span>Pericardium Pain Adverse Event. <br><i>New Terms: CTCAE Grade 1 Pericardium Pain, Pericardium Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>886</td>
               <td colspan="2">CTCAE Grade 1 Perineum Pain<span class="subclass"> SubClassOf </span>Perineum Pain Adverse Event. <br><i>New Terms: CTCAE Grade 1 Perineum Pain, Perineum Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>887</td>
               <td colspan="2">CTCAE Grade 1 Periodontal Disease<span class="subclass"> SubClassOf </span>Periodontal Disease Adverse Event. <br><i>New Terms: Periodontal Disease Adverse Event, CTCAE Grade 1 Periodontal Disease</i></td>
            </tr>
            <tr class="addition">
               <td>888</td>
               <td colspan="2">CTCAE Grade 1 Peripheral Motor Nerve NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Peripheral Motor Nerve NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: Peripheral Motor Nerve NOS Intra-Operative Injury Adverse Event, CTCAE Grade 1 Peripheral
                     Motor Nerve NOS Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>889</td>
               <td colspan="2">CTCAE Grade 1 Peripheral Sensory Nerve NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Peripheral Sensory Nerve NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Peripheral Sensory Nerve NOS Intra-Operative Injury, Peripheral Sensory
                     Nerve NOS Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>890</td>
               <td colspan="2">CTCAE Grade 1 Peritoneal Cavity Hemorrhage<span class="subclass"> SubClassOf </span>Peritoneal Hemorrhage Adverse Event. <br><i>New Terms: Peritoneal Hemorrhage Adverse Event, CTCAE Grade 1 Peritoneal Cavity Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>891</td>
               <td colspan="2">CTCAE Grade 1 Peritoneal Cavity Intra-Operative Injury<span class="subclass"> SubClassOf </span>Peritoneal Cavity Intra-Operative Injury Adverse Event. <br><i>New Terms: Peritoneal Cavity Intra-Operative Injury Adverse Event, CTCAE Grade 1 Peritoneal Cavity
                     Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>892</td>
               <td colspan="2">CTCAE Grade 1 Peritoneum Pain<span class="subclass"> SubClassOf </span>Peritoneum Pain Adverse Event. <br><i>New Terms: CTCAE Grade 1 Peritoneum Pain, Peritoneum Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>893</td>
               <td colspan="2">CTCAE Grade 1 Personality<br><span class="keyword"> and </span>Behavioral Change<span class="subclass"> SubClassOf </span>Personality<br><span class="keyword"> and </span>Behavioral Change Adverse Event. <br><i>New Terms: CTCAE Grade 1 Personality and Behavioral Change, Personality and Behavioral Change
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>894</td>
               <td colspan="2">CTCAE Grade 1 Petechiae<br><span class="keyword"> and </span>Purpura<span class="subclass"> SubClassOf </span>Petechiae<br><span class="keyword"> and </span>Purpura Adverse Event. <br><i>New Terms: CTCAE Grade 1 Petechiae and Purpura, Petechiae and Purpura Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>895</td>
               <td colspan="2">CTCAE Grade 1 Phantom Pain Associated with Missing Limb<span class="subclass"> SubClassOf </span>Phantom Pain Associated with Missing Limb Adverse Event. <br><i>New Terms: CTCAE Grade 1 Phantom Pain Associated with Missing Limb, Phantom Pain Associated with
                     Missing Limb Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>896</td>
               <td colspan="2">CTCAE Grade 1 Pharynx GI Fistula<span class="subclass"> SubClassOf </span>Pharynx GI Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 1 Pharynx GI Fistula, Pharynx GI Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>897</td>
               <td colspan="2">CTCAE Grade 1 Pharynx Hemorrhage<span class="subclass"> SubClassOf </span>Pharynx Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 1 Pharynx Hemorrhage, Pharynx Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>898</td>
               <td colspan="2">CTCAE Grade 1 Pharynx Intra-Operative Injury<span class="subclass"> SubClassOf </span>Pharynx Intra-Operative Injury Adverse Event. <br><i>New Terms: Pharynx Intra-Operative Injury Adverse Event, CTCAE Grade 1 Pharynx Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>899</td>
               <td colspan="2">CTCAE Grade 1 Pharynx Leak<span class="subclass"> SubClassOf </span>Pharynx Leak Adverse Event. <br><i>New Terms: CTCAE Grade 1 Pharynx Leak, Pharynx Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>900</td>
               <td colspan="2">CTCAE Grade 1 Pharynx Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Pharynx Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification. <br><i>New Terms: CTCAE Grade 1 Pharynx Mucositis or Stomatitis by Clinical Examination Classification,
                     Pharynx Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>901</td>
               <td colspan="2">CTCAE Grade 1 Pharynx Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Pharynx Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: Pharynx Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification,
                     CTCAE Grade 1 Pharynx Mucositis or Stomatitis by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>902</td>
               <td colspan="2">CTCAE Grade 1 Pharynx Obstruction<br><span class="keyword"> and </span>Stenosis<span class="subclass"> SubClassOf </span>Pharynx Obstruction<br><span class="keyword"> and </span>Stenosis Adverse Event. <br><i>New Terms: Pharynx Obstruction and Stenosis Adverse Event, CTCAE Grade 1 Pharynx Obstruction
                     and Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>903</td>
               <td colspan="2">CTCAE Grade 1 Pharynx Pulmonary Fistula<span class="subclass"> SubClassOf </span>Pharynx Pulmonary Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 1 Pharynx Pulmonary Fistula, Pharynx Pulmonary Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>904</td>
               <td colspan="2">CTCAE Grade 1 Pharynx Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Pharynx Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 1 Pharynx Stricture or Stenosis, Pharynx Stricture or Stenosis Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>905</td>
               <td colspan="2">CTCAE Grade 1 Phlebolymphatic Cording<span class="subclass"> SubClassOf </span>Phlebolymphatic Cording Adverse Event. <br><i>New Terms: Phlebolymphatic Cording Adverse Event, CTCAE Grade 1 Phlebolymphatic Cording</i></td>
            </tr>
            <tr class="addition">
               <td>906</td>
               <td colspan="2">CTCAE Grade 1 Photophobia<span class="subclass"> SubClassOf </span>Photophobia Adverse Event. <br><i>New Terms: Photophobia Adverse Event, CTCAE Grade 1 Photophobia</i></td>
            </tr>
            <tr class="addition">
               <td>907</td>
               <td colspan="2">CTCAE Grade 1 Photosensitivity<span class="subclass"> SubClassOf </span>Photosensitivity Adverse Event. <br><i>New Terms: CTCAE Grade 1 Photosensitivity, Photosensitivity Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>908</td>
               <td colspan="2">CTCAE Grade 1 Phrenic Nerve Dysfunction<span class="subclass"> SubClassOf </span>Phrenic Nerve Dysfunction Adverse Event. <br><i>New Terms: Phrenic Nerve Dysfunction Adverse Event, CTCAE Grade 1 Phrenic Nerve Dysfunction</i></td>
            </tr>
            <tr class="addition">
               <td>909</td>
               <td colspan="2">CTCAE Grade 1 Pituitary Intra-Operative Injury<span class="subclass"> SubClassOf </span>Pituitary Intra-Operative Injury Adverse Event. <br><i>New Terms: Pituitary Intra-Operative Injury Adverse Event, CTCAE Grade 1 Pituitary Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>910</td>
               <td colspan="2">CTCAE Grade 1 Platelets<span class="subclass"> SubClassOf </span>Platelets Adverse Event. <br><i>New Terms: CTCAE Grade 1 Platelets, Platelets Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>911</td>
               <td colspan="2">CTCAE Grade 1 Pleura Fistula<span class="subclass"> SubClassOf </span>Pleura Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 1 Pleura Fistula, Pleura Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>912</td>
               <td colspan="2">CTCAE Grade 1 Pleura Hemorrhage<span class="subclass"> SubClassOf </span>Pleura Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 1 Pleura Hemorrhage, Pleura Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>913</td>
               <td colspan="2">CTCAE Grade 1 Pleura Intra-Operative Injury<span class="subclass"> SubClassOf </span>Pleura Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Pleura Intra-Operative Injury, Pleura Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>914</td>
               <td colspan="2">CTCAE Grade 1 Pleura Pain<span class="subclass"> SubClassOf </span>Pleura Pain Adverse Event. <br><i>New Terms: Pleura Pain Adverse Event, CTCAE Grade 1 Pleura Pain</i></td>
            </tr>
            <tr class="addition">
               <td>915</td>
               <td colspan="2">CTCAE Grade 1 Pneumonitis<br><span class="keyword"> and </span>Pulmonary Infiltrates<span class="subclass"> SubClassOf </span>Pneumonitis<br><span class="keyword"> and </span>Pulmonary Infiltrates Adverse Event. <br><i>New Terms: Pneumonitis and Pulmonary Infiltrates Adverse Event, CTCAE Grade 1 Pneumonitis and
                     Pulmonary Infiltrates</i></td>
            </tr>
            <tr class="addition">
               <td>916</td>
               <td colspan="2">CTCAE Grade 1 Pneumothorax<span class="subclass"> SubClassOf </span>Pneumothorax Adverse Event. <br><i>New Terms: Pneumothorax Adverse Event, CTCAE Grade 1 Pneumothorax</i></td>
            </tr>
            <tr class="addition">
               <td>917</td>
               <td colspan="2">CTCAE Grade 1 Portal Vein Intra-Operative Injury<span class="subclass"> SubClassOf </span>Portal Vein Intra-Operative Injury Adverse Event. <br><i>New Terms: Portal Vein Intra-Operative Injury Adverse Event, CTCAE Grade 1 Portal Vein Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>918</td>
               <td colspan="2">CTCAE Grade 1 Proctitis<span class="subclass"> SubClassOf </span>Proctitis Adverse Event. <br><i>New Terms: Proctitis Adverse Event, CTCAE Grade 1 Proctitis</i></td>
            </tr>
            <tr class="addition">
               <td>919</td>
               <td colspan="2">CTCAE Grade 1 Prolapse of Gastrointestinal Stoma<span class="subclass"> SubClassOf </span>Prolapse of Gastrointestinal Stoma Adverse Event. <br><i>New Terms: CTCAE Grade 1 Prolapse of Gastrointestinal Stoma, Prolapse of Gastrointestinal Stoma
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>920</td>
               <td colspan="2">CTCAE Grade 1 Prolonged QTc Interval<span class="subclass"> SubClassOf </span>Prolonged QTc Interval Adverse Event. <br><i>New Terms: CTCAE Grade 1 Prolonged QTc Interval, Prolonged QTc Interval Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>921</td>
               <td colspan="2">CTCAE Grade 1 Proptosis<br><span class="keyword"> and </span>Enophthalmos<span class="subclass"> SubClassOf </span>Proptosis<br><span class="keyword"> and </span>Enophthalmos Adverse Event. <br><i>New Terms: CTCAE Grade 1 Proptosis and Enophthalmos, Proptosis and Enophthalmos Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>922</td>
               <td colspan="2">CTCAE Grade 1 Prostate Hemorrhage<span class="subclass"> SubClassOf </span>Prostate Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 1 Prostate Hemorrhage, Prostate Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>923</td>
               <td colspan="2">CTCAE Grade 1 Prostate Intra-Operative Injury<span class="subclass"> SubClassOf </span>Prostate Intra-Operative Injury Adverse Event. <br><i>New Terms: Prostate Intra-Operative Injury Adverse Event, CTCAE Grade 1 Prostate Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>924</td>
               <td colspan="2">CTCAE Grade 1 Prostate Obstruction<span class="subclass"> SubClassOf </span>Prostate Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 1 Prostate Obstruction, Prostate Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>925</td>
               <td colspan="2">CTCAE Grade 1 Prostate Pain<span class="subclass"> SubClassOf </span>Prostate Pain Adverse Event. <br><i>New Terms: CTCAE Grade 1 Prostate Pain, Prostate Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>926</td>
               <td colspan="2">CTCAE Grade 1 Prostate Perforation<span class="subclass"> SubClassOf </span>Prostate Perforation Adverse Event. <br><i>New Terms: Prostate Perforation Adverse Event, CTCAE Grade 1 Prostate Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>927</td>
               <td colspan="2">CTCAE Grade 1 Prostate Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Prostate Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 1 Prostate Stricture or Stenosis, Prostate Stricture or Stenosis Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>928</td>
               <td colspan="2">CTCAE Grade 1 Proteinuria<span class="subclass"> SubClassOf </span>Proteinuria Adverse Event. <br><i>New Terms: Proteinuria Adverse Event, CTCAE Grade 1 Proteinuria</i></td>
            </tr>
            <tr class="addition">
               <td>929</td>
               <td colspan="2">CTCAE Grade 1 Pruritus<span class="subclass"> SubClassOf </span>Pruritus Adverse Event. <br><i>New Terms: CTCAE Grade 1 Pruritus, Pruritus Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>931</td>
               <td colspan="2">CTCAE Grade 1 Pulmonary Fibrosis Radiographic Changes<span class="subclass"> SubClassOf </span>Pulmonary Fibrosis Radiographic Changes Adverse Event. <br><i>New Terms: Pulmonary Fibrosis Radiographic Changes Adverse Event, CTCAE Grade 1 Pulmonary Fibrosis
                     Radiographic Changes</i></td>
            </tr>
            <tr class="addition">
               <td>932</td>
               <td colspan="2">CTCAE Grade 1 Pulmonary Hypertension<span class="subclass"> SubClassOf </span>Pulmonary Hypertension Adverse Event. <br><i>New Terms: CTCAE Grade 1 Pulmonary Hypertension, Pulmonary Hypertension Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>933</td>
               <td colspan="2">CTCAE Grade 1 Pulmonary Vein Intra-Operative Injury<span class="subclass"> SubClassOf </span>Pulmonary Vein Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Pulmonary Vein Intra-Operative Injury, Pulmonary Vein Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>934</td>
               <td colspan="2">CTCAE Grade 1 Pyramidal Tract Dysfunction<span class="subclass"> SubClassOf </span>Pyramidal Tract Dysfunction Adverse Event. <br><i>New Terms: Pyramidal Tract Dysfunction Adverse Event, CTCAE Grade 1 Pyramidal Tract Dysfunction</i></td>
            </tr>
            <tr class="addition">
               <td>935</td>
               <td colspan="2">CTCAE Grade 1 Radiation Excluding Chemoradiation<span class="subclass"> SubClassOf </span>Rash<br><span class="keyword"> and </span>Dermatitis Adverse Event Associated with Radiation Excluding Chemoradiation. <br><i>New Terms: CTCAE Grade 1 Radiation Excluding Chemoradiation, Rash and Dermatitis Adverse Event
                     Associated with Radiation Excluding Chemoradiation</i></td>
            </tr>
            <tr class="addition">
               <td>936</td>
               <td colspan="2">CTCAE Grade 1 Rash Acne<br><span class="keyword"> or </span>Acneiform Adverse Event<span class="subclass"> SubClassOf </span>Rash Acne<br><span class="keyword"> or </span>Acneiform Adverse Event. <br><i>New Terms: CTCAE Grade 1 Rash Acne or Acneiform Adverse Event, Rash Acne or Acneiform Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>937</td>
               <td colspan="2">CTCAE Grade 1 Rash Desquamation<span class="subclass"> SubClassOf </span>Rash Desquamation Adverse Event. <br><i>New Terms: Rash Desquamation Adverse Event, CTCAE Grade 1 Rash Desquamation</i></td>
            </tr>
            <tr class="addition">
               <td>938</td>
               <td colspan="2">CTCAE Grade 1 Rash Hand<br><span class="keyword"> or </span>Foot Skin Reaction<span class="subclass"> SubClassOf </span>Rash Hand<br><span class="keyword"> or </span>Foot Skin Reaction Adverse Event. <br><i>New Terms: Rash Hand or Foot Skin Reaction Adverse Event, CTCAE Grade 1 Rash Hand or Foot Skin
                     Reaction</i></td>
            </tr>
            <tr class="addition">
               <td>939</td>
               <td colspan="2">CTCAE Grade 1 Rectal Varices Hemorrhage<span class="subclass"> SubClassOf </span>Rectal Varices Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 1 Rectal Varices Hemorrhage, Rectal Varices Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>940</td>
               <td colspan="2">CTCAE Grade 1 Rectum Fistula<span class="subclass"> SubClassOf </span>Rectum Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 1 Rectum Fistula, Rectum Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>941</td>
               <td colspan="2">CTCAE Grade 1 Rectum Hemorrhage<span class="subclass"> SubClassOf </span>Rectum Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 1 Rectum Hemorrhage, Rectum Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>942</td>
               <td colspan="2">CTCAE Grade 1 Rectum Intra-Operative Injury<span class="subclass"> SubClassOf </span>Rectum Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Rectum Intra-Operative Injury, Rectum Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>943</td>
               <td colspan="2">CTCAE Grade 1 Rectum Leak<span class="subclass"> SubClassOf </span>Rectum Leak Adverse Event. <br><i>New Terms: CTCAE Grade 1 Rectum Leak, Rectum Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>944</td>
               <td colspan="2">CTCAE Grade 1 Rectum Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Rectum Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification. <br><i>New Terms: CTCAE Grade 1 Rectum Mucositis or Stomatitis by Clinical Examination Classification,
                     Rectum Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>945</td>
               <td colspan="2">CTCAE Grade 1 Rectum Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Rectum Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: Rectum Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification,
                     CTCAE Grade 1 Rectum Mucositis or Stomatitis by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>946</td>
               <td colspan="2">CTCAE Grade 1 Rectum Obstruction<span class="subclass"> SubClassOf </span>Rectum Obstruction Adverse Event. <br><i>New Terms: Rectum Obstruction Adverse Event, CTCAE Grade 1 Rectum Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>947</td>
               <td colspan="2">CTCAE Grade 1 Rectum Pain<span class="subclass"> SubClassOf </span>Rectum Pain Adverse Event. <br><i>New Terms: Rectum Pain Adverse Event, CTCAE Grade 1 Rectum Pain</i></td>
            </tr>
            <tr class="addition">
               <td>948</td>
               <td colspan="2">CTCAE Grade 1 Rectum Perforation<span class="subclass"> SubClassOf </span>Rectum Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 1 Rectum Perforation, Rectum Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>949</td>
               <td colspan="2">CTCAE Grade 1 Rectum Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Rectum Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 1 Rectum Stricture or Stenosis, Rectum Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>950</td>
               <td colspan="2">CTCAE Grade 1 Rectum Ulcer<span class="subclass"> SubClassOf </span>Rectum Ulcer Adverse Event. <br><i>New Terms: Rectum Ulcer Adverse Event, CTCAE Grade 1 Rectum Ulcer</i></td>
            </tr>
            <tr class="addition">
               <td>951</td>
               <td colspan="2">CTCAE Grade 1 Recurrent Laryngeal Nerve Intra-Operative Injury<span class="subclass"> SubClassOf </span>Recurrent Laryngeal Nerve Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Recurrent Laryngeal Nerve Intra-Operative Injury, Recurrent Laryngeal
                     Nerve Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>952</td>
               <td colspan="2">CTCAE Grade 1 Reduction in Growth Velocity<span class="subclass"> SubClassOf </span>Reduction in Growth Velocity Adverse Event. <br><i>New Terms: CTCAE Grade 1 Reduction in Growth Velocity, Reduction in Growth Velocity Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>953</td>
               <td colspan="2">CTCAE Grade 1 Respiratory Tract Hemorrhage NOS<span class="subclass"> SubClassOf </span>Respiratory Tract Hemorrhage Adverse Event NOS. <br><i>New Terms: Respiratory Tract Hemorrhage Adverse Event NOS, CTCAE Grade 1 Respiratory Tract Hemorrhage
                     NOS</i></td>
            </tr>
            <tr class="addition">
               <td>954</td>
               <td colspan="2">CTCAE Grade 1 Restrictive Cardiomyopathy<span class="subclass"> SubClassOf </span>Restrictive Cardiomyopathy Adverse Event. <br><i>New Terms: Restrictive Cardiomyopathy Adverse Event, CTCAE Grade 1 Restrictive Cardiomyopathy</i></td>
            </tr>
            <tr class="addition">
               <td>955</td>
               <td colspan="2">CTCAE Grade 1 Retina Intra-Operative Injury<span class="subclass"> SubClassOf </span>Retina Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Retina Intra-Operative Injury, Retina Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>956</td>
               <td colspan="2">CTCAE Grade 1 Retinal Detachment<span class="subclass"> SubClassOf </span>Retinal Detachment Adverse Event. <br><i>New Terms: CTCAE Grade 1 Retinal Detachment, Retinal Detachment Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>957</td>
               <td colspan="2">CTCAE Grade 1 Retinoic Acid Syndrome<span class="subclass"> SubClassOf </span>Retinoic Acid Syndrome Adverse Event. <br><i>New Terms: Retinoic Acid Syndrome Adverse Event, CTCAE Grade 1 Retinoic Acid Syndrome</i></td>
            </tr>
            <tr class="addition">
               <td>958</td>
               <td colspan="2">CTCAE Grade 1 Retinopathy<span class="subclass"> SubClassOf </span>Retinopathy Adverse Event. <br><i>New Terms: Retinopathy Adverse Event, CTCAE Grade 1 Retinopathy</i></td>
            </tr>
            <tr class="addition">
               <td>959</td>
               <td colspan="2">CTCAE Grade 1 Retroperitoneum Hemorrhage<span class="subclass"> SubClassOf </span>Retroperitoneum Hemorrhage Adverse Event. <br><i>New Terms: Retroperitoneum Hemorrhage Adverse Event, CTCAE Grade 1 Retroperitoneum Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>961</td>
               <td colspan="2">CTCAE Grade 1 Right Ventricular Dysfunction<span class="subclass"> SubClassOf </span>Right Ventricular Dysfunction Adverse Event. <br><i>New Terms: Right Ventricular Dysfunction Adverse Event, CTCAE Grade 1 Right Ventricular Dysfunction</i></td>
            </tr>
            <tr class="addition">
               <td>960</td>
               <td colspan="2">CTCAE Grade 1 Right-Sided Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Right-Sided Muscle Weakness Not Due to Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 1 Right-Sided Muscle Weakness Not Due to Neuropathy, Right-Sided Muscle
                     Weakness Not Due to Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>962</td>
               <td colspan="2">CTCAE Grade 1 Rigors<br><span class="keyword"> and </span>Chills<span class="subclass"> SubClassOf </span>Rigors<br><span class="keyword"> and </span>Chills Adverse Event. <br><i>New Terms: Rigors and Chills Adverse Event, CTCAE Grade 1 Rigors and Chills</i></td>
            </tr>
            <tr class="addition">
               <td>963</td>
               <td colspan="2">CTCAE Grade 1 Sacral Plexus Intra-Operative Injury<span class="subclass"> SubClassOf </span>Sacral Plexus Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Sacral Plexus Intra-Operative Injury, Sacral Plexus Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>964</td>
               <td colspan="2">CTCAE Grade 1 Salivary Duct Intra-Operative Injury<span class="subclass"> SubClassOf </span>Salivary Duct Intra-Operative Injury Adverse Event. <br><i>New Terms: Salivary Duct Intra-Operative Injury Adverse Event, CTCAE Grade 1 Salivary Duct Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>965</td>
               <td colspan="2">CTCAE Grade 1 Salivary Gland Fistula<span class="subclass"> SubClassOf </span>Salivary Gland Fistula. <br><i>New Terms: Salivary Gland Fistula, CTCAE Grade 1 Salivary Gland Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>966</td>
               <td colspan="2">CTCAE Grade 1 Salivary Gland Intra-Operative Injury<span class="subclass"> SubClassOf </span>Salivary Gland Intra-Operative Injury Adverse Event. <br><i>New Terms: Salivary Gland Intra-Operative Injury Adverse Event, CTCAE Grade 1 Salivary Gland
                     Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>967</td>
               <td colspan="2">CTCAE Grade 1 Salivary Gland<br><span class="keyword"> or </span>Saliva Changes<span class="subclass"> SubClassOf </span>Salivary Gland<br><span class="keyword"> or </span>Saliva Changes Adverse Event. <br><i>New Terms: CTCAE Grade 1 Salivary Gland or Saliva Changes, Salivary Gland or Saliva Changes Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>968</td>
               <td colspan="2">CTCAE Grade 1 Scalp Pain<span class="subclass"> SubClassOf </span>Scalp Pain Adverse Event. <br><i>New Terms: Scalp Pain Adverse Event, CTCAE Grade 1 Scalp Pain</i></td>
            </tr>
            <tr class="addition">
               <td>969</td>
               <td colspan="2">CTCAE Grade 1 Sciatic Nerve Intra-Operative Injury<span class="subclass"> SubClassOf </span>Sciatic Nerve Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Sciatic Nerve Intra-Operative Injury, Sciatic Nerve Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>970</td>
               <td colspan="2">CTCAE Grade 1 Scleral Necrosis<br><span class="keyword"> and </span>Melt<span class="subclass"> SubClassOf </span>Scleral Necrosis<br><span class="keyword"> and </span>Melt Adverse Event. <br><i>New Terms: Scleral Necrosis and Melt Adverse Event, CTCAE Grade 1 Scleral Necrosis and Melt</i></td>
            </tr>
            <tr class="addition">
               <td>971</td>
               <td colspan="2">CTCAE Grade 1 Scrotum Intra-Operative Injury<span class="subclass"> SubClassOf </span>Scrotum Intra-Operative Injury Adverse Event. <br><i>New Terms: Scrotum Intra-Operative Injury Adverse Event, CTCAE Grade 1 Scrotum Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>972</td>
               <td colspan="2">CTCAE Grade 1 Scrotum Pain<span class="subclass"> SubClassOf </span>Scrotum Pain Adverse Event. <br><i>New Terms: Scrotum Pain Adverse Event, CTCAE Grade 1 Scrotum Pain</i></td>
            </tr>
            <tr class="addition">
               <td>973</td>
               <td colspan="2">CTCAE Grade 1 Sensory Neuropathy<span class="subclass"> SubClassOf </span>Sensory Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 1 Sensory Neuropathy, Sensory Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>974</td>
               <td colspan="2">CTCAE Grade 1 Seroma<span class="subclass"> SubClassOf </span>Seroma Adverse Event. <br><i>New Terms: CTCAE Grade 1 Seroma, Seroma Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>975</td>
               <td colspan="2">CTCAE Grade 1 Serum Glutamic Oxaloacetic Transaminase<span class="subclass"> SubClassOf </span>Serum Glutamic Oxaloacetic Transaminase Adverse Event. <br><i>New Terms: Serum Glutamic Oxaloacetic Transaminase Adverse Event, CTCAE Grade 1 Serum Glutamic
                     Oxaloacetic Transaminase</i></td>
            </tr>
            <tr class="addition">
               <td>976</td>
               <td colspan="2">CTCAE Grade 1 Serum Glutamic Pyruvic Transaminase<span class="subclass"> SubClassOf </span>Serum Glutamic Pyruvic Transaminase Adverse Event. <br><i>New Terms: CTCAE Grade 1 Serum Glutamic Pyruvic Transaminase, Serum Glutamic Pyruvic Transaminase
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>977</td>
               <td colspan="2">CTCAE Grade 1 Serum Hypercalcemia<span class="subclass"> SubClassOf </span>Serum Hypercalcemia Adverse Event. <br><i>New Terms: CTCAE Grade 1 Serum Hypercalcemia, Serum Hypercalcemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>978</td>
               <td colspan="2">CTCAE Grade 1 Serum Hypercholesteremia<span class="subclass"> SubClassOf </span>Serum Hypercholesteremia Adverse Event. <br><i>New Terms: CTCAE Grade 1 Serum Hypercholesteremia, Serum Hypercholesteremia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>979</td>
               <td colspan="2">CTCAE Grade 1 Serum Hyperglycemia<span class="subclass"> SubClassOf </span>Serum Hyperglycemia Adverse Event. <br><i>New Terms: Serum Hyperglycemia Adverse Event, CTCAE Grade 1 Serum Hyperglycemia</i></td>
            </tr>
            <tr class="addition">
               <td>980</td>
               <td colspan="2">CTCAE Grade 1 Serum Hyperkalemia<span class="subclass"> SubClassOf </span>Serum Hyperkalemia Adverse Event. <br><i>New Terms: CTCAE Grade 1 Serum Hyperkalemia, Serum Hyperkalemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>981</td>
               <td colspan="2">CTCAE Grade 1 Serum Hypermagnesemia<span class="subclass"> SubClassOf </span>Serum Hypermagnesemia Adverse Event. <br><i>New Terms: Serum Hypermagnesemia Adverse Event, CTCAE Grade 1 Serum Hypermagnesemia</i></td>
            </tr>
            <tr class="addition">
               <td>982</td>
               <td colspan="2">CTCAE Grade 1 Serum Hypernatremia<span class="subclass"> SubClassOf </span>Serum Hypernatremia Adverse Event. <br><i>New Terms: Serum Hypernatremia Adverse Event, CTCAE Grade 1 Serum Hypernatremia</i></td>
            </tr>
            <tr class="addition">
               <td>983</td>
               <td colspan="2">CTCAE Grade 1 Serum Hypertriglyceridemia<span class="subclass"> SubClassOf </span>Serum Hypertriglyceridemia Adverse Event. <br><i>New Terms: CTCAE Grade 1 Serum Hypertriglyceridemia, Serum Hypertriglyceridemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>984</td>
               <td colspan="2">CTCAE Grade 1 Serum Hyperuricemia<span class="subclass"> SubClassOf </span>Serum Hyperuricemia Adverse Event. <br><i>New Terms: CTCAE Grade 1 Serum Hyperuricemia, Serum Hyperuricemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>985</td>
               <td colspan="2">CTCAE Grade 1 Serum Hypoalbuminemia<span class="subclass"> SubClassOf </span>Serum Hypoalbuminemia Adverse Event. <br><i>New Terms: Serum Hypoalbuminemia Adverse Event, CTCAE Grade 1 Serum Hypoalbuminemia</i></td>
            </tr>
            <tr class="addition">
               <td>986</td>
               <td colspan="2">CTCAE Grade 1 Serum Hypocalcemia<span class="subclass"> SubClassOf </span>Serum Hypocalcemia Adverse Event. <br><i>New Terms: CTCAE Grade 1 Serum Hypocalcemia, Serum Hypocalcemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>987</td>
               <td colspan="2">CTCAE Grade 1 Serum Hypoglycemia<span class="subclass"> SubClassOf </span>Serum Hypoglycemia Adverse Event. <br><i>New Terms: CTCAE Grade 1 Serum Hypoglycemia, Serum Hypoglycemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>988</td>
               <td colspan="2">CTCAE Grade 1 Serum Hypokalemia<span class="subclass"> SubClassOf </span>Serum Hypokalemia Adverse Event. <br><i>New Terms: CTCAE Grade 1 Serum Hypokalemia, Serum Hypokalemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>989</td>
               <td colspan="2">CTCAE Grade 1 Serum Hypomagnesemia<span class="subclass"> SubClassOf </span>Serum Hypomagnesemia Adverse Event. <br><i>New Terms: Serum Hypomagnesemia Adverse Event, CTCAE Grade 1 Serum Hypomagnesemia</i></td>
            </tr>
            <tr class="addition">
               <td>990</td>
               <td colspan="2">CTCAE Grade 1 Serum Hyponatremia<span class="subclass"> SubClassOf </span>Serum Hyponatremia Adverse Event. <br><i>New Terms: Serum Hyponatremia Adverse Event, CTCAE Grade 1 Serum Hyponatremia</i></td>
            </tr>
            <tr class="addition">
               <td>991</td>
               <td colspan="2">CTCAE Grade 1 Serum Hypophosphatemia<span class="subclass"> SubClassOf </span>Serum Hypophosphatemia Adverse Event. <br><i>New Terms: CTCAE Grade 1 Serum Hypophosphatemia, Serum Hypophosphatemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>992</td>
               <td colspan="2">CTCAE Grade 1 Short Stature<span class="subclass"> SubClassOf </span>Short Stature Adverse Event. <br><i>New Terms: CTCAE Grade 1 Short Stature, Short Stature Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>993</td>
               <td colspan="2">CTCAE Grade 1 Sick Sinus Syndrome<span class="subclass"> SubClassOf </span>Sick Sinus Syndrome Adverse Event. <br><i>New Terms: CTCAE Grade 1 Sick Sinus Syndrome, Sick Sinus Syndrome Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>994</td>
               <td colspan="2">CTCAE Grade 1 Sinus Arrhythmia<span class="subclass"> SubClassOf </span>Sinus Arrhythmia Adverse Event. <br><i>New Terms: CTCAE Grade 1 Sinus Arrhythmia, Sinus Arrhythmia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>995</td>
               <td colspan="2">CTCAE Grade 1 Sinus Bradycardia<span class="subclass"> SubClassOf </span>Sinus Bradycardia Adverse Event. <br><i>New Terms: CTCAE Grade 1 Sinus Bradycardia, Sinus Bradycardia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>996</td>
               <td colspan="2">CTCAE Grade 1 Sinus Intra-Operative Injury<span class="subclass"> SubClassOf </span>Sinus Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Sinus Intra-Operative Injury, Sinus Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>997</td>
               <td colspan="2">CTCAE Grade 1 Sinus Pain<span class="subclass"> SubClassOf </span>Sinus Pain Adverse Event. <br><i>New Terms: CTCAE Grade 1 Sinus Pain, Sinus Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>998</td>
               <td colspan="2">CTCAE Grade 1 Sinus Tachycardia<span class="subclass"> SubClassOf </span>Sinus Tachycardia Adverse Event. <br><i>New Terms: CTCAE Grade 1 Sinus Tachycardia, Sinus Tachycardia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>999</td>
               <td colspan="2">CTCAE Grade 1 Skin Atrophy<span class="subclass"> SubClassOf </span>Skin Atrophy Adverse Event. <br><i>New Terms: Skin Atrophy Adverse Event, CTCAE Grade 1 Skin Atrophy</i></td>
            </tr>
            <tr class="addition">
               <td>1000</td>
               <td colspan="2">CTCAE Grade 1 Skin Intra-Operative Injury<span class="subclass"> SubClassOf </span>Skin Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Skin Intra-Operative Injury, Skin Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1001</td>
               <td colspan="2">CTCAE Grade 1 Skin Pain<span class="subclass"> SubClassOf </span>Skin Pain Adverse Event. <br><i>New Terms: CTCAE Grade 1 Skin Pain, Skin Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1002</td>
               <td colspan="2">CTCAE Grade 1 Slipped Capital Femoral Epiphysis<span class="subclass"> SubClassOf </span>Slipped Capital Femoral Epiphysis Adverse Event. <br><i>New Terms: Slipped Capital Femoral Epiphysis Adverse Event, CTCAE Grade 1 Slipped Capital Femoral
                     Epiphysis</i></td>
            </tr>
            <tr class="addition">
               <td>1003</td>
               <td colspan="2">CTCAE Grade 1 Small Bowel Fistula NOS<span class="subclass"> SubClassOf </span>Small Bowel Fistula Adverse Event NOS. <br><i>New Terms: CTCAE Grade 1 Small Bowel Fistula NOS, Small Bowel Fistula Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>1004</td>
               <td colspan="2">CTCAE Grade 1 Small Bowel Leak<span class="subclass"> SubClassOf </span>Small Bowel Leak Adverse Event. <br><i>New Terms: CTCAE Grade 1 Small Bowel Leak, Small Bowel Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1005</td>
               <td colspan="2">CTCAE Grade 1 Small Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Small Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification. <br><i>New Terms: CTCAE Grade 1 Small Bowel Mucositis or Stomatitis by Clinical Examination Classification,
                     Small Bowel Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>1006</td>
               <td colspan="2">CTCAE Grade 1 Small Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Small Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: CTCAE Grade 1 Small Bowel Mucositis or Stomatitis by Functional or Symptomatic Classification,
                     Small Bowel Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>1007</td>
               <td colspan="2">CTCAE Grade 1 Small Bowel NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Small Bowel NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: Small Bowel NOS Intra-Operative Injury Adverse Event, CTCAE Grade 1 Small Bowel NOS
                     Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1008</td>
               <td colspan="2">CTCAE Grade 1 Small Bowel Obstruction NOS<span class="subclass"> SubClassOf </span>Small Bowel Obstruction Adverse Event NOS. <br><i>New Terms: Small Bowel Obstruction Adverse Event NOS, CTCAE Grade 1 Small Bowel Obstruction NOS</i></td>
            </tr>
            <tr class="addition">
               <td>1009</td>
               <td colspan="2">CTCAE Grade 1 Small Bowel Perforation NOS<span class="subclass"> SubClassOf </span>Small Bowel Perforation Adverse Event NOS. <br><i>New Terms: CTCAE Grade 1 Small Bowel Perforation NOS, Small Bowel Perforation Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>1010</td>
               <td colspan="2">CTCAE Grade 1 Small Bowel Stricture<br><span class="keyword"> or </span>Stenosis NOS<span class="subclass"> SubClassOf </span>Small Bowel Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event NOS. <br><i>New Terms: CTCAE Grade 1 Small Bowel Stricture or Stenosis NOS, Small Bowel Stricture or Stenosis
                     Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>1011</td>
               <td colspan="2">CTCAE Grade 1 Small Bowel Ulcer NOS<span class="subclass"> SubClassOf </span>Small Bowel Ulcer Adverse Event NOS. <br><i>New Terms: CTCAE Grade 1 Small Bowel Ulcer NOS, Small Bowel Ulcer Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>1012</td>
               <td colspan="2">CTCAE Grade 1 Soft Tissue NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Soft Tissue NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Soft Tissue NOS Intra-Operative Injury, Soft Tissue NOS Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1013</td>
               <td colspan="2">CTCAE Grade 1 Spermatic Cord Hemorrhage<span class="subclass"> SubClassOf </span>Spermatic Cord Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 1 Spermatic Cord Hemorrhage, Spermatic Cord Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1014</td>
               <td colspan="2">CTCAE Grade 1 Spermatic Cord Leak<span class="subclass"> SubClassOf </span>Spermatic Cord Leak Adverse Event. <br><i>New Terms: CTCAE Grade 1 Spermatic Cord Leak, Spermatic Cord Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1015</td>
               <td colspan="2">CTCAE Grade 1 Spermatic Cord Obstruction<span class="subclass"> SubClassOf </span>Spermatic Cord Obstruction Adverse Event. <br><i>New Terms: Spermatic Cord Obstruction Adverse Event, CTCAE Grade 1 Spermatic Cord Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>1016</td>
               <td colspan="2">CTCAE Grade 1 Spermatic Cord Perforation<span class="subclass"> SubClassOf </span>Spermatic Cord Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 1 Spermatic Cord Perforation, Spermatic Cord Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1017</td>
               <td colspan="2">CTCAE Grade 1 Spermatic Cord Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Spermatic Cord Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Spermatic Cord Stricture or Stenosis Adverse Event, CTCAE Grade 1 Spermatic Cord Stricture
                     or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>1018</td>
               <td colspan="2">CTCAE Grade 1 Spinal Cord Intra-Operative Injury<span class="subclass"> SubClassOf </span>Spinal Cord Intra-Operative Injury Adverse Event. <br><i>New Terms: Spinal Cord Intra-Operative Injury Adverse Event, CTCAE Grade 1 Spinal Cord Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1019</td>
               <td colspan="2">CTCAE Grade 1 Spine Kyphosis<br><span class="keyword"> or </span>Lordosis<span class="subclass"> SubClassOf </span>Spine Kyphosis<br><span class="keyword"> or </span>Lordosis Adverse Event. <br><i>New Terms: Spine Kyphosis or Lordosis Adverse Event, CTCAE Grade 1 Spine Kyphosis or Lordosis</i></td>
            </tr>
            <tr class="addition">
               <td>1020</td>
               <td colspan="2">CTCAE Grade 1 Spine Scoliosis<span class="subclass"> SubClassOf </span>Spine Scoliosis Adverse Event. <br><i>New Terms: Spine Scoliosis Adverse Event, CTCAE Grade 1 Spine Scoliosis</i></td>
            </tr>
            <tr class="addition">
               <td>1021</td>
               <td colspan="2">CTCAE Grade 1 Spleen Intra-Operative Injury<span class="subclass"> SubClassOf </span>Spleen Intra-Operative Injury Adverse Event. <br><i>New Terms: Spleen Intra-Operative Injury Adverse Event, CTCAE Grade 1 Spleen Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1022</td>
               <td colspan="2">CTCAE Grade 1 Splenic Function<span class="subclass"> SubClassOf </span>Splenic Function Adverse Event. <br><i>New Terms: Splenic Function Adverse Event, CTCAE Grade 1 Splenic Function</i></td>
            </tr>
            <tr class="addition">
               <td>1023</td>
               <td colspan="2">CTCAE Grade 1 Stokes-Adams Syndrome<span class="subclass"> SubClassOf </span>Stokes-Adams Syndrome Adverse Event. <br><i>New Terms: CTCAE Grade 1 Stokes-Adams Syndrome, Stokes-Adams Syndrome Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1024</td>
               <td colspan="2">CTCAE Grade 1 Stoma GI Obstruction<span class="subclass"> SubClassOf </span>Gastrointestinal Stoma Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 1 Stoma GI Obstruction, Gastrointestinal Stoma Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1025</td>
               <td colspan="2">CTCAE Grade 1 Stoma GI Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Stoma GI Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Stoma GI Stricture or Stenosis Adverse Event, CTCAE Grade 1 Stoma GI Stricture or
                     Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>1026</td>
               <td colspan="2">CTCAE Grade 1 Stoma Perforation<span class="subclass"> SubClassOf </span>Stoma Perforation Adverse Event. <br><i>New Terms: Stoma Perforation Adverse Event, CTCAE Grade 1 Stoma Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>1027</td>
               <td colspan="2">CTCAE Grade 1 Stoma Pulmonary Hemorrhage<span class="subclass"> SubClassOf </span>Pulmonary Stoma Hemorrhage Adverse Event. <br><i>New Terms: Pulmonary Stoma Hemorrhage Adverse Event, CTCAE Grade 1 Stoma Pulmonary Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>1028</td>
               <td colspan="2">CTCAE Grade 1 Stoma Ulcer<span class="subclass"> SubClassOf </span>Stoma Ulcer Adverse Event. <br><i>New Terms: Stoma Ulcer Adverse Event, CTCAE Grade 1 Stoma Ulcer</i></td>
            </tr>
            <tr class="addition">
               <td>1029</td>
               <td colspan="2">CTCAE Grade 1 Stomach Fistula<span class="subclass"> SubClassOf </span>Stomach Fistula Adverse Event. <br><i>New Terms: Stomach Fistula Adverse Event, CTCAE Grade 1 Stomach Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>1030</td>
               <td colspan="2">CTCAE Grade 1 Stomach Hemorrhage<span class="subclass"> SubClassOf </span>Stomach Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 1 Stomach Hemorrhage, Stomach Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1031</td>
               <td colspan="2">CTCAE Grade 1 Stomach Intra-Operative Injury<span class="subclass"> SubClassOf </span>Stomach Intra-Operative Injury Adverse Event. <br><i>New Terms: Stomach Intra-Operative Injury Adverse Event, CTCAE Grade 1 Stomach Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1032</td>
               <td colspan="2">CTCAE Grade 1 Stomach Leak<span class="subclass"> SubClassOf </span>Stomach Leak Adverse Event. <br><i>New Terms: Stomach Leak Adverse Event, CTCAE Grade 1 Stomach Leak</i></td>
            </tr>
            <tr class="addition">
               <td>1033</td>
               <td colspan="2">CTCAE Grade 1 Stomach Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Stomach Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification. <br><i>New Terms: Stomach Mucositis or Stomatitis by Clinical Examination Classification, CTCAE Grade
                     1 Stomach Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>1034</td>
               <td colspan="2">CTCAE Grade 1 Stomach Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Stomach Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: Stomach Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification,
                     CTCAE Grade 1 Stomach Mucositis or Stomatitis by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>1035</td>
               <td colspan="2">CTCAE Grade 1 Stomach Obstruction<span class="subclass"> SubClassOf </span>Stomach Obstruction Adverse Event. <br><i>New Terms: Stomach Obstruction Adverse Event, CTCAE Grade 1 Stomach Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>1036</td>
               <td colspan="2">CTCAE Grade 1 Stomach Pain<span class="subclass"> SubClassOf </span>Stomach Pain Adverse Event. <br><i>New Terms: CTCAE Grade 1 Stomach Pain, Stomach Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1037</td>
               <td colspan="2">CTCAE Grade 1 Stomach Perforation<span class="subclass"> SubClassOf </span>Stomach Perforation Adverse Event. <br><i>New Terms: Stomach Perforation Adverse Event, CTCAE Grade 1 Stomach Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>1038</td>
               <td colspan="2">CTCAE Grade 1 Stomach Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Stomach Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 1 Stomach Stricture or Stenosis, Stomach Stricture or Stenosis Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1039</td>
               <td colspan="2">CTCAE Grade 1 Stomach Ulcer<span class="subclass"> SubClassOf </span>Stomach Ulcer Adverse Event. <br><i>New Terms: CTCAE Grade 1 Stomach Ulcer, Stomach Ulcer Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1040</td>
               <td colspan="2">CTCAE Grade 1 Striae<span class="subclass"> SubClassOf </span>Striae Adverse Event. <br><i>New Terms: Striae Adverse Event, CTCAE Grade 1 Striae</i></td>
            </tr>
            <tr class="addition">
               <td>1041</td>
               <td colspan="2">CTCAE Grade 1 Subcutaneous Fat Atrophy<span class="subclass"> SubClassOf </span>Subcutaneous Fat Atrophy. <br><i>New Terms: Subcutaneous Fat Atrophy, CTCAE Grade 1 Subcutaneous Fat Atrophy</i></td>
            </tr>
            <tr class="addition">
               <td>1042</td>
               <td colspan="2">CTCAE Grade 1 Superior Vena Cava Intra-Operative Injury<span class="subclass"> SubClassOf </span>Superior Vena Cava Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Superior Vena Cava Intra-Operative Injury, Superior Vena Cava Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1043</td>
               <td colspan="2">CTCAE Grade 1 Superior Vena Cava Vein Injury<span class="subclass"> SubClassOf </span>Superior Vena Cava Vein Injury Adverse Event. <br><i>New Terms: Superior Vena Cava Vein Injury Adverse Event, CTCAE Grade 1 Superior Vena Cava Vein
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1044</td>
               <td colspan="2">CTCAE Grade 1 Supraventricular Arrhythmia NOS<span class="subclass"> SubClassOf </span>Supraventricular Arrhythmia Adverse Event NOS. <br><i>New Terms: Supraventricular Arrhythmia Adverse Event NOS, CTCAE Grade 1 Supraventricular Arrhythmia
                     NOS</i></td>
            </tr>
            <tr class="addition">
               <td>1045</td>
               <td colspan="2">CTCAE Grade 1 Supraventricular Extrasystoles<span class="subclass"> SubClassOf </span>Supraventricular Extrasystoles Adverse Event. <br><i>New Terms: CTCAE Grade 1 Supraventricular Extrasystoles, Supraventricular Extrasystoles Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1046</td>
               <td colspan="2">CTCAE Grade 1 Supraventricular Tachycardia<span class="subclass"> SubClassOf </span>Supraventricular Tachycardia Adverse Event. <br><i>New Terms: CTCAE Grade 1 Supraventricular Tachycardia, Supraventricular Tachycardia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1047</td>
               <td colspan="2">CTCAE Grade 1 Taste Alteration<span class="subclass"> SubClassOf </span>Taste Alteration Adverse Event. <br><i>New Terms: CTCAE Grade 1 Taste Alteration, Taste Alteration Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1048</td>
               <td colspan="2">CTCAE Grade 1 Teeth Intra-Operative Injury<span class="subclass"> SubClassOf </span>Teeth Intra-Operative Injury Adverse Event. <br><i>New Terms: Teeth Intra-Operative Injury Adverse Event, CTCAE Grade 1 Teeth Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1049</td>
               <td colspan="2">CTCAE Grade 1 Telangiectasia<span class="subclass"> SubClassOf </span>Telangiectasia Adverse Event. <br><i>New Terms: Telangiectasia Adverse Event, CTCAE Grade 1 Telangiectasia</i></td>
            </tr>
            <tr class="addition">
               <td>1050</td>
               <td colspan="2">CTCAE Grade 1 Tendon Intra-Operative Injury<span class="subclass"> SubClassOf </span>Tendon Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Tendon Intra-Operative Injury, Tendon Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1051</td>
               <td colspan="2">CTCAE Grade 1 Testes Hemorrhage<span class="subclass"> SubClassOf </span>Testes Hemorrhage Adverse Event. <br><i>New Terms: Testes Hemorrhage Adverse Event, CTCAE Grade 1 Testes Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>1052</td>
               <td colspan="2">CTCAE Grade 1 Testes Obstruction<span class="subclass"> SubClassOf </span>Testes Obstruction Adverse Event. <br><i>New Terms: Testes Obstruction Adverse Event, CTCAE Grade 1 Testes Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>1053</td>
               <td colspan="2">CTCAE Grade 1 Testes Perforation<span class="subclass"> SubClassOf </span>Testes Perforation Adverse Event. <br><i>New Terms: Testes Perforation Adverse Event, CTCAE Grade 1 Testes Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>1054</td>
               <td colspan="2">CTCAE Grade 1 Testes Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Testes Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 1 Testes Stricture or Stenosis, Testes Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1055</td>
               <td colspan="2">CTCAE Grade 1 Testicle Pain<span class="subclass"> SubClassOf </span>Testicle Pain Adverse Event. <br><i>New Terms: Testicle Pain Adverse Event, CTCAE Grade 1 Testicle Pain</i></td>
            </tr>
            <tr class="addition">
               <td>1056</td>
               <td colspan="2">CTCAE Grade 1 Testis Intra-Operative Injury<span class="subclass"> SubClassOf </span>Testis Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Testis Intra-Operative Injury, Testis Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1057</td>
               <td colspan="2">CTCAE Grade 1 Thoracic Duct Intra-Operative Injury<span class="subclass"> SubClassOf </span>Thoracic Duct Intra-Operative Injury Adverse Event. <br><i>New Terms: Thoracic Duct Intra-Operative Injury Adverse Event, CTCAE Grade 1 Thoracic Duct Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1058</td>
               <td colspan="2">CTCAE Grade 1 Thoracodorsal Nerve Intra-Operative Injury<span class="subclass"> SubClassOf </span>Thoracodorsal Nerve Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Thoracodorsal Nerve Intra-Operative Injury, Thoracodorsal Nerve Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1059</td>
               <td colspan="2">CTCAE Grade 1 Throat<br><span class="keyword"> and </span>Pharynx<br><span class="keyword"> and </span>Larynx Pain<span class="subclass"> SubClassOf </span>Throat<br><span class="keyword"> and </span>Pharynx<br><span class="keyword"> and </span>Larynx Pain Adverse Event. <br><i>New Terms: CTCAE Grade 1 Throat and Pharynx and Larynx Pain, Throat and Pharynx and Larynx Pain
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1060</td>
               <td colspan="2">CTCAE Grade 1 Thrombotic Microangiopathy<span class="subclass"> SubClassOf </span>Thrombotic Microangiopathy Adverse Event. <br><i>New Terms: Thrombotic Microangiopathy Adverse Event, CTCAE Grade 1 Thrombotic Microangiopathy</i></td>
            </tr>
            <tr class="addition">
               <td>1061</td>
               <td colspan="2">CTCAE Grade 1 Thyroid Function High<span class="subclass"> SubClassOf </span>Thyroid Function High Adverse Event. <br><i>New Terms: CTCAE Grade 1 Thyroid Function High, Thyroid Function High Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1062</td>
               <td colspan="2">CTCAE Grade 1 Thyroid Function Low<span class="subclass"> SubClassOf </span>Thyroid Function Low Adverse Event. <br><i>New Terms: Thyroid Function Low Adverse Event, CTCAE Grade 1 Thyroid Function Low</i></td>
            </tr>
            <tr class="addition">
               <td>1063</td>
               <td colspan="2">CTCAE Grade 1 Thyroid Intra-Operative Injury<span class="subclass"> SubClassOf </span>Thyroid Intra-Operative Injury Adverse Event. <br><i>New Terms: Thyroid Intra-Operative Injury Adverse Event, CTCAE Grade 1 Thyroid Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1064</td>
               <td colspan="2">CTCAE Grade 1 Tongue Intra-Operative Injury<span class="subclass"> SubClassOf </span>Tongue Intra-Operative Injury Adverse Event. <br><i>New Terms: Tongue Intra-Operative Injury Adverse Event, CTCAE Grade 1 Tongue Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1065</td>
               <td colspan="2">CTCAE Grade 1 Tooth Development<span class="subclass"> SubClassOf </span>Tooth Development Adverse Event. <br><i>New Terms: Tooth Development Adverse Event, CTCAE Grade 1 Tooth Development</i></td>
            </tr>
            <tr class="addition">
               <td>1066</td>
               <td colspan="2">CTCAE Grade 1 Torsade de Pointes<span class="subclass"> SubClassOf </span>Torsade de Pointes Adverse Event. <br><i>New Terms: CTCAE Grade 1 Torsade de Pointes, Torsade de Pointes Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1067</td>
               <td colspan="2">CTCAE Grade 1 Trachea Fistula<span class="subclass"> SubClassOf </span>Trachea Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 1 Trachea Fistula, Trachea Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1068</td>
               <td colspan="2">CTCAE Grade 1 Trachea Hemorrhage<span class="subclass"> SubClassOf </span>Trachea Hemorrhage Adverse Event. <br><i>New Terms: Trachea Hemorrhage Adverse Event, CTCAE Grade 1 Trachea Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>1069</td>
               <td colspan="2">CTCAE Grade 1 Trachea Intra-Operative Injury<span class="subclass"> SubClassOf </span>Trachea Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Trachea Intra-Operative Injury, Trachea Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1070</td>
               <td colspan="2">CTCAE Grade 1 Trachea Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Trachea Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification. <br><i>New Terms: Trachea Mucositis or Stomatitis by Clinical Examination Classification, CTCAE Grade
                     1 Trachea Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>1071</td>
               <td colspan="2">CTCAE Grade 1 Trachea Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Trachea Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: Trachea Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification,
                     CTCAE Grade 1 Trachea Mucositis or Stomatitis by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>1072</td>
               <td colspan="2">CTCAE Grade 1 Trachea Obstruction<br><span class="keyword"> and </span>Stenosis<span class="subclass"> SubClassOf </span>Trachea Obstruction<br><span class="keyword"> and </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 1 Trachea Obstruction and Stenosis, Trachea Obstruction and Stenosis Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1073</td>
               <td colspan="2">CTCAE Grade 1 Tremor<span class="subclass"> SubClassOf </span>Tremor Adverse Event. <br><i>New Terms: Tremor Adverse Event, CTCAE Grade 1 Tremor</i></td>
            </tr>
            <tr class="addition">
               <td>1074</td>
               <td colspan="2">CTCAE Grade 1 Trigeminy<span class="subclass"> SubClassOf </span>Trigeminy Adverse Event. <br><i>New Terms: CTCAE Grade 1 Trigeminy, Trigeminy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1075</td>
               <td colspan="2">CTCAE Grade 1 Trismus<span class="subclass"> SubClassOf </span>Trismus Adverse Event. <br><i>New Terms: CTCAE Grade 1 Trismus, Trismus Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1076</td>
               <td colspan="2">CTCAE Grade 1 Trunk Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Trunk Muscle Weakness Not Due to Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 1 Trunk Muscle Weakness Not Due to Neuropathy, Trunk Muscle Weakness Not
                     Due to Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1077</td>
               <td colspan="2">CTCAE Grade 1 Tumor Flare<span class="subclass"> SubClassOf </span>Tumor Flare Adverse Event. <br><i>New Terms: CTCAE Grade 1 Tumor Flare, Tumor Flare Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1078</td>
               <td colspan="2">CTCAE Grade 1 Tumor Pain<span class="subclass"> SubClassOf </span>Tumor Pain Adverse Event. <br><i>New Terms: CTCAE Grade 1 Tumor Pain, Tumor Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1079</td>
               <td colspan="2">CTCAE Grade 1 Typhlitis<span class="subclass"> SubClassOf </span>Typhlitis Adverse Event. <br><i>New Terms: Typhlitis Adverse Event, CTCAE Grade 1 Typhlitis</i></td>
            </tr>
            <tr class="addition">
               <td>1080</td>
               <td colspan="2">CTCAE Grade 1 Upper Aerodigestive NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Upper Aerodigestive NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: Upper Aerodigestive NOS Intra-Operative Injury Adverse Event, CTCAE Grade 1 Upper
                     Aerodigestive NOS Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1081</td>
               <td colspan="2">CTCAE Grade 1 Upper Airway NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Upper Airway NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: Upper Airway NOS Intra-Operative Injury Adverse Event, CTCAE Grade 1 Upper Airway
                     NOS Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1082</td>
               <td colspan="2">CTCAE Grade 1 Upper Extremity Artery Injury<span class="subclass"> SubClassOf </span>Upper Extremity Artery Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Upper Extremity Artery Injury, Upper Extremity Artery Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1083</td>
               <td colspan="2">CTCAE Grade 1 Upper Extremity Artery Intra-Operative Injury<span class="subclass"> SubClassOf </span>Upper Extremity Artery Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Upper Extremity Artery Intra-Operative Injury, Upper Extremity Artery
                     Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1084</td>
               <td colspan="2">CTCAE Grade 1 Upper Extremity Function<span class="subclass"> SubClassOf </span>Upper Extremity Function Adverse Event. <br><i>New Terms: CTCAE Grade 1 Upper Extremity Function, Upper Extremity Function Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1085</td>
               <td colspan="2">CTCAE Grade 1 Upper Extremity Intra-Operative Injury<span class="subclass"> SubClassOf </span>Upper Extremity Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Upper Extremity Intra-Operative Injury, Upper Extremity Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1086</td>
               <td colspan="2">CTCAE Grade 1 Upper Extremity Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Upper Extremity Muscle Weakness Adverse Event Not Due to Neuropathy. <br><i>New Terms: Upper Extremity Muscle Weakness Adverse Event Not Due to Neuropathy, CTCAE Grade 1
                     Upper Extremity Muscle Weakness Not Due to Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>1087</td>
               <td colspan="2">CTCAE Grade 1 Upper Extremity Vein Injury<span class="subclass"> SubClassOf </span>Upper Extremity Vein Injury Adverse Event. <br><i>New Terms: Upper Extremity Vein Injury Adverse Event, CTCAE Grade 1 Upper Extremity Vein Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1088</td>
               <td colspan="2">CTCAE Grade 1 Upper Extremity Vein Intra-Operative Injury<span class="subclass"> SubClassOf </span>Upper Extremity Vein Intra-Operative Injury Adverse Event. <br><i>New Terms: Upper Extremity Vein Intra-Operative Injury Adverse Event, CTCAE Grade 1 Upper Extremity
                     Vein Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1089</td>
               <td colspan="2">CTCAE Grade 1 Upper Gastrointestinal Hemorrhage NOS<span class="subclass"> SubClassOf </span>Upper Gastrointestinal Hemorrhage Adverse Event NOS. <br><i>New Terms: Upper Gastrointestinal Hemorrhage Adverse Event NOS, CTCAE Grade 1 Upper Gastrointestinal
                     Hemorrhage NOS</i></td>
            </tr>
            <tr class="addition">
               <td>1090</td>
               <td colspan="2">CTCAE Grade 1 Ureter Fistula<span class="subclass"> SubClassOf </span>Ureter Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 1 Ureter Fistula, Ureter Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1091</td>
               <td colspan="2">CTCAE Grade 1 Ureter Hemorrhage<span class="subclass"> SubClassOf </span>Ureter Hemorrhage Adverse Event. <br><i>New Terms: Ureter Hemorrhage Adverse Event, CTCAE Grade 1 Ureter Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>1092</td>
               <td colspan="2">CTCAE Grade 1 Ureter Intra-Operative Injury<span class="subclass"> SubClassOf </span>Ureter Intra-Operative Injury Adverse Event. <br><i>New Terms: Ureter Intra-Operative Injury Adverse Event, CTCAE Grade 1 Ureter Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1093</td>
               <td colspan="2">CTCAE Grade 1 Ureter Leak<span class="subclass"> SubClassOf </span>Ureter Leak Adverse Event. <br><i>New Terms: CTCAE Grade 1 Ureter Leak, Ureter Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1094</td>
               <td colspan="2">CTCAE Grade 1 Ureter Obstruction<span class="subclass"> SubClassOf </span>Ureter Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 1 Ureter Obstruction, Ureter Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1095</td>
               <td colspan="2">CTCAE Grade 1 Ureter Perforation<span class="subclass"> SubClassOf </span>Ureter Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 1 Ureter Perforation, Ureter Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1096</td>
               <td colspan="2">CTCAE Grade 1 Ureter Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Ureter Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Ureter Stricture or Stenosis Adverse Event, CTCAE Grade 1 Ureter Stricture or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>1097</td>
               <td colspan="2">CTCAE Grade 1 Urethra Fistula<span class="subclass"> SubClassOf </span>Urethra Fistula Adverse Event. <br><i>New Terms: Urethra Fistula Adverse Event, CTCAE Grade 1 Urethra Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>1098</td>
               <td colspan="2">CTCAE Grade 1 Urethra Hemorrhage<span class="subclass"> SubClassOf </span>Urethra Hemorrhage Adverse Event. <br><i>New Terms: Urethra Hemorrhage Adverse Event, CTCAE Grade 1 Urethra Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>1099</td>
               <td colspan="2">CTCAE Grade 1 Urethra Intra-Operative Injury<span class="subclass"> SubClassOf </span>Urethra Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Urethra Intra-Operative Injury, Urethra Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1100</td>
               <td colspan="2">CTCAE Grade 1 Urethra Leak<span class="subclass"> SubClassOf </span>Urethra Leak Adverse Event. <br><i>New Terms: CTCAE Grade 1 Urethra Leak, Urethra Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1101</td>
               <td colspan="2">CTCAE Grade 1 Urethra Obstruction<span class="subclass"> SubClassOf </span>Urethra Obstruction Adverse Event. <br><i>New Terms: Urethra Obstruction Adverse Event, CTCAE Grade 1 Urethra Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>1102</td>
               <td colspan="2">CTCAE Grade 1 Urethra Pain<span class="subclass"> SubClassOf </span>Urethra Pain Adverse Event. <br><i>New Terms: CTCAE Grade 1 Urethra Pain, Urethra Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1103</td>
               <td colspan="2">CTCAE Grade 1 Urethra Perforation<span class="subclass"> SubClassOf </span>Urethra Perforation Adverse Event. <br><i>New Terms: Urethra Perforation Adverse Event, CTCAE Grade 1 Urethra Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>1104</td>
               <td colspan="2">CTCAE Grade 1 Urethra Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Urethra Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 1 Urethra Stricture or Stenosis, Urethra Stricture or Stenosis Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1105</td>
               <td colspan="2">CTCAE Grade 1 Urinary Conduit Intra-Operative Injury<span class="subclass"> SubClassOf </span>Urinary Conduit Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Urinary Conduit Intra-Operative Injury, Urinary Conduit Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1106</td>
               <td colspan="2">CTCAE Grade 1 Urinary Electrolyte Wasting<span class="subclass"> SubClassOf </span>Urinary Electrolyte Wasting Adverse Event. <br><i>New Terms: CTCAE Grade 1 Urinary Electrolyte Wasting, Urinary Electrolyte Wasting Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1107</td>
               <td colspan="2">CTCAE Grade 1 Urinary Frequency<br><span class="keyword"> or </span>Urgency<span class="subclass"> SubClassOf </span>Urinary Frequency<br><span class="keyword"> or </span>Urgency Adverse Event. <br><i>New Terms: CTCAE Grade 1 Urinary Frequency or Urgency, Urinary Frequency or Urgency Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1108</td>
               <td colspan="2">CTCAE Grade 1 Urinary Hemorrhage NOS<span class="subclass"> SubClassOf </span>Urinary Hemorrhage Adverse Event NOS. <br><i>New Terms: CTCAE Grade 1 Urinary Hemorrhage NOS, Urinary Hemorrhage Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>1109</td>
               <td colspan="2">CTCAE Grade 1 Urinary Incontinence<span class="subclass"> SubClassOf </span>Urinary Incontinence Adverse Event. <br><i>New Terms: CTCAE Grade 1 Urinary Incontinence, Urinary Incontinence Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1110</td>
               <td colspan="2">CTCAE Grade 1 Urinary Retention<span class="subclass"> SubClassOf </span>Urinary Retention Adverse Event. <br><i>New Terms: Urinary Retention Adverse Event, CTCAE Grade 1 Urinary Retention</i></td>
            </tr>
            <tr class="addition">
               <td>1111</td>
               <td colspan="2">CTCAE Grade 1 Urinary Tract NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Urinary Tract NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: Urinary Tract NOS Intra-Operative Injury Adverse Event, CTCAE Grade 1 Urinary Tract
                     NOS Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1112</td>
               <td colspan="2">CTCAE Grade 1 Urine Color Change<span class="subclass"> SubClassOf </span>Urine Color Change Adverse Event. <br><i>New Terms: Urine Color Change Adverse Event, CTCAE Grade 1 Urine Color Change</i></td>
            </tr>
            <tr class="addition">
               <td>1113</td>
               <td colspan="2">CTCAE Grade 1 Urticaria<span class="subclass"> SubClassOf </span>Urticaria Adverse Reaction. <br><i>New Terms: CTCAE Grade 1 Urticaria, Urticaria Adverse Reaction</i></td>
            </tr>
            <tr class="addition">
               <td>1114</td>
               <td colspan="2">CTCAE Grade 1 Uterus Fistula<span class="subclass"> SubClassOf </span>Uterus Fistula Adverse Event. <br><i>New Terms: Uterus Fistula Adverse Event, CTCAE Grade 1 Uterus Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>1115</td>
               <td colspan="2">CTCAE Grade 1 Uterus Hemorrhage<span class="subclass"> SubClassOf </span>Uterus Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 1 Uterus Hemorrhage, Uterus Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1116</td>
               <td colspan="2">CTCAE Grade 1 Uterus Intra-Operative Injury<span class="subclass"> SubClassOf </span>Uterus Intra-Operative Injury Adverse Event. <br><i>New Terms: Uterus Intra-Operative Injury Adverse Event, CTCAE Grade 1 Uterus Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1117</td>
               <td colspan="2">CTCAE Grade 1 Uterus Leak<span class="subclass"> SubClassOf </span>Uterus Leak Adverse Event. <br><i>New Terms: Uterus Leak Adverse Event, CTCAE Grade 1 Uterus Leak</i></td>
            </tr>
            <tr class="addition">
               <td>1118</td>
               <td colspan="2">CTCAE Grade 1 Uterus Obstruction<span class="subclass"> SubClassOf </span>Uterus Obstruction Adverse Event. <br><i>New Terms: Uterus Obstruction Adverse Event, CTCAE Grade 1 Uterus Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>1119</td>
               <td colspan="2">CTCAE Grade 1 Uterus Pain<span class="subclass"> SubClassOf </span>Uterus Pain Adverse Event. <br><i>New Terms: CTCAE Grade 1 Uterus Pain, Uterus Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1120</td>
               <td colspan="2">CTCAE Grade 1 Uterus Perforation<span class="subclass"> SubClassOf </span>Uterus Perforation Adverse Event. <br><i>New Terms: Uterus Perforation Adverse Event, CTCAE Grade 1 Uterus Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>1121</td>
               <td colspan="2">CTCAE Grade 1 Uterus Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Uterus Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 1 Uterus Stricture or Stenosis, Uterus Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1122</td>
               <td colspan="2">CTCAE Grade 1 Uveitis<span class="subclass"> SubClassOf </span>Uveitis Adverse Event. <br><i>New Terms: Uveitis Adverse Event, CTCAE Grade 1 Uveitis</i></td>
            </tr>
            <tr class="addition">
               <td>1123</td>
               <td colspan="2">CTCAE Grade 1 Vagina Fistula<span class="subclass"> SubClassOf </span>Vagina Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 1 Vagina Fistula, Vagina Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1124</td>
               <td colspan="2">CTCAE Grade 1 Vagina Hemorrhage<span class="subclass"> SubClassOf </span>Vagina Hemorrhage Adverse Event. <br><i>New Terms: Vagina Hemorrhage Adverse Event, CTCAE Grade 1 Vagina Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>1125</td>
               <td colspan="2">CTCAE Grade 1 Vagina Intra-Operative Injury<span class="subclass"> SubClassOf </span>Vagina Intra-Operative Injury Adverse Event. <br><i>New Terms: Vagina Intra-Operative Injury Adverse Event, CTCAE Grade 1 Vagina Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1126</td>
               <td colspan="2">CTCAE Grade 1 Vagina Leak<span class="subclass"> SubClassOf </span>Vagina Leak Adverse Event. <br><i>New Terms: CTCAE Grade 1 Vagina Leak, Vagina Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1127</td>
               <td colspan="2">CTCAE Grade 1 Vagina Obstruction<span class="subclass"> SubClassOf </span>Vagina Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 1 Vagina Obstruction, Vagina Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1128</td>
               <td colspan="2">CTCAE Grade 1 Vagina Pain<span class="subclass"> SubClassOf </span>Vagina Pain Adverse Event. <br><i>New Terms: Vagina Pain Adverse Event, CTCAE Grade 1 Vagina Pain</i></td>
            </tr>
            <tr class="addition">
               <td>1129</td>
               <td colspan="2">CTCAE Grade 1 Vagina Perforation<span class="subclass"> SubClassOf </span>Vagina Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 1 Vagina Perforation, Vagina Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1130</td>
               <td colspan="2">CTCAE Grade 1 Vagina Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Vagina Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 1 Vagina Stricture or Stenosis, Vagina Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1131</td>
               <td colspan="2">CTCAE Grade 1 Vaginal Dryness<span class="subclass"> SubClassOf </span>Vaginal Dryness Adverse Event. <br><i>New Terms: CTCAE Grade 1 Vaginal Dryness, Vaginal Dryness Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1132</td>
               <td colspan="2">CTCAE Grade 1 Vaginal Mucositis<span class="subclass"> SubClassOf </span>Vaginal Mucositis Adverse Event. <br><i>New Terms: CTCAE Grade 1 Vaginal Mucositis, Vaginal Mucositis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1133</td>
               <td colspan="2">CTCAE Grade 1 Vaginal Stenosis<br><span class="keyword"> and </span>Length<span class="subclass"> SubClassOf </span>Vaginal Stenosis<br><span class="keyword"> and </span>Length Adverse Event. <br><i>New Terms: CTCAE Grade 1 Vaginal Stenosis and Length, Vaginal Stenosis and Length Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1134</td>
               <td colspan="2">CTCAE Grade 1 Vaginitis Not Due to Infection<span class="subclass"> SubClassOf </span>Vaginitis Not Due to Infection Adverse Event. <br><i>New Terms: CTCAE Grade 1 Vaginitis Not Due to Infection, Vaginitis Not Due to Infection Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1135</td>
               <td colspan="2">CTCAE Grade 1 Valvular Heart Disease<span class="subclass"> SubClassOf </span>Valvular Heart Disease Adverse Event. <br><i>New Terms: CTCAE Grade 1 Valvular Heart Disease, Valvular Heart Disease Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1136</td>
               <td colspan="2">CTCAE Grade 1 Vas Deferens Hemorrhage<span class="subclass"> SubClassOf </span>Vas Deferens Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 1 Vas Deferens Hemorrhage, Vas Deferens Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1137</td>
               <td colspan="2">CTCAE Grade 1 Vas Deferens Leak<span class="subclass"> SubClassOf </span>Vas Deferens Leak Adverse Event. <br><i>New Terms: Vas Deferens Leak Adverse Event, CTCAE Grade 1 Vas Deferens Leak</i></td>
            </tr>
            <tr class="addition">
               <td>1138</td>
               <td colspan="2">CTCAE Grade 1 Vas Deferens Obstruction<span class="subclass"> SubClassOf </span>Vas Deferens Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 1 Vas Deferens Obstruction, Vas Deferens Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1139</td>
               <td colspan="2">CTCAE Grade 1 Vas Deferens Perforation<span class="subclass"> SubClassOf </span>Vas Deferens Perforation Adverse Event. <br><i>New Terms: Vas Deferens Perforation Adverse Event, CTCAE Grade 1 Vas Deferens Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>1140</td>
               <td colspan="2">CTCAE Grade 1 Vas Deferens Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Vas Deferens Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 1 Vas Deferens Stricture or Stenosis, Vas Deferens Stricture or Stenosis
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1141</td>
               <td colspan="2">CTCAE Grade 1 Vasculitis<span class="subclass"> SubClassOf </span>Vasculitis Adverse Event. <br><i>New Terms: Vasculitis Adverse Event, CTCAE Grade 1 Vasculitis</i></td>
            </tr>
            <tr class="addition">
               <td>1142</td>
               <td colspan="2">CTCAE Grade 1 Vein NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Vein NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Vein NOS Intra-Operative Injury, Vein NOS Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1143</td>
               <td colspan="2">CTCAE Grade 1 Ventricular Arrhythmia NOS<span class="subclass"> SubClassOf </span>Ventricular Arrhythmia Adverse Event NOS. <br><i>New Terms: CTCAE Grade 1 Ventricular Arrhythmia NOS, Ventricular Arrhythmia Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>1144</td>
               <td colspan="2">CTCAE Grade 1 Ventricular Fibrillation<span class="subclass"> SubClassOf </span>Ventricular Fibrillation Adverse Event. <br><i>New Terms: Ventricular Fibrillation Adverse Event, CTCAE Grade 1 Ventricular Fibrillation</i></td>
            </tr>
            <tr class="addition">
               <td>1145</td>
               <td colspan="2">CTCAE Grade 1 Ventricular Flutter<span class="subclass"> SubClassOf </span>Ventricular Flutter Adverse Event. <br><i>New Terms: Ventricular Flutter Adverse Event, CTCAE Grade 1 Ventricular Flutter</i></td>
            </tr>
            <tr class="addition">
               <td>1146</td>
               <td colspan="2">CTCAE Grade 1 Ventricular Tachycardia<span class="subclass"> SubClassOf </span>Ventricular Tachycardia Adverse Event. <br><i>New Terms: Ventricular Tachycardia Adverse Event, CTCAE Grade 1 Ventricular Tachycardia</i></td>
            </tr>
            <tr class="addition">
               <td>1147</td>
               <td colspan="2">CTCAE Grade 1 Viral Hepatitis<span class="subclass"> SubClassOf </span>Viral Hepatitis Adverse Event. <br><i>New Terms: Viral Hepatitis Adverse Event, CTCAE Grade 1 Viral Hepatitis</i></td>
            </tr>
            <tr class="addition">
               <td>1148</td>
               <td colspan="2">CTCAE Grade 1 Viscera Vein Injury<span class="subclass"> SubClassOf </span>Viscera Vein Injury Adverse Event. <br><i>New Terms: Viscera Vein Injury Adverse Event, CTCAE Grade 1 Viscera Vein Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1149</td>
               <td colspan="2">CTCAE Grade 1 Visceral Artery Injury<span class="subclass"> SubClassOf </span>Visceral Artery Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Visceral Artery Injury, Visceral Artery Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1150</td>
               <td colspan="2">CTCAE Grade 1 Vital Capacity<span class="subclass"> SubClassOf </span>Vital Capacity Adverse Event. <br><i>New Terms: CTCAE Grade 1 Vital Capacity, Vital Capacity Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1151</td>
               <td colspan="2">CTCAE Grade 1 Vitreous Hemorrhage<span class="subclass"> SubClassOf </span>Vitreous Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 1 Vitreous Hemorrhage, Vitreous Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1152</td>
               <td colspan="2">CTCAE Grade 1 Voice Changes<br><span class="keyword"> and </span>Dysarthria<span class="subclass"> SubClassOf </span>Voice Changes<br><span class="keyword"> and </span>Dysarthria Adverse Event. <br><i>New Terms: Voice Changes and Dysarthria Adverse Event, CTCAE Grade 1 Voice Changes and Dysarthria</i></td>
            </tr>
            <tr class="addition">
               <td>1153</td>
               <td colspan="2">CTCAE Grade 1 Vomiting<span class="subclass"> SubClassOf </span>Vomiting Adverse Event. <br><i>New Terms: Vomiting Adverse Event, CTCAE Grade 1 Vomiting</i></td>
            </tr>
            <tr class="addition">
               <td>1154</td>
               <td colspan="2">CTCAE Grade 1 Vulva Intra-Operative Injury<span class="subclass"> SubClassOf </span>Vulva Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 1 Vulva Intra-Operative Injury, Vulva Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1155</td>
               <td colspan="2">CTCAE Grade 1 Weight Gain<span class="subclass"> SubClassOf </span>Weight Gain Adverse Event. <br><i>New Terms: Weight Gain Adverse Event, CTCAE Grade 1 Weight Gain</i></td>
            </tr>
            <tr class="addition">
               <td>1156</td>
               <td colspan="2">CTCAE Grade 1 Weight Loss<span class="subclass"> SubClassOf </span>Weight Loss Adverse Event. <br><i>New Terms: CTCAE Grade 1 Weight Loss, Weight Loss Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1157</td>
               <td colspan="2">CTCAE Grade 1 Whole Body<br><span class="keyword"> and </span>Generalized Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Whole Body<br><span class="keyword"> and </span>Generalized Muscle Weakness Not Due to Neuropathy Adverse Event. <br><i>New Terms: Whole Body and Generalized Muscle Weakness Not Due to Neuropathy Adverse Event, CTCAE
                     Grade 1 Whole Body and Generalized Muscle Weakness Not Due to Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>1158</td>
               <td colspan="2">CTCAE Grade 1 Wolff-Parkinson-White Syndrome<span class="subclass"> SubClassOf </span>Wolff-Parkinson-White Syndrome Adverse Event. <br><i>New Terms: Wolff-Parkinson-White Syndrome Adverse Event, CTCAE Grade 1 Wolff-Parkinson-White
                     Syndrome</i></td>
            </tr>
            <tr class="addition">
               <td>1159</td>
               <td colspan="2">CTCAE Grade 1 Xerostomia<span class="subclass"> SubClassOf </span>Xerostomia Adverse Event. <br><i>New Terms: CTCAE Grade 1 Xerostomia, Xerostomia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1160</td>
               <td colspan="2">CTCAE Grade 2 AV Block First Degree<span class="subclass"> SubClassOf </span>AV Block First Degree Adverse Event. <br><i>New Terms: AV Block First Degree Adverse Event, CTCAE Grade 2 AV Block First Degree</i></td>
            </tr>
            <tr class="addition">
               <td>1161</td>
               <td colspan="2">CTCAE Grade 2 AV Block Second Degree Mobitz<span class="subclass"> Type </span>I<span class="subclass"> SubClassOf </span>AV Block Second Degree Mobitz<span class="subclass"> Type </span>I Adverse Event. <br><i>New Terms: AV Block Second Degree Mobitz Type I Adverse Event, CTCAE Grade 2 AV Block Second
                     Degree Mobitz Type I</i></td>
            </tr>
            <tr class="addition">
               <td>1162</td>
               <td colspan="2">CTCAE Grade 2 AV Block Second Degree Mobitz<span class="subclass"> Type </span>II<span class="subclass"> SubClassOf </span>AV Block Second Degree Mobitz<span class="subclass"> Type </span>II Adverse Event. <br><i>New Terms: AV Block Second Degree Mobitz Type II Adverse Event, CTCAE Grade 2 AV Block Second
                     Degree Mobitz Type II</i></td>
            </tr>
            <tr class="addition">
               <td>1163</td>
               <td colspan="2">CTCAE Grade 2 AV Block Third Degree<span class="subclass"> SubClassOf </span>AV Block Third Degree Adverse Event. <br><i>New Terms: CTCAE Grade 2 AV Block Third Degree, AV Block Third Degree Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1164</td>
               <td colspan="2">CTCAE Grade 2 Abdomen Fistula NOS<span class="subclass"> SubClassOf </span>Abdomen Fistula Adverse Event NOS. <br><i>New Terms: CTCAE Grade 2 Abdomen Fistula NOS, Abdomen Fistula Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>1165</td>
               <td colspan="2">CTCAE Grade 2 Abdomen Hemorrhage NOS<span class="subclass"> SubClassOf </span>Abdomen Hemorrhage Adverse Event NOS. <br><i>New Terms: CTCAE Grade 2 Abdomen Hemorrhage NOS, Abdomen Hemorrhage Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>1166</td>
               <td colspan="2">CTCAE Grade 2 Abdomen Infection NOS Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Abdomen Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Abdomen Infection NOS Adverse Event Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, CTCAE Grade 2 Abdomen Infection NOS Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1167</td>
               <td colspan="2">CTCAE Grade 2 Abdomen Infection NOS with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Abdomen Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Abdomen Infection NOS with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, Abdomen Infection NOS Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1168</td>
               <td colspan="2">CTCAE Grade 2 Abdomen Infection NOS with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Abdomen Infection NOS Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Abdomen Infection NOS Adverse Event with Unknown Absolute Neutrophil Count, CTCAE
                     Grade 2 Abdomen Infection NOS with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1169</td>
               <td colspan="2">CTCAE Grade 2 Abdomen NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Abdomen NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: Abdomen NOS Intra-Operative Injury Adverse Event, CTCAE Grade 2 Abdomen NOS Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1170</td>
               <td colspan="2">CTCAE Grade 2 Abdomen Pain NOS<span class="subclass"> SubClassOf </span>Abdomen Pain NOS Adverse Event. <br><i>New Terms: CTCAE Grade 2 Abdomen Pain NOS, Abdomen Pain NOS Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1171</td>
               <td colspan="2">CTCAE Grade 2 Abdomen Soft Tissue Necrosis<span class="subclass"> SubClassOf </span>Abdomen Soft Tissue Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 2 Abdomen Soft Tissue Necrosis, Abdomen Soft Tissue Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1172</td>
               <td colspan="2">CTCAE Grade 2 Abdominal Distension<br><span class="keyword"> or </span>Bloating<span class="subclass"> SubClassOf </span>Abdominal Distension<br><span class="keyword"> or </span>Bloating Adverse Event. <br><i>New Terms: CTCAE Grade 2 Abdominal Distension or Bloating, Abdominal Distension or Bloating Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1173</td>
               <td colspan="2">CTCAE Grade 2 Acute Vascular Leak Syndrome<span class="subclass"> SubClassOf </span>Acute Vascular Leak Syndrome Adverse Event. <br><i>New Terms: CTCAE Grade 2 Acute Vascular Leak Syndrome, Acute Vascular Leak Syndrome Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1174</td>
               <td colspan="2">CTCAE Grade 2 Adrenal Gland Intra-Operative Injury<span class="subclass"> SubClassOf </span>Adrenal Gland Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Adrenal Gland Intra-Operative Injury, Adrenal Gland Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1175</td>
               <td colspan="2">CTCAE Grade 2 Adrenal Insufficiency<span class="subclass"> SubClassOf </span>Adrenal Insufficiency Adverse Event. <br><i>New Terms: Adrenal Insufficiency Adverse Event, CTCAE Grade 2 Adrenal Insufficiency</i></td>
            </tr>
            <tr class="addition">
               <td>1176</td>
               <td colspan="2">CTCAE Grade 2 Agitation<span class="subclass"> SubClassOf </span>Agitation Adverse Event. <br><i>New Terms: Agitation Adverse Event, CTCAE Grade 2 Agitation</i></td>
            </tr>
            <tr class="addition">
               <td>1177</td>
               <td colspan="2">CTCAE Grade 2 Alkaline phosphatase<span class="subclass"> SubClassOf </span>Alkaline Phosphatase Adverse Event. <br><i>New Terms: Alkaline Phosphatase Adverse Event, CTCAE Grade 2 Alkaline phosphatase</i></td>
            </tr>
            <tr class="addition">
               <td>1178</td>
               <td colspan="2">CTCAE Grade 2 Allergic Reaction<br><span class="keyword"> and </span>Hypersensitivity Including Drug Fever<span class="subclass"> SubClassOf </span>Allergic Reaction<br><span class="keyword"> and </span>Hypersensitivity Adverse Event Including Drug Fever. <br><i>New Terms: Allergic Reaction and Hypersensitivity Adverse Event Including Drug Fever, CTCAE Grade
                     2 Allergic Reaction and Hypersensitivity Including Drug Fever</i></td>
            </tr>
            <tr class="addition">
               <td>1179</td>
               <td colspan="2">CTCAE Grade 2 Allergic Rhinitis Including Sneezing Nasal Stuffiness Postnasal Drip<span class="subclass"> SubClassOf </span>Allergic Rhinitis Adverse Event Including Sneezing Nasal Stuffiness Postnasal Drip. <br><i>New Terms: CTCAE Grade 2 Allergic Rhinitis Including Sneezing Nasal Stuffiness Postnasal Drip,
                     Allergic Rhinitis Adverse Event Including Sneezing Nasal Stuffiness Postnasal Drip</i></td>
            </tr>
            <tr class="addition">
               <td>1180</td>
               <td colspan="2">CTCAE Grade 2 Alopecia<span class="subclass"> SubClassOf </span>Alopecia Adverse Event. <br><i>New Terms: CTCAE Grade 2 Alopecia, Alopecia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1181</td>
               <td colspan="2">CTCAE Grade 2 Alteration in Bone Age<span class="subclass"> SubClassOf </span>Alteration in Bone Age Adverse Event. <br><i>New Terms: CTCAE Grade 2 Alteration in Bone Age, Alteration in Bone Age Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1182</td>
               <td colspan="2">CTCAE Grade 2 Amylase<span class="subclass"> SubClassOf </span>Amylase Adverse Event. <br><i>New Terms: Amylase Adverse Event, CTCAE Grade 2 Amylase</i></td>
            </tr>
            <tr class="addition">
               <td>1183</td>
               <td colspan="2">CTCAE Grade 2 Anal Incontinence<span class="subclass"> SubClassOf </span>Anal Incontinence Adverse Event. <br><i>New Terms: CTCAE Grade 2 Anal Incontinence, Anal Incontinence Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1184</td>
               <td colspan="2">CTCAE Grade 2 Anal Sphincter Intra-Operative Injury<span class="subclass"> SubClassOf </span>Anal Sphincter Intra-Operative Injury Adverse Event. <br><i>New Terms: Anal Sphincter Intra-Operative Injury Adverse Event, CTCAE Grade 2 Anal Sphincter
                     Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1185</td>
               <td colspan="2">CTCAE Grade 2 Anal<br><span class="keyword"> or </span>Perianal Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Anal<br><span class="keyword"> or </span>Perianal Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Anal or Perianal Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, Anal or Perianal Infection Adverse Event Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1186</td>
               <td colspan="2">CTCAE Grade 2 Anal<br><span class="keyword"> or </span>Perianal Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Anal<br><span class="keyword"> or </span>Perianal Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Anal or Perianal Infection with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils, Anal or Perianal Infection Adverse Event with Normal Absolute
                     Neutrophil Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1187</td>
               <td colspan="2">CTCAE Grade 2 Anal<br><span class="keyword"> or </span>Perianal Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Anal<br><span class="keyword"> or </span>Perianal Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Anal or Perianal Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE
                     Grade 2 Anal or Perianal Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1188</td>
               <td colspan="2">CTCAE Grade 2 Anorexia<span class="subclass"> SubClassOf </span>Anorexia Adverse Event. <br><i>New Terms: Anorexia Adverse Event, CTCAE Grade 2 Anorexia</i></td>
            </tr>
            <tr class="addition">
               <td>1189</td>
               <td colspan="2">CTCAE Grade 2 Anus Fistula<span class="subclass"> SubClassOf </span>Anus Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 2 Anus Fistula, Anus Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1190</td>
               <td colspan="2">CTCAE Grade 2 Anus Hemorrhage<span class="subclass"> SubClassOf </span>Anus Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 2 Anus Hemorrhage, Anus Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1191</td>
               <td colspan="2">CTCAE Grade 2 Anus Intra-Operative Injury<span class="subclass"> SubClassOf </span>Anus Intra-Operative Injury Adverse Event. <br><i>New Terms: Anus Intra-Operative Injury Adverse Event, CTCAE Grade 2 Anus Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1192</td>
               <td colspan="2">CTCAE Grade 2 Anus Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Anus Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Clinical Examination Classification. <br><i>New Terms: CTCAE Grade 2 Anus Mucositis or Stomatitis by Clinical Examination Classification,
                     Anus Mucositis or Stomatitis Adverse Event by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>1193</td>
               <td colspan="2">CTCAE Grade 2 Anus Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Anus Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: CTCAE Grade 2 Anus Mucositis or Stomatitis by Functional or Symptomatic Classification,
                     Anus Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>1194</td>
               <td colspan="2">CTCAE Grade 2 Anus Pain<span class="subclass"> SubClassOf </span>Anus Pain Adverse Event. <br><i>New Terms: Anus Pain Adverse Event, CTCAE Grade 2 Anus Pain</i></td>
            </tr>
            <tr class="addition">
               <td>1195</td>
               <td colspan="2">CTCAE Grade 2 Anus Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Anus Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Anus Stricture or Stenosis Adverse Event, CTCAE Grade 2 Anus Stricture or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>1196</td>
               <td colspan="2">CTCAE Grade 2 Anus Ulcer<span class="subclass"> SubClassOf </span>Anus Ulcer Adverse Event. <br><i>New Terms: Anus Ulcer Adverse Event, CTCAE Grade 2 Anus Ulcer</i></td>
            </tr>
            <tr class="addition">
               <td>1197</td>
               <td colspan="2">CTCAE Grade 2 Anxiety<span class="subclass"> SubClassOf </span>Anxiety Adverse Event. <br><i>New Terms: Anxiety Adverse Event, CTCAE Grade 2 Anxiety</i></td>
            </tr>
            <tr class="addition">
               <td>1198</td>
               <td colspan="2">CTCAE Grade 2 Aorta Artery Injury<span class="subclass"> SubClassOf </span>Aorta Artery Injury Adverse Event. <br><i>New Terms: Aorta Artery Injury Adverse Event, CTCAE Grade 2 Aorta Artery Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1199</td>
               <td colspan="2">CTCAE Grade 2 Aorta Artery Intra-Operative Injury<span class="subclass"> SubClassOf </span>Aorta Artery Intra-Operative Injury Adverse Event. <br><i>New Terms: Aorta Artery Intra-Operative Injury Adverse Event, CTCAE Grade 2 Aorta Artery Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1200</td>
               <td colspan="2">CTCAE Grade 2 Appendix Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Appendix Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Appendix Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Appendix Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1201</td>
               <td colspan="2">CTCAE Grade 2 Appendix Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Appendix Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Appendix Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, CTCAE Grade 2 Appendix Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1202</td>
               <td colspan="2">CTCAE Grade 2 Appendix Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Appendix Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Appendix Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     2 Appendix Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1203</td>
               <td colspan="2">CTCAE Grade 2 Appendix Intra-Operative Injury<span class="subclass"> SubClassOf </span>Appendix Intra-Operative Injury Adverse Event. <br><i>New Terms: Appendix Intra-Operative Injury Adverse Event, CTCAE Grade 2 Appendix Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1204</td>
               <td colspan="2">CTCAE Grade 2 Appendix Perforation<span class="subclass"> SubClassOf </span>Appendix Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 2 Appendix Perforation, Appendix Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1205</td>
               <td colspan="2">CTCAE Grade 2 Arachnoiditis<br><span class="keyword"> and </span>Meningismus<br><span class="keyword"> and </span>Radiculitis<span class="subclass"> SubClassOf </span>Arachnoiditis<br><span class="keyword"> and </span>Meningismus<br><span class="keyword"> and </span>Radiculitis Adverse Event. <br><i>New Terms: CTCAE Grade 2 Arachnoiditis and Meningismus and Radiculitis, Arachnoiditis and Meningismus
                     and Radiculitis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1206</td>
               <td colspan="2">CTCAE Grade 2 Artery Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Artery Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Artery Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Artery Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1207</td>
               <td colspan="2">CTCAE Grade 2 Artery Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Artery Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Artery Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Artery Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1208</td>
               <td colspan="2">CTCAE Grade 2 Artery Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Artery Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 2 Artery Infection with Unknown Absolute Neutrophil Count, Artery Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1209</td>
               <td colspan="2">CTCAE Grade 2 Artery NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Artery NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: Artery NOS Intra-Operative Injury Adverse Event, CTCAE Grade 2 Artery NOS Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1210</td>
               <td colspan="2">CTCAE Grade 2 Aspiration<span class="subclass"> SubClassOf </span>Aspiration Adverse Event. <br><i>New Terms: CTCAE Grade 2 Aspiration, Aspiration Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1211</td>
               <td colspan="2">CTCAE Grade 2 Associated with Dentures<br><span class="keyword"> or </span>Dental Prosthesis<span class="subclass"> SubClassOf </span>Adverse Event Associated with Dentures<br><span class="keyword"> or </span>Dental Prostheses. <br><i>New Terms: Adverse Event Associated with Dentures or Dental Prostheses, CTCAE Grade 2 Associated
                     with Dentures or Dental Prosthesis</i></td>
            </tr>
            <tr class="addition">
               <td>1212</td>
               <td colspan="2">CTCAE Grade 2 Associated with the Teeth<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Teeth. <br><i>New Terms: Adverse Event Associated with the Teeth, CTCAE Grade 2 Associated with the Teeth</i></td>
            </tr>
            <tr class="addition">
               <td>1213</td>
               <td colspan="2">CTCAE Grade 2 Asystole<span class="subclass"> SubClassOf </span>Asystole Adverse Event. <br><i>New Terms: CTCAE Grade 2 Asystole, Asystole Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1214</td>
               <td colspan="2">CTCAE Grade 2 Ataxia<span class="subclass"> SubClassOf </span>Ataxia Adverse Event. <br><i>New Terms: Ataxia Adverse Event, CTCAE Grade 2 Ataxia</i></td>
            </tr>
            <tr class="addition">
               <td>1215</td>
               <td colspan="2">CTCAE Grade 2 Atelectasis<span class="subclass"> SubClassOf </span>Atelectasis Adverse Event. <br><i>New Terms: CTCAE Grade 2 Atelectasis, Atelectasis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1216</td>
               <td colspan="2">CTCAE Grade 2 Atrial Fibrillation<span class="subclass"> SubClassOf </span>Atrial Fibrillation Adverse Event. <br><i>New Terms: CTCAE Grade 2 Atrial Fibrillation, Atrial Fibrillation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1217</td>
               <td colspan="2">CTCAE Grade 2 Atrial Flutter<span class="subclass"> SubClassOf </span>Atrial Flutter Adverse Event. <br><i>New Terms: Atrial Flutter Adverse Event, CTCAE Grade 2 Atrial Flutter</i></td>
            </tr>
            <tr class="addition">
               <td>1218</td>
               <td colspan="2">CTCAE Grade 2 Atrial Tachycardia<br><span class="keyword"> or </span>Paroxysmal Atrial Tachycardia<span class="subclass"> SubClassOf </span>Atrial Tachycardia<br><span class="keyword"> or </span>Paroxysmal Atrial Tachycardia Adverse Event. <br><i>New Terms: Atrial Tachycardia or Paroxysmal Atrial Tachycardia Adverse Event, CTCAE Grade 2 Atrial
                     Tachycardia or Paroxysmal Atrial Tachycardia</i></td>
            </tr>
            <tr class="addition">
               <td>1219</td>
               <td colspan="2">CTCAE Grade 2 Autoimmune Reaction<span class="subclass"> SubClassOf </span>Autoimmune Reaction Adverse Event. <br><i>New Terms: Autoimmune Reaction Adverse Event, CTCAE Grade 2 Autoimmune Reaction</i></td>
            </tr>
            <tr class="addition">
               <td>1220</td>
               <td colspan="2">CTCAE Grade 2 Avascular Osteonecrosis<span class="subclass"> SubClassOf </span>Avascular Osteonecrosis Adverse Event. <br><i>New Terms: CTCAE Grade 2 Avascular Osteonecrosis, Avascular Osteonecrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1221</td>
               <td colspan="2">CTCAE Grade 2 Back Pain<span class="subclass"> SubClassOf </span>Back Pain Adverse Event. <br><i>New Terms: CTCAE Grade 2 Back Pain, Back Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1222</td>
               <td colspan="2">CTCAE Grade 2 Bigeminy<span class="subclass"> SubClassOf </span>Bigeminy Adverse Event. <br><i>New Terms: Bigeminy Adverse Event, CTCAE Grade 2 Bigeminy</i></td>
            </tr>
            <tr class="addition">
               <td>1223</td>
               <td colspan="2">CTCAE Grade 2 Biliary Tree Common Bile Duct Intra-Operative Injury<span class="subclass"> SubClassOf </span>Biliary Tree Common Bile Duct Intra-Operative Injury Adverse Event. <br><i>New Terms: Biliary Tree Common Bile Duct Intra-Operative Injury Adverse Event, CTCAE Grade 2
                     Biliary Tree Common Bile Duct Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1224</td>
               <td colspan="2">CTCAE Grade 2 Biliary Tree Common Hepatic Duct Intra-Operative Injury<span class="subclass"> SubClassOf </span>Biliary Tree Common Hepatic Duct Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Biliary Tree Common Hepatic Duct Intra-Operative Injury, Biliary Tree
                     Common Hepatic Duct Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1225</td>
               <td colspan="2">CTCAE Grade 2 Biliary Tree Fistula<span class="subclass"> SubClassOf </span>Biliary Tree Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 2 Biliary Tree Fistula, Biliary Tree Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1226</td>
               <td colspan="2">CTCAE Grade 2 Biliary Tree Hemorrhage<span class="subclass"> SubClassOf </span>Biliary Tree Hemorrhage Adverse Event. <br><i>New Terms: Biliary Tree Hemorrhage Adverse Event, CTCAE Grade 2 Biliary Tree Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>1227</td>
               <td colspan="2">CTCAE Grade 2 Biliary Tree Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Biliary Tree Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Biliary Tree Infection Adverse Event Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, CTCAE Grade 2 Biliary Tree Infection Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1228</td>
               <td colspan="2">CTCAE Grade 2 Biliary Tree Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Biliary Tree Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Biliary Tree Infection Adverse Event with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, CTCAE Grade 2 Biliary Tree Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1229</td>
               <td colspan="2">CTCAE Grade 2 Biliary Tree Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Biliary Tree Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 2 Biliary Tree Infection with Unknown Absolute Neutrophil Count, Biliary
                     Tree Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1230</td>
               <td colspan="2">CTCAE Grade 2 Biliary Tree Leak<span class="subclass"> SubClassOf </span>Biliary Tree Leak Adverse Event. <br><i>New Terms: CTCAE Grade 2 Biliary Tree Leak, Biliary Tree Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1231</td>
               <td colspan="2">CTCAE Grade 2 Biliary Tree Left Hepatic Duct Intra-Operative Injury<span class="subclass"> SubClassOf </span>Biliary Tree Left Hepatic Duct Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Biliary Tree Left Hepatic Duct Intra-Operative Injury, Biliary Tree
                     Left Hepatic Duct Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1232</td>
               <td colspan="2">CTCAE Grade 2 Biliary Tree NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Biliary Tree NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: Biliary Tree NOS Intra-Operative Injury Adverse Event, CTCAE Grade 2 Biliary Tree
                     NOS Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1233</td>
               <td colspan="2">CTCAE Grade 2 Biliary Tree Perforation<span class="subclass"> SubClassOf </span>Biliary Tree Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 2 Biliary Tree Perforation, Biliary Tree Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1234</td>
               <td colspan="2">CTCAE Grade 2 Biliary Tree Right Hepatic Duct Intra-Operative Injury<span class="subclass"> SubClassOf </span>Biliary Tree Right Hepatic Duct Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Biliary Tree Right Hepatic Duct Intra-Operative Injury, Biliary Tree
                     Right Hepatic Duct Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1235</td>
               <td colspan="2">CTCAE Grade 2 Biliary Tree Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Biliary Tree Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Biliary Tree Stricture or Stenosis Adverse Event, CTCAE Grade 2 Biliary Tree Stricture
                     or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>1236</td>
               <td colspan="2">CTCAE Grade 2 Bladder Fistula<span class="subclass"> SubClassOf </span>Bladder Fistula Adverse Event. <br><i>New Terms: Bladder Fistula Adverse Event, CTCAE Grade 2 Bladder Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>1237</td>
               <td colspan="2">CTCAE Grade 2 Bladder Hemorrhage<span class="subclass"> SubClassOf </span>Bladder Hemorrhage Adverse Event. <br><i>New Terms: Bladder Hemorrhage Adverse Event, CTCAE Grade 2 Bladder Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>1238</td>
               <td colspan="2">CTCAE Grade 2 Bladder Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Bladder Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Bladder Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 2 Bladder Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1239</td>
               <td colspan="2">CTCAE Grade 2 Bladder Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Bladder Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Bladder Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Bladder Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1240</td>
               <td colspan="2">CTCAE Grade 2 Bladder Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Bladder Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Bladder Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     2 Bladder Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1241</td>
               <td colspan="2">CTCAE Grade 2 Bladder Intra-Operative Injury<span class="subclass"> SubClassOf </span>Bladder Intra-Operative Injury Adverse Event. <br><i>New Terms: Bladder Intra-Operative Injury Adverse Event, CTCAE Grade 2 Bladder Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1242</td>
               <td colspan="2">CTCAE Grade 2 Bladder Leak<span class="subclass"> SubClassOf </span>Bladder Leak Adverse Event. <br><i>New Terms: Bladder Leak Adverse Event, CTCAE Grade 2 Bladder Leak</i></td>
            </tr>
            <tr class="addition">
               <td>1243</td>
               <td colspan="2">CTCAE Grade 2 Bladder Obstruction<span class="subclass"> SubClassOf </span>Bladder Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 2 Bladder Obstruction, Bladder Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1244</td>
               <td colspan="2">CTCAE Grade 2 Bladder Pain<span class="subclass"> SubClassOf </span>Bladder Pain Adverse Event. <br><i>New Terms: CTCAE Grade 2 Bladder Pain, Bladder Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1245</td>
               <td colspan="2">CTCAE Grade 2 Bladder Perforation<span class="subclass"> SubClassOf </span>Bladder Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 2 Bladder Perforation, Bladder Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1246</td>
               <td colspan="2">CTCAE Grade 2 Bladder Spasms<span class="subclass"> SubClassOf </span>Bladder Spasm Adverse Event. <br><i>New Terms: Bladder Spasm Adverse Event, CTCAE Grade 2 Bladder Spasms</i></td>
            </tr>
            <tr class="addition">
               <td>1247</td>
               <td colspan="2">CTCAE Grade 2 Bladder Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Bladder Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 2 Bladder Stricture or Stenosis, Bladder Stricture or Stenosis Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1248</td>
               <td colspan="2">CTCAE Grade 2 Blood Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Blood Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Blood Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 2 Blood Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1249</td>
               <td colspan="2">CTCAE Grade 2 Blood Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Blood Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Blood Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 2 Blood Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1250</td>
               <td colspan="2">CTCAE Grade 2 Blood Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Blood Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 2 Blood Infection with Unknown Absolute Neutrophil Count, Blood Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1251</td>
               <td colspan="2">CTCAE Grade 2 Blurred Vision<span class="subclass"> SubClassOf </span>Blurred Vision Adverse Event. <br><i>New Terms: CTCAE Grade 2 Blurred Vision, Blurred Vision Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1252</td>
               <td colspan="2">CTCAE Grade 2 Bone Growth Limb Length Discrepancy<span class="subclass"> SubClassOf </span>Bone Growth Limb Length Discrepancy Adverse Event. <br><i>New Terms: CTCAE Grade 2 Bone Growth Limb Length Discrepancy, Bone Growth Limb Length Discrepancy
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1253</td>
               <td colspan="2">CTCAE Grade 2 Bone Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Bone Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Bone Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Bone Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1254</td>
               <td colspan="2">CTCAE Grade 2 Bone Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Bone Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Bone Infection with Normal Absolute Neutrophil Count or Grade 1 or 2
                     Neutrophils, Bone Infection Adverse Event with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1255</td>
               <td colspan="2">CTCAE Grade 2 Bone Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Bone Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 2 Bone Infection with Unknown Absolute Neutrophil Count, Bone Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1256</td>
               <td colspan="2">CTCAE Grade 2 Bone Intra-Operative Injury<span class="subclass"> SubClassOf </span>Bone Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Bone Intra-Operative Injury, Bone Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1257</td>
               <td colspan="2">CTCAE Grade 2 Bone Marrow Cellularity<span class="subclass"> SubClassOf </span>Bone Marrow Cellularity Adverse Event. <br><i>New Terms: Bone Marrow Cellularity Adverse Event, CTCAE Grade 2 Bone Marrow Cellularity</i></td>
            </tr>
            <tr class="addition">
               <td>1258</td>
               <td colspan="2">CTCAE Grade 2 Bone Pain<span class="subclass"> SubClassOf </span>Bone Pain Adverse Event. <br><i>New Terms: CTCAE Grade 2 Bone Pain, Bone Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1259</td>
               <td colspan="2">CTCAE Grade 2 Brachial Plexopathy<span class="subclass"> SubClassOf </span>Brachial Plexopathy Adverse Event. <br><i>New Terms: Brachial Plexopathy Adverse Event, CTCAE Grade 2 Brachial Plexopathy</i></td>
            </tr>
            <tr class="addition">
               <td>1260</td>
               <td colspan="2">CTCAE Grade 2 Brachial Plexus Intra-Operative Injury<span class="subclass"> SubClassOf </span>Brachial Plexus Intra-Operative Injury Adverse Event. <br><i>New Terms: Brachial Plexus Intra-Operative Injury Adverse Event, CTCAE Grade 2 Brachial Plexus
                     Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1261</td>
               <td colspan="2">CTCAE Grade 2 Brain Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Brain Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Brain Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Brain Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1262</td>
               <td colspan="2">CTCAE Grade 2 Brain Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Brain Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Brain Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 2 Brain Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1263</td>
               <td colspan="2">CTCAE Grade 2 Brain Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Brain Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 2 Brain Infection with Unknown Absolute Neutrophil Count, Brain Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1264</td>
               <td colspan="2">CTCAE Grade 2 Brain Intra-Operative Injury<span class="subclass"> SubClassOf </span>Brain Intra-Operative Injury Adverse Event. <br><i>New Terms: Brain Intra-Operative Injury Adverse Event, CTCAE Grade 2 Brain Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1265</td>
               <td colspan="2">CTCAE Grade 2 Brain<br><span class="keyword"> and </span>Spinal Cord Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Brain<br><span class="keyword"> and </span>Spinal Cord Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Brain and Spinal Cord Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, Brain and Spinal Cord Infection Adverse Event Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1266</td>
               <td colspan="2">CTCAE Grade 2 Brain<br><span class="keyword"> and </span>Spinal Cord Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Brain<br><span class="keyword"> and </span>Spinal Cord Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Brain and Spinal Cord Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils, CTCAE Grade 2 Brain and Spinal Cord Infection with Normal
                     Absolute Neutrophil Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1267</td>
               <td colspan="2">CTCAE Grade 2 Brain<br><span class="keyword"> and </span>Spinal Cord Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Brain<br><span class="keyword"> and </span>Spinal Cord Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Brain and Spinal Cord Infection Adverse Event with Unknown Absolute Neutrophil Count,
                     CTCAE Grade 2 Brain and Spinal Cord Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1268</td>
               <td colspan="2">CTCAE Grade 2 Breast Function<br><span class="keyword"> and </span>Lactation<span class="subclass"> SubClassOf </span>Breast Function<br><span class="keyword"> and </span>Lactation Adverse Event. <br><i>New Terms: CTCAE Grade 2 Breast Function and Lactation, Breast Function and Lactation Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1269</td>
               <td colspan="2">CTCAE Grade 2 Breast Intra-Operative Injury<span class="subclass"> SubClassOf </span>Breast Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Breast Intra-Operative Injury, Breast Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1270</td>
               <td colspan="2">CTCAE Grade 2 Breast Nipple<br><span class="keyword"> and </span>Areolar Deformity<span class="subclass"> SubClassOf </span>Breast Nipple<br><span class="keyword"> and </span>Areolar Deformity Adverse Event. <br><i>New Terms: CTCAE Grade 2 Breast Nipple and Areolar Deformity, Breast Nipple and Areolar Deformity
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1271</td>
               <td colspan="2">CTCAE Grade 2 Breast Pain<span class="subclass"> SubClassOf </span>Breast Pain Adverse Event. <br><i>New Terms: Breast Pain Adverse Event, CTCAE Grade 2 Breast Pain</i></td>
            </tr>
            <tr class="addition">
               <td>1272</td>
               <td colspan="2">CTCAE Grade 2 Breast Volume<br><span class="keyword"> and </span>Hypoplasia<span class="subclass"> SubClassOf </span>Breast Volume<br><span class="keyword"> and </span>Hypoplasia Adverse Event. <br><i>New Terms: CTCAE Grade 2 Breast Volume and Hypoplasia, Breast Volume and Hypoplasia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1273</td>
               <td colspan="2">CTCAE Grade 2 Bronchopulmonary Hemorrhage NOS<span class="subclass"> SubClassOf </span>Bronchopulmonary Hemorrhage Adverse Event NOS. <br><i>New Terms: CTCAE Grade 2 Bronchopulmonary Hemorrhage NOS, Bronchopulmonary Hemorrhage Adverse
                     Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>1274</td>
               <td colspan="2">CTCAE Grade 2 Bronchospasm<br><span class="keyword"> and </span>Wheezing<span class="subclass"> SubClassOf </span>Bronchospasm<br><span class="keyword"> and </span>Wheezing Adverse Event. <br><i>New Terms: CTCAE Grade 2 Bronchospasm and Wheezing, Bronchospasm and Wheezing Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1275</td>
               <td colspan="2">CTCAE Grade 2 Bronchus Fistula<span class="subclass"> SubClassOf </span>Bronchus Fistula Adverse Event. <br><i>New Terms: Bronchus Fistula Adverse Event, CTCAE Grade 2 Bronchus Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>1276</td>
               <td colspan="2">CTCAE Grade 2 Bronchus Hemorrhage<span class="subclass"> SubClassOf </span>Bronchus Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 2 Bronchus Hemorrhage, Bronchus Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1277</td>
               <td colspan="2">CTCAE Grade 2 Bronchus Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Bronchus Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Bronchus Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Bronchus Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1278</td>
               <td colspan="2">CTCAE Grade 2 Bronchus Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Bronchus Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Bronchus Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, CTCAE Grade 2 Bronchus Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1279</td>
               <td colspan="2">CTCAE Grade 2 Bronchus Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Bronchus Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Bronchus Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     2 Bronchus Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1280</td>
               <td colspan="2">CTCAE Grade 2 Bronchus Intra-Operative Injury<span class="subclass"> SubClassOf </span>Bronchus Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Bronchus Intra-Operative Injury, Bronchus Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1281</td>
               <td colspan="2">CTCAE Grade 2 Bronchus Obstruction<br><span class="keyword"> and </span>Stenosis<span class="subclass"> SubClassOf </span>Bronchus Obstruction<br><span class="keyword"> and </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 2 Bronchus Obstruction and Stenosis, Bronchus Obstruction and Stenosis
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1282</td>
               <td colspan="2">CTCAE Grade 2 Bruising in the Absence of Grade 3<br><span class="keyword"> or </span>Grade 4 Thrombocytopenia<span class="subclass"> SubClassOf </span>Bruising in the Absence of Grade 3<br><span class="keyword"> or </span>Grade 4 Thrombocytopenia Adverse Event. <br><i>New Terms: Bruising in the Absence of Grade 3 or Grade 4 Thrombocytopenia Adverse Event, CTCAE
                     Grade 2 Bruising in the Absence of Grade 3 or Grade 4 Thrombocytopenia</i></td>
            </tr>
            <tr class="addition">
               <td>1283</td>
               <td colspan="2">CTCAE Grade 2 Burn<span class="subclass"> SubClassOf </span>Burn Adverse Event. <br><i>New Terms: CTCAE Grade 2 Burn, Burn Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1284</td>
               <td colspan="2">CTCAE Grade 2 Buttock Pain<span class="subclass"> SubClassOf </span>Buttock Pain Adverse Event. <br><i>New Terms: Buttock Pain Adverse Event, CTCAE Grade 2 Buttock Pain</i></td>
            </tr>
            <tr class="addition">
               <td>1285</td>
               <td colspan="2">CTCAE Grade 2 CD4 Count<span class="subclass"> SubClassOf </span>CD4 Count Adverse Event. <br><i>New Terms: CD4 Count Adverse Event, CTCAE Grade 2 CD4 Count</i></td>
            </tr>
            <tr class="addition">
               <td>1286</td>
               <td colspan="2">CTCAE Grade 2 CNS Cerebrovascular Ischemia<span class="subclass"> SubClassOf </span>CNS Cerebrovascular Ischemia Adverse Event. <br><i>New Terms: CNS Cerebrovascular Ischemia Adverse Event, CTCAE Grade 2 CNS Cerebrovascular Ischemia</i></td>
            </tr>
            <tr class="addition">
               <td>1287</td>
               <td colspan="2">CTCAE Grade 2 CNS Necrosis<br><span class="keyword"> and </span>Cystic Progression<span class="subclass"> SubClassOf </span>CNS Necrosis<br><span class="keyword"> and </span>Cystic Progression Adverse Event. <br><i>New Terms: CNS Necrosis and Cystic Progression Adverse Event, CTCAE Grade 2 CNS Necrosis and
                     Cystic Progression</i></td>
            </tr>
            <tr class="addition">
               <td>1288</td>
               <td colspan="2">CTCAE Grade 2 Carbon Monoxide Diffusion Capacity<span class="subclass"> SubClassOf </span>Carbon Monoxide Diffusion Capacity Adverse Event. <br><i>New Terms: Carbon Monoxide Diffusion Capacity Adverse Event, CTCAE Grade 2 Carbon Monoxide Diffusion
                     Capacity</i></td>
            </tr>
            <tr class="addition">
               <td>1289</td>
               <td colspan="2">CTCAE Grade 2 Cardiac Ischemia<br><span class="keyword"> or </span>Infarction<span class="subclass"> SubClassOf </span>Cardiac Ischemia<br><span class="keyword"> or </span>Infarction Adverse Event. <br><i>New Terms: Cardiac Ischemia or Infarction Adverse Event, CTCAE Grade 2 Cardiac Ischemia or Infarction</i></td>
            </tr>
            <tr class="addition">
               <td>1290</td>
               <td colspan="2">CTCAE Grade 2 Cardiac Troponin T<span class="subclass"> SubClassOf </span>Cardiac Troponin T Adverse Event. <br><i>New Terms: CTCAE Grade 2 Cardiac Troponin T, Cardiac Troponin T Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1291</td>
               <td colspan="2">CTCAE Grade 2 Cardiac<br><span class="keyword"> and </span>Heart Pain<span class="subclass"> SubClassOf </span>Cardiac<br><span class="keyword"> and </span>Heart Pain Adverse Event. <br><i>New Terms: Cardiac and Heart Pain Adverse Event, CTCAE Grade 2 Cardiac and Heart Pain</i></td>
            </tr>
            <tr class="addition">
               <td>1292</td>
               <td colspan="2">CTCAE Grade 2 Carotid Artery Injury<span class="subclass"> SubClassOf </span>Carotid Artery Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Carotid Artery Injury, Carotid Artery Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1293</td>
               <td colspan="2">CTCAE Grade 2 Carotid Artery Intra-Operative Injury<span class="subclass"> SubClassOf </span>Carotid Artery Intra-Operative Injury Adverse Event. <br><i>New Terms: Carotid Artery Intra-Operative Injury Adverse Event, CTCAE Grade 2 Carotid Artery
                     Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1294</td>
               <td colspan="2">CTCAE Grade 2 Cartilage Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cartilage Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Cartilage Intra-Operative Injury, Cartilage Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1295</td>
               <td colspan="2">CTCAE Grade 2 Cataract<span class="subclass"> SubClassOf </span>Cataract Adverse Event. <br><i>New Terms: Cataract Adverse Event, CTCAE Grade 2 Cataract</i></td>
            </tr>
            <tr class="addition">
               <td>1296</td>
               <td colspan="2">CTCAE Grade 2 Catheter-Related Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Catheter-Related Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Catheter-Related Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, CTCAE Grade 2 Catheter-Related Infection Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1297</td>
               <td colspan="2">CTCAE Grade 2 Catheter-Related Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Catheter-Related Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Catheter-Related Infection with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils, Catheter-Related Infection Adverse Event with Normal Absolute
                     Neutrophil Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1298</td>
               <td colspan="2">CTCAE Grade 2 Catheter-Related Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Catheter-Related Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Catheter-Related Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE
                     Grade 2 Catheter-Related Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1299</td>
               <td colspan="2">CTCAE Grade 2 Cecum Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Cecum Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Cecum Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Cecum Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1300</td>
               <td colspan="2">CTCAE Grade 2 Cecum Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Cecum Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Cecum Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Cecum Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1301</td>
               <td colspan="2">CTCAE Grade 2 Cecum Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Cecum Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Cecum Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     2 Cecum Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1302</td>
               <td colspan="2">CTCAE Grade 2 Cecum Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cecum Intra-Operative Injury Adverse Event. <br><i>New Terms: Cecum Intra-Operative Injury Adverse Event, CTCAE Grade 2 Cecum Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1303</td>
               <td colspan="2">CTCAE Grade 2 Cecum Obstruction<span class="subclass"> SubClassOf </span>Cecum Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 2 Cecum Obstruction, Cecum Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1304</td>
               <td colspan="2">CTCAE Grade 2 Cecum Perforation<span class="subclass"> SubClassOf </span>Cecum Perforation Adverse Event. <br><i>New Terms: Cecum Perforation Adverse Event, CTCAE Grade 2 Cecum Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>1305</td>
               <td colspan="2">CTCAE Grade 2 Cecum Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Cecum Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 2 Cecum Stricture or Stenosis, Cecum Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1306</td>
               <td colspan="2">CTCAE Grade 2 Cecum Ulcer<span class="subclass"> SubClassOf </span>Cecum Ulcer Adverse Event. <br><i>New Terms: CTCAE Grade 2 Cecum Ulcer, Cecum Ulcer Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1307</td>
               <td colspan="2">CTCAE Grade 2 Cecum<br><span class="keyword"> or </span>Appendix Hemorrhage<span class="subclass"> SubClassOf </span>Cecum<br><span class="keyword"> or </span>Appendix Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 2 Cecum or Appendix Hemorrhage, Cecum or Appendix Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1308</td>
               <td colspan="2">CTCAE Grade 2 Central Nervous System Hemorrhage<span class="subclass"> SubClassOf </span>Central Nervous System Hemorrhage Adverse Event. <br><i>New Terms: Central Nervous System Hemorrhage Adverse Event, CTCAE Grade 2 Central Nervous System
                     Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>1309</td>
               <td colspan="2">CTCAE Grade 2 Cerebral Artery Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cerebral Artery Intra-Operative Injury Adverse Event. <br><i>New Terms: Cerebral Artery Intra-Operative Injury Adverse Event, CTCAE Grade 2 Cerebral Artery
                     Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1310</td>
               <td colspan="2">CTCAE Grade 2 Cerebrospinal Fluid Leak<span class="subclass"> SubClassOf </span>Cerebrospinal Fluid Leak Adverse Event. <br><i>New Terms: Cerebrospinal Fluid Leak Adverse Event, CTCAE Grade 2 Cerebrospinal Fluid Leak</i></td>
            </tr>
            <tr class="addition">
               <td>1311</td>
               <td colspan="2">CTCAE Grade 2 Cervical Spine<span class="subclass"> Range </span>of Motion<span class="subclass"> SubClassOf </span>Cervical Spine<span class="subclass"> Range </span>of Motion Adverse Event. <br><i>New Terms: CTCAE Grade 2 Cervical Spine Range of Motion, Cervical Spine Range of Motion Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1312</td>
               <td colspan="2">CTCAE Grade 2 Cervix Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Cervix Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Cervix Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Cervix Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1313</td>
               <td colspan="2">CTCAE Grade 2 Cervix Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Cervix Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Cervix Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Cervix Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1314</td>
               <td colspan="2">CTCAE Grade 2 Cervix Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Cervix Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Cervix Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     2 Cervix Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1315</td>
               <td colspan="2">CTCAE Grade 2 Cervix Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cervix Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Cervix Intra-Operative Injury, Cervix Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1316</td>
               <td colspan="2">CTCAE Grade 2 Cheilitis<span class="subclass"> SubClassOf </span>Cheilitis Adverse Event. <br><i>New Terms: Cheilitis Adverse Event, CTCAE Grade 2 Cheilitis</i></td>
            </tr>
            <tr class="addition">
               <td>1317</td>
               <td colspan="2">CTCAE Grade 2 Chemoradiation<span class="subclass"> SubClassOf </span>Rash<br><span class="keyword"> and </span>Dermatitis Adverse Event Associated with Chemoradiation. <br><i>New Terms: CTCAE Grade 2 Chemoradiation, Rash and Dermatitis Adverse Event Associated with Chemoradiation</i></td>
            </tr>
            <tr class="addition">
               <td>1318</td>
               <td colspan="2">CTCAE Grade 2 Chest Wall Pain<span class="subclass"> SubClassOf </span>Chest Wall Pain Adverse Event. <br><i>New Terms: CTCAE Grade 2 Chest Wall Pain, Chest Wall Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1319</td>
               <td colspan="2">CTCAE Grade 2 Chest<br><span class="keyword"> and </span>Thorax Pain<span class="subclass"> SubClassOf </span>Chest<br><span class="keyword"> and </span>Thorax Pain NOS Adverse Event. <br><i>New Terms: Chest and Thorax Pain NOS Adverse Event, CTCAE Grade 2 Chest and Thorax Pain</i></td>
            </tr>
            <tr class="addition">
               <td>1320</td>
               <td colspan="2">CTCAE Grade 2 Cholecystitis<span class="subclass"> SubClassOf </span>Cholecystitis Adverse Event. <br><i>New Terms: Cholecystitis Adverse Event, CTCAE Grade 2 Cholecystitis</i></td>
            </tr>
            <tr class="addition">
               <td>1321</td>
               <td colspan="2">CTCAE Grade 2 Chyle<br><span class="keyword"> or </span>Lymph Leakage<span class="subclass"> SubClassOf </span>Chyle<br><span class="keyword"> or </span>Lymph Leakage Adverse Event. <br><i>New Terms: CTCAE Grade 2 Chyle or Lymph Leakage, Chyle or Lymph Leakage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1322</td>
               <td colspan="2">CTCAE Grade 2 Chylothorax<span class="subclass"> SubClassOf </span>Chylothorax Adverse Event. <br><i>New Terms: Chylothorax Adverse Event, CTCAE Grade 2 Chylothorax</i></td>
            </tr>
            <tr class="addition">
               <td>1323</td>
               <td colspan="2">CTCAE Grade 2 Cognitive Disturbance<span class="subclass"> SubClassOf </span>Cognitive Disturbance Adverse Event. <br><i>New Terms: Cognitive Disturbance Adverse Event, CTCAE Grade 2 Cognitive Disturbance</i></td>
            </tr>
            <tr class="addition">
               <td>1324</td>
               <td colspan="2">CTCAE Grade 2 Colitis<span class="subclass"> SubClassOf </span>Colitis Adverse Event. <br><i>New Terms: Colitis Adverse Event, CTCAE Grade 2 Colitis</i></td>
            </tr>
            <tr class="addition">
               <td>1325</td>
               <td colspan="2">CTCAE Grade 2 Colon Hemorrhage<span class="subclass"> SubClassOf </span>Colon Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 2 Colon Hemorrhage, Colon Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1326</td>
               <td colspan="2">CTCAE Grade 2 Colon Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Colon Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Colon Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Colon Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1327</td>
               <td colspan="2">CTCAE Grade 2 Colon Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Colon Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Colon Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Colon Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1328</td>
               <td colspan="2">CTCAE Grade 2 Colon Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Colon Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 2 Colon Infection with Unknown Absolute Neutrophil Count, Colon Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1329</td>
               <td colspan="2">CTCAE Grade 2 Colon Intra-Operative Injury<span class="subclass"> SubClassOf </span>Colon Intra-Operative Injury Adverse Event. <br><i>New Terms: Colon Intra-Operative Injury Adverse Event, CTCAE Grade 2 Colon Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1330</td>
               <td colspan="2">CTCAE Grade 2 Colon Obstruction<span class="subclass"> SubClassOf </span>Colon Obstruction Adverse Event. <br><i>New Terms: Colon Obstruction Adverse Event, CTCAE Grade 2 Colon Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>1331</td>
               <td colspan="2">CTCAE Grade 2 Colon Perforation<span class="subclass"> SubClassOf </span>Colon Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 2 Colon Perforation, Colon Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1332</td>
               <td colspan="2">CTCAE Grade 2 Colon Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Colon Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Colon Stricture or Stenosis Adverse Event, CTCAE Grade 2 Colon Stricture or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>1333</td>
               <td colspan="2">CTCAE Grade 2 Colon Ulcer<span class="subclass"> SubClassOf </span>Colon Ulcer Adverse Event. <br><i>New Terms: CTCAE Grade 2 Colon Ulcer, Colon Ulcer Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1334</td>
               <td colspan="2">CTCAE Grade 2 Colon<br><span class="keyword"> or </span>Cecum<br><span class="keyword"> or </span>Appendix Fistula<span class="subclass"> SubClassOf </span>Colon<br><span class="keyword"> or </span>Cecum<br><span class="keyword"> or </span>Appendix Fistula Adverse Event. <br><i>New Terms: Colon or Cecum or Appendix Fistula Adverse Event, CTCAE Grade 2 Colon or Cecum or
                     Appendix Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>1335</td>
               <td colspan="2">CTCAE Grade 2 Conduction Abnormality NOS<span class="subclass"> SubClassOf </span>Conduction Abnormality Adverse Event NOS. <br><i>New Terms: CTCAE Grade 2 Conduction Abnormality NOS, Conduction Abnormality Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>1336</td>
               <td colspan="2">CTCAE Grade 2 Confusion<span class="subclass"> SubClassOf </span>Confusion Adverse Event. <br><i>New Terms: CTCAE Grade 2 Confusion, Confusion Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1337</td>
               <td colspan="2">CTCAE Grade 2 Conjunctiva Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Conjunctiva Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Conjunctiva Infection Adverse Event Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, CTCAE Grade 2 Conjunctiva Infection Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1338</td>
               <td colspan="2">CTCAE Grade 2 Conjunctiva Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Conjunctiva Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Conjunctiva Infection with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, Conjunctiva Infection Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1339</td>
               <td colspan="2">CTCAE Grade 2 Conjunctiva Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Conjunctiva Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Conjunctiva Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE
                     Grade 2 Conjunctiva Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1340</td>
               <td colspan="2">CTCAE Grade 2 Conjunctiva Intra-Operative Injury<span class="subclass"> SubClassOf </span>Conjunctiva Intra-Operative Injury Adverse Event. <br><i>New Terms: Conjunctiva Intra-Operative Injury Adverse Event, CTCAE Grade 2 Conjunctiva Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1341</td>
               <td colspan="2">CTCAE Grade 2 Constipation<span class="subclass"> SubClassOf </span>Constipation Adverse Event. <br><i>New Terms: CTCAE Grade 2 Constipation, Constipation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1342</td>
               <td colspan="2">CTCAE Grade 2 Cornea Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Cornea Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Cornea Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Cornea Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1343</td>
               <td colspan="2">CTCAE Grade 2 Cornea Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Cornea Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Cornea Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 2 Cornea Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1344</td>
               <td colspan="2">CTCAE Grade 2 Cornea Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Cornea Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Cornea Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     2 Cornea Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1345</td>
               <td colspan="2">CTCAE Grade 2 Cornea Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cornea Intra-Operative Injury Adverse Event. <br><i>New Terms: Cornea Intra-Operative Injury Adverse Event, CTCAE Grade 2 Cornea Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1346</td>
               <td colspan="2">CTCAE Grade 2 Cough<span class="subclass"> SubClassOf </span>Cough Adverse Event. <br><i>New Terms: CTCAE Grade 2 Cough, Cough Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1356</td>
               <td colspan="2">CTCAE Grade 2 Cranial Nerve I Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve I Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Cranial Nerve I Intra-Operative Injury, Cranial Nerve I Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1357</td>
               <td colspan="2">CTCAE Grade 2 Cranial Nerve I Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve I Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve I Neuropathy Adverse Event, CTCAE Grade 2 Cranial Nerve I Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>1349</td>
               <td colspan="2">CTCAE Grade 2 Cranial Nerve II Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve II Intra-Operative Injury Adverse Event. <br><i>New Terms: Cranial Nerve II Intra-Operative Injury Adverse Event, CTCAE Grade 2 Cranial Nerve
                     II Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1350</td>
               <td colspan="2">CTCAE Grade 2 Cranial Nerve II Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve II Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve II Neuropathy Adverse Event, CTCAE Grade 2 Cranial Nerve II Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>1347</td>
               <td colspan="2">CTCAE Grade 2 Cranial Nerve III Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve III Intra-Operative Injury Adverse Event. <br><i>New Terms: Cranial Nerve III Intra-Operative Injury Adverse Event, CTCAE Grade 2 Cranial Nerve
                     III Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1348</td>
               <td colspan="2">CTCAE Grade 2 Cranial Nerve III Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve III Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 2 Cranial Nerve III Neuropathy, Cranial Nerve III Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1351</td>
               <td colspan="2">CTCAE Grade 2 Cranial Nerve IV Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve IV Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Cranial Nerve IV Intra-Operative Injury, Cranial Nerve IV Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1352</td>
               <td colspan="2">CTCAE Grade 2 Cranial Nerve IV Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve IV Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 2 Cranial Nerve IV Neuropathy, Cranial Nerve IV Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1353</td>
               <td colspan="2">CTCAE Grade 2 Cranial Nerve IX Motor Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve IX Motor Intra-Operative Injury Adverse Event. <br><i>New Terms: Cranial Nerve IX Motor Intra-Operative Injury Adverse Event, CTCAE Grade 2 Cranial
                     Nerve IX Motor Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1354</td>
               <td colspan="2">CTCAE Grade 2 Cranial Nerve IX Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve IX Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 2 Cranial Nerve IX Neuropathy, Cranial Nerve IX Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1355</td>
               <td colspan="2">CTCAE Grade 2 Cranial Nerve IX Sensory Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve IX Sensory Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Cranial Nerve IX Sensory Intra-Operative Injury, Cranial Nerve IX Sensory
                     Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1358</td>
               <td colspan="2">CTCAE Grade 2 Cranial Nerve Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Cranial Nerve Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Cranial Nerve Infection Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, Cranial Nerve Infection Adverse Event Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1359</td>
               <td colspan="2">CTCAE Grade 2 Cranial Nerve Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Cranial Nerve Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Cranial Nerve Infection Adverse Event with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, CTCAE Grade 2 Cranial Nerve Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1360</td>
               <td colspan="2">CTCAE Grade 2 Cranial Nerve Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Cranial Nerve Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 2 Cranial Nerve Infection with Unknown Absolute Neutrophil Count, Cranial
                     Nerve Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1361</td>
               <td colspan="2">CTCAE Grade 2 Cranial Nerve Or Branch NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve Or Branch NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: Cranial Nerve Or Branch NOS Intra-Operative Injury Adverse Event, CTCAE Grade 2 Cranial
                     Nerve Or Branch NOS Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1369</td>
               <td colspan="2">CTCAE Grade 2 Cranial Nerve V Motor Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve V Motor Intra-Operative Injury Adverse Event. <br><i>New Terms: Cranial Nerve V Motor Intra-Operative Injury Adverse Event, CTCAE Grade 2 Cranial
                     Nerve V Motor Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1370</td>
               <td colspan="2">CTCAE Grade 2 Cranial Nerve V Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve V Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve V Neuropathy Adverse Event, CTCAE Grade 2 Cranial Nerve V Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>1371</td>
               <td colspan="2">CTCAE Grade 2 Cranial Nerve V Sensory Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve V Sensory Intra-Operative Injury Adverse Event. <br><i>New Terms: Cranial Nerve V Sensory Intra-Operative Injury Adverse Event, CTCAE Grade 2 Cranial
                     Nerve V Sensory Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1367</td>
               <td colspan="2">CTCAE Grade 2 Cranial Nerve VI Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve VI Intra-Operative Injury Adverse Event. <br><i>New Terms: Cranial Nerve VI Intra-Operative Injury Adverse Event, CTCAE Grade 2 Cranial Nerve
                     VI Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1368</td>
               <td colspan="2">CTCAE Grade 2 Cranial Nerve VI Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve VI Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve VI Neuropathy Adverse Event, CTCAE Grade 2 Cranial Nerve VI Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>1364</td>
               <td colspan="2">CTCAE Grade 2 Cranial Nerve VII Motor Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve VII Motor Intra-Operative Injury Adverse Event. <br><i>New Terms: Cranial Nerve VII Motor Intra-Operative Injury Adverse Event, CTCAE Grade 2 Cranial
                     Nerve VII Motor Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1365</td>
               <td colspan="2">CTCAE Grade 2 Cranial Nerve VII Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve VII Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve VII Neuropathy Adverse Event, CTCAE Grade 2 Cranial Nerve VII Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>1366</td>
               <td colspan="2">CTCAE Grade 2 Cranial Nerve VII Sensory Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve VII Sensory Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Cranial Nerve VII Sensory Intra-Operative Injury, Cranial Nerve VII
                     Sensory Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1362</td>
               <td colspan="2">CTCAE Grade 2 Cranial Nerve VIII Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve VIII Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Cranial Nerve VIII Intra-Operative Injury, Cranial Nerve VIII Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1363</td>
               <td colspan="2">CTCAE Grade 2 Cranial Nerve VIII Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve VIII Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 2 Cranial Nerve VIII Neuropathy, Cranial Nerve VIII Neuropathy Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1376</td>
               <td colspan="2">CTCAE Grade 2 Cranial Nerve X Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve X Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Cranial Nerve X Intra-Operative Injury, Cranial Nerve X Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1377</td>
               <td colspan="2">CTCAE Grade 2 Cranial Nerve X Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve X Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 2 Cranial Nerve X Neuropathy, Cranial Nerve X Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1374</td>
               <td colspan="2">CTCAE Grade 2 Cranial Nerve XI Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve XI Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Cranial Nerve XI Intra-Operative Injury, Cranial Nerve XI Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1375</td>
               <td colspan="2">CTCAE Grade 2 Cranial Nerve XI Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve XI Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 2 Cranial Nerve XI Neuropathy, Cranial Nerve XI Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1372</td>
               <td colspan="2">CTCAE Grade 2 Cranial Nerve XII Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve XII Intra-Operative Injury Adverse Event. <br><i>New Terms: Cranial Nerve XII Intra-Operative Injury Adverse Event, CTCAE Grade 2 Cranial Nerve
                     XII Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1373</td>
               <td colspan="2">CTCAE Grade 2 Cranial Nerve XII Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve XII Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve XII Neuropathy Adverse Event, CTCAE Grade 2 Cranial Nerve XII Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>1378</td>
               <td colspan="2">CTCAE Grade 2 Creatine Phosphokinase<span class="subclass"> SubClassOf </span>Creatine Phosphokinase Adverse Event. <br><i>New Terms: CTCAE Grade 2 Creatine Phosphokinase, Creatine Phosphokinase Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1379</td>
               <td colspan="2">CTCAE Grade 2 Creatinine<span class="subclass"> SubClassOf </span>Creatinine Adverse Event. <br><i>New Terms: Creatinine Adverse Event, CTCAE Grade 2 Creatinine</i></td>
            </tr>
            <tr class="addition">
               <td>1380</td>
               <td colspan="2">CTCAE Grade 2 Cushingoid Appearance<span class="subclass"> SubClassOf </span>Cushingoid Appearance Adverse Event. <br><i>New Terms: CTCAE Grade 2 Cushingoid Appearance, Cushingoid Appearance Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1381</td>
               <td colspan="2">CTCAE Grade 2 Cystitis<span class="subclass"> SubClassOf </span>Cystitis Adverse Event. <br><i>New Terms: Cystitis Adverse Event, CTCAE Grade 2 Cystitis</i></td>
            </tr>
            <tr class="addition">
               <td>1382</td>
               <td colspan="2">CTCAE Grade 2 Cytokine Release Syndrome<br><span class="keyword"> or </span>Acute Infusion Reaction<span class="subclass"> SubClassOf </span>Cytokine Release Syndrome<br><span class="keyword"> or </span>Acute Infusion Reaction Adverse Event. <br><i>New Terms: CTCAE Grade 2 Cytokine Release Syndrome or Acute Infusion Reaction, Cytokine Release
                     Syndrome or Acute Infusion Reaction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1383</td>
               <td colspan="2">CTCAE Grade 2 Dehydration<span class="subclass"> SubClassOf </span>Dehydration Adverse Event. <br><i>New Terms: CTCAE Grade 2 Dehydration, Dehydration Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1384</td>
               <td colspan="2">CTCAE Grade 2 Delayed Puberty<span class="subclass"> SubClassOf </span>Delayed Puberty Adverse Event. <br><i>New Terms: Delayed Puberty Adverse Event, CTCAE Grade 2 Delayed Puberty</i></td>
            </tr>
            <tr class="addition">
               <td>1388</td>
               <td colspan="2">CTCAE Grade 2 Dental<br><span class="keyword"> and </span>Teeth<br><span class="keyword"> and </span>Peridontal Pain<span class="subclass"> SubClassOf </span>Dental<br><span class="keyword"> and </span>Teeth<br><span class="keyword"> and </span>Peridontal Pain Adverse Event. <br><i>New Terms: Dental and Teeth and Peridontal Pain Adverse Event, CTCAE Grade 2 Dental and Teeth
                     and Peridontal Pain</i></td>
            </tr>
            <tr class="addition">
               <td>1385</td>
               <td colspan="2">CTCAE Grade 2 Dental-Tooth Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Tooth Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Dental-Tooth Infection Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, Tooth Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1386</td>
               <td colspan="2">CTCAE Grade 2 Dental-Tooth Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Tooth Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Tooth Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 2 Dental-Tooth Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1387</td>
               <td colspan="2">CTCAE Grade 2 Dental-Tooth Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Tooth Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Tooth Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     2 Dental-Tooth Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1389</td>
               <td colspan="2">CTCAE Grade 2 Depression<span class="subclass"> SubClassOf </span>Depression Adverse Event. <br><i>New Terms: Depression Adverse Event, CTCAE Grade 2 Depression</i></td>
            </tr>
            <tr class="addition">
               <td>1390</td>
               <td colspan="2">CTCAE Grade 2 Dermal Change Lymphedema<br><span class="keyword"> or </span>Phlebolymphedema<span class="subclass"> SubClassOf </span>Dermal Change Adverse Event Lymphedema<br><span class="keyword"> or </span>Phlebolymphedema. <br><i>New Terms: CTCAE Grade 2 Dermal Change Lymphedema or Phlebolymphedema, Dermal Change Adverse
                     Event Lymphedema or Phlebolymphedema</i></td>
            </tr>
            <tr class="addition">
               <td>1391</td>
               <td colspan="2">CTCAE Grade 2 Diaphoresis<span class="subclass"> SubClassOf </span>Diaphoresis Adverse Event. <br><i>New Terms: CTCAE Grade 2 Diaphoresis, Diaphoresis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1392</td>
               <td colspan="2">CTCAE Grade 2 Diarrhea<span class="subclass"> SubClassOf </span>Diarrhea Adverse Event. <br><i>New Terms: Diarrhea Adverse Event, CTCAE Grade 2 Diarrhea</i></td>
            </tr>
            <tr class="addition">
               <td>1393</td>
               <td colspan="2">CTCAE Grade 2 Disseminated Intravascular Coagulation<span class="subclass"> SubClassOf </span>Disseminated Intravascular Coagulation Adverse Event. <br><i>New Terms: CTCAE Grade 2 Disseminated Intravascular Coagulation, Disseminated Intravascular Coagulation
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1394</td>
               <td colspan="2">CTCAE Grade 2 Dizziness<span class="subclass"> SubClassOf </span>Dizziness Adverse Event. <br><i>New Terms: CTCAE Grade 2 Dizziness, Dizziness Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1395</td>
               <td colspan="2">CTCAE Grade 2 Dry Eye Syndrome<span class="subclass"> SubClassOf </span>Dry Eye Syndrome Adverse Event. <br><i>New Terms: Dry Eye Syndrome Adverse Event, CTCAE Grade 2 Dry Eye Syndrome</i></td>
            </tr>
            <tr class="addition">
               <td>1396</td>
               <td colspan="2">CTCAE Grade 2 Dry Skin<span class="subclass"> SubClassOf </span>Dry Skin Adverse Event. <br><i>New Terms: Dry Skin Adverse Event, CTCAE Grade 2 Dry Skin</i></td>
            </tr>
            <tr class="addition">
               <td>1397</td>
               <td colspan="2">CTCAE Grade 2 Duodenum Fistula<span class="subclass"> SubClassOf </span>Duodenum Fistula Adverse Event. <br><i>New Terms: Duodenum Fistula Adverse Event, CTCAE Grade 2 Duodenum Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>1398</td>
               <td colspan="2">CTCAE Grade 2 Duodenum Hemorrhage<span class="subclass"> SubClassOf </span>Duodenum Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 2 Duodenum Hemorrhage, Duodenum Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1399</td>
               <td colspan="2">CTCAE Grade 2 Duodenum Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Duodenum Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Duodenum Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 2 Duodenum Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1400</td>
               <td colspan="2">CTCAE Grade 2 Duodenum Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Duodenum Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Duodenum Infection with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, Duodenum Infection Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1401</td>
               <td colspan="2">CTCAE Grade 2 Duodenum Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Duodenum Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 2 Duodenum Infection with Unknown Absolute Neutrophil Count, Duodenum
                     Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1402</td>
               <td colspan="2">CTCAE Grade 2 Duodenum Intra-Operative Injury<span class="subclass"> SubClassOf </span>Duodenum Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Duodenum Intra-Operative Injury, Duodenum Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1403</td>
               <td colspan="2">CTCAE Grade 2 Duodenum Obstruction<span class="subclass"> SubClassOf </span>Duodenum Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 2 Duodenum Obstruction, Duodenum Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1404</td>
               <td colspan="2">CTCAE Grade 2 Duodenum Perforation<span class="subclass"> SubClassOf </span>Duodenum Perforation Adverse Event. <br><i>New Terms: Duodenum Perforation Adverse Event, CTCAE Grade 2 Duodenum Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>1405</td>
               <td colspan="2">CTCAE Grade 2 Duodenum Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Duodenum Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 2 Duodenum Stricture or Stenosis, Duodenum Stricture or Stenosis Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1406</td>
               <td colspan="2">CTCAE Grade 2 Duodenum Ulcer<span class="subclass"> SubClassOf </span>Duodenum Ulcer Adverse Event. <br><i>New Terms: Duodenum Ulcer Adverse Event, CTCAE Grade 2 Duodenum Ulcer</i></td>
            </tr>
            <tr class="addition">
               <td>1407</td>
               <td colspan="2">CTCAE Grade 2 Dysphagia<span class="subclass"> SubClassOf </span>Dysphagia Adverse Event. <br><i>New Terms: CTCAE Grade 2 Dysphagia, Dysphagia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1408</td>
               <td colspan="2">CTCAE Grade 2 Dyspnea<span class="subclass"> SubClassOf </span>Dyspnea Adverse Event. <br><i>New Terms: CTCAE Grade 2 Dyspnea, Dyspnea Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1409</td>
               <td colspan="2">CTCAE Grade 2 Edema of the Head<br><span class="keyword"> and </span>Neck<span class="subclass"> SubClassOf </span>Edema Adverse Event of the Head<br><span class="keyword"> and </span>Neck. <br><i>New Terms: CTCAE Grade 2 Edema of the Head and Neck, Edema Adverse Event of the Head and Neck</i></td>
            </tr>
            <tr class="addition">
               <td>1410</td>
               <td colspan="2">CTCAE Grade 2 Edema of the Limb<span class="subclass"> SubClassOf </span>Edema Adverse Event of the Limb. <br><i>New Terms: CTCAE Grade 2 Edema of the Limb, Edema Adverse Event of the Limb</i></td>
            </tr>
            <tr class="addition">
               <td>1411</td>
               <td colspan="2">CTCAE Grade 2 Edema of the Trunk<br><span class="keyword"> and </span>Genital Area<span class="subclass"> SubClassOf </span>Edema Adverse Event of the Trunk<br><span class="keyword"> and </span>Genital Area. <br><i>New Terms: Edema Adverse Event of the Trunk and Genital Area, CTCAE Grade 2 Edema of the Trunk
                     and Genital Area</i></td>
            </tr>
            <tr class="addition">
               <td>1412</td>
               <td colspan="2">CTCAE Grade 2 Edema of the Viscera<span class="subclass"> SubClassOf </span>Edema Adverse Event of the Viscera. <br><i>New Terms: Edema Adverse Event of the Viscera, CTCAE Grade 2 Edema of the Viscera</i></td>
            </tr>
            <tr class="addition">
               <td>1413</td>
               <td colspan="2">CTCAE Grade 2 Ejaculatory Dysfunction<span class="subclass"> SubClassOf </span>Ejaculatory Dysfunction Adverse Event. <br><i>New Terms: Ejaculatory Dysfunction Adverse Event, CTCAE Grade 2 Ejaculatory Dysfunction</i></td>
            </tr>
            <tr class="addition">
               <td>1414</td>
               <td colspan="2">CTCAE Grade 2 Encephalopathy<span class="subclass"> SubClassOf </span>Encephalopathy Adverse Event. <br><i>New Terms: CTCAE Grade 2 Encephalopathy, Encephalopathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1415</td>
               <td colspan="2">CTCAE Grade 2 Enteritis<span class="subclass"> SubClassOf </span>Enteritis Adverse Event. <br><i>New Terms: CTCAE Grade 2 Enteritis, Enteritis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1416</td>
               <td colspan="2">CTCAE Grade 2 Epiphora<span class="subclass"> SubClassOf </span>Epiphora Adverse Event. <br><i>New Terms: CTCAE Grade 2 Epiphora, Epiphora Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1417</td>
               <td colspan="2">CTCAE Grade 2 Erectile Dysfunction<span class="subclass"> SubClassOf </span>Erectile Dysfunction Adverse Event. <br><i>New Terms: Erectile Dysfunction Adverse Event, CTCAE Grade 2 Erectile Dysfunction</i></td>
            </tr>
            <tr class="addition">
               <td>1418</td>
               <td colspan="2">CTCAE Grade 2 Esophageal Varices Hemorrhage<span class="subclass"> SubClassOf </span>Esophageal Varices Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 2 Esophageal Varices Hemorrhage, Esophageal Varices Hemorrhage Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1419</td>
               <td colspan="2">CTCAE Grade 2 Esophagitis<span class="subclass"> SubClassOf </span>Esophagitis Adverse Event. <br><i>New Terms: CTCAE Grade 2 Esophagitis, Esophagitis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1420</td>
               <td colspan="2">CTCAE Grade 2 Esophagus Fistula<span class="subclass"> SubClassOf </span>Esophagus Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 2 Esophagus Fistula, Esophagus Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1421</td>
               <td colspan="2">CTCAE Grade 2 Esophagus Hemorrhage<span class="subclass"> SubClassOf </span>Esophagus Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 2 Esophagus Hemorrhage, Esophagus Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1422</td>
               <td colspan="2">CTCAE Grade 2 Esophagus Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Esophagus Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Esophagus Infection Adverse Event Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, CTCAE Grade 2 Esophagus Infection Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1423</td>
               <td colspan="2">CTCAE Grade 2 Esophagus Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Esophagus Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Esophagus Infection with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, Esophagus Infection Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1424</td>
               <td colspan="2">CTCAE Grade 2 Esophagus Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Esophagus Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Esophagus Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     2 Esophagus Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1425</td>
               <td colspan="2">CTCAE Grade 2 Esophagus Intra-Operative Injury<span class="subclass"> SubClassOf </span>Esophagus Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Esophagus Intra-Operative Injury, Esophagus Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1426</td>
               <td colspan="2">CTCAE Grade 2 Esophagus Leak<span class="subclass"> SubClassOf </span>Esophagus Leak Adverse Event. <br><i>New Terms: CTCAE Grade 2 Esophagus Leak, Esophagus Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1427</td>
               <td colspan="2">CTCAE Grade 2 Esophagus Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Esophagus Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Clinical Examination Classification. <br><i>New Terms: Esophagus Mucositis or Stomatitis Adverse Event by Clinical Examination Classification,
                     CTCAE Grade 2 Esophagus Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>1428</td>
               <td colspan="2">CTCAE Grade 2 Esophagus Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Esophagus Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: Esophagus Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification,
                     CTCAE Grade 2 Esophagus Mucositis or Stomatitis by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>1429</td>
               <td colspan="2">CTCAE Grade 2 Esophagus Obstruction<span class="subclass"> SubClassOf </span>Esophagus Obstruction Adverse Event. <br><i>New Terms: Esophagus Obstruction Adverse Event, CTCAE Grade 2 Esophagus Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>1430</td>
               <td colspan="2">CTCAE Grade 2 Esophagus Pain<span class="subclass"> SubClassOf </span>Esophagus Pain Adverse Event. <br><i>New Terms: CTCAE Grade 2 Esophagus Pain, Esophagus Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1431</td>
               <td colspan="2">CTCAE Grade 2 Esophagus Perforation<span class="subclass"> SubClassOf </span>Esophagus Perforation Adverse Event. <br><i>New Terms: Esophagus Perforation Adverse Event, CTCAE Grade 2 Esophagus Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>1432</td>
               <td colspan="2">CTCAE Grade 2 Esophagus Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Esophagus Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Esophagus Stricture or Stenosis Adverse Event, CTCAE Grade 2 Esophagus Stricture or
                     Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>1433</td>
               <td colspan="2">CTCAE Grade 2 Esophagus Ulcer<span class="subclass"> SubClassOf </span>Esophagus Ulcer Adverse Event. <br><i>New Terms: CTCAE Grade 2 Esophagus Ulcer, Esophagus Ulcer Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1434</td>
               <td colspan="2">CTCAE Grade 2 Euphoria<span class="subclass"> SubClassOf </span>Euphoria Adverse Event. <br><i>New Terms: Euphoria Adverse Event, CTCAE Grade 2 Euphoria</i></td>
            </tr>
            <tr class="addition">
               <td>1435</td>
               <td colspan="2">CTCAE Grade 2 Exostosis<span class="subclass"> SubClassOf </span>Exostosis Adverse Event. <br><i>New Terms: CTCAE Grade 2 Exostosis, Exostosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1436</td>
               <td colspan="2">CTCAE Grade 2 External Ear Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>External Ear Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 External Ear Infection Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, External Ear Infection Adverse Event Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1437</td>
               <td colspan="2">CTCAE Grade 2 External Ear Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>External Ear Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 2 External Ear Infection with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, External Ear Infection Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1438</td>
               <td colspan="2">CTCAE Grade 2 External Ear Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>External Ear Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: External Ear Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE
                     Grade 2 External Ear Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1439</td>
               <td colspan="2">CTCAE Grade 2 External Ear Pain<span class="subclass"> SubClassOf </span>External Ear Pain Adverse Event. <br><i>New Terms: CTCAE Grade 2 External Ear Pain, External Ear Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1440</td>
               <td colspan="2">CTCAE Grade 2 Extraocular Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Extraocular Muscle Weakness Not Due to Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 2 Extraocular Muscle Weakness Not Due to Neuropathy, Extraocular Muscle
                     Weakness Not Due to Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1441</td>
               <td colspan="2">CTCAE Grade 2 Extrapyramidal<br><span class="keyword"> and </span>Involuntary Movement<br><span class="keyword"> and </span>Restlessness<span class="subclass"> SubClassOf </span>Extrapyramidal<br><span class="keyword"> and </span>Involuntary Movement<br><span class="keyword"> and </span>Restlessness Adverse Event. <br><i>New Terms: Extrapyramidal and Involuntary Movement and Restlessness Adverse Event, CTCAE Grade
                     2 Extrapyramidal and Involuntary Movement and Restlessness</i></td>
            </tr>
            <tr class="addition">
               <td>1442</td>
               <td colspan="2">CTCAE Grade 2 Extremity Limb Pain<span class="subclass"> SubClassOf </span>Extremity Limb Pain Adverse Event. <br><i>New Terms: Extremity Limb Pain Adverse Event, CTCAE Grade 2 Extremity Limb Pain</i></td>
            </tr>
            <tr class="addition">
               <td>1443</td>
               <td colspan="2">CTCAE Grade 2 Eye Infection NOS Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Eye Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Eye Infection NOS Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Eye Infection NOS Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1444</td>
               <td colspan="2">CTCAE Grade 2 Eye Infection NOS with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Eye Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Eye Infection NOS with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Eye Infection NOS Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1445</td>
               <td colspan="2">CTCAE Grade 2 Eye Infection NOS with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Eye Infection NOS Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 2 Eye Infection NOS with Unknown Absolute Neutrophil Count, Eye Infection
                     NOS Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1446</td>
               <td colspan="2">CTCAE Grade 2 Eye NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Eye NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Eye NOS Intra-Operative Injury, Eye NOS Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1447</td>
               <td colspan="2">CTCAE Grade 2 Eye Pain<span class="subclass"> SubClassOf </span>Eye Pain Adverse Event. <br><i>New Terms: CTCAE Grade 2 Eye Pain, Eye Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1448</td>
               <td colspan="2">CTCAE Grade 2 Eyelid Dysfunction<span class="subclass"> SubClassOf </span>Eyelid Dysfunction Adverse Event. <br><i>New Terms: CTCAE Grade 2 Eyelid Dysfunction, Eyelid Dysfunction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1449</td>
               <td colspan="2">CTCAE Grade 2 FEV1<span class="subclass"> SubClassOf </span>FEV1 Adverse Event. <br><i>New Terms: FEV1 Adverse Event, CTCAE Grade 2 FEV1</i></td>
            </tr>
            <tr class="addition">
               <td>1450</td>
               <td colspan="2">CTCAE Grade 2 Face NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Face NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: Face NOS Intra-Operative Injury Adverse Event, CTCAE Grade 2 Face NOS Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1451</td>
               <td colspan="2">CTCAE Grade 2 Face Pain<span class="subclass"> SubClassOf </span>Face Pain Adverse Event. <br><i>New Terms: Face Pain Adverse Event, CTCAE Grade 2 Face Pain</i></td>
            </tr>
            <tr class="addition">
               <td>1452</td>
               <td colspan="2">CTCAE Grade 2 Facial Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Facial Muscle Weakness Not Due to Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 2 Facial Muscle Weakness Not Due to Neuropathy, Facial Muscle Weakness
                     Not Due to Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1453</td>
               <td colspan="2">CTCAE Grade 2 Fallopian Tube Hemorrhage<span class="subclass"> SubClassOf </span>Fallopian Tube Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 2 Fallopian Tube Hemorrhage, Fallopian Tube Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1454</td>
               <td colspan="2">CTCAE Grade 2 Fallopian Tube Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Fallopian Tube Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Fallopian Tube Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, CTCAE Grade 2 Fallopian Tube Infection Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1455</td>
               <td colspan="2">CTCAE Grade 2 Fallopian Tube Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Fallopian Tube Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Fallopian Tube Infection Adverse Event with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, CTCAE Grade 2 Fallopian Tube Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1456</td>
               <td colspan="2">CTCAE Grade 2 Fallopian Tube Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Fallopian Tube Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 2 Fallopian Tube Infection with Unknown Absolute Neutrophil Count, Fallopian
                     Tube Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1457</td>
               <td colspan="2">CTCAE Grade 2 Fallopian Tube Intra-Operative Injury<span class="subclass"> SubClassOf </span>Fallopian Tube Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Fallopian Tube Intra-Operative Injury, Fallopian Tube Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1458</td>
               <td colspan="2">CTCAE Grade 2 Fallopian Tube Leak<span class="subclass"> SubClassOf </span>Fallopian Tube Leak Adverse Event. <br><i>New Terms: Fallopian Tube Leak Adverse Event, CTCAE Grade 2 Fallopian Tube Leak</i></td>
            </tr>
            <tr class="addition">
               <td>1459</td>
               <td colspan="2">CTCAE Grade 2 Fallopian Tube Obstruction<span class="subclass"> SubClassOf </span>Fallopian Tube Obstruction Adverse Event. <br><i>New Terms: Fallopian Tube Obstruction Adverse Event, CTCAE Grade 2 Fallopian Tube Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>1460</td>
               <td colspan="2">CTCAE Grade 2 Fallopian Tube Perforation<span class="subclass"> SubClassOf </span>Fallopian Tube Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 2 Fallopian Tube Perforation, Fallopian Tube Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1461</td>
               <td colspan="2">CTCAE Grade 2 Fallopian Tube Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Fallopian Tube Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Fallopian Tube Stricture or Stenosis Adverse Event, CTCAE Grade 2 Fallopian Tube Stricture
                     or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>1462</td>
               <td colspan="2">CTCAE Grade 2 Fatigue<span class="subclass"> SubClassOf </span>Fatigue Adverse Event. <br><i>New Terms: CTCAE Grade 2 Fatigue, Fatigue Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1463</td>
               <td colspan="2">CTCAE Grade 2 Female Genital Tract Fistula<span class="subclass"> SubClassOf </span>Female Genital Tract Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 2 Female Genital Tract Fistula, Female Genital Tract Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1464</td>
               <td colspan="2">CTCAE Grade 2 Fever Without Neutropenia<span class="subclass"> SubClassOf </span>Fever Without Neutropenia Adverse Event. <br><i>New Terms: CTCAE Grade 2 Fever Without Neutropenia, Fever Without Neutropenia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1465</td>
               <td colspan="2">CTCAE Grade 2 Fibrinogen<span class="subclass"> SubClassOf </span>Fibrinogen Adverse Event. <br><i>New Terms: CTCAE Grade 2 Fibrinogen, Fibrinogen Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1466</td>
               <td colspan="2">CTCAE Grade 2 Fibrosis-Cosmesis<span class="subclass"> SubClassOf </span>Fibrosis-Cosmesis Adverse Event. <br><i>New Terms: Fibrosis-Cosmesis Adverse Event, CTCAE Grade 2 Fibrosis-Cosmesis</i></td>
            </tr>
            <tr class="addition">
               <td>1467</td>
               <td colspan="2">CTCAE Grade 2 Fibrosis-Deep Connective Tissue<span class="subclass"> SubClassOf </span>Fibrosis-Deep Connective Tissue Adverse Event. <br><i>New Terms: Fibrosis-Deep Connective Tissue Adverse Event, CTCAE Grade 2 Fibrosis-Deep Connective
                     Tissue</i></td>
            </tr>
            <tr class="addition">
               <td>1468</td>
               <td colspan="2">CTCAE Grade 2 Flashing Lights<br><span class="keyword"> and </span>Floaters in Vision<span class="subclass"> SubClassOf </span>Flashing Lights<br><span class="keyword"> and </span>Floaters in Vision Adverse Event. <br><i>New Terms: CTCAE Grade 2 Flashing Lights and Floaters in Vision, Flashing Lights and Floaters
                     in Vision Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1469</td>
               <td colspan="2">CTCAE Grade 2 Flatulence<span class="subclass"> SubClassOf </span>Flatulence Adverse Event. <br><i>New Terms: Flatulence Adverse Event, CTCAE Grade 2 Flatulence</i></td>
            </tr>
            <tr class="addition">
               <td>1470</td>
               <td colspan="2">CTCAE Grade 2 Flu-Like Syndrome<span class="subclass"> SubClassOf </span>Flu-Like Syndrome Adverse Event. <br><i>New Terms: Flu-Like Syndrome Adverse Event, CTCAE Grade 2 Flu-Like Syndrome</i></td>
            </tr>
            <tr class="addition">
               <td>1471</td>
               <td colspan="2">CTCAE Grade 2 Flushing<span class="subclass"> SubClassOf </span>Flushing Adverse Event. <br><i>New Terms: Flushing Adverse Event, CTCAE Grade 2 Flushing</i></td>
            </tr>
            <tr class="addition">
               <td>1472</td>
               <td colspan="2">CTCAE Grade 2 Foreign Body Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Foreign Body Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Foreign Body Infection Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, Foreign Body Infection Adverse Event Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1473</td>
               <td colspan="2">CTCAE Grade 2 Foreign Body Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Foreign Body Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Foreign Body Infection Adverse Event with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, CTCAE Grade 2 Foreign Body Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1474</td>
               <td colspan="2">CTCAE Grade 2 Foreign Body Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Foreign Body Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 2 Foreign Body Infection with Unknown Absolute Neutrophil Count, Foreign
                     Body Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1475</td>
               <td colspan="2">CTCAE Grade 2 Fracture<span class="subclass"> SubClassOf </span>Fracture Adverse Event. <br><i>New Terms: Fracture Adverse Event, CTCAE Grade 2 Fracture</i></td>
            </tr>
            <tr class="addition">
               <td>1476</td>
               <td colspan="2">CTCAE Grade 2 Gallbladder Fistula<span class="subclass"> SubClassOf </span>Gallbladder Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 2 Gallbladder Fistula, Gallbladder Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1477</td>
               <td colspan="2">CTCAE Grade 2 Gallbladder Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Gallbladder Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Gallbladder Infection Adverse Event Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, CTCAE Grade 2 Gallbladder Infection Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1478</td>
               <td colspan="2">CTCAE Grade 2 Gallbladder Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Gallbladder Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Gallbladder Infection with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, Gallbladder Infection Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1479</td>
               <td colspan="2">CTCAE Grade 2 Gallbladder Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Gallbladder Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Gallbladder Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE
                     Grade 2 Gallbladder Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1480</td>
               <td colspan="2">CTCAE Grade 2 Gallbladder Intra-Operative Injury<span class="subclass"> SubClassOf </span>Gallbladder Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Gallbladder Intra-Operative Injury, Gallbladder Intra-Operative Injury
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1481</td>
               <td colspan="2">CTCAE Grade 2 Gallbladder Obstruction<span class="subclass"> SubClassOf </span>Gallbladder Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 2 Gallbladder Obstruction, Gallbladder Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1482</td>
               <td colspan="2">CTCAE Grade 2 Gallbladder Pain<span class="subclass"> SubClassOf </span>Gallbladder Pain Adverse Event. <br><i>New Terms: Gallbladder Pain Adverse Event, CTCAE Grade 2 Gallbladder Pain</i></td>
            </tr>
            <tr class="addition">
               <td>1483</td>
               <td colspan="2">CTCAE Grade 2 Gallbladder Perforation<span class="subclass"> SubClassOf </span>Gallbladder Perforation Adverse Event. <br><i>New Terms: Gallbladder Perforation Adverse Event, CTCAE Grade 2 Gallbladder Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>1484</td>
               <td colspan="2">CTCAE Grade 2 Gamma-Glutamyl Transpeptidase<span class="subclass"> SubClassOf </span>Gamma-Glutamyl Transpeptidase Adverse Event. <br><i>New Terms: Gamma-Glutamyl Transpeptidase Adverse Event, CTCAE Grade 2 Gamma-Glutamyl Transpeptidase</i></td>
            </tr>
            <tr class="addition">
               <td>1485</td>
               <td colspan="2">CTCAE Grade 2 Gastritis<span class="subclass"> SubClassOf </span>Gastritis Adverse Event. <br><i>New Terms: Gastritis Adverse Event, CTCAE Grade 2 Gastritis</i></td>
            </tr>
            <tr class="addition">
               <td>1486</td>
               <td colspan="2">CTCAE Grade 2 Gastrointestinal Leak NOS<span class="subclass"> SubClassOf </span>Gastrointestinal Leak Adverse Event NOS. <br><i>New Terms: Gastrointestinal Leak Adverse Event NOS, CTCAE Grade 2 Gastrointestinal Leak NOS</i></td>
            </tr>
            <tr class="addition">
               <td>1487</td>
               <td colspan="2">CTCAE Grade 2 Gastrointestinal Stoma Hemorrhage<span class="subclass"> SubClassOf </span>Gastrointestinal Stoma Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 2 Gastrointestinal Stoma Hemorrhage, Gastrointestinal Stoma Hemorrhage
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1488</td>
               <td colspan="2">CTCAE Grade 2 Gastrointestinal Stoma Intra-Operative Injury<span class="subclass"> SubClassOf </span>Gastointestinal Stoma Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Gastrointestinal Stoma Intra-Operative Injury, Gastointestinal Stoma
                     Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1489</td>
               <td colspan="2">CTCAE Grade 2 Gastrointestinal Stoma Leak<span class="subclass"> SubClassOf </span>Gastrointestinal Stoma Leak Adverse Event. <br><i>New Terms: Gastrointestinal Stoma Leak Adverse Event, CTCAE Grade 2 Gastrointestinal Stoma Leak</i></td>
            </tr>
            <tr class="addition">
               <td>1490</td>
               <td colspan="2">CTCAE Grade 2 Genitourinary Stoma Hemorrhage<span class="subclass"> SubClassOf </span>Genitourinary Stoma Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 2 Genitourinary Stoma Hemorrhage, Genitourinary Stoma Hemorrhage Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1491</td>
               <td colspan="2">CTCAE Grade 2 Genitourinary Stoma Leak<span class="subclass"> SubClassOf </span>Genitourinary Stoma Leak Adverse Event. <br><i>New Terms: CTCAE Grade 2 Genitourinary Stoma Leak, Genitourinary Stoma Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1492</td>
               <td colspan="2">CTCAE Grade 2 Genitourinary Stoma Obstruction<span class="subclass"> SubClassOf </span>Genitourinary Stoma Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 2 Genitourinary Stoma Obstruction, Genitourinary Stoma Obstruction Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1493</td>
               <td colspan="2">CTCAE Grade 2 Genitourinary Stoma Prolapse<span class="subclass"> SubClassOf </span>Genitourinary Stoma Prolapse Adverse Event. <br><i>New Terms: Genitourinary Stoma Prolapse Adverse Event, CTCAE Grade 2 Genitourinary Stoma Prolapse</i></td>
            </tr>
            <tr class="addition">
               <td>1494</td>
               <td colspan="2">CTCAE Grade 2 Genitourinary Stoma Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Genitourinary Stoma Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Genitourinary Stoma Stricture or Stenosis Adverse Event, CTCAE Grade 2 Genitourinary
                     Stoma Stricture or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>1495</td>
               <td colspan="2">CTCAE Grade 2 Gingiva Intra-Operative Injury<span class="subclass"> SubClassOf </span>Gingiva Intra-Operative Injury Adverse Event. <br><i>New Terms: Gingiva Intra-Operative Injury Adverse Event, CTCAE Grade 2 Gingiva Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1496</td>
               <td colspan="2">CTCAE Grade 2 Glaucoma<span class="subclass"> SubClassOf </span>Glaucoma Adverse Event. <br><i>New Terms: Glaucoma Adverse Event, CTCAE Grade 2 Glaucoma</i></td>
            </tr>
            <tr class="addition">
               <td>1497</td>
               <td colspan="2">CTCAE Grade 2 Glomerular Filtration Rate<span class="subclass"> SubClassOf </span>Glomerular Filtration Rate Adverse Event. <br><i>New Terms: Glomerular Filtration Rate Adverse Event, CTCAE Grade 2 Glomerular Filtration Rate</i></td>
            </tr>
            <tr class="addition">
               <td>1498</td>
               <td colspan="2">CTCAE Grade 2 Gynecomastia<span class="subclass"> SubClassOf </span>Gynecomastia Adverse Event. <br><i>New Terms: Gynecomastia Adverse Event, CTCAE Grade 2 Gynecomastia</i></td>
            </tr>
            <tr class="addition">
               <td>1499</td>
               <td colspan="2">CTCAE Grade 2 Head Soft Tissue Necrosis<span class="subclass"> SubClassOf </span>Head Soft Tissue Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 2 Head Soft Tissue Necrosis, Head Soft Tissue Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1500</td>
               <td colspan="2">CTCAE Grade 2 Head<br><span class="keyword"> and </span>Headache Pain<span class="subclass"> SubClassOf </span>Head<br><span class="keyword"> and </span>Headache Pain Adverse Event. <br><i>New Terms: Head and Headache Pain Adverse Event, CTCAE Grade 2 Head and Headache Pain</i></td>
            </tr>
            <tr class="addition">
               <td>1501</td>
               <td colspan="2">CTCAE Grade 2 Hearing Patients with<br><span class="keyword"> or </span>without Baseline Audiogram<br><span class="keyword"> and </span>Enrolled in a Monitoring Program<span class="subclass"> SubClassOf </span>Hearing Adverse Event Patients with<br><span class="keyword"> or </span>without Baseline Audiogram<br><span class="keyword"> and </span>Enrolled in a Monitoring Program. <br><i>New Terms: CTCAE Grade 2 Hearing Patients with or without Baseline Audiogram and Enrolled in
                     a Monitoring Program, Hearing Adverse Event Patients with or without Baseline Audiogram
                     and Enrolled in a Monitoring Program</i></td>
            </tr>
            <tr class="addition">
               <td>1502</td>
               <td colspan="2">CTCAE Grade 2 Hearing Patients without Baseline Audiogram<br><span class="keyword"> and </span>Not Enrolled in a Monitoring Program<span class="subclass"> SubClassOf </span>Hearing Adverse Event Patients without Baseline Audiogram<br><span class="keyword"> and </span>Not Enrolled in a Monitoring Program. <br><i>New Terms: Hearing Adverse Event Patients without Baseline Audiogram and Not Enrolled in a Monitoring
                     Program, CTCAE Grade 2 Hearing Patients without Baseline Audiogram and Not Enrolled
                     in a Monitoring Program</i></td>
            </tr>
            <tr class="addition">
               <td>1503</td>
               <td colspan="2">CTCAE Grade 2 Heart Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Heart Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Heart Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 2 Heart Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1504</td>
               <td colspan="2">CTCAE Grade 2 Heart Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Heart Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Heart Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Heart Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1505</td>
               <td colspan="2">CTCAE Grade 2 Heart Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Heart Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Heart Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     2 Heart Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1506</td>
               <td colspan="2">CTCAE Grade 2 Heart Intra-Operative Injury<span class="subclass"> SubClassOf </span>Heart Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Heart Intra-Operative Injury, Heart Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1507</td>
               <td colspan="2">CTCAE Grade 2 Heartburn<br><span class="keyword"> or </span>Dyspepsia<span class="subclass"> SubClassOf </span>Heartburn<br><span class="keyword"> or </span>Dyspepsia. <br><i>New Terms: Heartburn or Dyspepsia, CTCAE Grade 2 Heartburn or Dyspepsia</i></td>
            </tr>
            <tr class="addition">
               <td>1508</td>
               <td colspan="2">CTCAE Grade 2 Hematoma<span class="subclass"> SubClassOf </span>Hematoma Adverse Event. <br><i>New Terms: Hematoma Adverse Event, CTCAE Grade 2 Hematoma</i></td>
            </tr>
            <tr class="addition">
               <td>1509</td>
               <td colspan="2">CTCAE Grade 2 Hemoglobin<span class="subclass"> SubClassOf </span>Hemoglobin Adverse Event. <br><i>New Terms: Hemoglobin Adverse Event, CTCAE Grade 2 Hemoglobin</i></td>
            </tr>
            <tr class="addition">
               <td>1510</td>
               <td colspan="2">CTCAE Grade 2 Hemolysis<span class="subclass"> SubClassOf </span>Hemolysis Adverse Event. <br><i>New Terms: CTCAE Grade 2 Hemolysis, Hemolysis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1511</td>
               <td colspan="2">CTCAE Grade 2 Hemorrhoids<span class="subclass"> SubClassOf </span>Hemorrhoids Adverse Event. <br><i>New Terms: CTCAE Grade 2 Hemorrhoids, Hemorrhoids Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1512</td>
               <td colspan="2">CTCAE Grade 2 Hepatic Artery Intra-Operative Injury<span class="subclass"> SubClassOf </span>Hepatic Artery Intra-Operative Injury Adverse Event. <br><i>New Terms: Hepatic Artery Intra-Operative Injury Adverse Event, CTCAE Grade 2 Hepatic Artery
                     Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1513</td>
               <td colspan="2">CTCAE Grade 2 Hepatic Vein Intra-Operative Injury<span class="subclass"> SubClassOf </span>Hepatic Vein Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Hepatic Vein Intra-Operative Injury, Hepatic Vein Intra-Operative Injury
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1514</td>
               <td colspan="2">CTCAE Grade 2 Hiccoughs<span class="subclass"> SubClassOf </span>Hiccoughs Adverse Event. <br><i>New Terms: Hiccoughs Adverse Event, CTCAE Grade 2 Hiccoughs</i></td>
            </tr>
            <tr class="addition">
               <td>1515</td>
               <td colspan="2">CTCAE Grade 2 Hot Flashes<br><span class="keyword"> or </span>Flushes<span class="subclass"> SubClassOf </span>Hot Flashes<br><span class="keyword"> or </span>Flushes Adverse Event. <br><i>New Terms: CTCAE Grade 2 Hot Flashes or Flushes, Hot Flashes or Flushes Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1516</td>
               <td colspan="2">CTCAE Grade 2 Hydrocephalus<span class="subclass"> SubClassOf </span>Hydrocephalus Adverse Event. <br><i>New Terms: Hydrocephalus Adverse Event, CTCAE Grade 2 Hydrocephalus</i></td>
            </tr>
            <tr class="addition">
               <td>1517</td>
               <td colspan="2">CTCAE Grade 2 Hyperbilirubinemia<span class="subclass"> SubClassOf </span>Hyperbilirubinemia Adverse Event. <br><i>New Terms: Hyperbilirubinemia Adverse Event, CTCAE Grade 2 Hyperbilirubinemia</i></td>
            </tr>
            <tr class="addition">
               <td>1518</td>
               <td colspan="2">CTCAE Grade 2 Hyperpigmentation<span class="subclass"> SubClassOf </span>Hyperpigmentation Adverse Event. <br><i>New Terms: Hyperpigmentation Adverse Event, CTCAE Grade 2 Hyperpigmentation</i></td>
            </tr>
            <tr class="addition">
               <td>1519</td>
               <td colspan="2">CTCAE Grade 2 Hypertension<span class="subclass"> SubClassOf </span>Hypertension Adverse Event. <br><i>New Terms: Hypertension Adverse Event, CTCAE Grade 2 Hypertension</i></td>
            </tr>
            <tr class="addition">
               <td>1520</td>
               <td colspan="2">CTCAE Grade 2 Hypopigmentation<span class="subclass"> SubClassOf </span>Hypopigmentation Adverse Event. <br><i>New Terms: CTCAE Grade 2 Hypopigmentation, Hypopigmentation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1521</td>
               <td colspan="2">CTCAE Grade 2 Hypotension<span class="subclass"> SubClassOf </span>Hypotension Adverse Event. <br><i>New Terms: Hypotension Adverse Event, CTCAE Grade 2 Hypotension</i></td>
            </tr>
            <tr class="addition">
               <td>1522</td>
               <td colspan="2">CTCAE Grade 2 Hypothermia<span class="subclass"> SubClassOf </span>Hypothermia Adverse Event. <br><i>New Terms: Hypothermia Adverse Event, CTCAE Grade 2 Hypothermia</i></td>
            </tr>
            <tr class="addition">
               <td>1523</td>
               <td colspan="2">CTCAE Grade 2 Hypoxia<span class="subclass"> SubClassOf </span>Hypoxia Adverse Event. <br><i>New Terms: Hypoxia Adverse Event, CTCAE Grade 2 Hypoxia</i></td>
            </tr>
            <tr class="addition">
               <td>1524</td>
               <td colspan="2">CTCAE Grade 2 Idioventricular Rhythm<span class="subclass"> SubClassOf </span>Idioventricular Rhythm Adverse Event. <br><i>New Terms: Idioventricular Rhythm Adverse Event, CTCAE Grade 2 Idioventricular Rhythm</i></td>
            </tr>
            <tr class="addition">
               <td>1525</td>
               <td colspan="2">CTCAE Grade 2 Ileum Fistula<span class="subclass"> SubClassOf </span>Ileum Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 2 Ileum Fistula, Ileum Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1526</td>
               <td colspan="2">CTCAE Grade 2 Ileum Hemorrhage<span class="subclass"> SubClassOf </span>Ileum Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 2 Ileum Hemorrhage, Ileum Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1527</td>
               <td colspan="2">CTCAE Grade 2 Ileum Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Ileum Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Ileum Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 2 Ileum Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1528</td>
               <td colspan="2">CTCAE Grade 2 Ileum Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Ileum Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Ileum Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Ileum Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1529</td>
               <td colspan="2">CTCAE Grade 2 Ileum Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Ileum Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Ileum Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     2 Ileum Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1530</td>
               <td colspan="2">CTCAE Grade 2 Ileum Intra-Operative Injury<span class="subclass"> SubClassOf </span>Ileum Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Ileum Intra-Operative Injury, Ileum Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1531</td>
               <td colspan="2">CTCAE Grade 2 Ileum Obstruction<span class="subclass"> SubClassOf </span>Ileum Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 2 Ileum Obstruction, Ileum Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1532</td>
               <td colspan="2">CTCAE Grade 2 Ileum Perforation<span class="subclass"> SubClassOf </span>Ileum Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 2 Ileum Perforation, Ileum Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1533</td>
               <td colspan="2">CTCAE Grade 2 Ileum Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Ileum Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Ileum Stricture or Stenosis Adverse Event, CTCAE Grade 2 Ileum Stricture or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>1534</td>
               <td colspan="2">CTCAE Grade 2 Ileum Ulcer<span class="subclass"> SubClassOf </span>Ileum Ulcer Adverse Event. <br><i>New Terms: CTCAE Grade 2 Ileum Ulcer, Ileum Ulcer Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1535</td>
               <td colspan="2">CTCAE Grade 2 Ileus<span class="subclass"> SubClassOf </span>Gastrointestinal Ileus Adverse Event. <br><i>New Terms: CTCAE Grade 2 Ileus, Gastrointestinal Ileus Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1536</td>
               <td colspan="2">CTCAE Grade 2 Induration<br><span class="keyword"> or </span>Fibrosis of the Skin<br><span class="keyword"> and </span>Subcutaneous Tissue<span class="subclass"> SubClassOf </span>Induration<br><span class="keyword"> or </span>Fibrosis of the Skin<br><span class="keyword"> and </span>Subcutaneous Tissue Adverse Event. <br><i>New Terms: Induration or Fibrosis of the Skin and Subcutaneous Tissue Adverse Event, CTCAE Grade
                     2 Induration or Fibrosis of the Skin and Subcutaneous Tissue</i></td>
            </tr>
            <tr class="addition">
               <td>1537</td>
               <td colspan="2">CTCAE Grade 2 Infectious Colitis<span class="subclass"> SubClassOf </span>Infectious Colitis Adverse Event. <br><i>New Terms: Infectious Colitis Adverse Event, CTCAE Grade 2 Infectious Colitis</i></td>
            </tr>
            <tr class="addition">
               <td>1538</td>
               <td colspan="2">CTCAE Grade 2 Inferior Vena Cava Intra-Operative Injury<span class="subclass"> SubClassOf </span>Inferior Vena Cava Intra-Operative Injury Adverse Event. <br><i>New Terms: Inferior Vena Cava Intra-Operative Injury Adverse Event, CTCAE Grade 2 Inferior Vena
                     Cava Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1539</td>
               <td colspan="2">CTCAE Grade 2 Inferior Vena Cava Vein Injury<span class="subclass"> SubClassOf </span>Inferior Vena Cava Vein Injury Adverse Event. <br><i>New Terms: Inferior Vena Cava Vein Injury Adverse Event, CTCAE Grade 2 Inferior Vena Cava Vein
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1540</td>
               <td colspan="2">CTCAE Grade 2 Infertility<br><span class="keyword"> and </span>Sterility<span class="subclass"> SubClassOf </span>Infertility<br><span class="keyword"> and </span>Sterility Adverse Event. <br><i>New Terms: Infertility and Sterility Adverse Event, CTCAE Grade 2 Infertility and Sterility</i></td>
            </tr>
            <tr class="addition">
               <td>1541</td>
               <td colspan="2">CTCAE Grade 2 Injection Site Reaction<br><span class="keyword"> or </span>Extravasation Changes<span class="subclass"> SubClassOf </span>Injection Site Reaction<br><span class="keyword"> or </span>Extravasation Changes Adverse Event. <br><i>New Terms: Injection Site Reaction or Extravasation Changes Adverse Event, CTCAE Grade 2 Injection
                     Site Reaction or Extravasation Changes</i></td>
            </tr>
            <tr class="addition">
               <td>1542</td>
               <td colspan="2">CTCAE Grade 2 Inner Ear Intra-Operative Injury<span class="subclass"> SubClassOf </span>Inner Ear Intra-Operative Injury Adverse Event. <br><i>New Terms: Inner Ear Intra-Operative Injury Adverse Event, CTCAE Grade 2 Inner Ear Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1543</td>
               <td colspan="2">CTCAE Grade 2 Insomnia<span class="subclass"> SubClassOf </span>Insomnia Adverse Event. <br><i>New Terms: Insomnia Adverse Event, CTCAE Grade 2 Insomnia</i></td>
            </tr>
            <tr class="addition">
               <td>1544</td>
               <td colspan="2">CTCAE Grade 2 International Normalized Ratio of Prothrombin Time<span class="subclass"> SubClassOf </span>International Normalized Ratio of Prothrombin Time Adverse Event. <br><i>New Terms: CTCAE Grade 2 International Normalized Ratio of Prothrombin Time, International Normalized
                     Ratio of Prothrombin Time Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1545</td>
               <td colspan="2">CTCAE Grade 2 Intestine Pain<span class="subclass"> SubClassOf </span>Intestine Pain Adverse Event. <br><i>New Terms: CTCAE Grade 2 Intestine Pain, Intestine Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1546</td>
               <td colspan="2">CTCAE Grade 2 Iron Overload<span class="subclass"> SubClassOf </span>Iron Overload Adverse Event. <br><i>New Terms: CTCAE Grade 2 Iron Overload, Iron Overload Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1547</td>
               <td colspan="2">CTCAE Grade 2 Irregular Menses<span class="subclass"> SubClassOf </span>Irregular Menses Adverse Event. <br><i>New Terms: Irregular Menses Adverse Event, CTCAE Grade 2 Irregular Menses</i></td>
            </tr>
            <tr class="addition">
               <td>1548</td>
               <td colspan="2">CTCAE Grade 2 Irritability in Children Less Than 3 Years of Age<span class="subclass"> SubClassOf </span>Irritability in Children Less Than 3 Years of Age Adverse Event. <br><i>New Terms: Irritability in Children Less Than 3 Years of Age Adverse Event, CTCAE Grade 2 Irritability
                     in Children Less Than 3 Years of Age</i></td>
            </tr>
            <tr class="addition">
               <td>1549</td>
               <td colspan="2">CTCAE Grade 2 Jejunum Fistula<span class="subclass"> SubClassOf </span>Jejunum Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 2 Jejunum Fistula, Jejunum Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1550</td>
               <td colspan="2">CTCAE Grade 2 Jejunum Hemorrhage<span class="subclass"> SubClassOf </span>Jejunum Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 2 Jejunum Hemorrhage, Jejunum Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1551</td>
               <td colspan="2">CTCAE Grade 2 Jejunum Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Jejunum Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Jejunum Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Jejunum Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1552</td>
               <td colspan="2">CTCAE Grade 2 Jejunum Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Jejunum Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Jejunum Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 2 Jejunum Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1553</td>
               <td colspan="2">CTCAE Grade 2 Jejunum Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Jejunum Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Jejunum Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     2 Jejunum Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1554</td>
               <td colspan="2">CTCAE Grade 2 Jejunum Intra-Operative Injury<span class="subclass"> SubClassOf </span>Jejunum Intra-Operative Injury Adverse Event. <br><i>New Terms: Jejunum Intra-Operative Injury Adverse Event, CTCAE Grade 2 Jejunum Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1555</td>
               <td colspan="2">CTCAE Grade 2 Jejunum Obstruction<span class="subclass"> SubClassOf </span>Jejunum Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 2 Jejunum Obstruction, Jejunum Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1556</td>
               <td colspan="2">CTCAE Grade 2 Jejunum Perforation<span class="subclass"> SubClassOf </span>Jejunum Perforation Adverse Event. <br><i>New Terms: Jejunum Perforation Adverse Event, CTCAE Grade 2 Jejunum Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>1557</td>
               <td colspan="2">CTCAE Grade 2 Jejunum Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Jejunum Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 2 Jejunum Stricture or Stenosis, Jejunum Stricture or Stenosis Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1558</td>
               <td colspan="2">CTCAE Grade 2 Jejunum Ulcer<span class="subclass"> SubClassOf </span>Jejunum Ulcer Adverse Event. <br><i>New Terms: CTCAE Grade 2 Jejunum Ulcer, Jejunum Ulcer Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1559</td>
               <td colspan="2">CTCAE Grade 2 Joint Effusion<span class="subclass"> SubClassOf </span>Joint Effusion Adverse Event. <br><i>New Terms: Joint Effusion Adverse Event, CTCAE Grade 2 Joint Effusion</i></td>
            </tr>
            <tr class="addition">
               <td>1560</td>
               <td colspan="2">CTCAE Grade 2 Joint Function<span class="subclass"> SubClassOf </span>Joint Function Adverse Event. <br><i>New Terms: Joint Function Adverse Event, CTCAE Grade 2 Joint Function</i></td>
            </tr>
            <tr class="addition">
               <td>1561</td>
               <td colspan="2">CTCAE Grade 2 Joint Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Joint Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Joint Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Joint Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1562</td>
               <td colspan="2">CTCAE Grade 2 Joint Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Joint Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Joint Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 2 Joint Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1563</td>
               <td colspan="2">CTCAE Grade 2 Joint Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Joint Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Joint Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     2 Joint Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1564</td>
               <td colspan="2">CTCAE Grade 2 Joint Intra-Operative Injury<span class="subclass"> SubClassOf </span>Joint Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Joint Intra-Operative Injury, Joint Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1565</td>
               <td colspan="2">CTCAE Grade 2 Joint Pain<span class="subclass"> SubClassOf </span>Joint Pain Adverse Event. <br><i>New Terms: CTCAE Grade 2 Joint Pain, Joint Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1566</td>
               <td colspan="2">CTCAE Grade 2 Jugular Vein Injury<span class="subclass"> SubClassOf </span>Jugular Vein Injury Adverse Event. <br><i>New Terms: Jugular Vein Injury Adverse Event, CTCAE Grade 2 Jugular Vein Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1567</td>
               <td colspan="2">CTCAE Grade 2 Jugular Vein Intra-Operative Injury<span class="subclass"> SubClassOf </span>Jugular Vein Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Jugular Vein Intra-Operative Injury, Jugular Vein Intra-Operative Injury
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1568</td>
               <td colspan="2">CTCAE Grade 2 Keratitis<span class="subclass"> SubClassOf </span>Keratitis Adverse Event. <br><i>New Terms: CTCAE Grade 2 Keratitis, Keratitis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1569</td>
               <td colspan="2">CTCAE Grade 2 Kidney Fistula<span class="subclass"> SubClassOf </span>Kidney Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 2 Kidney Fistula, Kidney Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1570</td>
               <td colspan="2">CTCAE Grade 2 Kidney Hemorrhage<span class="subclass"> SubClassOf </span>Kidney Hemorrhage Adverse Event. <br><i>New Terms: Kidney Hemorrhage Adverse Event, CTCAE Grade 2 Kidney Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>1571</td>
               <td colspan="2">CTCAE Grade 2 Kidney Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Kidney Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Kidney Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Kidney Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1572</td>
               <td colspan="2">CTCAE Grade 2 Kidney Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Kidney Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Kidney Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 2 Kidney Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1573</td>
               <td colspan="2">CTCAE Grade 2 Kidney Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Kidney Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 2 Kidney Infection with Unknown Absolute Neutrophil Count, Kidney Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1574</td>
               <td colspan="2">CTCAE Grade 2 Kidney Intra-Operative Injury<span class="subclass"> SubClassOf </span>Kidney Intra-Operative Injury Adverse Event. <br><i>New Terms: Kidney Intra-Operative Injury Adverse Event, CTCAE Grade 2 Kidney Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1575</td>
               <td colspan="2">CTCAE Grade 2 Kidney Leak<span class="subclass"> SubClassOf </span>Kidney Leak Adverse Event. <br><i>New Terms: CTCAE Grade 2 Kidney Leak, Kidney Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1576</td>
               <td colspan="2">CTCAE Grade 2 Kidney Pain<span class="subclass"> SubClassOf </span>Kidney Pain Adverse Event. <br><i>New Terms: CTCAE Grade 2 Kidney Pain, Kidney Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1577</td>
               <td colspan="2">CTCAE Grade 2 Kidney Perforation<span class="subclass"> SubClassOf </span>Kidney Perforation Adverse Event. <br><i>New Terms: Kidney Perforation Adverse Event, CTCAE Grade 2 Kidney Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>1578</td>
               <td colspan="2">CTCAE Grade 2 Large Bowel Leak<span class="subclass"> SubClassOf </span>Large Bowel Leak Adverse Event. <br><i>New Terms: Large Bowel Leak Adverse Event, CTCAE Grade 2 Large Bowel Leak</i></td>
            </tr>
            <tr class="addition">
               <td>1579</td>
               <td colspan="2">CTCAE Grade 2 Large Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Large Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification. <br><i>New Terms: CTCAE Grade 2 Large Bowel Mucositis or Stomatitis by Clinical Examination Classification,
                     Large Bowel Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>1580</td>
               <td colspan="2">CTCAE Grade 2 Large Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Large Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: CTCAE Grade 2 Large Bowel Mucositis or Stomatitis by Functional or Symptomatic Classification,
                     Large Bowel Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>1581</td>
               <td colspan="2">CTCAE Grade 2 Laryngeal Nerve Dysfunction<span class="subclass"> SubClassOf </span>Laryngeal Nerve Dysfunction Adverse Event. <br><i>New Terms: CTCAE Grade 2 Laryngeal Nerve Dysfunction, Laryngeal Nerve Dysfunction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1582</td>
               <td colspan="2">CTCAE Grade 2 Larynx Edema<span class="subclass"> SubClassOf </span>Larynx Edema Adverse Event. <br><i>New Terms: CTCAE Grade 2 Larynx Edema, Larynx Edema Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1583</td>
               <td colspan="2">CTCAE Grade 2 Larynx Fistula<span class="subclass"> SubClassOf </span>Larynx Fistula Adverse Event. <br><i>New Terms: Larynx Fistula Adverse Event, CTCAE Grade 2 Larynx Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>1584</td>
               <td colspan="2">CTCAE Grade 2 Larynx Hemorrhage<span class="subclass"> SubClassOf </span>Larynx Hemorrhage Adverse Event. <br><i>New Terms: Larynx Hemorrhage Adverse Event, CTCAE Grade 2 Larynx Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>1585</td>
               <td colspan="2">CTCAE Grade 2 Larynx Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Larynx Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Larynx Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 2 Larynx Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1586</td>
               <td colspan="2">CTCAE Grade 2 Larynx Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Larynx Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Larynx Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 2 Larynx Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1587</td>
               <td colspan="2">CTCAE Grade 2 Larynx Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Larynx Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Larynx Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     2 Larynx Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1588</td>
               <td colspan="2">CTCAE Grade 2 Larynx Intra-Operative Injury<span class="subclass"> SubClassOf </span>Larynx Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Larynx Intra-Operative Injury, Larynx Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1589</td>
               <td colspan="2">CTCAE Grade 2 Larynx Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Larynx Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification. <br><i>New Terms: CTCAE Grade 2 Larynx Mucositis or Stomatitis by Clinical Examination Classification,
                     Larynx Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>1590</td>
               <td colspan="2">CTCAE Grade 2 Larynx Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Larynx Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: Larynx Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification,
                     CTCAE Grade 2 Larynx Mucositis or Stomatitis by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>1591</td>
               <td colspan="2">CTCAE Grade 2 Larynx Obstruction<br><span class="keyword"> and </span>Stenosis<span class="subclass"> SubClassOf </span>Larynx Obstruction<br><span class="keyword"> and </span>Stenosis Adverse Event. <br><i>New Terms: Larynx Obstruction and Stenosis Adverse Event, CTCAE Grade 2 Larynx Obstruction and
                     Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>1592</td>
               <td colspan="2">CTCAE Grade 2 Larynx Pain<span class="subclass"> SubClassOf </span>Larynx Pain Adverse Event. <br><i>New Terms: Larynx Pain Adverse Event, CTCAE Grade 2 Larynx Pain</i></td>
            </tr>
            <tr class="addition">
               <td>1594</td>
               <td colspan="2">CTCAE Grade 2 Left Ventricular Diastolic Dysfunction<span class="subclass"> SubClassOf </span>Left Ventricular Diastolic Dysfunction Adverse Event. <br><i>New Terms: CTCAE Grade 2 Left Ventricular Diastolic Dysfunction, Left Ventricular Diastolic Dysfunction
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1595</td>
               <td colspan="2">CTCAE Grade 2 Left Ventricular Systolic Dysfunction<span class="subclass"> SubClassOf </span>Left Ventricular Systolic Dysfunction Adverse Event. <br><i>New Terms: CTCAE Grade 2 Left Ventricular Systolic Dysfunction, Left Ventricular Systolic Dysfunction
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1593</td>
               <td colspan="2">CTCAE Grade 2 Left-Sided Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Left-Sided Muscle Weakness Not Due to Neuropathy Adverse Event. <br><i>New Terms: Left-Sided Muscle Weakness Not Due to Neuropathy Adverse Event, CTCAE Grade 2 Left-Sided
                     Muscle Weakness Not Due to Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>1596</td>
               <td colspan="2">CTCAE Grade 2 Lens Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Lens Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Lens Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 2 Lens Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1597</td>
               <td colspan="2">CTCAE Grade 2 Lens Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Lens Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Lens Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or 2
                     Neutrophils, CTCAE Grade 2 Lens Infection with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1598</td>
               <td colspan="2">CTCAE Grade 2 Lens Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Lens Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Lens Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade 2
                     Lens Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1599</td>
               <td colspan="2">CTCAE Grade 2 Lens Intra-Operative Injury<span class="subclass"> SubClassOf </span>Lens Intra-Operative Injury Adverse Event. <br><i>New Terms: Lens Intra-Operative Injury Adverse Event, CTCAE Grade 2 Lens Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1600</td>
               <td colspan="2">CTCAE Grade 2 Leukocytes<span class="subclass"> SubClassOf </span>Leukocytes Adverse Event. <br><i>New Terms: Leukocytes Adverse Event, CTCAE Grade 2 Leukocytes</i></td>
            </tr>
            <tr class="addition">
               <td>1601</td>
               <td colspan="2">CTCAE Grade 2 Leukoencephalopathy Radiographic Findings<span class="subclass"> SubClassOf </span>Leukoencephalopathy Radiographic Findings Adverse Event. <br><i>New Terms: Leukoencephalopathy Radiographic Findings Adverse Event, CTCAE Grade 2 Leukoencephalopathy
                     Radiographic Findings</i></td>
            </tr>
            <tr class="addition">
               <td>1602</td>
               <td colspan="2">CTCAE Grade 2 Libido<span class="subclass"> SubClassOf </span>Libido Adverse Event. <br><i>New Terms: Libido Adverse Event, CTCAE Grade 2 Libido</i></td>
            </tr>
            <tr class="addition">
               <td>1603</td>
               <td colspan="2">CTCAE Grade 2 Ligament Intra-Operative Injury<span class="subclass"> SubClassOf </span>Ligament Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Ligament Intra-Operative Injury, Ligament Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1604</td>
               <td colspan="2">CTCAE Grade 2 Lingual Nerve Intra-Operative Injury<span class="subclass"> SubClassOf </span>Lingual Nerve Intra-Operative Injury Adverse Event. <br><i>New Terms: Lingual Nerve Intra-Operative Injury Adverse Event, CTCAE Grade 2 Lingual Nerve Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1605</td>
               <td colspan="2">CTCAE Grade 2 Lip Or Perioral Area Intra-Operative Injury<span class="subclass"> SubClassOf </span>Lip Or Perioral Area Intra-Operative Injury Adverse Event. <br><i>New Terms: Lip Or Perioral Area Intra-Operative Injury Adverse Event, CTCAE Grade 2 Lip Or Perioral
                     Area Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1606</td>
               <td colspan="2">CTCAE Grade 2 Lip Pain<span class="subclass"> SubClassOf </span>Lip Pain Adverse Event. <br><i>New Terms: CTCAE Grade 2 Lip Pain, Lip Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1607</td>
               <td colspan="2">CTCAE Grade 2 Lip<br><span class="keyword"> or </span>Perioral Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Lip<br><span class="keyword"> or </span>Perioral Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Lip or Perioral Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, Lip or Perioral Infection Adverse Event Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1608</td>
               <td colspan="2">CTCAE Grade 2 Lip<br><span class="keyword"> or </span>Perioral Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Lip<br><span class="keyword"> or </span>Perioral Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Lip or Perioral Infection with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, Lip or Perioral Infection Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1609</td>
               <td colspan="2">CTCAE Grade 2 Lip<br><span class="keyword"> or </span>Perioral Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Lip<br><span class="keyword"> or </span>Perioral Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 2 Lip or Perioral Infection with Unknown Absolute Neutrophil Count, Lip
                     or Perioral Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1610</td>
               <td colspan="2">CTCAE Grade 2 Lipase<span class="subclass"> SubClassOf </span>Lipase Adverse Event. <br><i>New Terms: Lipase Adverse Event, CTCAE Grade 2 Lipase</i></td>
            </tr>
            <tr class="addition">
               <td>1611</td>
               <td colspan="2">CTCAE Grade 2 Liver Dysfunction<br><span class="keyword"> or </span>Failure by Clinical Classification<span class="subclass"> SubClassOf </span>Liver Dysfunction<br><span class="keyword"> or </span>Failure by Clinical Classification Adverse Event. <br><i>New Terms: CTCAE Grade 2 Liver Dysfunction or Failure by Clinical Classification, Liver Dysfunction
                     or Failure by Clinical Classification Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1612</td>
               <td colspan="2">CTCAE Grade 2 Liver Hemorrhage<span class="subclass"> SubClassOf </span>Liver Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 2 Liver Hemorrhage, Liver Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1613</td>
               <td colspan="2">CTCAE Grade 2 Liver Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Liver Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Liver Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Liver Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1614</td>
               <td colspan="2">CTCAE Grade 2 Liver Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Liver Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Liver Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Liver Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1615</td>
               <td colspan="2">CTCAE Grade 2 Liver Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Liver Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 2 Liver Infection with Unknown Absolute Neutrophil Count, Liver Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1616</td>
               <td colspan="2">CTCAE Grade 2 Liver Intra-Operative Injury<span class="subclass"> SubClassOf </span>Liver Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Liver Intra-Operative Injury, Liver Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1617</td>
               <td colspan="2">CTCAE Grade 2 Liver Pain<span class="subclass"> SubClassOf </span>Liver Pain Adverse Event. <br><i>New Terms: CTCAE Grade 2 Liver Pain, Liver Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1618</td>
               <td colspan="2">CTCAE Grade 2 Local Complication of Device<br><span class="keyword"> and </span>Prosthesis<span class="subclass"> SubClassOf </span>Local Complication of Device<br><span class="keyword"> and </span>Prosthesis Adverse Event. <br><i>New Terms: Local Complication of Device and Prosthesis Adverse Event, CTCAE Grade 2 Local Complication
                     of Device and Prosthesis</i></td>
            </tr>
            <tr class="addition">
               <td>1619</td>
               <td colspan="2">CTCAE Grade 2 Low Serum Bicarbonate<span class="subclass"> SubClassOf </span>Low Serum Bicarbonate Adverse Event. <br><i>New Terms: CTCAE Grade 2 Low Serum Bicarbonate, Low Serum Bicarbonate Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1620</td>
               <td colspan="2">CTCAE Grade 2 Lower Extremity Artery Injury<span class="subclass"> SubClassOf </span>Lower Extremity Artery Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Lower Extremity Artery Injury, Lower Extremity Artery Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1621</td>
               <td colspan="2">CTCAE Grade 2 Lower Extremity Artery Intra-Operative Injury<span class="subclass"> SubClassOf </span>Lower Extremity Artery Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Lower Extremity Artery Intra-Operative Injury, Lower Extremity Artery
                     Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1622</td>
               <td colspan="2">CTCAE Grade 2 Lower Extremity Gait<span class="subclass"> SubClassOf </span>Lower Extremity Gait Adverse Event. <br><i>New Terms: CTCAE Grade 2 Lower Extremity Gait, Lower Extremity Gait Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1623</td>
               <td colspan="2">CTCAE Grade 2 Lower Extremity Intra-Operative Injury<span class="subclass"> SubClassOf </span>Lower Extremity Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Lower Extremity Intra-Operative Injury, Lower Extremity Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1624</td>
               <td colspan="2">CTCAE Grade 2 Lower Extremity Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Lower Extremity Muscle Weakness Adverse Event Not Due to Neuropathy. <br><i>New Terms: Lower Extremity Muscle Weakness Adverse Event Not Due to Neuropathy, CTCAE Grade 2
                     Lower Extremity Muscle Weakness Not Due to Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>1625</td>
               <td colspan="2">CTCAE Grade 2 Lower Extremity Soft Tissue Necrosis<span class="subclass"> SubClassOf </span>Lower Extremity Soft Tissue Necrosis Adverse Event. <br><i>New Terms: Lower Extremity Soft Tissue Necrosis Adverse Event, CTCAE Grade 2 Lower Extremity
                     Soft Tissue Necrosis</i></td>
            </tr>
            <tr class="addition">
               <td>1626</td>
               <td colspan="2">CTCAE Grade 2 Lower Extremity Vein Injury<span class="subclass"> SubClassOf </span>Lower Extremity Vein Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Lower Extremity Vein Injury, Lower Extremity Vein Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1627</td>
               <td colspan="2">CTCAE Grade 2 Lower Extremity Vein Intra-Operative Injury<span class="subclass"> SubClassOf </span>Lower Extremity Vein Intra-Operative Injury Adverse Event. <br><i>New Terms: Lower Extremity Vein Intra-Operative Injury Adverse Event, CTCAE Grade 2 Lower Extremity
                     Vein Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1628</td>
               <td colspan="2">CTCAE Grade 2 Lower Gastrointestinal Hemorrhage NOS<span class="subclass"> SubClassOf </span>Lower Gastrointestinal Hemorrhage Adverse Event NOS. <br><i>New Terms: CTCAE Grade 2 Lower Gastrointestinal Hemorrhage NOS, Lower Gastrointestinal Hemorrhage
                     Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>1629</td>
               <td colspan="2">CTCAE Grade 2 Lumbar Spine<span class="subclass"> Range </span>of Motion<span class="subclass"> SubClassOf </span>Lumbar Spine<span class="subclass"> Range </span>of Motion Adverse Event. <br><i>New Terms: Lumbar Spine Range of Motion Adverse Event, CTCAE Grade 2 Lumbar Spine Range of Motion</i></td>
            </tr>
            <tr class="addition">
               <td>1630</td>
               <td colspan="2">CTCAE Grade 2 Lung Fistula<span class="subclass"> SubClassOf </span>Lung Fistula Adverse Event. <br><i>New Terms: Lung Fistula Adverse Event, CTCAE Grade 2 Lung Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>1631</td>
               <td colspan="2">CTCAE Grade 2 Lung Hemorrhage<span class="subclass"> SubClassOf </span>Lung Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 2 Lung Hemorrhage, Lung Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1632</td>
               <td colspan="2">CTCAE Grade 2 Lung Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Lung Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Lung Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Lung Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1633</td>
               <td colspan="2">CTCAE Grade 2 Lung Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Lung Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Lung Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or 2
                     Neutrophils, CTCAE Grade 2 Lung Infection with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1634</td>
               <td colspan="2">CTCAE Grade 2 Lung Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Lung Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 2 Lung Infection with Unknown Absolute Neutrophil Count, Lung Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1635</td>
               <td colspan="2">CTCAE Grade 2 Lung Intra-Operative Injury<span class="subclass"> SubClassOf </span>Lung Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Lung Intra-Operative Injury, Lung Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1636</td>
               <td colspan="2">CTCAE Grade 2 Lung Thoracic Nerve Intra-Operative Injury<span class="subclass"> SubClassOf </span>Lung Thoracic Nerve Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Lung Thoracic Nerve Intra-Operative Injury, Lung Thoracic Nerve Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1637</td>
               <td colspan="2">CTCAE Grade 2 Lymph Node Pain<span class="subclass"> SubClassOf </span>Lymph Node Pain Adverse Event. <br><i>New Terms: Lymph Node Pain Adverse Event, CTCAE Grade 2 Lymph Node Pain</i></td>
            </tr>
            <tr class="addition">
               <td>1638</td>
               <td colspan="2">CTCAE Grade 2 Lymphatic Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Lymphatic Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Lymphatic Infection Adverse Event Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, CTCAE Grade 2 Lymphatic Infection Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1639</td>
               <td colspan="2">CTCAE Grade 2 Lymphatic Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Lymphatic Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Lymphatic Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, CTCAE Grade 2 Lymphatic Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1640</td>
               <td colspan="2">CTCAE Grade 2 Lymphatic Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Lymphatic Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 2 Lymphatic Infection with Unknown Absolute Neutrophil Count, Lymphatic
                     Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1641</td>
               <td colspan="2">CTCAE Grade 2 Lymphedema-Related Fibrosis<span class="subclass"> SubClassOf </span>Lymphedema-Related Fibrosis Adverse Event. <br><i>New Terms: CTCAE Grade 2 Lymphedema-Related Fibrosis, Lymphedema-Related Fibrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1642</td>
               <td colspan="2">CTCAE Grade 2 Lymphocele<span class="subclass"> SubClassOf </span>Lymphocele Adverse Event. <br><i>New Terms: CTCAE Grade 2 Lymphocele, Lymphocele Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1643</td>
               <td colspan="2">CTCAE Grade 2 Lymphopenia<span class="subclass"> SubClassOf </span>Lymphopenia Adverse Event. <br><i>New Terms: Lymphopenia Adverse Event, CTCAE Grade 2 Lymphopenia</i></td>
            </tr>
            <tr class="addition">
               <td>1644</td>
               <td colspan="2">CTCAE Grade 2 Major Visceral Artery Intra-Operative Injury<span class="subclass"> SubClassOf </span>Major Visceral Artery Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Major Visceral Artery Intra-Operative Injury, Major Visceral Artery
                     Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1645</td>
               <td colspan="2">CTCAE Grade 2 Major Visceral Vein Intra-Operative Injury<span class="subclass"> SubClassOf </span>Major Visceral Vein Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Major Visceral Vein Intra-Operative Injury, Major Visceral Vein Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1646</td>
               <td colspan="2">CTCAE Grade 2 Malabsorption<span class="subclass"> SubClassOf </span>Malabsorption Adverse Event. <br><i>New Terms: CTCAE Grade 2 Malabsorption, Malabsorption Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1647</td>
               <td colspan="2">CTCAE Grade 2 Mediastinum Hemorrhage<span class="subclass"> SubClassOf </span>Mediastinum Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 2 Mediastinum Hemorrhage, Mediastinum Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1648</td>
               <td colspan="2">CTCAE Grade 2 Mediastinum Infection NOS Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Mediastinum Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Mediastinum Infection NOS Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, Mediastinum Infection NOS Adverse Event Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1649</td>
               <td colspan="2">CTCAE Grade 2 Mediastinum Infection NOS with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Mediastinum Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Mediastinum Infection NOS with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, Mediastinum Infection NOS Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1650</td>
               <td colspan="2">CTCAE Grade 2 Mediastinum Infection NOS with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Mediastinum Infection NOS Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Mediastinum Infection NOS Adverse Event with Unknown Absolute Neutrophil Count, CTCAE
                     Grade 2 Mediastinum Infection NOS with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1651</td>
               <td colspan="2">CTCAE Grade 2 Mediastinum Intra-Operative Injury<span class="subclass"> SubClassOf </span>Mediastinum Intra-Operative Injury Adverse Event. <br><i>New Terms: Mediastinum Intra-Operative Injury Adverse Event, CTCAE Grade 2 Mediastinum Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1652</td>
               <td colspan="2">CTCAE Grade 2 Memory Impairment<span class="subclass"> SubClassOf </span>Memory Impairment Adverse Event. <br><i>New Terms: Memory Impairment Adverse Event, CTCAE Grade 2 Memory Impairment</i></td>
            </tr>
            <tr class="addition">
               <td>1653</td>
               <td colspan="2">CTCAE Grade 2 Meninges Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Meninges Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Meninges Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 2 Meninges Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1654</td>
               <td colspan="2">CTCAE Grade 2 Meninges Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Meninges Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Meninges Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, CTCAE Grade 2 Meninges Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1655</td>
               <td colspan="2">CTCAE Grade 2 Meninges Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Meninges Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Meninges Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     2 Meninges Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1656</td>
               <td colspan="2">CTCAE Grade 2 Meninges Intra-Operative Injury<span class="subclass"> SubClassOf </span>Meninges Intra-Operative Injury Adverse Event. <br><i>New Terms: Meninges Intra-Operative Injury Adverse Event, CTCAE Grade 2 Meninges Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1657</td>
               <td colspan="2">CTCAE Grade 2 Mental Status<span class="subclass"> SubClassOf </span>Mental Status Adverse Event. <br><i>New Terms: CTCAE Grade 2 Mental Status, Mental Status Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1658</td>
               <td colspan="2">CTCAE Grade 2 Middle Ear Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Middle Ear Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Middle Ear Infection Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, Middle Ear Infection Adverse Event Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1659</td>
               <td colspan="2">CTCAE Grade 2 Middle Ear Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Middle Ear Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Middle Ear Infection Adverse Event with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, CTCAE Grade 2 Middle Ear Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1660</td>
               <td colspan="2">CTCAE Grade 2 Middle Ear Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Middle Ear Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Middle Ear Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     2 Middle Ear Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1661</td>
               <td colspan="2">CTCAE Grade 2 Middle Ear Intra-Operative Injury<span class="subclass"> SubClassOf </span>Middle Ear Intra-Operative Injury Adverse Event. <br><i>New Terms: Middle Ear Intra-Operative Injury Adverse Event, CTCAE Grade 2 Middle Ear Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1662</td>
               <td colspan="2">CTCAE Grade 2 Middle Ear Pain<span class="subclass"> SubClassOf </span>Middle Ear Pain Adverse Event. <br><i>New Terms: Middle Ear Pain Adverse Event, CTCAE Grade 2 Middle Ear Pain</i></td>
            </tr>
            <tr class="addition">
               <td>1663</td>
               <td colspan="2">CTCAE Grade 2 Motor Neuropathy<span class="subclass"> SubClassOf </span>Motor Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 2 Motor Neuropathy, Motor Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1664</td>
               <td colspan="2">CTCAE Grade 2 Mucosa Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Mucosa Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Mucosa Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 2 Mucosa Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1665</td>
               <td colspan="2">CTCAE Grade 2 Mucosa Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Mucosa Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Mucosa Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Mucosa Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1666</td>
               <td colspan="2">CTCAE Grade 2 Mucosa Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Mucosa Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Mucosa Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     2 Mucosa Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1667</td>
               <td colspan="2">CTCAE Grade 2 Muscle Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Muscle Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Muscle Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 2 Muscle Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1668</td>
               <td colspan="2">CTCAE Grade 2 Muscle Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Muscle Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Muscle Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 2 Muscle Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1669</td>
               <td colspan="2">CTCAE Grade 2 Muscle Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Muscle Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 2 Muscle Infection with Unknown Absolute Neutrophil Count, Muscle Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1670</td>
               <td colspan="2">CTCAE Grade 2 Muscle Intra-Operative Injury<span class="subclass"> SubClassOf </span>Muscle Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Muscle Intra-Operative Injury, Muscle Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1671</td>
               <td colspan="2">CTCAE Grade 2 Muscle Pain<span class="subclass"> SubClassOf </span>Muscle Pain Adverse Event. <br><i>New Terms: CTCAE Grade 2 Muscle Pain, Muscle Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1672</td>
               <td colspan="2">CTCAE Grade 2 Muscular<br><span class="keyword"> and </span>Skeletal Hypoplasia<span class="subclass"> SubClassOf </span>Muscular<br><span class="keyword"> and </span>Skeletal Hypoplasia Adverse Event. <br><i>New Terms: CTCAE Grade 2 Muscular and Skeletal Hypoplasia, Muscular and Skeletal Hypoplasia Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1673</td>
               <td colspan="2">CTCAE Grade 2 Myelitis<span class="subclass"> SubClassOf </span>Myelitis Adverse Event. <br><i>New Terms: Myelitis Adverse Event, CTCAE Grade 2 Myelitis</i></td>
            </tr>
            <tr class="addition">
               <td>1674</td>
               <td colspan="2">CTCAE Grade 2 Myositis<span class="subclass"> SubClassOf </span>Myositis Adverse Event. <br><i>New Terms: Myositis Adverse Event, CTCAE Grade 2 Myositis</i></td>
            </tr>
            <tr class="addition">
               <td>1675</td>
               <td colspan="2">CTCAE Grade 2 Nail Changes<span class="subclass"> SubClassOf </span>Nail Changes Adverse Event. <br><i>New Terms: CTCAE Grade 2 Nail Changes, Nail Changes Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1676</td>
               <td colspan="2">CTCAE Grade 2 Nails Intra-Operative Injury<span class="subclass"> SubClassOf </span>Nails Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Nails Intra-Operative Injury, Nails Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1677</td>
               <td colspan="2">CTCAE Grade 2 Nasal Cavity Intra-Operative Injury<span class="subclass"> SubClassOf </span>Nasal Cavity Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Nasal Cavity Intra-Operative Injury, Nasal Cavity Intra-Operative Injury
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1678</td>
               <td colspan="2">CTCAE Grade 2 Nasal Cavity<br><span class="keyword"> and </span>Paranasal Sinus Reactions<span class="subclass"> SubClassOf </span>Nasal Cavity<br><span class="keyword"> and </span>Paranasal Sinus Reactions Adverse Event. <br><i>New Terms: CTCAE Grade 2 Nasal Cavity and Paranasal Sinus Reactions, Nasal Cavity and Paranasal
                     Sinus Reactions Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1679</td>
               <td colspan="2">CTCAE Grade 2 Nasopharynx Intra-Operative Injury<span class="subclass"> SubClassOf </span>Nasopharynx Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Nasopharynx Intra-Operative Injury, Nasopharynx Intra-Operative Injury
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1680</td>
               <td colspan="2">CTCAE Grade 2 Nausea<span class="subclass"> SubClassOf </span>Nausea Adverse Event. <br><i>New Terms: CTCAE Grade 2 Nausea, Nausea Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1681</td>
               <td colspan="2">CTCAE Grade 2 Neck Infection NOS Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Neck Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Neck Infection NOS Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 2 Neck Infection NOS Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1682</td>
               <td colspan="2">CTCAE Grade 2 Neck Infection NOS with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Neck Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Neck Infection NOS with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, Neck Infection NOS Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1683</td>
               <td colspan="2">CTCAE Grade 2 Neck Infection NOS with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Neck Infection NOS Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 2 Neck Infection NOS with Unknown Absolute Neutrophil Count, Neck Infection
                     NOS Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1684</td>
               <td colspan="2">CTCAE Grade 2 Neck NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Neck NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Neck NOS Intra-Operative Injury, Neck NOS Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1685</td>
               <td colspan="2">CTCAE Grade 2 Neck Pain<span class="subclass"> SubClassOf </span>Neck Pain Adverse Event. <br><i>New Terms: Neck Pain Adverse Event, CTCAE Grade 2 Neck Pain</i></td>
            </tr>
            <tr class="addition">
               <td>1686</td>
               <td colspan="2">CTCAE Grade 2 Neck Soft Tissue Necrosis<span class="subclass"> SubClassOf </span>Neck Soft Tissue Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 2 Neck Soft Tissue Necrosis, Neck Soft Tissue Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1687</td>
               <td colspan="2">CTCAE Grade 2 Neuralgia<br><span class="keyword"> and </span>Peripheral Nerve Pain<span class="subclass"> SubClassOf </span>Neuralgia<br><span class="keyword"> and </span>Peripheral Nerve Pain Adverse Event. <br><i>New Terms: CTCAE Grade 2 Neuralgia and Peripheral Nerve Pain, Neuralgia and Peripheral Nerve
                     Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1688</td>
               <td colspan="2">CTCAE Grade 2 Neuroendocrine ACTH Deficiency<span class="subclass"> SubClassOf </span>Neuroendocrine ACTH Deficiency Adverse Event. <br><i>New Terms: CTCAE Grade 2 Neuroendocrine ACTH Deficiency, Neuroendocrine ACTH Deficiency Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1689</td>
               <td colspan="2">CTCAE Grade 2 Neuroendocrine ADH Secretion Abnormality<span class="subclass"> SubClassOf </span>Neuroendocrine ADH Secretion Abnormality Adverse Event. <br><i>New Terms: CTCAE Grade 2 Neuroendocrine ADH Secretion Abnormality, Neuroendocrine ADH Secretion
                     Abnormality Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1690</td>
               <td colspan="2">CTCAE Grade 2 Neuroendocrine Gonadotropin Secretion Abnormality<span class="subclass"> SubClassOf </span>Neuroendocrine Gonadotropin Secretion Abnormality Adverse Event. <br><i>New Terms: CTCAE Grade 2 Neuroendocrine Gonadotropin Secretion Abnormality, Neuroendocrine Gonadotropin
                     Secretion Abnormality Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1691</td>
               <td colspan="2">CTCAE Grade 2 Neuroendocrine Growth Hormone Secretion Abnormality<span class="subclass"> SubClassOf </span>Neuroendocrine Growth Hormone Secretion Abnormality Adverse Event. <br><i>New Terms: CTCAE Grade 2 Neuroendocrine Growth Hormone Secretion Abnormality, Neuroendocrine
                     Growth Hormone Secretion Abnormality Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1692</td>
               <td colspan="2">CTCAE Grade 2 Neuroendocrine Prolactin Hormone Secretion Abnormality<span class="subclass"> SubClassOf </span>Neuroendocrine Prolactin Hormone Secretion Abnormality Adverse Event. <br><i>New Terms: Neuroendocrine Prolactin Hormone Secretion Abnormality Adverse Event, CTCAE Grade
                     2 Neuroendocrine Prolactin Hormone Secretion Abnormality</i></td>
            </tr>
            <tr class="addition">
               <td>1693</td>
               <td colspan="2">CTCAE Grade 2 Neutrophils<br><span class="keyword"> and </span>Granulocytes<span class="subclass"> SubClassOf </span>Neutrophils<br><span class="keyword"> and </span>Granulocytes Adverse Event. <br><i>New Terms: CTCAE Grade 2 Neutrophils and Granulocytes, Neutrophils and Granulocytes Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1694</td>
               <td colspan="2">CTCAE Grade 2 Nodal<br><span class="keyword"> or </span>Junctional Rhythm<span class="subclass"> SubClassOf </span>Nodal<br><span class="keyword"> or </span>Junctional Rhythm Adverse Event. <br><i>New Terms: CTCAE Grade 2 Nodal or Junctional Rhythm, Nodal or Junctional Rhythm Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1695</td>
               <td colspan="2">CTCAE Grade 2 Non-Infectious Vaginal Discharge<span class="subclass"> SubClassOf </span>Non-Infectious Vaginal Discharge Adverse Event. <br><i>New Terms: Non-Infectious Vaginal Discharge Adverse Event, CTCAE Grade 2 Non-Infectious Vaginal
                     Discharge</i></td>
            </tr>
            <tr class="addition">
               <td>1696</td>
               <td colspan="2">CTCAE Grade 2 Non-Infectious Wound Complication<span class="subclass"> SubClassOf </span>Non-Infectious Wound Complication Adverse Event. <br><i>New Terms: CTCAE Grade 2 Non-Infectious Wound Complication, Non-Infectious Wound Complication
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1697</td>
               <td colspan="2">CTCAE Grade 2 Non-Malignant Ascites<span class="subclass"> SubClassOf </span>Non-Malignant Ascites Adverse Event. <br><i>New Terms: Non-Malignant Ascites Adverse Event, CTCAE Grade 2 Non-Malignant Ascites</i></td>
            </tr>
            <tr class="addition">
               <td>1698</td>
               <td colspan="2">CTCAE Grade 2 Non-Malignant Pleural Effusion<span class="subclass"> SubClassOf </span>Non-Malignant Pleural Effusion Adverse Event. <br><i>New Terms: Non-Malignant Pleural Effusion Adverse Event, CTCAE Grade 2 Non-Malignant Pleural
                     Effusion</i></td>
            </tr>
            <tr class="addition">
               <td>1699</td>
               <td colspan="2">CTCAE Grade 2 Non-Myocardial Visceral Arterial Ischemia<span class="subclass"> SubClassOf </span>Non-Myocardial Visceral Arterial Ischemia Adverse Event. <br><i>New Terms: CTCAE Grade 2 Non-Myocardial Visceral Arterial Ischemia, Non-Myocardial Visceral Arterial
                     Ischemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1700</td>
               <td colspan="2">CTCAE Grade 2 Non-Septic Arthritis<span class="subclass"> SubClassOf </span>Non-Septic Arthritis Adverse Event. <br><i>New Terms: CTCAE Grade 2 Non-Septic Arthritis, Non-Septic Arthritis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1701</td>
               <td colspan="2">CTCAE Grade 2 Nose Hemorrhage<span class="subclass"> SubClassOf </span>Nose Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 2 Nose Hemorrhage, Nose Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1702</td>
               <td colspan="2">CTCAE Grade 2 Nose Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Nose Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Nose Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Nose Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1703</td>
               <td colspan="2">CTCAE Grade 2 Nose Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Nose Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Nose Infection with Normal Absolute Neutrophil Count or Grade 1 or 2
                     Neutrophils, Nose Infection Adverse Event with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1704</td>
               <td colspan="2">CTCAE Grade 2 Nose Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Nose Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 2 Nose Infection with Unknown Absolute Neutrophil Count, Nose Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1705</td>
               <td colspan="2">CTCAE Grade 2 Nose Intra-Operative Injury<span class="subclass"> SubClassOf </span>Nose Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Nose Intra-Operative Injury, Nose Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1706</td>
               <td colspan="2">CTCAE Grade 2 Nyctalopia<span class="subclass"> SubClassOf </span>Nyctalopia Adverse Event. <br><i>New Terms: Nyctalopia Adverse Event, CTCAE Grade 2 Nyctalopia</i></td>
            </tr>
            <tr class="addition">
               <td>1707</td>
               <td colspan="2">CTCAE Grade 2 Nystagmus<span class="subclass"> SubClassOf </span>Nystagmus Adverse Event. <br><i>New Terms: CTCAE Grade 2 Nystagmus, Nystagmus Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1708</td>
               <td colspan="2">CTCAE Grade 2 Obesity<span class="subclass"> SubClassOf </span>Obesity Adverse Event. <br><i>New Terms: CTCAE Grade 2 Obesity, Obesity Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1709</td>
               <td colspan="2">CTCAE Grade 2 Ocular Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Ocular Muscle Weakness Not Due to Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 2 Ocular Muscle Weakness Not Due to Neuropathy, Ocular Muscle Weakness
                     Not Due to Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1710</td>
               <td colspan="2">CTCAE Grade 2 Ocular Surface Disease<span class="subclass"> SubClassOf </span>Ocular Surface Disease Adverse Event. <br><i>New Terms: CTCAE Grade 2 Ocular Surface Disease, Ocular Surface Disease Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1711</td>
               <td colspan="2">CTCAE Grade 2 Ophthalmoplegia<br><span class="keyword"> and </span>Diplopia<span class="subclass"> SubClassOf </span>Ophthalmoplegia<br><span class="keyword"> and </span>Diplopia Adverse Event. <br><i>New Terms: CTCAE Grade 2 Ophthalmoplegia and Diplopia, Ophthalmoplegia and Diplopia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1712</td>
               <td colspan="2">CTCAE Grade 2 Opportunistic Infection<span class="subclass"> SubClassOf </span>Opportunistic Infection Adverse Event Associated with Grade 2<br><span class="keyword"> or </span>Greater Lymphopenia. <br><i>New Terms: Opportunistic Infection Adverse Event Associated with Grade 2 or Greater Lymphopenia,
                     CTCAE Grade 2 Opportunistic Infection</i></td>
            </tr>
            <tr class="addition">
               <td>1713</td>
               <td colspan="2">CTCAE Grade 2 Optic Disc Edema<span class="subclass"> SubClassOf </span>Optic Disc Edema Adverse Event. <br><i>New Terms: Optic Disc Edema Adverse Event, CTCAE Grade 2 Optic Disc Edema</i></td>
            </tr>
            <tr class="addition">
               <td>1714</td>
               <td colspan="2">CTCAE Grade 2 Oral Cavity GI Fistula<span class="subclass"> SubClassOf </span>Oral Cavity GI Fistula Adverse Event. <br><i>New Terms: Oral Cavity GI Fistula Adverse Event, CTCAE Grade 2 Oral Cavity GI Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>1715</td>
               <td colspan="2">CTCAE Grade 2 Oral Cavity Hemorrhage<span class="subclass"> SubClassOf </span>Oral Cavity Adverse Event Hemorrhage. <br><i>New Terms: CTCAE Grade 2 Oral Cavity Hemorrhage, Oral Cavity Adverse Event Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>1716</td>
               <td colspan="2">CTCAE Grade 2 Oral Cavity Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Oral Cavity Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification. <br><i>New Terms: CTCAE Grade 2 Oral Cavity Mucositis or Stomatitis by Clinical Examination Classification,
                     Oral Cavity Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>1717</td>
               <td colspan="2">CTCAE Grade 2 Oral Cavity Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Oral Cavity Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: CTCAE Grade 2 Oral Cavity Mucositis or Stomatitis by Functional or Symptomatic Classification,
                     Oral Cavity Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>1718</td>
               <td colspan="2">CTCAE Grade 2 Oral Cavity NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Oral Cavity NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Oral Cavity NOS Intra-Operative Injury, Oral Cavity NOS Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1719</td>
               <td colspan="2">CTCAE Grade 2 Oral Cavity Pain<span class="subclass"> SubClassOf </span>Oral Cavity Pain Adverse Event. <br><i>New Terms: CTCAE Grade 2 Oral Cavity Pain, Oral Cavity Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1720</td>
               <td colspan="2">CTCAE Grade 2 Oral Cavity Pulmonary Fistula<span class="subclass"> SubClassOf </span>Oral Cavity Pulmonary Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 2 Oral Cavity Pulmonary Fistula, Oral Cavity Pulmonary Fistula Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1721</td>
               <td colspan="2">CTCAE Grade 2 Oral Cavity<br><span class="keyword"> or </span>Gum Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Oral Cavity<br><span class="keyword"> or </span>Gum Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Oral Cavity or Gum Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, Oral Cavity or Gum Infection Adverse Event Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1722</td>
               <td colspan="2">CTCAE Grade 2 Oral Cavity<br><span class="keyword"> or </span>Gum Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Oral Cavity<br><span class="keyword"> or </span>Gum Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Oral Cavity or Gum Infection with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils, Oral Cavity or Gum Infection Adverse Event with Normal Absolute
                     Neutrophil Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1723</td>
               <td colspan="2">CTCAE Grade 2 Oral Cavity<br><span class="keyword"> or </span>Gum Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Oral Cavity<br><span class="keyword"> or </span>Gum Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Oral Cavity or Gum Infection Adverse Event with Unknown Absolute Neutrophil Count,
                     CTCAE Grade 2 Oral Cavity or Gum Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1724</td>
               <td colspan="2">CTCAE Grade 2 Oral Intra-Operative Injury<span class="subclass"> SubClassOf </span>Oral Intra-Operative Injury Adverse Event. <br><i>New Terms: Oral Intra-Operative Injury Adverse Event, CTCAE Grade 2 Oral Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1725</td>
               <td colspan="2">CTCAE Grade 2 Oral Pain of the Gums<span class="subclass"> SubClassOf </span>Oral Pain of the Gums Adverse Event. <br><i>New Terms: Oral Pain of the Gums Adverse Event, CTCAE Grade 2 Oral Pain of the Gums</i></td>
            </tr>
            <tr class="addition">
               <td>1726</td>
               <td colspan="2">CTCAE Grade 2 Orgasmic Dysfunction<span class="subclass"> SubClassOf </span>Orgasmic Dysfunction Adverse Event. <br><i>New Terms: CTCAE Grade 2 Orgasmic Dysfunction, Orgasmic Dysfunction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1727</td>
               <td colspan="2">CTCAE Grade 2 Osteoporosis<span class="subclass"> SubClassOf </span>Osteoporosis Adverse Event. <br><i>New Terms: Osteoporosis Adverse Event, CTCAE Grade 2 Osteoporosis</i></td>
            </tr>
            <tr class="addition">
               <td>1728</td>
               <td colspan="2">CTCAE Grade 2 Other Allergy<br><span class="keyword"> and </span>Immunology<span class="subclass"> SubClassOf </span>Other Allergy<br><span class="keyword"> and </span>Immunology Adverse Event. <br><i>New Terms: CTCAE Grade 2 Other Allergy and Immunology, Other Allergy and Immunology Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1729</td>
               <td colspan="2">CTCAE Grade 2 Other Auditory<br><span class="keyword"> and </span>Ear<span class="subclass"> SubClassOf </span>Other Auditory<br><span class="keyword"> and </span>Ear Adverse Event. <br><i>New Terms: Other Auditory and Ear Adverse Event, CTCAE Grade 2 Other Auditory and Ear</i></td>
            </tr>
            <tr class="addition">
               <td>1730</td>
               <td colspan="2">CTCAE Grade 2 Other Blood<br><span class="keyword"> and </span>Bone Marrow<span class="subclass"> SubClassOf </span>Other Blood<br><span class="keyword"> and </span>Bone Marrow Adverse Event. <br><i>New Terms: CTCAE Grade 2 Other Blood and Bone Marrow, Other Blood and Bone Marrow Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1731</td>
               <td colspan="2">CTCAE Grade 2 Other Cardiac Arrhythmia<span class="subclass"> SubClassOf </span>Other Cardiac Arrhythmia Adverse Event. <br><i>New Terms: Other Cardiac Arrhythmia Adverse Event, CTCAE Grade 2 Other Cardiac Arrhythmia</i></td>
            </tr>
            <tr class="addition">
               <td>1732</td>
               <td colspan="2">CTCAE Grade 2 Other Coagulation<span class="subclass"> SubClassOf </span>Other Coagulation Adverse Event. <br><i>New Terms: CTCAE Grade 2 Other Coagulation, Other Coagulation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1733</td>
               <td colspan="2">CTCAE Grade 2 Other Constitutional Symptoms<span class="subclass"> SubClassOf </span>Other Constitutional Symptoms Adverse Event. <br><i>New Terms: CTCAE Grade 2 Other Constitutional Symptoms, Other Constitutional Symptoms Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1734</td>
               <td colspan="2">CTCAE Grade 2 Other Dermatology<br><span class="keyword"> or </span>Skin<span class="subclass"> SubClassOf </span>Other Dermatology<br><span class="keyword"> or </span>Skin Adverse Event. <br><i>New Terms: Other Dermatology or Skin Adverse Event, CTCAE Grade 2 Other Dermatology or Skin</i></td>
            </tr>
            <tr class="addition">
               <td>1735</td>
               <td colspan="2">CTCAE Grade 2 Other Endocrine<span class="subclass"> SubClassOf </span>Other Endocrine Adverse Event. <br><i>New Terms: CTCAE Grade 2 Other Endocrine, Other Endocrine Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1736</td>
               <td colspan="2">CTCAE Grade 2 Other Gastrointestinal<span class="subclass"> SubClassOf </span>Other Gastrointestinal Adverse Event. <br><i>New Terms: Other Gastrointestinal Adverse Event, CTCAE Grade 2 Other Gastrointestinal</i></td>
            </tr>
            <tr class="addition">
               <td>1737</td>
               <td colspan="2">CTCAE Grade 2 Other Growth<br><span class="keyword"> and </span>Development<span class="subclass"> SubClassOf </span>Other Growth<br><span class="keyword"> and </span>Development Adverse Event. <br><i>New Terms: Other Growth and Development Adverse Event, CTCAE Grade 2 Other Growth and Development</i></td>
            </tr>
            <tr class="addition">
               <td>1738</td>
               <td colspan="2">CTCAE Grade 2 Other Heart in General<span class="subclass"> SubClassOf </span>Other Adverse Event Associated with the Heart in General. <br><i>New Terms: CTCAE Grade 2 Other Heart in General, Other Adverse Event Associated with the Heart
                     in General</i></td>
            </tr>
            <tr class="addition">
               <td>1739</td>
               <td colspan="2">CTCAE Grade 2 Other Hepatobiliary<br><span class="keyword"> and </span>Pancreas<span class="subclass"> SubClassOf </span>Other Hepatobiliary<br><span class="keyword"> and </span>Pancreas Adverse Event. <br><i>New Terms: CTCAE Grade 2 Other Hepatobiliary and Pancreas, Other Hepatobiliary and Pancreas Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1740</td>
               <td colspan="2">CTCAE Grade 2 Other Infection<span class="subclass"> SubClassOf </span>Infection Other Adverse Event. <br><i>New Terms: CTCAE Grade 2 Other Infection, Infection Other Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1741</td>
               <td colspan="2">CTCAE Grade 2 Other Intra-Operative Injury<span class="subclass"> SubClassOf </span>Other Intra-Operative Injury Adverse Event. <br><i>New Terms: Other Intra-Operative Injury Adverse Event, CTCAE Grade 2 Other Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1742</td>
               <td colspan="2">CTCAE Grade 2 Other Lymphatics<span class="subclass"> SubClassOf </span>Other Lymphatics Adverse Event. <br><i>New Terms: CTCAE Grade 2 Other Lymphatics, Other Lymphatics Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1743</td>
               <td colspan="2">CTCAE Grade 2 Other Metabolic<br><span class="keyword"> and </span>Laboratory<span class="subclass"> SubClassOf </span>Other Metabolic<br><span class="keyword"> and </span>Laboratory Adverse Event. <br><i>New Terms: CTCAE Grade 2 Other Metabolic and Laboratory, Other Metabolic and Laboratory Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1744</td>
               <td colspan="2">CTCAE Grade 2 Other Musculoskeletal<br><span class="keyword"> and </span>Soft Tissue<span class="subclass"> SubClassOf </span>Other Musculoskeletal<br><span class="keyword"> and </span>Soft Tissue Adverse Event. <br><i>New Terms: CTCAE Grade 2 Other Musculoskeletal and Soft Tissue, Other Musculoskeletal and Soft
                     Tissue Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1745</td>
               <td colspan="2">CTCAE Grade 2 Other NOS Artery Injury<span class="subclass"> SubClassOf </span>Other NOS Artery Injury Adverse Event. <br><i>New Terms: Other NOS Artery Injury Adverse Event, CTCAE Grade 2 Other NOS Artery Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1746</td>
               <td colspan="2">CTCAE Grade 2 Other NOS Vein Injury<span class="subclass"> SubClassOf </span>Other NOS Vein Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Other NOS Vein Injury, Other NOS Vein Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1747</td>
               <td colspan="2">CTCAE Grade 2 Other Neurology<span class="subclass"> SubClassOf </span>Other Neurology Adverse Event. <br><i>New Terms: CTCAE Grade 2 Other Neurology, Other Neurology Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1748</td>
               <td colspan="2">CTCAE Grade 2 Other Ocular<br><span class="keyword"> and </span>Visual<span class="subclass"> SubClassOf </span>Other Ocular<br><span class="keyword"> and </span>Visual Adverse Event. <br><i>New Terms: Other Ocular and Visual Adverse Event, CTCAE Grade 2 Other Ocular and Visual</i></td>
            </tr>
            <tr class="addition">
               <td>1749</td>
               <td colspan="2">CTCAE Grade 2 Other Pain<span class="subclass"> SubClassOf </span>Other Pain Adverse Event. <br><i>New Terms: Other Pain Adverse Event, CTCAE Grade 2 Other Pain</i></td>
            </tr>
            <tr class="addition">
               <td>1750</td>
               <td colspan="2">CTCAE Grade 2 Other Pulmonary<br><span class="keyword"> and </span>Upper Respiratory<span class="subclass"> SubClassOf </span>Other Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Adverse Event. <br><i>New Terms: CTCAE Grade 2 Other Pulmonary and Upper Respiratory, Other Pulmonary and Upper Respiratory
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1751</td>
               <td colspan="2">CTCAE Grade 2 Other Renal<br><span class="keyword"> or </span>Genitourinary<span class="subclass"> SubClassOf </span>Renal<br><span class="keyword"> or </span>Genitourinary Other Adverse Event. <br><i>New Terms: Renal or Genitourinary Other Adverse Event, CTCAE Grade 2 Other Renal or Genitourinary</i></td>
            </tr>
            <tr class="addition">
               <td>1752</td>
               <td colspan="2">CTCAE Grade 2 Other Sexual Reproductive Function<span class="subclass"> SubClassOf </span>Other Sexual Reproductive Function Adverse Event. <br><i>New Terms: CTCAE Grade 2 Other Sexual Reproductive Function, Other Sexual Reproductive Function
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1753</td>
               <td colspan="2">CTCAE Grade 2 Other Syndromes<span class="subclass"> SubClassOf </span>Other Syndromes Adverse Event. <br><i>New Terms: Other Syndromes Adverse Event, CTCAE Grade 2 Other Syndromes</i></td>
            </tr>
            <tr class="addition">
               <td>1754</td>
               <td colspan="2">CTCAE Grade 2 Other Vascular<span class="subclass"> SubClassOf </span>Other Vascular Adverse Event. <br><i>New Terms: CTCAE Grade 2 Other Vascular, Other Vascular Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1755</td>
               <td colspan="2">CTCAE Grade 2 Otitis External Ear Non Infectious<span class="subclass"> SubClassOf </span>Otitis Adverse Event External Ear Non Infectious. <br><i>New Terms: Otitis Adverse Event External Ear Non Infectious, CTCAE Grade 2 Otitis External Ear
                     Non Infectious</i></td>
            </tr>
            <tr class="addition">
               <td>1756</td>
               <td colspan="2">CTCAE Grade 2 Otitis Middle Ear Non Infectious<span class="subclass"> SubClassOf </span>Otitis Adverse Event Middle Ear Non Infectious. <br><i>New Terms: CTCAE Grade 2 Otitis Middle Ear Non Infectious, Otitis Adverse Event Middle Ear Non
                     Infectious</i></td>
            </tr>
            <tr class="addition">
               <td>1757</td>
               <td colspan="2">CTCAE Grade 2 Outer Ear NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Outer Ear NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Outer Ear NOS Intra-Operative Injury, Outer Ear NOS Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1758</td>
               <td colspan="2">CTCAE Grade 2 Outer Ear Pinna Intra-Operative Injury<span class="subclass"> SubClassOf </span>Outer Ear Pinna Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Outer Ear Pinna Intra-Operative Injury, Outer Ear Pinna Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1759</td>
               <td colspan="2">CTCAE Grade 2 Ovary Hemorrhage<span class="subclass"> SubClassOf </span>Ovary Hemorrhage Adverse Event. <br><i>New Terms: Ovary Hemorrhage Adverse Event, CTCAE Grade 2 Ovary Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>1760</td>
               <td colspan="2">CTCAE Grade 2 Ovary Intra-Operative Injury<span class="subclass"> SubClassOf </span>Ovary Intra-Operative Injury Adverse Event. <br><i>New Terms: Ovary Intra-Operative Injury Adverse Event, CTCAE Grade 2 Ovary Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1761</td>
               <td colspan="2">CTCAE Grade 2 Ovary Perforation<span class="subclass"> SubClassOf </span>Ovary Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 2 Ovary Perforation, Ovary Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1762</td>
               <td colspan="2">CTCAE Grade 2 Ovulatory Pain<span class="subclass"> SubClassOf </span>Ovulatory Pain Adverse Event. <br><i>New Terms: CTCAE Grade 2 Ovulatory Pain, Ovulatory Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1763</td>
               <td colspan="2">CTCAE Grade 2 PVCs<span class="subclass"> SubClassOf </span>Premature Ventricular Contraction Adverse Event. <br><i>New Terms: Premature Ventricular Contraction Adverse Event, CTCAE Grade 2 PVCs</i></td>
            </tr>
            <tr class="addition">
               <td>1764</td>
               <td colspan="2">CTCAE Grade 2 Pain NOS<span class="subclass"> SubClassOf </span>Pain NOS Adverse Event. <br><i>New Terms: Pain NOS Adverse Event, CTCAE Grade 2 Pain NOS</i></td>
            </tr>
            <tr class="addition">
               <td>1765</td>
               <td colspan="2">CTCAE Grade 2 Palpitations<span class="subclass"> SubClassOf </span>Palpitations Adverse Event. <br><i>New Terms: Palpitations Adverse Event, CTCAE Grade 2 Palpitations</i></td>
            </tr>
            <tr class="addition">
               <td>1766</td>
               <td colspan="2">CTCAE Grade 2 Pancreas Exocrine Enzyme Deficiency<span class="subclass"> SubClassOf </span>Pancreas Exocrine Enzyme Deficiency Adverse Event. <br><i>New Terms: Pancreas Exocrine Enzyme Deficiency Adverse Event, CTCAE Grade 2 Pancreas Exocrine
                     Enzyme Deficiency</i></td>
            </tr>
            <tr class="addition">
               <td>1767</td>
               <td colspan="2">CTCAE Grade 2 Pancreas Fistula<span class="subclass"> SubClassOf </span>Pancreas Fistula Adverse Event. <br><i>New Terms: Pancreas Fistula Adverse Event, CTCAE Grade 2 Pancreas Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>1768</td>
               <td colspan="2">CTCAE Grade 2 Pancreas Hemorrhage<span class="subclass"> SubClassOf </span>Pancreas Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 2 Pancreas Hemorrhage, Pancreas Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1769</td>
               <td colspan="2">CTCAE Grade 2 Pancreas Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Pancreas Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Pancreas Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 2 Pancreas Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1770</td>
               <td colspan="2">CTCAE Grade 2 Pancreas Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Pancreas Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Pancreas Infection with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, Pancreas Infection Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1771</td>
               <td colspan="2">CTCAE Grade 2 Pancreas Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Pancreas Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 2 Pancreas Infection with Unknown Absolute Neutrophil Count, Pancreas
                     Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1772</td>
               <td colspan="2">CTCAE Grade 2 Pancreas Intra-Operative Injury<span class="subclass"> SubClassOf </span>Pancreas Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Pancreas Intra-Operative Injury, Pancreas Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1773</td>
               <td colspan="2">CTCAE Grade 2 Pancreas Leak<span class="subclass"> SubClassOf </span>Pancreas Leak Adverse Event. <br><i>New Terms: Pancreas Leak Adverse Event, CTCAE Grade 2 Pancreas Leak</i></td>
            </tr>
            <tr class="addition">
               <td>1774</td>
               <td colspan="2">CTCAE Grade 2 Pancreas<br><span class="keyword"> or </span>Pancreatic Duct Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Pancreas<br><span class="keyword"> or </span>Pancreatic Duct Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 2 Pancreas or Pancreatic Duct Stricture or Stenosis, Pancreas or Pancreatic
                     Duct Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1775</td>
               <td colspan="2">CTCAE Grade 2 Pancreatic Duct Intra-Operative Injury<span class="subclass"> SubClassOf </span>Pancreatic Duct Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Pancreatic Duct Intra-Operative Injury, Pancreatic Duct Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1776</td>
               <td colspan="2">CTCAE Grade 2 Pancreatic Endocrine Glucose Intolerance<span class="subclass"> SubClassOf </span>Pancreatic Endocrine Glucose Intolerance Adverse Event. <br><i>New Terms: Pancreatic Endocrine Glucose Intolerance Adverse Event, CTCAE Grade 2 Pancreatic Endocrine
                     Glucose Intolerance</i></td>
            </tr>
            <tr class="addition">
               <td>1777</td>
               <td colspan="2">CTCAE Grade 2 Pancreatitis<span class="subclass"> SubClassOf </span>Pancreatitis Adverse Event. <br><i>New Terms: Pancreatitis Adverse Event, CTCAE Grade 2 Pancreatitis</i></td>
            </tr>
            <tr class="addition">
               <td>1778</td>
               <td colspan="2">CTCAE Grade 2 Paranasal Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Paranasal Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Paranasal Infection Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, Paranasal Infection Adverse Event Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1779</td>
               <td colspan="2">CTCAE Grade 2 Paranasal Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Paranasal Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Paranasal Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, CTCAE Grade 2 Paranasal Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1780</td>
               <td colspan="2">CTCAE Grade 2 Paranasal Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Paranasal Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 2 Paranasal Infection with Unknown Absolute Neutrophil Count, Paranasal
                     Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1781</td>
               <td colspan="2">CTCAE Grade 2 Parathyroid Function Low<span class="subclass"> SubClassOf </span>Parathyroid Function Low Adverse Event. <br><i>New Terms: CTCAE Grade 2 Parathyroid Function Low, Parathyroid Function Low Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1782</td>
               <td colspan="2">CTCAE Grade 2 Parathyroid Intra-Operative Injury<span class="subclass"> SubClassOf </span>Parathyroid Intra-Operative Injury Adverse Event. <br><i>New Terms: Parathyroid Intra-Operative Injury Adverse Event, CTCAE Grade 2 Parathyroid Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1783</td>
               <td colspan="2">CTCAE Grade 2 Parotid Gland Intra-Operative Injury<span class="subclass"> SubClassOf </span>Parotid Gland Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Parotid Gland Intra-Operative Injury, Parotid Gland Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1784</td>
               <td colspan="2">CTCAE Grade 2 Partial Thromboplastin Time<span class="subclass"> SubClassOf </span>Partial Thromboplastin Time Adverse Event. <br><i>New Terms: Partial Thromboplastin Time Adverse Event, CTCAE Grade 2 Partial Thromboplastin Time</i></td>
            </tr>
            <tr class="addition">
               <td>1785</td>
               <td colspan="2">CTCAE Grade 2 Patient Odor<span class="subclass"> SubClassOf </span>Patient Odor Adverse Event. <br><i>New Terms: CTCAE Grade 2 Patient Odor, Patient Odor Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1786</td>
               <td colspan="2">CTCAE Grade 2 Pelvic Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Pelvic Muscle Weakness Not Due to Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 2 Pelvic Muscle Weakness Not Due to Neuropathy, Pelvic Muscle Weakness
                     Not Due to Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1787</td>
               <td colspan="2">CTCAE Grade 2 Pelvic Soft Tissue Necrosis<span class="subclass"> SubClassOf </span>Pelvic Soft Tissue Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 2 Pelvic Soft Tissue Necrosis, Pelvic Soft Tissue Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1788</td>
               <td colspan="2">CTCAE Grade 2 Pelvis Infection NOS Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Pelvis Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Pelvis Infection NOS Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, Pelvis Infection NOS Adverse Event Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1789</td>
               <td colspan="2">CTCAE Grade 2 Pelvis Infection NOS with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Pelvis Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Pelvis Infection NOS Adverse Event with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, CTCAE Grade 2 Pelvis Infection NOS with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1790</td>
               <td colspan="2">CTCAE Grade 2 Pelvis Infection NOS with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Pelvis Infection NOS Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Pelvis Infection NOS Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     2 Pelvis Infection NOS with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1791</td>
               <td colspan="2">CTCAE Grade 2 Pelvis NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Pelvis Intra-Operative Injury Adverse Event. <br><i>New Terms: Pelvis Intra-Operative Injury Adverse Event, CTCAE Grade 2 Pelvis NOS Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1792</td>
               <td colspan="2">CTCAE Grade 2 Pelvis Pain<span class="subclass"> SubClassOf </span>Pelvis Pain Adverse Event. <br><i>New Terms: CTCAE Grade 2 Pelvis Pain, Pelvis Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1793</td>
               <td colspan="2">CTCAE Grade 2 Penis Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Penis Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Penis Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Penis Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1794</td>
               <td colspan="2">CTCAE Grade 2 Penis Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Penis Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Penis Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 2 Penis Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1795</td>
               <td colspan="2">CTCAE Grade 2 Penis Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Penis Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 2 Penis Infection with Unknown Absolute Neutrophil Count, Penis Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1796</td>
               <td colspan="2">CTCAE Grade 2 Penis Intra-Operative Injury<span class="subclass"> SubClassOf </span>Penis Intra-Operative Injury Adverse Event. <br><i>New Terms: Penis Intra-Operative Injury Adverse Event, CTCAE Grade 2 Penis Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1797</td>
               <td colspan="2">CTCAE Grade 2 Penis Pain<span class="subclass"> SubClassOf </span>Penis Pain Adverse Event. <br><i>New Terms: CTCAE Grade 2 Penis Pain, Penis Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1798</td>
               <td colspan="2">CTCAE Grade 2 Pericarditis<span class="subclass"> SubClassOf </span>Pericarditis Adverse Event. <br><i>New Terms: Pericarditis Adverse Event, CTCAE Grade 2 Pericarditis</i></td>
            </tr>
            <tr class="addition">
               <td>1799</td>
               <td colspan="2">CTCAE Grade 2 Pericardium Pain<span class="subclass"> SubClassOf </span>Pericardium Pain Adverse Event. <br><i>New Terms: CTCAE Grade 2 Pericardium Pain, Pericardium Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1800</td>
               <td colspan="2">CTCAE Grade 2 Perineum Pain<span class="subclass"> SubClassOf </span>Perineum Pain Adverse Event. <br><i>New Terms: CTCAE Grade 2 Perineum Pain, Perineum Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1801</td>
               <td colspan="2">CTCAE Grade 2 Periodontal Disease<span class="subclass"> SubClassOf </span>Periodontal Disease Adverse Event. <br><i>New Terms: Periodontal Disease Adverse Event, CTCAE Grade 2 Periodontal Disease</i></td>
            </tr>
            <tr class="addition">
               <td>1802</td>
               <td colspan="2">CTCAE Grade 2 Peripheral Arterial Ischemia<span class="subclass"> SubClassOf </span>Peripheral Arterial Ischemia Adverse Event. <br><i>New Terms: Peripheral Arterial Ischemia Adverse Event, CTCAE Grade 2 Peripheral Arterial Ischemia</i></td>
            </tr>
            <tr class="addition">
               <td>1803</td>
               <td colspan="2">CTCAE Grade 2 Peripheral Motor Nerve NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Peripheral Motor Nerve NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: Peripheral Motor Nerve NOS Intra-Operative Injury Adverse Event, CTCAE Grade 2 Peripheral
                     Motor Nerve NOS Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1804</td>
               <td colspan="2">CTCAE Grade 2 Peripheral Nerve Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Peripheral Nerve Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Peripheral Nerve Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, CTCAE Grade 2 Peripheral Nerve Infection Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1805</td>
               <td colspan="2">CTCAE Grade 2 Peripheral Nerve Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Peripheral Nerve Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Peripheral Nerve Infection Adverse Event with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils, CTCAE Grade 2 Peripheral Nerve Infection with Normal Absolute
                     Neutrophil Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1806</td>
               <td colspan="2">CTCAE Grade 2 Peripheral Nerve Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Peripheral Nerve Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Peripheral Nerve Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE
                     Grade 2 Peripheral Nerve Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1807</td>
               <td colspan="2">CTCAE Grade 2 Peripheral Sensory Nerve NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Peripheral Sensory Nerve NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: Peripheral Sensory Nerve NOS Intra-Operative Injury Adverse Event, CTCAE Grade 2 Peripheral
                     Sensory Nerve NOS Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1808</td>
               <td colspan="2">CTCAE Grade 2 Peristomal Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Peristomal Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Peristomal Infection Adverse Event Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, CTCAE Grade 2 Peristomal Infection Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1809</td>
               <td colspan="2">CTCAE Grade 2 Peristomal Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Peristomal Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Peristomal Infection with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, Peristomal Infection Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1810</td>
               <td colspan="2">CTCAE Grade 2 Peristomal Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Peristomal Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Peristomal Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     2 Peristomal Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1811</td>
               <td colspan="2">CTCAE Grade 2 Peritoneal Cavity Hemorrhage<span class="subclass"> SubClassOf </span>Peritoneal Hemorrhage Adverse Event. <br><i>New Terms: Peritoneal Hemorrhage Adverse Event, CTCAE Grade 2 Peritoneal Cavity Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>1812</td>
               <td colspan="2">CTCAE Grade 2 Peritoneal Cavity Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Peritoneal Cavity Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Peritoneal Cavity Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, Peritoneal Cavity Infection Adverse Event Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1813</td>
               <td colspan="2">CTCAE Grade 2 Peritoneal Cavity Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Peritoneal Cavity Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Peritoneal Cavity Infection Adverse Event with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils, CTCAE Grade 2 Peritoneal Cavity Infection with Normal Absolute
                     Neutrophil Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1814</td>
               <td colspan="2">CTCAE Grade 2 Peritoneal Cavity Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Peritoneal Cavity Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 2 Peritoneal Cavity Infection with Unknown Absolute Neutrophil Count,
                     Peritoneal Cavity Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1815</td>
               <td colspan="2">CTCAE Grade 2 Peritoneal Cavity Intra-Operative Injury<span class="subclass"> SubClassOf </span>Peritoneal Cavity Intra-Operative Injury Adverse Event. <br><i>New Terms: Peritoneal Cavity Intra-Operative Injury Adverse Event, CTCAE Grade 2 Peritoneal Cavity
                     Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1816</td>
               <td colspan="2">CTCAE Grade 2 Peritoneum Pain<span class="subclass"> SubClassOf </span>Peritoneum Pain Adverse Event. <br><i>New Terms: CTCAE Grade 2 Peritoneum Pain, Peritoneum Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1817</td>
               <td colspan="2">CTCAE Grade 2 Personality<br><span class="keyword"> and </span>Behavioral Change<span class="subclass"> SubClassOf </span>Personality<br><span class="keyword"> and </span>Behavioral Change Adverse Event. <br><i>New Terms: Personality and Behavioral Change Adverse Event, CTCAE Grade 2 Personality and Behavioral
                     Change</i></td>
            </tr>
            <tr class="addition">
               <td>1818</td>
               <td colspan="2">CTCAE Grade 2 Petechiae<br><span class="keyword"> and </span>Purpura<span class="subclass"> SubClassOf </span>Petechiae<br><span class="keyword"> and </span>Purpura Adverse Event. <br><i>New Terms: CTCAE Grade 2 Petechiae and Purpura, Petechiae and Purpura Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1819</td>
               <td colspan="2">CTCAE Grade 2 Phantom Pain Associated with Missing Limb<span class="subclass"> SubClassOf </span>Phantom Pain Associated with Missing Limb Adverse Event. <br><i>New Terms: Phantom Pain Associated with Missing Limb Adverse Event, CTCAE Grade 2 Phantom Pain
                     Associated with Missing Limb</i></td>
            </tr>
            <tr class="addition">
               <td>1820</td>
               <td colspan="2">CTCAE Grade 2 Pharynx GI Fistula<span class="subclass"> SubClassOf </span>Pharynx GI Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 2 Pharynx GI Fistula, Pharynx GI Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1821</td>
               <td colspan="2">CTCAE Grade 2 Pharynx Hemorrhage<span class="subclass"> SubClassOf </span>Pharynx Hemorrhage Adverse Event. <br><i>New Terms: Pharynx Hemorrhage Adverse Event, CTCAE Grade 2 Pharynx Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>1822</td>
               <td colspan="2">CTCAE Grade 2 Pharynx Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Pharynx Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Pharynx Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Pharynx Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1823</td>
               <td colspan="2">CTCAE Grade 2 Pharynx Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Pharynx Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Pharynx Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 2 Pharynx Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1824</td>
               <td colspan="2">CTCAE Grade 2 Pharynx Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Pharynx Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 2 Pharynx Infection with Unknown Absolute Neutrophil Count, Pharynx Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1825</td>
               <td colspan="2">CTCAE Grade 2 Pharynx Intra-Operative Injury<span class="subclass"> SubClassOf </span>Pharynx Intra-Operative Injury Adverse Event. <br><i>New Terms: Pharynx Intra-Operative Injury Adverse Event, CTCAE Grade 2 Pharynx Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1826</td>
               <td colspan="2">CTCAE Grade 2 Pharynx Leak<span class="subclass"> SubClassOf </span>Pharynx Leak Adverse Event. <br><i>New Terms: CTCAE Grade 2 Pharynx Leak, Pharynx Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1827</td>
               <td colspan="2">CTCAE Grade 2 Pharynx Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Pharynx Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification. <br><i>New Terms: CTCAE Grade 2 Pharynx Mucositis or Stomatitis by Clinical Examination Classification,
                     Pharynx Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>1828</td>
               <td colspan="2">CTCAE Grade 2 Pharynx Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Pharynx Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: Pharynx Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification,
                     CTCAE Grade 2 Pharynx Mucositis or Stomatitis by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>1829</td>
               <td colspan="2">CTCAE Grade 2 Pharynx Obstruction<br><span class="keyword"> and </span>Stenosis<span class="subclass"> SubClassOf </span>Pharynx Obstruction<br><span class="keyword"> and </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 2 Pharynx Obstruction and Stenosis, Pharynx Obstruction and Stenosis Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1830</td>
               <td colspan="2">CTCAE Grade 2 Pharynx Pulmonary Fistula<span class="subclass"> SubClassOf </span>Pharynx Pulmonary Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 2 Pharynx Pulmonary Fistula, Pharynx Pulmonary Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1831</td>
               <td colspan="2">CTCAE Grade 2 Pharynx Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Pharynx Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Pharynx Stricture or Stenosis Adverse Event, CTCAE Grade 2 Pharynx Stricture or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>1832</td>
               <td colspan="2">CTCAE Grade 2 Phlebitis Including Superficial Thrombosis<span class="subclass"> SubClassOf </span>Phlebitis Including Superficial Thrombosis Adverse Event. <br><i>New Terms: CTCAE Grade 2 Phlebitis Including Superficial Thrombosis, Phlebitis Including Superficial
                     Thrombosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1833</td>
               <td colspan="2">CTCAE Grade 2 Phlebolymphatic Cording<span class="subclass"> SubClassOf </span>Phlebolymphatic Cording Adverse Event. <br><i>New Terms: Phlebolymphatic Cording Adverse Event, CTCAE Grade 2 Phlebolymphatic Cording</i></td>
            </tr>
            <tr class="addition">
               <td>1834</td>
               <td colspan="2">CTCAE Grade 2 Photophobia<span class="subclass"> SubClassOf </span>Photophobia Adverse Event. <br><i>New Terms: Photophobia Adverse Event, CTCAE Grade 2 Photophobia</i></td>
            </tr>
            <tr class="addition">
               <td>1835</td>
               <td colspan="2">CTCAE Grade 2 Photosensitivity<span class="subclass"> SubClassOf </span>Photosensitivity Adverse Event. <br><i>New Terms: Photosensitivity Adverse Event, CTCAE Grade 2 Photosensitivity</i></td>
            </tr>
            <tr class="addition">
               <td>1836</td>
               <td colspan="2">CTCAE Grade 2 Phrenic Nerve Dysfunction<span class="subclass"> SubClassOf </span>Phrenic Nerve Dysfunction Adverse Event. <br><i>New Terms: CTCAE Grade 2 Phrenic Nerve Dysfunction, Phrenic Nerve Dysfunction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1837</td>
               <td colspan="2">CTCAE Grade 2 Pituitary Intra-Operative Injury<span class="subclass"> SubClassOf </span>Pituitary Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Pituitary Intra-Operative Injury, Pituitary Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1838</td>
               <td colspan="2">CTCAE Grade 2 Platelets<span class="subclass"> SubClassOf </span>Platelets Adverse Event. <br><i>New Terms: CTCAE Grade 2 Platelets, Platelets Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1839</td>
               <td colspan="2">CTCAE Grade 2 Pleura Fistula<span class="subclass"> SubClassOf </span>Pleura Fistula Adverse Event. <br><i>New Terms: Pleura Fistula Adverse Event, CTCAE Grade 2 Pleura Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>1840</td>
               <td colspan="2">CTCAE Grade 2 Pleura Hemorrhage<span class="subclass"> SubClassOf </span>Pleura Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 2 Pleura Hemorrhage, Pleura Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1841</td>
               <td colspan="2">CTCAE Grade 2 Pleura Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Pleura Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Pleura Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Pleura Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1842</td>
               <td colspan="2">CTCAE Grade 2 Pleura Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Pleura Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Pleura Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Pleura Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1843</td>
               <td colspan="2">CTCAE Grade 2 Pleura Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Pleura Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Pleura Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     2 Pleura Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1844</td>
               <td colspan="2">CTCAE Grade 2 Pleura Intra-Operative Injury<span class="subclass"> SubClassOf </span>Pleura Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Pleura Intra-Operative Injury, Pleura Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1845</td>
               <td colspan="2">CTCAE Grade 2 Pleura Pain<span class="subclass"> SubClassOf </span>Pleura Pain Adverse Event. <br><i>New Terms: Pleura Pain Adverse Event, CTCAE Grade 2 Pleura Pain</i></td>
            </tr>
            <tr class="addition">
               <td>1846</td>
               <td colspan="2">CTCAE Grade 2 Pneumonitis<br><span class="keyword"> and </span>Pulmonary Infiltrates<span class="subclass"> SubClassOf </span>Pneumonitis<br><span class="keyword"> and </span>Pulmonary Infiltrates Adverse Event. <br><i>New Terms: Pneumonitis and Pulmonary Infiltrates Adverse Event, CTCAE Grade 2 Pneumonitis and
                     Pulmonary Infiltrates</i></td>
            </tr>
            <tr class="addition">
               <td>1847</td>
               <td colspan="2">CTCAE Grade 2 Pneumothorax<span class="subclass"> SubClassOf </span>Pneumothorax Adverse Event. <br><i>New Terms: Pneumothorax Adverse Event, CTCAE Grade 2 Pneumothorax</i></td>
            </tr>
            <tr class="addition">
               <td>1848</td>
               <td colspan="2">CTCAE Grade 2 Portal Vein Flow<span class="subclass"> SubClassOf </span>Portal Vein Flow Adverse Event. <br><i>New Terms: Portal Vein Flow Adverse Event, CTCAE Grade 2 Portal Vein Flow</i></td>
            </tr>
            <tr class="addition">
               <td>1849</td>
               <td colspan="2">CTCAE Grade 2 Portal Vein Intra-Operative Injury<span class="subclass"> SubClassOf </span>Portal Vein Intra-Operative Injury Adverse Event. <br><i>New Terms: Portal Vein Intra-Operative Injury Adverse Event, CTCAE Grade 2 Portal Vein Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1850</td>
               <td colspan="2">CTCAE Grade 2 Precocious Puberty<span class="subclass"> SubClassOf </span>Precocious Puberty Adverse Event. <br><i>New Terms: CTCAE Grade 2 Precocious Puberty, Precocious Puberty Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1851</td>
               <td colspan="2">CTCAE Grade 2 Proctitis<span class="subclass"> SubClassOf </span>Proctitis Adverse Event. <br><i>New Terms: Proctitis Adverse Event, CTCAE Grade 2 Proctitis</i></td>
            </tr>
            <tr class="addition">
               <td>1852</td>
               <td colspan="2">CTCAE Grade 2 Prolapse of Gastrointestinal Stoma<span class="subclass"> SubClassOf </span>Prolapse of Gastrointestinal Stoma Adverse Event. <br><i>New Terms: CTCAE Grade 2 Prolapse of Gastrointestinal Stoma, Prolapse of Gastrointestinal Stoma
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1853</td>
               <td colspan="2">CTCAE Grade 2 Prolonged Chest Tube Drainage<br><span class="keyword"> or </span>Air Leak After Pulmonary Resection<span class="subclass"> SubClassOf </span>Prolonged Chest Tube Drainage<br><span class="keyword"> or </span>Air Leak After Pulmonary Resection Adverse Event. <br><i>New Terms: CTCAE Grade 2 Prolonged Chest Tube Drainage or Air Leak After Pulmonary Resection,
                     Prolonged Chest Tube Drainage or Air Leak After Pulmonary Resection Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1854</td>
               <td colspan="2">CTCAE Grade 2 Prolonged Intubation After Pulmonary Resection<span class="subclass"> SubClassOf </span>Prolonged Intubation After Pulmonary Resection Adverse Event. <br><i>New Terms: Prolonged Intubation After Pulmonary Resection Adverse Event, CTCAE Grade 2 Prolonged
                     Intubation After Pulmonary Resection</i></td>
            </tr>
            <tr class="addition">
               <td>1855</td>
               <td colspan="2">CTCAE Grade 2 Prolonged QTc Interval<span class="subclass"> SubClassOf </span>Prolonged QTc Interval Adverse Event. <br><i>New Terms: Prolonged QTc Interval Adverse Event, CTCAE Grade 2 Prolonged QTc Interval</i></td>
            </tr>
            <tr class="addition">
               <td>1856</td>
               <td colspan="2">CTCAE Grade 2 Proptosis<br><span class="keyword"> and </span>Enophthalmos<span class="subclass"> SubClassOf </span>Proptosis<br><span class="keyword"> and </span>Enophthalmos Adverse Event. <br><i>New Terms: CTCAE Grade 2 Proptosis and Enophthalmos, Proptosis and Enophthalmos Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1857</td>
               <td colspan="2">CTCAE Grade 2 Prostate Hemorrhage<span class="subclass"> SubClassOf </span>Prostate Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 2 Prostate Hemorrhage, Prostate Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1858</td>
               <td colspan="2">CTCAE Grade 2 Prostate Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Prostate Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Prostate Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 2 Prostate Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1859</td>
               <td colspan="2">CTCAE Grade 2 Prostate Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Prostate Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Prostate Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, CTCAE Grade 2 Prostate Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1860</td>
               <td colspan="2">CTCAE Grade 2 Prostate Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Prostate Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 2 Prostate Infection with Unknown Absolute Neutrophil Count, Prostate
                     Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1861</td>
               <td colspan="2">CTCAE Grade 2 Prostate Intra-Operative Injury<span class="subclass"> SubClassOf </span>Prostate Intra-Operative Injury Adverse Event. <br><i>New Terms: Prostate Intra-Operative Injury Adverse Event, CTCAE Grade 2 Prostate Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1862</td>
               <td colspan="2">CTCAE Grade 2 Prostate Obstruction<span class="subclass"> SubClassOf </span>Prostate Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 2 Prostate Obstruction, Prostate Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1863</td>
               <td colspan="2">CTCAE Grade 2 Prostate Pain<span class="subclass"> SubClassOf </span>Prostate Pain Adverse Event. <br><i>New Terms: Prostate Pain Adverse Event, CTCAE Grade 2 Prostate Pain</i></td>
            </tr>
            <tr class="addition">
               <td>1864</td>
               <td colspan="2">CTCAE Grade 2 Prostate Perforation<span class="subclass"> SubClassOf </span>Prostate Perforation Adverse Event. <br><i>New Terms: Prostate Perforation Adverse Event, CTCAE Grade 2 Prostate Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>1865</td>
               <td colspan="2">CTCAE Grade 2 Prostate Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Prostate Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Prostate Stricture or Stenosis Adverse Event, CTCAE Grade 2 Prostate Stricture or
                     Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>1866</td>
               <td colspan="2">CTCAE Grade 2 Proteinuria<span class="subclass"> SubClassOf </span>Proteinuria Adverse Event. <br><i>New Terms: Proteinuria Adverse Event, CTCAE Grade 2 Proteinuria</i></td>
            </tr>
            <tr class="addition">
               <td>1867</td>
               <td colspan="2">CTCAE Grade 2 Pruritus<span class="subclass"> SubClassOf </span>Pruritus Adverse Event. <br><i>New Terms: Pruritus Adverse Event, CTCAE Grade 2 Pruritus</i></td>
            </tr>
            <tr class="addition">
               <td>1868</td>
               <td colspan="2">CTCAE Grade 2 Psychosis Including Hallucinations<br><span class="keyword"> and </span>Delusions<span class="subclass"> SubClassOf </span>Psychosis Including Hallucinations<br><span class="keyword"> and </span>Delusions Adverse Event. <br><i>New Terms: CTCAE Grade 2 Psychosis Including Hallucinations and Delusions, Psychosis Including
                     Hallucinations and Delusions Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1870</td>
               <td colspan="2">CTCAE Grade 2 Pulmonary Fibrosis Radiographic Changes<span class="subclass"> SubClassOf </span>Pulmonary Fibrosis Radiographic Changes Adverse Event. <br><i>New Terms: Pulmonary Fibrosis Radiographic Changes Adverse Event, CTCAE Grade 2 Pulmonary Fibrosis
                     Radiographic Changes</i></td>
            </tr>
            <tr class="addition">
               <td>1871</td>
               <td colspan="2">CTCAE Grade 2 Pulmonary Hypertension<span class="subclass"> SubClassOf </span>Pulmonary Hypertension Adverse Event. <br><i>New Terms: CTCAE Grade 2 Pulmonary Hypertension, Pulmonary Hypertension Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1872</td>
               <td colspan="2">CTCAE Grade 2 Pulmonary Vein Intra-Operative Injury<span class="subclass"> SubClassOf </span>Pulmonary Vein Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Pulmonary Vein Intra-Operative Injury, Pulmonary Vein Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1873</td>
               <td colspan="2">CTCAE Grade 2 Pyramidal Tract Dysfunction<span class="subclass"> SubClassOf </span>Pyramidal Tract Dysfunction Adverse Event. <br><i>New Terms: Pyramidal Tract Dysfunction Adverse Event, CTCAE Grade 2 Pyramidal Tract Dysfunction</i></td>
            </tr>
            <tr class="addition">
               <td>1874</td>
               <td colspan="2">CTCAE Grade 2 Radiation Excluding Chemoradiation<span class="subclass"> SubClassOf </span>Rash<br><span class="keyword"> and </span>Dermatitis Adverse Event Associated with Radiation Excluding Chemoradiation. <br><i>New Terms: CTCAE Grade 2 Radiation Excluding Chemoradiation, Rash and Dermatitis Adverse Event
                     Associated with Radiation Excluding Chemoradiation</i></td>
            </tr>
            <tr class="addition">
               <td>1875</td>
               <td colspan="2">CTCAE Grade 2 Rash Acne<br><span class="keyword"> or </span>Acneiform Adverse Event<span class="subclass"> SubClassOf </span>Rash Acne<br><span class="keyword"> or </span>Acneiform Adverse Event. <br><i>New Terms: Rash Acne or Acneiform Adverse Event, CTCAE Grade 2 Rash Acne or Acneiform Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1876</td>
               <td colspan="2">CTCAE Grade 2 Rash Desquamation<span class="subclass"> SubClassOf </span>Rash Desquamation Adverse Event. <br><i>New Terms: Rash Desquamation Adverse Event, CTCAE Grade 2 Rash Desquamation</i></td>
            </tr>
            <tr class="addition">
               <td>1877</td>
               <td colspan="2">CTCAE Grade 2 Rash Erythema Multiforme<span class="subclass"> SubClassOf </span>Rash Erythema Multiforme Adverse Event. <br><i>New Terms: CTCAE Grade 2 Rash Erythema Multiforme, Rash Erythema Multiforme Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1878</td>
               <td colspan="2">CTCAE Grade 2 Rash Hand<br><span class="keyword"> or </span>Foot Skin Reaction<span class="subclass"> SubClassOf </span>Rash Hand<br><span class="keyword"> or </span>Foot Skin Reaction Adverse Event. <br><i>New Terms: Rash Hand or Foot Skin Reaction Adverse Event, CTCAE Grade 2 Rash Hand or Foot Skin
                     Reaction</i></td>
            </tr>
            <tr class="addition">
               <td>1879</td>
               <td colspan="2">CTCAE Grade 2 Rectal Varices Hemorrhage<span class="subclass"> SubClassOf </span>Rectal Varices Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 2 Rectal Varices Hemorrhage, Rectal Varices Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1880</td>
               <td colspan="2">CTCAE Grade 2 Rectum Fistula<span class="subclass"> SubClassOf </span>Rectum Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 2 Rectum Fistula, Rectum Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1881</td>
               <td colspan="2">CTCAE Grade 2 Rectum Hemorrhage<span class="subclass"> SubClassOf </span>Rectum Hemorrhage Adverse Event. <br><i>New Terms: Rectum Hemorrhage Adverse Event, CTCAE Grade 2 Rectum Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>1882</td>
               <td colspan="2">CTCAE Grade 2 Rectum Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Rectum Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Rectum Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Rectum Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1883</td>
               <td colspan="2">CTCAE Grade 2 Rectum Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Rectum Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Rectum Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 2 Rectum Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1884</td>
               <td colspan="2">CTCAE Grade 2 Rectum Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Rectum Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Rectum Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     2 Rectum Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1885</td>
               <td colspan="2">CTCAE Grade 2 Rectum Intra-Operative Injury<span class="subclass"> SubClassOf </span>Rectum Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Rectum Intra-Operative Injury, Rectum Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1886</td>
               <td colspan="2">CTCAE Grade 2 Rectum Leak<span class="subclass"> SubClassOf </span>Rectum Leak Adverse Event. <br><i>New Terms: CTCAE Grade 2 Rectum Leak, Rectum Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1887</td>
               <td colspan="2">CTCAE Grade 2 Rectum Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Rectum Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification. <br><i>New Terms: Rectum Mucositis or Stomatitis by Clinical Examination Classification, CTCAE Grade
                     2 Rectum Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>1888</td>
               <td colspan="2">CTCAE Grade 2 Rectum Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Rectum Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: Rectum Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification,
                     CTCAE Grade 2 Rectum Mucositis or Stomatitis by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>1889</td>
               <td colspan="2">CTCAE Grade 2 Rectum Obstruction<span class="subclass"> SubClassOf </span>Rectum Obstruction Adverse Event. <br><i>New Terms: Rectum Obstruction Adverse Event, CTCAE Grade 2 Rectum Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>1890</td>
               <td colspan="2">CTCAE Grade 2 Rectum Pain<span class="subclass"> SubClassOf </span>Rectum Pain Adverse Event. <br><i>New Terms: Rectum Pain Adverse Event, CTCAE Grade 2 Rectum Pain</i></td>
            </tr>
            <tr class="addition">
               <td>1891</td>
               <td colspan="2">CTCAE Grade 2 Rectum Perforation<span class="subclass"> SubClassOf </span>Rectum Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 2 Rectum Perforation, Rectum Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1892</td>
               <td colspan="2">CTCAE Grade 2 Rectum Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Rectum Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Rectum Stricture or Stenosis Adverse Event, CTCAE Grade 2 Rectum Stricture or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>1893</td>
               <td colspan="2">CTCAE Grade 2 Rectum Ulcer<span class="subclass"> SubClassOf </span>Rectum Ulcer Adverse Event. <br><i>New Terms: Rectum Ulcer Adverse Event, CTCAE Grade 2 Rectum Ulcer</i></td>
            </tr>
            <tr class="addition">
               <td>1894</td>
               <td colspan="2">CTCAE Grade 2 Recurrent Laryngeal Nerve Intra-Operative Injury<span class="subclass"> SubClassOf </span>Recurrent Laryngeal Nerve Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Recurrent Laryngeal Nerve Intra-Operative Injury, Recurrent Laryngeal
                     Nerve Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1895</td>
               <td colspan="2">CTCAE Grade 2 Reduction in Growth Velocity<span class="subclass"> SubClassOf </span>Reduction in Growth Velocity Adverse Event. <br><i>New Terms: CTCAE Grade 2 Reduction in Growth Velocity, Reduction in Growth Velocity Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1896</td>
               <td colspan="2">CTCAE Grade 2 Respiratory Tract Hemorrhage NOS<span class="subclass"> SubClassOf </span>Respiratory Tract Hemorrhage Adverse Event NOS. <br><i>New Terms: Respiratory Tract Hemorrhage Adverse Event NOS, CTCAE Grade 2 Respiratory Tract Hemorrhage
                     NOS</i></td>
            </tr>
            <tr class="addition">
               <td>1897</td>
               <td colspan="2">CTCAE Grade 2 Restrictive Cardiomyopathy<span class="subclass"> SubClassOf </span>Restrictive Cardiomyopathy Adverse Event. <br><i>New Terms: Restrictive Cardiomyopathy Adverse Event, CTCAE Grade 2 Restrictive Cardiomyopathy</i></td>
            </tr>
            <tr class="addition">
               <td>1898</td>
               <td colspan="2">CTCAE Grade 2 Retina Intra-Operative Injury<span class="subclass"> SubClassOf </span>Retina Intra-Operative Injury Adverse Event. <br><i>New Terms: Retina Intra-Operative Injury Adverse Event, CTCAE Grade 2 Retina Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1899</td>
               <td colspan="2">CTCAE Grade 2 Retinal Detachment<span class="subclass"> SubClassOf </span>Retinal Detachment Adverse Event. <br><i>New Terms: Retinal Detachment Adverse Event, CTCAE Grade 2 Retinal Detachment</i></td>
            </tr>
            <tr class="addition">
               <td>1900</td>
               <td colspan="2">CTCAE Grade 2 Retinoic Acid Syndrome<span class="subclass"> SubClassOf </span>Retinoic Acid Syndrome Adverse Event. <br><i>New Terms: Retinoic Acid Syndrome Adverse Event, CTCAE Grade 2 Retinoic Acid Syndrome</i></td>
            </tr>
            <tr class="addition">
               <td>1901</td>
               <td colspan="2">CTCAE Grade 2 Retinopathy<span class="subclass"> SubClassOf </span>Retinopathy Adverse Event. <br><i>New Terms: CTCAE Grade 2 Retinopathy, Retinopathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1902</td>
               <td colspan="2">CTCAE Grade 2 Retroperitoneum Hemorrhage<span class="subclass"> SubClassOf </span>Retroperitoneum Hemorrhage Adverse Event. <br><i>New Terms: Retroperitoneum Hemorrhage Adverse Event, CTCAE Grade 2 Retroperitoneum Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>1904</td>
               <td colspan="2">CTCAE Grade 2 Right Ventricular Dysfunction<span class="subclass"> SubClassOf </span>Right Ventricular Dysfunction Adverse Event. <br><i>New Terms: Right Ventricular Dysfunction Adverse Event, CTCAE Grade 2 Right Ventricular Dysfunction</i></td>
            </tr>
            <tr class="addition">
               <td>1903</td>
               <td colspan="2">CTCAE Grade 2 Right-Sided Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Right-Sided Muscle Weakness Not Due to Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 2 Right-Sided Muscle Weakness Not Due to Neuropathy, Right-Sided Muscle
                     Weakness Not Due to Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1905</td>
               <td colspan="2">CTCAE Grade 2 Rigors<br><span class="keyword"> and </span>Chills<span class="subclass"> SubClassOf </span>Rigors<br><span class="keyword"> and </span>Chills Adverse Event. <br><i>New Terms: Rigors and Chills Adverse Event, CTCAE Grade 2 Rigors and Chills</i></td>
            </tr>
            <tr class="addition">
               <td>1906</td>
               <td colspan="2">CTCAE Grade 2 Sacral Plexus Intra-Operative Injury<span class="subclass"> SubClassOf </span>Sacral Plexus Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Sacral Plexus Intra-Operative Injury, Sacral Plexus Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1907</td>
               <td colspan="2">CTCAE Grade 2 Salivary Duct Intra-Operative Injury<span class="subclass"> SubClassOf </span>Salivary Duct Intra-Operative Injury Adverse Event. <br><i>New Terms: Salivary Duct Intra-Operative Injury Adverse Event, CTCAE Grade 2 Salivary Duct Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1908</td>
               <td colspan="2">CTCAE Grade 2 Salivary Gland Fistula<span class="subclass"> SubClassOf </span>Salivary Gland Fistula. <br><i>New Terms: CTCAE Grade 2 Salivary Gland Fistula, Salivary Gland Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>1909</td>
               <td colspan="2">CTCAE Grade 2 Salivary Gland Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Salivary Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Salivary Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 2 Salivary Gland Infection Documented Clinically or
                     Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1910</td>
               <td colspan="2">CTCAE Grade 2 Salivary Gland Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Salivary Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Salivary Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, CTCAE Grade 2 Salivary Gland Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1911</td>
               <td colspan="2">CTCAE Grade 2 Salivary Gland Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Salivary Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Salivary Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     2 Salivary Gland Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1912</td>
               <td colspan="2">CTCAE Grade 2 Salivary Gland Intra-Operative Injury<span class="subclass"> SubClassOf </span>Salivary Gland Intra-Operative Injury Adverse Event. <br><i>New Terms: Salivary Gland Intra-Operative Injury Adverse Event, CTCAE Grade 2 Salivary Gland
                     Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1913</td>
               <td colspan="2">CTCAE Grade 2 Salivary Gland<br><span class="keyword"> or </span>Saliva Changes<span class="subclass"> SubClassOf </span>Salivary Gland<br><span class="keyword"> or </span>Saliva Changes Adverse Event. <br><i>New Terms: Salivary Gland or Saliva Changes Adverse Event, CTCAE Grade 2 Salivary Gland or Saliva
                     Changes</i></td>
            </tr>
            <tr class="addition">
               <td>1914</td>
               <td colspan="2">CTCAE Grade 2 Scalp Pain<span class="subclass"> SubClassOf </span>Scalp Pain Adverse Event. <br><i>New Terms: Scalp Pain Adverse Event, CTCAE Grade 2 Scalp Pain</i></td>
            </tr>
            <tr class="addition">
               <td>1915</td>
               <td colspan="2">CTCAE Grade 2 Sciatic Nerve Intra-Operative Injury<span class="subclass"> SubClassOf </span>Sciatic Nerve Intra-Operative Injury Adverse Event. <br><i>New Terms: Sciatic Nerve Intra-Operative Injury Adverse Event, CTCAE Grade 2 Sciatic Nerve Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1916</td>
               <td colspan="2">CTCAE Grade 2 Scleral Necrosis<br><span class="keyword"> and </span>Melt<span class="subclass"> SubClassOf </span>Scleral Necrosis<br><span class="keyword"> and </span>Melt Adverse Event. <br><i>New Terms: CTCAE Grade 2 Scleral Necrosis and Melt, Scleral Necrosis and Melt Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1917</td>
               <td colspan="2">CTCAE Grade 2 Scrotum Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Scrotum Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Scrotum Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Scrotum Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1918</td>
               <td colspan="2">CTCAE Grade 2 Scrotum Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Scrotum Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Scrotum Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Scrotum Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1919</td>
               <td colspan="2">CTCAE Grade 2 Scrotum Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Scrotum Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 2 Scrotum Infection with Unknown Absolute Neutrophil Count, Scrotum Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1920</td>
               <td colspan="2">CTCAE Grade 2 Scrotum Intra-Operative Injury<span class="subclass"> SubClassOf </span>Scrotum Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Scrotum Intra-Operative Injury, Scrotum Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>1921</td>
               <td colspan="2">CTCAE Grade 2 Scrotum Pain<span class="subclass"> SubClassOf </span>Scrotum Pain Adverse Event. <br><i>New Terms: CTCAE Grade 2 Scrotum Pain, Scrotum Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1922</td>
               <td colspan="2">CTCAE Grade 2 Seizure<span class="subclass"> SubClassOf </span>Seizure Adverse Event. <br><i>New Terms: CTCAE Grade 2 Seizure, Seizure Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1923</td>
               <td colspan="2">CTCAE Grade 2 Sensory Neuropathy<span class="subclass"> SubClassOf </span>Sensory Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 2 Sensory Neuropathy, Sensory Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1924</td>
               <td colspan="2">CTCAE Grade 2 Seroma<span class="subclass"> SubClassOf </span>Seroma Adverse Event. <br><i>New Terms: CTCAE Grade 2 Seroma, Seroma Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1925</td>
               <td colspan="2">CTCAE Grade 2 Serum Glutamic Oxaloacetic Transaminase<span class="subclass"> SubClassOf </span>Serum Glutamic Oxaloacetic Transaminase Adverse Event. <br><i>New Terms: CTCAE Grade 2 Serum Glutamic Oxaloacetic Transaminase, Serum Glutamic Oxaloacetic
                     Transaminase Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1926</td>
               <td colspan="2">CTCAE Grade 2 Serum Glutamic Pyruvic Transaminase<span class="subclass"> SubClassOf </span>Serum Glutamic Pyruvic Transaminase Adverse Event. <br><i>New Terms: CTCAE Grade 2 Serum Glutamic Pyruvic Transaminase, Serum Glutamic Pyruvic Transaminase
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1927</td>
               <td colspan="2">CTCAE Grade 2 Serum Hypercalcemia<span class="subclass"> SubClassOf </span>Serum Hypercalcemia Adverse Event. <br><i>New Terms: CTCAE Grade 2 Serum Hypercalcemia, Serum Hypercalcemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1928</td>
               <td colspan="2">CTCAE Grade 2 Serum Hypercholesteremia<span class="subclass"> SubClassOf </span>Serum Hypercholesteremia Adverse Event. <br><i>New Terms: CTCAE Grade 2 Serum Hypercholesteremia, Serum Hypercholesteremia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1929</td>
               <td colspan="2">CTCAE Grade 2 Serum Hyperglycemia<span class="subclass"> SubClassOf </span>Serum Hyperglycemia Adverse Event. <br><i>New Terms: Serum Hyperglycemia Adverse Event, CTCAE Grade 2 Serum Hyperglycemia</i></td>
            </tr>
            <tr class="addition">
               <td>1930</td>
               <td colspan="2">CTCAE Grade 2 Serum Hyperkalemia<span class="subclass"> SubClassOf </span>Serum Hyperkalemia Adverse Event. <br><i>New Terms: Serum Hyperkalemia Adverse Event, CTCAE Grade 2 Serum Hyperkalemia</i></td>
            </tr>
            <tr class="addition">
               <td>1931</td>
               <td colspan="2">CTCAE Grade 2 Serum Hypernatremia<span class="subclass"> SubClassOf </span>Serum Hypernatremia Adverse Event. <br><i>New Terms: Serum Hypernatremia Adverse Event, CTCAE Grade 2 Serum Hypernatremia</i></td>
            </tr>
            <tr class="addition">
               <td>1932</td>
               <td colspan="2">CTCAE Grade 2 Serum Hypertriglyceridemia<span class="subclass"> SubClassOf </span>Serum Hypertriglyceridemia Adverse Event. <br><i>New Terms: CTCAE Grade 2 Serum Hypertriglyceridemia, Serum Hypertriglyceridemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1933</td>
               <td colspan="2">CTCAE Grade 2 Serum Hypoalbuminemia<span class="subclass"> SubClassOf </span>Serum Hypoalbuminemia Adverse Event. <br><i>New Terms: CTCAE Grade 2 Serum Hypoalbuminemia, Serum Hypoalbuminemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1934</td>
               <td colspan="2">CTCAE Grade 2 Serum Hypocalcemia<span class="subclass"> SubClassOf </span>Serum Hypocalcemia Adverse Event. <br><i>New Terms: CTCAE Grade 2 Serum Hypocalcemia, Serum Hypocalcemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1935</td>
               <td colspan="2">CTCAE Grade 2 Serum Hypoglycemia<span class="subclass"> SubClassOf </span>Serum Hypoglycemia Adverse Event. <br><i>New Terms: Serum Hypoglycemia Adverse Event, CTCAE Grade 2 Serum Hypoglycemia</i></td>
            </tr>
            <tr class="addition">
               <td>1936</td>
               <td colspan="2">CTCAE Grade 2 Serum Hypomagnesemia<span class="subclass"> SubClassOf </span>Serum Hypomagnesemia Adverse Event. <br><i>New Terms: Serum Hypomagnesemia Adverse Event, CTCAE Grade 2 Serum Hypomagnesemia</i></td>
            </tr>
            <tr class="addition">
               <td>1937</td>
               <td colspan="2">CTCAE Grade 2 Serum Hypophosphatemia<span class="subclass"> SubClassOf </span>Serum Hypophosphatemia Adverse Event. <br><i>New Terms: Serum Hypophosphatemia Adverse Event, CTCAE Grade 2 Serum Hypophosphatemia</i></td>
            </tr>
            <tr class="addition">
               <td>1938</td>
               <td colspan="2">CTCAE Grade 2 Short Stature<span class="subclass"> SubClassOf </span>Short Stature Adverse Event. <br><i>New Terms: CTCAE Grade 2 Short Stature, Short Stature Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1939</td>
               <td colspan="2">CTCAE Grade 2 Sick Sinus Syndrome<span class="subclass"> SubClassOf </span>Sick Sinus Syndrome Adverse Event. <br><i>New Terms: CTCAE Grade 2 Sick Sinus Syndrome, Sick Sinus Syndrome Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1940</td>
               <td colspan="2">CTCAE Grade 2 Sinus Arrhythmia<span class="subclass"> SubClassOf </span>Sinus Arrhythmia Adverse Event. <br><i>New Terms: CTCAE Grade 2 Sinus Arrhythmia, Sinus Arrhythmia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1941</td>
               <td colspan="2">CTCAE Grade 2 Sinus Bradycardia<span class="subclass"> SubClassOf </span>Sinus Bradycardia Adverse Event. <br><i>New Terms: CTCAE Grade 2 Sinus Bradycardia, Sinus Bradycardia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1942</td>
               <td colspan="2">CTCAE Grade 2 Sinus Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Sinus Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Sinus Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Sinus Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1943</td>
               <td colspan="2">CTCAE Grade 2 Sinus Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Sinus Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Sinus Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 2 Sinus Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1944</td>
               <td colspan="2">CTCAE Grade 2 Sinus Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Sinus Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 2 Sinus Infection with Unknown Absolute Neutrophil Count, Sinus Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1945</td>
               <td colspan="2">CTCAE Grade 2 Sinus Intra-Operative Injury<span class="subclass"> SubClassOf </span>Sinus Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Sinus Intra-Operative Injury, Sinus Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1946</td>
               <td colspan="2">CTCAE Grade 2 Sinus Pain<span class="subclass"> SubClassOf </span>Sinus Pain Adverse Event. <br><i>New Terms: Sinus Pain Adverse Event, CTCAE Grade 2 Sinus Pain</i></td>
            </tr>
            <tr class="addition">
               <td>1947</td>
               <td colspan="2">CTCAE Grade 2 Sinus Tachycardia<span class="subclass"> SubClassOf </span>Sinus Tachycardia Adverse Event. <br><i>New Terms: Sinus Tachycardia Adverse Event, CTCAE Grade 2 Sinus Tachycardia</i></td>
            </tr>
            <tr class="addition">
               <td>1948</td>
               <td colspan="2">CTCAE Grade 2 Skin Atrophy<span class="subclass"> SubClassOf </span>Skin Atrophy Adverse Event. <br><i>New Terms: Skin Atrophy Adverse Event, CTCAE Grade 2 Skin Atrophy</i></td>
            </tr>
            <tr class="addition">
               <td>1949</td>
               <td colspan="2">CTCAE Grade 2 Skin Breakdown<br><span class="keyword"> or </span>Decubitus Ulcer<span class="subclass"> SubClassOf </span>Skin Breakdown<br><span class="keyword"> or </span>Decubitus Ulcer Adverse Event. <br><i>New Terms: CTCAE Grade 2 Skin Breakdown or Decubitus Ulcer, Skin Breakdown or Decubitus Ulcer
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1950</td>
               <td colspan="2">CTCAE Grade 2 Skin Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Skin Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Skin Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Skin Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1951</td>
               <td colspan="2">CTCAE Grade 2 Skin Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Skin Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Skin Infection with Normal Absolute Neutrophil Count or Grade 1 or 2
                     Neutrophils, Skin Infection Adverse Event with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1952</td>
               <td colspan="2">CTCAE Grade 2 Skin Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Skin Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 2 Skin Infection with Unknown Absolute Neutrophil Count, Skin Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1953</td>
               <td colspan="2">CTCAE Grade 2 Skin Intra-Operative Injury<span class="subclass"> SubClassOf </span>Skin Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Skin Intra-Operative Injury, Skin Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1954</td>
               <td colspan="2">CTCAE Grade 2 Skin Pain<span class="subclass"> SubClassOf </span>Skin Pain Adverse Event. <br><i>New Terms: CTCAE Grade 2 Skin Pain, Skin Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1955</td>
               <td colspan="2">CTCAE Grade 2 Slipped Capital Femoral Epiphysis<span class="subclass"> SubClassOf </span>Slipped Capital Femoral Epiphysis Adverse Event. <br><i>New Terms: Slipped Capital Femoral Epiphysis Adverse Event, CTCAE Grade 2 Slipped Capital Femoral
                     Epiphysis</i></td>
            </tr>
            <tr class="addition">
               <td>1956</td>
               <td colspan="2">CTCAE Grade 2 Small Bowel Fistula NOS<span class="subclass"> SubClassOf </span>Small Bowel Fistula Adverse Event NOS. <br><i>New Terms: CTCAE Grade 2 Small Bowel Fistula NOS, Small Bowel Fistula Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>1957</td>
               <td colspan="2">CTCAE Grade 2 Small Bowel Infection NOS Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Small Bowel Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Small Bowel Infection NOS Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, CTCAE Grade 2 Small Bowel Infection NOS Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1958</td>
               <td colspan="2">CTCAE Grade 2 Small Bowel Infection NOS with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Small Bowel Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Small Bowel Infection NOS Adverse Event with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, CTCAE Grade 2 Small Bowel Infection NOS with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1959</td>
               <td colspan="2">CTCAE Grade 2 Small Bowel Infection NOS with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Small Bowel Infection NOS Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Small Bowel Infection NOS Adverse Event with Unknown Absolute Neutrophil Count, CTCAE
                     Grade 2 Small Bowel Infection NOS with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1960</td>
               <td colspan="2">CTCAE Grade 2 Small Bowel Leak<span class="subclass"> SubClassOf </span>Small Bowel Leak Adverse Event. <br><i>New Terms: CTCAE Grade 2 Small Bowel Leak, Small Bowel Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1961</td>
               <td colspan="2">CTCAE Grade 2 Small Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Small Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification. <br><i>New Terms: Small Bowel Mucositis or Stomatitis by Clinical Examination Classification, CTCAE
                     Grade 2 Small Bowel Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>1962</td>
               <td colspan="2">CTCAE Grade 2 Small Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Small Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: CTCAE Grade 2 Small Bowel Mucositis or Stomatitis by Functional or Symptomatic Classification,
                     Small Bowel Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>1963</td>
               <td colspan="2">CTCAE Grade 2 Small Bowel NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Small Bowel NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: Small Bowel NOS Intra-Operative Injury Adverse Event, CTCAE Grade 2 Small Bowel NOS
                     Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1964</td>
               <td colspan="2">CTCAE Grade 2 Small Bowel Obstruction NOS<span class="subclass"> SubClassOf </span>Small Bowel Obstruction Adverse Event NOS. <br><i>New Terms: Small Bowel Obstruction Adverse Event NOS, CTCAE Grade 2 Small Bowel Obstruction NOS</i></td>
            </tr>
            <tr class="addition">
               <td>1965</td>
               <td colspan="2">CTCAE Grade 2 Small Bowel Perforation NOS<span class="subclass"> SubClassOf </span>Small Bowel Perforation Adverse Event NOS. <br><i>New Terms: CTCAE Grade 2 Small Bowel Perforation NOS, Small Bowel Perforation Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>1966</td>
               <td colspan="2">CTCAE Grade 2 Small Bowel Stricture<br><span class="keyword"> or </span>Stenosis NOS<span class="subclass"> SubClassOf </span>Small Bowel Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event NOS. <br><i>New Terms: CTCAE Grade 2 Small Bowel Stricture or Stenosis NOS, Small Bowel Stricture or Stenosis
                     Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>1967</td>
               <td colspan="2">CTCAE Grade 2 Small Bowel Ulcer NOS<span class="subclass"> SubClassOf </span>Small Bowel Ulcer Adverse Event NOS. <br><i>New Terms: CTCAE Grade 2 Small Bowel Ulcer NOS, Small Bowel Ulcer Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>1968</td>
               <td colspan="2">CTCAE Grade 2 Soft Tissue Infection NOS Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Soft Tissue Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Soft Tissue Infection NOS Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, Soft Tissue Infection NOS Adverse Event Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1969</td>
               <td colspan="2">CTCAE Grade 2 Soft Tissue Infection NOS with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Soft Tissue Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Soft Tissue Infection NOS with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, Soft Tissue Infection NOS Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1970</td>
               <td colspan="2">CTCAE Grade 2 Soft Tissue Infection NOS with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Soft Tissue Infection NOS Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Soft Tissue Infection NOS Adverse Event with Unknown Absolute Neutrophil Count, CTCAE
                     Grade 2 Soft Tissue Infection NOS with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1971</td>
               <td colspan="2">CTCAE Grade 2 Soft Tissue NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Soft Tissue NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: Soft Tissue NOS Intra-Operative Injury Adverse Event, CTCAE Grade 2 Soft Tissue NOS
                     Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1972</td>
               <td colspan="2">CTCAE Grade 2 Somnolence<br><span class="keyword"> and </span>Depressed Level of Consciousness<span class="subclass"> SubClassOf </span>Somnolence<br><span class="keyword"> and </span>Depressed Level of Consciousness Adverse Event. <br><i>New Terms: Somnolence and Depressed Level of Consciousness Adverse Event, CTCAE Grade 2 Somnolence
                     and Depressed Level of Consciousness</i></td>
            </tr>
            <tr class="addition">
               <td>1973</td>
               <td colspan="2">CTCAE Grade 2 Speech Impairment<span class="subclass"> SubClassOf </span>Speech Impairment Adverse Event. <br><i>New Terms: Speech Impairment Adverse Event, CTCAE Grade 2 Speech Impairment</i></td>
            </tr>
            <tr class="addition">
               <td>1974</td>
               <td colspan="2">CTCAE Grade 2 Spermatic Cord Hemorrhage<span class="subclass"> SubClassOf </span>Spermatic Cord Hemorrhage Adverse Event. <br><i>New Terms: Spermatic Cord Hemorrhage Adverse Event, CTCAE Grade 2 Spermatic Cord Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>1975</td>
               <td colspan="2">CTCAE Grade 2 Spermatic Cord Leak<span class="subclass"> SubClassOf </span>Spermatic Cord Leak Adverse Event. <br><i>New Terms: Spermatic Cord Leak Adverse Event, CTCAE Grade 2 Spermatic Cord Leak</i></td>
            </tr>
            <tr class="addition">
               <td>1976</td>
               <td colspan="2">CTCAE Grade 2 Spermatic Cord Obstruction<span class="subclass"> SubClassOf </span>Spermatic Cord Obstruction Adverse Event. <br><i>New Terms: Spermatic Cord Obstruction Adverse Event, CTCAE Grade 2 Spermatic Cord Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>1977</td>
               <td colspan="2">CTCAE Grade 2 Spermatic Cord Perforation<span class="subclass"> SubClassOf </span>Spermatic Cord Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 2 Spermatic Cord Perforation, Spermatic Cord Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1978</td>
               <td colspan="2">CTCAE Grade 2 Spermatic Cord Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Spermatic Cord Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Spermatic Cord Stricture or Stenosis Adverse Event, CTCAE Grade 2 Spermatic Cord Stricture
                     or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>1979</td>
               <td colspan="2">CTCAE Grade 2 Spinal Cord Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Spinal Cord Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Spinal Cord Infection Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, Spinal Cord Infection Adverse Event Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1980</td>
               <td colspan="2">CTCAE Grade 2 Spinal Cord Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Spinal Cord Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Spinal Cord Infection Adverse Event with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, CTCAE Grade 2 Spinal Cord Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1981</td>
               <td colspan="2">CTCAE Grade 2 Spinal Cord Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Spinal Cord Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Spinal Cord Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE
                     Grade 2 Spinal Cord Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1982</td>
               <td colspan="2">CTCAE Grade 2 Spinal Cord Intra-Operative Injury<span class="subclass"> SubClassOf </span>Spinal Cord Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Spinal Cord Intra-Operative Injury, Spinal Cord Intra-Operative Injury
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1983</td>
               <td colspan="2">CTCAE Grade 2 Spine Kyphosis<br><span class="keyword"> or </span>Lordosis<span class="subclass"> SubClassOf </span>Spine Kyphosis<br><span class="keyword"> or </span>Lordosis Adverse Event. <br><i>New Terms: Spine Kyphosis or Lordosis Adverse Event, CTCAE Grade 2 Spine Kyphosis or Lordosis</i></td>
            </tr>
            <tr class="addition">
               <td>1984</td>
               <td colspan="2">CTCAE Grade 2 Spine Scoliosis<span class="subclass"> SubClassOf </span>Spine Scoliosis Adverse Event. <br><i>New Terms: CTCAE Grade 2 Spine Scoliosis, Spine Scoliosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1985</td>
               <td colspan="2">CTCAE Grade 2 Spleen Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Spleen Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Spleen Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 2 Spleen Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1986</td>
               <td colspan="2">CTCAE Grade 2 Spleen Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Spleen Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Spleen Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 2 Spleen Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1987</td>
               <td colspan="2">CTCAE Grade 2 Spleen Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Spleen Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 2 Spleen Infection with Unknown Absolute Neutrophil Count, Spleen Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>1988</td>
               <td colspan="2">CTCAE Grade 2 Spleen Intra-Operative Injury<span class="subclass"> SubClassOf </span>Spleen Intra-Operative Injury Adverse Event. <br><i>New Terms: Spleen Intra-Operative Injury Adverse Event, CTCAE Grade 2 Spleen Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>1989</td>
               <td colspan="2">CTCAE Grade 2 Splenic Function<span class="subclass"> SubClassOf </span>Splenic Function Adverse Event. <br><i>New Terms: Splenic Function Adverse Event, CTCAE Grade 2 Splenic Function</i></td>
            </tr>
            <tr class="addition">
               <td>1990</td>
               <td colspan="2">CTCAE Grade 2 Stokes-Adams Syndrome<span class="subclass"> SubClassOf </span>Stokes-Adams Syndrome Adverse Event. <br><i>New Terms: CTCAE Grade 2 Stokes-Adams Syndrome, Stokes-Adams Syndrome Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1991</td>
               <td colspan="2">CTCAE Grade 2 Stoma GI Obstruction<span class="subclass"> SubClassOf </span>Gastrointestinal Stoma Obstruction Adverse Event. <br><i>New Terms: Gastrointestinal Stoma Obstruction Adverse Event, CTCAE Grade 2 Stoma GI Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>1992</td>
               <td colspan="2">CTCAE Grade 2 Stoma GI Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Stoma GI Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Stoma GI Stricture or Stenosis Adverse Event, CTCAE Grade 2 Stoma GI Stricture or
                     Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>1993</td>
               <td colspan="2">CTCAE Grade 2 Stoma Perforation<span class="subclass"> SubClassOf </span>Stoma Perforation Adverse Event. <br><i>New Terms: Stoma Perforation Adverse Event, CTCAE Grade 2 Stoma Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>1994</td>
               <td colspan="2">CTCAE Grade 2 Stoma Pulmonary Hemorrhage<span class="subclass"> SubClassOf </span>Pulmonary Stoma Hemorrhage Adverse Event. <br><i>New Terms: Pulmonary Stoma Hemorrhage Adverse Event, CTCAE Grade 2 Stoma Pulmonary Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>1995</td>
               <td colspan="2">CTCAE Grade 2 Stoma Ulcer<span class="subclass"> SubClassOf </span>Stoma Ulcer Adverse Event. <br><i>New Terms: CTCAE Grade 2 Stoma Ulcer, Stoma Ulcer Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1996</td>
               <td colspan="2">CTCAE Grade 2 Stomach Fistula<span class="subclass"> SubClassOf </span>Stomach Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 2 Stomach Fistula, Stomach Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1997</td>
               <td colspan="2">CTCAE Grade 2 Stomach Hemorrhage<span class="subclass"> SubClassOf </span>Stomach Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 2 Stomach Hemorrhage, Stomach Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1998</td>
               <td colspan="2">CTCAE Grade 2 Stomach Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Stomach Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Stomach Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Stomach Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>1999</td>
               <td colspan="2">CTCAE Grade 2 Stomach Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Stomach Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Stomach Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Stomach Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2000</td>
               <td colspan="2">CTCAE Grade 2 Stomach Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Stomach Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 2 Stomach Infection with Unknown Absolute Neutrophil Count, Stomach Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2001</td>
               <td colspan="2">CTCAE Grade 2 Stomach Intra-Operative Injury<span class="subclass"> SubClassOf </span>Stomach Intra-Operative Injury Adverse Event. <br><i>New Terms: Stomach Intra-Operative Injury Adverse Event, CTCAE Grade 2 Stomach Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2002</td>
               <td colspan="2">CTCAE Grade 2 Stomach Leak<span class="subclass"> SubClassOf </span>Stomach Leak Adverse Event. <br><i>New Terms: Stomach Leak Adverse Event, CTCAE Grade 2 Stomach Leak</i></td>
            </tr>
            <tr class="addition">
               <td>2003</td>
               <td colspan="2">CTCAE Grade 2 Stomach Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Stomach Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification. <br><i>New Terms: CTCAE Grade 2 Stomach Mucositis or Stomatitis by Clinical Examination Classification,
                     Stomach Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>2004</td>
               <td colspan="2">CTCAE Grade 2 Stomach Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Stomach Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: CTCAE Grade 2 Stomach Mucositis or Stomatitis by Functional or Symptomatic Classification,
                     Stomach Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>2005</td>
               <td colspan="2">CTCAE Grade 2 Stomach Obstruction<span class="subclass"> SubClassOf </span>Stomach Obstruction Adverse Event. <br><i>New Terms: Stomach Obstruction Adverse Event, CTCAE Grade 2 Stomach Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>2006</td>
               <td colspan="2">CTCAE Grade 2 Stomach Pain<span class="subclass"> SubClassOf </span>Stomach Pain Adverse Event. <br><i>New Terms: Stomach Pain Adverse Event, CTCAE Grade 2 Stomach Pain</i></td>
            </tr>
            <tr class="addition">
               <td>2007</td>
               <td colspan="2">CTCAE Grade 2 Stomach Perforation<span class="subclass"> SubClassOf </span>Stomach Perforation Adverse Event. <br><i>New Terms: Stomach Perforation Adverse Event, CTCAE Grade 2 Stomach Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>2008</td>
               <td colspan="2">CTCAE Grade 2 Stomach Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Stomach Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 2 Stomach Stricture or Stenosis, Stomach Stricture or Stenosis Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>2009</td>
               <td colspan="2">CTCAE Grade 2 Stomach Ulcer<span class="subclass"> SubClassOf </span>Stomach Ulcer Adverse Event. <br><i>New Terms: CTCAE Grade 2 Stomach Ulcer, Stomach Ulcer Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2010</td>
               <td colspan="2">CTCAE Grade 2 Striae<span class="subclass"> SubClassOf </span>Striae Adverse Event. <br><i>New Terms: Striae Adverse Event, CTCAE Grade 2 Striae</i></td>
            </tr>
            <tr class="addition">
               <td>2011</td>
               <td colspan="2">CTCAE Grade 2 Subcutaneous Fat Atrophy<span class="subclass"> SubClassOf </span>Subcutaneous Fat Atrophy. <br><i>New Terms: CTCAE Grade 2 Subcutaneous Fat Atrophy, Subcutaneous Fat Atrophy</i></td>
            </tr>
            <tr class="addition">
               <td>2012</td>
               <td colspan="2">CTCAE Grade 2 Superior Vena Cava Intra-Operative Injury<span class="subclass"> SubClassOf </span>Superior Vena Cava Intra-Operative Injury Adverse Event. <br><i>New Terms: Superior Vena Cava Intra-Operative Injury Adverse Event, CTCAE Grade 2 Superior Vena
                     Cava Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2013</td>
               <td colspan="2">CTCAE Grade 2 Superior Vena Cava Vein Injury<span class="subclass"> SubClassOf </span>Superior Vena Cava Vein Injury Adverse Event. <br><i>New Terms: Superior Vena Cava Vein Injury Adverse Event, CTCAE Grade 2 Superior Vena Cava Vein
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2014</td>
               <td colspan="2">CTCAE Grade 2 Supraventricular Arrhythmia NOS<span class="subclass"> SubClassOf </span>Supraventricular Arrhythmia Adverse Event NOS. <br><i>New Terms: Supraventricular Arrhythmia Adverse Event NOS, CTCAE Grade 2 Supraventricular Arrhythmia
                     NOS</i></td>
            </tr>
            <tr class="addition">
               <td>2015</td>
               <td colspan="2">CTCAE Grade 2 Supraventricular Extrasystoles<span class="subclass"> SubClassOf </span>Supraventricular Extrasystoles Adverse Event. <br><i>New Terms: Supraventricular Extrasystoles Adverse Event, CTCAE Grade 2 Supraventricular Extrasystoles</i></td>
            </tr>
            <tr class="addition">
               <td>2016</td>
               <td colspan="2">CTCAE Grade 2 Supraventricular Tachycardia<span class="subclass"> SubClassOf </span>Supraventricular Tachycardia Adverse Event. <br><i>New Terms: Supraventricular Tachycardia Adverse Event, CTCAE Grade 2 Supraventricular Tachycardia</i></td>
            </tr>
            <tr class="addition">
               <td>2017</td>
               <td colspan="2">CTCAE Grade 2 Taste Alteration<span class="subclass"> SubClassOf </span>Taste Alteration Adverse Event. <br><i>New Terms: Taste Alteration Adverse Event, CTCAE Grade 2 Taste Alteration</i></td>
            </tr>
            <tr class="addition">
               <td>2018</td>
               <td colspan="2">CTCAE Grade 2 Teeth Intra-Operative Injury<span class="subclass"> SubClassOf </span>Teeth Intra-Operative Injury Adverse Event. <br><i>New Terms: Teeth Intra-Operative Injury Adverse Event, CTCAE Grade 2 Teeth Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2019</td>
               <td colspan="2">CTCAE Grade 2 Telangiectasia<span class="subclass"> SubClassOf </span>Telangiectasia Adverse Event. <br><i>New Terms: Telangiectasia Adverse Event, CTCAE Grade 2 Telangiectasia</i></td>
            </tr>
            <tr class="addition">
               <td>2020</td>
               <td colspan="2">CTCAE Grade 2 Tendon Intra-Operative Injury<span class="subclass"> SubClassOf </span>Tendon Intra-Operative Injury Adverse Event. <br><i>New Terms: Tendon Intra-Operative Injury Adverse Event, CTCAE Grade 2 Tendon Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2021</td>
               <td colspan="2">CTCAE Grade 2 Testes Hemorrhage<span class="subclass"> SubClassOf </span>Testes Hemorrhage Adverse Event. <br><i>New Terms: Testes Hemorrhage Adverse Event, CTCAE Grade 2 Testes Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>2022</td>
               <td colspan="2">CTCAE Grade 2 Testes Obstruction<span class="subclass"> SubClassOf </span>Testes Obstruction Adverse Event. <br><i>New Terms: Testes Obstruction Adverse Event, CTCAE Grade 2 Testes Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>2023</td>
               <td colspan="2">CTCAE Grade 2 Testes Perforation<span class="subclass"> SubClassOf </span>Testes Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 2 Testes Perforation, Testes Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2024</td>
               <td colspan="2">CTCAE Grade 2 Testes Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Testes Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 2 Testes Stricture or Stenosis, Testes Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2025</td>
               <td colspan="2">CTCAE Grade 2 Testicle Pain<span class="subclass"> SubClassOf </span>Testicle Pain Adverse Event. <br><i>New Terms: Testicle Pain Adverse Event, CTCAE Grade 2 Testicle Pain</i></td>
            </tr>
            <tr class="addition">
               <td>2026</td>
               <td colspan="2">CTCAE Grade 2 Testis Intra-Operative Injury<span class="subclass"> SubClassOf </span>Testis Intra-Operative Injury Adverse Event. <br><i>New Terms: Testis Intra-Operative Injury Adverse Event, CTCAE Grade 2 Testis Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2027</td>
               <td colspan="2">CTCAE Grade 2 Thoracic Duct Intra-Operative Injury<span class="subclass"> SubClassOf </span>Thoracic Duct Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Thoracic Duct Intra-Operative Injury, Thoracic Duct Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2028</td>
               <td colspan="2">CTCAE Grade 2 Thoracodorsal Nerve Intra-Operative Injury<span class="subclass"> SubClassOf </span>Thoracodorsal Nerve Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Thoracodorsal Nerve Intra-Operative Injury, Thoracodorsal Nerve Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2029</td>
               <td colspan="2">CTCAE Grade 2 Thorax Soft Tissue Necrosis<span class="subclass"> SubClassOf </span>Thorax Soft Tissue Necrosis Adverse Event. <br><i>New Terms: Thorax Soft Tissue Necrosis Adverse Event, CTCAE Grade 2 Thorax Soft Tissue Necrosis</i></td>
            </tr>
            <tr class="addition">
               <td>2030</td>
               <td colspan="2">CTCAE Grade 2 Throat<br><span class="keyword"> and </span>Pharynx<br><span class="keyword"> and </span>Larynx Pain<span class="subclass"> SubClassOf </span>Throat<br><span class="keyword"> and </span>Pharynx<br><span class="keyword"> and </span>Larynx Pain Adverse Event. <br><i>New Terms: Throat and Pharynx and Larynx Pain Adverse Event, CTCAE Grade 2 Throat and Pharynx
                     and Larynx Pain</i></td>
            </tr>
            <tr class="addition">
               <td>2031</td>
               <td colspan="2">CTCAE Grade 2 Thrombosis<br><span class="keyword"> or </span>Embolism Vascular Access Related<span class="subclass"> SubClassOf </span>Thrombosis<br><span class="keyword"> or </span>Embolism Vascular Access Related Adverse Event. <br><i>New Terms: CTCAE Grade 2 Thrombosis or Embolism Vascular Access Related, Thrombosis or Embolism
                     Vascular Access Related Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2032</td>
               <td colspan="2">CTCAE Grade 2 Thrombosis<br><span class="keyword"> or </span>Thrombus<br><span class="keyword"> or </span>Embolism<span class="subclass"> SubClassOf </span>Thrombosis<br><span class="keyword"> or </span>Thrombus<br><span class="keyword"> or </span>Embolism Adverse Event. <br><i>New Terms: CTCAE Grade 2 Thrombosis or Thrombus or Embolism, Thrombosis or Thrombus or Embolism
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2033</td>
               <td colspan="2">CTCAE Grade 2 Thyroid Function High<span class="subclass"> SubClassOf </span>Thyroid Function High Adverse Event. <br><i>New Terms: Thyroid Function High Adverse Event, CTCAE Grade 2 Thyroid Function High</i></td>
            </tr>
            <tr class="addition">
               <td>2034</td>
               <td colspan="2">CTCAE Grade 2 Thyroid Function Low<span class="subclass"> SubClassOf </span>Thyroid Function Low Adverse Event. <br><i>New Terms: Thyroid Function Low Adverse Event, CTCAE Grade 2 Thyroid Function Low</i></td>
            </tr>
            <tr class="addition">
               <td>2035</td>
               <td colspan="2">CTCAE Grade 2 Thyroid Intra-Operative Injury<span class="subclass"> SubClassOf </span>Thyroid Intra-Operative Injury Adverse Event. <br><i>New Terms: Thyroid Intra-Operative Injury Adverse Event, CTCAE Grade 2 Thyroid Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2036</td>
               <td colspan="2">CTCAE Grade 2 Tinnitus<span class="subclass"> SubClassOf </span>Tinnitus Adverse Event. <br><i>New Terms: Tinnitus Adverse Event, CTCAE Grade 2 Tinnitus</i></td>
            </tr>
            <tr class="addition">
               <td>2037</td>
               <td colspan="2">CTCAE Grade 2 Tongue Intra-Operative Injury<span class="subclass"> SubClassOf </span>Tongue Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Tongue Intra-Operative Injury, Tongue Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>2038</td>
               <td colspan="2">CTCAE Grade 2 Tooth Development<span class="subclass"> SubClassOf </span>Tooth Development Adverse Event. <br><i>New Terms: CTCAE Grade 2 Tooth Development, Tooth Development Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2039</td>
               <td colspan="2">CTCAE Grade 2 Torsade de Pointes<span class="subclass"> SubClassOf </span>Torsade de Pointes Adverse Event. <br><i>New Terms: Torsade de Pointes Adverse Event, CTCAE Grade 2 Torsade de Pointes</i></td>
            </tr>
            <tr class="addition">
               <td>2040</td>
               <td colspan="2">CTCAE Grade 2 Trachea Fistula<span class="subclass"> SubClassOf </span>Trachea Fistula Adverse Event. <br><i>New Terms: Trachea Fistula Adverse Event, CTCAE Grade 2 Trachea Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>2041</td>
               <td colspan="2">CTCAE Grade 2 Trachea Hemorrhage<span class="subclass"> SubClassOf </span>Trachea Hemorrhage Adverse Event. <br><i>New Terms: Trachea Hemorrhage Adverse Event, CTCAE Grade 2 Trachea Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>2042</td>
               <td colspan="2">CTCAE Grade 2 Trachea Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Trachea Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Trachea Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 2 Trachea Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2043</td>
               <td colspan="2">CTCAE Grade 2 Trachea Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Trachea Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Trachea Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 2 Trachea Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2044</td>
               <td colspan="2">CTCAE Grade 2 Trachea Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Trachea Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Trachea Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     2 Trachea Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2045</td>
               <td colspan="2">CTCAE Grade 2 Trachea Intra-Operative Injury<span class="subclass"> SubClassOf </span>Trachea Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Trachea Intra-Operative Injury, Trachea Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>2046</td>
               <td colspan="2">CTCAE Grade 2 Trachea Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Trachea Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification. <br><i>New Terms: CTCAE Grade 2 Trachea Mucositis or Stomatitis by Clinical Examination Classification,
                     Trachea Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>2047</td>
               <td colspan="2">CTCAE Grade 2 Trachea Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Trachea Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: Trachea Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification,
                     CTCAE Grade 2 Trachea Mucositis or Stomatitis by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>2048</td>
               <td colspan="2">CTCAE Grade 2 Trachea Obstruction<br><span class="keyword"> and </span>Stenosis<span class="subclass"> SubClassOf </span>Trachea Obstruction<br><span class="keyword"> and </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 2 Trachea Obstruction and Stenosis, Trachea Obstruction and Stenosis Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>2049</td>
               <td colspan="2">CTCAE Grade 2 Tremor<span class="subclass"> SubClassOf </span>Tremor Adverse Event. <br><i>New Terms: Tremor Adverse Event, CTCAE Grade 2 Tremor</i></td>
            </tr>
            <tr class="addition">
               <td>2050</td>
               <td colspan="2">CTCAE Grade 2 Trigeminy<span class="subclass"> SubClassOf </span>Trigeminy Adverse Event. <br><i>New Terms: Trigeminy Adverse Event, CTCAE Grade 2 Trigeminy</i></td>
            </tr>
            <tr class="addition">
               <td>2051</td>
               <td colspan="2">CTCAE Grade 2 Trismus<span class="subclass"> SubClassOf </span>Trismus Adverse Event. <br><i>New Terms: CTCAE Grade 2 Trismus, Trismus Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2052</td>
               <td colspan="2">CTCAE Grade 2 Trunk Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Trunk Muscle Weakness Not Due to Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 2 Trunk Muscle Weakness Not Due to Neuropathy, Trunk Muscle Weakness Not
                     Due to Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2053</td>
               <td colspan="2">CTCAE Grade 2 Tumor Flare<span class="subclass"> SubClassOf </span>Tumor Flare Adverse Event. <br><i>New Terms: CTCAE Grade 2 Tumor Flare, Tumor Flare Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2054</td>
               <td colspan="2">CTCAE Grade 2 Tumor Pain<span class="subclass"> SubClassOf </span>Tumor Pain Adverse Event. <br><i>New Terms: CTCAE Grade 2 Tumor Pain, Tumor Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2055</td>
               <td colspan="2">CTCAE Grade 2 Typhlitis<span class="subclass"> SubClassOf </span>Typhlitis Adverse Event. <br><i>New Terms: CTCAE Grade 2 Typhlitis, Typhlitis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2056</td>
               <td colspan="2">CTCAE Grade 2 Ulceration<span class="subclass"> SubClassOf </span>Ulceration Adverse Event. <br><i>New Terms: Ulceration Adverse Event, CTCAE Grade 2 Ulceration</i></td>
            </tr>
            <tr class="addition">
               <td>2057</td>
               <td colspan="2">CTCAE Grade 2 Ungual Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Ungual Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Ungual Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 2 Ungual Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2058</td>
               <td colspan="2">CTCAE Grade 2 Ungual Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Ungual Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Ungual Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 2 Ungual Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2059</td>
               <td colspan="2">CTCAE Grade 2 Ungual Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Ungual Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 2 Ungual Infection with Unknown Absolute Neutrophil Count, Ungual Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2060</td>
               <td colspan="2">CTCAE Grade 2 Upper Aerodigestive Infection NOS Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Upper Aerodigestive Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Upper Aerodigestive Infection NOS Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, Upper Aerodigestive Infection NOS Adverse Event Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2061</td>
               <td colspan="2">CTCAE Grade 2 Upper Aerodigestive Infection NOS with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Upper Aerodigestive Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Upper Aerodigestive Infection NOS with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils, Upper Aerodigestive Infection NOS Adverse Event with
                     Normal Absolute Neutrophil Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2062</td>
               <td colspan="2">CTCAE Grade 2 Upper Aerodigestive Infection NOS with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Upper Aerodigestive Infection NOS Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 2 Upper Aerodigestive Infection NOS with Unknown Absolute Neutrophil Count,
                     Upper Aerodigestive Infection NOS Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2063</td>
               <td colspan="2">CTCAE Grade 2 Upper Aerodigestive NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Upper Aerodigestive NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Upper Aerodigestive NOS Intra-Operative Injury, Upper Aerodigestive
                     NOS Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2064</td>
               <td colspan="2">CTCAE Grade 2 Upper Airway Infection NOS Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Upper Airway Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Upper Airway Infection NOS Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, CTCAE Grade 2 Upper Airway Infection NOS Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2065</td>
               <td colspan="2">CTCAE Grade 2 Upper Airway Infection NOS with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Upper Airway Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Upper Airway Infection NOS Adverse Event with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils, CTCAE Grade 2 Upper Airway Infection NOS with Normal Absolute
                     Neutrophil Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2066</td>
               <td colspan="2">CTCAE Grade 2 Upper Airway Infection NOS with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Upper Airway Infection NOS Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 2 Upper Airway Infection NOS with Unknown Absolute Neutrophil Count, Upper
                     Airway Infection NOS Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2067</td>
               <td colspan="2">CTCAE Grade 2 Upper Airway NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Upper Airway NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Upper Airway NOS Intra-Operative Injury, Upper Airway NOS Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2068</td>
               <td colspan="2">CTCAE Grade 2 Upper Extremity Artery Injury<span class="subclass"> SubClassOf </span>Upper Extremity Artery Injury Adverse Event. <br><i>New Terms: Upper Extremity Artery Injury Adverse Event, CTCAE Grade 2 Upper Extremity Artery
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2069</td>
               <td colspan="2">CTCAE Grade 2 Upper Extremity Artery Intra-Operative Injury<span class="subclass"> SubClassOf </span>Upper Extremity Artery Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Upper Extremity Artery Intra-Operative Injury, Upper Extremity Artery
                     Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2070</td>
               <td colspan="2">CTCAE Grade 2 Upper Extremity Function<span class="subclass"> SubClassOf </span>Upper Extremity Function Adverse Event. <br><i>New Terms: Upper Extremity Function Adverse Event, CTCAE Grade 2 Upper Extremity Function</i></td>
            </tr>
            <tr class="addition">
               <td>2071</td>
               <td colspan="2">CTCAE Grade 2 Upper Extremity Intra-Operative Injury<span class="subclass"> SubClassOf </span>Upper Extremity Intra-Operative Injury Adverse Event. <br><i>New Terms: Upper Extremity Intra-Operative Injury Adverse Event, CTCAE Grade 2 Upper Extremity
                     Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2072</td>
               <td colspan="2">CTCAE Grade 2 Upper Extremity Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Upper Extremity Muscle Weakness Adverse Event Not Due to Neuropathy. <br><i>New Terms: CTCAE Grade 2 Upper Extremity Muscle Weakness Not Due to Neuropathy, Upper Extremity
                     Muscle Weakness Adverse Event Not Due to Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>2073</td>
               <td colspan="2">CTCAE Grade 2 Upper Extremity Soft Tissue Necrosis Adverse Event<span class="subclass"> SubClassOf </span>Upper Extremity Soft Tissue Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 2 Upper Extremity Soft Tissue Necrosis Adverse Event, Upper Extremity
                     Soft Tissue Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2074</td>
               <td colspan="2">CTCAE Grade 2 Upper Extremity Vein Injury<span class="subclass"> SubClassOf </span>Upper Extremity Vein Injury Adverse Event. <br><i>New Terms: Upper Extremity Vein Injury Adverse Event, CTCAE Grade 2 Upper Extremity Vein Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2075</td>
               <td colspan="2">CTCAE Grade 2 Upper Extremity Vein Intra-Operative Injury<span class="subclass"> SubClassOf </span>Upper Extremity Vein Intra-Operative Injury Adverse Event. <br><i>New Terms: Upper Extremity Vein Intra-Operative Injury Adverse Event, CTCAE Grade 2 Upper Extremity
                     Vein Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2076</td>
               <td colspan="2">CTCAE Grade 2 Upper Gastrointestinal Hemorrhage NOS<span class="subclass"> SubClassOf </span>Upper Gastrointestinal Hemorrhage Adverse Event NOS. <br><i>New Terms: CTCAE Grade 2 Upper Gastrointestinal Hemorrhage NOS, Upper Gastrointestinal Hemorrhage
                     Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>2077</td>
               <td colspan="2">CTCAE Grade 2 Ureter Fistula<span class="subclass"> SubClassOf </span>Ureter Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 2 Ureter Fistula, Ureter Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2078</td>
               <td colspan="2">CTCAE Grade 2 Ureter Hemorrhage<span class="subclass"> SubClassOf </span>Ureter Hemorrhage Adverse Event. <br><i>New Terms: Ureter Hemorrhage Adverse Event, CTCAE Grade 2 Ureter Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>2079</td>
               <td colspan="2">CTCAE Grade 2 Ureter Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Ureter Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Ureter Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 2 Ureter Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2080</td>
               <td colspan="2">CTCAE Grade 2 Ureter Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Ureter Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Ureter Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 2 Ureter Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2081</td>
               <td colspan="2">CTCAE Grade 2 Ureter Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Ureter Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 2 Ureter Infection with Unknown Absolute Neutrophil Count, Ureter Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2082</td>
               <td colspan="2">CTCAE Grade 2 Ureter Intra-Operative Injury<span class="subclass"> SubClassOf </span>Ureter Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Ureter Intra-Operative Injury, Ureter Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>2083</td>
               <td colspan="2">CTCAE Grade 2 Ureter Leak<span class="subclass"> SubClassOf </span>Ureter Leak Adverse Event. <br><i>New Terms: CTCAE Grade 2 Ureter Leak, Ureter Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2084</td>
               <td colspan="2">CTCAE Grade 2 Ureter Obstruction<span class="subclass"> SubClassOf </span>Ureter Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 2 Ureter Obstruction, Ureter Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2085</td>
               <td colspan="2">CTCAE Grade 2 Ureter Perforation<span class="subclass"> SubClassOf </span>Ureter Perforation Adverse Event. <br><i>New Terms: Ureter Perforation Adverse Event, CTCAE Grade 2 Ureter Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>2086</td>
               <td colspan="2">CTCAE Grade 2 Ureter Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Ureter Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Ureter Stricture or Stenosis Adverse Event, CTCAE Grade 2 Ureter Stricture or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>2087</td>
               <td colspan="2">CTCAE Grade 2 Urethra Fistula<span class="subclass"> SubClassOf </span>Urethra Fistula Adverse Event. <br><i>New Terms: Urethra Fistula Adverse Event, CTCAE Grade 2 Urethra Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>2088</td>
               <td colspan="2">CTCAE Grade 2 Urethra Hemorrhage<span class="subclass"> SubClassOf </span>Urethra Hemorrhage Adverse Event. <br><i>New Terms: Urethra Hemorrhage Adverse Event, CTCAE Grade 2 Urethra Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>2089</td>
               <td colspan="2">CTCAE Grade 2 Urethra Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Urethra Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Urethra Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 2 Urethra Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2090</td>
               <td colspan="2">CTCAE Grade 2 Urethra Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Urethra Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Urethra Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Urethra Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2091</td>
               <td colspan="2">CTCAE Grade 2 Urethra Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Urethra Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Urethra Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     2 Urethra Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2092</td>
               <td colspan="2">CTCAE Grade 2 Urethra Intra-Operative Injury<span class="subclass"> SubClassOf </span>Urethra Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Urethra Intra-Operative Injury, Urethra Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>2093</td>
               <td colspan="2">CTCAE Grade 2 Urethra Leak<span class="subclass"> SubClassOf </span>Urethra Leak Adverse Event. <br><i>New Terms: CTCAE Grade 2 Urethra Leak, Urethra Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2094</td>
               <td colspan="2">CTCAE Grade 2 Urethra Obstruction<span class="subclass"> SubClassOf </span>Urethra Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 2 Urethra Obstruction, Urethra Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2095</td>
               <td colspan="2">CTCAE Grade 2 Urethra Pain<span class="subclass"> SubClassOf </span>Urethra Pain Adverse Event. <br><i>New Terms: CTCAE Grade 2 Urethra Pain, Urethra Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2096</td>
               <td colspan="2">CTCAE Grade 2 Urethra Perforation<span class="subclass"> SubClassOf </span>Urethra Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 2 Urethra Perforation, Urethra Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2097</td>
               <td colspan="2">CTCAE Grade 2 Urethra Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Urethra Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 2 Urethra Stricture or Stenosis, Urethra Stricture or Stenosis Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>2098</td>
               <td colspan="2">CTCAE Grade 2 Urinary Conduit Intra-Operative Injury<span class="subclass"> SubClassOf </span>Urinary Conduit Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Urinary Conduit Intra-Operative Injury, Urinary Conduit Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2099</td>
               <td colspan="2">CTCAE Grade 2 Urinary Electrolyte Wasting<span class="subclass"> SubClassOf </span>Urinary Electrolyte Wasting Adverse Event. <br><i>New Terms: CTCAE Grade 2 Urinary Electrolyte Wasting, Urinary Electrolyte Wasting Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2100</td>
               <td colspan="2">CTCAE Grade 2 Urinary Frequency<br><span class="keyword"> or </span>Urgency<span class="subclass"> SubClassOf </span>Urinary Frequency<br><span class="keyword"> or </span>Urgency Adverse Event. <br><i>New Terms: CTCAE Grade 2 Urinary Frequency or Urgency, Urinary Frequency or Urgency Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2101</td>
               <td colspan="2">CTCAE Grade 2 Urinary Hemorrhage NOS<span class="subclass"> SubClassOf </span>Urinary Hemorrhage Adverse Event NOS. <br><i>New Terms: CTCAE Grade 2 Urinary Hemorrhage NOS, Urinary Hemorrhage Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>2102</td>
               <td colspan="2">CTCAE Grade 2 Urinary Incontinence<span class="subclass"> SubClassOf </span>Urinary Incontinence Adverse Event. <br><i>New Terms: CTCAE Grade 2 Urinary Incontinence, Urinary Incontinence Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2103</td>
               <td colspan="2">CTCAE Grade 2 Urinary Retention<span class="subclass"> SubClassOf </span>Urinary Retention Adverse Event. <br><i>New Terms: Urinary Retention Adverse Event, CTCAE Grade 2 Urinary Retention</i></td>
            </tr>
            <tr class="addition">
               <td>2104</td>
               <td colspan="2">CTCAE Grade 2 Urinary Tract Infection NOS Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Urinary Tract Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Urinary Tract Infection NOS Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, Urinary Tract Infection NOS Adverse Event Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2105</td>
               <td colspan="2">CTCAE Grade 2 Urinary Tract Infection NOS with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Urinary Tract Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Urinary Tract Infection NOS Adverse Event with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils, CTCAE Grade 2 Urinary Tract Infection NOS with Normal Absolute
                     Neutrophil Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2106</td>
               <td colspan="2">CTCAE Grade 2 Urinary Tract Infection NOS with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Urinary Tract Infection NOS Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 2 Urinary Tract Infection NOS with Unknown Absolute Neutrophil Count,
                     Urinary Tract Infection NOS Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2107</td>
               <td colspan="2">CTCAE Grade 2 Urinary Tract NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Urinary Tract NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Urinary Tract NOS Intra-Operative Injury, Urinary Tract NOS Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2108</td>
               <td colspan="2">CTCAE Grade 2 Urticaria<span class="subclass"> SubClassOf </span>Urticaria Adverse Reaction. <br><i>New Terms: Urticaria Adverse Reaction, CTCAE Grade 2 Urticaria</i></td>
            </tr>
            <tr class="addition">
               <td>2109</td>
               <td colspan="2">CTCAE Grade 2 Uterus Fistula<span class="subclass"> SubClassOf </span>Uterus Fistula Adverse Event. <br><i>New Terms: Uterus Fistula Adverse Event, CTCAE Grade 2 Uterus Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>2110</td>
               <td colspan="2">CTCAE Grade 2 Uterus Hemorrhage<span class="subclass"> SubClassOf </span>Uterus Hemorrhage Adverse Event. <br><i>New Terms: Uterus Hemorrhage Adverse Event, CTCAE Grade 2 Uterus Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>2111</td>
               <td colspan="2">CTCAE Grade 2 Uterus Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Uterus Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Uterus Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 2 Uterus Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2112</td>
               <td colspan="2">CTCAE Grade 2 Uterus Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Uterus Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Uterus Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 2 Uterus Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2113</td>
               <td colspan="2">CTCAE Grade 2 Uterus Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Uterus Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Uterus Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     2 Uterus Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2114</td>
               <td colspan="2">CTCAE Grade 2 Uterus Intra-Operative Injury<span class="subclass"> SubClassOf </span>Uterus Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Uterus Intra-Operative Injury, Uterus Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>2115</td>
               <td colspan="2">CTCAE Grade 2 Uterus Leak<span class="subclass"> SubClassOf </span>Uterus Leak Adverse Event. <br><i>New Terms: Uterus Leak Adverse Event, CTCAE Grade 2 Uterus Leak</i></td>
            </tr>
            <tr class="addition">
               <td>2116</td>
               <td colspan="2">CTCAE Grade 2 Uterus Obstruction<span class="subclass"> SubClassOf </span>Uterus Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 2 Uterus Obstruction, Uterus Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2117</td>
               <td colspan="2">CTCAE Grade 2 Uterus Pain<span class="subclass"> SubClassOf </span>Uterus Pain Adverse Event. <br><i>New Terms: CTCAE Grade 2 Uterus Pain, Uterus Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2118</td>
               <td colspan="2">CTCAE Grade 2 Uterus Perforation<span class="subclass"> SubClassOf </span>Uterus Perforation Adverse Event. <br><i>New Terms: Uterus Perforation Adverse Event, CTCAE Grade 2 Uterus Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>2119</td>
               <td colspan="2">CTCAE Grade 2 Uterus Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Uterus Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Uterus Stricture or Stenosis Adverse Event, CTCAE Grade 2 Uterus Stricture or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>2120</td>
               <td colspan="2">CTCAE Grade 2 Uveitis<span class="subclass"> SubClassOf </span>Uveitis Adverse Event. <br><i>New Terms: Uveitis Adverse Event, CTCAE Grade 2 Uveitis</i></td>
            </tr>
            <tr class="addition">
               <td>2121</td>
               <td colspan="2">CTCAE Grade 2 Vagina Fistula<span class="subclass"> SubClassOf </span>Vagina Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 2 Vagina Fistula, Vagina Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2122</td>
               <td colspan="2">CTCAE Grade 2 Vagina Hemorrhage<span class="subclass"> SubClassOf </span>Vagina Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 2 Vagina Hemorrhage, Vagina Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2123</td>
               <td colspan="2">CTCAE Grade 2 Vagina Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Vagina Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Vagina Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Vagina Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2124</td>
               <td colspan="2">CTCAE Grade 2 Vagina Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Vagina Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Vagina Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Vagina Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2125</td>
               <td colspan="2">CTCAE Grade 2 Vagina Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Vagina Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 2 Vagina Infection with Unknown Absolute Neutrophil Count, Vagina Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2126</td>
               <td colspan="2">CTCAE Grade 2 Vagina Intra-Operative Injury<span class="subclass"> SubClassOf </span>Vagina Intra-Operative Injury Adverse Event. <br><i>New Terms: Vagina Intra-Operative Injury Adverse Event, CTCAE Grade 2 Vagina Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2127</td>
               <td colspan="2">CTCAE Grade 2 Vagina Leak<span class="subclass"> SubClassOf </span>Vagina Leak Adverse Event. <br><i>New Terms: Vagina Leak Adverse Event, CTCAE Grade 2 Vagina Leak</i></td>
            </tr>
            <tr class="addition">
               <td>2128</td>
               <td colspan="2">CTCAE Grade 2 Vagina Obstruction<span class="subclass"> SubClassOf </span>Vagina Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 2 Vagina Obstruction, Vagina Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2129</td>
               <td colspan="2">CTCAE Grade 2 Vagina Pain<span class="subclass"> SubClassOf </span>Vagina Pain Adverse Event. <br><i>New Terms: Vagina Pain Adverse Event, CTCAE Grade 2 Vagina Pain</i></td>
            </tr>
            <tr class="addition">
               <td>2130</td>
               <td colspan="2">CTCAE Grade 2 Vagina Perforation<span class="subclass"> SubClassOf </span>Vagina Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 2 Vagina Perforation, Vagina Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2131</td>
               <td colspan="2">CTCAE Grade 2 Vagina Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Vagina Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 2 Vagina Stricture or Stenosis, Vagina Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2132</td>
               <td colspan="2">CTCAE Grade 2 Vaginal Dryness<span class="subclass"> SubClassOf </span>Vaginal Dryness Adverse Event. <br><i>New Terms: Vaginal Dryness Adverse Event, CTCAE Grade 2 Vaginal Dryness</i></td>
            </tr>
            <tr class="addition">
               <td>2133</td>
               <td colspan="2">CTCAE Grade 2 Vaginal Mucositis<span class="subclass"> SubClassOf </span>Vaginal Mucositis Adverse Event. <br><i>New Terms: CTCAE Grade 2 Vaginal Mucositis, Vaginal Mucositis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2134</td>
               <td colspan="2">CTCAE Grade 2 Vaginal Stenosis<br><span class="keyword"> and </span>Length<span class="subclass"> SubClassOf </span>Vaginal Stenosis<br><span class="keyword"> and </span>Length Adverse Event. <br><i>New Terms: CTCAE Grade 2 Vaginal Stenosis and Length, Vaginal Stenosis and Length Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2135</td>
               <td colspan="2">CTCAE Grade 2 Vaginitis Not Due to Infection<span class="subclass"> SubClassOf </span>Vaginitis Not Due to Infection Adverse Event. <br><i>New Terms: Vaginitis Not Due to Infection Adverse Event, CTCAE Grade 2 Vaginitis Not Due to Infection</i></td>
            </tr>
            <tr class="addition">
               <td>2136</td>
               <td colspan="2">CTCAE Grade 2 Valvular Heart Disease<span class="subclass"> SubClassOf </span>Valvular Heart Disease Adverse Event. <br><i>New Terms: Valvular Heart Disease Adverse Event, CTCAE Grade 2 Valvular Heart Disease</i></td>
            </tr>
            <tr class="addition">
               <td>2137</td>
               <td colspan="2">CTCAE Grade 2 Vas Deferens Hemorrhage<span class="subclass"> SubClassOf </span>Vas Deferens Hemorrhage Adverse Event. <br><i>New Terms: Vas Deferens Hemorrhage Adverse Event, CTCAE Grade 2 Vas Deferens Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>2138</td>
               <td colspan="2">CTCAE Grade 2 Vas Deferens Leak<span class="subclass"> SubClassOf </span>Vas Deferens Leak Adverse Event. <br><i>New Terms: CTCAE Grade 2 Vas Deferens Leak, Vas Deferens Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2139</td>
               <td colspan="2">CTCAE Grade 2 Vas Deferens Obstruction<span class="subclass"> SubClassOf </span>Vas Deferens Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 2 Vas Deferens Obstruction, Vas Deferens Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2140</td>
               <td colspan="2">CTCAE Grade 2 Vas Deferens Perforation<span class="subclass"> SubClassOf </span>Vas Deferens Perforation Adverse Event. <br><i>New Terms: Vas Deferens Perforation Adverse Event, CTCAE Grade 2 Vas Deferens Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>2141</td>
               <td colspan="2">CTCAE Grade 2 Vas Deferens Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Vas Deferens Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 2 Vas Deferens Stricture or Stenosis, Vas Deferens Stricture or Stenosis
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2142</td>
               <td colspan="2">CTCAE Grade 2 Vasculitis<span class="subclass"> SubClassOf </span>Vasculitis Adverse Event. <br><i>New Terms: Vasculitis Adverse Event, CTCAE Grade 2 Vasculitis</i></td>
            </tr>
            <tr class="addition">
               <td>2143</td>
               <td colspan="2">CTCAE Grade 2 Vasovagal Episode<span class="subclass"> SubClassOf </span>Vasovagal Episode Adverse Event. <br><i>New Terms: Vasovagal Episode Adverse Event, CTCAE Grade 2 Vasovagal Episode</i></td>
            </tr>
            <tr class="addition">
               <td>2144</td>
               <td colspan="2">CTCAE Grade 2 Vein Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Vein Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Vein Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 2 Vein Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2145</td>
               <td colspan="2">CTCAE Grade 2 Vein Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Vein Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Vein Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or 2
                     Neutrophils, CTCAE Grade 2 Vein Infection with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2146</td>
               <td colspan="2">CTCAE Grade 2 Vein Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Vein Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Vein Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade 2
                     Vein Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2147</td>
               <td colspan="2">CTCAE Grade 2 Vein NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Vein NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Vein NOS Intra-Operative Injury, Vein NOS Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>2148</td>
               <td colspan="2">CTCAE Grade 2 Ventricular Arrhythmia NOS<span class="subclass"> SubClassOf </span>Ventricular Arrhythmia Adverse Event NOS. <br><i>New Terms: Ventricular Arrhythmia Adverse Event NOS, CTCAE Grade 2 Ventricular Arrhythmia NOS</i></td>
            </tr>
            <tr class="addition">
               <td>2149</td>
               <td colspan="2">CTCAE Grade 2 Ventricular Fibrillation<span class="subclass"> SubClassOf </span>Ventricular Fibrillation Adverse Event. <br><i>New Terms: Ventricular Fibrillation Adverse Event, CTCAE Grade 2 Ventricular Fibrillation</i></td>
            </tr>
            <tr class="addition">
               <td>2150</td>
               <td colspan="2">CTCAE Grade 2 Ventricular Flutter<span class="subclass"> SubClassOf </span>Ventricular Flutter Adverse Event. <br><i>New Terms: Ventricular Flutter Adverse Event, CTCAE Grade 2 Ventricular Flutter</i></td>
            </tr>
            <tr class="addition">
               <td>2151</td>
               <td colspan="2">CTCAE Grade 2 Ventricular Tachycardia<span class="subclass"> SubClassOf </span>Ventricular Tachycardia Adverse Event. <br><i>New Terms: Ventricular Tachycardia Adverse Event, CTCAE Grade 2 Ventricular Tachycardia</i></td>
            </tr>
            <tr class="addition">
               <td>2152</td>
               <td colspan="2">CTCAE Grade 2 Viral Hepatitis<span class="subclass"> SubClassOf </span>Viral Hepatitis Adverse Event. <br><i>New Terms: Viral Hepatitis Adverse Event, CTCAE Grade 2 Viral Hepatitis</i></td>
            </tr>
            <tr class="addition">
               <td>2153</td>
               <td colspan="2">CTCAE Grade 2 Viscera Vein Injury<span class="subclass"> SubClassOf </span>Viscera Vein Injury Adverse Event. <br><i>New Terms: Viscera Vein Injury Adverse Event, CTCAE Grade 2 Viscera Vein Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2154</td>
               <td colspan="2">CTCAE Grade 2 Visceral Artery Injury<span class="subclass"> SubClassOf </span>Visceral Artery Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Visceral Artery Injury, Visceral Artery Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2155</td>
               <td colspan="2">CTCAE Grade 2 Vital Capacity<span class="subclass"> SubClassOf </span>Vital Capacity Adverse Event. <br><i>New Terms: Vital Capacity Adverse Event, CTCAE Grade 2 Vital Capacity</i></td>
            </tr>
            <tr class="addition">
               <td>2156</td>
               <td colspan="2">CTCAE Grade 2 Vitreous Hemorrhage<span class="subclass"> SubClassOf </span>Vitreous Hemorrhage Adverse Event. <br><i>New Terms: Vitreous Hemorrhage Adverse Event, CTCAE Grade 2 Vitreous Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>2157</td>
               <td colspan="2">CTCAE Grade 2 Voice Changes<br><span class="keyword"> and </span>Dysarthria<span class="subclass"> SubClassOf </span>Voice Changes<br><span class="keyword"> and </span>Dysarthria Adverse Event. <br><i>New Terms: Voice Changes and Dysarthria Adverse Event, CTCAE Grade 2 Voice Changes and Dysarthria</i></td>
            </tr>
            <tr class="addition">
               <td>2158</td>
               <td colspan="2">CTCAE Grade 2 Vomiting<span class="subclass"> SubClassOf </span>Vomiting Adverse Event. <br><i>New Terms: CTCAE Grade 2 Vomiting, Vomiting Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2159</td>
               <td colspan="2">CTCAE Grade 2 Vulva Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Vulva Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Vulva Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Vulva Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2160</td>
               <td colspan="2">CTCAE Grade 2 Vulva Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Vulva Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Vulva Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Vulva Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2161</td>
               <td colspan="2">CTCAE Grade 2 Vulva Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Vulva Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 2 Vulva Infection with Unknown Absolute Neutrophil Count, Vulva Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2162</td>
               <td colspan="2">CTCAE Grade 2 Vulva Intra-Operative Injury<span class="subclass"> SubClassOf </span>Vulva Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 2 Vulva Intra-Operative Injury, Vulva Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2163</td>
               <td colspan="2">CTCAE Grade 2 Weight Gain<span class="subclass"> SubClassOf </span>Weight Gain Adverse Event. <br><i>New Terms: Weight Gain Adverse Event, CTCAE Grade 2 Weight Gain</i></td>
            </tr>
            <tr class="addition">
               <td>2164</td>
               <td colspan="2">CTCAE Grade 2 Weight Loss<span class="subclass"> SubClassOf </span>Weight Loss Adverse Event. <br><i>New Terms: CTCAE Grade 2 Weight Loss, Weight Loss Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2165</td>
               <td colspan="2">CTCAE Grade 2 Whole Body<br><span class="keyword"> and </span>Generalized Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Whole Body<br><span class="keyword"> and </span>Generalized Muscle Weakness Not Due to Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 2 Whole Body and Generalized Muscle Weakness Not Due to Neuropathy, Whole
                     Body and Generalized Muscle Weakness Not Due to Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2166</td>
               <td colspan="2">CTCAE Grade 2 Wolff-Parkinson-White Syndrome<span class="subclass"> SubClassOf </span>Wolff-Parkinson-White Syndrome Adverse Event. <br><i>New Terms: Wolff-Parkinson-White Syndrome Adverse Event, CTCAE Grade 2 Wolff-Parkinson-White
                     Syndrome</i></td>
            </tr>
            <tr class="addition">
               <td>2167</td>
               <td colspan="2">CTCAE Grade 2 Wound Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Wound Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 2 Wound Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Wound Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2168</td>
               <td colspan="2">CTCAE Grade 2 Wound Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Wound Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Wound Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 2 Wound Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2169</td>
               <td colspan="2">CTCAE Grade 2 Wound Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Wound Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Wound Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     2 Wound Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2170</td>
               <td colspan="2">CTCAE Grade 2 Xerostomia<span class="subclass"> SubClassOf </span>Xerostomia Adverse Event. <br><i>New Terms: CTCAE Grade 2 Xerostomia, Xerostomia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2171</td>
               <td colspan="2">CTCAE Grade 3 AV Block First Degree<span class="subclass"> SubClassOf </span>AV Block First Degree Adverse Event. <br><i>New Terms: AV Block First Degree Adverse Event, CTCAE Grade 3 AV Block First Degree</i></td>
            </tr>
            <tr class="addition">
               <td>2172</td>
               <td colspan="2">CTCAE Grade 3 AV Block Second Degree Mobitz<span class="subclass"> Type </span>I<span class="subclass"> SubClassOf </span>AV Block Second Degree Mobitz<span class="subclass"> Type </span>I Adverse Event. <br><i>New Terms: AV Block Second Degree Mobitz Type I Adverse Event, CTCAE Grade 3 AV Block Second
                     Degree Mobitz Type I</i></td>
            </tr>
            <tr class="addition">
               <td>2173</td>
               <td colspan="2">CTCAE Grade 3 AV Block Second Degree Mobitz<span class="subclass"> Type </span>II<span class="subclass"> SubClassOf </span>AV Block Second Degree Mobitz<span class="subclass"> Type </span>II Adverse Event. <br><i>New Terms: AV Block Second Degree Mobitz Type II Adverse Event, CTCAE Grade 3 AV Block Second
                     Degree Mobitz Type II</i></td>
            </tr>
            <tr class="addition">
               <td>2174</td>
               <td colspan="2">CTCAE Grade 3 AV Block Third Degree<span class="subclass"> SubClassOf </span>AV Block Third Degree Adverse Event. <br><i>New Terms: AV Block Third Degree Adverse Event, CTCAE Grade 3 AV Block Third Degree</i></td>
            </tr>
            <tr class="addition">
               <td>2175</td>
               <td colspan="2">CTCAE Grade 3 Abdomen Fistula NOS<span class="subclass"> SubClassOf </span>Abdomen Fistula Adverse Event NOS. <br><i>New Terms: CTCAE Grade 3 Abdomen Fistula NOS, Abdomen Fistula Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>2176</td>
               <td colspan="2">CTCAE Grade 3 Abdomen Hemorrhage NOS<span class="subclass"> SubClassOf </span>Abdomen Hemorrhage Adverse Event NOS. <br><i>New Terms: CTCAE Grade 3 Abdomen Hemorrhage NOS, Abdomen Hemorrhage Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>2177</td>
               <td colspan="2">CTCAE Grade 3 Abdomen Infection NOS Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Abdomen Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Abdomen Infection NOS Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, Abdomen Infection NOS Adverse Event Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2178</td>
               <td colspan="2">CTCAE Grade 3 Abdomen Infection NOS with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Abdomen Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Abdomen Infection NOS with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, Abdomen Infection NOS Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2179</td>
               <td colspan="2">CTCAE Grade 3 Abdomen Infection NOS with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Abdomen Infection NOS Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Abdomen Infection NOS with Unknown Absolute Neutrophil Count, Abdomen
                     Infection NOS Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2180</td>
               <td colspan="2">CTCAE Grade 3 Abdomen NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Abdomen NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: Abdomen NOS Intra-Operative Injury Adverse Event, CTCAE Grade 3 Abdomen NOS Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2181</td>
               <td colspan="2">CTCAE Grade 3 Abdomen Pain NOS<span class="subclass"> SubClassOf </span>Abdomen Pain NOS Adverse Event. <br><i>New Terms: Abdomen Pain NOS Adverse Event, CTCAE Grade 3 Abdomen Pain NOS</i></td>
            </tr>
            <tr class="addition">
               <td>2182</td>
               <td colspan="2">CTCAE Grade 3 Abdomen Soft Tissue Necrosis<span class="subclass"> SubClassOf </span>Abdomen Soft Tissue Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Abdomen Soft Tissue Necrosis, Abdomen Soft Tissue Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2183</td>
               <td colspan="2">CTCAE Grade 3 Abdominal Distension<br><span class="keyword"> or </span>Bloating<span class="subclass"> SubClassOf </span>Abdominal Distension<br><span class="keyword"> or </span>Bloating Adverse Event. <br><i>New Terms: Abdominal Distension or Bloating Adverse Event, CTCAE Grade 3 Abdominal Distension
                     or Bloating</i></td>
            </tr>
            <tr class="addition">
               <td>2184</td>
               <td colspan="2">CTCAE Grade 3 Acute Vascular Leak Syndrome<span class="subclass"> SubClassOf </span>Acute Vascular Leak Syndrome Adverse Event. <br><i>New Terms: CTCAE Grade 3 Acute Vascular Leak Syndrome, Acute Vascular Leak Syndrome Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2185</td>
               <td colspan="2">CTCAE Grade 3 Adrenal Gland Intra-Operative Injury<span class="subclass"> SubClassOf </span>Adrenal Gland Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Adrenal Gland Intra-Operative Injury, Adrenal Gland Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2186</td>
               <td colspan="2">CTCAE Grade 3 Adrenal Insufficiency<span class="subclass"> SubClassOf </span>Adrenal Insufficiency Adverse Event. <br><i>New Terms: Adrenal Insufficiency Adverse Event, CTCAE Grade 3 Adrenal Insufficiency</i></td>
            </tr>
            <tr class="addition">
               <td>2187</td>
               <td colspan="2">CTCAE Grade 3 Adult Respiratory Distress Syndrome<span class="subclass"> SubClassOf </span>Adult Respiratory Distress Syndrome Adverse Event. <br><i>New Terms: Adult Respiratory Distress Syndrome Adverse Event, CTCAE Grade 3 Adult Respiratory
                     Distress Syndrome</i></td>
            </tr>
            <tr class="addition">
               <td>2188</td>
               <td colspan="2">CTCAE Grade 3 Agitation<span class="subclass"> SubClassOf </span>Agitation Adverse Event. <br><i>New Terms: Agitation Adverse Event, CTCAE Grade 3 Agitation</i></td>
            </tr>
            <tr class="addition">
               <td>2189</td>
               <td colspan="2">CTCAE Grade 3 Alcohol Intolerance Antabuse-Like Syndrome<span class="subclass"> SubClassOf </span>Alcohol Intolerance Antabuse-Like Syndrome Adverse Event. <br><i>New Terms: CTCAE Grade 3 Alcohol Intolerance Antabuse-Like Syndrome, Alcohol Intolerance Antabuse-Like
                     Syndrome Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2190</td>
               <td colspan="2">CTCAE Grade 3 Alkaline phosphatase<span class="subclass"> SubClassOf </span>Alkaline Phosphatase Adverse Event. <br><i>New Terms: Alkaline Phosphatase Adverse Event, CTCAE Grade 3 Alkaline phosphatase</i></td>
            </tr>
            <tr class="addition">
               <td>2191</td>
               <td colspan="2">CTCAE Grade 3 Allergic Reaction<br><span class="keyword"> and </span>Hypersensitivity Including Drug Fever<span class="subclass"> SubClassOf </span>Allergic Reaction<br><span class="keyword"> and </span>Hypersensitivity Adverse Event Including Drug Fever. <br><i>New Terms: CTCAE Grade 3 Allergic Reaction and Hypersensitivity Including Drug Fever, Allergic
                     Reaction and Hypersensitivity Adverse Event Including Drug Fever</i></td>
            </tr>
            <tr class="addition">
               <td>2192</td>
               <td colspan="2">CTCAE Grade 3 Amylase<span class="subclass"> SubClassOf </span>Amylase Adverse Event. <br><i>New Terms: Amylase Adverse Event, CTCAE Grade 3 Amylase</i></td>
            </tr>
            <tr class="addition">
               <td>2193</td>
               <td colspan="2">CTCAE Grade 3 Anal Incontinence<span class="subclass"> SubClassOf </span>Anal Incontinence Adverse Event. <br><i>New Terms: CTCAE Grade 3 Anal Incontinence, Anal Incontinence Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2194</td>
               <td colspan="2">CTCAE Grade 3 Anal Sphincter Intra-Operative Injury<span class="subclass"> SubClassOf </span>Anal Sphincter Intra-Operative Injury Adverse Event. <br><i>New Terms: Anal Sphincter Intra-Operative Injury Adverse Event, CTCAE Grade 3 Anal Sphincter
                     Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2195</td>
               <td colspan="2">CTCAE Grade 3 Anal<br><span class="keyword"> or </span>Perianal Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Anal<br><span class="keyword"> or </span>Perianal Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Anal or Perianal Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, Anal or Perianal Infection Adverse Event Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2196</td>
               <td colspan="2">CTCAE Grade 3 Anal<br><span class="keyword"> or </span>Perianal Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Anal<br><span class="keyword"> or </span>Perianal Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Anal or Perianal Infection with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils, Anal or Perianal Infection Adverse Event with Normal Absolute
                     Neutrophil Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2197</td>
               <td colspan="2">CTCAE Grade 3 Anal<br><span class="keyword"> or </span>Perianal Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Anal<br><span class="keyword"> or </span>Perianal Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Anal or Perianal Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE
                     Grade 3 Anal or Perianal Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2198</td>
               <td colspan="2">CTCAE Grade 3 Anorexia<span class="subclass"> SubClassOf </span>Anorexia Adverse Event. <br><i>New Terms: Anorexia Adverse Event, CTCAE Grade 3 Anorexia</i></td>
            </tr>
            <tr class="addition">
               <td>2199</td>
               <td colspan="2">CTCAE Grade 3 Anus Fistula<span class="subclass"> SubClassOf </span>Anus Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 3 Anus Fistula, Anus Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2200</td>
               <td colspan="2">CTCAE Grade 3 Anus Hemorrhage<span class="subclass"> SubClassOf </span>Anus Hemorrhage Adverse Event. <br><i>New Terms: Anus Hemorrhage Adverse Event, CTCAE Grade 3 Anus Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>2201</td>
               <td colspan="2">CTCAE Grade 3 Anus Intra-Operative Injury<span class="subclass"> SubClassOf </span>Anus Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Anus Intra-Operative Injury, Anus Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2202</td>
               <td colspan="2">CTCAE Grade 3 Anus Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Anus Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Clinical Examination Classification. <br><i>New Terms: Anus Mucositis or Stomatitis Adverse Event by Clinical Examination Classification,
                     CTCAE Grade 3 Anus Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>2203</td>
               <td colspan="2">CTCAE Grade 3 Anus Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Anus Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: CTCAE Grade 3 Anus Mucositis or Stomatitis by Functional or Symptomatic Classification,
                     Anus Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>2204</td>
               <td colspan="2">CTCAE Grade 3 Anus Necrosis<span class="subclass"> SubClassOf </span>Anus Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Anus Necrosis, Anus Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2205</td>
               <td colspan="2">CTCAE Grade 3 Anus Pain<span class="subclass"> SubClassOf </span>Anus Pain Adverse Event. <br><i>New Terms: CTCAE Grade 3 Anus Pain, Anus Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2206</td>
               <td colspan="2">CTCAE Grade 3 Anus Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Anus Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Anus Stricture or Stenosis, Anus Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2207</td>
               <td colspan="2">CTCAE Grade 3 Anus Ulcer<span class="subclass"> SubClassOf </span>Anus Ulcer Adverse Event. <br><i>New Terms: Anus Ulcer Adverse Event, CTCAE Grade 3 Anus Ulcer</i></td>
            </tr>
            <tr class="addition">
               <td>2208</td>
               <td colspan="2">CTCAE Grade 3 Anxiety<span class="subclass"> SubClassOf </span>Anxiety Adverse Event. <br><i>New Terms: Anxiety Adverse Event, CTCAE Grade 3 Anxiety</i></td>
            </tr>
            <tr class="addition">
               <td>2209</td>
               <td colspan="2">CTCAE Grade 3 Aorta Artery Injury<span class="subclass"> SubClassOf </span>Aorta Artery Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Aorta Artery Injury, Aorta Artery Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2210</td>
               <td colspan="2">CTCAE Grade 3 Aorta Artery Intra-Operative Injury<span class="subclass"> SubClassOf </span>Aorta Artery Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Aorta Artery Intra-Operative Injury, Aorta Artery Intra-Operative Injury
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2211</td>
               <td colspan="2">CTCAE Grade 3 Apnea<span class="subclass"> SubClassOf </span>Apnea Adverse Event. <br><i>New Terms: Apnea Adverse Event, CTCAE Grade 3 Apnea</i></td>
            </tr>
            <tr class="addition">
               <td>2212</td>
               <td colspan="2">CTCAE Grade 3 Appendix Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Appendix Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Appendix Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Appendix Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2213</td>
               <td colspan="2">CTCAE Grade 3 Appendix Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Appendix Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Appendix Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, CTCAE Grade 3 Appendix Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2214</td>
               <td colspan="2">CTCAE Grade 3 Appendix Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Appendix Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Appendix Infection with Unknown Absolute Neutrophil Count, Appendix
                     Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2215</td>
               <td colspan="2">CTCAE Grade 3 Appendix Intra-Operative Injury<span class="subclass"> SubClassOf </span>Appendix Intra-Operative Injury Adverse Event. <br><i>New Terms: Appendix Intra-Operative Injury Adverse Event, CTCAE Grade 3 Appendix Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2216</td>
               <td colspan="2">CTCAE Grade 3 Appendix Perforation<span class="subclass"> SubClassOf </span>Appendix Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 3 Appendix Perforation, Appendix Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2217</td>
               <td colspan="2">CTCAE Grade 3 Arachnoiditis<br><span class="keyword"> and </span>Meningismus<br><span class="keyword"> and </span>Radiculitis<span class="subclass"> SubClassOf </span>Arachnoiditis<br><span class="keyword"> and </span>Meningismus<br><span class="keyword"> and </span>Radiculitis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Arachnoiditis and Meningismus and Radiculitis, Arachnoiditis and Meningismus
                     and Radiculitis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2218</td>
               <td colspan="2">CTCAE Grade 3 Artery Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Artery Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Artery Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Artery Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2219</td>
               <td colspan="2">CTCAE Grade 3 Artery Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Artery Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Artery Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 3 Artery Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2220</td>
               <td colspan="2">CTCAE Grade 3 Artery Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Artery Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Artery Infection with Unknown Absolute Neutrophil Count, Artery Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2221</td>
               <td colspan="2">CTCAE Grade 3 Artery NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Artery NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: Artery NOS Intra-Operative Injury Adverse Event, CTCAE Grade 3 Artery NOS Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2222</td>
               <td colspan="2">CTCAE Grade 3 Aspiration<span class="subclass"> SubClassOf </span>Aspiration Adverse Event. <br><i>New Terms: CTCAE Grade 3 Aspiration, Aspiration Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2223</td>
               <td colspan="2">CTCAE Grade 3 Associated with Dentures<br><span class="keyword"> or </span>Dental Prosthesis<span class="subclass"> SubClassOf </span>Adverse Event Associated with Dentures<br><span class="keyword"> or </span>Dental Prostheses. <br><i>New Terms: Adverse Event Associated with Dentures or Dental Prostheses, CTCAE Grade 3 Associated
                     with Dentures or Dental Prosthesis</i></td>
            </tr>
            <tr class="addition">
               <td>2224</td>
               <td colspan="2">CTCAE Grade 3 Associated with the Teeth<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Teeth. <br><i>New Terms: Adverse Event Associated with the Teeth, CTCAE Grade 3 Associated with the Teeth</i></td>
            </tr>
            <tr class="addition">
               <td>2225</td>
               <td colspan="2">CTCAE Grade 3 Asystole<span class="subclass"> SubClassOf </span>Asystole Adverse Event. <br><i>New Terms: Asystole Adverse Event, CTCAE Grade 3 Asystole</i></td>
            </tr>
            <tr class="addition">
               <td>2226</td>
               <td colspan="2">CTCAE Grade 3 Ataxia<span class="subclass"> SubClassOf </span>Ataxia Adverse Event. <br><i>New Terms: Ataxia Adverse Event, CTCAE Grade 3 Ataxia</i></td>
            </tr>
            <tr class="addition">
               <td>2227</td>
               <td colspan="2">CTCAE Grade 3 Atelectasis<span class="subclass"> SubClassOf </span>Atelectasis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Atelectasis, Atelectasis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2228</td>
               <td colspan="2">CTCAE Grade 3 Atrial Fibrillation<span class="subclass"> SubClassOf </span>Atrial Fibrillation Adverse Event. <br><i>New Terms: CTCAE Grade 3 Atrial Fibrillation, Atrial Fibrillation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2229</td>
               <td colspan="2">CTCAE Grade 3 Atrial Flutter<span class="subclass"> SubClassOf </span>Atrial Flutter Adverse Event. <br><i>New Terms: CTCAE Grade 3 Atrial Flutter, Atrial Flutter Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2230</td>
               <td colspan="2">CTCAE Grade 3 Atrial Tachycardia<br><span class="keyword"> or </span>Paroxysmal Atrial Tachycardia<span class="subclass"> SubClassOf </span>Atrial Tachycardia<br><span class="keyword"> or </span>Paroxysmal Atrial Tachycardia Adverse Event. <br><i>New Terms: Atrial Tachycardia or Paroxysmal Atrial Tachycardia Adverse Event, CTCAE Grade 3 Atrial
                     Tachycardia or Paroxysmal Atrial Tachycardia</i></td>
            </tr>
            <tr class="addition">
               <td>2231</td>
               <td colspan="2">CTCAE Grade 3 Autoimmune Reaction<span class="subclass"> SubClassOf </span>Autoimmune Reaction Adverse Event. <br><i>New Terms: Autoimmune Reaction Adverse Event, CTCAE Grade 3 Autoimmune Reaction</i></td>
            </tr>
            <tr class="addition">
               <td>2232</td>
               <td colspan="2">CTCAE Grade 3 Avascular Osteonecrosis<span class="subclass"> SubClassOf </span>Avascular Osteonecrosis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Avascular Osteonecrosis, Avascular Osteonecrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2233</td>
               <td colspan="2">CTCAE Grade 3 Back Pain<span class="subclass"> SubClassOf </span>Back Pain Adverse Event. <br><i>New Terms: Back Pain Adverse Event, CTCAE Grade 3 Back Pain</i></td>
            </tr>
            <tr class="addition">
               <td>2234</td>
               <td colspan="2">CTCAE Grade 3 Bigeminy<span class="subclass"> SubClassOf </span>Bigeminy Adverse Event. <br><i>New Terms: CTCAE Grade 3 Bigeminy, Bigeminy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2235</td>
               <td colspan="2">CTCAE Grade 3 Biliary Tree Common Bile Duct Intra-Operative Injury<span class="subclass"> SubClassOf </span>Biliary Tree Common Bile Duct Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Biliary Tree Common Bile Duct Intra-Operative Injury, Biliary Tree Common
                     Bile Duct Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2236</td>
               <td colspan="2">CTCAE Grade 3 Biliary Tree Common Hepatic Duct Intra-Operative Injury<span class="subclass"> SubClassOf </span>Biliary Tree Common Hepatic Duct Intra-Operative Injury Adverse Event. <br><i>New Terms: Biliary Tree Common Hepatic Duct Intra-Operative Injury Adverse Event, CTCAE Grade
                     3 Biliary Tree Common Hepatic Duct Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2237</td>
               <td colspan="2">CTCAE Grade 3 Biliary Tree Fistula<span class="subclass"> SubClassOf </span>Biliary Tree Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 3 Biliary Tree Fistula, Biliary Tree Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2238</td>
               <td colspan="2">CTCAE Grade 3 Biliary Tree Hemorrhage<span class="subclass"> SubClassOf </span>Biliary Tree Hemorrhage Adverse Event. <br><i>New Terms: Biliary Tree Hemorrhage Adverse Event, CTCAE Grade 3 Biliary Tree Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>2239</td>
               <td colspan="2">CTCAE Grade 3 Biliary Tree Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Biliary Tree Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Biliary Tree Infection Adverse Event Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, CTCAE Grade 3 Biliary Tree Infection Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2240</td>
               <td colspan="2">CTCAE Grade 3 Biliary Tree Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Biliary Tree Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Biliary Tree Infection with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, Biliary Tree Infection Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2241</td>
               <td colspan="2">CTCAE Grade 3 Biliary Tree Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Biliary Tree Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Biliary Tree Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE
                     Grade 3 Biliary Tree Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2242</td>
               <td colspan="2">CTCAE Grade 3 Biliary Tree Leak<span class="subclass"> SubClassOf </span>Biliary Tree Leak Adverse Event. <br><i>New Terms: CTCAE Grade 3 Biliary Tree Leak, Biliary Tree Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2243</td>
               <td colspan="2">CTCAE Grade 3 Biliary Tree Left Hepatic Duct Intra-Operative Injury<span class="subclass"> SubClassOf </span>Biliary Tree Left Hepatic Duct Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Biliary Tree Left Hepatic Duct Intra-Operative Injury, Biliary Tree
                     Left Hepatic Duct Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2244</td>
               <td colspan="2">CTCAE Grade 3 Biliary Tree NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Biliary Tree NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: Biliary Tree NOS Intra-Operative Injury Adverse Event, CTCAE Grade 3 Biliary Tree
                     NOS Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2245</td>
               <td colspan="2">CTCAE Grade 3 Biliary Tree Perforation<span class="subclass"> SubClassOf </span>Biliary Tree Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 3 Biliary Tree Perforation, Biliary Tree Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2246</td>
               <td colspan="2">CTCAE Grade 3 Biliary Tree Right Hepatic Duct Intra-Operative Injury<span class="subclass"> SubClassOf </span>Biliary Tree Right Hepatic Duct Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Biliary Tree Right Hepatic Duct Intra-Operative Injury, Biliary Tree
                     Right Hepatic Duct Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2247</td>
               <td colspan="2">CTCAE Grade 3 Biliary Tree Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Biliary Tree Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Biliary Tree Stricture or Stenosis Adverse Event, CTCAE Grade 3 Biliary Tree Stricture
                     or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>2248</td>
               <td colspan="2">CTCAE Grade 3 Bladder Fistula<span class="subclass"> SubClassOf </span>Bladder Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 3 Bladder Fistula, Bladder Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2249</td>
               <td colspan="2">CTCAE Grade 3 Bladder Hemorrhage<span class="subclass"> SubClassOf </span>Bladder Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 3 Bladder Hemorrhage, Bladder Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2250</td>
               <td colspan="2">CTCAE Grade 3 Bladder Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Bladder Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Bladder Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Bladder Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2251</td>
               <td colspan="2">CTCAE Grade 3 Bladder Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Bladder Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Bladder Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 3 Bladder Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2252</td>
               <td colspan="2">CTCAE Grade 3 Bladder Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Bladder Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Bladder Infection with Unknown Absolute Neutrophil Count, Bladder Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2253</td>
               <td colspan="2">CTCAE Grade 3 Bladder Intra-Operative Injury<span class="subclass"> SubClassOf </span>Bladder Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Bladder Intra-Operative Injury, Bladder Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>2254</td>
               <td colspan="2">CTCAE Grade 3 Bladder Leak<span class="subclass"> SubClassOf </span>Bladder Leak Adverse Event. <br><i>New Terms: Bladder Leak Adverse Event, CTCAE Grade 3 Bladder Leak</i></td>
            </tr>
            <tr class="addition">
               <td>2255</td>
               <td colspan="2">CTCAE Grade 3 Bladder Obstruction<span class="subclass"> SubClassOf </span>Bladder Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 3 Bladder Obstruction, Bladder Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2256</td>
               <td colspan="2">CTCAE Grade 3 Bladder Pain<span class="subclass"> SubClassOf </span>Bladder Pain Adverse Event. <br><i>New Terms: Bladder Pain Adverse Event, CTCAE Grade 3 Bladder Pain</i></td>
            </tr>
            <tr class="addition">
               <td>2257</td>
               <td colspan="2">CTCAE Grade 3 Bladder Perforation<span class="subclass"> SubClassOf </span>Bladder Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 3 Bladder Perforation, Bladder Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2258</td>
               <td colspan="2">CTCAE Grade 3 Bladder Spasms<span class="subclass"> SubClassOf </span>Bladder Spasm Adverse Event. <br><i>New Terms: CTCAE Grade 3 Bladder Spasms, Bladder Spasm Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2259</td>
               <td colspan="2">CTCAE Grade 3 Bladder Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Bladder Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Bladder Stricture or Stenosis Adverse Event, CTCAE Grade 3 Bladder Stricture or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>2260</td>
               <td colspan="2">CTCAE Grade 3 Blood Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Blood Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Blood Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 3 Blood Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2261</td>
               <td colspan="2">CTCAE Grade 3 Blood Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Blood Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Blood Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Blood Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2262</td>
               <td colspan="2">CTCAE Grade 3 Blood Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Blood Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Blood Infection with Unknown Absolute Neutrophil Count, Blood Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2263</td>
               <td colspan="2">CTCAE Grade 3 Blurred Vision<span class="subclass"> SubClassOf </span>Blurred Vision Adverse Event. <br><i>New Terms: CTCAE Grade 3 Blurred Vision, Blurred Vision Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2264</td>
               <td colspan="2">CTCAE Grade 3 Bone Growth Limb Length Discrepancy<span class="subclass"> SubClassOf </span>Bone Growth Limb Length Discrepancy Adverse Event. <br><i>New Terms: CTCAE Grade 3 Bone Growth Limb Length Discrepancy, Bone Growth Limb Length Discrepancy
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2265</td>
               <td colspan="2">CTCAE Grade 3 Bone Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Bone Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Bone Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Bone Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2266</td>
               <td colspan="2">CTCAE Grade 3 Bone Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Bone Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Bone Infection with Normal Absolute Neutrophil Count or Grade 1 or 2
                     Neutrophils, Bone Infection Adverse Event with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2267</td>
               <td colspan="2">CTCAE Grade 3 Bone Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Bone Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Bone Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade 3
                     Bone Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2268</td>
               <td colspan="2">CTCAE Grade 3 Bone Intra-Operative Injury<span class="subclass"> SubClassOf </span>Bone Intra-Operative Injury Adverse Event. <br><i>New Terms: Bone Intra-Operative Injury Adverse Event, CTCAE Grade 3 Bone Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2269</td>
               <td colspan="2">CTCAE Grade 3 Bone Marrow Cellularity<span class="subclass"> SubClassOf </span>Bone Marrow Cellularity Adverse Event. <br><i>New Terms: CTCAE Grade 3 Bone Marrow Cellularity, Bone Marrow Cellularity Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2270</td>
               <td colspan="2">CTCAE Grade 3 Bone Pain<span class="subclass"> SubClassOf </span>Bone Pain Adverse Event. <br><i>New Terms: CTCAE Grade 3 Bone Pain, Bone Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2271</td>
               <td colspan="2">CTCAE Grade 3 Brachial Plexopathy<span class="subclass"> SubClassOf </span>Brachial Plexopathy Adverse Event. <br><i>New Terms: Brachial Plexopathy Adverse Event, CTCAE Grade 3 Brachial Plexopathy</i></td>
            </tr>
            <tr class="addition">
               <td>2272</td>
               <td colspan="2">CTCAE Grade 3 Brachial Plexus Intra-Operative Injury<span class="subclass"> SubClassOf </span>Brachial Plexus Intra-Operative Injury Adverse Event. <br><i>New Terms: Brachial Plexus Intra-Operative Injury Adverse Event, CTCAE Grade 3 Brachial Plexus
                     Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2273</td>
               <td colspan="2">CTCAE Grade 3 Brain Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Brain Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Brain Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 3 Brain Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2274</td>
               <td colspan="2">CTCAE Grade 3 Brain Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Brain Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Brain Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 3 Brain Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2275</td>
               <td colspan="2">CTCAE Grade 3 Brain Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Brain Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Brain Infection with Unknown Absolute Neutrophil Count, Brain Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2276</td>
               <td colspan="2">CTCAE Grade 3 Brain Intra-Operative Injury<span class="subclass"> SubClassOf </span>Brain Intra-Operative Injury Adverse Event. <br><i>New Terms: Brain Intra-Operative Injury Adverse Event, CTCAE Grade 3 Brain Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2277</td>
               <td colspan="2">CTCAE Grade 3 Brain<br><span class="keyword"> and </span>Spinal Cord Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Brain<br><span class="keyword"> and </span>Spinal Cord Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Brain and Spinal Cord Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, Brain and Spinal Cord Infection Adverse Event Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2278</td>
               <td colspan="2">CTCAE Grade 3 Brain<br><span class="keyword"> and </span>Spinal Cord Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Brain<br><span class="keyword"> and </span>Spinal Cord Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Brain and Spinal Cord Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils, CTCAE Grade 3 Brain and Spinal Cord Infection with Normal
                     Absolute Neutrophil Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2279</td>
               <td colspan="2">CTCAE Grade 3 Brain<br><span class="keyword"> and </span>Spinal Cord Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Brain<br><span class="keyword"> and </span>Spinal Cord Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Brain and Spinal Cord Infection with Unknown Absolute Neutrophil Count,
                     Brain and Spinal Cord Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2280</td>
               <td colspan="2">CTCAE Grade 3 Breast Intra-Operative Injury<span class="subclass"> SubClassOf </span>Breast Intra-Operative Injury Adverse Event. <br><i>New Terms: Breast Intra-Operative Injury Adverse Event, CTCAE Grade 3 Breast Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2281</td>
               <td colspan="2">CTCAE Grade 3 Breast Nipple<br><span class="keyword"> and </span>Areolar Deformity<span class="subclass"> SubClassOf </span>Breast Nipple<br><span class="keyword"> and </span>Areolar Deformity Adverse Event. <br><i>New Terms: Breast Nipple and Areolar Deformity Adverse Event, CTCAE Grade 3 Breast Nipple and
                     Areolar Deformity</i></td>
            </tr>
            <tr class="addition">
               <td>2282</td>
               <td colspan="2">CTCAE Grade 3 Breast Pain<span class="subclass"> SubClassOf </span>Breast Pain Adverse Event. <br><i>New Terms: Breast Pain Adverse Event, CTCAE Grade 3 Breast Pain</i></td>
            </tr>
            <tr class="addition">
               <td>2283</td>
               <td colspan="2">CTCAE Grade 3 Breast Volume<br><span class="keyword"> and </span>Hypoplasia<span class="subclass"> SubClassOf </span>Breast Volume<br><span class="keyword"> and </span>Hypoplasia Adverse Event. <br><i>New Terms: Breast Volume and Hypoplasia Adverse Event, CTCAE Grade 3 Breast Volume and Hypoplasia</i></td>
            </tr>
            <tr class="addition">
               <td>2284</td>
               <td colspan="2">CTCAE Grade 3 Bronchopulmonary Hemorrhage NOS<span class="subclass"> SubClassOf </span>Bronchopulmonary Hemorrhage Adverse Event NOS. <br><i>New Terms: Bronchopulmonary Hemorrhage Adverse Event NOS, CTCAE Grade 3 Bronchopulmonary Hemorrhage
                     NOS</i></td>
            </tr>
            <tr class="addition">
               <td>2285</td>
               <td colspan="2">CTCAE Grade 3 Bronchospasm<br><span class="keyword"> and </span>Wheezing<span class="subclass"> SubClassOf </span>Bronchospasm<br><span class="keyword"> and </span>Wheezing Adverse Event. <br><i>New Terms: Bronchospasm and Wheezing Adverse Event, CTCAE Grade 3 Bronchospasm and Wheezing</i></td>
            </tr>
            <tr class="addition">
               <td>2286</td>
               <td colspan="2">CTCAE Grade 3 Bronchus Fistula<span class="subclass"> SubClassOf </span>Bronchus Fistula Adverse Event. <br><i>New Terms: Bronchus Fistula Adverse Event, CTCAE Grade 3 Bronchus Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>2287</td>
               <td colspan="2">CTCAE Grade 3 Bronchus Hemorrhage<span class="subclass"> SubClassOf </span>Bronchus Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 3 Bronchus Hemorrhage, Bronchus Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2288</td>
               <td colspan="2">CTCAE Grade 3 Bronchus Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Bronchus Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Bronchus Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Bronchus Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2289</td>
               <td colspan="2">CTCAE Grade 3 Bronchus Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Bronchus Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Bronchus Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, CTCAE Grade 3 Bronchus Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2290</td>
               <td colspan="2">CTCAE Grade 3 Bronchus Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Bronchus Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Bronchus Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     3 Bronchus Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2291</td>
               <td colspan="2">CTCAE Grade 3 Bronchus Intra-Operative Injury<span class="subclass"> SubClassOf </span>Bronchus Intra-Operative Injury Adverse Event. <br><i>New Terms: Bronchus Intra-Operative Injury Adverse Event, CTCAE Grade 3 Bronchus Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2292</td>
               <td colspan="2">CTCAE Grade 3 Bronchus Obstruction<br><span class="keyword"> and </span>Stenosis<span class="subclass"> SubClassOf </span>Bronchus Obstruction<br><span class="keyword"> and </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Bronchus Obstruction and Stenosis, Bronchus Obstruction and Stenosis
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2293</td>
               <td colspan="2">CTCAE Grade 3 Burn<span class="subclass"> SubClassOf </span>Burn Adverse Event. <br><i>New Terms: Burn Adverse Event, CTCAE Grade 3 Burn</i></td>
            </tr>
            <tr class="addition">
               <td>2294</td>
               <td colspan="2">CTCAE Grade 3 Buttock Pain<span class="subclass"> SubClassOf </span>Buttock Pain Adverse Event. <br><i>New Terms: Buttock Pain Adverse Event, CTCAE Grade 3 Buttock Pain</i></td>
            </tr>
            <tr class="addition">
               <td>2295</td>
               <td colspan="2">CTCAE Grade 3 CD4 Count<span class="subclass"> SubClassOf </span>CD4 Count Adverse Event. <br><i>New Terms: CTCAE Grade 3 CD4 Count, CD4 Count Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2296</td>
               <td colspan="2">CTCAE Grade 3 CNS Cerebrovascular Ischemia<span class="subclass"> SubClassOf </span>CNS Cerebrovascular Ischemia Adverse Event. <br><i>New Terms: CNS Cerebrovascular Ischemia Adverse Event, CTCAE Grade 3 CNS Cerebrovascular Ischemia</i></td>
            </tr>
            <tr class="addition">
               <td>2297</td>
               <td colspan="2">CTCAE Grade 3 CNS Necrosis<br><span class="keyword"> and </span>Cystic Progression<span class="subclass"> SubClassOf </span>CNS Necrosis<br><span class="keyword"> and </span>Cystic Progression Adverse Event. <br><i>New Terms: CNS Necrosis and Cystic Progression Adverse Event, CTCAE Grade 3 CNS Necrosis and
                     Cystic Progression</i></td>
            </tr>
            <tr class="addition">
               <td>2298</td>
               <td colspan="2">CTCAE Grade 3 Carbon Monoxide Diffusion Capacity<span class="subclass"> SubClassOf </span>Carbon Monoxide Diffusion Capacity Adverse Event. <br><i>New Terms: CTCAE Grade 3 Carbon Monoxide Diffusion Capacity, Carbon Monoxide Diffusion Capacity
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2299</td>
               <td colspan="2">CTCAE Grade 3 Cardiac Ischemia<br><span class="keyword"> or </span>Infarction<span class="subclass"> SubClassOf </span>Cardiac Ischemia<br><span class="keyword"> or </span>Infarction Adverse Event. <br><i>New Terms: Cardiac Ischemia or Infarction Adverse Event, CTCAE Grade 3 Cardiac Ischemia or Infarction</i></td>
            </tr>
            <tr class="addition">
               <td>2300</td>
               <td colspan="2">CTCAE Grade 3 Cardiac Troponin I<span class="subclass"> SubClassOf </span>Cardiac Troponin I Adverse Event. <br><i>New Terms: CTCAE Grade 3 Cardiac Troponin I, Cardiac Troponin I Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2301</td>
               <td colspan="2">CTCAE Grade 3 Cardiac Troponin T<span class="subclass"> SubClassOf </span>Cardiac Troponin T Adverse Event. <br><i>New Terms: Cardiac Troponin T Adverse Event, CTCAE Grade 3 Cardiac Troponin T</i></td>
            </tr>
            <tr class="addition">
               <td>2302</td>
               <td colspan="2">CTCAE Grade 3 Cardiac<br><span class="keyword"> and </span>Heart Pain<span class="subclass"> SubClassOf </span>Cardiac<br><span class="keyword"> and </span>Heart Pain Adverse Event. <br><i>New Terms: CTCAE Grade 3 Cardiac and Heart Pain, Cardiac and Heart Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2303</td>
               <td colspan="2">CTCAE Grade 3 Carotid Artery Injury<span class="subclass"> SubClassOf </span>Carotid Artery Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Carotid Artery Injury, Carotid Artery Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2304</td>
               <td colspan="2">CTCAE Grade 3 Carotid Artery Intra-Operative Injury<span class="subclass"> SubClassOf </span>Carotid Artery Intra-Operative Injury Adverse Event. <br><i>New Terms: Carotid Artery Intra-Operative Injury Adverse Event, CTCAE Grade 3 Carotid Artery
                     Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2305</td>
               <td colspan="2">CTCAE Grade 3 Cartilage Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cartilage Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Cartilage Intra-Operative Injury, Cartilage Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>2306</td>
               <td colspan="2">CTCAE Grade 3 Cataract<span class="subclass"> SubClassOf </span>Cataract Adverse Event. <br><i>New Terms: CTCAE Grade 3 Cataract, Cataract Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2307</td>
               <td colspan="2">CTCAE Grade 3 Catheter-Related Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Catheter-Related Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Catheter-Related Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, CTCAE Grade 3 Catheter-Related Infection Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2308</td>
               <td colspan="2">CTCAE Grade 3 Catheter-Related Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Catheter-Related Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Catheter-Related Infection with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils, Catheter-Related Infection Adverse Event with Normal Absolute
                     Neutrophil Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2309</td>
               <td colspan="2">CTCAE Grade 3 Catheter-Related Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Catheter-Related Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Catheter-Related Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE
                     Grade 3 Catheter-Related Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2310</td>
               <td colspan="2">CTCAE Grade 3 Cecum Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Cecum Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Cecum Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Cecum Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2311</td>
               <td colspan="2">CTCAE Grade 3 Cecum Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Cecum Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Cecum Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Cecum Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2312</td>
               <td colspan="2">CTCAE Grade 3 Cecum Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Cecum Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Cecum Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     3 Cecum Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2313</td>
               <td colspan="2">CTCAE Grade 3 Cecum Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cecum Intra-Operative Injury Adverse Event. <br><i>New Terms: Cecum Intra-Operative Injury Adverse Event, CTCAE Grade 3 Cecum Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2314</td>
               <td colspan="2">CTCAE Grade 3 Cecum Obstruction<span class="subclass"> SubClassOf </span>Cecum Obstruction Adverse Event. <br><i>New Terms: Cecum Obstruction Adverse Event, CTCAE Grade 3 Cecum Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>2315</td>
               <td colspan="2">CTCAE Grade 3 Cecum Perforation<span class="subclass"> SubClassOf </span>Cecum Perforation Adverse Event. <br><i>New Terms: Cecum Perforation Adverse Event, CTCAE Grade 3 Cecum Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>2316</td>
               <td colspan="2">CTCAE Grade 3 Cecum Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Cecum Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Cecum Stricture or Stenosis Adverse Event, CTCAE Grade 3 Cecum Stricture or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>2317</td>
               <td colspan="2">CTCAE Grade 3 Cecum Ulcer<span class="subclass"> SubClassOf </span>Cecum Ulcer Adverse Event. <br><i>New Terms: Cecum Ulcer Adverse Event, CTCAE Grade 3 Cecum Ulcer</i></td>
            </tr>
            <tr class="addition">
               <td>2318</td>
               <td colspan="2">CTCAE Grade 3 Cecum<br><span class="keyword"> or </span>Appendix Hemorrhage<span class="subclass"> SubClassOf </span>Cecum<br><span class="keyword"> or </span>Appendix Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 3 Cecum or Appendix Hemorrhage, Cecum or Appendix Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2319</td>
               <td colspan="2">CTCAE Grade 3 Central Nervous System Hemorrhage<span class="subclass"> SubClassOf </span>Central Nervous System Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 3 Central Nervous System Hemorrhage, Central Nervous System Hemorrhage
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2320</td>
               <td colspan="2">CTCAE Grade 3 Cerebral Artery Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cerebral Artery Intra-Operative Injury Adverse Event. <br><i>New Terms: Cerebral Artery Intra-Operative Injury Adverse Event, CTCAE Grade 3 Cerebral Artery
                     Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2321</td>
               <td colspan="2">CTCAE Grade 3 Cerebrospinal Fluid Leak<span class="subclass"> SubClassOf </span>Cerebrospinal Fluid Leak Adverse Event. <br><i>New Terms: Cerebrospinal Fluid Leak Adverse Event, CTCAE Grade 3 Cerebrospinal Fluid Leak</i></td>
            </tr>
            <tr class="addition">
               <td>2322</td>
               <td colspan="2">CTCAE Grade 3 Cervical Spine<span class="subclass"> Range </span>of Motion<span class="subclass"> SubClassOf </span>Cervical Spine<span class="subclass"> Range </span>of Motion Adverse Event. <br><i>New Terms: CTCAE Grade 3 Cervical Spine Range of Motion, Cervical Spine Range of Motion Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>2323</td>
               <td colspan="2">CTCAE Grade 3 Cervix Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Cervix Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Cervix Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 3 Cervix Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2324</td>
               <td colspan="2">CTCAE Grade 3 Cervix Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Cervix Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Cervix Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Cervix Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2325</td>
               <td colspan="2">CTCAE Grade 3 Cervix Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Cervix Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Cervix Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     3 Cervix Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2326</td>
               <td colspan="2">CTCAE Grade 3 Cervix Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cervix Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Cervix Intra-Operative Injury, Cervix Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>2327</td>
               <td colspan="2">CTCAE Grade 3 Cheilitis<span class="subclass"> SubClassOf </span>Cheilitis Adverse Event. <br><i>New Terms: Cheilitis Adverse Event, CTCAE Grade 3 Cheilitis</i></td>
            </tr>
            <tr class="addition">
               <td>2328</td>
               <td colspan="2">CTCAE Grade 3 Chemoradiation<span class="subclass"> SubClassOf </span>Rash<br><span class="keyword"> and </span>Dermatitis Adverse Event Associated with Chemoradiation. <br><i>New Terms: Rash and Dermatitis Adverse Event Associated with Chemoradiation, CTCAE Grade 3 Chemoradiation</i></td>
            </tr>
            <tr class="addition">
               <td>2329</td>
               <td colspan="2">CTCAE Grade 3 Chest Wall Pain<span class="subclass"> SubClassOf </span>Chest Wall Pain Adverse Event. <br><i>New Terms: CTCAE Grade 3 Chest Wall Pain, Chest Wall Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2330</td>
               <td colspan="2">CTCAE Grade 3 Chest<br><span class="keyword"> and </span>Thorax Pain<span class="subclass"> SubClassOf </span>Chest<br><span class="keyword"> and </span>Thorax Pain NOS Adverse Event. <br><i>New Terms: Chest and Thorax Pain NOS Adverse Event, CTCAE Grade 3 Chest and Thorax Pain</i></td>
            </tr>
            <tr class="addition">
               <td>2331</td>
               <td colspan="2">CTCAE Grade 3 Cholecystitis<span class="subclass"> SubClassOf </span>Cholecystitis Adverse Event. <br><i>New Terms: Cholecystitis Adverse Event, CTCAE Grade 3 Cholecystitis</i></td>
            </tr>
            <tr class="addition">
               <td>2332</td>
               <td colspan="2">CTCAE Grade 3 Chyle<br><span class="keyword"> or </span>Lymph Leakage<span class="subclass"> SubClassOf </span>Chyle<br><span class="keyword"> or </span>Lymph Leakage Adverse Event. <br><i>New Terms: Chyle or Lymph Leakage Adverse Event, CTCAE Grade 3 Chyle or Lymph Leakage</i></td>
            </tr>
            <tr class="addition">
               <td>2333</td>
               <td colspan="2">CTCAE Grade 3 Chylothorax<span class="subclass"> SubClassOf </span>Chylothorax Adverse Event. <br><i>New Terms: Chylothorax Adverse Event, CTCAE Grade 3 Chylothorax</i></td>
            </tr>
            <tr class="addition">
               <td>2334</td>
               <td colspan="2">CTCAE Grade 3 Cognitive Disturbance<span class="subclass"> SubClassOf </span>Cognitive Disturbance Adverse Event. <br><i>New Terms: Cognitive Disturbance Adverse Event, CTCAE Grade 3 Cognitive Disturbance</i></td>
            </tr>
            <tr class="addition">
               <td>2335</td>
               <td colspan="2">CTCAE Grade 3 Colitis<span class="subclass"> SubClassOf </span>Colitis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Colitis, Colitis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2336</td>
               <td colspan="2">CTCAE Grade 3 Colon Hemorrhage<span class="subclass"> SubClassOf </span>Colon Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 3 Colon Hemorrhage, Colon Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2337</td>
               <td colspan="2">CTCAE Grade 3 Colon Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Colon Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Colon Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Colon Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2338</td>
               <td colspan="2">CTCAE Grade 3 Colon Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Colon Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Colon Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 3 Colon Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2339</td>
               <td colspan="2">CTCAE Grade 3 Colon Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Colon Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Colon Infection with Unknown Absolute Neutrophil Count, Colon Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2340</td>
               <td colspan="2">CTCAE Grade 3 Colon Intra-Operative Injury<span class="subclass"> SubClassOf </span>Colon Intra-Operative Injury Adverse Event. <br><i>New Terms: Colon Intra-Operative Injury Adverse Event, CTCAE Grade 3 Colon Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2341</td>
               <td colspan="2">CTCAE Grade 3 Colon Obstruction<span class="subclass"> SubClassOf </span>Colon Obstruction Adverse Event. <br><i>New Terms: Colon Obstruction Adverse Event, CTCAE Grade 3 Colon Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>2342</td>
               <td colspan="2">CTCAE Grade 3 Colon Perforation<span class="subclass"> SubClassOf </span>Colon Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 3 Colon Perforation, Colon Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2343</td>
               <td colspan="2">CTCAE Grade 3 Colon Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Colon Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Colon Stricture or Stenosis Adverse Event, CTCAE Grade 3 Colon Stricture or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>2344</td>
               <td colspan="2">CTCAE Grade 3 Colon Ulcer<span class="subclass"> SubClassOf </span>Colon Ulcer Adverse Event. <br><i>New Terms: CTCAE Grade 3 Colon Ulcer, Colon Ulcer Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2345</td>
               <td colspan="2">CTCAE Grade 3 Colon<br><span class="keyword"> or </span>Cecum<br><span class="keyword"> or </span>Appendix Fistula<span class="subclass"> SubClassOf </span>Colon<br><span class="keyword"> or </span>Cecum<br><span class="keyword"> or </span>Appendix Fistula Adverse Event. <br><i>New Terms: Colon or Cecum or Appendix Fistula Adverse Event, CTCAE Grade 3 Colon or Cecum or
                     Appendix Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>2346</td>
               <td colspan="2">CTCAE Grade 3 Colon<br><span class="keyword"> or </span>Cecum<br><span class="keyword"> or </span>Appendix Necrosis<span class="subclass"> SubClassOf </span>Colon<br><span class="keyword"> or </span>Cecum<br><span class="keyword"> or </span>Appendix Necrosis Adverse Event. <br><i>New Terms: Colon or Cecum or Appendix Necrosis Adverse Event, CTCAE Grade 3 Colon or Cecum or
                     Appendix Necrosis</i></td>
            </tr>
            <tr class="addition">
               <td>2347</td>
               <td colspan="2">CTCAE Grade 3 Conduction Abnormality NOS<span class="subclass"> SubClassOf </span>Conduction Abnormality Adverse Event NOS. <br><i>New Terms: Conduction Abnormality Adverse Event NOS, CTCAE Grade 3 Conduction Abnormality NOS</i></td>
            </tr>
            <tr class="addition">
               <td>2348</td>
               <td colspan="2">CTCAE Grade 3 Confusion<span class="subclass"> SubClassOf </span>Confusion Adverse Event. <br><i>New Terms: Confusion Adverse Event, CTCAE Grade 3 Confusion</i></td>
            </tr>
            <tr class="addition">
               <td>2349</td>
               <td colspan="2">CTCAE Grade 3 Conjunctiva Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Conjunctiva Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Conjunctiva Infection Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, Conjunctiva Infection Adverse Event Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2350</td>
               <td colspan="2">CTCAE Grade 3 Conjunctiva Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Conjunctiva Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Conjunctiva Infection with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, Conjunctiva Infection Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2351</td>
               <td colspan="2">CTCAE Grade 3 Conjunctiva Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Conjunctiva Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Conjunctiva Infection with Unknown Absolute Neutrophil Count, Conjunctiva
                     Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2352</td>
               <td colspan="2">CTCAE Grade 3 Conjunctiva Intra-Operative Injury<span class="subclass"> SubClassOf </span>Conjunctiva Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Conjunctiva Intra-Operative Injury, Conjunctiva Intra-Operative Injury
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2353</td>
               <td colspan="2">CTCAE Grade 3 Constipation<span class="subclass"> SubClassOf </span>Constipation Adverse Event. <br><i>New Terms: CTCAE Grade 3 Constipation, Constipation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2354</td>
               <td colspan="2">CTCAE Grade 3 Cornea Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Cornea Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Cornea Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 3 Cornea Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2355</td>
               <td colspan="2">CTCAE Grade 3 Cornea Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Cornea Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Cornea Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 3 Cornea Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2356</td>
               <td colspan="2">CTCAE Grade 3 Cornea Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Cornea Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Cornea Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     3 Cornea Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2357</td>
               <td colspan="2">CTCAE Grade 3 Cornea Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cornea Intra-Operative Injury Adverse Event. <br><i>New Terms: Cornea Intra-Operative Injury Adverse Event, CTCAE Grade 3 Cornea Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2358</td>
               <td colspan="2">CTCAE Grade 3 Cough<span class="subclass"> SubClassOf </span>Cough Adverse Event. <br><i>New Terms: Cough Adverse Event, CTCAE Grade 3 Cough</i></td>
            </tr>
            <tr class="addition">
               <td>2368</td>
               <td colspan="2">CTCAE Grade 3 Cranial Nerve I Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve I Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Cranial Nerve I Intra-Operative Injury, Cranial Nerve I Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2369</td>
               <td colspan="2">CTCAE Grade 3 Cranial Nerve I Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve I Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve I Neuropathy Adverse Event, CTCAE Grade 3 Cranial Nerve I Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>2361</td>
               <td colspan="2">CTCAE Grade 3 Cranial Nerve II Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve II Intra-Operative Injury Adverse Event. <br><i>New Terms: Cranial Nerve II Intra-Operative Injury Adverse Event, CTCAE Grade 3 Cranial Nerve
                     II Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2362</td>
               <td colspan="2">CTCAE Grade 3 Cranial Nerve II Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve II Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve II Neuropathy Adverse Event, CTCAE Grade 3 Cranial Nerve II Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>2359</td>
               <td colspan="2">CTCAE Grade 3 Cranial Nerve III Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve III Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Cranial Nerve III Intra-Operative Injury, Cranial Nerve III Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2360</td>
               <td colspan="2">CTCAE Grade 3 Cranial Nerve III Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve III Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve III Neuropathy Adverse Event, CTCAE Grade 3 Cranial Nerve III Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>2363</td>
               <td colspan="2">CTCAE Grade 3 Cranial Nerve IV Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve IV Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Cranial Nerve IV Intra-Operative Injury, Cranial Nerve IV Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2364</td>
               <td colspan="2">CTCAE Grade 3 Cranial Nerve IV Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve IV Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 3 Cranial Nerve IV Neuropathy, Cranial Nerve IV Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2365</td>
               <td colspan="2">CTCAE Grade 3 Cranial Nerve IX Motor Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve IX Motor Intra-Operative Injury Adverse Event. <br><i>New Terms: Cranial Nerve IX Motor Intra-Operative Injury Adverse Event, CTCAE Grade 3 Cranial
                     Nerve IX Motor Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2366</td>
               <td colspan="2">CTCAE Grade 3 Cranial Nerve IX Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve IX Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 3 Cranial Nerve IX Neuropathy, Cranial Nerve IX Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2367</td>
               <td colspan="2">CTCAE Grade 3 Cranial Nerve IX Sensory Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve IX Sensory Intra-Operative Injury Adverse Event. <br><i>New Terms: Cranial Nerve IX Sensory Intra-Operative Injury Adverse Event, CTCAE Grade 3 Cranial
                     Nerve IX Sensory Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2370</td>
               <td colspan="2">CTCAE Grade 3 Cranial Nerve Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Cranial Nerve Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Cranial Nerve Infection Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, Cranial Nerve Infection Adverse Event Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2371</td>
               <td colspan="2">CTCAE Grade 3 Cranial Nerve Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Cranial Nerve Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Cranial Nerve Infection with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, Cranial Nerve Infection Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2372</td>
               <td colspan="2">CTCAE Grade 3 Cranial Nerve Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Cranial Nerve Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Cranial Nerve Infection with Unknown Absolute Neutrophil Count, Cranial
                     Nerve Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2373</td>
               <td colspan="2">CTCAE Grade 3 Cranial Nerve Or Branch NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve Or Branch NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Cranial Nerve Or Branch NOS Intra-Operative Injury, Cranial Nerve Or
                     Branch NOS Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2381</td>
               <td colspan="2">CTCAE Grade 3 Cranial Nerve V Motor Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve V Motor Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Cranial Nerve V Motor Intra-Operative Injury, Cranial Nerve V Motor
                     Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2382</td>
               <td colspan="2">CTCAE Grade 3 Cranial Nerve V Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve V Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve V Neuropathy Adverse Event, CTCAE Grade 3 Cranial Nerve V Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>2383</td>
               <td colspan="2">CTCAE Grade 3 Cranial Nerve V Sensory Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve V Sensory Intra-Operative Injury Adverse Event. <br><i>New Terms: Cranial Nerve V Sensory Intra-Operative Injury Adverse Event, CTCAE Grade 3 Cranial
                     Nerve V Sensory Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2379</td>
               <td colspan="2">CTCAE Grade 3 Cranial Nerve VI Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve VI Intra-Operative Injury Adverse Event. <br><i>New Terms: Cranial Nerve VI Intra-Operative Injury Adverse Event, CTCAE Grade 3 Cranial Nerve
                     VI Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2380</td>
               <td colspan="2">CTCAE Grade 3 Cranial Nerve VI Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve VI Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 3 Cranial Nerve VI Neuropathy, Cranial Nerve VI Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2376</td>
               <td colspan="2">CTCAE Grade 3 Cranial Nerve VII Motor Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve VII Motor Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Cranial Nerve VII Motor Intra-Operative Injury, Cranial Nerve VII Motor
                     Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2377</td>
               <td colspan="2">CTCAE Grade 3 Cranial Nerve VII Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve VII Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 3 Cranial Nerve VII Neuropathy, Cranial Nerve VII Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2378</td>
               <td colspan="2">CTCAE Grade 3 Cranial Nerve VII Sensory Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve VII Sensory Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Cranial Nerve VII Sensory Intra-Operative Injury, Cranial Nerve VII
                     Sensory Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2374</td>
               <td colspan="2">CTCAE Grade 3 Cranial Nerve VIII Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve VIII Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Cranial Nerve VIII Intra-Operative Injury, Cranial Nerve VIII Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2375</td>
               <td colspan="2">CTCAE Grade 3 Cranial Nerve VIII Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve VIII Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 3 Cranial Nerve VIII Neuropathy, Cranial Nerve VIII Neuropathy Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>2388</td>
               <td colspan="2">CTCAE Grade 3 Cranial Nerve X Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve X Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Cranial Nerve X Intra-Operative Injury, Cranial Nerve X Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2389</td>
               <td colspan="2">CTCAE Grade 3 Cranial Nerve X Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve X Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 3 Cranial Nerve X Neuropathy, Cranial Nerve X Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2386</td>
               <td colspan="2">CTCAE Grade 3 Cranial Nerve XI Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve XI Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Cranial Nerve XI Intra-Operative Injury, Cranial Nerve XI Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2387</td>
               <td colspan="2">CTCAE Grade 3 Cranial Nerve XI Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve XI Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 3 Cranial Nerve XI Neuropathy, Cranial Nerve XI Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2384</td>
               <td colspan="2">CTCAE Grade 3 Cranial Nerve XII Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve XII Intra-Operative Injury Adverse Event. <br><i>New Terms: Cranial Nerve XII Intra-Operative Injury Adverse Event, CTCAE Grade 3 Cranial Nerve
                     XII Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2385</td>
               <td colspan="2">CTCAE Grade 3 Cranial Nerve XII Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve XII Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve XII Neuropathy Adverse Event, CTCAE Grade 3 Cranial Nerve XII Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>2390</td>
               <td colspan="2">CTCAE Grade 3 Creatine Phosphokinase<span class="subclass"> SubClassOf </span>Creatine Phosphokinase Adverse Event. <br><i>New Terms: CTCAE Grade 3 Creatine Phosphokinase, Creatine Phosphokinase Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2391</td>
               <td colspan="2">CTCAE Grade 3 Creatinine<span class="subclass"> SubClassOf </span>Creatinine Adverse Event. <br><i>New Terms: Creatinine Adverse Event, CTCAE Grade 3 Creatinine</i></td>
            </tr>
            <tr class="addition">
               <td>2392</td>
               <td colspan="2">CTCAE Grade 3 Cystitis<span class="subclass"> SubClassOf </span>Cystitis Adverse Event. <br><i>New Terms: Cystitis Adverse Event, CTCAE Grade 3 Cystitis</i></td>
            </tr>
            <tr class="addition">
               <td>2393</td>
               <td colspan="2">CTCAE Grade 3 Cytokine Release Syndrome<br><span class="keyword"> or </span>Acute Infusion Reaction<span class="subclass"> SubClassOf </span>Cytokine Release Syndrome<br><span class="keyword"> or </span>Acute Infusion Reaction Adverse Event. <br><i>New Terms: CTCAE Grade 3 Cytokine Release Syndrome or Acute Infusion Reaction, Cytokine Release
                     Syndrome or Acute Infusion Reaction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2394</td>
               <td colspan="2">CTCAE Grade 3 Dehydration<span class="subclass"> SubClassOf </span>Dehydration Adverse Event. <br><i>New Terms: CTCAE Grade 3 Dehydration, Dehydration Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2395</td>
               <td colspan="2">CTCAE Grade 3 Delayed Puberty<span class="subclass"> SubClassOf </span>Delayed Puberty Adverse Event. <br><i>New Terms: CTCAE Grade 3 Delayed Puberty, Delayed Puberty Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2399</td>
               <td colspan="2">CTCAE Grade 3 Dental<br><span class="keyword"> and </span>Teeth<br><span class="keyword"> and </span>Peridontal Pain<span class="subclass"> SubClassOf </span>Dental<br><span class="keyword"> and </span>Teeth<br><span class="keyword"> and </span>Peridontal Pain Adverse Event. <br><i>New Terms: Dental and Teeth and Peridontal Pain Adverse Event, CTCAE Grade 3 Dental and Teeth
                     and Peridontal Pain</i></td>
            </tr>
            <tr class="addition">
               <td>2396</td>
               <td colspan="2">CTCAE Grade 3 Dental-Tooth Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Tooth Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Tooth Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 3 Dental-Tooth Infection Documented Clinically or
                     Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2397</td>
               <td colspan="2">CTCAE Grade 3 Dental-Tooth Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Tooth Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Tooth Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 3 Dental-Tooth Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2398</td>
               <td colspan="2">CTCAE Grade 3 Dental-Tooth Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Tooth Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Dental-Tooth Infection with Unknown Absolute Neutrophil Count, Tooth
                     Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2400</td>
               <td colspan="2">CTCAE Grade 3 Depression<span class="subclass"> SubClassOf </span>Depression Adverse Event. <br><i>New Terms: CTCAE Grade 3 Depression, Depression Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2401</td>
               <td colspan="2">CTCAE Grade 3 Diarrhea<span class="subclass"> SubClassOf </span>Diarrhea Adverse Event. <br><i>New Terms: CTCAE Grade 3 Diarrhea, Diarrhea Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2402</td>
               <td colspan="2">CTCAE Grade 3 Disseminated Intravascular Coagulation<span class="subclass"> SubClassOf </span>Disseminated Intravascular Coagulation Adverse Event. <br><i>New Terms: CTCAE Grade 3 Disseminated Intravascular Coagulation, Disseminated Intravascular Coagulation
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2403</td>
               <td colspan="2">CTCAE Grade 3 Dizziness<span class="subclass"> SubClassOf </span>Dizziness Adverse Event. <br><i>New Terms: CTCAE Grade 3 Dizziness, Dizziness Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2404</td>
               <td colspan="2">CTCAE Grade 3 Dry Eye Syndrome<span class="subclass"> SubClassOf </span>Dry Eye Syndrome Adverse Event. <br><i>New Terms: Dry Eye Syndrome Adverse Event, CTCAE Grade 3 Dry Eye Syndrome</i></td>
            </tr>
            <tr class="addition">
               <td>2405</td>
               <td colspan="2">CTCAE Grade 3 Dry Skin<span class="subclass"> SubClassOf </span>Dry Skin Adverse Event. <br><i>New Terms: Dry Skin Adverse Event, CTCAE Grade 3 Dry Skin</i></td>
            </tr>
            <tr class="addition">
               <td>2406</td>
               <td colspan="2">CTCAE Grade 3 Duodenum Fistula<span class="subclass"> SubClassOf </span>Duodenum Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 3 Duodenum Fistula, Duodenum Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2407</td>
               <td colspan="2">CTCAE Grade 3 Duodenum Hemorrhage<span class="subclass"> SubClassOf </span>Duodenum Hemorrhage Adverse Event. <br><i>New Terms: Duodenum Hemorrhage Adverse Event, CTCAE Grade 3 Duodenum Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>2408</td>
               <td colspan="2">CTCAE Grade 3 Duodenum Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Duodenum Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Duodenum Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 3 Duodenum Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2409</td>
               <td colspan="2">CTCAE Grade 3 Duodenum Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Duodenum Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Duodenum Infection with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, Duodenum Infection Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2410</td>
               <td colspan="2">CTCAE Grade 3 Duodenum Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Duodenum Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Duodenum Infection with Unknown Absolute Neutrophil Count, Duodenum
                     Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2411</td>
               <td colspan="2">CTCAE Grade 3 Duodenum Intra-Operative Injury<span class="subclass"> SubClassOf </span>Duodenum Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Duodenum Intra-Operative Injury, Duodenum Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>2412</td>
               <td colspan="2">CTCAE Grade 3 Duodenum Necrosis<span class="subclass"> SubClassOf </span>Duodenum Necrosis Adverse Event. <br><i>New Terms: Duodenum Necrosis Adverse Event, CTCAE Grade 3 Duodenum Necrosis</i></td>
            </tr>
            <tr class="addition">
               <td>2413</td>
               <td colspan="2">CTCAE Grade 3 Duodenum Obstruction<span class="subclass"> SubClassOf </span>Duodenum Obstruction Adverse Event. <br><i>New Terms: Duodenum Obstruction Adverse Event, CTCAE Grade 3 Duodenum Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>2414</td>
               <td colspan="2">CTCAE Grade 3 Duodenum Perforation<span class="subclass"> SubClassOf </span>Duodenum Perforation Adverse Event. <br><i>New Terms: Duodenum Perforation Adverse Event, CTCAE Grade 3 Duodenum Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>2415</td>
               <td colspan="2">CTCAE Grade 3 Duodenum Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Duodenum Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Duodenum Stricture or Stenosis Adverse Event, CTCAE Grade 3 Duodenum Stricture or
                     Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>2416</td>
               <td colspan="2">CTCAE Grade 3 Duodenum Ulcer<span class="subclass"> SubClassOf </span>Duodenum Ulcer Adverse Event. <br><i>New Terms: CTCAE Grade 3 Duodenum Ulcer, Duodenum Ulcer Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2417</td>
               <td colspan="2">CTCAE Grade 3 Dysphagia<span class="subclass"> SubClassOf </span>Dysphagia Adverse Event. <br><i>New Terms: CTCAE Grade 3 Dysphagia, Dysphagia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2418</td>
               <td colspan="2">CTCAE Grade 3 Dyspnea<span class="subclass"> SubClassOf </span>Dyspnea Adverse Event. <br><i>New Terms: Dyspnea Adverse Event, CTCAE Grade 3 Dyspnea</i></td>
            </tr>
            <tr class="addition">
               <td>2419</td>
               <td colspan="2">CTCAE Grade 3 Edema of the Head<br><span class="keyword"> and </span>Neck<span class="subclass"> SubClassOf </span>Edema Adverse Event of the Head<br><span class="keyword"> and </span>Neck. <br><i>New Terms: CTCAE Grade 3 Edema of the Head and Neck, Edema Adverse Event of the Head and Neck</i></td>
            </tr>
            <tr class="addition">
               <td>2420</td>
               <td colspan="2">CTCAE Grade 3 Edema of the Limb<span class="subclass"> SubClassOf </span>Edema Adverse Event of the Limb. <br><i>New Terms: CTCAE Grade 3 Edema of the Limb, Edema Adverse Event of the Limb</i></td>
            </tr>
            <tr class="addition">
               <td>2421</td>
               <td colspan="2">CTCAE Grade 3 Edema of the Trunk<br><span class="keyword"> and </span>Genital Area<span class="subclass"> SubClassOf </span>Edema Adverse Event of the Trunk<br><span class="keyword"> and </span>Genital Area. <br><i>New Terms: CTCAE Grade 3 Edema of the Trunk and Genital Area, Edema Adverse Event of the Trunk
                     and Genital Area</i></td>
            </tr>
            <tr class="addition">
               <td>2422</td>
               <td colspan="2">CTCAE Grade 3 Edema of the Viscera<span class="subclass"> SubClassOf </span>Edema Adverse Event of the Viscera. <br><i>New Terms: Edema Adverse Event of the Viscera, CTCAE Grade 3 Edema of the Viscera</i></td>
            </tr>
            <tr class="addition">
               <td>2423</td>
               <td colspan="2">CTCAE Grade 3 Encephalopathy<span class="subclass"> SubClassOf </span>Encephalopathy Adverse Event. <br><i>New Terms: CTCAE Grade 3 Encephalopathy, Encephalopathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2424</td>
               <td colspan="2">CTCAE Grade 3 Enteritis<span class="subclass"> SubClassOf </span>Enteritis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Enteritis, Enteritis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2425</td>
               <td colspan="2">CTCAE Grade 3 Epiphora<span class="subclass"> SubClassOf </span>Epiphora Adverse Event. <br><i>New Terms: CTCAE Grade 3 Epiphora, Epiphora Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2426</td>
               <td colspan="2">CTCAE Grade 3 Erectile Dysfunction<span class="subclass"> SubClassOf </span>Erectile Dysfunction Adverse Event. <br><i>New Terms: Erectile Dysfunction Adverse Event, CTCAE Grade 3 Erectile Dysfunction</i></td>
            </tr>
            <tr class="addition">
               <td>2427</td>
               <td colspan="2">CTCAE Grade 3 Esophageal Varices Hemorrhage<span class="subclass"> SubClassOf </span>Esophageal Varices Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 3 Esophageal Varices Hemorrhage, Esophageal Varices Hemorrhage Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>2428</td>
               <td colspan="2">CTCAE Grade 3 Esophagitis<span class="subclass"> SubClassOf </span>Esophagitis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Esophagitis, Esophagitis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2429</td>
               <td colspan="2">CTCAE Grade 3 Esophagus Fistula<span class="subclass"> SubClassOf </span>Esophagus Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 3 Esophagus Fistula, Esophagus Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2430</td>
               <td colspan="2">CTCAE Grade 3 Esophagus Hemorrhage<span class="subclass"> SubClassOf </span>Esophagus Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 3 Esophagus Hemorrhage, Esophagus Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2431</td>
               <td colspan="2">CTCAE Grade 3 Esophagus Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Esophagus Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Esophagus Infection Adverse Event Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, CTCAE Grade 3 Esophagus Infection Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2432</td>
               <td colspan="2">CTCAE Grade 3 Esophagus Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Esophagus Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Esophagus Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, CTCAE Grade 3 Esophagus Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2433</td>
               <td colspan="2">CTCAE Grade 3 Esophagus Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Esophagus Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Esophagus Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     3 Esophagus Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2434</td>
               <td colspan="2">CTCAE Grade 3 Esophagus Intra-Operative Injury<span class="subclass"> SubClassOf </span>Esophagus Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Esophagus Intra-Operative Injury, Esophagus Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>2435</td>
               <td colspan="2">CTCAE Grade 3 Esophagus Leak<span class="subclass"> SubClassOf </span>Esophagus Leak Adverse Event. <br><i>New Terms: CTCAE Grade 3 Esophagus Leak, Esophagus Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2436</td>
               <td colspan="2">CTCAE Grade 3 Esophagus Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Esophagus Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Clinical Examination Classification. <br><i>New Terms: CTCAE Grade 3 Esophagus Mucositis or Stomatitis by Clinical Examination Classification,
                     Esophagus Mucositis or Stomatitis Adverse Event by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>2437</td>
               <td colspan="2">CTCAE Grade 3 Esophagus Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Esophagus Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: Esophagus Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification,
                     CTCAE Grade 3 Esophagus Mucositis or Stomatitis by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>2438</td>
               <td colspan="2">CTCAE Grade 3 Esophagus Necrosis<span class="subclass"> SubClassOf </span>Esophagus Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Esophagus Necrosis, Esophagus Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2439</td>
               <td colspan="2">CTCAE Grade 3 Esophagus Obstruction<span class="subclass"> SubClassOf </span>Esophagus Obstruction Adverse Event. <br><i>New Terms: Esophagus Obstruction Adverse Event, CTCAE Grade 3 Esophagus Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>2440</td>
               <td colspan="2">CTCAE Grade 3 Esophagus Pain<span class="subclass"> SubClassOf </span>Esophagus Pain Adverse Event. <br><i>New Terms: CTCAE Grade 3 Esophagus Pain, Esophagus Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2441</td>
               <td colspan="2">CTCAE Grade 3 Esophagus Perforation<span class="subclass"> SubClassOf </span>Esophagus Perforation Adverse Event. <br><i>New Terms: Esophagus Perforation Adverse Event, CTCAE Grade 3 Esophagus Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>2442</td>
               <td colspan="2">CTCAE Grade 3 Esophagus Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Esophagus Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Esophagus Stricture or Stenosis Adverse Event, CTCAE Grade 3 Esophagus Stricture or
                     Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>2443</td>
               <td colspan="2">CTCAE Grade 3 Esophagus Ulcer<span class="subclass"> SubClassOf </span>Esophagus Ulcer Adverse Event. <br><i>New Terms: Esophagus Ulcer Adverse Event, CTCAE Grade 3 Esophagus Ulcer</i></td>
            </tr>
            <tr class="addition">
               <td>2444</td>
               <td colspan="2">CTCAE Grade 3 Euphoria<span class="subclass"> SubClassOf </span>Euphoria Adverse Event. <br><i>New Terms: CTCAE Grade 3 Euphoria, Euphoria Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2445</td>
               <td colspan="2">CTCAE Grade 3 Exostosis<span class="subclass"> SubClassOf </span>Exostosis Adverse Event. <br><i>New Terms: Exostosis Adverse Event, CTCAE Grade 3 Exostosis</i></td>
            </tr>
            <tr class="addition">
               <td>2446</td>
               <td colspan="2">CTCAE Grade 3 External Ear Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>External Ear Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 3 External Ear Infection Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, External Ear Infection Adverse Event Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2447</td>
               <td colspan="2">CTCAE Grade 3 External Ear Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>External Ear Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: External Ear Infection Adverse Event with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, CTCAE Grade 3 External Ear Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2448</td>
               <td colspan="2">CTCAE Grade 3 External Ear Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>External Ear Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: External Ear Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE
                     Grade 3 External Ear Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2449</td>
               <td colspan="2">CTCAE Grade 3 External Ear Pain<span class="subclass"> SubClassOf </span>External Ear Pain Adverse Event. <br><i>New Terms: CTCAE Grade 3 External Ear Pain, External Ear Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2450</td>
               <td colspan="2">CTCAE Grade 3 Extraocular Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Extraocular Muscle Weakness Not Due to Neuropathy Adverse Event. <br><i>New Terms: Extraocular Muscle Weakness Not Due to Neuropathy Adverse Event, CTCAE Grade 3 Extraocular
                     Muscle Weakness Not Due to Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>2451</td>
               <td colspan="2">CTCAE Grade 3 Extrapyramidal<br><span class="keyword"> and </span>Involuntary Movement<br><span class="keyword"> and </span>Restlessness<span class="subclass"> SubClassOf </span>Extrapyramidal<br><span class="keyword"> and </span>Involuntary Movement<br><span class="keyword"> and </span>Restlessness Adverse Event. <br><i>New Terms: Extrapyramidal and Involuntary Movement and Restlessness Adverse Event, CTCAE Grade
                     3 Extrapyramidal and Involuntary Movement and Restlessness</i></td>
            </tr>
            <tr class="addition">
               <td>2452</td>
               <td colspan="2">CTCAE Grade 3 Extremity Limb Pain<span class="subclass"> SubClassOf </span>Extremity Limb Pain Adverse Event. <br><i>New Terms: CTCAE Grade 3 Extremity Limb Pain, Extremity Limb Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2453</td>
               <td colspan="2">CTCAE Grade 3 Eye Infection NOS Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Eye Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Eye Infection NOS Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 3 Eye Infection NOS Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2454</td>
               <td colspan="2">CTCAE Grade 3 Eye Infection NOS with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Eye Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Eye Infection NOS with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Eye Infection NOS Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2455</td>
               <td colspan="2">CTCAE Grade 3 Eye Infection NOS with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Eye Infection NOS Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Eye Infection NOS Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     3 Eye Infection NOS with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2456</td>
               <td colspan="2">CTCAE Grade 3 Eye NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Eye NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: Eye NOS Intra-Operative Injury Adverse Event, CTCAE Grade 3 Eye NOS Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2457</td>
               <td colspan="2">CTCAE Grade 3 Eye Pain<span class="subclass"> SubClassOf </span>Eye Pain Adverse Event. <br><i>New Terms: CTCAE Grade 3 Eye Pain, Eye Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2458</td>
               <td colspan="2">CTCAE Grade 3 Eyelid Dysfunction<span class="subclass"> SubClassOf </span>Eyelid Dysfunction Adverse Event. <br><i>New Terms: CTCAE Grade 3 Eyelid Dysfunction, Eyelid Dysfunction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2459</td>
               <td colspan="2">CTCAE Grade 3 FEV1<span class="subclass"> SubClassOf </span>FEV1 Adverse Event. <br><i>New Terms: CTCAE Grade 3 FEV1, FEV1 Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2460</td>
               <td colspan="2">CTCAE Grade 3 Face NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Face NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Face NOS Intra-Operative Injury, Face NOS Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>2461</td>
               <td colspan="2">CTCAE Grade 3 Face Pain<span class="subclass"> SubClassOf </span>Face Pain Adverse Event. <br><i>New Terms: Face Pain Adverse Event, CTCAE Grade 3 Face Pain</i></td>
            </tr>
            <tr class="addition">
               <td>2462</td>
               <td colspan="2">CTCAE Grade 3 Facial Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Facial Muscle Weakness Not Due to Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 3 Facial Muscle Weakness Not Due to Neuropathy, Facial Muscle Weakness
                     Not Due to Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2463</td>
               <td colspan="2">CTCAE Grade 3 Fallopian Tube Hemorrhage<span class="subclass"> SubClassOf </span>Fallopian Tube Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 3 Fallopian Tube Hemorrhage, Fallopian Tube Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2464</td>
               <td colspan="2">CTCAE Grade 3 Fallopian Tube Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Fallopian Tube Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Fallopian Tube Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, CTCAE Grade 3 Fallopian Tube Infection Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2465</td>
               <td colspan="2">CTCAE Grade 3 Fallopian Tube Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Fallopian Tube Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Fallopian Tube Infection with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, Fallopian Tube Infection Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2466</td>
               <td colspan="2">CTCAE Grade 3 Fallopian Tube Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Fallopian Tube Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Fallopian Tube Infection with Unknown Absolute Neutrophil Count, Fallopian
                     Tube Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2467</td>
               <td colspan="2">CTCAE Grade 3 Fallopian Tube Intra-Operative Injury<span class="subclass"> SubClassOf </span>Fallopian Tube Intra-Operative Injury Adverse Event. <br><i>New Terms: Fallopian Tube Intra-Operative Injury Adverse Event, CTCAE Grade 3 Fallopian Tube
                     Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2468</td>
               <td colspan="2">CTCAE Grade 3 Fallopian Tube Leak<span class="subclass"> SubClassOf </span>Fallopian Tube Leak Adverse Event. <br><i>New Terms: Fallopian Tube Leak Adverse Event, CTCAE Grade 3 Fallopian Tube Leak</i></td>
            </tr>
            <tr class="addition">
               <td>2469</td>
               <td colspan="2">CTCAE Grade 3 Fallopian Tube Obstruction<span class="subclass"> SubClassOf </span>Fallopian Tube Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 3 Fallopian Tube Obstruction, Fallopian Tube Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2470</td>
               <td colspan="2">CTCAE Grade 3 Fallopian Tube Perforation<span class="subclass"> SubClassOf </span>Fallopian Tube Perforation Adverse Event. <br><i>New Terms: Fallopian Tube Perforation Adverse Event, CTCAE Grade 3 Fallopian Tube Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>2471</td>
               <td colspan="2">CTCAE Grade 3 Fallopian Tube Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Fallopian Tube Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Fallopian Tube Stricture or Stenosis, Fallopian Tube Stricture or Stenosis
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2472</td>
               <td colspan="2">CTCAE Grade 3 Fatigue<span class="subclass"> SubClassOf </span>Fatigue Adverse Event. <br><i>New Terms: CTCAE Grade 3 Fatigue, Fatigue Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2473</td>
               <td colspan="2">CTCAE Grade 3 Febrile Neutropenia<span class="subclass"> SubClassOf </span>Febrile Neutropenia without Clinically<br><span class="keyword"> or </span>Microbiologically Documented Infection with Absolute Neutrophil Count Less Than 1
                  X 10e9 per Liter<br><span class="keyword"> and </span>Temperature Greater Than<br><span class="keyword"> or </span>Equal to 38 Point 5 Degrees Celsius. <br><i>New Terms: Febrile Neutropenia without Clinically or Microbiologically Documented Infection with
                     Absolute Neutrophil Count Less Than 1 X 10e9 per Liter and Temperature Greater Than
                     or Equal to 38 Point 5 Degrees Celsius, CTCAE Grade 3 Febrile Neutropenia</i></td>
            </tr>
            <tr class="addition">
               <td>2474</td>
               <td colspan="2">CTCAE Grade 3 Female Genital Tract Fistula<span class="subclass"> SubClassOf </span>Female Genital Tract Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 3 Female Genital Tract Fistula, Female Genital Tract Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2475</td>
               <td colspan="2">CTCAE Grade 3 Feminization of Male<span class="subclass"> SubClassOf </span>Feminization of Male Adverse Event. <br><i>New Terms: CTCAE Grade 3 Feminization of Male, Feminization of Male Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2476</td>
               <td colspan="2">CTCAE Grade 3 Fever Without Neutropenia<span class="subclass"> SubClassOf </span>Fever Without Neutropenia Adverse Event. <br><i>New Terms: CTCAE Grade 3 Fever Without Neutropenia, Fever Without Neutropenia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2477</td>
               <td colspan="2">CTCAE Grade 3 Fibrinogen<span class="subclass"> SubClassOf </span>Fibrinogen Adverse Event. <br><i>New Terms: CTCAE Grade 3 Fibrinogen, Fibrinogen Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2478</td>
               <td colspan="2">CTCAE Grade 3 Fibrosis-Cosmesis<span class="subclass"> SubClassOf </span>Fibrosis-Cosmesis Adverse Event. <br><i>New Terms: Fibrosis-Cosmesis Adverse Event, CTCAE Grade 3 Fibrosis-Cosmesis</i></td>
            </tr>
            <tr class="addition">
               <td>2479</td>
               <td colspan="2">CTCAE Grade 3 Fibrosis-Deep Connective Tissue<span class="subclass"> SubClassOf </span>Fibrosis-Deep Connective Tissue Adverse Event. <br><i>New Terms: Fibrosis-Deep Connective Tissue Adverse Event, CTCAE Grade 3 Fibrosis-Deep Connective
                     Tissue</i></td>
            </tr>
            <tr class="addition">
               <td>2480</td>
               <td colspan="2">CTCAE Grade 3 Flashing Lights<br><span class="keyword"> and </span>Floaters in Vision<span class="subclass"> SubClassOf </span>Flashing Lights<br><span class="keyword"> and </span>Floaters in Vision Adverse Event. <br><i>New Terms: Flashing Lights and Floaters in Vision Adverse Event, CTCAE Grade 3 Flashing Lights
                     and Floaters in Vision</i></td>
            </tr>
            <tr class="addition">
               <td>2481</td>
               <td colspan="2">CTCAE Grade 3 Flu-Like Syndrome<span class="subclass"> SubClassOf </span>Flu-Like Syndrome Adverse Event. <br><i>New Terms: Flu-Like Syndrome Adverse Event, CTCAE Grade 3 Flu-Like Syndrome</i></td>
            </tr>
            <tr class="addition">
               <td>2482</td>
               <td colspan="2">CTCAE Grade 3 Foreign Body Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Foreign Body Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Foreign Body Infection Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, Foreign Body Infection Adverse Event Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2483</td>
               <td colspan="2">CTCAE Grade 3 Foreign Body Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Foreign Body Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Foreign Body Infection Adverse Event with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, CTCAE Grade 3 Foreign Body Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2484</td>
               <td colspan="2">CTCAE Grade 3 Foreign Body Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Foreign Body Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Foreign Body Infection with Unknown Absolute Neutrophil Count, Foreign
                     Body Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2485</td>
               <td colspan="2">CTCAE Grade 3 Fracture<span class="subclass"> SubClassOf </span>Fracture Adverse Event. <br><i>New Terms: CTCAE Grade 3 Fracture, Fracture Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2486</td>
               <td colspan="2">CTCAE Grade 3 Gallbladder Fistula<span class="subclass"> SubClassOf </span>Gallbladder Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 3 Gallbladder Fistula, Gallbladder Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2487</td>
               <td colspan="2">CTCAE Grade 3 Gallbladder Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Gallbladder Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Gallbladder Infection Adverse Event Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, CTCAE Grade 3 Gallbladder Infection Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2488</td>
               <td colspan="2">CTCAE Grade 3 Gallbladder Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Gallbladder Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Gallbladder Infection Adverse Event with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, CTCAE Grade 3 Gallbladder Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2489</td>
               <td colspan="2">CTCAE Grade 3 Gallbladder Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Gallbladder Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Gallbladder Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE
                     Grade 3 Gallbladder Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2490</td>
               <td colspan="2">CTCAE Grade 3 Gallbladder Intra-Operative Injury<span class="subclass"> SubClassOf </span>Gallbladder Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Gallbladder Intra-Operative Injury, Gallbladder Intra-Operative Injury
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2491</td>
               <td colspan="2">CTCAE Grade 3 Gallbladder Necrosis<span class="subclass"> SubClassOf </span>Gallbladder Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Gallbladder Necrosis, Gallbladder Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2492</td>
               <td colspan="2">CTCAE Grade 3 Gallbladder Obstruction<span class="subclass"> SubClassOf </span>Gallbladder Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 3 Gallbladder Obstruction, Gallbladder Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2493</td>
               <td colspan="2">CTCAE Grade 3 Gallbladder Pain<span class="subclass"> SubClassOf </span>Gallbladder Pain Adverse Event. <br><i>New Terms: Gallbladder Pain Adverse Event, CTCAE Grade 3 Gallbladder Pain</i></td>
            </tr>
            <tr class="addition">
               <td>2494</td>
               <td colspan="2">CTCAE Grade 3 Gallbladder Perforation<span class="subclass"> SubClassOf </span>Gallbladder Perforation Adverse Event. <br><i>New Terms: Gallbladder Perforation Adverse Event, CTCAE Grade 3 Gallbladder Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>2495</td>
               <td colspan="2">CTCAE Grade 3 Gamma-Glutamyl Transpeptidase<span class="subclass"> SubClassOf </span>Gamma-Glutamyl Transpeptidase Adverse Event. <br><i>New Terms: Gamma-Glutamyl Transpeptidase Adverse Event, CTCAE Grade 3 Gamma-Glutamyl Transpeptidase</i></td>
            </tr>
            <tr class="addition">
               <td>2496</td>
               <td colspan="2">CTCAE Grade 3 Gastritis<span class="subclass"> SubClassOf </span>Gastritis Adverse Event. <br><i>New Terms: Gastritis Adverse Event, CTCAE Grade 3 Gastritis</i></td>
            </tr>
            <tr class="addition">
               <td>2497</td>
               <td colspan="2">CTCAE Grade 3 Gastrointestinal Leak NOS<span class="subclass"> SubClassOf </span>Gastrointestinal Leak Adverse Event NOS. <br><i>New Terms: CTCAE Grade 3 Gastrointestinal Leak NOS, Gastrointestinal Leak Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>2498</td>
               <td colspan="2">CTCAE Grade 3 Gastrointestinal Stoma Hemorrhage<span class="subclass"> SubClassOf </span>Gastrointestinal Stoma Hemorrhage Adverse Event. <br><i>New Terms: Gastrointestinal Stoma Hemorrhage Adverse Event, CTCAE Grade 3 Gastrointestinal Stoma
                     Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>2499</td>
               <td colspan="2">CTCAE Grade 3 Gastrointestinal Stoma Intra-Operative Injury<span class="subclass"> SubClassOf </span>Gastointestinal Stoma Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Gastrointestinal Stoma Intra-Operative Injury, Gastointestinal Stoma
                     Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2500</td>
               <td colspan="2">CTCAE Grade 3 Gastrointestinal Stoma Leak<span class="subclass"> SubClassOf </span>Gastrointestinal Stoma Leak Adverse Event. <br><i>New Terms: CTCAE Grade 3 Gastrointestinal Stoma Leak, Gastrointestinal Stoma Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2501</td>
               <td colspan="2">CTCAE Grade 3 Genitourinary Stoma Hemorrhage<span class="subclass"> SubClassOf </span>Genitourinary Stoma Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 3 Genitourinary Stoma Hemorrhage, Genitourinary Stoma Hemorrhage Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>2502</td>
               <td colspan="2">CTCAE Grade 3 Genitourinary Stoma Leak<span class="subclass"> SubClassOf </span>Genitourinary Stoma Leak Adverse Event. <br><i>New Terms: Genitourinary Stoma Leak Adverse Event, CTCAE Grade 3 Genitourinary Stoma Leak</i></td>
            </tr>
            <tr class="addition">
               <td>2503</td>
               <td colspan="2">CTCAE Grade 3 Genitourinary Stoma Obstruction<span class="subclass"> SubClassOf </span>Genitourinary Stoma Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 3 Genitourinary Stoma Obstruction, Genitourinary Stoma Obstruction Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>2504</td>
               <td colspan="2">CTCAE Grade 3 Genitourinary Stoma Prolapse<span class="subclass"> SubClassOf </span>Genitourinary Stoma Prolapse Adverse Event. <br><i>New Terms: Genitourinary Stoma Prolapse Adverse Event, CTCAE Grade 3 Genitourinary Stoma Prolapse</i></td>
            </tr>
            <tr class="addition">
               <td>2505</td>
               <td colspan="2">CTCAE Grade 3 Genitourinary Stoma Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Genitourinary Stoma Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Genitourinary Stoma Stricture or Stenosis Adverse Event, CTCAE Grade 3 Genitourinary
                     Stoma Stricture or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>2506</td>
               <td colspan="2">CTCAE Grade 3 Gingiva Intra-Operative Injury<span class="subclass"> SubClassOf </span>Gingiva Intra-Operative Injury Adverse Event. <br><i>New Terms: Gingiva Intra-Operative Injury Adverse Event, CTCAE Grade 3 Gingiva Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2507</td>
               <td colspan="2">CTCAE Grade 3 Glaucoma<span class="subclass"> SubClassOf </span>Glaucoma Adverse Event. <br><i>New Terms: CTCAE Grade 3 Glaucoma, Glaucoma Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2508</td>
               <td colspan="2">CTCAE Grade 3 Glomerular Filtration Rate<span class="subclass"> SubClassOf </span>Glomerular Filtration Rate Adverse Event. <br><i>New Terms: CTCAE Grade 3 Glomerular Filtration Rate, Glomerular Filtration Rate Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2509</td>
               <td colspan="2">CTCAE Grade 3 Gynecomastia<span class="subclass"> SubClassOf </span>Gynecomastia Adverse Event. <br><i>New Terms: CTCAE Grade 3 Gynecomastia, Gynecomastia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2510</td>
               <td colspan="2">CTCAE Grade 3 Haptoglobin<span class="subclass"> SubClassOf </span>Haptoglobin Adverse Event. <br><i>New Terms: Haptoglobin Adverse Event, CTCAE Grade 3 Haptoglobin</i></td>
            </tr>
            <tr class="addition">
               <td>2511</td>
               <td colspan="2">CTCAE Grade 3 Head Soft Tissue Necrosis<span class="subclass"> SubClassOf </span>Head Soft Tissue Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Head Soft Tissue Necrosis, Head Soft Tissue Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2512</td>
               <td colspan="2">CTCAE Grade 3 Head<br><span class="keyword"> and </span>Headache Pain<span class="subclass"> SubClassOf </span>Head<br><span class="keyword"> and </span>Headache Pain Adverse Event. <br><i>New Terms: CTCAE Grade 3 Head and Headache Pain, Head and Headache Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2513</td>
               <td colspan="2">CTCAE Grade 3 Hearing Patients with<br><span class="keyword"> or </span>without Baseline Audiogram<br><span class="keyword"> and </span>Enrolled in a Monitoring Program<span class="subclass"> SubClassOf </span>Hearing Adverse Event Patients with<br><span class="keyword"> or </span>without Baseline Audiogram<br><span class="keyword"> and </span>Enrolled in a Monitoring Program. <br><i>New Terms: Hearing Adverse Event Patients with or without Baseline Audiogram and Enrolled in
                     a Monitoring Program, CTCAE Grade 3 Hearing Patients with or without Baseline Audiogram
                     and Enrolled in a Monitoring Program</i></td>
            </tr>
            <tr class="addition">
               <td>2514</td>
               <td colspan="2">CTCAE Grade 3 Hearing Patients without Baseline Audiogram<br><span class="keyword"> and </span>Not Enrolled in a Monitoring Program<span class="subclass"> SubClassOf </span>Hearing Adverse Event Patients without Baseline Audiogram<br><span class="keyword"> and </span>Not Enrolled in a Monitoring Program. <br><i>New Terms: CTCAE Grade 3 Hearing Patients without Baseline Audiogram and Not Enrolled in a Monitoring
                     Program, Hearing Adverse Event Patients without Baseline Audiogram and Not Enrolled
                     in a Monitoring Program</i></td>
            </tr>
            <tr class="addition">
               <td>2515</td>
               <td colspan="2">CTCAE Grade 3 Heart Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Heart Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Heart Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 3 Heart Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2516</td>
               <td colspan="2">CTCAE Grade 3 Heart Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Heart Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Heart Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 3 Heart Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2517</td>
               <td colspan="2">CTCAE Grade 3 Heart Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Heart Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Heart Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     3 Heart Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2518</td>
               <td colspan="2">CTCAE Grade 3 Heart Intra-Operative Injury<span class="subclass"> SubClassOf </span>Heart Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Heart Intra-Operative Injury, Heart Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2519</td>
               <td colspan="2">CTCAE Grade 3 Heartburn<br><span class="keyword"> or </span>Dyspepsia<span class="subclass"> SubClassOf </span>Heartburn<br><span class="keyword"> or </span>Dyspepsia. <br><i>New Terms: Heartburn or Dyspepsia, CTCAE Grade 3 Heartburn or Dyspepsia</i></td>
            </tr>
            <tr class="addition">
               <td>2520</td>
               <td colspan="2">CTCAE Grade 3 Hematoma<span class="subclass"> SubClassOf </span>Hematoma Adverse Event. <br><i>New Terms: Hematoma Adverse Event, CTCAE Grade 3 Hematoma</i></td>
            </tr>
            <tr class="addition">
               <td>2521</td>
               <td colspan="2">CTCAE Grade 3 Hemoglobin<span class="subclass"> SubClassOf </span>Hemoglobin Adverse Event. <br><i>New Terms: Hemoglobin Adverse Event, CTCAE Grade 3 Hemoglobin</i></td>
            </tr>
            <tr class="addition">
               <td>2522</td>
               <td colspan="2">CTCAE Grade 3 Hemolysis<span class="subclass"> SubClassOf </span>Hemolysis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Hemolysis, Hemolysis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2523</td>
               <td colspan="2">CTCAE Grade 3 Hemorrhage<br><span class="keyword"> and </span>Bleeding Adverse Event Associated with Surgery<span class="subclass"> SubClassOf </span>Hemorrhage<br><span class="keyword"> and </span>Bleeding Adverse Event Associated with Surgery. <br><i>New Terms: CTCAE Grade 3 Hemorrhage and Bleeding Adverse Event Associated with Surgery, Hemorrhage
                     and Bleeding Adverse Event Associated with Surgery</i></td>
            </tr>
            <tr class="addition">
               <td>2524</td>
               <td colspan="2">CTCAE Grade 3 Hemorrhoids<span class="subclass"> SubClassOf </span>Hemorrhoids Adverse Event. <br><i>New Terms: CTCAE Grade 3 Hemorrhoids, Hemorrhoids Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2525</td>
               <td colspan="2">CTCAE Grade 3 Hepatic Artery Intra-Operative Injury<span class="subclass"> SubClassOf </span>Hepatic Artery Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Hepatic Artery Intra-Operative Injury, Hepatic Artery Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2526</td>
               <td colspan="2">CTCAE Grade 3 Hepatic Necrosis<span class="subclass"> SubClassOf </span>Hepatic Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Hepatic Necrosis, Hepatic Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2527</td>
               <td colspan="2">CTCAE Grade 3 Hepatic Vein Intra-Operative Injury<span class="subclass"> SubClassOf </span>Hepatic Vein Intra-Operative Injury Adverse Event. <br><i>New Terms: Hepatic Vein Intra-Operative Injury Adverse Event, CTCAE Grade 3 Hepatic Vein Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2528</td>
               <td colspan="2">CTCAE Grade 3 Hiccoughs<span class="subclass"> SubClassOf </span>Hiccoughs Adverse Event. <br><i>New Terms: Hiccoughs Adverse Event, CTCAE Grade 3 Hiccoughs</i></td>
            </tr>
            <tr class="addition">
               <td>2529</td>
               <td colspan="2">CTCAE Grade 3 Hot Flashes<br><span class="keyword"> or </span>Flushes<span class="subclass"> SubClassOf </span>Hot Flashes<br><span class="keyword"> or </span>Flushes Adverse Event. <br><i>New Terms: Hot Flashes or Flushes Adverse Event, CTCAE Grade 3 Hot Flashes or Flushes</i></td>
            </tr>
            <tr class="addition">
               <td>2530</td>
               <td colspan="2">CTCAE Grade 3 Hydrocephalus<span class="subclass"> SubClassOf </span>Hydrocephalus Adverse Event. <br><i>New Terms: CTCAE Grade 3 Hydrocephalus, Hydrocephalus Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2531</td>
               <td colspan="2">CTCAE Grade 3 Hyperbilirubinemia<span class="subclass"> SubClassOf </span>Hyperbilirubinemia Adverse Event. <br><i>New Terms: CTCAE Grade 3 Hyperbilirubinemia, Hyperbilirubinemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2532</td>
               <td colspan="2">CTCAE Grade 3 Hypertension<span class="subclass"> SubClassOf </span>Hypertension Adverse Event. <br><i>New Terms: CTCAE Grade 3 Hypertension, Hypertension Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2533</td>
               <td colspan="2">CTCAE Grade 3 Hypotension<span class="subclass"> SubClassOf </span>Hypotension Adverse Event. <br><i>New Terms: Hypotension Adverse Event, CTCAE Grade 3 Hypotension</i></td>
            </tr>
            <tr class="addition">
               <td>2534</td>
               <td colspan="2">CTCAE Grade 3 Hypothermia<span class="subclass"> SubClassOf </span>Hypothermia Adverse Event. <br><i>New Terms: Hypothermia Adverse Event, CTCAE Grade 3 Hypothermia</i></td>
            </tr>
            <tr class="addition">
               <td>2535</td>
               <td colspan="2">CTCAE Grade 3 Hypoxia<span class="subclass"> SubClassOf </span>Hypoxia Adverse Event. <br><i>New Terms: Hypoxia Adverse Event, CTCAE Grade 3 Hypoxia</i></td>
            </tr>
            <tr class="addition">
               <td>2536</td>
               <td colspan="2">CTCAE Grade 3 Idioventricular Rhythm<span class="subclass"> SubClassOf </span>Idioventricular Rhythm Adverse Event. <br><i>New Terms: CTCAE Grade 3 Idioventricular Rhythm, Idioventricular Rhythm Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2537</td>
               <td colspan="2">CTCAE Grade 3 Ileum Fistula<span class="subclass"> SubClassOf </span>Ileum Fistula Adverse Event. <br><i>New Terms: Ileum Fistula Adverse Event, CTCAE Grade 3 Ileum Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>2538</td>
               <td colspan="2">CTCAE Grade 3 Ileum Hemorrhage<span class="subclass"> SubClassOf </span>Ileum Hemorrhage Adverse Event. <br><i>New Terms: Ileum Hemorrhage Adverse Event, CTCAE Grade 3 Ileum Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>2539</td>
               <td colspan="2">CTCAE Grade 3 Ileum Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Ileum Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Ileum Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Ileum Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2540</td>
               <td colspan="2">CTCAE Grade 3 Ileum Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Ileum Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Ileum Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Ileum Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2541</td>
               <td colspan="2">CTCAE Grade 3 Ileum Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Ileum Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Ileum Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     3 Ileum Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2542</td>
               <td colspan="2">CTCAE Grade 3 Ileum Intra-Operative Injury<span class="subclass"> SubClassOf </span>Ileum Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Ileum Intra-Operative Injury, Ileum Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2543</td>
               <td colspan="2">CTCAE Grade 3 Ileum Necrosis<span class="subclass"> SubClassOf </span>Ileum Necrosis Adverse Event. <br><i>New Terms: Ileum Necrosis Adverse Event, CTCAE Grade 3 Ileum Necrosis</i></td>
            </tr>
            <tr class="addition">
               <td>2544</td>
               <td colspan="2">CTCAE Grade 3 Ileum Obstruction<span class="subclass"> SubClassOf </span>Ileum Obstruction Adverse Event. <br><i>New Terms: Ileum Obstruction Adverse Event, CTCAE Grade 3 Ileum Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>2545</td>
               <td colspan="2">CTCAE Grade 3 Ileum Perforation<span class="subclass"> SubClassOf </span>Ileum Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 3 Ileum Perforation, Ileum Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2546</td>
               <td colspan="2">CTCAE Grade 3 Ileum Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Ileum Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Ileum Stricture or Stenosis Adverse Event, CTCAE Grade 3 Ileum Stricture or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>2547</td>
               <td colspan="2">CTCAE Grade 3 Ileum Ulcer<span class="subclass"> SubClassOf </span>Ileum Ulcer Adverse Event. <br><i>New Terms: CTCAE Grade 3 Ileum Ulcer, Ileum Ulcer Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2548</td>
               <td colspan="2">CTCAE Grade 3 Ileus<span class="subclass"> SubClassOf </span>Gastrointestinal Ileus Adverse Event. <br><i>New Terms: CTCAE Grade 3 Ileus, Gastrointestinal Ileus Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2549</td>
               <td colspan="2">CTCAE Grade 3 Induration<br><span class="keyword"> or </span>Fibrosis of the Skin<br><span class="keyword"> and </span>Subcutaneous Tissue<span class="subclass"> SubClassOf </span>Induration<br><span class="keyword"> or </span>Fibrosis of the Skin<br><span class="keyword"> and </span>Subcutaneous Tissue Adverse Event. <br><i>New Terms: Induration or Fibrosis of the Skin and Subcutaneous Tissue Adverse Event, CTCAE Grade
                     3 Induration or Fibrosis of the Skin and Subcutaneous Tissue</i></td>
            </tr>
            <tr class="addition">
               <td>2550</td>
               <td colspan="2">CTCAE Grade 3 Infectious Colitis<span class="subclass"> SubClassOf </span>Infectious Colitis Adverse Event. <br><i>New Terms: Infectious Colitis Adverse Event, CTCAE Grade 3 Infectious Colitis</i></td>
            </tr>
            <tr class="addition">
               <td>2551</td>
               <td colspan="2">CTCAE Grade 3 Inferior Vena Cava Intra-Operative Injury<span class="subclass"> SubClassOf </span>Inferior Vena Cava Intra-Operative Injury Adverse Event. <br><i>New Terms: Inferior Vena Cava Intra-Operative Injury Adverse Event, CTCAE Grade 3 Inferior Vena
                     Cava Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2552</td>
               <td colspan="2">CTCAE Grade 3 Inferior Vena Cava Vein Injury<span class="subclass"> SubClassOf </span>Inferior Vena Cava Vein Injury Adverse Event. <br><i>New Terms: Inferior Vena Cava Vein Injury Adverse Event, CTCAE Grade 3 Inferior Vena Cava Vein
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2553</td>
               <td colspan="2">CTCAE Grade 3 Infertility<br><span class="keyword"> and </span>Sterility<span class="subclass"> SubClassOf </span>Infertility<br><span class="keyword"> and </span>Sterility Adverse Event. <br><i>New Terms: Infertility and Sterility Adverse Event, CTCAE Grade 3 Infertility and Sterility</i></td>
            </tr>
            <tr class="addition">
               <td>2554</td>
               <td colspan="2">CTCAE Grade 3 Injection Site Reaction<br><span class="keyword"> or </span>Extravasation Changes<span class="subclass"> SubClassOf </span>Injection Site Reaction<br><span class="keyword"> or </span>Extravasation Changes Adverse Event. <br><i>New Terms: CTCAE Grade 3 Injection Site Reaction or Extravasation Changes, Injection Site Reaction
                     or Extravasation Changes Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2555</td>
               <td colspan="2">CTCAE Grade 3 Inner Ear Intra-Operative Injury<span class="subclass"> SubClassOf </span>Inner Ear Intra-Operative Injury Adverse Event. <br><i>New Terms: Inner Ear Intra-Operative Injury Adverse Event, CTCAE Grade 3 Inner Ear Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2556</td>
               <td colspan="2">CTCAE Grade 3 Insomnia<span class="subclass"> SubClassOf </span>Insomnia Adverse Event. <br><i>New Terms: Insomnia Adverse Event, CTCAE Grade 3 Insomnia</i></td>
            </tr>
            <tr class="addition">
               <td>2557</td>
               <td colspan="2">CTCAE Grade 3 International Normalized Ratio of Prothrombin Time<span class="subclass"> SubClassOf </span>International Normalized Ratio of Prothrombin Time Adverse Event. <br><i>New Terms: International Normalized Ratio of Prothrombin Time Adverse Event, CTCAE Grade 3 International
                     Normalized Ratio of Prothrombin Time</i></td>
            </tr>
            <tr class="addition">
               <td>2558</td>
               <td colspan="2">CTCAE Grade 3 Intestine Pain<span class="subclass"> SubClassOf </span>Intestine Pain Adverse Event. <br><i>New Terms: CTCAE Grade 3 Intestine Pain, Intestine Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2559</td>
               <td colspan="2">CTCAE Grade 3 Iron Overload<span class="subclass"> SubClassOf </span>Iron Overload Adverse Event. <br><i>New Terms: Iron Overload Adverse Event, CTCAE Grade 3 Iron Overload</i></td>
            </tr>
            <tr class="addition">
               <td>2560</td>
               <td colspan="2">CTCAE Grade 3 Irregular Menses<span class="subclass"> SubClassOf </span>Irregular Menses Adverse Event. <br><i>New Terms: Irregular Menses Adverse Event, CTCAE Grade 3 Irregular Menses</i></td>
            </tr>
            <tr class="addition">
               <td>2561</td>
               <td colspan="2">CTCAE Grade 3 Irritability in Children Less Than 3 Years of Age<span class="subclass"> SubClassOf </span>Irritability in Children Less Than 3 Years of Age Adverse Event. <br><i>New Terms: Irritability in Children Less Than 3 Years of Age Adverse Event, CTCAE Grade 3 Irritability
                     in Children Less Than 3 Years of Age</i></td>
            </tr>
            <tr class="addition">
               <td>2562</td>
               <td colspan="2">CTCAE Grade 3 Jejunum Fistula<span class="subclass"> SubClassOf </span>Jejunum Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 3 Jejunum Fistula, Jejunum Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2563</td>
               <td colspan="2">CTCAE Grade 3 Jejunum Hemorrhage<span class="subclass"> SubClassOf </span>Jejunum Hemorrhage Adverse Event. <br><i>New Terms: Jejunum Hemorrhage Adverse Event, CTCAE Grade 3 Jejunum Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>2564</td>
               <td colspan="2">CTCAE Grade 3 Jejunum Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Jejunum Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Jejunum Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Jejunum Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2565</td>
               <td colspan="2">CTCAE Grade 3 Jejunum Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Jejunum Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Jejunum Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Jejunum Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2566</td>
               <td colspan="2">CTCAE Grade 3 Jejunum Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Jejunum Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Jejunum Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     3 Jejunum Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2567</td>
               <td colspan="2">CTCAE Grade 3 Jejunum Intra-Operative Injury<span class="subclass"> SubClassOf </span>Jejunum Intra-Operative Injury Adverse Event. <br><i>New Terms: Jejunum Intra-Operative Injury Adverse Event, CTCAE Grade 3 Jejunum Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2568</td>
               <td colspan="2">CTCAE Grade 3 Jejunum Necrosis<span class="subclass"> SubClassOf </span>Jejunum Necrosis Adverse Event. <br><i>New Terms: Jejunum Necrosis Adverse Event, CTCAE Grade 3 Jejunum Necrosis</i></td>
            </tr>
            <tr class="addition">
               <td>2569</td>
               <td colspan="2">CTCAE Grade 3 Jejunum Obstruction<span class="subclass"> SubClassOf </span>Jejunum Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 3 Jejunum Obstruction, Jejunum Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2570</td>
               <td colspan="2">CTCAE Grade 3 Jejunum Perforation<span class="subclass"> SubClassOf </span>Jejunum Perforation Adverse Event. <br><i>New Terms: Jejunum Perforation Adverse Event, CTCAE Grade 3 Jejunum Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>2571</td>
               <td colspan="2">CTCAE Grade 3 Jejunum Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Jejunum Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Jejunum Stricture or Stenosis, Jejunum Stricture or Stenosis Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>2572</td>
               <td colspan="2">CTCAE Grade 3 Jejunum Ulcer<span class="subclass"> SubClassOf </span>Jejunum Ulcer Adverse Event. <br><i>New Terms: CTCAE Grade 3 Jejunum Ulcer, Jejunum Ulcer Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2573</td>
               <td colspan="2">CTCAE Grade 3 Joint Effusion<span class="subclass"> SubClassOf </span>Joint Effusion Adverse Event. <br><i>New Terms: Joint Effusion Adverse Event, CTCAE Grade 3 Joint Effusion</i></td>
            </tr>
            <tr class="addition">
               <td>2574</td>
               <td colspan="2">CTCAE Grade 3 Joint Function<span class="subclass"> SubClassOf </span>Joint Function Adverse Event. <br><i>New Terms: CTCAE Grade 3 Joint Function, Joint Function Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2575</td>
               <td colspan="2">CTCAE Grade 3 Joint Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Joint Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Joint Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 3 Joint Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2576</td>
               <td colspan="2">CTCAE Grade 3 Joint Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Joint Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Joint Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 3 Joint Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2577</td>
               <td colspan="2">CTCAE Grade 3 Joint Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Joint Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Joint Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     3 Joint Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2578</td>
               <td colspan="2">CTCAE Grade 3 Joint Intra-Operative Injury<span class="subclass"> SubClassOf </span>Joint Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Joint Intra-Operative Injury, Joint Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2579</td>
               <td colspan="2">CTCAE Grade 3 Joint Pain<span class="subclass"> SubClassOf </span>Joint Pain Adverse Event. <br><i>New Terms: CTCAE Grade 3 Joint Pain, Joint Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2580</td>
               <td colspan="2">CTCAE Grade 3 Jugular Vein Injury<span class="subclass"> SubClassOf </span>Jugular Vein Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Jugular Vein Injury, Jugular Vein Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2581</td>
               <td colspan="2">CTCAE Grade 3 Jugular Vein Intra-Operative Injury<span class="subclass"> SubClassOf </span>Jugular Vein Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Jugular Vein Intra-Operative Injury, Jugular Vein Intra-Operative Injury
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2582</td>
               <td colspan="2">CTCAE Grade 3 Keratitis<span class="subclass"> SubClassOf </span>Keratitis Adverse Event. <br><i>New Terms: Keratitis Adverse Event, CTCAE Grade 3 Keratitis</i></td>
            </tr>
            <tr class="addition">
               <td>2583</td>
               <td colspan="2">CTCAE Grade 3 Kidney Fistula<span class="subclass"> SubClassOf </span>Kidney Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 3 Kidney Fistula, Kidney Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2584</td>
               <td colspan="2">CTCAE Grade 3 Kidney Hemorrhage<span class="subclass"> SubClassOf </span>Kidney Hemorrhage Adverse Event. <br><i>New Terms: Kidney Hemorrhage Adverse Event, CTCAE Grade 3 Kidney Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>2585</td>
               <td colspan="2">CTCAE Grade 3 Kidney Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Kidney Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Kidney Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 3 Kidney Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2586</td>
               <td colspan="2">CTCAE Grade 3 Kidney Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Kidney Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Kidney Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 3 Kidney Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2587</td>
               <td colspan="2">CTCAE Grade 3 Kidney Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Kidney Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Kidney Infection with Unknown Absolute Neutrophil Count, Kidney Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2588</td>
               <td colspan="2">CTCAE Grade 3 Kidney Intra-Operative Injury<span class="subclass"> SubClassOf </span>Kidney Intra-Operative Injury Adverse Event. <br><i>New Terms: Kidney Intra-Operative Injury Adverse Event, CTCAE Grade 3 Kidney Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2589</td>
               <td colspan="2">CTCAE Grade 3 Kidney Leak<span class="subclass"> SubClassOf </span>Kidney Leak Adverse Event. <br><i>New Terms: CTCAE Grade 3 Kidney Leak, Kidney Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2590</td>
               <td colspan="2">CTCAE Grade 3 Kidney Pain<span class="subclass"> SubClassOf </span>Kidney Pain Adverse Event. <br><i>New Terms: CTCAE Grade 3 Kidney Pain, Kidney Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2591</td>
               <td colspan="2">CTCAE Grade 3 Kidney Perforation<span class="subclass"> SubClassOf </span>Kidney Perforation Adverse Event. <br><i>New Terms: Kidney Perforation Adverse Event, CTCAE Grade 3 Kidney Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>2592</td>
               <td colspan="2">CTCAE Grade 3 Large Bowel Leak<span class="subclass"> SubClassOf </span>Large Bowel Leak Adverse Event. <br><i>New Terms: Large Bowel Leak Adverse Event, CTCAE Grade 3 Large Bowel Leak</i></td>
            </tr>
            <tr class="addition">
               <td>2593</td>
               <td colspan="2">CTCAE Grade 3 Large Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Large Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification. <br><i>New Terms: CTCAE Grade 3 Large Bowel Mucositis or Stomatitis by Clinical Examination Classification,
                     Large Bowel Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>2594</td>
               <td colspan="2">CTCAE Grade 3 Large Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Large Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: Large Bowel Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification,
                     CTCAE Grade 3 Large Bowel Mucositis or Stomatitis by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>2595</td>
               <td colspan="2">CTCAE Grade 3 Laryngeal Nerve Dysfunction<span class="subclass"> SubClassOf </span>Laryngeal Nerve Dysfunction Adverse Event. <br><i>New Terms: CTCAE Grade 3 Laryngeal Nerve Dysfunction, Laryngeal Nerve Dysfunction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2596</td>
               <td colspan="2">CTCAE Grade 3 Larynx Edema<span class="subclass"> SubClassOf </span>Larynx Edema Adverse Event. <br><i>New Terms: CTCAE Grade 3 Larynx Edema, Larynx Edema Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2597</td>
               <td colspan="2">CTCAE Grade 3 Larynx Fistula<span class="subclass"> SubClassOf </span>Larynx Fistula Adverse Event. <br><i>New Terms: Larynx Fistula Adverse Event, CTCAE Grade 3 Larynx Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>2598</td>
               <td colspan="2">CTCAE Grade 3 Larynx Hemorrhage<span class="subclass"> SubClassOf </span>Larynx Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 3 Larynx Hemorrhage, Larynx Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2599</td>
               <td colspan="2">CTCAE Grade 3 Larynx Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Larynx Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Larynx Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 3 Larynx Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2600</td>
               <td colspan="2">CTCAE Grade 3 Larynx Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Larynx Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Larynx Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 3 Larynx Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2601</td>
               <td colspan="2">CTCAE Grade 3 Larynx Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Larynx Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Larynx Infection with Unknown Absolute Neutrophil Count, Larynx Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2602</td>
               <td colspan="2">CTCAE Grade 3 Larynx Intra-Operative Injury<span class="subclass"> SubClassOf </span>Larynx Intra-Operative Injury Adverse Event. <br><i>New Terms: Larynx Intra-Operative Injury Adverse Event, CTCAE Grade 3 Larynx Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2603</td>
               <td colspan="2">CTCAE Grade 3 Larynx Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Larynx Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification. <br><i>New Terms: CTCAE Grade 3 Larynx Mucositis or Stomatitis by Clinical Examination Classification,
                     Larynx Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>2604</td>
               <td colspan="2">CTCAE Grade 3 Larynx Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Larynx Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: Larynx Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification,
                     CTCAE Grade 3 Larynx Mucositis or Stomatitis by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>2605</td>
               <td colspan="2">CTCAE Grade 3 Larynx Obstruction<br><span class="keyword"> and </span>Stenosis<span class="subclass"> SubClassOf </span>Larynx Obstruction<br><span class="keyword"> and </span>Stenosis Adverse Event. <br><i>New Terms: Larynx Obstruction and Stenosis Adverse Event, CTCAE Grade 3 Larynx Obstruction and
                     Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>2606</td>
               <td colspan="2">CTCAE Grade 3 Larynx Pain<span class="subclass"> SubClassOf </span>Larynx Pain Adverse Event. <br><i>New Terms: Larynx Pain Adverse Event, CTCAE Grade 3 Larynx Pain</i></td>
            </tr>
            <tr class="addition">
               <td>2608</td>
               <td colspan="2">CTCAE Grade 3 Left Ventricular Diastolic Dysfunction<span class="subclass"> SubClassOf </span>Left Ventricular Diastolic Dysfunction Adverse Event. <br><i>New Terms: Left Ventricular Diastolic Dysfunction Adverse Event, CTCAE Grade 3 Left Ventricular
                     Diastolic Dysfunction</i></td>
            </tr>
            <tr class="addition">
               <td>2609</td>
               <td colspan="2">CTCAE Grade 3 Left Ventricular Systolic Dysfunction<span class="subclass"> SubClassOf </span>Left Ventricular Systolic Dysfunction Adverse Event. <br><i>New Terms: Left Ventricular Systolic Dysfunction Adverse Event, CTCAE Grade 3 Left Ventricular
                     Systolic Dysfunction</i></td>
            </tr>
            <tr class="addition">
               <td>2607</td>
               <td colspan="2">CTCAE Grade 3 Left-Sided Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Left-Sided Muscle Weakness Not Due to Neuropathy Adverse Event. <br><i>New Terms: Left-Sided Muscle Weakness Not Due to Neuropathy Adverse Event, CTCAE Grade 3 Left-Sided
                     Muscle Weakness Not Due to Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>2610</td>
               <td colspan="2">CTCAE Grade 3 Lens Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Lens Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Lens Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Lens Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2611</td>
               <td colspan="2">CTCAE Grade 3 Lens Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Lens Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Lens Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or 2
                     Neutrophils, CTCAE Grade 3 Lens Infection with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2612</td>
               <td colspan="2">CTCAE Grade 3 Lens Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Lens Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Lens Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade 3
                     Lens Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2613</td>
               <td colspan="2">CTCAE Grade 3 Lens Intra-Operative Injury<span class="subclass"> SubClassOf </span>Lens Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Lens Intra-Operative Injury, Lens Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2614</td>
               <td colspan="2">CTCAE Grade 3 Leukocytes<span class="subclass"> SubClassOf </span>Leukocytes Adverse Event. <br><i>New Terms: CTCAE Grade 3 Leukocytes, Leukocytes Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2615</td>
               <td colspan="2">CTCAE Grade 3 Leukoencephalopathy Radiographic Findings<span class="subclass"> SubClassOf </span>Leukoencephalopathy Radiographic Findings Adverse Event. <br><i>New Terms: Leukoencephalopathy Radiographic Findings Adverse Event, CTCAE Grade 3 Leukoencephalopathy
                     Radiographic Findings</i></td>
            </tr>
            <tr class="addition">
               <td>2616</td>
               <td colspan="2">CTCAE Grade 3 Ligament Intra-Operative Injury<span class="subclass"> SubClassOf </span>Ligament Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Ligament Intra-Operative Injury, Ligament Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>2617</td>
               <td colspan="2">CTCAE Grade 3 Lingual Nerve Intra-Operative Injury<span class="subclass"> SubClassOf </span>Lingual Nerve Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Lingual Nerve Intra-Operative Injury, Lingual Nerve Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2618</td>
               <td colspan="2">CTCAE Grade 3 Lip Or Perioral Area Intra-Operative Injury<span class="subclass"> SubClassOf </span>Lip Or Perioral Area Intra-Operative Injury Adverse Event. <br><i>New Terms: Lip Or Perioral Area Intra-Operative Injury Adverse Event, CTCAE Grade 3 Lip Or Perioral
                     Area Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2619</td>
               <td colspan="2">CTCAE Grade 3 Lip Pain<span class="subclass"> SubClassOf </span>Lip Pain Adverse Event. <br><i>New Terms: CTCAE Grade 3 Lip Pain, Lip Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2620</td>
               <td colspan="2">CTCAE Grade 3 Lip<br><span class="keyword"> or </span>Perioral Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Lip<br><span class="keyword"> or </span>Perioral Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Lip or Perioral Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, Lip or Perioral Infection Adverse Event Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2621</td>
               <td colspan="2">CTCAE Grade 3 Lip<br><span class="keyword"> or </span>Perioral Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Lip<br><span class="keyword"> or </span>Perioral Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Lip or Perioral Infection with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, Lip or Perioral Infection Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2622</td>
               <td colspan="2">CTCAE Grade 3 Lip<br><span class="keyword"> or </span>Perioral Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Lip<br><span class="keyword"> or </span>Perioral Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Lip or Perioral Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE
                     Grade 3 Lip or Perioral Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2623</td>
               <td colspan="2">CTCAE Grade 3 Lipase<span class="subclass"> SubClassOf </span>Lipase Adverse Event. <br><i>New Terms: CTCAE Grade 3 Lipase, Lipase Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2624</td>
               <td colspan="2">CTCAE Grade 3 Liver Dysfunction<br><span class="keyword"> or </span>Failure by Clinical Classification<span class="subclass"> SubClassOf </span>Liver Dysfunction<br><span class="keyword"> or </span>Failure by Clinical Classification Adverse Event. <br><i>New Terms: Liver Dysfunction or Failure by Clinical Classification Adverse Event, CTCAE Grade
                     3 Liver Dysfunction or Failure by Clinical Classification</i></td>
            </tr>
            <tr class="addition">
               <td>2625</td>
               <td colspan="2">CTCAE Grade 3 Liver Hemorrhage<span class="subclass"> SubClassOf </span>Liver Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 3 Liver Hemorrhage, Liver Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2626</td>
               <td colspan="2">CTCAE Grade 3 Liver Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Liver Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Liver Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 3 Liver Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2627</td>
               <td colspan="2">CTCAE Grade 3 Liver Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Liver Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Liver Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Liver Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2628</td>
               <td colspan="2">CTCAE Grade 3 Liver Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Liver Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Liver Infection with Unknown Absolute Neutrophil Count, Liver Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2629</td>
               <td colspan="2">CTCAE Grade 3 Liver Intra-Operative Injury<span class="subclass"> SubClassOf </span>Liver Intra-Operative Injury Adverse Event. <br><i>New Terms: Liver Intra-Operative Injury Adverse Event, CTCAE Grade 3 Liver Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2630</td>
               <td colspan="2">CTCAE Grade 3 Liver Pain<span class="subclass"> SubClassOf </span>Liver Pain Adverse Event. <br><i>New Terms: Liver Pain Adverse Event, CTCAE Grade 3 Liver Pain</i></td>
            </tr>
            <tr class="addition">
               <td>2631</td>
               <td colspan="2">CTCAE Grade 3 Local Complication of Device<br><span class="keyword"> and </span>Prosthesis<span class="subclass"> SubClassOf </span>Local Complication of Device<br><span class="keyword"> and </span>Prosthesis Adverse Event. <br><i>New Terms: Local Complication of Device and Prosthesis Adverse Event, CTCAE Grade 3 Local Complication
                     of Device and Prosthesis</i></td>
            </tr>
            <tr class="addition">
               <td>2632</td>
               <td colspan="2">CTCAE Grade 3 Low Serum Bicarbonate<span class="subclass"> SubClassOf </span>Low Serum Bicarbonate Adverse Event. <br><i>New Terms: Low Serum Bicarbonate Adverse Event, CTCAE Grade 3 Low Serum Bicarbonate</i></td>
            </tr>
            <tr class="addition">
               <td>2633</td>
               <td colspan="2">CTCAE Grade 3 Lower Extremity Artery Injury<span class="subclass"> SubClassOf </span>Lower Extremity Artery Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Lower Extremity Artery Injury, Lower Extremity Artery Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>2634</td>
               <td colspan="2">CTCAE Grade 3 Lower Extremity Artery Intra-Operative Injury<span class="subclass"> SubClassOf </span>Lower Extremity Artery Intra-Operative Injury Adverse Event. <br><i>New Terms: Lower Extremity Artery Intra-Operative Injury Adverse Event, CTCAE Grade 3 Lower Extremity
                     Artery Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2635</td>
               <td colspan="2">CTCAE Grade 3 Lower Extremity Gait<span class="subclass"> SubClassOf </span>Lower Extremity Gait Adverse Event. <br><i>New Terms: CTCAE Grade 3 Lower Extremity Gait, Lower Extremity Gait Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2636</td>
               <td colspan="2">CTCAE Grade 3 Lower Extremity Intra-Operative Injury<span class="subclass"> SubClassOf </span>Lower Extremity Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Lower Extremity Intra-Operative Injury, Lower Extremity Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2637</td>
               <td colspan="2">CTCAE Grade 3 Lower Extremity Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Lower Extremity Muscle Weakness Adverse Event Not Due to Neuropathy. <br><i>New Terms: CTCAE Grade 3 Lower Extremity Muscle Weakness Not Due to Neuropathy, Lower Extremity
                     Muscle Weakness Adverse Event Not Due to Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>2638</td>
               <td colspan="2">CTCAE Grade 3 Lower Extremity Soft Tissue Necrosis<span class="subclass"> SubClassOf </span>Lower Extremity Soft Tissue Necrosis Adverse Event. <br><i>New Terms: Lower Extremity Soft Tissue Necrosis Adverse Event, CTCAE Grade 3 Lower Extremity
                     Soft Tissue Necrosis</i></td>
            </tr>
            <tr class="addition">
               <td>2639</td>
               <td colspan="2">CTCAE Grade 3 Lower Extremity Vein Injury<span class="subclass"> SubClassOf </span>Lower Extremity Vein Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Lower Extremity Vein Injury, Lower Extremity Vein Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2640</td>
               <td colspan="2">CTCAE Grade 3 Lower Extremity Vein Intra-Operative Injury<span class="subclass"> SubClassOf </span>Lower Extremity Vein Intra-Operative Injury Adverse Event. <br><i>New Terms: Lower Extremity Vein Intra-Operative Injury Adverse Event, CTCAE Grade 3 Lower Extremity
                     Vein Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2641</td>
               <td colspan="2">CTCAE Grade 3 Lower Gastrointestinal Hemorrhage NOS<span class="subclass"> SubClassOf </span>Lower Gastrointestinal Hemorrhage Adverse Event NOS. <br><i>New Terms: Lower Gastrointestinal Hemorrhage Adverse Event NOS, CTCAE Grade 3 Lower Gastrointestinal
                     Hemorrhage NOS</i></td>
            </tr>
            <tr class="addition">
               <td>2642</td>
               <td colspan="2">CTCAE Grade 3 Lumbar Spine<span class="subclass"> Range </span>of Motion<span class="subclass"> SubClassOf </span>Lumbar Spine<span class="subclass"> Range </span>of Motion Adverse Event. <br><i>New Terms: Lumbar Spine Range of Motion Adverse Event, CTCAE Grade 3 Lumbar Spine Range of Motion</i></td>
            </tr>
            <tr class="addition">
               <td>2643</td>
               <td colspan="2">CTCAE Grade 3 Lung Fistula<span class="subclass"> SubClassOf </span>Lung Fistula Adverse Event. <br><i>New Terms: Lung Fistula Adverse Event, CTCAE Grade 3 Lung Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>2644</td>
               <td colspan="2">CTCAE Grade 3 Lung Hemorrhage<span class="subclass"> SubClassOf </span>Lung Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 3 Lung Hemorrhage, Lung Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2645</td>
               <td colspan="2">CTCAE Grade 3 Lung Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Lung Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Lung Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Lung Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2646</td>
               <td colspan="2">CTCAE Grade 3 Lung Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Lung Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Lung Infection with Normal Absolute Neutrophil Count or Grade 1 or 2
                     Neutrophils, Lung Infection Adverse Event with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2647</td>
               <td colspan="2">CTCAE Grade 3 Lung Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Lung Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Lung Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade 3
                     Lung Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2648</td>
               <td colspan="2">CTCAE Grade 3 Lung Intra-Operative Injury<span class="subclass"> SubClassOf </span>Lung Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Lung Intra-Operative Injury, Lung Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2649</td>
               <td colspan="2">CTCAE Grade 3 Lung Thoracic Nerve Intra-Operative Injury<span class="subclass"> SubClassOf </span>Lung Thoracic Nerve Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Lung Thoracic Nerve Intra-Operative Injury, Lung Thoracic Nerve Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2650</td>
               <td colspan="2">CTCAE Grade 3 Lymph Node Pain<span class="subclass"> SubClassOf </span>Lymph Node Pain Adverse Event. <br><i>New Terms: Lymph Node Pain Adverse Event, CTCAE Grade 3 Lymph Node Pain</i></td>
            </tr>
            <tr class="addition">
               <td>2651</td>
               <td colspan="2">CTCAE Grade 3 Lymphatic Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Lymphatic Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Lymphatic Infection Adverse Event Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, CTCAE Grade 3 Lymphatic Infection Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2652</td>
               <td colspan="2">CTCAE Grade 3 Lymphatic Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Lymphatic Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Lymphatic Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, CTCAE Grade 3 Lymphatic Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2653</td>
               <td colspan="2">CTCAE Grade 3 Lymphatic Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Lymphatic Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Lymphatic Infection with Unknown Absolute Neutrophil Count, Lymphatic
                     Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2654</td>
               <td colspan="2">CTCAE Grade 3 Lymphedema-Related Fibrosis<span class="subclass"> SubClassOf </span>Lymphedema-Related Fibrosis Adverse Event. <br><i>New Terms: Lymphedema-Related Fibrosis Adverse Event, CTCAE Grade 3 Lymphedema-Related Fibrosis</i></td>
            </tr>
            <tr class="addition">
               <td>2655</td>
               <td colspan="2">CTCAE Grade 3 Lymphocele<span class="subclass"> SubClassOf </span>Lymphocele Adverse Event. <br><i>New Terms: Lymphocele Adverse Event, CTCAE Grade 3 Lymphocele</i></td>
            </tr>
            <tr class="addition">
               <td>2656</td>
               <td colspan="2">CTCAE Grade 3 Lymphopenia<span class="subclass"> SubClassOf </span>Lymphopenia Adverse Event. <br><i>New Terms: Lymphopenia Adverse Event, CTCAE Grade 3 Lymphopenia</i></td>
            </tr>
            <tr class="addition">
               <td>2657</td>
               <td colspan="2">CTCAE Grade 3 Major Visceral Artery Intra-Operative Injury<span class="subclass"> SubClassOf </span>Major Visceral Artery Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Major Visceral Artery Intra-Operative Injury, Major Visceral Artery
                     Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2658</td>
               <td colspan="2">CTCAE Grade 3 Major Visceral Vein Intra-Operative Injury<span class="subclass"> SubClassOf </span>Major Visceral Vein Intra-Operative Injury Adverse Event. <br><i>New Terms: Major Visceral Vein Intra-Operative Injury Adverse Event, CTCAE Grade 3 Major Visceral
                     Vein Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2659</td>
               <td colspan="2">CTCAE Grade 3 Malabsorption<span class="subclass"> SubClassOf </span>Malabsorption Adverse Event. <br><i>New Terms: CTCAE Grade 3 Malabsorption, Malabsorption Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2660</td>
               <td colspan="2">CTCAE Grade 3 Masculinization of Female<span class="subclass"> SubClassOf </span>Masculinization of Female Adverse Event. <br><i>New Terms: CTCAE Grade 3 Masculinization of Female, Masculinization of Female Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2661</td>
               <td colspan="2">CTCAE Grade 3 Mediastinum Hemorrhage<span class="subclass"> SubClassOf </span>Mediastinum Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 3 Mediastinum Hemorrhage, Mediastinum Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2662</td>
               <td colspan="2">CTCAE Grade 3 Mediastinum Infection NOS Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Mediastinum Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Mediastinum Infection NOS Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, Mediastinum Infection NOS Adverse Event Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2663</td>
               <td colspan="2">CTCAE Grade 3 Mediastinum Infection NOS with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Mediastinum Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Mediastinum Infection NOS with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, Mediastinum Infection NOS Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2664</td>
               <td colspan="2">CTCAE Grade 3 Mediastinum Infection NOS with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Mediastinum Infection NOS Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Mediastinum Infection NOS with Unknown Absolute Neutrophil Count, Mediastinum
                     Infection NOS Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2665</td>
               <td colspan="2">CTCAE Grade 3 Mediastinum Intra-Operative Injury<span class="subclass"> SubClassOf </span>Mediastinum Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Mediastinum Intra-Operative Injury, Mediastinum Intra-Operative Injury
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2666</td>
               <td colspan="2">CTCAE Grade 3 Memory Impairment<span class="subclass"> SubClassOf </span>Memory Impairment Adverse Event. <br><i>New Terms: CTCAE Grade 3 Memory Impairment, Memory Impairment Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2667</td>
               <td colspan="2">CTCAE Grade 3 Meninges Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Meninges Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Meninges Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Meninges Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2668</td>
               <td colspan="2">CTCAE Grade 3 Meninges Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Meninges Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Meninges Infection with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, Meninges Infection Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2669</td>
               <td colspan="2">CTCAE Grade 3 Meninges Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Meninges Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Meninges Infection with Unknown Absolute Neutrophil Count, Meninges
                     Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2670</td>
               <td colspan="2">CTCAE Grade 3 Meninges Intra-Operative Injury<span class="subclass"> SubClassOf </span>Meninges Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Meninges Intra-Operative Injury, Meninges Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>2671</td>
               <td colspan="2">CTCAE Grade 3 Mental Status<span class="subclass"> SubClassOf </span>Mental Status Adverse Event. <br><i>New Terms: CTCAE Grade 3 Mental Status, Mental Status Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2672</td>
               <td colspan="2">CTCAE Grade 3 Metabolic<br><span class="keyword"> or </span>Respiratory Acidosis<span class="subclass"> SubClassOf </span>Metabolic<br><span class="keyword"> or </span>Respiratory Acidosis Adverse Event. <br><i>New Terms: Metabolic or Respiratory Acidosis Adverse Event, CTCAE Grade 3 Metabolic or Respiratory
                     Acidosis</i></td>
            </tr>
            <tr class="addition">
               <td>2673</td>
               <td colspan="2">CTCAE Grade 3 Metabolic<br><span class="keyword"> or </span>Respiratory Alkalosis<span class="subclass"> SubClassOf </span>Metabolic<br><span class="keyword"> or </span>Respiratory Alkalosis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Metabolic or Respiratory Alkalosis, Metabolic or Respiratory Alkalosis
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2674</td>
               <td colspan="2">CTCAE Grade 3 Middle Ear Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Middle Ear Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Middle Ear Infection Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, Middle Ear Infection Adverse Event Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2675</td>
               <td colspan="2">CTCAE Grade 3 Middle Ear Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Middle Ear Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Middle Ear Infection with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, Middle Ear Infection Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2676</td>
               <td colspan="2">CTCAE Grade 3 Middle Ear Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Middle Ear Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Middle Ear Infection with Unknown Absolute Neutrophil Count, Middle
                     Ear Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2677</td>
               <td colspan="2">CTCAE Grade 3 Middle Ear Intra-Operative Injury<span class="subclass"> SubClassOf </span>Middle Ear Intra-Operative Injury Adverse Event. <br><i>New Terms: Middle Ear Intra-Operative Injury Adverse Event, CTCAE Grade 3 Middle Ear Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2678</td>
               <td colspan="2">CTCAE Grade 3 Middle Ear Pain<span class="subclass"> SubClassOf </span>Middle Ear Pain Adverse Event. <br><i>New Terms: Middle Ear Pain Adverse Event, CTCAE Grade 3 Middle Ear Pain</i></td>
            </tr>
            <tr class="addition">
               <td>2679</td>
               <td colspan="2">CTCAE Grade 3 Motor Neuropathy<span class="subclass"> SubClassOf </span>Motor Neuropathy Adverse Event. <br><i>New Terms: Motor Neuropathy Adverse Event, CTCAE Grade 3 Motor Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>2680</td>
               <td colspan="2">CTCAE Grade 3 Mucosa Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Mucosa Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Mucosa Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Mucosa Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2681</td>
               <td colspan="2">CTCAE Grade 3 Mucosa Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Mucosa Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Mucosa Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 3 Mucosa Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2682</td>
               <td colspan="2">CTCAE Grade 3 Mucosa Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Mucosa Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Mucosa Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     3 Mucosa Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2683</td>
               <td colspan="2">CTCAE Grade 3 Muscle Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Muscle Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Muscle Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 3 Muscle Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2684</td>
               <td colspan="2">CTCAE Grade 3 Muscle Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Muscle Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Muscle Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 3 Muscle Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2685</td>
               <td colspan="2">CTCAE Grade 3 Muscle Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Muscle Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Muscle Infection with Unknown Absolute Neutrophil Count, Muscle Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2686</td>
               <td colspan="2">CTCAE Grade 3 Muscle Intra-Operative Injury<span class="subclass"> SubClassOf </span>Muscle Intra-Operative Injury Adverse Event. <br><i>New Terms: Muscle Intra-Operative Injury Adverse Event, CTCAE Grade 3 Muscle Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2687</td>
               <td colspan="2">CTCAE Grade 3 Muscle Pain<span class="subclass"> SubClassOf </span>Muscle Pain Adverse Event. <br><i>New Terms: CTCAE Grade 3 Muscle Pain, Muscle Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2688</td>
               <td colspan="2">CTCAE Grade 3 Muscular<br><span class="keyword"> and </span>Skeletal Hypoplasia<span class="subclass"> SubClassOf </span>Muscular<br><span class="keyword"> and </span>Skeletal Hypoplasia Adverse Event. <br><i>New Terms: Muscular and Skeletal Hypoplasia Adverse Event, CTCAE Grade 3 Muscular and Skeletal
                     Hypoplasia</i></td>
            </tr>
            <tr class="addition">
               <td>2689</td>
               <td colspan="2">CTCAE Grade 3 Myelitis<span class="subclass"> SubClassOf </span>Myelitis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Myelitis, Myelitis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2690</td>
               <td colspan="2">CTCAE Grade 3 Myelodysplasia<span class="subclass"> SubClassOf </span>Myelodysplasia Adverse Event. <br><i>New Terms: CTCAE Grade 3 Myelodysplasia, Myelodysplasia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2691</td>
               <td colspan="2">CTCAE Grade 3 Myocarditis<span class="subclass"> SubClassOf </span>Myocarditis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Myocarditis, Myocarditis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2692</td>
               <td colspan="2">CTCAE Grade 3 Myositis<span class="subclass"> SubClassOf </span>Myositis Adverse Event. <br><i>New Terms: Myositis Adverse Event, CTCAE Grade 3 Myositis</i></td>
            </tr>
            <tr class="addition">
               <td>2693</td>
               <td colspan="2">CTCAE Grade 3 Nail Changes<span class="subclass"> SubClassOf </span>Nail Changes Adverse Event. <br><i>New Terms: Nail Changes Adverse Event, CTCAE Grade 3 Nail Changes</i></td>
            </tr>
            <tr class="addition">
               <td>2694</td>
               <td colspan="2">CTCAE Grade 3 Nails Intra-Operative Injury<span class="subclass"> SubClassOf </span>Nails Intra-Operative Injury Adverse Event. <br><i>New Terms: Nails Intra-Operative Injury Adverse Event, CTCAE Grade 3 Nails Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2695</td>
               <td colspan="2">CTCAE Grade 3 Nasal Cavity Intra-Operative Injury<span class="subclass"> SubClassOf </span>Nasal Cavity Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Nasal Cavity Intra-Operative Injury, Nasal Cavity Intra-Operative Injury
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2696</td>
               <td colspan="2">CTCAE Grade 3 Nasal Cavity<br><span class="keyword"> and </span>Paranasal Sinus Reactions<span class="subclass"> SubClassOf </span>Nasal Cavity<br><span class="keyword"> and </span>Paranasal Sinus Reactions Adverse Event. <br><i>New Terms: CTCAE Grade 3 Nasal Cavity and Paranasal Sinus Reactions, Nasal Cavity and Paranasal
                     Sinus Reactions Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2697</td>
               <td colspan="2">CTCAE Grade 3 Nasopharynx Intra-Operative Injury<span class="subclass"> SubClassOf </span>Nasopharynx Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Nasopharynx Intra-Operative Injury, Nasopharynx Intra-Operative Injury
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2698</td>
               <td colspan="2">CTCAE Grade 3 Nausea<span class="subclass"> SubClassOf </span>Nausea Adverse Event. <br><i>New Terms: CTCAE Grade 3 Nausea, Nausea Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2699</td>
               <td colspan="2">CTCAE Grade 3 Neck Infection NOS Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Neck Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Neck Infection NOS Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 3 Neck Infection NOS Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2700</td>
               <td colspan="2">CTCAE Grade 3 Neck Infection NOS with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Neck Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Neck Infection NOS Adverse Event with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, CTCAE Grade 3 Neck Infection NOS with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2701</td>
               <td colspan="2">CTCAE Grade 3 Neck Infection NOS with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Neck Infection NOS Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Neck Infection NOS Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     3 Neck Infection NOS with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2702</td>
               <td colspan="2">CTCAE Grade 3 Neck NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Neck NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Neck NOS Intra-Operative Injury, Neck NOS Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>2703</td>
               <td colspan="2">CTCAE Grade 3 Neck Pain<span class="subclass"> SubClassOf </span>Neck Pain Adverse Event. <br><i>New Terms: CTCAE Grade 3 Neck Pain, Neck Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2704</td>
               <td colspan="2">CTCAE Grade 3 Neck Soft Tissue Necrosis<span class="subclass"> SubClassOf </span>Neck Soft Tissue Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Neck Soft Tissue Necrosis, Neck Soft Tissue Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2705</td>
               <td colspan="2">CTCAE Grade 3 Neuralgia<br><span class="keyword"> and </span>Peripheral Nerve Pain<span class="subclass"> SubClassOf </span>Neuralgia<br><span class="keyword"> and </span>Peripheral Nerve Pain Adverse Event. <br><i>New Terms: CTCAE Grade 3 Neuralgia and Peripheral Nerve Pain, Neuralgia and Peripheral Nerve
                     Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2706</td>
               <td colspan="2">CTCAE Grade 3 Neuroendocrine ACTH Deficiency<span class="subclass"> SubClassOf </span>Neuroendocrine ACTH Deficiency Adverse Event. <br><i>New Terms: CTCAE Grade 3 Neuroendocrine ACTH Deficiency, Neuroendocrine ACTH Deficiency Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>2707</td>
               <td colspan="2">CTCAE Grade 3 Neuroendocrine ADH Secretion Abnormality<span class="subclass"> SubClassOf </span>Neuroendocrine ADH Secretion Abnormality Adverse Event. <br><i>New Terms: CTCAE Grade 3 Neuroendocrine ADH Secretion Abnormality, Neuroendocrine ADH Secretion
                     Abnormality Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2708</td>
               <td colspan="2">CTCAE Grade 3 Neuroendocrine Gonadotropin Secretion Abnormality<span class="subclass"> SubClassOf </span>Neuroendocrine Gonadotropin Secretion Abnormality Adverse Event. <br><i>New Terms: Neuroendocrine Gonadotropin Secretion Abnormality Adverse Event, CTCAE Grade 3 Neuroendocrine
                     Gonadotropin Secretion Abnormality</i></td>
            </tr>
            <tr class="addition">
               <td>2709</td>
               <td colspan="2">CTCAE Grade 3 Neuroendocrine Prolactin Hormone Secretion Abnormality<span class="subclass"> SubClassOf </span>Neuroendocrine Prolactin Hormone Secretion Abnormality Adverse Event. <br><i>New Terms: CTCAE Grade 3 Neuroendocrine Prolactin Hormone Secretion Abnormality, Neuroendocrine
                     Prolactin Hormone Secretion Abnormality Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2710</td>
               <td colspan="2">CTCAE Grade 3 Neutrophils<br><span class="keyword"> and </span>Granulocytes<span class="subclass"> SubClassOf </span>Neutrophils<br><span class="keyword"> and </span>Granulocytes Adverse Event. <br><i>New Terms: CTCAE Grade 3 Neutrophils and Granulocytes, Neutrophils and Granulocytes Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2711</td>
               <td colspan="2">CTCAE Grade 3 Nodal<br><span class="keyword"> or </span>Junctional Rhythm<span class="subclass"> SubClassOf </span>Nodal<br><span class="keyword"> or </span>Junctional Rhythm Adverse Event. <br><i>New Terms: CTCAE Grade 3 Nodal or Junctional Rhythm, Nodal or Junctional Rhythm Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2712</td>
               <td colspan="2">CTCAE Grade 3 Non-Infectious Wound Complication<span class="subclass"> SubClassOf </span>Non-Infectious Wound Complication Adverse Event. <br><i>New Terms: CTCAE Grade 3 Non-Infectious Wound Complication, Non-Infectious Wound Complication
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2713</td>
               <td colspan="2">CTCAE Grade 3 Non-Malignant Ascites<span class="subclass"> SubClassOf </span>Non-Malignant Ascites Adverse Event. <br><i>New Terms: CTCAE Grade 3 Non-Malignant Ascites, Non-Malignant Ascites Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2714</td>
               <td colspan="2">CTCAE Grade 3 Non-Malignant Pericardial Effusion<span class="subclass"> SubClassOf </span>Non-Malignant Pericardial Effusion Adverse Event. <br><i>New Terms: Non-Malignant Pericardial Effusion Adverse Event, CTCAE Grade 3 Non-Malignant Pericardial
                     Effusion</i></td>
            </tr>
            <tr class="addition">
               <td>2715</td>
               <td colspan="2">CTCAE Grade 3 Non-Malignant Pleural Effusion<span class="subclass"> SubClassOf </span>Non-Malignant Pleural Effusion Adverse Event. <br><i>New Terms: CTCAE Grade 3 Non-Malignant Pleural Effusion, Non-Malignant Pleural Effusion Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>2716</td>
               <td colspan="2">CTCAE Grade 3 Non-Myocardial Visceral Arterial Ischemia<span class="subclass"> SubClassOf </span>Non-Myocardial Visceral Arterial Ischemia Adverse Event. <br><i>New Terms: CTCAE Grade 3 Non-Myocardial Visceral Arterial Ischemia, Non-Myocardial Visceral Arterial
                     Ischemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2717</td>
               <td colspan="2">CTCAE Grade 3 Non-Septic Arthritis<span class="subclass"> SubClassOf </span>Non-Septic Arthritis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Non-Septic Arthritis, Non-Septic Arthritis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2718</td>
               <td colspan="2">CTCAE Grade 3 Nose Hemorrhage<span class="subclass"> SubClassOf </span>Nose Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 3 Nose Hemorrhage, Nose Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2719</td>
               <td colspan="2">CTCAE Grade 3 Nose Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Nose Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Nose Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Nose Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2720</td>
               <td colspan="2">CTCAE Grade 3 Nose Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Nose Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Nose Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or 2
                     Neutrophils, CTCAE Grade 3 Nose Infection with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2721</td>
               <td colspan="2">CTCAE Grade 3 Nose Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Nose Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Nose Infection with Unknown Absolute Neutrophil Count, Nose Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2722</td>
               <td colspan="2">CTCAE Grade 3 Nose Intra-Operative Injury<span class="subclass"> SubClassOf </span>Nose Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Nose Intra-Operative Injury, Nose Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2723</td>
               <td colspan="2">CTCAE Grade 3 Nyctalopia<span class="subclass"> SubClassOf </span>Nyctalopia Adverse Event. <br><i>New Terms: CTCAE Grade 3 Nyctalopia, Nyctalopia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2724</td>
               <td colspan="2">CTCAE Grade 3 Nystagmus<span class="subclass"> SubClassOf </span>Nystagmus Adverse Event. <br><i>New Terms: CTCAE Grade 3 Nystagmus, Nystagmus Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2725</td>
               <td colspan="2">CTCAE Grade 3 Obesity<span class="subclass"> SubClassOf </span>Obesity Adverse Event. <br><i>New Terms: CTCAE Grade 3 Obesity, Obesity Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2726</td>
               <td colspan="2">CTCAE Grade 3 Ocular Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Ocular Muscle Weakness Not Due to Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 3 Ocular Muscle Weakness Not Due to Neuropathy, Ocular Muscle Weakness
                     Not Due to Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2727</td>
               <td colspan="2">CTCAE Grade 3 Ocular Surface Disease<span class="subclass"> SubClassOf </span>Ocular Surface Disease Adverse Event. <br><i>New Terms: CTCAE Grade 3 Ocular Surface Disease, Ocular Surface Disease Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2728</td>
               <td colspan="2">CTCAE Grade 3 Ophthalmoplegia<br><span class="keyword"> and </span>Diplopia<span class="subclass"> SubClassOf </span>Ophthalmoplegia<br><span class="keyword"> and </span>Diplopia Adverse Event. <br><i>New Terms: CTCAE Grade 3 Ophthalmoplegia and Diplopia, Ophthalmoplegia and Diplopia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2729</td>
               <td colspan="2">CTCAE Grade 3 Opportunistic Infection<span class="subclass"> SubClassOf </span>Opportunistic Infection Adverse Event Associated with Grade 2<br><span class="keyword"> or </span>Greater Lymphopenia. <br><i>New Terms: CTCAE Grade 3 Opportunistic Infection, Opportunistic Infection Adverse Event Associated
                     with Grade 2 or Greater Lymphopenia</i></td>
            </tr>
            <tr class="addition">
               <td>2730</td>
               <td colspan="2">CTCAE Grade 3 Optic Disc Edema<span class="subclass"> SubClassOf </span>Optic Disc Edema Adverse Event. <br><i>New Terms: Optic Disc Edema Adverse Event, CTCAE Grade 3 Optic Disc Edema</i></td>
            </tr>
            <tr class="addition">
               <td>2731</td>
               <td colspan="2">CTCAE Grade 3 Oral Cavity GI Fistula<span class="subclass"> SubClassOf </span>Oral Cavity GI Fistula Adverse Event. <br><i>New Terms: Oral Cavity GI Fistula Adverse Event, CTCAE Grade 3 Oral Cavity GI Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>2732</td>
               <td colspan="2">CTCAE Grade 3 Oral Cavity Hemorrhage<span class="subclass"> SubClassOf </span>Oral Cavity Adverse Event Hemorrhage. <br><i>New Terms: CTCAE Grade 3 Oral Cavity Hemorrhage, Oral Cavity Adverse Event Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>2733</td>
               <td colspan="2">CTCAE Grade 3 Oral Cavity Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Oral Cavity Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification. <br><i>New Terms: CTCAE Grade 3 Oral Cavity Mucositis or Stomatitis by Clinical Examination Classification,
                     Oral Cavity Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>2734</td>
               <td colspan="2">CTCAE Grade 3 Oral Cavity Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Oral Cavity Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: CTCAE Grade 3 Oral Cavity Mucositis or Stomatitis by Functional or Symptomatic Classification,
                     Oral Cavity Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>2735</td>
               <td colspan="2">CTCAE Grade 3 Oral Cavity NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Oral Cavity NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: Oral Cavity NOS Intra-Operative Injury Adverse Event, CTCAE Grade 3 Oral Cavity NOS
                     Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2736</td>
               <td colspan="2">CTCAE Grade 3 Oral Cavity Pain<span class="subclass"> SubClassOf </span>Oral Cavity Pain Adverse Event. <br><i>New Terms: CTCAE Grade 3 Oral Cavity Pain, Oral Cavity Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2737</td>
               <td colspan="2">CTCAE Grade 3 Oral Cavity Pulmonary Fistula<span class="subclass"> SubClassOf </span>Oral Cavity Pulmonary Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 3 Oral Cavity Pulmonary Fistula, Oral Cavity Pulmonary Fistula Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>2738</td>
               <td colspan="2">CTCAE Grade 3 Oral Cavity<br><span class="keyword"> or </span>Gum Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Oral Cavity<br><span class="keyword"> or </span>Gum Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Oral Cavity or Gum Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, Oral Cavity or Gum Infection Adverse Event Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2739</td>
               <td colspan="2">CTCAE Grade 3 Oral Cavity<br><span class="keyword"> or </span>Gum Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Oral Cavity<br><span class="keyword"> or </span>Gum Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Oral Cavity or Gum Infection with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils, Oral Cavity or Gum Infection Adverse Event with Normal Absolute
                     Neutrophil Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2740</td>
               <td colspan="2">CTCAE Grade 3 Oral Cavity<br><span class="keyword"> or </span>Gum Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Oral Cavity<br><span class="keyword"> or </span>Gum Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Oral Cavity or Gum Infection with Unknown Absolute Neutrophil Count,
                     Oral Cavity or Gum Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2741</td>
               <td colspan="2">CTCAE Grade 3 Oral Intra-Operative Injury<span class="subclass"> SubClassOf </span>Oral Intra-Operative Injury Adverse Event. <br><i>New Terms: Oral Intra-Operative Injury Adverse Event, CTCAE Grade 3 Oral Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2742</td>
               <td colspan="2">CTCAE Grade 3 Oral Necrosis<span class="subclass"> SubClassOf </span>Oral Necrosis Adverse Event. <br><i>New Terms: Oral Necrosis Adverse Event, CTCAE Grade 3 Oral Necrosis</i></td>
            </tr>
            <tr class="addition">
               <td>2743</td>
               <td colspan="2">CTCAE Grade 3 Oral Pain of the Gums<span class="subclass"> SubClassOf </span>Oral Pain of the Gums Adverse Event. <br><i>New Terms: Oral Pain of the Gums Adverse Event, CTCAE Grade 3 Oral Pain of the Gums</i></td>
            </tr>
            <tr class="addition">
               <td>2744</td>
               <td colspan="2">CTCAE Grade 3 Orgasmic Dysfunction<span class="subclass"> SubClassOf </span>Orgasmic Dysfunction Adverse Event. <br><i>New Terms: Orgasmic Dysfunction Adverse Event, CTCAE Grade 3 Orgasmic Dysfunction</i></td>
            </tr>
            <tr class="addition">
               <td>2745</td>
               <td colspan="2">CTCAE Grade 3 Osteoporosis<span class="subclass"> SubClassOf </span>Osteoporosis Adverse Event. <br><i>New Terms: Osteoporosis Adverse Event, CTCAE Grade 3 Osteoporosis</i></td>
            </tr>
            <tr class="addition">
               <td>2746</td>
               <td colspan="2">CTCAE Grade 3 Other Allergy<br><span class="keyword"> and </span>Immunology<span class="subclass"> SubClassOf </span>Other Allergy<br><span class="keyword"> and </span>Immunology Adverse Event. <br><i>New Terms: CTCAE Grade 3 Other Allergy and Immunology, Other Allergy and Immunology Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2747</td>
               <td colspan="2">CTCAE Grade 3 Other Auditory<br><span class="keyword"> and </span>Ear<span class="subclass"> SubClassOf </span>Other Auditory<br><span class="keyword"> and </span>Ear Adverse Event. <br><i>New Terms: Other Auditory and Ear Adverse Event, CTCAE Grade 3 Other Auditory and Ear</i></td>
            </tr>
            <tr class="addition">
               <td>2748</td>
               <td colspan="2">CTCAE Grade 3 Other Blood<br><span class="keyword"> and </span>Bone Marrow<span class="subclass"> SubClassOf </span>Other Blood<br><span class="keyword"> and </span>Bone Marrow Adverse Event. <br><i>New Terms: CTCAE Grade 3 Other Blood and Bone Marrow, Other Blood and Bone Marrow Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2749</td>
               <td colspan="2">CTCAE Grade 3 Other Cardiac Arrhythmia<span class="subclass"> SubClassOf </span>Other Cardiac Arrhythmia Adverse Event. <br><i>New Terms: Other Cardiac Arrhythmia Adverse Event, CTCAE Grade 3 Other Cardiac Arrhythmia</i></td>
            </tr>
            <tr class="addition">
               <td>2750</td>
               <td colspan="2">CTCAE Grade 3 Other Coagulation<span class="subclass"> SubClassOf </span>Other Coagulation Adverse Event. <br><i>New Terms: CTCAE Grade 3 Other Coagulation, Other Coagulation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2751</td>
               <td colspan="2">CTCAE Grade 3 Other Constitutional Symptoms<span class="subclass"> SubClassOf </span>Other Constitutional Symptoms Adverse Event. <br><i>New Terms: Other Constitutional Symptoms Adverse Event, CTCAE Grade 3 Other Constitutional Symptoms</i></td>
            </tr>
            <tr class="addition">
               <td>2752</td>
               <td colspan="2">CTCAE Grade 3 Other Dermatology<br><span class="keyword"> or </span>Skin<span class="subclass"> SubClassOf </span>Other Dermatology<br><span class="keyword"> or </span>Skin Adverse Event. <br><i>New Terms: Other Dermatology or Skin Adverse Event, CTCAE Grade 3 Other Dermatology or Skin</i></td>
            </tr>
            <tr class="addition">
               <td>2753</td>
               <td colspan="2">CTCAE Grade 3 Other Endocrine<span class="subclass"> SubClassOf </span>Other Endocrine Adverse Event. <br><i>New Terms: CTCAE Grade 3 Other Endocrine, Other Endocrine Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2754</td>
               <td colspan="2">CTCAE Grade 3 Other Gastrointestinal<span class="subclass"> SubClassOf </span>Other Gastrointestinal Adverse Event. <br><i>New Terms: Other Gastrointestinal Adverse Event, CTCAE Grade 3 Other Gastrointestinal</i></td>
            </tr>
            <tr class="addition">
               <td>2755</td>
               <td colspan="2">CTCAE Grade 3 Other Growth<br><span class="keyword"> and </span>Development<span class="subclass"> SubClassOf </span>Other Growth<br><span class="keyword"> and </span>Development Adverse Event. <br><i>New Terms: CTCAE Grade 3 Other Growth and Development, Other Growth and Development Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2756</td>
               <td colspan="2">CTCAE Grade 3 Other Heart in General<span class="subclass"> SubClassOf </span>Other Adverse Event Associated with the Heart in General. <br><i>New Terms: CTCAE Grade 3 Other Heart in General, Other Adverse Event Associated with the Heart
                     in General</i></td>
            </tr>
            <tr class="addition">
               <td>2757</td>
               <td colspan="2">CTCAE Grade 3 Other Hemorrhage<br><span class="keyword"> and </span>Bleeding<span class="subclass"> SubClassOf </span>Other Hemorrhage<br><span class="keyword"> and </span>Bleeding Adverse Event. <br><i>New Terms: Other Hemorrhage and Bleeding Adverse Event, CTCAE Grade 3 Other Hemorrhage and Bleeding</i></td>
            </tr>
            <tr class="addition">
               <td>2758</td>
               <td colspan="2">CTCAE Grade 3 Other Hepatobiliary<br><span class="keyword"> and </span>Pancreas<span class="subclass"> SubClassOf </span>Other Hepatobiliary<br><span class="keyword"> and </span>Pancreas Adverse Event. <br><i>New Terms: CTCAE Grade 3 Other Hepatobiliary and Pancreas, Other Hepatobiliary and Pancreas Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>2759</td>
               <td colspan="2">CTCAE Grade 3 Other Infection<span class="subclass"> SubClassOf </span>Infection Other Adverse Event. <br><i>New Terms: Infection Other Adverse Event, CTCAE Grade 3 Other Infection</i></td>
            </tr>
            <tr class="addition">
               <td>2760</td>
               <td colspan="2">CTCAE Grade 3 Other Intra-Operative Injury<span class="subclass"> SubClassOf </span>Other Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Other Intra-Operative Injury, Other Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2761</td>
               <td colspan="2">CTCAE Grade 3 Other Lymphatics<span class="subclass"> SubClassOf </span>Other Lymphatics Adverse Event. <br><i>New Terms: CTCAE Grade 3 Other Lymphatics, Other Lymphatics Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2762</td>
               <td colspan="2">CTCAE Grade 3 Other Metabolic<br><span class="keyword"> and </span>Laboratory<span class="subclass"> SubClassOf </span>Other Metabolic<br><span class="keyword"> and </span>Laboratory Adverse Event. <br><i>New Terms: Other Metabolic and Laboratory Adverse Event, CTCAE Grade 3 Other Metabolic and Laboratory</i></td>
            </tr>
            <tr class="addition">
               <td>2763</td>
               <td colspan="2">CTCAE Grade 3 Other Musculoskeletal<br><span class="keyword"> and </span>Soft Tissue<span class="subclass"> SubClassOf </span>Other Musculoskeletal<br><span class="keyword"> and </span>Soft Tissue Adverse Event. <br><i>New Terms: Other Musculoskeletal and Soft Tissue Adverse Event, CTCAE Grade 3 Other Musculoskeletal
                     and Soft Tissue</i></td>
            </tr>
            <tr class="addition">
               <td>2764</td>
               <td colspan="2">CTCAE Grade 3 Other NOS Artery Injury<span class="subclass"> SubClassOf </span>Other NOS Artery Injury Adverse Event. <br><i>New Terms: Other NOS Artery Injury Adverse Event, CTCAE Grade 3 Other NOS Artery Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2765</td>
               <td colspan="2">CTCAE Grade 3 Other NOS Vein Injury<span class="subclass"> SubClassOf </span>Other NOS Vein Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Other NOS Vein Injury, Other NOS Vein Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2766</td>
               <td colspan="2">CTCAE Grade 3 Other Neurology<span class="subclass"> SubClassOf </span>Other Neurology Adverse Event. <br><i>New Terms: Other Neurology Adverse Event, CTCAE Grade 3 Other Neurology</i></td>
            </tr>
            <tr class="addition">
               <td>2767</td>
               <td colspan="2">CTCAE Grade 3 Other Ocular<br><span class="keyword"> and </span>Visual<span class="subclass"> SubClassOf </span>Other Ocular<br><span class="keyword"> and </span>Visual Adverse Event. <br><i>New Terms: CTCAE Grade 3 Other Ocular and Visual, Other Ocular and Visual Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2768</td>
               <td colspan="2">CTCAE Grade 3 Other Pain<span class="subclass"> SubClassOf </span>Other Pain Adverse Event. <br><i>New Terms: Other Pain Adverse Event, CTCAE Grade 3 Other Pain</i></td>
            </tr>
            <tr class="addition">
               <td>2769</td>
               <td colspan="2">CTCAE Grade 3 Other Pulmonary<br><span class="keyword"> and </span>Upper Respiratory<span class="subclass"> SubClassOf </span>Other Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Adverse Event. <br><i>New Terms: CTCAE Grade 3 Other Pulmonary and Upper Respiratory, Other Pulmonary and Upper Respiratory
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2770</td>
               <td colspan="2">CTCAE Grade 3 Other Renal<br><span class="keyword"> or </span>Genitourinary<span class="subclass"> SubClassOf </span>Renal<br><span class="keyword"> or </span>Genitourinary Other Adverse Event. <br><i>New Terms: CTCAE Grade 3 Other Renal or Genitourinary, Renal or Genitourinary Other Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2771</td>
               <td colspan="2">CTCAE Grade 3 Other Secondary Malignancy Possibly Related to Cancer Treatment<span class="subclass"> SubClassOf </span>Other Secondary Malignancy Possibly Related to Cancer Treatment Adverse Event. <br><i>New Terms: CTCAE Grade 3 Other Secondary Malignancy Possibly Related to Cancer Treatment, Other
                     Secondary Malignancy Possibly Related to Cancer Treatment Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2772</td>
               <td colspan="2">CTCAE Grade 3 Other Sexual Reproductive Function<span class="subclass"> SubClassOf </span>Other Sexual Reproductive Function Adverse Event. <br><i>New Terms: CTCAE Grade 3 Other Sexual Reproductive Function, Other Sexual Reproductive Function
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2773</td>
               <td colspan="2">CTCAE Grade 3 Other Syndromes<span class="subclass"> SubClassOf </span>Other Syndromes Adverse Event. <br><i>New Terms: Other Syndromes Adverse Event, CTCAE Grade 3 Other Syndromes</i></td>
            </tr>
            <tr class="addition">
               <td>2774</td>
               <td colspan="2">CTCAE Grade 3 Other Vascular<span class="subclass"> SubClassOf </span>Other Vascular Adverse Event. <br><i>New Terms: CTCAE Grade 3 Other Vascular, Other Vascular Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2775</td>
               <td colspan="2">CTCAE Grade 3 Otitis External Ear Non Infectious<span class="subclass"> SubClassOf </span>Otitis Adverse Event External Ear Non Infectious. <br><i>New Terms: Otitis Adverse Event External Ear Non Infectious, CTCAE Grade 3 Otitis External Ear
                     Non Infectious</i></td>
            </tr>
            <tr class="addition">
               <td>2776</td>
               <td colspan="2">CTCAE Grade 3 Otitis Middle Ear Non Infectious<span class="subclass"> SubClassOf </span>Otitis Adverse Event Middle Ear Non Infectious. <br><i>New Terms: CTCAE Grade 3 Otitis Middle Ear Non Infectious, Otitis Adverse Event Middle Ear Non
                     Infectious</i></td>
            </tr>
            <tr class="addition">
               <td>2777</td>
               <td colspan="2">CTCAE Grade 3 Outer Ear NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Outer Ear NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: Outer Ear NOS Intra-Operative Injury Adverse Event, CTCAE Grade 3 Outer Ear NOS Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2778</td>
               <td colspan="2">CTCAE Grade 3 Outer Ear Pinna Intra-Operative Injury<span class="subclass"> SubClassOf </span>Outer Ear Pinna Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Outer Ear Pinna Intra-Operative Injury, Outer Ear Pinna Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2779</td>
               <td colspan="2">CTCAE Grade 3 Ovary Hemorrhage<span class="subclass"> SubClassOf </span>Ovary Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 3 Ovary Hemorrhage, Ovary Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2780</td>
               <td colspan="2">CTCAE Grade 3 Ovary Intra-Operative Injury<span class="subclass"> SubClassOf </span>Ovary Intra-Operative Injury Adverse Event. <br><i>New Terms: Ovary Intra-Operative Injury Adverse Event, CTCAE Grade 3 Ovary Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2781</td>
               <td colspan="2">CTCAE Grade 3 Ovary Perforation<span class="subclass"> SubClassOf </span>Ovary Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 3 Ovary Perforation, Ovary Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2782</td>
               <td colspan="2">CTCAE Grade 3 Ovulatory Pain<span class="subclass"> SubClassOf </span>Ovulatory Pain Adverse Event. <br><i>New Terms: Ovulatory Pain Adverse Event, CTCAE Grade 3 Ovulatory Pain</i></td>
            </tr>
            <tr class="addition">
               <td>2783</td>
               <td colspan="2">CTCAE Grade 3 PVCs<span class="subclass"> SubClassOf </span>Premature Ventricular Contraction Adverse Event. <br><i>New Terms: CTCAE Grade 3 PVCs, Premature Ventricular Contraction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2784</td>
               <td colspan="2">CTCAE Grade 3 Pain NOS<span class="subclass"> SubClassOf </span>Pain NOS Adverse Event. <br><i>New Terms: Pain NOS Adverse Event, CTCAE Grade 3 Pain NOS</i></td>
            </tr>
            <tr class="addition">
               <td>2785</td>
               <td colspan="2">CTCAE Grade 3 Pancreas Exocrine Enzyme Deficiency<span class="subclass"> SubClassOf </span>Pancreas Exocrine Enzyme Deficiency Adverse Event. <br><i>New Terms: CTCAE Grade 3 Pancreas Exocrine Enzyme Deficiency, Pancreas Exocrine Enzyme Deficiency
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2786</td>
               <td colspan="2">CTCAE Grade 3 Pancreas Fistula<span class="subclass"> SubClassOf </span>Pancreas Fistula Adverse Event. <br><i>New Terms: Pancreas Fistula Adverse Event, CTCAE Grade 3 Pancreas Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>2787</td>
               <td colspan="2">CTCAE Grade 3 Pancreas Hemorrhage<span class="subclass"> SubClassOf </span>Pancreas Hemorrhage Adverse Event. <br><i>New Terms: Pancreas Hemorrhage Adverse Event, CTCAE Grade 3 Pancreas Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>2788</td>
               <td colspan="2">CTCAE Grade 3 Pancreas Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Pancreas Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Pancreas Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Pancreas Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2789</td>
               <td colspan="2">CTCAE Grade 3 Pancreas Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Pancreas Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Pancreas Infection with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, Pancreas Infection Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2790</td>
               <td colspan="2">CTCAE Grade 3 Pancreas Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Pancreas Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Pancreas Infection with Unknown Absolute Neutrophil Count, Pancreas
                     Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2791</td>
               <td colspan="2">CTCAE Grade 3 Pancreas Intra-Operative Injury<span class="subclass"> SubClassOf </span>Pancreas Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Pancreas Intra-Operative Injury, Pancreas Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>2792</td>
               <td colspan="2">CTCAE Grade 3 Pancreas Leak<span class="subclass"> SubClassOf </span>Pancreas Leak Adverse Event. <br><i>New Terms: Pancreas Leak Adverse Event, CTCAE Grade 3 Pancreas Leak</i></td>
            </tr>
            <tr class="addition">
               <td>2793</td>
               <td colspan="2">CTCAE Grade 3 Pancreas Necrosis<span class="subclass"> SubClassOf </span>Pancreas Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Pancreas Necrosis, Pancreas Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2794</td>
               <td colspan="2">CTCAE Grade 3 Pancreas<br><span class="keyword"> or </span>Pancreatic Duct Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Pancreas<br><span class="keyword"> or </span>Pancreatic Duct Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Pancreas or Pancreatic Duct Stricture or Stenosis Adverse Event, CTCAE Grade 3 Pancreas
                     or Pancreatic Duct Stricture or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>2795</td>
               <td colspan="2">CTCAE Grade 3 Pancreatic Duct Intra-Operative Injury<span class="subclass"> SubClassOf </span>Pancreatic Duct Intra-Operative Injury Adverse Event. <br><i>New Terms: Pancreatic Duct Intra-Operative Injury Adverse Event, CTCAE Grade 3 Pancreatic Duct
                     Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2796</td>
               <td colspan="2">CTCAE Grade 3 Pancreatic Endocrine Glucose Intolerance<span class="subclass"> SubClassOf </span>Pancreatic Endocrine Glucose Intolerance Adverse Event. <br><i>New Terms: CTCAE Grade 3 Pancreatic Endocrine Glucose Intolerance, Pancreatic Endocrine Glucose
                     Intolerance Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2797</td>
               <td colspan="2">CTCAE Grade 3 Pancreatitis<span class="subclass"> SubClassOf </span>Pancreatitis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Pancreatitis, Pancreatitis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2798</td>
               <td colspan="2">CTCAE Grade 3 Paranasal Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Paranasal Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Paranasal Infection Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, Paranasal Infection Adverse Event Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2799</td>
               <td colspan="2">CTCAE Grade 3 Paranasal Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Paranasal Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Paranasal Infection with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, Paranasal Infection Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2800</td>
               <td colspan="2">CTCAE Grade 3 Paranasal Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Paranasal Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Paranasal Infection with Unknown Absolute Neutrophil Count, Paranasal
                     Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2801</td>
               <td colspan="2">CTCAE Grade 3 Parathyroid Intra-Operative Injury<span class="subclass"> SubClassOf </span>Parathyroid Intra-Operative Injury Adverse Event. <br><i>New Terms: Parathyroid Intra-Operative Injury Adverse Event, CTCAE Grade 3 Parathyroid Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2802</td>
               <td colspan="2">CTCAE Grade 3 Parotid Gland Intra-Operative Injury<span class="subclass"> SubClassOf </span>Parotid Gland Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Parotid Gland Intra-Operative Injury, Parotid Gland Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2803</td>
               <td colspan="2">CTCAE Grade 3 Partial Thromboplastin Time<span class="subclass"> SubClassOf </span>Partial Thromboplastin Time Adverse Event. <br><i>New Terms: CTCAE Grade 3 Partial Thromboplastin Time, Partial Thromboplastin Time Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2804</td>
               <td colspan="2">CTCAE Grade 3 Pelvic Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Pelvic Muscle Weakness Not Due to Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 3 Pelvic Muscle Weakness Not Due to Neuropathy, Pelvic Muscle Weakness
                     Not Due to Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2805</td>
               <td colspan="2">CTCAE Grade 3 Pelvic Soft Tissue Necrosis<span class="subclass"> SubClassOf </span>Pelvic Soft Tissue Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Pelvic Soft Tissue Necrosis, Pelvic Soft Tissue Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2806</td>
               <td colspan="2">CTCAE Grade 3 Pelvis Infection NOS Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Pelvis Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Pelvis Infection NOS Adverse Event Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, CTCAE Grade 3 Pelvis Infection NOS Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2807</td>
               <td colspan="2">CTCAE Grade 3 Pelvis Infection NOS with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Pelvis Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Pelvis Infection NOS Adverse Event with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, CTCAE Grade 3 Pelvis Infection NOS with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2808</td>
               <td colspan="2">CTCAE Grade 3 Pelvis Infection NOS with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Pelvis Infection NOS Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Pelvis Infection NOS with Unknown Absolute Neutrophil Count, Pelvis
                     Infection NOS Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2809</td>
               <td colspan="2">CTCAE Grade 3 Pelvis NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Pelvis Intra-Operative Injury Adverse Event. <br><i>New Terms: Pelvis Intra-Operative Injury Adverse Event, CTCAE Grade 3 Pelvis NOS Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2810</td>
               <td colspan="2">CTCAE Grade 3 Pelvis Pain<span class="subclass"> SubClassOf </span>Pelvis Pain Adverse Event. <br><i>New Terms: CTCAE Grade 3 Pelvis Pain, Pelvis Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2811</td>
               <td colspan="2">CTCAE Grade 3 Penis Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Penis Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Penis Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Penis Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2812</td>
               <td colspan="2">CTCAE Grade 3 Penis Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Penis Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Penis Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 3 Penis Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2813</td>
               <td colspan="2">CTCAE Grade 3 Penis Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Penis Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Penis Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     3 Penis Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2814</td>
               <td colspan="2">CTCAE Grade 3 Penis Intra-Operative Injury<span class="subclass"> SubClassOf </span>Penis Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Penis Intra-Operative Injury, Penis Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2815</td>
               <td colspan="2">CTCAE Grade 3 Penis Pain<span class="subclass"> SubClassOf </span>Penis Pain Adverse Event. <br><i>New Terms: Penis Pain Adverse Event, CTCAE Grade 3 Penis Pain</i></td>
            </tr>
            <tr class="addition">
               <td>2816</td>
               <td colspan="2">CTCAE Grade 3 Pericarditis<span class="subclass"> SubClassOf </span>Pericarditis Adverse Event. <br><i>New Terms: Pericarditis Adverse Event, CTCAE Grade 3 Pericarditis</i></td>
            </tr>
            <tr class="addition">
               <td>2817</td>
               <td colspan="2">CTCAE Grade 3 Pericardium Pain<span class="subclass"> SubClassOf </span>Pericardium Pain Adverse Event. <br><i>New Terms: CTCAE Grade 3 Pericardium Pain, Pericardium Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2818</td>
               <td colspan="2">CTCAE Grade 3 Perineum Pain<span class="subclass"> SubClassOf </span>Perineum Pain Adverse Event. <br><i>New Terms: CTCAE Grade 3 Perineum Pain, Perineum Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2819</td>
               <td colspan="2">CTCAE Grade 3 Periodontal Disease<span class="subclass"> SubClassOf </span>Periodontal Disease Adverse Event. <br><i>New Terms: Periodontal Disease Adverse Event, CTCAE Grade 3 Periodontal Disease</i></td>
            </tr>
            <tr class="addition">
               <td>2820</td>
               <td colspan="2">CTCAE Grade 3 Peripheral Arterial Ischemia<span class="subclass"> SubClassOf </span>Peripheral Arterial Ischemia Adverse Event. <br><i>New Terms: CTCAE Grade 3 Peripheral Arterial Ischemia, Peripheral Arterial Ischemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2821</td>
               <td colspan="2">CTCAE Grade 3 Peripheral Motor Nerve NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Peripheral Motor Nerve NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: Peripheral Motor Nerve NOS Intra-Operative Injury Adverse Event, CTCAE Grade 3 Peripheral
                     Motor Nerve NOS Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2822</td>
               <td colspan="2">CTCAE Grade 3 Peripheral Nerve Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Peripheral Nerve Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Peripheral Nerve Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, CTCAE Grade 3 Peripheral Nerve Infection Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2823</td>
               <td colspan="2">CTCAE Grade 3 Peripheral Nerve Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Peripheral Nerve Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Peripheral Nerve Infection Adverse Event with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils, CTCAE Grade 3 Peripheral Nerve Infection with Normal Absolute
                     Neutrophil Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2824</td>
               <td colspan="2">CTCAE Grade 3 Peripheral Nerve Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Peripheral Nerve Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Peripheral Nerve Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE
                     Grade 3 Peripheral Nerve Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2825</td>
               <td colspan="2">CTCAE Grade 3 Peripheral Sensory Nerve NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Peripheral Sensory Nerve NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: Peripheral Sensory Nerve NOS Intra-Operative Injury Adverse Event, CTCAE Grade 3 Peripheral
                     Sensory Nerve NOS Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2826</td>
               <td colspan="2">CTCAE Grade 3 Peristomal Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Peristomal Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Peristomal Infection Adverse Event Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, CTCAE Grade 3 Peristomal Infection Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2827</td>
               <td colspan="2">CTCAE Grade 3 Peristomal Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Peristomal Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Peristomal Infection with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, Peristomal Infection Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2828</td>
               <td colspan="2">CTCAE Grade 3 Peristomal Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Peristomal Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Peristomal Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     3 Peristomal Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2829</td>
               <td colspan="2">CTCAE Grade 3 Peritoneal Cavity Hemorrhage<span class="subclass"> SubClassOf </span>Peritoneal Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 3 Peritoneal Cavity Hemorrhage, Peritoneal Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2830</td>
               <td colspan="2">CTCAE Grade 3 Peritoneal Cavity Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Peritoneal Cavity Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Peritoneal Cavity Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, CTCAE Grade 3 Peritoneal Cavity Infection Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2831</td>
               <td colspan="2">CTCAE Grade 3 Peritoneal Cavity Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Peritoneal Cavity Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Peritoneal Cavity Infection with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils, Peritoneal Cavity Infection Adverse Event with Normal Absolute
                     Neutrophil Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2832</td>
               <td colspan="2">CTCAE Grade 3 Peritoneal Cavity Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Peritoneal Cavity Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Peritoneal Cavity Infection with Unknown Absolute Neutrophil Count,
                     Peritoneal Cavity Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2833</td>
               <td colspan="2">CTCAE Grade 3 Peritoneal Cavity Intra-Operative Injury<span class="subclass"> SubClassOf </span>Peritoneal Cavity Intra-Operative Injury Adverse Event. <br><i>New Terms: Peritoneal Cavity Intra-Operative Injury Adverse Event, CTCAE Grade 3 Peritoneal Cavity
                     Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2834</td>
               <td colspan="2">CTCAE Grade 3 Peritoneal Cavity Necrosis<span class="subclass"> SubClassOf </span>Peritoneal Cavity Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Peritoneal Cavity Necrosis, Peritoneal Cavity Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2835</td>
               <td colspan="2">CTCAE Grade 3 Peritoneum Pain<span class="subclass"> SubClassOf </span>Peritoneum Pain Adverse Event. <br><i>New Terms: Peritoneum Pain Adverse Event, CTCAE Grade 3 Peritoneum Pain</i></td>
            </tr>
            <tr class="addition">
               <td>2836</td>
               <td colspan="2">CTCAE Grade 3 Personality<br><span class="keyword"> and </span>Behavioral Change<span class="subclass"> SubClassOf </span>Personality<br><span class="keyword"> and </span>Behavioral Change Adverse Event. <br><i>New Terms: Personality and Behavioral Change Adverse Event, CTCAE Grade 3 Personality and Behavioral
                     Change</i></td>
            </tr>
            <tr class="addition">
               <td>2837</td>
               <td colspan="2">CTCAE Grade 3 Petechiae<br><span class="keyword"> and </span>Purpura<span class="subclass"> SubClassOf </span>Petechiae<br><span class="keyword"> and </span>Purpura Adverse Event. <br><i>New Terms: Petechiae and Purpura Adverse Event, CTCAE Grade 3 Petechiae and Purpura</i></td>
            </tr>
            <tr class="addition">
               <td>2838</td>
               <td colspan="2">CTCAE Grade 3 Phantom Pain Associated with Missing Limb<span class="subclass"> SubClassOf </span>Phantom Pain Associated with Missing Limb Adverse Event. <br><i>New Terms: CTCAE Grade 3 Phantom Pain Associated with Missing Limb, Phantom Pain Associated with
                     Missing Limb Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2839</td>
               <td colspan="2">CTCAE Grade 3 Pharynx GI Fistula<span class="subclass"> SubClassOf </span>Pharynx GI Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 3 Pharynx GI Fistula, Pharynx GI Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2840</td>
               <td colspan="2">CTCAE Grade 3 Pharynx Hemorrhage<span class="subclass"> SubClassOf </span>Pharynx Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 3 Pharynx Hemorrhage, Pharynx Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2841</td>
               <td colspan="2">CTCAE Grade 3 Pharynx Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Pharynx Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Pharynx Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 3 Pharynx Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2842</td>
               <td colspan="2">CTCAE Grade 3 Pharynx Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Pharynx Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Pharynx Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Pharynx Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2843</td>
               <td colspan="2">CTCAE Grade 3 Pharynx Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Pharynx Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Pharynx Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     3 Pharynx Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2844</td>
               <td colspan="2">CTCAE Grade 3 Pharynx Intra-Operative Injury<span class="subclass"> SubClassOf </span>Pharynx Intra-Operative Injury Adverse Event. <br><i>New Terms: Pharynx Intra-Operative Injury Adverse Event, CTCAE Grade 3 Pharynx Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2845</td>
               <td colspan="2">CTCAE Grade 3 Pharynx Leak<span class="subclass"> SubClassOf </span>Pharynx Leak Adverse Event. <br><i>New Terms: CTCAE Grade 3 Pharynx Leak, Pharynx Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2846</td>
               <td colspan="2">CTCAE Grade 3 Pharynx Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Pharynx Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification. <br><i>New Terms: CTCAE Grade 3 Pharynx Mucositis or Stomatitis by Clinical Examination Classification,
                     Pharynx Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>2847</td>
               <td colspan="2">CTCAE Grade 3 Pharynx Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Pharynx Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: Pharynx Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification,
                     CTCAE Grade 3 Pharynx Mucositis or Stomatitis by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>2848</td>
               <td colspan="2">CTCAE Grade 3 Pharynx Necrosis<span class="subclass"> SubClassOf </span>Pharynx Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Pharynx Necrosis, Pharynx Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2849</td>
               <td colspan="2">CTCAE Grade 3 Pharynx Obstruction<br><span class="keyword"> and </span>Stenosis<span class="subclass"> SubClassOf </span>Pharynx Obstruction<br><span class="keyword"> and </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Pharynx Obstruction and Stenosis, Pharynx Obstruction and Stenosis Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>2850</td>
               <td colspan="2">CTCAE Grade 3 Pharynx Pulmonary Fistula<span class="subclass"> SubClassOf </span>Pharynx Pulmonary Fistula Adverse Event. <br><i>New Terms: Pharynx Pulmonary Fistula Adverse Event, CTCAE Grade 3 Pharynx Pulmonary Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>2851</td>
               <td colspan="2">CTCAE Grade 3 Pharynx Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Pharynx Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Pharynx Stricture or Stenosis Adverse Event, CTCAE Grade 3 Pharynx Stricture or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>2852</td>
               <td colspan="2">CTCAE Grade 3 Phlebolymphatic Cording<span class="subclass"> SubClassOf </span>Phlebolymphatic Cording Adverse Event. <br><i>New Terms: Phlebolymphatic Cording Adverse Event, CTCAE Grade 3 Phlebolymphatic Cording</i></td>
            </tr>
            <tr class="addition">
               <td>2853</td>
               <td colspan="2">CTCAE Grade 3 Photophobia<span class="subclass"> SubClassOf </span>Photophobia Adverse Event. <br><i>New Terms: CTCAE Grade 3 Photophobia, Photophobia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2854</td>
               <td colspan="2">CTCAE Grade 3 Photosensitivity<span class="subclass"> SubClassOf </span>Photosensitivity Adverse Event. <br><i>New Terms: CTCAE Grade 3 Photosensitivity, Photosensitivity Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2855</td>
               <td colspan="2">CTCAE Grade 3 Phrenic Nerve Dysfunction<span class="subclass"> SubClassOf </span>Phrenic Nerve Dysfunction Adverse Event. <br><i>New Terms: Phrenic Nerve Dysfunction Adverse Event, CTCAE Grade 3 Phrenic Nerve Dysfunction</i></td>
            </tr>
            <tr class="addition">
               <td>2856</td>
               <td colspan="2">CTCAE Grade 3 Pituitary Intra-Operative Injury<span class="subclass"> SubClassOf </span>Pituitary Intra-Operative Injury Adverse Event. <br><i>New Terms: Pituitary Intra-Operative Injury Adverse Event, CTCAE Grade 3 Pituitary Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2857</td>
               <td colspan="2">CTCAE Grade 3 Platelets<span class="subclass"> SubClassOf </span>Platelets Adverse Event. <br><i>New Terms: CTCAE Grade 3 Platelets, Platelets Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2858</td>
               <td colspan="2">CTCAE Grade 3 Pleura Fistula<span class="subclass"> SubClassOf </span>Pleura Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 3 Pleura Fistula, Pleura Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2859</td>
               <td colspan="2">CTCAE Grade 3 Pleura Hemorrhage<span class="subclass"> SubClassOf </span>Pleura Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 3 Pleura Hemorrhage, Pleura Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2860</td>
               <td colspan="2">CTCAE Grade 3 Pleura Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Pleura Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Pleura Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 3 Pleura Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2861</td>
               <td colspan="2">CTCAE Grade 3 Pleura Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Pleura Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Pleura Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Pleura Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2862</td>
               <td colspan="2">CTCAE Grade 3 Pleura Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Pleura Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Pleura Infection with Unknown Absolute Neutrophil Count, Pleura Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2863</td>
               <td colspan="2">CTCAE Grade 3 Pleura Intra-Operative Injury<span class="subclass"> SubClassOf </span>Pleura Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Pleura Intra-Operative Injury, Pleura Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>2864</td>
               <td colspan="2">CTCAE Grade 3 Pleura Pain<span class="subclass"> SubClassOf </span>Pleura Pain Adverse Event. <br><i>New Terms: CTCAE Grade 3 Pleura Pain, Pleura Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2865</td>
               <td colspan="2">CTCAE Grade 3 Pneumonitis<br><span class="keyword"> and </span>Pulmonary Infiltrates<span class="subclass"> SubClassOf </span>Pneumonitis<br><span class="keyword"> and </span>Pulmonary Infiltrates Adverse Event. <br><i>New Terms: Pneumonitis and Pulmonary Infiltrates Adverse Event, CTCAE Grade 3 Pneumonitis and
                     Pulmonary Infiltrates</i></td>
            </tr>
            <tr class="addition">
               <td>2866</td>
               <td colspan="2">CTCAE Grade 3 Pneumothorax<span class="subclass"> SubClassOf </span>Pneumothorax Adverse Event. <br><i>New Terms: Pneumothorax Adverse Event, CTCAE Grade 3 Pneumothorax</i></td>
            </tr>
            <tr class="addition">
               <td>2867</td>
               <td colspan="2">CTCAE Grade 3 Portal Vein Flow<span class="subclass"> SubClassOf </span>Portal Vein Flow Adverse Event. <br><i>New Terms: CTCAE Grade 3 Portal Vein Flow, Portal Vein Flow Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2868</td>
               <td colspan="2">CTCAE Grade 3 Portal Vein Intra-Operative Injury<span class="subclass"> SubClassOf </span>Portal Vein Intra-Operative Injury Adverse Event. <br><i>New Terms: Portal Vein Intra-Operative Injury Adverse Event, CTCAE Grade 3 Portal Vein Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2869</td>
               <td colspan="2">CTCAE Grade 3 Proctitis<span class="subclass"> SubClassOf </span>Proctitis Adverse Event. <br><i>New Terms: Proctitis Adverse Event, CTCAE Grade 3 Proctitis</i></td>
            </tr>
            <tr class="addition">
               <td>2870</td>
               <td colspan="2">CTCAE Grade 3 Prolapse of Gastrointestinal Stoma<span class="subclass"> SubClassOf </span>Prolapse of Gastrointestinal Stoma Adverse Event. <br><i>New Terms: CTCAE Grade 3 Prolapse of Gastrointestinal Stoma, Prolapse of Gastrointestinal Stoma
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2871</td>
               <td colspan="2">CTCAE Grade 3 Prolonged Chest Tube Drainage<br><span class="keyword"> or </span>Air Leak After Pulmonary Resection<span class="subclass"> SubClassOf </span>Prolonged Chest Tube Drainage<br><span class="keyword"> or </span>Air Leak After Pulmonary Resection Adverse Event. <br><i>New Terms: Prolonged Chest Tube Drainage or Air Leak After Pulmonary Resection Adverse Event,
                     CTCAE Grade 3 Prolonged Chest Tube Drainage or Air Leak After Pulmonary Resection</i></td>
            </tr>
            <tr class="addition">
               <td>2872</td>
               <td colspan="2">CTCAE Grade 3 Prolonged Intubation After Pulmonary Resection<span class="subclass"> SubClassOf </span>Prolonged Intubation After Pulmonary Resection Adverse Event. <br><i>New Terms: CTCAE Grade 3 Prolonged Intubation After Pulmonary Resection, Prolonged Intubation
                     After Pulmonary Resection Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2873</td>
               <td colspan="2">CTCAE Grade 3 Prolonged QTc Interval<span class="subclass"> SubClassOf </span>Prolonged QTc Interval Adverse Event. <br><i>New Terms: Prolonged QTc Interval Adverse Event, CTCAE Grade 3 Prolonged QTc Interval</i></td>
            </tr>
            <tr class="addition">
               <td>2874</td>
               <td colspan="2">CTCAE Grade 3 Proptosis<br><span class="keyword"> and </span>Enophthalmos<span class="subclass"> SubClassOf </span>Proptosis<br><span class="keyword"> and </span>Enophthalmos Adverse Event. <br><i>New Terms: Proptosis and Enophthalmos Adverse Event, CTCAE Grade 3 Proptosis and Enophthalmos</i></td>
            </tr>
            <tr class="addition">
               <td>2875</td>
               <td colspan="2">CTCAE Grade 3 Prostate Hemorrhage<span class="subclass"> SubClassOf </span>Prostate Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 3 Prostate Hemorrhage, Prostate Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2876</td>
               <td colspan="2">CTCAE Grade 3 Prostate Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Prostate Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Prostate Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 3 Prostate Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2877</td>
               <td colspan="2">CTCAE Grade 3 Prostate Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Prostate Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Prostate Infection with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, Prostate Infection Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2878</td>
               <td colspan="2">CTCAE Grade 3 Prostate Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Prostate Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Prostate Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     3 Prostate Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2879</td>
               <td colspan="2">CTCAE Grade 3 Prostate Intra-Operative Injury<span class="subclass"> SubClassOf </span>Prostate Intra-Operative Injury Adverse Event. <br><i>New Terms: Prostate Intra-Operative Injury Adverse Event, CTCAE Grade 3 Prostate Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2880</td>
               <td colspan="2">CTCAE Grade 3 Prostate Obstruction<span class="subclass"> SubClassOf </span>Prostate Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 3 Prostate Obstruction, Prostate Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2881</td>
               <td colspan="2">CTCAE Grade 3 Prostate Pain<span class="subclass"> SubClassOf </span>Prostate Pain Adverse Event. <br><i>New Terms: CTCAE Grade 3 Prostate Pain, Prostate Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2882</td>
               <td colspan="2">CTCAE Grade 3 Prostate Perforation<span class="subclass"> SubClassOf </span>Prostate Perforation Adverse Event. <br><i>New Terms: Prostate Perforation Adverse Event, CTCAE Grade 3 Prostate Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>2883</td>
               <td colspan="2">CTCAE Grade 3 Prostate Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Prostate Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Prostate Stricture or Stenosis, Prostate Stricture or Stenosis Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>2884</td>
               <td colspan="2">CTCAE Grade 3 Proteinuria<span class="subclass"> SubClassOf </span>Proteinuria Adverse Event. <br><i>New Terms: Proteinuria Adverse Event, CTCAE Grade 3 Proteinuria</i></td>
            </tr>
            <tr class="addition">
               <td>2885</td>
               <td colspan="2">CTCAE Grade 3 Pruritus<span class="subclass"> SubClassOf </span>Pruritus Adverse Event. <br><i>New Terms: Pruritus Adverse Event, CTCAE Grade 3 Pruritus</i></td>
            </tr>
            <tr class="addition">
               <td>2886</td>
               <td colspan="2">CTCAE Grade 3 Psychosis Including Hallucinations<br><span class="keyword"> and </span>Delusions<span class="subclass"> SubClassOf </span>Psychosis Including Hallucinations<br><span class="keyword"> and </span>Delusions Adverse Event. <br><i>New Terms: CTCAE Grade 3 Psychosis Including Hallucinations and Delusions, Psychosis Including
                     Hallucinations and Delusions Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2888</td>
               <td colspan="2">CTCAE Grade 3 Pulmonary Fibrosis Radiographic Changes<span class="subclass"> SubClassOf </span>Pulmonary Fibrosis Radiographic Changes Adverse Event. <br><i>New Terms: CTCAE Grade 3 Pulmonary Fibrosis Radiographic Changes, Pulmonary Fibrosis Radiographic
                     Changes Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2889</td>
               <td colspan="2">CTCAE Grade 3 Pulmonary Hypertension<span class="subclass"> SubClassOf </span>Pulmonary Hypertension Adverse Event. <br><i>New Terms: Pulmonary Hypertension Adverse Event, CTCAE Grade 3 Pulmonary Hypertension</i></td>
            </tr>
            <tr class="addition">
               <td>2890</td>
               <td colspan="2">CTCAE Grade 3 Pulmonary Vein Intra-Operative Injury<span class="subclass"> SubClassOf </span>Pulmonary Vein Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Pulmonary Vein Intra-Operative Injury, Pulmonary Vein Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2891</td>
               <td colspan="2">CTCAE Grade 3 Pyramidal Tract Dysfunction<span class="subclass"> SubClassOf </span>Pyramidal Tract Dysfunction Adverse Event. <br><i>New Terms: Pyramidal Tract Dysfunction Adverse Event, CTCAE Grade 3 Pyramidal Tract Dysfunction</i></td>
            </tr>
            <tr class="addition">
               <td>2892</td>
               <td colspan="2">CTCAE Grade 3 Radiation Excluding Chemoradiation<span class="subclass"> SubClassOf </span>Rash<br><span class="keyword"> and </span>Dermatitis Adverse Event Associated with Radiation Excluding Chemoradiation. <br><i>New Terms: CTCAE Grade 3 Radiation Excluding Chemoradiation, Rash and Dermatitis Adverse Event
                     Associated with Radiation Excluding Chemoradiation</i></td>
            </tr>
            <tr class="addition">
               <td>2893</td>
               <td colspan="2">CTCAE Grade 3 Rash Acne<br><span class="keyword"> or </span>Acneiform Adverse Event<span class="subclass"> SubClassOf </span>Rash Acne<br><span class="keyword"> or </span>Acneiform Adverse Event. <br><i>New Terms: CTCAE Grade 3 Rash Acne or Acneiform Adverse Event, Rash Acne or Acneiform Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>2894</td>
               <td colspan="2">CTCAE Grade 3 Rash Desquamation<span class="subclass"> SubClassOf </span>Rash Desquamation Adverse Event. <br><i>New Terms: Rash Desquamation Adverse Event, CTCAE Grade 3 Rash Desquamation</i></td>
            </tr>
            <tr class="addition">
               <td>2895</td>
               <td colspan="2">CTCAE Grade 3 Rash Erythema Multiforme<span class="subclass"> SubClassOf </span>Rash Erythema Multiforme Adverse Event. <br><i>New Terms: CTCAE Grade 3 Rash Erythema Multiforme, Rash Erythema Multiforme Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2896</td>
               <td colspan="2">CTCAE Grade 3 Rash Hand<br><span class="keyword"> or </span>Foot Skin Reaction<span class="subclass"> SubClassOf </span>Rash Hand<br><span class="keyword"> or </span>Foot Skin Reaction Adverse Event. <br><i>New Terms: Rash Hand or Foot Skin Reaction Adverse Event, CTCAE Grade 3 Rash Hand or Foot Skin
                     Reaction</i></td>
            </tr>
            <tr class="addition">
               <td>2897</td>
               <td colspan="2">CTCAE Grade 3 Rectal Varices Hemorrhage<span class="subclass"> SubClassOf </span>Rectal Varices Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 3 Rectal Varices Hemorrhage, Rectal Varices Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2898</td>
               <td colspan="2">CTCAE Grade 3 Rectum Fistula<span class="subclass"> SubClassOf </span>Rectum Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 3 Rectum Fistula, Rectum Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2899</td>
               <td colspan="2">CTCAE Grade 3 Rectum Hemorrhage<span class="subclass"> SubClassOf </span>Rectum Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 3 Rectum Hemorrhage, Rectum Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2900</td>
               <td colspan="2">CTCAE Grade 3 Rectum Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Rectum Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Rectum Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 3 Rectum Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2901</td>
               <td colspan="2">CTCAE Grade 3 Rectum Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Rectum Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Rectum Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Rectum Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2902</td>
               <td colspan="2">CTCAE Grade 3 Rectum Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Rectum Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Rectum Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     3 Rectum Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2903</td>
               <td colspan="2">CTCAE Grade 3 Rectum Intra-Operative Injury<span class="subclass"> SubClassOf </span>Rectum Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Rectum Intra-Operative Injury, Rectum Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>2904</td>
               <td colspan="2">CTCAE Grade 3 Rectum Leak<span class="subclass"> SubClassOf </span>Rectum Leak Adverse Event. <br><i>New Terms: CTCAE Grade 3 Rectum Leak, Rectum Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2905</td>
               <td colspan="2">CTCAE Grade 3 Rectum Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Rectum Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification. <br><i>New Terms: CTCAE Grade 3 Rectum Mucositis or Stomatitis by Clinical Examination Classification,
                     Rectum Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>2906</td>
               <td colspan="2">CTCAE Grade 3 Rectum Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Rectum Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: Rectum Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification,
                     CTCAE Grade 3 Rectum Mucositis or Stomatitis by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>2907</td>
               <td colspan="2">CTCAE Grade 3 Rectum Necrosis<span class="subclass"> SubClassOf </span>Rectum Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Rectum Necrosis, Rectum Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2908</td>
               <td colspan="2">CTCAE Grade 3 Rectum Obstruction<span class="subclass"> SubClassOf </span>Rectum Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 3 Rectum Obstruction, Rectum Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2909</td>
               <td colspan="2">CTCAE Grade 3 Rectum Pain<span class="subclass"> SubClassOf </span>Rectum Pain Adverse Event. <br><i>New Terms: CTCAE Grade 3 Rectum Pain, Rectum Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2910</td>
               <td colspan="2">CTCAE Grade 3 Rectum Perforation<span class="subclass"> SubClassOf </span>Rectum Perforation Adverse Event. <br><i>New Terms: Rectum Perforation Adverse Event, CTCAE Grade 3 Rectum Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>2911</td>
               <td colspan="2">CTCAE Grade 3 Rectum Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Rectum Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Rectum Stricture or Stenosis, Rectum Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2912</td>
               <td colspan="2">CTCAE Grade 3 Rectum Ulcer<span class="subclass"> SubClassOf </span>Rectum Ulcer Adverse Event. <br><i>New Terms: Rectum Ulcer Adverse Event, CTCAE Grade 3 Rectum Ulcer</i></td>
            </tr>
            <tr class="addition">
               <td>2913</td>
               <td colspan="2">CTCAE Grade 3 Recurrent Laryngeal Nerve Intra-Operative Injury<span class="subclass"> SubClassOf </span>Recurrent Laryngeal Nerve Intra-Operative Injury Adverse Event. <br><i>New Terms: Recurrent Laryngeal Nerve Intra-Operative Injury Adverse Event, CTCAE Grade 3 Recurrent
                     Laryngeal Nerve Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2914</td>
               <td colspan="2">CTCAE Grade 3 Reduction in Growth Velocity<span class="subclass"> SubClassOf </span>Reduction in Growth Velocity Adverse Event. <br><i>New Terms: CTCAE Grade 3 Reduction in Growth Velocity, Reduction in Growth Velocity Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2915</td>
               <td colspan="2">CTCAE Grade 3 Renal Failure<span class="subclass"> SubClassOf </span>Renal Failure Adverse Event. <br><i>New Terms: CTCAE Grade 3 Renal Failure, Renal Failure Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2916</td>
               <td colspan="2">CTCAE Grade 3 Respiratory Tract Hemorrhage NOS<span class="subclass"> SubClassOf </span>Respiratory Tract Hemorrhage Adverse Event NOS. <br><i>New Terms: CTCAE Grade 3 Respiratory Tract Hemorrhage NOS, Respiratory Tract Hemorrhage Adverse
                     Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>2917</td>
               <td colspan="2">CTCAE Grade 3 Restrictive Cardiomyopathy<span class="subclass"> SubClassOf </span>Restrictive Cardiomyopathy Adverse Event. <br><i>New Terms: Restrictive Cardiomyopathy Adverse Event, CTCAE Grade 3 Restrictive Cardiomyopathy</i></td>
            </tr>
            <tr class="addition">
               <td>2918</td>
               <td colspan="2">CTCAE Grade 3 Retina Intra-Operative Injury<span class="subclass"> SubClassOf </span>Retina Intra-Operative Injury Adverse Event. <br><i>New Terms: Retina Intra-Operative Injury Adverse Event, CTCAE Grade 3 Retina Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2919</td>
               <td colspan="2">CTCAE Grade 3 Retinal Detachment<span class="subclass"> SubClassOf </span>Retinal Detachment Adverse Event. <br><i>New Terms: CTCAE Grade 3 Retinal Detachment, Retinal Detachment Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2920</td>
               <td colspan="2">CTCAE Grade 3 Retinoic Acid Syndrome<span class="subclass"> SubClassOf </span>Retinoic Acid Syndrome Adverse Event. <br><i>New Terms: CTCAE Grade 3 Retinoic Acid Syndrome, Retinoic Acid Syndrome Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2921</td>
               <td colspan="2">CTCAE Grade 3 Retinopathy<span class="subclass"> SubClassOf </span>Retinopathy Adverse Event. <br><i>New Terms: Retinopathy Adverse Event, CTCAE Grade 3 Retinopathy</i></td>
            </tr>
            <tr class="addition">
               <td>2922</td>
               <td colspan="2">CTCAE Grade 3 Retroperitoneum Hemorrhage<span class="subclass"> SubClassOf </span>Retroperitoneum Hemorrhage Adverse Event. <br><i>New Terms: Retroperitoneum Hemorrhage Adverse Event, CTCAE Grade 3 Retroperitoneum Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>2924</td>
               <td colspan="2">CTCAE Grade 3 Right Ventricular Dysfunction<span class="subclass"> SubClassOf </span>Right Ventricular Dysfunction Adverse Event. <br><i>New Terms: Right Ventricular Dysfunction Adverse Event, CTCAE Grade 3 Right Ventricular Dysfunction</i></td>
            </tr>
            <tr class="addition">
               <td>2923</td>
               <td colspan="2">CTCAE Grade 3 Right-Sided Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Right-Sided Muscle Weakness Not Due to Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 3 Right-Sided Muscle Weakness Not Due to Neuropathy, Right-Sided Muscle
                     Weakness Not Due to Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2925</td>
               <td colspan="2">CTCAE Grade 3 Rigors<br><span class="keyword"> and </span>Chills<span class="subclass"> SubClassOf </span>Rigors<br><span class="keyword"> and </span>Chills Adverse Event. <br><i>New Terms: Rigors and Chills Adverse Event, CTCAE Grade 3 Rigors and Chills</i></td>
            </tr>
            <tr class="addition">
               <td>2926</td>
               <td colspan="2">CTCAE Grade 3 Sacral Plexus Intra-Operative Injury<span class="subclass"> SubClassOf </span>Sacral Plexus Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Sacral Plexus Intra-Operative Injury, Sacral Plexus Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2927</td>
               <td colspan="2">CTCAE Grade 3 Salivary Duct Intra-Operative Injury<span class="subclass"> SubClassOf </span>Salivary Duct Intra-Operative Injury Adverse Event. <br><i>New Terms: Salivary Duct Intra-Operative Injury Adverse Event, CTCAE Grade 3 Salivary Duct Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2928</td>
               <td colspan="2">CTCAE Grade 3 Salivary Gland Fistula<span class="subclass"> SubClassOf </span>Salivary Gland Fistula. <br><i>New Terms: Salivary Gland Fistula, CTCAE Grade 3 Salivary Gland Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>2929</td>
               <td colspan="2">CTCAE Grade 3 Salivary Gland Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Salivary Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Salivary Gland Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, Salivary Infection Adverse Event Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2930</td>
               <td colspan="2">CTCAE Grade 3 Salivary Gland Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Salivary Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Salivary Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, CTCAE Grade 3 Salivary Gland Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2931</td>
               <td colspan="2">CTCAE Grade 3 Salivary Gland Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Salivary Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Salivary Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     3 Salivary Gland Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2932</td>
               <td colspan="2">CTCAE Grade 3 Salivary Gland Intra-Operative Injury<span class="subclass"> SubClassOf </span>Salivary Gland Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Salivary Gland Intra-Operative Injury, Salivary Gland Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2933</td>
               <td colspan="2">CTCAE Grade 3 Salivary Gland<br><span class="keyword"> or </span>Saliva Changes<span class="subclass"> SubClassOf </span>Salivary Gland<br><span class="keyword"> or </span>Saliva Changes Adverse Event. <br><i>New Terms: Salivary Gland or Saliva Changes Adverse Event, CTCAE Grade 3 Salivary Gland or Saliva
                     Changes</i></td>
            </tr>
            <tr class="addition">
               <td>2934</td>
               <td colspan="2">CTCAE Grade 3 Scalp Pain<span class="subclass"> SubClassOf </span>Scalp Pain Adverse Event. <br><i>New Terms: CTCAE Grade 3 Scalp Pain, Scalp Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2935</td>
               <td colspan="2">CTCAE Grade 3 Sciatic Nerve Intra-Operative Injury<span class="subclass"> SubClassOf </span>Sciatic Nerve Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Sciatic Nerve Intra-Operative Injury, Sciatic Nerve Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2936</td>
               <td colspan="2">CTCAE Grade 3 Scleral Necrosis<br><span class="keyword"> and </span>Melt<span class="subclass"> SubClassOf </span>Scleral Necrosis<br><span class="keyword"> and </span>Melt Adverse Event. <br><i>New Terms: Scleral Necrosis and Melt Adverse Event, CTCAE Grade 3 Scleral Necrosis and Melt</i></td>
            </tr>
            <tr class="addition">
               <td>2937</td>
               <td colspan="2">CTCAE Grade 3 Scrotum Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Scrotum Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Scrotum Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 3 Scrotum Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2938</td>
               <td colspan="2">CTCAE Grade 3 Scrotum Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Scrotum Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Scrotum Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Scrotum Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2939</td>
               <td colspan="2">CTCAE Grade 3 Scrotum Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Scrotum Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Scrotum Infection with Unknown Absolute Neutrophil Count, Scrotum Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2940</td>
               <td colspan="2">CTCAE Grade 3 Scrotum Intra-Operative Injury<span class="subclass"> SubClassOf </span>Scrotum Intra-Operative Injury Adverse Event. <br><i>New Terms: Scrotum Intra-Operative Injury Adverse Event, CTCAE Grade 3 Scrotum Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2941</td>
               <td colspan="2">CTCAE Grade 3 Scrotum Pain<span class="subclass"> SubClassOf </span>Scrotum Pain Adverse Event. <br><i>New Terms: CTCAE Grade 3 Scrotum Pain, Scrotum Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2942</td>
               <td colspan="2">CTCAE Grade 3 Seizure<span class="subclass"> SubClassOf </span>Seizure Adverse Event. <br><i>New Terms: CTCAE Grade 3 Seizure, Seizure Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2943</td>
               <td colspan="2">CTCAE Grade 3 Sensory Neuropathy<span class="subclass"> SubClassOf </span>Sensory Neuropathy Adverse Event. <br><i>New Terms: Sensory Neuropathy Adverse Event, CTCAE Grade 3 Sensory Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>2944</td>
               <td colspan="2">CTCAE Grade 3 Seroma<span class="subclass"> SubClassOf </span>Seroma Adverse Event. <br><i>New Terms: Seroma Adverse Event, CTCAE Grade 3 Seroma</i></td>
            </tr>
            <tr class="addition">
               <td>2945</td>
               <td colspan="2">CTCAE Grade 3 Serum Glutamic Oxaloacetic Transaminase<span class="subclass"> SubClassOf </span>Serum Glutamic Oxaloacetic Transaminase Adverse Event. <br><i>New Terms: CTCAE Grade 3 Serum Glutamic Oxaloacetic Transaminase, Serum Glutamic Oxaloacetic
                     Transaminase Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2946</td>
               <td colspan="2">CTCAE Grade 3 Serum Glutamic Pyruvic Transaminase<span class="subclass"> SubClassOf </span>Serum Glutamic Pyruvic Transaminase Adverse Event. <br><i>New Terms: CTCAE Grade 3 Serum Glutamic Pyruvic Transaminase, Serum Glutamic Pyruvic Transaminase
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2947</td>
               <td colspan="2">CTCAE Grade 3 Serum Hypercalcemia<span class="subclass"> SubClassOf </span>Serum Hypercalcemia Adverse Event. <br><i>New Terms: CTCAE Grade 3 Serum Hypercalcemia, Serum Hypercalcemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2948</td>
               <td colspan="2">CTCAE Grade 3 Serum Hypercholesteremia<span class="subclass"> SubClassOf </span>Serum Hypercholesteremia Adverse Event. <br><i>New Terms: CTCAE Grade 3 Serum Hypercholesteremia, Serum Hypercholesteremia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2949</td>
               <td colspan="2">CTCAE Grade 3 Serum Hyperglycemia<span class="subclass"> SubClassOf </span>Serum Hyperglycemia Adverse Event. <br><i>New Terms: Serum Hyperglycemia Adverse Event, CTCAE Grade 3 Serum Hyperglycemia</i></td>
            </tr>
            <tr class="addition">
               <td>2950</td>
               <td colspan="2">CTCAE Grade 3 Serum Hyperkalemia<span class="subclass"> SubClassOf </span>Serum Hyperkalemia Adverse Event. <br><i>New Terms: Serum Hyperkalemia Adverse Event, CTCAE Grade 3 Serum Hyperkalemia</i></td>
            </tr>
            <tr class="addition">
               <td>2951</td>
               <td colspan="2">CTCAE Grade 3 Serum Hypermagnesemia<span class="subclass"> SubClassOf </span>Serum Hypermagnesemia Adverse Event. <br><i>New Terms: CTCAE Grade 3 Serum Hypermagnesemia, Serum Hypermagnesemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2952</td>
               <td colspan="2">CTCAE Grade 3 Serum Hypernatremia<span class="subclass"> SubClassOf </span>Serum Hypernatremia Adverse Event. <br><i>New Terms: Serum Hypernatremia Adverse Event, CTCAE Grade 3 Serum Hypernatremia</i></td>
            </tr>
            <tr class="addition">
               <td>2953</td>
               <td colspan="2">CTCAE Grade 3 Serum Hypertriglyceridemia<span class="subclass"> SubClassOf </span>Serum Hypertriglyceridemia Adverse Event. <br><i>New Terms: CTCAE Grade 3 Serum Hypertriglyceridemia, Serum Hypertriglyceridemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2954</td>
               <td colspan="2">CTCAE Grade 3 Serum Hyperuricemia<span class="subclass"> SubClassOf </span>Serum Hyperuricemia Adverse Event. <br><i>New Terms: CTCAE Grade 3 Serum Hyperuricemia, Serum Hyperuricemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2955</td>
               <td colspan="2">CTCAE Grade 3 Serum Hypoalbuminemia<span class="subclass"> SubClassOf </span>Serum Hypoalbuminemia Adverse Event. <br><i>New Terms: Serum Hypoalbuminemia Adverse Event, CTCAE Grade 3 Serum Hypoalbuminemia</i></td>
            </tr>
            <tr class="addition">
               <td>2956</td>
               <td colspan="2">CTCAE Grade 3 Serum Hypocalcemia<span class="subclass"> SubClassOf </span>Serum Hypocalcemia Adverse Event. <br><i>New Terms: Serum Hypocalcemia Adverse Event, CTCAE Grade 3 Serum Hypocalcemia</i></td>
            </tr>
            <tr class="addition">
               <td>2957</td>
               <td colspan="2">CTCAE Grade 3 Serum Hypoglycemia<span class="subclass"> SubClassOf </span>Serum Hypoglycemia Adverse Event. <br><i>New Terms: Serum Hypoglycemia Adverse Event, CTCAE Grade 3 Serum Hypoglycemia</i></td>
            </tr>
            <tr class="addition">
               <td>2958</td>
               <td colspan="2">CTCAE Grade 3 Serum Hypokalemia<span class="subclass"> SubClassOf </span>Serum Hypokalemia Adverse Event. <br><i>New Terms: CTCAE Grade 3 Serum Hypokalemia, Serum Hypokalemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2959</td>
               <td colspan="2">CTCAE Grade 3 Serum Hypomagnesemia<span class="subclass"> SubClassOf </span>Serum Hypomagnesemia Adverse Event. <br><i>New Terms: Serum Hypomagnesemia Adverse Event, CTCAE Grade 3 Serum Hypomagnesemia</i></td>
            </tr>
            <tr class="addition">
               <td>2960</td>
               <td colspan="2">CTCAE Grade 3 Serum Hyponatremia<span class="subclass"> SubClassOf </span>Serum Hyponatremia Adverse Event. <br><i>New Terms: Serum Hyponatremia Adverse Event, CTCAE Grade 3 Serum Hyponatremia</i></td>
            </tr>
            <tr class="addition">
               <td>2961</td>
               <td colspan="2">CTCAE Grade 3 Serum Hypophosphatemia<span class="subclass"> SubClassOf </span>Serum Hypophosphatemia Adverse Event. <br><i>New Terms: Serum Hypophosphatemia Adverse Event, CTCAE Grade 3 Serum Hypophosphatemia</i></td>
            </tr>
            <tr class="addition">
               <td>2962</td>
               <td colspan="2">CTCAE Grade 3 Serum Sickness<span class="subclass"> SubClassOf </span>Serum Sickness Adverse Event. <br><i>New Terms: CTCAE Grade 3 Serum Sickness, Serum Sickness Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2963</td>
               <td colspan="2">CTCAE Grade 3 Sick Sinus Syndrome<span class="subclass"> SubClassOf </span>Sick Sinus Syndrome Adverse Event. <br><i>New Terms: CTCAE Grade 3 Sick Sinus Syndrome, Sick Sinus Syndrome Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2964</td>
               <td colspan="2">CTCAE Grade 3 Sinus Arrhythmia<span class="subclass"> SubClassOf </span>Sinus Arrhythmia Adverse Event. <br><i>New Terms: CTCAE Grade 3 Sinus Arrhythmia, Sinus Arrhythmia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2965</td>
               <td colspan="2">CTCAE Grade 3 Sinus Bradycardia<span class="subclass"> SubClassOf </span>Sinus Bradycardia Adverse Event. <br><i>New Terms: CTCAE Grade 3 Sinus Bradycardia, Sinus Bradycardia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2966</td>
               <td colspan="2">CTCAE Grade 3 Sinus Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Sinus Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Sinus Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Sinus Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2967</td>
               <td colspan="2">CTCAE Grade 3 Sinus Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Sinus Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Sinus Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 3 Sinus Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2968</td>
               <td colspan="2">CTCAE Grade 3 Sinus Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Sinus Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Sinus Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     3 Sinus Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2969</td>
               <td colspan="2">CTCAE Grade 3 Sinus Intra-Operative Injury<span class="subclass"> SubClassOf </span>Sinus Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Sinus Intra-Operative Injury, Sinus Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2970</td>
               <td colspan="2">CTCAE Grade 3 Sinus Pain<span class="subclass"> SubClassOf </span>Sinus Pain Adverse Event. <br><i>New Terms: Sinus Pain Adverse Event, CTCAE Grade 3 Sinus Pain</i></td>
            </tr>
            <tr class="addition">
               <td>2971</td>
               <td colspan="2">CTCAE Grade 3 Sinus Tachycardia<span class="subclass"> SubClassOf </span>Sinus Tachycardia Adverse Event. <br><i>New Terms: CTCAE Grade 3 Sinus Tachycardia, Sinus Tachycardia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2972</td>
               <td colspan="2">CTCAE Grade 3 Skin Breakdown<br><span class="keyword"> or </span>Decubitus Ulcer<span class="subclass"> SubClassOf </span>Skin Breakdown<br><span class="keyword"> or </span>Decubitus Ulcer Adverse Event. <br><i>New Terms: CTCAE Grade 3 Skin Breakdown or Decubitus Ulcer, Skin Breakdown or Decubitus Ulcer
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2973</td>
               <td colspan="2">CTCAE Grade 3 Skin Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Skin Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Skin Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Skin Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2974</td>
               <td colspan="2">CTCAE Grade 3 Skin Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Skin Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Skin Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or 2
                     Neutrophils, CTCAE Grade 3 Skin Infection with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2975</td>
               <td colspan="2">CTCAE Grade 3 Skin Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Skin Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Skin Infection with Unknown Absolute Neutrophil Count, Skin Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2976</td>
               <td colspan="2">CTCAE Grade 3 Skin Intra-Operative Injury<span class="subclass"> SubClassOf </span>Skin Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Skin Intra-Operative Injury, Skin Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2977</td>
               <td colspan="2">CTCAE Grade 3 Skin Pain<span class="subclass"> SubClassOf </span>Skin Pain Adverse Event. <br><i>New Terms: CTCAE Grade 3 Skin Pain, Skin Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2978</td>
               <td colspan="2">CTCAE Grade 3 Slipped Capital Femoral Epiphysis<span class="subclass"> SubClassOf </span>Slipped Capital Femoral Epiphysis Adverse Event. <br><i>New Terms: Slipped Capital Femoral Epiphysis Adverse Event, CTCAE Grade 3 Slipped Capital Femoral
                     Epiphysis</i></td>
            </tr>
            <tr class="addition">
               <td>2979</td>
               <td colspan="2">CTCAE Grade 3 Small Bowel Fistula NOS<span class="subclass"> SubClassOf </span>Small Bowel Fistula Adverse Event NOS. <br><i>New Terms: Small Bowel Fistula Adverse Event NOS, CTCAE Grade 3 Small Bowel Fistula NOS</i></td>
            </tr>
            <tr class="addition">
               <td>2980</td>
               <td colspan="2">CTCAE Grade 3 Small Bowel Infection NOS Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Small Bowel Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Small Bowel Infection NOS Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, Small Bowel Infection NOS Adverse Event Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2981</td>
               <td colspan="2">CTCAE Grade 3 Small Bowel Infection NOS with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Small Bowel Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Small Bowel Infection NOS Adverse Event with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, CTCAE Grade 3 Small Bowel Infection NOS with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2982</td>
               <td colspan="2">CTCAE Grade 3 Small Bowel Infection NOS with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Small Bowel Infection NOS Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Small Bowel Infection NOS Adverse Event with Unknown Absolute Neutrophil Count, CTCAE
                     Grade 3 Small Bowel Infection NOS with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2983</td>
               <td colspan="2">CTCAE Grade 3 Small Bowel Leak<span class="subclass"> SubClassOf </span>Small Bowel Leak Adverse Event. <br><i>New Terms: CTCAE Grade 3 Small Bowel Leak, Small Bowel Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2984</td>
               <td colspan="2">CTCAE Grade 3 Small Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Small Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification. <br><i>New Terms: Small Bowel Mucositis or Stomatitis by Clinical Examination Classification, CTCAE
                     Grade 3 Small Bowel Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>2985</td>
               <td colspan="2">CTCAE Grade 3 Small Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Small Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: CTCAE Grade 3 Small Bowel Mucositis or Stomatitis by Functional or Symptomatic Classification,
                     Small Bowel Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>2986</td>
               <td colspan="2">CTCAE Grade 3 Small Bowel NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Small Bowel NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: Small Bowel NOS Intra-Operative Injury Adverse Event, CTCAE Grade 3 Small Bowel NOS
                     Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2987</td>
               <td colspan="2">CTCAE Grade 3 Small Bowel Necrosis NOS<span class="subclass"> SubClassOf </span>Small Bowel Necrosis Adverse Event. <br><i>New Terms: Small Bowel Necrosis Adverse Event, CTCAE Grade 3 Small Bowel Necrosis NOS</i></td>
            </tr>
            <tr class="addition">
               <td>2988</td>
               <td colspan="2">CTCAE Grade 3 Small Bowel Obstruction NOS<span class="subclass"> SubClassOf </span>Small Bowel Obstruction Adverse Event NOS. <br><i>New Terms: CTCAE Grade 3 Small Bowel Obstruction NOS, Small Bowel Obstruction Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>2989</td>
               <td colspan="2">CTCAE Grade 3 Small Bowel Perforation NOS<span class="subclass"> SubClassOf </span>Small Bowel Perforation Adverse Event NOS. <br><i>New Terms: Small Bowel Perforation Adverse Event NOS, CTCAE Grade 3 Small Bowel Perforation NOS</i></td>
            </tr>
            <tr class="addition">
               <td>2990</td>
               <td colspan="2">CTCAE Grade 3 Small Bowel Stricture<br><span class="keyword"> or </span>Stenosis NOS<span class="subclass"> SubClassOf </span>Small Bowel Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event NOS. <br><i>New Terms: CTCAE Grade 3 Small Bowel Stricture or Stenosis NOS, Small Bowel Stricture or Stenosis
                     Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>2991</td>
               <td colspan="2">CTCAE Grade 3 Small Bowel Ulcer NOS<span class="subclass"> SubClassOf </span>Small Bowel Ulcer Adverse Event NOS. <br><i>New Terms: CTCAE Grade 3 Small Bowel Ulcer NOS, Small Bowel Ulcer Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>2992</td>
               <td colspan="2">CTCAE Grade 3 Soft Tissue Infection NOS Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Soft Tissue Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Soft Tissue Infection NOS Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, Soft Tissue Infection NOS Adverse Event Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2993</td>
               <td colspan="2">CTCAE Grade 3 Soft Tissue Infection NOS with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Soft Tissue Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Soft Tissue Infection NOS with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, Soft Tissue Infection NOS Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>2994</td>
               <td colspan="2">CTCAE Grade 3 Soft Tissue Infection NOS with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Soft Tissue Infection NOS Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Soft Tissue Infection NOS with Unknown Absolute Neutrophil Count, Soft
                     Tissue Infection NOS Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>2995</td>
               <td colspan="2">CTCAE Grade 3 Soft Tissue NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Soft Tissue NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: Soft Tissue NOS Intra-Operative Injury Adverse Event, CTCAE Grade 3 Soft Tissue NOS
                     Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2996</td>
               <td colspan="2">CTCAE Grade 3 Somnolence<br><span class="keyword"> and </span>Depressed Level of Consciousness<span class="subclass"> SubClassOf </span>Somnolence<br><span class="keyword"> and </span>Depressed Level of Consciousness Adverse Event. <br><i>New Terms: Somnolence and Depressed Level of Consciousness Adverse Event, CTCAE Grade 3 Somnolence
                     and Depressed Level of Consciousness</i></td>
            </tr>
            <tr class="addition">
               <td>2997</td>
               <td colspan="2">CTCAE Grade 3 Speech Impairment<span class="subclass"> SubClassOf </span>Speech Impairment Adverse Event. <br><i>New Terms: Speech Impairment Adverse Event, CTCAE Grade 3 Speech Impairment</i></td>
            </tr>
            <tr class="addition">
               <td>2998</td>
               <td colspan="2">CTCAE Grade 3 Spermatic Cord Hemorrhage<span class="subclass"> SubClassOf </span>Spermatic Cord Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 3 Spermatic Cord Hemorrhage, Spermatic Cord Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>2999</td>
               <td colspan="2">CTCAE Grade 3 Spermatic Cord Leak<span class="subclass"> SubClassOf </span>Spermatic Cord Leak Adverse Event. <br><i>New Terms: CTCAE Grade 3 Spermatic Cord Leak, Spermatic Cord Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3000</td>
               <td colspan="2">CTCAE Grade 3 Spermatic Cord Obstruction<span class="subclass"> SubClassOf </span>Spermatic Cord Obstruction Adverse Event. <br><i>New Terms: Spermatic Cord Obstruction Adverse Event, CTCAE Grade 3 Spermatic Cord Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>3001</td>
               <td colspan="2">CTCAE Grade 3 Spermatic Cord Perforation<span class="subclass"> SubClassOf </span>Spermatic Cord Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 3 Spermatic Cord Perforation, Spermatic Cord Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3002</td>
               <td colspan="2">CTCAE Grade 3 Spermatic Cord Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Spermatic Cord Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Spermatic Cord Stricture or Stenosis, Spermatic Cord Stricture or Stenosis
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3003</td>
               <td colspan="2">CTCAE Grade 3 Spinal Cord Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Spinal Cord Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Spinal Cord Infection Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, Spinal Cord Infection Adverse Event Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3004</td>
               <td colspan="2">CTCAE Grade 3 Spinal Cord Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Spinal Cord Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Spinal Cord Infection with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, Spinal Cord Infection Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3005</td>
               <td colspan="2">CTCAE Grade 3 Spinal Cord Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Spinal Cord Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Spinal Cord Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE
                     Grade 3 Spinal Cord Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3006</td>
               <td colspan="2">CTCAE Grade 3 Spinal Cord Intra-Operative Injury<span class="subclass"> SubClassOf </span>Spinal Cord Intra-Operative Injury Adverse Event. <br><i>New Terms: Spinal Cord Intra-Operative Injury Adverse Event, CTCAE Grade 3 Spinal Cord Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3007</td>
               <td colspan="2">CTCAE Grade 3 Spine Kyphosis<br><span class="keyword"> or </span>Lordosis<span class="subclass"> SubClassOf </span>Spine Kyphosis<br><span class="keyword"> or </span>Lordosis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Spine Kyphosis or Lordosis, Spine Kyphosis or Lordosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3008</td>
               <td colspan="2">CTCAE Grade 3 Spine Scoliosis<span class="subclass"> SubClassOf </span>Spine Scoliosis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Spine Scoliosis, Spine Scoliosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3009</td>
               <td colspan="2">CTCAE Grade 3 Spleen Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Spleen Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Spleen Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 3 Spleen Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3010</td>
               <td colspan="2">CTCAE Grade 3 Spleen Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Spleen Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Spleen Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 3 Spleen Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3011</td>
               <td colspan="2">CTCAE Grade 3 Spleen Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Spleen Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Spleen Infection with Unknown Absolute Neutrophil Count, Spleen Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3012</td>
               <td colspan="2">CTCAE Grade 3 Spleen Intra-Operative Injury<span class="subclass"> SubClassOf </span>Spleen Intra-Operative Injury Adverse Event. <br><i>New Terms: Spleen Intra-Operative Injury Adverse Event, CTCAE Grade 3 Spleen Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3013</td>
               <td colspan="2">CTCAE Grade 3 Stokes-Adams Syndrome<span class="subclass"> SubClassOf </span>Stokes-Adams Syndrome Adverse Event. <br><i>New Terms: CTCAE Grade 3 Stokes-Adams Syndrome, Stokes-Adams Syndrome Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3014</td>
               <td colspan="2">CTCAE Grade 3 Stoma GI Obstruction<span class="subclass"> SubClassOf </span>Gastrointestinal Stoma Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 3 Stoma GI Obstruction, Gastrointestinal Stoma Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3015</td>
               <td colspan="2">CTCAE Grade 3 Stoma GI Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Stoma GI Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Stoma GI Stricture or Stenosis Adverse Event, CTCAE Grade 3 Stoma GI Stricture or
                     Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>3016</td>
               <td colspan="2">CTCAE Grade 3 Stoma Necrosis<span class="subclass"> SubClassOf </span>Stoma Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Stoma Necrosis, Stoma Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3017</td>
               <td colspan="2">CTCAE Grade 3 Stoma Perforation<span class="subclass"> SubClassOf </span>Stoma Perforation Adverse Event. <br><i>New Terms: Stoma Perforation Adverse Event, CTCAE Grade 3 Stoma Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>3018</td>
               <td colspan="2">CTCAE Grade 3 Stoma Pulmonary Hemorrhage<span class="subclass"> SubClassOf </span>Pulmonary Stoma Hemorrhage Adverse Event. <br><i>New Terms: Pulmonary Stoma Hemorrhage Adverse Event, CTCAE Grade 3 Stoma Pulmonary Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>3019</td>
               <td colspan="2">CTCAE Grade 3 Stoma Ulcer<span class="subclass"> SubClassOf </span>Stoma Ulcer Adverse Event. <br><i>New Terms: Stoma Ulcer Adverse Event, CTCAE Grade 3 Stoma Ulcer</i></td>
            </tr>
            <tr class="addition">
               <td>3020</td>
               <td colspan="2">CTCAE Grade 3 Stomach Fistula<span class="subclass"> SubClassOf </span>Stomach Fistula Adverse Event. <br><i>New Terms: Stomach Fistula Adverse Event, CTCAE Grade 3 Stomach Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>3021</td>
               <td colspan="2">CTCAE Grade 3 Stomach Hemorrhage<span class="subclass"> SubClassOf </span>Stomach Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 3 Stomach Hemorrhage, Stomach Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3022</td>
               <td colspan="2">CTCAE Grade 3 Stomach Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Stomach Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Stomach Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Stomach Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3023</td>
               <td colspan="2">CTCAE Grade 3 Stomach Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Stomach Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Stomach Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Stomach Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3024</td>
               <td colspan="2">CTCAE Grade 3 Stomach Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Stomach Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Stomach Infection with Unknown Absolute Neutrophil Count, Stomach Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3025</td>
               <td colspan="2">CTCAE Grade 3 Stomach Intra-Operative Injury<span class="subclass"> SubClassOf </span>Stomach Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Stomach Intra-Operative Injury, Stomach Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>3026</td>
               <td colspan="2">CTCAE Grade 3 Stomach Leak<span class="subclass"> SubClassOf </span>Stomach Leak Adverse Event. <br><i>New Terms: Stomach Leak Adverse Event, CTCAE Grade 3 Stomach Leak</i></td>
            </tr>
            <tr class="addition">
               <td>3027</td>
               <td colspan="2">CTCAE Grade 3 Stomach Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Stomach Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification. <br><i>New Terms: CTCAE Grade 3 Stomach Mucositis or Stomatitis by Clinical Examination Classification,
                     Stomach Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>3028</td>
               <td colspan="2">CTCAE Grade 3 Stomach Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Stomach Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: Stomach Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification,
                     CTCAE Grade 3 Stomach Mucositis or Stomatitis by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>3029</td>
               <td colspan="2">CTCAE Grade 3 Stomach Necrosis<span class="subclass"> SubClassOf </span>Stomach Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Stomach Necrosis, Stomach Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3030</td>
               <td colspan="2">CTCAE Grade 3 Stomach Obstruction<span class="subclass"> SubClassOf </span>Stomach Obstruction Adverse Event. <br><i>New Terms: Stomach Obstruction Adverse Event, CTCAE Grade 3 Stomach Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>3031</td>
               <td colspan="2">CTCAE Grade 3 Stomach Pain<span class="subclass"> SubClassOf </span>Stomach Pain Adverse Event. <br><i>New Terms: Stomach Pain Adverse Event, CTCAE Grade 3 Stomach Pain</i></td>
            </tr>
            <tr class="addition">
               <td>3032</td>
               <td colspan="2">CTCAE Grade 3 Stomach Perforation<span class="subclass"> SubClassOf </span>Stomach Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 3 Stomach Perforation, Stomach Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3033</td>
               <td colspan="2">CTCAE Grade 3 Stomach Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Stomach Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Stomach Stricture or Stenosis, Stomach Stricture or Stenosis Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>3034</td>
               <td colspan="2">CTCAE Grade 3 Stomach Ulcer<span class="subclass"> SubClassOf </span>Stomach Ulcer Adverse Event. <br><i>New Terms: Stomach Ulcer Adverse Event, CTCAE Grade 3 Stomach Ulcer</i></td>
            </tr>
            <tr class="addition">
               <td>3035</td>
               <td colspan="2">CTCAE Grade 3 Superior Vena Cava Intra-Operative Injury<span class="subclass"> SubClassOf </span>Superior Vena Cava Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Superior Vena Cava Intra-Operative Injury, Superior Vena Cava Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3036</td>
               <td colspan="2">CTCAE Grade 3 Superior Vena Cava Vein Injury<span class="subclass"> SubClassOf </span>Superior Vena Cava Vein Injury Adverse Event. <br><i>New Terms: Superior Vena Cava Vein Injury Adverse Event, CTCAE Grade 3 Superior Vena Cava Vein
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3037</td>
               <td colspan="2">CTCAE Grade 3 Supraventricular Arrhythmia NOS<span class="subclass"> SubClassOf </span>Supraventricular Arrhythmia Adverse Event NOS. <br><i>New Terms: CTCAE Grade 3 Supraventricular Arrhythmia NOS, Supraventricular Arrhythmia Adverse
                     Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>3038</td>
               <td colspan="2">CTCAE Grade 3 Supraventricular Extrasystoles<span class="subclass"> SubClassOf </span>Supraventricular Extrasystoles Adverse Event. <br><i>New Terms: CTCAE Grade 3 Supraventricular Extrasystoles, Supraventricular Extrasystoles Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>3039</td>
               <td colspan="2">CTCAE Grade 3 Supraventricular Tachycardia<span class="subclass"> SubClassOf </span>Supraventricular Tachycardia Adverse Event. <br><i>New Terms: CTCAE Grade 3 Supraventricular Tachycardia, Supraventricular Tachycardia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3040</td>
               <td colspan="2">CTCAE Grade 3 Syncope<span class="subclass"> SubClassOf </span>Syncope Adverse Event. <br><i>New Terms: CTCAE Grade 3 Syncope, Syncope Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3041</td>
               <td colspan="2">CTCAE Grade 3 Teeth Intra-Operative Injury<span class="subclass"> SubClassOf </span>Teeth Intra-Operative Injury Adverse Event. <br><i>New Terms: Teeth Intra-Operative Injury Adverse Event, CTCAE Grade 3 Teeth Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3042</td>
               <td colspan="2">CTCAE Grade 3 Telangiectasia<span class="subclass"> SubClassOf </span>Telangiectasia Adverse Event. <br><i>New Terms: CTCAE Grade 3 Telangiectasia, Telangiectasia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3043</td>
               <td colspan="2">CTCAE Grade 3 Tendon Intra-Operative Injury<span class="subclass"> SubClassOf </span>Tendon Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Tendon Intra-Operative Injury, Tendon Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>3044</td>
               <td colspan="2">CTCAE Grade 3 Testes Hemorrhage<span class="subclass"> SubClassOf </span>Testes Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 3 Testes Hemorrhage, Testes Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3045</td>
               <td colspan="2">CTCAE Grade 3 Testes Obstruction<span class="subclass"> SubClassOf </span>Testes Obstruction Adverse Event. <br><i>New Terms: Testes Obstruction Adverse Event, CTCAE Grade 3 Testes Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>3046</td>
               <td colspan="2">CTCAE Grade 3 Testes Perforation<span class="subclass"> SubClassOf </span>Testes Perforation Adverse Event. <br><i>New Terms: Testes Perforation Adverse Event, CTCAE Grade 3 Testes Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>3047</td>
               <td colspan="2">CTCAE Grade 3 Testes Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Testes Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Testes Stricture or Stenosis, Testes Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3048</td>
               <td colspan="2">CTCAE Grade 3 Testicle Pain<span class="subclass"> SubClassOf </span>Testicle Pain Adverse Event. <br><i>New Terms: CTCAE Grade 3 Testicle Pain, Testicle Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3049</td>
               <td colspan="2">CTCAE Grade 3 Testis Intra-Operative Injury<span class="subclass"> SubClassOf </span>Testis Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Testis Intra-Operative Injury, Testis Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>3050</td>
               <td colspan="2">CTCAE Grade 3 Thoracic Duct Intra-Operative Injury<span class="subclass"> SubClassOf </span>Thoracic Duct Intra-Operative Injury Adverse Event. <br><i>New Terms: Thoracic Duct Intra-Operative Injury Adverse Event, CTCAE Grade 3 Thoracic Duct Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3051</td>
               <td colspan="2">CTCAE Grade 3 Thoracodorsal Nerve Intra-Operative Injury<span class="subclass"> SubClassOf </span>Thoracodorsal Nerve Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Thoracodorsal Nerve Intra-Operative Injury, Thoracodorsal Nerve Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3052</td>
               <td colspan="2">CTCAE Grade 3 Thorax Soft Tissue Necrosis<span class="subclass"> SubClassOf </span>Thorax Soft Tissue Necrosis Adverse Event. <br><i>New Terms: Thorax Soft Tissue Necrosis Adverse Event, CTCAE Grade 3 Thorax Soft Tissue Necrosis</i></td>
            </tr>
            <tr class="addition">
               <td>3053</td>
               <td colspan="2">CTCAE Grade 3 Throat<br><span class="keyword"> and </span>Pharynx<br><span class="keyword"> and </span>Larynx Pain<span class="subclass"> SubClassOf </span>Throat<br><span class="keyword"> and </span>Pharynx<br><span class="keyword"> and </span>Larynx Pain Adverse Event. <br><i>New Terms: CTCAE Grade 3 Throat and Pharynx and Larynx Pain, Throat and Pharynx and Larynx Pain
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3054</td>
               <td colspan="2">CTCAE Grade 3 Thrombosis<br><span class="keyword"> or </span>Embolism Vascular Access Related<span class="subclass"> SubClassOf </span>Thrombosis<br><span class="keyword"> or </span>Embolism Vascular Access Related Adverse Event. <br><i>New Terms: CTCAE Grade 3 Thrombosis or Embolism Vascular Access Related, Thrombosis or Embolism
                     Vascular Access Related Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3055</td>
               <td colspan="2">CTCAE Grade 3 Thrombosis<br><span class="keyword"> or </span>Thrombus<br><span class="keyword"> or </span>Embolism<span class="subclass"> SubClassOf </span>Thrombosis<br><span class="keyword"> or </span>Thrombus<br><span class="keyword"> or </span>Embolism Adverse Event. <br><i>New Terms: CTCAE Grade 3 Thrombosis or Thrombus or Embolism, Thrombosis or Thrombus or Embolism
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3056</td>
               <td colspan="2">CTCAE Grade 3 Thrombotic Microangiopathy<span class="subclass"> SubClassOf </span>Thrombotic Microangiopathy Adverse Event. <br><i>New Terms: Thrombotic Microangiopathy Adverse Event, CTCAE Grade 3 Thrombotic Microangiopathy</i></td>
            </tr>
            <tr class="addition">
               <td>3057</td>
               <td colspan="2">CTCAE Grade 3 Thyroid Function High<span class="subclass"> SubClassOf </span>Thyroid Function High Adverse Event. <br><i>New Terms: CTCAE Grade 3 Thyroid Function High, Thyroid Function High Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3058</td>
               <td colspan="2">CTCAE Grade 3 Thyroid Function Low<span class="subclass"> SubClassOf </span>Thyroid Function Low Adverse Event. <br><i>New Terms: CTCAE Grade 3 Thyroid Function Low, Thyroid Function Low Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3059</td>
               <td colspan="2">CTCAE Grade 3 Thyroid Intra-Operative Injury<span class="subclass"> SubClassOf </span>Thyroid Intra-Operative Injury Adverse Event. <br><i>New Terms: Thyroid Intra-Operative Injury Adverse Event, CTCAE Grade 3 Thyroid Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3060</td>
               <td colspan="2">CTCAE Grade 3 Tinnitus<span class="subclass"> SubClassOf </span>Tinnitus Adverse Event. <br><i>New Terms: Tinnitus Adverse Event, CTCAE Grade 3 Tinnitus</i></td>
            </tr>
            <tr class="addition">
               <td>3061</td>
               <td colspan="2">CTCAE Grade 3 Tongue Intra-Operative Injury<span class="subclass"> SubClassOf </span>Tongue Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Tongue Intra-Operative Injury, Tongue Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>3062</td>
               <td colspan="2">CTCAE Grade 3 Tooth Development<span class="subclass"> SubClassOf </span>Tooth Development Adverse Event. <br><i>New Terms: CTCAE Grade 3 Tooth Development, Tooth Development Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3063</td>
               <td colspan="2">CTCAE Grade 3 Torsade de Pointes<span class="subclass"> SubClassOf </span>Torsade de Pointes Adverse Event. <br><i>New Terms: CTCAE Grade 3 Torsade de Pointes, Torsade de Pointes Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3064</td>
               <td colspan="2">CTCAE Grade 3 Trachea Fistula<span class="subclass"> SubClassOf </span>Trachea Fistula Adverse Event. <br><i>New Terms: Trachea Fistula Adverse Event, CTCAE Grade 3 Trachea Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>3065</td>
               <td colspan="2">CTCAE Grade 3 Trachea Hemorrhage<span class="subclass"> SubClassOf </span>Trachea Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 3 Trachea Hemorrhage, Trachea Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3066</td>
               <td colspan="2">CTCAE Grade 3 Trachea Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Trachea Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Trachea Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 3 Trachea Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3067</td>
               <td colspan="2">CTCAE Grade 3 Trachea Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Trachea Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Trachea Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 3 Trachea Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3068</td>
               <td colspan="2">CTCAE Grade 3 Trachea Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Trachea Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Trachea Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     3 Trachea Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3069</td>
               <td colspan="2">CTCAE Grade 3 Trachea Intra-Operative Injury<span class="subclass"> SubClassOf </span>Trachea Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Trachea Intra-Operative Injury, Trachea Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>3070</td>
               <td colspan="2">CTCAE Grade 3 Trachea Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Trachea Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification. <br><i>New Terms: Trachea Mucositis or Stomatitis by Clinical Examination Classification, CTCAE Grade
                     3 Trachea Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>3071</td>
               <td colspan="2">CTCAE Grade 3 Trachea Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Trachea Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: Trachea Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification,
                     CTCAE Grade 3 Trachea Mucositis or Stomatitis by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>3072</td>
               <td colspan="2">CTCAE Grade 3 Trachea Obstruction<br><span class="keyword"> and </span>Stenosis<span class="subclass"> SubClassOf </span>Trachea Obstruction<br><span class="keyword"> and </span>Stenosis Adverse Event. <br><i>New Terms: Trachea Obstruction and Stenosis Adverse Event, CTCAE Grade 3 Trachea Obstruction
                     and Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>3073</td>
               <td colspan="2">CTCAE Grade 3 Tremor<span class="subclass"> SubClassOf </span>Tremor Adverse Event. <br><i>New Terms: Tremor Adverse Event, CTCAE Grade 3 Tremor</i></td>
            </tr>
            <tr class="addition">
               <td>3074</td>
               <td colspan="2">CTCAE Grade 3 Trigeminy<span class="subclass"> SubClassOf </span>Trigeminy Adverse Event. <br><i>New Terms: CTCAE Grade 3 Trigeminy, Trigeminy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3075</td>
               <td colspan="2">CTCAE Grade 3 Trismus<span class="subclass"> SubClassOf </span>Trismus Adverse Event. <br><i>New Terms: CTCAE Grade 3 Trismus, Trismus Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3076</td>
               <td colspan="2">CTCAE Grade 3 Trunk Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Trunk Muscle Weakness Not Due to Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 3 Trunk Muscle Weakness Not Due to Neuropathy, Trunk Muscle Weakness Not
                     Due to Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3077</td>
               <td colspan="2">CTCAE Grade 3 Tumor Flare<span class="subclass"> SubClassOf </span>Tumor Flare Adverse Event. <br><i>New Terms: CTCAE Grade 3 Tumor Flare, Tumor Flare Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3078</td>
               <td colspan="2">CTCAE Grade 3 Tumor Lysis Syndrome<span class="subclass"> SubClassOf </span>Tumor Lysis Syndrome Adverse Event. <br><i>New Terms: CTCAE Grade 3 Tumor Lysis Syndrome, Tumor Lysis Syndrome Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3079</td>
               <td colspan="2">CTCAE Grade 3 Tumor Pain<span class="subclass"> SubClassOf </span>Tumor Pain Adverse Event. <br><i>New Terms: CTCAE Grade 3 Tumor Pain, Tumor Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3080</td>
               <td colspan="2">CTCAE Grade 3 Typhlitis<span class="subclass"> SubClassOf </span>Typhlitis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Typhlitis, Typhlitis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3081</td>
               <td colspan="2">CTCAE Grade 3 Ulceration<span class="subclass"> SubClassOf </span>Ulceration Adverse Event. <br><i>New Terms: Ulceration Adverse Event, CTCAE Grade 3 Ulceration</i></td>
            </tr>
            <tr class="addition">
               <td>3082</td>
               <td colspan="2">CTCAE Grade 3 Ungual Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Ungual Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Ungual Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 3 Ungual Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3083</td>
               <td colspan="2">CTCAE Grade 3 Ungual Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Ungual Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Ungual Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 3 Ungual Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3084</td>
               <td colspan="2">CTCAE Grade 3 Ungual Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Ungual Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Ungual Infection with Unknown Absolute Neutrophil Count, Ungual Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3085</td>
               <td colspan="2">CTCAE Grade 3 Upper Aerodigestive Infection NOS Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Upper Aerodigestive Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Upper Aerodigestive Infection NOS Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, CTCAE Grade 3 Upper Aerodigestive Infection NOS Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3086</td>
               <td colspan="2">CTCAE Grade 3 Upper Aerodigestive Infection NOS with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Upper Aerodigestive Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Upper Aerodigestive Infection NOS with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils, Upper Aerodigestive Infection NOS Adverse Event with
                     Normal Absolute Neutrophil Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3087</td>
               <td colspan="2">CTCAE Grade 3 Upper Aerodigestive Infection NOS with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Upper Aerodigestive Infection NOS Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Upper Aerodigestive Infection NOS with Unknown Absolute Neutrophil Count,
                     Upper Aerodigestive Infection NOS Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3088</td>
               <td colspan="2">CTCAE Grade 3 Upper Aerodigestive NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Upper Aerodigestive NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: Upper Aerodigestive NOS Intra-Operative Injury Adverse Event, CTCAE Grade 3 Upper
                     Aerodigestive NOS Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3089</td>
               <td colspan="2">CTCAE Grade 3 Upper Airway Infection NOS Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Upper Airway Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Upper Airway Infection NOS Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, Upper Airway Infection NOS Adverse Event Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3090</td>
               <td colspan="2">CTCAE Grade 3 Upper Airway Infection NOS with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Upper Airway Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Upper Airway Infection NOS with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils, Upper Airway Infection NOS Adverse Event with Normal Absolute
                     Neutrophil Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3091</td>
               <td colspan="2">CTCAE Grade 3 Upper Airway Infection NOS with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Upper Airway Infection NOS Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Upper Airway Infection NOS with Unknown Absolute Neutrophil Count, Upper
                     Airway Infection NOS Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3092</td>
               <td colspan="2">CTCAE Grade 3 Upper Airway NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Upper Airway NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: Upper Airway NOS Intra-Operative Injury Adverse Event, CTCAE Grade 3 Upper Airway
                     NOS Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3093</td>
               <td colspan="2">CTCAE Grade 3 Upper Extremity Artery Injury<span class="subclass"> SubClassOf </span>Upper Extremity Artery Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Upper Extremity Artery Injury, Upper Extremity Artery Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>3094</td>
               <td colspan="2">CTCAE Grade 3 Upper Extremity Artery Intra-Operative Injury<span class="subclass"> SubClassOf </span>Upper Extremity Artery Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Upper Extremity Artery Intra-Operative Injury, Upper Extremity Artery
                     Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3095</td>
               <td colspan="2">CTCAE Grade 3 Upper Extremity Function<span class="subclass"> SubClassOf </span>Upper Extremity Function Adverse Event. <br><i>New Terms: CTCAE Grade 3 Upper Extremity Function, Upper Extremity Function Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3096</td>
               <td colspan="2">CTCAE Grade 3 Upper Extremity Intra-Operative Injury<span class="subclass"> SubClassOf </span>Upper Extremity Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Upper Extremity Intra-Operative Injury, Upper Extremity Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3097</td>
               <td colspan="2">CTCAE Grade 3 Upper Extremity Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Upper Extremity Muscle Weakness Adverse Event Not Due to Neuropathy. <br><i>New Terms: Upper Extremity Muscle Weakness Adverse Event Not Due to Neuropathy, CTCAE Grade 3
                     Upper Extremity Muscle Weakness Not Due to Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>3098</td>
               <td colspan="2">CTCAE Grade 3 Upper Extremity Soft Tissue Necrosis Adverse Event<span class="subclass"> SubClassOf </span>Upper Extremity Soft Tissue Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Upper Extremity Soft Tissue Necrosis Adverse Event, Upper Extremity
                     Soft Tissue Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3099</td>
               <td colspan="2">CTCAE Grade 3 Upper Extremity Vein Injury<span class="subclass"> SubClassOf </span>Upper Extremity Vein Injury Adverse Event. <br><i>New Terms: Upper Extremity Vein Injury Adverse Event, CTCAE Grade 3 Upper Extremity Vein Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3100</td>
               <td colspan="2">CTCAE Grade 3 Upper Extremity Vein Intra-Operative Injury<span class="subclass"> SubClassOf </span>Upper Extremity Vein Intra-Operative Injury Adverse Event. <br><i>New Terms: Upper Extremity Vein Intra-Operative Injury Adverse Event, CTCAE Grade 3 Upper Extremity
                     Vein Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3101</td>
               <td colspan="2">CTCAE Grade 3 Upper Gastrointestinal Hemorrhage NOS<span class="subclass"> SubClassOf </span>Upper Gastrointestinal Hemorrhage Adverse Event NOS. <br><i>New Terms: Upper Gastrointestinal Hemorrhage Adverse Event NOS, CTCAE Grade 3 Upper Gastrointestinal
                     Hemorrhage NOS</i></td>
            </tr>
            <tr class="addition">
               <td>3102</td>
               <td colspan="2">CTCAE Grade 3 Ureter Fistula<span class="subclass"> SubClassOf </span>Ureter Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 3 Ureter Fistula, Ureter Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3103</td>
               <td colspan="2">CTCAE Grade 3 Ureter Hemorrhage<span class="subclass"> SubClassOf </span>Ureter Hemorrhage Adverse Event. <br><i>New Terms: Ureter Hemorrhage Adverse Event, CTCAE Grade 3 Ureter Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>3104</td>
               <td colspan="2">CTCAE Grade 3 Ureter Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Ureter Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Ureter Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 3 Ureter Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3105</td>
               <td colspan="2">CTCAE Grade 3 Ureter Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Ureter Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Ureter Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 3 Ureter Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3106</td>
               <td colspan="2">CTCAE Grade 3 Ureter Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Ureter Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Ureter Infection with Unknown Absolute Neutrophil Count, Ureter Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3107</td>
               <td colspan="2">CTCAE Grade 3 Ureter Intra-Operative Injury<span class="subclass"> SubClassOf </span>Ureter Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Ureter Intra-Operative Injury, Ureter Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>3108</td>
               <td colspan="2">CTCAE Grade 3 Ureter Leak<span class="subclass"> SubClassOf </span>Ureter Leak Adverse Event. <br><i>New Terms: CTCAE Grade 3 Ureter Leak, Ureter Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3109</td>
               <td colspan="2">CTCAE Grade 3 Ureter Obstruction<span class="subclass"> SubClassOf </span>Ureter Obstruction Adverse Event. <br><i>New Terms: Ureter Obstruction Adverse Event, CTCAE Grade 3 Ureter Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>3110</td>
               <td colspan="2">CTCAE Grade 3 Ureter Perforation<span class="subclass"> SubClassOf </span>Ureter Perforation Adverse Event. <br><i>New Terms: Ureter Perforation Adverse Event, CTCAE Grade 3 Ureter Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>3111</td>
               <td colspan="2">CTCAE Grade 3 Ureter Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Ureter Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Ureter Stricture or Stenosis Adverse Event, CTCAE Grade 3 Ureter Stricture or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>3112</td>
               <td colspan="2">CTCAE Grade 3 Urethra Fistula<span class="subclass"> SubClassOf </span>Urethra Fistula Adverse Event. <br><i>New Terms: Urethra Fistula Adverse Event, CTCAE Grade 3 Urethra Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>3113</td>
               <td colspan="2">CTCAE Grade 3 Urethra Hemorrhage<span class="subclass"> SubClassOf </span>Urethra Hemorrhage Adverse Event. <br><i>New Terms: Urethra Hemorrhage Adverse Event, CTCAE Grade 3 Urethra Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>3114</td>
               <td colspan="2">CTCAE Grade 3 Urethra Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Urethra Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Urethra Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Urethra Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3115</td>
               <td colspan="2">CTCAE Grade 3 Urethra Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Urethra Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Urethra Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Urethra Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3116</td>
               <td colspan="2">CTCAE Grade 3 Urethra Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Urethra Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Urethra Infection with Unknown Absolute Neutrophil Count, Urethra Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3117</td>
               <td colspan="2">CTCAE Grade 3 Urethra Intra-Operative Injury<span class="subclass"> SubClassOf </span>Urethra Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Urethra Intra-Operative Injury, Urethra Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>3118</td>
               <td colspan="2">CTCAE Grade 3 Urethra Leak<span class="subclass"> SubClassOf </span>Urethra Leak Adverse Event. <br><i>New Terms: CTCAE Grade 3 Urethra Leak, Urethra Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3119</td>
               <td colspan="2">CTCAE Grade 3 Urethra Obstruction<span class="subclass"> SubClassOf </span>Urethra Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 3 Urethra Obstruction, Urethra Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3120</td>
               <td colspan="2">CTCAE Grade 3 Urethra Pain<span class="subclass"> SubClassOf </span>Urethra Pain Adverse Event. <br><i>New Terms: CTCAE Grade 3 Urethra Pain, Urethra Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3121</td>
               <td colspan="2">CTCAE Grade 3 Urethra Perforation<span class="subclass"> SubClassOf </span>Urethra Perforation Adverse Event. <br><i>New Terms: Urethra Perforation Adverse Event, CTCAE Grade 3 Urethra Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>3122</td>
               <td colspan="2">CTCAE Grade 3 Urethra Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Urethra Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Urethra Stricture or Stenosis, Urethra Stricture or Stenosis Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>3123</td>
               <td colspan="2">CTCAE Grade 3 Urinary Conduit Intra-Operative Injury<span class="subclass"> SubClassOf </span>Urinary Conduit Intra-Operative Injury Adverse Event. <br><i>New Terms: Urinary Conduit Intra-Operative Injury Adverse Event, CTCAE Grade 3 Urinary Conduit
                     Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3124</td>
               <td colspan="2">CTCAE Grade 3 Urinary Electrolyte Wasting<span class="subclass"> SubClassOf </span>Urinary Electrolyte Wasting Adverse Event. <br><i>New Terms: Urinary Electrolyte Wasting Adverse Event, CTCAE Grade 3 Urinary Electrolyte Wasting</i></td>
            </tr>
            <tr class="addition">
               <td>3125</td>
               <td colspan="2">CTCAE Grade 3 Urinary Frequency<br><span class="keyword"> or </span>Urgency<span class="subclass"> SubClassOf </span>Urinary Frequency<br><span class="keyword"> or </span>Urgency Adverse Event. <br><i>New Terms: CTCAE Grade 3 Urinary Frequency or Urgency, Urinary Frequency or Urgency Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3126</td>
               <td colspan="2">CTCAE Grade 3 Urinary Hemorrhage NOS<span class="subclass"> SubClassOf </span>Urinary Hemorrhage Adverse Event NOS. <br><i>New Terms: CTCAE Grade 3 Urinary Hemorrhage NOS, Urinary Hemorrhage Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>3127</td>
               <td colspan="2">CTCAE Grade 3 Urinary Incontinence<span class="subclass"> SubClassOf </span>Urinary Incontinence Adverse Event. <br><i>New Terms: CTCAE Grade 3 Urinary Incontinence, Urinary Incontinence Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3128</td>
               <td colspan="2">CTCAE Grade 3 Urinary Retention<span class="subclass"> SubClassOf </span>Urinary Retention Adverse Event. <br><i>New Terms: CTCAE Grade 3 Urinary Retention, Urinary Retention Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3129</td>
               <td colspan="2">CTCAE Grade 3 Urinary Tract Infection NOS Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Urinary Tract Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Urinary Tract Infection NOS Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, CTCAE Grade 3 Urinary Tract Infection NOS Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3130</td>
               <td colspan="2">CTCAE Grade 3 Urinary Tract Infection NOS with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Urinary Tract Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Urinary Tract Infection NOS Adverse Event with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils, CTCAE Grade 3 Urinary Tract Infection NOS with Normal Absolute
                     Neutrophil Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3131</td>
               <td colspan="2">CTCAE Grade 3 Urinary Tract Infection NOS with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Urinary Tract Infection NOS Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Urinary Tract Infection NOS with Unknown Absolute Neutrophil Count,
                     Urinary Tract Infection NOS Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3132</td>
               <td colspan="2">CTCAE Grade 3 Urinary Tract NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Urinary Tract NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: Urinary Tract NOS Intra-Operative Injury Adverse Event, CTCAE Grade 3 Urinary Tract
                     NOS Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3133</td>
               <td colspan="2">CTCAE Grade 3 Urticaria<span class="subclass"> SubClassOf </span>Urticaria Adverse Reaction. <br><i>New Terms: Urticaria Adverse Reaction, CTCAE Grade 3 Urticaria</i></td>
            </tr>
            <tr class="addition">
               <td>3134</td>
               <td colspan="2">CTCAE Grade 3 Uterus Fistula<span class="subclass"> SubClassOf </span>Uterus Fistula Adverse Event. <br><i>New Terms: Uterus Fistula Adverse Event, CTCAE Grade 3 Uterus Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>3135</td>
               <td colspan="2">CTCAE Grade 3 Uterus Hemorrhage<span class="subclass"> SubClassOf </span>Uterus Hemorrhage Adverse Event. <br><i>New Terms: Uterus Hemorrhage Adverse Event, CTCAE Grade 3 Uterus Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>3136</td>
               <td colspan="2">CTCAE Grade 3 Uterus Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Uterus Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Uterus Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 3 Uterus Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3137</td>
               <td colspan="2">CTCAE Grade 3 Uterus Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Uterus Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Uterus Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Uterus Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3138</td>
               <td colspan="2">CTCAE Grade 3 Uterus Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Uterus Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Uterus Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     3 Uterus Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3139</td>
               <td colspan="2">CTCAE Grade 3 Uterus Intra-Operative Injury<span class="subclass"> SubClassOf </span>Uterus Intra-Operative Injury Adverse Event. <br><i>New Terms: Uterus Intra-Operative Injury Adverse Event, CTCAE Grade 3 Uterus Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3140</td>
               <td colspan="2">CTCAE Grade 3 Uterus Leak<span class="subclass"> SubClassOf </span>Uterus Leak Adverse Event. <br><i>New Terms: CTCAE Grade 3 Uterus Leak, Uterus Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3141</td>
               <td colspan="2">CTCAE Grade 3 Uterus Obstruction<span class="subclass"> SubClassOf </span>Uterus Obstruction Adverse Event. <br><i>New Terms: Uterus Obstruction Adverse Event, CTCAE Grade 3 Uterus Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>3142</td>
               <td colspan="2">CTCAE Grade 3 Uterus Pain<span class="subclass"> SubClassOf </span>Uterus Pain Adverse Event. <br><i>New Terms: CTCAE Grade 3 Uterus Pain, Uterus Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3143</td>
               <td colspan="2">CTCAE Grade 3 Uterus Perforation<span class="subclass"> SubClassOf </span>Uterus Perforation Adverse Event. <br><i>New Terms: Uterus Perforation Adverse Event, CTCAE Grade 3 Uterus Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>3144</td>
               <td colspan="2">CTCAE Grade 3 Uterus Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Uterus Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Uterus Stricture or Stenosis Adverse Event, CTCAE Grade 3 Uterus Stricture or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>3145</td>
               <td colspan="2">CTCAE Grade 3 Uveitis<span class="subclass"> SubClassOf </span>Uveitis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Uveitis, Uveitis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3146</td>
               <td colspan="2">CTCAE Grade 3 Vagina Fistula<span class="subclass"> SubClassOf </span>Vagina Fistula Adverse Event. <br><i>New Terms: Vagina Fistula Adverse Event, CTCAE Grade 3 Vagina Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>3147</td>
               <td colspan="2">CTCAE Grade 3 Vagina Hemorrhage<span class="subclass"> SubClassOf </span>Vagina Hemorrhage Adverse Event. <br><i>New Terms: Vagina Hemorrhage Adverse Event, CTCAE Grade 3 Vagina Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>3148</td>
               <td colspan="2">CTCAE Grade 3 Vagina Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Vagina Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Vagina Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Vagina Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3149</td>
               <td colspan="2">CTCAE Grade 3 Vagina Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Vagina Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Vagina Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Vagina Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3150</td>
               <td colspan="2">CTCAE Grade 3 Vagina Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Vagina Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Vagina Infection with Unknown Absolute Neutrophil Count, Vagina Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3151</td>
               <td colspan="2">CTCAE Grade 3 Vagina Intra-Operative Injury<span class="subclass"> SubClassOf </span>Vagina Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Vagina Intra-Operative Injury, Vagina Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>3152</td>
               <td colspan="2">CTCAE Grade 3 Vagina Leak<span class="subclass"> SubClassOf </span>Vagina Leak Adverse Event. <br><i>New Terms: CTCAE Grade 3 Vagina Leak, Vagina Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3153</td>
               <td colspan="2">CTCAE Grade 3 Vagina Obstruction<span class="subclass"> SubClassOf </span>Vagina Obstruction Adverse Event. <br><i>New Terms: Vagina Obstruction Adverse Event, CTCAE Grade 3 Vagina Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>3154</td>
               <td colspan="2">CTCAE Grade 3 Vagina Pain<span class="subclass"> SubClassOf </span>Vagina Pain Adverse Event. <br><i>New Terms: Vagina Pain Adverse Event, CTCAE Grade 3 Vagina Pain</i></td>
            </tr>
            <tr class="addition">
               <td>3155</td>
               <td colspan="2">CTCAE Grade 3 Vagina Perforation<span class="subclass"> SubClassOf </span>Vagina Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 3 Vagina Perforation, Vagina Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3156</td>
               <td colspan="2">CTCAE Grade 3 Vagina Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Vagina Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Vagina Stricture or Stenosis, Vagina Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3157</td>
               <td colspan="2">CTCAE Grade 3 Vaginal Mucositis<span class="subclass"> SubClassOf </span>Vaginal Mucositis Adverse Event. <br><i>New Terms: Vaginal Mucositis Adverse Event, CTCAE Grade 3 Vaginal Mucositis</i></td>
            </tr>
            <tr class="addition">
               <td>3158</td>
               <td colspan="2">CTCAE Grade 3 Vaginal Stenosis<br><span class="keyword"> and </span>Length<span class="subclass"> SubClassOf </span>Vaginal Stenosis<br><span class="keyword"> and </span>Length Adverse Event. <br><i>New Terms: CTCAE Grade 3 Vaginal Stenosis and Length, Vaginal Stenosis and Length Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3159</td>
               <td colspan="2">CTCAE Grade 3 Vaginitis Not Due to Infection<span class="subclass"> SubClassOf </span>Vaginitis Not Due to Infection Adverse Event. <br><i>New Terms: CTCAE Grade 3 Vaginitis Not Due to Infection, Vaginitis Not Due to Infection Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>3160</td>
               <td colspan="2">CTCAE Grade 3 Valvular Heart Disease<span class="subclass"> SubClassOf </span>Valvular Heart Disease Adverse Event. <br><i>New Terms: CTCAE Grade 3 Valvular Heart Disease, Valvular Heart Disease Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3161</td>
               <td colspan="2">CTCAE Grade 3 Vas Deferens Hemorrhage<span class="subclass"> SubClassOf </span>Vas Deferens Hemorrhage Adverse Event. <br><i>New Terms: Vas Deferens Hemorrhage Adverse Event, CTCAE Grade 3 Vas Deferens Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>3162</td>
               <td colspan="2">CTCAE Grade 3 Vas Deferens Leak<span class="subclass"> SubClassOf </span>Vas Deferens Leak Adverse Event. <br><i>New Terms: CTCAE Grade 3 Vas Deferens Leak, Vas Deferens Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3163</td>
               <td colspan="2">CTCAE Grade 3 Vas Deferens Obstruction<span class="subclass"> SubClassOf </span>Vas Deferens Obstruction Adverse Event. <br><i>New Terms: Vas Deferens Obstruction Adverse Event, CTCAE Grade 3 Vas Deferens Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>3164</td>
               <td colspan="2">CTCAE Grade 3 Vas Deferens Perforation<span class="subclass"> SubClassOf </span>Vas Deferens Perforation Adverse Event. <br><i>New Terms: Vas Deferens Perforation Adverse Event, CTCAE Grade 3 Vas Deferens Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>3165</td>
               <td colspan="2">CTCAE Grade 3 Vas Deferens Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Vas Deferens Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 3 Vas Deferens Stricture or Stenosis, Vas Deferens Stricture or Stenosis
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3166</td>
               <td colspan="2">CTCAE Grade 3 Vasculitis<span class="subclass"> SubClassOf </span>Vasculitis Adverse Event. <br><i>New Terms: Vasculitis Adverse Event, CTCAE Grade 3 Vasculitis</i></td>
            </tr>
            <tr class="addition">
               <td>3167</td>
               <td colspan="2">CTCAE Grade 3 Vasovagal Episode<span class="subclass"> SubClassOf </span>Vasovagal Episode Adverse Event. <br><i>New Terms: CTCAE Grade 3 Vasovagal Episode, Vasovagal Episode Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3168</td>
               <td colspan="2">CTCAE Grade 3 Vein Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Vein Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Vein Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 3 Vein Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3169</td>
               <td colspan="2">CTCAE Grade 3 Vein Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Vein Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Vein Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or 2
                     Neutrophils, CTCAE Grade 3 Vein Infection with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3170</td>
               <td colspan="2">CTCAE Grade 3 Vein Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Vein Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Vein Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade 3
                     Vein Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3171</td>
               <td colspan="2">CTCAE Grade 3 Vein NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Vein NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Vein NOS Intra-Operative Injury, Vein NOS Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>3172</td>
               <td colspan="2">CTCAE Grade 3 Ventricular Arrhythmia NOS<span class="subclass"> SubClassOf </span>Ventricular Arrhythmia Adverse Event NOS. <br><i>New Terms: CTCAE Grade 3 Ventricular Arrhythmia NOS, Ventricular Arrhythmia Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>3173</td>
               <td colspan="2">CTCAE Grade 3 Ventricular Fibrillation<span class="subclass"> SubClassOf </span>Ventricular Fibrillation Adverse Event. <br><i>New Terms: Ventricular Fibrillation Adverse Event, CTCAE Grade 3 Ventricular Fibrillation</i></td>
            </tr>
            <tr class="addition">
               <td>3174</td>
               <td colspan="2">CTCAE Grade 3 Ventricular Flutter<span class="subclass"> SubClassOf </span>Ventricular Flutter Adverse Event. <br><i>New Terms: Ventricular Flutter Adverse Event, CTCAE Grade 3 Ventricular Flutter</i></td>
            </tr>
            <tr class="addition">
               <td>3175</td>
               <td colspan="2">CTCAE Grade 3 Ventricular Tachycardia<span class="subclass"> SubClassOf </span>Ventricular Tachycardia Adverse Event. <br><i>New Terms: CTCAE Grade 3 Ventricular Tachycardia, Ventricular Tachycardia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3176</td>
               <td colspan="2">CTCAE Grade 3 Viral Hepatitis<span class="subclass"> SubClassOf </span>Viral Hepatitis Adverse Event. <br><i>New Terms: Viral Hepatitis Adverse Event, CTCAE Grade 3 Viral Hepatitis</i></td>
            </tr>
            <tr class="addition">
               <td>3177</td>
               <td colspan="2">CTCAE Grade 3 Viscera Vein Injury<span class="subclass"> SubClassOf </span>Viscera Vein Injury Adverse Event. <br><i>New Terms: Viscera Vein Injury Adverse Event, CTCAE Grade 3 Viscera Vein Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3178</td>
               <td colspan="2">CTCAE Grade 3 Visceral Artery Injury<span class="subclass"> SubClassOf </span>Visceral Artery Injury Adverse Event. <br><i>New Terms: CTCAE Grade 3 Visceral Artery Injury, Visceral Artery Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3179</td>
               <td colspan="2">CTCAE Grade 3 Vital Capacity<span class="subclass"> SubClassOf </span>Vital Capacity Adverse Event. <br><i>New Terms: Vital Capacity Adverse Event, CTCAE Grade 3 Vital Capacity</i></td>
            </tr>
            <tr class="addition">
               <td>3180</td>
               <td colspan="2">CTCAE Grade 3 Vitreous Hemorrhage<span class="subclass"> SubClassOf </span>Vitreous Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 3 Vitreous Hemorrhage, Vitreous Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3181</td>
               <td colspan="2">CTCAE Grade 3 Voice Changes<br><span class="keyword"> and </span>Dysarthria<span class="subclass"> SubClassOf </span>Voice Changes<br><span class="keyword"> and </span>Dysarthria Adverse Event. <br><i>New Terms: Voice Changes and Dysarthria Adverse Event, CTCAE Grade 3 Voice Changes and Dysarthria</i></td>
            </tr>
            <tr class="addition">
               <td>3182</td>
               <td colspan="2">CTCAE Grade 3 Vomiting<span class="subclass"> SubClassOf </span>Vomiting Adverse Event. <br><i>New Terms: CTCAE Grade 3 Vomiting, Vomiting Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3183</td>
               <td colspan="2">CTCAE Grade 3 Vulva Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Vulva Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Vulva Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Vulva Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3184</td>
               <td colspan="2">CTCAE Grade 3 Vulva Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Vulva Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Vulva Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Vulva Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3185</td>
               <td colspan="2">CTCAE Grade 3 Vulva Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Vulva Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Vulva Infection with Unknown Absolute Neutrophil Count, Vulva Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3186</td>
               <td colspan="2">CTCAE Grade 3 Vulva Intra-Operative Injury<span class="subclass"> SubClassOf </span>Vulva Intra-Operative Injury Adverse Event. <br><i>New Terms: Vulva Intra-Operative Injury Adverse Event, CTCAE Grade 3 Vulva Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3187</td>
               <td colspan="2">CTCAE Grade 3 Weight Gain<span class="subclass"> SubClassOf </span>Weight Gain Adverse Event. <br><i>New Terms: CTCAE Grade 3 Weight Gain, Weight Gain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3188</td>
               <td colspan="2">CTCAE Grade 3 Weight Loss<span class="subclass"> SubClassOf </span>Weight Loss Adverse Event. <br><i>New Terms: CTCAE Grade 3 Weight Loss, Weight Loss Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3189</td>
               <td colspan="2">CTCAE Grade 3 Whole Body<br><span class="keyword"> and </span>Generalized Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Whole Body<br><span class="keyword"> and </span>Generalized Muscle Weakness Not Due to Neuropathy Adverse Event. <br><i>New Terms: Whole Body and Generalized Muscle Weakness Not Due to Neuropathy Adverse Event, CTCAE
                     Grade 3 Whole Body and Generalized Muscle Weakness Not Due to Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>3190</td>
               <td colspan="2">CTCAE Grade 3 Wolff-Parkinson-White Syndrome<span class="subclass"> SubClassOf </span>Wolff-Parkinson-White Syndrome Adverse Event. <br><i>New Terms: Wolff-Parkinson-White Syndrome Adverse Event, CTCAE Grade 3 Wolff-Parkinson-White
                     Syndrome</i></td>
            </tr>
            <tr class="addition">
               <td>3191</td>
               <td colspan="2">CTCAE Grade 3 Wound Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Wound Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 3 Wound Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Wound Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3192</td>
               <td colspan="2">CTCAE Grade 3 Wound Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Wound Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Wound Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 3 Wound Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3193</td>
               <td colspan="2">CTCAE Grade 3 Wound Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Wound Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 3 Wound Infection with Unknown Absolute Neutrophil Count, Wound Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3194</td>
               <td colspan="2">CTCAE Grade 3 Xerostomia<span class="subclass"> SubClassOf </span>Xerostomia Adverse Event. <br><i>New Terms: CTCAE Grade 3 Xerostomia, Xerostomia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3195</td>
               <td colspan="2">CTCAE Grade 4 AV Block First Degree<span class="subclass"> SubClassOf </span>AV Block First Degree Adverse Event. <br><i>New Terms: AV Block First Degree Adverse Event, CTCAE Grade 4 AV Block First Degree</i></td>
            </tr>
            <tr class="addition">
               <td>3196</td>
               <td colspan="2">CTCAE Grade 4 AV Block Second Degree Mobitz<span class="subclass"> Type </span>I<span class="subclass"> SubClassOf </span>AV Block Second Degree Mobitz<span class="subclass"> Type </span>I Adverse Event. <br><i>New Terms: AV Block Second Degree Mobitz Type I Adverse Event, CTCAE Grade 4 AV Block Second
                     Degree Mobitz Type I</i></td>
            </tr>
            <tr class="addition">
               <td>3197</td>
               <td colspan="2">CTCAE Grade 4 AV Block Second Degree Mobitz<span class="subclass"> Type </span>II<span class="subclass"> SubClassOf </span>AV Block Second Degree Mobitz<span class="subclass"> Type </span>II Adverse Event. <br><i>New Terms: AV Block Second Degree Mobitz Type II Adverse Event, CTCAE Grade 4 AV Block Second
                     Degree Mobitz Type II</i></td>
            </tr>
            <tr class="addition">
               <td>3198</td>
               <td colspan="2">CTCAE Grade 4 AV Block Third Degree<span class="subclass"> SubClassOf </span>AV Block Third Degree Adverse Event. <br><i>New Terms: CTCAE Grade 4 AV Block Third Degree, AV Block Third Degree Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3199</td>
               <td colspan="2">CTCAE Grade 4 Abdomen Fistula NOS<span class="subclass"> SubClassOf </span>Abdomen Fistula Adverse Event NOS. <br><i>New Terms: CTCAE Grade 4 Abdomen Fistula NOS, Abdomen Fistula Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>3200</td>
               <td colspan="2">CTCAE Grade 4 Abdomen Hemorrhage NOS<span class="subclass"> SubClassOf </span>Abdomen Hemorrhage Adverse Event NOS. <br><i>New Terms: CTCAE Grade 4 Abdomen Hemorrhage NOS, Abdomen Hemorrhage Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>3201</td>
               <td colspan="2">CTCAE Grade 4 Abdomen Infection NOS Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Abdomen Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Abdomen Infection NOS Adverse Event Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, CTCAE Grade 4 Abdomen Infection NOS Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3202</td>
               <td colspan="2">CTCAE Grade 4 Abdomen Infection NOS with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Abdomen Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Abdomen Infection NOS with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, Abdomen Infection NOS Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3203</td>
               <td colspan="2">CTCAE Grade 4 Abdomen Infection NOS with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Abdomen Infection NOS Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Abdomen Infection NOS Adverse Event with Unknown Absolute Neutrophil Count, CTCAE
                     Grade 4 Abdomen Infection NOS with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3204</td>
               <td colspan="2">CTCAE Grade 4 Abdomen NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Abdomen NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Abdomen NOS Intra-Operative Injury, Abdomen NOS Intra-Operative Injury
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3205</td>
               <td colspan="2">CTCAE Grade 4 Abdomen Pain NOS<span class="subclass"> SubClassOf </span>Abdomen Pain NOS Adverse Event. <br><i>New Terms: CTCAE Grade 4 Abdomen Pain NOS, Abdomen Pain NOS Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3206</td>
               <td colspan="2">CTCAE Grade 4 Abdomen Soft Tissue Necrosis<span class="subclass"> SubClassOf </span>Abdomen Soft Tissue Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 4 Abdomen Soft Tissue Necrosis, Abdomen Soft Tissue Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3207</td>
               <td colspan="2">CTCAE Grade 4 Acute Vascular Leak Syndrome<span class="subclass"> SubClassOf </span>Acute Vascular Leak Syndrome Adverse Event. <br><i>New Terms: CTCAE Grade 4 Acute Vascular Leak Syndrome, Acute Vascular Leak Syndrome Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3208</td>
               <td colspan="2">CTCAE Grade 4 Adrenal Gland Intra-Operative Injury<span class="subclass"> SubClassOf </span>Adrenal Gland Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Adrenal Gland Intra-Operative Injury, Adrenal Gland Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3209</td>
               <td colspan="2">CTCAE Grade 4 Adrenal Insufficiency<span class="subclass"> SubClassOf </span>Adrenal Insufficiency Adverse Event. <br><i>New Terms: Adrenal Insufficiency Adverse Event, CTCAE Grade 4 Adrenal Insufficiency</i></td>
            </tr>
            <tr class="addition">
               <td>3210</td>
               <td colspan="2">CTCAE Grade 4 Adult Respiratory Distress Syndrome<span class="subclass"> SubClassOf </span>Adult Respiratory Distress Syndrome Adverse Event. <br><i>New Terms: Adult Respiratory Distress Syndrome Adverse Event, CTCAE Grade 4 Adult Respiratory
                     Distress Syndrome</i></td>
            </tr>
            <tr class="addition">
               <td>3211</td>
               <td colspan="2">CTCAE Grade 4 Agitation<span class="subclass"> SubClassOf </span>Agitation Adverse Event. <br><i>New Terms: Agitation Adverse Event, CTCAE Grade 4 Agitation</i></td>
            </tr>
            <tr class="addition">
               <td>3212</td>
               <td colspan="2">CTCAE Grade 4 Alkaline phosphatase<span class="subclass"> SubClassOf </span>Alkaline Phosphatase Adverse Event. <br><i>New Terms: CTCAE Grade 4 Alkaline phosphatase, Alkaline Phosphatase Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3213</td>
               <td colspan="2">CTCAE Grade 4 Allergic Reaction<br><span class="keyword"> and </span>Hypersensitivity Including Drug Fever<span class="subclass"> SubClassOf </span>Allergic Reaction<br><span class="keyword"> and </span>Hypersensitivity Adverse Event Including Drug Fever. <br><i>New Terms: CTCAE Grade 4 Allergic Reaction and Hypersensitivity Including Drug Fever, Allergic
                     Reaction and Hypersensitivity Adverse Event Including Drug Fever</i></td>
            </tr>
            <tr class="addition">
               <td>3214</td>
               <td colspan="2">CTCAE Grade 4 Amylase<span class="subclass"> SubClassOf </span>Amylase Adverse Event. <br><i>New Terms: Amylase Adverse Event, CTCAE Grade 4 Amylase</i></td>
            </tr>
            <tr class="addition">
               <td>3215</td>
               <td colspan="2">CTCAE Grade 4 Anal Incontinence<span class="subclass"> SubClassOf </span>Anal Incontinence Adverse Event. <br><i>New Terms: CTCAE Grade 4 Anal Incontinence, Anal Incontinence Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3216</td>
               <td colspan="2">CTCAE Grade 4 Anal Sphincter Intra-Operative Injury<span class="subclass"> SubClassOf </span>Anal Sphincter Intra-Operative Injury Adverse Event. <br><i>New Terms: Anal Sphincter Intra-Operative Injury Adverse Event, CTCAE Grade 4 Anal Sphincter
                     Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3217</td>
               <td colspan="2">CTCAE Grade 4 Anal<br><span class="keyword"> or </span>Perianal Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Anal<br><span class="keyword"> or </span>Perianal Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Anal or Perianal Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, Anal or Perianal Infection Adverse Event Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3218</td>
               <td colspan="2">CTCAE Grade 4 Anal<br><span class="keyword"> or </span>Perianal Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Anal<br><span class="keyword"> or </span>Perianal Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Anal or Perianal Infection with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils, Anal or Perianal Infection Adverse Event with Normal Absolute
                     Neutrophil Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3219</td>
               <td colspan="2">CTCAE Grade 4 Anal<br><span class="keyword"> or </span>Perianal Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Anal<br><span class="keyword"> or </span>Perianal Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Anal or Perianal Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE
                     Grade 4 Anal or Perianal Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3220</td>
               <td colspan="2">CTCAE Grade 4 Anorexia<span class="subclass"> SubClassOf </span>Anorexia Adverse Event. <br><i>New Terms: Anorexia Adverse Event, CTCAE Grade 4 Anorexia</i></td>
            </tr>
            <tr class="addition">
               <td>3221</td>
               <td colspan="2">CTCAE Grade 4 Anus Fistula<span class="subclass"> SubClassOf </span>Anus Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 4 Anus Fistula, Anus Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3222</td>
               <td colspan="2">CTCAE Grade 4 Anus Hemorrhage<span class="subclass"> SubClassOf </span>Anus Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 4 Anus Hemorrhage, Anus Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3223</td>
               <td colspan="2">CTCAE Grade 4 Anus Intra-Operative Injury<span class="subclass"> SubClassOf </span>Anus Intra-Operative Injury Adverse Event. <br><i>New Terms: Anus Intra-Operative Injury Adverse Event, CTCAE Grade 4 Anus Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3224</td>
               <td colspan="2">CTCAE Grade 4 Anus Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Anus Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Clinical Examination Classification. <br><i>New Terms: Anus Mucositis or Stomatitis Adverse Event by Clinical Examination Classification,
                     CTCAE Grade 4 Anus Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>3225</td>
               <td colspan="2">CTCAE Grade 4 Anus Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Anus Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: CTCAE Grade 4 Anus Mucositis or Stomatitis by Functional or Symptomatic Classification,
                     Anus Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>3226</td>
               <td colspan="2">CTCAE Grade 4 Anus Necrosis<span class="subclass"> SubClassOf </span>Anus Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 4 Anus Necrosis, Anus Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3227</td>
               <td colspan="2">CTCAE Grade 4 Anus Pain<span class="subclass"> SubClassOf </span>Anus Pain Adverse Event. <br><i>New Terms: Anus Pain Adverse Event, CTCAE Grade 4 Anus Pain</i></td>
            </tr>
            <tr class="addition">
               <td>3228</td>
               <td colspan="2">CTCAE Grade 4 Anus Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Anus Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 4 Anus Stricture or Stenosis, Anus Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3229</td>
               <td colspan="2">CTCAE Grade 4 Anus Ulcer<span class="subclass"> SubClassOf </span>Anus Ulcer Adverse Event. <br><i>New Terms: Anus Ulcer Adverse Event, CTCAE Grade 4 Anus Ulcer</i></td>
            </tr>
            <tr class="addition">
               <td>3230</td>
               <td colspan="2">CTCAE Grade 4 Anxiety<span class="subclass"> SubClassOf </span>Anxiety Adverse Event. <br><i>New Terms: Anxiety Adverse Event, CTCAE Grade 4 Anxiety</i></td>
            </tr>
            <tr class="addition">
               <td>3231</td>
               <td colspan="2">CTCAE Grade 4 Aorta Artery Injury<span class="subclass"> SubClassOf </span>Aorta Artery Injury Adverse Event. <br><i>New Terms: Aorta Artery Injury Adverse Event, CTCAE Grade 4 Aorta Artery Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3232</td>
               <td colspan="2">CTCAE Grade 4 Aorta Artery Intra-Operative Injury<span class="subclass"> SubClassOf </span>Aorta Artery Intra-Operative Injury Adverse Event. <br><i>New Terms: Aorta Artery Intra-Operative Injury Adverse Event, CTCAE Grade 4 Aorta Artery Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3233</td>
               <td colspan="2">CTCAE Grade 4 Apnea<span class="subclass"> SubClassOf </span>Apnea Adverse Event. <br><i>New Terms: CTCAE Grade 4 Apnea, Apnea Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3234</td>
               <td colspan="2">CTCAE Grade 4 Appendix Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Appendix Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Appendix Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Appendix Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3235</td>
               <td colspan="2">CTCAE Grade 4 Appendix Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Appendix Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Appendix Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, CTCAE Grade 4 Appendix Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3236</td>
               <td colspan="2">CTCAE Grade 4 Appendix Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Appendix Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 4 Appendix Infection with Unknown Absolute Neutrophil Count, Appendix
                     Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3237</td>
               <td colspan="2">CTCAE Grade 4 Appendix Intra-Operative Injury<span class="subclass"> SubClassOf </span>Appendix Intra-Operative Injury Adverse Event. <br><i>New Terms: Appendix Intra-Operative Injury Adverse Event, CTCAE Grade 4 Appendix Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3238</td>
               <td colspan="2">CTCAE Grade 4 Appendix Perforation<span class="subclass"> SubClassOf </span>Appendix Perforation Adverse Event. <br><i>New Terms: Appendix Perforation Adverse Event, CTCAE Grade 4 Appendix Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>3239</td>
               <td colspan="2">CTCAE Grade 4 Arachnoiditis<br><span class="keyword"> and </span>Meningismus<br><span class="keyword"> and </span>Radiculitis<span class="subclass"> SubClassOf </span>Arachnoiditis<br><span class="keyword"> and </span>Meningismus<br><span class="keyword"> and </span>Radiculitis Adverse Event. <br><i>New Terms: CTCAE Grade 4 Arachnoiditis and Meningismus and Radiculitis, Arachnoiditis and Meningismus
                     and Radiculitis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3240</td>
               <td colspan="2">CTCAE Grade 4 Artery Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Artery Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Artery Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 4 Artery Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3241</td>
               <td colspan="2">CTCAE Grade 4 Artery Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Artery Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Artery Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Artery Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3242</td>
               <td colspan="2">CTCAE Grade 4 Artery Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Artery Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 4 Artery Infection with Unknown Absolute Neutrophil Count, Artery Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3243</td>
               <td colspan="2">CTCAE Grade 4 Artery NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Artery NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: Artery NOS Intra-Operative Injury Adverse Event, CTCAE Grade 4 Artery NOS Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3244</td>
               <td colspan="2">CTCAE Grade 4 Aspiration<span class="subclass"> SubClassOf </span>Aspiration Adverse Event. <br><i>New Terms: CTCAE Grade 4 Aspiration, Aspiration Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3245</td>
               <td colspan="2">CTCAE Grade 4 Asystole<span class="subclass"> SubClassOf </span>Asystole Adverse Event. <br><i>New Terms: Asystole Adverse Event, CTCAE Grade 4 Asystole</i></td>
            </tr>
            <tr class="addition">
               <td>3246</td>
               <td colspan="2">CTCAE Grade 4 Ataxia<span class="subclass"> SubClassOf </span>Ataxia Adverse Event. <br><i>New Terms: CTCAE Grade 4 Ataxia, Ataxia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3247</td>
               <td colspan="2">CTCAE Grade 4 Atelectasis<span class="subclass"> SubClassOf </span>Atelectasis Adverse Event. <br><i>New Terms: Atelectasis Adverse Event, CTCAE Grade 4 Atelectasis</i></td>
            </tr>
            <tr class="addition">
               <td>3248</td>
               <td colspan="2">CTCAE Grade 4 Atrial Fibrillation<span class="subclass"> SubClassOf </span>Atrial Fibrillation Adverse Event. <br><i>New Terms: CTCAE Grade 4 Atrial Fibrillation, Atrial Fibrillation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3249</td>
               <td colspan="2">CTCAE Grade 4 Atrial Flutter<span class="subclass"> SubClassOf </span>Atrial Flutter Adverse Event. <br><i>New Terms: CTCAE Grade 4 Atrial Flutter, Atrial Flutter Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3250</td>
               <td colspan="2">CTCAE Grade 4 Atrial Tachycardia<br><span class="keyword"> or </span>Paroxysmal Atrial Tachycardia<span class="subclass"> SubClassOf </span>Atrial Tachycardia<br><span class="keyword"> or </span>Paroxysmal Atrial Tachycardia Adverse Event. <br><i>New Terms: Atrial Tachycardia or Paroxysmal Atrial Tachycardia Adverse Event, CTCAE Grade 4 Atrial
                     Tachycardia or Paroxysmal Atrial Tachycardia</i></td>
            </tr>
            <tr class="addition">
               <td>3251</td>
               <td colspan="2">CTCAE Grade 4 Autoimmune Reaction<span class="subclass"> SubClassOf </span>Autoimmune Reaction Adverse Event. <br><i>New Terms: CTCAE Grade 4 Autoimmune Reaction, Autoimmune Reaction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3252</td>
               <td colspan="2">CTCAE Grade 4 Avascular Osteonecrosis<span class="subclass"> SubClassOf </span>Avascular Osteonecrosis Adverse Event. <br><i>New Terms: CTCAE Grade 4 Avascular Osteonecrosis, Avascular Osteonecrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3253</td>
               <td colspan="2">CTCAE Grade 4 Back Pain<span class="subclass"> SubClassOf </span>Back Pain Adverse Event. <br><i>New Terms: Back Pain Adverse Event, CTCAE Grade 4 Back Pain</i></td>
            </tr>
            <tr class="addition">
               <td>3254</td>
               <td colspan="2">CTCAE Grade 4 Bigeminy<span class="subclass"> SubClassOf </span>Bigeminy Adverse Event. <br><i>New Terms: CTCAE Grade 4 Bigeminy, Bigeminy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3255</td>
               <td colspan="2">CTCAE Grade 4 Biliary Tree Common Bile Duct Intra-Operative Injury<span class="subclass"> SubClassOf </span>Biliary Tree Common Bile Duct Intra-Operative Injury Adverse Event. <br><i>New Terms: Biliary Tree Common Bile Duct Intra-Operative Injury Adverse Event, CTCAE Grade 4
                     Biliary Tree Common Bile Duct Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3256</td>
               <td colspan="2">CTCAE Grade 4 Biliary Tree Common Hepatic Duct Intra-Operative Injury<span class="subclass"> SubClassOf </span>Biliary Tree Common Hepatic Duct Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Biliary Tree Common Hepatic Duct Intra-Operative Injury, Biliary Tree
                     Common Hepatic Duct Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3257</td>
               <td colspan="2">CTCAE Grade 4 Biliary Tree Fistula<span class="subclass"> SubClassOf </span>Biliary Tree Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 4 Biliary Tree Fistula, Biliary Tree Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3258</td>
               <td colspan="2">CTCAE Grade 4 Biliary Tree Hemorrhage<span class="subclass"> SubClassOf </span>Biliary Tree Hemorrhage Adverse Event. <br><i>New Terms: Biliary Tree Hemorrhage Adverse Event, CTCAE Grade 4 Biliary Tree Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>3259</td>
               <td colspan="2">CTCAE Grade 4 Biliary Tree Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Biliary Tree Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Biliary Tree Infection Adverse Event Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, CTCAE Grade 4 Biliary Tree Infection Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3260</td>
               <td colspan="2">CTCAE Grade 4 Biliary Tree Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Biliary Tree Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Biliary Tree Infection Adverse Event with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, CTCAE Grade 4 Biliary Tree Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3261</td>
               <td colspan="2">CTCAE Grade 4 Biliary Tree Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Biliary Tree Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Biliary Tree Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE
                     Grade 4 Biliary Tree Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3262</td>
               <td colspan="2">CTCAE Grade 4 Biliary Tree Leak<span class="subclass"> SubClassOf </span>Biliary Tree Leak Adverse Event. <br><i>New Terms: CTCAE Grade 4 Biliary Tree Leak, Biliary Tree Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3263</td>
               <td colspan="2">CTCAE Grade 4 Biliary Tree Left Hepatic Duct Intra-Operative Injury<span class="subclass"> SubClassOf </span>Biliary Tree Left Hepatic Duct Intra-Operative Injury Adverse Event. <br><i>New Terms: Biliary Tree Left Hepatic Duct Intra-Operative Injury Adverse Event, CTCAE Grade 4
                     Biliary Tree Left Hepatic Duct Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3264</td>
               <td colspan="2">CTCAE Grade 4 Biliary Tree NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Biliary Tree NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: Biliary Tree NOS Intra-Operative Injury Adverse Event, CTCAE Grade 4 Biliary Tree
                     NOS Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3265</td>
               <td colspan="2">CTCAE Grade 4 Biliary Tree Perforation<span class="subclass"> SubClassOf </span>Biliary Tree Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 4 Biliary Tree Perforation, Biliary Tree Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3266</td>
               <td colspan="2">CTCAE Grade 4 Biliary Tree Right Hepatic Duct Intra-Operative Injury<span class="subclass"> SubClassOf </span>Biliary Tree Right Hepatic Duct Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Biliary Tree Right Hepatic Duct Intra-Operative Injury, Biliary Tree
                     Right Hepatic Duct Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3267</td>
               <td colspan="2">CTCAE Grade 4 Biliary Tree Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Biliary Tree Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Biliary Tree Stricture or Stenosis Adverse Event, CTCAE Grade 4 Biliary Tree Stricture
                     or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>3268</td>
               <td colspan="2">CTCAE Grade 4 Bladder Fistula<span class="subclass"> SubClassOf </span>Bladder Fistula Adverse Event. <br><i>New Terms: Bladder Fistula Adverse Event, CTCAE Grade 4 Bladder Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>3269</td>
               <td colspan="2">CTCAE Grade 4 Bladder Hemorrhage<span class="subclass"> SubClassOf </span>Bladder Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 4 Bladder Hemorrhage, Bladder Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3270</td>
               <td colspan="2">CTCAE Grade 4 Bladder Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Bladder Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Bladder Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Bladder Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3271</td>
               <td colspan="2">CTCAE Grade 4 Bladder Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Bladder Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Bladder Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 4 Bladder Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3272</td>
               <td colspan="2">CTCAE Grade 4 Bladder Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Bladder Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Bladder Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     4 Bladder Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3273</td>
               <td colspan="2">CTCAE Grade 4 Bladder Intra-Operative Injury<span class="subclass"> SubClassOf </span>Bladder Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Bladder Intra-Operative Injury, Bladder Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>3274</td>
               <td colspan="2">CTCAE Grade 4 Bladder Leak<span class="subclass"> SubClassOf </span>Bladder Leak Adverse Event. <br><i>New Terms: Bladder Leak Adverse Event, CTCAE Grade 4 Bladder Leak</i></td>
            </tr>
            <tr class="addition">
               <td>3275</td>
               <td colspan="2">CTCAE Grade 4 Bladder Obstruction<span class="subclass"> SubClassOf </span>Bladder Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 4 Bladder Obstruction, Bladder Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3276</td>
               <td colspan="2">CTCAE Grade 4 Bladder Pain<span class="subclass"> SubClassOf </span>Bladder Pain Adverse Event. <br><i>New Terms: Bladder Pain Adverse Event, CTCAE Grade 4 Bladder Pain</i></td>
            </tr>
            <tr class="addition">
               <td>3277</td>
               <td colspan="2">CTCAE Grade 4 Bladder Perforation<span class="subclass"> SubClassOf </span>Bladder Perforation Adverse Event. <br><i>New Terms: Bladder Perforation Adverse Event, CTCAE Grade 4 Bladder Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>3278</td>
               <td colspan="2">CTCAE Grade 4 Bladder Spasms<span class="subclass"> SubClassOf </span>Bladder Spasm Adverse Event. <br><i>New Terms: Bladder Spasm Adverse Event, CTCAE Grade 4 Bladder Spasms</i></td>
            </tr>
            <tr class="addition">
               <td>3279</td>
               <td colspan="2">CTCAE Grade 4 Bladder Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Bladder Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 4 Bladder Stricture or Stenosis, Bladder Stricture or Stenosis Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>3280</td>
               <td colspan="2">CTCAE Grade 4 Blood Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Blood Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Blood Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 4 Blood Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3281</td>
               <td colspan="2">CTCAE Grade 4 Blood Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Blood Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Blood Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Blood Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3282</td>
               <td colspan="2">CTCAE Grade 4 Blood Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Blood Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Blood Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     4 Blood Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3283</td>
               <td colspan="2">CTCAE Grade 4 Blurred Vision<span class="subclass"> SubClassOf </span>Blurred Vision Adverse Event. <br><i>New Terms: CTCAE Grade 4 Blurred Vision, Blurred Vision Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3284</td>
               <td colspan="2">CTCAE Grade 4 Bone Growth Limb Length Discrepancy<span class="subclass"> SubClassOf </span>Bone Growth Limb Length Discrepancy Adverse Event. <br><i>New Terms: CTCAE Grade 4 Bone Growth Limb Length Discrepancy, Bone Growth Limb Length Discrepancy
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3285</td>
               <td colspan="2">CTCAE Grade 4 Bone Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Bone Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Bone Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 4 Bone Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3286</td>
               <td colspan="2">CTCAE Grade 4 Bone Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Bone Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Bone Infection with Normal Absolute Neutrophil Count or Grade 1 or 2
                     Neutrophils, Bone Infection Adverse Event with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3287</td>
               <td colspan="2">CTCAE Grade 4 Bone Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Bone Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 4 Bone Infection with Unknown Absolute Neutrophil Count, Bone Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3288</td>
               <td colspan="2">CTCAE Grade 4 Bone Intra-Operative Injury<span class="subclass"> SubClassOf </span>Bone Intra-Operative Injury Adverse Event. <br><i>New Terms: Bone Intra-Operative Injury Adverse Event, CTCAE Grade 4 Bone Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3289</td>
               <td colspan="2">CTCAE Grade 4 Bone Pain<span class="subclass"> SubClassOf </span>Bone Pain Adverse Event. <br><i>New Terms: CTCAE Grade 4 Bone Pain, Bone Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3290</td>
               <td colspan="2">CTCAE Grade 4 Brachial Plexopathy<span class="subclass"> SubClassOf </span>Brachial Plexopathy Adverse Event. <br><i>New Terms: Brachial Plexopathy Adverse Event, CTCAE Grade 4 Brachial Plexopathy</i></td>
            </tr>
            <tr class="addition">
               <td>3291</td>
               <td colspan="2">CTCAE Grade 4 Brachial Plexus Intra-Operative Injury<span class="subclass"> SubClassOf </span>Brachial Plexus Intra-Operative Injury Adverse Event. <br><i>New Terms: Brachial Plexus Intra-Operative Injury Adverse Event, CTCAE Grade 4 Brachial Plexus
                     Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3292</td>
               <td colspan="2">CTCAE Grade 4 Brain Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Brain Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Brain Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Brain Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3293</td>
               <td colspan="2">CTCAE Grade 4 Brain Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Brain Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Brain Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 4 Brain Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3294</td>
               <td colspan="2">CTCAE Grade 4 Brain Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Brain Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 4 Brain Infection with Unknown Absolute Neutrophil Count, Brain Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3295</td>
               <td colspan="2">CTCAE Grade 4 Brain Intra-Operative Injury<span class="subclass"> SubClassOf </span>Brain Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Brain Intra-Operative Injury, Brain Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3296</td>
               <td colspan="2">CTCAE Grade 4 Brain<br><span class="keyword"> and </span>Spinal Cord Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Brain<br><span class="keyword"> and </span>Spinal Cord Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Brain and Spinal Cord Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, CTCAE Grade 4 Brain and Spinal Cord Infection Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3297</td>
               <td colspan="2">CTCAE Grade 4 Brain<br><span class="keyword"> and </span>Spinal Cord Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Brain<br><span class="keyword"> and </span>Spinal Cord Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Brain and Spinal Cord Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils, CTCAE Grade 4 Brain and Spinal Cord Infection with Normal
                     Absolute Neutrophil Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3298</td>
               <td colspan="2">CTCAE Grade 4 Brain<br><span class="keyword"> and </span>Spinal Cord Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Brain<br><span class="keyword"> and </span>Spinal Cord Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Brain and Spinal Cord Infection Adverse Event with Unknown Absolute Neutrophil Count,
                     CTCAE Grade 4 Brain and Spinal Cord Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3299</td>
               <td colspan="2">CTCAE Grade 4 Breast Intra-Operative Injury<span class="subclass"> SubClassOf </span>Breast Intra-Operative Injury Adverse Event. <br><i>New Terms: Breast Intra-Operative Injury Adverse Event, CTCAE Grade 4 Breast Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3300</td>
               <td colspan="2">CTCAE Grade 4 Breast Pain<span class="subclass"> SubClassOf </span>Breast Pain Adverse Event. <br><i>New Terms: Breast Pain Adverse Event, CTCAE Grade 4 Breast Pain</i></td>
            </tr>
            <tr class="addition">
               <td>3301</td>
               <td colspan="2">CTCAE Grade 4 Bronchopulmonary Hemorrhage NOS<span class="subclass"> SubClassOf </span>Bronchopulmonary Hemorrhage Adverse Event NOS. <br><i>New Terms: Bronchopulmonary Hemorrhage Adverse Event NOS, CTCAE Grade 4 Bronchopulmonary Hemorrhage
                     NOS</i></td>
            </tr>
            <tr class="addition">
               <td>3302</td>
               <td colspan="2">CTCAE Grade 4 Bronchospasm<br><span class="keyword"> and </span>Wheezing<span class="subclass"> SubClassOf </span>Bronchospasm<br><span class="keyword"> and </span>Wheezing Adverse Event. <br><i>New Terms: Bronchospasm and Wheezing Adverse Event, CTCAE Grade 4 Bronchospasm and Wheezing</i></td>
            </tr>
            <tr class="addition">
               <td>3303</td>
               <td colspan="2">CTCAE Grade 4 Bronchus Fistula<span class="subclass"> SubClassOf </span>Bronchus Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 4 Bronchus Fistula, Bronchus Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3304</td>
               <td colspan="2">CTCAE Grade 4 Bronchus Hemorrhage<span class="subclass"> SubClassOf </span>Bronchus Hemorrhage Adverse Event. <br><i>New Terms: Bronchus Hemorrhage Adverse Event, CTCAE Grade 4 Bronchus Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>3305</td>
               <td colspan="2">CTCAE Grade 4 Bronchus Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Bronchus Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Bronchus Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Bronchus Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3306</td>
               <td colspan="2">CTCAE Grade 4 Bronchus Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Bronchus Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Bronchus Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, CTCAE Grade 4 Bronchus Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3307</td>
               <td colspan="2">CTCAE Grade 4 Bronchus Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Bronchus Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 4 Bronchus Infection with Unknown Absolute Neutrophil Count, Bronchus
                     Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3308</td>
               <td colspan="2">CTCAE Grade 4 Bronchus Intra-Operative Injury<span class="subclass"> SubClassOf </span>Bronchus Intra-Operative Injury Adverse Event. <br><i>New Terms: Bronchus Intra-Operative Injury Adverse Event, CTCAE Grade 4 Bronchus Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3309</td>
               <td colspan="2">CTCAE Grade 4 Bronchus Obstruction<br><span class="keyword"> and </span>Stenosis<span class="subclass"> SubClassOf </span>Bronchus Obstruction<br><span class="keyword"> and </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 4 Bronchus Obstruction and Stenosis, Bronchus Obstruction and Stenosis
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3310</td>
               <td colspan="2">CTCAE Grade 4 Burn<span class="subclass"> SubClassOf </span>Burn Adverse Event. <br><i>New Terms: CTCAE Grade 4 Burn, Burn Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3311</td>
               <td colspan="2">CTCAE Grade 4 Buttock Pain<span class="subclass"> SubClassOf </span>Buttock Pain Adverse Event. <br><i>New Terms: Buttock Pain Adverse Event, CTCAE Grade 4 Buttock Pain</i></td>
            </tr>
            <tr class="addition">
               <td>3312</td>
               <td colspan="2">CTCAE Grade 4 CD4 Count<span class="subclass"> SubClassOf </span>CD4 Count Adverse Event. <br><i>New Terms: CTCAE Grade 4 CD4 Count, CD4 Count Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3313</td>
               <td colspan="2">CTCAE Grade 4 CNS Cerebrovascular Ischemia<span class="subclass"> SubClassOf </span>CNS Cerebrovascular Ischemia Adverse Event. <br><i>New Terms: CNS Cerebrovascular Ischemia Adverse Event, CTCAE Grade 4 CNS Cerebrovascular Ischemia</i></td>
            </tr>
            <tr class="addition">
               <td>3314</td>
               <td colspan="2">CTCAE Grade 4 CNS Necrosis<br><span class="keyword"> and </span>Cystic Progression<span class="subclass"> SubClassOf </span>CNS Necrosis<br><span class="keyword"> and </span>Cystic Progression Adverse Event. <br><i>New Terms: CTCAE Grade 4 CNS Necrosis and Cystic Progression, CNS Necrosis and Cystic Progression
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3315</td>
               <td colspan="2">CTCAE Grade 4 Carbon Monoxide Diffusion Capacity<span class="subclass"> SubClassOf </span>Carbon Monoxide Diffusion Capacity Adverse Event. <br><i>New Terms: Carbon Monoxide Diffusion Capacity Adverse Event, CTCAE Grade 4 Carbon Monoxide Diffusion
                     Capacity</i></td>
            </tr>
            <tr class="addition">
               <td>3316</td>
               <td colspan="2">CTCAE Grade 4 Cardiac Ischemia<br><span class="keyword"> or </span>Infarction<span class="subclass"> SubClassOf </span>Cardiac Ischemia<br><span class="keyword"> or </span>Infarction Adverse Event. <br><i>New Terms: Cardiac Ischemia or Infarction Adverse Event, CTCAE Grade 4 Cardiac Ischemia or Infarction</i></td>
            </tr>
            <tr class="addition">
               <td>3317</td>
               <td colspan="2">CTCAE Grade 4 Cardiac Troponin I<span class="subclass"> SubClassOf </span>Cardiac Troponin I Adverse Event. <br><i>New Terms: Cardiac Troponin I Adverse Event, CTCAE Grade 4 Cardiac Troponin I</i></td>
            </tr>
            <tr class="addition">
               <td>3318</td>
               <td colspan="2">CTCAE Grade 4 Cardiac Troponin T<span class="subclass"> SubClassOf </span>Cardiac Troponin T Adverse Event. <br><i>New Terms: Cardiac Troponin T Adverse Event, CTCAE Grade 4 Cardiac Troponin T</i></td>
            </tr>
            <tr class="addition">
               <td>3319</td>
               <td colspan="2">CTCAE Grade 4 Cardiac<br><span class="keyword"> and </span>Heart Pain<span class="subclass"> SubClassOf </span>Cardiac<br><span class="keyword"> and </span>Heart Pain Adverse Event. <br><i>New Terms: CTCAE Grade 4 Cardiac and Heart Pain, Cardiac and Heart Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3320</td>
               <td colspan="2">CTCAE Grade 4 Carotid Artery Injury<span class="subclass"> SubClassOf </span>Carotid Artery Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Carotid Artery Injury, Carotid Artery Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3321</td>
               <td colspan="2">CTCAE Grade 4 Carotid Artery Intra-Operative Injury<span class="subclass"> SubClassOf </span>Carotid Artery Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Carotid Artery Intra-Operative Injury, Carotid Artery Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3322</td>
               <td colspan="2">CTCAE Grade 4 Cartilage Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cartilage Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Cartilage Intra-Operative Injury, Cartilage Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>3323</td>
               <td colspan="2">CTCAE Grade 4 Catheter-Related Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Catheter-Related Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Catheter-Related Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, Catheter-Related Infection Adverse Event Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3324</td>
               <td colspan="2">CTCAE Grade 4 Catheter-Related Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Catheter-Related Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Catheter-Related Infection with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils, Catheter-Related Infection Adverse Event with Normal Absolute
                     Neutrophil Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3325</td>
               <td colspan="2">CTCAE Grade 4 Catheter-Related Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Catheter-Related Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Catheter-Related Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE
                     Grade 4 Catheter-Related Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3326</td>
               <td colspan="2">CTCAE Grade 4 Cecum Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Cecum Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Cecum Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Cecum Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3327</td>
               <td colspan="2">CTCAE Grade 4 Cecum Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Cecum Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Cecum Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Cecum Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3328</td>
               <td colspan="2">CTCAE Grade 4 Cecum Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Cecum Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Cecum Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     4 Cecum Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3329</td>
               <td colspan="2">CTCAE Grade 4 Cecum Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cecum Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Cecum Intra-Operative Injury, Cecum Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3330</td>
               <td colspan="2">CTCAE Grade 4 Cecum Obstruction<span class="subclass"> SubClassOf </span>Cecum Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 4 Cecum Obstruction, Cecum Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3331</td>
               <td colspan="2">CTCAE Grade 4 Cecum Perforation<span class="subclass"> SubClassOf </span>Cecum Perforation Adverse Event. <br><i>New Terms: Cecum Perforation Adverse Event, CTCAE Grade 4 Cecum Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>3332</td>
               <td colspan="2">CTCAE Grade 4 Cecum Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Cecum Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 4 Cecum Stricture or Stenosis, Cecum Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3333</td>
               <td colspan="2">CTCAE Grade 4 Cecum Ulcer<span class="subclass"> SubClassOf </span>Cecum Ulcer Adverse Event. <br><i>New Terms: Cecum Ulcer Adverse Event, CTCAE Grade 4 Cecum Ulcer</i></td>
            </tr>
            <tr class="addition">
               <td>3334</td>
               <td colspan="2">CTCAE Grade 4 Cecum<br><span class="keyword"> or </span>Appendix Hemorrhage<span class="subclass"> SubClassOf </span>Cecum<br><span class="keyword"> or </span>Appendix Hemorrhage Adverse Event. <br><i>New Terms: Cecum or Appendix Hemorrhage Adverse Event, CTCAE Grade 4 Cecum or Appendix Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>3335</td>
               <td colspan="2">CTCAE Grade 4 Central Nervous System Hemorrhage<span class="subclass"> SubClassOf </span>Central Nervous System Hemorrhage Adverse Event. <br><i>New Terms: Central Nervous System Hemorrhage Adverse Event, CTCAE Grade 4 Central Nervous System
                     Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>3336</td>
               <td colspan="2">CTCAE Grade 4 Cerebral Artery Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cerebral Artery Intra-Operative Injury Adverse Event. <br><i>New Terms: Cerebral Artery Intra-Operative Injury Adverse Event, CTCAE Grade 4 Cerebral Artery
                     Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3337</td>
               <td colspan="2">CTCAE Grade 4 Cerebrospinal Fluid Leak<span class="subclass"> SubClassOf </span>Cerebrospinal Fluid Leak Adverse Event. <br><i>New Terms: CTCAE Grade 4 Cerebrospinal Fluid Leak, Cerebrospinal Fluid Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3338</td>
               <td colspan="2">CTCAE Grade 4 Cervix Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Cervix Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Cervix Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Cervix Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3339</td>
               <td colspan="2">CTCAE Grade 4 Cervix Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Cervix Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Cervix Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 4 Cervix Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3340</td>
               <td colspan="2">CTCAE Grade 4 Cervix Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Cervix Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Cervix Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     4 Cervix Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3341</td>
               <td colspan="2">CTCAE Grade 4 Cervix Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cervix Intra-Operative Injury Adverse Event. <br><i>New Terms: Cervix Intra-Operative Injury Adverse Event, CTCAE Grade 4 Cervix Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3342</td>
               <td colspan="2">CTCAE Grade 4 Chemoradiation<span class="subclass"> SubClassOf </span>Rash<br><span class="keyword"> and </span>Dermatitis Adverse Event Associated with Chemoradiation. <br><i>New Terms: Rash and Dermatitis Adverse Event Associated with Chemoradiation, CTCAE Grade 4 Chemoradiation</i></td>
            </tr>
            <tr class="addition">
               <td>3343</td>
               <td colspan="2">CTCAE Grade 4 Chest Wall Pain<span class="subclass"> SubClassOf </span>Chest Wall Pain Adverse Event. <br><i>New Terms: CTCAE Grade 4 Chest Wall Pain, Chest Wall Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3344</td>
               <td colspan="2">CTCAE Grade 4 Chest<br><span class="keyword"> and </span>Thorax Pain<span class="subclass"> SubClassOf </span>Chest<br><span class="keyword"> and </span>Thorax Pain NOS Adverse Event. <br><i>New Terms: Chest and Thorax Pain NOS Adverse Event, CTCAE Grade 4 Chest and Thorax Pain</i></td>
            </tr>
            <tr class="addition">
               <td>3345</td>
               <td colspan="2">CTCAE Grade 4 Cholecystitis<span class="subclass"> SubClassOf </span>Cholecystitis Adverse Event. <br><i>New Terms: Cholecystitis Adverse Event, CTCAE Grade 4 Cholecystitis</i></td>
            </tr>
            <tr class="addition">
               <td>3346</td>
               <td colspan="2">CTCAE Grade 4 Chyle<br><span class="keyword"> or </span>Lymph Leakage<span class="subclass"> SubClassOf </span>Chyle<br><span class="keyword"> or </span>Lymph Leakage Adverse Event. <br><i>New Terms: Chyle or Lymph Leakage Adverse Event, CTCAE Grade 4 Chyle or Lymph Leakage</i></td>
            </tr>
            <tr class="addition">
               <td>3347</td>
               <td colspan="2">CTCAE Grade 4 Chylothorax<span class="subclass"> SubClassOf </span>Chylothorax Adverse Event. <br><i>New Terms: Chylothorax Adverse Event, CTCAE Grade 4 Chylothorax</i></td>
            </tr>
            <tr class="addition">
               <td>3348</td>
               <td colspan="2">CTCAE Grade 4 Cognitive Disturbance<span class="subclass"> SubClassOf </span>Cognitive Disturbance Adverse Event. <br><i>New Terms: CTCAE Grade 4 Cognitive Disturbance, Cognitive Disturbance Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3349</td>
               <td colspan="2">CTCAE Grade 4 Colitis<span class="subclass"> SubClassOf </span>Colitis Adverse Event. <br><i>New Terms: Colitis Adverse Event, CTCAE Grade 4 Colitis</i></td>
            </tr>
            <tr class="addition">
               <td>3350</td>
               <td colspan="2">CTCAE Grade 4 Colon Hemorrhage<span class="subclass"> SubClassOf </span>Colon Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 4 Colon Hemorrhage, Colon Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3351</td>
               <td colspan="2">CTCAE Grade 4 Colon Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Colon Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Colon Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 4 Colon Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3352</td>
               <td colspan="2">CTCAE Grade 4 Colon Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Colon Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Colon Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 4 Colon Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3353</td>
               <td colspan="2">CTCAE Grade 4 Colon Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Colon Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 4 Colon Infection with Unknown Absolute Neutrophil Count, Colon Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3354</td>
               <td colspan="2">CTCAE Grade 4 Colon Intra-Operative Injury<span class="subclass"> SubClassOf </span>Colon Intra-Operative Injury Adverse Event. <br><i>New Terms: Colon Intra-Operative Injury Adverse Event, CTCAE Grade 4 Colon Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3355</td>
               <td colspan="2">CTCAE Grade 4 Colon Obstruction<span class="subclass"> SubClassOf </span>Colon Obstruction Adverse Event. <br><i>New Terms: Colon Obstruction Adverse Event, CTCAE Grade 4 Colon Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>3356</td>
               <td colspan="2">CTCAE Grade 4 Colon Perforation<span class="subclass"> SubClassOf </span>Colon Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 4 Colon Perforation, Colon Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3357</td>
               <td colspan="2">CTCAE Grade 4 Colon Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Colon Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Colon Stricture or Stenosis Adverse Event, CTCAE Grade 4 Colon Stricture or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>3358</td>
               <td colspan="2">CTCAE Grade 4 Colon Ulcer<span class="subclass"> SubClassOf </span>Colon Ulcer Adverse Event. <br><i>New Terms: CTCAE Grade 4 Colon Ulcer, Colon Ulcer Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3359</td>
               <td colspan="2">CTCAE Grade 4 Colon<br><span class="keyword"> or </span>Cecum<br><span class="keyword"> or </span>Appendix Fistula<span class="subclass"> SubClassOf </span>Colon<br><span class="keyword"> or </span>Cecum<br><span class="keyword"> or </span>Appendix Fistula Adverse Event. <br><i>New Terms: Colon or Cecum or Appendix Fistula Adverse Event, CTCAE Grade 4 Colon or Cecum or
                     Appendix Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>3360</td>
               <td colspan="2">CTCAE Grade 4 Colon<br><span class="keyword"> or </span>Cecum<br><span class="keyword"> or </span>Appendix Necrosis<span class="subclass"> SubClassOf </span>Colon<br><span class="keyword"> or </span>Cecum<br><span class="keyword"> or </span>Appendix Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 4 Colon or Cecum or Appendix Necrosis, Colon or Cecum or Appendix Necrosis
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3361</td>
               <td colspan="2">CTCAE Grade 4 Conduction Abnormality NOS<span class="subclass"> SubClassOf </span>Conduction Abnormality Adverse Event NOS. <br><i>New Terms: Conduction Abnormality Adverse Event NOS, CTCAE Grade 4 Conduction Abnormality NOS</i></td>
            </tr>
            <tr class="addition">
               <td>3362</td>
               <td colspan="2">CTCAE Grade 4 Confusion<span class="subclass"> SubClassOf </span>Confusion Adverse Event. <br><i>New Terms: CTCAE Grade 4 Confusion, Confusion Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3363</td>
               <td colspan="2">CTCAE Grade 4 Conjunctiva Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Conjunctiva Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Conjunctiva Infection Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, Conjunctiva Infection Adverse Event Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3364</td>
               <td colspan="2">CTCAE Grade 4 Conjunctiva Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Conjunctiva Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Conjunctiva Infection with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, Conjunctiva Infection Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3365</td>
               <td colspan="2">CTCAE Grade 4 Conjunctiva Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Conjunctiva Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 4 Conjunctiva Infection with Unknown Absolute Neutrophil Count, Conjunctiva
                     Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3366</td>
               <td colspan="2">CTCAE Grade 4 Conjunctiva Intra-Operative Injury<span class="subclass"> SubClassOf </span>Conjunctiva Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Conjunctiva Intra-Operative Injury, Conjunctiva Intra-Operative Injury
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3367</td>
               <td colspan="2">CTCAE Grade 4 Constipation<span class="subclass"> SubClassOf </span>Constipation Adverse Event. <br><i>New Terms: CTCAE Grade 4 Constipation, Constipation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3368</td>
               <td colspan="2">CTCAE Grade 4 Cornea Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Cornea Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Cornea Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 4 Cornea Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3369</td>
               <td colspan="2">CTCAE Grade 4 Cornea Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Cornea Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Cornea Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 4 Cornea Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3370</td>
               <td colspan="2">CTCAE Grade 4 Cornea Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Cornea Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 4 Cornea Infection with Unknown Absolute Neutrophil Count, Cornea Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3371</td>
               <td colspan="2">CTCAE Grade 4 Cornea Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cornea Intra-Operative Injury Adverse Event. <br><i>New Terms: Cornea Intra-Operative Injury Adverse Event, CTCAE Grade 4 Cornea Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3381</td>
               <td colspan="2">CTCAE Grade 4 Cranial Nerve I Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve I Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Cranial Nerve I Intra-Operative Injury, Cranial Nerve I Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3382</td>
               <td colspan="2">CTCAE Grade 4 Cranial Nerve I Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve I Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve I Neuropathy Adverse Event, CTCAE Grade 4 Cranial Nerve I Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>3374</td>
               <td colspan="2">CTCAE Grade 4 Cranial Nerve II Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve II Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Cranial Nerve II Intra-Operative Injury, Cranial Nerve II Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3375</td>
               <td colspan="2">CTCAE Grade 4 Cranial Nerve II Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve II Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve II Neuropathy Adverse Event, CTCAE Grade 4 Cranial Nerve II Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>3372</td>
               <td colspan="2">CTCAE Grade 4 Cranial Nerve III Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve III Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Cranial Nerve III Intra-Operative Injury, Cranial Nerve III Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3373</td>
               <td colspan="2">CTCAE Grade 4 Cranial Nerve III Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve III Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve III Neuropathy Adverse Event, CTCAE Grade 4 Cranial Nerve III Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>3376</td>
               <td colspan="2">CTCAE Grade 4 Cranial Nerve IV Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve IV Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Cranial Nerve IV Intra-Operative Injury, Cranial Nerve IV Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3377</td>
               <td colspan="2">CTCAE Grade 4 Cranial Nerve IV Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve IV Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 4 Cranial Nerve IV Neuropathy, Cranial Nerve IV Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3378</td>
               <td colspan="2">CTCAE Grade 4 Cranial Nerve IX Motor Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve IX Motor Intra-Operative Injury Adverse Event. <br><i>New Terms: Cranial Nerve IX Motor Intra-Operative Injury Adverse Event, CTCAE Grade 4 Cranial
                     Nerve IX Motor Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3379</td>
               <td colspan="2">CTCAE Grade 4 Cranial Nerve IX Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve IX Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve IX Neuropathy Adverse Event, CTCAE Grade 4 Cranial Nerve IX Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>3380</td>
               <td colspan="2">CTCAE Grade 4 Cranial Nerve IX Sensory Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve IX Sensory Intra-Operative Injury Adverse Event. <br><i>New Terms: Cranial Nerve IX Sensory Intra-Operative Injury Adverse Event, CTCAE Grade 4 Cranial
                     Nerve IX Sensory Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3383</td>
               <td colspan="2">CTCAE Grade 4 Cranial Nerve Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Cranial Nerve Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Cranial Nerve Infection Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, Cranial Nerve Infection Adverse Event Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3384</td>
               <td colspan="2">CTCAE Grade 4 Cranial Nerve Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Cranial Nerve Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Cranial Nerve Infection with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, Cranial Nerve Infection Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3385</td>
               <td colspan="2">CTCAE Grade 4 Cranial Nerve Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Cranial Nerve Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 4 Cranial Nerve Infection with Unknown Absolute Neutrophil Count, Cranial
                     Nerve Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3386</td>
               <td colspan="2">CTCAE Grade 4 Cranial Nerve Or Branch NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve Or Branch NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Cranial Nerve Or Branch NOS Intra-Operative Injury, Cranial Nerve Or
                     Branch NOS Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3394</td>
               <td colspan="2">CTCAE Grade 4 Cranial Nerve V Motor Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve V Motor Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Cranial Nerve V Motor Intra-Operative Injury, Cranial Nerve V Motor
                     Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3395</td>
               <td colspan="2">CTCAE Grade 4 Cranial Nerve V Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve V Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve V Neuropathy Adverse Event, CTCAE Grade 4 Cranial Nerve V Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>3396</td>
               <td colspan="2">CTCAE Grade 4 Cranial Nerve V Sensory Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve V Sensory Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Cranial Nerve V Sensory Intra-Operative Injury, Cranial Nerve V Sensory
                     Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3392</td>
               <td colspan="2">CTCAE Grade 4 Cranial Nerve VI Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve VI Intra-Operative Injury Adverse Event. <br><i>New Terms: Cranial Nerve VI Intra-Operative Injury Adverse Event, CTCAE Grade 4 Cranial Nerve
                     VI Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3393</td>
               <td colspan="2">CTCAE Grade 4 Cranial Nerve VI Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve VI Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 4 Cranial Nerve VI Neuropathy, Cranial Nerve VI Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3389</td>
               <td colspan="2">CTCAE Grade 4 Cranial Nerve VII Motor Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve VII Motor Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Cranial Nerve VII Motor Intra-Operative Injury, Cranial Nerve VII Motor
                     Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3390</td>
               <td colspan="2">CTCAE Grade 4 Cranial Nerve VII Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve VII Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve VII Neuropathy Adverse Event, CTCAE Grade 4 Cranial Nerve VII Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>3391</td>
               <td colspan="2">CTCAE Grade 4 Cranial Nerve VII Sensory Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve VII Sensory Intra-Operative Injury Adverse Event. <br><i>New Terms: Cranial Nerve VII Sensory Intra-Operative Injury Adverse Event, CTCAE Grade 4 Cranial
                     Nerve VII Sensory Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3387</td>
               <td colspan="2">CTCAE Grade 4 Cranial Nerve VIII Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve VIII Intra-Operative Injury Adverse Event. <br><i>New Terms: Cranial Nerve VIII Intra-Operative Injury Adverse Event, CTCAE Grade 4 Cranial Nerve
                     VIII Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3388</td>
               <td colspan="2">CTCAE Grade 4 Cranial Nerve VIII Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve VIII Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 4 Cranial Nerve VIII Neuropathy, Cranial Nerve VIII Neuropathy Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>3401</td>
               <td colspan="2">CTCAE Grade 4 Cranial Nerve X Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve X Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Cranial Nerve X Intra-Operative Injury, Cranial Nerve X Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3402</td>
               <td colspan="2">CTCAE Grade 4 Cranial Nerve X Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve X Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 4 Cranial Nerve X Neuropathy, Cranial Nerve X Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3399</td>
               <td colspan="2">CTCAE Grade 4 Cranial Nerve XI Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve XI Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Cranial Nerve XI Intra-Operative Injury, Cranial Nerve XI Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3400</td>
               <td colspan="2">CTCAE Grade 4 Cranial Nerve XI Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve XI Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 4 Cranial Nerve XI Neuropathy, Cranial Nerve XI Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3397</td>
               <td colspan="2">CTCAE Grade 4 Cranial Nerve XII Intra-Operative Injury<span class="subclass"> SubClassOf </span>Cranial Nerve XII Intra-Operative Injury Adverse Event. <br><i>New Terms: Cranial Nerve XII Intra-Operative Injury Adverse Event, CTCAE Grade 4 Cranial Nerve
                     XII Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3398</td>
               <td colspan="2">CTCAE Grade 4 Cranial Nerve XII Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve XII Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve XII Neuropathy Adverse Event, CTCAE Grade 4 Cranial Nerve XII Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>3403</td>
               <td colspan="2">CTCAE Grade 4 Creatine Phosphokinase<span class="subclass"> SubClassOf </span>Creatine Phosphokinase Adverse Event. <br><i>New Terms: Creatine Phosphokinase Adverse Event, CTCAE Grade 4 Creatine Phosphokinase</i></td>
            </tr>
            <tr class="addition">
               <td>3404</td>
               <td colspan="2">CTCAE Grade 4 Creatinine<span class="subclass"> SubClassOf </span>Creatinine Adverse Event. <br><i>New Terms: Creatinine Adverse Event, CTCAE Grade 4 Creatinine</i></td>
            </tr>
            <tr class="addition">
               <td>3405</td>
               <td colspan="2">CTCAE Grade 4 Cystitis<span class="subclass"> SubClassOf </span>Cystitis Adverse Event. <br><i>New Terms: Cystitis Adverse Event, CTCAE Grade 4 Cystitis</i></td>
            </tr>
            <tr class="addition">
               <td>3406</td>
               <td colspan="2">CTCAE Grade 4 Cytokine Release Syndrome<br><span class="keyword"> or </span>Acute Infusion Reaction<span class="subclass"> SubClassOf </span>Cytokine Release Syndrome<br><span class="keyword"> or </span>Acute Infusion Reaction Adverse Event. <br><i>New Terms: Cytokine Release Syndrome or Acute Infusion Reaction Adverse Event, CTCAE Grade 4
                     Cytokine Release Syndrome or Acute Infusion Reaction</i></td>
            </tr>
            <tr class="addition">
               <td>3407</td>
               <td colspan="2">CTCAE Grade 4 Dehydration<span class="subclass"> SubClassOf </span>Dehydration Adverse Event. <br><i>New Terms: CTCAE Grade 4 Dehydration, Dehydration Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3411</td>
               <td colspan="2">CTCAE Grade 4 Dental<br><span class="keyword"> and </span>Teeth<br><span class="keyword"> and </span>Peridontal Pain<span class="subclass"> SubClassOf </span>Dental<br><span class="keyword"> and </span>Teeth<br><span class="keyword"> and </span>Peridontal Pain Adverse Event. <br><i>New Terms: Dental and Teeth and Peridontal Pain Adverse Event, CTCAE Grade 4 Dental and Teeth
                     and Peridontal Pain</i></td>
            </tr>
            <tr class="addition">
               <td>3408</td>
               <td colspan="2">CTCAE Grade 4 Dental-Tooth Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Tooth Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Dental-Tooth Infection Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, Tooth Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3409</td>
               <td colspan="2">CTCAE Grade 4 Dental-Tooth Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Tooth Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Tooth Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 4 Dental-Tooth Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3410</td>
               <td colspan="2">CTCAE Grade 4 Dental-Tooth Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Tooth Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Tooth Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     4 Dental-Tooth Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3412</td>
               <td colspan="2">CTCAE Grade 4 Depression<span class="subclass"> SubClassOf </span>Depression Adverse Event. <br><i>New Terms: CTCAE Grade 4 Depression, Depression Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3413</td>
               <td colspan="2">CTCAE Grade 4 Diarrhea<span class="subclass"> SubClassOf </span>Diarrhea Adverse Event. <br><i>New Terms: CTCAE Grade 4 Diarrhea, Diarrhea Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3414</td>
               <td colspan="2">CTCAE Grade 4 Disseminated Intravascular Coagulation<span class="subclass"> SubClassOf </span>Disseminated Intravascular Coagulation Adverse Event. <br><i>New Terms: CTCAE Grade 4 Disseminated Intravascular Coagulation, Disseminated Intravascular Coagulation
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3415</td>
               <td colspan="2">CTCAE Grade 4 Dizziness<span class="subclass"> SubClassOf </span>Dizziness Adverse Event. <br><i>New Terms: CTCAE Grade 4 Dizziness, Dizziness Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3416</td>
               <td colspan="2">CTCAE Grade 4 Duodenum Fistula<span class="subclass"> SubClassOf </span>Duodenum Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 4 Duodenum Fistula, Duodenum Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3417</td>
               <td colspan="2">CTCAE Grade 4 Duodenum Hemorrhage<span class="subclass"> SubClassOf </span>Duodenum Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 4 Duodenum Hemorrhage, Duodenum Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3418</td>
               <td colspan="2">CTCAE Grade 4 Duodenum Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Duodenum Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Duodenum Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 4 Duodenum Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3419</td>
               <td colspan="2">CTCAE Grade 4 Duodenum Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Duodenum Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Duodenum Infection with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, Duodenum Infection Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3420</td>
               <td colspan="2">CTCAE Grade 4 Duodenum Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Duodenum Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 4 Duodenum Infection with Unknown Absolute Neutrophil Count, Duodenum
                     Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3421</td>
               <td colspan="2">CTCAE Grade 4 Duodenum Intra-Operative Injury<span class="subclass"> SubClassOf </span>Duodenum Intra-Operative Injury Adverse Event. <br><i>New Terms: Duodenum Intra-Operative Injury Adverse Event, CTCAE Grade 4 Duodenum Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3422</td>
               <td colspan="2">CTCAE Grade 4 Duodenum Necrosis<span class="subclass"> SubClassOf </span>Duodenum Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 4 Duodenum Necrosis, Duodenum Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3423</td>
               <td colspan="2">CTCAE Grade 4 Duodenum Obstruction<span class="subclass"> SubClassOf </span>Duodenum Obstruction Adverse Event. <br><i>New Terms: Duodenum Obstruction Adverse Event, CTCAE Grade 4 Duodenum Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>3424</td>
               <td colspan="2">CTCAE Grade 4 Duodenum Perforation<span class="subclass"> SubClassOf </span>Duodenum Perforation Adverse Event. <br><i>New Terms: Duodenum Perforation Adverse Event, CTCAE Grade 4 Duodenum Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>3425</td>
               <td colspan="2">CTCAE Grade 4 Duodenum Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Duodenum Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Duodenum Stricture or Stenosis Adverse Event, CTCAE Grade 4 Duodenum Stricture or
                     Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>3426</td>
               <td colspan="2">CTCAE Grade 4 Duodenum Ulcer<span class="subclass"> SubClassOf </span>Duodenum Ulcer Adverse Event. <br><i>New Terms: CTCAE Grade 4 Duodenum Ulcer, Duodenum Ulcer Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3427</td>
               <td colspan="2">CTCAE Grade 4 Dysphagia<span class="subclass"> SubClassOf </span>Dysphagia Adverse Event. <br><i>New Terms: CTCAE Grade 4 Dysphagia, Dysphagia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3428</td>
               <td colspan="2">CTCAE Grade 4 Dyspnea<span class="subclass"> SubClassOf </span>Dyspnea Adverse Event. <br><i>New Terms: CTCAE Grade 4 Dyspnea, Dyspnea Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3429</td>
               <td colspan="2">CTCAE Grade 4 Edema of the Head<br><span class="keyword"> and </span>Neck<span class="subclass"> SubClassOf </span>Edema Adverse Event of the Head<br><span class="keyword"> and </span>Neck. <br><i>New Terms: CTCAE Grade 4 Edema of the Head and Neck, Edema Adverse Event of the Head and Neck</i></td>
            </tr>
            <tr class="addition">
               <td>3430</td>
               <td colspan="2">CTCAE Grade 4 Edema of the Limb<span class="subclass"> SubClassOf </span>Edema Adverse Event of the Limb. <br><i>New Terms: Edema Adverse Event of the Limb, CTCAE Grade 4 Edema of the Limb</i></td>
            </tr>
            <tr class="addition">
               <td>3431</td>
               <td colspan="2">CTCAE Grade 4 Edema of the Trunk<br><span class="keyword"> and </span>Genital Area<span class="subclass"> SubClassOf </span>Edema Adverse Event of the Trunk<br><span class="keyword"> and </span>Genital Area. <br><i>New Terms: CTCAE Grade 4 Edema of the Trunk and Genital Area, Edema Adverse Event of the Trunk
                     and Genital Area</i></td>
            </tr>
            <tr class="addition">
               <td>3432</td>
               <td colspan="2">CTCAE Grade 4 Edema of the Viscera<span class="subclass"> SubClassOf </span>Edema Adverse Event of the Viscera. <br><i>New Terms: CTCAE Grade 4 Edema of the Viscera, Edema Adverse Event of the Viscera</i></td>
            </tr>
            <tr class="addition">
               <td>3433</td>
               <td colspan="2">CTCAE Grade 4 Encephalopathy<span class="subclass"> SubClassOf </span>Encephalopathy Adverse Event. <br><i>New Terms: CTCAE Grade 4 Encephalopathy, Encephalopathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3434</td>
               <td colspan="2">CTCAE Grade 4 Enteritis<span class="subclass"> SubClassOf </span>Enteritis Adverse Event. <br><i>New Terms: CTCAE Grade 4 Enteritis, Enteritis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3435</td>
               <td colspan="2">CTCAE Grade 4 Esophageal Varices Hemorrhage<span class="subclass"> SubClassOf </span>Esophageal Varices Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 4 Esophageal Varices Hemorrhage, Esophageal Varices Hemorrhage Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>3436</td>
               <td colspan="2">CTCAE Grade 4 Esophagitis<span class="subclass"> SubClassOf </span>Esophagitis Adverse Event. <br><i>New Terms: CTCAE Grade 4 Esophagitis, Esophagitis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3437</td>
               <td colspan="2">CTCAE Grade 4 Esophagus Fistula<span class="subclass"> SubClassOf </span>Esophagus Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 4 Esophagus Fistula, Esophagus Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3438</td>
               <td colspan="2">CTCAE Grade 4 Esophagus Hemorrhage<span class="subclass"> SubClassOf </span>Esophagus Hemorrhage Adverse Event. <br><i>New Terms: Esophagus Hemorrhage Adverse Event, CTCAE Grade 4 Esophagus Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>3439</td>
               <td colspan="2">CTCAE Grade 4 Esophagus Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Esophagus Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Esophagus Infection Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, Esophagus Infection Adverse Event Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3440</td>
               <td colspan="2">CTCAE Grade 4 Esophagus Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Esophagus Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Esophagus Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, CTCAE Grade 4 Esophagus Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3441</td>
               <td colspan="2">CTCAE Grade 4 Esophagus Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Esophagus Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Esophagus Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     4 Esophagus Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3442</td>
               <td colspan="2">CTCAE Grade 4 Esophagus Intra-Operative Injury<span class="subclass"> SubClassOf </span>Esophagus Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Esophagus Intra-Operative Injury, Esophagus Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>3443</td>
               <td colspan="2">CTCAE Grade 4 Esophagus Leak<span class="subclass"> SubClassOf </span>Esophagus Leak Adverse Event. <br><i>New Terms: CTCAE Grade 4 Esophagus Leak, Esophagus Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3444</td>
               <td colspan="2">CTCAE Grade 4 Esophagus Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Esophagus Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Clinical Examination Classification. <br><i>New Terms: CTCAE Grade 4 Esophagus Mucositis or Stomatitis by Clinical Examination Classification,
                     Esophagus Mucositis or Stomatitis Adverse Event by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>3445</td>
               <td colspan="2">CTCAE Grade 4 Esophagus Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Esophagus Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: Esophagus Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification,
                     CTCAE Grade 4 Esophagus Mucositis or Stomatitis by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>3446</td>
               <td colspan="2">CTCAE Grade 4 Esophagus Necrosis<span class="subclass"> SubClassOf </span>Esophagus Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 4 Esophagus Necrosis, Esophagus Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3447</td>
               <td colspan="2">CTCAE Grade 4 Esophagus Obstruction<span class="subclass"> SubClassOf </span>Esophagus Obstruction Adverse Event. <br><i>New Terms: Esophagus Obstruction Adverse Event, CTCAE Grade 4 Esophagus Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>3448</td>
               <td colspan="2">CTCAE Grade 4 Esophagus Pain<span class="subclass"> SubClassOf </span>Esophagus Pain Adverse Event. <br><i>New Terms: Esophagus Pain Adverse Event, CTCAE Grade 4 Esophagus Pain</i></td>
            </tr>
            <tr class="addition">
               <td>3449</td>
               <td colspan="2">CTCAE Grade 4 Esophagus Perforation<span class="subclass"> SubClassOf </span>Esophagus Perforation Adverse Event. <br><i>New Terms: Esophagus Perforation Adverse Event, CTCAE Grade 4 Esophagus Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>3450</td>
               <td colspan="2">CTCAE Grade 4 Esophagus Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Esophagus Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Esophagus Stricture or Stenosis Adverse Event, CTCAE Grade 4 Esophagus Stricture or
                     Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>3451</td>
               <td colspan="2">CTCAE Grade 4 Esophagus Ulcer<span class="subclass"> SubClassOf </span>Esophagus Ulcer Adverse Event. <br><i>New Terms: Esophagus Ulcer Adverse Event, CTCAE Grade 4 Esophagus Ulcer</i></td>
            </tr>
            <tr class="addition">
               <td>3452</td>
               <td colspan="2">CTCAE Grade 4 Euphoria<span class="subclass"> SubClassOf </span>Euphoria Adverse Event. <br><i>New Terms: Euphoria Adverse Event, CTCAE Grade 4 Euphoria</i></td>
            </tr>
            <tr class="addition">
               <td>3453</td>
               <td colspan="2">CTCAE Grade 4 Exostosis<span class="subclass"> SubClassOf </span>Exostosis Adverse Event. <br><i>New Terms: CTCAE Grade 4 Exostosis, Exostosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3454</td>
               <td colspan="2">CTCAE Grade 4 External Ear Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>External Ear Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: External Ear Infection Adverse Event Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, CTCAE Grade 4 External Ear Infection Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3455</td>
               <td colspan="2">CTCAE Grade 4 External Ear Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>External Ear Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 4 External Ear Infection with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, External Ear Infection Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3456</td>
               <td colspan="2">CTCAE Grade 4 External Ear Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>External Ear Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: External Ear Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE
                     Grade 4 External Ear Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3457</td>
               <td colspan="2">CTCAE Grade 4 External Ear Pain<span class="subclass"> SubClassOf </span>External Ear Pain Adverse Event. <br><i>New Terms: CTCAE Grade 4 External Ear Pain, External Ear Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3458</td>
               <td colspan="2">CTCAE Grade 4 Extraocular Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Extraocular Muscle Weakness Not Due to Neuropathy Adverse Event. <br><i>New Terms: Extraocular Muscle Weakness Not Due to Neuropathy Adverse Event, CTCAE Grade 4 Extraocular
                     Muscle Weakness Not Due to Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>3459</td>
               <td colspan="2">CTCAE Grade 4 Extrapyramidal<br><span class="keyword"> and </span>Involuntary Movement<br><span class="keyword"> and </span>Restlessness<span class="subclass"> SubClassOf </span>Extrapyramidal<br><span class="keyword"> and </span>Involuntary Movement<br><span class="keyword"> and </span>Restlessness Adverse Event. <br><i>New Terms: Extrapyramidal and Involuntary Movement and Restlessness Adverse Event, CTCAE Grade
                     4 Extrapyramidal and Involuntary Movement and Restlessness</i></td>
            </tr>
            <tr class="addition">
               <td>3460</td>
               <td colspan="2">CTCAE Grade 4 Extremity Limb Pain<span class="subclass"> SubClassOf </span>Extremity Limb Pain Adverse Event. <br><i>New Terms: CTCAE Grade 4 Extremity Limb Pain, Extremity Limb Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3461</td>
               <td colspan="2">CTCAE Grade 4 Eye Infection NOS Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Eye Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Eye Infection NOS Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 4 Eye Infection NOS Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3462</td>
               <td colspan="2">CTCAE Grade 4 Eye Infection NOS with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Eye Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Eye Infection NOS with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Eye Infection NOS Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3463</td>
               <td colspan="2">CTCAE Grade 4 Eye Infection NOS with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Eye Infection NOS Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Eye Infection NOS Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     4 Eye Infection NOS with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3464</td>
               <td colspan="2">CTCAE Grade 4 Eye NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Eye NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: Eye NOS Intra-Operative Injury Adverse Event, CTCAE Grade 4 Eye NOS Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3465</td>
               <td colspan="2">CTCAE Grade 4 Eye Pain<span class="subclass"> SubClassOf </span>Eye Pain Adverse Event. <br><i>New Terms: CTCAE Grade 4 Eye Pain, Eye Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3466</td>
               <td colspan="2">CTCAE Grade 4 FEV1<span class="subclass"> SubClassOf </span>FEV1 Adverse Event. <br><i>New Terms: CTCAE Grade 4 FEV1, FEV1 Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3467</td>
               <td colspan="2">CTCAE Grade 4 Face NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Face NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Face NOS Intra-Operative Injury, Face NOS Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>3468</td>
               <td colspan="2">CTCAE Grade 4 Face Pain<span class="subclass"> SubClassOf </span>Face Pain Adverse Event. <br><i>New Terms: Face Pain Adverse Event, CTCAE Grade 4 Face Pain</i></td>
            </tr>
            <tr class="addition">
               <td>3469</td>
               <td colspan="2">CTCAE Grade 4 Facial Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Facial Muscle Weakness Not Due to Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 4 Facial Muscle Weakness Not Due to Neuropathy, Facial Muscle Weakness
                     Not Due to Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3470</td>
               <td colspan="2">CTCAE Grade 4 Fallopian Tube Hemorrhage<span class="subclass"> SubClassOf </span>Fallopian Tube Hemorrhage Adverse Event. <br><i>New Terms: Fallopian Tube Hemorrhage Adverse Event, CTCAE Grade 4 Fallopian Tube Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>3471</td>
               <td colspan="2">CTCAE Grade 4 Fallopian Tube Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Fallopian Tube Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Fallopian Tube Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, CTCAE Grade 4 Fallopian Tube Infection Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3472</td>
               <td colspan="2">CTCAE Grade 4 Fallopian Tube Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Fallopian Tube Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Fallopian Tube Infection Adverse Event with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, CTCAE Grade 4 Fallopian Tube Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3473</td>
               <td colspan="2">CTCAE Grade 4 Fallopian Tube Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Fallopian Tube Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 4 Fallopian Tube Infection with Unknown Absolute Neutrophil Count, Fallopian
                     Tube Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3474</td>
               <td colspan="2">CTCAE Grade 4 Fallopian Tube Intra-Operative Injury<span class="subclass"> SubClassOf </span>Fallopian Tube Intra-Operative Injury Adverse Event. <br><i>New Terms: Fallopian Tube Intra-Operative Injury Adverse Event, CTCAE Grade 4 Fallopian Tube
                     Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3475</td>
               <td colspan="2">CTCAE Grade 4 Fallopian Tube Leak<span class="subclass"> SubClassOf </span>Fallopian Tube Leak Adverse Event. <br><i>New Terms: Fallopian Tube Leak Adverse Event, CTCAE Grade 4 Fallopian Tube Leak</i></td>
            </tr>
            <tr class="addition">
               <td>3476</td>
               <td colspan="2">CTCAE Grade 4 Fallopian Tube Obstruction<span class="subclass"> SubClassOf </span>Fallopian Tube Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 4 Fallopian Tube Obstruction, Fallopian Tube Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3477</td>
               <td colspan="2">CTCAE Grade 4 Fallopian Tube Perforation<span class="subclass"> SubClassOf </span>Fallopian Tube Perforation Adverse Event. <br><i>New Terms: Fallopian Tube Perforation Adverse Event, CTCAE Grade 4 Fallopian Tube Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>3478</td>
               <td colspan="2">CTCAE Grade 4 Fallopian Tube Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Fallopian Tube Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Fallopian Tube Stricture or Stenosis Adverse Event, CTCAE Grade 4 Fallopian Tube Stricture
                     or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>3479</td>
               <td colspan="2">CTCAE Grade 4 Fatigue<span class="subclass"> SubClassOf </span>Fatigue Adverse Event. <br><i>New Terms: CTCAE Grade 4 Fatigue, Fatigue Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3480</td>
               <td colspan="2">CTCAE Grade 4 Febrile Neutropenia<span class="subclass"> SubClassOf </span>Febrile Neutropenia without Clinically<br><span class="keyword"> or </span>Microbiologically Documented Infection with Absolute Neutrophil Count Less Than 1
                  X 10e9 per Liter<br><span class="keyword"> and </span>Temperature Greater Than<br><span class="keyword"> or </span>Equal to 38 Point 5 Degrees Celsius. <br><i>New Terms: Febrile Neutropenia without Clinically or Microbiologically Documented Infection with
                     Absolute Neutrophil Count Less Than 1 X 10e9 per Liter and Temperature Greater Than
                     or Equal to 38 Point 5 Degrees Celsius, CTCAE Grade 4 Febrile Neutropenia</i></td>
            </tr>
            <tr class="addition">
               <td>3481</td>
               <td colspan="2">CTCAE Grade 4 Female Genital Tract Fistula<span class="subclass"> SubClassOf </span>Female Genital Tract Fistula Adverse Event. <br><i>New Terms: Female Genital Tract Fistula Adverse Event, CTCAE Grade 4 Female Genital Tract Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>3482</td>
               <td colspan="2">CTCAE Grade 4 Fever Without Neutropenia<span class="subclass"> SubClassOf </span>Fever Without Neutropenia Adverse Event. <br><i>New Terms: CTCAE Grade 4 Fever Without Neutropenia, Fever Without Neutropenia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3483</td>
               <td colspan="2">CTCAE Grade 4 Fibrinogen<span class="subclass"> SubClassOf </span>Fibrinogen Adverse Event. <br><i>New Terms: CTCAE Grade 4 Fibrinogen, Fibrinogen Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3484</td>
               <td colspan="2">CTCAE Grade 4 Fibrosis-Deep Connective Tissue<span class="subclass"> SubClassOf </span>Fibrosis-Deep Connective Tissue Adverse Event. <br><i>New Terms: Fibrosis-Deep Connective Tissue Adverse Event, CTCAE Grade 4 Fibrosis-Deep Connective
                     Tissue</i></td>
            </tr>
            <tr class="addition">
               <td>3485</td>
               <td colspan="2">CTCAE Grade 4 Flashing Lights<br><span class="keyword"> and </span>Floaters in Vision<span class="subclass"> SubClassOf </span>Flashing Lights<br><span class="keyword"> and </span>Floaters in Vision Adverse Event. <br><i>New Terms: CTCAE Grade 4 Flashing Lights and Floaters in Vision, Flashing Lights and Floaters
                     in Vision Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3486</td>
               <td colspan="2">CTCAE Grade 4 Flu-Like Syndrome<span class="subclass"> SubClassOf </span>Flu-Like Syndrome Adverse Event. <br><i>New Terms: CTCAE Grade 4 Flu-Like Syndrome, Flu-Like Syndrome Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3487</td>
               <td colspan="2">CTCAE Grade 4 Foreign Body Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Foreign Body Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Foreign Body Infection Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, Foreign Body Infection Adverse Event Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3488</td>
               <td colspan="2">CTCAE Grade 4 Foreign Body Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Foreign Body Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Foreign Body Infection with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, Foreign Body Infection Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3489</td>
               <td colspan="2">CTCAE Grade 4 Foreign Body Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Foreign Body Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Foreign Body Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE
                     Grade 4 Foreign Body Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3490</td>
               <td colspan="2">CTCAE Grade 4 Fracture<span class="subclass"> SubClassOf </span>Fracture Adverse Event. <br><i>New Terms: Fracture Adverse Event, CTCAE Grade 4 Fracture</i></td>
            </tr>
            <tr class="addition">
               <td>3491</td>
               <td colspan="2">CTCAE Grade 4 Gallbladder Fistula<span class="subclass"> SubClassOf </span>Gallbladder Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 4 Gallbladder Fistula, Gallbladder Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3492</td>
               <td colspan="2">CTCAE Grade 4 Gallbladder Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Gallbladder Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Gallbladder Infection Adverse Event Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, CTCAE Grade 4 Gallbladder Infection Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3493</td>
               <td colspan="2">CTCAE Grade 4 Gallbladder Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Gallbladder Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Gallbladder Infection Adverse Event with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, CTCAE Grade 4 Gallbladder Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3494</td>
               <td colspan="2">CTCAE Grade 4 Gallbladder Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Gallbladder Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 4 Gallbladder Infection with Unknown Absolute Neutrophil Count, Gallbladder
                     Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3495</td>
               <td colspan="2">CTCAE Grade 4 Gallbladder Intra-Operative Injury<span class="subclass"> SubClassOf </span>Gallbladder Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Gallbladder Intra-Operative Injury, Gallbladder Intra-Operative Injury
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3496</td>
               <td colspan="2">CTCAE Grade 4 Gallbladder Necrosis<span class="subclass"> SubClassOf </span>Gallbladder Necrosis Adverse Event. <br><i>New Terms: Gallbladder Necrosis Adverse Event, CTCAE Grade 4 Gallbladder Necrosis</i></td>
            </tr>
            <tr class="addition">
               <td>3497</td>
               <td colspan="2">CTCAE Grade 4 Gallbladder Obstruction<span class="subclass"> SubClassOf </span>Gallbladder Obstruction Adverse Event. <br><i>New Terms: Gallbladder Obstruction Adverse Event, CTCAE Grade 4 Gallbladder Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>3498</td>
               <td colspan="2">CTCAE Grade 4 Gallbladder Pain<span class="subclass"> SubClassOf </span>Gallbladder Pain Adverse Event. <br><i>New Terms: Gallbladder Pain Adverse Event, CTCAE Grade 4 Gallbladder Pain</i></td>
            </tr>
            <tr class="addition">
               <td>3499</td>
               <td colspan="2">CTCAE Grade 4 Gallbladder Perforation<span class="subclass"> SubClassOf </span>Gallbladder Perforation Adverse Event. <br><i>New Terms: Gallbladder Perforation Adverse Event, CTCAE Grade 4 Gallbladder Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>3500</td>
               <td colspan="2">CTCAE Grade 4 Gamma-Glutamyl Transpeptidase<span class="subclass"> SubClassOf </span>Gamma-Glutamyl Transpeptidase Adverse Event. <br><i>New Terms: CTCAE Grade 4 Gamma-Glutamyl Transpeptidase, Gamma-Glutamyl Transpeptidase Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>3501</td>
               <td colspan="2">CTCAE Grade 4 Gastritis<span class="subclass"> SubClassOf </span>Gastritis Adverse Event. <br><i>New Terms: Gastritis Adverse Event, CTCAE Grade 4 Gastritis</i></td>
            </tr>
            <tr class="addition">
               <td>3502</td>
               <td colspan="2">CTCAE Grade 4 Gastrointestinal Leak NOS<span class="subclass"> SubClassOf </span>Gastrointestinal Leak Adverse Event NOS. <br><i>New Terms: CTCAE Grade 4 Gastrointestinal Leak NOS, Gastrointestinal Leak Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>3503</td>
               <td colspan="2">CTCAE Grade 4 Gastrointestinal Stoma Hemorrhage<span class="subclass"> SubClassOf </span>Gastrointestinal Stoma Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 4 Gastrointestinal Stoma Hemorrhage, Gastrointestinal Stoma Hemorrhage
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3504</td>
               <td colspan="2">CTCAE Grade 4 Gastrointestinal Stoma Intra-Operative Injury<span class="subclass"> SubClassOf </span>Gastointestinal Stoma Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Gastrointestinal Stoma Intra-Operative Injury, Gastointestinal Stoma
                     Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3505</td>
               <td colspan="2">CTCAE Grade 4 Gastrointestinal Stoma Leak<span class="subclass"> SubClassOf </span>Gastrointestinal Stoma Leak Adverse Event. <br><i>New Terms: Gastrointestinal Stoma Leak Adverse Event, CTCAE Grade 4 Gastrointestinal Stoma Leak</i></td>
            </tr>
            <tr class="addition">
               <td>3506</td>
               <td colspan="2">CTCAE Grade 4 Genitourinary Stoma Hemorrhage<span class="subclass"> SubClassOf </span>Genitourinary Stoma Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 4 Genitourinary Stoma Hemorrhage, Genitourinary Stoma Hemorrhage Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>3507</td>
               <td colspan="2">CTCAE Grade 4 Genitourinary Stoma Leak<span class="subclass"> SubClassOf </span>Genitourinary Stoma Leak Adverse Event. <br><i>New Terms: CTCAE Grade 4 Genitourinary Stoma Leak, Genitourinary Stoma Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3508</td>
               <td colspan="2">CTCAE Grade 4 Genitourinary Stoma Obstruction<span class="subclass"> SubClassOf </span>Genitourinary Stoma Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 4 Genitourinary Stoma Obstruction, Genitourinary Stoma Obstruction Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>3509</td>
               <td colspan="2">CTCAE Grade 4 Genitourinary Stoma Prolapse<span class="subclass"> SubClassOf </span>Genitourinary Stoma Prolapse Adverse Event. <br><i>New Terms: CTCAE Grade 4 Genitourinary Stoma Prolapse, Genitourinary Stoma Prolapse Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3510</td>
               <td colspan="2">CTCAE Grade 4 Genitourinary Stoma Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Genitourinary Stoma Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Genitourinary Stoma Stricture or Stenosis Adverse Event, CTCAE Grade 4 Genitourinary
                     Stoma Stricture or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>3511</td>
               <td colspan="2">CTCAE Grade 4 Gingiva Intra-Operative Injury<span class="subclass"> SubClassOf </span>Gingiva Intra-Operative Injury Adverse Event. <br><i>New Terms: Gingiva Intra-Operative Injury Adverse Event, CTCAE Grade 4 Gingiva Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3512</td>
               <td colspan="2">CTCAE Grade 4 Glaucoma<span class="subclass"> SubClassOf </span>Glaucoma Adverse Event. <br><i>New Terms: Glaucoma Adverse Event, CTCAE Grade 4 Glaucoma</i></td>
            </tr>
            <tr class="addition">
               <td>3513</td>
               <td colspan="2">CTCAE Grade 4 Glomerular Filtration Rate<span class="subclass"> SubClassOf </span>Glomerular Filtration Rate Adverse Event. <br><i>New Terms: CTCAE Grade 4 Glomerular Filtration Rate, Glomerular Filtration Rate Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3514</td>
               <td colspan="2">CTCAE Grade 4 Head Soft Tissue Necrosis<span class="subclass"> SubClassOf </span>Head Soft Tissue Necrosis Adverse Event. <br><i>New Terms: Head Soft Tissue Necrosis Adverse Event, CTCAE Grade 4 Head Soft Tissue Necrosis</i></td>
            </tr>
            <tr class="addition">
               <td>3515</td>
               <td colspan="2">CTCAE Grade 4 Head<br><span class="keyword"> and </span>Headache Pain<span class="subclass"> SubClassOf </span>Head<br><span class="keyword"> and </span>Headache Pain Adverse Event. <br><i>New Terms: CTCAE Grade 4 Head and Headache Pain, Head and Headache Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3516</td>
               <td colspan="2">CTCAE Grade 4 Hearing Patients with<br><span class="keyword"> or </span>without Baseline Audiogram<br><span class="keyword"> and </span>Enrolled in a Monitoring Program<span class="subclass"> SubClassOf </span>Hearing Adverse Event Patients with<br><span class="keyword"> or </span>without Baseline Audiogram<br><span class="keyword"> and </span>Enrolled in a Monitoring Program. <br><i>New Terms: CTCAE Grade 4 Hearing Patients with or without Baseline Audiogram and Enrolled in
                     a Monitoring Program, Hearing Adverse Event Patients with or without Baseline Audiogram
                     and Enrolled in a Monitoring Program</i></td>
            </tr>
            <tr class="addition">
               <td>3517</td>
               <td colspan="2">CTCAE Grade 4 Hearing Patients without Baseline Audiogram<br><span class="keyword"> and </span>Not Enrolled in a Monitoring Program<span class="subclass"> SubClassOf </span>Hearing Adverse Event Patients without Baseline Audiogram<br><span class="keyword"> and </span>Not Enrolled in a Monitoring Program. <br><i>New Terms: CTCAE Grade 4 Hearing Patients without Baseline Audiogram and Not Enrolled in a Monitoring
                     Program, Hearing Adverse Event Patients without Baseline Audiogram and Not Enrolled
                     in a Monitoring Program</i></td>
            </tr>
            <tr class="addition">
               <td>3518</td>
               <td colspan="2">CTCAE Grade 4 Heart Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Heart Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Heart Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 4 Heart Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3519</td>
               <td colspan="2">CTCAE Grade 4 Heart Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Heart Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Heart Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 4 Heart Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3520</td>
               <td colspan="2">CTCAE Grade 4 Heart Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Heart Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 4 Heart Infection with Unknown Absolute Neutrophil Count, Heart Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3521</td>
               <td colspan="2">CTCAE Grade 4 Heart Intra-Operative Injury<span class="subclass"> SubClassOf </span>Heart Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Heart Intra-Operative Injury, Heart Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3522</td>
               <td colspan="2">CTCAE Grade 4 Hematoma<span class="subclass"> SubClassOf </span>Hematoma Adverse Event. <br><i>New Terms: Hematoma Adverse Event, CTCAE Grade 4 Hematoma</i></td>
            </tr>
            <tr class="addition">
               <td>3523</td>
               <td colspan="2">CTCAE Grade 4 Hemoglobin<span class="subclass"> SubClassOf </span>Hemoglobin Adverse Event. <br><i>New Terms: CTCAE Grade 4 Hemoglobin, Hemoglobin Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3524</td>
               <td colspan="2">CTCAE Grade 4 Hemolysis<span class="subclass"> SubClassOf </span>Hemolysis Adverse Event. <br><i>New Terms: CTCAE Grade 4 Hemolysis, Hemolysis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3525</td>
               <td colspan="2">CTCAE Grade 4 Hemorrhage<br><span class="keyword"> and </span>Bleeding Adverse Event Associated with Surgery<span class="subclass"> SubClassOf </span>Hemorrhage<br><span class="keyword"> and </span>Bleeding Adverse Event Associated with Surgery. <br><i>New Terms: Hemorrhage and Bleeding Adverse Event Associated with Surgery, CTCAE Grade 4 Hemorrhage
                     and Bleeding Adverse Event Associated with Surgery</i></td>
            </tr>
            <tr class="addition">
               <td>3526</td>
               <td colspan="2">CTCAE Grade 4 Hemorrhoids<span class="subclass"> SubClassOf </span>Hemorrhoids Adverse Event. <br><i>New Terms: CTCAE Grade 4 Hemorrhoids, Hemorrhoids Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3527</td>
               <td colspan="2">CTCAE Grade 4 Hepatic Artery Intra-Operative Injury<span class="subclass"> SubClassOf </span>Hepatic Artery Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Hepatic Artery Intra-Operative Injury, Hepatic Artery Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3528</td>
               <td colspan="2">CTCAE Grade 4 Hepatic Necrosis<span class="subclass"> SubClassOf </span>Hepatic Necrosis Adverse Event. <br><i>New Terms: Hepatic Necrosis Adverse Event, CTCAE Grade 4 Hepatic Necrosis</i></td>
            </tr>
            <tr class="addition">
               <td>3529</td>
               <td colspan="2">CTCAE Grade 4 Hepatic Vein Intra-Operative Injury<span class="subclass"> SubClassOf </span>Hepatic Vein Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Hepatic Vein Intra-Operative Injury, Hepatic Vein Intra-Operative Injury
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3530</td>
               <td colspan="2">CTCAE Grade 4 Hydrocephalus<span class="subclass"> SubClassOf </span>Hydrocephalus Adverse Event. <br><i>New Terms: Hydrocephalus Adverse Event, CTCAE Grade 4 Hydrocephalus</i></td>
            </tr>
            <tr class="addition">
               <td>3531</td>
               <td colspan="2">CTCAE Grade 4 Hyperbilirubinemia<span class="subclass"> SubClassOf </span>Hyperbilirubinemia Adverse Event. <br><i>New Terms: Hyperbilirubinemia Adverse Event, CTCAE Grade 4 Hyperbilirubinemia</i></td>
            </tr>
            <tr class="addition">
               <td>3532</td>
               <td colspan="2">CTCAE Grade 4 Hypertension<span class="subclass"> SubClassOf </span>Hypertension Adverse Event. <br><i>New Terms: CTCAE Grade 4 Hypertension, Hypertension Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3533</td>
               <td colspan="2">CTCAE Grade 4 Hypotension<span class="subclass"> SubClassOf </span>Hypotension Adverse Event. <br><i>New Terms: Hypotension Adverse Event, CTCAE Grade 4 Hypotension</i></td>
            </tr>
            <tr class="addition">
               <td>3534</td>
               <td colspan="2">CTCAE Grade 4 Hypothermia<span class="subclass"> SubClassOf </span>Hypothermia Adverse Event. <br><i>New Terms: Hypothermia Adverse Event, CTCAE Grade 4 Hypothermia</i></td>
            </tr>
            <tr class="addition">
               <td>3535</td>
               <td colspan="2">CTCAE Grade 4 Hypoxia<span class="subclass"> SubClassOf </span>Hypoxia Adverse Event. <br><i>New Terms: CTCAE Grade 4 Hypoxia, Hypoxia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3536</td>
               <td colspan="2">CTCAE Grade 4 Idioventricular Rhythm<span class="subclass"> SubClassOf </span>Idioventricular Rhythm Adverse Event. <br><i>New Terms: Idioventricular Rhythm Adverse Event, CTCAE Grade 4 Idioventricular Rhythm</i></td>
            </tr>
            <tr class="addition">
               <td>3538</td>
               <td colspan="2">CTCAE Grade 4 Ileum Fistula<span class="subclass"> SubClassOf </span>Ileum Fistula Adverse Event. <br><i>New Terms: Ileum Fistula Adverse Event, CTCAE Grade 4 Ileum Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>3539</td>
               <td colspan="2">CTCAE Grade 4 Ileum Hemorrhage<span class="subclass"> SubClassOf </span>Ileum Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 4 Ileum Hemorrhage, Ileum Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3540</td>
               <td colspan="2">CTCAE Grade 4 Ileum Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Ileum Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Ileum Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Ileum Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3541</td>
               <td colspan="2">CTCAE Grade 4 Ileum Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Ileum Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Ileum Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Ileum Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3542</td>
               <td colspan="2">CTCAE Grade 4 Ileum Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Ileum Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Ileum Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     4 Ileum Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3543</td>
               <td colspan="2">CTCAE Grade 4 Ileum Necrosis<span class="subclass"> SubClassOf </span>Ileum Necrosis Adverse Event. <br><i>New Terms: Ileum Necrosis Adverse Event, CTCAE Grade 4 Ileum Necrosis</i></td>
            </tr>
            <tr class="addition">
               <td>3544</td>
               <td colspan="2">CTCAE Grade 4 Ileum Obstruction<span class="subclass"> SubClassOf </span>Ileum Obstruction Adverse Event. <br><i>New Terms: Ileum Obstruction Adverse Event, CTCAE Grade 4 Ileum Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>3545</td>
               <td colspan="2">CTCAE Grade 4 Ileum Perforation<span class="subclass"> SubClassOf </span>Ileum Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 4 Ileum Perforation, Ileum Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3546</td>
               <td colspan="2">CTCAE Grade 4 Ileum Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Ileum Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Ileum Stricture or Stenosis Adverse Event, CTCAE Grade 4 Ileum Stricture or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>3537</td>
               <td colspan="2">CTCAE Grade 4 Ileum<span class="subclass"> SubClassOf </span>Ileum Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Ileum, Ileum Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3547</td>
               <td colspan="2">CTCAE Grade 4 Ileum Ulcer<span class="subclass"> SubClassOf </span>Ileum Ulcer Adverse Event. <br><i>New Terms: CTCAE Grade 4 Ileum Ulcer, Ileum Ulcer Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3548</td>
               <td colspan="2">CTCAE Grade 4 Ileus<span class="subclass"> SubClassOf </span>Gastrointestinal Ileus Adverse Event. <br><i>New Terms: CTCAE Grade 4 Ileus, Gastrointestinal Ileus Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3549</td>
               <td colspan="2">CTCAE Grade 4 Infectious Colitis<span class="subclass"> SubClassOf </span>Infectious Colitis Adverse Event. <br><i>New Terms: Infectious Colitis Adverse Event, CTCAE Grade 4 Infectious Colitis</i></td>
            </tr>
            <tr class="addition">
               <td>3550</td>
               <td colspan="2">CTCAE Grade 4 Inferior Vena Cava Intra-Operative Injury<span class="subclass"> SubClassOf </span>Inferior Vena Cava Intra-Operative Injury Adverse Event. <br><i>New Terms: Inferior Vena Cava Intra-Operative Injury Adverse Event, CTCAE Grade 4 Inferior Vena
                     Cava Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3551</td>
               <td colspan="2">CTCAE Grade 4 Inferior Vena Cava Vein Injury<span class="subclass"> SubClassOf </span>Inferior Vena Cava Vein Injury Adverse Event. <br><i>New Terms: Inferior Vena Cava Vein Injury Adverse Event, CTCAE Grade 4 Inferior Vena Cava Vein
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3552</td>
               <td colspan="2">CTCAE Grade 4 Inner Ear Intra-Operative Injury<span class="subclass"> SubClassOf </span>Inner Ear Intra-Operative Injury Adverse Event. <br><i>New Terms: Inner Ear Intra-Operative Injury Adverse Event, CTCAE Grade 4 Inner Ear Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3553</td>
               <td colspan="2">CTCAE Grade 4 Insomnia<span class="subclass"> SubClassOf </span>Insomnia Adverse Event. <br><i>New Terms: CTCAE Grade 4 Insomnia, Insomnia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3554</td>
               <td colspan="2">CTCAE Grade 4 Intestine Pain<span class="subclass"> SubClassOf </span>Intestine Pain Adverse Event. <br><i>New Terms: CTCAE Grade 4 Intestine Pain, Intestine Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3555</td>
               <td colspan="2">CTCAE Grade 4 Iron Overload<span class="subclass"> SubClassOf </span>Iron Overload Adverse Event. <br><i>New Terms: CTCAE Grade 4 Iron Overload, Iron Overload Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3556</td>
               <td colspan="2">CTCAE Grade 4 Jejunum Fistula<span class="subclass"> SubClassOf </span>Jejunum Fistula Adverse Event. <br><i>New Terms: Jejunum Fistula Adverse Event, CTCAE Grade 4 Jejunum Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>3557</td>
               <td colspan="2">CTCAE Grade 4 Jejunum Hemorrhage<span class="subclass"> SubClassOf </span>Jejunum Hemorrhage Adverse Event. <br><i>New Terms: Jejunum Hemorrhage Adverse Event, CTCAE Grade 4 Jejunum Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>3558</td>
               <td colspan="2">CTCAE Grade 4 Jejunum Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Jejunum Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Jejunum Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Jejunum Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3559</td>
               <td colspan="2">CTCAE Grade 4 Jejunum Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Jejunum Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Jejunum Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 4 Jejunum Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3560</td>
               <td colspan="2">CTCAE Grade 4 Jejunum Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Jejunum Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Jejunum Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     4 Jejunum Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3561</td>
               <td colspan="2">CTCAE Grade 4 Jejunum Intra-Operative Injury<span class="subclass"> SubClassOf </span>Jejunum Intra-Operative Injury Adverse Event. <br><i>New Terms: Jejunum Intra-Operative Injury Adverse Event, CTCAE Grade 4 Jejunum Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3562</td>
               <td colspan="2">CTCAE Grade 4 Jejunum Necrosis<span class="subclass"> SubClassOf </span>Jejunum Necrosis Adverse Event. <br><i>New Terms: Jejunum Necrosis Adverse Event, CTCAE Grade 4 Jejunum Necrosis</i></td>
            </tr>
            <tr class="addition">
               <td>3563</td>
               <td colspan="2">CTCAE Grade 4 Jejunum Obstruction<span class="subclass"> SubClassOf </span>Jejunum Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 4 Jejunum Obstruction, Jejunum Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3564</td>
               <td colspan="2">CTCAE Grade 4 Jejunum Perforation<span class="subclass"> SubClassOf </span>Jejunum Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 4 Jejunum Perforation, Jejunum Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3565</td>
               <td colspan="2">CTCAE Grade 4 Jejunum Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Jejunum Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 4 Jejunum Stricture or Stenosis, Jejunum Stricture or Stenosis Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>3566</td>
               <td colspan="2">CTCAE Grade 4 Jejunum Ulcer<span class="subclass"> SubClassOf </span>Jejunum Ulcer Adverse Event. <br><i>New Terms: CTCAE Grade 4 Jejunum Ulcer, Jejunum Ulcer Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3567</td>
               <td colspan="2">CTCAE Grade 4 Joint Effusion<span class="subclass"> SubClassOf </span>Joint Effusion Adverse Event. <br><i>New Terms: Joint Effusion Adverse Event, CTCAE Grade 4 Joint Effusion</i></td>
            </tr>
            <tr class="addition">
               <td>3568</td>
               <td colspan="2">CTCAE Grade 4 Joint Function<span class="subclass"> SubClassOf </span>Joint Function Adverse Event. <br><i>New Terms: Joint Function Adverse Event, CTCAE Grade 4 Joint Function</i></td>
            </tr>
            <tr class="addition">
               <td>3569</td>
               <td colspan="2">CTCAE Grade 4 Joint Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Joint Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Joint Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 4 Joint Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3570</td>
               <td colspan="2">CTCAE Grade 4 Joint Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Joint Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Joint Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 4 Joint Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3571</td>
               <td colspan="2">CTCAE Grade 4 Joint Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Joint Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Joint Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     4 Joint Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3572</td>
               <td colspan="2">CTCAE Grade 4 Joint Intra-Operative Injury<span class="subclass"> SubClassOf </span>Joint Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Joint Intra-Operative Injury, Joint Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3573</td>
               <td colspan="2">CTCAE Grade 4 Joint Pain<span class="subclass"> SubClassOf </span>Joint Pain Adverse Event. <br><i>New Terms: CTCAE Grade 4 Joint Pain, Joint Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3574</td>
               <td colspan="2">CTCAE Grade 4 Jugular Vein Injury<span class="subclass"> SubClassOf </span>Jugular Vein Injury Adverse Event. <br><i>New Terms: Jugular Vein Injury Adverse Event, CTCAE Grade 4 Jugular Vein Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3575</td>
               <td colspan="2">CTCAE Grade 4 Jugular Vein Intra-Operative Injury<span class="subclass"> SubClassOf </span>Jugular Vein Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Jugular Vein Intra-Operative Injury, Jugular Vein Intra-Operative Injury
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3576</td>
               <td colspan="2">CTCAE Grade 4 Keratitis<span class="subclass"> SubClassOf </span>Keratitis Adverse Event. <br><i>New Terms: CTCAE Grade 4 Keratitis, Keratitis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3577</td>
               <td colspan="2">CTCAE Grade 4 Kidney Fistula<span class="subclass"> SubClassOf </span>Kidney Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 4 Kidney Fistula, Kidney Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3578</td>
               <td colspan="2">CTCAE Grade 4 Kidney Hemorrhage<span class="subclass"> SubClassOf </span>Kidney Hemorrhage Adverse Event. <br><i>New Terms: Kidney Hemorrhage Adverse Event, CTCAE Grade 4 Kidney Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>3579</td>
               <td colspan="2">CTCAE Grade 4 Kidney Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Kidney Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Kidney Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 4 Kidney Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3580</td>
               <td colspan="2">CTCAE Grade 4 Kidney Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Kidney Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Kidney Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 4 Kidney Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3581</td>
               <td colspan="2">CTCAE Grade 4 Kidney Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Kidney Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 4 Kidney Infection with Unknown Absolute Neutrophil Count, Kidney Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3582</td>
               <td colspan="2">CTCAE Grade 4 Kidney Intra-Operative Injury<span class="subclass"> SubClassOf </span>Kidney Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Kidney Intra-Operative Injury, Kidney Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>3583</td>
               <td colspan="2">CTCAE Grade 4 Kidney Leak<span class="subclass"> SubClassOf </span>Kidney Leak Adverse Event. <br><i>New Terms: CTCAE Grade 4 Kidney Leak, Kidney Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3584</td>
               <td colspan="2">CTCAE Grade 4 Kidney Pain<span class="subclass"> SubClassOf </span>Kidney Pain Adverse Event. <br><i>New Terms: Kidney Pain Adverse Event, CTCAE Grade 4 Kidney Pain</i></td>
            </tr>
            <tr class="addition">
               <td>3585</td>
               <td colspan="2">CTCAE Grade 4 Kidney Perforation<span class="subclass"> SubClassOf </span>Kidney Perforation Adverse Event. <br><i>New Terms: Kidney Perforation Adverse Event, CTCAE Grade 4 Kidney Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>3586</td>
               <td colspan="2">CTCAE Grade 4 Large Bowel Leak<span class="subclass"> SubClassOf </span>Large Bowel Leak Adverse Event. <br><i>New Terms: Large Bowel Leak Adverse Event, CTCAE Grade 4 Large Bowel Leak</i></td>
            </tr>
            <tr class="addition">
               <td>3587</td>
               <td colspan="2">CTCAE Grade 4 Large Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Large Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification. <br><i>New Terms: CTCAE Grade 4 Large Bowel Mucositis or Stomatitis by Clinical Examination Classification,
                     Large Bowel Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>3588</td>
               <td colspan="2">CTCAE Grade 4 Large Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Large Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: CTCAE Grade 4 Large Bowel Mucositis or Stomatitis by Functional or Symptomatic Classification,
                     Large Bowel Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>3589</td>
               <td colspan="2">CTCAE Grade 4 Laryngeal Nerve Dysfunction<span class="subclass"> SubClassOf </span>Laryngeal Nerve Dysfunction Adverse Event. <br><i>New Terms: CTCAE Grade 4 Laryngeal Nerve Dysfunction, Laryngeal Nerve Dysfunction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3590</td>
               <td colspan="2">CTCAE Grade 4 Larynx Edema<span class="subclass"> SubClassOf </span>Larynx Edema Adverse Event. <br><i>New Terms: CTCAE Grade 4 Larynx Edema, Larynx Edema Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3591</td>
               <td colspan="2">CTCAE Grade 4 Larynx Fistula<span class="subclass"> SubClassOf </span>Larynx Fistula Adverse Event. <br><i>New Terms: Larynx Fistula Adverse Event, CTCAE Grade 4 Larynx Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>3592</td>
               <td colspan="2">CTCAE Grade 4 Larynx Hemorrhage<span class="subclass"> SubClassOf </span>Larynx Hemorrhage Adverse Event. <br><i>New Terms: Larynx Hemorrhage Adverse Event, CTCAE Grade 4 Larynx Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>3593</td>
               <td colspan="2">CTCAE Grade 4 Larynx Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Larynx Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Larynx Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 4 Larynx Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3594</td>
               <td colspan="2">CTCAE Grade 4 Larynx Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Larynx Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Larynx Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 4 Larynx Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3595</td>
               <td colspan="2">CTCAE Grade 4 Larynx Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Larynx Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Larynx Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     4 Larynx Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3596</td>
               <td colspan="2">CTCAE Grade 4 Larynx Intra-Operative Injury<span class="subclass"> SubClassOf </span>Larynx Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Larynx Intra-Operative Injury, Larynx Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>3597</td>
               <td colspan="2">CTCAE Grade 4 Larynx Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Larynx Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification. <br><i>New Terms: Larynx Mucositis or Stomatitis by Clinical Examination Classification, CTCAE Grade
                     4 Larynx Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>3598</td>
               <td colspan="2">CTCAE Grade 4 Larynx Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Larynx Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: Larynx Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification,
                     CTCAE Grade 4 Larynx Mucositis or Stomatitis by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>3599</td>
               <td colspan="2">CTCAE Grade 4 Larynx Obstruction<br><span class="keyword"> and </span>Stenosis<span class="subclass"> SubClassOf </span>Larynx Obstruction<br><span class="keyword"> and </span>Stenosis Adverse Event. <br><i>New Terms: Larynx Obstruction and Stenosis Adverse Event, CTCAE Grade 4 Larynx Obstruction and
                     Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>3600</td>
               <td colspan="2">CTCAE Grade 4 Larynx Pain<span class="subclass"> SubClassOf </span>Larynx Pain Adverse Event. <br><i>New Terms: CTCAE Grade 4 Larynx Pain, Larynx Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3602</td>
               <td colspan="2">CTCAE Grade 4 Left Ventricular Diastolic Dysfunction<span class="subclass"> SubClassOf </span>Left Ventricular Diastolic Dysfunction Adverse Event. <br><i>New Terms: Left Ventricular Diastolic Dysfunction Adverse Event, CTCAE Grade 4 Left Ventricular
                     Diastolic Dysfunction</i></td>
            </tr>
            <tr class="addition">
               <td>3603</td>
               <td colspan="2">CTCAE Grade 4 Left Ventricular Systolic Dysfunction<span class="subclass"> SubClassOf </span>Left Ventricular Systolic Dysfunction Adverse Event. <br><i>New Terms: Left Ventricular Systolic Dysfunction Adverse Event, CTCAE Grade 4 Left Ventricular
                     Systolic Dysfunction</i></td>
            </tr>
            <tr class="addition">
               <td>3601</td>
               <td colspan="2">CTCAE Grade 4 Left-Sided Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Left-Sided Muscle Weakness Not Due to Neuropathy Adverse Event. <br><i>New Terms: Left-Sided Muscle Weakness Not Due to Neuropathy Adverse Event, CTCAE Grade 4 Left-Sided
                     Muscle Weakness Not Due to Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>3604</td>
               <td colspan="2">CTCAE Grade 4 Lens Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Lens Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Lens Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Lens Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3605</td>
               <td colspan="2">CTCAE Grade 4 Lens Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Lens Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Lens Infection with Normal Absolute Neutrophil Count or Grade 1 or 2
                     Neutrophils, Lens Infection Adverse Event with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3606</td>
               <td colspan="2">CTCAE Grade 4 Lens Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Lens Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 4 Lens Infection with Unknown Absolute Neutrophil Count, Lens Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3607</td>
               <td colspan="2">CTCAE Grade 4 Lens Intra-Operative Injury<span class="subclass"> SubClassOf </span>Lens Intra-Operative Injury Adverse Event. <br><i>New Terms: Lens Intra-Operative Injury Adverse Event, CTCAE Grade 4 Lens Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3608</td>
               <td colspan="2">CTCAE Grade 4 Leukocytes<span class="subclass"> SubClassOf </span>Leukocytes Adverse Event. <br><i>New Terms: CTCAE Grade 4 Leukocytes, Leukocytes Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3609</td>
               <td colspan="2">CTCAE Grade 4 Ligament Intra-Operative Injury<span class="subclass"> SubClassOf </span>Ligament Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Ligament Intra-Operative Injury, Ligament Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>3610</td>
               <td colspan="2">CTCAE Grade 4 Lingual Nerve Intra-Operative Injury<span class="subclass"> SubClassOf </span>Lingual Nerve Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Lingual Nerve Intra-Operative Injury, Lingual Nerve Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3611</td>
               <td colspan="2">CTCAE Grade 4 Lip Or Perioral Area Intra-Operative Injury<span class="subclass"> SubClassOf </span>Lip Or Perioral Area Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Lip Or Perioral Area Intra-Operative Injury, Lip Or Perioral Area Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3612</td>
               <td colspan="2">CTCAE Grade 4 Lip Pain<span class="subclass"> SubClassOf </span>Lip Pain Adverse Event. <br><i>New Terms: CTCAE Grade 4 Lip Pain, Lip Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3613</td>
               <td colspan="2">CTCAE Grade 4 Lip<br><span class="keyword"> or </span>Perioral Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Lip<br><span class="keyword"> or </span>Perioral Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Lip or Perioral Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, Lip or Perioral Infection Adverse Event Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3614</td>
               <td colspan="2">CTCAE Grade 4 Lip<br><span class="keyword"> or </span>Perioral Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Lip<br><span class="keyword"> or </span>Perioral Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Lip or Perioral Infection with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, Lip or Perioral Infection Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3615</td>
               <td colspan="2">CTCAE Grade 4 Lip<br><span class="keyword"> or </span>Perioral Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Lip<br><span class="keyword"> or </span>Perioral Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 4 Lip or Perioral Infection with Unknown Absolute Neutrophil Count, Lip
                     or Perioral Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3616</td>
               <td colspan="2">CTCAE Grade 4 Lipase<span class="subclass"> SubClassOf </span>Lipase Adverse Event. <br><i>New Terms: CTCAE Grade 4 Lipase, Lipase Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3617</td>
               <td colspan="2">CTCAE Grade 4 Liver Dysfunction<br><span class="keyword"> or </span>Failure by Clinical Classification<span class="subclass"> SubClassOf </span>Liver Dysfunction<br><span class="keyword"> or </span>Failure by Clinical Classification Adverse Event. <br><i>New Terms: CTCAE Grade 4 Liver Dysfunction or Failure by Clinical Classification, Liver Dysfunction
                     or Failure by Clinical Classification Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3618</td>
               <td colspan="2">CTCAE Grade 4 Liver Hemorrhage<span class="subclass"> SubClassOf </span>Liver Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 4 Liver Hemorrhage, Liver Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3619</td>
               <td colspan="2">CTCAE Grade 4 Liver Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Liver Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Liver Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 4 Liver Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3620</td>
               <td colspan="2">CTCAE Grade 4 Liver Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Liver Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Liver Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Liver Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3621</td>
               <td colspan="2">CTCAE Grade 4 Liver Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Liver Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Liver Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     4 Liver Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3622</td>
               <td colspan="2">CTCAE Grade 4 Liver Intra-Operative Injury<span class="subclass"> SubClassOf </span>Liver Intra-Operative Injury Adverse Event. <br><i>New Terms: Liver Intra-Operative Injury Adverse Event, CTCAE Grade 4 Liver Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3623</td>
               <td colspan="2">CTCAE Grade 4 Liver Pain<span class="subclass"> SubClassOf </span>Liver Pain Adverse Event. <br><i>New Terms: Liver Pain Adverse Event, CTCAE Grade 4 Liver Pain</i></td>
            </tr>
            <tr class="addition">
               <td>3624</td>
               <td colspan="2">CTCAE Grade 4 Local Complication of Device<br><span class="keyword"> and </span>Prosthesis<span class="subclass"> SubClassOf </span>Local Complication of Device<br><span class="keyword"> and </span>Prosthesis Adverse Event. <br><i>New Terms: Local Complication of Device and Prosthesis Adverse Event, CTCAE Grade 4 Local Complication
                     of Device and Prosthesis</i></td>
            </tr>
            <tr class="addition">
               <td>3625</td>
               <td colspan="2">CTCAE Grade 4 Low Serum Bicarbonate<span class="subclass"> SubClassOf </span>Low Serum Bicarbonate Adverse Event. <br><i>New Terms: CTCAE Grade 4 Low Serum Bicarbonate, Low Serum Bicarbonate Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3626</td>
               <td colspan="2">CTCAE Grade 4 Lower Extremity Artery Injury<span class="subclass"> SubClassOf </span>Lower Extremity Artery Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Lower Extremity Artery Injury, Lower Extremity Artery Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>3627</td>
               <td colspan="2">CTCAE Grade 4 Lower Extremity Artery Intra-Operative Injury<span class="subclass"> SubClassOf </span>Lower Extremity Artery Intra-Operative Injury Adverse Event. <br><i>New Terms: Lower Extremity Artery Intra-Operative Injury Adverse Event, CTCAE Grade 4 Lower Extremity
                     Artery Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3628</td>
               <td colspan="2">CTCAE Grade 4 Lower Extremity Gait<span class="subclass"> SubClassOf </span>Lower Extremity Gait Adverse Event. <br><i>New Terms: CTCAE Grade 4 Lower Extremity Gait, Lower Extremity Gait Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3629</td>
               <td colspan="2">CTCAE Grade 4 Lower Extremity Intra-Operative Injury<span class="subclass"> SubClassOf </span>Lower Extremity Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Lower Extremity Intra-Operative Injury, Lower Extremity Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3630</td>
               <td colspan="2">CTCAE Grade 4 Lower Extremity Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Lower Extremity Muscle Weakness Adverse Event Not Due to Neuropathy. <br><i>New Terms: Lower Extremity Muscle Weakness Adverse Event Not Due to Neuropathy, CTCAE Grade 4
                     Lower Extremity Muscle Weakness Not Due to Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>3631</td>
               <td colspan="2">CTCAE Grade 4 Lower Extremity Soft Tissue Necrosis<span class="subclass"> SubClassOf </span>Lower Extremity Soft Tissue Necrosis Adverse Event. <br><i>New Terms: Lower Extremity Soft Tissue Necrosis Adverse Event, CTCAE Grade 4 Lower Extremity
                     Soft Tissue Necrosis</i></td>
            </tr>
            <tr class="addition">
               <td>3632</td>
               <td colspan="2">CTCAE Grade 4 Lower Extremity Vein Injury<span class="subclass"> SubClassOf </span>Lower Extremity Vein Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Lower Extremity Vein Injury, Lower Extremity Vein Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3633</td>
               <td colspan="2">CTCAE Grade 4 Lower Extremity Vein Intra-Operative Injury<span class="subclass"> SubClassOf </span>Lower Extremity Vein Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Lower Extremity Vein Intra-Operative Injury, Lower Extremity Vein Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3634</td>
               <td colspan="2">CTCAE Grade 4 Lower Gastrointestinal Hemorrhage NOS<span class="subclass"> SubClassOf </span>Lower Gastrointestinal Hemorrhage Adverse Event NOS. <br><i>New Terms: Lower Gastrointestinal Hemorrhage Adverse Event NOS, CTCAE Grade 4 Lower Gastrointestinal
                     Hemorrhage NOS</i></td>
            </tr>
            <tr class="addition">
               <td>3635</td>
               <td colspan="2">CTCAE Grade 4 Lung Fistula<span class="subclass"> SubClassOf </span>Lung Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 4 Lung Fistula, Lung Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3636</td>
               <td colspan="2">CTCAE Grade 4 Lung Hemorrhage<span class="subclass"> SubClassOf </span>Lung Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 4 Lung Hemorrhage, Lung Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3637</td>
               <td colspan="2">CTCAE Grade 4 Lung Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Lung Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Lung Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Lung Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3638</td>
               <td colspan="2">CTCAE Grade 4 Lung Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Lung Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Lung Infection with Normal Absolute Neutrophil Count or Grade 1 or 2
                     Neutrophils, Lung Infection Adverse Event with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3639</td>
               <td colspan="2">CTCAE Grade 4 Lung Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Lung Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 4 Lung Infection with Unknown Absolute Neutrophil Count, Lung Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3640</td>
               <td colspan="2">CTCAE Grade 4 Lung Intra-Operative Injury<span class="subclass"> SubClassOf </span>Lung Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Lung Intra-Operative Injury, Lung Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3641</td>
               <td colspan="2">CTCAE Grade 4 Lung Thoracic Nerve Intra-Operative Injury<span class="subclass"> SubClassOf </span>Lung Thoracic Nerve Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Lung Thoracic Nerve Intra-Operative Injury, Lung Thoracic Nerve Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3642</td>
               <td colspan="2">CTCAE Grade 4 Lymph Node Pain<span class="subclass"> SubClassOf </span>Lymph Node Pain Adverse Event. <br><i>New Terms: Lymph Node Pain Adverse Event, CTCAE Grade 4 Lymph Node Pain</i></td>
            </tr>
            <tr class="addition">
               <td>3643</td>
               <td colspan="2">CTCAE Grade 4 Lymphatic Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Lymphatic Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Lymphatic Infection Adverse Event Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, CTCAE Grade 4 Lymphatic Infection Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3644</td>
               <td colspan="2">CTCAE Grade 4 Lymphatic Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Lymphatic Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Lymphatic Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, CTCAE Grade 4 Lymphatic Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3645</td>
               <td colspan="2">CTCAE Grade 4 Lymphatic Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Lymphatic Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 4 Lymphatic Infection with Unknown Absolute Neutrophil Count, Lymphatic
                     Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3646</td>
               <td colspan="2">CTCAE Grade 4 Lymphopenia<span class="subclass"> SubClassOf </span>Lymphopenia Adverse Event. <br><i>New Terms: Lymphopenia Adverse Event, CTCAE Grade 4 Lymphopenia</i></td>
            </tr>
            <tr class="addition">
               <td>3647</td>
               <td colspan="2">CTCAE Grade 4 Major Visceral Artery Intra-Operative Injury<span class="subclass"> SubClassOf </span>Major Visceral Artery Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Major Visceral Artery Intra-Operative Injury, Major Visceral Artery
                     Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3648</td>
               <td colspan="2">CTCAE Grade 4 Major Visceral Vein Intra-Operative Injury<span class="subclass"> SubClassOf </span>Major Visceral Vein Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Major Visceral Vein Intra-Operative Injury, Major Visceral Vein Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3649</td>
               <td colspan="2">CTCAE Grade 4 Malabsorption<span class="subclass"> SubClassOf </span>Malabsorption Adverse Event. <br><i>New Terms: CTCAE Grade 4 Malabsorption, Malabsorption Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3650</td>
               <td colspan="2">CTCAE Grade 4 Mediastinum Hemorrhage<span class="subclass"> SubClassOf </span>Mediastinum Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 4 Mediastinum Hemorrhage, Mediastinum Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3651</td>
               <td colspan="2">CTCAE Grade 4 Mediastinum Infection NOS Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Mediastinum Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Mediastinum Infection NOS Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, Mediastinum Infection NOS Adverse Event Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3652</td>
               <td colspan="2">CTCAE Grade 4 Mediastinum Infection NOS with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Mediastinum Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Mediastinum Infection NOS with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, Mediastinum Infection NOS Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3653</td>
               <td colspan="2">CTCAE Grade 4 Mediastinum Infection NOS with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Mediastinum Infection NOS Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Mediastinum Infection NOS Adverse Event with Unknown Absolute Neutrophil Count, CTCAE
                     Grade 4 Mediastinum Infection NOS with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3654</td>
               <td colspan="2">CTCAE Grade 4 Mediastinum Intra-Operative Injury<span class="subclass"> SubClassOf </span>Mediastinum Intra-Operative Injury Adverse Event. <br><i>New Terms: Mediastinum Intra-Operative Injury Adverse Event, CTCAE Grade 4 Mediastinum Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3655</td>
               <td colspan="2">CTCAE Grade 4 Memory Impairment<span class="subclass"> SubClassOf </span>Memory Impairment Adverse Event. <br><i>New Terms: CTCAE Grade 4 Memory Impairment, Memory Impairment Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3656</td>
               <td colspan="2">CTCAE Grade 4 Meninges Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Meninges Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Meninges Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 4 Meninges Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3657</td>
               <td colspan="2">CTCAE Grade 4 Meninges Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Meninges Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Meninges Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, CTCAE Grade 4 Meninges Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3658</td>
               <td colspan="2">CTCAE Grade 4 Meninges Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Meninges Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Meninges Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     4 Meninges Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3659</td>
               <td colspan="2">CTCAE Grade 4 Meninges Intra-Operative Injury<span class="subclass"> SubClassOf </span>Meninges Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Meninges Intra-Operative Injury, Meninges Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>3660</td>
               <td colspan="2">CTCAE Grade 4 Metabolic<br><span class="keyword"> or </span>Respiratory Acidosis<span class="subclass"> SubClassOf </span>Metabolic<br><span class="keyword"> or </span>Respiratory Acidosis Adverse Event. <br><i>New Terms: Metabolic or Respiratory Acidosis Adverse Event, CTCAE Grade 4 Metabolic or Respiratory
                     Acidosis</i></td>
            </tr>
            <tr class="addition">
               <td>3661</td>
               <td colspan="2">CTCAE Grade 4 Metabolic<br><span class="keyword"> or </span>Respiratory Alkalosis<span class="subclass"> SubClassOf </span>Metabolic<br><span class="keyword"> or </span>Respiratory Alkalosis Adverse Event. <br><i>New Terms: CTCAE Grade 4 Metabolic or Respiratory Alkalosis, Metabolic or Respiratory Alkalosis
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3662</td>
               <td colspan="2">CTCAE Grade 4 Middle Ear Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Middle Ear Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Middle Ear Infection Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, Middle Ear Infection Adverse Event Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3663</td>
               <td colspan="2">CTCAE Grade 4 Middle Ear Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Middle Ear Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Middle Ear Infection with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, Middle Ear Infection Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3664</td>
               <td colspan="2">CTCAE Grade 4 Middle Ear Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Middle Ear Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 4 Middle Ear Infection with Unknown Absolute Neutrophil Count, Middle
                     Ear Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3665</td>
               <td colspan="2">CTCAE Grade 4 Middle Ear Intra-Operative Injury<span class="subclass"> SubClassOf </span>Middle Ear Intra-Operative Injury Adverse Event. <br><i>New Terms: Middle Ear Intra-Operative Injury Adverse Event, CTCAE Grade 4 Middle Ear Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3666</td>
               <td colspan="2">CTCAE Grade 4 Middle Ear Pain<span class="subclass"> SubClassOf </span>Middle Ear Pain Adverse Event. <br><i>New Terms: Middle Ear Pain Adverse Event, CTCAE Grade 4 Middle Ear Pain</i></td>
            </tr>
            <tr class="addition">
               <td>3667</td>
               <td colspan="2">CTCAE Grade 4 Motor Neuropathy<span class="subclass"> SubClassOf </span>Motor Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 4 Motor Neuropathy, Motor Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3668</td>
               <td colspan="2">CTCAE Grade 4 Mucosa Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Mucosa Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Mucosa Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Mucosa Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3669</td>
               <td colspan="2">CTCAE Grade 4 Mucosa Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Mucosa Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Mucosa Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Mucosa Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3670</td>
               <td colspan="2">CTCAE Grade 4 Mucosa Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Mucosa Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Mucosa Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     4 Mucosa Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3671</td>
               <td colspan="2">CTCAE Grade 4 Muscle Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Muscle Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Muscle Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 4 Muscle Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3672</td>
               <td colspan="2">CTCAE Grade 4 Muscle Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Muscle Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Muscle Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 4 Muscle Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3673</td>
               <td colspan="2">CTCAE Grade 4 Muscle Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Muscle Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 4 Muscle Infection with Unknown Absolute Neutrophil Count, Muscle Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3674</td>
               <td colspan="2">CTCAE Grade 4 Muscle Intra-Operative Injury<span class="subclass"> SubClassOf </span>Muscle Intra-Operative Injury Adverse Event. <br><i>New Terms: Muscle Intra-Operative Injury Adverse Event, CTCAE Grade 4 Muscle Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3675</td>
               <td colspan="2">CTCAE Grade 4 Muscle Pain<span class="subclass"> SubClassOf </span>Muscle Pain Adverse Event. <br><i>New Terms: CTCAE Grade 4 Muscle Pain, Muscle Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3676</td>
               <td colspan="2">CTCAE Grade 4 Muscular<br><span class="keyword"> and </span>Skeletal Hypoplasia<span class="subclass"> SubClassOf </span>Muscular<br><span class="keyword"> and </span>Skeletal Hypoplasia Adverse Event. <br><i>New Terms: CTCAE Grade 4 Muscular and Skeletal Hypoplasia, Muscular and Skeletal Hypoplasia Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>3677</td>
               <td colspan="2">CTCAE Grade 4 Myelitis<span class="subclass"> SubClassOf </span>Myelitis Adverse Event. <br><i>New Terms: Myelitis Adverse Event, CTCAE Grade 4 Myelitis</i></td>
            </tr>
            <tr class="addition">
               <td>3678</td>
               <td colspan="2">CTCAE Grade 4 Myelodysplasia<span class="subclass"> SubClassOf </span>Myelodysplasia Adverse Event. <br><i>New Terms: CTCAE Grade 4 Myelodysplasia, Myelodysplasia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3679</td>
               <td colspan="2">CTCAE Grade 4 Myocarditis<span class="subclass"> SubClassOf </span>Myocarditis Adverse Event. <br><i>New Terms: CTCAE Grade 4 Myocarditis, Myocarditis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3680</td>
               <td colspan="2">CTCAE Grade 4 Myositis<span class="subclass"> SubClassOf </span>Myositis Adverse Event. <br><i>New Terms: CTCAE Grade 4 Myositis, Myositis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3681</td>
               <td colspan="2">CTCAE Grade 4 Nails Intra-Operative Injury<span class="subclass"> SubClassOf </span>Nails Intra-Operative Injury Adverse Event. <br><i>New Terms: Nails Intra-Operative Injury Adverse Event, CTCAE Grade 4 Nails Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3682</td>
               <td colspan="2">CTCAE Grade 4 Nasal Cavity Intra-Operative Injury<span class="subclass"> SubClassOf </span>Nasal Cavity Intra-Operative Injury Adverse Event. <br><i>New Terms: Nasal Cavity Intra-Operative Injury Adverse Event, CTCAE Grade 4 Nasal Cavity Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3683</td>
               <td colspan="2">CTCAE Grade 4 Nasal Cavity<br><span class="keyword"> and </span>Paranasal Sinus Reactions<span class="subclass"> SubClassOf </span>Nasal Cavity<br><span class="keyword"> and </span>Paranasal Sinus Reactions Adverse Event. <br><i>New Terms: CTCAE Grade 4 Nasal Cavity and Paranasal Sinus Reactions, Nasal Cavity and Paranasal
                     Sinus Reactions Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3684</td>
               <td colspan="2">CTCAE Grade 4 Nasopharynx Intra-Operative Injury<span class="subclass"> SubClassOf </span>Nasopharynx Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Nasopharynx Intra-Operative Injury, Nasopharynx Intra-Operative Injury
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3685</td>
               <td colspan="2">CTCAE Grade 4 Nausea<span class="subclass"> SubClassOf </span>Nausea Adverse Event. <br><i>New Terms: CTCAE Grade 4 Nausea, Nausea Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3686</td>
               <td colspan="2">CTCAE Grade 4 Neck Infection NOS Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Neck Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Neck Infection NOS Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 4 Neck Infection NOS Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3687</td>
               <td colspan="2">CTCAE Grade 4 Neck Infection NOS with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Neck Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Neck Infection NOS Adverse Event with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, CTCAE Grade 4 Neck Infection NOS with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3688</td>
               <td colspan="2">CTCAE Grade 4 Neck Infection NOS with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Neck Infection NOS Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 4 Neck Infection NOS with Unknown Absolute Neutrophil Count, Neck Infection
                     NOS Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3689</td>
               <td colspan="2">CTCAE Grade 4 Neck NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Neck NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: Neck NOS Intra-Operative Injury Adverse Event, CTCAE Grade 4 Neck NOS Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3690</td>
               <td colspan="2">CTCAE Grade 4 Neck Pain<span class="subclass"> SubClassOf </span>Neck Pain Adverse Event. <br><i>New Terms: Neck Pain Adverse Event, CTCAE Grade 4 Neck Pain</i></td>
            </tr>
            <tr class="addition">
               <td>3691</td>
               <td colspan="2">CTCAE Grade 4 Neck Soft Tissue Necrosis<span class="subclass"> SubClassOf </span>Neck Soft Tissue Necrosis Adverse Event. <br><i>New Terms: Neck Soft Tissue Necrosis Adverse Event, CTCAE Grade 4 Neck Soft Tissue Necrosis</i></td>
            </tr>
            <tr class="addition">
               <td>3692</td>
               <td colspan="2">CTCAE Grade 4 Neuralgia<br><span class="keyword"> and </span>Peripheral Nerve Pain<span class="subclass"> SubClassOf </span>Neuralgia<br><span class="keyword"> and </span>Peripheral Nerve Pain Adverse Event. <br><i>New Terms: Neuralgia and Peripheral Nerve Pain Adverse Event, CTCAE Grade 4 Neuralgia and Peripheral
                     Nerve Pain</i></td>
            </tr>
            <tr class="addition">
               <td>3693</td>
               <td colspan="2">CTCAE Grade 4 Neuroendocrine ACTH Deficiency<span class="subclass"> SubClassOf </span>Neuroendocrine ACTH Deficiency Adverse Event. <br><i>New Terms: Neuroendocrine ACTH Deficiency Adverse Event, CTCAE Grade 4 Neuroendocrine ACTH Deficiency</i></td>
            </tr>
            <tr class="addition">
               <td>3694</td>
               <td colspan="2">CTCAE Grade 4 Neuroendocrine ADH Secretion Abnormality<span class="subclass"> SubClassOf </span>Neuroendocrine ADH Secretion Abnormality Adverse Event. <br><i>New Terms: CTCAE Grade 4 Neuroendocrine ADH Secretion Abnormality, Neuroendocrine ADH Secretion
                     Abnormality Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3695</td>
               <td colspan="2">CTCAE Grade 4 Neutrophils<br><span class="keyword"> and </span>Granulocytes<span class="subclass"> SubClassOf </span>Neutrophils<br><span class="keyword"> and </span>Granulocytes Adverse Event. <br><i>New Terms: Neutrophils and Granulocytes Adverse Event, CTCAE Grade 4 Neutrophils and Granulocytes</i></td>
            </tr>
            <tr class="addition">
               <td>3696</td>
               <td colspan="2">CTCAE Grade 4 Nodal<br><span class="keyword"> or </span>Junctional Rhythm<span class="subclass"> SubClassOf </span>Nodal<br><span class="keyword"> or </span>Junctional Rhythm Adverse Event. <br><i>New Terms: CTCAE Grade 4 Nodal or Junctional Rhythm, Nodal or Junctional Rhythm Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3697</td>
               <td colspan="2">CTCAE Grade 4 Non-Fatal Cardiopulmonary Arrest Cause Unknown<span class="subclass"> SubClassOf </span>Non-Fatal Cardiopulmonary Arrest Adverse Event Cause Unknown. <br><i>New Terms: Non-Fatal Cardiopulmonary Arrest Adverse Event Cause Unknown, CTCAE Grade 4 Non-Fatal
                     Cardiopulmonary Arrest Cause Unknown</i></td>
            </tr>
            <tr class="addition">
               <td>3698</td>
               <td colspan="2">CTCAE Grade 4 Non-Infectious Wound Complication<span class="subclass"> SubClassOf </span>Non-Infectious Wound Complication Adverse Event. <br><i>New Terms: CTCAE Grade 4 Non-Infectious Wound Complication, Non-Infectious Wound Complication
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3699</td>
               <td colspan="2">CTCAE Grade 4 Non-Malignant Ascites<span class="subclass"> SubClassOf </span>Non-Malignant Ascites Adverse Event. <br><i>New Terms: CTCAE Grade 4 Non-Malignant Ascites, Non-Malignant Ascites Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3700</td>
               <td colspan="2">CTCAE Grade 4 Non-Malignant Pericardial Effusion<span class="subclass"> SubClassOf </span>Non-Malignant Pericardial Effusion Adverse Event. <br><i>New Terms: Non-Malignant Pericardial Effusion Adverse Event, CTCAE Grade 4 Non-Malignant Pericardial
                     Effusion</i></td>
            </tr>
            <tr class="addition">
               <td>3701</td>
               <td colspan="2">CTCAE Grade 4 Non-Malignant Pleural Effusion<span class="subclass"> SubClassOf </span>Non-Malignant Pleural Effusion Adverse Event. <br><i>New Terms: Non-Malignant Pleural Effusion Adverse Event, CTCAE Grade 4 Non-Malignant Pleural
                     Effusion</i></td>
            </tr>
            <tr class="addition">
               <td>3702</td>
               <td colspan="2">CTCAE Grade 4 Non-Myocardial Visceral Arterial Ischemia<span class="subclass"> SubClassOf </span>Non-Myocardial Visceral Arterial Ischemia Adverse Event. <br><i>New Terms: CTCAE Grade 4 Non-Myocardial Visceral Arterial Ischemia, Non-Myocardial Visceral Arterial
                     Ischemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3703</td>
               <td colspan="2">CTCAE Grade 4 Non-Septic Arthritis<span class="subclass"> SubClassOf </span>Non-Septic Arthritis Adverse Event. <br><i>New Terms: CTCAE Grade 4 Non-Septic Arthritis, Non-Septic Arthritis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3704</td>
               <td colspan="2">CTCAE Grade 4 Nose Hemorrhage<span class="subclass"> SubClassOf </span>Nose Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 4 Nose Hemorrhage, Nose Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3705</td>
               <td colspan="2">CTCAE Grade 4 Nose Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Nose Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Nose Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Nose Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3706</td>
               <td colspan="2">CTCAE Grade 4 Nose Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Nose Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Nose Infection with Normal Absolute Neutrophil Count or Grade 1 or 2
                     Neutrophils, Nose Infection Adverse Event with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3707</td>
               <td colspan="2">CTCAE Grade 4 Nose Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Nose Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 4 Nose Infection with Unknown Absolute Neutrophil Count, Nose Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3708</td>
               <td colspan="2">CTCAE Grade 4 Nose Intra-Operative Injury<span class="subclass"> SubClassOf </span>Nose Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Nose Intra-Operative Injury, Nose Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3709</td>
               <td colspan="2">CTCAE Grade 4 Nyctalopia<span class="subclass"> SubClassOf </span>Nyctalopia Adverse Event. <br><i>New Terms: CTCAE Grade 4 Nyctalopia, Nyctalopia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3710</td>
               <td colspan="2">CTCAE Grade 4 Nystagmus<span class="subclass"> SubClassOf </span>Nystagmus Adverse Event. <br><i>New Terms: CTCAE Grade 4 Nystagmus, Nystagmus Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3711</td>
               <td colspan="2">CTCAE Grade 4 Obesity<span class="subclass"> SubClassOf </span>Obesity Adverse Event. <br><i>New Terms: CTCAE Grade 4 Obesity, Obesity Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3712</td>
               <td colspan="2">CTCAE Grade 4 Ocular Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Ocular Muscle Weakness Not Due to Neuropathy Adverse Event. <br><i>New Terms: Ocular Muscle Weakness Not Due to Neuropathy Adverse Event, CTCAE Grade 4 Ocular Muscle
                     Weakness Not Due to Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>3713</td>
               <td colspan="2">CTCAE Grade 4 Ophthalmoplegia<br><span class="keyword"> and </span>Diplopia<span class="subclass"> SubClassOf </span>Ophthalmoplegia<br><span class="keyword"> and </span>Diplopia Adverse Event. <br><i>New Terms: CTCAE Grade 4 Ophthalmoplegia and Diplopia, Ophthalmoplegia and Diplopia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3714</td>
               <td colspan="2">CTCAE Grade 4 Opportunistic Infection<span class="subclass"> SubClassOf </span>Opportunistic Infection Adverse Event Associated with Grade 2<br><span class="keyword"> or </span>Greater Lymphopenia. <br><i>New Terms: Opportunistic Infection Adverse Event Associated with Grade 2 or Greater Lymphopenia,
                     CTCAE Grade 4 Opportunistic Infection</i></td>
            </tr>
            <tr class="addition">
               <td>3715</td>
               <td colspan="2">CTCAE Grade 4 Optic Disc Edema<span class="subclass"> SubClassOf </span>Optic Disc Edema Adverse Event. <br><i>New Terms: CTCAE Grade 4 Optic Disc Edema, Optic Disc Edema Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3716</td>
               <td colspan="2">CTCAE Grade 4 Oral Cavity GI Fistula<span class="subclass"> SubClassOf </span>Oral Cavity GI Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 4 Oral Cavity GI Fistula, Oral Cavity GI Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3717</td>
               <td colspan="2">CTCAE Grade 4 Oral Cavity Hemorrhage<span class="subclass"> SubClassOf </span>Oral Cavity Adverse Event Hemorrhage. <br><i>New Terms: Oral Cavity Adverse Event Hemorrhage, CTCAE Grade 4 Oral Cavity Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>3718</td>
               <td colspan="2">CTCAE Grade 4 Oral Cavity Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Oral Cavity Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification. <br><i>New Terms: CTCAE Grade 4 Oral Cavity Mucositis or Stomatitis by Clinical Examination Classification,
                     Oral Cavity Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>3719</td>
               <td colspan="2">CTCAE Grade 4 Oral Cavity Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Oral Cavity Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: CTCAE Grade 4 Oral Cavity Mucositis or Stomatitis by Functional or Symptomatic Classification,
                     Oral Cavity Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>3720</td>
               <td colspan="2">CTCAE Grade 4 Oral Cavity NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Oral Cavity NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Oral Cavity NOS Intra-Operative Injury, Oral Cavity NOS Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3721</td>
               <td colspan="2">CTCAE Grade 4 Oral Cavity Pain<span class="subclass"> SubClassOf </span>Oral Cavity Pain Adverse Event. <br><i>New Terms: CTCAE Grade 4 Oral Cavity Pain, Oral Cavity Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3722</td>
               <td colspan="2">CTCAE Grade 4 Oral Cavity Pulmonary Fistula<span class="subclass"> SubClassOf </span>Oral Cavity Pulmonary Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 4 Oral Cavity Pulmonary Fistula, Oral Cavity Pulmonary Fistula Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>3723</td>
               <td colspan="2">CTCAE Grade 4 Oral Cavity<br><span class="keyword"> or </span>Gum Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Oral Cavity<br><span class="keyword"> or </span>Gum Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Oral Cavity or Gum Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, Oral Cavity or Gum Infection Adverse Event Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3724</td>
               <td colspan="2">CTCAE Grade 4 Oral Cavity<br><span class="keyword"> or </span>Gum Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Oral Cavity<br><span class="keyword"> or </span>Gum Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Oral Cavity or Gum Infection Adverse Event with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils, CTCAE Grade 4 Oral Cavity or Gum Infection with Normal Absolute
                     Neutrophil Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3725</td>
               <td colspan="2">CTCAE Grade 4 Oral Cavity<br><span class="keyword"> or </span>Gum Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Oral Cavity<br><span class="keyword"> or </span>Gum Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Oral Cavity or Gum Infection Adverse Event with Unknown Absolute Neutrophil Count,
                     CTCAE Grade 4 Oral Cavity or Gum Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3726</td>
               <td colspan="2">CTCAE Grade 4 Oral Intra-Operative Injury<span class="subclass"> SubClassOf </span>Oral Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Oral Intra-Operative Injury, Oral Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3727</td>
               <td colspan="2">CTCAE Grade 4 Oral Necrosis<span class="subclass"> SubClassOf </span>Oral Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 4 Oral Necrosis, Oral Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3728</td>
               <td colspan="2">CTCAE Grade 4 Oral Pain of the Gums<span class="subclass"> SubClassOf </span>Oral Pain of the Gums Adverse Event. <br><i>New Terms: Oral Pain of the Gums Adverse Event, CTCAE Grade 4 Oral Pain of the Gums</i></td>
            </tr>
            <tr class="addition">
               <td>3729</td>
               <td colspan="2">CTCAE Grade 4 Osteoporosis<span class="subclass"> SubClassOf </span>Osteoporosis Adverse Event. <br><i>New Terms: Osteoporosis Adverse Event, CTCAE Grade 4 Osteoporosis</i></td>
            </tr>
            <tr class="addition">
               <td>3730</td>
               <td colspan="2">CTCAE Grade 4 Other Allergy<br><span class="keyword"> and </span>Immunology<span class="subclass"> SubClassOf </span>Other Allergy<br><span class="keyword"> and </span>Immunology Adverse Event. <br><i>New Terms: CTCAE Grade 4 Other Allergy and Immunology, Other Allergy and Immunology Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3731</td>
               <td colspan="2">CTCAE Grade 4 Other Auditory<br><span class="keyword"> and </span>Ear<span class="subclass"> SubClassOf </span>Other Auditory<br><span class="keyword"> and </span>Ear Adverse Event. <br><i>New Terms: Other Auditory and Ear Adverse Event, CTCAE Grade 4 Other Auditory and Ear</i></td>
            </tr>
            <tr class="addition">
               <td>3732</td>
               <td colspan="2">CTCAE Grade 4 Other Blood<br><span class="keyword"> and </span>Bone Marrow<span class="subclass"> SubClassOf </span>Other Blood<br><span class="keyword"> and </span>Bone Marrow Adverse Event. <br><i>New Terms: Other Blood and Bone Marrow Adverse Event, CTCAE Grade 4 Other Blood and Bone Marrow</i></td>
            </tr>
            <tr class="addition">
               <td>3733</td>
               <td colspan="2">CTCAE Grade 4 Other Cardiac Arrhythmia<span class="subclass"> SubClassOf </span>Other Cardiac Arrhythmia Adverse Event. <br><i>New Terms: Other Cardiac Arrhythmia Adverse Event, CTCAE Grade 4 Other Cardiac Arrhythmia</i></td>
            </tr>
            <tr class="addition">
               <td>3734</td>
               <td colspan="2">CTCAE Grade 4 Other Coagulation<span class="subclass"> SubClassOf </span>Other Coagulation Adverse Event. <br><i>New Terms: CTCAE Grade 4 Other Coagulation, Other Coagulation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3735</td>
               <td colspan="2">CTCAE Grade 4 Other Constitutional Symptoms<span class="subclass"> SubClassOf </span>Other Constitutional Symptoms Adverse Event. <br><i>New Terms: Other Constitutional Symptoms Adverse Event, CTCAE Grade 4 Other Constitutional Symptoms</i></td>
            </tr>
            <tr class="addition">
               <td>3736</td>
               <td colspan="2">CTCAE Grade 4 Other Dermatology<br><span class="keyword"> or </span>Skin<span class="subclass"> SubClassOf </span>Other Dermatology<br><span class="keyword"> or </span>Skin Adverse Event. <br><i>New Terms: Other Dermatology or Skin Adverse Event, CTCAE Grade 4 Other Dermatology or Skin</i></td>
            </tr>
            <tr class="addition">
               <td>3737</td>
               <td colspan="2">CTCAE Grade 4 Other Endocrine<span class="subclass"> SubClassOf </span>Other Endocrine Adverse Event. <br><i>New Terms: CTCAE Grade 4 Other Endocrine, Other Endocrine Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3738</td>
               <td colspan="2">CTCAE Grade 4 Other Gastrointestinal<span class="subclass"> SubClassOf </span>Other Gastrointestinal Adverse Event. <br><i>New Terms: Other Gastrointestinal Adverse Event, CTCAE Grade 4 Other Gastrointestinal</i></td>
            </tr>
            <tr class="addition">
               <td>3739</td>
               <td colspan="2">CTCAE Grade 4 Other Growth<br><span class="keyword"> and </span>Development<span class="subclass"> SubClassOf </span>Other Growth<br><span class="keyword"> and </span>Development Adverse Event. <br><i>New Terms: Other Growth and Development Adverse Event, CTCAE Grade 4 Other Growth and Development</i></td>
            </tr>
            <tr class="addition">
               <td>3740</td>
               <td colspan="2">CTCAE Grade 4 Other Heart in General<span class="subclass"> SubClassOf </span>Other Adverse Event Associated with the Heart in General. <br><i>New Terms: CTCAE Grade 4 Other Heart in General, Other Adverse Event Associated with the Heart
                     in General</i></td>
            </tr>
            <tr class="addition">
               <td>3741</td>
               <td colspan="2">CTCAE Grade 4 Other Hemorrhage<br><span class="keyword"> and </span>Bleeding<span class="subclass"> SubClassOf </span>Other Hemorrhage<br><span class="keyword"> and </span>Bleeding Adverse Event. <br><i>New Terms: Other Hemorrhage and Bleeding Adverse Event, CTCAE Grade 4 Other Hemorrhage and Bleeding</i></td>
            </tr>
            <tr class="addition">
               <td>3742</td>
               <td colspan="2">CTCAE Grade 4 Other Hepatobiliary<br><span class="keyword"> and </span>Pancreas<span class="subclass"> SubClassOf </span>Other Hepatobiliary<br><span class="keyword"> and </span>Pancreas Adverse Event. <br><i>New Terms: CTCAE Grade 4 Other Hepatobiliary and Pancreas, Other Hepatobiliary and Pancreas Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>3743</td>
               <td colspan="2">CTCAE Grade 4 Other Infection<span class="subclass"> SubClassOf </span>Infection Other Adverse Event. <br><i>New Terms: Infection Other Adverse Event, CTCAE Grade 4 Other Infection</i></td>
            </tr>
            <tr class="addition">
               <td>3744</td>
               <td colspan="2">CTCAE Grade 4 Other Intra-Operative Injury<span class="subclass"> SubClassOf </span>Other Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Other Intra-Operative Injury, Other Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3745</td>
               <td colspan="2">CTCAE Grade 4 Other Lymphatics<span class="subclass"> SubClassOf </span>Other Lymphatics Adverse Event. <br><i>New Terms: CTCAE Grade 4 Other Lymphatics, Other Lymphatics Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3746</td>
               <td colspan="2">CTCAE Grade 4 Other Metabolic<br><span class="keyword"> and </span>Laboratory<span class="subclass"> SubClassOf </span>Other Metabolic<br><span class="keyword"> and </span>Laboratory Adverse Event. <br><i>New Terms: CTCAE Grade 4 Other Metabolic and Laboratory, Other Metabolic and Laboratory Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>3747</td>
               <td colspan="2">CTCAE Grade 4 Other Musculoskeletal<br><span class="keyword"> and </span>Soft Tissue<span class="subclass"> SubClassOf </span>Other Musculoskeletal<br><span class="keyword"> and </span>Soft Tissue Adverse Event. <br><i>New Terms: CTCAE Grade 4 Other Musculoskeletal and Soft Tissue, Other Musculoskeletal and Soft
                     Tissue Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3748</td>
               <td colspan="2">CTCAE Grade 4 Other NOS Artery Injury<span class="subclass"> SubClassOf </span>Other NOS Artery Injury Adverse Event. <br><i>New Terms: Other NOS Artery Injury Adverse Event, CTCAE Grade 4 Other NOS Artery Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3749</td>
               <td colspan="2">CTCAE Grade 4 Other NOS Vein Injury<span class="subclass"> SubClassOf </span>Other NOS Vein Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Other NOS Vein Injury, Other NOS Vein Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3750</td>
               <td colspan="2">CTCAE Grade 4 Other Neurology<span class="subclass"> SubClassOf </span>Other Neurology Adverse Event. <br><i>New Terms: Other Neurology Adverse Event, CTCAE Grade 4 Other Neurology</i></td>
            </tr>
            <tr class="addition">
               <td>3751</td>
               <td colspan="2">CTCAE Grade 4 Other Ocular<br><span class="keyword"> and </span>Visual<span class="subclass"> SubClassOf </span>Other Ocular<br><span class="keyword"> and </span>Visual Adverse Event. <br><i>New Terms: Other Ocular and Visual Adverse Event, CTCAE Grade 4 Other Ocular and Visual</i></td>
            </tr>
            <tr class="addition">
               <td>3752</td>
               <td colspan="2">CTCAE Grade 4 Other Pain<span class="subclass"> SubClassOf </span>Other Pain Adverse Event. <br><i>New Terms: Other Pain Adverse Event, CTCAE Grade 4 Other Pain</i></td>
            </tr>
            <tr class="addition">
               <td>3753</td>
               <td colspan="2">CTCAE Grade 4 Other Pulmonary<br><span class="keyword"> and </span>Upper Respiratory<span class="subclass"> SubClassOf </span>Other Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Adverse Event. <br><i>New Terms: CTCAE Grade 4 Other Pulmonary and Upper Respiratory, Other Pulmonary and Upper Respiratory
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3754</td>
               <td colspan="2">CTCAE Grade 4 Other Renal<br><span class="keyword"> or </span>Genitourinary<span class="subclass"> SubClassOf </span>Renal<br><span class="keyword"> or </span>Genitourinary Other Adverse Event. <br><i>New Terms: Renal or Genitourinary Other Adverse Event, CTCAE Grade 4 Other Renal or Genitourinary</i></td>
            </tr>
            <tr class="addition">
               <td>3755</td>
               <td colspan="2">CTCAE Grade 4 Other Secondary Malignancy Possibly Related to Cancer Treatment<span class="subclass"> SubClassOf </span>Other Secondary Malignancy Possibly Related to Cancer Treatment Adverse Event. <br><i>New Terms: CTCAE Grade 4 Other Secondary Malignancy Possibly Related to Cancer Treatment, Other
                     Secondary Malignancy Possibly Related to Cancer Treatment Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3756</td>
               <td colspan="2">CTCAE Grade 4 Other Sexual Reproductive Function<span class="subclass"> SubClassOf </span>Other Sexual Reproductive Function Adverse Event. <br><i>New Terms: CTCAE Grade 4 Other Sexual Reproductive Function, Other Sexual Reproductive Function
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3757</td>
               <td colspan="2">CTCAE Grade 4 Other Syndromes<span class="subclass"> SubClassOf </span>Other Syndromes Adverse Event. <br><i>New Terms: Other Syndromes Adverse Event, CTCAE Grade 4 Other Syndromes</i></td>
            </tr>
            <tr class="addition">
               <td>3758</td>
               <td colspan="2">CTCAE Grade 4 Other Vascular<span class="subclass"> SubClassOf </span>Other Vascular Adverse Event. <br><i>New Terms: CTCAE Grade 4 Other Vascular, Other Vascular Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3759</td>
               <td colspan="2">CTCAE Grade 4 Otitis External Ear Non Infectious<span class="subclass"> SubClassOf </span>Otitis Adverse Event External Ear Non Infectious. <br><i>New Terms: Otitis Adverse Event External Ear Non Infectious, CTCAE Grade 4 Otitis External Ear
                     Non Infectious</i></td>
            </tr>
            <tr class="addition">
               <td>3760</td>
               <td colspan="2">CTCAE Grade 4 Otitis Middle Ear Non Infectious<span class="subclass"> SubClassOf </span>Otitis Adverse Event Middle Ear Non Infectious. <br><i>New Terms: CTCAE Grade 4 Otitis Middle Ear Non Infectious, Otitis Adverse Event Middle Ear Non
                     Infectious</i></td>
            </tr>
            <tr class="addition">
               <td>3761</td>
               <td colspan="2">CTCAE Grade 4 Outer Ear NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Outer Ear NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Outer Ear NOS Intra-Operative Injury, Outer Ear NOS Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3762</td>
               <td colspan="2">CTCAE Grade 4 Outer Ear Pinna Intra-Operative Injury<span class="subclass"> SubClassOf </span>Outer Ear Pinna Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Outer Ear Pinna Intra-Operative Injury, Outer Ear Pinna Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3763</td>
               <td colspan="2">CTCAE Grade 4 Ovary Hemorrhage<span class="subclass"> SubClassOf </span>Ovary Hemorrhage Adverse Event. <br><i>New Terms: Ovary Hemorrhage Adverse Event, CTCAE Grade 4 Ovary Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>3764</td>
               <td colspan="2">CTCAE Grade 4 Ovary Intra-Operative Injury<span class="subclass"> SubClassOf </span>Ovary Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Ovary Intra-Operative Injury, Ovary Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3765</td>
               <td colspan="2">CTCAE Grade 4 Ovary Perforation<span class="subclass"> SubClassOf </span>Ovary Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 4 Ovary Perforation, Ovary Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3766</td>
               <td colspan="2">CTCAE Grade 4 Ovulatory Pain<span class="subclass"> SubClassOf </span>Ovulatory Pain Adverse Event. <br><i>New Terms: CTCAE Grade 4 Ovulatory Pain, Ovulatory Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3767</td>
               <td colspan="2">CTCAE Grade 4 PVCs<span class="subclass"> SubClassOf </span>Premature Ventricular Contraction Adverse Event. <br><i>New Terms: Premature Ventricular Contraction Adverse Event, CTCAE Grade 4 PVCs</i></td>
            </tr>
            <tr class="addition">
               <td>3768</td>
               <td colspan="2">CTCAE Grade 4 Pain NOS<span class="subclass"> SubClassOf </span>Pain NOS Adverse Event. <br><i>New Terms: Pain NOS Adverse Event, CTCAE Grade 4 Pain NOS</i></td>
            </tr>
            <tr class="addition">
               <td>3769</td>
               <td colspan="2">CTCAE Grade 4 Pancreas Exocrine Enzyme Deficiency<span class="subclass"> SubClassOf </span>Pancreas Exocrine Enzyme Deficiency Adverse Event. <br><i>New Terms: CTCAE Grade 4 Pancreas Exocrine Enzyme Deficiency, Pancreas Exocrine Enzyme Deficiency
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3770</td>
               <td colspan="2">CTCAE Grade 4 Pancreas Fistula<span class="subclass"> SubClassOf </span>Pancreas Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 4 Pancreas Fistula, Pancreas Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3771</td>
               <td colspan="2">CTCAE Grade 4 Pancreas Hemorrhage<span class="subclass"> SubClassOf </span>Pancreas Hemorrhage Adverse Event. <br><i>New Terms: Pancreas Hemorrhage Adverse Event, CTCAE Grade 4 Pancreas Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>3772</td>
               <td colspan="2">CTCAE Grade 4 Pancreas Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Pancreas Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Pancreas Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Pancreas Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3773</td>
               <td colspan="2">CTCAE Grade 4 Pancreas Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Pancreas Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Pancreas Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, CTCAE Grade 4 Pancreas Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3774</td>
               <td colspan="2">CTCAE Grade 4 Pancreas Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Pancreas Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Pancreas Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     4 Pancreas Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3775</td>
               <td colspan="2">CTCAE Grade 4 Pancreas Intra-Operative Injury<span class="subclass"> SubClassOf </span>Pancreas Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Pancreas Intra-Operative Injury, Pancreas Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>3776</td>
               <td colspan="2">CTCAE Grade 4 Pancreas Leak<span class="subclass"> SubClassOf </span>Pancreas Leak Adverse Event. <br><i>New Terms: CTCAE Grade 4 Pancreas Leak, Pancreas Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3777</td>
               <td colspan="2">CTCAE Grade 4 Pancreas Necrosis<span class="subclass"> SubClassOf </span>Pancreas Necrosis Adverse Event. <br><i>New Terms: Pancreas Necrosis Adverse Event, CTCAE Grade 4 Pancreas Necrosis</i></td>
            </tr>
            <tr class="addition">
               <td>3778</td>
               <td colspan="2">CTCAE Grade 4 Pancreas<br><span class="keyword"> or </span>Pancreatic Duct Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Pancreas<br><span class="keyword"> or </span>Pancreatic Duct Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Pancreas or Pancreatic Duct Stricture or Stenosis Adverse Event, CTCAE Grade 4 Pancreas
                     or Pancreatic Duct Stricture or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>3779</td>
               <td colspan="2">CTCAE Grade 4 Pancreatic Duct Intra-Operative Injury<span class="subclass"> SubClassOf </span>Pancreatic Duct Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Pancreatic Duct Intra-Operative Injury, Pancreatic Duct Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3780</td>
               <td colspan="2">CTCAE Grade 4 Pancreatic Endocrine Glucose Intolerance<span class="subclass"> SubClassOf </span>Pancreatic Endocrine Glucose Intolerance Adverse Event. <br><i>New Terms: Pancreatic Endocrine Glucose Intolerance Adverse Event, CTCAE Grade 4 Pancreatic Endocrine
                     Glucose Intolerance</i></td>
            </tr>
            <tr class="addition">
               <td>3781</td>
               <td colspan="2">CTCAE Grade 4 Pancreatitis<span class="subclass"> SubClassOf </span>Pancreatitis Adverse Event. <br><i>New Terms: CTCAE Grade 4 Pancreatitis, Pancreatitis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3782</td>
               <td colspan="2">CTCAE Grade 4 Paranasal Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Paranasal Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Paranasal Infection Adverse Event Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, CTCAE Grade 4 Paranasal Infection Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3783</td>
               <td colspan="2">CTCAE Grade 4 Paranasal Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Paranasal Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Paranasal Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, CTCAE Grade 4 Paranasal Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3784</td>
               <td colspan="2">CTCAE Grade 4 Paranasal Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Paranasal Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 4 Paranasal Infection with Unknown Absolute Neutrophil Count, Paranasal
                     Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3785</td>
               <td colspan="2">CTCAE Grade 4 Parathyroid Intra-Operative Injury<span class="subclass"> SubClassOf </span>Parathyroid Intra-Operative Injury Adverse Event. <br><i>New Terms: Parathyroid Intra-Operative Injury Adverse Event, CTCAE Grade 4 Parathyroid Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3786</td>
               <td colspan="2">CTCAE Grade 4 Parotid Gland Intra-Operative Injury<span class="subclass"> SubClassOf </span>Parotid Gland Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Parotid Gland Intra-Operative Injury, Parotid Gland Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3787</td>
               <td colspan="2">CTCAE Grade 4 Pelvic Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Pelvic Muscle Weakness Not Due to Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 4 Pelvic Muscle Weakness Not Due to Neuropathy, Pelvic Muscle Weakness
                     Not Due to Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3788</td>
               <td colspan="2">CTCAE Grade 4 Pelvic Soft Tissue Necrosis<span class="subclass"> SubClassOf </span>Pelvic Soft Tissue Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 4 Pelvic Soft Tissue Necrosis, Pelvic Soft Tissue Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3789</td>
               <td colspan="2">CTCAE Grade 4 Pelvis Infection NOS Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Pelvis Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Pelvis Infection NOS Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, Pelvis Infection NOS Adverse Event Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3790</td>
               <td colspan="2">CTCAE Grade 4 Pelvis Infection NOS with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Pelvis Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Pelvis Infection NOS with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, Pelvis Infection NOS Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3791</td>
               <td colspan="2">CTCAE Grade 4 Pelvis Infection NOS with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Pelvis Infection NOS Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Pelvis Infection NOS Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     4 Pelvis Infection NOS with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3792</td>
               <td colspan="2">CTCAE Grade 4 Pelvis NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Pelvis Intra-Operative Injury Adverse Event. <br><i>New Terms: Pelvis Intra-Operative Injury Adverse Event, CTCAE Grade 4 Pelvis NOS Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3793</td>
               <td colspan="2">CTCAE Grade 4 Pelvis Pain<span class="subclass"> SubClassOf </span>Pelvis Pain Adverse Event. <br><i>New Terms: CTCAE Grade 4 Pelvis Pain, Pelvis Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3794</td>
               <td colspan="2">CTCAE Grade 4 Penis Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Penis Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Penis Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Penis Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3795</td>
               <td colspan="2">CTCAE Grade 4 Penis Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Penis Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Penis Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 4 Penis Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3796</td>
               <td colspan="2">CTCAE Grade 4 Penis Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Penis Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 4 Penis Infection with Unknown Absolute Neutrophil Count, Penis Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3797</td>
               <td colspan="2">CTCAE Grade 4 Penis Intra-Operative Injury<span class="subclass"> SubClassOf </span>Penis Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Penis Intra-Operative Injury, Penis Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3798</td>
               <td colspan="2">CTCAE Grade 4 Penis Pain<span class="subclass"> SubClassOf </span>Penis Pain Adverse Event. <br><i>New Terms: CTCAE Grade 4 Penis Pain, Penis Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3799</td>
               <td colspan="2">CTCAE Grade 4 Pericarditis<span class="subclass"> SubClassOf </span>Pericarditis Adverse Event. <br><i>New Terms: Pericarditis Adverse Event, CTCAE Grade 4 Pericarditis</i></td>
            </tr>
            <tr class="addition">
               <td>3800</td>
               <td colspan="2">CTCAE Grade 4 Pericardium Pain<span class="subclass"> SubClassOf </span>Pericardium Pain Adverse Event. <br><i>New Terms: CTCAE Grade 4 Pericardium Pain, Pericardium Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3801</td>
               <td colspan="2">CTCAE Grade 4 Perineum Pain<span class="subclass"> SubClassOf </span>Perineum Pain Adverse Event. <br><i>New Terms: Perineum Pain Adverse Event, CTCAE Grade 4 Perineum Pain</i></td>
            </tr>
            <tr class="addition">
               <td>3802</td>
               <td colspan="2">CTCAE Grade 4 Peripheral Arterial Ischemia<span class="subclass"> SubClassOf </span>Peripheral Arterial Ischemia Adverse Event. <br><i>New Terms: Peripheral Arterial Ischemia Adverse Event, CTCAE Grade 4 Peripheral Arterial Ischemia</i></td>
            </tr>
            <tr class="addition">
               <td>3803</td>
               <td colspan="2">CTCAE Grade 4 Peripheral Motor Nerve NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Peripheral Motor Nerve NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Peripheral Motor Nerve NOS Intra-Operative Injury, Peripheral Motor
                     Nerve NOS Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3804</td>
               <td colspan="2">CTCAE Grade 4 Peripheral Nerve Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Peripheral Nerve Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Peripheral Nerve Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, CTCAE Grade 4 Peripheral Nerve Infection Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3805</td>
               <td colspan="2">CTCAE Grade 4 Peripheral Nerve Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Peripheral Nerve Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Peripheral Nerve Infection Adverse Event with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils, CTCAE Grade 4 Peripheral Nerve Infection with Normal Absolute
                     Neutrophil Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3806</td>
               <td colspan="2">CTCAE Grade 4 Peripheral Nerve Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Peripheral Nerve Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Peripheral Nerve Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE
                     Grade 4 Peripheral Nerve Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3807</td>
               <td colspan="2">CTCAE Grade 4 Peripheral Sensory Nerve NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Peripheral Sensory Nerve NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: Peripheral Sensory Nerve NOS Intra-Operative Injury Adverse Event, CTCAE Grade 4 Peripheral
                     Sensory Nerve NOS Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3808</td>
               <td colspan="2">CTCAE Grade 4 Peristomal Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Peristomal Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Peristomal Infection Adverse Event Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, CTCAE Grade 4 Peristomal Infection Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3809</td>
               <td colspan="2">CTCAE Grade 4 Peristomal Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Peristomal Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Peristomal Infection with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, Peristomal Infection Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3810</td>
               <td colspan="2">CTCAE Grade 4 Peristomal Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Peristomal Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Peristomal Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     4 Peristomal Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3811</td>
               <td colspan="2">CTCAE Grade 4 Peritoneal Cavity Hemorrhage<span class="subclass"> SubClassOf </span>Peritoneal Hemorrhage Adverse Event. <br><i>New Terms: Peritoneal Hemorrhage Adverse Event, CTCAE Grade 4 Peritoneal Cavity Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>3812</td>
               <td colspan="2">CTCAE Grade 4 Peritoneal Cavity Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Peritoneal Cavity Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Peritoneal Cavity Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, CTCAE Grade 4 Peritoneal Cavity Infection Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3813</td>
               <td colspan="2">CTCAE Grade 4 Peritoneal Cavity Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Peritoneal Cavity Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Peritoneal Cavity Infection with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils, Peritoneal Cavity Infection Adverse Event with Normal Absolute
                     Neutrophil Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3814</td>
               <td colspan="2">CTCAE Grade 4 Peritoneal Cavity Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Peritoneal Cavity Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Peritoneal Cavity Infection Adverse Event with Unknown Absolute Neutrophil Count,
                     CTCAE Grade 4 Peritoneal Cavity Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3815</td>
               <td colspan="2">CTCAE Grade 4 Peritoneal Cavity Intra-Operative Injury<span class="subclass"> SubClassOf </span>Peritoneal Cavity Intra-Operative Injury Adverse Event. <br><i>New Terms: Peritoneal Cavity Intra-Operative Injury Adverse Event, CTCAE Grade 4 Peritoneal Cavity
                     Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3816</td>
               <td colspan="2">CTCAE Grade 4 Peritoneal Cavity Necrosis<span class="subclass"> SubClassOf </span>Peritoneal Cavity Necrosis Adverse Event. <br><i>New Terms: Peritoneal Cavity Necrosis Adverse Event, CTCAE Grade 4 Peritoneal Cavity Necrosis</i></td>
            </tr>
            <tr class="addition">
               <td>3817</td>
               <td colspan="2">CTCAE Grade 4 Peritoneum Pain<span class="subclass"> SubClassOf </span>Peritoneum Pain Adverse Event. <br><i>New Terms: Peritoneum Pain Adverse Event, CTCAE Grade 4 Peritoneum Pain</i></td>
            </tr>
            <tr class="addition">
               <td>3818</td>
               <td colspan="2">CTCAE Grade 4 Personality<br><span class="keyword"> and </span>Behavioral Change<span class="subclass"> SubClassOf </span>Personality<br><span class="keyword"> and </span>Behavioral Change Adverse Event. <br><i>New Terms: CTCAE Grade 4 Personality and Behavioral Change, Personality and Behavioral Change
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3819</td>
               <td colspan="2">CTCAE Grade 4 Phantom Pain Associated with Missing Limb<span class="subclass"> SubClassOf </span>Phantom Pain Associated with Missing Limb Adverse Event. <br><i>New Terms: Phantom Pain Associated with Missing Limb Adverse Event, CTCAE Grade 4 Phantom Pain
                     Associated with Missing Limb</i></td>
            </tr>
            <tr class="addition">
               <td>3820</td>
               <td colspan="2">CTCAE Grade 4 Pharynx GI Fistula<span class="subclass"> SubClassOf </span>Pharynx GI Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 4 Pharynx GI Fistula, Pharynx GI Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3821</td>
               <td colspan="2">CTCAE Grade 4 Pharynx Hemorrhage<span class="subclass"> SubClassOf </span>Pharynx Hemorrhage Adverse Event. <br><i>New Terms: Pharynx Hemorrhage Adverse Event, CTCAE Grade 4 Pharynx Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>3822</td>
               <td colspan="2">CTCAE Grade 4 Pharynx Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Pharynx Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Pharynx Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Pharynx Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3823</td>
               <td colspan="2">CTCAE Grade 4 Pharynx Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Pharynx Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Pharynx Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 4 Pharynx Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3824</td>
               <td colspan="2">CTCAE Grade 4 Pharynx Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Pharynx Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Pharynx Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     4 Pharynx Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3825</td>
               <td colspan="2">CTCAE Grade 4 Pharynx Intra-Operative Injury<span class="subclass"> SubClassOf </span>Pharynx Intra-Operative Injury Adverse Event. <br><i>New Terms: Pharynx Intra-Operative Injury Adverse Event, CTCAE Grade 4 Pharynx Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3826</td>
               <td colspan="2">CTCAE Grade 4 Pharynx Leak<span class="subclass"> SubClassOf </span>Pharynx Leak Adverse Event. <br><i>New Terms: CTCAE Grade 4 Pharynx Leak, Pharynx Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3827</td>
               <td colspan="2">CTCAE Grade 4 Pharynx Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Pharynx Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification. <br><i>New Terms: CTCAE Grade 4 Pharynx Mucositis or Stomatitis by Clinical Examination Classification,
                     Pharynx Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>3828</td>
               <td colspan="2">CTCAE Grade 4 Pharynx Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Pharynx Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: Pharynx Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification,
                     CTCAE Grade 4 Pharynx Mucositis or Stomatitis by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>3829</td>
               <td colspan="2">CTCAE Grade 4 Pharynx Necrosis<span class="subclass"> SubClassOf </span>Pharynx Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 4 Pharynx Necrosis, Pharynx Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3830</td>
               <td colspan="2">CTCAE Grade 4 Pharynx Obstruction<br><span class="keyword"> and </span>Stenosis<span class="subclass"> SubClassOf </span>Pharynx Obstruction<br><span class="keyword"> and </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 4 Pharynx Obstruction and Stenosis, Pharynx Obstruction and Stenosis Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>3831</td>
               <td colspan="2">CTCAE Grade 4 Pharynx Pulmonary Fistula<span class="subclass"> SubClassOf </span>Pharynx Pulmonary Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 4 Pharynx Pulmonary Fistula, Pharynx Pulmonary Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3832</td>
               <td colspan="2">CTCAE Grade 4 Pharynx Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Pharynx Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Pharynx Stricture or Stenosis Adverse Event, CTCAE Grade 4 Pharynx Stricture or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>3833</td>
               <td colspan="2">CTCAE Grade 4 Photophobia<span class="subclass"> SubClassOf </span>Photophobia Adverse Event. <br><i>New Terms: Photophobia Adverse Event, CTCAE Grade 4 Photophobia</i></td>
            </tr>
            <tr class="addition">
               <td>3834</td>
               <td colspan="2">CTCAE Grade 4 Photosensitivity<span class="subclass"> SubClassOf </span>Photosensitivity Adverse Event. <br><i>New Terms: CTCAE Grade 4 Photosensitivity, Photosensitivity Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3835</td>
               <td colspan="2">CTCAE Grade 4 Phrenic Nerve Dysfunction<span class="subclass"> SubClassOf </span>Phrenic Nerve Dysfunction Adverse Event. <br><i>New Terms: Phrenic Nerve Dysfunction Adverse Event, CTCAE Grade 4 Phrenic Nerve Dysfunction</i></td>
            </tr>
            <tr class="addition">
               <td>3836</td>
               <td colspan="2">CTCAE Grade 4 Pituitary Intra-Operative Injury<span class="subclass"> SubClassOf </span>Pituitary Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Pituitary Intra-Operative Injury, Pituitary Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>3837</td>
               <td colspan="2">CTCAE Grade 4 Platelets<span class="subclass"> SubClassOf </span>Platelets Adverse Event. <br><i>New Terms: CTCAE Grade 4 Platelets, Platelets Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3838</td>
               <td colspan="2">CTCAE Grade 4 Pleura Fistula<span class="subclass"> SubClassOf </span>Pleura Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 4 Pleura Fistula, Pleura Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3839</td>
               <td colspan="2">CTCAE Grade 4 Pleura Hemorrhage<span class="subclass"> SubClassOf </span>Pleura Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 4 Pleura Hemorrhage, Pleura Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3840</td>
               <td colspan="2">CTCAE Grade 4 Pleura Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Pleura Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Pleura Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Pleura Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3841</td>
               <td colspan="2">CTCAE Grade 4 Pleura Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Pleura Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Pleura Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 4 Pleura Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3842</td>
               <td colspan="2">CTCAE Grade 4 Pleura Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Pleura Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 4 Pleura Infection with Unknown Absolute Neutrophil Count, Pleura Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3843</td>
               <td colspan="2">CTCAE Grade 4 Pleura Intra-Operative Injury<span class="subclass"> SubClassOf </span>Pleura Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Pleura Intra-Operative Injury, Pleura Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>3844</td>
               <td colspan="2">CTCAE Grade 4 Pleura Pain<span class="subclass"> SubClassOf </span>Pleura Pain Adverse Event. <br><i>New Terms: Pleura Pain Adverse Event, CTCAE Grade 4 Pleura Pain</i></td>
            </tr>
            <tr class="addition">
               <td>3845</td>
               <td colspan="2">CTCAE Grade 4 Pneumonitis<br><span class="keyword"> and </span>Pulmonary Infiltrates<span class="subclass"> SubClassOf </span>Pneumonitis<br><span class="keyword"> and </span>Pulmonary Infiltrates Adverse Event. <br><i>New Terms: CTCAE Grade 4 Pneumonitis and Pulmonary Infiltrates, Pneumonitis and Pulmonary Infiltrates
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3846</td>
               <td colspan="2">CTCAE Grade 4 Pneumothorax<span class="subclass"> SubClassOf </span>Pneumothorax Adverse Event. <br><i>New Terms: Pneumothorax Adverse Event, CTCAE Grade 4 Pneumothorax</i></td>
            </tr>
            <tr class="addition">
               <td>3847</td>
               <td colspan="2">CTCAE Grade 4 Portal Vein Intra-Operative Injury<span class="subclass"> SubClassOf </span>Portal Vein Intra-Operative Injury Adverse Event. <br><i>New Terms: Portal Vein Intra-Operative Injury Adverse Event, CTCAE Grade 4 Portal Vein Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3848</td>
               <td colspan="2">CTCAE Grade 4 Proctitis<span class="subclass"> SubClassOf </span>Proctitis Adverse Event. <br><i>New Terms: Proctitis Adverse Event, CTCAE Grade 4 Proctitis</i></td>
            </tr>
            <tr class="addition">
               <td>3849</td>
               <td colspan="2">CTCAE Grade 4 Prolapse of Gastrointestinal Stoma<span class="subclass"> SubClassOf </span>Prolapse of Gastrointestinal Stoma Adverse Event. <br><i>New Terms: CTCAE Grade 4 Prolapse of Gastrointestinal Stoma, Prolapse of Gastrointestinal Stoma
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3850</td>
               <td colspan="2">CTCAE Grade 4 Prolonged Chest Tube Drainage<br><span class="keyword"> or </span>Air Leak After Pulmonary Resection<span class="subclass"> SubClassOf </span>Prolonged Chest Tube Drainage<br><span class="keyword"> or </span>Air Leak After Pulmonary Resection Adverse Event. <br><i>New Terms: CTCAE Grade 4 Prolonged Chest Tube Drainage or Air Leak After Pulmonary Resection,
                     Prolonged Chest Tube Drainage or Air Leak After Pulmonary Resection Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3851</td>
               <td colspan="2">CTCAE Grade 4 Prolonged Intubation After Pulmonary Resection<span class="subclass"> SubClassOf </span>Prolonged Intubation After Pulmonary Resection Adverse Event. <br><i>New Terms: Prolonged Intubation After Pulmonary Resection Adverse Event, CTCAE Grade 4 Prolonged
                     Intubation After Pulmonary Resection</i></td>
            </tr>
            <tr class="addition">
               <td>3852</td>
               <td colspan="2">CTCAE Grade 4 Prolonged QTc Interval<span class="subclass"> SubClassOf </span>Prolonged QTc Interval Adverse Event. <br><i>New Terms: CTCAE Grade 4 Prolonged QTc Interval, Prolonged QTc Interval Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3853</td>
               <td colspan="2">CTCAE Grade 4 Prostate Hemorrhage<span class="subclass"> SubClassOf </span>Prostate Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 4 Prostate Hemorrhage, Prostate Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3854</td>
               <td colspan="2">CTCAE Grade 4 Prostate Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Prostate Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Prostate Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Prostate Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3855</td>
               <td colspan="2">CTCAE Grade 4 Prostate Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Prostate Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Prostate Infection with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, Prostate Infection Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3856</td>
               <td colspan="2">CTCAE Grade 4 Prostate Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Prostate Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Prostate Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     4 Prostate Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3857</td>
               <td colspan="2">CTCAE Grade 4 Prostate Intra-Operative Injury<span class="subclass"> SubClassOf </span>Prostate Intra-Operative Injury Adverse Event. <br><i>New Terms: Prostate Intra-Operative Injury Adverse Event, CTCAE Grade 4 Prostate Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3858</td>
               <td colspan="2">CTCAE Grade 4 Prostate Obstruction<span class="subclass"> SubClassOf </span>Prostate Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 4 Prostate Obstruction, Prostate Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3859</td>
               <td colspan="2">CTCAE Grade 4 Prostate Pain<span class="subclass"> SubClassOf </span>Prostate Pain Adverse Event. <br><i>New Terms: CTCAE Grade 4 Prostate Pain, Prostate Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3860</td>
               <td colspan="2">CTCAE Grade 4 Prostate Perforation<span class="subclass"> SubClassOf </span>Prostate Perforation Adverse Event. <br><i>New Terms: Prostate Perforation Adverse Event, CTCAE Grade 4 Prostate Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>3861</td>
               <td colspan="2">CTCAE Grade 4 Prostate Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Prostate Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 4 Prostate Stricture or Stenosis, Prostate Stricture or Stenosis Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>3862</td>
               <td colspan="2">CTCAE Grade 4 Proteinuria<span class="subclass"> SubClassOf </span>Proteinuria Adverse Event. <br><i>New Terms: CTCAE Grade 4 Proteinuria, Proteinuria Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3863</td>
               <td colspan="2">CTCAE Grade 4 Psychosis Including Hallucinations<br><span class="keyword"> and </span>Delusions<span class="subclass"> SubClassOf </span>Psychosis Including Hallucinations<br><span class="keyword"> and </span>Delusions Adverse Event. <br><i>New Terms: CTCAE Grade 4 Psychosis Including Hallucinations and Delusions, Psychosis Including
                     Hallucinations and Delusions Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3865</td>
               <td colspan="2">CTCAE Grade 4 Pulmonary Fibrosis Radiographic Changes<span class="subclass"> SubClassOf </span>Pulmonary Fibrosis Radiographic Changes Adverse Event. <br><i>New Terms: Pulmonary Fibrosis Radiographic Changes Adverse Event, CTCAE Grade 4 Pulmonary Fibrosis
                     Radiographic Changes</i></td>
            </tr>
            <tr class="addition">
               <td>3866</td>
               <td colspan="2">CTCAE Grade 4 Pulmonary Hypertension<span class="subclass"> SubClassOf </span>Pulmonary Hypertension Adverse Event. <br><i>New Terms: CTCAE Grade 4 Pulmonary Hypertension, Pulmonary Hypertension Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3867</td>
               <td colspan="2">CTCAE Grade 4 Pulmonary Vein Intra-Operative Injury<span class="subclass"> SubClassOf </span>Pulmonary Vein Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Pulmonary Vein Intra-Operative Injury, Pulmonary Vein Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3868</td>
               <td colspan="2">CTCAE Grade 4 Pyramidal Tract Dysfunction<span class="subclass"> SubClassOf </span>Pyramidal Tract Dysfunction Adverse Event. <br><i>New Terms: CTCAE Grade 4 Pyramidal Tract Dysfunction, Pyramidal Tract Dysfunction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3869</td>
               <td colspan="2">CTCAE Grade 4 Radiation Excluding Chemoradiation<span class="subclass"> SubClassOf </span>Rash<br><span class="keyword"> and </span>Dermatitis Adverse Event Associated with Radiation Excluding Chemoradiation. <br><i>New Terms: CTCAE Grade 4 Radiation Excluding Chemoradiation, Rash and Dermatitis Adverse Event
                     Associated with Radiation Excluding Chemoradiation</i></td>
            </tr>
            <tr class="addition">
               <td>3870</td>
               <td colspan="2">CTCAE Grade 4 Rash Desquamation<span class="subclass"> SubClassOf </span>Rash Desquamation Adverse Event. <br><i>New Terms: Rash Desquamation Adverse Event, CTCAE Grade 4 Rash Desquamation</i></td>
            </tr>
            <tr class="addition">
               <td>3871</td>
               <td colspan="2">CTCAE Grade 4 Rash Erythema Multiforme<span class="subclass"> SubClassOf </span>Rash Erythema Multiforme Adverse Event. <br><i>New Terms: CTCAE Grade 4 Rash Erythema Multiforme, Rash Erythema Multiforme Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3872</td>
               <td colspan="2">CTCAE Grade 4 Rectal Varices Hemorrhage<span class="subclass"> SubClassOf </span>Rectal Varices Hemorrhage Adverse Event. <br><i>New Terms: Rectal Varices Hemorrhage Adverse Event, CTCAE Grade 4 Rectal Varices Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>3873</td>
               <td colspan="2">CTCAE Grade 4 Rectum Fistula<span class="subclass"> SubClassOf </span>Rectum Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 4 Rectum Fistula, Rectum Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3874</td>
               <td colspan="2">CTCAE Grade 4 Rectum Hemorrhage<span class="subclass"> SubClassOf </span>Rectum Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 4 Rectum Hemorrhage, Rectum Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3875</td>
               <td colspan="2">CTCAE Grade 4 Rectum Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Rectum Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Rectum Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Rectum Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3876</td>
               <td colspan="2">CTCAE Grade 4 Rectum Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Rectum Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Rectum Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 4 Rectum Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3877</td>
               <td colspan="2">CTCAE Grade 4 Rectum Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Rectum Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Rectum Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     4 Rectum Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3878</td>
               <td colspan="2">CTCAE Grade 4 Rectum Intra-Operative Injury<span class="subclass"> SubClassOf </span>Rectum Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Rectum Intra-Operative Injury, Rectum Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>3879</td>
               <td colspan="2">CTCAE Grade 4 Rectum Leak<span class="subclass"> SubClassOf </span>Rectum Leak Adverse Event. <br><i>New Terms: CTCAE Grade 4 Rectum Leak, Rectum Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3880</td>
               <td colspan="2">CTCAE Grade 4 Rectum Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Rectum Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification. <br><i>New Terms: CTCAE Grade 4 Rectum Mucositis or Stomatitis by Clinical Examination Classification,
                     Rectum Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>3881</td>
               <td colspan="2">CTCAE Grade 4 Rectum Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Rectum Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: Rectum Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification,
                     CTCAE Grade 4 Rectum Mucositis or Stomatitis by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>3882</td>
               <td colspan="2">CTCAE Grade 4 Rectum Necrosis<span class="subclass"> SubClassOf </span>Rectum Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 4 Rectum Necrosis, Rectum Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3883</td>
               <td colspan="2">CTCAE Grade 4 Rectum Obstruction<span class="subclass"> SubClassOf </span>Rectum Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 4 Rectum Obstruction, Rectum Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3884</td>
               <td colspan="2">CTCAE Grade 4 Rectum Pain<span class="subclass"> SubClassOf </span>Rectum Pain Adverse Event. <br><i>New Terms: CTCAE Grade 4 Rectum Pain, Rectum Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3885</td>
               <td colspan="2">CTCAE Grade 4 Rectum Perforation<span class="subclass"> SubClassOf </span>Rectum Perforation Adverse Event. <br><i>New Terms: Rectum Perforation Adverse Event, CTCAE Grade 4 Rectum Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>3886</td>
               <td colspan="2">CTCAE Grade 4 Rectum Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Rectum Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 4 Rectum Stricture or Stenosis, Rectum Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3887</td>
               <td colspan="2">CTCAE Grade 4 Rectum Ulcer<span class="subclass"> SubClassOf </span>Rectum Ulcer Adverse Event. <br><i>New Terms: CTCAE Grade 4 Rectum Ulcer, Rectum Ulcer Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3888</td>
               <td colspan="2">CTCAE Grade 4 Recurrent Laryngeal Nerve Intra-Operative Injury<span class="subclass"> SubClassOf </span>Recurrent Laryngeal Nerve Intra-Operative Injury Adverse Event. <br><i>New Terms: Recurrent Laryngeal Nerve Intra-Operative Injury Adverse Event, CTCAE Grade 4 Recurrent
                     Laryngeal Nerve Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3889</td>
               <td colspan="2">CTCAE Grade 4 Renal Failure<span class="subclass"> SubClassOf </span>Renal Failure Adverse Event. <br><i>New Terms: CTCAE Grade 4 Renal Failure, Renal Failure Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3890</td>
               <td colspan="2">CTCAE Grade 4 Respiratory Tract Hemorrhage NOS<span class="subclass"> SubClassOf </span>Respiratory Tract Hemorrhage Adverse Event NOS. <br><i>New Terms: CTCAE Grade 4 Respiratory Tract Hemorrhage NOS, Respiratory Tract Hemorrhage Adverse
                     Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>3891</td>
               <td colspan="2">CTCAE Grade 4 Restrictive Cardiomyopathy<span class="subclass"> SubClassOf </span>Restrictive Cardiomyopathy Adverse Event. <br><i>New Terms: Restrictive Cardiomyopathy Adverse Event, CTCAE Grade 4 Restrictive Cardiomyopathy</i></td>
            </tr>
            <tr class="addition">
               <td>3892</td>
               <td colspan="2">CTCAE Grade 4 Retina Intra-Operative Injury<span class="subclass"> SubClassOf </span>Retina Intra-Operative Injury Adverse Event. <br><i>New Terms: Retina Intra-Operative Injury Adverse Event, CTCAE Grade 4 Retina Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3893</td>
               <td colspan="2">CTCAE Grade 4 Retinal Detachment<span class="subclass"> SubClassOf </span>Retinal Detachment Adverse Event. <br><i>New Terms: Retinal Detachment Adverse Event, CTCAE Grade 4 Retinal Detachment</i></td>
            </tr>
            <tr class="addition">
               <td>3894</td>
               <td colspan="2">CTCAE Grade 4 Retinoic Acid Syndrome<span class="subclass"> SubClassOf </span>Retinoic Acid Syndrome Adverse Event. <br><i>New Terms: Retinoic Acid Syndrome Adverse Event, CTCAE Grade 4 Retinoic Acid Syndrome</i></td>
            </tr>
            <tr class="addition">
               <td>3895</td>
               <td colspan="2">CTCAE Grade 4 Retinopathy<span class="subclass"> SubClassOf </span>Retinopathy Adverse Event. <br><i>New Terms: Retinopathy Adverse Event, CTCAE Grade 4 Retinopathy</i></td>
            </tr>
            <tr class="addition">
               <td>3896</td>
               <td colspan="2">CTCAE Grade 4 Retroperitoneum Hemorrhage<span class="subclass"> SubClassOf </span>Retroperitoneum Hemorrhage Adverse Event. <br><i>New Terms: Retroperitoneum Hemorrhage Adverse Event, CTCAE Grade 4 Retroperitoneum Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>3898</td>
               <td colspan="2">CTCAE Grade 4 Right Ventricular Dysfunction<span class="subclass"> SubClassOf </span>Right Ventricular Dysfunction Adverse Event. <br><i>New Terms: Right Ventricular Dysfunction Adverse Event, CTCAE Grade 4 Right Ventricular Dysfunction</i></td>
            </tr>
            <tr class="addition">
               <td>3897</td>
               <td colspan="2">CTCAE Grade 4 Right-Sided Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Right-Sided Muscle Weakness Not Due to Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 4 Right-Sided Muscle Weakness Not Due to Neuropathy, Right-Sided Muscle
                     Weakness Not Due to Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3899</td>
               <td colspan="2">CTCAE Grade 4 Sacral Plexus Intra-Operative Injury<span class="subclass"> SubClassOf </span>Sacral Plexus Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Sacral Plexus Intra-Operative Injury, Sacral Plexus Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3900</td>
               <td colspan="2">CTCAE Grade 4 Salivary Duct Intra-Operative Injury<span class="subclass"> SubClassOf </span>Salivary Duct Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Salivary Duct Intra-Operative Injury, Salivary Duct Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3901</td>
               <td colspan="2">CTCAE Grade 4 Salivary Gland Fistula<span class="subclass"> SubClassOf </span>Salivary Gland Fistula. <br><i>New Terms: CTCAE Grade 4 Salivary Gland Fistula, Salivary Gland Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>3902</td>
               <td colspan="2">CTCAE Grade 4 Salivary Gland Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Salivary Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Salivary Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 4 Salivary Gland Infection Documented Clinically or
                     Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3903</td>
               <td colspan="2">CTCAE Grade 4 Salivary Gland Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Salivary Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Salivary Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, CTCAE Grade 4 Salivary Gland Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3904</td>
               <td colspan="2">CTCAE Grade 4 Salivary Gland Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Salivary Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Salivary Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     4 Salivary Gland Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3905</td>
               <td colspan="2">CTCAE Grade 4 Salivary Gland Intra-Operative Injury<span class="subclass"> SubClassOf </span>Salivary Gland Intra-Operative Injury Adverse Event. <br><i>New Terms: Salivary Gland Intra-Operative Injury Adverse Event, CTCAE Grade 4 Salivary Gland
                     Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3906</td>
               <td colspan="2">CTCAE Grade 4 Salivary Gland<br><span class="keyword"> or </span>Saliva Changes<span class="subclass"> SubClassOf </span>Salivary Gland<br><span class="keyword"> or </span>Saliva Changes Adverse Event. <br><i>New Terms: Salivary Gland or Saliva Changes Adverse Event, CTCAE Grade 4 Salivary Gland or Saliva
                     Changes</i></td>
            </tr>
            <tr class="addition">
               <td>3907</td>
               <td colspan="2">CTCAE Grade 4 Scalp Pain<span class="subclass"> SubClassOf </span>Scalp Pain Adverse Event. <br><i>New Terms: Scalp Pain Adverse Event, CTCAE Grade 4 Scalp Pain</i></td>
            </tr>
            <tr class="addition">
               <td>3908</td>
               <td colspan="2">CTCAE Grade 4 Sciatic Nerve Intra-Operative Injury<span class="subclass"> SubClassOf </span>Sciatic Nerve Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Sciatic Nerve Intra-Operative Injury, Sciatic Nerve Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3909</td>
               <td colspan="2">CTCAE Grade 4 Scleral Necrosis<br><span class="keyword"> and </span>Melt<span class="subclass"> SubClassOf </span>Scleral Necrosis<br><span class="keyword"> and </span>Melt Adverse Event. <br><i>New Terms: CTCAE Grade 4 Scleral Necrosis and Melt, Scleral Necrosis and Melt Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3910</td>
               <td colspan="2">CTCAE Grade 4 Scrotum Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Scrotum Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Scrotum Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Scrotum Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3911</td>
               <td colspan="2">CTCAE Grade 4 Scrotum Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Scrotum Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Scrotum Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Scrotum Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3912</td>
               <td colspan="2">CTCAE Grade 4 Scrotum Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Scrotum Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Scrotum Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     4 Scrotum Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3913</td>
               <td colspan="2">CTCAE Grade 4 Scrotum Intra-Operative Injury<span class="subclass"> SubClassOf </span>Scrotum Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Scrotum Intra-Operative Injury, Scrotum Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>3914</td>
               <td colspan="2">CTCAE Grade 4 Scrotum Pain<span class="subclass"> SubClassOf </span>Scrotum Pain Adverse Event. <br><i>New Terms: Scrotum Pain Adverse Event, CTCAE Grade 4 Scrotum Pain</i></td>
            </tr>
            <tr class="addition">
               <td>3915</td>
               <td colspan="2">CTCAE Grade 4 Seizure<span class="subclass"> SubClassOf </span>Seizure Adverse Event. <br><i>New Terms: CTCAE Grade 4 Seizure, Seizure Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3916</td>
               <td colspan="2">CTCAE Grade 4 Sensory Neuropathy<span class="subclass"> SubClassOf </span>Sensory Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 4 Sensory Neuropathy, Sensory Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3917</td>
               <td colspan="2">CTCAE Grade 4 Serum Glutamic Oxaloacetic Transaminase<span class="subclass"> SubClassOf </span>Serum Glutamic Oxaloacetic Transaminase Adverse Event. <br><i>New Terms: CTCAE Grade 4 Serum Glutamic Oxaloacetic Transaminase, Serum Glutamic Oxaloacetic
                     Transaminase Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3918</td>
               <td colspan="2">CTCAE Grade 4 Serum Glutamic Pyruvic Transaminase<span class="subclass"> SubClassOf </span>Serum Glutamic Pyruvic Transaminase Adverse Event. <br><i>New Terms: CTCAE Grade 4 Serum Glutamic Pyruvic Transaminase, Serum Glutamic Pyruvic Transaminase
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3919</td>
               <td colspan="2">CTCAE Grade 4 Serum Hypercalcemia<span class="subclass"> SubClassOf </span>Serum Hypercalcemia Adverse Event. <br><i>New Terms: CTCAE Grade 4 Serum Hypercalcemia, Serum Hypercalcemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3920</td>
               <td colspan="2">CTCAE Grade 4 Serum Hypercholesteremia<span class="subclass"> SubClassOf </span>Serum Hypercholesteremia Adverse Event. <br><i>New Terms: CTCAE Grade 4 Serum Hypercholesteremia, Serum Hypercholesteremia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3921</td>
               <td colspan="2">CTCAE Grade 4 Serum Hyperglycemia<span class="subclass"> SubClassOf </span>Serum Hyperglycemia Adverse Event. <br><i>New Terms: CTCAE Grade 4 Serum Hyperglycemia, Serum Hyperglycemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3922</td>
               <td colspan="2">CTCAE Grade 4 Serum Hyperkalemia<span class="subclass"> SubClassOf </span>Serum Hyperkalemia Adverse Event. <br><i>New Terms: Serum Hyperkalemia Adverse Event, CTCAE Grade 4 Serum Hyperkalemia</i></td>
            </tr>
            <tr class="addition">
               <td>3923</td>
               <td colspan="2">CTCAE Grade 4 Serum Hypermagnesemia<span class="subclass"> SubClassOf </span>Serum Hypermagnesemia Adverse Event. <br><i>New Terms: Serum Hypermagnesemia Adverse Event, CTCAE Grade 4 Serum Hypermagnesemia</i></td>
            </tr>
            <tr class="addition">
               <td>3924</td>
               <td colspan="2">CTCAE Grade 4 Serum Hypernatremia<span class="subclass"> SubClassOf </span>Serum Hypernatremia Adverse Event. <br><i>New Terms: Serum Hypernatremia Adverse Event, CTCAE Grade 4 Serum Hypernatremia</i></td>
            </tr>
            <tr class="addition">
               <td>3925</td>
               <td colspan="2">CTCAE Grade 4 Serum Hypertriglyceridemia<span class="subclass"> SubClassOf </span>Serum Hypertriglyceridemia Adverse Event. <br><i>New Terms: CTCAE Grade 4 Serum Hypertriglyceridemia, Serum Hypertriglyceridemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3926</td>
               <td colspan="2">CTCAE Grade 4 Serum Hyperuricemia<span class="subclass"> SubClassOf </span>Serum Hyperuricemia Adverse Event. <br><i>New Terms: CTCAE Grade 4 Serum Hyperuricemia, Serum Hyperuricemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3927</td>
               <td colspan="2">CTCAE Grade 4 Serum Hypocalcemia<span class="subclass"> SubClassOf </span>Serum Hypocalcemia Adverse Event. <br><i>New Terms: Serum Hypocalcemia Adverse Event, CTCAE Grade 4 Serum Hypocalcemia</i></td>
            </tr>
            <tr class="addition">
               <td>3928</td>
               <td colspan="2">CTCAE Grade 4 Serum Hypoglycemia<span class="subclass"> SubClassOf </span>Serum Hypoglycemia Adverse Event. <br><i>New Terms: CTCAE Grade 4 Serum Hypoglycemia, Serum Hypoglycemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3929</td>
               <td colspan="2">CTCAE Grade 4 Serum Hypokalemia<span class="subclass"> SubClassOf </span>Serum Hypokalemia Adverse Event. <br><i>New Terms: CTCAE Grade 4 Serum Hypokalemia, Serum Hypokalemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3930</td>
               <td colspan="2">CTCAE Grade 4 Serum Hypomagnesemia<span class="subclass"> SubClassOf </span>Serum Hypomagnesemia Adverse Event. <br><i>New Terms: Serum Hypomagnesemia Adverse Event, CTCAE Grade 4 Serum Hypomagnesemia</i></td>
            </tr>
            <tr class="addition">
               <td>3931</td>
               <td colspan="2">CTCAE Grade 4 Serum Hyponatremia<span class="subclass"> SubClassOf </span>Serum Hyponatremia Adverse Event. <br><i>New Terms: CTCAE Grade 4 Serum Hyponatremia, Serum Hyponatremia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3932</td>
               <td colspan="2">CTCAE Grade 4 Serum Hypophosphatemia<span class="subclass"> SubClassOf </span>Serum Hypophosphatemia Adverse Event. <br><i>New Terms: CTCAE Grade 4 Serum Hypophosphatemia, Serum Hypophosphatemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3933</td>
               <td colspan="2">CTCAE Grade 4 Sick Sinus Syndrome<span class="subclass"> SubClassOf </span>Sick Sinus Syndrome Adverse Event. <br><i>New Terms: CTCAE Grade 4 Sick Sinus Syndrome, Sick Sinus Syndrome Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3934</td>
               <td colspan="2">CTCAE Grade 4 Sinus Arrhythmia<span class="subclass"> SubClassOf </span>Sinus Arrhythmia Adverse Event. <br><i>New Terms: CTCAE Grade 4 Sinus Arrhythmia, Sinus Arrhythmia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3935</td>
               <td colspan="2">CTCAE Grade 4 Sinus Bradycardia<span class="subclass"> SubClassOf </span>Sinus Bradycardia Adverse Event. <br><i>New Terms: CTCAE Grade 4 Sinus Bradycardia, Sinus Bradycardia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3936</td>
               <td colspan="2">CTCAE Grade 4 Sinus Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Sinus Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Sinus Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 4 Sinus Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3937</td>
               <td colspan="2">CTCAE Grade 4 Sinus Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Sinus Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Sinus Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 4 Sinus Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3938</td>
               <td colspan="2">CTCAE Grade 4 Sinus Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Sinus Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 4 Sinus Infection with Unknown Absolute Neutrophil Count, Sinus Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3939</td>
               <td colspan="2">CTCAE Grade 4 Sinus Intra-Operative Injury<span class="subclass"> SubClassOf </span>Sinus Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Sinus Intra-Operative Injury, Sinus Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3940</td>
               <td colspan="2">CTCAE Grade 4 Sinus Pain<span class="subclass"> SubClassOf </span>Sinus Pain Adverse Event. <br><i>New Terms: Sinus Pain Adverse Event, CTCAE Grade 4 Sinus Pain</i></td>
            </tr>
            <tr class="addition">
               <td>3941</td>
               <td colspan="2">CTCAE Grade 4 Sinus Tachycardia<span class="subclass"> SubClassOf </span>Sinus Tachycardia Adverse Event. <br><i>New Terms: Sinus Tachycardia Adverse Event, CTCAE Grade 4 Sinus Tachycardia</i></td>
            </tr>
            <tr class="addition">
               <td>3942</td>
               <td colspan="2">CTCAE Grade 4 Skin Breakdown<br><span class="keyword"> or </span>Decubitus Ulcer<span class="subclass"> SubClassOf </span>Skin Breakdown<br><span class="keyword"> or </span>Decubitus Ulcer Adverse Event. <br><i>New Terms: CTCAE Grade 4 Skin Breakdown or Decubitus Ulcer, Skin Breakdown or Decubitus Ulcer
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3943</td>
               <td colspan="2">CTCAE Grade 4 Skin Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Skin Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Skin Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Skin Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3944</td>
               <td colspan="2">CTCAE Grade 4 Skin Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Skin Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Skin Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or 2
                     Neutrophils, CTCAE Grade 4 Skin Infection with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3945</td>
               <td colspan="2">CTCAE Grade 4 Skin Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Skin Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 4 Skin Infection with Unknown Absolute Neutrophil Count, Skin Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3946</td>
               <td colspan="2">CTCAE Grade 4 Skin Intra-Operative Injury<span class="subclass"> SubClassOf </span>Skin Intra-Operative Injury Adverse Event. <br><i>New Terms: Skin Intra-Operative Injury Adverse Event, CTCAE Grade 4 Skin Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3947</td>
               <td colspan="2">CTCAE Grade 4 Skin Pain<span class="subclass"> SubClassOf </span>Skin Pain Adverse Event. <br><i>New Terms: CTCAE Grade 4 Skin Pain, Skin Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3948</td>
               <td colspan="2">CTCAE Grade 4 Slipped Capital Femoral Epiphysis<span class="subclass"> SubClassOf </span>Slipped Capital Femoral Epiphysis Adverse Event. <br><i>New Terms: Slipped Capital Femoral Epiphysis Adverse Event, CTCAE Grade 4 Slipped Capital Femoral
                     Epiphysis</i></td>
            </tr>
            <tr class="addition">
               <td>3949</td>
               <td colspan="2">CTCAE Grade 4 Small Bowel Fistula NOS<span class="subclass"> SubClassOf </span>Small Bowel Fistula Adverse Event NOS. <br><i>New Terms: CTCAE Grade 4 Small Bowel Fistula NOS, Small Bowel Fistula Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>3950</td>
               <td colspan="2">CTCAE Grade 4 Small Bowel Infection NOS Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Small Bowel Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Small Bowel Infection NOS Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, Small Bowel Infection NOS Adverse Event Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3951</td>
               <td colspan="2">CTCAE Grade 4 Small Bowel Infection NOS with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Small Bowel Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Small Bowel Infection NOS Adverse Event with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, CTCAE Grade 4 Small Bowel Infection NOS with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3952</td>
               <td colspan="2">CTCAE Grade 4 Small Bowel Infection NOS with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Small Bowel Infection NOS Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Small Bowel Infection NOS Adverse Event with Unknown Absolute Neutrophil Count, CTCAE
                     Grade 4 Small Bowel Infection NOS with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3953</td>
               <td colspan="2">CTCAE Grade 4 Small Bowel Leak<span class="subclass"> SubClassOf </span>Small Bowel Leak Adverse Event. <br><i>New Terms: CTCAE Grade 4 Small Bowel Leak, Small Bowel Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3954</td>
               <td colspan="2">CTCAE Grade 4 Small Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Small Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification. <br><i>New Terms: CTCAE Grade 4 Small Bowel Mucositis or Stomatitis by Clinical Examination Classification,
                     Small Bowel Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>3955</td>
               <td colspan="2">CTCAE Grade 4 Small Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Small Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: CTCAE Grade 4 Small Bowel Mucositis or Stomatitis by Functional or Symptomatic Classification,
                     Small Bowel Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>3956</td>
               <td colspan="2">CTCAE Grade 4 Small Bowel NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Small Bowel NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: Small Bowel NOS Intra-Operative Injury Adverse Event, CTCAE Grade 4 Small Bowel NOS
                     Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3957</td>
               <td colspan="2">CTCAE Grade 4 Small Bowel Necrosis NOS<span class="subclass"> SubClassOf </span>Small Bowel Necrosis Adverse Event. <br><i>New Terms: Small Bowel Necrosis Adverse Event, CTCAE Grade 4 Small Bowel Necrosis NOS</i></td>
            </tr>
            <tr class="addition">
               <td>3958</td>
               <td colspan="2">CTCAE Grade 4 Small Bowel Obstruction NOS<span class="subclass"> SubClassOf </span>Small Bowel Obstruction Adverse Event NOS. <br><i>New Terms: Small Bowel Obstruction Adverse Event NOS, CTCAE Grade 4 Small Bowel Obstruction NOS</i></td>
            </tr>
            <tr class="addition">
               <td>3959</td>
               <td colspan="2">CTCAE Grade 4 Small Bowel Perforation NOS<span class="subclass"> SubClassOf </span>Small Bowel Perforation Adverse Event NOS. <br><i>New Terms: CTCAE Grade 4 Small Bowel Perforation NOS, Small Bowel Perforation Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>3960</td>
               <td colspan="2">CTCAE Grade 4 Small Bowel Stricture<br><span class="keyword"> or </span>Stenosis NOS<span class="subclass"> SubClassOf </span>Small Bowel Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event NOS. <br><i>New Terms: CTCAE Grade 4 Small Bowel Stricture or Stenosis NOS, Small Bowel Stricture or Stenosis
                     Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>3961</td>
               <td colspan="2">CTCAE Grade 4 Small Bowel Ulcer NOS<span class="subclass"> SubClassOf </span>Small Bowel Ulcer Adverse Event NOS. <br><i>New Terms: CTCAE Grade 4 Small Bowel Ulcer NOS, Small Bowel Ulcer Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>3962</td>
               <td colspan="2">CTCAE Grade 4 Soft Tissue Infection NOS Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Soft Tissue Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Soft Tissue Infection NOS Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, Soft Tissue Infection NOS Adverse Event Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3963</td>
               <td colspan="2">CTCAE Grade 4 Soft Tissue Infection NOS with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Soft Tissue Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Soft Tissue Infection NOS with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, Soft Tissue Infection NOS Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3964</td>
               <td colspan="2">CTCAE Grade 4 Soft Tissue Infection NOS with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Soft Tissue Infection NOS Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 4 Soft Tissue Infection NOS with Unknown Absolute Neutrophil Count, Soft
                     Tissue Infection NOS Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3965</td>
               <td colspan="2">CTCAE Grade 4 Soft Tissue NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Soft Tissue NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: Soft Tissue NOS Intra-Operative Injury Adverse Event, CTCAE Grade 4 Soft Tissue NOS
                     Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3966</td>
               <td colspan="2">CTCAE Grade 4 Somnolence<br><span class="keyword"> and </span>Depressed Level of Consciousness<span class="subclass"> SubClassOf </span>Somnolence<br><span class="keyword"> and </span>Depressed Level of Consciousness Adverse Event. <br><i>New Terms: Somnolence and Depressed Level of Consciousness Adverse Event, CTCAE Grade 4 Somnolence
                     and Depressed Level of Consciousness</i></td>
            </tr>
            <tr class="addition">
               <td>3967</td>
               <td colspan="2">CTCAE Grade 4 Speech Impairment<span class="subclass"> SubClassOf </span>Speech Impairment Adverse Event. <br><i>New Terms: Speech Impairment Adverse Event, CTCAE Grade 4 Speech Impairment</i></td>
            </tr>
            <tr class="addition">
               <td>3968</td>
               <td colspan="2">CTCAE Grade 4 Spermatic Cord Hemorrhage<span class="subclass"> SubClassOf </span>Spermatic Cord Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 4 Spermatic Cord Hemorrhage, Spermatic Cord Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3969</td>
               <td colspan="2">CTCAE Grade 4 Spermatic Cord Leak<span class="subclass"> SubClassOf </span>Spermatic Cord Leak Adverse Event. <br><i>New Terms: CTCAE Grade 4 Spermatic Cord Leak, Spermatic Cord Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3970</td>
               <td colspan="2">CTCAE Grade 4 Spermatic Cord Obstruction<span class="subclass"> SubClassOf </span>Spermatic Cord Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 4 Spermatic Cord Obstruction, Spermatic Cord Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3971</td>
               <td colspan="2">CTCAE Grade 4 Spermatic Cord Perforation<span class="subclass"> SubClassOf </span>Spermatic Cord Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 4 Spermatic Cord Perforation, Spermatic Cord Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3972</td>
               <td colspan="2">CTCAE Grade 4 Spermatic Cord Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Spermatic Cord Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Spermatic Cord Stricture or Stenosis Adverse Event, CTCAE Grade 4 Spermatic Cord Stricture
                     or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>3973</td>
               <td colspan="2">CTCAE Grade 4 Spinal Cord Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Spinal Cord Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Spinal Cord Infection Adverse Event Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, CTCAE Grade 4 Spinal Cord Infection Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3974</td>
               <td colspan="2">CTCAE Grade 4 Spinal Cord Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Spinal Cord Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Spinal Cord Infection with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, Spinal Cord Infection Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3975</td>
               <td colspan="2">CTCAE Grade 4 Spinal Cord Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Spinal Cord Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 4 Spinal Cord Infection with Unknown Absolute Neutrophil Count, Spinal
                     Cord Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3976</td>
               <td colspan="2">CTCAE Grade 4 Spinal Cord Intra-Operative Injury<span class="subclass"> SubClassOf </span>Spinal Cord Intra-Operative Injury Adverse Event. <br><i>New Terms: Spinal Cord Intra-Operative Injury Adverse Event, CTCAE Grade 4 Spinal Cord Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3977</td>
               <td colspan="2">CTCAE Grade 4 Spine Kyphosis<br><span class="keyword"> or </span>Lordosis<span class="subclass"> SubClassOf </span>Spine Kyphosis<br><span class="keyword"> or </span>Lordosis Adverse Event. <br><i>New Terms: Spine Kyphosis or Lordosis Adverse Event, CTCAE Grade 4 Spine Kyphosis or Lordosis</i></td>
            </tr>
            <tr class="addition">
               <td>3978</td>
               <td colspan="2">CTCAE Grade 4 Spine Scoliosis<span class="subclass"> SubClassOf </span>Spine Scoliosis Adverse Event. <br><i>New Terms: CTCAE Grade 4 Spine Scoliosis, Spine Scoliosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3979</td>
               <td colspan="2">CTCAE Grade 4 Spleen Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Spleen Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Spleen Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 4 Spleen Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3980</td>
               <td colspan="2">CTCAE Grade 4 Spleen Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Spleen Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Spleen Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Spleen Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3981</td>
               <td colspan="2">CTCAE Grade 4 Spleen Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Spleen Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Spleen Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     4 Spleen Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3982</td>
               <td colspan="2">CTCAE Grade 4 Spleen Intra-Operative Injury<span class="subclass"> SubClassOf </span>Spleen Intra-Operative Injury Adverse Event. <br><i>New Terms: Spleen Intra-Operative Injury Adverse Event, CTCAE Grade 4 Spleen Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3983</td>
               <td colspan="2">CTCAE Grade 4 Splenic Function<span class="subclass"> SubClassOf </span>Splenic Function Adverse Event. <br><i>New Terms: Splenic Function Adverse Event, CTCAE Grade 4 Splenic Function</i></td>
            </tr>
            <tr class="addition">
               <td>3984</td>
               <td colspan="2">CTCAE Grade 4 Stokes-Adams Syndrome<span class="subclass"> SubClassOf </span>Stokes-Adams Syndrome Adverse Event. <br><i>New Terms: CTCAE Grade 4 Stokes-Adams Syndrome, Stokes-Adams Syndrome Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3985</td>
               <td colspan="2">CTCAE Grade 4 Stoma GI Obstruction<span class="subclass"> SubClassOf </span>Gastrointestinal Stoma Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 4 Stoma GI Obstruction, Gastrointestinal Stoma Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3986</td>
               <td colspan="2">CTCAE Grade 4 Stoma GI Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Stoma GI Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Stoma GI Stricture or Stenosis Adverse Event, CTCAE Grade 4 Stoma GI Stricture or
                     Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>3987</td>
               <td colspan="2">CTCAE Grade 4 Stoma Necrosis<span class="subclass"> SubClassOf </span>Stoma Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 4 Stoma Necrosis, Stoma Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3988</td>
               <td colspan="2">CTCAE Grade 4 Stoma Perforation<span class="subclass"> SubClassOf </span>Stoma Perforation Adverse Event. <br><i>New Terms: Stoma Perforation Adverse Event, CTCAE Grade 4 Stoma Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>3989</td>
               <td colspan="2">CTCAE Grade 4 Stoma Pulmonary Hemorrhage<span class="subclass"> SubClassOf </span>Pulmonary Stoma Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 4 Stoma Pulmonary Hemorrhage, Pulmonary Stoma Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3990</td>
               <td colspan="2">CTCAE Grade 4 Stoma Ulcer<span class="subclass"> SubClassOf </span>Stoma Ulcer Adverse Event. <br><i>New Terms: CTCAE Grade 4 Stoma Ulcer, Stoma Ulcer Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3991</td>
               <td colspan="2">CTCAE Grade 4 Stomach Fistula<span class="subclass"> SubClassOf </span>Stomach Fistula Adverse Event. <br><i>New Terms: Stomach Fistula Adverse Event, CTCAE Grade 4 Stomach Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>3992</td>
               <td colspan="2">CTCAE Grade 4 Stomach Hemorrhage<span class="subclass"> SubClassOf </span>Stomach Hemorrhage Adverse Event. <br><i>New Terms: Stomach Hemorrhage Adverse Event, CTCAE Grade 4 Stomach Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>3993</td>
               <td colspan="2">CTCAE Grade 4 Stomach Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Stomach Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Stomach Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Stomach Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3994</td>
               <td colspan="2">CTCAE Grade 4 Stomach Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Stomach Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Stomach Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Stomach Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>3995</td>
               <td colspan="2">CTCAE Grade 4 Stomach Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Stomach Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 4 Stomach Infection with Unknown Absolute Neutrophil Count, Stomach Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>3996</td>
               <td colspan="2">CTCAE Grade 4 Stomach Intra-Operative Injury<span class="subclass"> SubClassOf </span>Stomach Intra-Operative Injury Adverse Event. <br><i>New Terms: Stomach Intra-Operative Injury Adverse Event, CTCAE Grade 4 Stomach Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3997</td>
               <td colspan="2">CTCAE Grade 4 Stomach Leak<span class="subclass"> SubClassOf </span>Stomach Leak Adverse Event. <br><i>New Terms: CTCAE Grade 4 Stomach Leak, Stomach Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>3998</td>
               <td colspan="2">CTCAE Grade 4 Stomach Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Stomach Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification. <br><i>New Terms: Stomach Mucositis or Stomatitis by Clinical Examination Classification, CTCAE Grade
                     4 Stomach Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>3999</td>
               <td colspan="2">CTCAE Grade 4 Stomach Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Stomach Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: CTCAE Grade 4 Stomach Mucositis or Stomatitis by Functional or Symptomatic Classification,
                     Stomach Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>4000</td>
               <td colspan="2">CTCAE Grade 4 Stomach Necrosis<span class="subclass"> SubClassOf </span>Stomach Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 4 Stomach Necrosis, Stomach Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4001</td>
               <td colspan="2">CTCAE Grade 4 Stomach Obstruction<span class="subclass"> SubClassOf </span>Stomach Obstruction Adverse Event. <br><i>New Terms: Stomach Obstruction Adverse Event, CTCAE Grade 4 Stomach Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>4002</td>
               <td colspan="2">CTCAE Grade 4 Stomach Pain<span class="subclass"> SubClassOf </span>Stomach Pain Adverse Event. <br><i>New Terms: Stomach Pain Adverse Event, CTCAE Grade 4 Stomach Pain</i></td>
            </tr>
            <tr class="addition">
               <td>4003</td>
               <td colspan="2">CTCAE Grade 4 Stomach Perforation<span class="subclass"> SubClassOf </span>Stomach Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 4 Stomach Perforation, Stomach Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4004</td>
               <td colspan="2">CTCAE Grade 4 Stomach Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Stomach Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 4 Stomach Stricture or Stenosis, Stomach Stricture or Stenosis Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>4005</td>
               <td colspan="2">CTCAE Grade 4 Stomach Ulcer<span class="subclass"> SubClassOf </span>Stomach Ulcer Adverse Event. <br><i>New Terms: CTCAE Grade 4 Stomach Ulcer, Stomach Ulcer Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4006</td>
               <td colspan="2">CTCAE Grade 4 Superior Vena Cava Intra-Operative Injury<span class="subclass"> SubClassOf </span>Superior Vena Cava Intra-Operative Injury Adverse Event. <br><i>New Terms: Superior Vena Cava Intra-Operative Injury Adverse Event, CTCAE Grade 4 Superior Vena
                     Cava Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>4007</td>
               <td colspan="2">CTCAE Grade 4 Superior Vena Cava Vein Injury<span class="subclass"> SubClassOf </span>Superior Vena Cava Vein Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Superior Vena Cava Vein Injury, Superior Vena Cava Vein Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>4008</td>
               <td colspan="2">CTCAE Grade 4 Supraventricular Arrhythmia NOS<span class="subclass"> SubClassOf </span>Supraventricular Arrhythmia Adverse Event NOS. <br><i>New Terms: CTCAE Grade 4 Supraventricular Arrhythmia NOS, Supraventricular Arrhythmia Adverse
                     Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>4009</td>
               <td colspan="2">CTCAE Grade 4 Supraventricular Extrasystoles<span class="subclass"> SubClassOf </span>Supraventricular Extrasystoles Adverse Event. <br><i>New Terms: Supraventricular Extrasystoles Adverse Event, CTCAE Grade 4 Supraventricular Extrasystoles</i></td>
            </tr>
            <tr class="addition">
               <td>4010</td>
               <td colspan="2">CTCAE Grade 4 Supraventricular Tachycardia<span class="subclass"> SubClassOf </span>Supraventricular Tachycardia Adverse Event. <br><i>New Terms: CTCAE Grade 4 Supraventricular Tachycardia, Supraventricular Tachycardia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4011</td>
               <td colspan="2">CTCAE Grade 4 Syncope<span class="subclass"> SubClassOf </span>Syncope Adverse Event. <br><i>New Terms: Syncope Adverse Event, CTCAE Grade 4 Syncope</i></td>
            </tr>
            <tr class="addition">
               <td>4012</td>
               <td colspan="2">CTCAE Grade 4 Teeth Intra-Operative Injury<span class="subclass"> SubClassOf </span>Teeth Intra-Operative Injury Adverse Event. <br><i>New Terms: Teeth Intra-Operative Injury Adverse Event, CTCAE Grade 4 Teeth Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>4013</td>
               <td colspan="2">CTCAE Grade 4 Tendon Intra-Operative Injury<span class="subclass"> SubClassOf </span>Tendon Intra-Operative Injury Adverse Event. <br><i>New Terms: Tendon Intra-Operative Injury Adverse Event, CTCAE Grade 4 Tendon Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>4014</td>
               <td colspan="2">CTCAE Grade 4 Testes Hemorrhage<span class="subclass"> SubClassOf </span>Testes Hemorrhage Adverse Event. <br><i>New Terms: Testes Hemorrhage Adverse Event, CTCAE Grade 4 Testes Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>4015</td>
               <td colspan="2">CTCAE Grade 4 Testes Obstruction<span class="subclass"> SubClassOf </span>Testes Obstruction Adverse Event. <br><i>New Terms: Testes Obstruction Adverse Event, CTCAE Grade 4 Testes Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>4016</td>
               <td colspan="2">CTCAE Grade 4 Testes Perforation<span class="subclass"> SubClassOf </span>Testes Perforation Adverse Event. <br><i>New Terms: Testes Perforation Adverse Event, CTCAE Grade 4 Testes Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>4017</td>
               <td colspan="2">CTCAE Grade 4 Testes Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Testes Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 4 Testes Stricture or Stenosis, Testes Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4018</td>
               <td colspan="2">CTCAE Grade 4 Testicle Pain<span class="subclass"> SubClassOf </span>Testicle Pain Adverse Event. <br><i>New Terms: Testicle Pain Adverse Event, CTCAE Grade 4 Testicle Pain</i></td>
            </tr>
            <tr class="addition">
               <td>4019</td>
               <td colspan="2">CTCAE Grade 4 Testis Intra-Operative Injury<span class="subclass"> SubClassOf </span>Testis Intra-Operative Injury Adverse Event. <br><i>New Terms: Testis Intra-Operative Injury Adverse Event, CTCAE Grade 4 Testis Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>4020</td>
               <td colspan="2">CTCAE Grade 4 Thoracic Duct Intra-Operative Injury<span class="subclass"> SubClassOf </span>Thoracic Duct Intra-Operative Injury Adverse Event. <br><i>New Terms: Thoracic Duct Intra-Operative Injury Adverse Event, CTCAE Grade 4 Thoracic Duct Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>4021</td>
               <td colspan="2">CTCAE Grade 4 Thoracodorsal Nerve Intra-Operative Injury<span class="subclass"> SubClassOf </span>Thoracodorsal Nerve Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Thoracodorsal Nerve Intra-Operative Injury, Thoracodorsal Nerve Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4022</td>
               <td colspan="2">CTCAE Grade 4 Thorax Soft Tissue Necrosis<span class="subclass"> SubClassOf </span>Thorax Soft Tissue Necrosis Adverse Event. <br><i>New Terms: Thorax Soft Tissue Necrosis Adverse Event, CTCAE Grade 4 Thorax Soft Tissue Necrosis</i></td>
            </tr>
            <tr class="addition">
               <td>4023</td>
               <td colspan="2">CTCAE Grade 4 Throat<br><span class="keyword"> and </span>Pharynx<br><span class="keyword"> and </span>Larynx Pain<span class="subclass"> SubClassOf </span>Throat<br><span class="keyword"> and </span>Pharynx<br><span class="keyword"> and </span>Larynx Pain Adverse Event. <br><i>New Terms: CTCAE Grade 4 Throat and Pharynx and Larynx Pain, Throat and Pharynx and Larynx Pain
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4024</td>
               <td colspan="2">CTCAE Grade 4 Thrombosis<br><span class="keyword"> or </span>Embolism Vascular Access Related<span class="subclass"> SubClassOf </span>Thrombosis<br><span class="keyword"> or </span>Embolism Vascular Access Related Adverse Event. <br><i>New Terms: Thrombosis or Embolism Vascular Access Related Adverse Event, CTCAE Grade 4 Thrombosis
                     or Embolism Vascular Access Related</i></td>
            </tr>
            <tr class="addition">
               <td>4025</td>
               <td colspan="2">CTCAE Grade 4 Thrombosis<br><span class="keyword"> or </span>Thrombus<br><span class="keyword"> or </span>Embolism<span class="subclass"> SubClassOf </span>Thrombosis<br><span class="keyword"> or </span>Thrombus<br><span class="keyword"> or </span>Embolism Adverse Event. <br><i>New Terms: CTCAE Grade 4 Thrombosis or Thrombus or Embolism, Thrombosis or Thrombus or Embolism
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4026</td>
               <td colspan="2">CTCAE Grade 4 Thrombotic Microangiopathy<span class="subclass"> SubClassOf </span>Thrombotic Microangiopathy Adverse Event. <br><i>New Terms: Thrombotic Microangiopathy Adverse Event, CTCAE Grade 4 Thrombotic Microangiopathy</i></td>
            </tr>
            <tr class="addition">
               <td>4027</td>
               <td colspan="2">CTCAE Grade 4 Thyroid Function High<span class="subclass"> SubClassOf </span>Thyroid Function High Adverse Event. <br><i>New Terms: CTCAE Grade 4 Thyroid Function High, Thyroid Function High Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4028</td>
               <td colspan="2">CTCAE Grade 4 Thyroid Function Low<span class="subclass"> SubClassOf </span>Thyroid Function Low Adverse Event. <br><i>New Terms: CTCAE Grade 4 Thyroid Function Low, Thyroid Function Low Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4029</td>
               <td colspan="2">CTCAE Grade 4 Thyroid Intra-Operative Injury<span class="subclass"> SubClassOf </span>Thyroid Intra-Operative Injury Adverse Event. <br><i>New Terms: Thyroid Intra-Operative Injury Adverse Event, CTCAE Grade 4 Thyroid Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>4030</td>
               <td colspan="2">CTCAE Grade 4 Tinnitus<span class="subclass"> SubClassOf </span>Tinnitus Adverse Event. <br><i>New Terms: Tinnitus Adverse Event, CTCAE Grade 4 Tinnitus</i></td>
            </tr>
            <tr class="addition">
               <td>4031</td>
               <td colspan="2">CTCAE Grade 4 Tongue Intra-Operative Injury<span class="subclass"> SubClassOf </span>Tongue Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Tongue Intra-Operative Injury, Tongue Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>4032</td>
               <td colspan="2">CTCAE Grade 4 Torsade de Pointes<span class="subclass"> SubClassOf </span>Torsade de Pointes Adverse Event. <br><i>New Terms: Torsade de Pointes Adverse Event, CTCAE Grade 4 Torsade de Pointes</i></td>
            </tr>
            <tr class="addition">
               <td>4033</td>
               <td colspan="2">CTCAE Grade 4 Trachea Fistula<span class="subclass"> SubClassOf </span>Trachea Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 4 Trachea Fistula, Trachea Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4034</td>
               <td colspan="2">CTCAE Grade 4 Trachea Hemorrhage<span class="subclass"> SubClassOf </span>Trachea Hemorrhage Adverse Event. <br><i>New Terms: Trachea Hemorrhage Adverse Event, CTCAE Grade 4 Trachea Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>4035</td>
               <td colspan="2">CTCAE Grade 4 Trachea Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Trachea Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Trachea Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 4 Trachea Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4036</td>
               <td colspan="2">CTCAE Grade 4 Trachea Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Trachea Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Trachea Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 4 Trachea Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4037</td>
               <td colspan="2">CTCAE Grade 4 Trachea Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Trachea Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Trachea Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     4 Trachea Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4038</td>
               <td colspan="2">CTCAE Grade 4 Trachea Intra-Operative Injury<span class="subclass"> SubClassOf </span>Trachea Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Trachea Intra-Operative Injury, Trachea Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>4039</td>
               <td colspan="2">CTCAE Grade 4 Trachea Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Trachea Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification. <br><i>New Terms: Trachea Mucositis or Stomatitis by Clinical Examination Classification, CTCAE Grade
                     4 Trachea Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>4040</td>
               <td colspan="2">CTCAE Grade 4 Trachea Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Trachea Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: Trachea Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification,
                     CTCAE Grade 4 Trachea Mucositis or Stomatitis by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>4041</td>
               <td colspan="2">CTCAE Grade 4 Trachea Obstruction<br><span class="keyword"> and </span>Stenosis<span class="subclass"> SubClassOf </span>Trachea Obstruction<br><span class="keyword"> and </span>Stenosis Adverse Event. <br><i>New Terms: Trachea Obstruction and Stenosis Adverse Event, CTCAE Grade 4 Trachea Obstruction
                     and Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>4042</td>
               <td colspan="2">CTCAE Grade 4 Tremor<span class="subclass"> SubClassOf </span>Tremor Adverse Event. <br><i>New Terms: Tremor Adverse Event, CTCAE Grade 4 Tremor</i></td>
            </tr>
            <tr class="addition">
               <td>4043</td>
               <td colspan="2">CTCAE Grade 4 Trigeminy<span class="subclass"> SubClassOf </span>Trigeminy Adverse Event. <br><i>New Terms: Trigeminy Adverse Event, CTCAE Grade 4 Trigeminy</i></td>
            </tr>
            <tr class="addition">
               <td>4044</td>
               <td colspan="2">CTCAE Grade 4 Trunk Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Trunk Muscle Weakness Not Due to Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 4 Trunk Muscle Weakness Not Due to Neuropathy, Trunk Muscle Weakness Not
                     Due to Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4045</td>
               <td colspan="2">CTCAE Grade 4 Tumor Flare<span class="subclass"> SubClassOf </span>Tumor Flare Adverse Event. <br><i>New Terms: CTCAE Grade 4 Tumor Flare, Tumor Flare Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4046</td>
               <td colspan="2">CTCAE Grade 4 Tumor Pain<span class="subclass"> SubClassOf </span>Tumor Pain Adverse Event. <br><i>New Terms: CTCAE Grade 4 Tumor Pain, Tumor Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4047</td>
               <td colspan="2">CTCAE Grade 4 Typhlitis<span class="subclass"> SubClassOf </span>Typhlitis Adverse Event. <br><i>New Terms: Typhlitis Adverse Event, CTCAE Grade 4 Typhlitis</i></td>
            </tr>
            <tr class="addition">
               <td>4048</td>
               <td colspan="2">CTCAE Grade 4 Ulceration<span class="subclass"> SubClassOf </span>Ulceration Adverse Event. <br><i>New Terms: Ulceration Adverse Event, CTCAE Grade 4 Ulceration</i></td>
            </tr>
            <tr class="addition">
               <td>4049</td>
               <td colspan="2">CTCAE Grade 4 Ungual Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Ungual Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Ungual Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 4 Ungual Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4050</td>
               <td colspan="2">CTCAE Grade 4 Ungual Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Ungual Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Ungual Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 4 Ungual Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4051</td>
               <td colspan="2">CTCAE Grade 4 Ungual Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Ungual Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 4 Ungual Infection with Unknown Absolute Neutrophil Count, Ungual Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4052</td>
               <td colspan="2">CTCAE Grade 4 Upper Aerodigestive Infection NOS Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Upper Aerodigestive Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Upper Aerodigestive Infection NOS Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, Upper Aerodigestive Infection NOS Adverse Event Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4053</td>
               <td colspan="2">CTCAE Grade 4 Upper Aerodigestive Infection NOS with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Upper Aerodigestive Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Upper Aerodigestive Infection NOS with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils, Upper Aerodigestive Infection NOS Adverse Event with
                     Normal Absolute Neutrophil Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4054</td>
               <td colspan="2">CTCAE Grade 4 Upper Aerodigestive Infection NOS with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Upper Aerodigestive Infection NOS Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 4 Upper Aerodigestive Infection NOS with Unknown Absolute Neutrophil Count,
                     Upper Aerodigestive Infection NOS Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4055</td>
               <td colspan="2">CTCAE Grade 4 Upper Aerodigestive NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Upper Aerodigestive NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: Upper Aerodigestive NOS Intra-Operative Injury Adverse Event, CTCAE Grade 4 Upper
                     Aerodigestive NOS Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>4056</td>
               <td colspan="2">CTCAE Grade 4 Upper Airway Infection NOS Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Upper Airway Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Upper Airway Infection NOS Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, Upper Airway Infection NOS Adverse Event Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4057</td>
               <td colspan="2">CTCAE Grade 4 Upper Airway Infection NOS with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Upper Airway Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Upper Airway Infection NOS Adverse Event with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils, CTCAE Grade 4 Upper Airway Infection NOS with Normal Absolute
                     Neutrophil Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4058</td>
               <td colspan="2">CTCAE Grade 4 Upper Airway Infection NOS with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Upper Airway Infection NOS Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Upper Airway Infection NOS Adverse Event with Unknown Absolute Neutrophil Count, CTCAE
                     Grade 4 Upper Airway Infection NOS with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4059</td>
               <td colspan="2">CTCAE Grade 4 Upper Airway NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Upper Airway NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Upper Airway NOS Intra-Operative Injury, Upper Airway NOS Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4060</td>
               <td colspan="2">CTCAE Grade 4 Upper Extremity Artery Injury<span class="subclass"> SubClassOf </span>Upper Extremity Artery Injury Adverse Event. <br><i>New Terms: Upper Extremity Artery Injury Adverse Event, CTCAE Grade 4 Upper Extremity Artery
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>4061</td>
               <td colspan="2">CTCAE Grade 4 Upper Extremity Artery Intra-Operative Injury<span class="subclass"> SubClassOf </span>Upper Extremity Artery Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Upper Extremity Artery Intra-Operative Injury, Upper Extremity Artery
                     Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4062</td>
               <td colspan="2">CTCAE Grade 4 Upper Extremity Function<span class="subclass"> SubClassOf </span>Upper Extremity Function Adverse Event. <br><i>New Terms: CTCAE Grade 4 Upper Extremity Function, Upper Extremity Function Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4063</td>
               <td colspan="2">CTCAE Grade 4 Upper Extremity Intra-Operative Injury<span class="subclass"> SubClassOf </span>Upper Extremity Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Upper Extremity Intra-Operative Injury, Upper Extremity Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4064</td>
               <td colspan="2">CTCAE Grade 4 Upper Extremity Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Upper Extremity Muscle Weakness Adverse Event Not Due to Neuropathy. <br><i>New Terms: Upper Extremity Muscle Weakness Adverse Event Not Due to Neuropathy, CTCAE Grade 4
                     Upper Extremity Muscle Weakness Not Due to Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>4065</td>
               <td colspan="2">CTCAE Grade 4 Upper Extremity Soft Tissue Necrosis Adverse Event<span class="subclass"> SubClassOf </span>Upper Extremity Soft Tissue Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 4 Upper Extremity Soft Tissue Necrosis Adverse Event, Upper Extremity
                     Soft Tissue Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4066</td>
               <td colspan="2">CTCAE Grade 4 Upper Extremity Vein Injury<span class="subclass"> SubClassOf </span>Upper Extremity Vein Injury Adverse Event. <br><i>New Terms: Upper Extremity Vein Injury Adverse Event, CTCAE Grade 4 Upper Extremity Vein Injury</i></td>
            </tr>
            <tr class="addition">
               <td>4067</td>
               <td colspan="2">CTCAE Grade 4 Upper Extremity Vein Intra-Operative Injury<span class="subclass"> SubClassOf </span>Upper Extremity Vein Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Upper Extremity Vein Intra-Operative Injury, Upper Extremity Vein Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4068</td>
               <td colspan="2">CTCAE Grade 4 Upper Gastrointestinal Hemorrhage NOS<span class="subclass"> SubClassOf </span>Upper Gastrointestinal Hemorrhage Adverse Event NOS. <br><i>New Terms: CTCAE Grade 4 Upper Gastrointestinal Hemorrhage NOS, Upper Gastrointestinal Hemorrhage
                     Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>4069</td>
               <td colspan="2">CTCAE Grade 4 Ureter Fistula<span class="subclass"> SubClassOf </span>Ureter Fistula Adverse Event. <br><i>New Terms: Ureter Fistula Adverse Event, CTCAE Grade 4 Ureter Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>4070</td>
               <td colspan="2">CTCAE Grade 4 Ureter Hemorrhage<span class="subclass"> SubClassOf </span>Ureter Hemorrhage Adverse Event. <br><i>New Terms: Ureter Hemorrhage Adverse Event, CTCAE Grade 4 Ureter Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>4071</td>
               <td colspan="2">CTCAE Grade 4 Ureter Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Ureter Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Ureter Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Ureter Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4072</td>
               <td colspan="2">CTCAE Grade 4 Ureter Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Ureter Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Ureter Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 4 Ureter Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4073</td>
               <td colspan="2">CTCAE Grade 4 Ureter Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Ureter Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 4 Ureter Infection with Unknown Absolute Neutrophil Count, Ureter Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4074</td>
               <td colspan="2">CTCAE Grade 4 Ureter Intra-Operative Injury<span class="subclass"> SubClassOf </span>Ureter Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Ureter Intra-Operative Injury, Ureter Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>4075</td>
               <td colspan="2">CTCAE Grade 4 Ureter Leak<span class="subclass"> SubClassOf </span>Ureter Leak Adverse Event. <br><i>New Terms: CTCAE Grade 4 Ureter Leak, Ureter Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4076</td>
               <td colspan="2">CTCAE Grade 4 Ureter Obstruction<span class="subclass"> SubClassOf </span>Ureter Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 4 Ureter Obstruction, Ureter Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4077</td>
               <td colspan="2">CTCAE Grade 4 Ureter Perforation<span class="subclass"> SubClassOf </span>Ureter Perforation Adverse Event. <br><i>New Terms: Ureter Perforation Adverse Event, CTCAE Grade 4 Ureter Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>4078</td>
               <td colspan="2">CTCAE Grade 4 Ureter Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Ureter Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Ureter Stricture or Stenosis Adverse Event, CTCAE Grade 4 Ureter Stricture or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>4079</td>
               <td colspan="2">CTCAE Grade 4 Urethra Fistula<span class="subclass"> SubClassOf </span>Urethra Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 4 Urethra Fistula, Urethra Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4080</td>
               <td colspan="2">CTCAE Grade 4 Urethra Hemorrhage<span class="subclass"> SubClassOf </span>Urethra Hemorrhage Adverse Event. <br><i>New Terms: Urethra Hemorrhage Adverse Event, CTCAE Grade 4 Urethra Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>4081</td>
               <td colspan="2">CTCAE Grade 4 Urethra Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Urethra Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Urethra Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Urethra Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4082</td>
               <td colspan="2">CTCAE Grade 4 Urethra Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Urethra Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Urethra Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Urethra Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4083</td>
               <td colspan="2">CTCAE Grade 4 Urethra Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Urethra Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Urethra Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     4 Urethra Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4084</td>
               <td colspan="2">CTCAE Grade 4 Urethra Intra-Operative Injury<span class="subclass"> SubClassOf </span>Urethra Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Urethra Intra-Operative Injury, Urethra Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>4085</td>
               <td colspan="2">CTCAE Grade 4 Urethra Leak<span class="subclass"> SubClassOf </span>Urethra Leak Adverse Event. <br><i>New Terms: CTCAE Grade 4 Urethra Leak, Urethra Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4086</td>
               <td colspan="2">CTCAE Grade 4 Urethra Obstruction<span class="subclass"> SubClassOf </span>Urethra Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 4 Urethra Obstruction, Urethra Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4087</td>
               <td colspan="2">CTCAE Grade 4 Urethra Pain<span class="subclass"> SubClassOf </span>Urethra Pain Adverse Event. <br><i>New Terms: CTCAE Grade 4 Urethra Pain, Urethra Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4088</td>
               <td colspan="2">CTCAE Grade 4 Urethra Perforation<span class="subclass"> SubClassOf </span>Urethra Perforation Adverse Event. <br><i>New Terms: Urethra Perforation Adverse Event, CTCAE Grade 4 Urethra Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>4089</td>
               <td colspan="2">CTCAE Grade 4 Urethra Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Urethra Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 4 Urethra Stricture or Stenosis, Urethra Stricture or Stenosis Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>4090</td>
               <td colspan="2">CTCAE Grade 4 Urinary Conduit Intra-Operative Injury<span class="subclass"> SubClassOf </span>Urinary Conduit Intra-Operative Injury Adverse Event. <br><i>New Terms: Urinary Conduit Intra-Operative Injury Adverse Event, CTCAE Grade 4 Urinary Conduit
                     Intra-Operative Injury</i></td>
            </tr>
            <tr class="addition">
               <td>4091</td>
               <td colspan="2">CTCAE Grade 4 Urinary Hemorrhage NOS<span class="subclass"> SubClassOf </span>Urinary Hemorrhage Adverse Event NOS. <br><i>New Terms: CTCAE Grade 4 Urinary Hemorrhage NOS, Urinary Hemorrhage Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>4092</td>
               <td colspan="2">CTCAE Grade 4 Urinary Incontinence<span class="subclass"> SubClassOf </span>Urinary Incontinence Adverse Event. <br><i>New Terms: CTCAE Grade 4 Urinary Incontinence, Urinary Incontinence Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4093</td>
               <td colspan="2">CTCAE Grade 4 Urinary Retention<span class="subclass"> SubClassOf </span>Urinary Retention Adverse Event. <br><i>New Terms: Urinary Retention Adverse Event, CTCAE Grade 4 Urinary Retention</i></td>
            </tr>
            <tr class="addition">
               <td>4094</td>
               <td colspan="2">CTCAE Grade 4 Urinary Tract Infection NOS Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Urinary Tract Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Urinary Tract Infection NOS Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, CTCAE Grade 4 Urinary Tract Infection NOS Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4095</td>
               <td colspan="2">CTCAE Grade 4 Urinary Tract Infection NOS with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Urinary Tract Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Urinary Tract Infection NOS Adverse Event with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils, CTCAE Grade 4 Urinary Tract Infection NOS with Normal Absolute
                     Neutrophil Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4096</td>
               <td colspan="2">CTCAE Grade 4 Urinary Tract Infection NOS with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Urinary Tract Infection NOS Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 4 Urinary Tract Infection NOS with Unknown Absolute Neutrophil Count,
                     Urinary Tract Infection NOS Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4097</td>
               <td colspan="2">CTCAE Grade 4 Urinary Tract NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Urinary Tract NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Urinary Tract NOS Intra-Operative Injury, Urinary Tract NOS Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4098</td>
               <td colspan="2">CTCAE Grade 4 Uterus Fistula<span class="subclass"> SubClassOf </span>Uterus Fistula Adverse Event. <br><i>New Terms: Uterus Fistula Adverse Event, CTCAE Grade 4 Uterus Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>4099</td>
               <td colspan="2">CTCAE Grade 4 Uterus Hemorrhage<span class="subclass"> SubClassOf </span>Uterus Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 4 Uterus Hemorrhage, Uterus Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4100</td>
               <td colspan="2">CTCAE Grade 4 Uterus Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Uterus Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Uterus Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Uterus Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4101</td>
               <td colspan="2">CTCAE Grade 4 Uterus Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Uterus Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Uterus Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Uterus Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4102</td>
               <td colspan="2">CTCAE Grade 4 Uterus Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Uterus Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Uterus Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     4 Uterus Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4103</td>
               <td colspan="2">CTCAE Grade 4 Uterus Intra-Operative Injury<span class="subclass"> SubClassOf </span>Uterus Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Uterus Intra-Operative Injury, Uterus Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>4104</td>
               <td colspan="2">CTCAE Grade 4 Uterus Leak<span class="subclass"> SubClassOf </span>Uterus Leak Adverse Event. <br><i>New Terms: CTCAE Grade 4 Uterus Leak, Uterus Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4105</td>
               <td colspan="2">CTCAE Grade 4 Uterus Obstruction<span class="subclass"> SubClassOf </span>Uterus Obstruction Adverse Event. <br><i>New Terms: Uterus Obstruction Adverse Event, CTCAE Grade 4 Uterus Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>4106</td>
               <td colspan="2">CTCAE Grade 4 Uterus Pain<span class="subclass"> SubClassOf </span>Uterus Pain Adverse Event. <br><i>New Terms: CTCAE Grade 4 Uterus Pain, Uterus Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4107</td>
               <td colspan="2">CTCAE Grade 4 Uterus Perforation<span class="subclass"> SubClassOf </span>Uterus Perforation Adverse Event. <br><i>New Terms: Uterus Perforation Adverse Event, CTCAE Grade 4 Uterus Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>4108</td>
               <td colspan="2">CTCAE Grade 4 Uterus Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Uterus Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Uterus Stricture or Stenosis Adverse Event, CTCAE Grade 4 Uterus Stricture or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>4109</td>
               <td colspan="2">CTCAE Grade 4 Uveitis<span class="subclass"> SubClassOf </span>Uveitis Adverse Event. <br><i>New Terms: CTCAE Grade 4 Uveitis, Uveitis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4110</td>
               <td colspan="2">CTCAE Grade 4 Vagina Fistula<span class="subclass"> SubClassOf </span>Vagina Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 4 Vagina Fistula, Vagina Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4111</td>
               <td colspan="2">CTCAE Grade 4 Vagina Hemorrhage<span class="subclass"> SubClassOf </span>Vagina Hemorrhage Adverse Event. <br><i>New Terms: Vagina Hemorrhage Adverse Event, CTCAE Grade 4 Vagina Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>4112</td>
               <td colspan="2">CTCAE Grade 4 Vagina Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Vagina Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Vagina Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 4 Vagina Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4113</td>
               <td colspan="2">CTCAE Grade 4 Vagina Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Vagina Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Vagina Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Vagina Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4114</td>
               <td colspan="2">CTCAE Grade 4 Vagina Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Vagina Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 4 Vagina Infection with Unknown Absolute Neutrophil Count, Vagina Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4115</td>
               <td colspan="2">CTCAE Grade 4 Vagina Intra-Operative Injury<span class="subclass"> SubClassOf </span>Vagina Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Vagina Intra-Operative Injury, Vagina Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>4116</td>
               <td colspan="2">CTCAE Grade 4 Vagina Leak<span class="subclass"> SubClassOf </span>Vagina Leak Adverse Event. <br><i>New Terms: Vagina Leak Adverse Event, CTCAE Grade 4 Vagina Leak</i></td>
            </tr>
            <tr class="addition">
               <td>4117</td>
               <td colspan="2">CTCAE Grade 4 Vagina Obstruction<span class="subclass"> SubClassOf </span>Vagina Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 4 Vagina Obstruction, Vagina Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4118</td>
               <td colspan="2">CTCAE Grade 4 Vagina Pain<span class="subclass"> SubClassOf </span>Vagina Pain Adverse Event. <br><i>New Terms: CTCAE Grade 4 Vagina Pain, Vagina Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4119</td>
               <td colspan="2">CTCAE Grade 4 Vagina Perforation<span class="subclass"> SubClassOf </span>Vagina Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 4 Vagina Perforation, Vagina Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4120</td>
               <td colspan="2">CTCAE Grade 4 Vagina Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Vagina Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 4 Vagina Stricture or Stenosis, Vagina Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4121</td>
               <td colspan="2">CTCAE Grade 4 Vaginal Mucositis<span class="subclass"> SubClassOf </span>Vaginal Mucositis Adverse Event. <br><i>New Terms: CTCAE Grade 4 Vaginal Mucositis, Vaginal Mucositis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4122</td>
               <td colspan="2">CTCAE Grade 4 Vaginitis Not Due to Infection<span class="subclass"> SubClassOf </span>Vaginitis Not Due to Infection Adverse Event. <br><i>New Terms: CTCAE Grade 4 Vaginitis Not Due to Infection, Vaginitis Not Due to Infection Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>4123</td>
               <td colspan="2">CTCAE Grade 4 Valvular Heart Disease<span class="subclass"> SubClassOf </span>Valvular Heart Disease Adverse Event. <br><i>New Terms: Valvular Heart Disease Adverse Event, CTCAE Grade 4 Valvular Heart Disease</i></td>
            </tr>
            <tr class="addition">
               <td>4124</td>
               <td colspan="2">CTCAE Grade 4 Vas Deferens Hemorrhage<span class="subclass"> SubClassOf </span>Vas Deferens Hemorrhage Adverse Event. <br><i>New Terms: Vas Deferens Hemorrhage Adverse Event, CTCAE Grade 4 Vas Deferens Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>4125</td>
               <td colspan="2">CTCAE Grade 4 Vas Deferens Leak<span class="subclass"> SubClassOf </span>Vas Deferens Leak Adverse Event. <br><i>New Terms: CTCAE Grade 4 Vas Deferens Leak, Vas Deferens Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4126</td>
               <td colspan="2">CTCAE Grade 4 Vas Deferens Obstruction<span class="subclass"> SubClassOf </span>Vas Deferens Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 4 Vas Deferens Obstruction, Vas Deferens Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4127</td>
               <td colspan="2">CTCAE Grade 4 Vas Deferens Perforation<span class="subclass"> SubClassOf </span>Vas Deferens Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 4 Vas Deferens Perforation, Vas Deferens Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4128</td>
               <td colspan="2">CTCAE Grade 4 Vas Deferens Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Vas Deferens Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 4 Vas Deferens Stricture or Stenosis, Vas Deferens Stricture or Stenosis
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4129</td>
               <td colspan="2">CTCAE Grade 4 Vasculitis<span class="subclass"> SubClassOf </span>Vasculitis Adverse Event. <br><i>New Terms: Vasculitis Adverse Event, CTCAE Grade 4 Vasculitis</i></td>
            </tr>
            <tr class="addition">
               <td>4130</td>
               <td colspan="2">CTCAE Grade 4 Vasovagal Episode<span class="subclass"> SubClassOf </span>Vasovagal Episode Adverse Event. <br><i>New Terms: Vasovagal Episode Adverse Event, CTCAE Grade 4 Vasovagal Episode</i></td>
            </tr>
            <tr class="addition">
               <td>4131</td>
               <td colspan="2">CTCAE Grade 4 Vein Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Vein Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Vein Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Vein Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4132</td>
               <td colspan="2">CTCAE Grade 4 Vein Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Vein Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Vein Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or 2
                     Neutrophils, CTCAE Grade 4 Vein Infection with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4133</td>
               <td colspan="2">CTCAE Grade 4 Vein Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Vein Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Vein Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade 4
                     Vein Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4134</td>
               <td colspan="2">CTCAE Grade 4 Vein NOS Intra-Operative Injury<span class="subclass"> SubClassOf </span>Vein NOS Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Vein NOS Intra-Operative Injury, Vein NOS Intra-Operative Injury Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>4135</td>
               <td colspan="2">CTCAE Grade 4 Ventricular Arrhythmia NOS<span class="subclass"> SubClassOf </span>Ventricular Arrhythmia Adverse Event NOS. <br><i>New Terms: CTCAE Grade 4 Ventricular Arrhythmia NOS, Ventricular Arrhythmia Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>4136</td>
               <td colspan="2">CTCAE Grade 4 Ventricular Fibrillation<span class="subclass"> SubClassOf </span>Ventricular Fibrillation Adverse Event. <br><i>New Terms: Ventricular Fibrillation Adverse Event, CTCAE Grade 4 Ventricular Fibrillation</i></td>
            </tr>
            <tr class="addition">
               <td>4137</td>
               <td colspan="2">CTCAE Grade 4 Ventricular Flutter<span class="subclass"> SubClassOf </span>Ventricular Flutter Adverse Event. <br><i>New Terms: Ventricular Flutter Adverse Event, CTCAE Grade 4 Ventricular Flutter</i></td>
            </tr>
            <tr class="addition">
               <td>4138</td>
               <td colspan="2">CTCAE Grade 4 Ventricular Tachycardia<span class="subclass"> SubClassOf </span>Ventricular Tachycardia Adverse Event. <br><i>New Terms: Ventricular Tachycardia Adverse Event, CTCAE Grade 4 Ventricular Tachycardia</i></td>
            </tr>
            <tr class="addition">
               <td>4139</td>
               <td colspan="2">CTCAE Grade 4 Viral Hepatitis<span class="subclass"> SubClassOf </span>Viral Hepatitis Adverse Event. <br><i>New Terms: Viral Hepatitis Adverse Event, CTCAE Grade 4 Viral Hepatitis</i></td>
            </tr>
            <tr class="addition">
               <td>4140</td>
               <td colspan="2">CTCAE Grade 4 Viscera Vein Injury<span class="subclass"> SubClassOf </span>Viscera Vein Injury Adverse Event. <br><i>New Terms: Viscera Vein Injury Adverse Event, CTCAE Grade 4 Viscera Vein Injury</i></td>
            </tr>
            <tr class="addition">
               <td>4141</td>
               <td colspan="2">CTCAE Grade 4 Visceral Artery Injury<span class="subclass"> SubClassOf </span>Visceral Artery Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Visceral Artery Injury, Visceral Artery Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4142</td>
               <td colspan="2">CTCAE Grade 4 Vital Capacity<span class="subclass"> SubClassOf </span>Vital Capacity Adverse Event. <br><i>New Terms: Vital Capacity Adverse Event, CTCAE Grade 4 Vital Capacity</i></td>
            </tr>
            <tr class="addition">
               <td>4143</td>
               <td colspan="2">CTCAE Grade 4 Voice Changes<br><span class="keyword"> and </span>Dysarthria<span class="subclass"> SubClassOf </span>Voice Changes<br><span class="keyword"> and </span>Dysarthria Adverse Event. <br><i>New Terms: Voice Changes and Dysarthria Adverse Event, CTCAE Grade 4 Voice Changes and Dysarthria</i></td>
            </tr>
            <tr class="addition">
               <td>4144</td>
               <td colspan="2">CTCAE Grade 4 Vomiting<span class="subclass"> SubClassOf </span>Vomiting Adverse Event. <br><i>New Terms: CTCAE Grade 4 Vomiting, Vomiting Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4145</td>
               <td colspan="2">CTCAE Grade 4 Vulva Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Vulva Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Vulva Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Vulva Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4146</td>
               <td colspan="2">CTCAE Grade 4 Vulva Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Vulva Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Vulva Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Vulva Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4147</td>
               <td colspan="2">CTCAE Grade 4 Vulva Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Vulva Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Vulva Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     4 Vulva Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4148</td>
               <td colspan="2">CTCAE Grade 4 Vulva Intra-Operative Injury<span class="subclass"> SubClassOf </span>Vulva Intra-Operative Injury Adverse Event. <br><i>New Terms: CTCAE Grade 4 Vulva Intra-Operative Injury, Vulva Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4149</td>
               <td colspan="2">CTCAE Grade 4 Whole Body<br><span class="keyword"> and </span>Generalized Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Whole Body<br><span class="keyword"> and </span>Generalized Muscle Weakness Not Due to Neuropathy Adverse Event. <br><i>New Terms: Whole Body and Generalized Muscle Weakness Not Due to Neuropathy Adverse Event, CTCAE
                     Grade 4 Whole Body and Generalized Muscle Weakness Not Due to Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>4150</td>
               <td colspan="2">CTCAE Grade 4 Wolff-Parkinson-White Syndrome<span class="subclass"> SubClassOf </span>Wolff-Parkinson-White Syndrome Adverse Event. <br><i>New Terms: CTCAE Grade 4 Wolff-Parkinson-White Syndrome, Wolff-Parkinson-White Syndrome Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>4151</td>
               <td colspan="2">CTCAE Grade 4 Wound Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Wound Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 4 Wound Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Wound Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4152</td>
               <td colspan="2">CTCAE Grade 4 Wound Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Wound Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Wound Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 4 Wound Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4153</td>
               <td colspan="2">CTCAE Grade 4 Wound Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Wound Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Wound Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     4 Wound Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4154</td>
               <td colspan="2">CTCAE Grade 5 AV Block First Degree<span class="subclass"> SubClassOf </span>AV Block First Degree Adverse Event. <br><i>New Terms: CTCAE Grade 5 AV Block First Degree, AV Block First Degree Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4155</td>
               <td colspan="2">CTCAE Grade 5 AV Block Second Degree Mobitz<span class="subclass"> Type </span>I<span class="subclass"> SubClassOf </span>AV Block Second Degree Mobitz<span class="subclass"> Type </span>I Adverse Event. <br><i>New Terms: CTCAE Grade 5 AV Block Second Degree Mobitz Type I, AV Block Second Degree Mobitz
                     Type I Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4156</td>
               <td colspan="2">CTCAE Grade 5 AV Block Second Degree Mobitz<span class="subclass"> Type </span>II<span class="subclass"> SubClassOf </span>AV Block Second Degree Mobitz<span class="subclass"> Type </span>II Adverse Event. <br><i>New Terms: AV Block Second Degree Mobitz Type II Adverse Event, CTCAE Grade 5 AV Block Second
                     Degree Mobitz Type II</i></td>
            </tr>
            <tr class="addition">
               <td>4157</td>
               <td colspan="2">CTCAE Grade 5 AV Block Third Degree<span class="subclass"> SubClassOf </span>AV Block Third Degree Adverse Event. <br><i>New Terms: CTCAE Grade 5 AV Block Third Degree, AV Block Third Degree Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4158</td>
               <td colspan="2">CTCAE Grade 5 Abdomen Fistula NOS<span class="subclass"> SubClassOf </span>Abdomen Fistula Adverse Event NOS. <br><i>New Terms: CTCAE Grade 5 Abdomen Fistula NOS, Abdomen Fistula Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>4159</td>
               <td colspan="2">CTCAE Grade 5 Abdomen Hemorrhage NOS<span class="subclass"> SubClassOf </span>Abdomen Hemorrhage Adverse Event NOS. <br><i>New Terms: CTCAE Grade 5 Abdomen Hemorrhage NOS, Abdomen Hemorrhage Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>4160</td>
               <td colspan="2">CTCAE Grade 5 Abdomen Infection NOS Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Abdomen Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Abdomen Infection NOS Adverse Event Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, CTCAE Grade 5 Abdomen Infection NOS Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4161</td>
               <td colspan="2">CTCAE Grade 5 Abdomen Infection NOS with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Abdomen Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Abdomen Infection NOS with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, Abdomen Infection NOS Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4162</td>
               <td colspan="2">CTCAE Grade 5 Abdomen Infection NOS with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Abdomen Infection NOS Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Abdomen Infection NOS Adverse Event with Unknown Absolute Neutrophil Count, CTCAE
                     Grade 5 Abdomen Infection NOS with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4163</td>
               <td colspan="2">CTCAE Grade 5 Abdomen Soft Tissue Necrosis<span class="subclass"> SubClassOf </span>Abdomen Soft Tissue Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 5 Abdomen Soft Tissue Necrosis, Abdomen Soft Tissue Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4164</td>
               <td colspan="2">CTCAE Grade 5 Acute Vascular Leak Syndrome<span class="subclass"> SubClassOf </span>Acute Vascular Leak Syndrome Adverse Event. <br><i>New Terms: CTCAE Grade 5 Acute Vascular Leak Syndrome, Acute Vascular Leak Syndrome Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4165</td>
               <td colspan="2">CTCAE Grade 5 Adrenal Insufficiency<span class="subclass"> SubClassOf </span>Adrenal Insufficiency Adverse Event. <br><i>New Terms: Adrenal Insufficiency Adverse Event, CTCAE Grade 5 Adrenal Insufficiency</i></td>
            </tr>
            <tr class="addition">
               <td>4166</td>
               <td colspan="2">CTCAE Grade 5 Adult Respiratory Distress Syndrome<span class="subclass"> SubClassOf </span>Adult Respiratory Distress Syndrome Adverse Event. <br><i>New Terms: CTCAE Grade 5 Adult Respiratory Distress Syndrome, Adult Respiratory Distress Syndrome
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4167</td>
               <td colspan="2">CTCAE Grade 5 Agitation<span class="subclass"> SubClassOf </span>Agitation Adverse Event. <br><i>New Terms: CTCAE Grade 5 Agitation, Agitation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4168</td>
               <td colspan="2">CTCAE Grade 5 Alcohol Intolerance Antabuse-Like Syndrome<span class="subclass"> SubClassOf </span>Alcohol Intolerance Antabuse-Like Syndrome Adverse Event. <br><i>New Terms: CTCAE Grade 5 Alcohol Intolerance Antabuse-Like Syndrome, Alcohol Intolerance Antabuse-Like
                     Syndrome Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4169</td>
               <td colspan="2">CTCAE Grade 5 Allergic Reaction<br><span class="keyword"> and </span>Hypersensitivity Including Drug Fever<span class="subclass"> SubClassOf </span>Allergic Reaction<br><span class="keyword"> and </span>Hypersensitivity Adverse Event Including Drug Fever. <br><i>New Terms: Allergic Reaction and Hypersensitivity Adverse Event Including Drug Fever, CTCAE Grade
                     5 Allergic Reaction and Hypersensitivity Including Drug Fever</i></td>
            </tr>
            <tr class="addition">
               <td>4170</td>
               <td colspan="2">CTCAE Grade 5 Anal Incontinence<span class="subclass"> SubClassOf </span>Anal Incontinence Adverse Event. <br><i>New Terms: CTCAE Grade 5 Anal Incontinence, Anal Incontinence Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4171</td>
               <td colspan="2">CTCAE Grade 5 Anal<br><span class="keyword"> or </span>Perianal Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Anal<br><span class="keyword"> or </span>Perianal Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Anal or Perianal Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, CTCAE Grade 5 Anal or Perianal Infection Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4172</td>
               <td colspan="2">CTCAE Grade 5 Anal<br><span class="keyword"> or </span>Perianal Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Anal<br><span class="keyword"> or </span>Perianal Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Anal or Perianal Infection with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils, Anal or Perianal Infection Adverse Event with Normal Absolute
                     Neutrophil Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4173</td>
               <td colspan="2">CTCAE Grade 5 Anal<br><span class="keyword"> or </span>Perianal Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Anal<br><span class="keyword"> or </span>Perianal Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Anal or Perianal Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE
                     Grade 5 Anal or Perianal Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4174</td>
               <td colspan="2">CTCAE Grade 5 Anorexia<span class="subclass"> SubClassOf </span>Anorexia Adverse Event. <br><i>New Terms: Anorexia Adverse Event, CTCAE Grade 5 Anorexia</i></td>
            </tr>
            <tr class="addition">
               <td>4175</td>
               <td colspan="2">CTCAE Grade 5 Anus Fistula<span class="subclass"> SubClassOf </span>Anus Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 5 Anus Fistula, Anus Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4176</td>
               <td colspan="2">CTCAE Grade 5 Anus Hemorrhage<span class="subclass"> SubClassOf </span>Anus Hemorrhage Adverse Event. <br><i>New Terms: Anus Hemorrhage Adverse Event, CTCAE Grade 5 Anus Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>4177</td>
               <td colspan="2">CTCAE Grade 5 Anus Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Anus Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Clinical Examination Classification. <br><i>New Terms: Anus Mucositis or Stomatitis Adverse Event by Clinical Examination Classification,
                     CTCAE Grade 5 Anus Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>4178</td>
               <td colspan="2">CTCAE Grade 5 Anus Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Anus Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: CTCAE Grade 5 Anus Mucositis or Stomatitis by Functional or Symptomatic Classification,
                     Anus Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>4179</td>
               <td colspan="2">CTCAE Grade 5 Anus Necrosis<span class="subclass"> SubClassOf </span>Anus Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 5 Anus Necrosis, Anus Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4180</td>
               <td colspan="2">CTCAE Grade 5 Anus Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Anus Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 5 Anus Stricture or Stenosis, Anus Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4181</td>
               <td colspan="2">CTCAE Grade 5 Anus Ulcer<span class="subclass"> SubClassOf </span>Anus Ulcer Adverse Event. <br><i>New Terms: Anus Ulcer Adverse Event, CTCAE Grade 5 Anus Ulcer</i></td>
            </tr>
            <tr class="addition">
               <td>4182</td>
               <td colspan="2">CTCAE Grade 5 Anxiety<span class="subclass"> SubClassOf </span>Anxiety Adverse Event. <br><i>New Terms: Anxiety Adverse Event, CTCAE Grade 5 Anxiety</i></td>
            </tr>
            <tr class="addition">
               <td>4183</td>
               <td colspan="2">CTCAE Grade 5 Aorta Artery Injury<span class="subclass"> SubClassOf </span>Aorta Artery Injury Adverse Event. <br><i>New Terms: CTCAE Grade 5 Aorta Artery Injury, Aorta Artery Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4184</td>
               <td colspan="2">CTCAE Grade 5 Apnea<span class="subclass"> SubClassOf </span>Apnea Adverse Event. <br><i>New Terms: Apnea Adverse Event, CTCAE Grade 5 Apnea</i></td>
            </tr>
            <tr class="addition">
               <td>4185</td>
               <td colspan="2">CTCAE Grade 5 Appendix Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Appendix Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Appendix Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Appendix Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4186</td>
               <td colspan="2">CTCAE Grade 5 Appendix Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Appendix Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Appendix Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, CTCAE Grade 5 Appendix Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4187</td>
               <td colspan="2">CTCAE Grade 5 Appendix Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Appendix Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Appendix Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     5 Appendix Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4188</td>
               <td colspan="2">CTCAE Grade 5 Appendix Perforation<span class="subclass"> SubClassOf </span>Appendix Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 5 Appendix Perforation, Appendix Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4189</td>
               <td colspan="2">CTCAE Grade 5 Arachnoiditis<br><span class="keyword"> and </span>Meningismus<br><span class="keyword"> and </span>Radiculitis<span class="subclass"> SubClassOf </span>Arachnoiditis<br><span class="keyword"> and </span>Meningismus<br><span class="keyword"> and </span>Radiculitis Adverse Event. <br><i>New Terms: Arachnoiditis and Meningismus and Radiculitis Adverse Event, CTCAE Grade 5 Arachnoiditis
                     and Meningismus and Radiculitis</i></td>
            </tr>
            <tr class="addition">
               <td>4190</td>
               <td colspan="2">CTCAE Grade 5 Artery Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Artery Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Artery Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Artery Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4191</td>
               <td colspan="2">CTCAE Grade 5 Artery Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Artery Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Artery Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Artery Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4192</td>
               <td colspan="2">CTCAE Grade 5 Artery Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Artery Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Artery Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     5 Artery Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4193</td>
               <td colspan="2">CTCAE Grade 5 Aspiration<span class="subclass"> SubClassOf </span>Aspiration Adverse Event. <br><i>New Terms: Aspiration Adverse Event, CTCAE Grade 5 Aspiration</i></td>
            </tr>
            <tr class="addition">
               <td>4194</td>
               <td colspan="2">CTCAE Grade 5 Asystole<span class="subclass"> SubClassOf </span>Asystole Adverse Event. <br><i>New Terms: Asystole Adverse Event, CTCAE Grade 5 Asystole</i></td>
            </tr>
            <tr class="addition">
               <td>4195</td>
               <td colspan="2">CTCAE Grade 5 Ataxia<span class="subclass"> SubClassOf </span>Ataxia Adverse Event. <br><i>New Terms: CTCAE Grade 5 Ataxia, Ataxia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4196</td>
               <td colspan="2">CTCAE Grade 5 Atelectasis<span class="subclass"> SubClassOf </span>Atelectasis Adverse Event. <br><i>New Terms: Atelectasis Adverse Event, CTCAE Grade 5 Atelectasis</i></td>
            </tr>
            <tr class="addition">
               <td>4197</td>
               <td colspan="2">CTCAE Grade 5 Atrial Fibrillation<span class="subclass"> SubClassOf </span>Atrial Fibrillation Adverse Event. <br><i>New Terms: CTCAE Grade 5 Atrial Fibrillation, Atrial Fibrillation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4198</td>
               <td colspan="2">CTCAE Grade 5 Atrial Flutter<span class="subclass"> SubClassOf </span>Atrial Flutter Adverse Event. <br><i>New Terms: Atrial Flutter Adverse Event, CTCAE Grade 5 Atrial Flutter</i></td>
            </tr>
            <tr class="addition">
               <td>4199</td>
               <td colspan="2">CTCAE Grade 5 Atrial Tachycardia<br><span class="keyword"> or </span>Paroxysmal Atrial Tachycardia<span class="subclass"> SubClassOf </span>Atrial Tachycardia<br><span class="keyword"> or </span>Paroxysmal Atrial Tachycardia Adverse Event. <br><i>New Terms: CTCAE Grade 5 Atrial Tachycardia or Paroxysmal Atrial Tachycardia, Atrial Tachycardia
                     or Paroxysmal Atrial Tachycardia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4200</td>
               <td colspan="2">CTCAE Grade 5 Autoimmune Reaction<span class="subclass"> SubClassOf </span>Autoimmune Reaction Adverse Event. <br><i>New Terms: CTCAE Grade 5 Autoimmune Reaction, Autoimmune Reaction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4201</td>
               <td colspan="2">CTCAE Grade 5 Avascular Osteonecrosis<span class="subclass"> SubClassOf </span>Avascular Osteonecrosis Adverse Event. <br><i>New Terms: Avascular Osteonecrosis Adverse Event, CTCAE Grade 5 Avascular Osteonecrosis</i></td>
            </tr>
            <tr class="addition">
               <td>4202</td>
               <td colspan="2">CTCAE Grade 5 Bigeminy<span class="subclass"> SubClassOf </span>Bigeminy Adverse Event. <br><i>New Terms: CTCAE Grade 5 Bigeminy, Bigeminy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4203</td>
               <td colspan="2">CTCAE Grade 5 Biliary Tree Fistula<span class="subclass"> SubClassOf </span>Biliary Tree Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 5 Biliary Tree Fistula, Biliary Tree Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4204</td>
               <td colspan="2">CTCAE Grade 5 Biliary Tree Hemorrhage<span class="subclass"> SubClassOf </span>Biliary Tree Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 5 Biliary Tree Hemorrhage, Biliary Tree Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4205</td>
               <td colspan="2">CTCAE Grade 5 Biliary Tree Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Biliary Tree Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Biliary Tree Infection Adverse Event Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, CTCAE Grade 5 Biliary Tree Infection Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4206</td>
               <td colspan="2">CTCAE Grade 5 Biliary Tree Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Biliary Tree Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Biliary Tree Infection Adverse Event with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, CTCAE Grade 5 Biliary Tree Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4207</td>
               <td colspan="2">CTCAE Grade 5 Biliary Tree Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Biliary Tree Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Biliary Tree Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE
                     Grade 5 Biliary Tree Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4208</td>
               <td colspan="2">CTCAE Grade 5 Biliary Tree Leak<span class="subclass"> SubClassOf </span>Biliary Tree Leak Adverse Event. <br><i>New Terms: CTCAE Grade 5 Biliary Tree Leak, Biliary Tree Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4209</td>
               <td colspan="2">CTCAE Grade 5 Biliary Tree Perforation<span class="subclass"> SubClassOf </span>Biliary Tree Perforation Adverse Event. <br><i>New Terms: Biliary Tree Perforation Adverse Event, CTCAE Grade 5 Biliary Tree Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>4210</td>
               <td colspan="2">CTCAE Grade 5 Biliary Tree Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Biliary Tree Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Biliary Tree Stricture or Stenosis Adverse Event, CTCAE Grade 5 Biliary Tree Stricture
                     or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>4211</td>
               <td colspan="2">CTCAE Grade 5 Bladder Fistula<span class="subclass"> SubClassOf </span>Bladder Fistula Adverse Event. <br><i>New Terms: Bladder Fistula Adverse Event, CTCAE Grade 5 Bladder Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>4212</td>
               <td colspan="2">CTCAE Grade 5 Bladder Hemorrhage<span class="subclass"> SubClassOf </span>Bladder Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 5 Bladder Hemorrhage, Bladder Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4213</td>
               <td colspan="2">CTCAE Grade 5 Bladder Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Bladder Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Bladder Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 5 Bladder Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4214</td>
               <td colspan="2">CTCAE Grade 5 Bladder Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Bladder Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Bladder Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 5 Bladder Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4215</td>
               <td colspan="2">CTCAE Grade 5 Bladder Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Bladder Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Bladder Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     5 Bladder Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4216</td>
               <td colspan="2">CTCAE Grade 5 Bladder Leak<span class="subclass"> SubClassOf </span>Bladder Leak Adverse Event. <br><i>New Terms: Bladder Leak Adverse Event, CTCAE Grade 5 Bladder Leak</i></td>
            </tr>
            <tr class="addition">
               <td>4217</td>
               <td colspan="2">CTCAE Grade 5 Bladder Obstruction<span class="subclass"> SubClassOf </span>Bladder Obstruction Adverse Event. <br><i>New Terms: Bladder Obstruction Adverse Event, CTCAE Grade 5 Bladder Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>4218</td>
               <td colspan="2">CTCAE Grade 5 Bladder Perforation<span class="subclass"> SubClassOf </span>Bladder Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 5 Bladder Perforation, Bladder Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4219</td>
               <td colspan="2">CTCAE Grade 5 Bladder Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Bladder Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 5 Bladder Stricture or Stenosis, Bladder Stricture or Stenosis Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>4220</td>
               <td colspan="2">CTCAE Grade 5 Blood Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Blood Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Blood Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Blood Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4221</td>
               <td colspan="2">CTCAE Grade 5 Blood Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Blood Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Blood Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 5 Blood Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4222</td>
               <td colspan="2">CTCAE Grade 5 Blood Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Blood Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 5 Blood Infection with Unknown Absolute Neutrophil Count, Blood Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4223</td>
               <td colspan="2">CTCAE Grade 5 Bone Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Bone Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Bone Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 5 Bone Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4224</td>
               <td colspan="2">CTCAE Grade 5 Bone Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Bone Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Bone Infection with Normal Absolute Neutrophil Count or Grade 1 or 2
                     Neutrophils, Bone Infection Adverse Event with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4225</td>
               <td colspan="2">CTCAE Grade 5 Bone Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Bone Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 5 Bone Infection with Unknown Absolute Neutrophil Count, Bone Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4226</td>
               <td colspan="2">CTCAE Grade 5 Bone Marrow Cellularity<span class="subclass"> SubClassOf </span>Bone Marrow Cellularity Adverse Event. <br><i>New Terms: CTCAE Grade 5 Bone Marrow Cellularity, Bone Marrow Cellularity Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4227</td>
               <td colspan="2">CTCAE Grade 5 Brachial Plexopathy<span class="subclass"> SubClassOf </span>Brachial Plexopathy Adverse Event. <br><i>New Terms: CTCAE Grade 5 Brachial Plexopathy, Brachial Plexopathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4228</td>
               <td colspan="2">CTCAE Grade 5 Brain Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Brain Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Brain Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Brain Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4229</td>
               <td colspan="2">CTCAE Grade 5 Brain Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Brain Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Brain Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 5 Brain Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4230</td>
               <td colspan="2">CTCAE Grade 5 Brain Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Brain Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 5 Brain Infection with Unknown Absolute Neutrophil Count, Brain Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4231</td>
               <td colspan="2">CTCAE Grade 5 Brain<br><span class="keyword"> and </span>Spinal Cord Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Brain<br><span class="keyword"> and </span>Spinal Cord Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Brain and Spinal Cord Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, Brain and Spinal Cord Infection Adverse Event Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4232</td>
               <td colspan="2">CTCAE Grade 5 Brain<br><span class="keyword"> and </span>Spinal Cord Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Brain<br><span class="keyword"> and </span>Spinal Cord Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Brain and Spinal Cord Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils, Brain and Spinal Cord Infection Adverse Event with Normal
                     Absolute Neutrophil Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4233</td>
               <td colspan="2">CTCAE Grade 5 Brain<br><span class="keyword"> and </span>Spinal Cord Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Brain<br><span class="keyword"> and </span>Spinal Cord Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 5 Brain and Spinal Cord Infection with Unknown Absolute Neutrophil Count,
                     Brain and Spinal Cord Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4234</td>
               <td colspan="2">CTCAE Grade 5 Bronchopulmonary Hemorrhage NOS<span class="subclass"> SubClassOf </span>Bronchopulmonary Hemorrhage Adverse Event NOS. <br><i>New Terms: CTCAE Grade 5 Bronchopulmonary Hemorrhage NOS, Bronchopulmonary Hemorrhage Adverse
                     Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>4235</td>
               <td colspan="2">CTCAE Grade 5 Bronchospasm<br><span class="keyword"> and </span>Wheezing<span class="subclass"> SubClassOf </span>Bronchospasm<br><span class="keyword"> and </span>Wheezing Adverse Event. <br><i>New Terms: Bronchospasm and Wheezing Adverse Event, CTCAE Grade 5 Bronchospasm and Wheezing</i></td>
            </tr>
            <tr class="addition">
               <td>4236</td>
               <td colspan="2">CTCAE Grade 5 Bronchus Fistula<span class="subclass"> SubClassOf </span>Bronchus Fistula Adverse Event. <br><i>New Terms: Bronchus Fistula Adverse Event, CTCAE Grade 5 Bronchus Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>4237</td>
               <td colspan="2">CTCAE Grade 5 Bronchus Hemorrhage<span class="subclass"> SubClassOf </span>Bronchus Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 5 Bronchus Hemorrhage, Bronchus Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4238</td>
               <td colspan="2">CTCAE Grade 5 Bronchus Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Bronchus Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Bronchus Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Bronchus Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4239</td>
               <td colspan="2">CTCAE Grade 5 Bronchus Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Bronchus Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Bronchus Infection with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, Bronchus Infection Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4240</td>
               <td colspan="2">CTCAE Grade 5 Bronchus Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Bronchus Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 5 Bronchus Infection with Unknown Absolute Neutrophil Count, Bronchus
                     Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4241</td>
               <td colspan="2">CTCAE Grade 5 Bronchus Obstruction<br><span class="keyword"> and </span>Stenosis<span class="subclass"> SubClassOf </span>Bronchus Obstruction<br><span class="keyword"> and </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 5 Bronchus Obstruction and Stenosis, Bronchus Obstruction and Stenosis
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4242</td>
               <td colspan="2">CTCAE Grade 5 Burn<span class="subclass"> SubClassOf </span>Burn Adverse Event. <br><i>New Terms: CTCAE Grade 5 Burn, Burn Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4243</td>
               <td colspan="2">CTCAE Grade 5 CD4 Count<span class="subclass"> SubClassOf </span>CD4 Count Adverse Event. <br><i>New Terms: CTCAE Grade 5 CD4 Count, CD4 Count Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4244</td>
               <td colspan="2">CTCAE Grade 5 CNS Cerebrovascular Ischemia<span class="subclass"> SubClassOf </span>CNS Cerebrovascular Ischemia Adverse Event. <br><i>New Terms: CNS Cerebrovascular Ischemia Adverse Event, CTCAE Grade 5 CNS Cerebrovascular Ischemia</i></td>
            </tr>
            <tr class="addition">
               <td>4245</td>
               <td colspan="2">CTCAE Grade 5 CNS Necrosis<br><span class="keyword"> and </span>Cystic Progression<span class="subclass"> SubClassOf </span>CNS Necrosis<br><span class="keyword"> and </span>Cystic Progression Adverse Event. <br><i>New Terms: CNS Necrosis and Cystic Progression Adverse Event, CTCAE Grade 5 CNS Necrosis and
                     Cystic Progression</i></td>
            </tr>
            <tr class="addition">
               <td>4246</td>
               <td colspan="2">CTCAE Grade 5 Carbon Monoxide Diffusion Capacity<span class="subclass"> SubClassOf </span>Carbon Monoxide Diffusion Capacity Adverse Event. <br><i>New Terms: Carbon Monoxide Diffusion Capacity Adverse Event, CTCAE Grade 5 Carbon Monoxide Diffusion
                     Capacity</i></td>
            </tr>
            <tr class="addition">
               <td>4247</td>
               <td colspan="2">CTCAE Grade 5 Cardiac Ischemia<br><span class="keyword"> or </span>Infarction<span class="subclass"> SubClassOf </span>Cardiac Ischemia<br><span class="keyword"> or </span>Infarction Adverse Event. <br><i>New Terms: Cardiac Ischemia or Infarction Adverse Event, CTCAE Grade 5 Cardiac Ischemia or Infarction</i></td>
            </tr>
            <tr class="addition">
               <td>4248</td>
               <td colspan="2">CTCAE Grade 5 Cardiac Troponin I<span class="subclass"> SubClassOf </span>Cardiac Troponin I Adverse Event. <br><i>New Terms: Cardiac Troponin I Adverse Event, CTCAE Grade 5 Cardiac Troponin I</i></td>
            </tr>
            <tr class="addition">
               <td>4249</td>
               <td colspan="2">CTCAE Grade 5 Cardiac Troponin T<span class="subclass"> SubClassOf </span>Cardiac Troponin T Adverse Event. <br><i>New Terms: Cardiac Troponin T Adverse Event, CTCAE Grade 5 Cardiac Troponin T</i></td>
            </tr>
            <tr class="addition">
               <td>4250</td>
               <td colspan="2">CTCAE Grade 5 Carotid Artery Injury<span class="subclass"> SubClassOf </span>Carotid Artery Injury Adverse Event. <br><i>New Terms: CTCAE Grade 5 Carotid Artery Injury, Carotid Artery Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4251</td>
               <td colspan="2">CTCAE Grade 5 Catheter-Related Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Catheter-Related Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Catheter-Related Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, Catheter-Related Infection Adverse Event Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4252</td>
               <td colspan="2">CTCAE Grade 5 Catheter-Related Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Catheter-Related Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Catheter-Related Infection with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils, Catheter-Related Infection Adverse Event with Normal Absolute
                     Neutrophil Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4253</td>
               <td colspan="2">CTCAE Grade 5 Catheter-Related Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Catheter-Related Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Catheter-Related Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE
                     Grade 5 Catheter-Related Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4254</td>
               <td colspan="2">CTCAE Grade 5 Cecum Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Cecum Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Cecum Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Cecum Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4255</td>
               <td colspan="2">CTCAE Grade 5 Cecum Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Cecum Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Cecum Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Cecum Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4256</td>
               <td colspan="2">CTCAE Grade 5 Cecum Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Cecum Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Cecum Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     5 Cecum Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4257</td>
               <td colspan="2">CTCAE Grade 5 Cecum Obstruction<span class="subclass"> SubClassOf </span>Cecum Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 5 Cecum Obstruction, Cecum Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4258</td>
               <td colspan="2">CTCAE Grade 5 Cecum Perforation<span class="subclass"> SubClassOf </span>Cecum Perforation Adverse Event. <br><i>New Terms: Cecum Perforation Adverse Event, CTCAE Grade 5 Cecum Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>4259</td>
               <td colspan="2">CTCAE Grade 5 Cecum Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Cecum Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Cecum Stricture or Stenosis Adverse Event, CTCAE Grade 5 Cecum Stricture or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>4260</td>
               <td colspan="2">CTCAE Grade 5 Cecum Ulcer<span class="subclass"> SubClassOf </span>Cecum Ulcer Adverse Event. <br><i>New Terms: Cecum Ulcer Adverse Event, CTCAE Grade 5 Cecum Ulcer</i></td>
            </tr>
            <tr class="addition">
               <td>4261</td>
               <td colspan="2">CTCAE Grade 5 Cecum<br><span class="keyword"> or </span>Appendix Hemorrhage<span class="subclass"> SubClassOf </span>Cecum<br><span class="keyword"> or </span>Appendix Hemorrhage Adverse Event. <br><i>New Terms: Cecum or Appendix Hemorrhage Adverse Event, CTCAE Grade 5 Cecum or Appendix Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>4262</td>
               <td colspan="2">CTCAE Grade 5 Central Nervous System Hemorrhage<span class="subclass"> SubClassOf </span>Central Nervous System Hemorrhage Adverse Event. <br><i>New Terms: Central Nervous System Hemorrhage Adverse Event, CTCAE Grade 5 Central Nervous System
                     Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>4263</td>
               <td colspan="2">CTCAE Grade 5 Cerebrospinal Fluid Leak<span class="subclass"> SubClassOf </span>Cerebrospinal Fluid Leak Adverse Event. <br><i>New Terms: CTCAE Grade 5 Cerebrospinal Fluid Leak, Cerebrospinal Fluid Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4264</td>
               <td colspan="2">CTCAE Grade 5 Cervix Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Cervix Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Cervix Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Cervix Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4265</td>
               <td colspan="2">CTCAE Grade 5 Cervix Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Cervix Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Cervix Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Cervix Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4266</td>
               <td colspan="2">CTCAE Grade 5 Cervix Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Cervix Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Cervix Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     5 Cervix Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4267</td>
               <td colspan="2">CTCAE Grade 5 Chemoradiation<span class="subclass"> SubClassOf </span>Rash<br><span class="keyword"> and </span>Dermatitis Adverse Event Associated with Chemoradiation. <br><i>New Terms: Rash and Dermatitis Adverse Event Associated with Chemoradiation, CTCAE Grade 5 Chemoradiation</i></td>
            </tr>
            <tr class="addition">
               <td>4268</td>
               <td colspan="2">CTCAE Grade 5 Cholecystitis<span class="subclass"> SubClassOf </span>Cholecystitis Adverse Event. <br><i>New Terms: Cholecystitis Adverse Event, CTCAE Grade 5 Cholecystitis</i></td>
            </tr>
            <tr class="addition">
               <td>4269</td>
               <td colspan="2">CTCAE Grade 5 Chyle<br><span class="keyword"> or </span>Lymph Leakage<span class="subclass"> SubClassOf </span>Chyle<br><span class="keyword"> or </span>Lymph Leakage Adverse Event. <br><i>New Terms: Chyle or Lymph Leakage Adverse Event, CTCAE Grade 5 Chyle or Lymph Leakage</i></td>
            </tr>
            <tr class="addition">
               <td>4270</td>
               <td colspan="2">CTCAE Grade 5 Chylothorax<span class="subclass"> SubClassOf </span>Chylothorax Adverse Event. <br><i>New Terms: Chylothorax Adverse Event, CTCAE Grade 5 Chylothorax</i></td>
            </tr>
            <tr class="addition">
               <td>4271</td>
               <td colspan="2">CTCAE Grade 5 Cognitive Disturbance<span class="subclass"> SubClassOf </span>Cognitive Disturbance Adverse Event. <br><i>New Terms: CTCAE Grade 5 Cognitive Disturbance, Cognitive Disturbance Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4272</td>
               <td colspan="2">CTCAE Grade 5 Colitis<span class="subclass"> SubClassOf </span>Colitis Adverse Event. <br><i>New Terms: CTCAE Grade 5 Colitis, Colitis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4273</td>
               <td colspan="2">CTCAE Grade 5 Colon Hemorrhage<span class="subclass"> SubClassOf </span>Colon Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 5 Colon Hemorrhage, Colon Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4274</td>
               <td colspan="2">CTCAE Grade 5 Colon Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Colon Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Colon Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Colon Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4275</td>
               <td colspan="2">CTCAE Grade 5 Colon Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Colon Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Colon Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 5 Colon Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4276</td>
               <td colspan="2">CTCAE Grade 5 Colon Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Colon Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 5 Colon Infection with Unknown Absolute Neutrophil Count, Colon Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4277</td>
               <td colspan="2">CTCAE Grade 5 Colon Obstruction<span class="subclass"> SubClassOf </span>Colon Obstruction Adverse Event. <br><i>New Terms: Colon Obstruction Adverse Event, CTCAE Grade 5 Colon Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>4278</td>
               <td colspan="2">CTCAE Grade 5 Colon Perforation<span class="subclass"> SubClassOf </span>Colon Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 5 Colon Perforation, Colon Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4279</td>
               <td colspan="2">CTCAE Grade 5 Colon Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Colon Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 5 Colon Stricture or Stenosis, Colon Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4280</td>
               <td colspan="2">CTCAE Grade 5 Colon Ulcer<span class="subclass"> SubClassOf </span>Colon Ulcer Adverse Event. <br><i>New Terms: CTCAE Grade 5 Colon Ulcer, Colon Ulcer Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4281</td>
               <td colspan="2">CTCAE Grade 5 Colon<br><span class="keyword"> or </span>Cecum<br><span class="keyword"> or </span>Appendix Fistula<span class="subclass"> SubClassOf </span>Colon<br><span class="keyword"> or </span>Cecum<br><span class="keyword"> or </span>Appendix Fistula Adverse Event. <br><i>New Terms: Colon or Cecum or Appendix Fistula Adverse Event, CTCAE Grade 5 Colon or Cecum or
                     Appendix Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>4282</td>
               <td colspan="2">CTCAE Grade 5 Colon<br><span class="keyword"> or </span>Cecum<br><span class="keyword"> or </span>Appendix Necrosis<span class="subclass"> SubClassOf </span>Colon<br><span class="keyword"> or </span>Cecum<br><span class="keyword"> or </span>Appendix Necrosis Adverse Event. <br><i>New Terms: Colon or Cecum or Appendix Necrosis Adverse Event, CTCAE Grade 5 Colon or Cecum or
                     Appendix Necrosis</i></td>
            </tr>
            <tr class="addition">
               <td>4283</td>
               <td colspan="2">CTCAE Grade 5 Conduction Abnormality NOS<span class="subclass"> SubClassOf </span>Conduction Abnormality Adverse Event NOS. <br><i>New Terms: Conduction Abnormality Adverse Event NOS, CTCAE Grade 5 Conduction Abnormality NOS</i></td>
            </tr>
            <tr class="addition">
               <td>4284</td>
               <td colspan="2">CTCAE Grade 5 Confusion<span class="subclass"> SubClassOf </span>Confusion Adverse Event. <br><i>New Terms: CTCAE Grade 5 Confusion, Confusion Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4285</td>
               <td colspan="2">CTCAE Grade 5 Conjunctiva Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Conjunctiva Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Conjunctiva Infection Adverse Event Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, CTCAE Grade 5 Conjunctiva Infection Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4286</td>
               <td colspan="2">CTCAE Grade 5 Conjunctiva Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Conjunctiva Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Conjunctiva Infection with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, Conjunctiva Infection Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4287</td>
               <td colspan="2">CTCAE Grade 5 Conjunctiva Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Conjunctiva Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 5 Conjunctiva Infection with Unknown Absolute Neutrophil Count, Conjunctiva
                     Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4288</td>
               <td colspan="2">CTCAE Grade 5 Constipation<span class="subclass"> SubClassOf </span>Constipation Adverse Event. <br><i>New Terms: CTCAE Grade 5 Constipation, Constipation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4289</td>
               <td colspan="2">CTCAE Grade 5 Cornea Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Cornea Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Cornea Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 5 Cornea Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4290</td>
               <td colspan="2">CTCAE Grade 5 Cornea Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Cornea Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Cornea Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Cornea Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4291</td>
               <td colspan="2">CTCAE Grade 5 Cornea Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Cornea Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Cornea Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     5 Cornea Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4296</td>
               <td colspan="2">CTCAE Grade 5 Cranial Nerve I Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve I Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve I Neuropathy Adverse Event, CTCAE Grade 5 Cranial Nerve I Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>4293</td>
               <td colspan="2">CTCAE Grade 5 Cranial Nerve II Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve II Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve II Neuropathy Adverse Event, CTCAE Grade 5 Cranial Nerve II Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>4292</td>
               <td colspan="2">CTCAE Grade 5 Cranial Nerve III Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve III Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve III Neuropathy Adverse Event, CTCAE Grade 5 Cranial Nerve III Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>4294</td>
               <td colspan="2">CTCAE Grade 5 Cranial Nerve IV Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve IV Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 5 Cranial Nerve IV Neuropathy, Cranial Nerve IV Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4295</td>
               <td colspan="2">CTCAE Grade 5 Cranial Nerve IX Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve IX Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 5 Cranial Nerve IX Neuropathy, Cranial Nerve IX Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4297</td>
               <td colspan="2">CTCAE Grade 5 Cranial Nerve Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Cranial Nerve Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Cranial Nerve Infection Adverse Event Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, CTCAE Grade 5 Cranial Nerve Infection Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4298</td>
               <td colspan="2">CTCAE Grade 5 Cranial Nerve Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Cranial Nerve Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Cranial Nerve Infection with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, Cranial Nerve Infection Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4299</td>
               <td colspan="2">CTCAE Grade 5 Cranial Nerve Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Cranial Nerve Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Cranial Nerve Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE
                     Grade 5 Cranial Nerve Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4303</td>
               <td colspan="2">CTCAE Grade 5 Cranial Nerve V Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve V Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve V Neuropathy Adverse Event, CTCAE Grade 5 Cranial Nerve V Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>4302</td>
               <td colspan="2">CTCAE Grade 5 Cranial Nerve VI Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve VI Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 5 Cranial Nerve VI Neuropathy, Cranial Nerve VI Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4301</td>
               <td colspan="2">CTCAE Grade 5 Cranial Nerve VII Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve VII Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve VII Neuropathy Adverse Event, CTCAE Grade 5 Cranial Nerve VII Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>4300</td>
               <td colspan="2">CTCAE Grade 5 Cranial Nerve VIII Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve VIII Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve VIII Neuropathy Adverse Event, CTCAE Grade 5 Cranial Nerve VIII Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>4306</td>
               <td colspan="2">CTCAE Grade 5 Cranial Nerve X Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve X Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 5 Cranial Nerve X Neuropathy, Cranial Nerve X Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4305</td>
               <td colspan="2">CTCAE Grade 5 Cranial Nerve XI Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve XI Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 5 Cranial Nerve XI Neuropathy, Cranial Nerve XI Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4304</td>
               <td colspan="2">CTCAE Grade 5 Cranial Nerve XII Neuropathy<span class="subclass"> SubClassOf </span>Cranial Nerve XII Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve XII Neuropathy Adverse Event, CTCAE Grade 5 Cranial Nerve XII Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>4307</td>
               <td colspan="2">CTCAE Grade 5 Creatine Phosphokinase<span class="subclass"> SubClassOf </span>Creatine Phosphokinase Adverse Event. <br><i>New Terms: Creatine Phosphokinase Adverse Event, CTCAE Grade 5 Creatine Phosphokinase</i></td>
            </tr>
            <tr class="addition">
               <td>4308</td>
               <td colspan="2">CTCAE Grade 5 Creatinine<span class="subclass"> SubClassOf </span>Creatinine Adverse Event. <br><i>New Terms: CTCAE Grade 5 Creatinine, Creatinine Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4309</td>
               <td colspan="2">CTCAE Grade 5 Cystitis<span class="subclass"> SubClassOf </span>Cystitis Adverse Event. <br><i>New Terms: Cystitis Adverse Event, CTCAE Grade 5 Cystitis</i></td>
            </tr>
            <tr class="addition">
               <td>4310</td>
               <td colspan="2">CTCAE Grade 5 Cytokine Release Syndrome<br><span class="keyword"> or </span>Acute Infusion Reaction<span class="subclass"> SubClassOf </span>Cytokine Release Syndrome<br><span class="keyword"> or </span>Acute Infusion Reaction Adverse Event. <br><i>New Terms: CTCAE Grade 5 Cytokine Release Syndrome or Acute Infusion Reaction, Cytokine Release
                     Syndrome or Acute Infusion Reaction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4311</td>
               <td colspan="2">CTCAE Grade 5 Death NOS<span class="subclass"> SubClassOf </span>Death Adverse Event Not Associated with More Specific CTCAE Term NOS. <br><i>New Terms: Death Adverse Event Not Associated with More Specific CTCAE Term NOS, CTCAE Grade
                     5 Death NOS</i></td>
            </tr>
            <tr class="addition">
               <td>4312</td>
               <td colspan="2">CTCAE Grade 5 Dehydration<span class="subclass"> SubClassOf </span>Dehydration Adverse Event. <br><i>New Terms: Dehydration Adverse Event, CTCAE Grade 5 Dehydration</i></td>
            </tr>
            <tr class="addition">
               <td>4313</td>
               <td colspan="2">CTCAE Grade 5 Dental-Tooth Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Tooth Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Dental-Tooth Infection Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, Tooth Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4314</td>
               <td colspan="2">CTCAE Grade 5 Dental-Tooth Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Tooth Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Tooth Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 5 Dental-Tooth Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4315</td>
               <td colspan="2">CTCAE Grade 5 Dental-Tooth Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Tooth Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Tooth Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     5 Dental-Tooth Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4316</td>
               <td colspan="2">CTCAE Grade 5 Depression<span class="subclass"> SubClassOf </span>Depression Adverse Event. <br><i>New Terms: Depression Adverse Event, CTCAE Grade 5 Depression</i></td>
            </tr>
            <tr class="addition">
               <td>4317</td>
               <td colspan="2">CTCAE Grade 5 Diarrhea<span class="subclass"> SubClassOf </span>Diarrhea Adverse Event. <br><i>New Terms: Diarrhea Adverse Event, CTCAE Grade 5 Diarrhea</i></td>
            </tr>
            <tr class="addition">
               <td>4318</td>
               <td colspan="2">CTCAE Grade 5 Disease Progression NOS<span class="subclass"> SubClassOf </span>Death Adverse Event Due to Disease Progression Not Associated with More Specific CTCAE
                  Term NOS. <br><i>New Terms: Death Adverse Event Due to Disease Progression Not Associated with More Specific CTCAE
                     Term NOS, CTCAE Grade 5 Disease Progression NOS</i></td>
            </tr>
            <tr class="addition">
               <td>4319</td>
               <td colspan="2">CTCAE Grade 5 Disseminated Intravascular Coagulation<span class="subclass"> SubClassOf </span>Disseminated Intravascular Coagulation Adverse Event. <br><i>New Terms: CTCAE Grade 5 Disseminated Intravascular Coagulation, Disseminated Intravascular Coagulation
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4320</td>
               <td colspan="2">CTCAE Grade 5 Duodenum Fistula<span class="subclass"> SubClassOf </span>Duodenum Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 5 Duodenum Fistula, Duodenum Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4321</td>
               <td colspan="2">CTCAE Grade 5 Duodenum Hemorrhage<span class="subclass"> SubClassOf </span>Duodenum Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 5 Duodenum Hemorrhage, Duodenum Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4322</td>
               <td colspan="2">CTCAE Grade 5 Duodenum Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Duodenum Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Duodenum Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 5 Duodenum Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4323</td>
               <td colspan="2">CTCAE Grade 5 Duodenum Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Duodenum Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Duodenum Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, CTCAE Grade 5 Duodenum Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4324</td>
               <td colspan="2">CTCAE Grade 5 Duodenum Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Duodenum Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 5 Duodenum Infection with Unknown Absolute Neutrophil Count, Duodenum
                     Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4325</td>
               <td colspan="2">CTCAE Grade 5 Duodenum Necrosis<span class="subclass"> SubClassOf </span>Duodenum Necrosis Adverse Event. <br><i>New Terms: Duodenum Necrosis Adverse Event, CTCAE Grade 5 Duodenum Necrosis</i></td>
            </tr>
            <tr class="addition">
               <td>4326</td>
               <td colspan="2">CTCAE Grade 5 Duodenum Obstruction<span class="subclass"> SubClassOf </span>Duodenum Obstruction Adverse Event. <br><i>New Terms: Duodenum Obstruction Adverse Event, CTCAE Grade 5 Duodenum Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>4327</td>
               <td colspan="2">CTCAE Grade 5 Duodenum Perforation<span class="subclass"> SubClassOf </span>Duodenum Perforation Adverse Event. <br><i>New Terms: Duodenum Perforation Adverse Event, CTCAE Grade 5 Duodenum Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>4328</td>
               <td colspan="2">CTCAE Grade 5 Duodenum Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Duodenum Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Duodenum Stricture or Stenosis Adverse Event, CTCAE Grade 5 Duodenum Stricture or
                     Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>4329</td>
               <td colspan="2">CTCAE Grade 5 Duodenum Ulcer<span class="subclass"> SubClassOf </span>Duodenum Ulcer Adverse Event. <br><i>New Terms: Duodenum Ulcer Adverse Event, CTCAE Grade 5 Duodenum Ulcer</i></td>
            </tr>
            <tr class="addition">
               <td>4330</td>
               <td colspan="2">CTCAE Grade 5 Dysphagia<span class="subclass"> SubClassOf </span>Dysphagia Adverse Event. <br><i>New Terms: CTCAE Grade 5 Dysphagia, Dysphagia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4331</td>
               <td colspan="2">CTCAE Grade 5 Dyspnea<span class="subclass"> SubClassOf </span>Dyspnea Adverse Event. <br><i>New Terms: Dyspnea Adverse Event, CTCAE Grade 5 Dyspnea</i></td>
            </tr>
            <tr class="addition">
               <td>4332</td>
               <td colspan="2">CTCAE Grade 5 Edema of the Head<br><span class="keyword"> and </span>Neck<span class="subclass"> SubClassOf </span>Edema Adverse Event of the Head<br><span class="keyword"> and </span>Neck. <br><i>New Terms: CTCAE Grade 5 Edema of the Head and Neck, Edema Adverse Event of the Head and Neck</i></td>
            </tr>
            <tr class="addition">
               <td>4333</td>
               <td colspan="2">CTCAE Grade 5 Edema of the Limb<span class="subclass"> SubClassOf </span>Edema Adverse Event of the Limb. <br><i>New Terms: Edema Adverse Event of the Limb, CTCAE Grade 5 Edema of the Limb</i></td>
            </tr>
            <tr class="addition">
               <td>4334</td>
               <td colspan="2">CTCAE Grade 5 Edema of the Trunk<br><span class="keyword"> and </span>Genital Area<span class="subclass"> SubClassOf </span>Edema Adverse Event of the Trunk<br><span class="keyword"> and </span>Genital Area. <br><i>New Terms: CTCAE Grade 5 Edema of the Trunk and Genital Area, Edema Adverse Event of the Trunk
                     and Genital Area</i></td>
            </tr>
            <tr class="addition">
               <td>4335</td>
               <td colspan="2">CTCAE Grade 5 Edema of the Viscera<span class="subclass"> SubClassOf </span>Edema Adverse Event of the Viscera. <br><i>New Terms: Edema Adverse Event of the Viscera, CTCAE Grade 5 Edema of the Viscera</i></td>
            </tr>
            <tr class="addition">
               <td>4336</td>
               <td colspan="2">CTCAE Grade 5 Encephalopathy<span class="subclass"> SubClassOf </span>Encephalopathy Adverse Event. <br><i>New Terms: CTCAE Grade 5 Encephalopathy, Encephalopathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4337</td>
               <td colspan="2">CTCAE Grade 5 Enteritis<span class="subclass"> SubClassOf </span>Enteritis Adverse Event. <br><i>New Terms: CTCAE Grade 5 Enteritis, Enteritis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4338</td>
               <td colspan="2">CTCAE Grade 5 Esophageal Varices Hemorrhage<span class="subclass"> SubClassOf </span>Esophageal Varices Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 5 Esophageal Varices Hemorrhage, Esophageal Varices Hemorrhage Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>4339</td>
               <td colspan="2">CTCAE Grade 5 Esophagitis<span class="subclass"> SubClassOf </span>Esophagitis Adverse Event. <br><i>New Terms: CTCAE Grade 5 Esophagitis, Esophagitis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4340</td>
               <td colspan="2">CTCAE Grade 5 Esophagus Fistula<span class="subclass"> SubClassOf </span>Esophagus Fistula Adverse Event. <br><i>New Terms: Esophagus Fistula Adverse Event, CTCAE Grade 5 Esophagus Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>4341</td>
               <td colspan="2">CTCAE Grade 5 Esophagus Hemorrhage<span class="subclass"> SubClassOf </span>Esophagus Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 5 Esophagus Hemorrhage, Esophagus Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4342</td>
               <td colspan="2">CTCAE Grade 5 Esophagus Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Esophagus Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Esophagus Infection Adverse Event Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, CTCAE Grade 5 Esophagus Infection Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4343</td>
               <td colspan="2">CTCAE Grade 5 Esophagus Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Esophagus Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Esophagus Infection with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, Esophagus Infection Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4344</td>
               <td colspan="2">CTCAE Grade 5 Esophagus Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Esophagus Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 5 Esophagus Infection with Unknown Absolute Neutrophil Count, Esophagus
                     Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4345</td>
               <td colspan="2">CTCAE Grade 5 Esophagus Leak<span class="subclass"> SubClassOf </span>Esophagus Leak Adverse Event. <br><i>New Terms: CTCAE Grade 5 Esophagus Leak, Esophagus Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4346</td>
               <td colspan="2">CTCAE Grade 5 Esophagus Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Esophagus Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Clinical Examination Classification. <br><i>New Terms: CTCAE Grade 5 Esophagus Mucositis or Stomatitis by Clinical Examination Classification,
                     Esophagus Mucositis or Stomatitis Adverse Event by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>4347</td>
               <td colspan="2">CTCAE Grade 5 Esophagus Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Esophagus Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: Esophagus Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification,
                     CTCAE Grade 5 Esophagus Mucositis or Stomatitis by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>4348</td>
               <td colspan="2">CTCAE Grade 5 Esophagus Necrosis<span class="subclass"> SubClassOf </span>Esophagus Necrosis Adverse Event. <br><i>New Terms: Esophagus Necrosis Adverse Event, CTCAE Grade 5 Esophagus Necrosis</i></td>
            </tr>
            <tr class="addition">
               <td>4349</td>
               <td colspan="2">CTCAE Grade 5 Esophagus Obstruction<span class="subclass"> SubClassOf </span>Esophagus Obstruction Adverse Event. <br><i>New Terms: Esophagus Obstruction Adverse Event, CTCAE Grade 5 Esophagus Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>4350</td>
               <td colspan="2">CTCAE Grade 5 Esophagus Perforation<span class="subclass"> SubClassOf </span>Esophagus Perforation Adverse Event. <br><i>New Terms: Esophagus Perforation Adverse Event, CTCAE Grade 5 Esophagus Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>4351</td>
               <td colspan="2">CTCAE Grade 5 Esophagus Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Esophagus Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Esophagus Stricture or Stenosis Adverse Event, CTCAE Grade 5 Esophagus Stricture or
                     Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>4352</td>
               <td colspan="2">CTCAE Grade 5 Esophagus Ulcer<span class="subclass"> SubClassOf </span>Esophagus Ulcer Adverse Event. <br><i>New Terms: Esophagus Ulcer Adverse Event, CTCAE Grade 5 Esophagus Ulcer</i></td>
            </tr>
            <tr class="addition">
               <td>4353</td>
               <td colspan="2">CTCAE Grade 5 Euphoria<span class="subclass"> SubClassOf </span>Euphoria Adverse Event. <br><i>New Terms: CTCAE Grade 5 Euphoria, Euphoria Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4354</td>
               <td colspan="2">CTCAE Grade 5 Exostosis<span class="subclass"> SubClassOf </span>Exostosis Adverse Event. <br><i>New Terms: CTCAE Grade 5 Exostosis, Exostosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4355</td>
               <td colspan="2">CTCAE Grade 5 External Ear Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>External Ear Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 External Ear Infection Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, External Ear Infection Adverse Event Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4356</td>
               <td colspan="2">CTCAE Grade 5 External Ear Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>External Ear Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 5 External Ear Infection with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, External Ear Infection Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4357</td>
               <td colspan="2">CTCAE Grade 5 External Ear Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>External Ear Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 5 External Ear Infection with Unknown Absolute Neutrophil Count, External
                     Ear Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4358</td>
               <td colspan="2">CTCAE Grade 5 Extraocular Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Extraocular Muscle Weakness Not Due to Neuropathy Adverse Event. <br><i>New Terms: Extraocular Muscle Weakness Not Due to Neuropathy Adverse Event, CTCAE Grade 5 Extraocular
                     Muscle Weakness Not Due to Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>4359</td>
               <td colspan="2">CTCAE Grade 5 Extrapyramidal<br><span class="keyword"> and </span>Involuntary Movement<br><span class="keyword"> and </span>Restlessness<span class="subclass"> SubClassOf </span>Extrapyramidal<br><span class="keyword"> and </span>Involuntary Movement<br><span class="keyword"> and </span>Restlessness Adverse Event. <br><i>New Terms: Extrapyramidal and Involuntary Movement and Restlessness Adverse Event, CTCAE Grade
                     5 Extrapyramidal and Involuntary Movement and Restlessness</i></td>
            </tr>
            <tr class="addition">
               <td>4360</td>
               <td colspan="2">CTCAE Grade 5 Eye Infection NOS Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Eye Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Eye Infection NOS Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Eye Infection NOS Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4361</td>
               <td colspan="2">CTCAE Grade 5 Eye Infection NOS with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Eye Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Eye Infection NOS with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Eye Infection NOS Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4362</td>
               <td colspan="2">CTCAE Grade 5 Eye Infection NOS with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Eye Infection NOS Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Eye Infection NOS Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     5 Eye Infection NOS with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4363</td>
               <td colspan="2">CTCAE Grade 5 FEV1<span class="subclass"> SubClassOf </span>FEV1 Adverse Event. <br><i>New Terms: FEV1 Adverse Event, CTCAE Grade 5 FEV1</i></td>
            </tr>
            <tr class="addition">
               <td>4364</td>
               <td colspan="2">CTCAE Grade 5 Facial Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Facial Muscle Weakness Not Due to Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 5 Facial Muscle Weakness Not Due to Neuropathy, Facial Muscle Weakness
                     Not Due to Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4365</td>
               <td colspan="2">CTCAE Grade 5 Fallopian Tube Hemorrhage<span class="subclass"> SubClassOf </span>Fallopian Tube Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 5 Fallopian Tube Hemorrhage, Fallopian Tube Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4366</td>
               <td colspan="2">CTCAE Grade 5 Fallopian Tube Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Fallopian Tube Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Fallopian Tube Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, CTCAE Grade 5 Fallopian Tube Infection Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4367</td>
               <td colspan="2">CTCAE Grade 5 Fallopian Tube Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Fallopian Tube Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Fallopian Tube Infection Adverse Event with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, CTCAE Grade 5 Fallopian Tube Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4368</td>
               <td colspan="2">CTCAE Grade 5 Fallopian Tube Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Fallopian Tube Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 5 Fallopian Tube Infection with Unknown Absolute Neutrophil Count, Fallopian
                     Tube Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4369</td>
               <td colspan="2">CTCAE Grade 5 Fallopian Tube Leak<span class="subclass"> SubClassOf </span>Fallopian Tube Leak Adverse Event. <br><i>New Terms: Fallopian Tube Leak Adverse Event, CTCAE Grade 5 Fallopian Tube Leak</i></td>
            </tr>
            <tr class="addition">
               <td>4370</td>
               <td colspan="2">CTCAE Grade 5 Fallopian Tube Obstruction<span class="subclass"> SubClassOf </span>Fallopian Tube Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 5 Fallopian Tube Obstruction, Fallopian Tube Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4371</td>
               <td colspan="2">CTCAE Grade 5 Fallopian Tube Perforation<span class="subclass"> SubClassOf </span>Fallopian Tube Perforation Adverse Event. <br><i>New Terms: Fallopian Tube Perforation Adverse Event, CTCAE Grade 5 Fallopian Tube Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>4372</td>
               <td colspan="2">CTCAE Grade 5 Fallopian Tube Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Fallopian Tube Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 5 Fallopian Tube Stricture or Stenosis, Fallopian Tube Stricture or Stenosis
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4373</td>
               <td colspan="2">CTCAE Grade 5 Febrile Neutropenia<span class="subclass"> SubClassOf </span>Febrile Neutropenia without Clinically<br><span class="keyword"> or </span>Microbiologically Documented Infection with Absolute Neutrophil Count Less Than 1
                  X 10e9 per Liter<br><span class="keyword"> and </span>Temperature Greater Than<br><span class="keyword"> or </span>Equal to 38 Point 5 Degrees Celsius. <br><i>New Terms: Febrile Neutropenia without Clinically or Microbiologically Documented Infection with
                     Absolute Neutrophil Count Less Than 1 X 10e9 per Liter and Temperature Greater Than
                     or Equal to 38 Point 5 Degrees Celsius, CTCAE Grade 5 Febrile Neutropenia</i></td>
            </tr>
            <tr class="addition">
               <td>4374</td>
               <td colspan="2">CTCAE Grade 5 Female Genital Tract Fistula<span class="subclass"> SubClassOf </span>Female Genital Tract Fistula Adverse Event. <br><i>New Terms: Female Genital Tract Fistula Adverse Event, CTCAE Grade 5 Female Genital Tract Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>4375</td>
               <td colspan="2">CTCAE Grade 5 Fever Without Neutropenia<span class="subclass"> SubClassOf </span>Fever Without Neutropenia Adverse Event. <br><i>New Terms: CTCAE Grade 5 Fever Without Neutropenia, Fever Without Neutropenia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4376</td>
               <td colspan="2">CTCAE Grade 5 Fibrinogen<span class="subclass"> SubClassOf </span>Fibrinogen Adverse Event. <br><i>New Terms: CTCAE Grade 5 Fibrinogen, Fibrinogen Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4377</td>
               <td colspan="2">CTCAE Grade 5 Fibrosis-Deep Connective Tissue<span class="subclass"> SubClassOf </span>Fibrosis-Deep Connective Tissue Adverse Event. <br><i>New Terms: Fibrosis-Deep Connective Tissue Adverse Event, CTCAE Grade 5 Fibrosis-Deep Connective
                     Tissue</i></td>
            </tr>
            <tr class="addition">
               <td>4378</td>
               <td colspan="2">CTCAE Grade 5 Flu-Like Syndrome<span class="subclass"> SubClassOf </span>Flu-Like Syndrome Adverse Event. <br><i>New Terms: Flu-Like Syndrome Adverse Event, CTCAE Grade 5 Flu-Like Syndrome</i></td>
            </tr>
            <tr class="addition">
               <td>4379</td>
               <td colspan="2">CTCAE Grade 5 Foreign Body Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Foreign Body Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Foreign Body Infection Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, Foreign Body Infection Adverse Event Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4380</td>
               <td colspan="2">CTCAE Grade 5 Foreign Body Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Foreign Body Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Foreign Body Infection with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, Foreign Body Infection Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4381</td>
               <td colspan="2">CTCAE Grade 5 Foreign Body Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Foreign Body Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 5 Foreign Body Infection with Unknown Absolute Neutrophil Count, Foreign
                     Body Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4382</td>
               <td colspan="2">CTCAE Grade 5 Fracture<span class="subclass"> SubClassOf </span>Fracture Adverse Event. <br><i>New Terms: Fracture Adverse Event, CTCAE Grade 5 Fracture</i></td>
            </tr>
            <tr class="addition">
               <td>4383</td>
               <td colspan="2">CTCAE Grade 5 Gallbladder Fistula<span class="subclass"> SubClassOf </span>Gallbladder Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 5 Gallbladder Fistula, Gallbladder Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4384</td>
               <td colspan="2">CTCAE Grade 5 Gallbladder Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Gallbladder Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Gallbladder Infection Adverse Event Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, CTCAE Grade 5 Gallbladder Infection Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4385</td>
               <td colspan="2">CTCAE Grade 5 Gallbladder Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Gallbladder Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Gallbladder Infection Adverse Event with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, CTCAE Grade 5 Gallbladder Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4386</td>
               <td colspan="2">CTCAE Grade 5 Gallbladder Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Gallbladder Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Gallbladder Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE
                     Grade 5 Gallbladder Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4387</td>
               <td colspan="2">CTCAE Grade 5 Gallbladder Necrosis<span class="subclass"> SubClassOf </span>Gallbladder Necrosis Adverse Event. <br><i>New Terms: Gallbladder Necrosis Adverse Event, CTCAE Grade 5 Gallbladder Necrosis</i></td>
            </tr>
            <tr class="addition">
               <td>4388</td>
               <td colspan="2">CTCAE Grade 5 Gallbladder Obstruction<span class="subclass"> SubClassOf </span>Gallbladder Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 5 Gallbladder Obstruction, Gallbladder Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4389</td>
               <td colspan="2">CTCAE Grade 5 Gallbladder Perforation<span class="subclass"> SubClassOf </span>Gallbladder Perforation Adverse Event. <br><i>New Terms: Gallbladder Perforation Adverse Event, CTCAE Grade 5 Gallbladder Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>4390</td>
               <td colspan="2">CTCAE Grade 5 Gastritis<span class="subclass"> SubClassOf </span>Gastritis Adverse Event. <br><i>New Terms: Gastritis Adverse Event, CTCAE Grade 5 Gastritis</i></td>
            </tr>
            <tr class="addition">
               <td>4391</td>
               <td colspan="2">CTCAE Grade 5 Gastrointestinal Leak NOS<span class="subclass"> SubClassOf </span>Gastrointestinal Leak Adverse Event NOS. <br><i>New Terms: Gastrointestinal Leak Adverse Event NOS, CTCAE Grade 5 Gastrointestinal Leak NOS</i></td>
            </tr>
            <tr class="addition">
               <td>4392</td>
               <td colspan="2">CTCAE Grade 5 Gastrointestinal Stoma Hemorrhage<span class="subclass"> SubClassOf </span>Gastrointestinal Stoma Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 5 Gastrointestinal Stoma Hemorrhage, Gastrointestinal Stoma Hemorrhage
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4393</td>
               <td colspan="2">CTCAE Grade 5 Gastrointestinal Stoma Leak<span class="subclass"> SubClassOf </span>Gastrointestinal Stoma Leak Adverse Event. <br><i>New Terms: CTCAE Grade 5 Gastrointestinal Stoma Leak, Gastrointestinal Stoma Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4394</td>
               <td colspan="2">CTCAE Grade 5 Genitourinary Stoma Hemorrhage<span class="subclass"> SubClassOf </span>Genitourinary Stoma Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 5 Genitourinary Stoma Hemorrhage, Genitourinary Stoma Hemorrhage Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>4395</td>
               <td colspan="2">CTCAE Grade 5 Genitourinary Stoma Leak<span class="subclass"> SubClassOf </span>Genitourinary Stoma Leak Adverse Event. <br><i>New Terms: Genitourinary Stoma Leak Adverse Event, CTCAE Grade 5 Genitourinary Stoma Leak</i></td>
            </tr>
            <tr class="addition">
               <td>4396</td>
               <td colspan="2">CTCAE Grade 5 Genitourinary Stoma Obstruction<span class="subclass"> SubClassOf </span>Genitourinary Stoma Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 5 Genitourinary Stoma Obstruction, Genitourinary Stoma Obstruction Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>4397</td>
               <td colspan="2">CTCAE Grade 5 Genitourinary Stoma Prolapse<span class="subclass"> SubClassOf </span>Genitourinary Stoma Prolapse Adverse Event. <br><i>New Terms: Genitourinary Stoma Prolapse Adverse Event, CTCAE Grade 5 Genitourinary Stoma Prolapse</i></td>
            </tr>
            <tr class="addition">
               <td>4398</td>
               <td colspan="2">CTCAE Grade 5 Genitourinary Stoma Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Genitourinary Stoma Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Genitourinary Stoma Stricture or Stenosis Adverse Event, CTCAE Grade 5 Genitourinary
                     Stoma Stricture or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>4399</td>
               <td colspan="2">CTCAE Grade 5 Glomerular Filtration Rate<span class="subclass"> SubClassOf </span>Glomerular Filtration Rate Adverse Event. <br><i>New Terms: CTCAE Grade 5 Glomerular Filtration Rate, Glomerular Filtration Rate Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4400</td>
               <td colspan="2">CTCAE Grade 5 Haptoglobin<span class="subclass"> SubClassOf </span>Haptoglobin Adverse Event. <br><i>New Terms: CTCAE Grade 5 Haptoglobin, Haptoglobin Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4401</td>
               <td colspan="2">CTCAE Grade 5 Head Soft Tissue Necrosis<span class="subclass"> SubClassOf </span>Head Soft Tissue Necrosis Adverse Event. <br><i>New Terms: Head Soft Tissue Necrosis Adverse Event, CTCAE Grade 5 Head Soft Tissue Necrosis</i></td>
            </tr>
            <tr class="addition">
               <td>4402</td>
               <td colspan="2">CTCAE Grade 5 Heart Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Heart Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Heart Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 5 Heart Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4403</td>
               <td colspan="2">CTCAE Grade 5 Heart Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Heart Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Heart Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 5 Heart Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4404</td>
               <td colspan="2">CTCAE Grade 5 Heart Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Heart Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Heart Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     5 Heart Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4405</td>
               <td colspan="2">CTCAE Grade 5 Hematoma<span class="subclass"> SubClassOf </span>Hematoma Adverse Event. <br><i>New Terms: Hematoma Adverse Event, CTCAE Grade 5 Hematoma</i></td>
            </tr>
            <tr class="addition">
               <td>4406</td>
               <td colspan="2">CTCAE Grade 5 Hemoglobin<span class="subclass"> SubClassOf </span>Hemoglobin Adverse Event. <br><i>New Terms: CTCAE Grade 5 Hemoglobin, Hemoglobin Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4407</td>
               <td colspan="2">CTCAE Grade 5 Hemoglobinuria<span class="subclass"> SubClassOf </span>Hemoglobinuria Adverse Event. <br><i>New Terms: CTCAE Grade 5 Hemoglobinuria, Hemoglobinuria Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4408</td>
               <td colspan="2">CTCAE Grade 5 Hemolysis<span class="subclass"> SubClassOf </span>Hemolysis Adverse Event. <br><i>New Terms: CTCAE Grade 5 Hemolysis, Hemolysis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4409</td>
               <td colspan="2">CTCAE Grade 5 Hemorrhage<br><span class="keyword"> and </span>Bleeding Adverse Event Associated with Surgery<span class="subclass"> SubClassOf </span>Hemorrhage<br><span class="keyword"> and </span>Bleeding Adverse Event Associated with Surgery. <br><i>New Terms: Hemorrhage and Bleeding Adverse Event Associated with Surgery, CTCAE Grade 5 Hemorrhage
                     and Bleeding Adverse Event Associated with Surgery</i></td>
            </tr>
            <tr class="addition">
               <td>4410</td>
               <td colspan="2">CTCAE Grade 5 Hemorrhoids<span class="subclass"> SubClassOf </span>Hemorrhoids Adverse Event. <br><i>New Terms: Hemorrhoids Adverse Event, CTCAE Grade 5 Hemorrhoids</i></td>
            </tr>
            <tr class="addition">
               <td>4411</td>
               <td colspan="2">CTCAE Grade 5 Hepatic Necrosis<span class="subclass"> SubClassOf </span>Hepatic Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 5 Hepatic Necrosis, Hepatic Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4412</td>
               <td colspan="2">CTCAE Grade 5 Hydrocephalus<span class="subclass"> SubClassOf </span>Hydrocephalus Adverse Event. <br><i>New Terms: Hydrocephalus Adverse Event, CTCAE Grade 5 Hydrocephalus</i></td>
            </tr>
            <tr class="addition">
               <td>4413</td>
               <td colspan="2">CTCAE Grade 5 Hypertension<span class="subclass"> SubClassOf </span>Hypertension Adverse Event. <br><i>New Terms: Hypertension Adverse Event, CTCAE Grade 5 Hypertension</i></td>
            </tr>
            <tr class="addition">
               <td>4414</td>
               <td colspan="2">CTCAE Grade 5 Hypotension<span class="subclass"> SubClassOf </span>Hypotension Adverse Event. <br><i>New Terms: Hypotension Adverse Event, CTCAE Grade 5 Hypotension</i></td>
            </tr>
            <tr class="addition">
               <td>4415</td>
               <td colspan="2">CTCAE Grade 5 Hypothermia<span class="subclass"> SubClassOf </span>Hypothermia Adverse Event. <br><i>New Terms: CTCAE Grade 5 Hypothermia, Hypothermia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4416</td>
               <td colspan="2">CTCAE Grade 5 Hypoxia<span class="subclass"> SubClassOf </span>Hypoxia Adverse Event. <br><i>New Terms: Hypoxia Adverse Event, CTCAE Grade 5 Hypoxia</i></td>
            </tr>
            <tr class="addition">
               <td>4417</td>
               <td colspan="2">CTCAE Grade 5 Idioventricular Rhythm<span class="subclass"> SubClassOf </span>Idioventricular Rhythm Adverse Event. <br><i>New Terms: Idioventricular Rhythm Adverse Event, CTCAE Grade 5 Idioventricular Rhythm</i></td>
            </tr>
            <tr class="addition">
               <td>4418</td>
               <td colspan="2">CTCAE Grade 5 Ileum Fistula<span class="subclass"> SubClassOf </span>Ileum Fistula Adverse Event. <br><i>New Terms: Ileum Fistula Adverse Event, CTCAE Grade 5 Ileum Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>4419</td>
               <td colspan="2">CTCAE Grade 5 Ileum Hemorrhage<span class="subclass"> SubClassOf </span>Ileum Hemorrhage Adverse Event. <br><i>New Terms: Ileum Hemorrhage Adverse Event, CTCAE Grade 5 Ileum Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>4420</td>
               <td colspan="2">CTCAE Grade 5 Ileum Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Ileum Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Ileum Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Ileum Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4421</td>
               <td colspan="2">CTCAE Grade 5 Ileum Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Ileum Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Ileum Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Ileum Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4422</td>
               <td colspan="2">CTCAE Grade 5 Ileum Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Ileum Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Ileum Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     5 Ileum Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4423</td>
               <td colspan="2">CTCAE Grade 5 Ileum Necrosis<span class="subclass"> SubClassOf </span>Ileum Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 5 Ileum Necrosis, Ileum Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4424</td>
               <td colspan="2">CTCAE Grade 5 Ileum Obstruction<span class="subclass"> SubClassOf </span>Ileum Obstruction Adverse Event. <br><i>New Terms: Ileum Obstruction Adverse Event, CTCAE Grade 5 Ileum Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>4425</td>
               <td colspan="2">CTCAE Grade 5 Ileum Perforation<span class="subclass"> SubClassOf </span>Ileum Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 5 Ileum Perforation, Ileum Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4426</td>
               <td colspan="2">CTCAE Grade 5 Ileum Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Ileum Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Ileum Stricture or Stenosis Adverse Event, CTCAE Grade 5 Ileum Stricture or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>4427</td>
               <td colspan="2">CTCAE Grade 5 Ileum Ulcer<span class="subclass"> SubClassOf </span>Ileum Ulcer Adverse Event. <br><i>New Terms: CTCAE Grade 5 Ileum Ulcer, Ileum Ulcer Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4428</td>
               <td colspan="2">CTCAE Grade 5 Ileus<span class="subclass"> SubClassOf </span>Gastrointestinal Ileus Adverse Event. <br><i>New Terms: CTCAE Grade 5 Ileus, Gastrointestinal Ileus Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4429</td>
               <td colspan="2">CTCAE Grade 5 Infectious Colitis<span class="subclass"> SubClassOf </span>Infectious Colitis Adverse Event. <br><i>New Terms: Infectious Colitis Adverse Event, CTCAE Grade 5 Infectious Colitis</i></td>
            </tr>
            <tr class="addition">
               <td>4430</td>
               <td colspan="2">CTCAE Grade 5 Inferior Vena Cava Vein Injury<span class="subclass"> SubClassOf </span>Inferior Vena Cava Vein Injury Adverse Event. <br><i>New Terms: Inferior Vena Cava Vein Injury Adverse Event, CTCAE Grade 5 Inferior Vena Cava Vein
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>4431</td>
               <td colspan="2">CTCAE Grade 5 Iron Overload<span class="subclass"> SubClassOf </span>Iron Overload Adverse Event. <br><i>New Terms: Iron Overload Adverse Event, CTCAE Grade 5 Iron Overload</i></td>
            </tr>
            <tr class="addition">
               <td>4432</td>
               <td colspan="2">CTCAE Grade 5 Jejunum Fistula<span class="subclass"> SubClassOf </span>Jejunum Fistula Adverse Event. <br><i>New Terms: Jejunum Fistula Adverse Event, CTCAE Grade 5 Jejunum Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>4433</td>
               <td colspan="2">CTCAE Grade 5 Jejunum Hemorrhage<span class="subclass"> SubClassOf </span>Jejunum Hemorrhage Adverse Event. <br><i>New Terms: Jejunum Hemorrhage Adverse Event, CTCAE Grade 5 Jejunum Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>4434</td>
               <td colspan="2">CTCAE Grade 5 Jejunum Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Jejunum Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Jejunum Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Jejunum Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4435</td>
               <td colspan="2">CTCAE Grade 5 Jejunum Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Jejunum Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Jejunum Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 5 Jejunum Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4436</td>
               <td colspan="2">CTCAE Grade 5 Jejunum Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Jejunum Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 5 Jejunum Infection with Unknown Absolute Neutrophil Count, Jejunum Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4437</td>
               <td colspan="2">CTCAE Grade 5 Jejunum Necrosis<span class="subclass"> SubClassOf </span>Jejunum Necrosis Adverse Event. <br><i>New Terms: Jejunum Necrosis Adverse Event, CTCAE Grade 5 Jejunum Necrosis</i></td>
            </tr>
            <tr class="addition">
               <td>4438</td>
               <td colspan="2">CTCAE Grade 5 Jejunum Obstruction<span class="subclass"> SubClassOf </span>Jejunum Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 5 Jejunum Obstruction, Jejunum Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4439</td>
               <td colspan="2">CTCAE Grade 5 Jejunum Perforation<span class="subclass"> SubClassOf </span>Jejunum Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 5 Jejunum Perforation, Jejunum Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4440</td>
               <td colspan="2">CTCAE Grade 5 Jejunum Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Jejunum Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 5 Jejunum Stricture or Stenosis, Jejunum Stricture or Stenosis Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>4441</td>
               <td colspan="2">CTCAE Grade 5 Jejunum Ulcer<span class="subclass"> SubClassOf </span>Jejunum Ulcer Adverse Event. <br><i>New Terms: CTCAE Grade 5 Jejunum Ulcer, Jejunum Ulcer Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4442</td>
               <td colspan="2">CTCAE Grade 5 Joint Effusion<span class="subclass"> SubClassOf </span>Joint Effusion Adverse Event. <br><i>New Terms: Joint Effusion Adverse Event, CTCAE Grade 5 Joint Effusion</i></td>
            </tr>
            <tr class="addition">
               <td>4443</td>
               <td colspan="2">CTCAE Grade 5 Joint Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Joint Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Joint Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 5 Joint Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4444</td>
               <td colspan="2">CTCAE Grade 5 Joint Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Joint Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Joint Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 5 Joint Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4445</td>
               <td colspan="2">CTCAE Grade 5 Joint Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Joint Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 5 Joint Infection with Unknown Absolute Neutrophil Count, Joint Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4446</td>
               <td colspan="2">CTCAE Grade 5 Jugular Vein Injury<span class="subclass"> SubClassOf </span>Jugular Vein Injury Adverse Event. <br><i>New Terms: Jugular Vein Injury Adverse Event, CTCAE Grade 5 Jugular Vein Injury</i></td>
            </tr>
            <tr class="addition">
               <td>4447</td>
               <td colspan="2">CTCAE Grade 5 Kidney Fistula<span class="subclass"> SubClassOf </span>Kidney Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 5 Kidney Fistula, Kidney Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4448</td>
               <td colspan="2">CTCAE Grade 5 Kidney Hemorrhage<span class="subclass"> SubClassOf </span>Kidney Hemorrhage Adverse Event. <br><i>New Terms: Kidney Hemorrhage Adverse Event, CTCAE Grade 5 Kidney Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>4449</td>
               <td colspan="2">CTCAE Grade 5 Kidney Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Kidney Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Kidney Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 5 Kidney Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4450</td>
               <td colspan="2">CTCAE Grade 5 Kidney Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Kidney Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Kidney Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 5 Kidney Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4451</td>
               <td colspan="2">CTCAE Grade 5 Kidney Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Kidney Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 5 Kidney Infection with Unknown Absolute Neutrophil Count, Kidney Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4452</td>
               <td colspan="2">CTCAE Grade 5 Kidney Leak<span class="subclass"> SubClassOf </span>Kidney Leak Adverse Event. <br><i>New Terms: CTCAE Grade 5 Kidney Leak, Kidney Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4453</td>
               <td colspan="2">CTCAE Grade 5 Kidney Perforation<span class="subclass"> SubClassOf </span>Kidney Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 5 Kidney Perforation, Kidney Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4454</td>
               <td colspan="2">CTCAE Grade 5 Large Bowel Leak<span class="subclass"> SubClassOf </span>Large Bowel Leak Adverse Event. <br><i>New Terms: CTCAE Grade 5 Large Bowel Leak, Large Bowel Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4455</td>
               <td colspan="2">CTCAE Grade 5 Large Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Large Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification. <br><i>New Terms: CTCAE Grade 5 Large Bowel Mucositis or Stomatitis by Clinical Examination Classification,
                     Large Bowel Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>4456</td>
               <td colspan="2">CTCAE Grade 5 Large Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Large Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: CTCAE Grade 5 Large Bowel Mucositis or Stomatitis by Functional or Symptomatic Classification,
                     Large Bowel Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>4457</td>
               <td colspan="2">CTCAE Grade 5 Laryngeal Nerve Dysfunction<span class="subclass"> SubClassOf </span>Laryngeal Nerve Dysfunction Adverse Event. <br><i>New Terms: CTCAE Grade 5 Laryngeal Nerve Dysfunction, Laryngeal Nerve Dysfunction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4458</td>
               <td colspan="2">CTCAE Grade 5 Larynx Edema<span class="subclass"> SubClassOf </span>Larynx Edema Adverse Event. <br><i>New Terms: CTCAE Grade 5 Larynx Edema, Larynx Edema Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4459</td>
               <td colspan="2">CTCAE Grade 5 Larynx Fistula<span class="subclass"> SubClassOf </span>Larynx Fistula Adverse Event. <br><i>New Terms: Larynx Fistula Adverse Event, CTCAE Grade 5 Larynx Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>4460</td>
               <td colspan="2">CTCAE Grade 5 Larynx Hemorrhage<span class="subclass"> SubClassOf </span>Larynx Hemorrhage Adverse Event. <br><i>New Terms: Larynx Hemorrhage Adverse Event, CTCAE Grade 5 Larynx Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>4461</td>
               <td colspan="2">CTCAE Grade 5 Larynx Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Larynx Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Larynx Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Larynx Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4462</td>
               <td colspan="2">CTCAE Grade 5 Larynx Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Larynx Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Larynx Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 5 Larynx Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4463</td>
               <td colspan="2">CTCAE Grade 5 Larynx Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Larynx Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Larynx Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     5 Larynx Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4464</td>
               <td colspan="2">CTCAE Grade 5 Larynx Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Larynx Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification. <br><i>New Terms: Larynx Mucositis or Stomatitis by Clinical Examination Classification, CTCAE Grade
                     5 Larynx Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>4465</td>
               <td colspan="2">CTCAE Grade 5 Larynx Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Larynx Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: Larynx Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification,
                     CTCAE Grade 5 Larynx Mucositis or Stomatitis by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>4466</td>
               <td colspan="2">CTCAE Grade 5 Larynx Obstruction<br><span class="keyword"> and </span>Stenosis<span class="subclass"> SubClassOf </span>Larynx Obstruction<br><span class="keyword"> and </span>Stenosis Adverse Event. <br><i>New Terms: Larynx Obstruction and Stenosis Adverse Event, CTCAE Grade 5 Larynx Obstruction and
                     Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>4468</td>
               <td colspan="2">CTCAE Grade 5 Left Ventricular Diastolic Dysfunction<span class="subclass"> SubClassOf </span>Left Ventricular Diastolic Dysfunction Adverse Event. <br><i>New Terms: Left Ventricular Diastolic Dysfunction Adverse Event, CTCAE Grade 5 Left Ventricular
                     Diastolic Dysfunction</i></td>
            </tr>
            <tr class="addition">
               <td>4469</td>
               <td colspan="2">CTCAE Grade 5 Left Ventricular Systolic Dysfunction<span class="subclass"> SubClassOf </span>Left Ventricular Systolic Dysfunction Adverse Event. <br><i>New Terms: CTCAE Grade 5 Left Ventricular Systolic Dysfunction, Left Ventricular Systolic Dysfunction
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4467</td>
               <td colspan="2">CTCAE Grade 5 Left-Sided Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Left-Sided Muscle Weakness Not Due to Neuropathy Adverse Event. <br><i>New Terms: Left-Sided Muscle Weakness Not Due to Neuropathy Adverse Event, CTCAE Grade 5 Left-Sided
                     Muscle Weakness Not Due to Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>4470</td>
               <td colspan="2">CTCAE Grade 5 Lens Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Lens Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Lens Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Lens Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4471</td>
               <td colspan="2">CTCAE Grade 5 Lens Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Lens Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Lens Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or 2
                     Neutrophils, CTCAE Grade 5 Lens Infection with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4472</td>
               <td colspan="2">CTCAE Grade 5 Lens Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Lens Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Lens Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade 5
                     Lens Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4473</td>
               <td colspan="2">CTCAE Grade 5 Leukocytes<span class="subclass"> SubClassOf </span>Leukocytes Adverse Event. <br><i>New Terms: CTCAE Grade 5 Leukocytes, Leukocytes Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4474</td>
               <td colspan="2">CTCAE Grade 5 Lip<br><span class="keyword"> or </span>Perioral Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Lip<br><span class="keyword"> or </span>Perioral Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Lip or Perioral Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, Lip or Perioral Infection Adverse Event Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4475</td>
               <td colspan="2">CTCAE Grade 5 Lip<br><span class="keyword"> or </span>Perioral Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Lip<br><span class="keyword"> or </span>Perioral Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Lip or Perioral Infection with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, Lip or Perioral Infection Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4476</td>
               <td colspan="2">CTCAE Grade 5 Lip<br><span class="keyword"> or </span>Perioral Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Lip<br><span class="keyword"> or </span>Perioral Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 5 Lip or Perioral Infection with Unknown Absolute Neutrophil Count, Lip
                     or Perioral Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4477</td>
               <td colspan="2">CTCAE Grade 5 Liver Dysfunction<br><span class="keyword"> or </span>Failure by Clinical Classification<span class="subclass"> SubClassOf </span>Liver Dysfunction<br><span class="keyword"> or </span>Failure by Clinical Classification Adverse Event. <br><i>New Terms: Liver Dysfunction or Failure by Clinical Classification Adverse Event, CTCAE Grade
                     5 Liver Dysfunction or Failure by Clinical Classification</i></td>
            </tr>
            <tr class="addition">
               <td>4478</td>
               <td colspan="2">CTCAE Grade 5 Liver Hemorrhage<span class="subclass"> SubClassOf </span>Liver Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 5 Liver Hemorrhage, Liver Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4479</td>
               <td colspan="2">CTCAE Grade 5 Liver Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Liver Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Liver Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Liver Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4480</td>
               <td colspan="2">CTCAE Grade 5 Liver Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Liver Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Liver Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Liver Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4481</td>
               <td colspan="2">CTCAE Grade 5 Liver Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Liver Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Liver Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     5 Liver Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4482</td>
               <td colspan="2">CTCAE Grade 5 Local Complication of Device<br><span class="keyword"> and </span>Prosthesis<span class="subclass"> SubClassOf </span>Local Complication of Device<br><span class="keyword"> and </span>Prosthesis Adverse Event. <br><i>New Terms: Local Complication of Device and Prosthesis Adverse Event, CTCAE Grade 5 Local Complication
                     of Device and Prosthesis</i></td>
            </tr>
            <tr class="addition">
               <td>4483</td>
               <td colspan="2">CTCAE Grade 5 Low Serum Bicarbonate<span class="subclass"> SubClassOf </span>Low Serum Bicarbonate Adverse Event. <br><i>New Terms: CTCAE Grade 5 Low Serum Bicarbonate, Low Serum Bicarbonate Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4484</td>
               <td colspan="2">CTCAE Grade 5 Lower Extremity Artery Injury<span class="subclass"> SubClassOf </span>Lower Extremity Artery Injury Adverse Event. <br><i>New Terms: Lower Extremity Artery Injury Adverse Event, CTCAE Grade 5 Lower Extremity Artery
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>4485</td>
               <td colspan="2">CTCAE Grade 5 Lower Extremity Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Lower Extremity Muscle Weakness Adverse Event Not Due to Neuropathy. <br><i>New Terms: CTCAE Grade 5 Lower Extremity Muscle Weakness Not Due to Neuropathy, Lower Extremity
                     Muscle Weakness Adverse Event Not Due to Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>4486</td>
               <td colspan="2">CTCAE Grade 5 Lower Extremity Soft Tissue Necrosis<span class="subclass"> SubClassOf </span>Lower Extremity Soft Tissue Necrosis Adverse Event. <br><i>New Terms: Lower Extremity Soft Tissue Necrosis Adverse Event, CTCAE Grade 5 Lower Extremity
                     Soft Tissue Necrosis</i></td>
            </tr>
            <tr class="addition">
               <td>4487</td>
               <td colspan="2">CTCAE Grade 5 Lower Extremity Vein Injury<span class="subclass"> SubClassOf </span>Lower Extremity Vein Injury Adverse Event. <br><i>New Terms: CTCAE Grade 5 Lower Extremity Vein Injury, Lower Extremity Vein Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4488</td>
               <td colspan="2">CTCAE Grade 5 Lower Gastrointestinal Hemorrhage NOS<span class="subclass"> SubClassOf </span>Lower Gastrointestinal Hemorrhage Adverse Event NOS. <br><i>New Terms: Lower Gastrointestinal Hemorrhage Adverse Event NOS, CTCAE Grade 5 Lower Gastrointestinal
                     Hemorrhage NOS</i></td>
            </tr>
            <tr class="addition">
               <td>4489</td>
               <td colspan="2">CTCAE Grade 5 Lung Fistula<span class="subclass"> SubClassOf </span>Lung Fistula Adverse Event. <br><i>New Terms: Lung Fistula Adverse Event, CTCAE Grade 5 Lung Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>4490</td>
               <td colspan="2">CTCAE Grade 5 Lung Hemorrhage<span class="subclass"> SubClassOf </span>Lung Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 5 Lung Hemorrhage, Lung Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4491</td>
               <td colspan="2">CTCAE Grade 5 Lung Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Lung Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Lung Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Lung Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4492</td>
               <td colspan="2">CTCAE Grade 5 Lung Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Lung Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Lung Infection with Normal Absolute Neutrophil Count or Grade 1 or 2
                     Neutrophils, Lung Infection Adverse Event with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4493</td>
               <td colspan="2">CTCAE Grade 5 Lung Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Lung Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 5 Lung Infection with Unknown Absolute Neutrophil Count, Lung Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4494</td>
               <td colspan="2">CTCAE Grade 5 Lymphatic Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Lymphatic Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Lymphatic Infection Adverse Event Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, CTCAE Grade 5 Lymphatic Infection Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4495</td>
               <td colspan="2">CTCAE Grade 5 Lymphatic Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Lymphatic Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Lymphatic Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, CTCAE Grade 5 Lymphatic Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4496</td>
               <td colspan="2">CTCAE Grade 5 Lymphatic Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Lymphatic Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 5 Lymphatic Infection with Unknown Absolute Neutrophil Count, Lymphatic
                     Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4497</td>
               <td colspan="2">CTCAE Grade 5 Lymphopenia<span class="subclass"> SubClassOf </span>Lymphopenia Adverse Event. <br><i>New Terms: Lymphopenia Adverse Event, CTCAE Grade 5 Lymphopenia</i></td>
            </tr>
            <tr class="addition">
               <td>4498</td>
               <td colspan="2">CTCAE Grade 5 Malabsorption<span class="subclass"> SubClassOf </span>Malabsorption Adverse Event. <br><i>New Terms: CTCAE Grade 5 Malabsorption, Malabsorption Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4499</td>
               <td colspan="2">CTCAE Grade 5 Mediastinum Hemorrhage<span class="subclass"> SubClassOf </span>Mediastinum Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 5 Mediastinum Hemorrhage, Mediastinum Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4500</td>
               <td colspan="2">CTCAE Grade 5 Mediastinum Infection NOS Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Mediastinum Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Mediastinum Infection NOS Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, Mediastinum Infection NOS Adverse Event Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4501</td>
               <td colspan="2">CTCAE Grade 5 Mediastinum Infection NOS with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Mediastinum Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Mediastinum Infection NOS with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, Mediastinum Infection NOS Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4502</td>
               <td colspan="2">CTCAE Grade 5 Mediastinum Infection NOS with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Mediastinum Infection NOS Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Mediastinum Infection NOS Adverse Event with Unknown Absolute Neutrophil Count, CTCAE
                     Grade 5 Mediastinum Infection NOS with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4503</td>
               <td colspan="2">CTCAE Grade 5 Meninges Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Meninges Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Meninges Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 5 Meninges Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4504</td>
               <td colspan="2">CTCAE Grade 5 Meninges Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Meninges Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Meninges Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, CTCAE Grade 5 Meninges Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4505</td>
               <td colspan="2">CTCAE Grade 5 Meninges Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Meninges Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 5 Meninges Infection with Unknown Absolute Neutrophil Count, Meninges
                     Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4506</td>
               <td colspan="2">CTCAE Grade 5 Metabolic<br><span class="keyword"> or </span>Respiratory Acidosis<span class="subclass"> SubClassOf </span>Metabolic<br><span class="keyword"> or </span>Respiratory Acidosis Adverse Event. <br><i>New Terms: Metabolic or Respiratory Acidosis Adverse Event, CTCAE Grade 5 Metabolic or Respiratory
                     Acidosis</i></td>
            </tr>
            <tr class="addition">
               <td>4507</td>
               <td colspan="2">CTCAE Grade 5 Metabolic<br><span class="keyword"> or </span>Respiratory Alkalosis<span class="subclass"> SubClassOf </span>Metabolic<br><span class="keyword"> or </span>Respiratory Alkalosis Adverse Event. <br><i>New Terms: CTCAE Grade 5 Metabolic or Respiratory Alkalosis, Metabolic or Respiratory Alkalosis
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4508</td>
               <td colspan="2">CTCAE Grade 5 Middle Ear Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Middle Ear Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Middle Ear Infection Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, Middle Ear Infection Adverse Event Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4509</td>
               <td colspan="2">CTCAE Grade 5 Middle Ear Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Middle Ear Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Middle Ear Infection with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, Middle Ear Infection Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4510</td>
               <td colspan="2">CTCAE Grade 5 Middle Ear Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Middle Ear Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Middle Ear Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     5 Middle Ear Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4511</td>
               <td colspan="2">CTCAE Grade 5 Motor Neuropathy<span class="subclass"> SubClassOf </span>Motor Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 5 Motor Neuropathy, Motor Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4512</td>
               <td colspan="2">CTCAE Grade 5 Mucosa Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Mucosa Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Mucosa Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 5 Mucosa Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4513</td>
               <td colspan="2">CTCAE Grade 5 Mucosa Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Mucosa Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Mucosa Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Mucosa Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4514</td>
               <td colspan="2">CTCAE Grade 5 Mucosa Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Mucosa Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Mucosa Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     5 Mucosa Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4515</td>
               <td colspan="2">CTCAE Grade 5 Multi-Organ Failure<span class="subclass"> SubClassOf </span>Death Adverse Event Due to Multi-Organ Failure Not Associated with More Specific CTCAE
                  Term. <br><i>New Terms: Death Adverse Event Due to Multi-Organ Failure Not Associated with More Specific CTCAE
                     Term, CTCAE Grade 5 Multi-Organ Failure</i></td>
            </tr>
            <tr class="addition">
               <td>4516</td>
               <td colspan="2">CTCAE Grade 5 Muscle Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Muscle Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Muscle Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 5 Muscle Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4517</td>
               <td colspan="2">CTCAE Grade 5 Muscle Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Muscle Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Muscle Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 5 Muscle Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4518</td>
               <td colspan="2">CTCAE Grade 5 Muscle Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Muscle Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 5 Muscle Infection with Unknown Absolute Neutrophil Count, Muscle Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4519</td>
               <td colspan="2">CTCAE Grade 5 Myelitis<span class="subclass"> SubClassOf </span>Myelitis Adverse Event. <br><i>New Terms: CTCAE Grade 5 Myelitis, Myelitis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4520</td>
               <td colspan="2">CTCAE Grade 5 Myelodysplasia<span class="subclass"> SubClassOf </span>Myelodysplasia Adverse Event. <br><i>New Terms: CTCAE Grade 5 Myelodysplasia, Myelodysplasia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4521</td>
               <td colspan="2">CTCAE Grade 5 Myocarditis<span class="subclass"> SubClassOf </span>Myocarditis Adverse Event. <br><i>New Terms: CTCAE Grade 5 Myocarditis, Myocarditis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4522</td>
               <td colspan="2">CTCAE Grade 5 Myositis<span class="subclass"> SubClassOf </span>Myositis Adverse Event. <br><i>New Terms: Myositis Adverse Event, CTCAE Grade 5 Myositis</i></td>
            </tr>
            <tr class="addition">
               <td>4523</td>
               <td colspan="2">CTCAE Grade 5 Nasal Cavity<br><span class="keyword"> and </span>Paranasal Sinus Reactions<span class="subclass"> SubClassOf </span>Nasal Cavity<br><span class="keyword"> and </span>Paranasal Sinus Reactions Adverse Event. <br><i>New Terms: CTCAE Grade 5 Nasal Cavity and Paranasal Sinus Reactions, Nasal Cavity and Paranasal
                     Sinus Reactions Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4524</td>
               <td colspan="2">CTCAE Grade 5 Nausea<span class="subclass"> SubClassOf </span>Nausea Adverse Event. <br><i>New Terms: CTCAE Grade 5 Nausea, Nausea Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4525</td>
               <td colspan="2">CTCAE Grade 5 Neck Infection NOS Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Neck Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Neck Infection NOS Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 5 Neck Infection NOS Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4526</td>
               <td colspan="2">CTCAE Grade 5 Neck Infection NOS with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Neck Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Neck Infection NOS Adverse Event with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, CTCAE Grade 5 Neck Infection NOS with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4527</td>
               <td colspan="2">CTCAE Grade 5 Neck Infection NOS with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Neck Infection NOS Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 5 Neck Infection NOS with Unknown Absolute Neutrophil Count, Neck Infection
                     NOS Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4528</td>
               <td colspan="2">CTCAE Grade 5 Neck Soft Tissue Necrosis<span class="subclass"> SubClassOf </span>Neck Soft Tissue Necrosis Adverse Event. <br><i>New Terms: Neck Soft Tissue Necrosis Adverse Event, CTCAE Grade 5 Neck Soft Tissue Necrosis</i></td>
            </tr>
            <tr class="addition">
               <td>4529</td>
               <td colspan="2">CTCAE Grade 5 Neuroendocrine ACTH Deficiency<span class="subclass"> SubClassOf </span>Neuroendocrine ACTH Deficiency Adverse Event. <br><i>New Terms: CTCAE Grade 5 Neuroendocrine ACTH Deficiency, Neuroendocrine ACTH Deficiency Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>4530</td>
               <td colspan="2">CTCAE Grade 5 Neuroendocrine ADH Secretion Abnormality<span class="subclass"> SubClassOf </span>Neuroendocrine ADH Secretion Abnormality Adverse Event. <br><i>New Terms: CTCAE Grade 5 Neuroendocrine ADH Secretion Abnormality, Neuroendocrine ADH Secretion
                     Abnormality Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4531</td>
               <td colspan="2">CTCAE Grade 5 Neuroendocrine Prolactin Hormone Secretion Abnormality<span class="subclass"> SubClassOf </span>Neuroendocrine Prolactin Hormone Secretion Abnormality Adverse Event. <br><i>New Terms: CTCAE Grade 5 Neuroendocrine Prolactin Hormone Secretion Abnormality, Neuroendocrine
                     Prolactin Hormone Secretion Abnormality Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4532</td>
               <td colspan="2">CTCAE Grade 5 Neutrophils<br><span class="keyword"> and </span>Granulocytes<span class="subclass"> SubClassOf </span>Neutrophils<br><span class="keyword"> and </span>Granulocytes Adverse Event. <br><i>New Terms: Neutrophils and Granulocytes Adverse Event, CTCAE Grade 5 Neutrophils and Granulocytes</i></td>
            </tr>
            <tr class="addition">
               <td>4533</td>
               <td colspan="2">CTCAE Grade 5 Nodal<br><span class="keyword"> or </span>Junctional Rhythm<span class="subclass"> SubClassOf </span>Nodal<br><span class="keyword"> or </span>Junctional Rhythm Adverse Event. <br><i>New Terms: CTCAE Grade 5 Nodal or Junctional Rhythm, Nodal or Junctional Rhythm Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4534</td>
               <td colspan="2">CTCAE Grade 5 Non-Infectious Wound Complication<span class="subclass"> SubClassOf </span>Non-Infectious Wound Complication Adverse Event. <br><i>New Terms: CTCAE Grade 5 Non-Infectious Wound Complication, Non-Infectious Wound Complication
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4535</td>
               <td colspan="2">CTCAE Grade 5 Non-Malignant Ascites<span class="subclass"> SubClassOf </span>Non-Malignant Ascites Adverse Event. <br><i>New Terms: Non-Malignant Ascites Adverse Event, CTCAE Grade 5 Non-Malignant Ascites</i></td>
            </tr>
            <tr class="addition">
               <td>4536</td>
               <td colspan="2">CTCAE Grade 5 Non-Malignant Pericardial Effusion<span class="subclass"> SubClassOf </span>Non-Malignant Pericardial Effusion Adverse Event. <br><i>New Terms: CTCAE Grade 5 Non-Malignant Pericardial Effusion, Non-Malignant Pericardial Effusion
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4537</td>
               <td colspan="2">CTCAE Grade 5 Non-Malignant Pleural Effusion<span class="subclass"> SubClassOf </span>Non-Malignant Pleural Effusion Adverse Event. <br><i>New Terms: CTCAE Grade 5 Non-Malignant Pleural Effusion, Non-Malignant Pleural Effusion Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>4538</td>
               <td colspan="2">CTCAE Grade 5 Non-Myocardial Visceral Arterial Ischemia<span class="subclass"> SubClassOf </span>Non-Myocardial Visceral Arterial Ischemia Adverse Event. <br><i>New Terms: CTCAE Grade 5 Non-Myocardial Visceral Arterial Ischemia, Non-Myocardial Visceral Arterial
                     Ischemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4539</td>
               <td colspan="2">CTCAE Grade 5 Non-Septic Arthritis<span class="subclass"> SubClassOf </span>Non-Septic Arthritis Adverse Event. <br><i>New Terms: CTCAE Grade 5 Non-Septic Arthritis, Non-Septic Arthritis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4540</td>
               <td colspan="2">CTCAE Grade 5 Nose Hemorrhage<span class="subclass"> SubClassOf </span>Nose Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 5 Nose Hemorrhage, Nose Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4541</td>
               <td colspan="2">CTCAE Grade 5 Nose Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Nose Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Nose Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Nose Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4542</td>
               <td colspan="2">CTCAE Grade 5 Nose Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Nose Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Nose Infection with Normal Absolute Neutrophil Count or Grade 1 or 2
                     Neutrophils, Nose Infection Adverse Event with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4543</td>
               <td colspan="2">CTCAE Grade 5 Nose Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Nose Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 5 Nose Infection with Unknown Absolute Neutrophil Count, Nose Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4544</td>
               <td colspan="2">CTCAE Grade 5 Ocular Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Ocular Muscle Weakness Not Due to Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 5 Ocular Muscle Weakness Not Due to Neuropathy, Ocular Muscle Weakness
                     Not Due to Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4545</td>
               <td colspan="2">CTCAE Grade 5 Opportunistic Infection<span class="subclass"> SubClassOf </span>Opportunistic Infection Adverse Event Associated with Grade 2<br><span class="keyword"> or </span>Greater Lymphopenia. <br><i>New Terms: CTCAE Grade 5 Opportunistic Infection, Opportunistic Infection Adverse Event Associated
                     with Grade 2 or Greater Lymphopenia</i></td>
            </tr>
            <tr class="addition">
               <td>4546</td>
               <td colspan="2">CTCAE Grade 5 Oral Cavity GI Fistula<span class="subclass"> SubClassOf </span>Oral Cavity GI Fistula Adverse Event. <br><i>New Terms: Oral Cavity GI Fistula Adverse Event, CTCAE Grade 5 Oral Cavity GI Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>4547</td>
               <td colspan="2">CTCAE Grade 5 Oral Cavity Hemorrhage<span class="subclass"> SubClassOf </span>Oral Cavity Adverse Event Hemorrhage. <br><i>New Terms: CTCAE Grade 5 Oral Cavity Hemorrhage, Oral Cavity Adverse Event Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>4548</td>
               <td colspan="2">CTCAE Grade 5 Oral Cavity Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Oral Cavity Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification. <br><i>New Terms: CTCAE Grade 5 Oral Cavity Mucositis or Stomatitis by Clinical Examination Classification,
                     Oral Cavity Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>4549</td>
               <td colspan="2">CTCAE Grade 5 Oral Cavity Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Oral Cavity Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: CTCAE Grade 5 Oral Cavity Mucositis or Stomatitis by Functional or Symptomatic Classification,
                     Oral Cavity Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>4550</td>
               <td colspan="2">CTCAE Grade 5 Oral Cavity Pulmonary Fistula<span class="subclass"> SubClassOf </span>Oral Cavity Pulmonary Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 5 Oral Cavity Pulmonary Fistula, Oral Cavity Pulmonary Fistula Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>4551</td>
               <td colspan="2">CTCAE Grade 5 Oral Cavity<br><span class="keyword"> or </span>Gum Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Oral Cavity<br><span class="keyword"> or </span>Gum Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Oral Cavity or Gum Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, Oral Cavity or Gum Infection Adverse Event Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4552</td>
               <td colspan="2">CTCAE Grade 5 Oral Cavity<br><span class="keyword"> or </span>Gum Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Oral Cavity<br><span class="keyword"> or </span>Gum Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Oral Cavity or Gum Infection with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils, Oral Cavity or Gum Infection Adverse Event with Normal Absolute
                     Neutrophil Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4553</td>
               <td colspan="2">CTCAE Grade 5 Oral Cavity<br><span class="keyword"> or </span>Gum Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Oral Cavity<br><span class="keyword"> or </span>Gum Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Oral Cavity or Gum Infection Adverse Event with Unknown Absolute Neutrophil Count,
                     CTCAE Grade 5 Oral Cavity or Gum Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4554</td>
               <td colspan="2">CTCAE Grade 5 Oral Necrosis<span class="subclass"> SubClassOf </span>Oral Necrosis Adverse Event. <br><i>New Terms: Oral Necrosis Adverse Event, CTCAE Grade 5 Oral Necrosis</i></td>
            </tr>
            <tr class="addition">
               <td>4555</td>
               <td colspan="2">CTCAE Grade 5 Osteoporosis<span class="subclass"> SubClassOf </span>Osteoporosis Adverse Event. <br><i>New Terms: Osteoporosis Adverse Event, CTCAE Grade 5 Osteoporosis</i></td>
            </tr>
            <tr class="addition">
               <td>4556</td>
               <td colspan="2">CTCAE Grade 5 Other Allergy<br><span class="keyword"> and </span>Immunology<span class="subclass"> SubClassOf </span>Other Allergy<br><span class="keyword"> and </span>Immunology Adverse Event. <br><i>New Terms: CTCAE Grade 5 Other Allergy and Immunology, Other Allergy and Immunology Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4557</td>
               <td colspan="2">CTCAE Grade 5 Other Auditory<br><span class="keyword"> and </span>Ear<span class="subclass"> SubClassOf </span>Other Auditory<br><span class="keyword"> and </span>Ear Adverse Event. <br><i>New Terms: CTCAE Grade 5 Other Auditory and Ear, Other Auditory and Ear Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4558</td>
               <td colspan="2">CTCAE Grade 5 Other Blood<br><span class="keyword"> and </span>Bone Marrow<span class="subclass"> SubClassOf </span>Other Blood<br><span class="keyword"> and </span>Bone Marrow Adverse Event. <br><i>New Terms: CTCAE Grade 5 Other Blood and Bone Marrow, Other Blood and Bone Marrow Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4559</td>
               <td colspan="2">CTCAE Grade 5 Other Cardiac Arrhythmia<span class="subclass"> SubClassOf </span>Other Cardiac Arrhythmia Adverse Event. <br><i>New Terms: CTCAE Grade 5 Other Cardiac Arrhythmia, Other Cardiac Arrhythmia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4560</td>
               <td colspan="2">CTCAE Grade 5 Other Coagulation<span class="subclass"> SubClassOf </span>Other Coagulation Adverse Event. <br><i>New Terms: CTCAE Grade 5 Other Coagulation, Other Coagulation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4561</td>
               <td colspan="2">CTCAE Grade 5 Other Constitutional Symptoms<span class="subclass"> SubClassOf </span>Other Constitutional Symptoms Adverse Event. <br><i>New Terms: CTCAE Grade 5 Other Constitutional Symptoms, Other Constitutional Symptoms Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>4562</td>
               <td colspan="2">CTCAE Grade 5 Other Dermatology<br><span class="keyword"> or </span>Skin<span class="subclass"> SubClassOf </span>Other Dermatology<br><span class="keyword"> or </span>Skin Adverse Event. <br><i>New Terms: Other Dermatology or Skin Adverse Event, CTCAE Grade 5 Other Dermatology or Skin</i></td>
            </tr>
            <tr class="addition">
               <td>4563</td>
               <td colspan="2">CTCAE Grade 5 Other Endocrine<span class="subclass"> SubClassOf </span>Other Endocrine Adverse Event. <br><i>New Terms: CTCAE Grade 5 Other Endocrine, Other Endocrine Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4564</td>
               <td colspan="2">CTCAE Grade 5 Other Gastrointestinal<span class="subclass"> SubClassOf </span>Other Gastrointestinal Adverse Event. <br><i>New Terms: Other Gastrointestinal Adverse Event, CTCAE Grade 5 Other Gastrointestinal</i></td>
            </tr>
            <tr class="addition">
               <td>4565</td>
               <td colspan="2">CTCAE Grade 5 Other Growth<br><span class="keyword"> and </span>Development<span class="subclass"> SubClassOf </span>Other Growth<br><span class="keyword"> and </span>Development Adverse Event. <br><i>New Terms: Other Growth and Development Adverse Event, CTCAE Grade 5 Other Growth and Development</i></td>
            </tr>
            <tr class="addition">
               <td>4566</td>
               <td colspan="2">CTCAE Grade 5 Other Heart in General<span class="subclass"> SubClassOf </span>Other Adverse Event Associated with the Heart in General. <br><i>New Terms: CTCAE Grade 5 Other Heart in General, Other Adverse Event Associated with the Heart
                     in General</i></td>
            </tr>
            <tr class="addition">
               <td>4567</td>
               <td colspan="2">CTCAE Grade 5 Other Hemorrhage<br><span class="keyword"> and </span>Bleeding<span class="subclass"> SubClassOf </span>Other Hemorrhage<br><span class="keyword"> and </span>Bleeding Adverse Event. <br><i>New Terms: Other Hemorrhage and Bleeding Adverse Event, CTCAE Grade 5 Other Hemorrhage and Bleeding</i></td>
            </tr>
            <tr class="addition">
               <td>4568</td>
               <td colspan="2">CTCAE Grade 5 Other Hepatobiliary<br><span class="keyword"> and </span>Pancreas<span class="subclass"> SubClassOf </span>Other Hepatobiliary<br><span class="keyword"> and </span>Pancreas Adverse Event. <br><i>New Terms: CTCAE Grade 5 Other Hepatobiliary and Pancreas, Other Hepatobiliary and Pancreas Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>4569</td>
               <td colspan="2">CTCAE Grade 5 Other Infection<span class="subclass"> SubClassOf </span>Infection Other Adverse Event. <br><i>New Terms: CTCAE Grade 5 Other Infection, Infection Other Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4570</td>
               <td colspan="2">CTCAE Grade 5 Other Lymphatics<span class="subclass"> SubClassOf </span>Other Lymphatics Adverse Event. <br><i>New Terms: CTCAE Grade 5 Other Lymphatics, Other Lymphatics Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4571</td>
               <td colspan="2">CTCAE Grade 5 Other Metabolic<br><span class="keyword"> and </span>Laboratory<span class="subclass"> SubClassOf </span>Other Metabolic<br><span class="keyword"> and </span>Laboratory Adverse Event. <br><i>New Terms: Other Metabolic and Laboratory Adverse Event, CTCAE Grade 5 Other Metabolic and Laboratory</i></td>
            </tr>
            <tr class="addition">
               <td>4572</td>
               <td colspan="2">CTCAE Grade 5 Other Musculoskeletal<br><span class="keyword"> and </span>Soft Tissue<span class="subclass"> SubClassOf </span>Other Musculoskeletal<br><span class="keyword"> and </span>Soft Tissue Adverse Event. <br><i>New Terms: CTCAE Grade 5 Other Musculoskeletal and Soft Tissue, Other Musculoskeletal and Soft
                     Tissue Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4573</td>
               <td colspan="2">CTCAE Grade 5 Other NOS Artery Injury<span class="subclass"> SubClassOf </span>Other NOS Artery Injury Adverse Event. <br><i>New Terms: Other NOS Artery Injury Adverse Event, CTCAE Grade 5 Other NOS Artery Injury</i></td>
            </tr>
            <tr class="addition">
               <td>4574</td>
               <td colspan="2">CTCAE Grade 5 Other NOS Vein Injury<span class="subclass"> SubClassOf </span>Other NOS Vein Injury Adverse Event. <br><i>New Terms: CTCAE Grade 5 Other NOS Vein Injury, Other NOS Vein Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4575</td>
               <td colspan="2">CTCAE Grade 5 Other Neurology<span class="subclass"> SubClassOf </span>Other Neurology Adverse Event. <br><i>New Terms: Other Neurology Adverse Event, CTCAE Grade 5 Other Neurology</i></td>
            </tr>
            <tr class="addition">
               <td>4576</td>
               <td colspan="2">CTCAE Grade 5 Other Ocular<br><span class="keyword"> and </span>Visual<span class="subclass"> SubClassOf </span>Other Ocular<br><span class="keyword"> and </span>Visual Adverse Event. <br><i>New Terms: Other Ocular and Visual Adverse Event, CTCAE Grade 5 Other Ocular and Visual</i></td>
            </tr>
            <tr class="addition">
               <td>4577</td>
               <td colspan="2">CTCAE Grade 5 Other Pulmonary<br><span class="keyword"> and </span>Upper Respiratory<span class="subclass"> SubClassOf </span>Other Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Adverse Event. <br><i>New Terms: CTCAE Grade 5 Other Pulmonary and Upper Respiratory, Other Pulmonary and Upper Respiratory
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4578</td>
               <td colspan="2">CTCAE Grade 5 Other Renal<br><span class="keyword"> or </span>Genitourinary<span class="subclass"> SubClassOf </span>Renal<br><span class="keyword"> or </span>Genitourinary Other Adverse Event. <br><i>New Terms: Renal or Genitourinary Other Adverse Event, CTCAE Grade 5 Other Renal or Genitourinary</i></td>
            </tr>
            <tr class="addition">
               <td>4579</td>
               <td colspan="2">CTCAE Grade 5 Other Secondary Malignancy Possibly Related to Cancer Treatment<span class="subclass"> SubClassOf </span>Other Secondary Malignancy Possibly Related to Cancer Treatment Adverse Event. <br><i>New Terms: Other Secondary Malignancy Possibly Related to Cancer Treatment Adverse Event, CTCAE
                     Grade 5 Other Secondary Malignancy Possibly Related to Cancer Treatment</i></td>
            </tr>
            <tr class="addition">
               <td>4580</td>
               <td colspan="2">CTCAE Grade 5 Other Sexual Reproductive Function<span class="subclass"> SubClassOf </span>Other Sexual Reproductive Function Adverse Event. <br><i>New Terms: CTCAE Grade 5 Other Sexual Reproductive Function, Other Sexual Reproductive Function
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4581</td>
               <td colspan="2">CTCAE Grade 5 Other Syndromes<span class="subclass"> SubClassOf </span>Other Syndromes Adverse Event. <br><i>New Terms: Other Syndromes Adverse Event, CTCAE Grade 5 Other Syndromes</i></td>
            </tr>
            <tr class="addition">
               <td>4582</td>
               <td colspan="2">CTCAE Grade 5 Other Vascular<span class="subclass"> SubClassOf </span>Other Vascular Adverse Event. <br><i>New Terms: CTCAE Grade 5 Other Vascular, Other Vascular Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4583</td>
               <td colspan="2">CTCAE Grade 5 Otitis External Ear Non Infectious<span class="subclass"> SubClassOf </span>Otitis Adverse Event External Ear Non Infectious. <br><i>New Terms: Otitis Adverse Event External Ear Non Infectious, CTCAE Grade 5 Otitis External Ear
                     Non Infectious</i></td>
            </tr>
            <tr class="addition">
               <td>4584</td>
               <td colspan="2">CTCAE Grade 5 Otitis Middle Ear Non Infectious<span class="subclass"> SubClassOf </span>Otitis Adverse Event Middle Ear Non Infectious. <br><i>New Terms: CTCAE Grade 5 Otitis Middle Ear Non Infectious, Otitis Adverse Event Middle Ear Non
                     Infectious</i></td>
            </tr>
            <tr class="addition">
               <td>4585</td>
               <td colspan="2">CTCAE Grade 5 Ovary Hemorrhage<span class="subclass"> SubClassOf </span>Ovary Hemorrhage Adverse Event. <br><i>New Terms: Ovary Hemorrhage Adverse Event, CTCAE Grade 5 Ovary Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>4586</td>
               <td colspan="2">CTCAE Grade 5 Ovary Perforation<span class="subclass"> SubClassOf </span>Ovary Perforation Adverse Event. <br><i>New Terms: Ovary Perforation Adverse Event, CTCAE Grade 5 Ovary Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>4587</td>
               <td colspan="2">CTCAE Grade 5 PVCs<span class="subclass"> SubClassOf </span>Premature Ventricular Contraction Adverse Event. <br><i>New Terms: CTCAE Grade 5 PVCs, Premature Ventricular Contraction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4588</td>
               <td colspan="2">CTCAE Grade 5 Pancreas Exocrine Enzyme Deficiency<span class="subclass"> SubClassOf </span>Pancreas Exocrine Enzyme Deficiency Adverse Event. <br><i>New Terms: CTCAE Grade 5 Pancreas Exocrine Enzyme Deficiency, Pancreas Exocrine Enzyme Deficiency
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4589</td>
               <td colspan="2">CTCAE Grade 5 Pancreas Fistula<span class="subclass"> SubClassOf </span>Pancreas Fistula Adverse Event. <br><i>New Terms: Pancreas Fistula Adverse Event, CTCAE Grade 5 Pancreas Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>4590</td>
               <td colspan="2">CTCAE Grade 5 Pancreas Hemorrhage<span class="subclass"> SubClassOf </span>Pancreas Hemorrhage Adverse Event. <br><i>New Terms: Pancreas Hemorrhage Adverse Event, CTCAE Grade 5 Pancreas Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>4591</td>
               <td colspan="2">CTCAE Grade 5 Pancreas Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Pancreas Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Pancreas Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Pancreas Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4592</td>
               <td colspan="2">CTCAE Grade 5 Pancreas Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Pancreas Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Pancreas Infection with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, Pancreas Infection Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4593</td>
               <td colspan="2">CTCAE Grade 5 Pancreas Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Pancreas Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 5 Pancreas Infection with Unknown Absolute Neutrophil Count, Pancreas
                     Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4594</td>
               <td colspan="2">CTCAE Grade 5 Pancreas Leak<span class="subclass"> SubClassOf </span>Pancreas Leak Adverse Event. <br><i>New Terms: Pancreas Leak Adverse Event, CTCAE Grade 5 Pancreas Leak</i></td>
            </tr>
            <tr class="addition">
               <td>4595</td>
               <td colspan="2">CTCAE Grade 5 Pancreas Necrosis<span class="subclass"> SubClassOf </span>Pancreas Necrosis Adverse Event. <br><i>New Terms: Pancreas Necrosis Adverse Event, CTCAE Grade 5 Pancreas Necrosis</i></td>
            </tr>
            <tr class="addition">
               <td>4596</td>
               <td colspan="2">CTCAE Grade 5 Pancreas<br><span class="keyword"> or </span>Pancreatic Duct Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Pancreas<br><span class="keyword"> or </span>Pancreatic Duct Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 5 Pancreas or Pancreatic Duct Stricture or Stenosis, Pancreas or Pancreatic
                     Duct Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4597</td>
               <td colspan="2">CTCAE Grade 5 Pancreatic Endocrine Glucose Intolerance<span class="subclass"> SubClassOf </span>Pancreatic Endocrine Glucose Intolerance Adverse Event. <br><i>New Terms: CTCAE Grade 5 Pancreatic Endocrine Glucose Intolerance, Pancreatic Endocrine Glucose
                     Intolerance Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4598</td>
               <td colspan="2">CTCAE Grade 5 Pancreatitis<span class="subclass"> SubClassOf </span>Pancreatitis Adverse Event. <br><i>New Terms: CTCAE Grade 5 Pancreatitis, Pancreatitis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4599</td>
               <td colspan="2">CTCAE Grade 5 Paranasal Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Paranasal Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Paranasal Infection Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, Paranasal Infection Adverse Event Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4600</td>
               <td colspan="2">CTCAE Grade 5 Paranasal Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Paranasal Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Paranasal Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, CTCAE Grade 5 Paranasal Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4601</td>
               <td colspan="2">CTCAE Grade 5 Paranasal Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Paranasal Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 5 Paranasal Infection with Unknown Absolute Neutrophil Count, Paranasal
                     Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4602</td>
               <td colspan="2">CTCAE Grade 5 Pelvic Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Pelvic Muscle Weakness Not Due to Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 5 Pelvic Muscle Weakness Not Due to Neuropathy, Pelvic Muscle Weakness
                     Not Due to Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4603</td>
               <td colspan="2">CTCAE Grade 5 Pelvic Soft Tissue Necrosis<span class="subclass"> SubClassOf </span>Pelvic Soft Tissue Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 5 Pelvic Soft Tissue Necrosis, Pelvic Soft Tissue Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4604</td>
               <td colspan="2">CTCAE Grade 5 Pelvis Infection NOS Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Pelvis Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Pelvis Infection NOS Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, Pelvis Infection NOS Adverse Event Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4605</td>
               <td colspan="2">CTCAE Grade 5 Pelvis Infection NOS with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Pelvis Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Pelvis Infection NOS Adverse Event with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, CTCAE Grade 5 Pelvis Infection NOS with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4606</td>
               <td colspan="2">CTCAE Grade 5 Pelvis Infection NOS with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Pelvis Infection NOS Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Pelvis Infection NOS Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     5 Pelvis Infection NOS with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4607</td>
               <td colspan="2">CTCAE Grade 5 Penis Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Penis Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Penis Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Penis Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4608</td>
               <td colspan="2">CTCAE Grade 5 Penis Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Penis Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Penis Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 5 Penis Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4609</td>
               <td colspan="2">CTCAE Grade 5 Penis Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Penis Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 5 Penis Infection with Unknown Absolute Neutrophil Count, Penis Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4610</td>
               <td colspan="2">CTCAE Grade 5 Pericarditis<span class="subclass"> SubClassOf </span>Pericarditis Adverse Event. <br><i>New Terms: Pericarditis Adverse Event, CTCAE Grade 5 Pericarditis</i></td>
            </tr>
            <tr class="addition">
               <td>4611</td>
               <td colspan="2">CTCAE Grade 5 Peripheral Arterial Ischemia<span class="subclass"> SubClassOf </span>Peripheral Arterial Ischemia Adverse Event. <br><i>New Terms: Peripheral Arterial Ischemia Adverse Event, CTCAE Grade 5 Peripheral Arterial Ischemia</i></td>
            </tr>
            <tr class="addition">
               <td>4612</td>
               <td colspan="2">CTCAE Grade 5 Peripheral Nerve Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Peripheral Nerve Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Peripheral Nerve Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, CTCAE Grade 5 Peripheral Nerve Infection Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4613</td>
               <td colspan="2">CTCAE Grade 5 Peripheral Nerve Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Peripheral Nerve Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Peripheral Nerve Infection with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils, Peripheral Nerve Infection Adverse Event with Normal Absolute
                     Neutrophil Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4614</td>
               <td colspan="2">CTCAE Grade 5 Peripheral Nerve Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Peripheral Nerve Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Peripheral Nerve Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE
                     Grade 5 Peripheral Nerve Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4615</td>
               <td colspan="2">CTCAE Grade 5 Peristomal Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Peristomal Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Peristomal Infection Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, Peristomal Infection Adverse Event Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4616</td>
               <td colspan="2">CTCAE Grade 5 Peristomal Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Peristomal Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Peristomal Infection with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, Peristomal Infection Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4617</td>
               <td colspan="2">CTCAE Grade 5 Peristomal Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Peristomal Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Peristomal Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     5 Peristomal Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4618</td>
               <td colspan="2">CTCAE Grade 5 Peritoneal Cavity Hemorrhage<span class="subclass"> SubClassOf </span>Peritoneal Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 5 Peritoneal Cavity Hemorrhage, Peritoneal Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4619</td>
               <td colspan="2">CTCAE Grade 5 Peritoneal Cavity Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Peritoneal Cavity Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Peritoneal Cavity Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, Peritoneal Cavity Infection Adverse Event Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4620</td>
               <td colspan="2">CTCAE Grade 5 Peritoneal Cavity Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Peritoneal Cavity Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Peritoneal Cavity Infection with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils, Peritoneal Cavity Infection Adverse Event with Normal Absolute
                     Neutrophil Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4621</td>
               <td colspan="2">CTCAE Grade 5 Peritoneal Cavity Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Peritoneal Cavity Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 5 Peritoneal Cavity Infection with Unknown Absolute Neutrophil Count,
                     Peritoneal Cavity Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4622</td>
               <td colspan="2">CTCAE Grade 5 Peritoneal Cavity Necrosis<span class="subclass"> SubClassOf </span>Peritoneal Cavity Necrosis Adverse Event. <br><i>New Terms: Peritoneal Cavity Necrosis Adverse Event, CTCAE Grade 5 Peritoneal Cavity Necrosis</i></td>
            </tr>
            <tr class="addition">
               <td>4623</td>
               <td colspan="2">CTCAE Grade 5 Personality<br><span class="keyword"> and </span>Behavioral Change<span class="subclass"> SubClassOf </span>Personality<br><span class="keyword"> and </span>Behavioral Change Adverse Event. <br><i>New Terms: CTCAE Grade 5 Personality and Behavioral Change, Personality and Behavioral Change
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4624</td>
               <td colspan="2">CTCAE Grade 5 Pharynx GI Fistula<span class="subclass"> SubClassOf </span>Pharynx GI Fistula Adverse Event. <br><i>New Terms: Pharynx GI Fistula Adverse Event, CTCAE Grade 5 Pharynx GI Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>4625</td>
               <td colspan="2">CTCAE Grade 5 Pharynx Hemorrhage<span class="subclass"> SubClassOf </span>Pharynx Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 5 Pharynx Hemorrhage, Pharynx Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4626</td>
               <td colspan="2">CTCAE Grade 5 Pharynx Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Pharynx Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Pharynx Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 5 Pharynx Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4627</td>
               <td colspan="2">CTCAE Grade 5 Pharynx Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Pharynx Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Pharynx Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 5 Pharynx Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4628</td>
               <td colspan="2">CTCAE Grade 5 Pharynx Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Pharynx Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 5 Pharynx Infection with Unknown Absolute Neutrophil Count, Pharynx Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4629</td>
               <td colspan="2">CTCAE Grade 5 Pharynx Leak<span class="subclass"> SubClassOf </span>Pharynx Leak Adverse Event. <br><i>New Terms: CTCAE Grade 5 Pharynx Leak, Pharynx Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4630</td>
               <td colspan="2">CTCAE Grade 5 Pharynx Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Pharynx Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification. <br><i>New Terms: CTCAE Grade 5 Pharynx Mucositis or Stomatitis by Clinical Examination Classification,
                     Pharynx Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>4631</td>
               <td colspan="2">CTCAE Grade 5 Pharynx Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Pharynx Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: Pharynx Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification,
                     CTCAE Grade 5 Pharynx Mucositis or Stomatitis by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>4632</td>
               <td colspan="2">CTCAE Grade 5 Pharynx Necrosis<span class="subclass"> SubClassOf </span>Pharynx Necrosis Adverse Event. <br><i>New Terms: Pharynx Necrosis Adverse Event, CTCAE Grade 5 Pharynx Necrosis</i></td>
            </tr>
            <tr class="addition">
               <td>4633</td>
               <td colspan="2">CTCAE Grade 5 Pharynx Obstruction<br><span class="keyword"> and </span>Stenosis<span class="subclass"> SubClassOf </span>Pharynx Obstruction<br><span class="keyword"> and </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 5 Pharynx Obstruction and Stenosis, Pharynx Obstruction and Stenosis Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>4634</td>
               <td colspan="2">CTCAE Grade 5 Pharynx Pulmonary Fistula<span class="subclass"> SubClassOf </span>Pharynx Pulmonary Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 5 Pharynx Pulmonary Fistula, Pharynx Pulmonary Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4635</td>
               <td colspan="2">CTCAE Grade 5 Pharynx Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Pharynx Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 5 Pharynx Stricture or Stenosis, Pharynx Stricture or Stenosis Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>4636</td>
               <td colspan="2">CTCAE Grade 5 Photosensitivity<span class="subclass"> SubClassOf </span>Photosensitivity Adverse Event. <br><i>New Terms: CTCAE Grade 5 Photosensitivity, Photosensitivity Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4637</td>
               <td colspan="2">CTCAE Grade 5 Phrenic Nerve Dysfunction<span class="subclass"> SubClassOf </span>Phrenic Nerve Dysfunction Adverse Event. <br><i>New Terms: Phrenic Nerve Dysfunction Adverse Event, CTCAE Grade 5 Phrenic Nerve Dysfunction</i></td>
            </tr>
            <tr class="addition">
               <td>4638</td>
               <td colspan="2">CTCAE Grade 5 Platelets<span class="subclass"> SubClassOf </span>Platelets Adverse Event. <br><i>New Terms: CTCAE Grade 5 Platelets, Platelets Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4639</td>
               <td colspan="2">CTCAE Grade 5 Pleura Fistula<span class="subclass"> SubClassOf </span>Pleura Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 5 Pleura Fistula, Pleura Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4640</td>
               <td colspan="2">CTCAE Grade 5 Pleura Hemorrhage<span class="subclass"> SubClassOf </span>Pleura Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 5 Pleura Hemorrhage, Pleura Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4641</td>
               <td colspan="2">CTCAE Grade 5 Pleura Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Pleura Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Pleura Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Pleura Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4642</td>
               <td colspan="2">CTCAE Grade 5 Pleura Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Pleura Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Pleura Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Pleura Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4643</td>
               <td colspan="2">CTCAE Grade 5 Pleura Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Pleura Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Pleura Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     5 Pleura Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4644</td>
               <td colspan="2">CTCAE Grade 5 Pneumonitis<br><span class="keyword"> and </span>Pulmonary Infiltrates<span class="subclass"> SubClassOf </span>Pneumonitis<br><span class="keyword"> and </span>Pulmonary Infiltrates Adverse Event. <br><i>New Terms: Pneumonitis and Pulmonary Infiltrates Adverse Event, CTCAE Grade 5 Pneumonitis and
                     Pulmonary Infiltrates</i></td>
            </tr>
            <tr class="addition">
               <td>4645</td>
               <td colspan="2">CTCAE Grade 5 Pneumothorax<span class="subclass"> SubClassOf </span>Pneumothorax Adverse Event. <br><i>New Terms: Pneumothorax Adverse Event, CTCAE Grade 5 Pneumothorax</i></td>
            </tr>
            <tr class="addition">
               <td>4646</td>
               <td colspan="2">CTCAE Grade 5 Proctitis<span class="subclass"> SubClassOf </span>Proctitis Adverse Event. <br><i>New Terms: CTCAE Grade 5 Proctitis, Proctitis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4647</td>
               <td colspan="2">CTCAE Grade 5 Prolapse of Gastrointestinal Stoma<span class="subclass"> SubClassOf </span>Prolapse of Gastrointestinal Stoma Adverse Event. <br><i>New Terms: CTCAE Grade 5 Prolapse of Gastrointestinal Stoma, Prolapse of Gastrointestinal Stoma
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4648</td>
               <td colspan="2">CTCAE Grade 5 Prolonged Chest Tube Drainage<br><span class="keyword"> or </span>Air Leak After Pulmonary Resection<span class="subclass"> SubClassOf </span>Prolonged Chest Tube Drainage<br><span class="keyword"> or </span>Air Leak After Pulmonary Resection Adverse Event. <br><i>New Terms: CTCAE Grade 5 Prolonged Chest Tube Drainage or Air Leak After Pulmonary Resection,
                     Prolonged Chest Tube Drainage or Air Leak After Pulmonary Resection Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4649</td>
               <td colspan="2">CTCAE Grade 5 Prolonged Intubation After Pulmonary Resection<span class="subclass"> SubClassOf </span>Prolonged Intubation After Pulmonary Resection Adverse Event. <br><i>New Terms: Prolonged Intubation After Pulmonary Resection Adverse Event, CTCAE Grade 5 Prolonged
                     Intubation After Pulmonary Resection</i></td>
            </tr>
            <tr class="addition">
               <td>4650</td>
               <td colspan="2">CTCAE Grade 5 Prolonged QTc Interval<span class="subclass"> SubClassOf </span>Prolonged QTc Interval Adverse Event. <br><i>New Terms: CTCAE Grade 5 Prolonged QTc Interval, Prolonged QTc Interval Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4651</td>
               <td colspan="2">CTCAE Grade 5 Prostate Hemorrhage<span class="subclass"> SubClassOf </span>Prostate Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 5 Prostate Hemorrhage, Prostate Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4652</td>
               <td colspan="2">CTCAE Grade 5 Prostate Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Prostate Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Prostate Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 5 Prostate Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4653</td>
               <td colspan="2">CTCAE Grade 5 Prostate Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Prostate Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Prostate Infection with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, Prostate Infection Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4654</td>
               <td colspan="2">CTCAE Grade 5 Prostate Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Prostate Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 5 Prostate Infection with Unknown Absolute Neutrophil Count, Prostate
                     Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4655</td>
               <td colspan="2">CTCAE Grade 5 Prostate Obstruction<span class="subclass"> SubClassOf </span>Prostate Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 5 Prostate Obstruction, Prostate Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4656</td>
               <td colspan="2">CTCAE Grade 5 Prostate Perforation<span class="subclass"> SubClassOf </span>Prostate Perforation Adverse Event. <br><i>New Terms: Prostate Perforation Adverse Event, CTCAE Grade 5 Prostate Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>4657</td>
               <td colspan="2">CTCAE Grade 5 Prostate Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Prostate Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Prostate Stricture or Stenosis Adverse Event, CTCAE Grade 5 Prostate Stricture or
                     Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>4658</td>
               <td colspan="2">CTCAE Grade 5 Proteinuria<span class="subclass"> SubClassOf </span>Proteinuria Adverse Event. <br><i>New Terms: Proteinuria Adverse Event, CTCAE Grade 5 Proteinuria</i></td>
            </tr>
            <tr class="addition">
               <td>4659</td>
               <td colspan="2">CTCAE Grade 5 Psychosis Including Hallucinations<br><span class="keyword"> and </span>Delusions<span class="subclass"> SubClassOf </span>Psychosis Including Hallucinations<br><span class="keyword"> and </span>Delusions Adverse Event. <br><i>New Terms: CTCAE Grade 5 Psychosis Including Hallucinations and Delusions, Psychosis Including
                     Hallucinations and Delusions Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4660</td>
               <td colspan="2">CTCAE Grade 5 Pulmonary Fibrosis Radiographic Changes<span class="subclass"> SubClassOf </span>Pulmonary Fibrosis Radiographic Changes Adverse Event. <br><i>New Terms: Pulmonary Fibrosis Radiographic Changes Adverse Event, CTCAE Grade 5 Pulmonary Fibrosis
                     Radiographic Changes</i></td>
            </tr>
            <tr class="addition">
               <td>4661</td>
               <td colspan="2">CTCAE Grade 5 Pulmonary Hypertension<span class="subclass"> SubClassOf </span>Pulmonary Hypertension Adverse Event. <br><i>New Terms: CTCAE Grade 5 Pulmonary Hypertension, Pulmonary Hypertension Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4662</td>
               <td colspan="2">CTCAE Grade 5 Pyramidal Tract Dysfunction<span class="subclass"> SubClassOf </span>Pyramidal Tract Dysfunction Adverse Event. <br><i>New Terms: CTCAE Grade 5 Pyramidal Tract Dysfunction, Pyramidal Tract Dysfunction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4663</td>
               <td colspan="2">CTCAE Grade 5 Radiation Excluding Chemoradiation<span class="subclass"> SubClassOf </span>Rash<br><span class="keyword"> and </span>Dermatitis Adverse Event Associated with Radiation Excluding Chemoradiation. <br><i>New Terms: CTCAE Grade 5 Radiation Excluding Chemoradiation, Rash and Dermatitis Adverse Event
                     Associated with Radiation Excluding Chemoradiation</i></td>
            </tr>
            <tr class="addition">
               <td>4664</td>
               <td colspan="2">CTCAE Grade 5 Rash Acne<br><span class="keyword"> or </span>Acneiform Adverse Event<span class="subclass"> SubClassOf </span>Rash Acne<br><span class="keyword"> or </span>Acneiform Adverse Event. <br><i>New Terms: Rash Acne or Acneiform Adverse Event, CTCAE Grade 5 Rash Acne or Acneiform Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>4665</td>
               <td colspan="2">CTCAE Grade 5 Rash Desquamation<span class="subclass"> SubClassOf </span>Rash Desquamation Adverse Event. <br><i>New Terms: CTCAE Grade 5 Rash Desquamation, Rash Desquamation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4666</td>
               <td colspan="2">CTCAE Grade 5 Rash Erythema Multiforme<span class="subclass"> SubClassOf </span>Rash Erythema Multiforme Adverse Event. <br><i>New Terms: Rash Erythema Multiforme Adverse Event, CTCAE Grade 5 Rash Erythema Multiforme</i></td>
            </tr>
            <tr class="addition">
               <td>4667</td>
               <td colspan="2">CTCAE Grade 5 Rectal Varices Hemorrhage<span class="subclass"> SubClassOf </span>Rectal Varices Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 5 Rectal Varices Hemorrhage, Rectal Varices Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4668</td>
               <td colspan="2">CTCAE Grade 5 Rectum Fistula<span class="subclass"> SubClassOf </span>Rectum Fistula Adverse Event. <br><i>New Terms: Rectum Fistula Adverse Event, CTCAE Grade 5 Rectum Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>4669</td>
               <td colspan="2">CTCAE Grade 5 Rectum Hemorrhage<span class="subclass"> SubClassOf </span>Rectum Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 5 Rectum Hemorrhage, Rectum Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4670</td>
               <td colspan="2">CTCAE Grade 5 Rectum Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Rectum Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Rectum Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 5 Rectum Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4671</td>
               <td colspan="2">CTCAE Grade 5 Rectum Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Rectum Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Rectum Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 5 Rectum Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4672</td>
               <td colspan="2">CTCAE Grade 5 Rectum Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Rectum Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Rectum Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     5 Rectum Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4673</td>
               <td colspan="2">CTCAE Grade 5 Rectum Leak<span class="subclass"> SubClassOf </span>Rectum Leak Adverse Event. <br><i>New Terms: CTCAE Grade 5 Rectum Leak, Rectum Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4674</td>
               <td colspan="2">CTCAE Grade 5 Rectum Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Rectum Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification. <br><i>New Terms: CTCAE Grade 5 Rectum Mucositis or Stomatitis by Clinical Examination Classification,
                     Rectum Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>4675</td>
               <td colspan="2">CTCAE Grade 5 Rectum Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Rectum Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: CTCAE Grade 5 Rectum Mucositis or Stomatitis by Functional or Symptomatic Classification,
                     Rectum Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>4676</td>
               <td colspan="2">CTCAE Grade 5 Rectum Necrosis<span class="subclass"> SubClassOf </span>Rectum Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 5 Rectum Necrosis, Rectum Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4677</td>
               <td colspan="2">CTCAE Grade 5 Rectum Obstruction<span class="subclass"> SubClassOf </span>Rectum Obstruction Adverse Event. <br><i>New Terms: Rectum Obstruction Adverse Event, CTCAE Grade 5 Rectum Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>4678</td>
               <td colspan="2">CTCAE Grade 5 Rectum Perforation<span class="subclass"> SubClassOf </span>Rectum Perforation Adverse Event. <br><i>New Terms: Rectum Perforation Adverse Event, CTCAE Grade 5 Rectum Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>4679</td>
               <td colspan="2">CTCAE Grade 5 Rectum Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Rectum Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Rectum Stricture or Stenosis Adverse Event, CTCAE Grade 5 Rectum Stricture or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>4680</td>
               <td colspan="2">CTCAE Grade 5 Rectum Ulcer<span class="subclass"> SubClassOf </span>Rectum Ulcer Adverse Event. <br><i>New Terms: Rectum Ulcer Adverse Event, CTCAE Grade 5 Rectum Ulcer</i></td>
            </tr>
            <tr class="addition">
               <td>4681</td>
               <td colspan="2">CTCAE Grade 5 Renal Failure<span class="subclass"> SubClassOf </span>Renal Failure Adverse Event. <br><i>New Terms: CTCAE Grade 5 Renal Failure, Renal Failure Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4682</td>
               <td colspan="2">CTCAE Grade 5 Respiratory Tract Hemorrhage NOS<span class="subclass"> SubClassOf </span>Respiratory Tract Hemorrhage Adverse Event NOS. <br><i>New Terms: CTCAE Grade 5 Respiratory Tract Hemorrhage NOS, Respiratory Tract Hemorrhage Adverse
                     Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>4683</td>
               <td colspan="2">CTCAE Grade 5 Restrictive Cardiomyopathy<span class="subclass"> SubClassOf </span>Restrictive Cardiomyopathy Adverse Event. <br><i>New Terms: Restrictive Cardiomyopathy Adverse Event, CTCAE Grade 5 Restrictive Cardiomyopathy</i></td>
            </tr>
            <tr class="addition">
               <td>4684</td>
               <td colspan="2">CTCAE Grade 5 Retinoic Acid Syndrome<span class="subclass"> SubClassOf </span>Retinoic Acid Syndrome Adverse Event. <br><i>New Terms: CTCAE Grade 5 Retinoic Acid Syndrome, Retinoic Acid Syndrome Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4685</td>
               <td colspan="2">CTCAE Grade 5 Retroperitoneum Hemorrhage<span class="subclass"> SubClassOf </span>Retroperitoneum Hemorrhage Adverse Event. <br><i>New Terms: Retroperitoneum Hemorrhage Adverse Event, CTCAE Grade 5 Retroperitoneum Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>4687</td>
               <td colspan="2">CTCAE Grade 5 Right Ventricular Dysfunction<span class="subclass"> SubClassOf </span>Right Ventricular Dysfunction Adverse Event. <br><i>New Terms: Right Ventricular Dysfunction Adverse Event, CTCAE Grade 5 Right Ventricular Dysfunction</i></td>
            </tr>
            <tr class="addition">
               <td>4686</td>
               <td colspan="2">CTCAE Grade 5 Right-Sided Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Right-Sided Muscle Weakness Not Due to Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 5 Right-Sided Muscle Weakness Not Due to Neuropathy, Right-Sided Muscle
                     Weakness Not Due to Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4688</td>
               <td colspan="2">CTCAE Grade 5 Salivary Gland Fistula<span class="subclass"> SubClassOf </span>Salivary Gland Fistula. <br><i>New Terms: CTCAE Grade 5 Salivary Gland Fistula, Salivary Gland Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>4689</td>
               <td colspan="2">CTCAE Grade 5 Salivary Gland Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Salivary Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Salivary Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 5 Salivary Gland Infection Documented Clinically or
                     Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4690</td>
               <td colspan="2">CTCAE Grade 5 Salivary Gland Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Salivary Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Salivary Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils, CTCAE Grade 5 Salivary Gland Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4691</td>
               <td colspan="2">CTCAE Grade 5 Salivary Gland Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Salivary Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 5 Salivary Gland Infection with Unknown Absolute Neutrophil Count, Salivary
                     Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4692</td>
               <td colspan="2">CTCAE Grade 5 Scrotum Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Scrotum Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Scrotum Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 5 Scrotum Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4693</td>
               <td colspan="2">CTCAE Grade 5 Scrotum Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Scrotum Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Scrotum Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Scrotum Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4694</td>
               <td colspan="2">CTCAE Grade 5 Scrotum Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Scrotum Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Scrotum Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     5 Scrotum Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4695</td>
               <td colspan="2">CTCAE Grade 5 Seizure<span class="subclass"> SubClassOf </span>Seizure Adverse Event. <br><i>New Terms: CTCAE Grade 5 Seizure, Seizure Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4696</td>
               <td colspan="2">CTCAE Grade 5 Sensory Neuropathy<span class="subclass"> SubClassOf </span>Sensory Neuropathy Adverse Event. <br><i>New Terms: Sensory Neuropathy Adverse Event, CTCAE Grade 5 Sensory Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>4697</td>
               <td colspan="2">CTCAE Grade 5 Serum Hypercalcemia<span class="subclass"> SubClassOf </span>Serum Hypercalcemia Adverse Event. <br><i>New Terms: CTCAE Grade 5 Serum Hypercalcemia, Serum Hypercalcemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4698</td>
               <td colspan="2">CTCAE Grade 5 Serum Hypercholesteremia<span class="subclass"> SubClassOf </span>Serum Hypercholesteremia Adverse Event. <br><i>New Terms: CTCAE Grade 5 Serum Hypercholesteremia, Serum Hypercholesteremia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4699</td>
               <td colspan="2">CTCAE Grade 5 Serum Hyperglycemia<span class="subclass"> SubClassOf </span>Serum Hyperglycemia Adverse Event. <br><i>New Terms: CTCAE Grade 5 Serum Hyperglycemia, Serum Hyperglycemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4700</td>
               <td colspan="2">CTCAE Grade 5 Serum Hyperkalemia<span class="subclass"> SubClassOf </span>Serum Hyperkalemia Adverse Event. <br><i>New Terms: Serum Hyperkalemia Adverse Event, CTCAE Grade 5 Serum Hyperkalemia</i></td>
            </tr>
            <tr class="addition">
               <td>4701</td>
               <td colspan="2">CTCAE Grade 5 Serum Hypermagnesemia<span class="subclass"> SubClassOf </span>Serum Hypermagnesemia Adverse Event. <br><i>New Terms: Serum Hypermagnesemia Adverse Event, CTCAE Grade 5 Serum Hypermagnesemia</i></td>
            </tr>
            <tr class="addition">
               <td>4702</td>
               <td colspan="2">CTCAE Grade 5 Serum Hypernatremia<span class="subclass"> SubClassOf </span>Serum Hypernatremia Adverse Event. <br><i>New Terms: Serum Hypernatremia Adverse Event, CTCAE Grade 5 Serum Hypernatremia</i></td>
            </tr>
            <tr class="addition">
               <td>4703</td>
               <td colspan="2">CTCAE Grade 5 Serum Hypertriglyceridemia<span class="subclass"> SubClassOf </span>Serum Hypertriglyceridemia Adverse Event. <br><i>New Terms: CTCAE Grade 5 Serum Hypertriglyceridemia, Serum Hypertriglyceridemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4704</td>
               <td colspan="2">CTCAE Grade 5 Serum Hyperuricemia<span class="subclass"> SubClassOf </span>Serum Hyperuricemia Adverse Event. <br><i>New Terms: CTCAE Grade 5 Serum Hyperuricemia, Serum Hyperuricemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4705</td>
               <td colspan="2">CTCAE Grade 5 Serum Hypoalbuminemia<span class="subclass"> SubClassOf </span>Serum Hypoalbuminemia Adverse Event. <br><i>New Terms: Serum Hypoalbuminemia Adverse Event, CTCAE Grade 5 Serum Hypoalbuminemia</i></td>
            </tr>
            <tr class="addition">
               <td>4706</td>
               <td colspan="2">CTCAE Grade 5 Serum Hypocalcemia<span class="subclass"> SubClassOf </span>Serum Hypocalcemia Adverse Event. <br><i>New Terms: Serum Hypocalcemia Adverse Event, CTCAE Grade 5 Serum Hypocalcemia</i></td>
            </tr>
            <tr class="addition">
               <td>4707</td>
               <td colspan="2">CTCAE Grade 5 Serum Hypoglycemia<span class="subclass"> SubClassOf </span>Serum Hypoglycemia Adverse Event. <br><i>New Terms: Serum Hypoglycemia Adverse Event, CTCAE Grade 5 Serum Hypoglycemia</i></td>
            </tr>
            <tr class="addition">
               <td>4708</td>
               <td colspan="2">CTCAE Grade 5 Serum Hypokalemia<span class="subclass"> SubClassOf </span>Serum Hypokalemia Adverse Event. <br><i>New Terms: Serum Hypokalemia Adverse Event, CTCAE Grade 5 Serum Hypokalemia</i></td>
            </tr>
            <tr class="addition">
               <td>4709</td>
               <td colspan="2">CTCAE Grade 5 Serum Hypomagnesemia<span class="subclass"> SubClassOf </span>Serum Hypomagnesemia Adverse Event. <br><i>New Terms: Serum Hypomagnesemia Adverse Event, CTCAE Grade 5 Serum Hypomagnesemia</i></td>
            </tr>
            <tr class="addition">
               <td>4710</td>
               <td colspan="2">CTCAE Grade 5 Serum Hyponatremia<span class="subclass"> SubClassOf </span>Serum Hyponatremia Adverse Event. <br><i>New Terms: CTCAE Grade 5 Serum Hyponatremia, Serum Hyponatremia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4711</td>
               <td colspan="2">CTCAE Grade 5 Serum Hypophosphatemia<span class="subclass"> SubClassOf </span>Serum Hypophosphatemia Adverse Event. <br><i>New Terms: Serum Hypophosphatemia Adverse Event, CTCAE Grade 5 Serum Hypophosphatemia</i></td>
            </tr>
            <tr class="addition">
               <td>4712</td>
               <td colspan="2">CTCAE Grade 5 Serum Sickness<span class="subclass"> SubClassOf </span>Serum Sickness Adverse Event. <br><i>New Terms: CTCAE Grade 5 Serum Sickness, Serum Sickness Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4713</td>
               <td colspan="2">CTCAE Grade 5 Sick Sinus Syndrome<span class="subclass"> SubClassOf </span>Sick Sinus Syndrome Adverse Event. <br><i>New Terms: Sick Sinus Syndrome Adverse Event, CTCAE Grade 5 Sick Sinus Syndrome</i></td>
            </tr>
            <tr class="addition">
               <td>4714</td>
               <td colspan="2">CTCAE Grade 5 Sinus Arrhythmia<span class="subclass"> SubClassOf </span>Sinus Arrhythmia Adverse Event. <br><i>New Terms: CTCAE Grade 5 Sinus Arrhythmia, Sinus Arrhythmia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4715</td>
               <td colspan="2">CTCAE Grade 5 Sinus Bradycardia<span class="subclass"> SubClassOf </span>Sinus Bradycardia Adverse Event. <br><i>New Terms: CTCAE Grade 5 Sinus Bradycardia, Sinus Bradycardia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4716</td>
               <td colspan="2">CTCAE Grade 5 Sinus Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Sinus Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Sinus Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 5 Sinus Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4717</td>
               <td colspan="2">CTCAE Grade 5 Sinus Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Sinus Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Sinus Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 5 Sinus Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4718</td>
               <td colspan="2">CTCAE Grade 5 Sinus Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Sinus Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 5 Sinus Infection with Unknown Absolute Neutrophil Count, Sinus Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4719</td>
               <td colspan="2">CTCAE Grade 5 Sinus Tachycardia<span class="subclass"> SubClassOf </span>Sinus Tachycardia Adverse Event. <br><i>New Terms: CTCAE Grade 5 Sinus Tachycardia, Sinus Tachycardia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4720</td>
               <td colspan="2">CTCAE Grade 5 Skin Breakdown<br><span class="keyword"> or </span>Decubitus Ulcer<span class="subclass"> SubClassOf </span>Skin Breakdown<br><span class="keyword"> or </span>Decubitus Ulcer Adverse Event. <br><i>New Terms: CTCAE Grade 5 Skin Breakdown or Decubitus Ulcer, Skin Breakdown or Decubitus Ulcer
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4721</td>
               <td colspan="2">CTCAE Grade 5 Skin Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Skin Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Skin Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Skin Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4722</td>
               <td colspan="2">CTCAE Grade 5 Skin Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Skin Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Skin Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or 2
                     Neutrophils, CTCAE Grade 5 Skin Infection with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4723</td>
               <td colspan="2">CTCAE Grade 5 Skin Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Skin Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 5 Skin Infection with Unknown Absolute Neutrophil Count, Skin Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4724</td>
               <td colspan="2">CTCAE Grade 5 Small Bowel Fistula NOS<span class="subclass"> SubClassOf </span>Small Bowel Fistula Adverse Event NOS. <br><i>New Terms: CTCAE Grade 5 Small Bowel Fistula NOS, Small Bowel Fistula Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>4725</td>
               <td colspan="2">CTCAE Grade 5 Small Bowel Infection NOS Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Small Bowel Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Small Bowel Infection NOS Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, CTCAE Grade 5 Small Bowel Infection NOS Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4726</td>
               <td colspan="2">CTCAE Grade 5 Small Bowel Infection NOS with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Small Bowel Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Small Bowel Infection NOS Adverse Event with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, CTCAE Grade 5 Small Bowel Infection NOS with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4727</td>
               <td colspan="2">CTCAE Grade 5 Small Bowel Infection NOS with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Small Bowel Infection NOS Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Small Bowel Infection NOS Adverse Event with Unknown Absolute Neutrophil Count, CTCAE
                     Grade 5 Small Bowel Infection NOS with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4728</td>
               <td colspan="2">CTCAE Grade 5 Small Bowel Leak<span class="subclass"> SubClassOf </span>Small Bowel Leak Adverse Event. <br><i>New Terms: CTCAE Grade 5 Small Bowel Leak, Small Bowel Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4729</td>
               <td colspan="2">CTCAE Grade 5 Small Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Small Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification. <br><i>New Terms: Small Bowel Mucositis or Stomatitis by Clinical Examination Classification, CTCAE
                     Grade 5 Small Bowel Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>4730</td>
               <td colspan="2">CTCAE Grade 5 Small Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Small Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: CTCAE Grade 5 Small Bowel Mucositis or Stomatitis by Functional or Symptomatic Classification,
                     Small Bowel Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>4731</td>
               <td colspan="2">CTCAE Grade 5 Small Bowel Necrosis NOS<span class="subclass"> SubClassOf </span>Small Bowel Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 5 Small Bowel Necrosis NOS, Small Bowel Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4732</td>
               <td colspan="2">CTCAE Grade 5 Small Bowel Obstruction NOS<span class="subclass"> SubClassOf </span>Small Bowel Obstruction Adverse Event NOS. <br><i>New Terms: Small Bowel Obstruction Adverse Event NOS, CTCAE Grade 5 Small Bowel Obstruction NOS</i></td>
            </tr>
            <tr class="addition">
               <td>4733</td>
               <td colspan="2">CTCAE Grade 5 Small Bowel Perforation NOS<span class="subclass"> SubClassOf </span>Small Bowel Perforation Adverse Event NOS. <br><i>New Terms: CTCAE Grade 5 Small Bowel Perforation NOS, Small Bowel Perforation Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>4734</td>
               <td colspan="2">CTCAE Grade 5 Small Bowel Stricture<br><span class="keyword"> or </span>Stenosis NOS<span class="subclass"> SubClassOf </span>Small Bowel Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event NOS. <br><i>New Terms: CTCAE Grade 5 Small Bowel Stricture or Stenosis NOS, Small Bowel Stricture or Stenosis
                     Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>4735</td>
               <td colspan="2">CTCAE Grade 5 Small Bowel Ulcer NOS<span class="subclass"> SubClassOf </span>Small Bowel Ulcer Adverse Event NOS. <br><i>New Terms: Small Bowel Ulcer Adverse Event NOS, CTCAE Grade 5 Small Bowel Ulcer NOS</i></td>
            </tr>
            <tr class="addition">
               <td>4736</td>
               <td colspan="2">CTCAE Grade 5 Soft Tissue Infection NOS Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Soft Tissue Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Soft Tissue Infection NOS Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, Soft Tissue Infection NOS Adverse Event Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4737</td>
               <td colspan="2">CTCAE Grade 5 Soft Tissue Infection NOS with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Soft Tissue Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Soft Tissue Infection NOS with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, Soft Tissue Infection NOS Adverse Event with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4738</td>
               <td colspan="2">CTCAE Grade 5 Soft Tissue Infection NOS with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Soft Tissue Infection NOS Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Soft Tissue Infection NOS Adverse Event with Unknown Absolute Neutrophil Count, CTCAE
                     Grade 5 Soft Tissue Infection NOS with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4739</td>
               <td colspan="2">CTCAE Grade 5 Somnolence<br><span class="keyword"> and </span>Depressed Level of Consciousness<span class="subclass"> SubClassOf </span>Somnolence<br><span class="keyword"> and </span>Depressed Level of Consciousness Adverse Event. <br><i>New Terms: CTCAE Grade 5 Somnolence and Depressed Level of Consciousness, Somnolence and Depressed
                     Level of Consciousness Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4740</td>
               <td colspan="2">CTCAE Grade 5 Spermatic Cord Hemorrhage<span class="subclass"> SubClassOf </span>Spermatic Cord Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 5 Spermatic Cord Hemorrhage, Spermatic Cord Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4741</td>
               <td colspan="2">CTCAE Grade 5 Spermatic Cord Leak<span class="subclass"> SubClassOf </span>Spermatic Cord Leak Adverse Event. <br><i>New Terms: Spermatic Cord Leak Adverse Event, CTCAE Grade 5 Spermatic Cord Leak</i></td>
            </tr>
            <tr class="addition">
               <td>4742</td>
               <td colspan="2">CTCAE Grade 5 Spermatic Cord Obstruction<span class="subclass"> SubClassOf </span>Spermatic Cord Obstruction Adverse Event. <br><i>New Terms: Spermatic Cord Obstruction Adverse Event, CTCAE Grade 5 Spermatic Cord Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>4743</td>
               <td colspan="2">CTCAE Grade 5 Spermatic Cord Perforation<span class="subclass"> SubClassOf </span>Spermatic Cord Perforation Adverse Event. <br><i>New Terms: Spermatic Cord Perforation Adverse Event, CTCAE Grade 5 Spermatic Cord Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>4744</td>
               <td colspan="2">CTCAE Grade 5 Spermatic Cord Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Spermatic Cord Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 5 Spermatic Cord Stricture or Stenosis, Spermatic Cord Stricture or Stenosis
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4745</td>
               <td colspan="2">CTCAE Grade 5 Spinal Cord Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Spinal Cord Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Spinal Cord Infection Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils, Spinal Cord Infection Adverse Event Documented Clinically
                     or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4746</td>
               <td colspan="2">CTCAE Grade 5 Spinal Cord Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Spinal Cord Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Spinal Cord Infection Adverse Event with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils, CTCAE Grade 5 Spinal Cord Infection with Normal Absolute Neutrophil
                     Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4747</td>
               <td colspan="2">CTCAE Grade 5 Spinal Cord Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Spinal Cord Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Spinal Cord Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE
                     Grade 5 Spinal Cord Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4748</td>
               <td colspan="2">CTCAE Grade 5 Spine Scoliosis<span class="subclass"> SubClassOf </span>Spine Scoliosis Adverse Event. <br><i>New Terms: CTCAE Grade 5 Spine Scoliosis, Spine Scoliosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4749</td>
               <td colspan="2">CTCAE Grade 5 Spleen Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Spleen Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Spleen Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Spleen Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4750</td>
               <td colspan="2">CTCAE Grade 5 Spleen Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Spleen Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Spleen Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Spleen Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4751</td>
               <td colspan="2">CTCAE Grade 5 Spleen Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Spleen Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 5 Spleen Infection with Unknown Absolute Neutrophil Count, Spleen Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4752</td>
               <td colspan="2">CTCAE Grade 5 Splenic Function<span class="subclass"> SubClassOf </span>Splenic Function Adverse Event. <br><i>New Terms: CTCAE Grade 5 Splenic Function, Splenic Function Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4753</td>
               <td colspan="2">CTCAE Grade 5 Stokes-Adams Syndrome<span class="subclass"> SubClassOf </span>Stokes-Adams Syndrome Adverse Event. <br><i>New Terms: CTCAE Grade 5 Stokes-Adams Syndrome, Stokes-Adams Syndrome Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4754</td>
               <td colspan="2">CTCAE Grade 5 Stoma GI Obstruction<span class="subclass"> SubClassOf </span>Gastrointestinal Stoma Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 5 Stoma GI Obstruction, Gastrointestinal Stoma Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4755</td>
               <td colspan="2">CTCAE Grade 5 Stoma GI Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Stoma GI Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 5 Stoma GI Stricture or Stenosis, Stoma GI Stricture or Stenosis Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>4756</td>
               <td colspan="2">CTCAE Grade 5 Stoma Necrosis<span class="subclass"> SubClassOf </span>Stoma Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 5 Stoma Necrosis, Stoma Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4757</td>
               <td colspan="2">CTCAE Grade 5 Stoma Perforation<span class="subclass"> SubClassOf </span>Stoma Perforation Adverse Event. <br><i>New Terms: Stoma Perforation Adverse Event, CTCAE Grade 5 Stoma Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>4758</td>
               <td colspan="2">CTCAE Grade 5 Stoma Pulmonary Hemorrhage<span class="subclass"> SubClassOf </span>Pulmonary Stoma Hemorrhage Adverse Event. <br><i>New Terms: Pulmonary Stoma Hemorrhage Adverse Event, CTCAE Grade 5 Stoma Pulmonary Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>4759</td>
               <td colspan="2">CTCAE Grade 5 Stoma Ulcer<span class="subclass"> SubClassOf </span>Stoma Ulcer Adverse Event. <br><i>New Terms: CTCAE Grade 5 Stoma Ulcer, Stoma Ulcer Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4760</td>
               <td colspan="2">CTCAE Grade 5 Stomach Fistula<span class="subclass"> SubClassOf </span>Stomach Fistula Adverse Event. <br><i>New Terms: Stomach Fistula Adverse Event, CTCAE Grade 5 Stomach Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>4761</td>
               <td colspan="2">CTCAE Grade 5 Stomach Hemorrhage<span class="subclass"> SubClassOf </span>Stomach Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 5 Stomach Hemorrhage, Stomach Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4762</td>
               <td colspan="2">CTCAE Grade 5 Stomach Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Stomach Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Stomach Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Stomach Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4763</td>
               <td colspan="2">CTCAE Grade 5 Stomach Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Stomach Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Stomach Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 5 Stomach Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4764</td>
               <td colspan="2">CTCAE Grade 5 Stomach Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Stomach Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 5 Stomach Infection with Unknown Absolute Neutrophil Count, Stomach Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4765</td>
               <td colspan="2">CTCAE Grade 5 Stomach Leak<span class="subclass"> SubClassOf </span>Stomach Leak Adverse Event. <br><i>New Terms: Stomach Leak Adverse Event, CTCAE Grade 5 Stomach Leak</i></td>
            </tr>
            <tr class="addition">
               <td>4766</td>
               <td colspan="2">CTCAE Grade 5 Stomach Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Stomach Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification. <br><i>New Terms: Stomach Mucositis or Stomatitis by Clinical Examination Classification, CTCAE Grade
                     5 Stomach Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>4767</td>
               <td colspan="2">CTCAE Grade 5 Stomach Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Stomach Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: Stomach Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification,
                     CTCAE Grade 5 Stomach Mucositis or Stomatitis by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>4768</td>
               <td colspan="2">CTCAE Grade 5 Stomach Necrosis<span class="subclass"> SubClassOf </span>Stomach Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 5 Stomach Necrosis, Stomach Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4769</td>
               <td colspan="2">CTCAE Grade 5 Stomach Obstruction<span class="subclass"> SubClassOf </span>Stomach Obstruction Adverse Event. <br><i>New Terms: Stomach Obstruction Adverse Event, CTCAE Grade 5 Stomach Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>4770</td>
               <td colspan="2">CTCAE Grade 5 Stomach Perforation<span class="subclass"> SubClassOf </span>Stomach Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 5 Stomach Perforation, Stomach Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4771</td>
               <td colspan="2">CTCAE Grade 5 Stomach Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Stomach Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 5 Stomach Stricture or Stenosis, Stomach Stricture or Stenosis Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>4772</td>
               <td colspan="2">CTCAE Grade 5 Stomach Ulcer<span class="subclass"> SubClassOf </span>Stomach Ulcer Adverse Event. <br><i>New Terms: CTCAE Grade 5 Stomach Ulcer, Stomach Ulcer Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4773</td>
               <td colspan="2">CTCAE Grade 5 Sudden Death<span class="subclass"> SubClassOf </span>Sudden Death Adverse Event Not Associated with More Specific CTCAE Term. <br><i>New Terms: Sudden Death Adverse Event Not Associated with More Specific CTCAE Term, CTCAE Grade
                     5 Sudden Death</i></td>
            </tr>
            <tr class="addition">
               <td>4774</td>
               <td colspan="2">CTCAE Grade 5 Superior Vena Cava Vein Injury<span class="subclass"> SubClassOf </span>Superior Vena Cava Vein Injury Adverse Event. <br><i>New Terms: Superior Vena Cava Vein Injury Adverse Event, CTCAE Grade 5 Superior Vena Cava Vein
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>4775</td>
               <td colspan="2">CTCAE Grade 5 Supraventricular Arrhythmia NOS<span class="subclass"> SubClassOf </span>Supraventricular Arrhythmia Adverse Event NOS. <br><i>New Terms: CTCAE Grade 5 Supraventricular Arrhythmia NOS, Supraventricular Arrhythmia Adverse
                     Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>4776</td>
               <td colspan="2">CTCAE Grade 5 Supraventricular Extrasystoles<span class="subclass"> SubClassOf </span>Supraventricular Extrasystoles Adverse Event. <br><i>New Terms: CTCAE Grade 5 Supraventricular Extrasystoles, Supraventricular Extrasystoles Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>4777</td>
               <td colspan="2">CTCAE Grade 5 Supraventricular Tachycardia<span class="subclass"> SubClassOf </span>Supraventricular Tachycardia Adverse Event. <br><i>New Terms: CTCAE Grade 5 Supraventricular Tachycardia, Supraventricular Tachycardia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4778</td>
               <td colspan="2">CTCAE Grade 5 Syncope<span class="subclass"> SubClassOf </span>Syncope Adverse Event. <br><i>New Terms: Syncope Adverse Event, CTCAE Grade 5 Syncope</i></td>
            </tr>
            <tr class="addition">
               <td>4779</td>
               <td colspan="2">CTCAE Grade 5 Testes Hemorrhage<span class="subclass"> SubClassOf </span>Testes Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 5 Testes Hemorrhage, Testes Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4780</td>
               <td colspan="2">CTCAE Grade 5 Testes Obstruction<span class="subclass"> SubClassOf </span>Testes Obstruction Adverse Event. <br><i>New Terms: Testes Obstruction Adverse Event, CTCAE Grade 5 Testes Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>4781</td>
               <td colspan="2">CTCAE Grade 5 Testes Perforation<span class="subclass"> SubClassOf </span>Testes Perforation Adverse Event. <br><i>New Terms: Testes Perforation Adverse Event, CTCAE Grade 5 Testes Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>4782</td>
               <td colspan="2">CTCAE Grade 5 Testes Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Testes Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 5 Testes Stricture or Stenosis, Testes Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4783</td>
               <td colspan="2">CTCAE Grade 5 Thorax Soft Tissue Necrosis<span class="subclass"> SubClassOf </span>Thorax Soft Tissue Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 5 Thorax Soft Tissue Necrosis, Thorax Soft Tissue Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4784</td>
               <td colspan="2">CTCAE Grade 5 Thrombosis<br><span class="keyword"> or </span>Embolism Vascular Access Related<span class="subclass"> SubClassOf </span>Thrombosis<br><span class="keyword"> or </span>Embolism Vascular Access Related Adverse Event. <br><i>New Terms: CTCAE Grade 5 Thrombosis or Embolism Vascular Access Related, Thrombosis or Embolism
                     Vascular Access Related Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4785</td>
               <td colspan="2">CTCAE Grade 5 Thrombosis<br><span class="keyword"> or </span>Thrombus<br><span class="keyword"> or </span>Embolism<span class="subclass"> SubClassOf </span>Thrombosis<br><span class="keyword"> or </span>Thrombus<br><span class="keyword"> or </span>Embolism Adverse Event. <br><i>New Terms: CTCAE Grade 5 Thrombosis or Thrombus or Embolism, Thrombosis or Thrombus or Embolism
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4786</td>
               <td colspan="2">CTCAE Grade 5 Thrombotic Microangiopathy<span class="subclass"> SubClassOf </span>Thrombotic Microangiopathy Adverse Event. <br><i>New Terms: CTCAE Grade 5 Thrombotic Microangiopathy, Thrombotic Microangiopathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4787</td>
               <td colspan="2">CTCAE Grade 5 Thyroid Function High<span class="subclass"> SubClassOf </span>Thyroid Function High Adverse Event. <br><i>New Terms: CTCAE Grade 5 Thyroid Function High, Thyroid Function High Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4788</td>
               <td colspan="2">CTCAE Grade 5 Thyroid Function Low<span class="subclass"> SubClassOf </span>Thyroid Function Low Adverse Event. <br><i>New Terms: Thyroid Function Low Adverse Event, CTCAE Grade 5 Thyroid Function Low</i></td>
            </tr>
            <tr class="addition">
               <td>4789</td>
               <td colspan="2">CTCAE Grade 5 Torsade de Pointes<span class="subclass"> SubClassOf </span>Torsade de Pointes Adverse Event. <br><i>New Terms: CTCAE Grade 5 Torsade de Pointes, Torsade de Pointes Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4790</td>
               <td colspan="2">CTCAE Grade 5 Trachea Fistula<span class="subclass"> SubClassOf </span>Trachea Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 5 Trachea Fistula, Trachea Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4791</td>
               <td colspan="2">CTCAE Grade 5 Trachea Hemorrhage<span class="subclass"> SubClassOf </span>Trachea Hemorrhage Adverse Event. <br><i>New Terms: CTCAE Grade 5 Trachea Hemorrhage, Trachea Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4792</td>
               <td colspan="2">CTCAE Grade 5 Trachea Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Trachea Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Trachea Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 5 Trachea Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4793</td>
               <td colspan="2">CTCAE Grade 5 Trachea Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Trachea Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Trachea Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 5 Trachea Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4794</td>
               <td colspan="2">CTCAE Grade 5 Trachea Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Trachea Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Trachea Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     5 Trachea Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4795</td>
               <td colspan="2">CTCAE Grade 5 Trachea Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Trachea Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification. <br><i>New Terms: Trachea Mucositis or Stomatitis by Clinical Examination Classification, CTCAE Grade
                     5 Trachea Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>4796</td>
               <td colspan="2">CTCAE Grade 5 Trachea Mucositis<br><span class="keyword"> or </span>Stomatitis by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Trachea Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification. <br><i>New Terms: Trachea Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification,
                     CTCAE Grade 5 Trachea Mucositis or Stomatitis by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>4797</td>
               <td colspan="2">CTCAE Grade 5 Trachea Obstruction<br><span class="keyword"> and </span>Stenosis<span class="subclass"> SubClassOf </span>Trachea Obstruction<br><span class="keyword"> and </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 5 Trachea Obstruction and Stenosis, Trachea Obstruction and Stenosis Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>4798</td>
               <td colspan="2">CTCAE Grade 5 Trigeminy<span class="subclass"> SubClassOf </span>Trigeminy Adverse Event. <br><i>New Terms: CTCAE Grade 5 Trigeminy, Trigeminy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4799</td>
               <td colspan="2">CTCAE Grade 5 Trunk Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Trunk Muscle Weakness Not Due to Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 5 Trunk Muscle Weakness Not Due to Neuropathy, Trunk Muscle Weakness Not
                     Due to Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4800</td>
               <td colspan="2">CTCAE Grade 5 Tumor Flare<span class="subclass"> SubClassOf </span>Tumor Flare Adverse Event. <br><i>New Terms: CTCAE Grade 5 Tumor Flare, Tumor Flare Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4801</td>
               <td colspan="2">CTCAE Grade 5 Tumor Lysis Syndrome<span class="subclass"> SubClassOf </span>Tumor Lysis Syndrome Adverse Event. <br><i>New Terms: CTCAE Grade 5 Tumor Lysis Syndrome, Tumor Lysis Syndrome Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4802</td>
               <td colspan="2">CTCAE Grade 5 Typhlitis<span class="subclass"> SubClassOf </span>Typhlitis Adverse Event. <br><i>New Terms: CTCAE Grade 5 Typhlitis, Typhlitis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4803</td>
               <td colspan="2">CTCAE Grade 5 Ulceration<span class="subclass"> SubClassOf </span>Ulceration Adverse Event. <br><i>New Terms: Ulceration Adverse Event, CTCAE Grade 5 Ulceration</i></td>
            </tr>
            <tr class="addition">
               <td>4804</td>
               <td colspan="2">CTCAE Grade 5 Ungual Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Ungual Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Ungual Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Ungual Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4805</td>
               <td colspan="2">CTCAE Grade 5 Ungual Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Ungual Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Ungual Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 5 Ungual Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4806</td>
               <td colspan="2">CTCAE Grade 5 Ungual Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Ungual Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 5 Ungual Infection with Unknown Absolute Neutrophil Count, Ungual Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4807</td>
               <td colspan="2">CTCAE Grade 5 Upper Aerodigestive Infection NOS Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Upper Aerodigestive Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Upper Aerodigestive Infection NOS Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, Upper Aerodigestive Infection NOS Adverse Event Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4808</td>
               <td colspan="2">CTCAE Grade 5 Upper Aerodigestive Infection NOS with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Upper Aerodigestive Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Upper Aerodigestive Infection NOS with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils, Upper Aerodigestive Infection NOS Adverse Event with
                     Normal Absolute Neutrophil Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4809</td>
               <td colspan="2">CTCAE Grade 5 Upper Aerodigestive Infection NOS with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Upper Aerodigestive Infection NOS Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 5 Upper Aerodigestive Infection NOS with Unknown Absolute Neutrophil Count,
                     Upper Aerodigestive Infection NOS Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4810</td>
               <td colspan="2">CTCAE Grade 5 Upper Airway Infection NOS Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Upper Airway Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Upper Airway Infection NOS Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, Upper Airway Infection NOS Adverse Event Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4811</td>
               <td colspan="2">CTCAE Grade 5 Upper Airway Infection NOS with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Upper Airway Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Upper Airway Infection NOS with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils, Upper Airway Infection NOS Adverse Event with Normal Absolute
                     Neutrophil Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4812</td>
               <td colspan="2">CTCAE Grade 5 Upper Airway Infection NOS with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Upper Airway Infection NOS Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Upper Airway Infection NOS Adverse Event with Unknown Absolute Neutrophil Count, CTCAE
                     Grade 5 Upper Airway Infection NOS with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4813</td>
               <td colspan="2">CTCAE Grade 5 Upper Extremity Artery Injury<span class="subclass"> SubClassOf </span>Upper Extremity Artery Injury Adverse Event. <br><i>New Terms: Upper Extremity Artery Injury Adverse Event, CTCAE Grade 5 Upper Extremity Artery
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>4814</td>
               <td colspan="2">CTCAE Grade 5 Upper Extremity Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Upper Extremity Muscle Weakness Adverse Event Not Due to Neuropathy. <br><i>New Terms: Upper Extremity Muscle Weakness Adverse Event Not Due to Neuropathy, CTCAE Grade 5
                     Upper Extremity Muscle Weakness Not Due to Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>4815</td>
               <td colspan="2">CTCAE Grade 5 Upper Extremity Soft Tissue Necrosis Adverse Event<span class="subclass"> SubClassOf </span>Upper Extremity Soft Tissue Necrosis Adverse Event. <br><i>New Terms: CTCAE Grade 5 Upper Extremity Soft Tissue Necrosis Adverse Event, Upper Extremity
                     Soft Tissue Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4816</td>
               <td colspan="2">CTCAE Grade 5 Upper Extremity Vein Injury<span class="subclass"> SubClassOf </span>Upper Extremity Vein Injury Adverse Event. <br><i>New Terms: Upper Extremity Vein Injury Adverse Event, CTCAE Grade 5 Upper Extremity Vein Injury</i></td>
            </tr>
            <tr class="addition">
               <td>4817</td>
               <td colspan="2">CTCAE Grade 5 Upper Gastrointestinal Hemorrhage NOS<span class="subclass"> SubClassOf </span>Upper Gastrointestinal Hemorrhage Adverse Event NOS. <br><i>New Terms: CTCAE Grade 5 Upper Gastrointestinal Hemorrhage NOS, Upper Gastrointestinal Hemorrhage
                     Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>4818</td>
               <td colspan="2">CTCAE Grade 5 Ureter Fistula<span class="subclass"> SubClassOf </span>Ureter Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 5 Ureter Fistula, Ureter Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4819</td>
               <td colspan="2">CTCAE Grade 5 Ureter Hemorrhage<span class="subclass"> SubClassOf </span>Ureter Hemorrhage Adverse Event. <br><i>New Terms: Ureter Hemorrhage Adverse Event, CTCAE Grade 5 Ureter Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>4820</td>
               <td colspan="2">CTCAE Grade 5 Ureter Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Ureter Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Ureter Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 5 Ureter Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4821</td>
               <td colspan="2">CTCAE Grade 5 Ureter Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Ureter Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Ureter Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Ureter Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4822</td>
               <td colspan="2">CTCAE Grade 5 Ureter Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Ureter Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 5 Ureter Infection with Unknown Absolute Neutrophil Count, Ureter Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4823</td>
               <td colspan="2">CTCAE Grade 5 Ureter Leak<span class="subclass"> SubClassOf </span>Ureter Leak Adverse Event. <br><i>New Terms: CTCAE Grade 5 Ureter Leak, Ureter Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4824</td>
               <td colspan="2">CTCAE Grade 5 Ureter Obstruction<span class="subclass"> SubClassOf </span>Ureter Obstruction Adverse Event. <br><i>New Terms: Ureter Obstruction Adverse Event, CTCAE Grade 5 Ureter Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>4825</td>
               <td colspan="2">CTCAE Grade 5 Ureter Perforation<span class="subclass"> SubClassOf </span>Ureter Perforation Adverse Event. <br><i>New Terms: Ureter Perforation Adverse Event, CTCAE Grade 5 Ureter Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>4826</td>
               <td colspan="2">CTCAE Grade 5 Ureter Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Ureter Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Ureter Stricture or Stenosis Adverse Event, CTCAE Grade 5 Ureter Stricture or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>4827</td>
               <td colspan="2">CTCAE Grade 5 Urethra Fistula<span class="subclass"> SubClassOf </span>Urethra Fistula Adverse Event. <br><i>New Terms: Urethra Fistula Adverse Event, CTCAE Grade 5 Urethra Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>4828</td>
               <td colspan="2">CTCAE Grade 5 Urethra Hemorrhage<span class="subclass"> SubClassOf </span>Urethra Hemorrhage Adverse Event. <br><i>New Terms: Urethra Hemorrhage Adverse Event, CTCAE Grade 5 Urethra Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>4829</td>
               <td colspan="2">CTCAE Grade 5 Urethra Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Urethra Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Urethra Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 5 Urethra Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4830</td>
               <td colspan="2">CTCAE Grade 5 Urethra Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Urethra Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Urethra Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Urethra Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4831</td>
               <td colspan="2">CTCAE Grade 5 Urethra Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Urethra Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Urethra Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     5 Urethra Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4832</td>
               <td colspan="2">CTCAE Grade 5 Urethra Leak<span class="subclass"> SubClassOf </span>Urethra Leak Adverse Event. <br><i>New Terms: CTCAE Grade 5 Urethra Leak, Urethra Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4833</td>
               <td colspan="2">CTCAE Grade 5 Urethra Obstruction<span class="subclass"> SubClassOf </span>Urethra Obstruction Adverse Event. <br><i>New Terms: Urethra Obstruction Adverse Event, CTCAE Grade 5 Urethra Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>4834</td>
               <td colspan="2">CTCAE Grade 5 Urethra Perforation<span class="subclass"> SubClassOf </span>Urethra Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 5 Urethra Perforation, Urethra Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4835</td>
               <td colspan="2">CTCAE Grade 5 Urethra Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Urethra Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 5 Urethra Stricture or Stenosis, Urethra Stricture or Stenosis Adverse
                     Event</i></td>
            </tr>
            <tr class="addition">
               <td>4836</td>
               <td colspan="2">CTCAE Grade 5 Urinary Hemorrhage NOS<span class="subclass"> SubClassOf </span>Urinary Hemorrhage Adverse Event NOS. <br><i>New Terms: CTCAE Grade 5 Urinary Hemorrhage NOS, Urinary Hemorrhage Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>4837</td>
               <td colspan="2">CTCAE Grade 5 Urinary Retention<span class="subclass"> SubClassOf </span>Urinary Retention Adverse Event. <br><i>New Terms: CTCAE Grade 5 Urinary Retention, Urinary Retention Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4838</td>
               <td colspan="2">CTCAE Grade 5 Urinary Tract Infection NOS Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Urinary Tract Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Urinary Tract Infection NOS Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils, Urinary Tract Infection NOS Adverse Event Documented
                     Clinically or Microbiologically with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4839</td>
               <td colspan="2">CTCAE Grade 5 Urinary Tract Infection NOS with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Urinary Tract Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Urinary Tract Infection NOS Adverse Event with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils, CTCAE Grade 5 Urinary Tract Infection NOS with Normal Absolute
                     Neutrophil Count or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4840</td>
               <td colspan="2">CTCAE Grade 5 Urinary Tract Infection NOS with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Urinary Tract Infection NOS Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Urinary Tract Infection NOS Adverse Event with Unknown Absolute Neutrophil Count,
                     CTCAE Grade 5 Urinary Tract Infection NOS with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4841</td>
               <td colspan="2">CTCAE Grade 5 Uterus Fistula<span class="subclass"> SubClassOf </span>Uterus Fistula Adverse Event. <br><i>New Terms: Uterus Fistula Adverse Event, CTCAE Grade 5 Uterus Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>4842</td>
               <td colspan="2">CTCAE Grade 5 Uterus Hemorrhage<span class="subclass"> SubClassOf </span>Uterus Hemorrhage Adverse Event. <br><i>New Terms: Uterus Hemorrhage Adverse Event, CTCAE Grade 5 Uterus Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>4843</td>
               <td colspan="2">CTCAE Grade 5 Uterus Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Uterus Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Uterus Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 5 Uterus Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4844</td>
               <td colspan="2">CTCAE Grade 5 Uterus Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Uterus Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Uterus Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Uterus Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4845</td>
               <td colspan="2">CTCAE Grade 5 Uterus Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Uterus Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Uterus Infection Adverse Event with Unknown Absolute Neutrophil Count, CTCAE Grade
                     5 Uterus Infection with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4846</td>
               <td colspan="2">CTCAE Grade 5 Uterus Leak<span class="subclass"> SubClassOf </span>Uterus Leak Adverse Event. <br><i>New Terms: CTCAE Grade 5 Uterus Leak, Uterus Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4847</td>
               <td colspan="2">CTCAE Grade 5 Uterus Obstruction<span class="subclass"> SubClassOf </span>Uterus Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 5 Uterus Obstruction, Uterus Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4848</td>
               <td colspan="2">CTCAE Grade 5 Uterus Perforation<span class="subclass"> SubClassOf </span>Uterus Perforation Adverse Event. <br><i>New Terms: Uterus Perforation Adverse Event, CTCAE Grade 5 Uterus Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>4849</td>
               <td colspan="2">CTCAE Grade 5 Uterus Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Uterus Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: Uterus Stricture or Stenosis Adverse Event, CTCAE Grade 5 Uterus Stricture or Stenosis</i></td>
            </tr>
            <tr class="addition">
               <td>4850</td>
               <td colspan="2">CTCAE Grade 5 Vagina Fistula<span class="subclass"> SubClassOf </span>Vagina Fistula Adverse Event. <br><i>New Terms: CTCAE Grade 5 Vagina Fistula, Vagina Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4851</td>
               <td colspan="2">CTCAE Grade 5 Vagina Hemorrhage<span class="subclass"> SubClassOf </span>Vagina Hemorrhage Adverse Event. <br><i>New Terms: Vagina Hemorrhage Adverse Event, CTCAE Grade 5 Vagina Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>4852</td>
               <td colspan="2">CTCAE Grade 5 Vagina Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Vagina Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Vagina Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Vagina Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4853</td>
               <td colspan="2">CTCAE Grade 5 Vagina Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Vagina Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Vagina Infection with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, Vagina Infection Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4854</td>
               <td colspan="2">CTCAE Grade 5 Vagina Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Vagina Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 5 Vagina Infection with Unknown Absolute Neutrophil Count, Vagina Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4855</td>
               <td colspan="2">CTCAE Grade 5 Vagina Leak<span class="subclass"> SubClassOf </span>Vagina Leak Adverse Event. <br><i>New Terms: Vagina Leak Adverse Event, CTCAE Grade 5 Vagina Leak</i></td>
            </tr>
            <tr class="addition">
               <td>4856</td>
               <td colspan="2">CTCAE Grade 5 Vagina Obstruction<span class="subclass"> SubClassOf </span>Vagina Obstruction Adverse Event. <br><i>New Terms: Vagina Obstruction Adverse Event, CTCAE Grade 5 Vagina Obstruction</i></td>
            </tr>
            <tr class="addition">
               <td>4857</td>
               <td colspan="2">CTCAE Grade 5 Vagina Perforation<span class="subclass"> SubClassOf </span>Vagina Perforation Adverse Event. <br><i>New Terms: CTCAE Grade 5 Vagina Perforation, Vagina Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4858</td>
               <td colspan="2">CTCAE Grade 5 Vagina Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Vagina Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 5 Vagina Stricture or Stenosis, Vagina Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4859</td>
               <td colspan="2">CTCAE Grade 5 Valvular Heart Disease<span class="subclass"> SubClassOf </span>Valvular Heart Disease Adverse Event. <br><i>New Terms: Valvular Heart Disease Adverse Event, CTCAE Grade 5 Valvular Heart Disease</i></td>
            </tr>
            <tr class="addition">
               <td>4860</td>
               <td colspan="2">CTCAE Grade 5 Vas Deferens Hemorrhage<span class="subclass"> SubClassOf </span>Vas Deferens Hemorrhage Adverse Event. <br><i>New Terms: Vas Deferens Hemorrhage Adverse Event, CTCAE Grade 5 Vas Deferens Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>4861</td>
               <td colspan="2">CTCAE Grade 5 Vas Deferens Leak<span class="subclass"> SubClassOf </span>Vas Deferens Leak Adverse Event. <br><i>New Terms: CTCAE Grade 5 Vas Deferens Leak, Vas Deferens Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4862</td>
               <td colspan="2">CTCAE Grade 5 Vas Deferens Obstruction<span class="subclass"> SubClassOf </span>Vas Deferens Obstruction Adverse Event. <br><i>New Terms: CTCAE Grade 5 Vas Deferens Obstruction, Vas Deferens Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4863</td>
               <td colspan="2">CTCAE Grade 5 Vas Deferens Perforation<span class="subclass"> SubClassOf </span>Vas Deferens Perforation Adverse Event. <br><i>New Terms: Vas Deferens Perforation Adverse Event, CTCAE Grade 5 Vas Deferens Perforation</i></td>
            </tr>
            <tr class="addition">
               <td>4864</td>
               <td colspan="2">CTCAE Grade 5 Vas Deferens Stricture<br><span class="keyword"> or </span>Stenosis<span class="subclass"> SubClassOf </span>Vas Deferens Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event. <br><i>New Terms: CTCAE Grade 5 Vas Deferens Stricture or Stenosis, Vas Deferens Stricture or Stenosis
                     Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4865</td>
               <td colspan="2">CTCAE Grade 5 Vasculitis<span class="subclass"> SubClassOf </span>Vasculitis Adverse Event. <br><i>New Terms: Vasculitis Adverse Event, CTCAE Grade 5 Vasculitis</i></td>
            </tr>
            <tr class="addition">
               <td>4866</td>
               <td colspan="2">CTCAE Grade 5 Vasovagal Episode<span class="subclass"> SubClassOf </span>Vasovagal Episode Adverse Event. <br><i>New Terms: Vasovagal Episode Adverse Event, CTCAE Grade 5 Vasovagal Episode</i></td>
            </tr>
            <tr class="addition">
               <td>4867</td>
               <td colspan="2">CTCAE Grade 5 Vein Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Vein Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: Vein Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, CTCAE Grade 5 Vein Infection Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4868</td>
               <td colspan="2">CTCAE Grade 5 Vein Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Vein Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Vein Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or 2
                     Neutrophils, CTCAE Grade 5 Vein Infection with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4869</td>
               <td colspan="2">CTCAE Grade 5 Vein Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Vein Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 5 Vein Infection with Unknown Absolute Neutrophil Count, Vein Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4870</td>
               <td colspan="2">CTCAE Grade 5 Ventricular Arrhythmia NOS<span class="subclass"> SubClassOf </span>Ventricular Arrhythmia Adverse Event NOS. <br><i>New Terms: CTCAE Grade 5 Ventricular Arrhythmia NOS, Ventricular Arrhythmia Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>4871</td>
               <td colspan="2">CTCAE Grade 5 Ventricular Fibrillation<span class="subclass"> SubClassOf </span>Ventricular Fibrillation Adverse Event. <br><i>New Terms: Ventricular Fibrillation Adverse Event, CTCAE Grade 5 Ventricular Fibrillation</i></td>
            </tr>
            <tr class="addition">
               <td>4872</td>
               <td colspan="2">CTCAE Grade 5 Ventricular Flutter<span class="subclass"> SubClassOf </span>Ventricular Flutter Adverse Event. <br><i>New Terms: Ventricular Flutter Adverse Event, CTCAE Grade 5 Ventricular Flutter</i></td>
            </tr>
            <tr class="addition">
               <td>4873</td>
               <td colspan="2">CTCAE Grade 5 Ventricular Tachycardia<span class="subclass"> SubClassOf </span>Ventricular Tachycardia Adverse Event. <br><i>New Terms: Ventricular Tachycardia Adverse Event, CTCAE Grade 5 Ventricular Tachycardia</i></td>
            </tr>
            <tr class="addition">
               <td>4874</td>
               <td colspan="2">CTCAE Grade 5 Viral Hepatitis<span class="subclass"> SubClassOf </span>Viral Hepatitis Adverse Event. <br><i>New Terms: Viral Hepatitis Adverse Event, CTCAE Grade 5 Viral Hepatitis</i></td>
            </tr>
            <tr class="addition">
               <td>4875</td>
               <td colspan="2">CTCAE Grade 5 Viscera Vein Injury<span class="subclass"> SubClassOf </span>Viscera Vein Injury Adverse Event. <br><i>New Terms: CTCAE Grade 5 Viscera Vein Injury, Viscera Vein Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4876</td>
               <td colspan="2">CTCAE Grade 5 Visceral Artery Injury<span class="subclass"> SubClassOf </span>Visceral Artery Injury Adverse Event. <br><i>New Terms: CTCAE Grade 5 Visceral Artery Injury, Visceral Artery Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4877</td>
               <td colspan="2">CTCAE Grade 5 Vital Capacity<span class="subclass"> SubClassOf </span>Vital Capacity Adverse Event. <br><i>New Terms: Vital Capacity Adverse Event, CTCAE Grade 5 Vital Capacity</i></td>
            </tr>
            <tr class="addition">
               <td>4878</td>
               <td colspan="2">CTCAE Grade 5 Voice Changes<br><span class="keyword"> and </span>Dysarthria<span class="subclass"> SubClassOf </span>Voice Changes<br><span class="keyword"> and </span>Dysarthria Adverse Event. <br><i>New Terms: CTCAE Grade 5 Voice Changes and Dysarthria, Voice Changes and Dysarthria Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4879</td>
               <td colspan="2">CTCAE Grade 5 Vomiting<span class="subclass"> SubClassOf </span>Vomiting Adverse Event. <br><i>New Terms: CTCAE Grade 5 Vomiting, Vomiting Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4880</td>
               <td colspan="2">CTCAE Grade 5 Vulva Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Vulva Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Vulva Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Vulva Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4881</td>
               <td colspan="2">CTCAE Grade 5 Vulva Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Vulva Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Vulva Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 5 Vulva Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4882</td>
               <td colspan="2">CTCAE Grade 5 Vulva Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Vulva Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 5 Vulva Infection with Unknown Absolute Neutrophil Count, Vulva Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4883</td>
               <td colspan="2">CTCAE Grade 5 Whole Body<br><span class="keyword"> and </span>Generalized Muscle Weakness Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Whole Body<br><span class="keyword"> and </span>Generalized Muscle Weakness Not Due to Neuropathy Adverse Event. <br><i>New Terms: CTCAE Grade 5 Whole Body and Generalized Muscle Weakness Not Due to Neuropathy, Whole
                     Body and Generalized Muscle Weakness Not Due to Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4884</td>
               <td colspan="2">CTCAE Grade 5 Wolff-Parkinson-White Syndrome<span class="subclass"> SubClassOf </span>Wolff-Parkinson-White Syndrome Adverse Event. <br><i>New Terms: Wolff-Parkinson-White Syndrome Adverse Event, CTCAE Grade 5 Wolff-Parkinson-White
                     Syndrome</i></td>
            </tr>
            <tr class="addition">
               <td>4885</td>
               <td colspan="2">CTCAE Grade 5 Wound Infection Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Wound Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils. <br><i>New Terms: CTCAE Grade 5 Wound Infection Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils, Wound Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4886</td>
               <td colspan="2">CTCAE Grade 5 Wound Infection with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Wound Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Wound Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils, CTCAE Grade 5 Wound Infection with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4887</td>
               <td colspan="2">CTCAE Grade 5 Wound Infection with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Wound Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: CTCAE Grade 5 Wound Infection with Unknown Absolute Neutrophil Count, Wound Infection
                     Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4888</td>
               <td colspan="2">Candidate Tumor Suppressor Protein<span class="subclass"> SubClassOf </span>Gene_Product_Encoded_By_Gene<span class="some"> some </span>Candidate Tumor Suppressor Gene. <br><i>New Terms: Candidate Tumor Suppressor Protein</i></td>
            </tr>
            <tr class="addition">
               <td>4889</td>
               <td colspan="2">Candidate Tumor Suppressor Protein<span class="subclass"> SubClassOf </span>Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Cell Proliferation Regulation. <br><i>New Terms: Candidate Tumor Suppressor Protein</i></td>
            </tr>
            <tr class="addition">
               <td>4890</td>
               <td colspan="2">Candidate Tumor Suppressor Protein<span class="subclass"> SubClassOf </span>Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Tumor Suppression. <br><i>New Terms: Candidate Tumor Suppressor Protein</i></td>
            </tr>
            <tr class="addition">
               <td>4891</td>
               <td colspan="2">Candidate Tumor Suppressor Protein<span class="subclass"> SubClassOf </span>Tumor Suppressor Protein. <br><i>New Terms: Candidate Tumor Suppressor Protein</i></td>
            </tr>
            <tr class="addition">
               <td>4892</td>
               <td colspan="2">Carbon Monoxide Diffusion Capacity Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Systems. <br><i>New Terms: Carbon Monoxide Diffusion Capacity Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4893</td>
               <td colspan="2">Cardiac Ischemia<br><span class="keyword"> or </span>Infarction Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Heart in General. <br><i>New Terms: Cardiac Ischemia or Infarction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4894</td>
               <td colspan="2">Cardiac Troponin I Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Heart in General. <br><i>New Terms: Cardiac Troponin I Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4895</td>
               <td colspan="2">Cardiac Troponin T Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Heart in General. <br><i>New Terms: Cardiac Troponin T Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4896</td>
               <td colspan="2">Cardiac<br><span class="keyword"> and </span>Heart Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Cardiac and Heart Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4897</td>
               <td colspan="2">Carotid Artery Injury Adverse Event<span class="subclass"> SubClassOf </span>Artery Injury Adverse Event. <br><i>New Terms: Carotid Artery Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4898</td>
               <td colspan="2">Carotid Artery Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Carotid Artery Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4899</td>
               <td colspan="2">Cartilage Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Cartilage Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4900</td>
               <td colspan="2">Carton Dosing Unit<span class="subclass"> SubClassOf </span>Potency Unit. <br><i>New Terms: Carton Dosing Unit</i></td>
            </tr>
            <tr class="addition">
               <td>4901</td>
               <td colspan="2">Cataract Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Ocular<br><span class="keyword"> and </span>Visual Systems. <br><i>New Terms: Cataract Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4902</td>
               <td colspan="2">Catheter-Related Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Catheter-Related Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4903</td>
               <td colspan="2">Catheter-Related Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Catheter-Related Infection Adverse Event with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4904</td>
               <td colspan="2">Catheter-Related Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Catheter-Related Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4905</td>
               <td colspan="2">Cecum Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Cecum Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4906</td>
               <td colspan="2">Cecum Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Cecum Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4907</td>
               <td colspan="2">Cecum Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Cecum Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4908</td>
               <td colspan="2">Cecum Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Cecum Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4909</td>
               <td colspan="2">Cecum Obstruction Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Obstruction Adverse Event. <br><i>New Terms: Cecum Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4910</td>
               <td colspan="2">Cecum Perforation Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Perforation Adverse Event. <br><i>New Terms: Cecum Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4911</td>
               <td colspan="2">Cecum Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Stricture<br><span class="keyword"> and </span>Stenosis Adverse Event Including Anastomotic Stricture<br><span class="keyword"> and </span>Stenosis. <br><i>New Terms: Cecum Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4912</td>
               <td colspan="2">Cecum Ulcer Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Ulcer Adverse Event. <br><i>New Terms: Cecum Ulcer Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4913</td>
               <td colspan="2">Cecum<br><span class="keyword"> or </span>Appendix Hemorrhage Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Hemorrhage Adverse Event. <br><i>New Terms: Cecum or Appendix Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4914</td>
               <td colspan="2">Central Nervous System Hemorrhage Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Hemorrhage<br><span class="keyword"> and </span>Bleeding. <br><i>New Terms: Central Nervous System Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4915</td>
               <td colspan="2">Cerebral Artery Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Cerebral Artery Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4916</td>
               <td colspan="2">Cerebrospinal Fluid Leak Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Nervous System. <br><i>New Terms: Cerebrospinal Fluid Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4917</td>
               <td colspan="2">Cervical Spine<span class="subclass"> Range </span>of Motion Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Musculoskeletal System<br><span class="keyword"> and </span>Soft Tissue. <br><i>New Terms: Cervical Spine Range of Motion Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4918</td>
               <td colspan="2">Cervix Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Cervix Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4919</td>
               <td colspan="2">Cervix Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Cervix Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4920</td>
               <td colspan="2">Cervix Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Cervix Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4921</td>
               <td colspan="2">Cervix Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Cervix Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4922</td>
               <td colspan="2">Cheilitis Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Dermatology<br><span class="keyword"> and </span>Skin. <br><i>New Terms: Cheilitis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4923</td>
               <td colspan="2">Chemical Effects in Biological Systems<span class="subclass"> SubClassOf </span>Database. <br><i>New Terms: Chemical Effects in Biological Systems</i></td>
            </tr>
            <tr class="addition">
               <td>4924</td>
               <td colspan="2">Chest Wall Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Chest Wall Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4925</td>
               <td colspan="2">Chest<br><span class="keyword"> and </span>Thorax Pain NOS Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Chest and Thorax Pain NOS Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4926</td>
               <td colspan="2">Cholecystitis Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Hepatobiliary System<br><span class="keyword"> and </span>Pancreas. <br><i>New Terms: Cholecystitis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4927</td>
               <td colspan="2">Chyle<br><span class="keyword"> or </span>Lymph Leakage Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Lymphatic System. <br><i>New Terms: Chyle or Lymph Leakage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4928</td>
               <td colspan="2">Chylothorax Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Systems. <br><i>New Terms: Chylothorax Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4929</td>
               <td colspan="2">Clara Cell Differentiation<span class="subclass"> SubClassOf </span>Epithelial Differentiation. <br><i>New Terms: Clara Cell Differentiation</i></td>
            </tr>
            <tr class="addition">
               <td>4930</td>
               <td colspan="2">Clear Cell Eccrine Carcinoma<span class="subclass"> SubClassOf </span>Clear Cell Adenocarcinoma. <br><i>New Terms: Clear Cell Eccrine Carcinoma</i></td>
            </tr>
            <tr class="addition">
               <td>4931</td>
               <td colspan="2">Clear Cell Eccrine Carcinoma<span class="subclass"> SubClassOf </span>Eccrine Carcinoma. <br><i>New Terms: Clear Cell Eccrine Carcinoma</i></td>
            </tr>
            <tr class="addition">
               <td>4932</td>
               <td colspan="2">Cognitive Disturbance Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Nervous System. <br><i>New Terms: Cognitive Disturbance Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4933</td>
               <td colspan="2">Coin Lesion<span class="subclass"> SubClassOf </span>Radiologic Finding. <br><i>New Terms: Coin Lesion</i></td>
            </tr>
            <tr class="addition">
               <td>4934</td>
               <td colspan="2">Colitis Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Gastrointestinal System. <br><i>New Terms: Colitis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4935</td>
               <td colspan="2">Colon Hemorrhage Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Hemorrhage Adverse Event. <br><i>New Terms: Colon Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4936</td>
               <td colspan="2">Colon Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Colon Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4937</td>
               <td colspan="2">Colon Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Colon Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4938</td>
               <td colspan="2">Colon Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Colon Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4939</td>
               <td colspan="2">Colon Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Colon Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4940</td>
               <td colspan="2">Colon Obstruction Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Obstruction Adverse Event. <br><i>New Terms: Colon Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4941</td>
               <td colspan="2">Colon Perforation Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Perforation Adverse Event. <br><i>New Terms: Colon Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4942</td>
               <td colspan="2">Colon Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Stricture<br><span class="keyword"> and </span>Stenosis Adverse Event Including Anastomotic Stricture<br><span class="keyword"> and </span>Stenosis. <br><i>New Terms: Colon Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4943</td>
               <td colspan="2">Colon Ulcer Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Ulcer Adverse Event. <br><i>New Terms: Colon Ulcer Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4944</td>
               <td colspan="2">Colon<br><span class="keyword"> or </span>Cecum<br><span class="keyword"> or </span>Appendix Fistula Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Fistula Adverse Event. <br><i>New Terms: Colon or Cecum or Appendix Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4945</td>
               <td colspan="2">Colon<br><span class="keyword"> or </span>Cecum<br><span class="keyword"> or </span>Appendix Necrosis Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Necrosis Adverse Event. <br><i>New Terms: Colon or Cecum or Appendix Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4946</td>
               <td colspan="2">Combination Product<span class="subclass"> SubClassOf </span>Regulated Medical Product. <br><i>New Terms: Combination Product, Regulated Medical Product</i></td>
            </tr>
            <tr class="addition">
               <td>4947</td>
               <td colspan="2">Commercial Organization<span class="subclass"> SubClassOf </span>Professional Organization<br><span class="keyword"> or </span>Group. <br><i>New Terms: Commercial Organization</i></td>
            </tr>
            <tr class="addition">
               <td>4948</td>
               <td colspan="2">Conduction Abnormality Adverse Event NOS<span class="subclass"> SubClassOf </span>Conduction Abnormality<br><span class="keyword"> and </span>Atrioventricular Heart Block Adverse Event. <br><i>New Terms: Conduction Abnormality Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>4949</td>
               <td colspan="2">Confusion Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Nervous System. <br><i>New Terms: Confusion Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4950</td>
               <td colspan="2">Conjunctiva Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Conjunctiva Infection Adverse Event Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4951</td>
               <td colspan="2">Conjunctiva Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Conjunctiva Infection Adverse Event with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4952</td>
               <td colspan="2">Conjunctiva Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Conjunctiva Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4953</td>
               <td colspan="2">Conjunctiva Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Conjunctiva Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4954</td>
               <td colspan="2">Constipation Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Gastrointestinal System. <br><i>New Terms: Constipation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4956</td>
               <td colspan="2">Cornea Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Cornea Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4957</td>
               <td colspan="2">Cornea Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Cornea Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4958</td>
               <td colspan="2">Cornea Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Cornea Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4959</td>
               <td colspan="2">Cornea Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Cornea Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4960</td>
               <td colspan="2">Correction<span class="subclass"> SubClassOf </span>Change. <br><i>New Terms: Correction</i></td>
            </tr>
            <tr class="addition">
               <td>4961</td>
               <td colspan="2">Cough Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Systems. <br><i>New Terms: Cough Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4962</td>
               <td colspan="2">CpG Island<span class="subclass"> SubClassOf </span>Gene Feature. <br><i>New Terms: CpG Island</i></td>
            </tr>
            <tr class="addition">
               <td>4972</td>
               <td colspan="2">Cranial Nerve I Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Cranial Nerve I Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4973</td>
               <td colspan="2">Cranial Nerve I Neuropathy Adverse Event<span class="subclass"> SubClassOf </span>Cranial Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve I Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4965</td>
               <td colspan="2">Cranial Nerve II Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Cranial Nerve II Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4966</td>
               <td colspan="2">Cranial Nerve II Neuropathy Adverse Event<span class="subclass"> SubClassOf </span>Cranial Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve II Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4963</td>
               <td colspan="2">Cranial Nerve III Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Cranial Nerve III Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4964</td>
               <td colspan="2">Cranial Nerve III Neuropathy Adverse Event<span class="subclass"> SubClassOf </span>Cranial Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve III Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4967</td>
               <td colspan="2">Cranial Nerve IV Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Cranial Nerve IV Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4968</td>
               <td colspan="2">Cranial Nerve IV Neuropathy Adverse Event<span class="subclass"> SubClassOf </span>Cranial Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve IV Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4969</td>
               <td colspan="2">Cranial Nerve IX Motor Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Cranial Nerve IX Motor Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4970</td>
               <td colspan="2">Cranial Nerve IX Neuropathy Adverse Event<span class="subclass"> SubClassOf </span>Cranial Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve IX Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4971</td>
               <td colspan="2">Cranial Nerve IX Sensory Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Cranial Nerve IX Sensory Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4974</td>
               <td colspan="2">Cranial Nerve Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Cranial Nerve Infection Adverse Event Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4975</td>
               <td colspan="2">Cranial Nerve Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Cranial Nerve Infection Adverse Event with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>4976</td>
               <td colspan="2">Cranial Nerve Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Cranial Nerve Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>4977</td>
               <td colspan="2">Cranial Nerve Or Branch NOS Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Cranial Nerve Or Branch NOS Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4985</td>
               <td colspan="2">Cranial Nerve V Motor Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Cranial Nerve V Motor Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4986</td>
               <td colspan="2">Cranial Nerve V Neuropathy Adverse Event<span class="subclass"> SubClassOf </span>Cranial Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve V Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4987</td>
               <td colspan="2">Cranial Nerve V Sensory Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Cranial Nerve V Sensory Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4983</td>
               <td colspan="2">Cranial Nerve VI Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Cranial Nerve VI Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4984</td>
               <td colspan="2">Cranial Nerve VI Neuropathy Adverse Event<span class="subclass"> SubClassOf </span>Cranial Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve VI Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4980</td>
               <td colspan="2">Cranial Nerve VII Motor Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Cranial Nerve VII Motor Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4981</td>
               <td colspan="2">Cranial Nerve VII Neuropathy Adverse Event<span class="subclass"> SubClassOf </span>Cranial Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve VII Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4982</td>
               <td colspan="2">Cranial Nerve VII Sensory Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Cranial Nerve VII Sensory Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4978</td>
               <td colspan="2">Cranial Nerve VIII Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Cranial Nerve VIII Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4979</td>
               <td colspan="2">Cranial Nerve VIII Neuropathy Adverse Event<span class="subclass"> SubClassOf </span>Cranial Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve VIII Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4992</td>
               <td colspan="2">Cranial Nerve X Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Cranial Nerve X Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4993</td>
               <td colspan="2">Cranial Nerve X Neuropathy Adverse Event<span class="subclass"> SubClassOf </span>Cranial Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve X Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4990</td>
               <td colspan="2">Cranial Nerve XI Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Cranial Nerve XI Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4991</td>
               <td colspan="2">Cranial Nerve XI Neuropathy Adverse Event<span class="subclass"> SubClassOf </span>Cranial Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve XI Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4988</td>
               <td colspan="2">Cranial Nerve XII Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Cranial Nerve XII Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4989</td>
               <td colspan="2">Cranial Nerve XII Neuropathy Adverse Event<span class="subclass"> SubClassOf </span>Cranial Neuropathy Adverse Event. <br><i>New Terms: Cranial Nerve XII Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4994</td>
               <td colspan="2">Creatine Phosphokinase Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Metabolic<br><span class="keyword"> and </span>Laboratory Abnormalities. <br><i>New Terms: Creatine Phosphokinase Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4995</td>
               <td colspan="2">Creatinine Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Metabolic<br><span class="keyword"> and </span>Laboratory Abnormalities. <br><i>New Terms: Creatinine Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4996</td>
               <td colspan="2">Critical Assessment of Microarray Data Analysis<span class="subclass"> SubClassOf </span>Professional Organization<br><span class="keyword"> or </span>Group. <br><i>New Terms: Critical Assessment of Microarray Data Analysis</i></td>
            </tr>
            <tr class="addition">
               <td>4997</td>
               <td colspan="2">Critical Reprocessed Single-Use Device<span class="subclass"> SubClassOf </span>Device Labeled for Single Use. <br><i>New Terms: Critical Reprocessed Single-Use Device</i></td>
            </tr>
            <tr class="addition">
               <td>4998</td>
               <td colspan="2">Cup Dosing Unit<span class="subclass"> SubClassOf </span>Potency Unit. <br><i>New Terms: Cup Dosing Unit</i></td>
            </tr>
            <tr class="addition">
               <td>4999</td>
               <td colspan="2">Curriculum Vitae<span class="subclass"> SubClassOf </span>Document. <br><i>New Terms: Curriculum Vitae</i></td>
            </tr>
            <tr class="addition">
               <td>5000</td>
               <td colspan="2">Cushingoid Appearance Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Endocrine System. <br><i>New Terms: Cushingoid Appearance Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5001</td>
               <td colspan="2">Cystitis Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Kidney<br><span class="keyword"> and </span>Genitourinary System. <br><i>New Terms: Cystitis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5002</td>
               <td colspan="2">Cytokine Release Syndrome<br><span class="keyword"> or </span>Acute Infusion Reaction Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Syndromes. <br><i>New Terms: Cytokine Release Syndrome or Acute Infusion Reaction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5003</td>
               <td colspan="2">Death Adverse Event Due to Disease Progression Not Associated with More Specific CTCAE
                  Term NOS<span class="subclass"> SubClassOf </span>Death Adverse Event Not Associated with More Specific CTCAE Term. <br><i>New Terms: Death Adverse Event Due to Disease Progression Not Associated with More Specific CTCAE
                     Term NOS</i></td>
            </tr>
            <tr class="addition">
               <td>5004</td>
               <td colspan="2">Death Adverse Event Due to Multi-Organ Failure Not Associated with More Specific CTCAE
                  Term<span class="subclass"> SubClassOf </span>Death Adverse Event Not Associated with More Specific CTCAE Term. <br><i>New Terms: Death Adverse Event Due to Multi-Organ Failure Not Associated with More Specific CTCAE
                     Term</i></td>
            </tr>
            <tr class="addition">
               <td>5005</td>
               <td colspan="2">Death Adverse Event Not Associated with More Specific CTCAE Term NOS<span class="subclass"> SubClassOf </span>Death Adverse Event Not Associated with More Specific CTCAE Term. <br><i>New Terms: Death Adverse Event Not Associated with More Specific CTCAE Term NOS</i></td>
            </tr>
            <tr class="addition">
               <td>5006</td>
               <td colspan="2">Dehydration Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Gastrointestinal System. <br><i>New Terms: Dehydration Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5007</td>
               <td colspan="2">Delayed Puberty Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Growth<br><span class="keyword"> and </span>Development. <br><i>New Terms: Delayed Puberty Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5008</td>
               <td colspan="2">Delegate<span class="subclass"> SubClassOf </span>Person. <br><i>New Terms: Delegate</i></td>
            </tr>
            <tr class="addition">
               <td>5009</td>
               <td colspan="2">Dental<br><span class="keyword"> and </span>Teeth<br><span class="keyword"> and </span>Peridontal Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Dental and Teeth and Peridontal Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5010</td>
               <td colspan="2">Depression Adverse Event<span class="subclass"> SubClassOf </span>Mood Alteration Adverse Event. <br><i>New Terms: Depression Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5011</td>
               <td colspan="2">Dermal Change Adverse Event Lymphedema<br><span class="keyword"> or </span>Phlebolymphedema<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Lymphatic System. <br><i>New Terms: Dermal Change Adverse Event Lymphedema or Phlebolymphedema</i></td>
            </tr>
            <tr class="addition">
               <td>5012</td>
               <td colspan="2">Diaphoresis Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Constitutional Symptoms. <br><i>New Terms: Diaphoresis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5013</td>
               <td colspan="2">Diarrhea Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Gastrointestinal System. <br><i>New Terms: Diarrhea Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5014</td>
               <td colspan="2">Disseminated Intravascular Coagulation Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Coagulation. <br><i>New Terms: Disseminated Intravascular Coagulation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5015</td>
               <td colspan="2">Dizziness Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Nervous System. <br><i>New Terms: Dizziness Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5016</td>
               <td colspan="2">Document Management System<span class="subclass"> SubClassOf </span>Computer System. <br><i>New Terms: Document Management System</i></td>
            </tr>
            <tr class="addition">
               <td>5017</td>
               <td colspan="2">Drug Interaction<span class="subclass"> SubClassOf </span>Biochemical Process. <br><i>New Terms: Drug Interaction</i></td>
            </tr>
            <tr class="addition">
               <td>5018</td>
               <td colspan="2">Dry Eye Syndrome Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Ocular<br><span class="keyword"> and </span>Visual Systems. <br><i>New Terms: Dry Eye Syndrome Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5019</td>
               <td colspan="2">Dry Skin Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Dermatology<br><span class="keyword"> and </span>Skin. <br><i>New Terms: Dry Skin Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5020</td>
               <td colspan="2">Duodenum Fistula Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Fistula Adverse Event. <br><i>New Terms: Duodenum Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5021</td>
               <td colspan="2">Duodenum Hemorrhage Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Hemorrhage Adverse Event. <br><i>New Terms: Duodenum Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5022</td>
               <td colspan="2">Duodenum Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Duodenum Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5023</td>
               <td colspan="2">Duodenum Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Duodenum Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5024</td>
               <td colspan="2">Duodenum Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Duodenum Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5025</td>
               <td colspan="2">Duodenum Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Duodenum Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5026</td>
               <td colspan="2">Duodenum Necrosis Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Necrosis Adverse Event. <br><i>New Terms: Duodenum Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5027</td>
               <td colspan="2">Duodenum Obstruction Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Obstruction Adverse Event. <br><i>New Terms: Duodenum Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5028</td>
               <td colspan="2">Duodenum Perforation Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Perforation Adverse Event. <br><i>New Terms: Duodenum Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5029</td>
               <td colspan="2">Duodenum Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Stricture<br><span class="keyword"> and </span>Stenosis Adverse Event Including Anastomotic Stricture<br><span class="keyword"> and </span>Stenosis. <br><i>New Terms: Duodenum Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5030</td>
               <td colspan="2">Duodenum Ulcer Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Ulcer Adverse Event. <br><i>New Terms: Duodenum Ulcer Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5031</td>
               <td colspan="2">Dysphagia Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Gastrointestinal System. <br><i>New Terms: Dysphagia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5032</td>
               <td colspan="2">Dyspnea Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Systems. <br><i>New Terms: Dyspnea Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5033</td>
               <td colspan="2">Edema Adverse Event of the Head<br><span class="keyword"> and </span>Neck<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Lymphatic System. <br><i>New Terms: Edema Adverse Event of the Head and Neck</i></td>
            </tr>
            <tr class="addition">
               <td>5034</td>
               <td colspan="2">Edema Adverse Event of the Limb<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Lymphatic System. <br><i>New Terms: Edema Adverse Event of the Limb</i></td>
            </tr>
            <tr class="addition">
               <td>5035</td>
               <td colspan="2">Edema Adverse Event of the Trunk<br><span class="keyword"> and </span>Genital Area<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Lymphatic System. <br><i>New Terms: Edema Adverse Event of the Trunk and Genital Area</i></td>
            </tr>
            <tr class="addition">
               <td>5036</td>
               <td colspan="2">Edema Adverse Event of the Viscera<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Lymphatic System. <br><i>New Terms: Edema Adverse Event of the Viscera</i></td>
            </tr>
            <tr class="addition">
               <td>5037</td>
               <td colspan="2">Ejaculatory Dysfunction Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Sexual<br><span class="keyword"> and </span>Reproductive Function. <br><i>New Terms: Ejaculatory Dysfunction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5038</td>
               <td colspan="2">Empiric<span class="subclass"> SubClassOf </span>General Qualifier. <br><i>New Terms: Empiric</i></td>
            </tr>
            <tr class="addition">
               <td>5039</td>
               <td colspan="2">Encephalopathy Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Nervous System. <br><i>New Terms: Encephalopathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5040</td>
               <td colspan="2">Endopeptidase<span class="subclass"> SubClassOf </span>Enzyme. <br><i>New Terms: Endopeptidase</i></td>
            </tr>
            <tr class="addition">
               <td>5041</td>
               <td colspan="2">Endopeptidase<span class="subclass"> SubClassOf </span>Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Enzyme. <br><i>New Terms: Endopeptidase</i></td>
            </tr>
            <tr class="addition">
               <td>5042</td>
               <td colspan="2">Endopeptidase<span class="subclass"> SubClassOf </span>Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Hydrolysis. <br><i>New Terms: Endopeptidase</i></td>
            </tr>
            <tr class="addition">
               <td>5043</td>
               <td colspan="2">Enteritis Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Gastrointestinal System. <br><i>New Terms: Enteritis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5044</td>
               <td colspan="2">Epiphora Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Ocular<br><span class="keyword"> and </span>Visual Systems. <br><i>New Terms: Epiphora Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5045</td>
               <td colspan="2">Erectile Dysfunction Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Sexual<br><span class="keyword"> and </span>Reproductive Function. <br><i>New Terms: Erectile Dysfunction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5046</td>
               <td colspan="2">Esophageal Varices Hemorrhage Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Hemorrhage Adverse Event. <br><i>New Terms: Esophageal Varices Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5047</td>
               <td colspan="2">Esophagitis Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Gastrointestinal System. <br><i>New Terms: Esophagitis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5048</td>
               <td colspan="2">Esophagus Fistula Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Fistula Adverse Event. <br><i>New Terms: Esophagus Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5049</td>
               <td colspan="2">Esophagus Hemorrhage Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Hemorrhage Adverse Event. <br><i>New Terms: Esophagus Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5050</td>
               <td colspan="2">Esophagus Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Esophagus Infection Adverse Event Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5051</td>
               <td colspan="2">Esophagus Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Esophagus Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5052</td>
               <td colspan="2">Esophagus Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Esophagus Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5053</td>
               <td colspan="2">Esophagus Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Esophagus Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5054</td>
               <td colspan="2">Esophagus Leak Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Leak Adverse Event Including Anastomotic Leak. <br><i>New Terms: Esophagus Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5055</td>
               <td colspan="2">Esophagus Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Mucositis<br><span class="keyword"> and </span>Stomatitis Adverse Event by Clinical Examination Classification. <br><i>New Terms: Esophagus Mucositis or Stomatitis Adverse Event by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>5056</td>
               <td colspan="2">Esophagus Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Mucositis<br><span class="keyword"> and </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> and </span>Symptomatic Classification. <br><i>New Terms: Esophagus Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>5057</td>
               <td colspan="2">Esophagus Necrosis Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Necrosis Adverse Event. <br><i>New Terms: Esophagus Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5058</td>
               <td colspan="2">Esophagus Obstruction Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Obstruction Adverse Event. <br><i>New Terms: Esophagus Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5059</td>
               <td colspan="2">Esophagus Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Esophagus Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5060</td>
               <td colspan="2">Esophagus Perforation Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Perforation Adverse Event. <br><i>New Terms: Esophagus Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5061</td>
               <td colspan="2">Esophagus Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Stricture<br><span class="keyword"> and </span>Stenosis Adverse Event Including Anastomotic Stricture<br><span class="keyword"> and </span>Stenosis. <br><i>New Terms: Esophagus Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5062</td>
               <td colspan="2">Esophagus Ulcer Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Ulcer Adverse Event. <br><i>New Terms: Esophagus Ulcer Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5063</td>
               <td colspan="2">Euphoria Adverse Event<span class="subclass"> SubClassOf </span>Mood Alteration Adverse Event. <br><i>New Terms: Euphoria Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5064</td>
               <td colspan="2">Excellent Tissue Fixation with Well Preserved Nuclear Details<span class="subclass"> SubClassOf </span>Morphologic Finding. <br><i>New Terms: Excellent Tissue Fixation with Well Preserved Nuclear Details</i></td>
            </tr>
            <tr class="addition">
               <td>5065</td>
               <td colspan="2">Exostosis Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Musculoskeletal System<br><span class="keyword"> and </span>Soft Tissue. <br><i>New Terms: Exostosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5066</td>
               <td colspan="2">Experience<span class="subclass"> SubClassOf </span>Conceptual Entity. <br><i>New Terms: Experience</i></td>
            </tr>
            <tr class="addition">
               <td>5067</td>
               <td colspan="2">External Ear Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: External Ear Infection Adverse Event Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5068</td>
               <td colspan="2">External Ear Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: External Ear Infection Adverse Event with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5069</td>
               <td colspan="2">External Ear Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: External Ear Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5070</td>
               <td colspan="2">External Ear Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: External Ear Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5071</td>
               <td colspan="2">Extraocular Muscle Weakness Not Due to Neuropathy Adverse Event<span class="subclass"> SubClassOf </span>Generalized<br><span class="keyword"> or </span>Specific Area Muscle Weakness Adverse Event Not Due to Neuropathy. <br><i>New Terms: Extraocular Muscle Weakness Not Due to Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5072</td>
               <td colspan="2">Extrapyramidal<br><span class="keyword"> and </span>Involuntary Movement<br><span class="keyword"> and </span>Restlessness Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Nervous System. <br><i>New Terms: Extrapyramidal and Involuntary Movement and Restlessness Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5073</td>
               <td colspan="2">Extremity Limb Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Extremity Limb Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5074</td>
               <td colspan="2">Eye Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Eye Infection NOS Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5075</td>
               <td colspan="2">Eye Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Eye Infection NOS Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5076</td>
               <td colspan="2">Eye Infection NOS Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Eye Infection NOS Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5077</td>
               <td colspan="2">Eye NOS Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Eye NOS Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5078</td>
               <td colspan="2">Eye Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Eye Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5079</td>
               <td colspan="2">Eyelid Dysfunction Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Ocular<br><span class="keyword"> and </span>Visual Systems. <br><i>New Terms: Eyelid Dysfunction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5080</td>
               <td colspan="2">FEV1 Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Systems. <br><i>New Terms: FEV1 Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5081</td>
               <td colspan="2">Face NOS Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Face NOS Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5082</td>
               <td colspan="2">Face Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Face Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5083</td>
               <td colspan="2">Facial Muscle Weakness Not Due to Neuropathy Adverse Event<span class="subclass"> SubClassOf </span>Generalized<br><span class="keyword"> or </span>Specific Area Muscle Weakness Adverse Event Not Due to Neuropathy. <br><i>New Terms: Facial Muscle Weakness Not Due to Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5084</td>
               <td colspan="2">Fair Tissue Fixation with Definable Architectural Characteristics<span class="subclass"> SubClassOf </span>Morphologic Finding. <br><i>New Terms: Fair Tissue Fixation with Definable Architectural Characteristics</i></td>
            </tr>
            <tr class="addition">
               <td>5085</td>
               <td colspan="2">Fallopian Tube Hemorrhage Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Hemorrhage Adverse Event. <br><i>New Terms: Fallopian Tube Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5086</td>
               <td colspan="2">Fallopian Tube Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Fallopian Tube Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5087</td>
               <td colspan="2">Fallopian Tube Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Fallopian Tube Infection Adverse Event with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5088</td>
               <td colspan="2">Fallopian Tube Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Fallopian Tube Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5089</td>
               <td colspan="2">Fallopian Tube Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Fallopian Tube Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5090</td>
               <td colspan="2">Fallopian Tube Leak Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Leak Adverse Event Including Anastomotic Leak. <br><i>New Terms: Fallopian Tube Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5091</td>
               <td colspan="2">Fallopian Tube Obstruction Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Obstruction Adverse Event. <br><i>New Terms: Fallopian Tube Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5092</td>
               <td colspan="2">Fallopian Tube Perforation Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Perforation Adverse Event. <br><i>New Terms: Fallopian Tube Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5093</td>
               <td colspan="2">Fallopian Tube Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Stricture<br><span class="keyword"> and </span>Stenosis Adverse Event Including Anastomotic Stricture<br><span class="keyword"> and </span>Stenosis. <br><i>New Terms: Fallopian Tube Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5094</td>
               <td colspan="2">Fatigue Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Constitutional Symptoms. <br><i>New Terms: Fatigue Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5095</td>
               <td colspan="2">Febrile Neutropenia without Clinically<br><span class="keyword"> or </span>Microbiologically Documented Infection with Absolute Neutrophil Count Less Than 1
                  X 10e9 per Liter<br><span class="keyword"> and </span>Temperature Greater Than<br><span class="keyword"> or </span>Equal to 38 Point 5 Degrees Celsius<span class="subclass"> SubClassOf </span>Adverse Event Associated with Infection. <br><i>New Terms: Febrile Neutropenia without Clinically or Microbiologically Documented Infection with
                     Absolute Neutrophil Count Less Than 1 X 10e9 per Liter and Temperature Greater Than
                     or Equal to 38 Point 5 Degrees Celsius</i></td>
            </tr>
            <tr class="addition">
               <td>5096</td>
               <td colspan="2">Female Genital Tract Fistula Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Fistula Adverse Event. <br><i>New Terms: Female Genital Tract Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5097</td>
               <td colspan="2">Feminization of Male Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Endocrine System. <br><i>New Terms: Feminization of Male Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5098</td>
               <td colspan="2">Fever Without Neutropenia Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Constitutional Symptoms. <br><i>New Terms: Fever Without Neutropenia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5099</td>
               <td colspan="2">Fibrinogen Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Coagulation. <br><i>New Terms: Fibrinogen Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5100</td>
               <td colspan="2">Fibrosis-Cosmesis Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Musculoskeletal System<br><span class="keyword"> and </span>Soft Tissue. <br><i>New Terms: Fibrosis-Cosmesis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5101</td>
               <td colspan="2">Fibrosis-Deep Connective Tissue Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Musculoskeletal System<br><span class="keyword"> and </span>Soft Tissue. <br><i>New Terms: Fibrosis-Deep Connective Tissue Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5102</td>
               <td colspan="2">Fibrotic Stroma with Finger-Like Projections Present<span class="subclass"> SubClassOf </span>Fibrotic Stroma Formation. <br><i>New Terms: Fibrotic Stroma with Finger-Like Projections Present</i></td>
            </tr>
            <tr class="addition">
               <td>5103</td>
               <td colspan="2">Financial Disclosure Form<span class="subclass"> SubClassOf </span>Form. <br><i>New Terms: Financial Disclosure Form</i></td>
            </tr>
            <tr class="addition">
               <td>5104</td>
               <td colspan="2">Flashing Lights<br><span class="keyword"> and </span>Floaters in Vision Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Ocular<br><span class="keyword"> and </span>Visual Systems. <br><i>New Terms: Flashing Lights and Floaters in Vision Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5105</td>
               <td colspan="2">Flatulence Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Gastrointestinal System. <br><i>New Terms: Flatulence Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5106</td>
               <td colspan="2">Flexural Skin Nevus<span class="subclass"> SubClassOf </span>Melanocytic Nevus. <br><i>New Terms: Flexural Skin Nevus</i></td>
            </tr>
            <tr class="addition">
               <td>5107</td>
               <td colspan="2">Flu-Like Syndrome Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Syndromes. <br><i>New Terms: Flu-Like Syndrome Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5108</td>
               <td colspan="2">Flushing Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Dermatology<br><span class="keyword"> and </span>Skin. <br><i>New Terms: Flushing Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5109</td>
               <td colspan="2">Foley Catheter<span class="subclass"> SubClassOf </span>Indwelling Catheter. <br><i>New Terms: Foley Catheter, Indwelling Catheter</i></td>
            </tr>
            <tr class="addition">
               <td>5110</td>
               <td colspan="2">Foreign Body Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Foreign Body Infection Adverse Event Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5111</td>
               <td colspan="2">Foreign Body Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Foreign Body Infection Adverse Event with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5112</td>
               <td colspan="2">Foreign Body Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Foreign Body Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5113</td>
               <td colspan="2">Form FDA 1572<span class="subclass"> SubClassOf </span>Form. <br><i>New Terms: Form FDA 1572</i></td>
            </tr>
            <tr class="addition">
               <td>5114</td>
               <td colspan="2">Fracture Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Musculoskeletal System<br><span class="keyword"> and </span>Soft Tissue. <br><i>New Terms: Fracture Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5115</td>
               <td colspan="2">GPX1 Gene<span class="subclass"> SubClassOf </span>Gene_Associated_With_Disease<span class="some"> some </span>Non-Insulin Dependent Diabetes Mellitus. <br><i>New Terms: GPX1 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>5116</td>
               <td colspan="2">GPX1 Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Detoxification. <br><i>New Terms: GPX1 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>5117</td>
               <td colspan="2">GPX1 Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Oxidative Stress. <br><i>New Terms: GPX1 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>5118</td>
               <td colspan="2">GPX1 Gene<span class="subclass"> SubClassOf </span>Oxidoreductase Gene. <br><i>New Terms: GPX1 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>5119</td>
               <td colspan="2">GPX1 wt Allele<span class="subclass"> SubClassOf </span>GPX1 Gene. <br><i>New Terms: GPX1 Gene, GPX1 wt Allele</i></td>
            </tr>
            <tr class="addition">
               <td>5120</td>
               <td colspan="2">GPX1 wt Allele<span class="subclass"> SubClassOf </span>Gene_Found_In_Organism<span class="some"> some </span>Human. <br><i>New Terms: GPX1 wt Allele</i></td>
            </tr>
            <tr class="addition">
               <td>5121</td>
               <td colspan="2">GPX1 wt Allele<span class="subclass"> SubClassOf </span>Gene_In_Chromosomal_Location<span class="some"> some </span>3p21.3. <br><i>New Terms: GPX1 wt Allele</i></td>
            </tr>
            <tr class="addition">
               <td>5122</td>
               <td colspan="2">GPX1 wt Allele<span class="subclass"> SubClassOf </span>Gene_Is_Element_In_Pathway<span class="some"> some </span>Amyotrophic Lateral Sclerosis Pathway. <br><i>New Terms: GPX1 wt Allele</i></td>
            </tr>
            <tr class="addition">
               <td>5123</td>
               <td colspan="2">GPX1 wt Allele<span class="subclass"> SubClassOf </span>Gene_Is_Element_In_Pathway<span class="some"> some </span>Arachidonic Acid Metabolism Pathway. <br><i>New Terms: Arachidonic Acid Metabolism Pathway, GPX1 wt Allele</i></td>
            </tr>
            <tr class="addition">
               <td>5124</td>
               <td colspan="2">GPX1 wt Allele<span class="subclass"> SubClassOf </span>Gene_Is_Element_In_Pathway<span class="some"> some </span>Glutathione Metabolism Pathway. <br><i>New Terms: GPX1 wt Allele</i></td>
            </tr>
            <tr class="addition">
               <td>5125</td>
               <td colspan="2">Gallbladder Fistula Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Fistula Adverse Event. <br><i>New Terms: Gallbladder Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5126</td>
               <td colspan="2">Gallbladder Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Gallbladder Infection Adverse Event Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5127</td>
               <td colspan="2">Gallbladder Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Gallbladder Infection Adverse Event with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5128</td>
               <td colspan="2">Gallbladder Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Gallbladder Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5129</td>
               <td colspan="2">Gallbladder Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Gallbladder Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5130</td>
               <td colspan="2">Gallbladder Necrosis Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Necrosis Adverse Event. <br><i>New Terms: Gallbladder Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5131</td>
               <td colspan="2">Gallbladder Obstruction Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Obstruction Adverse Event. <br><i>New Terms: Gallbladder Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5132</td>
               <td colspan="2">Gallbladder Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Gallbladder Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5133</td>
               <td colspan="2">Gallbladder Perforation Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Perforation Adverse Event. <br><i>New Terms: Gallbladder Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5134</td>
               <td colspan="2">Gamma-Glutamyl Transpeptidase Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Metabolic<br><span class="keyword"> and </span>Laboratory Abnormalities. <br><i>New Terms: Gamma-Glutamyl Transpeptidase Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5135</td>
               <td colspan="2">Gastointestinal Stoma Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Gastointestinal Stoma Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5136</td>
               <td colspan="2">Gastritis Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Gastrointestinal System. <br><i>New Terms: Gastritis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5137</td>
               <td colspan="2">Gastrointestinal Ileus Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Gastrointestinal System. <br><i>New Terms: Gastrointestinal Ileus Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5138</td>
               <td colspan="2">Gastrointestinal Leak Adverse Event NOS<span class="subclass"> SubClassOf </span>Gastrointestinal Leak Adverse Event Including Anastomotic Leak. <br><i>New Terms: Gastrointestinal Leak Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>5139</td>
               <td colspan="2">Gastrointestinal Stoma Hemorrhage Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Hemorrhage Adverse Event. <br><i>New Terms: Gastrointestinal Stoma Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5140</td>
               <td colspan="2">Gastrointestinal Stoma Leak Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Leak Adverse Event Including Anastomotic Leak. <br><i>New Terms: Gastrointestinal Stoma Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5141</td>
               <td colspan="2">Gastrointestinal Stoma Obstruction Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Obstruction Adverse Event. <br><i>New Terms: Gastrointestinal Stoma Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5142</td>
               <td colspan="2">Gene Feature Physical Location<span class="subclass"> SubClassOf </span>Microanatomic Structure. <br><i>New Terms: Gene Feature Physical Location</i></td>
            </tr>
            <tr class="addition">
               <td>5143</td>
               <td colspan="2">Genitourinary Stoma Hemorrhage Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Hemorrhage Adverse Event. <br><i>New Terms: Genitourinary Stoma Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5144</td>
               <td colspan="2">Genitourinary Stoma Leak Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Leak Adverse Event Including Anastomotic Leak. <br><i>New Terms: Genitourinary Stoma Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5145</td>
               <td colspan="2">Genitourinary Stoma Obstruction Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Obstruction Adverse Event. <br><i>New Terms: Genitourinary Stoma Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5146</td>
               <td colspan="2">Genitourinary Stoma Prolapse Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Kidney<br><span class="keyword"> and </span>Genitourinary System. <br><i>New Terms: Genitourinary Stoma Prolapse Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5147</td>
               <td colspan="2">Genitourinary Stoma Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Stricture<br><span class="keyword"> and </span>Stenosis Adverse Event Including Anastomotic Stricture<br><span class="keyword"> and </span>Stenosis. <br><i>New Terms: Genitourinary Stoma Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5148</td>
               <td colspan="2">Gingiva Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Gingiva Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5149</td>
               <td colspan="2">Glaucoma Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Ocular<br><span class="keyword"> and </span>Visual Systems. <br><i>New Terms: Glaucoma Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5150</td>
               <td colspan="2">Glomerular Filtration Rate Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Metabolic<br><span class="keyword"> and </span>Laboratory Abnormalities. <br><i>New Terms: Glomerular Filtration Rate Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5151</td>
               <td colspan="2">Glutathione Peroxidase 1<span class="subclass"> SubClassOf </span>Gene_Product_Encoded_By_Gene<span class="some"> some </span>GPX1 Gene. <br><i>New Terms: GPX1 Gene, Glutathione Peroxidase 1</i></td>
            </tr>
            <tr class="addition">
               <td>5152</td>
               <td colspan="2">Glutathione Peroxidase 1<span class="subclass"> SubClassOf </span>Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Oxidoreductase. <br><i>New Terms: Glutathione Peroxidase 1</i></td>
            </tr>
            <tr class="addition">
               <td>5153</td>
               <td colspan="2">Glutathione Peroxidase 1<span class="subclass"> SubClassOf </span>Gene_Product_Has_Organism_Source<span class="some"> some </span>Human. <br><i>New Terms: Glutathione Peroxidase 1</i></td>
            </tr>
            <tr class="addition">
               <td>5154</td>
               <td colspan="2">Glutathione Peroxidase 1<span class="subclass"> SubClassOf </span>Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>Amyotrophic Lateral Sclerosis Pathway. <br><i>New Terms: Glutathione Peroxidase 1</i></td>
            </tr>
            <tr class="addition">
               <td>5155</td>
               <td colspan="2">Glutathione Peroxidase 1<span class="subclass"> SubClassOf </span>Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>Arachidonic Acid Metabolism Pathway. <br><i>New Terms: Arachidonic Acid Metabolism Pathway, Glutathione Peroxidase 1</i></td>
            </tr>
            <tr class="addition">
               <td>5156</td>
               <td colspan="2">Glutathione Peroxidase 1<span class="subclass"> SubClassOf </span>Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>Glutathione Metabolism Pathway. <br><i>New Terms: Glutathione Peroxidase 1</i></td>
            </tr>
            <tr class="addition">
               <td>5157</td>
               <td colspan="2">Glutathione Peroxidase 1<span class="subclass"> SubClassOf </span>Gene_Product_Malfunction_Associated_With_Disease<span class="some"> some </span>Hemolytic Anemia. <br><i>New Terms: Glutathione Peroxidase 1</i></td>
            </tr>
            <tr class="addition">
               <td>5158</td>
               <td colspan="2">Glutathione Peroxidase 1<span class="subclass"> SubClassOf </span>Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Detoxification. <br><i>New Terms: Glutathione Peroxidase 1</i></td>
            </tr>
            <tr class="addition">
               <td>5159</td>
               <td colspan="2">Glutathione Peroxidase 1<span class="subclass"> SubClassOf </span>Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Oxidative Stress. <br><i>New Terms: Glutathione Peroxidase 1</i></td>
            </tr>
            <tr class="addition">
               <td>5160</td>
               <td colspan="2">Glutathione Peroxidase 1<span class="subclass"> SubClassOf </span>Oxidoreductase. <br><i>New Terms: Glutathione Peroxidase 1</i></td>
            </tr>
            <tr class="addition">
               <td>5161</td>
               <td colspan="2">Good Tissue Fixation with Definable Cellular Details<span class="subclass"> SubClassOf </span>Morphologic Finding. <br><i>New Terms: Good Tissue Fixation with Definable Cellular Details</i></td>
            </tr>
            <tr class="addition">
               <td>930</td>
               <td colspan="2">Grade 1 Pulmonary Artery Intra-Operative Injury<span class="subclass"> SubClassOf </span>Pulmonary Artery Intra-Operative Injury Adverse Event. <br><i>New Terms: Grade 1 Pulmonary Artery Intra-Operative Injury, Pulmonary Artery Intra-Operative
                     Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>1869</td>
               <td colspan="2">Grade 2 Pulmonary Artery Intra-Operative Injury<span class="subclass"> SubClassOf </span>Pulmonary Artery Intra-Operative Injury Adverse Event. <br><i>New Terms: Pulmonary Artery Intra-Operative Injury Adverse Event, Grade 2 Pulmonary Artery Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>2887</td>
               <td colspan="2">Grade 3 Pulmonary Artery Intra-Operative Injury<span class="subclass"> SubClassOf </span>Pulmonary Artery Intra-Operative Injury Adverse Event. <br><i>New Terms: Pulmonary Artery Intra-Operative Injury Adverse Event, Grade 3 Pulmonary Artery Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>3864</td>
               <td colspan="2">Grade 4 Pulmonary Artery Intra-Operative Injury<span class="subclass"> SubClassOf </span>Pulmonary Artery Intra-Operative Injury Adverse Event. <br><i>New Terms: Pulmonary Artery Intra-Operative Injury Adverse Event, Grade 4 Pulmonary Artery Intra-Operative
                     Injury</i></td>
            </tr>
            <tr class="addition">
               <td>5162</td>
               <td colspan="2">Gynecomastia Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Sexual<br><span class="keyword"> and </span>Reproductive Function. <br><i>New Terms: Gynecomastia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5163</td>
               <td colspan="2">HMG-CoA Reductase<span class="subclass"> SubClassOf </span>Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Oxidoreductase. <br><i>New Terms: HMG-CoA Reductase</i></td>
            </tr>
            <tr class="addition">
               <td>5164</td>
               <td colspan="2">HMG-CoA Reductase<span class="subclass"> SubClassOf </span>Gene_Product_Has_Chemical_Classification<span class="some"> some </span>Glycoprotein. <br><i>New Terms: HMG-CoA Reductase</i></td>
            </tr>
            <tr class="addition">
               <td>5165</td>
               <td colspan="2">HMG-CoA Reductase<span class="subclass"> SubClassOf </span>Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>Sterol Biosynthesis Pathway. <br><i>New Terms: HMG-CoA Reductase</i></td>
            </tr>
            <tr class="addition">
               <td>5166</td>
               <td colspan="2">HMG-CoA Reductase<span class="subclass"> SubClassOf </span>Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Cholesterol Homeostasis. <br><i>New Terms: HMG-CoA Reductase</i></td>
            </tr>
            <tr class="addition">
               <td>5167</td>
               <td colspan="2">HMG-CoA Reductase<span class="subclass"> SubClassOf </span>Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Triglyceride Metabolism. <br><i>New Terms: HMG-CoA Reductase</i></td>
            </tr>
            <tr class="addition">
               <td>5168</td>
               <td colspan="2">HMG-CoA Reductase<span class="subclass"> SubClassOf </span>Oxidoreductase. <br><i>New Terms: HMG-CoA Reductase</i></td>
            </tr>
            <tr class="addition">
               <td>5169</td>
               <td colspan="2">Haptoglobin Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Blood<br><span class="keyword"> and </span>Bone Marrow. <br><i>New Terms: Haptoglobin Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5170</td>
               <td colspan="2">Head Soft Tissue Necrosis Adverse Event<span class="subclass"> SubClassOf </span>Soft Tissue Necrosis Adverse Event. <br><i>New Terms: Head Soft Tissue Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5171</td>
               <td colspan="2">Head<br><span class="keyword"> and </span>Headache Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Head and Headache Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5172</td>
               <td colspan="2">Head<br><span class="keyword"> and </span>Neck Nevus<span class="subclass"> SubClassOf </span>Melanocytic Nevus. <br><i>New Terms: Head and Neck Nevus</i></td>
            </tr>
            <tr class="addition">
               <td>5173</td>
               <td colspan="2">Hearing Adverse Event Patients with<br><span class="keyword"> or </span>without Baseline Audiogram<br><span class="keyword"> and </span>Enrolled in a Monitoring Program<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Ear<br><span class="keyword"> and </span>Auditory System. <br><i>New Terms: Hearing Adverse Event Patients with or without Baseline Audiogram and Enrolled in
                     a Monitoring Program</i></td>
            </tr>
            <tr class="addition">
               <td>5174</td>
               <td colspan="2">Hearing Adverse Event Patients without Baseline Audiogram<br><span class="keyword"> and </span>Not Enrolled in a Monitoring Program<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Ear<br><span class="keyword"> and </span>Auditory System. <br><i>New Terms: Hearing Adverse Event Patients without Baseline Audiogram and Not Enrolled in a Monitoring
                     Program</i></td>
            </tr>
            <tr class="addition">
               <td>5175</td>
               <td colspan="2">Heart Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Heart Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5176</td>
               <td colspan="2">Heart Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Heart Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5177</td>
               <td colspan="2">Heart Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Heart Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5178</td>
               <td colspan="2">Heart Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Heart Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5179</td>
               <td colspan="2">Heartburn<br><span class="keyword"> or </span>Dyspepsia<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Gastrointestinal System. <br><i>New Terms: Heartburn or Dyspepsia</i></td>
            </tr>
            <tr class="addition">
               <td>5180</td>
               <td colspan="2">Hematoma Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Hemorrhage<br><span class="keyword"> and </span>Bleeding. <br><i>New Terms: Hematoma Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5181</td>
               <td colspan="2">Hemoglobin Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Blood<br><span class="keyword"> and </span>Bone Marrow. <br><i>New Terms: Hemoglobin Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5182</td>
               <td colspan="2">Hemoglobinuria Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Metabolic<br><span class="keyword"> and </span>Laboratory Abnormalities. <br><i>New Terms: Hemoglobinuria Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5183</td>
               <td colspan="2">Hemolysis Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Blood<br><span class="keyword"> and </span>Bone Marrow. <br><i>New Terms: Hemolysis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5184</td>
               <td colspan="2">Hemorrhage<br><span class="keyword"> and </span>Bleeding Adverse Event Associated with Surgery<span class="subclass"> SubClassOf </span>Adverse Event Associated with Hemorrhage<br><span class="keyword"> and </span>Bleeding. <br><i>New Terms: Hemorrhage and Bleeding Adverse Event Associated with Surgery</i></td>
            </tr>
            <tr class="addition">
               <td>5185</td>
               <td colspan="2">Hemorrhoids Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Gastrointestinal System. <br><i>New Terms: Hemorrhoids Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5186</td>
               <td colspan="2">Hepatic Artery Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Hepatic Artery Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5187</td>
               <td colspan="2">Hepatic Necrosis Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Necrosis Adverse Event. <br><i>New Terms: Hepatic Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5188</td>
               <td colspan="2">Hepatic Vein Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Hepatic Vein Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5189</td>
               <td colspan="2">Hiccoughs Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Systems. <br><i>New Terms: Hiccoughs Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5190</td>
               <td colspan="2">History<span class="subclass"> SubClassOf </span>Conceptual Entity. <br><i>New Terms: History</i></td>
            </tr>
            <tr class="addition">
               <td>5191</td>
               <td colspan="2">Hot Flashes<br><span class="keyword"> or </span>Flushes Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Endocrine System. <br><i>New Terms: Hot Flashes or Flushes Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5192</td>
               <td colspan="2">Hydrocephalus Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Nervous System. <br><i>New Terms: Hydrocephalus Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5193</td>
               <td colspan="2">Hydroxysteroid Dehydrogenase Inhibitor<span class="subclass"> SubClassOf </span>Enzyme Inhibitor. <br><i>New Terms: Hydroxysteroid Dehydrogenase Inhibitor</i></td>
            </tr>
            <tr class="addition">
               <td>5194</td>
               <td colspan="2">Hyperbilirubinemia Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Metabolic<br><span class="keyword"> and </span>Laboratory Abnormalities. <br><i>New Terms: Hyperbilirubinemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5195</td>
               <td colspan="2">Hyperpigmentation Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Dermatology<br><span class="keyword"> and </span>Skin. <br><i>New Terms: Hyperpigmentation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5196</td>
               <td colspan="2">Hypertension Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Heart in General. <br><i>New Terms: Hypertension Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5197</td>
               <td colspan="2">Hypopigmentation Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Dermatology<br><span class="keyword"> and </span>Skin. <br><i>New Terms: Hypopigmentation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5198</td>
               <td colspan="2">Hypotension Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Heart in General. <br><i>New Terms: Hypotension Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5199</td>
               <td colspan="2">Hypothermia Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Constitutional Symptoms. <br><i>New Terms: Hypothermia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5200</td>
               <td colspan="2">Hypoxia Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Systems. <br><i>New Terms: Hypoxia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5201</td>
               <td colspan="2">Idioventricular Rhythm Adverse Event<span class="subclass"> SubClassOf </span>Ventricular Arrhythmia Adverse Event. <br><i>New Terms: Idioventricular Rhythm Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5202</td>
               <td colspan="2">Ileum Fistula Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Fistula Adverse Event. <br><i>New Terms: Ileum Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5203</td>
               <td colspan="2">Ileum Hemorrhage Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Hemorrhage Adverse Event. <br><i>New Terms: Ileum Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5204</td>
               <td colspan="2">Ileum Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Ileum Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5205</td>
               <td colspan="2">Ileum Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Ileum Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5206</td>
               <td colspan="2">Ileum Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Ileum Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5207</td>
               <td colspan="2">Ileum Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Ileum Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5208</td>
               <td colspan="2">Ileum Necrosis Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Necrosis Adverse Event. <br><i>New Terms: Ileum Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5209</td>
               <td colspan="2">Ileum Obstruction Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Obstruction Adverse Event. <br><i>New Terms: Ileum Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5210</td>
               <td colspan="2">Ileum Perforation Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Perforation Adverse Event. <br><i>New Terms: Ileum Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5211</td>
               <td colspan="2">Ileum Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Stricture<br><span class="keyword"> and </span>Stenosis Adverse Event Including Anastomotic Stricture<br><span class="keyword"> and </span>Stenosis. <br><i>New Terms: Ileum Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5212</td>
               <td colspan="2">Ileum Ulcer Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Ulcer Adverse Event. <br><i>New Terms: Ileum Ulcer Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5213</td>
               <td colspan="2">Imprinted Protein<span class="subclass"> SubClassOf </span>Protein. <br><i>New Terms: Imprinted Protein</i></td>
            </tr>
            <tr class="addition">
               <td>5214</td>
               <td colspan="2">Indole Compound<span class="subclass"> SubClassOf </span>Aromatic Compounds. <br><i>New Terms: Indole Compound</i></td>
            </tr>
            <tr class="addition">
               <td>5215</td>
               <td colspan="2">Induration<br><span class="keyword"> or </span>Fibrosis of the Skin<br><span class="keyword"> and </span>Subcutaneous Tissue Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Dermatology<br><span class="keyword"> and </span>Skin. <br><i>New Terms: Induration or Fibrosis of the Skin and Subcutaneous Tissue Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5216</td>
               <td colspan="2">Indwelling Catheter<span class="subclass"> SubClassOf </span>Catheter. <br><i>New Terms: Indwelling Catheter</i></td>
            </tr>
            <tr class="addition">
               <td>5217</td>
               <td colspan="2">Infection Other Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Infection. <br><i>New Terms: Infection Other Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5218</td>
               <td colspan="2">Infectious Colitis Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Infection. <br><i>New Terms: Infectious Colitis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5219</td>
               <td colspan="2">Inferior Vena Cava Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Inferior Vena Cava Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5220</td>
               <td colspan="2">Inferior Vena Cava Vein Injury Adverse Event<span class="subclass"> SubClassOf </span>Vein Injury Adverse Event. <br><i>New Terms: Inferior Vena Cava Vein Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5221</td>
               <td colspan="2">Infertility<br><span class="keyword"> and </span>Sterility Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Sexual<br><span class="keyword"> and </span>Reproductive Function. <br><i>New Terms: Infertility and Sterility Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5222</td>
               <td colspan="2">Injection Site Reaction<br><span class="keyword"> or </span>Extravasation Changes Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Dermatology<br><span class="keyword"> and </span>Skin. <br><i>New Terms: Injection Site Reaction or Extravasation Changes Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5223</td>
               <td colspan="2">Inner Ear Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Inner Ear Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5224</td>
               <td colspan="2">Insomnia Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Constitutional Symptoms. <br><i>New Terms: Insomnia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5225</td>
               <td colspan="2">International Chemical Identifier<span class="subclass"> SubClassOf </span>Identifier. <br><i>New Terms: International Chemical Identifier</i></td>
            </tr>
            <tr class="addition">
               <td>5226</td>
               <td colspan="2">International Normalized Ratio of Prothrombin Time Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Coagulation. <br><i>New Terms: International Normalized Ratio of Prothrombin Time Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5227</td>
               <td colspan="2">Intestine Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Intestine Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5228</td>
               <td colspan="2">Intracanalicular Growth Pattern<span class="subclass"> SubClassOf </span>Morphologic Architectural Pattern. <br><i>New Terms: Intracanalicular Growth Pattern</i></td>
            </tr>
            <tr class="addition">
               <td>5229</td>
               <td colspan="2">Intracytoplasmic<br><span class="keyword"> and </span>Extracytoplasmic Eosinophilic Material Present<span class="subclass"> SubClassOf </span>Abnormal Tissue Present. <br><i>New Terms: Intracytoplasmic and Extracytoplasmic Eosinophilic Material Present</i></td>
            </tr>
            <tr class="addition">
               <td>5230</td>
               <td colspan="2">Iron Overload Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Blood<br><span class="keyword"> and </span>Bone Marrow. <br><i>New Terms: Iron Overload Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5231</td>
               <td colspan="2">Irregular Menses Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Sexual<br><span class="keyword"> and </span>Reproductive Function. <br><i>New Terms: Irregular Menses Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5232</td>
               <td colspan="2">Irritability in Children Less Than 3 Years of Age Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Nervous System. <br><i>New Terms: Irritability in Children Less Than 3 Years of Age Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5233</td>
               <td colspan="2">Isocenter<span class="subclass"> SubClassOf </span>Center. <br><i>New Terms: Isocenter</i></td>
            </tr>
            <tr class="addition">
               <td>5234</td>
               <td colspan="2">Isodose<span class="subclass"> SubClassOf </span>Dose. <br><i>New Terms: Isodose</i></td>
            </tr>
            <tr class="addition">
               <td>5235</td>
               <td colspan="2">Jejunum Fistula Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Fistula Adverse Event. <br><i>New Terms: Jejunum Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5236</td>
               <td colspan="2">Jejunum Hemorrhage Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Hemorrhage Adverse Event. <br><i>New Terms: Jejunum Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5237</td>
               <td colspan="2">Jejunum Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Jejunum Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5238</td>
               <td colspan="2">Jejunum Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Jejunum Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5239</td>
               <td colspan="2">Jejunum Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Jejunum Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5240</td>
               <td colspan="2">Jejunum Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Jejunum Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5241</td>
               <td colspan="2">Jejunum Necrosis Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Necrosis Adverse Event. <br><i>New Terms: Jejunum Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5242</td>
               <td colspan="2">Jejunum Obstruction Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Obstruction Adverse Event. <br><i>New Terms: Jejunum Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5243</td>
               <td colspan="2">Jejunum Perforation Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Perforation Adverse Event. <br><i>New Terms: Jejunum Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5244</td>
               <td colspan="2">Jejunum Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Stricture<br><span class="keyword"> and </span>Stenosis Adverse Event Including Anastomotic Stricture<br><span class="keyword"> and </span>Stenosis. <br><i>New Terms: Jejunum Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5245</td>
               <td colspan="2">Jejunum Ulcer Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Ulcer Adverse Event. <br><i>New Terms: Jejunum Ulcer Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5246</td>
               <td colspan="2">Joint Effusion Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Musculoskeletal System<br><span class="keyword"> and </span>Soft Tissue. <br><i>New Terms: Joint Effusion Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5247</td>
               <td colspan="2">Joint Function Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Musculoskeletal System<br><span class="keyword"> and </span>Soft Tissue. <br><i>New Terms: Joint Function Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5248</td>
               <td colspan="2">Joint Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Joint Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5249</td>
               <td colspan="2">Joint Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Joint Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5250</td>
               <td colspan="2">Joint Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Joint Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5251</td>
               <td colspan="2">Joint Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Joint Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5252</td>
               <td colspan="2">Joint Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Joint Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5253</td>
               <td colspan="2">Jugular Vein Injury Adverse Event<span class="subclass"> SubClassOf </span>Vein Injury Adverse Event. <br><i>New Terms: Jugular Vein Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5254</td>
               <td colspan="2">Jugular Vein Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Jugular Vein Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5255</td>
               <td colspan="2">Keratitis Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Ocular<br><span class="keyword"> and </span>Visual Systems. <br><i>New Terms: Keratitis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5256</td>
               <td colspan="2">Keratotic Basal Cell Carcinoma<span class="subclass"> SubClassOf </span>Skin Basal Cell Carcinoma. <br><i>New Terms: Keratotic Basal Cell Carcinoma</i></td>
            </tr>
            <tr class="addition">
               <td>5257</td>
               <td colspan="2">Kidney Fistula Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Fistula Adverse Event. <br><i>New Terms: Kidney Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5258</td>
               <td colspan="2">Kidney Hemorrhage Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Hemorrhage Adverse Event. <br><i>New Terms: Kidney Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5259</td>
               <td colspan="2">Kidney Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Kidney Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5260</td>
               <td colspan="2">Kidney Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Kidney Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5261</td>
               <td colspan="2">Kidney Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Kidney Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5262</td>
               <td colspan="2">Kidney Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Kidney Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5263</td>
               <td colspan="2">Kidney Leak Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Leak Adverse Event Including Anastomotic Leak. <br><i>New Terms: Kidney Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5264</td>
               <td colspan="2">Kidney Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Kidney Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5265</td>
               <td colspan="2">Kidney Perforation Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Perforation Adverse Event. <br><i>New Terms: Kidney Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5266</td>
               <td colspan="2">Labeling<span class="subclass"> SubClassOf </span>Medical Product Document. <br><i>New Terms: Medical Product Document, Labeling</i></td>
            </tr>
            <tr class="addition">
               <td>5267</td>
               <td colspan="2">Large Bowel Leak Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Leak Adverse Event Including Anastomotic Leak. <br><i>New Terms: Large Bowel Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5268</td>
               <td colspan="2">Large Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Mucositis<br><span class="keyword"> and </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> and </span>Symptomatic Classification. <br><i>New Terms: Large Bowel Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>5269</td>
               <td colspan="2">Large Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Mucositis<br><span class="keyword"> and </span>Stomatitis Adverse Event by Clinical Examination Classification. <br><i>New Terms: Large Bowel Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>5270</td>
               <td colspan="2">Laryngeal Nerve Dysfunction Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Nervous System. <br><i>New Terms: Laryngeal Nerve Dysfunction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5271</td>
               <td colspan="2">Larynx Edema Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Systems. <br><i>New Terms: Larynx Edema Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5272</td>
               <td colspan="2">Larynx Fistula Adverse Event<span class="subclass"> SubClassOf </span>Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Fistula Adverse Event. <br><i>New Terms: Larynx Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5273</td>
               <td colspan="2">Larynx Hemorrhage Adverse Event<span class="subclass"> SubClassOf </span>Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Hemorrhage Adverse Event. <br><i>New Terms: Larynx Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5274</td>
               <td colspan="2">Larynx Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Larynx Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5275</td>
               <td colspan="2">Larynx Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Larynx Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5276</td>
               <td colspan="2">Larynx Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Larynx Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5277</td>
               <td colspan="2">Larynx Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Larynx Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5278</td>
               <td colspan="2">Larynx Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Mucositis<br><span class="keyword"> and </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> and </span>Symptomatic Classification. <br><i>New Terms: Larynx Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>5279</td>
               <td colspan="2">Larynx Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Mucositis<br><span class="keyword"> and </span>Stomatitis Adverse Event by Clinical Examination Classification. <br><i>New Terms: Larynx Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>5280</td>
               <td colspan="2">Larynx Obstruction<br><span class="keyword"> and </span>Stenosis Adverse Event<span class="subclass"> SubClassOf </span>Airway Obstruction<br><span class="keyword"> and </span>Stenosis Adverse Event. <br><i>New Terms: Larynx Obstruction and Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5281</td>
               <td colspan="2">Larynx Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Larynx Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5283</td>
               <td colspan="2">Left Ventricular Diastolic Dysfunction Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Heart in General. <br><i>New Terms: Left Ventricular Diastolic Dysfunction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5284</td>
               <td colspan="2">Left Ventricular Systolic Dysfunction Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Heart in General. <br><i>New Terms: Left Ventricular Systolic Dysfunction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5282</td>
               <td colspan="2">Left-Sided Muscle Weakness Not Due to Neuropathy Adverse Event<span class="subclass"> SubClassOf </span>Generalized<br><span class="keyword"> or </span>Specific Area Muscle Weakness Adverse Event Not Due to Neuropathy. <br><i>New Terms: Left-Sided Muscle Weakness Not Due to Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5285</td>
               <td colspan="2">Lens Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Lens Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5286</td>
               <td colspan="2">Lens Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Lens Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or 2
                     Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5287</td>
               <td colspan="2">Lens Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Lens Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5288</td>
               <td colspan="2">Lens Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Lens Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5289</td>
               <td colspan="2">Lepidic Growth Pattern<span class="subclass"> SubClassOf </span>Morphologic Architectural Pattern. <br><i>New Terms: Lepidic Growth Pattern</i></td>
            </tr>
            <tr class="addition">
               <td>5290</td>
               <td colspan="2">Less than 2 Mitoses per 10HPF<span class="subclass"> SubClassOf </span>Mitotic Activity. <br><i>New Terms: Less than 2 Mitoses per 10HPF</i></td>
            </tr>
            <tr class="addition">
               <td>5291</td>
               <td colspan="2">Leukocytes Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Blood<br><span class="keyword"> and </span>Bone Marrow. <br><i>New Terms: Leukocytes Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5292</td>
               <td colspan="2">Leukoencephalopathy Radiographic Findings Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Nervous System. <br><i>New Terms: Leukoencephalopathy Radiographic Findings Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5293</td>
               <td colspan="2">Libido Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Sexual<br><span class="keyword"> and </span>Reproductive Function. <br><i>New Terms: Libido Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5294</td>
               <td colspan="2">Ligament Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Ligament Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5295</td>
               <td colspan="2">Lingual Nerve Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Lingual Nerve Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5296</td>
               <td colspan="2">Lip Or Perioral Area Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Lip Or Perioral Area Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5297</td>
               <td colspan="2">Lip Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Lip Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5298</td>
               <td colspan="2">Lip<br><span class="keyword"> or </span>Perioral Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Lip or Perioral Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5299</td>
               <td colspan="2">Lip<br><span class="keyword"> or </span>Perioral Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Lip or Perioral Infection Adverse Event with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5300</td>
               <td colspan="2">Lip<br><span class="keyword"> or </span>Perioral Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Lip or Perioral Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5301</td>
               <td colspan="2">Lipase Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Metabolic<br><span class="keyword"> and </span>Laboratory Abnormalities. <br><i>New Terms: Lipase Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5302</td>
               <td colspan="2">Liver Dysfunction<br><span class="keyword"> or </span>Failure by Clinical Classification Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Hepatobiliary System<br><span class="keyword"> and </span>Pancreas. <br><i>New Terms: Liver Dysfunction or Failure by Clinical Classification Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5303</td>
               <td colspan="2">Liver Hemorrhage Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Hemorrhage Adverse Event. <br><i>New Terms: Liver Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5304</td>
               <td colspan="2">Liver Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Liver Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5305</td>
               <td colspan="2">Liver Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Liver Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5306</td>
               <td colspan="2">Liver Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Liver Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5307</td>
               <td colspan="2">Liver Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Liver Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5308</td>
               <td colspan="2">Liver Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Liver Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5309</td>
               <td colspan="2">Local Complication of Device<br><span class="keyword"> and </span>Prosthesis Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Musculoskeletal System<br><span class="keyword"> and </span>Soft Tissue. <br><i>New Terms: Local Complication of Device and Prosthesis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5311</td>
               <td colspan="2">Low Serum Bicarbonate Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Metabolic<br><span class="keyword"> and </span>Laboratory Abnormalities. <br><i>New Terms: Low Serum Bicarbonate Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5310</td>
               <td colspan="2">Low<span class="subclass"> SubClassOf </span>General Qualifier. <br><i>New Terms: Low</i></td>
            </tr>
            <tr class="addition">
               <td>5312</td>
               <td colspan="2">Lower Extremity Artery Injury Adverse Event<span class="subclass"> SubClassOf </span>Artery Injury Adverse Event. <br><i>New Terms: Lower Extremity Artery Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5313</td>
               <td colspan="2">Lower Extremity Artery Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Lower Extremity Artery Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5314</td>
               <td colspan="2">Lower Extremity Gait Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Musculoskeletal System<br><span class="keyword"> and </span>Soft Tissue. <br><i>New Terms: Lower Extremity Gait Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5315</td>
               <td colspan="2">Lower Extremity Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Lower Extremity Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5316</td>
               <td colspan="2">Lower Extremity Muscle Weakness Adverse Event Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Generalized<br><span class="keyword"> or </span>Specific Area Muscle Weakness Adverse Event Not Due to Neuropathy. <br><i>New Terms: Lower Extremity Muscle Weakness Adverse Event Not Due to Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>5317</td>
               <td colspan="2">Lower Extremity Soft Tissue Necrosis Adverse Event<span class="subclass"> SubClassOf </span>Soft Tissue Necrosis Adverse Event. <br><i>New Terms: Lower Extremity Soft Tissue Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5318</td>
               <td colspan="2">Lower Extremity Vein Injury Adverse Event<span class="subclass"> SubClassOf </span>Vein Injury Adverse Event. <br><i>New Terms: Lower Extremity Vein Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5319</td>
               <td colspan="2">Lower Extremity Vein Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Lower Extremity Vein Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5320</td>
               <td colspan="2">Lower Gastrointestinal Hemorrhage Adverse Event NOS<span class="subclass"> SubClassOf </span>Gastrointestinal Hemorrhage Adverse Event. <br><i>New Terms: Lower Gastrointestinal Hemorrhage Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>5321</td>
               <td colspan="2">Lumbar Spine<span class="subclass"> Range </span>of Motion Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Musculoskeletal System<br><span class="keyword"> and </span>Soft Tissue. <br><i>New Terms: Lumbar Spine Range of Motion Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5322</td>
               <td colspan="2">Lung Fistula Adverse Event<span class="subclass"> SubClassOf </span>Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Fistula Adverse Event. <br><i>New Terms: Lung Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5323</td>
               <td colspan="2">Lung Hemorrhage Adverse Event<span class="subclass"> SubClassOf </span>Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Hemorrhage Adverse Event. <br><i>New Terms: Lung Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5324</td>
               <td colspan="2">Lung Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Lung Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5325</td>
               <td colspan="2">Lung Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Lung Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or 2
                     Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5326</td>
               <td colspan="2">Lung Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Lung Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5327</td>
               <td colspan="2">Lung Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Lung Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5328</td>
               <td colspan="2">Lung Thoracic Nerve Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Lung Thoracic Nerve Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5329</td>
               <td colspan="2">Lymph Node Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Lymph Node Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5330</td>
               <td colspan="2">Lymphatic Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Lymphatic Infection Adverse Event Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5331</td>
               <td colspan="2">Lymphatic Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Lymphatic Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5332</td>
               <td colspan="2">Lymphatic Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Lymphatic Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5333</td>
               <td colspan="2">Lymphedema-Related Fibrosis Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Lymphatic System. <br><i>New Terms: Lymphedema-Related Fibrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5334</td>
               <td colspan="2">Lymphocele Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Lymphatic System. <br><i>New Terms: Lymphocele Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5335</td>
               <td colspan="2">Lymphopenia Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Blood<br><span class="keyword"> and </span>Bone Marrow. <br><i>New Terms: Lymphopenia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5336</td>
               <td colspan="2">Major Visceral Artery Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Major Visceral Artery Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5337</td>
               <td colspan="2">Major Visceral Vein Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Major Visceral Vein Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5338</td>
               <td colspan="2">Malabsorption Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Gastrointestinal System. <br><i>New Terms: Malabsorption Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5339</td>
               <td colspan="2">Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present<span class="subclass"> SubClassOf </span>Abnormal Cells Present. <br><i>New Terms: Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present</i></td>
            </tr>
            <tr class="addition">
               <td>5340</td>
               <td colspan="2">Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present<span class="subclass"> SubClassOf </span>Abnormal Cells Present. <br><i>New Terms: Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present</i></td>
            </tr>
            <tr class="addition">
               <td>5341</td>
               <td colspan="2">Malignant Sebaceous Cell<span class="subclass"> SubClassOf </span>Retired Concept. <br><i>New Terms: Malignant Sebaceous Cell</i></td>
            </tr>
            <tr class="addition">
               <td>5342</td>
               <td colspan="2">Malignant Spindle Transitional Cell<span class="subclass"> SubClassOf </span>Malignant Epithelial Spindle Cell. <br><i>New Terms: Malignant Spindle Transitional Cell</i></td>
            </tr>
            <tr class="addition">
               <td>5343</td>
               <td colspan="2">Malignant Spindle Transitional Cell<span class="subclass"> SubClassOf </span>Malignant Transitional Cell. <br><i>New Terms: Malignant Spindle Transitional Cell</i></td>
            </tr>
            <tr class="addition">
               <td>5344</td>
               <td colspan="2">Market Withdrawal<span class="subclass"> SubClassOf </span>Remedial Action. <br><i>New Terms: Market Withdrawal</i></td>
            </tr>
            <tr class="addition">
               <td>5345</td>
               <td colspan="2">Masculinization of Female Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Endocrine System. <br><i>New Terms: Masculinization of Female Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5346</td>
               <td colspan="2">Mechanism of Action<span class="subclass"> SubClassOf </span>Activity. <br><i>New Terms: Mechanism of Action</i></td>
            </tr>
            <tr class="addition">
               <td>5347</td>
               <td colspan="2">Mediastinum Hemorrhage Adverse Event<span class="subclass"> SubClassOf </span>Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Hemorrhage Adverse Event. <br><i>New Terms: Mediastinum Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5348</td>
               <td colspan="2">Mediastinum Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Mediastinum Infection NOS Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5349</td>
               <td colspan="2">Mediastinum Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Mediastinum Infection NOS Adverse Event with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5350</td>
               <td colspan="2">Mediastinum Infection NOS Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Mediastinum Infection NOS Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5351</td>
               <td colspan="2">Mediastinum Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Mediastinum Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5352</td>
               <td colspan="2">Medical Device By Usage Mode<span class="subclass"> SubClassOf </span>Medical Device. <br><i>New Terms: Medical Device By Usage Mode</i></td>
            </tr>
            <tr class="addition">
               <td>5354</td>
               <td colspan="2">Medical Product Document<span class="subclass"> SubClassOf </span>Document. <br><i>New Terms: Medical Product Document</i></td>
            </tr>
            <tr class="addition">
               <td>5355</td>
               <td colspan="2">Medical Product Intent Of Use<span class="subclass"> SubClassOf </span>Medical Product Usage And Evaluation. <br><i>New Terms: Medical Product Intent Of Use</i></td>
            </tr>
            <tr class="addition">
               <td>5356</td>
               <td colspan="2">Mega<span class="subclass"> SubClassOf </span>Numerical Qualifier. <br><i>New Terms: Mega, Numerical Qualifier</i></td>
            </tr>
            <tr class="addition">
               <td>5357</td>
               <td colspan="2">Melancholic Depression<span class="subclass"> SubClassOf </span>Depression. <br><i>New Terms: Melancholic Depression</i></td>
            </tr>
            <tr class="addition">
               <td>5358</td>
               <td colspan="2">Melanoma Cells Present<span class="subclass"> SubClassOf </span>Abnormal Cells Present. <br><i>New Terms: Melanoma Cells Present</i></td>
            </tr>
            <tr class="addition">
               <td>5359</td>
               <td colspan="2">Memory Impairment Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Nervous System. <br><i>New Terms: Memory Impairment Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5360</td>
               <td colspan="2">Meninges Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Meninges Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5361</td>
               <td colspan="2">Meninges Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Meninges Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5362</td>
               <td colspan="2">Meninges Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Meninges Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5363</td>
               <td colspan="2">Meninges Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Meninges Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5364</td>
               <td colspan="2">Mental Status Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Nervous System. <br><i>New Terms: Mental Status Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5365</td>
               <td colspan="2">Mesenchymal Metaplasia<span class="subclass"> SubClassOf </span>Metaplasia. <br><i>New Terms: Mesenchymal Metaplasia</i></td>
            </tr>
            <tr class="addition">
               <td>5366</td>
               <td colspan="2">Metabolic<br><span class="keyword"> or </span>Respiratory Acidosis Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Metabolic<br><span class="keyword"> and </span>Laboratory Abnormalities. <br><i>New Terms: Metabolic or Respiratory Acidosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5367</td>
               <td colspan="2">Metabolic<br><span class="keyword"> or </span>Respiratory Alkalosis Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Metabolic<br><span class="keyword"> and </span>Laboratory Abnormalities. <br><i>New Terms: Metabolic or Respiratory Alkalosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5368</td>
               <td colspan="2">Metastasis Protein<span class="subclass"> SubClassOf </span>Gene_Product_Encoded_By_Gene<span class="some"> some </span>Metastasis Gene. <br><i>New Terms: Metastasis Protein</i></td>
            </tr>
            <tr class="addition">
               <td>5369</td>
               <td colspan="2">Metastasis Protein<span class="subclass"> SubClassOf </span>Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Metastasis Induction. <br><i>New Terms: Metastasis Protein</i></td>
            </tr>
            <tr class="addition">
               <td>5370</td>
               <td colspan="2">Metastasis Protein<span class="subclass"> SubClassOf </span>Protein, Organized by Function. <br><i>New Terms: Metastasis Protein</i></td>
            </tr>
            <tr class="addition">
               <td>5371</td>
               <td colspan="2">Middle Ear Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Middle Ear Infection Adverse Event Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5372</td>
               <td colspan="2">Middle Ear Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Middle Ear Infection Adverse Event with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5373</td>
               <td colspan="2">Middle Ear Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Middle Ear Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5374</td>
               <td colspan="2">Middle Ear Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Middle Ear Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5375</td>
               <td colspan="2">Middle Ear Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Middle Ear Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5376</td>
               <td colspan="2">More than 10 Mitoses per 10HPF<span class="subclass"> SubClassOf </span>Mitotic Activity. <br><i>New Terms: More than 10 Mitoses per 10HPF</i></td>
            </tr>
            <tr class="addition">
               <td>5377</td>
               <td colspan="2">Motor Neuropathy Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Nervous System. <br><i>New Terms: Motor Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5378</td>
               <td colspan="2">Mucin-Producing Tall Columnar Adenocarcinoma Cell<span class="subclass"> SubClassOf </span>Mucin-Producing Adenocarcinoma Cell. <br><i>New Terms: Mucin-Producing Tall Columnar Adenocarcinoma Cell</i></td>
            </tr>
            <tr class="addition">
               <td>5379</td>
               <td colspan="2">Mucosa Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Mucosa Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5380</td>
               <td colspan="2">Mucosa Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Mucosa Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5381</td>
               <td colspan="2">Mucosa Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Mucosa Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5382</td>
               <td colspan="2">Multidimensional Fatigue Inventory<span class="subclass"> SubClassOf </span>Symptom Specific Assessment Tool. <br><i>New Terms: Multidimensional Fatigue Inventory</i></td>
            </tr>
            <tr class="addition">
               <td>5383</td>
               <td colspan="2">Muscle Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Muscle Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5384</td>
               <td colspan="2">Muscle Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Muscle Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5385</td>
               <td colspan="2">Muscle Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Muscle Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5386</td>
               <td colspan="2">Muscle Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Muscle Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5387</td>
               <td colspan="2">Muscle Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Muscle Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5388</td>
               <td colspan="2">Muscular<br><span class="keyword"> and </span>Skeletal Hypoplasia Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Musculoskeletal System<br><span class="keyword"> and </span>Soft Tissue. <br><i>New Terms: Muscular and Skeletal Hypoplasia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5389</td>
               <td colspan="2">Myelitis Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Nervous System. <br><i>New Terms: Myelitis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5390</td>
               <td colspan="2">Myelodysplasia Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Blood<br><span class="keyword"> and </span>Bone Marrow. <br><i>New Terms: Myelodysplasia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5391</td>
               <td colspan="2">Myocarditis Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Heart in General. <br><i>New Terms: Myocarditis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5392</td>
               <td colspan="2">Myositis Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Musculoskeletal System<br><span class="keyword"> and </span>Soft Tissue. <br><i>New Terms: Myositis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5393</td>
               <td colspan="2">Nail Changes Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Dermatology<br><span class="keyword"> and </span>Skin. <br><i>New Terms: Nail Changes Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5394</td>
               <td colspan="2">Nails Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Nails Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5395</td>
               <td colspan="2">Nano<span class="subclass"> SubClassOf </span>Numerical Qualifier. <br><i>New Terms: Nano, Numerical Qualifier</i></td>
            </tr>
            <tr class="addition">
               <td>5396</td>
               <td colspan="2">Naphthalene Compound<span class="subclass"> SubClassOf </span>Aromatic Hydrocarbon. <br><i>New Terms: Naphthalene Compound</i></td>
            </tr>
            <tr class="addition">
               <td>5397</td>
               <td colspan="2">Nasal Cavity Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Nasal Cavity Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5398</td>
               <td colspan="2">Nasal Cavity<br><span class="keyword"> and </span>Paranasal Sinus Reactions Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Systems. <br><i>New Terms: Nasal Cavity and Paranasal Sinus Reactions Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5399</td>
               <td colspan="2">Nasopharynx Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Nasopharynx Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5400</td>
               <td colspan="2">National Provider Identifier<span class="subclass"> SubClassOf </span>Identifier. <br><i>New Terms: National Provider Identifier</i></td>
            </tr>
            <tr class="addition">
               <td>5401</td>
               <td colspan="2">Nausea Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Gastrointestinal System. <br><i>New Terms: Nausea Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5402</td>
               <td colspan="2">Neck Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Neck Infection NOS Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5403</td>
               <td colspan="2">Neck Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Neck Infection NOS Adverse Event with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5404</td>
               <td colspan="2">Neck Infection NOS Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Neck Infection NOS Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5405</td>
               <td colspan="2">Neck NOS Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Neck NOS Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5406</td>
               <td colspan="2">Neck Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Neck Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5407</td>
               <td colspan="2">Neck Soft Tissue Necrosis Adverse Event<span class="subclass"> SubClassOf </span>Soft Tissue Necrosis Adverse Event. <br><i>New Terms: Neck Soft Tissue Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5408</td>
               <td colspan="2">Neoplastic Syndrome<span class="subclass"> SubClassOf </span>Syndrome. <br><i>New Terms: Neoplastic Syndrome</i></td>
            </tr>
            <tr class="addition">
               <td>5409</td>
               <td colspan="2">Neuralgia<br><span class="keyword"> and </span>Peripheral Nerve Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Neuralgia and Peripheral Nerve Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5410</td>
               <td colspan="2">Neuroendocrine ACTH Deficiency Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Endocrine System. <br><i>New Terms: Neuroendocrine ACTH Deficiency Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5411</td>
               <td colspan="2">Neuroendocrine ADH Secretion Abnormality Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Endocrine System. <br><i>New Terms: Neuroendocrine ADH Secretion Abnormality Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5412</td>
               <td colspan="2">Neuroendocrine Gonadotropin Secretion Abnormality Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Endocrine System. <br><i>New Terms: Neuroendocrine Gonadotropin Secretion Abnormality Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5413</td>
               <td colspan="2">Neuroendocrine Growth Hormone Secretion Abnormality Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Endocrine System. <br><i>New Terms: Neuroendocrine Growth Hormone Secretion Abnormality Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5414</td>
               <td colspan="2">Neuroendocrine Prolactin Hormone Secretion Abnormality Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Endocrine System. <br><i>New Terms: Neuroendocrine Prolactin Hormone Secretion Abnormality Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5415</td>
               <td colspan="2">Neutrophils<br><span class="keyword"> and </span>Granulocytes Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Blood<br><span class="keyword"> and </span>Bone Marrow. <br><i>New Terms: Neutrophils and Granulocytes Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5416</td>
               <td colspan="2">Nevoid Melanoma<span class="subclass"> SubClassOf </span>Cutaneous Melanoma. <br><i>New Terms: Nevoid Melanoma</i></td>
            </tr>
            <tr class="addition">
               <td>5417</td>
               <td colspan="2">New Diagnosis<span class="subclass"> SubClassOf </span>Established Diagnosis. <br><i>New Terms: New Diagnosis</i></td>
            </tr>
            <tr class="addition">
               <td>5418</td>
               <td colspan="2">Nodal<br><span class="keyword"> or </span>Junctional Rhythm Adverse Event<span class="subclass"> SubClassOf </span>Supraventricular<br><span class="keyword"> and </span>Nodal Arrhythmia Adverse Event. <br><i>New Terms: Nodal or Junctional Rhythm Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5419</td>
               <td colspan="2">Non-Fatal Cardiopulmonary Arrest Adverse Event Cause Unknown<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Heart in General. <br><i>New Terms: Non-Fatal Cardiopulmonary Arrest Adverse Event Cause Unknown</i></td>
            </tr>
            <tr class="addition">
               <td>5420</td>
               <td colspan="2">Non-Infectious Vaginal Discharge Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Sexual<br><span class="keyword"> and </span>Reproductive Function. <br><i>New Terms: Non-Infectious Vaginal Discharge Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5421</td>
               <td colspan="2">Non-Infectious Wound Complication Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Dermatology<br><span class="keyword"> and </span>Skin. <br><i>New Terms: Non-Infectious Wound Complication Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5422</td>
               <td colspan="2">Non-Malignant Ascites Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Gastrointestinal System. <br><i>New Terms: Non-Malignant Ascites Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5423</td>
               <td colspan="2">Non-Malignant Pericardial Effusion Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Heart in General. <br><i>New Terms: Non-Malignant Pericardial Effusion Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5424</td>
               <td colspan="2">Non-Malignant Pleural Effusion Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Systems. <br><i>New Terms: Non-Malignant Pleural Effusion Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5425</td>
               <td colspan="2">Non-Myocardial Visceral Arterial Ischemia Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Vascular System. <br><i>New Terms: Non-Myocardial Visceral Arterial Ischemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5426</td>
               <td colspan="2">Non-Septic Arthritis Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Musculoskeletal System<br><span class="keyword"> and </span>Soft Tissue. <br><i>New Terms: Non-Septic Arthritis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5427</td>
               <td colspan="2">Nose Hemorrhage Adverse Event<span class="subclass"> SubClassOf </span>Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Hemorrhage Adverse Event. <br><i>New Terms: Nose Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5428</td>
               <td colspan="2">Nose Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Nose Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5429</td>
               <td colspan="2">Nose Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Nose Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or 2
                     Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5430</td>
               <td colspan="2">Nose Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Nose Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5431</td>
               <td colspan="2">Nose Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Nose Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5432</td>
               <td colspan="2">Nuclear Molding<span class="subclass"> SubClassOf </span>Morphologic Finding. <br><i>New Terms: Nuclear Molding</i></td>
            </tr>
            <tr class="addition">
               <td>5433</td>
               <td colspan="2">Numeric Country Code<span class="subclass"> SubClassOf </span>Country Code. <br><i>New Terms: Numeric Country Code</i></td>
            </tr>
            <tr class="addition">
               <td>5434</td>
               <td colspan="2">Numerical Qualifier<span class="subclass"> SubClassOf </span>Qualifier. <br><i>New Terms: Numerical Qualifier</i></td>
            </tr>
            <tr class="addition">
               <td>5435</td>
               <td colspan="2">Nyctalopia Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Ocular<br><span class="keyword"> and </span>Visual Systems. <br><i>New Terms: Nyctalopia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5436</td>
               <td colspan="2">Nystagmus Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Ocular<br><span class="keyword"> and </span>Visual Systems. <br><i>New Terms: Nystagmus Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5437</td>
               <td colspan="2">Obesity Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Constitutional Symptoms. <br><i>New Terms: Obesity Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5438</td>
               <td colspan="2">Ocular Muscle Weakness Not Due to Neuropathy Adverse Event<span class="subclass"> SubClassOf </span>Generalized<br><span class="keyword"> or </span>Specific Area Muscle Weakness Adverse Event Not Due to Neuropathy. <br><i>New Terms: Ocular Muscle Weakness Not Due to Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5439</td>
               <td colspan="2">Ocular Surface Disease Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Ocular<br><span class="keyword"> and </span>Visual Systems. <br><i>New Terms: Ocular Surface Disease Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5440</td>
               <td colspan="2">Operative<span class="subclass"> SubClassOf </span>Temporal Qualifier. <br><i>New Terms: Operative</i></td>
            </tr>
            <tr class="addition">
               <td>5441</td>
               <td colspan="2">Ophthalmoplegia<br><span class="keyword"> and </span>Diplopia Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Ocular<br><span class="keyword"> and </span>Visual Systems. <br><i>New Terms: Ophthalmoplegia and Diplopia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5442</td>
               <td colspan="2">Opportunistic Infection Adverse Event Associated with Grade 2<br><span class="keyword"> or </span>Greater Lymphopenia<span class="subclass"> SubClassOf </span>Adverse Event Associated with Infection. <br><i>New Terms: Opportunistic Infection Adverse Event Associated with Grade 2 or Greater Lymphopenia</i></td>
            </tr>
            <tr class="addition">
               <td>5443</td>
               <td colspan="2">Optic Disc Edema Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Ocular<br><span class="keyword"> and </span>Visual Systems. <br><i>New Terms: Optic Disc Edema Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5444</td>
               <td colspan="2">Oral Cavity Adverse Event Hemorrhage<span class="subclass"> SubClassOf </span>Gastrointestinal Hemorrhage Adverse Event. <br><i>New Terms: Oral Cavity Adverse Event Hemorrhage</i></td>
            </tr>
            <tr class="addition">
               <td>5445</td>
               <td colspan="2">Oral Cavity GI Fistula Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Fistula Adverse Event. <br><i>New Terms: Oral Cavity GI Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5446</td>
               <td colspan="2">Oral Cavity Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Mucositis<br><span class="keyword"> and </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> and </span>Symptomatic Classification. <br><i>New Terms: Oral Cavity Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>5447</td>
               <td colspan="2">Oral Cavity Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Mucositis<br><span class="keyword"> and </span>Stomatitis Adverse Event by Clinical Examination Classification. <br><i>New Terms: Oral Cavity Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>5448</td>
               <td colspan="2">Oral Cavity NOS Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Oral Cavity NOS Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5449</td>
               <td colspan="2">Oral Cavity Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Oral Cavity Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5450</td>
               <td colspan="2">Oral Cavity Pulmonary Fistula Adverse Event<span class="subclass"> SubClassOf </span>Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Fistula Adverse Event. <br><i>New Terms: Oral Cavity Pulmonary Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5451</td>
               <td colspan="2">Oral Cavity<br><span class="keyword"> or </span>Gum Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Oral Cavity or Gum Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5452</td>
               <td colspan="2">Oral Cavity<br><span class="keyword"> or </span>Gum Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Oral Cavity or Gum Infection Adverse Event with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5453</td>
               <td colspan="2">Oral Cavity<br><span class="keyword"> or </span>Gum Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Oral Cavity or Gum Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5454</td>
               <td colspan="2">Oral Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Oral Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5455</td>
               <td colspan="2">Oral Necrosis Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Necrosis Adverse Event. <br><i>New Terms: Oral Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5456</td>
               <td colspan="2">Oral Pain of the Gums Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Oral Pain of the Gums Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5457</td>
               <td colspan="2">Order<span class="subclass"> SubClassOf </span>Document. <br><i>New Terms: Order</i></td>
            </tr>
            <tr class="addition">
               <td>5458</td>
               <td colspan="2">Ordering Designee<span class="subclass"> SubClassOf </span>Research Personnel. <br><i>New Terms: Ordering Designee</i></td>
            </tr>
            <tr class="addition">
               <td>5459</td>
               <td colspan="2">Orgasmic Dysfunction Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Sexual<br><span class="keyword"> and </span>Reproductive Function. <br><i>New Terms: Orgasmic Dysfunction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5460</td>
               <td colspan="2">Original Device<span class="subclass"> SubClassOf </span>Device Labeled for Single Use. <br><i>New Terms: Original Device</i></td>
            </tr>
            <tr class="addition">
               <td>5461</td>
               <td colspan="2">Osteoporosis Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Musculoskeletal System<br><span class="keyword"> and </span>Soft Tissue. <br><i>New Terms: Osteoporosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5462</td>
               <td colspan="2">Other Adverse Event Associated with the Heart in General<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Heart in General. <br><i>New Terms: Other Adverse Event Associated with the Heart in General</i></td>
            </tr>
            <tr class="addition">
               <td>5463</td>
               <td colspan="2">Other Allergy<br><span class="keyword"> and </span>Immunology Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Allergy<br><span class="keyword"> and </span>Immunology. <br><i>New Terms: Other Allergy and Immunology Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5464</td>
               <td colspan="2">Other Auditory<br><span class="keyword"> and </span>Ear Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Ear<br><span class="keyword"> and </span>Auditory System. <br><i>New Terms: Other Auditory and Ear Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5465</td>
               <td colspan="2">Other Blood<br><span class="keyword"> and </span>Bone Marrow Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Blood<br><span class="keyword"> and </span>Bone Marrow. <br><i>New Terms: Other Blood and Bone Marrow Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5466</td>
               <td colspan="2">Other Cardiac Arrhythmia Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Cardiac Arrhythmia. <br><i>New Terms: Other Cardiac Arrhythmia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5467</td>
               <td colspan="2">Other Coagulation Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Coagulation. <br><i>New Terms: Other Coagulation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5468</td>
               <td colspan="2">Other Constitutional Symptoms Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Constitutional Symptoms. <br><i>New Terms: Other Constitutional Symptoms Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5469</td>
               <td colspan="2">Other Dermatology<br><span class="keyword"> or </span>Skin Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Dermatology<br><span class="keyword"> and </span>Skin. <br><i>New Terms: Other Dermatology or Skin Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5470</td>
               <td colspan="2">Other Endocrine Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Endocrine System. <br><i>New Terms: Other Endocrine Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5471</td>
               <td colspan="2">Other Gastrointestinal Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Gastrointestinal System. <br><i>New Terms: Other Gastrointestinal Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5472</td>
               <td colspan="2">Other Growth<br><span class="keyword"> and </span>Development Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Growth<br><span class="keyword"> and </span>Development. <br><i>New Terms: Other Growth and Development Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5473</td>
               <td colspan="2">Other Hemorrhage<br><span class="keyword"> and </span>Bleeding Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Hemorrhage<br><span class="keyword"> and </span>Bleeding. <br><i>New Terms: Other Hemorrhage and Bleeding Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5474</td>
               <td colspan="2">Other Hepatobiliary<br><span class="keyword"> and </span>Pancreas Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Hepatobiliary System<br><span class="keyword"> and </span>Pancreas. <br><i>New Terms: Other Hepatobiliary and Pancreas Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5475</td>
               <td colspan="2">Other Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Surgery<br><span class="keyword"> and </span>Intra-Operative Injury. <br><i>New Terms: Other Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5476</td>
               <td colspan="2">Other Lymphatics Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Lymphatic System. <br><i>New Terms: Other Lymphatics Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5477</td>
               <td colspan="2">Other Metabolic<br><span class="keyword"> and </span>Laboratory Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Metabolic<br><span class="keyword"> and </span>Laboratory Abnormalities. <br><i>New Terms: Other Metabolic and Laboratory Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5478</td>
               <td colspan="2">Other Musculoskeletal<br><span class="keyword"> and </span>Soft Tissue Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Musculoskeletal System<br><span class="keyword"> and </span>Soft Tissue. <br><i>New Terms: Other Musculoskeletal and Soft Tissue Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5479</td>
               <td colspan="2">Other NOS Artery Injury Adverse Event<span class="subclass"> SubClassOf </span>Artery Injury Adverse Event. <br><i>New Terms: Other NOS Artery Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5480</td>
               <td colspan="2">Other NOS Vein Injury Adverse Event<span class="subclass"> SubClassOf </span>Vein Injury Adverse Event. <br><i>New Terms: Other NOS Vein Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5481</td>
               <td colspan="2">Other Neurology Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Nervous System. <br><i>New Terms: Other Neurology Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5482</td>
               <td colspan="2">Other Ocular<br><span class="keyword"> and </span>Visual Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Ocular<br><span class="keyword"> and </span>Visual Systems. <br><i>New Terms: Other Ocular and Visual Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5483</td>
               <td colspan="2">Other Pain Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Pain. <br><i>New Terms: Other Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5484</td>
               <td colspan="2">Other Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Systems. <br><i>New Terms: Other Pulmonary and Upper Respiratory Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5485</td>
               <td colspan="2">Other Secondary Malignancy Possibly Related to Cancer Treatment Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Secondary Malignancy. <br><i>New Terms: Other Secondary Malignancy Possibly Related to Cancer Treatment Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5486</td>
               <td colspan="2">Other Sexual Reproductive Function Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Sexual<br><span class="keyword"> and </span>Reproductive Function. <br><i>New Terms: Other Sexual Reproductive Function Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5487</td>
               <td colspan="2">Other Syndromes Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Syndromes. <br><i>New Terms: Other Syndromes Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5488</td>
               <td colspan="2">Other Vascular Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Vascular System. <br><i>New Terms: Other Vascular Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5489</td>
               <td colspan="2">Otitis Adverse Event External Ear Non Infectious<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Ear<br><span class="keyword"> and </span>Auditory System. <br><i>New Terms: Otitis Adverse Event External Ear Non Infectious</i></td>
            </tr>
            <tr class="addition">
               <td>5490</td>
               <td colspan="2">Otitis Adverse Event Middle Ear Non Infectious<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Ear<br><span class="keyword"> and </span>Auditory System. <br><i>New Terms: Otitis Adverse Event Middle Ear Non Infectious</i></td>
            </tr>
            <tr class="addition">
               <td>5491</td>
               <td colspan="2">Outer Ear NOS Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Outer Ear NOS Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5492</td>
               <td colspan="2">Outer Ear Pinna Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Outer Ear Pinna Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5493</td>
               <td colspan="2">Ovary Hemorrhage Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Hemorrhage Adverse Event. <br><i>New Terms: Ovary Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5494</td>
               <td colspan="2">Ovary Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Ovary Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5495</td>
               <td colspan="2">Ovary Perforation Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Perforation Adverse Event. <br><i>New Terms: Ovary Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5496</td>
               <td colspan="2">Overlap<span class="subclass"> SubClassOf </span>Conceptual Entity. <br><i>New Terms: Overlap</i></td>
            </tr>
            <tr class="addition">
               <td>5497</td>
               <td colspan="2">Ovulatory Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Ovulatory Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5498</td>
               <td colspan="2">Pain NOS Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Pain NOS Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5499</td>
               <td colspan="2">Palpitations Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Cardiac Arrhythmia. <br><i>New Terms: Palpitations Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5500</td>
               <td colspan="2">Pancoast Syndrome<span class="subclass"> SubClassOf </span>Neoplastic Syndrome. <br><i>New Terms: Neoplastic Syndrome, Pancoast Syndrome</i></td>
            </tr>
            <tr class="addition">
               <td>5501</td>
               <td colspan="2">Pancreas Exocrine Enzyme Deficiency Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Hepatobiliary System<br><span class="keyword"> and </span>Pancreas. <br><i>New Terms: Pancreas Exocrine Enzyme Deficiency Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5502</td>
               <td colspan="2">Pancreas Fistula Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Fistula Adverse Event. <br><i>New Terms: Pancreas Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5503</td>
               <td colspan="2">Pancreas Hemorrhage Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Hemorrhage Adverse Event. <br><i>New Terms: Pancreas Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5504</td>
               <td colspan="2">Pancreas Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Pancreas Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5505</td>
               <td colspan="2">Pancreas Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Pancreas Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5506</td>
               <td colspan="2">Pancreas Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Pancreas Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5507</td>
               <td colspan="2">Pancreas Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Pancreas Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5508</td>
               <td colspan="2">Pancreas Leak Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Leak Adverse Event Including Anastomotic Leak. <br><i>New Terms: Pancreas Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5509</td>
               <td colspan="2">Pancreas Necrosis Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Necrosis Adverse Event. <br><i>New Terms: Pancreas Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5510</td>
               <td colspan="2">Pancreas<br><span class="keyword"> or </span>Pancreatic Duct Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Stricture<br><span class="keyword"> and </span>Stenosis Adverse Event Including Anastomotic Stricture<br><span class="keyword"> and </span>Stenosis. <br><i>New Terms: Pancreas or Pancreatic Duct Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5511</td>
               <td colspan="2">Pancreatic Duct Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Pancreatic Duct Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5512</td>
               <td colspan="2">Pancreatic Endocrine Glucose Intolerance Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Endocrine System. <br><i>New Terms: Pancreatic Endocrine Glucose Intolerance Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5513</td>
               <td colspan="2">Pancreatitis Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Hepatobiliary System<br><span class="keyword"> and </span>Pancreas. <br><i>New Terms: Pancreatitis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5514</td>
               <td colspan="2">Paranasal Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Paranasal Infection Adverse Event Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5515</td>
               <td colspan="2">Paranasal Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Paranasal Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5516</td>
               <td colspan="2">Paranasal Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Paranasal Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5517</td>
               <td colspan="2">Parathyroid Function Low Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Endocrine System. <br><i>New Terms: Parathyroid Function Low Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5518</td>
               <td colspan="2">Parathyroid Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Parathyroid Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5519</td>
               <td colspan="2">Parotid Gland Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Parotid Gland Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5520</td>
               <td colspan="2">Partial Thromboplastin Time Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Coagulation. <br><i>New Terms: Partial Thromboplastin Time Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5521</td>
               <td colspan="2">Partially Encapsulated Mass<span class="subclass"> SubClassOf </span>Encapsulated Mass. <br><i>New Terms: Partially Encapsulated Mass</i></td>
            </tr>
            <tr class="addition">
               <td>5523</td>
               <td colspan="2">Patient Odor Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Constitutional Symptoms. <br><i>New Terms: Patient Odor Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5522</td>
               <td colspan="2">Patient-Device Interaction<span class="subclass"> SubClassOf </span>Finding by Cause. <br><i>New Terms: Patient-Device Interaction</i></td>
            </tr>
            <tr class="addition">
               <td>5524</td>
               <td colspan="2">Pelvic Muscle Weakness Not Due to Neuropathy Adverse Event<span class="subclass"> SubClassOf </span>Generalized<br><span class="keyword"> or </span>Specific Area Muscle Weakness Adverse Event Not Due to Neuropathy. <br><i>New Terms: Pelvic Muscle Weakness Not Due to Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5525</td>
               <td colspan="2">Pelvic Soft Tissue Necrosis Adverse Event<span class="subclass"> SubClassOf </span>Soft Tissue Necrosis Adverse Event. <br><i>New Terms: Pelvic Soft Tissue Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5526</td>
               <td colspan="2">Pelvis Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Pelvis Infection NOS Adverse Event Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5527</td>
               <td colspan="2">Pelvis Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Pelvis Infection NOS Adverse Event with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5528</td>
               <td colspan="2">Pelvis Infection NOS Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Pelvis Infection NOS Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5529</td>
               <td colspan="2">Pelvis Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Pelvis Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5530</td>
               <td colspan="2">Pelvis Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Pelvis Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5531</td>
               <td colspan="2">Penis Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Penis Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5532</td>
               <td colspan="2">Penis Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Penis Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5533</td>
               <td colspan="2">Penis Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Penis Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5534</td>
               <td colspan="2">Penis Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Penis Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5535</td>
               <td colspan="2">Penis Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Penis Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5536</td>
               <td colspan="2">Pericarditis Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Heart in General. <br><i>New Terms: Pericarditis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5537</td>
               <td colspan="2">Pericardium Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Pericardium Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5538</td>
               <td colspan="2">Perineum Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Perineum Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5539</td>
               <td colspan="2">Periodontal Disease Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Gastrointestinal System. <br><i>New Terms: Periodontal Disease Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5540</td>
               <td colspan="2">Peripheral Arterial Ischemia Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Vascular System. <br><i>New Terms: Peripheral Arterial Ischemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5541</td>
               <td colspan="2">Peripheral Motor Nerve NOS Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Peripheral Motor Nerve NOS Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5542</td>
               <td colspan="2">Peripheral Nerve Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Peripheral Nerve Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5543</td>
               <td colspan="2">Peripheral Nerve Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Peripheral Nerve Infection Adverse Event with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5544</td>
               <td colspan="2">Peripheral Nerve Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Peripheral Nerve Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5545</td>
               <td colspan="2">Peripheral Sensory Nerve NOS Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Peripheral Sensory Nerve NOS Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5546</td>
               <td colspan="2">Peristomal Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Peristomal Infection Adverse Event Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5547</td>
               <td colspan="2">Peristomal Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Peristomal Infection Adverse Event with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5548</td>
               <td colspan="2">Peristomal Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Peristomal Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5549</td>
               <td colspan="2">Peritoneal Cavity Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Peritoneal Cavity Infection Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5550</td>
               <td colspan="2">Peritoneal Cavity Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Peritoneal Cavity Infection Adverse Event with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5551</td>
               <td colspan="2">Peritoneal Cavity Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Peritoneal Cavity Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5554</td>
               <td colspan="2">Peritoneal Cavity Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Peritoneal Cavity Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5552</td>
               <td colspan="2">Peritoneal Cavity Necrosis Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Necrosis Adverse Event. <br><i>New Terms: Peritoneal Cavity Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5553</td>
               <td colspan="2">Peritoneal Hemorrhage Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Hemorrhage Adverse Event. <br><i>New Terms: Peritoneal Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5555</td>
               <td colspan="2">Peritoneum Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Peritoneum Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5556</td>
               <td colspan="2">Perpendicular Axis<span class="subclass"> SubClassOf </span>Conceptual Entity. <br><i>New Terms: Perpendicular Axis</i></td>
            </tr>
            <tr class="addition">
               <td>5557</td>
               <td colspan="2">Personality<br><span class="keyword"> and </span>Behavioral Change Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Nervous System. <br><i>New Terms: Personality and Behavioral Change Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5558</td>
               <td colspan="2">Petechiae<br><span class="keyword"> and </span>Purpura Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Hemorrhage<br><span class="keyword"> and </span>Bleeding. <br><i>New Terms: Petechiae and Purpura Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5559</td>
               <td colspan="2">Phantom Pain Associated with Missing Limb Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Phantom Pain Associated with Missing Limb Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5560</td>
               <td colspan="2">Pharynx GI Fistula Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Fistula Adverse Event. <br><i>New Terms: Pharynx GI Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5561</td>
               <td colspan="2">Pharynx Hemorrhage Adverse Event<span class="subclass"> SubClassOf </span>Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Hemorrhage Adverse Event. <br><i>New Terms: Pharynx Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5562</td>
               <td colspan="2">Pharynx Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Pharynx Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5563</td>
               <td colspan="2">Pharynx Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Pharynx Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5564</td>
               <td colspan="2">Pharynx Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Pharynx Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5565</td>
               <td colspan="2">Pharynx Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Pharynx Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5566</td>
               <td colspan="2">Pharynx Leak Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Leak Adverse Event Including Anastomotic Leak. <br><i>New Terms: Pharynx Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5567</td>
               <td colspan="2">Pharynx Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Mucositis<br><span class="keyword"> and </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> and </span>Symptomatic Classification. <br><i>New Terms: Pharynx Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>5568</td>
               <td colspan="2">Pharynx Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Mucositis<br><span class="keyword"> and </span>Stomatitis Adverse Event by Clinical Examination Classification. <br><i>New Terms: Pharynx Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>5569</td>
               <td colspan="2">Pharynx Necrosis Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Necrosis Adverse Event. <br><i>New Terms: Pharynx Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5570</td>
               <td colspan="2">Pharynx Obstruction<br><span class="keyword"> and </span>Stenosis Adverse Event<span class="subclass"> SubClassOf </span>Airway Obstruction<br><span class="keyword"> and </span>Stenosis Adverse Event. <br><i>New Terms: Pharynx Obstruction and Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5571</td>
               <td colspan="2">Pharynx Pulmonary Fistula Adverse Event<span class="subclass"> SubClassOf </span>Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Fistula Adverse Event. <br><i>New Terms: Pharynx Pulmonary Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5572</td>
               <td colspan="2">Pharynx Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Stricture<br><span class="keyword"> and </span>Stenosis Adverse Event Including Anastomotic Stricture<br><span class="keyword"> and </span>Stenosis. <br><i>New Terms: Pharynx Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5573</td>
               <td colspan="2">Phase 0 Trial<span class="subclass"> SubClassOf </span>Clinical Trial. <br><i>New Terms: Phase 0 Trial</i></td>
            </tr>
            <tr class="addition">
               <td>5575</td>
               <td colspan="2">Phase I Enzymes Inhibitor<span class="subclass"> SubClassOf </span>Chemopreventive Agent. <br><i>New Terms: Phase I Enzymes Inhibitor</i></td>
            </tr>
            <tr class="addition">
               <td>5574</td>
               <td colspan="2">Phase II Enzymes Inducer<span class="subclass"> SubClassOf </span>Chemopreventive Agent. <br><i>New Terms: Phase II Enzymes Inducer</i></td>
            </tr>
            <tr class="addition">
               <td>5576</td>
               <td colspan="2">Phlebitis Including Superficial Thrombosis Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Vascular System. <br><i>New Terms: Phlebitis Including Superficial Thrombosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5577</td>
               <td colspan="2">Phlebolymphatic Cording Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Lymphatic System. <br><i>New Terms: Phlebolymphatic Cording Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5578</td>
               <td colspan="2">Photophobia Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Ocular<br><span class="keyword"> and </span>Visual Systems. <br><i>New Terms: Photophobia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5579</td>
               <td colspan="2">Photosensitivity Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Dermatology<br><span class="keyword"> and </span>Skin. <br><i>New Terms: Photosensitivity Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5580</td>
               <td colspan="2">Phrenic Nerve Dysfunction Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Nervous System. <br><i>New Terms: Phrenic Nerve Dysfunction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5581</td>
               <td colspan="2">Pituitary Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Pituitary Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5582</td>
               <td colspan="2">Platelets Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Blood<br><span class="keyword"> and </span>Bone Marrow. <br><i>New Terms: Platelets Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5583</td>
               <td colspan="2">Pleura Fistula Adverse Event<span class="subclass"> SubClassOf </span>Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Fistula Adverse Event. <br><i>New Terms: Pleura Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5584</td>
               <td colspan="2">Pleura Hemorrhage Adverse Event<span class="subclass"> SubClassOf </span>Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Hemorrhage Adverse Event. <br><i>New Terms: Pleura Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5585</td>
               <td colspan="2">Pleura Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Pleura Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5586</td>
               <td colspan="2">Pleura Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Pleura Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5587</td>
               <td colspan="2">Pleura Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Pleura Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5588</td>
               <td colspan="2">Pleura Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Pleura Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5589</td>
               <td colspan="2">Pleura Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Pleura Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5590</td>
               <td colspan="2">Pluripotent Bronchial Precursor Cell<span class="subclass"> SubClassOf </span>Cell. <br><i>New Terms: Pluripotent Bronchial Precursor Cell</i></td>
            </tr>
            <tr class="addition">
               <td>5591</td>
               <td colspan="2">Pneumonitis<br><span class="keyword"> and </span>Pulmonary Infiltrates Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Systems. <br><i>New Terms: Pneumonitis and Pulmonary Infiltrates Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5592</td>
               <td colspan="2">Pneumothorax Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Systems. <br><i>New Terms: Pneumothorax Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5593</td>
               <td colspan="2">Poor Tissue Fixation with No Definable Features<span class="subclass"> SubClassOf </span>Morphologic Finding. <br><i>New Terms: Poor Tissue Fixation with No Definable Features</i></td>
            </tr>
            <tr class="addition">
               <td>5594</td>
               <td colspan="2">Portal Vein Flow Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Vascular System. <br><i>New Terms: Portal Vein Flow Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5595</td>
               <td colspan="2">Portal Vein Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Portal Vein Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5596</td>
               <td colspan="2">Post-Therapy<span class="subclass"> SubClassOf </span>Temporal Qualifier. <br><i>New Terms: Post-Therapy</i></td>
            </tr>
            <tr class="addition">
               <td>5597</td>
               <td colspan="2">Pre-Therapy<span class="subclass"> SubClassOf </span>Temporal Qualifier. <br><i>New Terms: Pre-Therapy</i></td>
            </tr>
            <tr class="addition">
               <td>5598</td>
               <td colspan="2">Precocious Puberty Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Growth<br><span class="keyword"> and </span>Development. <br><i>New Terms: Precocious Puberty Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5599</td>
               <td colspan="2">Premarket Review<span class="subclass"> SubClassOf </span>Regulated Product Review Process. <br><i>New Terms: Premarket Review, Regulated Product Review Process</i></td>
            </tr>
            <tr class="addition">
               <td>5600</td>
               <td colspan="2">Premature Ventricular Contraction Adverse Event<span class="subclass"> SubClassOf </span>Ventricular Arrhythmia Adverse Event. <br><i>New Terms: Premature Ventricular Contraction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5601</td>
               <td colspan="2">Preoperative<span class="subclass"> SubClassOf </span>Temporal Qualifier. <br><i>New Terms: Preoperative</i></td>
            </tr>
            <tr class="addition">
               <td>5602</td>
               <td colspan="2">Primary Site Unspecified<span class="subclass"> SubClassOf </span>Finding by Site<br><span class="keyword"> or </span>System. <br><i>New Terms: Primary Site Unspecified</i></td>
            </tr>
            <tr class="addition">
               <td>5603</td>
               <td colspan="2">Proctitis Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Gastrointestinal System. <br><i>New Terms: Proctitis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5604</td>
               <td colspan="2">Prolapse of Gastrointestinal Stoma Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Gastrointestinal System. <br><i>New Terms: Prolapse of Gastrointestinal Stoma Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5605</td>
               <td colspan="2">Prolonged Chest Tube Drainage<br><span class="keyword"> or </span>Air Leak After Pulmonary Resection Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Systems. <br><i>New Terms: Prolonged Chest Tube Drainage or Air Leak After Pulmonary Resection Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5606</td>
               <td colspan="2">Prolonged Intubation After Pulmonary Resection Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Systems. <br><i>New Terms: Prolonged Intubation After Pulmonary Resection Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5607</td>
               <td colspan="2">Prolonged QTc Interval Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Cardiac Arrhythmia. <br><i>New Terms: Prolonged QTc Interval Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5608</td>
               <td colspan="2">Prominent In Situ Component Present<span class="subclass"> SubClassOf </span>Abnormal Tissue Present. <br><i>New Terms: Prominent In Situ Component Present</i></td>
            </tr>
            <tr class="addition">
               <td>5609</td>
               <td colspan="2">Prominent Intraductal Component Present<span class="subclass"> SubClassOf </span>Prominent In Situ Component Present. <br><i>New Terms: Prominent In Situ Component Present, Prominent Intraductal Component Present</i></td>
            </tr>
            <tr class="addition">
               <td>5610</td>
               <td colspan="2">Proptosis<br><span class="keyword"> and </span>Enophthalmos Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Ocular<br><span class="keyword"> and </span>Visual Systems. <br><i>New Terms: Proptosis and Enophthalmos Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5611</td>
               <td colspan="2">Prostate Hemorrhage Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Hemorrhage Adverse Event. <br><i>New Terms: Prostate Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5612</td>
               <td colspan="2">Prostate Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Prostate Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5613</td>
               <td colspan="2">Prostate Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Prostate Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5614</td>
               <td colspan="2">Prostate Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Prostate Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5615</td>
               <td colspan="2">Prostate Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Prostate Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5616</td>
               <td colspan="2">Prostate Obstruction Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Obstruction Adverse Event. <br><i>New Terms: Prostate Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5617</td>
               <td colspan="2">Prostate Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Prostate Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5618</td>
               <td colspan="2">Prostate Perforation Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Perforation Adverse Event. <br><i>New Terms: Prostate Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5619</td>
               <td colspan="2">Prostate Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Stricture<br><span class="keyword"> and </span>Stenosis Adverse Event Including Anastomotic Stricture<br><span class="keyword"> and </span>Stenosis. <br><i>New Terms: Prostate Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5620</td>
               <td colspan="2">Proteinuria Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Metabolic<br><span class="keyword"> and </span>Laboratory Abnormalities. <br><i>New Terms: Proteinuria Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5621</td>
               <td colspan="2">Pruritus Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Dermatology<br><span class="keyword"> and </span>Skin. <br><i>New Terms: Pruritus Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5622</td>
               <td colspan="2">Psychosis Including Hallucinations<br><span class="keyword"> and </span>Delusions Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Nervous System. <br><i>New Terms: Psychosis Including Hallucinations and Delusions Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5623</td>
               <td colspan="2">Pulmonary Artery Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Pulmonary Artery Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5624</td>
               <td colspan="2">Pulmonary Fibrosis Radiographic Changes Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Systems. <br><i>New Terms: Pulmonary Fibrosis Radiographic Changes Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5625</td>
               <td colspan="2">Pulmonary Hypertension Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Heart in General. <br><i>New Terms: Pulmonary Hypertension Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5626</td>
               <td colspan="2">Pulmonary Stoma Hemorrhage Adverse Event<span class="subclass"> SubClassOf </span>Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Hemorrhage Adverse Event. <br><i>New Terms: Pulmonary Stoma Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5627</td>
               <td colspan="2">Pulmonary Vein Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Pulmonary Vein Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5628</td>
               <td colspan="2">Pyramidal Tract Dysfunction Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Nervous System. <br><i>New Terms: Pyramidal Tract Dysfunction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5629</td>
               <td colspan="2">Radiation Arc<span class="subclass"> SubClassOf </span>Radiation Field. <br><i>New Terms: Radiation Arc, Radiation Field</i></td>
            </tr>
            <tr class="addition">
               <td>5630</td>
               <td colspan="2">Radiation Field<span class="subclass"> SubClassOf </span>Other Anatomic Concept. <br><i>New Terms: Radiation Field</i></td>
            </tr>
            <tr class="addition">
               <td>5631</td>
               <td colspan="2">Rash Acne<br><span class="keyword"> or </span>Acneiform Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Dermatology<br><span class="keyword"> and </span>Skin. <br><i>New Terms: Rash Acne or Acneiform Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5632</td>
               <td colspan="2">Rash Desquamation Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Dermatology<br><span class="keyword"> and </span>Skin. <br><i>New Terms: Rash Desquamation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5633</td>
               <td colspan="2">Rash Erythema Multiforme Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Dermatology<br><span class="keyword"> and </span>Skin. <br><i>New Terms: Rash Erythema Multiforme Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5634</td>
               <td colspan="2">Rash Hand<br><span class="keyword"> or </span>Foot Skin Reaction Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Dermatology<br><span class="keyword"> and </span>Skin. <br><i>New Terms: Rash Hand or Foot Skin Reaction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5635</td>
               <td colspan="2">Rash<br><span class="keyword"> and </span>Dermatitis Adverse Event Associated with Chemoradiation<span class="subclass"> SubClassOf </span>Rash<br><span class="keyword"> and </span>Dermatitis Adverse Event Associated with Radiation. <br><i>New Terms: Rash and Dermatitis Adverse Event Associated with Chemoradiation</i></td>
            </tr>
            <tr class="addition">
               <td>5636</td>
               <td colspan="2">Rash<br><span class="keyword"> and </span>Dermatitis Adverse Event Associated with Radiation Excluding Chemoradiation<span class="subclass"> SubClassOf </span>Rash<br><span class="keyword"> and </span>Dermatitis Adverse Event Associated with Radiation. <br><i>New Terms: Rash and Dermatitis Adverse Event Associated with Radiation Excluding Chemoradiation</i></td>
            </tr>
            <tr class="addition">
               <td>5637</td>
               <td colspan="2">Rectal Varices Hemorrhage Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Hemorrhage Adverse Event. <br><i>New Terms: Rectal Varices Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5638</td>
               <td colspan="2">Rectum Fistula Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Fistula Adverse Event. <br><i>New Terms: Rectum Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5639</td>
               <td colspan="2">Rectum Hemorrhage Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Hemorrhage Adverse Event. <br><i>New Terms: Rectum Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5640</td>
               <td colspan="2">Rectum Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Rectum Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5641</td>
               <td colspan="2">Rectum Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Rectum Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5642</td>
               <td colspan="2">Rectum Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Rectum Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5643</td>
               <td colspan="2">Rectum Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Rectum Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5644</td>
               <td colspan="2">Rectum Leak Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Leak Adverse Event Including Anastomotic Leak. <br><i>New Terms: Rectum Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5645</td>
               <td colspan="2">Rectum Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Mucositis<br><span class="keyword"> and </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> and </span>Symptomatic Classification. <br><i>New Terms: Rectum Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>5646</td>
               <td colspan="2">Rectum Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Mucositis<br><span class="keyword"> and </span>Stomatitis Adverse Event by Clinical Examination Classification. <br><i>New Terms: Rectum Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>5647</td>
               <td colspan="2">Rectum Necrosis Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Necrosis Adverse Event. <br><i>New Terms: Rectum Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5648</td>
               <td colspan="2">Rectum Obstruction Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Obstruction Adverse Event. <br><i>New Terms: Rectum Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5649</td>
               <td colspan="2">Rectum Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Rectum Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5650</td>
               <td colspan="2">Rectum Perforation Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Perforation Adverse Event. <br><i>New Terms: Rectum Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5651</td>
               <td colspan="2">Rectum Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Stricture<br><span class="keyword"> and </span>Stenosis Adverse Event Including Anastomotic Stricture<br><span class="keyword"> and </span>Stenosis. <br><i>New Terms: Rectum Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5652</td>
               <td colspan="2">Rectum Ulcer Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Ulcer Adverse Event. <br><i>New Terms: Rectum Ulcer Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5653</td>
               <td colspan="2">Recurrent Disease, Distant Site<span class="subclass"> SubClassOf </span>Recurrent Disease. <br><i>New Terms: Recurrent Disease, Distant Site</i></td>
            </tr>
            <tr class="addition">
               <td>5654</td>
               <td colspan="2">Recurrent Disease, Primary Site<span class="subclass"> SubClassOf </span>Recurrent Disease. <br><i>New Terms: Recurrent Disease, Primary Site</i></td>
            </tr>
            <tr class="addition">
               <td>5655</td>
               <td colspan="2">Recurrent Laryngeal Nerve Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Recurrent Laryngeal Nerve Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5656</td>
               <td colspan="2">Reduction in Growth Velocity Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Growth<br><span class="keyword"> and </span>Development. <br><i>New Terms: Reduction in Growth Velocity Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5657</td>
               <td colspan="2">Redundancy<span class="subclass"> SubClassOf </span>Property<br><span class="keyword"> or </span>Attribute. <br><i>New Terms: Redundancy</i></td>
            </tr>
            <tr class="addition">
               <td>5658</td>
               <td colspan="2">Registration Specialist<span class="subclass"> SubClassOf </span>Research Personnel. <br><i>New Terms: Registration Specialist</i></td>
            </tr>
            <tr class="addition">
               <td>5353</td>
               <td colspan="2">Regulated Medical Product<span class="subclass"> SubClassOf </span>Product. <br><i>New Terms: Regulated Medical Product</i></td>
            </tr>
            <tr class="addition">
               <td>5659</td>
               <td colspan="2">Regulated Product Review Process<span class="subclass"> SubClassOf </span>Business Rules. <br><i>New Terms: Regulated Product Review Process</i></td>
            </tr>
            <tr class="addition">
               <td>5660</td>
               <td colspan="2">Renal Failure Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Kidney<br><span class="keyword"> and </span>Genitourinary System. <br><i>New Terms: Renal Failure Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5661</td>
               <td colspan="2">Renal<br><span class="keyword"> or </span>Genitourinary Other Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Kidney<br><span class="keyword"> and </span>Genitourinary System. <br><i>New Terms: Renal or Genitourinary Other Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5662</td>
               <td colspan="2">Resident<span class="subclass"> SubClassOf </span>Physician. <br><i>New Terms: Resident</i></td>
            </tr>
            <tr class="addition">
               <td>5663</td>
               <td colspan="2">Respiratory Tract Hemorrhage Adverse Event NOS<span class="subclass"> SubClassOf </span>Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Hemorrhage Adverse Event. <br><i>New Terms: Respiratory Tract Hemorrhage Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>5664</td>
               <td colspan="2">Restriction Enzyme Cleavage Site<span class="subclass"> SubClassOf </span>DNA Sequence. <br><i>New Terms: Restriction Enzyme Cleavage Site</i></td>
            </tr>
            <tr class="addition">
               <td>5665</td>
               <td colspan="2">Restriction Site<span class="subclass"> SubClassOf </span>DNA Sequence. <br><i>New Terms: Restriction Site</i></td>
            </tr>
            <tr class="addition">
               <td>5666</td>
               <td colspan="2">Restrictive Cardiomyopathy Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Heart in General. <br><i>New Terms: Restrictive Cardiomyopathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5667</td>
               <td colspan="2">Retina Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Retina Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5668</td>
               <td colspan="2">Retinal Detachment Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Ocular<br><span class="keyword"> and </span>Visual Systems. <br><i>New Terms: Retinal Detachment Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5669</td>
               <td colspan="2">Retinoic Acid Syndrome Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Syndromes. <br><i>New Terms: Retinoic Acid Syndrome Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5670</td>
               <td colspan="2">Retinopathy Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Ocular<br><span class="keyword"> and </span>Visual Systems. <br><i>New Terms: Retinopathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5671</td>
               <td colspan="2">Retroperitoneum Hemorrhage Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Hemorrhage Adverse Event. <br><i>New Terms: Retroperitoneum Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5672</td>
               <td colspan="2">Reviewer<span class="subclass"> SubClassOf </span>Person. <br><i>New Terms: Reviewer</i></td>
            </tr>
            <tr class="addition">
               <td>5673</td>
               <td colspan="2">Richter's Syndrome<span class="subclass"> EquivalentTo </span>Neoplastic Syndrome<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Chronic Lymphocytic Leukemia). <br><i>New Terms: Neoplastic Syndrome</i></td>
            </tr>
            <tr class="addition">
               <td>5675</td>
               <td colspan="2">Right Ventricular Dysfunction Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Heart in General. <br><i>New Terms: Right Ventricular Dysfunction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5674</td>
               <td colspan="2">Right-Sided Muscle Weakness Not Due to Neuropathy Adverse Event<span class="subclass"> SubClassOf </span>Generalized<br><span class="keyword"> or </span>Specific Area Muscle Weakness Adverse Event Not Due to Neuropathy. <br><i>New Terms: Right-Sided Muscle Weakness Not Due to Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5676</td>
               <td colspan="2">Rigors<br><span class="keyword"> and </span>Chills Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Constitutional Symptoms. <br><i>New Terms: Rigors and Chills Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5677</td>
               <td colspan="2">Round Adenocarcinoma Cell with Abundant Cytoplasm<br><span class="keyword"> and </span>Vesicular Nucleus<span class="subclass"> SubClassOf </span>Round Adenocarcinoma Cell. <br><i>New Terms: Round Adenocarcinoma Cell with Abundant Cytoplasm and Vesicular Nucleus</i></td>
            </tr>
            <tr class="addition">
               <td>5678</td>
               <td colspan="2">Sacral Plexus Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Sacral Plexus Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5679</td>
               <td colspan="2">Salivary Duct Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Salivary Duct Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5680</td>
               <td colspan="2">Salivary Gland Fistula<span class="subclass"> SubClassOf </span>Gastrointestinal Fistula Adverse Event. <br><i>New Terms: Salivary Gland Fistula</i></td>
            </tr>
            <tr class="addition">
               <td>5681</td>
               <td colspan="2">Salivary Gland Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Salivary Gland Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5682</td>
               <td colspan="2">Salivary Gland<br><span class="keyword"> or </span>Saliva Changes Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Gastrointestinal System. <br><i>New Terms: Salivary Gland or Saliva Changes Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5683</td>
               <td colspan="2">Salivary Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Salivary Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5684</td>
               <td colspan="2">Salivary Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Salivary Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1
                     or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5685</td>
               <td colspan="2">Salivary Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Salivary Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5686</td>
               <td colspan="2">Sarcomatous Component Present<span class="subclass"> SubClassOf </span>Mesenchymal Component Present. <br><i>New Terms: Sarcomatous Component Present</i></td>
            </tr>
            <tr class="addition">
               <td>5687</td>
               <td colspan="2">Scalp Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Scalp Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5688</td>
               <td colspan="2">Sciatic Nerve Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Sciatic Nerve Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5689</td>
               <td colspan="2">Scleral Necrosis<br><span class="keyword"> and </span>Melt Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Ocular<br><span class="keyword"> and </span>Visual Systems. <br><i>New Terms: Scleral Necrosis and Melt Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5690</td>
               <td colspan="2">Scrotum Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Scrotum Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5691</td>
               <td colspan="2">Scrotum Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Scrotum Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5692</td>
               <td colspan="2">Scrotum Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Scrotum Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5693</td>
               <td colspan="2">Scrotum Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Scrotum Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5694</td>
               <td colspan="2">Scrotum Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Scrotum Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5695</td>
               <td colspan="2">Sebaceous Differentiation<span class="subclass"> SubClassOf </span>Epithelial Differentiation. <br><i>New Terms: Sebaceous Differentiation</i></td>
            </tr>
            <tr class="addition">
               <td>5696</td>
               <td colspan="2">Seizure Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Nervous System. <br><i>New Terms: Seizure Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5697</td>
               <td colspan="2">Semi-Critical Reprocessed Single-Use Device<span class="subclass"> SubClassOf </span>Device Labeled for Single Use. <br><i>New Terms: Semi-Critical Reprocessed Single-Use Device</i></td>
            </tr>
            <tr class="addition">
               <td>5698</td>
               <td colspan="2">Sensory Neuropathy Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Nervous System. <br><i>New Terms: Sensory Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5699</td>
               <td colspan="2">Seroma Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Musculoskeletal System<br><span class="keyword"> and </span>Soft Tissue. <br><i>New Terms: Seroma Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5700</td>
               <td colspan="2">Serum Glutamic Oxaloacetic Transaminase Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Metabolic<br><span class="keyword"> and </span>Laboratory Abnormalities. <br><i>New Terms: Serum Glutamic Oxaloacetic Transaminase Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5701</td>
               <td colspan="2">Serum Glutamic Pyruvic Transaminase Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Metabolic<br><span class="keyword"> and </span>Laboratory Abnormalities. <br><i>New Terms: Serum Glutamic Pyruvic Transaminase Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5702</td>
               <td colspan="2">Serum Hypercalcemia Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Metabolic<br><span class="keyword"> and </span>Laboratory Abnormalities. <br><i>New Terms: Serum Hypercalcemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5703</td>
               <td colspan="2">Serum Hypercholesteremia Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Metabolic<br><span class="keyword"> and </span>Laboratory Abnormalities. <br><i>New Terms: Serum Hypercholesteremia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5704</td>
               <td colspan="2">Serum Hyperglycemia Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Metabolic<br><span class="keyword"> and </span>Laboratory Abnormalities. <br><i>New Terms: Serum Hyperglycemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5705</td>
               <td colspan="2">Serum Hyperkalemia Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Metabolic<br><span class="keyword"> and </span>Laboratory Abnormalities. <br><i>New Terms: Serum Hyperkalemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5706</td>
               <td colspan="2">Serum Hypermagnesemia Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Metabolic<br><span class="keyword"> and </span>Laboratory Abnormalities. <br><i>New Terms: Serum Hypermagnesemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5707</td>
               <td colspan="2">Serum Hypernatremia Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Metabolic<br><span class="keyword"> and </span>Laboratory Abnormalities. <br><i>New Terms: Serum Hypernatremia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5708</td>
               <td colspan="2">Serum Hypertriglyceridemia Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Metabolic<br><span class="keyword"> and </span>Laboratory Abnormalities. <br><i>New Terms: Serum Hypertriglyceridemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5709</td>
               <td colspan="2">Serum Hyperuricemia Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Metabolic<br><span class="keyword"> and </span>Laboratory Abnormalities. <br><i>New Terms: Serum Hyperuricemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5710</td>
               <td colspan="2">Serum Hypoalbuminemia Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Metabolic<br><span class="keyword"> and </span>Laboratory Abnormalities. <br><i>New Terms: Serum Hypoalbuminemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5711</td>
               <td colspan="2">Serum Hypocalcemia Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Metabolic<br><span class="keyword"> and </span>Laboratory Abnormalities. <br><i>New Terms: Serum Hypocalcemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5712</td>
               <td colspan="2">Serum Hypoglycemia Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Metabolic<br><span class="keyword"> and </span>Laboratory Abnormalities. <br><i>New Terms: Serum Hypoglycemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5713</td>
               <td colspan="2">Serum Hypokalemia Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Metabolic<br><span class="keyword"> and </span>Laboratory Abnormalities. <br><i>New Terms: Serum Hypokalemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5714</td>
               <td colspan="2">Serum Hypomagnesemia Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Metabolic<br><span class="keyword"> and </span>Laboratory Abnormalities. <br><i>New Terms: Serum Hypomagnesemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5715</td>
               <td colspan="2">Serum Hyponatremia Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Metabolic<br><span class="keyword"> and </span>Laboratory Abnormalities. <br><i>New Terms: Serum Hyponatremia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5716</td>
               <td colspan="2">Serum Hypophosphatemia Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Metabolic<br><span class="keyword"> and </span>Laboratory Abnormalities. <br><i>New Terms: Serum Hypophosphatemia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5717</td>
               <td colspan="2">Serum Sickness Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Allergy<br><span class="keyword"> and </span>Immunology. <br><i>New Terms: Serum Sickness Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5718</td>
               <td colspan="2">Short Stature Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Growth<br><span class="keyword"> and </span>Development. <br><i>New Terms: Short Stature Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5719</td>
               <td colspan="2">Sick Sinus Syndrome Adverse Event<span class="subclass"> SubClassOf </span>Conduction Abnormality<br><span class="keyword"> and </span>Atrioventricular Heart Block Adverse Event. <br><i>New Terms: Sick Sinus Syndrome Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5720</td>
               <td colspan="2">Signet Ring Cell Lobular Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Lobular Breast Carcinoma<br><span class="keyword"> and </span>Signet Ring Cell Breast Carcinoma. <br><i>New Terms: Signet Ring Cell Lobular Breast Carcinoma</i></td>
            </tr>
            <tr class="addition">
               <td>5721</td>
               <td colspan="2">Signet Ring Melanoma<span class="subclass"> SubClassOf </span>Cutaneous Melanoma. <br><i>New Terms: Signet Ring Melanoma</i></td>
            </tr>
            <tr class="addition">
               <td>5722</td>
               <td colspan="2">Simplified Molecular Input Line Entry Specification<span class="subclass"> SubClassOf </span>Document. <br><i>New Terms: Simplified Molecular Input Line Entry Specification</i></td>
            </tr>
            <tr class="addition">
               <td>5723</td>
               <td colspan="2">Sinus Arrhythmia Adverse Event<span class="subclass"> SubClassOf </span>Supraventricular<br><span class="keyword"> and </span>Nodal Arrhythmia Adverse Event. <br><i>New Terms: Sinus Arrhythmia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5724</td>
               <td colspan="2">Sinus Bradycardia Adverse Event<span class="subclass"> SubClassOf </span>Supraventricular<br><span class="keyword"> and </span>Nodal Arrhythmia Adverse Event. <br><i>New Terms: Sinus Bradycardia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5725</td>
               <td colspan="2">Sinus Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Sinus Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5726</td>
               <td colspan="2">Sinus Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Sinus Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5727</td>
               <td colspan="2">Sinus Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Sinus Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5728</td>
               <td colspan="2">Sinus Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Sinus Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5729</td>
               <td colspan="2">Sinus Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Sinus Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5730</td>
               <td colspan="2">Sinus Tachycardia Adverse Event<span class="subclass"> SubClassOf </span>Supraventricular<br><span class="keyword"> and </span>Nodal Arrhythmia Adverse Event. <br><i>New Terms: Sinus Tachycardia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5731</td>
               <td colspan="2">Skin Atrophy Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Dermatology<br><span class="keyword"> and </span>Skin. <br><i>New Terms: Skin Atrophy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5732</td>
               <td colspan="2">Skin Breakdown<br><span class="keyword"> or </span>Decubitus Ulcer Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Dermatology<br><span class="keyword"> and </span>Skin. <br><i>New Terms: Skin Breakdown or Decubitus Ulcer Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5733</td>
               <td colspan="2">Skin Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Skin Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5734</td>
               <td colspan="2">Skin Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Skin Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or 2
                     Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5735</td>
               <td colspan="2">Skin Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Skin Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5736</td>
               <td colspan="2">Skin Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Skin Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5737</td>
               <td colspan="2">Skin Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Skin Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5738</td>
               <td colspan="2">Slipped Capital Femoral Epiphysis Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Growth<br><span class="keyword"> and </span>Development. <br><i>New Terms: Slipped Capital Femoral Epiphysis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5739</td>
               <td colspan="2">Small Bowel Fistula Adverse Event NOS<span class="subclass"> SubClassOf </span>Gastrointestinal Fistula Adverse Event. <br><i>New Terms: Small Bowel Fistula Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>5740</td>
               <td colspan="2">Small Bowel Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Small Bowel Infection NOS Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5741</td>
               <td colspan="2">Small Bowel Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Small Bowel Infection NOS Adverse Event with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5742</td>
               <td colspan="2">Small Bowel Infection NOS Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Small Bowel Infection NOS Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5743</td>
               <td colspan="2">Small Bowel Leak Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Leak Adverse Event Including Anastomotic Leak. <br><i>New Terms: Small Bowel Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5744</td>
               <td colspan="2">Small Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Mucositis<br><span class="keyword"> and </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> and </span>Symptomatic Classification. <br><i>New Terms: Small Bowel Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>5745</td>
               <td colspan="2">Small Bowel Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Mucositis<br><span class="keyword"> and </span>Stomatitis Adverse Event by Clinical Examination Classification. <br><i>New Terms: Small Bowel Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>5746</td>
               <td colspan="2">Small Bowel NOS Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Small Bowel NOS Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5747</td>
               <td colspan="2">Small Bowel Necrosis Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Necrosis Adverse Event. <br><i>New Terms: Small Bowel Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5748</td>
               <td colspan="2">Small Bowel Obstruction Adverse Event NOS<span class="subclass"> SubClassOf </span>Gastrointestinal Obstruction Adverse Event. <br><i>New Terms: Small Bowel Obstruction Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>5749</td>
               <td colspan="2">Small Bowel Perforation Adverse Event NOS<span class="subclass"> SubClassOf </span>Gastrointestinal Perforation Adverse Event. <br><i>New Terms: Small Bowel Perforation Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>5750</td>
               <td colspan="2">Small Bowel Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event NOS<span class="subclass"> SubClassOf </span>Gastrointestinal Stricture<br><span class="keyword"> and </span>Stenosis Adverse Event Including Anastomotic Stricture<br><span class="keyword"> and </span>Stenosis. <br><i>New Terms: Small Bowel Stricture or Stenosis Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>5751</td>
               <td colspan="2">Small Bowel Ulcer Adverse Event NOS<span class="subclass"> SubClassOf </span>Gastrointestinal Ulcer Adverse Event. <br><i>New Terms: Small Bowel Ulcer Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>5752</td>
               <td colspan="2">Soft Tissue Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Soft Tissue Infection NOS Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5753</td>
               <td colspan="2">Soft Tissue Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Soft Tissue Infection NOS Adverse Event with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5754</td>
               <td colspan="2">Soft Tissue Infection NOS Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Soft Tissue Infection NOS Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5755</td>
               <td colspan="2">Soft Tissue NOS Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Soft Tissue NOS Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5756</td>
               <td colspan="2">Somnolence<br><span class="keyword"> and </span>Depressed Level of Consciousness Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Nervous System. <br><i>New Terms: Somnolence and Depressed Level of Consciousness Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5757</td>
               <td colspan="2">Speech Impairment Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Nervous System. <br><i>New Terms: Speech Impairment Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5758</td>
               <td colspan="2">Spermatic Cord Hemorrhage Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Hemorrhage Adverse Event. <br><i>New Terms: Spermatic Cord Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5759</td>
               <td colspan="2">Spermatic Cord Leak Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Leak Adverse Event Including Anastomotic Leak. <br><i>New Terms: Spermatic Cord Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5760</td>
               <td colspan="2">Spermatic Cord Obstruction Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Obstruction Adverse Event. <br><i>New Terms: Spermatic Cord Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5761</td>
               <td colspan="2">Spermatic Cord Perforation Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Perforation Adverse Event. <br><i>New Terms: Spermatic Cord Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5762</td>
               <td colspan="2">Spermatic Cord Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Stricture<br><span class="keyword"> and </span>Stenosis Adverse Event Including Anastomotic Stricture<br><span class="keyword"> and </span>Stenosis. <br><i>New Terms: Spermatic Cord Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5763</td>
               <td colspan="2">Spinal Cord Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Spinal Cord Infection Adverse Event Documented Clinically or Microbiologically with
                     Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5764</td>
               <td colspan="2">Spinal Cord Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Spinal Cord Infection Adverse Event with Normal Absolute Neutrophil Count or Grade
                     1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5765</td>
               <td colspan="2">Spinal Cord Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Spinal Cord Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5766</td>
               <td colspan="2">Spinal Cord Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Spinal Cord Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5767</td>
               <td colspan="2">Spindle Cell Metaplasia<span class="subclass"> SubClassOf </span>Metaplasia. <br><i>New Terms: Spindle Cell Metaplasia</i></td>
            </tr>
            <tr class="addition">
               <td>5768</td>
               <td colspan="2">Spine Kyphosis<br><span class="keyword"> or </span>Lordosis Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Growth<br><span class="keyword"> and </span>Development. <br><i>New Terms: Spine Kyphosis or Lordosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5769</td>
               <td colspan="2">Spine Scoliosis Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Musculoskeletal System<br><span class="keyword"> and </span>Soft Tissue. <br><i>New Terms: Spine Scoliosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5770</td>
               <td colspan="2">Spleen Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Spleen Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5771</td>
               <td colspan="2">Spleen Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Spleen Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5772</td>
               <td colspan="2">Spleen Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Spleen Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5773</td>
               <td colspan="2">Spleen Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Spleen Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5774</td>
               <td colspan="2">Splenic Function Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Blood<br><span class="keyword"> and </span>Bone Marrow. <br><i>New Terms: Splenic Function Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5775</td>
               <td colspan="2">Stock Recovery<span class="subclass"> SubClassOf </span>Remedial Action. <br><i>New Terms: Stock Recovery</i></td>
            </tr>
            <tr class="addition">
               <td>5776</td>
               <td colspan="2">Stokes-Adams Syndrome Adverse Event<span class="subclass"> SubClassOf </span>Conduction Abnormality<br><span class="keyword"> and </span>Atrioventricular Heart Block Adverse Event. <br><i>New Terms: Stokes-Adams Syndrome Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5777</td>
               <td colspan="2">Stoma GI Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Stricture<br><span class="keyword"> and </span>Stenosis Adverse Event Including Anastomotic Stricture<br><span class="keyword"> and </span>Stenosis. <br><i>New Terms: Stoma GI Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5778</td>
               <td colspan="2">Stoma Necrosis Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Necrosis Adverse Event. <br><i>New Terms: Stoma Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5779</td>
               <td colspan="2">Stoma Perforation Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Perforation Adverse Event. <br><i>New Terms: Stoma Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5780</td>
               <td colspan="2">Stoma Ulcer Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Ulcer Adverse Event. <br><i>New Terms: Stoma Ulcer Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5781</td>
               <td colspan="2">Stomach Fistula Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Fistula Adverse Event. <br><i>New Terms: Stomach Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5782</td>
               <td colspan="2">Stomach Hemorrhage Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Hemorrhage Adverse Event. <br><i>New Terms: Stomach Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5783</td>
               <td colspan="2">Stomach Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Stomach Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5784</td>
               <td colspan="2">Stomach Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Stomach Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5785</td>
               <td colspan="2">Stomach Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Stomach Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5786</td>
               <td colspan="2">Stomach Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Stomach Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5787</td>
               <td colspan="2">Stomach Leak Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Leak Adverse Event Including Anastomotic Leak. <br><i>New Terms: Stomach Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5788</td>
               <td colspan="2">Stomach Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Mucositis<br><span class="keyword"> and </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> and </span>Symptomatic Classification. <br><i>New Terms: Stomach Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>5789</td>
               <td colspan="2">Stomach Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Mucositis<br><span class="keyword"> and </span>Stomatitis Adverse Event by Clinical Examination Classification. <br><i>New Terms: Stomach Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>5790</td>
               <td colspan="2">Stomach Necrosis Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Necrosis Adverse Event. <br><i>New Terms: Stomach Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5791</td>
               <td colspan="2">Stomach Obstruction Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Obstruction Adverse Event. <br><i>New Terms: Stomach Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5792</td>
               <td colspan="2">Stomach Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Stomach Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5793</td>
               <td colspan="2">Stomach Perforation Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Perforation Adverse Event. <br><i>New Terms: Stomach Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5794</td>
               <td colspan="2">Stomach Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Stricture<br><span class="keyword"> and </span>Stenosis Adverse Event Including Anastomotic Stricture<br><span class="keyword"> and </span>Stenosis. <br><i>New Terms: Stomach Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5795</td>
               <td colspan="2">Stomach Ulcer Adverse Event<span class="subclass"> SubClassOf </span>Gastrointestinal Ulcer Adverse Event. <br><i>New Terms: Stomach Ulcer Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5796</td>
               <td colspan="2">Striae Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Dermatology<br><span class="keyword"> and </span>Skin. <br><i>New Terms: Striae Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5797</td>
               <td colspan="2">Subcutaneous Fat Atrophy<span class="subclass"> SubClassOf </span>Adverse Event Associated with Dermatology<br><span class="keyword"> and </span>Skin. <br><i>New Terms: Subcutaneous Fat Atrophy</i></td>
            </tr>
            <tr class="addition">
               <td>5798</td>
               <td colspan="2">Subinvestigator<span class="subclass"> SubClassOf </span>Investigator. <br><i>New Terms: Subinvestigator</i></td>
            </tr>
            <tr class="addition">
               <td>5799</td>
               <td colspan="2">Sudden Death Adverse Event Not Associated with More Specific CTCAE Term<span class="subclass"> SubClassOf </span>Death Adverse Event Not Associated with More Specific CTCAE Term. <br><i>New Terms: Sudden Death Adverse Event Not Associated with More Specific CTCAE Term</i></td>
            </tr>
            <tr class="addition">
               <td>5800</td>
               <td colspan="2">Superior Vena Cava Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Superior Vena Cava Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5801</td>
               <td colspan="2">Superior Vena Cava Vein Injury Adverse Event<span class="subclass"> SubClassOf </span>Vein Injury Adverse Event. <br><i>New Terms: Superior Vena Cava Vein Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>4955</td>
               <td colspan="2">Superoxide Dismutase [Cu-Zn]<span class="subclass"> EquivalentTo </span>Superoxide Dismutase<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>SOD1 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Oxidoreductase)<br><span class="keyword"> and </span>(Gene_Product_Has_Organism_Source<span class="some"> some </span>Human)<br><span class="keyword"> and </span>(Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>Amyotrophic Lateral Sclerosis Pathway)<br><span class="keyword"> and </span>(Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>Neurodegenerative Disorders Pathway)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Detoxification)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Oxidative Stress). <br><i>New Terms: Superoxide Dismutase [Cu-Zn]</i></td>
            </tr>
            <tr class="addition">
               <td>5802</td>
               <td colspan="2">Supraventricular Arrhythmia Adverse Event NOS<span class="subclass"> SubClassOf </span>Supraventricular<br><span class="keyword"> and </span>Nodal Arrhythmia Adverse Event. <br><i>New Terms: Supraventricular Arrhythmia Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>5803</td>
               <td colspan="2">Supraventricular Extrasystoles Adverse Event<span class="subclass"> SubClassOf </span>Supraventricular<br><span class="keyword"> and </span>Nodal Arrhythmia Adverse Event. <br><i>New Terms: Supraventricular Extrasystoles Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5804</td>
               <td colspan="2">Supraventricular Tachycardia Adverse Event<span class="subclass"> SubClassOf </span>Supraventricular<br><span class="keyword"> and </span>Nodal Arrhythmia Adverse Event. <br><i>New Terms: Supraventricular Tachycardia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5805</td>
               <td colspan="2">Synchronous Lesion<span class="subclass"> SubClassOf </span>Lesion. <br><i>New Terms: Synchronous Lesion</i></td>
            </tr>
            <tr class="addition">
               <td>5806</td>
               <td colspan="2">Syncope Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Nervous System. <br><i>New Terms: Syncope Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5807</td>
               <td colspan="2">Taste Alteration Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Gastrointestinal System. <br><i>New Terms: Taste Alteration Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5808</td>
               <td colspan="2">Teeth Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Teeth Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5809</td>
               <td colspan="2">Telangiectasia Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Dermatology<br><span class="keyword"> and </span>Skin. <br><i>New Terms: Telangiectasia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5810</td>
               <td colspan="2">Tendon Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Tendon Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5811</td>
               <td colspan="2">Testes Hemorrhage Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Hemorrhage Adverse Event. <br><i>New Terms: Testes Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5812</td>
               <td colspan="2">Testes Obstruction Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Obstruction Adverse Event. <br><i>New Terms: Testes Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5813</td>
               <td colspan="2">Testes Perforation Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Perforation Adverse Event. <br><i>New Terms: Testes Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5814</td>
               <td colspan="2">Testes Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Stricture<br><span class="keyword"> and </span>Stenosis Adverse Event Including Anastomotic Stricture<br><span class="keyword"> and </span>Stenosis. <br><i>New Terms: Testes Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5815</td>
               <td colspan="2">Testicle Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Testicle Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5816</td>
               <td colspan="2">Testis Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Testis Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5817</td>
               <td colspan="2">Thoracic Duct Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Thoracic Duct Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5818</td>
               <td colspan="2">Thoracodorsal Nerve Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Thoracodorsal Nerve Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5819</td>
               <td colspan="2">Thorax Soft Tissue Necrosis Adverse Event<span class="subclass"> SubClassOf </span>Soft Tissue Necrosis Adverse Event. <br><i>New Terms: Thorax Soft Tissue Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5820</td>
               <td colspan="2">Throat<br><span class="keyword"> and </span>Pharynx<br><span class="keyword"> and </span>Larynx Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Throat and Pharynx and Larynx Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5821</td>
               <td colspan="2">Thrombosis<br><span class="keyword"> or </span>Embolism Vascular Access Related Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Vascular System. <br><i>New Terms: Thrombosis or Embolism Vascular Access Related Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5822</td>
               <td colspan="2">Thrombosis<br><span class="keyword"> or </span>Thrombus<br><span class="keyword"> or </span>Embolism Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Vascular System. <br><i>New Terms: Thrombosis or Thrombus or Embolism Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5823</td>
               <td colspan="2">Thrombotic Microangiopathy Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Coagulation. <br><i>New Terms: Thrombotic Microangiopathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5824</td>
               <td colspan="2">Thyroid Function High Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Endocrine System. <br><i>New Terms: Thyroid Function High Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5825</td>
               <td colspan="2">Thyroid Function Low Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Endocrine System. <br><i>New Terms: Thyroid Function Low Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5826</td>
               <td colspan="2">Thyroid Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Thyroid Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5827</td>
               <td colspan="2">Tinnitus Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Ear<br><span class="keyword"> and </span>Auditory System. <br><i>New Terms: Tinnitus Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5828</td>
               <td colspan="2">Tissue Adhesion<span class="subclass"> SubClassOf </span>Connective<br><span class="keyword"> and </span>Soft Tissue Finding. <br><i>New Terms: Tissue Adhesion</i></td>
            </tr>
            <tr class="addition">
               <td>5829</td>
               <td colspan="2">Tongue Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Tongue Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5830</td>
               <td colspan="2">Tooth Development Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Gastrointestinal System. <br><i>New Terms: Tooth Development Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5831</td>
               <td colspan="2">Tooth Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Tooth Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5832</td>
               <td colspan="2">Tooth Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Tooth Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5833</td>
               <td colspan="2">Tooth Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Tooth Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5834</td>
               <td colspan="2">Torsade de Pointes Adverse Event<span class="subclass"> SubClassOf </span>Ventricular Arrhythmia Adverse Event. <br><i>New Terms: Torsade de Pointes Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5835</td>
               <td colspan="2">Trachea Fistula Adverse Event<span class="subclass"> SubClassOf </span>Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Fistula Adverse Event. <br><i>New Terms: Trachea Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5836</td>
               <td colspan="2">Trachea Hemorrhage Adverse Event<span class="subclass"> SubClassOf </span>Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Hemorrhage Adverse Event. <br><i>New Terms: Trachea Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5837</td>
               <td colspan="2">Trachea Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Trachea Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5838</td>
               <td colspan="2">Trachea Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Trachea Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5839</td>
               <td colspan="2">Trachea Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Trachea Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5840</td>
               <td colspan="2">Trachea Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Trachea Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5841</td>
               <td colspan="2">Trachea Mucositis<br><span class="keyword"> or </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> or </span>Symptomatic Classification<span class="subclass"> SubClassOf </span>Mucositis<br><span class="keyword"> and </span>Stomatitis Adverse Event by Functional<br><span class="keyword"> and </span>Symptomatic Classification. <br><i>New Terms: Trachea Mucositis or Stomatitis Adverse Event by Functional or Symptomatic Classification</i></td>
            </tr>
            <tr class="addition">
               <td>5842</td>
               <td colspan="2">Trachea Mucositis<br><span class="keyword"> or </span>Stomatitis by Clinical Examination Classification<span class="subclass"> SubClassOf </span>Mucositis<br><span class="keyword"> and </span>Stomatitis Adverse Event by Clinical Examination Classification. <br><i>New Terms: Trachea Mucositis or Stomatitis by Clinical Examination Classification</i></td>
            </tr>
            <tr class="addition">
               <td>5843</td>
               <td colspan="2">Trachea Obstruction<br><span class="keyword"> and </span>Stenosis Adverse Event<span class="subclass"> SubClassOf </span>Airway Obstruction<br><span class="keyword"> and </span>Stenosis Adverse Event. <br><i>New Terms: Trachea Obstruction and Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5844</td>
               <td colspan="2">Tray Dosing Unit<span class="subclass"> SubClassOf </span>Potency Unit. <br><i>New Terms: Tray Dosing Unit</i></td>
            </tr>
            <tr class="addition">
               <td>5845</td>
               <td colspan="2">Tremor Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Nervous System. <br><i>New Terms: Tremor Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5846</td>
               <td colspan="2">Trigeminy Adverse Event<span class="subclass"> SubClassOf </span>Ventricular Arrhythmia Adverse Event. <br><i>New Terms: Trigeminy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5847</td>
               <td colspan="2">Trismus Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Musculoskeletal System<br><span class="keyword"> and </span>Soft Tissue. <br><i>New Terms: Trismus Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5848</td>
               <td colspan="2">Trunk Muscle Weakness Not Due to Neuropathy Adverse Event<span class="subclass"> SubClassOf </span>Generalized<br><span class="keyword"> or </span>Specific Area Muscle Weakness Adverse Event Not Due to Neuropathy. <br><i>New Terms: Trunk Muscle Weakness Not Due to Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5849</td>
               <td colspan="2">Tubular Structures of Glycogen-Rich Non-Ciliated Cells Present<span class="subclass"> SubClassOf </span>Abnormal Tissue Present. <br><i>New Terms: Tubular Structures of Glycogen-Rich Non-Ciliated Cells Present</i></td>
            </tr>
            <tr class="addition">
               <td>5850</td>
               <td colspan="2">Tumor Flare Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Syndromes. <br><i>New Terms: Tumor Flare Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5851</td>
               <td colspan="2">Tumor Lysis Syndrome Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Syndromes. <br><i>New Terms: Tumor Lysis Syndrome Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5852</td>
               <td colspan="2">Tumor Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Tumor Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5857</td>
               <td colspan="2">Tumor Replacement<span class="subclass"> SubClassOf </span>Tumor-Associated Process. <br><i>New Terms: Tumor Replacement</i></td>
            </tr>
            <tr class="addition">
               <td>5853</td>
               <td colspan="2">Tumor-Related Protein<span class="subclass"> SubClassOf </span>Gene_Product_Encoded_By_Gene<span class="some"> some </span>Cancer Gene. <br><i>New Terms: Tumor-Related Protein</i></td>
            </tr>
            <tr class="addition">
               <td>5854</td>
               <td colspan="2">Tumor-Related Protein<span class="subclass"> SubClassOf </span>Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Metastasis Induction. <br><i>New Terms: Tumor-Related Protein</i></td>
            </tr>
            <tr class="addition">
               <td>5855</td>
               <td colspan="2">Tumor-Related Protein<span class="subclass"> SubClassOf </span>Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Tumorigenesis. <br><i>New Terms: Tumor-Related Protein</i></td>
            </tr>
            <tr class="addition">
               <td>5856</td>
               <td colspan="2">Tumor-Related Protein<span class="subclass"> SubClassOf </span>Protein, Organized by Function. <br><i>New Terms: Tumor-Related Protein</i></td>
            </tr>
            <tr class="addition">
               <td>5858</td>
               <td colspan="2">Two to 10 Mitoses per 10HPF<span class="subclass"> SubClassOf </span>Mitotic Activity. <br><i>New Terms: Two to 10 Mitoses per 10HPF</i></td>
            </tr>
            <tr class="addition">
               <td>5859</td>
               <td colspan="2">Type II Cell Differentiation<span class="subclass"> SubClassOf </span>Epithelial Differentiation. <br><i>New Terms: Type II Cell Differentiation</i></td>
            </tr>
            <tr class="addition">
               <td>5860</td>
               <td colspan="2">Typhlitis Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Gastrointestinal System. <br><i>New Terms: Typhlitis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5861</td>
               <td colspan="2">Ulceration Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Dermatology<br><span class="keyword"> and </span>Skin. <br><i>New Terms: Ulceration Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5862</td>
               <td colspan="2">Ungual Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Ungual Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5863</td>
               <td colspan="2">Ungual Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Ungual Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5864</td>
               <td colspan="2">Ungual Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Ungual Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5865</td>
               <td colspan="2">Upper Aerodigestive Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Upper Aerodigestive Infection NOS Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5866</td>
               <td colspan="2">Upper Aerodigestive Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Upper Aerodigestive Infection NOS Adverse Event with Normal Absolute Neutrophil Count
                     or Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5867</td>
               <td colspan="2">Upper Aerodigestive Infection NOS Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Upper Aerodigestive Infection NOS Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5868</td>
               <td colspan="2">Upper Aerodigestive NOS Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Upper Aerodigestive NOS Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5869</td>
               <td colspan="2">Upper Airway Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Upper Airway Infection NOS Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5870</td>
               <td colspan="2">Upper Airway Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Upper Airway Infection NOS Adverse Event with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5871</td>
               <td colspan="2">Upper Airway Infection NOS Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Upper Airway Infection NOS Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5872</td>
               <td colspan="2">Upper Airway NOS Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Upper Airway NOS Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5873</td>
               <td colspan="2">Upper Extremity Artery Injury Adverse Event<span class="subclass"> SubClassOf </span>Artery Injury Adverse Event. <br><i>New Terms: Upper Extremity Artery Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5874</td>
               <td colspan="2">Upper Extremity Artery Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Upper Extremity Artery Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5875</td>
               <td colspan="2">Upper Extremity Function Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Musculoskeletal System<br><span class="keyword"> and </span>Soft Tissue. <br><i>New Terms: Upper Extremity Function Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5876</td>
               <td colspan="2">Upper Extremity Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Upper Extremity Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5877</td>
               <td colspan="2">Upper Extremity Muscle Weakness Adverse Event Not Due to Neuropathy<span class="subclass"> SubClassOf </span>Generalized<br><span class="keyword"> or </span>Specific Area Muscle Weakness Adverse Event Not Due to Neuropathy. <br><i>New Terms: Upper Extremity Muscle Weakness Adverse Event Not Due to Neuropathy</i></td>
            </tr>
            <tr class="addition">
               <td>5878</td>
               <td colspan="2">Upper Extremity Soft Tissue Necrosis Adverse Event<span class="subclass"> SubClassOf </span>Soft Tissue Necrosis Adverse Event. <br><i>New Terms: Upper Extremity Soft Tissue Necrosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5879</td>
               <td colspan="2">Upper Extremity Vein Injury Adverse Event<span class="subclass"> SubClassOf </span>Vein Injury Adverse Event. <br><i>New Terms: Upper Extremity Vein Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5880</td>
               <td colspan="2">Upper Extremity Vein Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Upper Extremity Vein Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5881</td>
               <td colspan="2">Upper Gastrointestinal Hemorrhage Adverse Event NOS<span class="subclass"> SubClassOf </span>Gastrointestinal Hemorrhage Adverse Event. <br><i>New Terms: Upper Gastrointestinal Hemorrhage Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>5882</td>
               <td colspan="2">Ureter Fistula Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Fistula Adverse Event. <br><i>New Terms: Ureter Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5883</td>
               <td colspan="2">Ureter Hemorrhage Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Hemorrhage Adverse Event. <br><i>New Terms: Ureter Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5884</td>
               <td colspan="2">Ureter Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Ureter Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5885</td>
               <td colspan="2">Ureter Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Ureter Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5886</td>
               <td colspan="2">Ureter Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Ureter Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5887</td>
               <td colspan="2">Ureter Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Ureter Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5888</td>
               <td colspan="2">Ureter Leak Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Leak Adverse Event Including Anastomotic Leak. <br><i>New Terms: Ureter Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5889</td>
               <td colspan="2">Ureter Obstruction Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Obstruction Adverse Event. <br><i>New Terms: Ureter Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5890</td>
               <td colspan="2">Ureter Perforation Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Perforation Adverse Event. <br><i>New Terms: Ureter Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5891</td>
               <td colspan="2">Ureter Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Stricture<br><span class="keyword"> and </span>Stenosis Adverse Event Including Anastomotic Stricture<br><span class="keyword"> and </span>Stenosis. <br><i>New Terms: Ureter Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5892</td>
               <td colspan="2">Urethra Fistula Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Fistula Adverse Event. <br><i>New Terms: Urethra Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5893</td>
               <td colspan="2">Urethra Hemorrhage Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Hemorrhage Adverse Event. <br><i>New Terms: Urethra Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5894</td>
               <td colspan="2">Urethra Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Urethra Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5895</td>
               <td colspan="2">Urethra Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Urethra Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5896</td>
               <td colspan="2">Urethra Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Urethra Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5897</td>
               <td colspan="2">Urethra Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Urethra Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5898</td>
               <td colspan="2">Urethra Leak Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Leak Adverse Event Including Anastomotic Leak. <br><i>New Terms: Urethra Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5899</td>
               <td colspan="2">Urethra Obstruction Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Obstruction Adverse Event. <br><i>New Terms: Urethra Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5900</td>
               <td colspan="2">Urethra Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Urethra Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5901</td>
               <td colspan="2">Urethra Perforation Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Perforation Adverse Event. <br><i>New Terms: Urethra Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5902</td>
               <td colspan="2">Urethra Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Stricture<br><span class="keyword"> and </span>Stenosis Adverse Event Including Anastomotic Stricture<br><span class="keyword"> and </span>Stenosis. <br><i>New Terms: Urethra Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5903</td>
               <td colspan="2">Urinary Conduit Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Urinary Conduit Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5904</td>
               <td colspan="2">Urinary Electrolyte Wasting Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Kidney<br><span class="keyword"> and </span>Genitourinary System. <br><i>New Terms: Urinary Electrolyte Wasting Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5905</td>
               <td colspan="2">Urinary Frequency<br><span class="keyword"> or </span>Urgency Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Kidney<br><span class="keyword"> and </span>Genitourinary System. <br><i>New Terms: Urinary Frequency or Urgency Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5906</td>
               <td colspan="2">Urinary Hemorrhage Adverse Event NOS<span class="subclass"> SubClassOf </span>Genitourinary Hemorrhage Adverse Event. <br><i>New Terms: Urinary Hemorrhage Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>5907</td>
               <td colspan="2">Urinary Incontinence Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Kidney<br><span class="keyword"> and </span>Genitourinary System. <br><i>New Terms: Urinary Incontinence Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5908</td>
               <td colspan="2">Urinary Retention Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Kidney<br><span class="keyword"> and </span>Genitourinary System. <br><i>New Terms: Urinary Retention Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5909</td>
               <td colspan="2">Urinary Tract Infection NOS Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Urinary Tract Infection NOS Adverse Event Documented Clinically or Microbiologically
                     with Grade 3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5910</td>
               <td colspan="2">Urinary Tract Infection NOS Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Urinary Tract Infection NOS Adverse Event with Normal Absolute Neutrophil Count or
                     Grade 1 or 2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5911</td>
               <td colspan="2">Urinary Tract Infection NOS Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Urinary Tract Infection NOS Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5912</td>
               <td colspan="2">Urinary Tract NOS Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Urinary Tract NOS Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5913</td>
               <td colspan="2">Urine Color Change Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Kidney<br><span class="keyword"> and </span>Genitourinary System. <br><i>New Terms: Urine Color Change Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5914</td>
               <td colspan="2">Urticaria Adverse Reaction<span class="subclass"> SubClassOf </span>Adverse Event Associated with Dermatology<br><span class="keyword"> and </span>Skin. <br><i>New Terms: Urticaria Adverse Reaction</i></td>
            </tr>
            <tr class="addition">
               <td>5915</td>
               <td colspan="2">Uterus Fistula Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Fistula Adverse Event. <br><i>New Terms: Uterus Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5916</td>
               <td colspan="2">Uterus Hemorrhage Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Hemorrhage Adverse Event. <br><i>New Terms: Uterus Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5917</td>
               <td colspan="2">Uterus Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Uterus Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5918</td>
               <td colspan="2">Uterus Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Uterus Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5919</td>
               <td colspan="2">Uterus Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Uterus Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5920</td>
               <td colspan="2">Uterus Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Uterus Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5921</td>
               <td colspan="2">Uterus Leak Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Leak Adverse Event Including Anastomotic Leak. <br><i>New Terms: Uterus Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5922</td>
               <td colspan="2">Uterus Obstruction Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Obstruction Adverse Event. <br><i>New Terms: Uterus Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5923</td>
               <td colspan="2">Uterus Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Uterus Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5924</td>
               <td colspan="2">Uterus Perforation Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Perforation Adverse Event. <br><i>New Terms: Uterus Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5925</td>
               <td colspan="2">Uterus Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Stricture<br><span class="keyword"> and </span>Stenosis Adverse Event Including Anastomotic Stricture<br><span class="keyword"> and </span>Stenosis. <br><i>New Terms: Uterus Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5926</td>
               <td colspan="2">Uveitis Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Ocular<br><span class="keyword"> and </span>Visual Systems. <br><i>New Terms: Uveitis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5927</td>
               <td colspan="2">Vagina Fistula Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Fistula Adverse Event. <br><i>New Terms: Vagina Fistula Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5928</td>
               <td colspan="2">Vagina Hemorrhage Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Hemorrhage Adverse Event. <br><i>New Terms: Vagina Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5929</td>
               <td colspan="2">Vagina Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Vagina Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5930</td>
               <td colspan="2">Vagina Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Vagina Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5931</td>
               <td colspan="2">Vagina Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Vagina Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5932</td>
               <td colspan="2">Vagina Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Vagina Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5933</td>
               <td colspan="2">Vagina Leak Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Leak Adverse Event Including Anastomotic Leak. <br><i>New Terms: Vagina Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5934</td>
               <td colspan="2">Vagina Obstruction Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Obstruction Adverse Event. <br><i>New Terms: Vagina Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5935</td>
               <td colspan="2">Vagina Pain Adverse Event<span class="subclass"> SubClassOf </span>Pain Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Vagina Pain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5936</td>
               <td colspan="2">Vagina Perforation Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Perforation Adverse Event. <br><i>New Terms: Vagina Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5937</td>
               <td colspan="2">Vagina Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Stricture<br><span class="keyword"> and </span>Stenosis Adverse Event Including Anastomotic Stricture<br><span class="keyword"> and </span>Stenosis. <br><i>New Terms: Vagina Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5938</td>
               <td colspan="2">Vaginal Dryness Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Sexual<br><span class="keyword"> and </span>Reproductive Function. <br><i>New Terms: Vaginal Dryness Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5939</td>
               <td colspan="2">Vaginal Mucositis Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Sexual<br><span class="keyword"> and </span>Reproductive Function. <br><i>New Terms: Vaginal Mucositis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5940</td>
               <td colspan="2">Vaginal Stenosis<br><span class="keyword"> and </span>Length Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Sexual<br><span class="keyword"> and </span>Reproductive Function. <br><i>New Terms: Vaginal Stenosis and Length Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5941</td>
               <td colspan="2">Vaginitis Not Due to Infection Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Sexual<br><span class="keyword"> and </span>Reproductive Function. <br><i>New Terms: Vaginitis Not Due to Infection Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5942</td>
               <td colspan="2">Valvular Heart Disease Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Heart in General. <br><i>New Terms: Valvular Heart Disease Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5943</td>
               <td colspan="2">Vas Deferens Hemorrhage Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Hemorrhage Adverse Event. <br><i>New Terms: Vas Deferens Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5944</td>
               <td colspan="2">Vas Deferens Leak Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Leak Adverse Event Including Anastomotic Leak. <br><i>New Terms: Vas Deferens Leak Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5945</td>
               <td colspan="2">Vas Deferens Obstruction Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Obstruction Adverse Event. <br><i>New Terms: Vas Deferens Obstruction Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5946</td>
               <td colspan="2">Vas Deferens Perforation Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Perforation Adverse Event. <br><i>New Terms: Vas Deferens Perforation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5947</td>
               <td colspan="2">Vas Deferens Stricture<br><span class="keyword"> or </span>Stenosis Adverse Event<span class="subclass"> SubClassOf </span>Genitourinary Stricture<br><span class="keyword"> and </span>Stenosis Adverse Event Including Anastomotic Stricture<br><span class="keyword"> and </span>Stenosis. <br><i>New Terms: Vas Deferens Stricture or Stenosis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5948</td>
               <td colspan="2">Vasculitis Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Allergy<br><span class="keyword"> and </span>Immunology. <br><i>New Terms: Vasculitis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5949</td>
               <td colspan="2">Vasovagal Episode Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Cardiac Arrhythmia. <br><i>New Terms: Vasovagal Episode Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5950</td>
               <td colspan="2">Vein Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Vein Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5951</td>
               <td colspan="2">Vein Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Vein Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or 2
                     Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5952</td>
               <td colspan="2">Vein Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Vein Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5953</td>
               <td colspan="2">Vein NOS Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Vein NOS Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5954</td>
               <td colspan="2">Ventricular Arrhythmia Adverse Event NOS<span class="subclass"> SubClassOf </span>Ventricular Arrhythmia Adverse Event. <br><i>New Terms: Ventricular Arrhythmia Adverse Event NOS</i></td>
            </tr>
            <tr class="addition">
               <td>5955</td>
               <td colspan="2">Ventricular Fibrillation Adverse Event<span class="subclass"> SubClassOf </span>Ventricular Arrhythmia Adverse Event. <br><i>New Terms: Ventricular Fibrillation Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5956</td>
               <td colspan="2">Ventricular Flutter Adverse Event<span class="subclass"> SubClassOf </span>Ventricular Arrhythmia Adverse Event. <br><i>New Terms: Ventricular Flutter Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5957</td>
               <td colspan="2">Ventricular Tachycardia Adverse Event<span class="subclass"> SubClassOf </span>Ventricular Arrhythmia Adverse Event. <br><i>New Terms: Ventricular Tachycardia Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5958</td>
               <td colspan="2">Viral Hepatitis Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Infection. <br><i>New Terms: Viral Hepatitis Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5959</td>
               <td colspan="2">Viscera Vein Injury Adverse Event<span class="subclass"> SubClassOf </span>Vein Injury Adverse Event. <br><i>New Terms: Viscera Vein Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5960</td>
               <td colspan="2">Visceral Artery Injury Adverse Event<span class="subclass"> SubClassOf </span>Artery Injury Adverse Event. <br><i>New Terms: Visceral Artery Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5961</td>
               <td colspan="2">Vital Capacity Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Systems. <br><i>New Terms: Vital Capacity Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5962</td>
               <td colspan="2">Vitreous Hemorrhage Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Ocular<br><span class="keyword"> and </span>Visual Systems. <br><i>New Terms: Vitreous Hemorrhage Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5963</td>
               <td colspan="2">Voice Changes<br><span class="keyword"> and </span>Dysarthria Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Pulmonary<br><span class="keyword"> and </span>Upper Respiratory Systems. <br><i>New Terms: Voice Changes and Dysarthria Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5964</td>
               <td colspan="2">Vomiting Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Gastrointestinal System. <br><i>New Terms: Vomiting Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5965</td>
               <td colspan="2">Vulva Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Vulva Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5966</td>
               <td colspan="2">Vulva Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Vulva Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5967</td>
               <td colspan="2">Vulva Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Vulva Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5968</td>
               <td colspan="2">Vulva Intra-Operative Injury Adverse Event<span class="subclass"> SubClassOf </span>Intra-Operative Injury Adverse Event by CTCAE Anatomic Descriptor. <br><i>New Terms: Vulva Intra-Operative Injury Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5969</td>
               <td colspan="2">Weight Gain Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Constitutional Symptoms. <br><i>New Terms: Weight Gain Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5970</td>
               <td colspan="2">Weight Loss Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with Constitutional Symptoms. <br><i>New Terms: Weight Loss Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5971</td>
               <td colspan="2">Wheeze<span class="subclass"> SubClassOf </span>Alteration in Respiration. <br><i>New Terms: Wheeze</i></td>
            </tr>
            <tr class="addition">
               <td>5972</td>
               <td colspan="2">Whole Body<br><span class="keyword"> and </span>Generalized Muscle Weakness Not Due to Neuropathy Adverse Event<span class="subclass"> SubClassOf </span>Generalized<br><span class="keyword"> or </span>Specific Area Muscle Weakness Adverse Event Not Due to Neuropathy. <br><i>New Terms: Whole Body and Generalized Muscle Weakness Not Due to Neuropathy Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5973</td>
               <td colspan="2">Wolff-Parkinson-White Syndrome Adverse Event<span class="subclass"> SubClassOf </span>Conduction Abnormality<br><span class="keyword"> and </span>Atrioventricular Heart Block Adverse Event. <br><i>New Terms: Wolff-Parkinson-White Syndrome Adverse Event</i></td>
            </tr>
            <tr class="addition">
               <td>5974</td>
               <td colspan="2">Wound Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event Documented Clinically<br><span class="keyword"> or </span>Microbiologically with Grade 3<br><span class="keyword"> or </span>4 Neutrophils Absolute Neutrophil Count Less Than 1 X 10e9 per Liter. <br><i>New Terms: Wound Infection Adverse Event Documented Clinically or Microbiologically with Grade
                     3 or 4 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5975</td>
               <td colspan="2">Wound Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils<span class="subclass"> SubClassOf </span>Infection Adverse Event with Normal Absolute Neutrophil Count<br><span class="keyword"> or </span>Grade 1<br><span class="keyword"> or </span>2 Neutrophils. <br><i>New Terms: Wound Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or
                     2 Neutrophils</i></td>
            </tr>
            <tr class="addition">
               <td>5976</td>
               <td colspan="2">Wound Infection Adverse Event with Unknown Absolute Neutrophil Count<span class="subclass"> SubClassOf </span>Infection Adverse Event with Unknown Absolute Neutrophil Count. <br><i>New Terms: Wound Infection Adverse Event with Unknown Absolute Neutrophil Count</i></td>
            </tr>
            <tr class="addition">
               <td>5977</td>
               <td colspan="2">Xerostomia Adverse Event<span class="subclass"> SubClassOf </span>Adverse Event Associated with the Gastrointestinal System. <br><i>New Terms: Xerostomia Adverse Event</i></td>
            </tr>
         </tbody>
         <tbody id="add" style="display:none">
            <tr class="withoutstyle">
               <td colspan="3">
                  <h4 style="display: inline-block;">Pure Additions with Shared Terms (355)</h4> [<a href="#">back to top</a>]
               </td>
            </tr>
            <tr>
               <th class="addition">ID</th>
               <th class="addition" colspan="2">Addition to Ontology 2</th>
            </tr>
            <tr class="addition">
               <td>6332</td>
               <td colspan="2">2-Methoxyestradiol<span class="subclass"> EquivalentTo </span>Selective Estrogen Receptor Modulator<br><span class="keyword"> and </span>Steroid Compound<br><span class="keyword"> and </span>(Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue<span class="some"> some </span>Endothelial Cell)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Mechanism_Of_Action<span class="some"> some </span>Microtubule Dynamics Alteration)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Angiogenic Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>G2 Phase Arrest)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Induction of Apoptosis)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Inhibition of Cell Proliferation)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Mitosis Inhibition). <br></td>
            </tr>
            <tr class="addition">
               <td>5979</td>
               <td colspan="2">AF-6 Protein<span class="subclass"> SubClassOf </span>Extracellular Matrix Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>5980</td>
               <td colspan="2">AGR2 Protein<span class="subclass"> SubClassOf </span>Signaling Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>5981</td>
               <td colspan="2">AGR2 Protein<span class="subclass"> SubClassOf </span>Transcription Factor. <br></td>
            </tr>
            <tr class="addition">
               <td>5983</td>
               <td colspan="2">ANP32C Protein<span class="subclass"> SubClassOf </span>Tumor Suppressor Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>5984</td>
               <td colspan="2">ANP32D Protein<span class="subclass"> SubClassOf </span>Tumor Suppressor Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>5985</td>
               <td colspan="2">ARMET Gene<span class="subclass"> SubClassOf </span>Transcription Regulation Gene. <br></td>
            </tr>
            <tr class="addition">
               <td>5986</td>
               <td colspan="2">ARMET Protein<span class="subclass"> SubClassOf </span>Transcription Factor. <br></td>
            </tr>
            <tr class="addition">
               <td>5987</td>
               <td colspan="2">ATPase, Aminophospholipid Transporter-Like, Class I,<span class="subclass"> Type </span>8A, Member 2<span class="subclass"> SubClassOf </span>Transport Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>5988</td>
               <td colspan="2">Absent in Melanoma 2<span class="subclass"> SubClassOf </span>Cell Cycle Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>5989</td>
               <td colspan="2">Academic Detailing<span class="subclass"> SubClassOf </span>Educational Activity. <br></td>
            </tr>
            <tr class="addition">
               <td>5990</td>
               <td colspan="2">Acetylcysteine<span class="subclass"> SubClassOf </span>Antioxidant. <br></td>
            </tr>
            <tr class="addition">
               <td>5991</td>
               <td colspan="2">Acetylcysteine<span class="subclass"> SubClassOf </span>Expectorant. <br></td>
            </tr>
            <tr class="addition">
               <td>5992</td>
               <td colspan="2">Adenocarcinoma with Squamous Metaplasia<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Squamous Metaplasia. <br></td>
            </tr>
            <tr class="addition">
               <td>5993</td>
               <td colspan="2">Allergic<span class="subclass"> SubClassOf </span>General Qualifier. <br></td>
            </tr>
            <tr class="addition">
               <td>5994</td>
               <td colspan="2">Aminophylline<span class="subclass"> SubClassOf </span>Alkaloid. <br></td>
            </tr>
            <tr class="addition">
               <td>6016</td>
               <td colspan="2">Ankyrin Repeat<span class="subclass"> Domain </span>30A<span class="subclass"> SubClassOf </span>Immunoprotein. <br></td>
            </tr>
            <tr class="addition">
               <td>5995</td>
               <td colspan="2">Anthraquinone Compound<span class="subclass"> SubClassOf </span>Quinone Compound. <br></td>
            </tr>
            <tr class="addition">
               <td>5996</td>
               <td colspan="2">Anti-human Chorionic Gonadotropin Vaccine<span class="subclass"> SubClassOf </span>Peptide Vaccine. <br></td>
            </tr>
            <tr class="addition">
               <td>5997</td>
               <td colspan="2">Apocrine Gland Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Abnormal_Cell<span class="some"> only </span>Apocrine Carcinoma Cell. <br></td>
            </tr>
            <tr class="addition">
               <td>5998</td>
               <td colspan="2">Atorvastatin<span class="subclass"> SubClassOf </span>Chemical_Or_Drug_Has_Mechanism_Of_Action<span class="some"> some </span>Enzyme Inhibition. <br></td>
            </tr>
            <tr class="addition">
               <td>5999</td>
               <td colspan="2">Atorvastatin<span class="subclass"> SubClassOf </span>Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Cholesterol Synthesis Inhibition. <br></td>
            </tr>
            <tr class="addition">
               <td>6000</td>
               <td colspan="2">Atorvastatin<span class="subclass"> SubClassOf </span>Chemical_Or_Drug_Plays_Role_In_Biological_Process<span class="some"> some </span>Cholesterol Homeostasis. <br></td>
            </tr>
            <tr class="addition">
               <td>6001</td>
               <td colspan="2">Atorvastatin<span class="subclass"> SubClassOf </span>Chemical_Or_Drug_Plays_Role_In_Biological_Process<span class="some"> some </span>Triglyceride Metabolism. <br></td>
            </tr>
            <tr class="addition">
               <td>6002</td>
               <td colspan="2">BC-2 Protein<span class="subclass"> SubClassOf </span>Transport Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6003</td>
               <td colspan="2">BCL7A Protein<span class="subclass"> SubClassOf </span>Signaling Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6004</td>
               <td colspan="2">BRMS1 Protein<span class="subclass"> SubClassOf </span>Metastasis Suppressor Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6005</td>
               <td colspan="2">Benign Phyllodes Tumor<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Pushing Tumor Margins Present. <br></td>
            </tr>
            <tr class="addition">
               <td>6006</td>
               <td colspan="2">Benign Respiratory Tract Neoplasm<span class="subclass"> SubClassOf </span>Disease_Excludes_Abnormal_Cell<span class="some"> only </span>Malignant Cell. <br></td>
            </tr>
            <tr class="addition">
               <td>6007</td>
               <td colspan="2">Benign Thoracic Neoplasm<span class="subclass"> SubClassOf </span>Disease_Excludes_Abnormal_Cell<span class="some"> only </span>Malignant Cell. <br></td>
            </tr>
            <tr class="addition">
               <td>6008</td>
               <td colspan="2">Birth<span class="subclass"> SubClassOf </span>Event. <br></td>
            </tr>
            <tr class="addition">
               <td>6009</td>
               <td colspan="2">Bladder Squamous Cell Carcinoma<span class="subclass"> EquivalentTo </span>Bladder Carcinoma<br><span class="keyword"> and </span>Metaplastic Carcinoma<br><span class="keyword"> and </span>Squamous Cell Carcinoma. <br></td>
            </tr>
            <tr class="addition">
               <td>6010</td>
               <td colspan="2">Blue Nevus-Like Melanoma<span class="subclass"> SubClassOf </span>Disease_Has_Associated_Disease<span class="some"> only </span>Cellular Blue Nevus. <br></td>
            </tr>
            <tr class="addition">
               <td>6011</td>
               <td colspan="2">Body Frame Size<span class="subclass"> SubClassOf </span>Personal Attribute. <br></td>
            </tr>
            <tr class="addition">
               <td>6012</td>
               <td colspan="2">Bowman-Birk Inhibitor Concentrate<span class="subclass"> SubClassOf </span>Protease Inhibitor. <br></td>
            </tr>
            <tr class="addition">
               <td>6013</td>
               <td colspan="2">Brain-Specific Angiogenesis Inhibitor 2<span class="subclass"> EquivalentTo </span>Angiogenesis Inhibitory Protein<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>BAI2 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Regulatory Protein)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Angiogenesis). <br></td>
            </tr>
            <tr class="addition">
               <td>6014</td>
               <td colspan="2">Brain-Specific Angiogenesis Inhibitor 3<span class="subclass"> EquivalentTo </span>Angiogenesis Inhibitory Protein<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>BAI3 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Regulatory Protein)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Angiogenesis). <br></td>
            </tr>
            <tr class="addition">
               <td>6015</td>
               <td colspan="2">Breast Cancer Anti-Estrogen Resistance 3<span class="subclass"> SubClassOf </span>Cell Cycle Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6017</td>
               <td colspan="2">Breast Carcinoma Amplified Sequence 2<span class="subclass"> SubClassOf </span>Transcription Regulatory Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6018</td>
               <td colspan="2">Breast Carcinoma Amplified Sequence 3<span class="subclass"> SubClassOf </span>Transcription Regulatory Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6019</td>
               <td colspan="2">Breast Carcinoma Amplified Sequence 4<span class="subclass"> SubClassOf </span>Transcription Regulatory Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6020</td>
               <td colspan="2">Breast Fibroepithelial Neoplasm<span class="subclass"> SubClassOf </span>Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Mammary Gland Tissue. <br></td>
            </tr>
            <tr class="addition">
               <td>6021</td>
               <td colspan="2">Breast Fibroepithelial Neoplasm<span class="subclass"> SubClassOf </span>Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Breast. <br></td>
            </tr>
            <tr class="addition">
               <td>6022</td>
               <td colspan="2">Breast Mucinous Cystadenocarcinoma<span class="subclass"> EquivalentTo </span>Breast Columnar Cell Mucinous Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Cystic Change). <br></td>
            </tr>
            <tr class="addition">
               <td>6222</td>
               <td colspan="2">Breast Phyllodes Tumor<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Painless Mass. <br></td>
            </tr>
            <tr class="addition">
               <td>6023</td>
               <td colspan="2">Bruceantin<span class="subclass"> SubClassOf </span>Protein Synthesis Inhibitor. <br></td>
            </tr>
            <tr class="addition">
               <td>6024</td>
               <td colspan="2">CD3-Epsilon-Associated Protein<span class="subclass"> SubClassOf </span>DNA Repair Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6025</td>
               <td colspan="2">CD3-Epsilon-Associated Protein<span class="subclass"> SubClassOf </span>Initiation Factor. <br></td>
            </tr>
            <tr class="addition">
               <td>6026</td>
               <td colspan="2">CDDO<span class="subclass"> SubClassOf </span>Triterpenoid Compound. <br></td>
            </tr>
            <tr class="addition">
               <td>6027</td>
               <td colspan="2">COX7A2L Protein<span class="subclass"> SubClassOf </span>Oxidoreductase. <br></td>
            </tr>
            <tr class="addition">
               <td>6028</td>
               <td colspan="2">Caffeine<span class="subclass"> SubClassOf </span>Alkaloid. <br></td>
            </tr>
            <tr class="addition">
               <td>6029</td>
               <td colspan="2">Calcified<span class="subclass"> SubClassOf </span>Disease Qualifier. <br></td>
            </tr>
            <tr class="addition">
               <td>6030</td>
               <td colspan="2">Calcineurin B<span class="subclass"> Type </span>II<span class="subclass"> SubClassOf </span>Hydrolase. <br></td>
            </tr>
            <tr class="addition">
               <td>6031</td>
               <td colspan="2">Calcineurin B<span class="subclass"> Type </span>II<span class="subclass"> SubClassOf </span>Signaling Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6032</td>
               <td colspan="2">Calcium Carbonate<span class="subclass"> SubClassOf </span>Nutritional Supplement. <br></td>
            </tr>
            <tr class="addition">
               <td>6033</td>
               <td colspan="2">Calcium Chloride<span class="subclass"> SubClassOf </span>Nutritional Supplement. <br></td>
            </tr>
            <tr class="addition">
               <td>6188</td>
               <td colspan="2">Calmodulin-Like 4 Protein<span class="subclass"> SubClassOf </span>Immunoprotein. <br></td>
            </tr>
            <tr class="addition">
               <td>6034</td>
               <td colspan="2">Cancer/Testis Antigen 1<span class="subclass"> SubClassOf </span>Immunoprotein. <br></td>
            </tr>
            <tr class="addition">
               <td>6035</td>
               <td colspan="2">Cancer/Testis Antigen 1<span class="subclass"> SubClassOf </span>Oncoprotein. <br></td>
            </tr>
            <tr class="addition">
               <td>6036</td>
               <td colspan="2">Carboxyamidotriazole<span class="subclass"> EquivalentTo </span>Angiogenesis Activator Inhibitor<br><span class="keyword"> and </span>Calcium Channel Blocker<br><span class="keyword"> and </span>(Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue<span class="some"> some </span>Endothelial Cell)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue<span class="some"> some </span>Vascular Endothelium)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Affects_Gene_Product<span class="some"> some </span>Non-Voltage-Dependent Calcium Channel)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Mechanism_Of_Action<span class="some"> some </span>Calcium Channel Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Angiogenic Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Signal Transduction Inhibition). <br></td>
            </tr>
            <tr class="addition">
               <td>6037</td>
               <td colspan="2">Carcinoid Tumor<span class="subclass"> SubClassOf </span>Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Neuroendocrine Polygonal Cell. <br></td>
            </tr>
            <tr class="addition">
               <td>6038</td>
               <td colspan="2">Carcinoid Tumor<span class="subclass"> SubClassOf </span>Disease_May_Have_Finding<span class="some"> some </span>Organoid Pattern. <br></td>
            </tr>
            <tr class="addition">
               <td>6039</td>
               <td colspan="2">Carcinoid Tumor<span class="subclass"> SubClassOf </span>Disease_May_Have_Finding<span class="some"> some </span>Rosette Formation. <br></td>
            </tr>
            <tr class="addition">
               <td>6040</td>
               <td colspan="2">Carcinoid Tumor<span class="subclass"> SubClassOf </span>Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern. <br></td>
            </tr>
            <tr class="addition">
               <td>6041</td>
               <td colspan="2">Carcinosarcoma<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Biphasic Pattern. <br></td>
            </tr>
            <tr class="addition">
               <td>6042</td>
               <td colspan="2">Carcinosarcoma<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Carcinomatous Component Present. <br></td>
            </tr>
            <tr class="addition">
               <td>6043</td>
               <td colspan="2">Cardinality<span class="subclass"> SubClassOf </span>Property<br><span class="keyword"> or </span>Attribute. <br></td>
            </tr>
            <tr class="addition">
               <td>6044</td>
               <td colspan="2">Cerebellar-Degeneration-Related Antigen 1<span class="subclass"> SubClassOf </span>Immunoprotein. <br></td>
            </tr>
            <tr class="addition">
               <td>6187</td>
               <td colspan="2">Chromosome 22 Open Reading Frame 19<span class="subclass"> SubClassOf </span>Transcription Factor. <br></td>
            </tr>
            <tr class="addition">
               <td>6045</td>
               <td colspan="2">Co-Investigator<span class="subclass"> SubClassOf </span>Investigator. <br></td>
            </tr>
            <tr class="addition">
               <td>6046</td>
               <td colspan="2">Completion Status<span class="subclass"> SubClassOf </span>Status. <br></td>
            </tr>
            <tr class="addition">
               <td>6047</td>
               <td colspan="2">Conduct Clinical Trials<span class="subclass"> SubClassOf </span>Administrative Activity. <br></td>
            </tr>
            <tr class="addition">
               <td>6048</td>
               <td colspan="2">Conformation<span class="subclass"> SubClassOf </span>Physical Phenomenon<br><span class="keyword"> or </span>Property. <br></td>
            </tr>
            <tr class="addition">
               <td>6049</td>
               <td colspan="2">Conjugated Linoleic Acid<span class="subclass"> SubClassOf </span>Antioxidant. <br></td>
            </tr>
            <tr class="addition">
               <td>6050</td>
               <td colspan="2">Conjugated Linoleic Acid<span class="subclass"> SubClassOf </span>Immunostimulant. <br></td>
            </tr>
            <tr class="addition">
               <td>6051</td>
               <td colspan="2">Connector Enhancer of KSR-Like Protein<span class="subclass"> SubClassOf </span>Adaptor Signaling Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6052</td>
               <td colspan="2">Contract Principal Investigator<span class="subclass"> SubClassOf </span>Investigator. <br></td>
            </tr>
            <tr class="addition">
               <td>6053</td>
               <td colspan="2">Coordinating Investigator<span class="subclass"> SubClassOf </span>Investigator. <br></td>
            </tr>
            <tr class="addition">
               <td>6054</td>
               <td colspan="2">Cribriform<span class="subclass"> SubClassOf </span>Disease Morphology Qualifier. <br></td>
            </tr>
            <tr class="addition">
               <td>6056</td>
               <td colspan="2">Curcumin C3 Complex<span class="subclass"> SubClassOf </span>Chemopreventive Agent. <br></td>
            </tr>
            <tr class="addition">
               <td>6057</td>
               <td colspan="2">Curcumin C3 Complex<span class="subclass"> SubClassOf </span>Polyphenol. <br></td>
            </tr>
            <tr class="addition">
               <td>6055</td>
               <td colspan="2">Curcumin<span class="subclass"> SubClassOf </span>Polyphenol. <br></td>
            </tr>
            <tr class="addition">
               <td>6058</td>
               <td colspan="2">Cystic Hypersecretory Breast Carcinoma<span class="subclass"> SubClassOf </span>Retired Concept. <br></td>
            </tr>
            <tr class="addition">
               <td>6059</td>
               <td colspan="2">DBCCR1 Protein<span class="subclass"> SubClassOf </span>Adaptor Signaling Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6060</td>
               <td colspan="2">DBCCR1 Protein<span class="subclass"> SubClassOf </span>Apoptosis Regulator. <br></td>
            </tr>
            <tr class="addition">
               <td>6061</td>
               <td colspan="2">DCC Protein<span class="subclass"> SubClassOf </span>Translation Process Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6062</td>
               <td colspan="2">DEAD/H Box Protein 1<span class="subclass"> SubClassOf </span>Translation Process Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6063</td>
               <td colspan="2">DEAD/H Box Protein 26<span class="subclass"> SubClassOf </span>Transcription Factor. <br></td>
            </tr>
            <tr class="addition">
               <td>6064</td>
               <td colspan="2">DLEU2 Protein<span class="subclass"> SubClassOf </span>Tumor Suppressor Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6067</td>
               <td colspan="2">Deleted in Split Hand/Split Foot Protein 1<span class="subclass"> SubClassOf </span>Cell Cycle Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6068</td>
               <td colspan="2">Deleted in Split Hand/Split Foot Protein 1<span class="subclass"> SubClassOf </span>Ligand Binding Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6069</td>
               <td colspan="2">Department<span class="subclass"> SubClassOf </span>Professional Organization<br><span class="keyword"> or </span>Group. <br></td>
            </tr>
            <tr class="addition">
               <td>6070</td>
               <td colspan="2">Directionality<span class="subclass"> SubClassOf </span>Characteristic. <br></td>
            </tr>
            <tr class="addition">
               <td>6071</td>
               <td colspan="2">Distance Learning<span class="subclass"> SubClassOf </span>Educational Activity. <br></td>
            </tr>
            <tr class="addition">
               <td>6072</td>
               <td colspan="2">Double<span class="subclass"> SubClassOf </span>Event. <br></td>
            </tr>
            <tr class="addition">
               <td>6073</td>
               <td colspan="2">Dyphylline<span class="subclass"> SubClassOf </span>Alkaloid. <br></td>
            </tr>
            <tr class="addition">
               <td>6076</td>
               <td colspan="2">Educational Intervention<span class="subclass"> SubClassOf </span>Intervention. <br></td>
            </tr>
            <tr class="addition">
               <td>6074</td>
               <td colspan="2">Epidermal Growth Factor Receptor Pathway Substrate 8-Like Protein 1<span class="subclass"> SubClassOf </span>Growth Factor Receptor. <br></td>
            </tr>
            <tr class="addition">
               <td>6075</td>
               <td colspan="2">Epidermal Growth Factor Receptor Pathway Substrate 8-Like Protein 2<span class="subclass"> SubClassOf </span>Growth Factor Receptor. <br></td>
            </tr>
            <tr class="addition">
               <td>6077</td>
               <td colspan="2">Epidermal Growth Factor-Like Protein 6<span class="subclass"> SubClassOf </span>Growth Factor Receptor. <br></td>
            </tr>
            <tr class="addition">
               <td>6078</td>
               <td colspan="2">Epigallocatechin Gallate<span class="subclass"> SubClassOf </span>Antioxidant. <br></td>
            </tr>
            <tr class="addition">
               <td>6079</td>
               <td colspan="2">Epigallocatechin Gallate<span class="subclass"> SubClassOf </span>Flavonoid. <br></td>
            </tr>
            <tr class="addition">
               <td>6083</td>
               <td colspan="2">Epithelial Stromal Interaction 1<span class="subclass"> SubClassOf </span>Signaling Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6080</td>
               <td colspan="2">Epithelial-Myoepithelial Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Myoepithelial Cell. <br></td>
            </tr>
            <tr class="addition">
               <td>6081</td>
               <td colspan="2">Epithelial-Myoepithelial Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Epithelial Clear Cell. <br></td>
            </tr>
            <tr class="addition">
               <td>6082</td>
               <td colspan="2">Epithelial-Myoepithelial Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Epithelial Spindle Cell. <br></td>
            </tr>
            <tr class="addition">
               <td>6084</td>
               <td colspan="2">Eplerenone<span class="subclass"> SubClassOf </span>Steroid Compound. <br></td>
            </tr>
            <tr class="addition">
               <td>6085</td>
               <td colspan="2">FGFR1 Oncogene Partner<span class="subclass"> SubClassOf </span>Transport Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6086</td>
               <td colspan="2">FUS-1 Protein<span class="subclass"> SubClassOf </span>Tumor Suppressor Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6088</td>
               <td colspan="2">Female Gender<span class="subclass"> SubClassOf </span>Female. <br></td>
            </tr>
            <tr class="addition">
               <td>6089</td>
               <td colspan="2">Female Phenotype<span class="subclass"> SubClassOf </span>Female. <br></td>
            </tr>
            <tr class="addition">
               <td>6090</td>
               <td colspan="2">Female, Self-Report<span class="subclass"> SubClassOf </span>Female. <br></td>
            </tr>
            <tr class="addition">
               <td>6087</td>
               <td colspan="2">Female-to-Male Transsexual Phenotype<span class="subclass"> SubClassOf </span>Transsexual. <br></td>
            </tr>
            <tr class="addition">
               <td>6091</td>
               <td colspan="2">Fibroepithelial Neoplasm<span class="subclass"> SubClassOf </span>Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Epithelial Cell. <br></td>
            </tr>
            <tr class="addition">
               <td>6092</td>
               <td colspan="2">Fibroepithelial Neoplasm<span class="subclass"> SubClassOf </span>Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Stromal Cell. <br></td>
            </tr>
            <tr class="addition">
               <td>6093</td>
               <td colspan="2">Fibroepithelial Neoplasm<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Biphasic Pattern. <br></td>
            </tr>
            <tr class="addition">
               <td>6094</td>
               <td colspan="2">Fibroepithelial Neoplasm<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Epithelial Component Present. <br></td>
            </tr>
            <tr class="addition">
               <td>6095</td>
               <td colspan="2">Fibroepithelial Neoplasm<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Mesenchymal Component Present. <br></td>
            </tr>
            <tr class="addition">
               <td>6096</td>
               <td colspan="2">Fibroepithelial Neoplasm<span class="subclass"> SubClassOf </span>Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Epithelial Cell. <br></td>
            </tr>
            <tr class="addition">
               <td>6097</td>
               <td colspan="2">Fibroepithelial Neoplasm<span class="subclass"> SubClassOf </span>Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Stromal Cell. <br></td>
            </tr>
            <tr class="addition">
               <td>6098</td>
               <td colspan="2">Finasteride<span class="subclass"> SubClassOf </span>Steroid Compound. <br></td>
            </tr>
            <tr class="addition">
               <td>6099</td>
               <td colspan="2">Five-A-Day Program<span class="subclass"> SubClassOf </span>Educational Intervention. <br></td>
            </tr>
            <tr class="addition">
               <td>6100</td>
               <td colspan="2">Flavopiridol<span class="subclass"> SubClassOf </span>Antioxidant. <br></td>
            </tr>
            <tr class="addition">
               <td>6101</td>
               <td colspan="2">Flavopiridol<span class="subclass"> SubClassOf </span>Flavonoid. <br></td>
            </tr>
            <tr class="addition">
               <td>6102</td>
               <td colspan="2">Folate<span class="subclass"> SubClassOf </span>B Vitamin. <br></td>
            </tr>
            <tr class="addition">
               <td>6103</td>
               <td colspan="2">Follicular Variant Translocation Protein 1<span class="subclass"> SubClassOf </span>Oxidoreductase. <br></td>
            </tr>
            <tr class="addition">
               <td>6104</td>
               <td colspan="2">GAGED3 Protein<span class="subclass"> SubClassOf </span>Immunoprotein. <br></td>
            </tr>
            <tr class="addition">
               <td>6107</td>
               <td colspan="2">Garlic Extract<span class="subclass"> SubClassOf </span>Antioxidant. <br></td>
            </tr>
            <tr class="addition">
               <td>6108</td>
               <td colspan="2">Genistein<span class="subclass"> SubClassOf </span>Selective Estrogen Receptor Modulator. <br></td>
            </tr>
            <tr class="addition">
               <td>6106</td>
               <td colspan="2">Glioma Tumor Suppressor Candidate Region Gene 2 Protein<span class="subclass"> SubClassOf </span>Phosphotransferase. <br></td>
            </tr>
            <tr class="addition">
               <td>6109</td>
               <td colspan="2">Glomulin<span class="subclass"> SubClassOf </span>Signaling Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6110</td>
               <td colspan="2">Glycoprotein A33<span class="subclass"> SubClassOf </span>Immunoprotein. <br></td>
            </tr>
            <tr class="addition">
               <td>6111</td>
               <td colspan="2">Golgi-Associated PR-1 Protein<span class="subclass"> SubClassOf </span>Immunoprotein. <br></td>
            </tr>
            <tr class="addition">
               <td>6112</td>
               <td colspan="2">Grant Investigator<span class="subclass"> SubClassOf </span>Investigator. <br></td>
            </tr>
            <tr class="addition">
               <td>6113</td>
               <td colspan="2">Grant Principal Investigator<span class="subclass"> SubClassOf </span>Investigator. <br></td>
            </tr>
            <tr class="addition">
               <td>6114</td>
               <td colspan="2">Green Tea Extract<span class="subclass"> SubClassOf </span>Antioxidant. <br></td>
            </tr>
            <tr class="addition">
               <td>6115</td>
               <td colspan="2">Green Tea Extract<span class="subclass"> SubClassOf </span>Fruit<br><span class="keyword"> and </span>Vegetable Extracts. <br></td>
            </tr>
            <tr class="addition">
               <td>6116</td>
               <td colspan="2">Growth Arrest-Specific Protein 8<span class="subclass"> SubClassOf </span>Cell Cycle Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6117</td>
               <td colspan="2">Halofuginone<span class="subclass"> EquivalentTo </span>Alkaloid<br><span class="keyword"> and </span>Angiogenesis Activator Inhibitor<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Mechanism_Of_Action<span class="some"> some </span>Transcriptional Repression)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Angiogenic Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Metastasis Suppression)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Signal Transduction Inhibition). <br></td>
            </tr>
            <tr class="addition">
               <td>6118</td>
               <td colspan="2">Haptoglobin-Related Protein<span class="subclass"> SubClassOf </span>Serine Protease. <br></td>
            </tr>
            <tr class="addition">
               <td>6119</td>
               <td colspan="2">Hereditary Thyroid Gland Medullary Carcinoma<span class="subclass"> EquivalentTo </span>Bilateral Carcinoma<br><span class="keyword"> and </span>Hereditary Malignant Neoplasm<br><span class="keyword"> and </span>Thyroid Gland Medullary Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Neoplastic C-Cell Hyperplasia)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>RET Gene Mutation). <br></td>
            </tr>
            <tr class="addition">
               <td>6120</td>
               <td colspan="2">Heterogeneous Nuclear Ribonucleoprotein A3<span class="subclass"> SubClassOf </span>Transport Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6121</td>
               <td colspan="2">High Throughput Screening<span class="subclass"> SubClassOf </span>Disease Screening. <br></td>
            </tr>
            <tr class="addition">
               <td>6123</td>
               <td colspan="2">Immune<span class="subclass"> SubClassOf </span>General Qualifier. <br></td>
            </tr>
            <tr class="addition">
               <td>6124</td>
               <td colspan="2">Indigenous<span class="subclass"> SubClassOf </span>General Qualifier. <br></td>
            </tr>
            <tr class="addition">
               <td>6125</td>
               <td colspan="2">Intake<span class="subclass"> SubClassOf </span>Action. <br></td>
            </tr>
            <tr class="addition">
               <td>6126</td>
               <td colspan="2">Intracavitary<span class="subclass"> SubClassOf </span>Anatomy Qualifier. <br></td>
            </tr>
            <tr class="addition">
               <td>6127</td>
               <td colspan="2">Intracellular<span class="subclass"> SubClassOf </span>Anatomy Qualifier. <br></td>
            </tr>
            <tr class="addition">
               <td>6128</td>
               <td colspan="2">Intradermal<span class="subclass"> SubClassOf </span>Anatomy Qualifier. <br></td>
            </tr>
            <tr class="addition">
               <td>6129</td>
               <td colspan="2">Intraductal Breast Neoplasm<span class="subclass"> SubClassOf </span>Disease_Excludes_Finding<span class="some"> only </span>Invasive Lesion. <br></td>
            </tr>
            <tr class="addition">
               <td>6130</td>
               <td colspan="2">Intralesional<span class="subclass"> SubClassOf </span>Anatomy Qualifier. <br></td>
            </tr>
            <tr class="addition">
               <td>6131</td>
               <td colspan="2">Intratumoral<span class="subclass"> SubClassOf </span>Anatomy Qualifier. <br></td>
            </tr>
            <tr class="addition">
               <td>6132</td>
               <td colspan="2">JAW1-Related Protein<span class="subclass"> SubClassOf </span>Signaling Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6133</td>
               <td colspan="2">Key<span class="subclass"> SubClassOf </span>Value. <br></td>
            </tr>
            <tr class="addition">
               <td>6134</td>
               <td colspan="2">KiSS1 Metastasis Suppressor Protein<span class="subclass"> SubClassOf </span>Metastasis Suppressor Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6135</td>
               <td colspan="2">LIM<span class="subclass"> Domain </span>Protein<span class="subclass"> SubClassOf </span>Extracellular Matrix Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6136</td>
               <td colspan="2">Large Cell Carcinoma<span class="subclass"> SubClassOf </span>Disease_Excludes_Finding<span class="some"> only </span>Glandular Differentiation. <br></td>
            </tr>
            <tr class="addition">
               <td>6137</td>
               <td colspan="2">Large Cell Carcinoma<span class="subclass"> SubClassOf </span>Disease_Excludes_Finding<span class="some"> only </span>Squamous Differentiation. <br></td>
            </tr>
            <tr class="addition">
               <td>6138</td>
               <td colspan="2">Large Cell Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Large Cell. <br></td>
            </tr>
            <tr class="addition">
               <td>6139</td>
               <td colspan="2">Large Cell Neuroendocrine Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Neuroendocrine Large Cell. <br></td>
            </tr>
            <tr class="addition">
               <td>6140</td>
               <td colspan="2">Large Cell Neuroendocrine Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Peripheral Nuclear Palisading. <br></td>
            </tr>
            <tr class="addition">
               <td>6141</td>
               <td colspan="2">Large Cell Neuroendocrine Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Rosette Formation. <br></td>
            </tr>
            <tr class="addition">
               <td>6142</td>
               <td colspan="2">Large Cell Neuroendocrine Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Sheet-Like Growth Pattern. <br></td>
            </tr>
            <tr class="addition">
               <td>6143</td>
               <td colspan="2">Large Cell Neuroendocrine Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Trabecular Pattern. <br></td>
            </tr>
            <tr class="addition">
               <td>6146</td>
               <td colspan="2">Leucine Rich Repeat Containing Protein 17<span class="subclass"> SubClassOf </span>Cell Cycle Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6147</td>
               <td colspan="2">Leucine Rich Repeat Neuronal 5 Protein<span class="subclass"> SubClassOf </span>Signaling Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6144</td>
               <td colspan="2">Leucine-Rich Glioma-Inactivated Protein<span class="subclass"> SubClassOf </span>Neuropeptide. <br></td>
            </tr>
            <tr class="addition">
               <td>6145</td>
               <td colspan="2">Leucine-Rich Repeat Transmembrane Protein FLRT3<span class="subclass"> SubClassOf </span>Apoptosis Regulator. <br></td>
            </tr>
            <tr class="addition">
               <td>6148</td>
               <td colspan="2">Localized Resectable Adult Liver Cancer<span class="subclass"> EquivalentTo </span>Adult Liver Carcinoma<br><span class="keyword"> and </span>Localized Carcinoma<br><span class="keyword"> and </span>Resectable Hepatic Malignant Neoplasm. <br></td>
            </tr>
            <tr class="addition">
               <td>6150</td>
               <td colspan="2">Localized Unresectable Adult Liver Cancer<span class="subclass"> EquivalentTo </span>Adult Liver Carcinoma<br><span class="keyword"> and </span>Localized Carcinoma<br><span class="keyword"> and </span>Non-Resectable Hepatic Malignant Neoplasm. <br></td>
            </tr>
            <tr class="addition">
               <td>6149</td>
               <td colspan="2">Localized Urothelial Carcinoma of the Renal Pelvis<br><span class="keyword"> and </span>Ureter<span class="subclass"> EquivalentTo </span>Localized Carcinoma<br><span class="keyword"> and </span>Renal Pelvis<br><span class="keyword"> and </span>Ureter Urothelial Carcinoma. <br></td>
            </tr>
            <tr class="addition">
               <td>6151</td>
               <td colspan="2">Login Name<span class="subclass"> SubClassOf </span>Person Name. <br></td>
            </tr>
            <tr class="addition">
               <td>6152</td>
               <td colspan="2">MAGE-12 Antigen<span class="subclass"> SubClassOf </span>Immunoprotein. <br></td>
            </tr>
            <tr class="addition">
               <td>6153</td>
               <td colspan="2">MAGE-3.1 Antigen<span class="subclass"> SubClassOf </span>Immunoprotein. <br></td>
            </tr>
            <tr class="addition">
               <td>6154</td>
               <td colspan="2">MASL1 Protein<span class="subclass"> SubClassOf </span>Cell Cycle Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6155</td>
               <td colspan="2">MCC Protein<span class="subclass"> SubClassOf </span>Cell Cycle Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6156</td>
               <td colspan="2">MCT-1 Protein<span class="subclass"> SubClassOf </span>Cell Cycle Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6157</td>
               <td colspan="2">MLN51 Protein<span class="subclass"> SubClassOf </span>Transport Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6158</td>
               <td colspan="2">MLSN1<br><span class="keyword"> and </span>TRP-Related Protein<span class="subclass"> SubClassOf </span>Ion Channel Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6159</td>
               <td colspan="2">MYB Binding Protein 1A<span class="subclass"> SubClassOf </span>Transcription Factor. <br></td>
            </tr>
            <tr class="addition">
               <td>6161</td>
               <td colspan="2">Male Gender<span class="subclass"> SubClassOf </span>Male. <br></td>
            </tr>
            <tr class="addition">
               <td>6162</td>
               <td colspan="2">Male Phenotype<span class="subclass"> SubClassOf </span>Male. <br></td>
            </tr>
            <tr class="addition">
               <td>6163</td>
               <td colspan="2">Male, Self-Report<span class="subclass"> SubClassOf </span>Male. <br></td>
            </tr>
            <tr class="addition">
               <td>6160</td>
               <td colspan="2">Male-to-Female Transsexual Phenotype<span class="subclass"> SubClassOf </span>Transsexual. <br></td>
            </tr>
            <tr class="addition">
               <td>6164</td>
               <td colspan="2">Malignant Apocrine Neoplasm<span class="subclass"> SubClassOf </span>Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Cell. <br></td>
            </tr>
            <tr class="addition">
               <td>6165</td>
               <td colspan="2">Malignant Eccrine Neoplasm<span class="subclass"> SubClassOf </span>Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Cell. <br></td>
            </tr>
            <tr class="addition">
               <td>6186</td>
               <td colspan="2">Malignant Myoepithelioma<span class="subclass"> SubClassOf </span>Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Myoepithelial Cell. <br></td>
            </tr>
            <tr class="addition">
               <td>6166</td>
               <td colspan="2">Malignant Phyllodes Tumor<span class="subclass"> SubClassOf </span>Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Stromal Cell. <br></td>
            </tr>
            <tr class="addition">
               <td>6167</td>
               <td colspan="2">Malignant Phyllodes Tumor<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Infiltrating Tumor Margins Present. <br></td>
            </tr>
            <tr class="addition">
               <td>6168</td>
               <td colspan="2">Malignant Sebocyte<span class="subclass"> SubClassOf </span>Adenocarcinoma Cell. <br></td>
            </tr>
            <tr class="addition">
               <td>6169</td>
               <td colspan="2">Malignant Skin Appendage Neoplasm<span class="subclass"> SubClassOf </span>Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Cell. <br></td>
            </tr>
            <tr class="addition">
               <td>6170</td>
               <td colspan="2">Marker Discovery<span class="subclass"> SubClassOf </span>Biomedical Research. <br></td>
            </tr>
            <tr class="addition">
               <td>6171</td>
               <td colspan="2">Matrix Gla Protein<span class="subclass"> SubClassOf </span>Extracellular Matrix Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6172</td>
               <td colspan="2">Mature T-Cell Proliferation 1 Protein<span class="subclass"> SubClassOf </span>Cell Cycle Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6173</td>
               <td colspan="2">Melan-A Protein<span class="subclass"> SubClassOf </span>Immunoprotein. <br></td>
            </tr>
            <tr class="addition">
               <td>6174</td>
               <td colspan="2">Melanocyte Lineage-Specific Antigen gp100<span class="subclass"> SubClassOf </span>Immunoprotein. <br></td>
            </tr>
            <tr class="addition">
               <td>6175</td>
               <td colspan="2">Melanoma Adhesion Molecule<span class="subclass"> SubClassOf </span>Cell Adhesion Molecule. <br></td>
            </tr>
            <tr class="addition">
               <td>6176</td>
               <td colspan="2">Melanoma Biomarker<span class="subclass"> SubClassOf </span>Tumor Marker. <br></td>
            </tr>
            <tr class="addition">
               <td>6177</td>
               <td colspan="2">Mesothelin<span class="subclass"> SubClassOf </span>Immunoprotein. <br></td>
            </tr>
            <tr class="addition">
               <td>6178</td>
               <td colspan="2">Misoprostol<span class="subclass"> SubClassOf </span>Anti-ulcer Agent. <br></td>
            </tr>
            <tr class="addition">
               <td>6179</td>
               <td colspan="2">Misoprostol<span class="subclass"> SubClassOf </span>Prostaglandin Compound. <br></td>
            </tr>
            <tr class="addition">
               <td>6180</td>
               <td colspan="2">Module<span class="subclass"> SubClassOf </span>Conceptual Entity. <br></td>
            </tr>
            <tr class="addition">
               <td>6181</td>
               <td colspan="2">Mucinous Tubular<br><span class="keyword"> and </span>Spindle Renal Cell Carcinoma<span class="subclass"> SubClassOf </span>Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Loss of Chromosome Y. <br></td>
            </tr>
            <tr class="addition">
               <td>6182</td>
               <td colspan="2">Multiplicity<span class="subclass"> SubClassOf </span>Property<br><span class="keyword"> or </span>Attribute. <br></td>
            </tr>
            <tr class="addition">
               <td>6183</td>
               <td colspan="2">Musculin<span class="subclass"> SubClassOf </span>Transcription Factor. <br></td>
            </tr>
            <tr class="addition">
               <td>6184</td>
               <td colspan="2">Myelin Protein Zero-Like 1<span class="subclass"> SubClassOf </span>Immunoprotein. <br></td>
            </tr>
            <tr class="addition">
               <td>5982</td>
               <td colspan="2">Myeloid/Lymphoid<br><span class="keyword"> or </span>Mixed-Lineage Leukemia Protein 2<span class="subclass"> SubClassOf </span>Methyltransferase. <br></td>
            </tr>
            <tr class="addition">
               <td>6185</td>
               <td colspan="2">Myoepithelial<span class="subclass"> SubClassOf </span>Anatomy Qualifier. <br></td>
            </tr>
            <tr class="addition">
               <td>6191</td>
               <td colspan="2">Netrin 1<span class="subclass"> SubClassOf </span>Neuropeptide. <br></td>
            </tr>
            <tr class="addition">
               <td>6192</td>
               <td colspan="2">Neural Network<span class="subclass"> SubClassOf </span>Algorithm. <br></td>
            </tr>
            <tr class="addition">
               <td>6193</td>
               <td colspan="2">Neuroendocrine Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Neuroendocrine Differentiation. <br></td>
            </tr>
            <tr class="addition">
               <td>6194</td>
               <td colspan="2">Neuroepithelial<span class="subclass"> SubClassOf </span>Anatomy Qualifier. <br></td>
            </tr>
            <tr class="addition">
               <td>6195</td>
               <td colspan="2">Niacinamide<span class="subclass"> SubClassOf </span>Antioxidant. <br></td>
            </tr>
            <tr class="addition">
               <td>6196</td>
               <td colspan="2">Nicotine<span class="subclass"> SubClassOf </span>Cholinergic Agonist. <br></td>
            </tr>
            <tr class="addition">
               <td>6197</td>
               <td colspan="2">Nimesulide<span class="subclass"> SubClassOf </span>Phenol Compound. <br></td>
            </tr>
            <tr class="addition">
               <td>6198</td>
               <td colspan="2">Non-Surgical<span class="subclass"> SubClassOf </span>Disease Qualifier. <br></td>
            </tr>
            <tr class="addition">
               <td>6199</td>
               <td colspan="2">Nonprofit Organization<span class="subclass"> SubClassOf </span>Professional Organization<br><span class="keyword"> or </span>Group. <br></td>
            </tr>
            <tr class="addition">
               <td>6200</td>
               <td colspan="2">Nordihydroguaiaretic Acid<span class="subclass"> SubClassOf </span>Lignans. <br></td>
            </tr>
            <tr class="addition">
               <td>6201</td>
               <td colspan="2">Nordihydroguaiaretic Acid<span class="subclass"> SubClassOf </span>Lipooxygenase Inhibitor. <br></td>
            </tr>
            <tr class="addition">
               <td>6202</td>
               <td colspan="2">Nuclear LIM Interactor-Interacting Factor 2<span class="subclass"> SubClassOf </span>Hydrolase. <br></td>
            </tr>
            <tr class="addition">
               <td>6203</td>
               <td colspan="2">Nuclear LIM Interactor-Interacting Factor 2<span class="subclass"> SubClassOf </span>Transcription Factor. <br></td>
            </tr>
            <tr class="addition">
               <td>6204</td>
               <td colspan="2">Nuclear Receptor Binding Protein<span class="subclass"> SubClassOf </span>Transport Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6205</td>
               <td colspan="2">OBTP Protein<span class="subclass"> SubClassOf </span>Signaling Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6326</td>
               <td colspan="2">Oncogenes, Other<span class="subclass"> SubClassOf </span>Retired Concept. <br></td>
            </tr>
            <tr class="addition">
               <td>6206</td>
               <td colspan="2">Organizational Unit<span class="subclass"> SubClassOf </span>Professional Organization<br><span class="keyword"> or </span>Group. <br></td>
            </tr>
            <tr class="addition">
               <td>6207</td>
               <td colspan="2">Other Types of Training<span class="subclass"> SubClassOf </span>Funding Category. <br></td>
            </tr>
            <tr class="addition">
               <td>6208</td>
               <td colspan="2">Oxyphilic Adenocarcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Oncocyte. <br></td>
            </tr>
            <tr class="addition">
               <td>6209</td>
               <td colspan="2">PHAPI2 Protein<span class="subclass"> SubClassOf </span>Apoptosis Regulator. <br></td>
            </tr>
            <tr class="addition">
               <td>6210</td>
               <td colspan="2">PVT1 Protein<span class="subclass"> SubClassOf </span>Transcription Factor. <br></td>
            </tr>
            <tr class="addition">
               <td>5978</td>
               <td colspan="2">Paclitaxel Albumin-Stabilized Nanoparticle Formulation<span class="subclass"> SubClassOf </span>Nanoparticle-targeted Drug. <br></td>
            </tr>
            <tr class="addition">
               <td>6211</td>
               <td colspan="2">Parafibromin<span class="subclass"> SubClassOf </span>Transcription Factor. <br></td>
            </tr>
            <tr class="addition">
               <td>6212</td>
               <td colspan="2">Party<span class="subclass"> SubClassOf </span>Name. <br></td>
            </tr>
            <tr class="addition">
               <td>6213</td>
               <td colspan="2">Pentoxifylline<span class="subclass"> SubClassOf </span>Alkaloid. <br></td>
            </tr>
            <tr class="addition">
               <td>6214</td>
               <td colspan="2">Pentoxifylline<span class="subclass"> SubClassOf </span>Phosphodiesterase Inhibitor. <br></td>
            </tr>
            <tr class="addition">
               <td>6215</td>
               <td colspan="2">Peptide Conformation<span class="subclass"> SubClassOf </span>Conformation. <br></td>
            </tr>
            <tr class="addition">
               <td>6216</td>
               <td colspan="2">Perillyl Alcohol<span class="subclass"> EquivalentTo </span>Farnesyl Transferase Inhibitor<br><span class="keyword"> and </span>Terpene Compound<br><span class="keyword"> and </span>(Chemical_Or_Drug_Affects_Gene_Product<span class="some"> some </span>Farnesyl Protein Transferase)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Affects_Gene_Product<span class="some"> some </span>Geranylgeranyl Transferase)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Mechanism_Of_Action<span class="some"> some </span>Enzyme Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Cell Differentiation Induction)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Farnesylation Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>G1 Arrest)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Isoprenylation Inhibition). <br></td>
            </tr>
            <tr class="addition">
               <td>6217</td>
               <td colspan="2">Perioperative<span class="subclass"> SubClassOf </span>Temporal Qualifier. <br></td>
            </tr>
            <tr class="addition">
               <td>6218</td>
               <td colspan="2">Permissible Value<span class="subclass"> SubClassOf </span>Value. <br></td>
            </tr>
            <tr class="addition">
               <td>6190</td>
               <td colspan="2">Person Name<span class="subclass"> SubClassOf </span>Name. <br></td>
            </tr>
            <tr class="addition">
               <td>6219</td>
               <td colspan="2">Phenethyl Isothiocyanate<span class="subclass"> SubClassOf </span>Isothiocyanate. <br></td>
            </tr>
            <tr class="addition">
               <td>6220</td>
               <td colspan="2">Phenylalanyl-tRNA Synthetase Beta-Subunit<span class="subclass"> SubClassOf </span>Translation Process Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6221</td>
               <td colspan="2">Phyllodes Tumor<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Well-Circumscribed Lesion. <br></td>
            </tr>
            <tr class="addition">
               <td>6223</td>
               <td colspan="2">Piroxicam<span class="subclass"> SubClassOf </span>Aromatic Compounds. <br></td>
            </tr>
            <tr class="addition">
               <td>6224</td>
               <td colspan="2">Postmeiotic Segregation Increased 2-Like Protein 1<span class="subclass"> SubClassOf </span>DNA Repair Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6225</td>
               <td colspan="2">Praziquantel<span class="subclass"> SubClassOf </span>Quinolone Compound. <br></td>
            </tr>
            <tr class="addition">
               <td>6226</td>
               <td colspan="2">Pregnant Mare Serum Gonadotropin<span class="subclass"> SubClassOf </span>Recombinant Follicle Stimulating Hormone. <br></td>
            </tr>
            <tr class="addition">
               <td>6227</td>
               <td colspan="2">Primary Key<span class="subclass"> SubClassOf </span>Key. <br></td>
            </tr>
            <tr class="addition">
               <td>6228</td>
               <td colspan="2">Primary Site Unknown<span class="subclass"> SubClassOf </span>Finding by Site<br><span class="keyword"> or </span>System. <br></td>
            </tr>
            <tr class="addition">
               <td>6229</td>
               <td colspan="2">Primary Squamous Cell Breast Carcinoma<span class="subclass"> SubClassOf </span>Retired Concept. <br></td>
            </tr>
            <tr class="addition">
               <td>6230</td>
               <td colspan="2">Principal Investigator<span class="subclass"> SubClassOf </span>Investigator. <br></td>
            </tr>
            <tr class="addition">
               <td>6231</td>
               <td colspan="2">Probability<span class="subclass"> SubClassOf </span>Property<br><span class="keyword"> or </span>Attribute. <br></td>
            </tr>
            <tr class="addition">
               <td>6232</td>
               <td colspan="2">Prognostic Factor<span class="subclass"> SubClassOf </span>Predictive Factor. <br></td>
            </tr>
            <tr class="addition">
               <td>6233</td>
               <td colspan="2">Programmed Death Ligand 2 Protein<span class="subclass"> SubClassOf </span>Immunoprotein. <br></td>
            </tr>
            <tr class="addition">
               <td>6234</td>
               <td colspan="2">Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function<span class="subclass"> SubClassOf </span>Retired Concept. <br></td>
            </tr>
            <tr class="addition">
               <td>6235</td>
               <td colspan="2">Protocol Lead Investigator<span class="subclass"> SubClassOf </span>Investigator. <br></td>
            </tr>
            <tr class="addition">
               <td>6236</td>
               <td colspan="2">Proximity<span class="subclass"> SubClassOf </span>Property<br><span class="keyword"> or </span>Attribute. <br></td>
            </tr>
            <tr class="addition">
               <td>6237</td>
               <td colspan="2">Putative Transmembrane Protein NMA<span class="subclass"> SubClassOf </span>Signaling Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6238</td>
               <td colspan="2">R-flurbiprofen<span class="subclass"> SubClassOf </span>Cyclooxygenase Inhibitor. <br></td>
            </tr>
            <tr class="addition">
               <td>6241</td>
               <td colspan="2">RAS Suppressor Protein 1<span class="subclass"> SubClassOf </span>Signaling Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6239</td>
               <td colspan="2">RAS-Like Protein RRP22<span class="subclass"> SubClassOf </span>RAS Superfamily Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6240</td>
               <td colspan="2">RAS-Related GTP-Binding Protein RAGA<span class="subclass"> SubClassOf </span>RAS Superfamily Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6242</td>
               <td colspan="2">RNA Conformation<span class="subclass"> SubClassOf </span>Conformation. <br></td>
            </tr>
            <tr class="addition">
               <td>6243</td>
               <td colspan="2">Razoxane<span class="subclass"> SubClassOf </span>Topoisomerase-II Inhibitor. <br></td>
            </tr>
            <tr class="addition">
               <td>6244</td>
               <td colspan="2">Relapse<span class="subclass"> SubClassOf </span>Retired Concept. <br></td>
            </tr>
            <tr class="addition">
               <td>6245</td>
               <td colspan="2">Reproducibility<span class="subclass"> SubClassOf </span>Property<br><span class="keyword"> or </span>Attribute. <br></td>
            </tr>
            <tr class="addition">
               <td>6246</td>
               <td colspan="2">Research Training<span class="subclass"> SubClassOf </span>Funding Category. <br></td>
            </tr>
            <tr class="addition">
               <td>6247</td>
               <td colspan="2">Resveratrol<span class="subclass"> SubClassOf </span>Chemical_Or_Drug_Affects_Gene_Product<span class="some"> some </span>Aromatase Cytochrome P450. <br></td>
            </tr>
            <tr class="addition">
               <td>6248</td>
               <td colspan="2">Resveratrol<span class="subclass"> SubClassOf </span>Chemical_Or_Drug_Has_Mechanism_Of_Action<span class="some"> some </span>Gene Expression Alteration. <br></td>
            </tr>
            <tr class="addition">
               <td>6249</td>
               <td colspan="2">Resveratrol<span class="subclass"> SubClassOf </span>Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Antiinflammatory Effect. <br></td>
            </tr>
            <tr class="addition">
               <td>6250</td>
               <td colspan="2">Resveratrol<span class="subclass"> SubClassOf </span>Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Chelating Activity. <br></td>
            </tr>
            <tr class="addition">
               <td>6251</td>
               <td colspan="2">Resveratrol<span class="subclass"> SubClassOf </span>Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Free Radical Scavenging. <br></td>
            </tr>
            <tr class="addition">
               <td>6252</td>
               <td colspan="2">Resveratrol<span class="subclass"> SubClassOf </span>Polyphenol. <br></td>
            </tr>
            <tr class="addition">
               <td>6253</td>
               <td colspan="2">Reticulon 1<span class="subclass"> SubClassOf </span>Transport Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6254</td>
               <td colspan="2">Retroperitoneal<span class="subclass"> SubClassOf </span>Anatomy Qualifier. <br></td>
            </tr>
            <tr class="addition">
               <td>6255</td>
               <td colspan="2">Ring Finger Protein 11<span class="subclass"> SubClassOf </span>Ligase. <br></td>
            </tr>
            <tr class="addition">
               <td>6256</td>
               <td colspan="2">Rodent Nomenclature Name<span class="subclass"> SubClassOf </span>Name. <br></td>
            </tr>
            <tr class="addition">
               <td>6122</td>
               <td colspan="2">SID1 Transmembrane Family, Member 1<span class="subclass"> SubClassOf </span>Adaptor Signaling Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6257</td>
               <td colspan="2">Salivary Gland Acinic Cell Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Abnormal_Cell<span class="some"> only </span>Serous Adenocarcinoma Cell. <br></td>
            </tr>
            <tr class="addition">
               <td>6258</td>
               <td colspan="2">Sarcomatoid Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Anaplastic Lesion. <br></td>
            </tr>
            <tr class="addition">
               <td>6259</td>
               <td colspan="2">Sarcomatoid Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Finding<span class="some"> some </span>Aggressive Clinical Course. <br></td>
            </tr>
            <tr class="addition">
               <td>6260</td>
               <td colspan="2">Scirrhous Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Ductal Carcinoma, Not Otherwise Specified<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Fibrotic Stroma Formation). <br></td>
            </tr>
            <tr class="addition">
               <td>6261</td>
               <td colspan="2">Secreted<br><span class="keyword"> and </span>Transmembrane 1 Protein<span class="subclass"> SubClassOf </span>Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Immune Function. <br></td>
            </tr>
            <tr class="addition">
               <td>6262</td>
               <td colspan="2">Secreted<br><span class="keyword"> and </span>Transmembrane 1 Protein<span class="subclass"> SubClassOf </span>Transmembrane Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6263</td>
               <td colspan="2">Secretory Carcinoma<span class="subclass"> SubClassOf </span>Retired Concept. <br></td>
            </tr>
            <tr class="addition">
               <td>6264</td>
               <td colspan="2">Selenomethionine<span class="subclass"> SubClassOf </span>Organoselenium Compound. <br></td>
            </tr>
            <tr class="addition">
               <td>6265</td>
               <td colspan="2">Seocalcitol<span class="subclass"> SubClassOf </span>Vitamin D Analog. <br></td>
            </tr>
            <tr class="addition">
               <td>6266</td>
               <td colspan="2">Sequential<span class="subclass"> SubClassOf </span>Temporal Qualifier. <br></td>
            </tr>
            <tr class="addition">
               <td>6189</td>
               <td colspan="2">Serologically Defined Breast Cancer Antigen 84<span class="subclass"> SubClassOf </span>Immunoprotein. <br></td>
            </tr>
            <tr class="addition">
               <td>6267</td>
               <td colspan="2">Serous Adenocarcinoma<span class="subclass"> SubClassOf </span>Adenocarcinoma. <br></td>
            </tr>
            <tr class="addition">
               <td>6268</td>
               <td colspan="2">Serous Adenocarcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Abnormal_Cell<span class="some"> only </span>Serous Adenocarcinoma Cell. <br></td>
            </tr>
            <tr class="addition">
               <td>6269</td>
               <td colspan="2">Serous Surface Papillary Carcinoma<span class="subclass"> SubClassOf </span>Serous Adenocarcinoma. <br></td>
            </tr>
            <tr class="addition">
               <td>6270</td>
               <td colspan="2">Severity<span class="subclass"> SubClassOf </span>Property<br><span class="keyword"> or </span>Attribute. <br></td>
            </tr>
            <tr class="addition">
               <td>6271</td>
               <td colspan="2">Single-Use Device Reprocessed<br><span class="keyword"> and </span>Reused on Patient<span class="subclass"> SubClassOf </span>Device Labeled for Single Use. <br></td>
            </tr>
            <tr class="addition">
               <td>6272</td>
               <td colspan="2">Site Representative Investigator<span class="subclass"> SubClassOf </span>Investigator. <br></td>
            </tr>
            <tr class="addition">
               <td>6273</td>
               <td colspan="2">Skin Appendage Neoplasm<span class="subclass"> SubClassOf </span>Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Exocrine System. <br></td>
            </tr>
            <tr class="addition">
               <td>6282</td>
               <td colspan="2">Skin Solid (Nodular) Basal Cell Carcinoma<span class="subclass"> SubClassOf </span>Solid Carcinoma. <br></td>
            </tr>
            <tr class="addition">
               <td>6274</td>
               <td colspan="2">Small Cell Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Neuroendocrine Small Cell. <br></td>
            </tr>
            <tr class="addition">
               <td>6275</td>
               <td colspan="2">Small Cell Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>High Mitotic Activity. <br></td>
            </tr>
            <tr class="addition">
               <td>6276</td>
               <td colspan="2">Small Cell Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Necrotic Change. <br></td>
            </tr>
            <tr class="addition">
               <td>6277</td>
               <td colspan="2">Small Cell Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Peripheral Nuclear Palisading. <br></td>
            </tr>
            <tr class="addition">
               <td>6278</td>
               <td colspan="2">Small Cell Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Rosette Formation. <br></td>
            </tr>
            <tr class="addition">
               <td>6279</td>
               <td colspan="2">Small Cell Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Sheet-Like Growth Pattern. <br></td>
            </tr>
            <tr class="addition">
               <td>6280</td>
               <td colspan="2">Small Cell Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Trabecular Pattern. <br></td>
            </tr>
            <tr class="addition">
               <td>6281</td>
               <td colspan="2">Small Cell Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Finding<span class="some"> some </span>Aggressive Clinical Course. <br></td>
            </tr>
            <tr class="addition">
               <td>6283</td>
               <td colspan="2">Solid Pseudopapillary Carcinoma of the Pancreas<span class="subclass"> SubClassOf </span>Solid Carcinoma. <br></td>
            </tr>
            <tr class="addition">
               <td>6284</td>
               <td colspan="2">Solid Variant Thyroid Gland Papillary Carcinoma<span class="subclass"> EquivalentTo </span>Thyroid Gland Papillary Carcinoma<br><span class="keyword"> and </span>Solid Carcinoma. <br></td>
            </tr>
            <tr class="addition">
               <td>6296</td>
               <td colspan="2">Stage I Adenosquamous Lung Carcinoma<span class="subclass"> EquivalentTo </span>Adenosquamous Lung Carcinoma<br><span class="keyword"> and </span>Stage I Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). <br></td>
            </tr>
            <tr class="addition">
               <td>6297</td>
               <td colspan="2">Stage I Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Squamous Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage I Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). <br></td>
            </tr>
            <tr class="addition">
               <td>6285</td>
               <td colspan="2">Stage IA Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IA Lung Carcinoma<br><span class="keyword"> and </span>Stage I Squamous Cell Lung Carcinoma. <br></td>
            </tr>
            <tr class="addition">
               <td>6286</td>
               <td colspan="2">Stage IB Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IB Lung Carcinoma<br><span class="keyword"> and </span>Stage I Squamous Cell Lung Carcinoma. <br></td>
            </tr>
            <tr class="addition">
               <td>6292</td>
               <td colspan="2">Stage II Adenosquamous Lung Carcinoma<span class="subclass"> EquivalentTo </span>Adenosquamous Lung Carcinoma<br><span class="keyword"> and </span>Stage II Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). <br></td>
            </tr>
            <tr class="addition">
               <td>6293</td>
               <td colspan="2">Stage II Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Squamous Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage II Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). <br></td>
            </tr>
            <tr class="addition">
               <td>6287</td>
               <td colspan="2">Stage IIA Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIA Lung Carcinoma<br><span class="keyword"> and </span>Stage II Squamous Cell Lung Carcinoma. <br></td>
            </tr>
            <tr class="addition">
               <td>6288</td>
               <td colspan="2">Stage IIB Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIB Lung Carcinoma<br><span class="keyword"> and </span>Stage II Squamous Cell Lung Carcinoma. <br></td>
            </tr>
            <tr class="addition">
               <td>6291</td>
               <td colspan="2">Stage III Adenosquamous Lung Carcinoma<span class="subclass"> EquivalentTo </span>Adenosquamous Lung Carcinoma<br><span class="keyword"> and </span>Stage III Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). <br></td>
            </tr>
            <tr class="addition">
               <td>6289</td>
               <td colspan="2">Stage IIIA Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIIA Lung Carcinoma<br><span class="keyword"> and </span>Stage III Squamous Cell Lung Carcinoma. <br></td>
            </tr>
            <tr class="addition">
               <td>6290</td>
               <td colspan="2">Stage IIIB Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIIB Lung Carcinoma<br><span class="keyword"> and </span>Stage III Squamous Cell Lung Carcinoma. <br></td>
            </tr>
            <tr class="addition">
               <td>6294</td>
               <td colspan="2">Stage IV Adenosquamous Lung Carcinoma<span class="subclass"> EquivalentTo </span>Adenosquamous Lung Carcinoma<br><span class="keyword"> and </span>Stage IV Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). <br></td>
            </tr>
            <tr class="addition">
               <td>6295</td>
               <td colspan="2">Stage IV Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Squamous Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage IV Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). <br></td>
            </tr>
            <tr class="addition">
               <td>6298</td>
               <td colspan="2">Sulforaphane<span class="subclass"> SubClassOf </span>Isothiocyanate. <br></td>
            </tr>
            <tr class="addition">
               <td>6299</td>
               <td colspan="2">Suppression of Tumorigenicity 7 Protein<span class="subclass"> SubClassOf </span>Extracellular Matrix Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6300</td>
               <td colspan="2">Sushi-Repeat Protein<span class="subclass"> SubClassOf </span>Immunoprotein. <br></td>
            </tr>
            <tr class="addition">
               <td>6301</td>
               <td colspan="2">Synuclein Gamma<span class="subclass"> SubClassOf </span>Cytoplasmic Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6302</td>
               <td colspan="2">T-Cell Leukemia/Lymphoma 1B<span class="subclass"> SubClassOf </span>Regulatory Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6303</td>
               <td colspan="2">TATA Box<span class="subclass"> SubClassOf </span>Gene Feature. <br></td>
            </tr>
            <tr class="addition">
               <td>6304</td>
               <td colspan="2">Taxol Resistance Associated Protein 3<span class="subclass"> SubClassOf </span>Immunoprotein. <br></td>
            </tr>
            <tr class="addition">
               <td>6305</td>
               <td colspan="2">Tectorigenin<span class="subclass"> SubClassOf </span>Isoflavone. <br></td>
            </tr>
            <tr class="addition">
               <td>6306</td>
               <td colspan="2">Terminal Ductal Lobular Unit<span class="subclass"> SubClassOf </span>Glandular Epithelium. <br></td>
            </tr>
            <tr class="addition">
               <td>6307</td>
               <td colspan="2">Testis-Specific Kinase Substrate<span class="subclass"> SubClassOf </span>Signaling Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6308</td>
               <td colspan="2">Testis-Specific Y-Encoded Protein<span class="subclass"> SubClassOf </span>Signaling Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6309</td>
               <td colspan="2">Tetratricopeptide Repeat Protein 4<span class="subclass"> SubClassOf </span>Transcription Regulatory Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6310</td>
               <td colspan="2">Theophylline<span class="subclass"> SubClassOf </span>Alkaloid. <br></td>
            </tr>
            <tr class="addition">
               <td>6311</td>
               <td colspan="2">Thrombospondin<span class="subclass"> Type </span>I<span class="subclass"> Domain </span>2 Protein<span class="subclass"> SubClassOf </span>Transport Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6312</td>
               <td colspan="2">Tocladesine<span class="subclass"> SubClassOf </span>Purine. <br></td>
            </tr>
            <tr class="addition">
               <td>6313</td>
               <td colspan="2">Tooth 30<span class="subclass"> SubClassOf </span>Molar Tooth. <br></td>
            </tr>
            <tr class="addition">
               <td>6314</td>
               <td colspan="2">Topoisomerase-II Inhibitor<span class="subclass"> SubClassOf </span>Antineoplastic Agent. <br></td>
            </tr>
            <tr class="addition">
               <td>6315</td>
               <td colspan="2">Training<span class="subclass"> SubClassOf </span>Educational Activity. <br></td>
            </tr>
            <tr class="addition">
               <td>6316</td>
               <td colspan="2">Training in Biomedical<br><span class="keyword"> and </span>Behavioral Research<span class="subclass"> SubClassOf </span>Funding Category. <br></td>
            </tr>
            <tr class="addition">
               <td>6317</td>
               <td colspan="2">Training of Investigators<span class="subclass"> SubClassOf </span>Funding Category. <br></td>
            </tr>
            <tr class="addition">
               <td>6319</td>
               <td colspan="2">Transforming Acidic Coiled-Coil Containing Protein 3<span class="subclass"> SubClassOf </span>Cell Cycle Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6318</td>
               <td colspan="2">Transforming Acidic Coiled-Coil-Containing Protein 1<span class="subclass"> SubClassOf </span>Cell Cycle Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6320</td>
               <td colspan="2">Transforming Growth Factor-Beta Induced Protein IGH3<span class="subclass"> SubClassOf </span>Cell Adhesion Molecule. <br></td>
            </tr>
            <tr class="addition">
               <td>6321</td>
               <td colspan="2">Triterpenoid Compound<span class="subclass"> SubClassOf </span>Phytochemical. <br></td>
            </tr>
            <tr class="addition">
               <td>6322</td>
               <td colspan="2">Tubular Adenocarcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Tubular Pattern. <br></td>
            </tr>
            <tr class="addition">
               <td>6323</td>
               <td colspan="2">Tumor Protein D52<span class="subclass"> SubClassOf </span>Regulatory Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6324</td>
               <td colspan="2">Tumor Protein D52-Like 1<span class="subclass"> SubClassOf </span>Regulatory Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6065</td>
               <td colspan="2">Tumor Suppressor Deleted in Oral Cancer-Related 1<span class="subclass"> SubClassOf </span>Cell Cycle Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6325</td>
               <td colspan="2">Ubiquitin D<span class="subclass"> SubClassOf </span>Ligase. <br></td>
            </tr>
            <tr class="addition">
               <td>6327</td>
               <td colspan="2">Ursodiol<span class="subclass"> SubClassOf </span>Antilipidemic Agent. <br></td>
            </tr>
            <tr class="addition">
               <td>6328</td>
               <td colspan="2">Ursodiol<span class="subclass"> SubClassOf </span>Protein Kinase C Inhibitor. <br></td>
            </tr>
            <tr class="addition">
               <td>6329</td>
               <td colspan="2">Valid Value<span class="subclass"> SubClassOf </span>Value. <br></td>
            </tr>
            <tr class="addition">
               <td>6066</td>
               <td colspan="2">Value<span class="subclass"> SubClassOf </span>Value. <br></td>
            </tr>
            <tr class="addition">
               <td>6330</td>
               <td colspan="2">WD Repeat<span class="subclass"> Domain </span>Protein 22<span class="subclass"> SubClassOf </span>Signaling Protein. <br></td>
            </tr>
            <tr class="addition">
               <td>6331</td>
               <td colspan="2">Wolf-Hirschhorn Syndrome Candidate 1 Protein<span class="subclass"> SubClassOf </span>Ligase. <br></td>
            </tr>
            <tr class="addition">
               <td>6105</td>
               <td colspan="2">YEATS<span class="subclass"> Domain </span>Containing 4<span class="subclass"> SubClassOf </span>Chromatin Remodeling Factor. <br></td>
            </tr>
         </tbody>
         <tbody id="addnt" style="display:none">
            <tr class="withoutstyle">
               <td colspan="3"><a name="add"></a><h4 style="display: inline-block;">Pure Additions with New Terms (90)</h4> [<a href="#">back to top</a>]
               </td>
            </tr>
            <tr>
               <th class="addition">ID</th>
               <th class="addition" colspan="2">Addition to Ontology 2</th>
            </tr>
            <tr class="addition">
               <td>6422</td>
               <td colspan="2">3-Hydroxysteroid Dehydrogenase Inhibitor<span class="subclass"> SubClassOf </span>Hydroxysteroid Dehydrogenase Inhibitor. <br><i>New Terms: Hydroxysteroid Dehydrogenase Inhibitor</i></td>
            </tr>
            <tr class="addition">
               <td>6333</td>
               <td colspan="2">Absent in Melanoma 1<span class="subclass"> SubClassOf </span>Candidate Tumor Suppressor Protein. <br><i>New Terms: Candidate Tumor Suppressor Protein</i></td>
            </tr>
            <tr class="addition">
               <td>6334</td>
               <td colspan="2">Anethole Trithione<span class="subclass"> SubClassOf </span>Phase II Enzymes Inducer. <br><i>New Terms: Phase II Enzymes Inducer</i></td>
            </tr>
            <tr class="addition">
               <td>6335</td>
               <td colspan="2">Asbestos-Related Malignant Neoplasm<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Asbestos Exposure. <br><i>New Terms: Asbestos Exposure</i></td>
            </tr>
            <tr class="addition">
               <td>6336</td>
               <td colspan="2">Atorvastatin<span class="subclass"> SubClassOf </span>Chemical_Or_Drug_Affects_Gene_Product<span class="some"> some </span>HMG-CoA Reductase. <br><i>New Terms: HMG-CoA Reductase</i></td>
            </tr>
            <tr class="addition">
               <td>6337</td>
               <td colspan="2">Autoimmune Lymphoproliferative Syndrome<span class="subclass"> EquivalentTo </span>Neoplastic Syndrome<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Atypical Lymphocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Autoimmune Disease)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Hodgkin's Lymphoma)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Non-Hodgkin's Lymphoma)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Sinus Histiocytosis with Massive Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-10 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Splenomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Thrombocytopenia)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Reactive Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Associated_Anatomic_Site<span class="some"> only </span>Immune System)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Lymphocyte). <br><i>New Terms: Neoplastic Syndrome</i></td>
            </tr>
            <tr class="addition">
               <td>6338</td>
               <td colspan="2">BCPR Protein<span class="subclass"> SubClassOf </span>Candidate Tumor Suppressor Protein. <br><i>New Terms: Candidate Tumor Suppressor Protein</i></td>
            </tr>
            <tr class="addition">
               <td>6339</td>
               <td colspan="2">BCSC-1<span class="subclass"> SubClassOf </span>Candidate Tumor Suppressor Protein. <br><i>New Terms: Candidate Tumor Suppressor Protein</i></td>
            </tr>
            <tr class="addition">
               <td>6340</td>
               <td colspan="2">BRCA3 Protein<span class="subclass"> SubClassOf </span>Candidate Tumor Suppressor Protein. <br><i>New Terms: Candidate Tumor Suppressor Protein</i></td>
            </tr>
            <tr class="addition">
               <td>6342</td>
               <td colspan="2">BRCD1 Protein<span class="subclass"> SubClassOf </span>Candidate Tumor Suppressor Protein. <br><i>New Terms: Candidate Tumor Suppressor Protein</i></td>
            </tr>
            <tr class="addition">
               <td>6343</td>
               <td colspan="2">Beta-Naphthoflavone<span class="subclass"> SubClassOf </span>Naphthalene Compound. <br><i>New Terms: Naphthalene Compound</i></td>
            </tr>
            <tr class="addition">
               <td>6345</td>
               <td colspan="2">Beta-Naphthoflavone<span class="subclass"> SubClassOf </span>Phase I Enzymes Inhibitor. <br><i>New Terms: Phase I Enzymes Inhibitor</i></td>
            </tr>
            <tr class="addition">
               <td>6344</td>
               <td colspan="2">Beta-Naphthoflavone<span class="subclass"> SubClassOf </span>Phase II Enzymes Inducer. <br><i>New Terms: Phase II Enzymes Inducer</i></td>
            </tr>
            <tr class="addition">
               <td>6346</td>
               <td colspan="2">Breast Cancer Anti-Estrogen Resistance 2 Protein<span class="subclass"> SubClassOf </span>Tumor-Related Protein. <br><i>New Terms: Tumor-Related Protein</i></td>
            </tr>
            <tr class="addition">
               <td>6347</td>
               <td colspan="2">Breast Cancer Suppressor-2<span class="subclass"> SubClassOf </span>Candidate Tumor Suppressor Protein. <br><i>New Terms: Candidate Tumor Suppressor Protein</i></td>
            </tr>
            <tr class="addition">
               <td>6341</td>
               <td colspan="2">Breast Cancer, 11;22 Translocation Associated Protein<span class="subclass"> SubClassOf </span>Tumor-Related Protein. <br><i>New Terms: Tumor-Related Protein</i></td>
            </tr>
            <tr class="addition">
               <td>6348</td>
               <td colspan="2">Breast Carcinoma Amplified Sequence 1<span class="subclass"> SubClassOf </span>Tumor-Related Protein. <br><i>New Terms: Tumor-Related Protein</i></td>
            </tr>
            <tr class="addition">
               <td>6349</td>
               <td colspan="2">Breast Columnar Cell Mucinous Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Mucin-Producing Adenocarcinoma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Mucin-Producing Tall Columnar Adenocarcinoma Cell). <br><i>New Terms: Mucin-Producing Tall Columnar Adenocarcinoma Cell</i></td>
            </tr>
            <tr class="addition">
               <td>6351</td>
               <td colspan="2">CDDO<span class="subclass"> SubClassOf </span>Phase II Enzymes Inducer. <br><i>New Terms: Phase II Enzymes Inducer</i></td>
            </tr>
            <tr class="addition">
               <td>6350</td>
               <td colspan="2">Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5<span class="subclass"> SubClassOf </span>Metastasis Protein. <br><i>New Terms: Metastasis Protein</i></td>
            </tr>
            <tr class="addition">
               <td>6352</td>
               <td colspan="2">Carcinosarcoma<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Sarcomatous Component Present. <br><i>New Terms: Sarcomatous Component Present</i></td>
            </tr>
            <tr class="addition">
               <td>6353</td>
               <td colspan="2">Cartilagenous Metaplasia<span class="subclass"> SubClassOf </span>Mesenchymal Metaplasia. <br><i>New Terms: Mesenchymal Metaplasia</i></td>
            </tr>
            <tr class="addition">
               <td>6354</td>
               <td colspan="2">D10S170 Protein<span class="subclass"> SubClassOf </span>Candidate Tumor Suppressor Protein. <br><i>New Terms: Candidate Tumor Suppressor Protein</i></td>
            </tr>
            <tr class="addition">
               <td>6355</td>
               <td colspan="2">DEC1 Protein<span class="subclass"> SubClassOf </span>Candidate Tumor Suppressor Protein. <br><i>New Terms: Candidate Tumor Suppressor Protein</i></td>
            </tr>
            <tr class="addition">
               <td>6356</td>
               <td colspan="2">DLEC1 Protein<span class="subclass"> SubClassOf </span>Candidate Tumor Suppressor Protein. <br><i>New Terms: Candidate Tumor Suppressor Protein</i></td>
            </tr>
            <tr class="addition">
               <td>6357</td>
               <td colspan="2">DLEU1 Protein<span class="subclass"> SubClassOf </span>Candidate Tumor Suppressor Protein. <br><i>New Terms: Candidate Tumor Suppressor Protein</i></td>
            </tr>
            <tr class="addition">
               <td>6358</td>
               <td colspan="2">Device Labeled for Single Use<span class="subclass"> SubClassOf </span>Medical Device By Usage Mode. <br><i>New Terms: Medical Device By Usage Mode</i></td>
            </tr>
            <tr class="addition">
               <td>6359</td>
               <td colspan="2">Diastolic Pressure<span class="subclass"> SubClassOf </span>Blood Pressure. <br><i>New Terms: Blood Pressure</i></td>
            </tr>
            <tr class="addition">
               <td>6360</td>
               <td colspan="2">Diffuse Leiomyomatosis Syndrome<span class="subclass"> SubClassOf </span>Neoplastic Syndrome. <br><i>New Terms: Neoplastic Syndrome</i></td>
            </tr>
            <tr class="addition">
               <td>6361</td>
               <td colspan="2">Diindolylmethane<span class="subclass"> SubClassOf </span>Indole Compound. <br><i>New Terms: Indole Compound</i></td>
            </tr>
            <tr class="addition">
               <td>6362</td>
               <td colspan="2">Diindolylmethane<span class="subclass"> SubClassOf </span>Phase II Enzymes Inducer. <br><i>New Terms: Phase II Enzymes Inducer</i></td>
            </tr>
            <tr class="addition">
               <td>6365</td>
               <td colspan="2">Ectopic Hormone Secretion Syndromes Associated with Neoplasia<span class="subclass"> SubClassOf </span>Neoplastic Syndrome. <br><i>New Terms: Neoplastic Syndrome</i></td>
            </tr>
            <tr class="addition">
               <td>6363</td>
               <td colspan="2">Epidermal Growth Factor Receptor Pathway Substrate 8-Like Protein 3<span class="subclass"> SubClassOf </span>Metastasis Protein. <br><i>New Terms: Metastasis Protein</i></td>
            </tr>
            <tr class="addition">
               <td>6364</td>
               <td colspan="2">Epidermal Growth Factor Receptor Pathway Substrate 8-Like Protein 3<span class="subclass"> SubClassOf </span>Tumor-Related Protein. <br><i>New Terms: Tumor-Related Protein</i></td>
            </tr>
            <tr class="addition">
               <td>6366</td>
               <td colspan="2">Epididymal Secretory Protein E4<span class="subclass"> SubClassOf </span>Endopeptidase. <br><i>New Terms: Endopeptidase</i></td>
            </tr>
            <tr class="addition">
               <td>6367</td>
               <td colspan="2">FGF Receptor Activating Protein 1<span class="subclass"> SubClassOf </span>Tumor-Related Protein. <br><i>New Terms: Tumor-Related Protein</i></td>
            </tr>
            <tr class="addition">
               <td>6368</td>
               <td colspan="2">Glioma Tumor Suppressor Candidate Region Gene 1 Protein<span class="subclass"> SubClassOf </span>Candidate Tumor Suppressor Protein. <br><i>New Terms: Candidate Tumor Suppressor Protein</i></td>
            </tr>
            <tr class="addition">
               <td>6369</td>
               <td colspan="2">Glycyrrhetic Acid<span class="subclass"> SubClassOf </span>Hydroxysteroid Dehydrogenase Inhibitor. <br><i>New Terms: Hydroxysteroid Dehydrogenase Inhibitor</i></td>
            </tr>
            <tr class="addition">
               <td>6370</td>
               <td colspan="2">Hepatocellular Carcinoma Protein HHCM<span class="subclass"> SubClassOf </span>Tumor-Related Protein. <br><i>New Terms: Tumor-Related Protein</i></td>
            </tr>
            <tr class="addition">
               <td>6371</td>
               <td colspan="2">Hereditary Neoplastic Syndrome<span class="subclass"> SubClassOf </span>Neoplastic Syndrome. <br><i>New Terms: Neoplastic Syndrome</i></td>
            </tr>
            <tr class="addition">
               <td>6372</td>
               <td colspan="2">Hypertension<span class="subclass"> SubClassOf </span>Blood Pressure Finding. <br><i>New Terms: Blood Pressure Finding</i></td>
            </tr>
            <tr class="addition">
               <td>6373</td>
               <td colspan="2">Hypotension<span class="subclass"> SubClassOf </span>Blood Pressure Finding. <br><i>New Terms: Blood Pressure Finding</i></td>
            </tr>
            <tr class="addition">
               <td>6374</td>
               <td colspan="2">Indomethacin<span class="subclass"> SubClassOf </span>Indole Compound. <br><i>New Terms: Indole Compound</i></td>
            </tr>
            <tr class="addition">
               <td>6375</td>
               <td colspan="2">Intent For Diagnosis<span class="subclass"> SubClassOf </span>Medical Product Intent Of Use. <br><i>New Terms: Medical Product Intent Of Use</i></td>
            </tr>
            <tr class="addition">
               <td>6376</td>
               <td colspan="2">Intent For Mitigation<span class="subclass"> SubClassOf </span>Medical Product Intent Of Use. <br><i>New Terms: Medical Product Intent Of Use</i></td>
            </tr>
            <tr class="addition">
               <td>6377</td>
               <td colspan="2">Intent For Prophylaxis<span class="subclass"> SubClassOf </span>Medical Product Intent Of Use. <br><i>New Terms: Medical Product Intent Of Use</i></td>
            </tr>
            <tr class="addition">
               <td>6378</td>
               <td colspan="2">Intent To Treat<span class="subclass"> SubClassOf </span>Medical Product Intent Of Use. <br><i>New Terms: Medical Product Intent Of Use</i></td>
            </tr>
            <tr class="addition">
               <td>6379</td>
               <td colspan="2">Kilo<span class="subclass"> SubClassOf </span>Numerical Qualifier. <br><i>New Terms: Numerical Qualifier</i></td>
            </tr>
            <tr class="addition">
               <td>6381</td>
               <td colspan="2">Large Cell Neuroendocrine Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Nuclear Molding. <br><i>New Terms: Nuclear Molding</i></td>
            </tr>
            <tr class="addition">
               <td>6382</td>
               <td colspan="2">Lipomatous Metaplasia<span class="subclass"> SubClassOf </span>Mesenchymal Metaplasia. <br><i>New Terms: Mesenchymal Metaplasia</i></td>
            </tr>
            <tr class="addition">
               <td>6383</td>
               <td colspan="2">Lovastatin<span class="subclass"> SubClassOf </span>Naphthalene Compound. <br><i>New Terms: Naphthalene Compound</i></td>
            </tr>
            <tr class="addition">
               <td>6384</td>
               <td colspan="2">Malignant Phyllodes Tumor<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Sarcomatous Component Present. <br><i>New Terms: Sarcomatous Component Present</i></td>
            </tr>
            <tr class="addition">
               <td>6385</td>
               <td colspan="2">Mantle Field<span class="subclass"> SubClassOf </span>Radiation Field. <br><i>New Terms: Radiation Field</i></td>
            </tr>
            <tr class="addition">
               <td>6386</td>
               <td colspan="2">Mean Arterial Pressure<span class="subclass"> SubClassOf </span>Blood Pressure Finding. <br><i>New Terms: Blood Pressure Finding</i></td>
            </tr>
            <tr class="addition">
               <td>6380</td>
               <td colspan="2">Medical Product Label<span class="subclass"> SubClassOf </span>Medical Product Document. <br><i>New Terms: Medical Product Document</i></td>
            </tr>
            <tr class="addition">
               <td>6387</td>
               <td colspan="2">Meigs' Syndrome<span class="subclass"> SubClassOf </span>Neoplastic Syndrome. <br><i>New Terms: Neoplastic Syndrome</i></td>
            </tr>
            <tr class="addition">
               <td>6388</td>
               <td colspan="2">Micro<span class="subclass"> SubClassOf </span>Numerical Qualifier. <br><i>New Terms: Numerical Qualifier</i></td>
            </tr>
            <tr class="addition">
               <td>6389</td>
               <td colspan="2">Milli<span class="subclass"> SubClassOf </span>Numerical Qualifier. <br><i>New Terms: Numerical Qualifier</i></td>
            </tr>
            <tr class="addition">
               <td>6390</td>
               <td colspan="2">Myelodysplastic Syndrome<span class="subclass"> EquivalentTo </span>Common Hematopoietic Neoplasm<br><span class="keyword"> and </span>Myeloid Neoplasm<br><span class="keyword"> and </span>Neoplastic Syndrome<br><span class="keyword"> and </span>Premalignant Hematologic Condition<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hypercellular Bone Marrow)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Bone Marrow Dysplasia Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Ineffective Hematopoiesis)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Myeloblasts Under 20 Percent of Peripheral Blood White Cells). <br><i>New Terms: Neoplastic Syndrome</i></td>
            </tr>
            <tr class="addition">
               <td>6391</td>
               <td colspan="2">N33 Protein<span class="subclass"> SubClassOf </span>Candidate Tumor Suppressor Protein. <br><i>New Terms: Candidate Tumor Suppressor Protein</i></td>
            </tr>
            <tr class="addition">
               <td>6392</td>
               <td colspan="2">Nabumetone<span class="subclass"> SubClassOf </span>Naphthalene Compound. <br><i>New Terms: Naphthalene Compound</i></td>
            </tr>
            <tr class="addition">
               <td>6393</td>
               <td colspan="2">Neuroblastoma-Amplified Protein<span class="subclass"> SubClassOf </span>Tumor-Related Protein. <br><i>New Terms: Tumor-Related Protein</i></td>
            </tr>
            <tr class="addition">
               <td>6395</td>
               <td colspan="2">Oltipraz<span class="subclass"> SubClassOf </span>Phase I Enzymes Inhibitor. <br><i>New Terms: Phase I Enzymes Inhibitor</i></td>
            </tr>
            <tr class="addition">
               <td>6394</td>
               <td colspan="2">Oltipraz<span class="subclass"> SubClassOf </span>Phase II Enzymes Inducer. <br><i>New Terms: Phase II Enzymes Inducer</i></td>
            </tr>
            <tr class="addition">
               <td>6396</td>
               <td colspan="2">Osseous Metaplasia<span class="subclass"> SubClassOf </span>Mesenchymal Metaplasia. <br><i>New Terms: Mesenchymal Metaplasia</i></td>
            </tr>
            <tr class="addition">
               <td>6397</td>
               <td colspan="2">Pharmaceutical Product Information<span class="subclass"> SubClassOf </span>Medical Product Document. <br><i>New Terms: Medical Product Document</i></td>
            </tr>
            <tr class="addition">
               <td>6398</td>
               <td colspan="2">Phenethyl Isothiocyanate<span class="subclass"> SubClassOf </span>Phase II Enzymes Inducer. <br><i>New Terms: Phase II Enzymes Inducer</i></td>
            </tr>
            <tr class="addition">
               <td>6399</td>
               <td colspan="2">Phyllodes Tumor<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Intracanalicular Growth Pattern. <br><i>New Terms: Intracanalicular Growth Pattern</i></td>
            </tr>
            <tr class="addition">
               <td>6400</td>
               <td colspan="2">Platelet-Derived Growth Factor Receptor-Like Protein<span class="subclass"> SubClassOf </span>Candidate Tumor Suppressor Protein. <br><i>New Terms: Candidate Tumor Suppressor Protein</i></td>
            </tr>
            <tr class="addition">
               <td>6401</td>
               <td colspan="2">Proto-Oncogene FRAT1 Protein<span class="subclass"> SubClassOf </span>Tumor-Related Protein. <br><i>New Terms: Tumor-Related Protein</i></td>
            </tr>
            <tr class="addition">
               <td>6402</td>
               <td colspan="2">Putative GR6 Protein<span class="subclass"> SubClassOf </span>Tumor-Related Protein. <br><i>New Terms: Tumor-Related Protein</i></td>
            </tr>
            <tr class="addition">
               <td>6403</td>
               <td colspan="2">RET Finger Protein 2<span class="subclass"> SubClassOf </span>Candidate Tumor Suppressor Protein. <br><i>New Terms: Candidate Tumor Suppressor Protein</i></td>
            </tr>
            <tr class="addition">
               <td>6404</td>
               <td colspan="2">Rare Cancer-Associated Syndrome<span class="subclass"> SubClassOf </span>Neoplastic Syndrome. <br><i>New Terms: Neoplastic Syndrome</i></td>
            </tr>
            <tr class="addition">
               <td>6405</td>
               <td colspan="2">Resveratrol<span class="subclass"> SubClassOf </span>Phase II Enzymes Inducer. <br><i>New Terms: Phase II Enzymes Inducer</i></td>
            </tr>
            <tr class="addition">
               <td>6406</td>
               <td colspan="2">Salivary Gland Acinic Cell Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Acinic Cell Differentiation. <br><i>New Terms: Acinic Cell Differentiation</i></td>
            </tr>
            <tr class="addition">
               <td>6407</td>
               <td colspan="2">Sebaceous Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Abnormal_Cell<span class="some"> only </span>Adenocarcinoma Cell with Abundant Finely Vacuolated Cytoplasm. <br><i>New Terms: Adenocarcinoma Cell with Abundant Finely Vacuolated Cytoplasm</i></td>
            </tr>
            <tr class="addition">
               <td>6408</td>
               <td colspan="2">Sebaceous Gland Neoplasm<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Sebaceous Differentiation. <br><i>New Terms: Sebaceous Differentiation</i></td>
            </tr>
            <tr class="addition">
               <td>6409</td>
               <td colspan="2">Small Breast Epithelial Mucin<span class="subclass"> SubClassOf </span>Metastasis Protein. <br><i>New Terms: Metastasis Protein</i></td>
            </tr>
            <tr class="addition">
               <td>6410</td>
               <td colspan="2">Small Cell Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Nuclear Molding. <br><i>New Terms: Nuclear Molding</i></td>
            </tr>
            <tr class="addition">
               <td>6411</td>
               <td colspan="2">Sulforaphane<span class="subclass"> SubClassOf </span>Phase II Enzymes Inducer. <br><i>New Terms: Phase II Enzymes Inducer</i></td>
            </tr>
            <tr class="addition">
               <td>6412</td>
               <td colspan="2">Systolic Pressure<span class="subclass"> SubClassOf </span>Blood Pressure. <br><i>New Terms: Blood Pressure</i></td>
            </tr>
            <tr class="addition">
               <td>6413</td>
               <td colspan="2">T-Cell Leukemia Translocation Altered Gene Product<span class="subclass"> SubClassOf </span>Candidate Tumor Suppressor Protein. <br><i>New Terms: Candidate Tumor Suppressor Protein</i></td>
            </tr>
            <tr class="addition">
               <td>6416</td>
               <td colspan="2">TSSC4 Protein<span class="subclass"> SubClassOf </span>Candidate Tumor Suppressor Protein. <br><i>New Terms: Candidate Tumor Suppressor Protein</i></td>
            </tr>
            <tr class="addition">
               <td>6417</td>
               <td colspan="2">Thalidomide<span class="subclass"> EquivalentTo </span>Immunosuppressant<br><span class="keyword"> and </span>Indole Compound<br><span class="keyword"> and </span>(Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue<span class="some"> some </span>Endothelial Cell)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue<span class="some"> some </span>Monocyte)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Mechanism_Of_Action<span class="some"> some </span>Unknown Cellular<br><span class="keyword"> or </span>Molecular Mechanism)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Angiogenic Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Chemotaxis Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Interferon Suppression)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Phagocytosis Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Tumor Necrosis Factor Suppression). <br><i>New Terms: Indole Compound</i></td>
            </tr>
            <tr class="addition">
               <td>6418</td>
               <td colspan="2">Transforming Acidic Coiled-Coil-Containing Protein 2<span class="subclass"> SubClassOf </span>Candidate Tumor Suppressor Protein. <br><i>New Terms: Candidate Tumor Suppressor Protein</i></td>
            </tr>
            <tr class="addition">
               <td>6419</td>
               <td colspan="2">Tumor Lysis Syndrome<span class="subclass"> SubClassOf </span>Neoplastic Syndrome. <br><i>New Terms: Neoplastic Syndrome</i></td>
            </tr>
            <tr class="addition">
               <td>6414</td>
               <td colspan="2">Tumor Suppressing Subtransferable Candidate 1 Protein<span class="subclass"> SubClassOf </span>Candidate Tumor Suppressor Protein. <br><i>New Terms: Candidate Tumor Suppressor Protein</i></td>
            </tr>
            <tr class="addition">
               <td>6415</td>
               <td colspan="2">Tumor Suppressing Subtransferable Candidate 3 Protein<span class="subclass"> SubClassOf </span>Imprinted Protein. <br><i>New Terms: Imprinted Protein</i></td>
            </tr>
            <tr class="addition">
               <td>6420</td>
               <td colspan="2">WT2 Protein<span class="subclass"> SubClassOf </span>Candidate Tumor Suppressor Protein. <br><i>New Terms: Candidate Tumor Suppressor Protein</i></td>
            </tr>
            <tr class="addition">
               <td>6421</td>
               <td colspan="2">Zollinger Ellison Syndrome<span class="subclass"> SubClassOf </span>Neoplastic Syndrome. <br><i>New Terms: Neoplastic Syndrome</i></td>
            </tr>
         </tbody>
         <tbody id="stequiv" style="display:none">
            <tr class="withoutstyle">
               <td colspan="3"><a name="aed"></a><h4 style="display: inline-block;">Modified Definitions with Shared Terms (22)</h4> [<a href="#">back to top</a>]
               </td>
            </tr>
            <tr>
               <th class="addition">ID</th>
               <th class="normaladd">Source Definition in Ontology 1</th>
               <th class="addition">Target Definition in Ontology 2</th>
            </tr>
            <tr class="addition">
               <td>6423</td>
               <td>Adenosquamous Lung Carcinoma<span class="subclass"> EquivalentTo </span>Adenosquamous Carcinoma<br><span class="keyword"> and </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>APC Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FHIT Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>LKB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Metaplasia)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Bronchial Epithelial Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Bronchial Epithelium). 
               </td>
               <td>Adenosquamous Lung Carcinoma<span class="subclass"> EquivalentTo </span>Adenosquamous Carcinoma<br><span class="keyword"> and </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>APC Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FHIT Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>LKB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Bronchial Epithelial Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Bronchial Epithelium).<br></td>
            </tr>
            <tr class="addition">
               <td>6424</td>
               <td>Adult Primary Cholangiocarcinoma<span class="subclass"> EquivalentTo </span>Cholangiocarcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Primary Lesion). 
               </td>
               <td>Adult Primary Cholangiocarcinoma<span class="subclass"> EquivalentTo </span>Cholangiocarcinoma<br><span class="keyword"> and </span>Primary Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Primary Lesion).<br></td>
            </tr>
            <tr class="addition">
               <td>6425</td>
               <td>Breast Lymphoma<span class="subclass"> EquivalentTo </span>Lymphoma by Site<br><span class="keyword"> and </span>Malignant Breast Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Breast). 
               </td>
               <td>Breast Lymphoma<span class="subclass"> EquivalentTo </span>Lymphoma by Site<br><span class="keyword"> and </span>Malignant Breast Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Mammary Gland Tissue)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Breast).<br></td>
            </tr>
            <tr class="addition">
               <td>6426</td>
               <td>Carcinoma ex Pleomorphic Adenoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>Malignant Mixed Neoplasm<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cartilagenous Component Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lipomatous Component Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Myxoid Stroma Formation)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Osseous Component Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Carcinomatous Component Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mesenchymal Component Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Metaplasia)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Secondary Lesion)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Myoepithelial Cell). 
               </td>
               <td>Carcinoma ex Pleomorphic Adenoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>Malignant Mixed Neoplasm<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cartilagenous Component Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lipomatous Component Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Myxoid Stroma Formation)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Osseous Component Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Carcinomatous Component Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mesenchymal Component Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Secondary Lesion)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Myoepithelial Cell).<br></td>
            </tr>
            <tr class="addition">
               <td>6427</td>
               <td>Flutamide<span class="subclass"> EquivalentTo </span>Anti-Androgen<br><span class="keyword"> and </span>(Chemical_Or_Drug_Affects_Gene_Product<span class="some"> some </span>Androgen Receptor)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Mechanism_Of_Action<span class="some"> some </span>Receptor Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Inhibition of Cell Proliferation)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Protein Synthesis Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>RNA Transcription Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Signal Transduction Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Is_Metabolized_By_Enzyme<span class="some"> some </span>Cytochrome P450, Family 1, Subfamily A, Polypeptide 2)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Is_Metabolized_By_Enzyme<span class="some"> some </span>Cytochrome P450 3A4). 
               </td>
               <td>Flutamide<span class="subclass"> EquivalentTo </span>Anti-Androgen<br><span class="keyword"> and </span>Aromatic Compounds<br><span class="keyword"> and </span>(Chemical_Or_Drug_Affects_Gene_Product<span class="some"> some </span>Androgen Receptor)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Mechanism_Of_Action<span class="some"> some </span>Receptor Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Inhibition of Cell Proliferation)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Protein Synthesis Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>RNA Transcription Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Signal Transduction Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Is_Metabolized_By_Enzyme<span class="some"> some </span>Cytochrome P450, Family 1, Subfamily A, Polypeptide 2)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Is_Metabolized_By_Enzyme<span class="some"> some </span>Cytochrome P450 3A4).<br></td>
            </tr>
            <tr class="addition">
               <td>6428</td>
               <td>Gefitinib<span class="subclass"> EquivalentTo </span>Tyrosine Kinase Inhibitor<br><span class="keyword"> and </span>(Chemical_Or_Drug_Affects_Gene_Product<span class="some"> some </span>Epidermal Growth Factor Receptor)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Mechanism_Of_Action<span class="some"> some </span>Receptor Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Phosphorylation Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Signal Transduction Inhibition). 
               </td>
               <td>Gefitinib<span class="subclass"> EquivalentTo </span>Tyrosine Kinase Inhibitor<br><span class="keyword"> and </span>(Chemical_Or_Drug_Affects_Gene_Product<span class="some"> some </span>Epidermal Growth Factor Receptor)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Mechanism_Of_Action<span class="some"> some </span>Receptor Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Phosphorylation Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Signal Transduction Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Is_Metabolized_By_Enzyme<span class="some"> some </span>Cytochrome P450 3A4).<br></td>
            </tr>
            <tr class="addition">
               <td>6429</td>
               <td>Lymphoepithelioma-Like Lung Carcinoma<span class="subclass"> EquivalentTo </span>Large Cell Lung Carcinoma<br><span class="keyword"> and </span>Nasopharyngeal<span class="subclass"> Type </span>Undifferentiated Carcinoma. 
               </td>
               <td>Lymphoepithelioma-Like Lung Carcinoma<span class="subclass"> EquivalentTo </span>Large Cell Lung Carcinoma<br><span class="keyword"> and </span>Nasopharyngeal<span class="subclass"> Type </span>Undifferentiated Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis).<br></td>
            </tr>
            <tr class="addition">
               <td>6430</td>
               <td>Mucin-Producing Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Mucin-Producing Malignant Epithelial Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mucoid Stroma Formation). 
               </td>
               <td>Mucin-Producing Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Mucin-Producing Malignant Epithelial Cell).<br></td>
            </tr>
            <tr class="addition">
               <td>6432</td>
               <td>Primary Intraosseous Squamous Cell Carcinoma<span class="subclass"> EquivalentTo </span>Malignant Odontogenic Neoplasm<br><span class="keyword"> and </span>Oral Cavity Squamous Cell Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Primary Lesion)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Odontogenic Epithelium)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Jaw). 
               </td>
               <td>Primary Intraosseous Squamous Cell Carcinoma<span class="subclass"> EquivalentTo </span>Malignant Odontogenic Neoplasm<br><span class="keyword"> and </span>Oral Cavity Squamous Cell Carcinoma<br><span class="keyword"> and </span>Primary Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Primary Lesion)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Odontogenic Epithelium)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Jaw).<br></td>
            </tr>
            <tr class="addition">
               <td>6433</td>
               <td>Primary Prostate Urothelial Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Prostate Carcinoma<br><span class="keyword"> and </span>Urothelial Carcinoma<br><span class="keyword"> and </span>(Disease_Excludes_Normal_Tissue_Origin<span class="some"> only </span>Bladder Urothelium). 
               </td>
               <td>Primary Prostate Urothelial Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Prostate Carcinoma<br><span class="keyword"> and </span>Primary Carcinoma<br><span class="keyword"> and </span>Urothelial Carcinoma<br><span class="keyword"> and </span>(Disease_Excludes_Normal_Tissue_Origin<span class="some"> only </span>Bladder Urothelium).<br></td>
            </tr>
            <tr class="addition">
               <td>6434</td>
               <td>Recurrent Adenosquamous Lung Carcinoma<span class="subclass"> EquivalentTo </span>Adenosquamous Lung Carcinoma<br><span class="keyword"> and </span>Recurrent Non-Small Cell Lung Cancer. 
               </td>
               <td>Recurrent Adenosquamous Lung Carcinoma<span class="subclass"> EquivalentTo </span>Adenosquamous Lung Carcinoma<br><span class="keyword"> and </span>Recurrent Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis).<br></td>
            </tr>
            <tr class="addition">
               <td>6435</td>
               <td>Recurrent Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Recurrent Lung Cancer<br><span class="keyword"> and </span>Squamous Cell Lung Carcinoma. 
               </td>
               <td>Recurrent Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Recurrent Lung Cancer<br><span class="keyword"> and </span>Squamous Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis).<br></td>
            </tr>
            <tr class="addition">
               <td>6436</td>
               <td>Small Intestinal Adenosquamous Carcinoma<span class="subclass"> EquivalentTo </span>Adenosquamous Carcinoma<br><span class="keyword"> and </span>Small Intestinal Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Intestinal Hemorrhage)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Metaplasia). 
               </td>
               <td>Small Intestinal Adenosquamous Carcinoma<span class="subclass"> EquivalentTo </span>Adenosquamous Carcinoma<br><span class="keyword"> and </span>Small Intestinal Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Intestinal Hemorrhage).<br></td>
            </tr>
            <tr class="addition">
               <td>6444</td>
               <td>Sodium Phenylbutyrate<span class="subclass"> EquivalentTo </span>Histone Deacetylase Inhibitor<br><span class="keyword"> and </span>(Chemical_Or_Drug_Affects_Gene_Product<span class="some"> some </span>Histone Deacetylase)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Mechanism_Of_Action<span class="some"> some </span>Enzyme Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>DNA Strand Break)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>DNA Synthesis Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Gene Expression Alteration). 
               </td>
               <td>Sodium Phenylbutyrate<span class="subclass"> EquivalentTo </span>Fatty Acid<br><span class="keyword"> and </span>Histone Deacetylase Inhibitor<br><span class="keyword"> and </span>(Chemical_Or_Drug_Affects_Gene_Product<span class="some"> some </span>Histone Deacetylase)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Mechanism_Of_Action<span class="some"> some </span>Enzyme Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>DNA Strand Break)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>DNA Synthesis Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Gene Expression Alteration).<br></td>
            </tr>
            <tr class="addition">
               <td>6437</td>
               <td>Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>Squamous Cell Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 12p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q24-qter)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 18q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 5q)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>APC Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FHIT Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Metaplasia)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Bronchial Epithelial Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Bronchial Epithelium)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchial Tree). 
               </td>
               <td>Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>Squamous Cell Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 12p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q24-qter)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 18q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 5q)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>APC Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FHIT Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Bronchial Epithelial Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Bronchial Epithelium)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchial Tree).<br></td>
            </tr>
            <tr class="addition">
               <td>6438</td>
               <td>Squamous Cell Lung Carcinoma, Basaloid Variant<span class="subclass"> EquivalentTo </span>Basaloid Squamous Cell Carcinoma<br><span class="keyword"> and </span>Keratinizing Squamous Cell Carcinoma<br><span class="keyword"> and </span>Squamous Cell Lung Carcinoma. 
               </td>
               <td>Squamous Cell Lung Carcinoma, Basaloid Variant<span class="subclass"> EquivalentTo </span>Basaloid Squamous Cell Carcinoma<br><span class="keyword"> and </span>Keratinizing Squamous Cell Carcinoma<br><span class="keyword"> and </span>Squamous Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis).<br></td>
            </tr>
            <tr class="addition">
               <td>6439</td>
               <td>Squamous Cell Lung Carcinoma, Clear Cell Variant<span class="subclass"> EquivalentTo </span>Keratinizing Squamous Cell Carcinoma<br><span class="keyword"> and </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Squamous Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Clear Squamous Cell). 
               </td>
               <td>Squamous Cell Lung Carcinoma, Clear Cell Variant<span class="subclass"> EquivalentTo </span>Keratinizing Squamous Cell Carcinoma<br><span class="keyword"> and </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Squamous Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Clear Squamous Cell).<br></td>
            </tr>
            <tr class="addition">
               <td>6440</td>
               <td>Squamous Cell Lung Carcinoma, Papillary Variant<span class="subclass"> EquivalentTo </span>Keratinizing Squamous Cell Carcinoma<br><span class="keyword"> and </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Papillary Squamous Cell Carcinoma<br><span class="keyword"> and </span>Squamous Cell Lung Carcinoma. 
               </td>
               <td>Squamous Cell Lung Carcinoma, Papillary Variant<span class="subclass"> EquivalentTo </span>Keratinizing Squamous Cell Carcinoma<br><span class="keyword"> and </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Papillary Squamous Cell Carcinoma<br><span class="keyword"> and </span>Squamous Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis).<br></td>
            </tr>
            <tr class="addition">
               <td>6441</td>
               <td>Squamous Cell Lung Carcinoma, Small Cell Variant<span class="subclass"> EquivalentTo </span>Keratinizing Squamous Cell Carcinoma<br><span class="keyword"> and </span>Squamous Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Small Squamous Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Poorly Differentiated Lesion). 
               </td>
               <td>Squamous Cell Lung Carcinoma, Small Cell Variant<span class="subclass"> EquivalentTo </span>Keratinizing Squamous Cell Carcinoma<br><span class="keyword"> and </span>Squamous Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Small Squamous Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Poorly Differentiated Lesion).<br></td>
            </tr>
            <tr class="addition">
               <td>6442</td>
               <td>Stage III Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Squamous Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage III). 
               </td>
               <td>Stage III Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Squamous Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage III Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage III).<br></td>
            </tr>
            <tr class="addition">
               <td>6431</td>
               <td>Thyroid Gland Diffuse Sclerosing Papillary Carcinoma<span class="subclass"> EquivalentTo </span>Thyroid Gland Papillary Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Diffuse Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Fibrotic Stroma Formation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphocytic Infiltrate)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Papillary Pattern)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Squamous Metaplasia). 
               </td>
               <td>Thyroid Gland Diffuse Sclerosing Papillary Carcinoma<span class="subclass"> EquivalentTo </span>Thyroid Gland Papillary Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Diffuse Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Fibrotic Stroma Formation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphocytic Infiltrate)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Papillary Pattern).<br></td>
            </tr>
            <tr class="addition">
               <td>6443</td>
               <td>Thyroid Gland Oncocytic Follicular Carcinoma<span class="subclass"> EquivalentTo </span>Thyroid Gland Follicular Carcinoma<br><span class="keyword"> and </span>Thyroid Gland Oncocytic Neoplasm<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Capsular Invasion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Tumor Vascular Invasion)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Thyroid Gland Oncocyte). 
               </td>
               <td>Thyroid Gland Oncocytic Follicular Carcinoma<span class="subclass"> EquivalentTo </span>Thyroid Gland Follicular Carcinoma<br><span class="keyword"> and </span>Oxyphilic Adenocarcinoma<br><span class="keyword"> and </span>Thyroid Gland Oncocytic Neoplasm<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Capsular Invasion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Tumor Vascular Invasion)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Thyroid Gland Oncocyte).<br></td>
            </tr>
         </tbody>
         <tbody id="stequivnt" style="display:none">
            <tr class="withoutstyle">
               <td colspan="3"><a name="aednt"></a><h4 style="display: inline-block;">Modified Definitions with New Terms (3)</h4> [<a href="#">back to top</a>]
               </td>
            </tr>
            <tr>
               <th class="addition">ID</th>
               <th class="normaladd">Source Definition in Ontology 1</th>
               <th class="addition">Target Definition in Ontology 2</th>
            </tr>
            <tr class="addition">
               <td>6445</td>
               <td>Lung Adenoid Cystic Carcinoma<span class="subclass"> EquivalentTo </span>Adenoid Cystic Carcinoma<br><span class="keyword"> and </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchus). 
               </td>
               <td>Lung Adenoid Cystic Carcinoma<span class="subclass"> EquivalentTo </span>Adenoid Cystic Carcinoma<br><span class="keyword"> and </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Chest Pain)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Wheeze)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchus).<br><i>New Terms: Wheeze</i></td>
            </tr>
            <tr class="addition">
               <td>6446</td>
               <td>Lung Mucoepidermoid Carcinoma<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>Mucoepidermoid Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchus). 
               </td>
               <td>Lung Mucoepidermoid Carcinoma<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>Mucoepidermoid Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Wheeze)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchus).<br><i>New Terms: Wheeze</i></td>
            </tr>
            <tr class="addition">
               <td>6447</td>
               <td>Sarcomatoid Transitional Cell Carcinoma<span class="subclass"> EquivalentTo </span>Sarcomatoid Carcinoma<br><span class="keyword"> and </span>Transitional Cell Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Biphasic Pattern)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Epithelial Differentiation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mesenchymal Differentiation)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Transitional Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Transitional Epithelium). 
               </td>
               <td>Sarcomatoid Transitional Cell Carcinoma<span class="subclass"> EquivalentTo </span>Sarcomatoid Carcinoma<br><span class="keyword"> and </span>Transitional Cell Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Spindle Transitional Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Biphasic Pattern)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Epithelial Differentiation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mesenchymal Differentiation)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Transitional Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Transitional Epithelium).<br><i>New Terms: Malignant Spindle Transitional Cell</i></td>
            </tr>
         </tbody>
         <tbody id="ared" style="display:none">
            <tr class="withoutstyle">
               <td colspan="3">
                  <h4 style="display: inline-block;">Redundant (2)</h4> [<a href="#">back to top</a>]
               </td>
            </tr>
            <tr>
               <th class="addition">ID</th>
               <th class="normaladd">Justifications in Ontology 1</th>
               <th class="addition">Axiom in Ontology 2</th>
            </tr>
            <tr class="addition">
               <td rowspan="1">6448</td>
               <td><i>(1)</i>&nbsp; Nutritional Supplement<span class="subclass"> SubClassOf </span>Food<br><span class="keyword"> or </span>Food Product. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Black Tea<span class="subclass"> SubClassOf </span>Nutritional Supplement. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
               <td rowspan="1">Black Tea<span class="subclass"> SubClassOf </span>Food<br><span class="keyword"> or </span>Food Product. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">6449</td>
               <td><i>(1)</i>&nbsp; Mucinous Neoplasm<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Mucoid Stroma Formation. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Mucinous Adenocarcinoma<span class="subclass"> SubClassOf </span>Mucinous Neoplasm. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
               <td rowspan="1">Mucinous Adenocarcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Mucoid Stroma Formation. 
               </td>
            </tr>
         </tbody>
         <tbody id="aweak" style="display:none">
            <tr class="withoutstyle">
               <td colspan="3">
                  <h4 style="display: inline-block;">Retrospective Novel Redundant (16)</h4> [<a href="#">back to top</a>]
               </td>
            </tr>
            <tr>
               <th class="addition">ID</th>
               <th class="normaladd">Justifications in Ontology 1</th>
               <th class="addition">Axiom in Ontology 2</th>
            </tr>
            <tr class="addition">
               <td rowspan="1">6459</td>
               <td><i>(1)</i>&nbsp; Acinar Prostate Adenocarcinoma, Sarcomatoid Variant<span class="subclass"> SubClassOf </span>Sarcomatoid Carcinoma. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Sarcomatoid Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Spindle Cell. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
               <td rowspan="1">Acinar Prostate Adenocarcinoma, Sarcomatoid Variant<span class="subclass"> SubClassOf </span>Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Spindle Cell. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">6450</td>
               <td><i>(1)</i>&nbsp; Apocrine Carcinoma Cell<span class="subclass"> SubClassOf </span>Ductal Carcinoma Cell. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Ductal Carcinoma Cell<span class="subclass"> SubClassOf </span>Adenocarcinoma Cell. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
               <td rowspan="1">Apocrine Carcinoma Cell<span class="subclass"> SubClassOf </span>Adenocarcinoma Cell. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">6451</td>
               <td><i>(1)</i>&nbsp; Asymmetry<span class="subclass"> SubClassOf </span>General Qualifier. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; General Qualifier<span class="subclass"> SubClassOf </span>Qualifier. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Qualifier<span class="subclass"> SubClassOf </span>Property<br><span class="keyword"> or </span>Attribute. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
               <td rowspan="1">Asymmetry<span class="subclass"> SubClassOf </span>Property<br><span class="keyword"> or </span>Attribute. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">6452</td>
               <td><i>(1)</i>&nbsp; BCL7A Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function<span class="subclass"> SubClassOf </span>Protein, Organized by Function. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
               <td rowspan="1">BCL7A Protein<span class="subclass"> SubClassOf </span>Protein, Organized by Function. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">6453</td>
               <td><i>(1)</i>&nbsp; Conjugated Linoleic Acid<span class="subclass"> SubClassOf </span>Omega-6 Fatty Acid. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Omega-6 Fatty Acid<span class="subclass"> SubClassOf </span>Fatty Acid. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
               <td rowspan="1">Conjugated Linoleic Acid<span class="subclass"> SubClassOf </span>Fatty Acid. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">6454</td>
               <td><i>(1)</i>&nbsp; Difluoromethylornithine<span class="subclass"> EquivalentTo </span>Ornithine Decarboxylase Inhibitor<br><span class="keyword"> and </span>Polyamine Synthesis Inhibitor<br><span class="keyword"> and </span>(Chemical_Or_Drug_Affects_Gene_Product<span class="some"> some </span>Ornithine Decarboxylase 1)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Mechanism_Of_Action<span class="some"> some </span>Enzyme Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Apoptosis)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Inhibition of Cell Proliferation)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Polyamine Synthesis Inhibition). 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Eflornithine Hydrochloride<span class="subclass"> SubClassOf </span>Difluoromethylornithine. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
               <td rowspan="1">Eflornithine Hydrochloride<span class="subclass"> SubClassOf </span>Ornithine Decarboxylase Inhibitor. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">6455</td>
               <td><i>(1)</i>&nbsp; Clear Cell Adenocarcinoma<span class="subclass"> SubClassOf </span>Adenocarcinoma. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Epithelial-Myoepithelial Carcinoma<span class="subclass"> SubClassOf </span>Clear Cell Adenocarcinoma. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Adenocarcinoma<span class="subclass"> SubClassOf </span>Carcinoma. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
               <td rowspan="1">Epithelial-Myoepithelial Carcinoma<span class="subclass"> SubClassOf </span>Carcinoma. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">6456</td>
               <td><i>(1)</i>&nbsp; Sarcomatoid Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Spindle Cell. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Lung Sarcomatoid Carcinoma<span class="subclass"> SubClassOf </span>Sarcomatoid Carcinoma. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Ineffectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[i]</sup></div><br><i>(3)</i>&nbsp; Lung Giant Cell Carcinoma<span class="subclass"> EquivalentTo </span>Giant Cell Carcinoma<br><span class="keyword"> and </span>Lung Sarcomatoid Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Aggressive Clinical Course)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Giant Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Emperipolesis)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Inflammatory Infiltrate). 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
               <td rowspan="1">Lung Giant Cell Carcinoma<span class="subclass"> EquivalentTo </span>Giant Cell Carcinoma<br><span class="keyword"> and </span>Lung Sarcomatoid Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Aggressive Clinical Course)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Giant Cell)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Spindle Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Emperipolesis)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Inflammatory Infiltrate). 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">6457</td>
               <td><i>(1)</i>&nbsp; Metastatic<span class="subclass"> SubClassOf </span>Disease Gross Finding Qualifier. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Disease Gross Finding Qualifier<span class="subclass"> SubClassOf </span>Disease Qualifier. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
               <td rowspan="1">Metastatic<span class="subclass"> SubClassOf </span>Disease Qualifier. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">6458</td>
               <td><i>(1)</i>&nbsp; Niacinamide<span class="subclass"> SubClassOf </span>Niacin. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Niacin<span class="subclass"> SubClassOf </span>B Vitamin. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
               <td rowspan="1">Niacinamide<span class="subclass"> SubClassOf </span>B Vitamin. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">6460</td>
               <td><i>(1)</i>&nbsp; Rectal Sarcomatoid Carcinoma<span class="subclass"> SubClassOf </span>Sarcomatoid Carcinoma. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Sarcomatoid Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Spindle Cell. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
               <td rowspan="1">Rectal Sarcomatoid Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Spindle Cell. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">6461</td>
               <td><i>(1)</i>&nbsp; Ductal Carcinoma Cell<span class="subclass"> SubClassOf </span>Adenocarcinoma Cell. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Round Adenocarcinoma Cell<span class="subclass"> SubClassOf </span>Ductal Carcinoma Cell. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
               <td rowspan="1">Round Adenocarcinoma Cell<span class="subclass"> SubClassOf </span>Adenocarcinoma Cell. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">6463</td>
               <td><i>(1)</i>&nbsp; Sarcomatoid Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Spindle Cell. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Sarcomatoid Renal Cell Carcinoma<span class="subclass"> SubClassOf </span>Sarcomatoid Carcinoma. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
               <td rowspan="1">Sarcomatoid Renal Cell Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Spindle Cell. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">6462</td>
               <td><i>(1)</i>&nbsp; Sarcomatoid Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Spindle Cell. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Skin Sarcomatoid Basal Cell Carcinoma<span class="subclass"> SubClassOf </span>Sarcomatoid Carcinoma. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
               <td rowspan="1">Skin Sarcomatoid Basal Cell Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Spindle Cell. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">6465</td>
               <td><i>(1)</i>&nbsp; Personal Attribute<span class="subclass"> SubClassOf </span>Property<br><span class="keyword"> or </span>Attribute. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Susceptibility<span class="subclass"> SubClassOf </span>Health Status. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Health Status<span class="subclass"> SubClassOf </span>Personal Attribute. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
               <td rowspan="1">Susceptibility<span class="subclass"> SubClassOf </span>Property<br><span class="keyword"> or </span>Attribute. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">6464</td>
               <td><i>(1)</i>&nbsp; Sarcomatoid Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Spindle Cell. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Thymic Sarcomatoid Carcinoma<span class="subclass"> SubClassOf </span>Sarcomatoid Carcinoma. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
               <td rowspan="1">Thymic Sarcomatoid Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Spindle Cell. 
               </td>
            </tr>
         </tbody>
         <tbody id="retdesc" style="display:none">
            <tr class="withoutstyle">
               <td colspan="3">
                  <h4 style="display: inline-block;">Retired Descriptions (2)</h4> [<a href="#">back to top</a>]
               </td>
            </tr>
            <tr>
               <th class="removal">ID</th>
               <th class="removal" colspan="2">Retired Description Axiom in Ontology 1</th>
            </tr>
            <tr class="removal">
               <td>6466</td>
               <td colspan="2">Medical Product Intent Of Use<span class="subclass"> SubClassOf </span>Medical Product Usage And Evaluation.<br><i>Retired Terms: Medical Product Intent Of Use</i></td>
            </tr>
            <tr class="removal">
               <td>6467</td>
               <td colspan="2">Order<span class="subclass"> SubClassOf </span>Document.<br><i>Retired Terms: Order</i></td>
            </tr>
         </tbody>
         <tbody id="rem" style="display:none">
            <tr class="withoutstyle">
               <td colspan="3">
                  <h4 style="display: inline-block;">Pure Removals with Shared Terms (270)</h4> [<a href="#">back to top</a>]
               </td>
            </tr>
            <tr>
               <th class="removal">ID</th>
               <th class="removal" colspan="2">Removal from Ontology 1</th>
            </tr>
            <tr class="removal">
               <td>6737</td>
               <td colspan="2">2-Methoxyestradiol<span class="subclass"> EquivalentTo </span>Endothelial Cell Inhibitor<br><span class="keyword"> and </span>Steroidal Estrogen<br><span class="keyword"> and </span>(Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue<span class="some"> some </span>Endothelial Cell)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Mechanism_Of_Action<span class="some"> some </span>Microtubule Dynamics Alteration)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Angiogenic Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>G2 Phase Arrest)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Induction of Apoptosis)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Inhibition of Cell Proliferation)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Mitosis Inhibition).<br></td>
            </tr>
            <tr class="removal">
               <td>6468</td>
               <td colspan="2">AF-6 Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6469</td>
               <td colspan="2">AGR2 Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6471</td>
               <td colspan="2">ANP32C Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6472</td>
               <td colspan="2">ANP32D Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6473</td>
               <td colspan="2">ARMET Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6474</td>
               <td colspan="2">ATPase, Aminophospholipid Transporter-Like, Class I,<span class="subclass"> Type </span>8A, Member 2<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6475</td>
               <td colspan="2">Absent in Melanoma 1<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6476</td>
               <td colspan="2">Absent in Melanoma 2<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6477</td>
               <td colspan="2">Academic Detailing<span class="subclass"> SubClassOf </span>Education.<br></td>
            </tr>
            <tr class="removal">
               <td>6478</td>
               <td colspan="2">Acetylcysteine<span class="subclass"> SubClassOf </span>Cysteine.<br></td>
            </tr>
            <tr class="removal">
               <td>6479</td>
               <td colspan="2">Acinic Cell Breast Carcinoma<span class="subclass"> SubClassOf </span>Acinar Cell Carcinoma.<br></td>
            </tr>
            <tr class="removal">
               <td>6480</td>
               <td colspan="2">Allergic<span class="subclass"> SubClassOf </span>Personal Attribute.<br></td>
            </tr>
            <tr class="removal">
               <td>6481</td>
               <td colspan="2">Anethole Trithione<span class="subclass"> SubClassOf </span>Miscellaneous Chemoprotective Agent.<br></td>
            </tr>
            <tr class="removal">
               <td>6503</td>
               <td colspan="2">Ankyrin Repeat<span class="subclass"> Domain </span>30A<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6482</td>
               <td colspan="2">Anti-human Chorionic Gonadotropin Vaccine<span class="subclass"> SubClassOf </span>Antineoplastic Vaccine.<br></td>
            </tr>
            <tr class="removal">
               <td>6483</td>
               <td colspan="2">Apocrine Carcinoma Cell<span class="subclass"> SubClassOf </span>Ductal Carcinoma Cell.<br></td>
            </tr>
            <tr class="removal">
               <td>6484</td>
               <td colspan="2">Asymmetry<span class="subclass"> SubClassOf </span>General Qualifier.<br></td>
            </tr>
            <tr class="removal">
               <td>6485</td>
               <td colspan="2">Autoimmune Lymphoproliferative Syndrome<span class="subclass"> EquivalentTo </span>Syndrome<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Atypical Lymphocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Autoimmune Disease)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Hodgkin's Lymphoma)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Non-Hodgkin's Lymphoma)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Sinus Histiocytosis with Massive Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-10 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Splenomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Thrombocytopenia)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Reactive Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Associated_Anatomic_Site<span class="some"> only </span>Immune System)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Lymphocyte).<br></td>
            </tr>
            <tr class="removal">
               <td>6486</td>
               <td colspan="2">BC-2 Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6487</td>
               <td colspan="2">BCL7A Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6488</td>
               <td colspan="2">BCPR Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6489</td>
               <td colspan="2">BCSC-1<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6490</td>
               <td colspan="2">BRCA3 Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6492</td>
               <td colspan="2">BRCD1 Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6493</td>
               <td colspan="2">BRMS1 Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6494</td>
               <td colspan="2">Beta-Naphthoflavone<span class="subclass"> SubClassOf </span>Polycyclic Aromatic Hydrocarbons.<br></td>
            </tr>
            <tr class="removal">
               <td>6495</td>
               <td colspan="2">Birth<span class="subclass"> SubClassOf </span>Personal Attribute.<br></td>
            </tr>
            <tr class="removal">
               <td>6496</td>
               <td colspan="2">Blastoma<span class="subclass"> SubClassOf </span>Malignant Mixed Neoplasm.<br></td>
            </tr>
            <tr class="removal">
               <td>6497</td>
               <td colspan="2">Body Frame Size<span class="subclass"> SubClassOf </span>Observation.<br></td>
            </tr>
            <tr class="removal">
               <td>6498</td>
               <td colspan="2">Bowman-Birk Inhibitor Concentrate<span class="subclass"> SubClassOf </span>Chemopreventive Agent.<br></td>
            </tr>
            <tr class="removal">
               <td>6499</td>
               <td colspan="2">Brain-Specific Angiogenesis Inhibitor 2<span class="subclass"> EquivalentTo </span>Regulatory Protein<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>BAI2 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Regulatory Protein)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Angiogenesis).<br></td>
            </tr>
            <tr class="removal">
               <td>6500</td>
               <td colspan="2">Brain-Specific Angiogenesis Inhibitor 3<span class="subclass"> EquivalentTo </span>Regulatory Protein<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>BAI3 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Regulatory Protein)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Angiogenesis).<br></td>
            </tr>
            <tr class="removal">
               <td>6501</td>
               <td colspan="2">Breast Cancer Anti-Estrogen Resistance 2 Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6502</td>
               <td colspan="2">Breast Cancer Anti-Estrogen Resistance 3<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6504</td>
               <td colspan="2">Breast Cancer Suppressor-2<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6491</td>
               <td colspan="2">Breast Cancer, 11;22 Translocation Associated Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6505</td>
               <td colspan="2">Breast Carcinoma Amplified Sequence 1<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6506</td>
               <td colspan="2">Breast Carcinoma Amplified Sequence 2<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6507</td>
               <td colspan="2">Breast Carcinoma Amplified Sequence 3<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6508</td>
               <td colspan="2">Breast Carcinoma Amplified Sequence 4<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6509</td>
               <td colspan="2">Breast Columnar Cell Mucinous Carcinoma<span class="subclass"> SubClassOf </span>Mucinous Breast Carcinoma.<br></td>
            </tr>
            <tr class="removal">
               <td>6510</td>
               <td colspan="2">Breast Mucinous Cystadenocarcinoma<span class="subclass"> SubClassOf </span>Mucinous Breast Carcinoma.<br></td>
            </tr>
            <tr class="removal">
               <td>6511</td>
               <td colspan="2">Breast Mucinous Cystadenocarcinoma<span class="subclass"> SubClassOf </span>Mucinous Cystadenocarcinoma.<br></td>
            </tr>
            <tr class="removal">
               <td>6512</td>
               <td colspan="2">Bruceantin<span class="subclass"> SubClassOf </span>Miscellaneous Antineoplastic Antibiotic.<br></td>
            </tr>
            <tr class="removal">
               <td>6513</td>
               <td colspan="2">CD3-Epsilon-Associated Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6515</td>
               <td colspan="2">CDDO<span class="subclass"> SubClassOf </span>Immunostimulant.<br></td>
            </tr>
            <tr class="removal">
               <td>6516</td>
               <td colspan="2">COX7A2L Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6517</td>
               <td colspan="2">Calcified<span class="subclass"> SubClassOf </span>General Qualifier.<br></td>
            </tr>
            <tr class="removal">
               <td>6518</td>
               <td colspan="2">Calcium Carbonate<span class="subclass"> SubClassOf </span>Chemopreventive Agent.<br></td>
            </tr>
            <tr class="removal">
               <td>6627</td>
               <td colspan="2">Calmodulin-Like 4 Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6519</td>
               <td colspan="2">Cancer/Testis Antigen 1<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6520</td>
               <td colspan="2">Carboxyamidotriazole<span class="subclass"> EquivalentTo </span>Miscellaneous Angiogenesis Inhibitor<br><span class="keyword"> and </span>(Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue<span class="some"> some </span>Endothelial Cell)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue<span class="some"> some </span>Vascular Endothelium)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Affects_Gene_Product<span class="some"> some </span>Non-Voltage-Dependent Calcium Channel)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Mechanism_Of_Action<span class="some"> some </span>Calcium Channel Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Angiogenic Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Signal Transduction Inhibition).<br></td>
            </tr>
            <tr class="removal">
               <td>6514</td>
               <td colspan="2">Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6521</td>
               <td colspan="2">Cardinality<span class="subclass"> SubClassOf </span>Conceptual Entity.<br></td>
            </tr>
            <tr class="removal">
               <td>6522</td>
               <td colspan="2">Cerebellar-Degeneration-Related Antigen 1<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6626</td>
               <td colspan="2">Chromosome 22 Open Reading Frame 19<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6523</td>
               <td colspan="2">Ciprofloxacin Hydrochloride<span class="subclass"> SubClassOf </span>Topoisomerase-II Inhibitor.<br></td>
            </tr>
            <tr class="removal">
               <td>6524</td>
               <td colspan="2">Completion Status<span class="subclass"> SubClassOf </span>Business Rules.<br></td>
            </tr>
            <tr class="removal">
               <td>6525</td>
               <td colspan="2">Conduct Clinical Trials<span class="subclass"> SubClassOf </span>Action.<br></td>
            </tr>
            <tr class="removal">
               <td>6526</td>
               <td colspan="2">Conformation<span class="subclass"> SubClassOf </span>Miscellaneous Molecular Biology Terms.<br></td>
            </tr>
            <tr class="removal">
               <td>6527</td>
               <td colspan="2">Conjugated Linoleic Acid<span class="subclass"> SubClassOf </span>Omega-6 Fatty Acid.<br></td>
            </tr>
            <tr class="removal">
               <td>6528</td>
               <td colspan="2">Connector Enhancer of KSR-Like Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6529</td>
               <td colspan="2">Cribriform<span class="subclass"> SubClassOf </span>General Qualifier.<br></td>
            </tr>
            <tr class="removal">
               <td>6530</td>
               <td colspan="2">Cyclooxygenase Inhibitor<span class="subclass"> SubClassOf </span>Miscellaneous Angiogenesis Inhibitor.<br></td>
            </tr>
            <tr class="removal">
               <td>6531</td>
               <td colspan="2">Cystic Hypersecretory Breast Carcinoma<span class="subclass"> SubClassOf </span>Secretory Breast Carcinoma.<br></td>
            </tr>
            <tr class="removal">
               <td>6532</td>
               <td colspan="2">DBCCR1 Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6533</td>
               <td colspan="2">DCC Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6534</td>
               <td colspan="2">DEAD/H Box Protein 1<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6535</td>
               <td colspan="2">DEC1 Gene<span class="subclass"> SubClassOf </span>Gene_Associated_With_Disease<span class="some"> some </span>Esophageal Squamous Cell Carcinoma.<br></td>
            </tr>
            <tr class="removal">
               <td>6536</td>
               <td colspan="2">DEC1 Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6537</td>
               <td colspan="2">DLEC1 Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6538</td>
               <td colspan="2">DLEU1 Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6539</td>
               <td colspan="2">DLEU2 Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6541</td>
               <td colspan="2">Deleted in Split Hand/Split Foot Protein 1<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6542</td>
               <td colspan="2">Department<span class="subclass"> SubClassOf </span>UML Entity.<br></td>
            </tr>
            <tr class="removal">
               <td>6543</td>
               <td colspan="2">Diindolylmethane<span class="subclass"> SubClassOf </span>Nutritional Supplement.<br></td>
            </tr>
            <tr class="removal">
               <td>6544</td>
               <td colspan="2">Directionality<span class="subclass"> SubClassOf </span>Conceptual Entity.<br></td>
            </tr>
            <tr class="removal">
               <td>6545</td>
               <td colspan="2">Distance Learning<span class="subclass"> SubClassOf </span>Education.<br></td>
            </tr>
            <tr class="removal">
               <td>6546</td>
               <td colspan="2">Double<span class="subclass"> SubClassOf </span>Action.<br></td>
            </tr>
            <tr class="removal">
               <td>6550</td>
               <td colspan="2">Educational Intervention<span class="subclass"> SubClassOf </span>Patient<br><span class="keyword"> or </span>Public Education.<br></td>
            </tr>
            <tr class="removal">
               <td>6551</td>
               <td colspan="2">Eflornithine Hydrochloride<span class="subclass"> SubClassOf </span>Difluoromethylornithine.<br></td>
            </tr>
            <tr class="removal">
               <td>6547</td>
               <td colspan="2">Epidermal Growth Factor Receptor Pathway Substrate 8-Like Protein 1<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6548</td>
               <td colspan="2">Epidermal Growth Factor Receptor Pathway Substrate 8-Like Protein 2<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6549</td>
               <td colspan="2">Epidermal Growth Factor Receptor Pathway Substrate 8-Like Protein 3<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6552</td>
               <td colspan="2">Epididymal Secretory Protein E4<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6553</td>
               <td colspan="2">Epigallocatechin Gallate<span class="subclass"> SubClassOf </span>Green Tea Extract.<br></td>
            </tr>
            <tr class="removal">
               <td>6555</td>
               <td colspan="2">Epithelial Stromal Interaction 1<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6554</td>
               <td colspan="2">Epithelial-Myoepithelial Carcinoma<span class="subclass"> SubClassOf </span>Clear Cell Adenocarcinoma.<br></td>
            </tr>
            <tr class="removal">
               <td>6557</td>
               <td colspan="2">FGF Receptor Activating Protein 1<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6556</td>
               <td colspan="2">FGFR1 Oncogene Partner<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6558</td>
               <td colspan="2">FUS-1 Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6559</td>
               <td colspan="2">Five-A-Day Program<span class="subclass"> SubClassOf </span>Patient<br><span class="keyword"> or </span>Public Education.<br></td>
            </tr>
            <tr class="removal">
               <td>6560</td>
               <td colspan="2">Folate<span class="subclass"> SubClassOf </span>Pteridines, Folic Acid Analogs.<br></td>
            </tr>
            <tr class="removal">
               <td>6561</td>
               <td colspan="2">Follicular Variant Translocation Protein 1<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6562</td>
               <td colspan="2">GAGED3 Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6565</td>
               <td colspan="2">Genistein<span class="subclass"> SubClassOf </span>Topoisomerase-II Inhibitor.<br></td>
            </tr>
            <tr class="removal">
               <td>6564</td>
               <td colspan="2">Glioma Tumor Suppressor Candidate Region Gene 1 Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6566</td>
               <td colspan="2">Glomulin<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6567</td>
               <td colspan="2">Glycoprotein A33<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6568</td>
               <td colspan="2">Glycyrrhetic Acid<span class="subclass"> SubClassOf </span>Cytoprotective Agent.<br></td>
            </tr>
            <tr class="removal">
               <td>6569</td>
               <td colspan="2">Golgi-Associated PR-1 Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6570</td>
               <td colspan="2">Green Tea Extract<span class="subclass"> SubClassOf </span>Chemopreventive Agent.<br></td>
            </tr>
            <tr class="removal">
               <td>6571</td>
               <td colspan="2">Growth Arrest-Specific Protein 8<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6572</td>
               <td colspan="2">Halofuginone<span class="subclass"> EquivalentTo </span>Matrix Metalloproteinase Inhibitor<br><span class="keyword"> and </span>Miscellaneous Angiogenesis Inhibitor<br><span class="keyword"> and </span>(Chemical_Or_Drug_Affects_Gene_Product<span class="some"> some </span>Matrix Metalloproteinase 2)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Mechanism_Of_Action<span class="some"> some </span>Enzyme Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Angiogenic Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Metastasis Suppression)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Signal Transduction Inhibition).<br></td>
            </tr>
            <tr class="removal">
               <td>6573</td>
               <td colspan="2">Haptoglobin-Related Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6574</td>
               <td colspan="2">Hepatocellular Carcinoma Protein HHCM<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6575</td>
               <td colspan="2">High Throughput Screening<span class="subclass"> SubClassOf </span>Action.<br></td>
            </tr>
            <tr class="removal">
               <td>6577</td>
               <td colspan="2">Immune<span class="subclass"> SubClassOf </span>Personal Attribute.<br></td>
            </tr>
            <tr class="removal">
               <td>6578</td>
               <td colspan="2">Indigenous<span class="subclass"> SubClassOf </span>Personal Attribute.<br></td>
            </tr>
            <tr class="removal">
               <td>6579</td>
               <td colspan="2">Intake<span class="subclass"> SubClassOf </span>Property<br><span class="keyword"> or </span>Attribute.<br></td>
            </tr>
            <tr class="removal">
               <td>6580</td>
               <td colspan="2">Intracavitary<span class="subclass"> SubClassOf </span>General Qualifier.<br></td>
            </tr>
            <tr class="removal">
               <td>6581</td>
               <td colspan="2">Intracellular<span class="subclass"> SubClassOf </span>General Qualifier.<br></td>
            </tr>
            <tr class="removal">
               <td>6582</td>
               <td colspan="2">Intradermal<span class="subclass"> SubClassOf </span>General Qualifier.<br></td>
            </tr>
            <tr class="removal">
               <td>6583</td>
               <td colspan="2">Intralesional<span class="subclass"> SubClassOf </span>General Qualifier.<br></td>
            </tr>
            <tr class="removal">
               <td>6584</td>
               <td colspan="2">Intratumoral<span class="subclass"> SubClassOf </span>General Qualifier.<br></td>
            </tr>
            <tr class="removal">
               <td>6585</td>
               <td colspan="2">Isoflavone<span class="subclass"> SubClassOf </span>Phytoestrogen.<br></td>
            </tr>
            <tr class="removal">
               <td>6586</td>
               <td colspan="2">JAW1-Related Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6587</td>
               <td colspan="2">Key<span class="subclass"> SubClassOf </span>UML Entity.<br></td>
            </tr>
            <tr class="removal">
               <td>6588</td>
               <td colspan="2">KiSS1 Metastasis Suppressor Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6589</td>
               <td colspan="2">Kilo<span class="subclass"> SubClassOf </span>General Qualifier.<br></td>
            </tr>
            <tr class="removal">
               <td>6590</td>
               <td colspan="2">LIM<span class="subclass"> Domain </span>Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6592</td>
               <td colspan="2">Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Bronchial Epithelial Cell.<br></td>
            </tr>
            <tr class="removal">
               <td>6593</td>
               <td colspan="2">Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Bronchial Epithelium.<br></td>
            </tr>
            <tr class="removal">
               <td>6596</td>
               <td colspan="2">Leucine Rich Repeat Containing Protein 17<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6594</td>
               <td colspan="2">Leucine-Rich Glioma-Inactivated Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6595</td>
               <td colspan="2">Leucine-Rich Repeat Transmembrane Protein FLRT3<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6597</td>
               <td colspan="2">Login Name<span class="subclass"> SubClassOf </span>UML Entity.<br></td>
            </tr>
            <tr class="removal">
               <td>6598</td>
               <td colspan="2">Lovastatin<span class="subclass"> SubClassOf </span>Ras Inhibitor.<br></td>
            </tr>
            <tr class="removal">
               <td>6599</td>
               <td colspan="2">MAGE-12 Antigen<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6600</td>
               <td colspan="2">MAGE-3.1 Antigen<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6601</td>
               <td colspan="2">MASL1 Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6602</td>
               <td colspan="2">MCC Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6603</td>
               <td colspan="2">MCT-1 Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6604</td>
               <td colspan="2">MLSN1<br><span class="keyword"> and </span>TRP-Related Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6605</td>
               <td colspan="2">MYB Binding Protein 1A<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6606</td>
               <td colspan="2">Marker Discovery<span class="subclass"> SubClassOf </span>Action.<br></td>
            </tr>
            <tr class="removal">
               <td>6607</td>
               <td colspan="2">Matrix Gla Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6608</td>
               <td colspan="2">Mature T-Cell Proliferation 1 Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6609</td>
               <td colspan="2">Mean Arterial Pressure<span class="subclass"> SubClassOf </span>Observation.<br></td>
            </tr>
            <tr class="removal">
               <td>6591</td>
               <td colspan="2">Medical Product Label<span class="subclass"> SubClassOf </span>Pharmaceutical Product Information.<br></td>
            </tr>
            <tr class="removal">
               <td>6610</td>
               <td colspan="2">Melan-A Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6611</td>
               <td colspan="2">Melanocyte Lineage-Specific Antigen gp100<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6612</td>
               <td colspan="2">Melanoma Adhesion Molecule<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6613</td>
               <td colspan="2">Mesothelin<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6614</td>
               <td colspan="2">Metastatic<span class="subclass"> SubClassOf </span>Disease Gross Finding Qualifier.<br></td>
            </tr>
            <tr class="removal">
               <td>6615</td>
               <td colspan="2">Micro<span class="subclass"> SubClassOf </span>General Qualifier.<br></td>
            </tr>
            <tr class="removal">
               <td>6616</td>
               <td colspan="2">Milli<span class="subclass"> SubClassOf </span>General Qualifier.<br></td>
            </tr>
            <tr class="removal">
               <td>6617</td>
               <td colspan="2">Module<span class="subclass"> SubClassOf </span>UML Entity.<br></td>
            </tr>
            <tr class="removal">
               <td>6618</td>
               <td colspan="2">Mucinous Tubular<br><span class="keyword"> and </span>Spindle Renal Cell Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17.<br></td>
            </tr>
            <tr class="removal">
               <td>6619</td>
               <td colspan="2">Mucinous Tubular<br><span class="keyword"> and </span>Spindle Renal Cell Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7.<br></td>
            </tr>
            <tr class="removal">
               <td>6620</td>
               <td colspan="2">Multiplicity<span class="subclass"> SubClassOf </span>Conceptual Entity.<br></td>
            </tr>
            <tr class="removal">
               <td>6621</td>
               <td colspan="2">Musculin<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6622</td>
               <td colspan="2">Myelin Protein Zero-Like 1<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6623</td>
               <td colspan="2">Myelodysplastic Syndrome<span class="subclass"> EquivalentTo </span>Common Hematopoietic Neoplasm<br><span class="keyword"> and </span>Myeloid Neoplasm<br><span class="keyword"> and </span>Premalignant Hematologic Condition<br><span class="keyword"> and </span>Syndrome<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hypercellular Bone Marrow)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Bone Marrow Dysplasia Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Ineffective Hematopoiesis)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Myeloblasts Under 20 Percent of Peripheral Blood White Cells).<br></td>
            </tr>
            <tr class="removal">
               <td>6470</td>
               <td colspan="2">Myeloid/Lymphoid<br><span class="keyword"> or </span>Mixed-Lineage Leukemia Protein 2<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6624</td>
               <td colspan="2">Myoepithelial<span class="subclass"> SubClassOf </span>General Qualifier.<br></td>
            </tr>
            <tr class="removal">
               <td>6625</td>
               <td colspan="2">N33 Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6630</td>
               <td colspan="2">Netrin 1<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6631</td>
               <td colspan="2">Neural Network<span class="subclass"> SubClassOf </span>Artificial Intelligence.<br></td>
            </tr>
            <tr class="removal">
               <td>6632</td>
               <td colspan="2">Neuroblastoma-Amplified Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6633</td>
               <td colspan="2">Neuroepithelial<span class="subclass"> SubClassOf </span>General Qualifier.<br></td>
            </tr>
            <tr class="removal">
               <td>6634</td>
               <td colspan="2">Niacinamide<span class="subclass"> SubClassOf </span>Niacin.<br></td>
            </tr>
            <tr class="removal">
               <td>6635</td>
               <td colspan="2">Non-Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p.<br></td>
            </tr>
            <tr class="removal">
               <td>6636</td>
               <td colspan="2">Non-Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation.<br></td>
            </tr>
            <tr class="removal">
               <td>6637</td>
               <td colspan="2">Non-Surgical<span class="subclass"> SubClassOf </span>General Qualifier.<br></td>
            </tr>
            <tr class="removal">
               <td>6638</td>
               <td colspan="2">Nuclear LIM Interactor-Interacting Factor 2<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6639</td>
               <td colspan="2">Nuclear Receptor Binding Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6640</td>
               <td colspan="2">OBTP Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6728</td>
               <td colspan="2">Oncogenes, Other<span class="subclass"> SubClassOf </span>Gene_Found_In_Organism<span class="some"> some </span>Human.<br></td>
            </tr>
            <tr class="removal">
               <td>6729</td>
               <td colspan="2">Oncogenes, Other<span class="subclass"> SubClassOf </span>Oncogene.<br></td>
            </tr>
            <tr class="removal">
               <td>6641</td>
               <td colspan="2">Organizational Unit<span class="subclass"> SubClassOf </span>UML Entity.<br></td>
            </tr>
            <tr class="removal">
               <td>6642</td>
               <td colspan="2">Other Types of Training<span class="subclass"> SubClassOf </span>Training.<br></td>
            </tr>
            <tr class="removal">
               <td>6643</td>
               <td colspan="2">PHAPI2 Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6644</td>
               <td colspan="2">PHEMX Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6645</td>
               <td colspan="2">PVT1 Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6646</td>
               <td colspan="2">Parafibromin<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6647</td>
               <td colspan="2">Party<span class="subclass"> SubClassOf </span>UML Entity.<br></td>
            </tr>
            <tr class="removal">
               <td>6648</td>
               <td colspan="2">Pentoxifylline<span class="subclass"> SubClassOf </span>Anticachexia Agent.<br></td>
            </tr>
            <tr class="removal">
               <td>6649</td>
               <td colspan="2">Peptide Conformation<span class="subclass"> SubClassOf </span>Miscellaneous Molecular Biology Terms.<br></td>
            </tr>
            <tr class="removal">
               <td>6650</td>
               <td colspan="2">Perillyl Alcohol<span class="subclass"> EquivalentTo </span>Chemopreventive Agent<br><span class="keyword"> and </span>Farnesyl Transferase Inhibitor<br><span class="keyword"> and </span>(Chemical_Or_Drug_Affects_Gene_Product<span class="some"> some </span>Farnesyl Protein Transferase)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Affects_Gene_Product<span class="some"> some </span>Geranylgeranyl Transferase)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Mechanism_Of_Action<span class="some"> some </span>Enzyme Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Cell Differentiation Induction)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Farnesylation Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>G1 Arrest)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Isoprenylation Inhibition).<br></td>
            </tr>
            <tr class="removal">
               <td>6651</td>
               <td colspan="2">Perioperative<span class="subclass"> SubClassOf </span>General Qualifier.<br></td>
            </tr>
            <tr class="removal">
               <td>6652</td>
               <td colspan="2">Permissible Value<span class="subclass"> SubClassOf </span>UML Entity.<br></td>
            </tr>
            <tr class="removal">
               <td>6629</td>
               <td colspan="2">Person Name<span class="subclass"> SubClassOf </span>Personal Attribute.<br></td>
            </tr>
            <tr class="removal">
               <td>6653</td>
               <td colspan="2">Phenylalanyl-tRNA Synthetase Beta-Subunit<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6654</td>
               <td colspan="2">Platelet-Derived Growth Factor Receptor-Like Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6655</td>
               <td colspan="2">Postmeiotic Segregation Increased 2-Like Protein 1<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6656</td>
               <td colspan="2">Pregnant Mare Serum Gonadotropin<span class="subclass"> SubClassOf </span>Biological Agent.<br></td>
            </tr>
            <tr class="removal">
               <td>6657</td>
               <td colspan="2">Primary Key<span class="subclass"> SubClassOf </span>UML Entity.<br></td>
            </tr>
            <tr class="removal">
               <td>6658</td>
               <td colspan="2">Primary Site Unknown<span class="subclass"> SubClassOf </span>Test Result.<br></td>
            </tr>
            <tr class="removal">
               <td>6659</td>
               <td colspan="2">Primary Squamous Cell Breast Carcinoma<span class="subclass"> EquivalentTo </span>Squamous Cell Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Primary Lesion).<br></td>
            </tr>
            <tr class="removal">
               <td>6660</td>
               <td colspan="2">Probability<span class="subclass"> SubClassOf </span>Conceptual Entity.<br></td>
            </tr>
            <tr class="removal">
               <td>6661</td>
               <td colspan="2">Programmed Death Ligand 2 Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6662</td>
               <td colspan="2">Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function<span class="subclass"> SubClassOf </span>Protein, Organized by Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6663</td>
               <td colspan="2">Proto-Oncogene FRAT1 Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6664</td>
               <td colspan="2">Proximity<span class="subclass"> SubClassOf </span>Conceptual Entity.<br></td>
            </tr>
            <tr class="removal">
               <td>6665</td>
               <td colspan="2">Putative GR6 Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6666</td>
               <td colspan="2">Putative Transmembrane Protein NMA<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6669</td>
               <td colspan="2">RAS Suppressor Protein 1<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6667</td>
               <td colspan="2">RAS-Like Protein RRP22<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6668</td>
               <td colspan="2">RAS-Related GTP-Binding Protein RAGA<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6670</td>
               <td colspan="2">RET Finger Protein 2<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6671</td>
               <td colspan="2">RNA Conformation<span class="subclass"> SubClassOf </span>Miscellaneous Molecular Biology Terms.<br></td>
            </tr>
            <tr class="removal">
               <td>6672</td>
               <td colspan="2">Relapse<span class="subclass"> SubClassOf </span>Conceptual Entity.<br></td>
            </tr>
            <tr class="removal">
               <td>6673</td>
               <td colspan="2">Reproducibility<span class="subclass"> SubClassOf </span>Clinical Testing.<br></td>
            </tr>
            <tr class="removal">
               <td>6674</td>
               <td colspan="2">Research Training<span class="subclass"> SubClassOf </span>Training.<br></td>
            </tr>
            <tr class="removal">
               <td>6675</td>
               <td colspan="2">Reticulon 1<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6676</td>
               <td colspan="2">Retroperitoneal<span class="subclass"> SubClassOf </span>General Qualifier.<br></td>
            </tr>
            <tr class="removal">
               <td>6677</td>
               <td colspan="2">Rhodacyanine Analog MKT-077<span class="subclass"> SubClassOf </span>Rhodamine.<br></td>
            </tr>
            <tr class="removal">
               <td>6678</td>
               <td colspan="2">Richter's Syndrome<span class="subclass"> EquivalentTo </span>Syndrome<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Chronic Lymphocytic Leukemia).<br></td>
            </tr>
            <tr class="removal">
               <td>6679</td>
               <td colspan="2">Ring Finger Protein 11<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6680</td>
               <td colspan="2">Rodent Nomenclature Name<span class="subclass"> SubClassOf </span>UML Entity.<br></td>
            </tr>
            <tr class="removal">
               <td>6681</td>
               <td colspan="2">Round Adenocarcinoma Cell<span class="subclass"> SubClassOf </span>Ductal Carcinoma Cell.<br></td>
            </tr>
            <tr class="removal">
               <td>6576</td>
               <td colspan="2">SID1 Transmembrane Family, Member 1<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6682</td>
               <td colspan="2">Salivary Gland Acinic Cell Carcinoma<span class="subclass"> SubClassOf </span>Acinar Cell Carcinoma.<br></td>
            </tr>
            <tr class="removal">
               <td>6683</td>
               <td colspan="2">Sarcomatoid Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Spindle Cell.<br></td>
            </tr>
            <tr class="removal">
               <td>6684</td>
               <td colspan="2">Sebaceous Breast Carcinoma<span class="subclass"> SubClassOf </span>Extraocular Cutaneous Sebaceous Carcinoma.<br></td>
            </tr>
            <tr class="removal">
               <td>6685</td>
               <td colspan="2">Secreted<br><span class="keyword"> and </span>Transmembrane 1 Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6686</td>
               <td colspan="2">Secretory Breast Carcinoma<span class="subclass"> SubClassOf </span>Secretory Carcinoma.<br></td>
            </tr>
            <tr class="removal">
               <td>6687</td>
               <td colspan="2">Secretory Carcinoma<span class="subclass"> SubClassOf </span>Adenocarcinoma.<br></td>
            </tr>
            <tr class="removal">
               <td>6688</td>
               <td colspan="2">Sequential<span class="subclass"> SubClassOf </span>General Qualifier.<br></td>
            </tr>
            <tr class="removal">
               <td>6628</td>
               <td colspan="2">Serologically Defined Breast Cancer Antigen 84<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6689</td>
               <td colspan="2">Severity<span class="subclass"> SubClassOf </span>Conceptual Entity.<br></td>
            </tr>
            <tr class="removal">
               <td>6690</td>
               <td colspan="2">Single-Use Device Reprocessed<br><span class="keyword"> and </span>Reused on Patient<span class="subclass"> SubClassOf </span>Device Usage.<br></td>
            </tr>
            <tr class="removal">
               <td>6691</td>
               <td colspan="2">Solid Carcinoma<span class="subclass"> SubClassOf </span>Solid Neoplasm.<br></td>
            </tr>
            <tr class="removal">
               <td>6697</td>
               <td colspan="2">Stage I Adenosquamous Lung Carcinoma<span class="subclass"> EquivalentTo </span>Adenosquamous Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage I).<br></td>
            </tr>
            <tr class="removal">
               <td>6698</td>
               <td colspan="2">Stage I Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Squamous Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage I).<br></td>
            </tr>
            <tr class="removal">
               <td>6693</td>
               <td colspan="2">Stage II Adenosquamous Lung Carcinoma<span class="subclass"> EquivalentTo </span>Adenosquamous Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage II).<br></td>
            </tr>
            <tr class="removal">
               <td>6694</td>
               <td colspan="2">Stage II Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Squamous Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage II).<br></td>
            </tr>
            <tr class="removal">
               <td>6692</td>
               <td colspan="2">Stage III Adenosquamous Lung Carcinoma<span class="subclass"> EquivalentTo </span>Adenosquamous Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage III).<br></td>
            </tr>
            <tr class="removal">
               <td>6695</td>
               <td colspan="2">Stage IV Adenosquamous Lung Carcinoma<span class="subclass"> EquivalentTo </span>Adenosquamous Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IV).<br></td>
            </tr>
            <tr class="removal">
               <td>6696</td>
               <td colspan="2">Stage IV Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Squamous Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IV).<br></td>
            </tr>
            <tr class="removal">
               <td>6699</td>
               <td colspan="2">Suppression of Tumorigenicity 7 Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6700</td>
               <td colspan="2">Susceptibility<span class="subclass"> SubClassOf </span>Health Status.<br></td>
            </tr>
            <tr class="removal">
               <td>6701</td>
               <td colspan="2">Sushi-Repeat Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6702</td>
               <td colspan="2">Synuclein Gamma<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6705</td>
               <td colspan="2">T-Cell Leukemia Translocation Altered Gene Product<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6703</td>
               <td colspan="2">T-Cell Leukemia/Lymphoma 1B<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6704</td>
               <td colspan="2">TATA Box<span class="subclass"> SubClassOf </span>DNA Sequence.<br></td>
            </tr>
            <tr class="removal">
               <td>6708</td>
               <td colspan="2">TSSC4 Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6709</td>
               <td colspan="2">Tamoxifen Citrate<span class="subclass"> SubClassOf </span>DNA Adduct Forming Agent.<br></td>
            </tr>
            <tr class="removal">
               <td>6710</td>
               <td colspan="2">Taxol Resistance Associated Protein 3<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6711</td>
               <td colspan="2">Testis-Specific Kinase Substrate<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6712</td>
               <td colspan="2">Testis-Specific Y-Encoded Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6713</td>
               <td colspan="2">Tetratricopeptide Repeat Protein 4<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6714</td>
               <td colspan="2">Thalidomide<span class="subclass"> EquivalentTo </span>Endothelial Cell Inhibitor<br><span class="keyword"> and </span>Immunosuppressant<br><span class="keyword"> and </span>(Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue<span class="some"> some </span>Endothelial Cell)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue<span class="some"> some </span>Monocyte)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Mechanism_Of_Action<span class="some"> some </span>Unknown Cellular<br><span class="keyword"> or </span>Molecular Mechanism)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Angiogenic Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Chemotaxis Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Interferon Suppression)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Phagocytosis Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Tumor Necrosis Factor Suppression).<br></td>
            </tr>
            <tr class="removal">
               <td>6715</td>
               <td colspan="2">Theophylline<span class="subclass"> SubClassOf </span>Multidrug Resistance Modulator.<br></td>
            </tr>
            <tr class="removal">
               <td>6716</td>
               <td colspan="2">Thrombospondin<span class="subclass"> Type </span>I<span class="subclass"> Domain </span>2 Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6717</td>
               <td colspan="2">Tocladesine<span class="subclass"> SubClassOf </span>Protein Kinase A Inhibitor.<br></td>
            </tr>
            <tr class="removal">
               <td>6718</td>
               <td colspan="2">Tooth 30<span class="subclass"> SubClassOf </span>Posterior Tooth.<br></td>
            </tr>
            <tr class="removal">
               <td>6719</td>
               <td colspan="2">Training<span class="subclass"> SubClassOf </span>Training<br><span class="keyword"> and </span>Education.<br></td>
            </tr>
            <tr class="removal">
               <td>6720</td>
               <td colspan="2">Training in Biomedical<br><span class="keyword"> and </span>Behavioral Research<span class="subclass"> SubClassOf </span>Training.<br></td>
            </tr>
            <tr class="removal">
               <td>6721</td>
               <td colspan="2">Training of Investigators<span class="subclass"> SubClassOf </span>Training.<br></td>
            </tr>
            <tr class="removal">
               <td>6723</td>
               <td colspan="2">Transforming Acidic Coiled-Coil Containing Protein 3<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6722</td>
               <td colspan="2">Transforming Acidic Coiled-Coil-Containing Protein 2<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6724</td>
               <td colspan="2">Transforming Growth Factor-Beta Induced Protein IGH3<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6725</td>
               <td colspan="2">Tumor Protein D52<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6726</td>
               <td colspan="2">Tumor Protein D52-Like 1<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6706</td>
               <td colspan="2">Tumor Suppressing Subtransferable Candidate 1 Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6707</td>
               <td colspan="2">Tumor Suppressing Subtransferable Candidate 3 Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6540</td>
               <td colspan="2">Tumor Suppressor Deleted in Oral Cancer-Related 1<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6727</td>
               <td colspan="2">Ubiquitin D<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6730</td>
               <td colspan="2">Ursodiol<span class="subclass"> SubClassOf </span>Chemopreventive Agent.<br></td>
            </tr>
            <tr class="removal">
               <td>6731</td>
               <td colspan="2">Valid Value<span class="subclass"> SubClassOf </span>UML Entity.<br></td>
            </tr>
            <tr class="removal">
               <td>6733</td>
               <td colspan="2">Vitamin E Acetate<span class="subclass"> SubClassOf </span>Miscellaneous Angiogenesis Inhibitor.<br></td>
            </tr>
            <tr class="removal">
               <td>6732</td>
               <td colspan="2">Vitamin E Compound<span class="subclass"> SubClassOf </span>Miscellaneous Angiogenesis Inhibitor.<br></td>
            </tr>
            <tr class="removal">
               <td>6734</td>
               <td colspan="2">WD Repeat<span class="subclass"> Domain </span>Protein 22<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6735</td>
               <td colspan="2">WT2 Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6736</td>
               <td colspan="2">Wolf-Hirschhorn Syndrome Candidate 1 Protein<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
            <tr class="removal">
               <td>6563</td>
               <td colspan="2">YEATS<span class="subclass"> Domain </span>Containing 4<span class="subclass"> SubClassOf </span>Protein with Unknown<br><span class="keyword"> or </span>Unclassified Function.<br></td>
            </tr>
         </tbody>
         <tbody id="remrt" style="display:none">
            <tr class="withoutstyle">
               <td colspan="3"><a name="rem"></a><h4 style="display: inline-block;">Pure Removals with Retired Terms (4)</h4> [<a href="#">back to top</a>]
               </td>
            </tr>
            <tr>
               <th class="removal">ID</th>
               <th class="removal" colspan="2">Removal from Ontology 1</th>
            </tr>
            <tr class="removal">
               <td>6738</td>
               <td colspan="2">Intent For Diagnosis<span class="subclass"> SubClassOf </span>Medical Product Intent Of Use.<br><i>Retired Terms: Medical Product Intent Of Use</i></td>
            </tr>
            <tr class="removal">
               <td>6739</td>
               <td colspan="2">Intent For Mitigation<span class="subclass"> SubClassOf </span>Medical Product Intent Of Use.<br><i>Retired Terms: Medical Product Intent Of Use</i></td>
            </tr>
            <tr class="removal">
               <td>6740</td>
               <td colspan="2">Intent For Prophylaxis<span class="subclass"> SubClassOf </span>Medical Product Intent Of Use.<br><i>Retired Terms: Medical Product Intent Of Use</i></td>
            </tr>
            <tr class="removal">
               <td>6741</td>
               <td colspan="2">Intent To Treat<span class="subclass"> SubClassOf </span>Medical Product Intent Of Use.<br><i>Retired Terms: Medical Product Intent Of Use</i></td>
            </tr>
         </tbody>
         <tbody id="wkequiv" style="display:none">
            <tr class="withoutstyle">
               <td colspan="3"><a name="redef"></a><h4 style="display: inline-block;">Modified Definitions with Shared Terms (24)</h4> [<a href="#">back to top</a>]
               </td>
            </tr>
            <tr>
               <th class="removal">ID</th>
               <th class="removal">Target Definition in Ontology 1</th>
               <th class="normalrem">Source Definition in Ontology 2</th>
            </tr>
            <tr class="removal">
               <td>6742</td>
               <td>Adenosquamous Lung Carcinoma<span class="subclass"> EquivalentTo </span>Adenosquamous Carcinoma<br><span class="keyword"> and </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>APC Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FHIT Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>LKB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Metaplasia)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Bronchial Epithelial Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Bronchial Epithelium). 
                  			
               </td>
               <td>Adenosquamous Lung Carcinoma<span class="subclass"> EquivalentTo </span>Adenosquamous Carcinoma<br><span class="keyword"> and </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>APC Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FHIT Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>LKB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Bronchial Epithelial Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Bronchial Epithelium).<br></td>
            </tr>
            <tr class="removal">
               <td>6743</td>
               <td>Breast Lymphoma<span class="subclass"> EquivalentTo </span>Lymphoma by Site<br><span class="keyword"> and </span>Malignant Breast Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Breast). 
                  			
               </td>
               <td>Breast Lymphoma<span class="subclass"> EquivalentTo </span>Lymphoma by Site<br><span class="keyword"> and </span>Malignant Breast Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Mammary Gland Tissue)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Breast).<br></td>
            </tr>
            <tr class="removal">
               <td>6744</td>
               <td>Carcinoma ex Pleomorphic Adenoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>Malignant Mixed Neoplasm<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cartilagenous Component Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lipomatous Component Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Myxoid Stroma Formation)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Osseous Component Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Carcinomatous Component Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mesenchymal Component Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Metaplasia)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Secondary Lesion)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Myoepithelial Cell). 
                  			
               </td>
               <td>Carcinoma ex Pleomorphic Adenoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>Malignant Mixed Neoplasm<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cartilagenous Component Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lipomatous Component Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Myxoid Stroma Formation)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Osseous Component Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Carcinomatous Component Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mesenchymal Component Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Secondary Lesion)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Myoepithelial Cell).<br></td>
            </tr>
            <tr class="removal">
               <td>6745</td>
               <td>Flutamide<span class="subclass"> EquivalentTo </span>Anti-Androgen<br><span class="keyword"> and </span>(Chemical_Or_Drug_Affects_Gene_Product<span class="some"> some </span>Androgen Receptor)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Mechanism_Of_Action<span class="some"> some </span>Receptor Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Inhibition of Cell Proliferation)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Protein Synthesis Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>RNA Transcription Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Signal Transduction Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Is_Metabolized_By_Enzyme<span class="some"> some </span>Cytochrome P450, Family 1, Subfamily A, Polypeptide 2)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Is_Metabolized_By_Enzyme<span class="some"> some </span>Cytochrome P450 3A4). 
                  			
               </td>
               <td>Flutamide<span class="subclass"> EquivalentTo </span>Anti-Androgen<br><span class="keyword"> and </span>Aromatic Compounds<br><span class="keyword"> and </span>(Chemical_Or_Drug_Affects_Gene_Product<span class="some"> some </span>Androgen Receptor)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Mechanism_Of_Action<span class="some"> some </span>Receptor Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Inhibition of Cell Proliferation)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Protein Synthesis Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>RNA Transcription Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Signal Transduction Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Is_Metabolized_By_Enzyme<span class="some"> some </span>Cytochrome P450, Family 1, Subfamily A, Polypeptide 2)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Is_Metabolized_By_Enzyme<span class="some"> some </span>Cytochrome P450 3A4).<br></td>
            </tr>
            <tr class="removal">
               <td>6746</td>
               <td>Gefitinib<span class="subclass"> EquivalentTo </span>Tyrosine Kinase Inhibitor<br><span class="keyword"> and </span>(Chemical_Or_Drug_Affects_Gene_Product<span class="some"> some </span>Epidermal Growth Factor Receptor)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Mechanism_Of_Action<span class="some"> some </span>Receptor Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Phosphorylation Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Signal Transduction Inhibition). 
                  			
               </td>
               <td>Gefitinib<span class="subclass"> EquivalentTo </span>Tyrosine Kinase Inhibitor<br><span class="keyword"> and </span>(Chemical_Or_Drug_Affects_Gene_Product<span class="some"> some </span>Epidermal Growth Factor Receptor)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Mechanism_Of_Action<span class="some"> some </span>Receptor Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Phosphorylation Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Signal Transduction Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Is_Metabolized_By_Enzyme<span class="some"> some </span>Cytochrome P450 3A4).<br></td>
            </tr>
            <tr class="removal">
               <td>6748</td>
               <td>Lung Adenoid Cystic Carcinoma<span class="subclass"> EquivalentTo </span>Adenoid Cystic Carcinoma<br><span class="keyword"> and </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchus). 
                  			
               </td>
               <td>Lung Adenoid Cystic Carcinoma<span class="subclass"> EquivalentTo </span>Adenoid Cystic Carcinoma<br><span class="keyword"> and </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Chest Pain)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Wheeze)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchus).<br></td>
            </tr>
            <tr class="removal">
               <td>6747</td>
               <td>Lung Giant Cell Carcinoma<span class="subclass"> EquivalentTo </span>Giant Cell Carcinoma<br><span class="keyword"> and </span>Lung Sarcomatoid Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Aggressive Clinical Course)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Giant Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Emperipolesis)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Inflammatory Infiltrate). 
                  			
               </td>
               <td>Lung Giant Cell Carcinoma<span class="subclass"> EquivalentTo </span>Giant Cell Carcinoma<br><span class="keyword"> and </span>Lung Sarcomatoid Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Aggressive Clinical Course)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Giant Cell)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Spindle Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Emperipolesis)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Inflammatory Infiltrate).<br></td>
            </tr>
            <tr class="removal">
               <td>6749</td>
               <td>Lung Mucoepidermoid Carcinoma<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>Mucoepidermoid Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchus). 
                  			
               </td>
               <td>Lung Mucoepidermoid Carcinoma<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>Mucoepidermoid Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Wheeze)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchus).<br></td>
            </tr>
            <tr class="removal">
               <td>6750</td>
               <td>Lymphoepithelioma-Like Lung Carcinoma<span class="subclass"> EquivalentTo </span>Large Cell Lung Carcinoma<br><span class="keyword"> and </span>Nasopharyngeal<span class="subclass"> Type </span>Undifferentiated Carcinoma. 
                  			
               </td>
               <td>Lymphoepithelioma-Like Lung Carcinoma<span class="subclass"> EquivalentTo </span>Large Cell Lung Carcinoma<br><span class="keyword"> and </span>Nasopharyngeal<span class="subclass"> Type </span>Undifferentiated Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis).<br></td>
            </tr>
            <tr class="removal">
               <td>6751</td>
               <td>Mucin-Producing Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Mucin-Producing Malignant Epithelial Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mucoid Stroma Formation). 
                  			
               </td>
               <td>Mucin-Producing Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Mucin-Producing Malignant Epithelial Cell).<br></td>
            </tr>
            <tr class="removal">
               <td>6753</td>
               <td>Primary Prostate Urothelial Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Prostate Carcinoma<br><span class="keyword"> and </span>Urothelial Carcinoma<br><span class="keyword"> and </span>(Disease_Excludes_Normal_Tissue_Origin<span class="some"> only </span>Bladder Urothelium). 
                  			
               </td>
               <td>Primary Prostate Urothelial Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Prostate Carcinoma<br><span class="keyword"> and </span>Primary Carcinoma<br><span class="keyword"> and </span>Urothelial Carcinoma<br><span class="keyword"> and </span>(Disease_Excludes_Normal_Tissue_Origin<span class="some"> only </span>Bladder Urothelium).<br></td>
            </tr>
            <tr class="removal">
               <td>6754</td>
               <td>Recurrent Adenosquamous Lung Carcinoma<span class="subclass"> EquivalentTo </span>Adenosquamous Lung Carcinoma<br><span class="keyword"> and </span>Recurrent Non-Small Cell Lung Cancer. 
                  			
               </td>
               <td>Recurrent Adenosquamous Lung Carcinoma<span class="subclass"> EquivalentTo </span>Adenosquamous Lung Carcinoma<br><span class="keyword"> and </span>Recurrent Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis).<br></td>
            </tr>
            <tr class="removal">
               <td>6755</td>
               <td>Recurrent Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Recurrent Lung Cancer<br><span class="keyword"> and </span>Squamous Cell Lung Carcinoma. 
                  			
               </td>
               <td>Recurrent Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Recurrent Lung Cancer<br><span class="keyword"> and </span>Squamous Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis).<br></td>
            </tr>
            <tr class="removal">
               <td>6756</td>
               <td>Sarcomatoid Transitional Cell Carcinoma<span class="subclass"> EquivalentTo </span>Sarcomatoid Carcinoma<br><span class="keyword"> and </span>Transitional Cell Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Biphasic Pattern)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Epithelial Differentiation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mesenchymal Differentiation)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Transitional Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Transitional Epithelium). 
                  			
               </td>
               <td>Sarcomatoid Transitional Cell Carcinoma<span class="subclass"> EquivalentTo </span>Sarcomatoid Carcinoma<br><span class="keyword"> and </span>Transitional Cell Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Spindle Transitional Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Biphasic Pattern)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Epithelial Differentiation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mesenchymal Differentiation)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Transitional Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Transitional Epithelium).<br></td>
            </tr>
            <tr class="removal">
               <td>6757</td>
               <td>Small Intestinal Adenosquamous Carcinoma<span class="subclass"> EquivalentTo </span>Adenosquamous Carcinoma<br><span class="keyword"> and </span>Small Intestinal Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Intestinal Hemorrhage)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Metaplasia). 
                  			
               </td>
               <td>Small Intestinal Adenosquamous Carcinoma<span class="subclass"> EquivalentTo </span>Adenosquamous Carcinoma<br><span class="keyword"> and </span>Small Intestinal Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Intestinal Hemorrhage).<br></td>
            </tr>
            <tr class="removal">
               <td>6765</td>
               <td>Sodium Phenylbutyrate<span class="subclass"> EquivalentTo </span>Histone Deacetylase Inhibitor<br><span class="keyword"> and </span>(Chemical_Or_Drug_Affects_Gene_Product<span class="some"> some </span>Histone Deacetylase)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Mechanism_Of_Action<span class="some"> some </span>Enzyme Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>DNA Strand Break)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>DNA Synthesis Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Gene Expression Alteration). 
                  			
               </td>
               <td>Sodium Phenylbutyrate<span class="subclass"> EquivalentTo </span>Fatty Acid<br><span class="keyword"> and </span>Histone Deacetylase Inhibitor<br><span class="keyword"> and </span>(Chemical_Or_Drug_Affects_Gene_Product<span class="some"> some </span>Histone Deacetylase)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Mechanism_Of_Action<span class="some"> some </span>Enzyme Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>DNA Strand Break)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>DNA Synthesis Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Gene Expression Alteration).<br></td>
            </tr>
            <tr class="removal">
               <td>6758</td>
               <td>Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>Squamous Cell Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 12p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q24-qter)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 18q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 5q)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>APC Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FHIT Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Metaplasia)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Bronchial Epithelial Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Bronchial Epithelium)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchial Tree). 
                  			
               </td>
               <td>Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>Squamous Cell Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 12p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q24-qter)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 18q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 5q)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>APC Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FHIT Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Bronchial Epithelial Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Bronchial Epithelium)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchial Tree).<br></td>
            </tr>
            <tr class="removal">
               <td>6759</td>
               <td>Squamous Cell Lung Carcinoma, Basaloid Variant<span class="subclass"> EquivalentTo </span>Basaloid Squamous Cell Carcinoma<br><span class="keyword"> and </span>Keratinizing Squamous Cell Carcinoma<br><span class="keyword"> and </span>Squamous Cell Lung Carcinoma. 
                  			
               </td>
               <td>Squamous Cell Lung Carcinoma, Basaloid Variant<span class="subclass"> EquivalentTo </span>Basaloid Squamous Cell Carcinoma<br><span class="keyword"> and </span>Keratinizing Squamous Cell Carcinoma<br><span class="keyword"> and </span>Squamous Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis).<br></td>
            </tr>
            <tr class="removal">
               <td>6760</td>
               <td>Squamous Cell Lung Carcinoma, Clear Cell Variant<span class="subclass"> EquivalentTo </span>Keratinizing Squamous Cell Carcinoma<br><span class="keyword"> and </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Squamous Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Clear Squamous Cell). 
                  			
               </td>
               <td>Squamous Cell Lung Carcinoma, Clear Cell Variant<span class="subclass"> EquivalentTo </span>Keratinizing Squamous Cell Carcinoma<br><span class="keyword"> and </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Squamous Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Clear Squamous Cell).<br></td>
            </tr>
            <tr class="removal">
               <td>6761</td>
               <td>Squamous Cell Lung Carcinoma, Papillary Variant<span class="subclass"> EquivalentTo </span>Keratinizing Squamous Cell Carcinoma<br><span class="keyword"> and </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Papillary Squamous Cell Carcinoma<br><span class="keyword"> and </span>Squamous Cell Lung Carcinoma. 
                  			
               </td>
               <td>Squamous Cell Lung Carcinoma, Papillary Variant<span class="subclass"> EquivalentTo </span>Keratinizing Squamous Cell Carcinoma<br><span class="keyword"> and </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Papillary Squamous Cell Carcinoma<br><span class="keyword"> and </span>Squamous Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis).<br></td>
            </tr>
            <tr class="removal">
               <td>6762</td>
               <td>Squamous Cell Lung Carcinoma, Small Cell Variant<span class="subclass"> EquivalentTo </span>Keratinizing Squamous Cell Carcinoma<br><span class="keyword"> and </span>Squamous Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Small Squamous Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Poorly Differentiated Lesion). 
                  			
               </td>
               <td>Squamous Cell Lung Carcinoma, Small Cell Variant<span class="subclass"> EquivalentTo </span>Keratinizing Squamous Cell Carcinoma<br><span class="keyword"> and </span>Squamous Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Small Squamous Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Poorly Differentiated Lesion).<br></td>
            </tr>
            <tr class="removal">
               <td>6763</td>
               <td>Stage III Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Squamous Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage III). 
                  			
               </td>
               <td>Stage III Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Squamous Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage III Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage III).<br></td>
            </tr>
            <tr class="removal">
               <td>6752</td>
               <td>Thyroid Gland Diffuse Sclerosing Papillary Carcinoma<span class="subclass"> EquivalentTo </span>Thyroid Gland Papillary Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Diffuse Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Fibrotic Stroma Formation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphocytic Infiltrate)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Papillary Pattern)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Squamous Metaplasia). 
                  			
               </td>
               <td>Thyroid Gland Diffuse Sclerosing Papillary Carcinoma<span class="subclass"> EquivalentTo </span>Thyroid Gland Papillary Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Diffuse Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Fibrotic Stroma Formation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphocytic Infiltrate)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Papillary Pattern).<br></td>
            </tr>
            <tr class="removal">
               <td>6764</td>
               <td>Thyroid Gland Oncocytic Follicular Carcinoma<span class="subclass"> EquivalentTo </span>Thyroid Gland Follicular Carcinoma<br><span class="keyword"> and </span>Thyroid Gland Oncocytic Neoplasm<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Capsular Invasion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Tumor Vascular Invasion)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Thyroid Gland Oncocyte). 
                  			
               </td>
               <td>Thyroid Gland Oncocytic Follicular Carcinoma<span class="subclass"> EquivalentTo </span>Thyroid Gland Follicular Carcinoma<br><span class="keyword"> and </span>Oxyphilic Adenocarcinoma<br><span class="keyword"> and </span>Thyroid Gland Oncocytic Neoplasm<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Capsular Invasion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Tumor Vascular Invasion)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Thyroid Gland Oncocyte).<br></td>
            </tr>
         </tbody>
         <tbody id="rred" style="display:none">
            <tr class="withoutstyle">
               <td colspan="3">
                  <h4 style="display: inline-block;">Redundant (1)</h4> [<a href="#">back to top</a>]
               </td>
            </tr>
            <tr>
               <th class="removal">ID</th>
               <th class="removal">Axiom in Ontology 1</th>
               <th class="normalrem">Justifications in Ontology 2</th>
            </tr>
            <tr class="removal">
               <td rowspan="1">6766</td>
               <td rowspan="1">Sebaceous Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Sebocyte. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Sebaceous Carcinoma<span class="subclass"> SubClassOf </span>Malignant Sebaceous Neoplasm. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Malignant Sebaceous Neoplasm<span class="subclass"> SubClassOf </span>Sebaceous Gland Neoplasm. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Sebaceous Gland Neoplasm<span class="subclass"> SubClassOf </span>Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Sebocyte. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
         </tbody>
         <tbody id="rst" style="display:none">
            <tr class="withoutstyle">
               <td colspan="3">
                  <h4 style="display: inline-block;">Prospective Novel Redundant (61)</h4> [<a href="#">back to top</a>]
               </td>
            </tr>
            <tr>
               <th class="removal">ID</th>
               <th class="removal">Axiom in Ontology 1</th>
               <th class="normalrem">Justifications in Ontology 2</th>
            </tr>
            <tr class="removal">
               <td rowspan="1">6827</td>
               <td rowspan="1">3-Hydroxysteroid Dehydrogenase Inhibitor<span class="subclass"> SubClassOf </span>Enzyme Inhibitor. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Hydroxysteroid Dehydrogenase Inhibitor<span class="subclass"> SubClassOf </span>Enzyme Inhibitor. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; 3-Hydroxysteroid Dehydrogenase Inhibitor<span class="subclass"> SubClassOf </span>Hydroxysteroid Dehydrogenase Inhibitor. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6767</td>
               <td rowspan="1">ARMET Gene<span class="subclass"> SubClassOf </span>Transcription Factor Gene. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; ARMET Gene<span class="subclass"> SubClassOf </span>Transcription Regulation Gene. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Transcription Regulation Gene<span class="subclass"> SubClassOf </span>Transcription Factor Gene. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="2">6768</td>
               <td rowspan="2">Adult Primary Cholangiocarcinoma<span class="subclass"> EquivalentTo </span>Cholangiocarcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Primary Lesion). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Cholangiocarcinoma<span class="subclass"> EquivalentTo </span>Bile Duct Adenocarcinoma<br><span class="keyword"> and </span>Common Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Abdominal Pain)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Malaise)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Weight Loss). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Bile Duct Adenocarcinoma<span class="subclass"> SubClassOf </span>Adenocarcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Primary Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Primary Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(4)</i>&nbsp; Adult Primary Cholangiocarcinoma<span class="subclass"> EquivalentTo </span>Cholangiocarcinoma<br><span class="keyword"> and </span>Primary Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Primary Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(5)</i>&nbsp; Adenocarcinoma<span class="subclass"> SubClassOf </span>Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Bile Duct Adenocarcinoma<span class="subclass"> SubClassOf </span>Bile Duct Carcinoma. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Cholangiocarcinoma<span class="subclass"> EquivalentTo </span>Bile Duct Adenocarcinoma<br><span class="keyword"> and </span>Common Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Abdominal Pain)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Malaise)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Weight Loss). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Primary Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Primary Lesion). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(4)</i>&nbsp; Adult Primary Cholangiocarcinoma<span class="subclass"> EquivalentTo </span>Cholangiocarcinoma<br><span class="keyword"> and </span>Primary Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Primary Lesion). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(5)</i>&nbsp; Bile Duct Carcinoma<span class="subclass"> SubClassOf </span>Carcinoma. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="2">6769</td>
               <td rowspan="2">Bladder Squamous Cell Carcinoma<span class="subclass"> EquivalentTo </span>Bladder Carcinoma<br><span class="keyword"> and </span>Squamous Cell Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Metaplasia). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Metaplastic Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Metaplasia). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Squamous Cell Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>Squamous Cell Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Squamous Cell). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Bladder Squamous Cell Carcinoma<span class="subclass"> EquivalentTo </span>Bladder Carcinoma<br><span class="keyword"> and </span>Metaplastic Carcinoma<br><span class="keyword"> and </span>Squamous Cell Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Metaplastic Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Metaplasia). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Bladder Squamous Cell Carcinoma<span class="subclass"> EquivalentTo </span>Bladder Carcinoma<br><span class="keyword"> and </span>Metaplastic Carcinoma<br><span class="keyword"> and </span>Squamous Cell Carcinoma. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Bladder Carcinoma<span class="subclass"> SubClassOf </span>Carcinoma. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6770</td>
               <td rowspan="1">Breast Adenocarcinoma with Squamous Metaplasia<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Breast Adenocarcinoma with Squamous Metaplasia<span class="subclass"> EquivalentTo </span>Adenocarcinoma with Squamous Metaplasia<br><span class="keyword"> and </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Metaplastic Breast Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Metaplastic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Metaplastic Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6771</td>
               <td rowspan="1">Cartilagenous Metaplasia<span class="subclass"> SubClassOf </span>Metaplasia. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Mesenchymal Metaplasia<span class="subclass"> SubClassOf </span>Metaplasia. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Cartilagenous Metaplasia<span class="subclass"> SubClassOf </span>Mesenchymal Metaplasia. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6772</td>
               <td rowspan="1">Co-Investigator<span class="subclass"> SubClassOf </span>Research Personnel. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Co-Investigator<span class="subclass"> SubClassOf </span>Investigator. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Investigator<span class="subclass"> SubClassOf </span>Research Personnel. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6773</td>
               <td rowspan="1">Contract Principal Investigator<span class="subclass"> SubClassOf </span>Research Personnel. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Contract Principal Investigator<span class="subclass"> SubClassOf </span>Investigator. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Investigator<span class="subclass"> SubClassOf </span>Research Personnel. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6774</td>
               <td rowspan="1">Coordinating Investigator<span class="subclass"> SubClassOf </span>Research Personnel. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Coordinating Investigator<span class="subclass"> SubClassOf </span>Investigator. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Investigator<span class="subclass"> SubClassOf </span>Research Personnel. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6775</td>
               <td rowspan="1">Curcumin C3 Complex<span class="subclass"> SubClassOf </span>Antioxidant. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Curcumin C3 Complex<span class="subclass"> SubClassOf </span>Polyphenol. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Polyphenol<span class="subclass"> SubClassOf </span>Antioxidant. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6777</td>
               <td rowspan="1">Device Labeled for Single Use<span class="subclass"> SubClassOf </span>Medical Device. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Medical Device By Usage Mode<span class="subclass"> SubClassOf </span>Medical Device. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Device Labeled for Single Use<span class="subclass"> SubClassOf </span>Medical Device By Usage Mode. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6778</td>
               <td rowspan="1">Diastolic Pressure<span class="subclass"> SubClassOf </span>Personal Attribute. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Blood Pressure<span class="subclass"> SubClassOf </span>Personal Attribute. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Diastolic Pressure<span class="subclass"> SubClassOf </span>Blood Pressure. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6779</td>
               <td rowspan="1">Diffuse Leiomyomatosis Syndrome<span class="subclass"> SubClassOf </span>Syndrome. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Diffuse Leiomyomatosis Syndrome<span class="subclass"> SubClassOf </span>Neoplastic Syndrome. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Neoplastic Syndrome<span class="subclass"> SubClassOf </span>Syndrome. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6781</td>
               <td rowspan="1">Female Gender<span class="subclass"> SubClassOf </span>General Qualifier. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Female<span class="subclass"> SubClassOf </span>General Qualifier. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Female Gender<span class="subclass"> SubClassOf </span>Female. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6782</td>
               <td rowspan="1">Female Phenotype<span class="subclass"> SubClassOf </span>General Qualifier. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Female Phenotype<span class="subclass"> SubClassOf </span>Female. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Female<span class="subclass"> SubClassOf </span>General Qualifier. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6783</td>
               <td rowspan="1">Female, Self-Report<span class="subclass"> SubClassOf </span>General Qualifier. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Female<span class="subclass"> SubClassOf </span>General Qualifier. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Female, Self-Report<span class="subclass"> SubClassOf </span>Female. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6780</td>
               <td rowspan="1">Female-to-Male Transsexual Phenotype<span class="subclass"> SubClassOf </span>General Qualifier. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Female-to-Male Transsexual Phenotype<span class="subclass"> SubClassOf </span>Transsexual. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Transsexual<span class="subclass"> SubClassOf </span>General Qualifier. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6784</td>
               <td rowspan="1">Grant Investigator<span class="subclass"> SubClassOf </span>Research Personnel. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Grant Investigator<span class="subclass"> SubClassOf </span>Investigator. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Investigator<span class="subclass"> SubClassOf </span>Research Personnel. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6785</td>
               <td rowspan="1">Grant Principal Investigator<span class="subclass"> SubClassOf </span>Research Personnel. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Investigator<span class="subclass"> SubClassOf </span>Research Personnel. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Grant Principal Investigator<span class="subclass"> SubClassOf </span>Investigator. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6786</td>
               <td rowspan="1">Hereditary Neoplastic Syndrome<span class="subclass"> SubClassOf </span>Syndrome. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Hereditary Neoplastic Syndrome<span class="subclass"> SubClassOf </span>Neoplastic Syndrome. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Neoplastic Syndrome<span class="subclass"> SubClassOf </span>Syndrome. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6787</td>
               <td rowspan="1">Hypertension<span class="subclass"> SubClassOf </span>Cardiovascular System Finding. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Hypertension<span class="subclass"> SubClassOf </span>Blood Pressure Finding. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Blood Pressure Finding<span class="subclass"> SubClassOf </span>Cardiovascular System Finding. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6788</td>
               <td rowspan="1">Hypotension<span class="subclass"> SubClassOf </span>Cardiovascular System Finding. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Hypotension<span class="subclass"> SubClassOf </span>Blood Pressure Finding. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Blood Pressure Finding<span class="subclass"> SubClassOf </span>Cardiovascular System Finding. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6789</td>
               <td rowspan="1">Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Large Cell. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Large Cell Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Large Cell. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Large Cell Carcinoma<br><span class="keyword"> and </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS Gene Mutation). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6790</td>
               <td rowspan="1">Lipomatous Metaplasia<span class="subclass"> SubClassOf </span>Metaplasia. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Mesenchymal Metaplasia<span class="subclass"> SubClassOf </span>Metaplasia. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Lipomatous Metaplasia<span class="subclass"> SubClassOf </span>Mesenchymal Metaplasia. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6791</td>
               <td rowspan="1">Localized Resectable Adult Liver Cancer<span class="subclass"> EquivalentTo </span>Adult Liver Carcinoma<br><span class="keyword"> and </span>Resectable Hepatic Malignant Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Localized Disease). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Liver<br><span class="keyword"> and </span>Intrahepatic Biliary Tract Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>Epithelial Hepatic<br><span class="keyword"> and </span>Intrahepatic Bile Duct Neoplasm<br><span class="keyword"> and </span>Primary Malignant Neoplasm of Liver. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Localized Resectable Adult Liver Cancer<span class="subclass"> EquivalentTo </span>Adult Liver Carcinoma<br><span class="keyword"> and </span>Localized Carcinoma<br><span class="keyword"> and </span>Resectable Hepatic Malignant Neoplasm. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Adult Liver Carcinoma<span class="subclass"> SubClassOf </span>Liver<br><span class="keyword"> and </span>Intrahepatic Biliary Tract Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Localized Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Localized Disease). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6793</td>
               <td rowspan="1">Localized Unresectable Adult Liver Cancer<span class="subclass"> EquivalentTo </span>Adult Liver Carcinoma<br><span class="keyword"> and </span>Non-Resectable Hepatic Malignant Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Localized Disease). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Liver<br><span class="keyword"> and </span>Intrahepatic Biliary Tract Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>Epithelial Hepatic<br><span class="keyword"> and </span>Intrahepatic Bile Duct Neoplasm<br><span class="keyword"> and </span>Primary Malignant Neoplasm of Liver. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Adult Liver Carcinoma<span class="subclass"> SubClassOf </span>Liver<br><span class="keyword"> and </span>Intrahepatic Biliary Tract Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Localized Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Localized Disease). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(4)</i>&nbsp; Localized Unresectable Adult Liver Cancer<span class="subclass"> EquivalentTo </span>Adult Liver Carcinoma<br><span class="keyword"> and </span>Localized Carcinoma<br><span class="keyword"> and </span>Non-Resectable Hepatic Malignant Neoplasm. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6792</td>
               <td rowspan="1">Localized Urothelial Carcinoma of the Renal Pelvis<br><span class="keyword"> and </span>Ureter<span class="subclass"> EquivalentTo </span>Renal Pelvis<br><span class="keyword"> and </span>Ureter Urothelial Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Localized Disease). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Transitional Cell Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>Transitional Cell Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Transitional Cell). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Localized Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Localized Disease). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Urothelial Carcinoma<span class="subclass"> EquivalentTo </span>Malignant Urinary Tract Neoplasm<br><span class="keyword"> and </span>Transitional Cell Carcinoma<br><span class="keyword"> and </span>Urothelial Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Transitional Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Transitional Epithelium). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Renal Pelvis<br><span class="keyword"> and </span>Ureter Urothelial Carcinoma<span class="subclass"> EquivalentTo </span>Renal Pelvis<br><span class="keyword"> and </span>Ureter Carcinoma<br><span class="keyword"> and </span>Urothelial Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Localized Urothelial Carcinoma of the Renal Pelvis<br><span class="keyword"> and </span>Ureter<span class="subclass"> EquivalentTo </span>Localized Carcinoma<br><span class="keyword"> and </span>Renal Pelvis<br><span class="keyword"> and </span>Ureter Urothelial Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6795</td>
               <td rowspan="1">Male Gender<span class="subclass"> SubClassOf </span>General Qualifier. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Male Gender<span class="subclass"> SubClassOf </span>Male. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Male<span class="subclass"> SubClassOf </span>General Qualifier. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6796</td>
               <td rowspan="1">Male Phenotype<span class="subclass"> SubClassOf </span>General Qualifier. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Male<span class="subclass"> SubClassOf </span>General Qualifier. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Male Phenotype<span class="subclass"> SubClassOf </span>Male. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6797</td>
               <td rowspan="1">Male, Self-Report<span class="subclass"> SubClassOf </span>General Qualifier. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Male, Self-Report<span class="subclass"> SubClassOf </span>Male. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Male<span class="subclass"> SubClassOf </span>General Qualifier. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6794</td>
               <td rowspan="1">Male-to-Female Transsexual Phenotype<span class="subclass"> SubClassOf </span>General Qualifier. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Transsexual<span class="subclass"> SubClassOf </span>General Qualifier. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Male-to-Female Transsexual Phenotype<span class="subclass"> SubClassOf </span>Transsexual. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6798</td>
               <td rowspan="1">Malignant Sebocyte<span class="subclass"> SubClassOf </span>Malignant Epithelial Cell. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Adenocarcinoma Cell<span class="subclass"> SubClassOf </span>Malignant Epithelial Cell. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Malignant Sebocyte<span class="subclass"> SubClassOf </span>Adenocarcinoma Cell. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6799</td>
               <td rowspan="1">Mantle Field<span class="subclass"> SubClassOf </span>Other Anatomic Concept. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Mantle Field<span class="subclass"> SubClassOf </span>Radiation Field. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Radiation Field<span class="subclass"> SubClassOf </span>Other Anatomic Concept. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6800</td>
               <td rowspan="1">Meigs' Syndrome<span class="subclass"> SubClassOf </span>Syndrome. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Meigs' Syndrome<span class="subclass"> SubClassOf </span>Neoplastic Syndrome. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Neoplastic Syndrome<span class="subclass"> SubClassOf </span>Syndrome. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6801</td>
               <td rowspan="1">Melanoma Biomarker<span class="subclass"> SubClassOf </span>Biomarker. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Melanoma Biomarker<span class="subclass"> SubClassOf </span>Tumor Marker. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Tumor Marker<span class="subclass"> SubClassOf </span>Disease Marker. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Disease Marker<span class="subclass"> SubClassOf </span>Biomarker. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6802</td>
               <td rowspan="1">Metaplastic Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Metaplasia. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Metaplastic Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Metaplasia). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Metaplastic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Metaplastic Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6803</td>
               <td rowspan="1">Nonprofit Organization<span class="subclass"> SubClassOf </span>Population Group. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Nonprofit Organization<span class="subclass"> SubClassOf </span>Professional Organization<br><span class="keyword"> or </span>Group. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Professional Organization<br><span class="keyword"> or </span>Group<span class="subclass"> SubClassOf </span>Population Group. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6804</td>
               <td rowspan="1">Osseous Metaplasia<span class="subclass"> SubClassOf </span>Metaplasia. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Mesenchymal Metaplasia<span class="subclass"> SubClassOf </span>Metaplasia. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Osseous Metaplasia<span class="subclass"> SubClassOf </span>Mesenchymal Metaplasia. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6805</td>
               <td rowspan="1">Pharmaceutical Product Information<span class="subclass"> SubClassOf </span>Document. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Pharmaceutical Product Information<span class="subclass"> SubClassOf </span>Medical Product Document. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Medical Product Document<span class="subclass"> SubClassOf </span>Document. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6806</td>
               <td rowspan="1">Phenethyl Isothiocyanate<span class="subclass"> SubClassOf </span>Chemopreventive Agent. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Phase II Enzymes Inducer<span class="subclass"> SubClassOf </span>Chemopreventive Agent. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Phenethyl Isothiocyanate<span class="subclass"> SubClassOf </span>Phase II Enzymes Inducer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="4">6807</td>
               <td rowspan="4">Primary Intraosseous Squamous Cell Carcinoma<span class="subclass"> EquivalentTo </span>Malignant Odontogenic Neoplasm<br><span class="keyword"> and </span>Oral Cavity Squamous Cell Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Primary Lesion)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Odontogenic Epithelium)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Jaw). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Primary Intraosseous Squamous Cell Carcinoma<span class="subclass"> EquivalentTo </span>Malignant Odontogenic Neoplasm<br><span class="keyword"> and </span>Oral Cavity Squamous Cell Carcinoma<br><span class="keyword"> and </span>Primary Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Primary Lesion)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Odontogenic Epithelium)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Jaw). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Lip<br><span class="keyword"> and </span>Oral Cavity Squamous Cell Carcinoma<span class="subclass"> EquivalentTo </span>Head<br><span class="keyword"> and </span>Neck Squamous Cell Carcinoma<br><span class="keyword"> and </span>Lip<br><span class="keyword"> and </span>Oral Cavity Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Squamous Cell Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>Squamous Cell Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Squamous Cell). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Head<br><span class="keyword"> and </span>Neck Squamous Cell Carcinoma<span class="subclass"> EquivalentTo </span>Head<br><span class="keyword"> and </span>Neck Carcinoma<br><span class="keyword"> and </span>Squamous Cell Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Squamous Cell). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Primary Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Primary Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(6)</i>&nbsp; Oral Cavity Squamous Cell Carcinoma<span class="subclass"> EquivalentTo </span>Lip<br><span class="keyword"> and </span>Oral Cavity Squamous Cell Carcinoma<br><span class="keyword"> and </span>Oral Cavity Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Primary Intraosseous Squamous Cell Carcinoma<span class="subclass"> EquivalentTo </span>Malignant Odontogenic Neoplasm<br><span class="keyword"> and </span>Oral Cavity Squamous Cell Carcinoma<br><span class="keyword"> and </span>Primary Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Primary Lesion)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Odontogenic Epithelium)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Jaw). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Lip<br><span class="keyword"> and </span>Oral Cavity Squamous Cell Carcinoma<span class="subclass"> EquivalentTo </span>Head<br><span class="keyword"> and </span>Neck Squamous Cell Carcinoma<br><span class="keyword"> and </span>Lip<br><span class="keyword"> and </span>Oral Cavity Carcinoma. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Head<br><span class="keyword"> and </span>Neck Squamous Cell Carcinoma<span class="subclass"> EquivalentTo </span>Head<br><span class="keyword"> and </span>Neck Carcinoma<br><span class="keyword"> and </span>Squamous Cell Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Squamous Cell). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Primary Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Primary Lesion). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(5)</i>&nbsp; Head<br><span class="keyword"> and </span>Neck Carcinoma<span class="subclass"> SubClassOf </span>Carcinoma. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Oral Cavity Squamous Cell Carcinoma<span class="subclass"> EquivalentTo </span>Lip<br><span class="keyword"> and </span>Oral Cavity Squamous Cell Carcinoma<br><span class="keyword"> and </span>Oral Cavity Carcinoma. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Primary Intraosseous Squamous Cell Carcinoma<span class="subclass"> EquivalentTo </span>Malignant Odontogenic Neoplasm<br><span class="keyword"> and </span>Oral Cavity Squamous Cell Carcinoma<br><span class="keyword"> and </span>Primary Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Primary Lesion)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Odontogenic Epithelium)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Jaw). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Lip<br><span class="keyword"> and </span>Oral Cavity Carcinoma<span class="subclass"> SubClassOf </span>Head<br><span class="keyword"> and </span>Neck Carcinoma. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Oral Cavity Carcinoma<span class="subclass"> EquivalentTo </span>Lip<br><span class="keyword"> and </span>Oral Cavity Carcinoma<br><span class="keyword"> and </span>Malignant Oral Cavity Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Oral Cavity Epithelium)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Oral Cavity). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Primary Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Primary Lesion). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(5)</i>&nbsp; Head<br><span class="keyword"> and </span>Neck Carcinoma<span class="subclass"> SubClassOf </span>Carcinoma. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Oral Cavity Squamous Cell Carcinoma<span class="subclass"> EquivalentTo </span>Lip<br><span class="keyword"> and </span>Oral Cavity Squamous Cell Carcinoma<br><span class="keyword"> and </span>Oral Cavity Carcinoma. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Primary Intraosseous Squamous Cell Carcinoma<span class="subclass"> EquivalentTo </span>Malignant Odontogenic Neoplasm<br><span class="keyword"> and </span>Oral Cavity Squamous Cell Carcinoma<br><span class="keyword"> and </span>Primary Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Primary Lesion)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Odontogenic Epithelium)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Jaw). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Lip<br><span class="keyword"> and </span>Oral Cavity Squamous Cell Carcinoma<span class="subclass"> EquivalentTo </span>Head<br><span class="keyword"> and </span>Neck Squamous Cell Carcinoma<br><span class="keyword"> and </span>Lip<br><span class="keyword"> and </span>Oral Cavity Carcinoma. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Lip<br><span class="keyword"> and </span>Oral Cavity Carcinoma<span class="subclass"> SubClassOf </span>Head<br><span class="keyword"> and </span>Neck Carcinoma. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Primary Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Primary Lesion). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(5)</i>&nbsp; Head<br><span class="keyword"> and </span>Neck Carcinoma<span class="subclass"> SubClassOf </span>Carcinoma. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Oral Cavity Squamous Cell Carcinoma<span class="subclass"> EquivalentTo </span>Lip<br><span class="keyword"> and </span>Oral Cavity Squamous Cell Carcinoma<br><span class="keyword"> and </span>Oral Cavity Carcinoma. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6808</td>
               <td rowspan="1">Primary Peritoneal Serous Adenocarcinoma<span class="subclass"> SubClassOf </span>Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Serous Adenocarcinoma<span class="subclass"> SubClassOf </span>Adenocarcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Primary Peritoneal Serous Adenocarcinoma<span class="subclass"> EquivalentTo </span>Primary Peritoneal Carcinoma<br><span class="keyword"> and </span>Serous Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Psammoma Body Formation). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6809</td>
               <td rowspan="1">Principal Investigator<span class="subclass"> SubClassOf </span>Research Personnel. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Principal Investigator<span class="subclass"> SubClassOf </span>Investigator. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Investigator<span class="subclass"> SubClassOf </span>Research Personnel. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6810</td>
               <td rowspan="1">Prognostic Factor<span class="subclass"> SubClassOf </span>Diagnostic<br><span class="keyword"> or </span>Prognostic Factor. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Prognostic Factor<span class="subclass"> SubClassOf </span>Predictive Factor. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Predictive Factor<span class="subclass"> SubClassOf </span>Diagnostic<br><span class="keyword"> or </span>Prognostic Factor. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6811</td>
               <td rowspan="1">Protocol Lead Investigator<span class="subclass"> SubClassOf </span>Research Personnel. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Investigator<span class="subclass"> SubClassOf </span>Research Personnel. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Protocol Lead Investigator<span class="subclass"> SubClassOf </span>Investigator. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6812</td>
               <td rowspan="1">R-flurbiprofen<span class="subclass"> SubClassOf </span>Chemopreventive Agent. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; R-flurbiprofen<span class="subclass"> SubClassOf </span>Cyclooxygenase Inhibitor. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Cyclooxygenase Inhibitor<span class="subclass"> SubClassOf </span>Chemopreventive Agent. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6813</td>
               <td rowspan="1">Rare Cancer-Associated Syndrome<span class="subclass"> SubClassOf </span>Syndrome. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Rare Cancer-Associated Syndrome<span class="subclass"> SubClassOf </span>Neoplastic Syndrome. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Neoplastic Syndrome<span class="subclass"> SubClassOf </span>Syndrome. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6814</td>
               <td rowspan="1">Razoxane<span class="subclass"> SubClassOf </span>Antineoplastic Agent. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Topoisomerase-II Inhibitor<span class="subclass"> SubClassOf </span>Antineoplastic Agent. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Razoxane<span class="subclass"> SubClassOf </span>Topoisomerase-II Inhibitor. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6815</td>
               <td rowspan="1">Site Representative Investigator<span class="subclass"> SubClassOf </span>Research Personnel. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Site Representative Investigator<span class="subclass"> SubClassOf </span>Investigator. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Investigator<span class="subclass"> SubClassOf </span>Research Personnel. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="4">6816</td>
               <td rowspan="4">Solid Variant Thyroid Gland Papillary Carcinoma<span class="subclass"> EquivalentTo </span>Thyroid Gland Papillary Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Solid Growth Pattern). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Thyroid Gland Adenocarcinoma<span class="subclass"> EquivalentTo </span>Adenocarcinoma<br><span class="keyword"> and </span>Common Carcinoma<br><span class="keyword"> and </span>Malignant Endocrine Neoplasm<br><span class="keyword"> and </span>Thyroid Gland Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cold Nodule)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Thyroid Gland Follicular Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Thyroglobulin Positive Neoplastic Cells Present)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Thyroid Gland Follicular Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Thyroid Gland Follicle). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Differentiated Thyroid Gland Carcinoma<span class="subclass"> EquivalentTo </span>Thyroid Gland Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Radiation Toxicity)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Follicular Cell Differentiation). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Thyroid Gland Papillary Carcinoma<span class="subclass"> EquivalentTo </span>Papillary Adenocarcinoma<br><span class="keyword"> and </span>Differentiated Thyroid Gland Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cystic Change)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Indolent Clinical Course)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Psammoma Body Formation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRAF Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>HRAS Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NRAS Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RET/PTC Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TRK Rearrangement)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Ground Glass Nuclear Inclusion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Nuclear Grooves)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Nuclear Pseudoinclusion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Solid Variant Thyroid Gland Papillary Carcinoma<span class="subclass"> EquivalentTo </span>Thyroid Gland Papillary Carcinoma<br><span class="keyword"> and </span>Solid Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(5)</i>&nbsp; Solid Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Solid Growth Pattern). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(6)</i>&nbsp; Adenocarcinoma<span class="subclass"> SubClassOf </span>Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Thyroid Gland Adenocarcinoma<span class="subclass"> EquivalentTo </span>Adenocarcinoma<br><span class="keyword"> and </span>Common Carcinoma<br><span class="keyword"> and </span>Malignant Endocrine Neoplasm<br><span class="keyword"> and </span>Thyroid Gland Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cold Nodule)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Thyroid Gland Follicular Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Thyroglobulin Positive Neoplastic Cells Present)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Thyroid Gland Follicular Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Thyroid Gland Follicle). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Differentiated Thyroid Gland Carcinoma<span class="subclass"> EquivalentTo </span>Thyroid Gland Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Radiation Toxicity)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Follicular Cell Differentiation). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Thyroid Gland Papillary Carcinoma<span class="subclass"> EquivalentTo </span>Papillary Adenocarcinoma<br><span class="keyword"> and </span>Differentiated Thyroid Gland Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cystic Change)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Indolent Clinical Course)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Psammoma Body Formation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRAF Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>HRAS Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NRAS Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RET/PTC Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TRK Rearrangement)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Ground Glass Nuclear Inclusion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Nuclear Grooves)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Nuclear Pseudoinclusion). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Thyroid Gland Carcinoma<span class="subclass"> EquivalentTo </span>Malignant Thyroid Gland Neoplasm<br><span class="keyword"> and </span>Neck Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Thyroid Gland Epithelial Tissue)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Thyroid Gland). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Solid Variant Thyroid Gland Papillary Carcinoma<span class="subclass"> EquivalentTo </span>Thyroid Gland Papillary Carcinoma<br><span class="keyword"> and </span>Solid Carcinoma. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(6)</i>&nbsp; Neck Carcinoma<span class="subclass"> SubClassOf </span>Head<br><span class="keyword"> and </span>Neck Carcinoma. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Solid Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Solid Growth Pattern). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(8)</i>&nbsp; Head<br><span class="keyword"> and </span>Neck Carcinoma<span class="subclass"> SubClassOf </span>Carcinoma. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Papillary Carcinoma<span class="subclass"> SubClassOf </span>Carcinoma. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Thyroid Gland Papillary Carcinoma<span class="subclass"> EquivalentTo </span>Papillary Adenocarcinoma<br><span class="keyword"> and </span>Differentiated Thyroid Gland Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cystic Change)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Indolent Clinical Course)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Psammoma Body Formation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRAF Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>HRAS Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NRAS Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RET/PTC Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TRK Rearrangement)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Ground Glass Nuclear Inclusion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Nuclear Grooves)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Nuclear Pseudoinclusion). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Solid Variant Thyroid Gland Papillary Carcinoma<span class="subclass"> EquivalentTo </span>Thyroid Gland Papillary Carcinoma<br><span class="keyword"> and </span>Solid Carcinoma. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(4)</i>&nbsp; Papillary Adenocarcinoma<span class="subclass"> SubClassOf </span>Papillary Carcinoma. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Solid Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Solid Growth Pattern). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Thyroid Gland Papillary Carcinoma<span class="subclass"> EquivalentTo </span>Papillary Adenocarcinoma<br><span class="keyword"> and </span>Differentiated Thyroid Gland Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cystic Change)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Indolent Clinical Course)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Psammoma Body Formation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRAF Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>HRAS Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NRAS Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RET/PTC Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TRK Rearrangement)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Ground Glass Nuclear Inclusion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Nuclear Grooves)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Nuclear Pseudoinclusion). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Papillary Adenocarcinoma<span class="subclass"> SubClassOf </span>Adenocarcinoma. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Solid Variant Thyroid Gland Papillary Carcinoma<span class="subclass"> EquivalentTo </span>Thyroid Gland Papillary Carcinoma<br><span class="keyword"> and </span>Solid Carcinoma. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(4)</i>&nbsp; Solid Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Solid Growth Pattern). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(5)</i>&nbsp; Adenocarcinoma<span class="subclass"> SubClassOf </span>Carcinoma. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6817</td>
               <td rowspan="1">Stage IA Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage I Squamous Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IA). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IA Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage I Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IA). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stage IA Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IA Lung Carcinoma<br><span class="keyword"> and </span>Stage I Squamous Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Stage I Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Squamous Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage I Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6818</td>
               <td rowspan="1">Stage IB Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage I Squamous Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IB). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage I Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Squamous Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage I Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stage IB Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage I Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IB). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Stage IB Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IB Lung Carcinoma<br><span class="keyword"> and </span>Stage I Squamous Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6819</td>
               <td rowspan="1">Stage IIA Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage II Squamous Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIA). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage II Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Squamous Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage II Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stage IIA Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage II Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIA). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Stage IIA Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIA Lung Carcinoma<br><span class="keyword"> and </span>Stage II Squamous Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6820</td>
               <td rowspan="1">Stage IIB Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage II Squamous Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIB). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIB Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage II Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIB). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stage II Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Squamous Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage II Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Stage IIB Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIB Lung Carcinoma<br><span class="keyword"> and </span>Stage II Squamous Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6821</td>
               <td rowspan="1">Stage IIIA Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage III Squamous Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIIA). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage III Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Squamous Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage III Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage III). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stage IIIA Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage III Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIIA). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Stage IIIA Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIIA Lung Carcinoma<br><span class="keyword"> and </span>Stage III Squamous Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6822</td>
               <td rowspan="1">Stage IIIB Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage III Squamous Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIIB). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage III Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Squamous Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage III Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage III). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stage IIIB Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage III Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIIB). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Stage IIIB Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIIB Lung Carcinoma<br><span class="keyword"> and </span>Stage III Squamous Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6823</td>
               <td rowspan="1">Sulforaphane<span class="subclass"> SubClassOf </span>Chemopreventive Agent. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Phase II Enzymes Inducer<span class="subclass"> SubClassOf </span>Chemopreventive Agent. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Sulforaphane<span class="subclass"> SubClassOf </span>Phase II Enzymes Inducer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6824</td>
               <td rowspan="1">Superior Sulcus Lung Carcinoma<span class="subclass"> SubClassOf </span>Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Superior Sulcus Lung Carcinoma<span class="subclass"> EquivalentTo </span>Bronchogenic Carcinoma<br><span class="keyword"> and </span>Malignant Superior Sulcus Neoplasm. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Bronchogenic Carcinoma<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Bronchial Epithelial Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Bronchial Epithelium)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchus). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6825</td>
               <td rowspan="1">Systolic Pressure<span class="subclass"> SubClassOf </span>Personal Attribute. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Blood Pressure<span class="subclass"> SubClassOf </span>Personal Attribute. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Systolic Pressure<span class="subclass"> SubClassOf </span>Blood Pressure. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6826</td>
               <td rowspan="1">Tumor Lysis Syndrome<span class="subclass"> SubClassOf </span>Syndrome. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Tumor Lysis Syndrome<span class="subclass"> SubClassOf </span>Neoplastic Syndrome. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Neoplastic Syndrome<span class="subclass"> SubClassOf </span>Syndrome. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6776</td>
               <td rowspan="1">Value<span class="subclass"> SubClassOf </span>Conceptual Entity. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Value<span class="subclass"> SubClassOf </span>Conceptual Entity. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Value<span class="subclass"> SubClassOf </span>Value. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
         </tbody>
         <tbody id="rpsnovred" style="display:none">
            <tr class="withoutstyle">
               <td colspan="3">
                  <h4 style="display: inline-block;">Prospective Pseudo Novel Redundant (676)</h4> [<a href="#">back to top</a>]
               </td>
            </tr>
            <tr>
               <th class="removal">ID</th>
               <th class="removal">Axiom in Ontology 1</th>
               <th class="normalrem">Justifications in Ontology 2</th>
            </tr>
            <tr class="removal">
               <td rowspan="1">6828</td>
               <td rowspan="1">ADAM17 wt Allele<span class="subclass"> SubClassOf </span>ADAM17 Gene. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; ADAM17 wt Allele<span class="subclass"> EquivalentTo </span>ADAM17 Gene<br><span class="keyword"> and </span>(Gene_Found_In_Organism<span class="some"> some </span>Human)<br><span class="keyword"> and </span>(Gene_In_Chromosomal_Location<span class="some"> some </span>2p25). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6829</td>
               <td rowspan="1">Acinar Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Lung Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Acinar Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Acinar Pattern). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6830</td>
               <td rowspan="1">Acinic Cell Breast Carcinoma<span class="subclass"> SubClassOf </span>Breast Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Acinic Cell Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Serous Adenocarcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Acinic Cell Differentiation). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6831</td>
               <td rowspan="1">Acinic Cell Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Acinic Cell Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Serous Adenocarcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Acinic Cell Differentiation). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6833</td>
               <td rowspan="1">Alcohol-Related Carcinoma<span class="subclass"> SubClassOf </span>Behavior-Related Disorder. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Alcohol-Related Carcinoma<span class="subclass"> EquivalentTo </span>Behavior-Related Disorder<br><span class="keyword"> and </span>Carcinoma<br><span class="keyword"> and </span>Neoplasm by Cause<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Toxicity). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6834</td>
               <td rowspan="1">Alcohol-Related Carcinoma<span class="subclass"> SubClassOf </span>Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Alcohol-Related Carcinoma<span class="subclass"> EquivalentTo </span>Behavior-Related Disorder<br><span class="keyword"> and </span>Carcinoma<br><span class="keyword"> and </span>Neoplasm by Cause<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Toxicity). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6835</td>
               <td rowspan="1">Alcohol-Related Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Toxicity. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Alcohol-Related Carcinoma<span class="subclass"> EquivalentTo </span>Behavior-Related Disorder<br><span class="keyword"> and </span>Carcinoma<br><span class="keyword"> and </span>Neoplasm by Cause<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Toxicity). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6836</td>
               <td rowspan="1">Alcohol-Related Carcinoma<span class="subclass"> SubClassOf </span>Neoplasm by Cause. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Alcohol-Related Carcinoma<span class="subclass"> EquivalentTo </span>Behavior-Related Disorder<br><span class="keyword"> and </span>Carcinoma<br><span class="keyword"> and </span>Neoplasm by Cause<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Toxicity). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6837</td>
               <td rowspan="1">Alcohol-Related Esophageal Carcinoma<span class="subclass"> SubClassOf </span>Alcohol-Related Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Alcohol-Related Esophageal Carcinoma<span class="subclass"> EquivalentTo </span>Alcohol-Related Carcinoma<br><span class="keyword"> and </span>Esophageal Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6838</td>
               <td rowspan="1">Alcohol-Related Esophageal Carcinoma<span class="subclass"> SubClassOf </span>Esophageal Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Alcohol-Related Esophageal Carcinoma<span class="subclass"> EquivalentTo </span>Alcohol-Related Carcinoma<br><span class="keyword"> and </span>Esophageal Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6839</td>
               <td rowspan="1">Alcohol-Related Laryngeal Carcinoma<span class="subclass"> SubClassOf </span>Alcohol-Related Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Alcohol-Related Laryngeal Carcinoma<span class="subclass"> EquivalentTo </span>Alcohol-Related Carcinoma<br><span class="keyword"> and </span>Laryngeal Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6840</td>
               <td rowspan="1">Alcohol-Related Laryngeal Carcinoma<span class="subclass"> SubClassOf </span>Laryngeal Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Alcohol-Related Laryngeal Carcinoma<span class="subclass"> EquivalentTo </span>Alcohol-Related Carcinoma<br><span class="keyword"> and </span>Laryngeal Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6841</td>
               <td rowspan="1">Apocrine Breast Carcinoma In Situ<span class="subclass"> SubClassOf </span>Apocrine Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Apocrine Breast Carcinoma In Situ<span class="subclass"> EquivalentTo </span>Apocrine Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Invasive Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>In Situ Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6842</td>
               <td rowspan="1">Apocrine Breast Carcinoma<span class="subclass"> SubClassOf </span>Apocrine Gland Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Apocrine Breast Carcinoma<span class="subclass"> EquivalentTo </span>Apocrine Gland Carcinoma<br><span class="keyword"> and </span>Breast Adenocarcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6843</td>
               <td rowspan="1">Apocrine Breast Carcinoma<span class="subclass"> SubClassOf </span>Breast Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Apocrine Breast Carcinoma<span class="subclass"> EquivalentTo </span>Apocrine Gland Carcinoma<br><span class="keyword"> and </span>Breast Adenocarcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6844</td>
               <td rowspan="1">Asbestos-Related Lung Carcinoma<span class="subclass"> SubClassOf </span>Asbestos-Related Malignant Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Asbestos-Related Lung Carcinoma<span class="subclass"> EquivalentTo </span>Asbestos-Related Malignant Neoplasm<br><span class="keyword"> and </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6845</td>
               <td rowspan="1">Asbestos-Related Lung Carcinoma<span class="subclass"> SubClassOf </span>Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Asbestos-Related Lung Carcinoma<span class="subclass"> EquivalentTo </span>Asbestos-Related Malignant Neoplasm<br><span class="keyword"> and </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6846</td>
               <td rowspan="1">Basal-Like Subtype of Invasive Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>c-erbB2 Messenger RNA Overexpression. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Basal-Like Subtype of Invasive Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Breast Carcinoma by Gene Expression Profile<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>c-erbB2 Messenger RNA Overexpression). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6847</td>
               <td rowspan="1">Basal-Like Subtype of Invasive Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Basal-Like Subtype of Invasive Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Breast Carcinoma by Gene Expression Profile<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>c-erbB2 Messenger RNA Overexpression). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6848</td>
               <td rowspan="1">Basal-Like Subtype of Invasive Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma by Gene Expression Profile. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Basal-Like Subtype of Invasive Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Breast Carcinoma by Gene Expression Profile<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>c-erbB2 Messenger RNA Overexpression). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6849</td>
               <td rowspan="1">Basaloid Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Basaloid Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Basaloid Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Basaloid Carcinoma<br><span class="keyword"> and </span>Large Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Comedo Necrosis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6850</td>
               <td rowspan="1">Basaloid Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Finding<span class="some"> some </span>Comedo Necrosis. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Basaloid Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Basaloid Carcinoma<br><span class="keyword"> and </span>Large Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Comedo Necrosis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6851</td>
               <td rowspan="1">Basaloid Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Large Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Basaloid Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Basaloid Carcinoma<br><span class="keyword"> and </span>Large Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Comedo Necrosis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6852</td>
               <td rowspan="1">Benign Lung Hilum Neoplasm<span class="subclass"> SubClassOf </span>Benign Lung Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Benign Lung Hilum Neoplasm<span class="subclass"> EquivalentTo </span>Benign Lung Neoplasm<br><span class="keyword"> and </span>Lung Hilum Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Hilar Area of the Lung). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6853</td>
               <td rowspan="1">Benign Lung Hilum Neoplasm<span class="subclass"> SubClassOf </span>Lung Hilum Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Benign Lung Hilum Neoplasm<span class="subclass"> EquivalentTo </span>Benign Lung Neoplasm<br><span class="keyword"> and </span>Lung Hilum Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Hilar Area of the Lung). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6854</td>
               <td rowspan="1">Benign Tracheal Neoplasm<span class="subclass"> SubClassOf </span>Benign Respiratory Tract Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Benign Tracheal Neoplasm<span class="subclass"> EquivalentTo </span>Benign Respiratory Tract Neoplasm<br><span class="keyword"> and </span>Tracheal Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Trachea). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6855</td>
               <td rowspan="1">Benign Tracheal Neoplasm<span class="subclass"> SubClassOf </span>Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Trachea. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Benign Tracheal Neoplasm<span class="subclass"> EquivalentTo </span>Benign Respiratory Tract Neoplasm<br><span class="keyword"> and </span>Tracheal Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Trachea). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6856</td>
               <td rowspan="1">Benign Tracheal Neoplasm<span class="subclass"> SubClassOf </span>Tracheal Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Benign Tracheal Neoplasm<span class="subclass"> EquivalentTo </span>Benign Respiratory Tract Neoplasm<br><span class="keyword"> and </span>Tracheal Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Trachea). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6857</td>
               <td rowspan="1">Bilateral Breast Carcinoma<span class="subclass"> SubClassOf </span>Bilateral Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Bilateral Breast Carcinoma<span class="subclass"> EquivalentTo </span>Bilateral Carcinoma<br><span class="keyword"> and </span>Breast Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6858</td>
               <td rowspan="1">Bilateral Breast Carcinoma<span class="subclass"> SubClassOf </span>Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Bilateral Breast Carcinoma<span class="subclass"> EquivalentTo </span>Bilateral Carcinoma<br><span class="keyword"> and </span>Breast Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6859</td>
               <td rowspan="1">Bilateral Carcinoma<span class="subclass"> SubClassOf </span>Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Bilateral Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Bilateral Mass). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6860</td>
               <td rowspan="1">Bilateral Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Bilateral Mass. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Bilateral Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Bilateral Mass). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6861</td>
               <td rowspan="1">Biphasic Pulmonary Blastoma<span class="subclass"> SubClassOf </span>Pulmonary Blastoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Biphasic Pulmonary Blastoma<span class="subclass"> EquivalentTo </span>Pulmonary Blastoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Biphasic Pattern)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Epithelial Component Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mesenchymal Component Present). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6862</td>
               <td rowspan="1">Breast Adenocarcinoma<span class="subclass"> SubClassOf </span>Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Breast Adenocarcinoma<span class="subclass"> EquivalentTo </span>Adenocarcinoma<br><span class="keyword"> and </span>Breast Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6863</td>
               <td rowspan="1">Breast Adenocarcinoma<span class="subclass"> SubClassOf </span>Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Breast Adenocarcinoma<span class="subclass"> EquivalentTo </span>Adenocarcinoma<br><span class="keyword"> and </span>Breast Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6864</td>
               <td rowspan="1">Breast Adenocarcinoma with Spindle Cell Metaplasia<span class="subclass"> SubClassOf </span>Breast Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Breast Adenocarcinoma with Spindle Cell Metaplasia<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Metaplastic Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Spindle Cell Metaplasia). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6865</td>
               <td rowspan="1">Breast Adenocarcinoma with Spindle Cell Metaplasia<span class="subclass"> SubClassOf </span>Metaplastic Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Breast Adenocarcinoma with Spindle Cell Metaplasia<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Metaplastic Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Spindle Cell Metaplasia). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6866</td>
               <td rowspan="1">Breast Adenocarcinoma with Squamous Metaplasia<span class="subclass"> SubClassOf </span>Adenocarcinoma with Squamous Metaplasia. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Breast Adenocarcinoma with Squamous Metaplasia<span class="subclass"> EquivalentTo </span>Adenocarcinoma with Squamous Metaplasia<br><span class="keyword"> and </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Metaplastic Breast Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6867</td>
               <td rowspan="1">Breast Adenocarcinoma with Squamous Metaplasia<span class="subclass"> SubClassOf </span>Breast Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Breast Adenocarcinoma with Squamous Metaplasia<span class="subclass"> EquivalentTo </span>Adenocarcinoma with Squamous Metaplasia<br><span class="keyword"> and </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Metaplastic Breast Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6868</td>
               <td rowspan="1">Breast Carcinoma<span class="subclass"> SubClassOf </span>Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Breast Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>Common Carcinoma<br><span class="keyword"> and </span>Malignant Breast Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Mammary Epithelium)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Breast). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6869</td>
               <td rowspan="1">Breast Carcinoma<span class="subclass"> SubClassOf </span>Common Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Breast Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>Common Carcinoma<br><span class="keyword"> and </span>Malignant Breast Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Mammary Epithelium)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Breast). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6870</td>
               <td rowspan="1">Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Mammary Epithelium. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Breast Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>Common Carcinoma<br><span class="keyword"> and </span>Malignant Breast Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Mammary Epithelium)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Breast). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6871</td>
               <td rowspan="1">Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Breast. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Breast Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>Common Carcinoma<br><span class="keyword"> and </span>Malignant Breast Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Mammary Epithelium)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Breast). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6872</td>
               <td rowspan="1">Breast Carcinoma<span class="subclass"> SubClassOf </span>Malignant Breast Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Breast Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>Common Carcinoma<br><span class="keyword"> and </span>Malignant Breast Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Mammary Epithelium)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Breast). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6873</td>
               <td rowspan="1">Breast Carcinoma with Chondroid Metaplasia<span class="subclass"> SubClassOf </span>Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Breast Carcinoma with Chondroid Metaplasia<span class="subclass"> EquivalentTo </span>Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Cartilagenous Metaplasia). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6874</td>
               <td rowspan="1">Breast Carcinoma with Choriocarcinomatous Features<span class="subclass"> SubClassOf </span>Invasive Ductal Carcinoma, Not Otherwise Specified. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Breast Carcinoma with Choriocarcinomatous Features<span class="subclass"> EquivalentTo </span>Invasive Ductal Carcinoma, Not Otherwise Specified<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Human Chorionic Gonadotropin Positive Neoplastic Cells Present). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6875</td>
               <td rowspan="1">Breast Carcinoma with Melanotic Features<span class="subclass"> SubClassOf </span>Invasive Ductal Carcinoma, Not Otherwise Specified. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Breast Carcinoma with Melanotic Features<span class="subclass"> EquivalentTo </span>Invasive Ductal Carcinoma, Not Otherwise Specified<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Melanoma Cells Present). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6876</td>
               <td rowspan="1">Breast Carcinoma with Osseous Metaplasia<span class="subclass"> SubClassOf </span>Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Breast Carcinoma with Osseous Metaplasia<span class="subclass"> EquivalentTo </span>Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Osseous Metaplasia). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6877</td>
               <td rowspan="1">Breast Carcinoma with Osteoclastic Giant Cells<span class="subclass"> SubClassOf </span>Breast Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Breast Carcinoma with Osteoclastic Giant Cells<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Large Osteoclastic Giant Cell). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6878</td>
               <td rowspan="1">Breast Carcinoma with Osteoclastic Giant Cells<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Breast Carcinoma with Osteoclastic Giant Cells<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Large Osteoclastic Giant Cell). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6879</td>
               <td rowspan="1">Breast Large Cell Neuroendocrine Carcinoma<span class="subclass"> SubClassOf </span>Breast Neuroendocrine Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Breast Large Cell Neuroendocrine Carcinoma<span class="subclass"> EquivalentTo </span>Breast Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Large Cell Neuroendocrine Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>High Mitotic Activity)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Necrotic Change). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6880</td>
               <td rowspan="1">Breast Large Cell Neuroendocrine Carcinoma<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Breast Large Cell Neuroendocrine Carcinoma<span class="subclass"> EquivalentTo </span>Breast Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Large Cell Neuroendocrine Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>High Mitotic Activity)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Necrotic Change). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6881</td>
               <td rowspan="1">Breast Large Cell Neuroendocrine Carcinoma<span class="subclass"> SubClassOf </span>Large Cell Neuroendocrine Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Breast Large Cell Neuroendocrine Carcinoma<span class="subclass"> EquivalentTo </span>Breast Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Large Cell Neuroendocrine Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>High Mitotic Activity)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Necrotic Change). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6882</td>
               <td rowspan="1">Breast Melanoma<span class="subclass"> SubClassOf </span>Malignant Breast Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Breast Melanoma<span class="subclass"> EquivalentTo </span>Malignant Breast Neoplasm<br><span class="keyword"> and </span>Melanoma<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Mammary Gland Tissue)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Breast). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6883</td>
               <td rowspan="1">Breast Melanoma<span class="subclass"> SubClassOf </span>Melanoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Breast Melanoma<span class="subclass"> EquivalentTo </span>Malignant Breast Neoplasm<br><span class="keyword"> and </span>Melanoma<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Mammary Gland Tissue)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Breast). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6884</td>
               <td rowspan="1">Breast Small Cell Carcinoma<span class="subclass"> SubClassOf </span>Breast Neuroendocrine Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Breast Small Cell Carcinoma<span class="subclass"> EquivalentTo </span>Breast Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Small Cell Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Neuroendocrine Small Cell). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6885</td>
               <td rowspan="1">Breast Small Cell Carcinoma<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Breast Small Cell Carcinoma<span class="subclass"> EquivalentTo </span>Breast Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Small Cell Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Neuroendocrine Small Cell). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6886</td>
               <td rowspan="1">Breast Small Cell Carcinoma<span class="subclass"> SubClassOf </span>Small Cell Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Breast Small Cell Carcinoma<span class="subclass"> EquivalentTo </span>Breast Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Small Cell Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Neuroendocrine Small Cell). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6887</td>
               <td rowspan="1">Bronchioloalveolar Carcinoma<span class="subclass"> SubClassOf </span>Lung Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Bronchioloalveolar Carcinoma<span class="subclass"> EquivalentTo </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Stromal Invasion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lepidic Growth Pattern). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6888</td>
               <td rowspan="1">Bronchogenic Carcinoma<span class="subclass"> SubClassOf </span>Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Bronchogenic Carcinoma<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Bronchial Epithelial Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Bronchial Epithelium)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchus). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6889</td>
               <td rowspan="1">Carcinoid Tumor of the Breast<span class="subclass"> SubClassOf </span>Breast Neuroendocrine Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Carcinoid Tumor of the Breast<span class="subclass"> EquivalentTo </span>Breast Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Carcinoid Tumor<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Breast). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6890</td>
               <td rowspan="1">Carcinoid Tumor of the Breast<span class="subclass"> SubClassOf </span>Carcinoid Tumor. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Carcinoid Tumor of the Breast<span class="subclass"> EquivalentTo </span>Breast Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Carcinoid Tumor<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Breast). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6892</td>
               <td rowspan="1">Combined Large Cell Lung Neuroendocrine Carcinoma<span class="subclass"> SubClassOf </span>Combined Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Combined Large Cell Lung Neuroendocrine Carcinoma<span class="subclass"> EquivalentTo </span>Combined Lung Carcinoma<br><span class="keyword"> and </span>Large Cell Lung Neuroendocrine Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Adenocarcinoma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Epithelial Giant Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Epithelial Spindle Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Squamous Cell). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6893</td>
               <td rowspan="1">Combined Large Cell Lung Neuroendocrine Carcinoma<span class="subclass"> SubClassOf </span>Large Cell Lung Neuroendocrine Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Combined Large Cell Lung Neuroendocrine Carcinoma<span class="subclass"> EquivalentTo </span>Combined Lung Carcinoma<br><span class="keyword"> and </span>Large Cell Lung Neuroendocrine Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Adenocarcinoma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Epithelial Giant Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Epithelial Spindle Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Squamous Cell). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6894</td>
               <td rowspan="1">Combined Lung Carcinoma<span class="subclass"> SubClassOf </span>Complex Epithelial Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Combined Lung Carcinoma<span class="subclass"> EquivalentTo </span>Complex Epithelial Neoplasm<br><span class="keyword"> and </span>High Grade Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Lung Carcinoma<br><span class="keyword"> and </span>Neuroendocrine Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mixed Cellular Population). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6895</td>
               <td rowspan="1">Combined Lung Carcinoma<span class="subclass"> SubClassOf </span>High Grade Lung Neuroendocrine Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Combined Lung Carcinoma<span class="subclass"> EquivalentTo </span>Complex Epithelial Neoplasm<br><span class="keyword"> and </span>High Grade Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Lung Carcinoma<br><span class="keyword"> and </span>Neuroendocrine Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mixed Cellular Population). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6896</td>
               <td rowspan="1">Combined Lung Carcinoma<span class="subclass"> SubClassOf </span>Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Combined Lung Carcinoma<span class="subclass"> EquivalentTo </span>Complex Epithelial Neoplasm<br><span class="keyword"> and </span>High Grade Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Lung Carcinoma<br><span class="keyword"> and </span>Neuroendocrine Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mixed Cellular Population). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6897</td>
               <td rowspan="1">Combined Lung Carcinoma<span class="subclass"> SubClassOf </span>Neuroendocrine Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Combined Lung Carcinoma<span class="subclass"> EquivalentTo </span>Complex Epithelial Neoplasm<br><span class="keyword"> and </span>High Grade Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Lung Carcinoma<br><span class="keyword"> and </span>Neuroendocrine Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mixed Cellular Population). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6898</td>
               <td rowspan="1">Combined Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Combined Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Combined Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Combined Lung Carcinoma<br><span class="keyword"> and </span>Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Coin Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hoarseness). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6899</td>
               <td rowspan="1">Combined Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Small Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Combined Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Combined Lung Carcinoma<br><span class="keyword"> and </span>Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Coin Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hoarseness). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6832</td>
               <td rowspan="1">Combined Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Combined Small Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Combined Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Combined Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Adenocarcinoma Cell). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7147</td>
               <td rowspan="1">Combined Small Cell<br><span class="keyword"> and </span>Squamous Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Combined Small Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Combined Small Cell<br><span class="keyword"> and </span>Squamous Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Combined Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Squamous Cell). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6900</td>
               <td rowspan="1">Comedocarcinoma<span class="subclass"> SubClassOf </span>Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Comedocarcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Comedo Necrosis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6901</td>
               <td rowspan="1">Comedocarcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Comedo Necrosis. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Comedocarcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Comedo Necrosis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6902</td>
               <td rowspan="1">Cribriform Carcinoma<span class="subclass"> SubClassOf </span>Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Cribriform Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Cribriform Pattern). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6903</td>
               <td rowspan="1">Cribriform Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Cribriform Pattern. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Cribriform Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Cribriform Pattern). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6928</td>
               <td rowspan="1">Ductal Breast Carcinoma In Situ<br><span class="keyword"> and </span>Invasive Lobular Carcinoma<span class="subclass"> SubClassOf </span>Intraductal<br><span class="keyword"> and </span>Lobular Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Ductal Breast Carcinoma In Situ<br><span class="keyword"> and </span>Invasive Lobular Carcinoma<span class="subclass"> EquivalentTo </span>Intraductal<br><span class="keyword"> and </span>Lobular Carcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Ductal Breast Carcinoma in Situ)<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Invasive Lobular Breast Carcinoma). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6929</td>
               <td rowspan="1">Ductal Breast Carcinoma In Situ<br><span class="keyword"> and </span>Invasive Lobular Carcinoma<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Ductal Breast Carcinoma In Situ<br><span class="keyword"> and </span>Invasive Lobular Carcinoma<span class="subclass"> EquivalentTo </span>Intraductal<br><span class="keyword"> and </span>Lobular Carcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Ductal Breast Carcinoma in Situ)<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Invasive Lobular Breast Carcinoma). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6904</td>
               <td rowspan="1">Ductal Breast Carcinoma<span class="subclass"> SubClassOf </span>Breast Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Ductal Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome Xq)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 22q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Calcification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CCND1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>c-erbB2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ERBB2 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>CDH1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Loss of E-cadherin Expression)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Ductal Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6905</td>
               <td rowspan="1">Ductal Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>CDH1 Gene Inactivation. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Ductal Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome Xq)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 22q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Calcification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CCND1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>c-erbB2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ERBB2 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>CDH1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Loss of E-cadherin Expression)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Ductal Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6906</td>
               <td rowspan="1">Ductal Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Loss of E-cadherin Expression. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Ductal Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome Xq)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 22q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Calcification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CCND1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>c-erbB2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ERBB2 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>CDH1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Loss of E-cadherin Expression)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Ductal Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6907</td>
               <td rowspan="1">Ductal Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Abnormal_Cell<span class="some"> only </span>Ductal Carcinoma Cell. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Ductal Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome Xq)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 22q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Calcification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CCND1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>c-erbB2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ERBB2 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>CDH1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Loss of E-cadherin Expression)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Ductal Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6908</td>
               <td rowspan="1">Ductal Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Ductal Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome Xq)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 22q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Calcification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CCND1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>c-erbB2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ERBB2 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>CDH1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Loss of E-cadherin Expression)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Ductal Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6909</td>
               <td rowspan="1">Ductal Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Ductal Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome Xq)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 22q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Calcification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CCND1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>c-erbB2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ERBB2 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>CDH1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Loss of E-cadherin Expression)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Ductal Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6910</td>
               <td rowspan="1">Ductal Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Ductal Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome Xq)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 22q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Calcification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CCND1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>c-erbB2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ERBB2 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>CDH1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Loss of E-cadherin Expression)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Ductal Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6911</td>
               <td rowspan="1">Ductal Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6q. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Ductal Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome Xq)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 22q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Calcification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CCND1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>c-erbB2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ERBB2 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>CDH1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Loss of E-cadherin Expression)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Ductal Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6912</td>
               <td rowspan="1">Ductal Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Ductal Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome Xq)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 22q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Calcification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CCND1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>c-erbB2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ERBB2 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>CDH1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Loss of E-cadherin Expression)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Ductal Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6913</td>
               <td rowspan="1">Ductal Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome Xq. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Ductal Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome Xq)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 22q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Calcification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CCND1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>c-erbB2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ERBB2 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>CDH1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Loss of E-cadherin Expression)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Ductal Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6914</td>
               <td rowspan="1">Ductal Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Ductal Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome Xq)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 22q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Calcification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CCND1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>c-erbB2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ERBB2 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>CDH1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Loss of E-cadherin Expression)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Ductal Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6915</td>
               <td rowspan="1">Ductal Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Ductal Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome Xq)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 22q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Calcification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CCND1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>c-erbB2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ERBB2 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>CDH1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Loss of E-cadherin Expression)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Ductal Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6916</td>
               <td rowspan="1">Ductal Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Ductal Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome Xq)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 22q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Calcification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CCND1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>c-erbB2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ERBB2 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>CDH1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Loss of E-cadherin Expression)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Ductal Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6917</td>
               <td rowspan="1">Ductal Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 22q. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Ductal Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome Xq)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 22q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Calcification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CCND1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>c-erbB2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ERBB2 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>CDH1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Loss of E-cadherin Expression)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Ductal Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6918</td>
               <td rowspan="1">Ductal Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Ductal Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome Xq)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 22q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Calcification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CCND1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>c-erbB2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ERBB2 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>CDH1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Loss of E-cadherin Expression)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Ductal Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6919</td>
               <td rowspan="1">Ductal Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Finding<span class="some"> some </span>Calcification. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Ductal Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome Xq)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 22q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Calcification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CCND1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>c-erbB2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ERBB2 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>CDH1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Loss of E-cadherin Expression)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Ductal Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6920</td>
               <td rowspan="1">Ductal Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CCND1 Gene Amplification. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Ductal Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome Xq)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 22q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Calcification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CCND1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>c-erbB2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ERBB2 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>CDH1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Loss of E-cadherin Expression)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Ductal Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6921</td>
               <td rowspan="1">Ductal Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Messenger RNA Overexpression. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Ductal Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome Xq)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 22q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Calcification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CCND1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>c-erbB2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ERBB2 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>CDH1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Loss of E-cadherin Expression)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Ductal Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6922</td>
               <td rowspan="1">Ductal Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Ductal Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome Xq)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 22q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Calcification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CCND1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>c-erbB2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ERBB2 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>CDH1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Loss of E-cadherin Expression)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Ductal Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6925</td>
               <td rowspan="1">Ductal Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ERBB2 Protein Overexpression. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Ductal Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome Xq)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 22q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Calcification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CCND1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>c-erbB2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ERBB2 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>CDH1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Loss of E-cadherin Expression)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Ductal Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6924</td>
               <td rowspan="1">Ductal Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Ductal Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome Xq)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 22q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Calcification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CCND1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>c-erbB2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ERBB2 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>CDH1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Loss of E-cadherin Expression)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Ductal Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6923</td>
               <td rowspan="1">Ductal Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>c-erbB2 Gene Amplification. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Ductal Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome Xq)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 22q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Calcification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CCND1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>c-erbB2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ERBB2 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>CDH1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Loss of E-cadherin Expression)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Ductal Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6926</td>
               <td rowspan="1">Ductal Breast Carcinoma with Squamous Metaplasia<span class="subclass"> SubClassOf </span>Breast Adenocarcinoma with Squamous Metaplasia. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Ductal Breast Carcinoma with Squamous Metaplasia<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma with Squamous Metaplasia<br><span class="keyword"> and </span>Invasive Ductal Carcinoma, Not Otherwise Specified. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6927</td>
               <td rowspan="1">Ductal Breast Carcinoma with Squamous Metaplasia<span class="subclass"> SubClassOf </span>Ductal Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Ductal Breast Carcinoma with Squamous Metaplasia<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma with Squamous Metaplasia<br><span class="keyword"> and </span>Invasive Ductal Carcinoma, Not Otherwise Specified. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> EquivalentTo </span>Ductal Breast Carcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>der(1;16)(q10;p10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(1)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(8)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cord-Like Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Solid Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Syncytial Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin E Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 12p). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6930</td>
               <td rowspan="1">ERBB2 Overexpressing Subtype of Invasive Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Molecular_Abnormality<span class="some"> only </span>c-erbB2 Messenger RNA Overexpression. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; ERBB2 Overexpressing Subtype of Invasive Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Breast Carcinoma by Gene Expression Profile<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>c-erbB2 Messenger RNA Overexpression). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6931</td>
               <td rowspan="1">ERBB2 Overexpressing Subtype of Invasive Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; ERBB2 Overexpressing Subtype of Invasive Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Breast Carcinoma by Gene Expression Profile<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>c-erbB2 Messenger RNA Overexpression). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6932</td>
               <td rowspan="1">ERBB2 Overexpressing Subtype of Invasive Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma by Gene Expression Profile. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; ERBB2 Overexpressing Subtype of Invasive Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Breast Carcinoma by Gene Expression Profile<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>c-erbB2 Messenger RNA Overexpression). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6933</td>
               <td rowspan="1">Epithelial Predominant Pulmonary Blastoma<span class="subclass"> SubClassOf </span>Pulmonary Blastoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Epithelial Predominant Pulmonary Blastoma<span class="subclass"> EquivalentTo </span>Pulmonary Blastoma<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Biphasic Pattern)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Epithelial Component Present). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6934</td>
               <td rowspan="1">Extensive Stage Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Extensive Stage. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Extensive Stage Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Coin Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hoarseness)<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Extensive Stage). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6935</td>
               <td rowspan="1">Extensive Stage Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Small Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Extensive Stage Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Coin Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hoarseness)<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Extensive Stage). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6936</td>
               <td rowspan="1">FANCM wt Allele<span class="subclass"> SubClassOf </span>FANCM Gene. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; FANCM wt Allele<span class="subclass"> EquivalentTo </span>FANCM Gene<br><span class="keyword"> and </span>(Gene_In_Chromosomal_Location<span class="some"> some </span>14q21.3). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6937</td>
               <td rowspan="1">FANCM wt Allele<span class="subclass"> SubClassOf </span>Gene_In_Chromosomal_Location<span class="some"> some </span>14q21.3. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; FANCM wt Allele<span class="subclass"> EquivalentTo </span>FANCM Gene<br><span class="keyword"> and </span>(Gene_In_Chromosomal_Location<span class="some"> some </span>14q21.3). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6938</td>
               <td rowspan="1">Fetal Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Lung Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Fetal Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Tubular Structures of Glycogen-Rich Non-Ciliated Cells Present). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6939</td>
               <td rowspan="1">Glycogen-Rich Carcinoma<span class="subclass"> SubClassOf </span>Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Glycogen-Rich Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Clear Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6940</td>
               <td rowspan="1">Glycogen-Rich, Clear Cell Breast Carcinoma<span class="subclass"> SubClassOf </span>Breast Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Glycogen-Rich, Clear Cell Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Clear Cell Adenocarcinoma<br><span class="keyword"> and </span>Glycogen-Rich Carcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Aggressive Clinical Course). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6941</td>
               <td rowspan="1">Glycogen-Rich, Clear Cell Breast Carcinoma<span class="subclass"> SubClassOf </span>Clear Cell Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Glycogen-Rich, Clear Cell Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Clear Cell Adenocarcinoma<br><span class="keyword"> and </span>Glycogen-Rich Carcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Aggressive Clinical Course). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6942</td>
               <td rowspan="1">Glycogen-Rich, Clear Cell Breast Carcinoma<span class="subclass"> SubClassOf </span>Glycogen-Rich Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Glycogen-Rich, Clear Cell Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Clear Cell Adenocarcinoma<br><span class="keyword"> and </span>Glycogen-Rich Carcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Aggressive Clinical Course). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6943</td>
               <td rowspan="1">Glycogen-Rich, Clear Cell Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Glycogen-Rich, Clear Cell Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Clear Cell Adenocarcinoma<br><span class="keyword"> and </span>Glycogen-Rich Carcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Aggressive Clinical Course). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6944</td>
               <td rowspan="1">Grade 1 Invasive Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Grade<span class="some"> only </span>Grade 1. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Grade 1 Invasive Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Breast Carcinoma by Histologic Grade<br><span class="keyword"> and </span>(Disease_Is_Grade<span class="some"> only </span>Grade 1). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6945</td>
               <td rowspan="1">Grade 1 Invasive Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma by Histologic Grade. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Grade 1 Invasive Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Breast Carcinoma by Histologic Grade<br><span class="keyword"> and </span>(Disease_Is_Grade<span class="some"> only </span>Grade 1). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6946</td>
               <td rowspan="1">Grade 2 Invasive Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Grade<span class="some"> only </span>Grade 2. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Grade 2 Invasive Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Breast Carcinoma by Histologic Grade<br><span class="keyword"> and </span>(Disease_Is_Grade<span class="some"> only </span>Grade 2). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6947</td>
               <td rowspan="1">Grade 2 Invasive Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma by Histologic Grade. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Grade 2 Invasive Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Breast Carcinoma by Histologic Grade<br><span class="keyword"> and </span>(Disease_Is_Grade<span class="some"> only </span>Grade 2). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6948</td>
               <td rowspan="1">Grade 3 Invasive Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Grade<span class="some"> only </span>Grade 3. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Grade 3 Invasive Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Breast Carcinoma by Histologic Grade<br><span class="keyword"> and </span>(Disease_Is_Grade<span class="some"> only </span>Grade 3). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6949</td>
               <td rowspan="1">Grade 3 Invasive Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma by Histologic Grade. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Grade 3 Invasive Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Breast Carcinoma by Histologic Grade<br><span class="keyword"> and </span>(Disease_Is_Grade<span class="some"> only </span>Grade 3). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6950</td>
               <td rowspan="1">Hereditary Breast Carcinoma<span class="subclass"> SubClassOf </span>Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Hereditary Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>Hereditary Malignant Neoplasm. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6951</td>
               <td rowspan="1">Hereditary Breast Carcinoma<span class="subclass"> SubClassOf </span>Hereditary Malignant Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Hereditary Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>Hereditary Malignant Neoplasm. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6952</td>
               <td rowspan="1">Hereditary Fallopian Tube Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRCA1 Gene Inactivation. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Hereditary Fallopian Tube Carcinoma<span class="subclass"> EquivalentTo </span>Fallopian Tube Carcinoma<br><span class="keyword"> and </span>Hereditary Malignant Neoplasm<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRCA1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRCA2 Gene Inactivation). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6953</td>
               <td rowspan="1">Hereditary Fallopian Tube Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRCA2 Gene Inactivation. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Hereditary Fallopian Tube Carcinoma<span class="subclass"> EquivalentTo </span>Fallopian Tube Carcinoma<br><span class="keyword"> and </span>Hereditary Malignant Neoplasm<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRCA1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRCA2 Gene Inactivation). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6954</td>
               <td rowspan="1">Hereditary Fallopian Tube Carcinoma<span class="subclass"> SubClassOf </span>Fallopian Tube Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Hereditary Fallopian Tube Carcinoma<span class="subclass"> EquivalentTo </span>Fallopian Tube Carcinoma<br><span class="keyword"> and </span>Hereditary Malignant Neoplasm<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRCA1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRCA2 Gene Inactivation). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6955</td>
               <td rowspan="1">Hereditary Fallopian Tube Carcinoma<span class="subclass"> SubClassOf </span>Hereditary Malignant Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Hereditary Fallopian Tube Carcinoma<span class="subclass"> EquivalentTo </span>Fallopian Tube Carcinoma<br><span class="keyword"> and </span>Hereditary Malignant Neoplasm<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRCA1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRCA2 Gene Inactivation). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6956</td>
               <td rowspan="1">Hereditary Female Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Associated_Disease<span class="some"> some </span>Basal-Like Subtype of Invasive Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Hereditary Female Breast Carcinoma<span class="subclass"> EquivalentTo </span>Female Breast Carcinoma<br><span class="keyword"> and </span>Hereditary Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Basal-Like Subtype of Invasive Breast Carcinoma)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRCA1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRCA2 Gene Inactivation). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6957</td>
               <td rowspan="1">Hereditary Female Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRCA1 Gene Inactivation. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Hereditary Female Breast Carcinoma<span class="subclass"> EquivalentTo </span>Female Breast Carcinoma<br><span class="keyword"> and </span>Hereditary Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Basal-Like Subtype of Invasive Breast Carcinoma)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRCA1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRCA2 Gene Inactivation). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6958</td>
               <td rowspan="1">Hereditary Female Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRCA2 Gene Inactivation. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Hereditary Female Breast Carcinoma<span class="subclass"> EquivalentTo </span>Female Breast Carcinoma<br><span class="keyword"> and </span>Hereditary Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Basal-Like Subtype of Invasive Breast Carcinoma)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRCA1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRCA2 Gene Inactivation). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6959</td>
               <td rowspan="1">Hereditary Female Breast Carcinoma<span class="subclass"> SubClassOf </span>Female Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Hereditary Female Breast Carcinoma<span class="subclass"> EquivalentTo </span>Female Breast Carcinoma<br><span class="keyword"> and </span>Hereditary Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Basal-Like Subtype of Invasive Breast Carcinoma)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRCA1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRCA2 Gene Inactivation). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6960</td>
               <td rowspan="1">Hereditary Female Breast Carcinoma<span class="subclass"> SubClassOf </span>Hereditary Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Hereditary Female Breast Carcinoma<span class="subclass"> EquivalentTo </span>Female Breast Carcinoma<br><span class="keyword"> and </span>Hereditary Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Basal-Like Subtype of Invasive Breast Carcinoma)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRCA1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRCA2 Gene Inactivation). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6961</td>
               <td rowspan="1">Hereditary Male Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Molecular_Abnormality<span class="some"> only </span>BRCA2 Gene Inactivation. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Hereditary Male Breast Carcinoma<span class="subclass"> EquivalentTo </span>Hereditary Breast Carcinoma<br><span class="keyword"> and </span>Male Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>BRCA2 Gene Inactivation). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6962</td>
               <td rowspan="1">Hereditary Male Breast Carcinoma<span class="subclass"> SubClassOf </span>Hereditary Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Hereditary Male Breast Carcinoma<span class="subclass"> EquivalentTo </span>Hereditary Breast Carcinoma<br><span class="keyword"> and </span>Male Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>BRCA2 Gene Inactivation). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6963</td>
               <td rowspan="1">Hereditary Male Breast Carcinoma<span class="subclass"> SubClassOf </span>Male Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Hereditary Male Breast Carcinoma<span class="subclass"> EquivalentTo </span>Hereditary Breast Carcinoma<br><span class="keyword"> and </span>Male Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>BRCA2 Gene Inactivation). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="3">6964</td>
               <td rowspan="3">Hereditary Thyroid Gland Medullary Carcinoma<span class="subclass"> EquivalentTo </span>Hereditary Malignant Neoplasm<br><span class="keyword"> and </span>Thyroid Gland Medullary Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Neoplastic C-Cell Hyperplasia)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Bilateral Mass)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>RET Gene Mutation). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Thyroid Gland Carcinoma<span class="subclass"> EquivalentTo </span>Malignant Thyroid Gland Neoplasm<br><span class="keyword"> and </span>Neck Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Thyroid Gland Epithelial Tissue)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Thyroid Gland). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Bilateral Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Bilateral Mass). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Thyroid Gland Medullary Carcinoma<span class="subclass"> EquivalentTo </span>Medullary Carcinoma<br><span class="keyword"> and </span>Neuroendocrine Carcinoma<br><span class="keyword"> and </span>Thyroid Gland Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Neuroendocrine Polygonal Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Neuroendocrine Round Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Neuroendocrine Spindle Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Paraneoplastic Syndrome)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cold Nodule)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Metastatic Malignant Neoplasm to the Lymph Node)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Organoid Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Calcitonin Positive Neoplastic Cells Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Serum Calcitonin Level Increased)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>C-Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Thyroid Gland Follicle). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Neck Carcinoma<span class="subclass"> SubClassOf </span>Head<br><span class="keyword"> and </span>Neck Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Hereditary Thyroid Gland Medullary Carcinoma<span class="subclass"> EquivalentTo </span>Bilateral Carcinoma<br><span class="keyword"> and </span>Hereditary Malignant Neoplasm<br><span class="keyword"> and </span>Thyroid Gland Medullary Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Neoplastic C-Cell Hyperplasia)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>RET Gene Mutation). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(6)</i>&nbsp; Head<br><span class="keyword"> and </span>Neck Carcinoma<span class="subclass"> SubClassOf </span>Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Neuroendocrine Carcinoma<span class="subclass"> SubClassOf </span>Carcinoma. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Bilateral Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Bilateral Mass). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Thyroid Gland Medullary Carcinoma<span class="subclass"> EquivalentTo </span>Medullary Carcinoma<br><span class="keyword"> and </span>Neuroendocrine Carcinoma<br><span class="keyword"> and </span>Thyroid Gland Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Neuroendocrine Polygonal Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Neuroendocrine Round Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Neuroendocrine Spindle Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Paraneoplastic Syndrome)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cold Nodule)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Metastatic Malignant Neoplasm to the Lymph Node)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Organoid Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Calcitonin Positive Neoplastic Cells Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Serum Calcitonin Level Increased)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>C-Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Thyroid Gland Follicle). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Hereditary Thyroid Gland Medullary Carcinoma<span class="subclass"> EquivalentTo </span>Bilateral Carcinoma<br><span class="keyword"> and </span>Hereditary Malignant Neoplasm<br><span class="keyword"> and </span>Thyroid Gland Medullary Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Neoplastic C-Cell Hyperplasia)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>RET Gene Mutation). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Bilateral Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Bilateral Mass). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Thyroid Gland Medullary Carcinoma<span class="subclass"> EquivalentTo </span>Medullary Carcinoma<br><span class="keyword"> and </span>Neuroendocrine Carcinoma<br><span class="keyword"> and </span>Thyroid Gland Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Neuroendocrine Polygonal Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Neuroendocrine Round Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Neuroendocrine Spindle Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Paraneoplastic Syndrome)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cold Nodule)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Metastatic Malignant Neoplasm to the Lymph Node)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Organoid Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Calcitonin Positive Neoplastic Cells Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Serum Calcitonin Level Increased)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>C-Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Thyroid Gland Follicle). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Medullary Carcinoma<span class="subclass"> SubClassOf </span>Carcinoma. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Hereditary Thyroid Gland Medullary Carcinoma<span class="subclass"> EquivalentTo </span>Bilateral Carcinoma<br><span class="keyword"> and </span>Hereditary Malignant Neoplasm<br><span class="keyword"> and </span>Thyroid Gland Medullary Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Neoplastic C-Cell Hyperplasia)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>RET Gene Mutation). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6965</td>
               <td rowspan="1">High Grade Lung Neuroendocrine Neoplasm<span class="subclass"> SubClassOf </span>Lung Neuroendocrine Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; High Grade Lung Neuroendocrine Neoplasm<span class="subclass"> EquivalentTo </span>Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>High Grade Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6967</td>
               <td rowspan="1">Inflammatory Breast Carcinoma<span class="subclass"> SubClassOf </span>Breast Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Inflammatory Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Aggressive Clinical Course)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphoplasmacytic Infiltrate)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Edema)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Erythema)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphatic Spread)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Peau d'orange). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6968</td>
               <td rowspan="1">Inflammatory Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Inflammatory Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Aggressive Clinical Course)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphoplasmacytic Infiltrate)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Edema)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Erythema)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphatic Spread)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Peau d'orange). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6969</td>
               <td rowspan="1">Intermediate Grade Lung Neuroendocrine Neoplasm<span class="subclass"> SubClassOf </span>Lung Neuroendocrine Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Intermediate Grade Lung Neuroendocrine Neoplasm<span class="subclass"> EquivalentTo </span>Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Intermediate Grade Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6970</td>
               <td rowspan="1">Intracystic Papillary Breast Carcinoma<span class="subclass"> SubClassOf </span>Intraductal Papillary Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Intracystic Papillary Breast Carcinoma<span class="subclass"> EquivalentTo </span>Intraductal Papillary Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Cystic Change). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6971</td>
               <td rowspan="1">Intraductal Micropapillary Breast Carcinoma<span class="subclass"> SubClassOf </span>Intraductal Papillary Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Intraductal Micropapillary Breast Carcinoma<span class="subclass"> EquivalentTo </span>Intraductal Papillary Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Micropapillary Pattern). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6972</td>
               <td rowspan="1">Intraductal Papillary Breast Carcinoma<span class="subclass"> SubClassOf </span>Intraductal Papillary Breast Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Intraductal Papillary Breast Carcinoma<span class="subclass"> EquivalentTo </span>Intraductal Papillary Breast Neoplasm<br><span class="keyword"> and </span>Papillary Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6973</td>
               <td rowspan="1">Intraductal Papillary Breast Carcinoma<span class="subclass"> SubClassOf </span>Papillary Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Intraductal Papillary Breast Carcinoma<span class="subclass"> EquivalentTo </span>Intraductal Papillary Breast Neoplasm<br><span class="keyword"> and </span>Papillary Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6974</td>
               <td rowspan="1">Intraductal<br><span class="keyword"> and </span>Lobular Carcinoma<span class="subclass"> SubClassOf </span>Mixed Lobular<br><span class="keyword"> and </span>Ductal Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Intraductal<br><span class="keyword"> and </span>Lobular Carcinoma<span class="subclass"> EquivalentTo </span>Mixed Lobular<br><span class="keyword"> and </span>Ductal Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Ductal Breast Carcinoma in Situ). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6975</td>
               <td rowspan="1">Invasive Apocrine Breast Carcinoma<span class="subclass"> SubClassOf </span>Apocrine Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Apocrine Breast Carcinoma<span class="subclass"> EquivalentTo </span>Apocrine Breast Carcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6976</td>
               <td rowspan="1">Invasive Apocrine Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Apocrine Breast Carcinoma<span class="subclass"> EquivalentTo </span>Apocrine Breast Carcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6977</td>
               <td rowspan="1">Invasive Breast Carcinoma<span class="subclass"> SubClassOf </span>Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>Invasive Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Breast Lump)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pain). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6978</td>
               <td rowspan="1">Invasive Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Finding<span class="some"> some </span>Breast Lump. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>Invasive Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Breast Lump)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pain). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6979</td>
               <td rowspan="1">Invasive Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Finding<span class="some"> some </span>Pain. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>Invasive Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Breast Lump)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pain). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6980</td>
               <td rowspan="1">Invasive Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>Invasive Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Breast Lump)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pain). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6981</td>
               <td rowspan="1">Invasive Cribriform Breast Carcinoma<span class="subclass"> SubClassOf </span>Breast Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Cribriform Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Cribriform Carcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6982</td>
               <td rowspan="1">Invasive Cribriform Breast Carcinoma<span class="subclass"> SubClassOf </span>Cribriform Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Cribriform Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Cribriform Carcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6983</td>
               <td rowspan="1">Invasive Cribriform Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Cribriform Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Cribriform Carcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6984</td>
               <td rowspan="1">Invasive Ductal Breast Carcinoma with Predominant Intraductal Component<span class="subclass"> SubClassOf </span>Invasive Ductal Carcinoma, Not Otherwise Specified. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Ductal Breast Carcinoma with Predominant Intraductal Component<span class="subclass"> EquivalentTo </span>Invasive Ductal Carcinoma, Not Otherwise Specified<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Prominent Intraductal Component Present). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6985</td>
               <td rowspan="1">Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> SubClassOf </span>Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 10p. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> EquivalentTo </span>Ductal Breast Carcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>der(1;16)(q10;p10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(1)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(8)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cord-Like Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Solid Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Syncytial Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin E Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 12p). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6986</td>
               <td rowspan="1">Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> SubClassOf </span>Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 12p. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> EquivalentTo </span>Ductal Breast Carcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>der(1;16)(q10;p10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(1)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(8)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cord-Like Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Solid Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Syncytial Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin E Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 12p). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6987</td>
               <td rowspan="1">Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> EquivalentTo </span>Ductal Breast Carcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>der(1;16)(q10;p10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(1)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(8)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cord-Like Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Solid Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Syncytial Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin E Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 12p). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6988</td>
               <td rowspan="1">Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> EquivalentTo </span>Ductal Breast Carcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>der(1;16)(q10;p10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(1)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(8)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cord-Like Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Solid Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Syncytial Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin E Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 12p). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6989</td>
               <td rowspan="1">Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> EquivalentTo </span>Ductal Breast Carcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>der(1;16)(q10;p10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(1)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(8)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cord-Like Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Solid Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Syncytial Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin E Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 12p). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6990</td>
               <td rowspan="1">Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> EquivalentTo </span>Ductal Breast Carcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>der(1;16)(q10;p10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(1)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(8)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cord-Like Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Solid Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Syncytial Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin E Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 12p). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6991</td>
               <td rowspan="1">Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> EquivalentTo </span>Ductal Breast Carcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>der(1;16)(q10;p10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(1)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(8)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cord-Like Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Solid Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Syncytial Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin E Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 12p). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6992</td>
               <td rowspan="1">Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> EquivalentTo </span>Ductal Breast Carcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>der(1;16)(q10;p10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(1)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(8)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cord-Like Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Solid Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Syncytial Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin E Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 12p). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6993</td>
               <td rowspan="1">Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> EquivalentTo </span>Ductal Breast Carcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>der(1;16)(q10;p10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(1)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(8)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cord-Like Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Solid Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Syncytial Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin E Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 12p). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6994</td>
               <td rowspan="1">Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> EquivalentTo </span>Ductal Breast Carcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>der(1;16)(q10;p10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(1)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(8)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cord-Like Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Solid Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Syncytial Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin E Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 12p). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6995</td>
               <td rowspan="1">Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> EquivalentTo </span>Ductal Breast Carcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>der(1;16)(q10;p10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(1)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(8)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cord-Like Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Solid Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Syncytial Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin E Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 12p). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6996</td>
               <td rowspan="1">Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> EquivalentTo </span>Ductal Breast Carcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>der(1;16)(q10;p10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(1)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(8)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cord-Like Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Solid Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Syncytial Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin E Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 12p). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6997</td>
               <td rowspan="1">Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>der(1;16)(q10;p10). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> EquivalentTo </span>Ductal Breast Carcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>der(1;16)(q10;p10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(1)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(8)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cord-Like Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Solid Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Syncytial Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin E Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 12p). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6998</td>
               <td rowspan="1">Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(1)(q10). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> EquivalentTo </span>Ductal Breast Carcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>der(1;16)(q10;p10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(1)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(8)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cord-Like Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Solid Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Syncytial Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin E Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 12p). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6999</td>
               <td rowspan="1">Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(8)(q10). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> EquivalentTo </span>Ductal Breast Carcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>der(1;16)(q10;p10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(1)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(8)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cord-Like Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Solid Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Syncytial Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin E Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 12p). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7000</td>
               <td rowspan="1">Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin E Protein Overexpression. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> EquivalentTo </span>Ductal Breast Carcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>der(1;16)(q10;p10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(1)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(8)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cord-Like Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Solid Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Syncytial Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin E Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 12p). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7001</td>
               <td rowspan="1">Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> EquivalentTo </span>Ductal Breast Carcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>der(1;16)(q10;p10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(1)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(8)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cord-Like Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Solid Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Syncytial Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin E Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 12p). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7002</td>
               <td rowspan="1">Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR1 Gene Amplification. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> EquivalentTo </span>Ductal Breast Carcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>der(1;16)(q10;p10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(1)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(8)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cord-Like Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Solid Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Syncytial Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin E Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 12p). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7003</td>
               <td rowspan="1">Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR2 Gene Amplification. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> EquivalentTo </span>Ductal Breast Carcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>der(1;16)(q10;p10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(1)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(8)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cord-Like Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Solid Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Syncytial Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin E Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 12p). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7004</td>
               <td rowspan="1">Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> EquivalentTo </span>Ductal Breast Carcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>der(1;16)(q10;p10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(1)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(8)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cord-Like Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Solid Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Syncytial Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin E Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 12p). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7005</td>
               <td rowspan="1">Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> EquivalentTo </span>Ductal Breast Carcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>der(1;16)(q10;p10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(1)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(8)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cord-Like Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Solid Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Syncytial Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin E Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 12p). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7006</td>
               <td rowspan="1">Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> EquivalentTo </span>Ductal Breast Carcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>der(1;16)(q10;p10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(1)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(8)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cord-Like Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Solid Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Syncytial Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin E Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 12p). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7007</td>
               <td rowspan="1">Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> SubClassOf </span>Ductal Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> EquivalentTo </span>Ductal Breast Carcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>der(1;16)(q10;p10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(1)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(8)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cord-Like Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Solid Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Syncytial Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin E Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 12p). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7008</td>
               <td rowspan="1">Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> EquivalentTo </span>Ductal Breast Carcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>der(1;16)(q10;p10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(1)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(8)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cord-Like Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Solid Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Syncytial Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin E Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 12p). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7009</td>
               <td rowspan="1">Invasive Ductal<br><span class="keyword"> and </span>Invasive Lobular Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Ductal<br><span class="keyword"> and </span>Lobular Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Ductal<br><span class="keyword"> and </span>Invasive Lobular Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Ductal<br><span class="keyword"> and </span>Lobular Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Invasive Lobular Breast Carcinoma). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6966</td>
               <td rowspan="1">Invasive Ductal<br><span class="keyword"> and </span>Lobular Carcinoma In Situ<span class="subclass"> SubClassOf </span>Invasive Ductal<br><span class="keyword"> and </span>Lobular Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Ductal<br><span class="keyword"> and </span>Lobular Carcinoma In Situ<span class="subclass"> EquivalentTo </span>Invasive Ductal<br><span class="keyword"> and </span>Lobular Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Lobular Breast Carcinoma In Situ). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7010</td>
               <td rowspan="1">Invasive Ductal<br><span class="keyword"> and </span>Lobular Carcinoma<span class="subclass"> SubClassOf </span>Invasive Mixed Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Ductal<br><span class="keyword"> and </span>Lobular Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Mixed Breast Carcinoma<br><span class="keyword"> and </span>Mixed Lobular<br><span class="keyword"> and </span>Ductal Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Invasive Ductal Carcinoma, Not Otherwise Specified). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7011</td>
               <td rowspan="1">Invasive Ductal<br><span class="keyword"> and </span>Lobular Carcinoma<span class="subclass"> SubClassOf </span>Mixed Lobular<br><span class="keyword"> and </span>Ductal Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Ductal<br><span class="keyword"> and </span>Lobular Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Mixed Breast Carcinoma<br><span class="keyword"> and </span>Mixed Lobular<br><span class="keyword"> and </span>Ductal Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Invasive Ductal Carcinoma, Not Otherwise Specified). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7012</td>
               <td rowspan="1">Invasive Lobular Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Lobular Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Lobular Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Single-File Linear Pattern). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7013</td>
               <td rowspan="1">Invasive Lobular Breast Carcinoma<span class="subclass"> SubClassOf </span>Lobular Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Lobular Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Lobular Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Single-File Linear Pattern). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7014</td>
               <td rowspan="1">Invasive Lobular Breast Carcinoma with Predominant In Situ Component<span class="subclass"> SubClassOf </span>Invasive Lobular Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Lobular Breast Carcinoma with Predominant In Situ Component<span class="subclass"> EquivalentTo </span>Invasive Lobular Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Prominent In Situ Component Present). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7015</td>
               <td rowspan="1">Invasive Micropapillary Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Papillary Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Micropapillary Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Papillary Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Micropapillary Pattern). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7016</td>
               <td rowspan="1">Invasive Mixed Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Mixed Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mixed Cellular Population). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7017</td>
               <td rowspan="1">Invasive Papillary Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Papillary Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Papillary Breast Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7018</td>
               <td rowspan="1">Invasive Papillary Breast Carcinoma<span class="subclass"> SubClassOf </span>Papillary Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Invasive Papillary Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Papillary Breast Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7019</td>
               <td rowspan="1">Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS Gene Mutation. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Large Cell Carcinoma<br><span class="keyword"> and </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS Gene Mutation). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7020</td>
               <td rowspan="1">Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Large Cell Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Large Cell Carcinoma<br><span class="keyword"> and </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS Gene Mutation). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7021</td>
               <td rowspan="1">Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Non-Small Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Large Cell Carcinoma<br><span class="keyword"> and </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS Gene Mutation). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7022</td>
               <td rowspan="1">Large Cell Lung Carcinoma with Rhabdoid Phenotype<span class="subclass"> SubClassOf </span>Large Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Large Cell Lung Carcinoma with Rhabdoid Phenotype<span class="subclass"> EquivalentTo </span>Large Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Rhabdoid Cell). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">6891</td>
               <td rowspan="1">Large Cell Lung Carcinoma, Clear Cell Variant<span class="subclass"> SubClassOf </span>Large Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Large Cell Lung Carcinoma, Clear Cell Variant<span class="subclass"> EquivalentTo </span>Large Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Clear Cell). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7023</td>
               <td rowspan="1">Large Cell Lung Neuroendocrine Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>C-KIT Tyrosine Kinase Protein Overexpression. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Large Cell Lung Neuroendocrine Carcinoma<span class="subclass"> EquivalentTo </span>High Grade Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Large Cell Lung Carcinoma<br><span class="keyword"> and </span>Large Cell Neuroendocrine Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>C-KIT Tyrosine Kinase Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>More than 10 Mitoses per 10HPF). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7024</td>
               <td rowspan="1">Large Cell Lung Neuroendocrine Carcinoma<span class="subclass"> SubClassOf </span>High Grade Lung Neuroendocrine Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Large Cell Lung Neuroendocrine Carcinoma<span class="subclass"> EquivalentTo </span>High Grade Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Large Cell Lung Carcinoma<br><span class="keyword"> and </span>Large Cell Neuroendocrine Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>C-KIT Tyrosine Kinase Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>More than 10 Mitoses per 10HPF). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7025</td>
               <td rowspan="1">Large Cell Lung Neuroendocrine Carcinoma<span class="subclass"> SubClassOf </span>Large Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Large Cell Lung Neuroendocrine Carcinoma<span class="subclass"> EquivalentTo </span>High Grade Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Large Cell Lung Carcinoma<br><span class="keyword"> and </span>Large Cell Neuroendocrine Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>C-KIT Tyrosine Kinase Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>More than 10 Mitoses per 10HPF). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7026</td>
               <td rowspan="1">Large Cell Lung Neuroendocrine Carcinoma<span class="subclass"> SubClassOf </span>Large Cell Neuroendocrine Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Large Cell Lung Neuroendocrine Carcinoma<span class="subclass"> EquivalentTo </span>High Grade Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Large Cell Lung Carcinoma<br><span class="keyword"> and </span>Large Cell Neuroendocrine Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>C-KIT Tyrosine Kinase Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>More than 10 Mitoses per 10HPF). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7027</td>
               <td rowspan="1">Limited Stage Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Limited Stage. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Limited Stage Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Coin Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hoarseness)<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Limited Stage). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7028</td>
               <td rowspan="1">Limited Stage Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Small Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Limited Stage Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Coin Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hoarseness)<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Limited Stage). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7029</td>
               <td rowspan="1">Lipid-Rich Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lipid-Rich Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Clear Cell Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Lipid-Rich Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7030</td>
               <td rowspan="1">Lipid-Rich Breast Carcinoma<span class="subclass"> SubClassOf </span>Lipid-Rich Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lipid-Rich Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Clear Cell Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Lipid-Rich Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7031</td>
               <td rowspan="1">Lipid-Rich Carcinoma<span class="subclass"> SubClassOf </span>Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lipid-Rich Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Clear Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7032</td>
               <td rowspan="1">Lobular Breast Carcinoma<span class="subclass"> SubClassOf </span>Breast Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lobular Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CDH1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Loss of E-cadherin Expression)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Mixed Cellular Population)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Lobular Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7033</td>
               <td rowspan="1">Lobular Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Abnormal_Cell<span class="some"> only </span>Lobular Carcinoma Cell. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lobular Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CDH1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Loss of E-cadherin Expression)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Mixed Cellular Population)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Lobular Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7034</td>
               <td rowspan="1">Lobular Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit Cell. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lobular Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CDH1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Loss of E-cadherin Expression)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Mixed Cellular Population)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Lobular Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7035</td>
               <td rowspan="1">Lobular Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lobular Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CDH1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Loss of E-cadherin Expression)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Mixed Cellular Population)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Lobular Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7036</td>
               <td rowspan="1">Lobular Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lobular Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CDH1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Loss of E-cadherin Expression)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Mixed Cellular Population)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Lobular Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7037</td>
               <td rowspan="1">Lobular Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CDH1 Gene Inactivation. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lobular Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CDH1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Loss of E-cadherin Expression)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Mixed Cellular Population)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Lobular Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7038</td>
               <td rowspan="1">Lobular Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Loss of E-cadherin Expression. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lobular Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CDH1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Loss of E-cadherin Expression)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Mixed Cellular Population)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Lobular Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7039</td>
               <td rowspan="1">Localized Carcinoma<span class="subclass"> SubClassOf </span>Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Localized Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Localized Disease). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7040</td>
               <td rowspan="1">Localized Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Localized Disease. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Localized Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Localized Disease). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7041</td>
               <td rowspan="1">Localized Extrahepatic Bile Duct Carcinoma<span class="subclass"> SubClassOf </span>Extrahepatic Bile Duct Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Localized Extrahepatic Bile Duct Carcinoma<span class="subclass"> EquivalentTo </span>Extrahepatic Bile Duct Carcinoma<br><span class="keyword"> and </span>Localized Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7042</td>
               <td rowspan="1">Localized Gallbladder Carcinoma<span class="subclass"> SubClassOf </span>Gallbladder Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Localized Gallbladder Carcinoma<span class="subclass"> EquivalentTo </span>Gallbladder Carcinoma<br><span class="keyword"> and </span>Localized Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7043</td>
               <td rowspan="1">Localized Gallbladder Carcinoma<span class="subclass"> SubClassOf </span>Localized Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Localized Gallbladder Carcinoma<span class="subclass"> EquivalentTo </span>Gallbladder Carcinoma<br><span class="keyword"> and </span>Localized Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7044</td>
               <td rowspan="1">Low Grade Lung Neuroendocrine Neoplasm<span class="subclass"> SubClassOf </span>Lung Neuroendocrine Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Low Grade Lung Neuroendocrine Neoplasm<span class="subclass"> EquivalentTo </span>Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Low Grade Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7045</td>
               <td rowspan="1">Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Non-Small Cell Adenocarcinoma<br><span class="keyword"> and </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q24-qter)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome Y)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>LKB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Loss of Chromosome 5q). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7046</td>
               <td rowspan="1">Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Non-Small Cell Adenocarcinoma<br><span class="keyword"> and </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q24-qter)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome Y)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>LKB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Loss of Chromosome 5q). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7047</td>
               <td rowspan="1">Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q24-qter. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Non-Small Cell Adenocarcinoma<br><span class="keyword"> and </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q24-qter)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome Y)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>LKB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Loss of Chromosome 5q). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7048</td>
               <td rowspan="1">Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Non-Small Cell Adenocarcinoma<br><span class="keyword"> and </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q24-qter)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome Y)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>LKB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Loss of Chromosome 5q). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7049</td>
               <td rowspan="1">Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Non-Small Cell Adenocarcinoma<br><span class="keyword"> and </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q24-qter)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome Y)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>LKB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Loss of Chromosome 5q). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7050</td>
               <td rowspan="1">Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Non-Small Cell Adenocarcinoma<br><span class="keyword"> and </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q24-qter)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome Y)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>LKB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Loss of Chromosome 5q). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7051</td>
               <td rowspan="1">Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4q. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Non-Small Cell Adenocarcinoma<br><span class="keyword"> and </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q24-qter)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome Y)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>LKB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Loss of Chromosome 5q). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7052</td>
               <td rowspan="1">Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Non-Small Cell Adenocarcinoma<br><span class="keyword"> and </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q24-qter)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome Y)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>LKB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Loss of Chromosome 5q). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7053</td>
               <td rowspan="1">Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Non-Small Cell Adenocarcinoma<br><span class="keyword"> and </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q24-qter)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome Y)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>LKB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Loss of Chromosome 5q). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7054</td>
               <td rowspan="1">Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Non-Small Cell Adenocarcinoma<br><span class="keyword"> and </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q24-qter)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome Y)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>LKB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Loss of Chromosome 5q). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7055</td>
               <td rowspan="1">Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome Y. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Non-Small Cell Adenocarcinoma<br><span class="keyword"> and </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q24-qter)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome Y)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>LKB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Loss of Chromosome 5q). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7056</td>
               <td rowspan="1">Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Non-Small Cell Adenocarcinoma<br><span class="keyword"> and </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q24-qter)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome Y)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>LKB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Loss of Chromosome 5q). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7057</td>
               <td rowspan="1">Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>LKB1 Gene Inactivation. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Non-Small Cell Adenocarcinoma<br><span class="keyword"> and </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q24-qter)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome Y)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>LKB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Loss of Chromosome 5q). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7058</td>
               <td rowspan="1">Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Loss of Chromosome 5q. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Non-Small Cell Adenocarcinoma<br><span class="keyword"> and </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q24-qter)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome Y)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>LKB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Loss of Chromosome 5q). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7059</td>
               <td rowspan="1">Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Non-Small Cell Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Non-Small Cell Adenocarcinoma<br><span class="keyword"> and </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q24-qter)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome Y)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>LKB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Loss of Chromosome 5q). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7060</td>
               <td rowspan="1">Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Non-Small Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Non-Small Cell Adenocarcinoma<br><span class="keyword"> and </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q24-qter)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome Y)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>LKB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Loss of Chromosome 5q). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7061</td>
               <td rowspan="1">Lung Adenocarcinoma, Mixed Subtype<span class="subclass"> SubClassOf </span>Lung Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Adenocarcinoma, Mixed Subtype<span class="subclass"> EquivalentTo </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Acinar Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lepidic Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Mild Cytologic Atypia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Moderate Cytologic Atypia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Moderately Differentiated Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Papillary Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Poorly Differentiated Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Severe Cytologic Atypia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Solid Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Well Differentiated Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7062</td>
               <td rowspan="1">Lung Atypical Carcinoid Tumor<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10q. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Atypical Carcinoid Tumor<span class="subclass"> EquivalentTo </span>Intermediate Grade Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Lung Carcinoid Tumor<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Necrotic Change)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Two to 10 Mitoses per 10HPF). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7063</td>
               <td rowspan="1">Lung Atypical Carcinoid Tumor<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Atypical Carcinoid Tumor<span class="subclass"> EquivalentTo </span>Intermediate Grade Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Lung Carcinoid Tumor<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Necrotic Change)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Two to 10 Mitoses per 10HPF). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7064</td>
               <td rowspan="1">Lung Atypical Carcinoid Tumor<span class="subclass"> SubClassOf </span>Intermediate Grade Lung Neuroendocrine Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Atypical Carcinoid Tumor<span class="subclass"> EquivalentTo </span>Intermediate Grade Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Lung Carcinoid Tumor<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Necrotic Change)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Two to 10 Mitoses per 10HPF). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7065</td>
               <td rowspan="1">Lung Atypical Carcinoid Tumor<span class="subclass"> SubClassOf </span>Lung Carcinoid Tumor. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Atypical Carcinoid Tumor<span class="subclass"> EquivalentTo </span>Intermediate Grade Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Lung Carcinoid Tumor<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Necrotic Change)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Two to 10 Mitoses per 10HPF). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7066</td>
               <td rowspan="1">Lung Carcinoid Tumor<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(11q). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Carcinoid Tumor<span class="subclass"> EquivalentTo </span>Foregut Carcinoid Tumor<br><span class="keyword"> and </span>Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(11q))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Atypia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Calcification)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Nuclear Pleomorphism)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>More than 10 Mitoses per 10HPF)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Nodular Lesion)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchus). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7067</td>
               <td rowspan="1">Lung Carcinoid Tumor<span class="subclass"> SubClassOf </span>Foregut Carcinoid Tumor. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Carcinoid Tumor<span class="subclass"> EquivalentTo </span>Foregut Carcinoid Tumor<br><span class="keyword"> and </span>Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(11q))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Atypia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Calcification)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Nuclear Pleomorphism)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>More than 10 Mitoses per 10HPF)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Nodular Lesion)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchus). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7068</td>
               <td rowspan="1">Lung Carcinoid Tumor<span class="subclass"> SubClassOf </span>Lung Neuroendocrine Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Carcinoid Tumor<span class="subclass"> EquivalentTo </span>Foregut Carcinoid Tumor<br><span class="keyword"> and </span>Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(11q))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Atypia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Calcification)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Nuclear Pleomorphism)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>More than 10 Mitoses per 10HPF)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Nodular Lesion)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchus). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7069</td>
               <td rowspan="1">Lung Carcinoma<span class="subclass"> SubClassOf </span>Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>Malignant Lung Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Lung). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7070</td>
               <td rowspan="1">Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Lung. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>Malignant Lung Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Lung). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7071</td>
               <td rowspan="1">Lung Carcinoma<span class="subclass"> SubClassOf </span>Malignant Lung Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>Malignant Lung Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Lung). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7072</td>
               <td rowspan="1">Lung Carcinosarcoma<span class="subclass"> SubClassOf </span>Carcinosarcoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Carcinosarcoma<span class="subclass"> EquivalentTo </span>Carcinosarcoma<br><span class="keyword"> and </span>Lung Sarcomatoid Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Spindle Cell). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7073</td>
               <td rowspan="1">Lung Carcinosarcoma<span class="subclass"> SubClassOf </span>Lung Sarcomatoid Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Carcinosarcoma<span class="subclass"> EquivalentTo </span>Carcinosarcoma<br><span class="keyword"> and </span>Lung Sarcomatoid Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Spindle Cell). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7074</td>
               <td rowspan="1">Lung Clear Cell Adenocarcinoma<span class="subclass"> SubClassOf </span>Clear Cell Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Clear Cell Adenocarcinoma<span class="subclass"> EquivalentTo </span>Clear Cell Adenocarcinoma<br><span class="keyword"> and </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7075</td>
               <td rowspan="1">Lung Clear Cell Adenocarcinoma<span class="subclass"> SubClassOf </span>Lung Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Clear Cell Adenocarcinoma<span class="subclass"> EquivalentTo </span>Clear Cell Adenocarcinoma<br><span class="keyword"> and </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7076</td>
               <td rowspan="1">Lung Epithelial-Myoepithelial Carcinoma<span class="subclass"> SubClassOf </span>Epithelial-Myoepithelial Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Epithelial-Myoepithelial Carcinoma<span class="subclass"> EquivalentTo </span>Epithelial-Myoepithelial Carcinoma<br><span class="keyword"> and </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchus). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7077</td>
               <td rowspan="1">Lung Epithelial-Myoepithelial Carcinoma<span class="subclass"> SubClassOf </span>Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Epithelial-Myoepithelial Carcinoma<span class="subclass"> EquivalentTo </span>Epithelial-Myoepithelial Carcinoma<br><span class="keyword"> and </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchus). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7078</td>
               <td rowspan="1">Lung Hilum Carcinoma<span class="subclass"> SubClassOf </span>Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Hilum Carcinoma<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>Malignant Lung Hilum Neoplasm. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7079</td>
               <td rowspan="1">Lung Hilum Carcinoma<span class="subclass"> SubClassOf </span>Malignant Lung Hilum Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Hilum Carcinoma<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>Malignant Lung Hilum Neoplasm. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7080</td>
               <td rowspan="1">Lung Hilum Neoplasm<span class="subclass"> SubClassOf </span>Lung Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Hilum Neoplasm<span class="subclass"> EquivalentTo </span>Lung Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Associated_Anatomic_Site<span class="some"> only </span>Hilar Area of the Lung). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7081</td>
               <td rowspan="1">Lung Melanoma<span class="subclass"> SubClassOf </span>Malignant Lung Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Melanoma<span class="subclass"> EquivalentTo </span>Malignant Lung Neoplasm<br><span class="keyword"> and </span>Melanoma<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Lung Tissue)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Lung). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7082</td>
               <td rowspan="1">Lung Melanoma<span class="subclass"> SubClassOf </span>Melanoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Melanoma<span class="subclass"> EquivalentTo </span>Malignant Lung Neoplasm<br><span class="keyword"> and </span>Melanoma<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Lung Tissue)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Lung). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7083</td>
               <td rowspan="1">Lung Mucinous Adenocarcinoma<span class="subclass"> SubClassOf </span>Lung Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Mucinous Adenocarcinoma<span class="subclass"> EquivalentTo </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>Mucinous Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Well Differentiated Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7084</td>
               <td rowspan="1">Lung Mucinous Adenocarcinoma<span class="subclass"> SubClassOf </span>Mucinous Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Mucinous Adenocarcinoma<span class="subclass"> EquivalentTo </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>Mucinous Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Well Differentiated Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7085</td>
               <td rowspan="1">Lung Mucinous Cystadenocarcinoma<span class="subclass"> SubClassOf </span>Lung Mucinous Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Mucinous Cystadenocarcinoma<span class="subclass"> EquivalentTo </span>Lung Mucinous Adenocarcinoma<br><span class="keyword"> and </span>Mucinous Cystadenocarcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Cystic Change)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Partially Encapsulated Mass). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7086</td>
               <td rowspan="1">Lung Mucinous Cystadenocarcinoma<span class="subclass"> SubClassOf </span>Mucinous Cystadenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Mucinous Cystadenocarcinoma<span class="subclass"> EquivalentTo </span>Lung Mucinous Adenocarcinoma<br><span class="keyword"> and </span>Mucinous Cystadenocarcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Cystic Change)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Partially Encapsulated Mass). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7087</td>
               <td rowspan="1">Lung Neuroendocrine Neoplasm<span class="subclass"> SubClassOf </span>Malignant Lung Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Neuroendocrine Neoplasm<span class="subclass"> EquivalentTo </span>Malignant Lung Neoplasm<br><span class="keyword"> and </span>Neuroendocrine Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Neuroendocrine Cell)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Lung). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7088</td>
               <td rowspan="1">Lung Neuroendocrine Neoplasm<span class="subclass"> SubClassOf </span>Neuroendocrine Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Neuroendocrine Neoplasm<span class="subclass"> EquivalentTo </span>Malignant Lung Neoplasm<br><span class="keyword"> and </span>Neuroendocrine Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Neuroendocrine Cell)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Lung). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7089</td>
               <td rowspan="1">Lung Pleomorphic Carcinoma<span class="subclass"> SubClassOf </span>Lung Sarcomatoid Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Pleomorphic Carcinoma<span class="subclass"> EquivalentTo </span>Lung Sarcomatoid Carcinoma<br><span class="keyword"> and </span>Pleomorphic Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Adenocarcinoma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Epithelial Giant Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Squamous Cell)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Spindle Cell). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7090</td>
               <td rowspan="1">Lung Pleomorphic Carcinoma<span class="subclass"> SubClassOf </span>Pleomorphic Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Pleomorphic Carcinoma<span class="subclass"> EquivalentTo </span>Lung Sarcomatoid Carcinoma<br><span class="keyword"> and </span>Pleomorphic Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Adenocarcinoma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Epithelial Giant Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Squamous Cell)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Spindle Cell). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7091</td>
               <td rowspan="1">Lung Sarcomatoid Carcinoma<span class="subclass"> SubClassOf </span>Non-Small Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Sarcomatoid Carcinoma<span class="subclass"> EquivalentTo </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Sarcomatoid Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7092</td>
               <td rowspan="1">Lung Sarcomatoid Carcinoma<span class="subclass"> SubClassOf </span>Sarcomatoid Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Sarcomatoid Carcinoma<span class="subclass"> EquivalentTo </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Sarcomatoid Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7093</td>
               <td rowspan="1">Lung Signet Ring Cell Carcinoma<span class="subclass"> SubClassOf </span>Lung Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Signet Ring Cell Carcinoma<span class="subclass"> EquivalentTo </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>Signet Ring Cell Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7094</td>
               <td rowspan="1">Lung Signet Ring Cell Carcinoma<span class="subclass"> SubClassOf </span>Signet Ring Cell Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Signet Ring Cell Carcinoma<span class="subclass"> EquivalentTo </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>Signet Ring Cell Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7095</td>
               <td rowspan="1">Lung Spindle Cell Carcinoma<span class="subclass"> SubClassOf </span>Lung Sarcomatoid Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Spindle Cell Carcinoma<span class="subclass"> EquivalentTo </span>Lung Sarcomatoid Carcinoma<br><span class="keyword"> and </span>(Disease_Excludes_Abnormal_Cell<span class="some"> only </span>Adenocarcinoma Cell)<br><span class="keyword"> and </span>(Disease_Excludes_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Giant Cell)<br><span class="keyword"> and </span>(Disease_Excludes_Abnormal_Cell<span class="some"> only </span>Malignant Squamous Cell)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Spindle Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphoplasmacytic Infiltrate). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7096</td>
               <td rowspan="1">Lung Typical Carcinoid Tumor<span class="subclass"> SubClassOf </span>Low Grade Lung Neuroendocrine Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Typical Carcinoid Tumor<span class="subclass"> EquivalentTo </span>Low Grade Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Lung Carcinoid Tumor<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Necrotic Change)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Less than 2 Mitoses per 10HPF). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7097</td>
               <td rowspan="1">Lung Typical Carcinoid Tumor<span class="subclass"> SubClassOf </span>Lung Carcinoid Tumor. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Lung Typical Carcinoid Tumor<span class="subclass"> EquivalentTo </span>Low Grade Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Lung Carcinoid Tumor<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Necrotic Change)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Less than 2 Mitoses per 10HPF). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7098</td>
               <td rowspan="1">Malignant Breast Adenomyoepithelioma<span class="subclass"> SubClassOf </span>Breast Adenomyoepithelioma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Malignant Breast Adenomyoepithelioma<span class="subclass"> EquivalentTo </span>Breast Adenomyoepithelioma<br><span class="keyword"> and </span>Malignant Breast Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Myoepithelial Cell)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Breast). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7099</td>
               <td rowspan="1">Malignant Breast Adenomyoepithelioma<span class="subclass"> SubClassOf </span>Malignant Breast Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Malignant Breast Adenomyoepithelioma<span class="subclass"> EquivalentTo </span>Breast Adenomyoepithelioma<br><span class="keyword"> and </span>Malignant Breast Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Myoepithelial Cell)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Breast). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7100</td>
               <td rowspan="1">Malignant Breast Eccrine Spiradenoma<span class="subclass"> SubClassOf </span>Malignant Breast Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Malignant Breast Eccrine Spiradenoma<span class="subclass"> EquivalentTo </span>Malignant Breast Neoplasm<br><span class="keyword"> and </span>Malignant Eccrine Spiradenoma<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Breast). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7101</td>
               <td rowspan="1">Malignant Breast Eccrine Spiradenoma<span class="subclass"> SubClassOf </span>Malignant Eccrine Spiradenoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Malignant Breast Eccrine Spiradenoma<span class="subclass"> EquivalentTo </span>Malignant Breast Neoplasm<br><span class="keyword"> and </span>Malignant Eccrine Spiradenoma<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Breast). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7102</td>
               <td rowspan="1">Malignant Breast Myoepithelioma<span class="subclass"> SubClassOf </span>Breast Myoepithelial Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Malignant Breast Myoepithelioma<span class="subclass"> EquivalentTo </span>Breast Myoepithelial Neoplasm<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Malignant Myoepithelioma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mitotic Activity). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7103</td>
               <td rowspan="1">Malignant Breast Myoepithelioma<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Malignant Breast Myoepithelioma<span class="subclass"> EquivalentTo </span>Breast Myoepithelial Neoplasm<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Malignant Myoepithelioma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mitotic Activity). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7104</td>
               <td rowspan="1">Malignant Breast Myoepithelioma<span class="subclass"> SubClassOf </span>Malignant Myoepithelioma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Malignant Breast Myoepithelioma<span class="subclass"> EquivalentTo </span>Breast Myoepithelial Neoplasm<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Malignant Myoepithelioma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mitotic Activity). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7105</td>
               <td rowspan="1">Malignant Breast Neoplasm<span class="subclass"> SubClassOf </span>Breast Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Malignant Breast Neoplasm<span class="subclass"> EquivalentTo </span>Breast Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Cell). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7106</td>
               <td rowspan="1">Malignant Breast Neoplasm<span class="subclass"> SubClassOf </span>Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Cell. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Malignant Breast Neoplasm<span class="subclass"> EquivalentTo </span>Breast Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Cell). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7118</td>
               <td rowspan="1">Malignant Breast Phyllodes Tumor<span class="subclass"> SubClassOf </span>Breast Phyllodes Tumor. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Malignant Breast Phyllodes Tumor<span class="subclass"> EquivalentTo </span>Malignant Breast Neoplasm<br><span class="keyword"> and </span>Malignant Phyllodes Tumor<br><span class="keyword"> and </span>Breast Phyllodes Tumor<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cartilagenous Metaplasia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lipomatous Metaplasia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Osseous Metaplasia). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7116</td>
               <td rowspan="1">Malignant Breast Phyllodes Tumor<span class="subclass"> SubClassOf </span>Malignant Breast Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Malignant Breast Phyllodes Tumor<span class="subclass"> EquivalentTo </span>Malignant Breast Neoplasm<br><span class="keyword"> and </span>Malignant Phyllodes Tumor<br><span class="keyword"> and </span>Breast Phyllodes Tumor<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cartilagenous Metaplasia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lipomatous Metaplasia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Osseous Metaplasia). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7117</td>
               <td rowspan="1">Malignant Breast Phyllodes Tumor<span class="subclass"> SubClassOf </span>Malignant Phyllodes Tumor. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Malignant Breast Phyllodes Tumor<span class="subclass"> EquivalentTo </span>Malignant Breast Neoplasm<br><span class="keyword"> and </span>Malignant Phyllodes Tumor<br><span class="keyword"> and </span>Breast Phyllodes Tumor<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cartilagenous Metaplasia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lipomatous Metaplasia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Osseous Metaplasia). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7107</td>
               <td rowspan="1">Malignant Chest Wall Neoplasm<span class="subclass"> SubClassOf </span>Chest Wall Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Malignant Chest Wall Neoplasm<span class="subclass"> EquivalentTo </span>Chest Wall Neoplasm<br><span class="keyword"> and </span>Malignant Thoracic Neoplasm. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7108</td>
               <td rowspan="1">Malignant Chest Wall Neoplasm<span class="subclass"> SubClassOf </span>Malignant Thoracic Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Malignant Chest Wall Neoplasm<span class="subclass"> EquivalentTo </span>Chest Wall Neoplasm<br><span class="keyword"> and </span>Malignant Thoracic Neoplasm. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7109</td>
               <td rowspan="1">Malignant Lung Hilum Neoplasm<span class="subclass"> SubClassOf </span>Lung Hilum Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Malignant Lung Hilum Neoplasm<span class="subclass"> EquivalentTo </span>Lung Hilum Neoplasm<br><span class="keyword"> and </span>Malignant Lung Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Hilar Area of the Lung). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7110</td>
               <td rowspan="1">Malignant Lung Hilum Neoplasm<span class="subclass"> SubClassOf </span>Malignant Lung Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Malignant Lung Hilum Neoplasm<span class="subclass"> EquivalentTo </span>Lung Hilum Neoplasm<br><span class="keyword"> and </span>Malignant Lung Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Hilar Area of the Lung). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7111</td>
               <td rowspan="1">Malignant Lung Neoplasm<span class="subclass"> SubClassOf </span>Lung Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Malignant Lung Neoplasm<span class="subclass"> EquivalentTo </span>Lung Neoplasm<br><span class="keyword"> and </span>Malignant Respiratory Tract Neoplasm<br><span class="keyword"> and </span>Malignant Thoracic Neoplasm. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7112</td>
               <td rowspan="1">Malignant Lung Neoplasm<span class="subclass"> SubClassOf </span>Malignant Respiratory Tract Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Malignant Lung Neoplasm<span class="subclass"> EquivalentTo </span>Lung Neoplasm<br><span class="keyword"> and </span>Malignant Respiratory Tract Neoplasm<br><span class="keyword"> and </span>Malignant Thoracic Neoplasm. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7113</td>
               <td rowspan="1">Malignant Lung Neoplasm<span class="subclass"> SubClassOf </span>Malignant Thoracic Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Malignant Lung Neoplasm<span class="subclass"> EquivalentTo </span>Lung Neoplasm<br><span class="keyword"> and </span>Malignant Respiratory Tract Neoplasm<br><span class="keyword"> and </span>Malignant Thoracic Neoplasm. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7114</td>
               <td rowspan="1">Malignant Nipple Neoplasm<span class="subclass"> SubClassOf </span>Malignant Breast Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Malignant Nipple Neoplasm<span class="subclass"> EquivalentTo </span>Malignant Breast Neoplasm<br><span class="keyword"> and </span>Nipple Neoplasm. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7115</td>
               <td rowspan="1">Malignant Nipple Neoplasm<span class="subclass"> SubClassOf </span>Nipple Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Malignant Nipple Neoplasm<span class="subclass"> EquivalentTo </span>Malignant Breast Neoplasm<br><span class="keyword"> and </span>Nipple Neoplasm. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7119</td>
               <td rowspan="1">Malignant Respiratory Tract Neoplasm<span class="subclass"> SubClassOf </span>Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Cell. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Malignant Respiratory Tract Neoplasm<span class="subclass"> EquivalentTo </span>Respiratory Tract Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Cell). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7120</td>
               <td rowspan="1">Malignant Respiratory Tract Neoplasm<span class="subclass"> SubClassOf </span>Respiratory Tract Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Malignant Respiratory Tract Neoplasm<span class="subclass"> EquivalentTo </span>Respiratory Tract Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Cell). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7121</td>
               <td rowspan="1">Malignant Superior Sulcus Neoplasm<span class="subclass"> SubClassOf </span>Malignant Lung Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Malignant Superior Sulcus Neoplasm<span class="subclass"> EquivalentTo </span>Malignant Lung Neoplasm<br><span class="keyword"> and </span>Pulmonary Sulcus Neoplasm<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Pancoast Syndrome)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Lung Tissue)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Apex of the Lung). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7122</td>
               <td rowspan="1">Malignant Superior Sulcus Neoplasm<span class="subclass"> SubClassOf </span>Pulmonary Sulcus Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Malignant Superior Sulcus Neoplasm<span class="subclass"> EquivalentTo </span>Malignant Lung Neoplasm<br><span class="keyword"> and </span>Pulmonary Sulcus Neoplasm<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Pancoast Syndrome)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Lung Tissue)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Apex of the Lung). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7123</td>
               <td rowspan="1">Malignant Tracheal Neoplasm<span class="subclass"> SubClassOf </span>Malignant Respiratory Tract Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Malignant Tracheal Neoplasm<span class="subclass"> EquivalentTo </span>Malignant Respiratory Tract Neoplasm<br><span class="keyword"> and </span>Tracheal Neoplasm. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7124</td>
               <td rowspan="1">Malignant Tracheal Neoplasm<span class="subclass"> SubClassOf </span>Tracheal Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Malignant Tracheal Neoplasm<span class="subclass"> EquivalentTo </span>Malignant Respiratory Tract Neoplasm<br><span class="keyword"> and </span>Tracheal Neoplasm. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7125</td>
               <td rowspan="1">Medullary Breast Carcinoma<span class="subclass"> SubClassOf </span>Breast Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Medullary Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Medullary Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 12p)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Glandular Pattern)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Round Adenocarcinoma Cell with Abundant Cytoplasm<br><span class="keyword"> and </span>Vesicular Nucleus)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>High Mitotic Activity)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphoplasmacytic Infiltrate)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Syncytial Pattern). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7126</td>
               <td rowspan="1">Medullary Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 10p. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Medullary Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Medullary Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 12p)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Glandular Pattern)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Round Adenocarcinoma Cell with Abundant Cytoplasm<br><span class="keyword"> and </span>Vesicular Nucleus)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>High Mitotic Activity)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphoplasmacytic Infiltrate)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Syncytial Pattern). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7127</td>
               <td rowspan="1">Medullary Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 12p. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Medullary Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Medullary Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 12p)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Glandular Pattern)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Round Adenocarcinoma Cell with Abundant Cytoplasm<br><span class="keyword"> and </span>Vesicular Nucleus)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>High Mitotic Activity)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphoplasmacytic Infiltrate)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Syncytial Pattern). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7128</td>
               <td rowspan="1">Medullary Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Medullary Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Medullary Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 12p)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Glandular Pattern)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Round Adenocarcinoma Cell with Abundant Cytoplasm<br><span class="keyword"> and </span>Vesicular Nucleus)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>High Mitotic Activity)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphoplasmacytic Infiltrate)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Syncytial Pattern). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7129</td>
               <td rowspan="1">Medullary Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Medullary Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Medullary Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 12p)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Glandular Pattern)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Round Adenocarcinoma Cell with Abundant Cytoplasm<br><span class="keyword"> and </span>Vesicular Nucleus)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>High Mitotic Activity)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphoplasmacytic Infiltrate)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Syncytial Pattern). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7130</td>
               <td rowspan="1">Medullary Breast Carcinoma<span class="subclass"> SubClassOf </span>Medullary Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Medullary Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Medullary Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 12p)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Glandular Pattern)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Round Adenocarcinoma Cell with Abundant Cytoplasm<br><span class="keyword"> and </span>Vesicular Nucleus)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>High Mitotic Activity)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphoplasmacytic Infiltrate)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Syncytial Pattern). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7131</td>
               <td rowspan="1">Metaplastic Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Metaplastic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Metaplastic Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7132</td>
               <td rowspan="1">Metaplastic Carcinoma<span class="subclass"> SubClassOf </span>Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Metaplastic Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Metaplasia). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7133</td>
               <td rowspan="1">Metastatic Breast Carcinoid Tumor<span class="subclass"> SubClassOf </span>Carcinoid Tumor of the Breast. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Metastatic Breast Carcinoid Tumor<span class="subclass"> EquivalentTo </span>Carcinoid Tumor of the Breast<br><span class="keyword"> and </span>Metastatic Carcinoid Tumor. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7134</td>
               <td rowspan="1">Metastatic Breast Carcinoid Tumor<span class="subclass"> SubClassOf </span>Metastatic Carcinoid Tumor. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Metastatic Breast Carcinoid Tumor<span class="subclass"> EquivalentTo </span>Carcinoid Tumor of the Breast<br><span class="keyword"> and </span>Metastatic Carcinoid Tumor. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7135</td>
               <td rowspan="1">Metastatic Signet Ring Cell Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Metastatic Lesion. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Metastatic Signet Ring Cell Breast Carcinoma<span class="subclass"> EquivalentTo </span>Signet Ring Cell Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Metastatic Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7136</td>
               <td rowspan="1">Metastatic Signet Ring Cell Breast Carcinoma<span class="subclass"> SubClassOf </span>Signet Ring Cell Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Metastatic Signet Ring Cell Breast Carcinoma<span class="subclass"> EquivalentTo </span>Signet Ring Cell Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Metastatic Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7137</td>
               <td rowspan="1">Microinvasive Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Microinvasive Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Microinvasive Malignant Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Ductal Breast Carcinoma in Situ). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7138</td>
               <td rowspan="1">Microinvasive Breast Carcinoma<span class="subclass"> SubClassOf </span>Microinvasive Malignant Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Microinvasive Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Microinvasive Malignant Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Ductal Breast Carcinoma in Situ). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7139</td>
               <td rowspan="1">Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma<span class="subclass"> SubClassOf </span>Metaplastic Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Metaplastic Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mesenchymal Metaplasia). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7140</td>
               <td rowspan="1">Mixed Lobular<br><span class="keyword"> and </span>Ductal Breast Carcinoma<span class="subclass"> SubClassOf </span>Breast Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Mixed Lobular<br><span class="keyword"> and </span>Ductal Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CDH1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Loss of E-cadherin Expression)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Ductal Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Lobular Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Ductal Breast Carcinoma)<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Lobular Breast Carcinoma)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mixed Cellular Population)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7141</td>
               <td rowspan="1">Mixed Lobular<br><span class="keyword"> and </span>Ductal Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Abnormal_Cell<span class="some"> only </span>Ductal Carcinoma Cell. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Mixed Lobular<br><span class="keyword"> and </span>Ductal Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CDH1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Loss of E-cadherin Expression)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Ductal Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Lobular Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Ductal Breast Carcinoma)<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Lobular Breast Carcinoma)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mixed Cellular Population)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7142</td>
               <td rowspan="1">Mixed Lobular<br><span class="keyword"> and </span>Ductal Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Abnormal_Cell<span class="some"> only </span>Lobular Carcinoma Cell. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Mixed Lobular<br><span class="keyword"> and </span>Ductal Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CDH1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Loss of E-cadherin Expression)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Ductal Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Lobular Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Ductal Breast Carcinoma)<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Lobular Breast Carcinoma)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mixed Cellular Population)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7143</td>
               <td rowspan="1">Mixed Lobular<br><span class="keyword"> and </span>Ductal Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Mixed Lobular<br><span class="keyword"> and </span>Ductal Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CDH1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Loss of E-cadherin Expression)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Ductal Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Lobular Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Ductal Breast Carcinoma)<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Lobular Breast Carcinoma)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mixed Cellular Population)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7144</td>
               <td rowspan="1">Mixed Lobular<br><span class="keyword"> and </span>Ductal Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CDH1 Gene Inactivation. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Mixed Lobular<br><span class="keyword"> and </span>Ductal Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CDH1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Loss of E-cadherin Expression)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Ductal Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Lobular Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Ductal Breast Carcinoma)<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Lobular Breast Carcinoma)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mixed Cellular Population)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7145</td>
               <td rowspan="1">Mixed Lobular<br><span class="keyword"> and </span>Ductal Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Loss of E-cadherin Expression. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Mixed Lobular<br><span class="keyword"> and </span>Ductal Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CDH1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Loss of E-cadherin Expression)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Ductal Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Lobular Carcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Ductal Breast Carcinoma)<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Lobular Breast Carcinoma)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mixed Cellular Population)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Terminal Ductal Lobular Unit). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7146</td>
               <td rowspan="1">Mixed Mucinous<br><span class="keyword"> and </span>Non-Mucinous Bronchioloalveolar Carcinoma<span class="subclass"> SubClassOf </span>Bronchioloalveolar Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Mixed Mucinous<br><span class="keyword"> and </span>Non-Mucinous Bronchioloalveolar Carcinoma<span class="subclass"> EquivalentTo </span>Bronchioloalveolar Carcinoma<br><span class="keyword"> and </span>Mucin-Producing Adenocarcinoma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Mucin-Producing Tall Columnar Adenocarcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Clara Cell Differentiation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Type II Cell Differentiation). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7148</td>
               <td rowspan="1">Mucinous Breast Carcinoma<span class="subclass"> SubClassOf </span>Breast Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Mucinous Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Mucinous Adenocarcinoma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Round Adenocarcinoma Cell). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7149</td>
               <td rowspan="1">Mucinous Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Mucinous Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Mucinous Adenocarcinoma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Round Adenocarcinoma Cell). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7150</td>
               <td rowspan="1">Mucinous Breast Carcinoma<span class="subclass"> SubClassOf </span>Mucinous Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Mucinous Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Mucinous Adenocarcinoma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Round Adenocarcinoma Cell). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7151</td>
               <td rowspan="1">Mucinous Bronchioloalveolar Carcinoma<span class="subclass"> SubClassOf </span>Bronchioloalveolar Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Mucinous Bronchioloalveolar Carcinoma<span class="subclass"> EquivalentTo </span>Bronchioloalveolar Carcinoma<br><span class="keyword"> and </span>Mucin-Producing Adenocarcinoma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Mucin-Producing Tall Columnar Adenocarcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mucoid Stroma Formation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Well Differentiated Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7152</td>
               <td rowspan="1">Nipple Duct Carcinoma<span class="subclass"> SubClassOf </span>Nipple Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Nipple Duct Carcinoma<span class="subclass"> EquivalentTo </span>Nipple Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Lactiferous Duct). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7153</td>
               <td rowspan="1">Non-Mucinous Bronchioloalveolar Carcinoma<span class="subclass"> SubClassOf </span>Bronchioloalveolar Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Non-Mucinous Bronchioloalveolar Carcinoma<span class="subclass"> EquivalentTo </span>Bronchioloalveolar Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Clara Cell Differentiation)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Moderately Differentiated Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Type II Cell Differentiation)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Well Differentiated Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7154</td>
               <td rowspan="1">Non-Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Common Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Non-Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Common Carcinoma<br><span class="keyword"> and </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Small Cell). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7155</td>
               <td rowspan="1">Non-Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_Excludes_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Small Cell. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Non-Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Common Carcinoma<br><span class="keyword"> and </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Small Cell). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7156</td>
               <td rowspan="1">Non-Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Non-Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Common Carcinoma<br><span class="keyword"> and </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Small Cell). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7157</td>
               <td rowspan="1">Non-Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Non-Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Common Carcinoma<br><span class="keyword"> and </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Small Cell). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7158</td>
               <td rowspan="1">Occult Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Large Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Occult Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Large Cell Lung Carcinoma<br><span class="keyword"> and </span>Occult Non-Small Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7159</td>
               <td rowspan="1">Occult Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Occult Non-Small Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Occult Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Large Cell Lung Carcinoma<br><span class="keyword"> and </span>Occult Non-Small Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7160</td>
               <td rowspan="1">Occult Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Lung Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Occult Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>Occult Non-Small Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7161</td>
               <td rowspan="1">Occult Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Occult Non-Small Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Occult Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>Occult Non-Small Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7162</td>
               <td rowspan="1">Occult Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_Excludes_Finding<span class="some"> only </span>No Evidence of Radiologic Finding. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Occult Lung Carcinoma<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>No Evidence of Radiologic Finding). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7163</td>
               <td rowspan="1">Occult Lung Carcinoma<span class="subclass"> SubClassOf </span>Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Occult Lung Carcinoma<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>No Evidence of Radiologic Finding). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7164</td>
               <td rowspan="1">Occult Non-Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Non-Small Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Occult Non-Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Occult Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7165</td>
               <td rowspan="1">Occult Non-Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Occult Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Occult Non-Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Occult Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7166</td>
               <td rowspan="1">Occult Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Occult Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Occult Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Occult Lung Carcinoma<br><span class="keyword"> and </span>Small Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7167</td>
               <td rowspan="1">Occult Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Small Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Occult Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Occult Lung Carcinoma<br><span class="keyword"> and </span>Small Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7168</td>
               <td rowspan="1">Oncocytic Breast Carcinoma<span class="subclass"> SubClassOf </span>Breast Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Oncocytic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Oxyphilic Adenocarcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7169</td>
               <td rowspan="1">Oncocytic Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Oncocytic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Oxyphilic Adenocarcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7170</td>
               <td rowspan="1">Paget's Disease<br><span class="keyword"> and </span>Intraductal Carcinoma of the Breast<span class="subclass"> SubClassOf </span>Paget's Disease of the Breast without Invasive Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Paget's Disease<br><span class="keyword"> and </span>Intraductal Carcinoma of the Breast<span class="subclass"> EquivalentTo </span>Paget's Disease of the Breast without Invasive Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Ductal Breast Carcinoma in Situ). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7171</td>
               <td rowspan="1">Paget's Disease of the Breast<span class="subclass"> SubClassOf </span>Breast Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Paget's Disease of the Breast<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Paget's Disease<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Eczema)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Erythema). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7172</td>
               <td rowspan="1">Paget's Disease of the Breast<span class="subclass"> SubClassOf </span>Paget's Disease. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Paget's Disease of the Breast<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Paget's Disease<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Eczema)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Erythema). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7173</td>
               <td rowspan="1">Paget's Disease of the Breast with Invasive Ductal Carcinoma<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Paget's Disease of the Breast with Invasive Ductal Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Paget's Disease of the Breast<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Invasive Ductal Carcinoma, Not Otherwise Specified)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Invasive Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7174</td>
               <td rowspan="1">Paget's Disease of the Breast with Invasive Ductal Carcinoma<span class="subclass"> SubClassOf </span>Paget's Disease of the Breast. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Paget's Disease of the Breast with Invasive Ductal Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Paget's Disease of the Breast<br><span class="keyword"> and </span>(Disease_Has_Associated_Disease<span class="some"> only </span>Invasive Ductal Carcinoma, Not Otherwise Specified)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Invasive Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7175</td>
               <td rowspan="1">Paget's Disease of the Breast without Invasive Carcinoma<span class="subclass"> SubClassOf </span>Paget's Disease of the Breast. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Paget's Disease of the Breast without Invasive Carcinoma<span class="subclass"> EquivalentTo </span>Paget's Disease of the Breast<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Invasive Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7176</td>
               <td rowspan="1">Paget's Disease of the Nipple<span class="subclass"> SubClassOf </span>Nipple Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Paget's Disease of the Nipple<span class="subclass"> EquivalentTo </span>Nipple Carcinoma<br><span class="keyword"> and </span>Paget's Disease of the Breast. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7177</td>
               <td rowspan="1">Paget's Disease of the Nipple<span class="subclass"> SubClassOf </span>Paget's Disease of the Breast. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Paget's Disease of the Nipple<span class="subclass"> EquivalentTo </span>Nipple Carcinoma<br><span class="keyword"> and </span>Paget's Disease of the Breast. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7178</td>
               <td rowspan="1">Papillary Breast Carcinoma<span class="subclass"> SubClassOf </span>Breast Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Papillary Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Papillary Adenocarcinoma<br><span class="keyword"> and </span>Papillary Breast Neoplasm. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7179</td>
               <td rowspan="1">Papillary Breast Carcinoma<span class="subclass"> SubClassOf </span>Papillary Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Papillary Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Papillary Adenocarcinoma<br><span class="keyword"> and </span>Papillary Breast Neoplasm. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7180</td>
               <td rowspan="1">Papillary Breast Carcinoma<span class="subclass"> SubClassOf </span>Papillary Breast Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Papillary Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Papillary Adenocarcinoma<br><span class="keyword"> and </span>Papillary Breast Neoplasm. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7181</td>
               <td rowspan="1">Papillary Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Lung Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Papillary Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>Papillary Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7182</td>
               <td rowspan="1">Papillary Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Papillary Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Papillary Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>Papillary Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7183</td>
               <td rowspan="1">Pleomorphic Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Aneuploidy. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Pleomorphic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Grade 3 Invasive Breast Carcinoma<br><span class="keyword"> and </span>Invasive Ductal Carcinoma, Not Otherwise Specified<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Aneuploidy)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Giant Adenocarcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Pleomorphic Adenocarcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>High Mitotic Activity)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Necrotic Change). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7184</td>
               <td rowspan="1">Pleomorphic Breast Carcinoma<span class="subclass"> SubClassOf </span>Grade 3 Invasive Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Pleomorphic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Grade 3 Invasive Breast Carcinoma<br><span class="keyword"> and </span>Invasive Ductal Carcinoma, Not Otherwise Specified<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Aneuploidy)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Giant Adenocarcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Pleomorphic Adenocarcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>High Mitotic Activity)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Necrotic Change). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7185</td>
               <td rowspan="1">Pleomorphic Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Ductal Carcinoma, Not Otherwise Specified. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Pleomorphic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Grade 3 Invasive Breast Carcinoma<br><span class="keyword"> and </span>Invasive Ductal Carcinoma, Not Otherwise Specified<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Aneuploidy)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Giant Adenocarcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Pleomorphic Adenocarcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>High Mitotic Activity)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Necrotic Change). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7186</td>
               <td rowspan="1">Pleomorphic Carcinoma<span class="subclass"> SubClassOf </span>Sarcomatoid Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Pleomorphic Carcinoma<span class="subclass"> EquivalentTo </span>Sarcomatoid Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Spindle Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Nuclear Pleomorphism). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7187</td>
               <td rowspan="1">Pleuropulmonary Blastoma<span class="subclass"> SubClassOf </span>Blastoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Pleuropulmonary Blastoma<span class="subclass"> EquivalentTo </span>Blastoma<br><span class="keyword"> and </span>Malignant Lung<br><span class="keyword"> and </span>Pleural Neoplasm<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Colon Polyp)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Cystic Nephroma)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Ovarian Teratoma)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Chest Pain)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pneumothorax)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Respiratory Distress)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Thoracic Cavity). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7188</td>
               <td rowspan="1">Pleuropulmonary Blastoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Associated_Disease<span class="some"> some </span>Colon Polyp. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Pleuropulmonary Blastoma<span class="subclass"> EquivalentTo </span>Blastoma<br><span class="keyword"> and </span>Malignant Lung<br><span class="keyword"> and </span>Pleural Neoplasm<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Colon Polyp)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Cystic Nephroma)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Ovarian Teratoma)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Chest Pain)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pneumothorax)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Respiratory Distress)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Thoracic Cavity). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7189</td>
               <td rowspan="1">Pleuropulmonary Blastoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Associated_Disease<span class="some"> some </span>Cystic Nephroma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Pleuropulmonary Blastoma<span class="subclass"> EquivalentTo </span>Blastoma<br><span class="keyword"> and </span>Malignant Lung<br><span class="keyword"> and </span>Pleural Neoplasm<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Colon Polyp)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Cystic Nephroma)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Ovarian Teratoma)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Chest Pain)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pneumothorax)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Respiratory Distress)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Thoracic Cavity). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7190</td>
               <td rowspan="1">Pleuropulmonary Blastoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Associated_Disease<span class="some"> some </span>Ovarian Teratoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Pleuropulmonary Blastoma<span class="subclass"> EquivalentTo </span>Blastoma<br><span class="keyword"> and </span>Malignant Lung<br><span class="keyword"> and </span>Pleural Neoplasm<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Colon Polyp)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Cystic Nephroma)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Ovarian Teratoma)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Chest Pain)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pneumothorax)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Respiratory Distress)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Thoracic Cavity). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7191</td>
               <td rowspan="1">Pleuropulmonary Blastoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Pleuropulmonary Blastoma<span class="subclass"> EquivalentTo </span>Blastoma<br><span class="keyword"> and </span>Malignant Lung<br><span class="keyword"> and </span>Pleural Neoplasm<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Colon Polyp)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Cystic Nephroma)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Ovarian Teratoma)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Chest Pain)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pneumothorax)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Respiratory Distress)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Thoracic Cavity). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7192</td>
               <td rowspan="1">Pleuropulmonary Blastoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Pleuropulmonary Blastoma<span class="subclass"> EquivalentTo </span>Blastoma<br><span class="keyword"> and </span>Malignant Lung<br><span class="keyword"> and </span>Pleural Neoplasm<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Colon Polyp)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Cystic Nephroma)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Ovarian Teratoma)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Chest Pain)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pneumothorax)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Respiratory Distress)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Thoracic Cavity). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7193</td>
               <td rowspan="1">Pleuropulmonary Blastoma<span class="subclass"> SubClassOf </span>Malignant Lung<br><span class="keyword"> and </span>Pleural Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Pleuropulmonary Blastoma<span class="subclass"> EquivalentTo </span>Blastoma<br><span class="keyword"> and </span>Malignant Lung<br><span class="keyword"> and </span>Pleural Neoplasm<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Colon Polyp)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Cystic Nephroma)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Ovarian Teratoma)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Chest Pain)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pneumothorax)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Respiratory Distress)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Thoracic Cavity). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7194</td>
               <td rowspan="1">Primary Breast Carcinoid Tumor<span class="subclass"> SubClassOf </span>Carcinoid Tumor of the Breast. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Primary Breast Carcinoid Tumor<span class="subclass"> EquivalentTo </span>Carcinoid Tumor of the Breast<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Primary Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7195</td>
               <td rowspan="1">Primary Carcinoma<span class="subclass"> SubClassOf </span>Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Primary Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Primary Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7196</td>
               <td rowspan="1">Primary Carcinoma Unspecified Site<span class="subclass"> SubClassOf </span>Primary Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Primary Carcinoma Unspecified Site<span class="subclass"> EquivalentTo </span>Primary Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Primary Site Unspecified). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7197</td>
               <td rowspan="1">Primary Peritoneal Carcinoma<span class="subclass"> SubClassOf </span>Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Primary Peritoneal Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>Malignant Peritoneal Neoplasm<br><span class="keyword"> and </span>Primary Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRCA1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>c-erbB2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Primary_Anatomic_Site<span class="some"> only </span>Ovary)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Peritoneum). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7198</td>
               <td rowspan="1">Primary Peritoneal Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Peritoneum. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Primary Peritoneal Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>Malignant Peritoneal Neoplasm<br><span class="keyword"> and </span>Primary Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRCA1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>c-erbB2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Primary_Anatomic_Site<span class="some"> only </span>Ovary)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Peritoneum). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7199</td>
               <td rowspan="1">Primary Peritoneal Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Primary Peritoneal Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>Malignant Peritoneal Neoplasm<br><span class="keyword"> and </span>Primary Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRCA1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>c-erbB2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Primary_Anatomic_Site<span class="some"> only </span>Ovary)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Peritoneum). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7201</td>
               <td rowspan="1">Primary Peritoneal Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Primary Peritoneal Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>Malignant Peritoneal Neoplasm<br><span class="keyword"> and </span>Primary Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRCA1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>c-erbB2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Primary_Anatomic_Site<span class="some"> only </span>Ovary)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Peritoneum). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7200</td>
               <td rowspan="1">Primary Peritoneal Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>c-erbB2 Gene Amplification. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Primary Peritoneal Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>Malignant Peritoneal Neoplasm<br><span class="keyword"> and </span>Primary Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRCA1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>c-erbB2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Primary_Anatomic_Site<span class="some"> only </span>Ovary)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Peritoneum). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7202</td>
               <td rowspan="1">Primary Peritoneal Carcinoma<span class="subclass"> SubClassOf </span>Malignant Peritoneal Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Primary Peritoneal Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>Malignant Peritoneal Neoplasm<br><span class="keyword"> and </span>Primary Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BRCA1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>c-erbB2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Primary_Anatomic_Site<span class="some"> only </span>Ovary)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Peritoneum). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7203</td>
               <td rowspan="1">Primary Peritoneal Serous Adenocarcinoma<span class="subclass"> SubClassOf </span>Primary Peritoneal Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Primary Peritoneal Serous Adenocarcinoma<span class="subclass"> EquivalentTo </span>Primary Peritoneal Carcinoma<br><span class="keyword"> and </span>Serous Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Psammoma Body Formation). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7204</td>
               <td rowspan="1">Primary Serous Papillary Carcinoma of Peritoneum<span class="subclass"> SubClassOf </span>Serous Surface Papillary Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Primary Serous Papillary Carcinoma of Peritoneum<span class="subclass"> EquivalentTo </span>Primary Peritoneal Serous Adenocarcinoma<br><span class="keyword"> and </span>Serous Surface Papillary Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Papillary Pattern). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7205</td>
               <td rowspan="1">Pulmonary Blastoma<span class="subclass"> SubClassOf </span>Blastoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Pulmonary Blastoma<span class="subclass"> EquivalentTo </span>Blastoma<br><span class="keyword"> and </span>Lung Sarcomatoid Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CTNNB1 Gene Mutation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Tubular Structures of Glycogen-Rich Non-Ciliated Cells Present). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7206</td>
               <td rowspan="1">Pulmonary Blastoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CTNNB1 Gene Mutation. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Pulmonary Blastoma<span class="subclass"> EquivalentTo </span>Blastoma<br><span class="keyword"> and </span>Lung Sarcomatoid Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CTNNB1 Gene Mutation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Tubular Structures of Glycogen-Rich Non-Ciliated Cells Present). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7207</td>
               <td rowspan="1">Pulmonary Blastoma<span class="subclass"> SubClassOf </span>Lung Sarcomatoid Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Pulmonary Blastoma<span class="subclass"> EquivalentTo </span>Blastoma<br><span class="keyword"> and </span>Lung Sarcomatoid Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CTNNB1 Gene Mutation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Tubular Structures of Glycogen-Rich Non-Ciliated Cells Present). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7208</td>
               <td rowspan="1">Pulmonary Sulcus Neoplasm<span class="subclass"> SubClassOf </span>Lung Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Pulmonary Sulcus Neoplasm<span class="subclass"> EquivalentTo </span>Lung Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Associated_Anatomic_Site<span class="some"> only </span>Apex of the Lung). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7209</td>
               <td rowspan="1">Recurrent Breast Cancer<span class="subclass"> SubClassOf </span>Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Recurrent Breast Cancer<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>Recurrent Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7210</td>
               <td rowspan="1">Recurrent Breast Cancer<span class="subclass"> SubClassOf </span>Recurrent Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Recurrent Breast Cancer<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>Recurrent Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7211</td>
               <td rowspan="1">Recurrent Inflammatory Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Recurrent Disease. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Recurrent Inflammatory Breast Carcinoma<span class="subclass"> EquivalentTo </span>Inflammatory Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Recurrent Disease). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7212</td>
               <td rowspan="1">Recurrent Inflammatory Breast Carcinoma<span class="subclass"> SubClassOf </span>Inflammatory Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Recurrent Inflammatory Breast Carcinoma<span class="subclass"> EquivalentTo </span>Inflammatory Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Recurrent Disease). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7213</td>
               <td rowspan="1">Recurrent Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Recurrent Non-Small Cell Lung Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Recurrent Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Large Cell Lung Carcinoma<br><span class="keyword"> and </span>Recurrent Non-Small Cell Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7214</td>
               <td rowspan="1">Recurrent Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Lung Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Recurrent Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>Recurrent Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7215</td>
               <td rowspan="1">Recurrent Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Recurrent Non-Small Cell Lung Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Recurrent Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>Recurrent Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7216</td>
               <td rowspan="1">Recurrent Lung Cancer<span class="subclass"> SubClassOf </span>Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Recurrent Lung Cancer<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>Recurrent Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7217</td>
               <td rowspan="1">Recurrent Lung Cancer<span class="subclass"> SubClassOf </span>Recurrent Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Recurrent Lung Cancer<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>Recurrent Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7218</td>
               <td rowspan="1">Recurrent Non-Small Cell Lung Cancer<span class="subclass"> SubClassOf </span>Non-Small Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Recurrent Non-Small Cell Lung Cancer<span class="subclass"> EquivalentTo </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Recurrent Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7219</td>
               <td rowspan="1">Recurrent Non-Small Cell Lung Cancer<span class="subclass"> SubClassOf </span>Recurrent Lung Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Recurrent Non-Small Cell Lung Cancer<span class="subclass"> EquivalentTo </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Recurrent Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7220</td>
               <td rowspan="1">Recurrent Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Recurrent Lung Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Recurrent Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Recurrent Lung Cancer<br><span class="keyword"> and </span>Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Coin Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hoarseness). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7221</td>
               <td rowspan="1">Recurrent Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Small Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Recurrent Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Recurrent Lung Cancer<br><span class="keyword"> and </span>Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Coin Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hoarseness). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7222</td>
               <td rowspan="1">Scirrhous Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Scirrhous Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Ductal Carcinoma, Not Otherwise Specified<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Fibrotic Stroma Formation). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Invasive Ductal Carcinoma, Not Otherwise Specified<span class="subclass"> EquivalentTo </span>Ductal Breast Carcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>der(1;16)(q10;p10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(1)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(8)(q10))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cord-Like Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Solid Growth Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Syncytial Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Trabecular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin E Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR1 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FGFR2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>KRAS2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Gain of Chromosome 12p). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7223</td>
               <td rowspan="1">Sebaceous Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Sebaceous Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Sebaceous Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7224</td>
               <td rowspan="1">Secretory Breast Carcinoma<span class="subclass"> SubClassOf </span>Breast Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Secretory Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(12;15)(p13;q26))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ETV6-NTRK3 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Adenocarcinoma Cell with Abundant Pale Staining Cytoplasm)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Compact Pattern)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Intracytoplasmic<br><span class="keyword"> and </span>Extracytoplasmic Eosinophilic Material Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Honeycombed Pattern)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Tubular Pattern)<br><span class="keyword"> and </span>(Disease_Is_Grade<span class="some"> only </span>Low Grade). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7225</td>
               <td rowspan="1">Secretory Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(12;15)(p13;q26). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Secretory Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(12;15)(p13;q26))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ETV6-NTRK3 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Adenocarcinoma Cell with Abundant Pale Staining Cytoplasm)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Compact Pattern)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Intracytoplasmic<br><span class="keyword"> and </span>Extracytoplasmic Eosinophilic Material Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Honeycombed Pattern)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Tubular Pattern)<br><span class="keyword"> and </span>(Disease_Is_Grade<span class="some"> only </span>Low Grade). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7226</td>
               <td rowspan="1">Secretory Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ETV6-NTRK3 Fusion Protein Expression. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Secretory Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(12;15)(p13;q26))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ETV6-NTRK3 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Adenocarcinoma Cell with Abundant Pale Staining Cytoplasm)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Compact Pattern)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Intracytoplasmic<br><span class="keyword"> and </span>Extracytoplasmic Eosinophilic Material Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Honeycombed Pattern)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Tubular Pattern)<br><span class="keyword"> and </span>(Disease_Is_Grade<span class="some"> only </span>Low Grade). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7227</td>
               <td rowspan="1">Secretory Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Secretory Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(12;15)(p13;q26))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ETV6-NTRK3 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Adenocarcinoma Cell with Abundant Pale Staining Cytoplasm)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Compact Pattern)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Intracytoplasmic<br><span class="keyword"> and </span>Extracytoplasmic Eosinophilic Material Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Honeycombed Pattern)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Tubular Pattern)<br><span class="keyword"> and </span>(Disease_Is_Grade<span class="some"> only </span>Low Grade). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7228</td>
               <td rowspan="1">Signet Ring Cell Breast Carcinoma<span class="subclass"> SubClassOf </span>Breast Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Signet Ring Cell Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Signet Ring Cell Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7229</td>
               <td rowspan="1">Signet Ring Cell Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Signet Ring Cell Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Signet Ring Cell Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7230</td>
               <td rowspan="1">Signet Ring Cell Breast Carcinoma<span class="subclass"> SubClassOf </span>Signet Ring Cell Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Signet Ring Cell Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Signet Ring Cell Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7231</td>
               <td rowspan="1">Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>High Grade Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Lung Carcinoma<br><span class="keyword"> and </span>Small Cell Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Paraneoplastic Syndrome)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 18q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 5q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>C-KIT Tyrosine Kinase Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NMYC Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>More than 10 Mitoses per 10HPF)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchus). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7232</td>
               <td rowspan="1">Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>High Grade Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Lung Carcinoma<br><span class="keyword"> and </span>Small Cell Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Paraneoplastic Syndrome)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 18q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 5q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>C-KIT Tyrosine Kinase Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NMYC Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>More than 10 Mitoses per 10HPF)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchus). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7233</td>
               <td rowspan="1">Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>High Grade Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Lung Carcinoma<br><span class="keyword"> and </span>Small Cell Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Paraneoplastic Syndrome)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 18q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 5q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>C-KIT Tyrosine Kinase Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NMYC Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>More than 10 Mitoses per 10HPF)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchus). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7234</td>
               <td rowspan="1">Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>High Grade Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Lung Carcinoma<br><span class="keyword"> and </span>Small Cell Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Paraneoplastic Syndrome)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 18q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 5q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>C-KIT Tyrosine Kinase Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NMYC Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>More than 10 Mitoses per 10HPF)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchus). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7235</td>
               <td rowspan="1">Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>High Grade Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Lung Carcinoma<br><span class="keyword"> and </span>Small Cell Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Paraneoplastic Syndrome)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 18q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 5q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>C-KIT Tyrosine Kinase Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NMYC Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>More than 10 Mitoses per 10HPF)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchus). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7236</td>
               <td rowspan="1">Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>High Grade Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Lung Carcinoma<br><span class="keyword"> and </span>Small Cell Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Paraneoplastic Syndrome)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 18q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 5q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>C-KIT Tyrosine Kinase Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NMYC Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>More than 10 Mitoses per 10HPF)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchus). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7237</td>
               <td rowspan="1">Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>High Grade Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Lung Carcinoma<br><span class="keyword"> and </span>Small Cell Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Paraneoplastic Syndrome)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 18q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 5q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>C-KIT Tyrosine Kinase Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NMYC Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>More than 10 Mitoses per 10HPF)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchus). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7238</td>
               <td rowspan="1">Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10q. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>High Grade Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Lung Carcinoma<br><span class="keyword"> and </span>Small Cell Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Paraneoplastic Syndrome)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 18q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 5q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>C-KIT Tyrosine Kinase Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NMYC Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>More than 10 Mitoses per 10HPF)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchus). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7239</td>
               <td rowspan="1">Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>High Grade Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Lung Carcinoma<br><span class="keyword"> and </span>Small Cell Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Paraneoplastic Syndrome)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 18q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 5q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>C-KIT Tyrosine Kinase Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NMYC Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>More than 10 Mitoses per 10HPF)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchus). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7240</td>
               <td rowspan="1">Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 18q. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>High Grade Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Lung Carcinoma<br><span class="keyword"> and </span>Small Cell Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Paraneoplastic Syndrome)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 18q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 5q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>C-KIT Tyrosine Kinase Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NMYC Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>More than 10 Mitoses per 10HPF)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchus). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7241</td>
               <td rowspan="1">Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>High Grade Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Lung Carcinoma<br><span class="keyword"> and </span>Small Cell Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Paraneoplastic Syndrome)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 18q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 5q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>C-KIT Tyrosine Kinase Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NMYC Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>More than 10 Mitoses per 10HPF)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchus). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7242</td>
               <td rowspan="1">Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>High Grade Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Lung Carcinoma<br><span class="keyword"> and </span>Small Cell Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Paraneoplastic Syndrome)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 18q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 5q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>C-KIT Tyrosine Kinase Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NMYC Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>More than 10 Mitoses per 10HPF)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchus). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7243</td>
               <td rowspan="1">Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 5q. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>High Grade Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Lung Carcinoma<br><span class="keyword"> and </span>Small Cell Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Paraneoplastic Syndrome)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 18q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 5q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>C-KIT Tyrosine Kinase Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NMYC Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>More than 10 Mitoses per 10HPF)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchus). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7244</td>
               <td rowspan="1">Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>High Grade Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Lung Carcinoma<br><span class="keyword"> and </span>Small Cell Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Paraneoplastic Syndrome)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 18q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 5q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>C-KIT Tyrosine Kinase Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NMYC Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>More than 10 Mitoses per 10HPF)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchus). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7245</td>
               <td rowspan="1">Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>C-KIT Tyrosine Kinase Protein Overexpression. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>High Grade Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Lung Carcinoma<br><span class="keyword"> and </span>Small Cell Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Paraneoplastic Syndrome)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 18q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 5q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>C-KIT Tyrosine Kinase Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NMYC Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>More than 10 Mitoses per 10HPF)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchus). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7246</td>
               <td rowspan="1">Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NMYC Gene Amplification. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>High Grade Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Lung Carcinoma<br><span class="keyword"> and </span>Small Cell Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Paraneoplastic Syndrome)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 18q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 5q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>C-KIT Tyrosine Kinase Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NMYC Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>More than 10 Mitoses per 10HPF)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchus). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7247</td>
               <td rowspan="1">Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>High Grade Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Lung Carcinoma<br><span class="keyword"> and </span>Small Cell Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Paraneoplastic Syndrome)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 18q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 5q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>C-KIT Tyrosine Kinase Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NMYC Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>More than 10 Mitoses per 10HPF)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchus). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7248</td>
               <td rowspan="1">Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>High Grade Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Lung Carcinoma<br><span class="keyword"> and </span>Small Cell Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Paraneoplastic Syndrome)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 18q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 5q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>C-KIT Tyrosine Kinase Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NMYC Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>More than 10 Mitoses per 10HPF)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchus). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7249</td>
               <td rowspan="1">Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>High Grade Lung Neuroendocrine Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>High Grade Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Lung Carcinoma<br><span class="keyword"> and </span>Small Cell Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Paraneoplastic Syndrome)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 18q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 5q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>C-KIT Tyrosine Kinase Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NMYC Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>More than 10 Mitoses per 10HPF)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchus). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7250</td>
               <td rowspan="1">Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>High Grade Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Lung Carcinoma<br><span class="keyword"> and </span>Small Cell Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Paraneoplastic Syndrome)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 18q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 5q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>C-KIT Tyrosine Kinase Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NMYC Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>More than 10 Mitoses per 10HPF)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchus). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7251</td>
               <td rowspan="1">Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Small Cell Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>High Grade Lung Neuroendocrine Neoplasm<br><span class="keyword"> and </span>Lung Carcinoma<br><span class="keyword"> and </span>Small Cell Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Paraneoplastic Syndrome)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 18q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 4)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 5q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>C-KIT Tyrosine Kinase Protein Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NMYC Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RB1 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>More than 10 Mitoses per 10HPF)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bronchus). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7252</td>
               <td rowspan="1">Solid Carcinoma<span class="subclass"> SubClassOf </span>Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Solid Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Solid Growth Pattern). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7253</td>
               <td rowspan="1">Solid Lung Adenocarcinoma with Mucin Production<span class="subclass"> SubClassOf </span>Lung Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Solid Lung Adenocarcinoma with Mucin Production<span class="subclass"> EquivalentTo </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>Mucin-Producing Adenocarcinoma<br><span class="keyword"> and </span>Solid Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7254</td>
               <td rowspan="1">Solid Papillary Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Papillary Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Solid Papillary Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Papillary Breast Carcinoma<br><span class="keyword"> and </span>Solid Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Fibrotic Stroma with Finger-Like Projections Present). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7255</td>
               <td rowspan="1">Sporadic Breast Carcinoma<span class="subclass"> SubClassOf </span>Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Sporadic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 16)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 22)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 6)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 18)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 7)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Non-Hereditary Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7256</td>
               <td rowspan="1">Sporadic Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> only </span>Non-Hereditary Lesion. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Sporadic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 16)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 22)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 6)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 18)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 7)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Non-Hereditary Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7257</td>
               <td rowspan="1">Sporadic Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Sporadic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 16)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 22)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 6)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 18)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 7)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Non-Hereditary Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7258</td>
               <td rowspan="1">Sporadic Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Sporadic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 16)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 22)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 6)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 18)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 7)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Non-Hereditary Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7259</td>
               <td rowspan="1">Sporadic Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Sporadic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 16)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 22)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 6)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 18)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 7)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Non-Hereditary Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7260</td>
               <td rowspan="1">Sporadic Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Sporadic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 16)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 22)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 6)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 18)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 7)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Non-Hereditary Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7261</td>
               <td rowspan="1">Sporadic Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Sporadic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 16)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 22)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 6)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 18)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 7)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Non-Hereditary Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7262</td>
               <td rowspan="1">Sporadic Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Sporadic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 16)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 22)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 6)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 18)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 7)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Non-Hereditary Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7263</td>
               <td rowspan="1">Sporadic Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Sporadic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 16)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 22)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 6)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 18)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 7)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Non-Hereditary Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7264</td>
               <td rowspan="1">Sporadic Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Sporadic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 16)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 22)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 6)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 18)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 7)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Non-Hereditary Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7265</td>
               <td rowspan="1">Sporadic Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Sporadic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 16)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 22)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 6)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 18)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 7)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Non-Hereditary Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7266</td>
               <td rowspan="1">Sporadic Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Sporadic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 16)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 22)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 6)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 18)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 7)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Non-Hereditary Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7267</td>
               <td rowspan="1">Sporadic Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Sporadic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 16)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 22)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 6)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 18)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 7)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Non-Hereditary Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7268</td>
               <td rowspan="1">Sporadic Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Sporadic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 16)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 22)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 6)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 18)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 7)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Non-Hereditary Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7269</td>
               <td rowspan="1">Sporadic Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Sporadic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 16)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 22)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 6)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 18)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 7)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Non-Hereditary Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7270</td>
               <td rowspan="1">Sporadic Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Sporadic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 16)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 22)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 6)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 18)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 7)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Non-Hereditary Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7271</td>
               <td rowspan="1">Sporadic Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 19. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Sporadic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 16)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 22)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 6)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 18)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 7)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Non-Hereditary Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7272</td>
               <td rowspan="1">Sporadic Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Sporadic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 16)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 22)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 6)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 18)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 7)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Non-Hereditary Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7273</td>
               <td rowspan="1">Sporadic Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Sporadic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 16)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 22)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 6)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 18)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 7)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Non-Hereditary Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7274</td>
               <td rowspan="1">Sporadic Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Sporadic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 16)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 22)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 6)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 18)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 7)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Non-Hereditary Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7275</td>
               <td rowspan="1">Sporadic Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Sporadic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 16)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 22)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 6)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 18)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 7)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Non-Hereditary Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7276</td>
               <td rowspan="1">Sporadic Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Sporadic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 16)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 22)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 6)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 18)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 7)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Non-Hereditary Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7277</td>
               <td rowspan="1">Sporadic Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 11. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Sporadic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 16)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 22)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 6)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 18)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 7)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Non-Hereditary Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7278</td>
               <td rowspan="1">Sporadic Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Sporadic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 16)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 22)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 6)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 18)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 7)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Non-Hereditary Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7279</td>
               <td rowspan="1">Sporadic Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 16. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Sporadic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 16)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 22)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 6)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 18)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 7)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Non-Hereditary Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7280</td>
               <td rowspan="1">Sporadic Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 17. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Sporadic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 16)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 22)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 6)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 18)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 7)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Non-Hereditary Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7281</td>
               <td rowspan="1">Sporadic Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 22. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Sporadic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 16)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 22)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 6)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 18)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 7)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Non-Hereditary Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7282</td>
               <td rowspan="1">Sporadic Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 6. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Sporadic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 16)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 22)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 6)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 18)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 7)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Non-Hereditary Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7283</td>
               <td rowspan="1">Sporadic Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 8. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Sporadic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 16)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 22)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 6)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 18)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 7)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Non-Hereditary Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7284</td>
               <td rowspan="1">Sporadic Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy X. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Sporadic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 16)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 22)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 6)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 18)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 7)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Non-Hereditary Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7285</td>
               <td rowspan="1">Sporadic Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 18. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Sporadic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 16)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 22)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 6)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 18)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 7)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Non-Hereditary Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7286</td>
               <td rowspan="1">Sporadic Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 7. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Sporadic Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 17q22-q24)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 20q13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 6p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 17p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 1p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 16)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 17)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 22)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 6)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 18)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 7)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Non-Hereditary Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7460</td>
               <td rowspan="1">Stage I Breast Cancer<span class="subclass"> SubClassOf </span>Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage I Breast Cancer<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage I). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7461</td>
               <td rowspan="1">Stage I Breast Cancer<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage I. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage I Breast Cancer<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage I). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7462</td>
               <td rowspan="1">Stage I Fallopian Tube Cancer<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage I. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage I Fallopian Tube Cancer<span class="subclass"> EquivalentTo </span>Fallopian Tube Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage I). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7463</td>
               <td rowspan="1">Stage I Fallopian Tube Cancer<span class="subclass"> SubClassOf </span>Fallopian Tube Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage I Fallopian Tube Cancer<span class="subclass"> EquivalentTo </span>Fallopian Tube Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage I). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7464</td>
               <td rowspan="1">Stage I Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage I. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage I Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Large Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage I Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stage I Non-Small Cell Lung Cancer<span class="subclass"> EquivalentTo </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage I Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Stage I Lung Cancer<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage I). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7465</td>
               <td rowspan="1">Stage I Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Large Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage I Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Large Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage I Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7466</td>
               <td rowspan="1">Stage I Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage I Non-Small Cell Lung Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage I Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Large Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage I Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7467</td>
               <td rowspan="1">Stage I Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage I. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage I Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>Stage I Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stage I Non-Small Cell Lung Cancer<span class="subclass"> EquivalentTo </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage I Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Stage I Lung Cancer<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage I). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7468</td>
               <td rowspan="1">Stage I Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Lung Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage I Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>Stage I Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7469</td>
               <td rowspan="1">Stage I Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Stage I Non-Small Cell Lung Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage I Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>Stage I Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7470</td>
               <td rowspan="1">Stage I Lung Cancer<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage I. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage I Lung Cancer<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage I). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7471</td>
               <td rowspan="1">Stage I Lung Cancer<span class="subclass"> SubClassOf </span>Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage I Lung Cancer<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage I). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7472</td>
               <td rowspan="1">Stage I Non-Small Cell Lung Cancer<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage I. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage I Non-Small Cell Lung Cancer<span class="subclass"> EquivalentTo </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage I Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stage I Lung Cancer<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage I). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7473</td>
               <td rowspan="1">Stage I Non-Small Cell Lung Cancer<span class="subclass"> SubClassOf </span>Non-Small Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage I Non-Small Cell Lung Cancer<span class="subclass"> EquivalentTo </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage I Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7474</td>
               <td rowspan="1">Stage I Non-Small Cell Lung Cancer<span class="subclass"> SubClassOf </span>Stage I Lung Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage I Non-Small Cell Lung Cancer<span class="subclass"> EquivalentTo </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage I Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7475</td>
               <td rowspan="1">Stage I Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage I. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage I Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Limited Stage Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage I Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stage I Lung Cancer<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage I). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7476</td>
               <td rowspan="1">Stage I Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Limited Stage Small Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage I Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Limited Stage Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage I Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7477</td>
               <td rowspan="1">Stage I Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage I Lung Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage I Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Limited Stage Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage I Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7287</td>
               <td rowspan="1">Stage IA Fallopian Tube Cancer<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IA. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IA Fallopian Tube Cancer<span class="subclass"> EquivalentTo </span>Stage I Fallopian Tube Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IA). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7288</td>
               <td rowspan="1">Stage IA Fallopian Tube Cancer<span class="subclass"> SubClassOf </span>Stage I Fallopian Tube Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IA Fallopian Tube Cancer<span class="subclass"> EquivalentTo </span>Stage I Fallopian Tube Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IA). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7289</td>
               <td rowspan="1">Stage IA Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IA. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IA Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage I Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IA). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stage IA Non-Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IA Lung Carcinoma<br><span class="keyword"> and </span>Stage I Non-Small Cell Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Stage IA Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IA Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage I Large Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7291</td>
               <td rowspan="1">Stage IA Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage I Large Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IA Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IA Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage I Large Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7290</td>
               <td rowspan="1">Stage IA Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage IA Non-Small Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IA Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IA Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage I Large Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7292</td>
               <td rowspan="1">Stage IA Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IA. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IA Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage I Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IA). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stage IA Non-Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IA Lung Carcinoma<br><span class="keyword"> and </span>Stage I Non-Small Cell Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Stage IA Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Stage IA Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage I Lung Adenocarcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7294</td>
               <td rowspan="1">Stage IA Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Stage I Lung Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IA Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Stage IA Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage I Lung Adenocarcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7293</td>
               <td rowspan="1">Stage IA Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Stage IA Non-Small Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IA Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Stage IA Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage I Lung Adenocarcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7295</td>
               <td rowspan="1">Stage IA Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IA. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IA Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage I Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IA). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7296</td>
               <td rowspan="1">Stage IA Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage I Lung Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IA Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage I Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IA). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7298</td>
               <td rowspan="1">Stage IA Non-Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage I Non-Small Cell Lung Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IA Non-Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IA Lung Carcinoma<br><span class="keyword"> and </span>Stage I Non-Small Cell Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7297</td>
               <td rowspan="1">Stage IA Non-Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage IA Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IA Non-Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IA Lung Carcinoma<br><span class="keyword"> and </span>Stage I Non-Small Cell Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7299</td>
               <td rowspan="1">Stage IA Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IA. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IA Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage I Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IA). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stage IA Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IA Lung Carcinoma<br><span class="keyword"> and </span>Stage I Small Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7301</td>
               <td rowspan="1">Stage IA Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage I Small Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IA Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IA Lung Carcinoma<br><span class="keyword"> and </span>Stage I Small Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7300</td>
               <td rowspan="1">Stage IA Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage IA Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IA Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IA Lung Carcinoma<br><span class="keyword"> and </span>Stage I Small Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7302</td>
               <td rowspan="1">Stage IB Fallopian Tube Cancer<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IB. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IB Fallopian Tube Cancer<span class="subclass"> EquivalentTo </span>Stage I Fallopian Tube Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IB). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7303</td>
               <td rowspan="1">Stage IB Fallopian Tube Cancer<span class="subclass"> SubClassOf </span>Stage I Fallopian Tube Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IB Fallopian Tube Cancer<span class="subclass"> EquivalentTo </span>Stage I Fallopian Tube Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IB). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7304</td>
               <td rowspan="1">Stage IB Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IB. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IB Non-Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IB Lung Carcinoma<br><span class="keyword"> and </span>Stage I Non-Small Cell Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stage IB Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage I Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IB). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Stage IB Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IB Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage I Large Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7306</td>
               <td rowspan="1">Stage IB Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage I Large Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IB Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IB Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage I Large Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7305</td>
               <td rowspan="1">Stage IB Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage IB Non-Small Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IB Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IB Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage I Large Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7307</td>
               <td rowspan="1">Stage IB Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IB. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IB Non-Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IB Lung Carcinoma<br><span class="keyword"> and </span>Stage I Non-Small Cell Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stage IB Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Stage IB Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage I Lung Adenocarcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Stage IB Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage I Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IB). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7309</td>
               <td rowspan="1">Stage IB Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Stage I Lung Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IB Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Stage IB Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage I Lung Adenocarcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7308</td>
               <td rowspan="1">Stage IB Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Stage IB Non-Small Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IB Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Stage IB Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage I Lung Adenocarcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7310</td>
               <td rowspan="1">Stage IB Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IB. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IB Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage I Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IB). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7311</td>
               <td rowspan="1">Stage IB Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage I Lung Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IB Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage I Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IB). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7313</td>
               <td rowspan="1">Stage IB Non-Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage I Non-Small Cell Lung Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IB Non-Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IB Lung Carcinoma<br><span class="keyword"> and </span>Stage I Non-Small Cell Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7312</td>
               <td rowspan="1">Stage IB Non-Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage IB Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IB Non-Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IB Lung Carcinoma<br><span class="keyword"> and </span>Stage I Non-Small Cell Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7314</td>
               <td rowspan="1">Stage IB Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IB. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IB Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IB Lung Carcinoma<br><span class="keyword"> and </span>Stage I Small Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stage IB Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage I Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IB). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7316</td>
               <td rowspan="1">Stage IB Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage I Small Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IB Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IB Lung Carcinoma<br><span class="keyword"> and </span>Stage I Small Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7315</td>
               <td rowspan="1">Stage IB Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage IB Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IB Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IB Lung Carcinoma<br><span class="keyword"> and </span>Stage I Small Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7317</td>
               <td rowspan="1">Stage IC Fallopian Tube Cancer<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IC. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IC Fallopian Tube Cancer<span class="subclass"> EquivalentTo </span>Stage I Fallopian Tube Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IC). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7318</td>
               <td rowspan="1">Stage IC Fallopian Tube Cancer<span class="subclass"> SubClassOf </span>Stage I Fallopian Tube Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IC Fallopian Tube Cancer<span class="subclass"> EquivalentTo </span>Stage I Fallopian Tube Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IC). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7421</td>
               <td rowspan="1">Stage II Breast Cancer<span class="subclass"> SubClassOf </span>Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage II Breast Cancer<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage II). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7422</td>
               <td rowspan="1">Stage II Breast Cancer<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage II. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage II Breast Cancer<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage II). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7423</td>
               <td rowspan="1">Stage II Fallopian Tube Cancer<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage II. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage II Fallopian Tube Cancer<span class="subclass"> EquivalentTo </span>Fallopian Tube Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage II). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7424</td>
               <td rowspan="1">Stage II Fallopian Tube Cancer<span class="subclass"> SubClassOf </span>Fallopian Tube Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage II Fallopian Tube Cancer<span class="subclass"> EquivalentTo </span>Fallopian Tube Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage II). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7425</td>
               <td rowspan="1">Stage II Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage II. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage II Non-Small Cell Lung Cancer<span class="subclass"> EquivalentTo </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage II Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stage II Lung Cancer<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage II). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Stage II Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Large Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage II Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7426</td>
               <td rowspan="1">Stage II Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Large Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage II Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Large Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage II Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7427</td>
               <td rowspan="1">Stage II Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage II Non-Small Cell Lung Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage II Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Large Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage II Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7428</td>
               <td rowspan="1">Stage II Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage II. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage II Non-Small Cell Lung Cancer<span class="subclass"> EquivalentTo </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage II Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stage II Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>Stage II Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Stage II Lung Cancer<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage II). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7429</td>
               <td rowspan="1">Stage II Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Lung Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage II Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>Stage II Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7430</td>
               <td rowspan="1">Stage II Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Stage II Non-Small Cell Lung Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage II Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>Stage II Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7431</td>
               <td rowspan="1">Stage II Lung Cancer<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage II. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage II Lung Cancer<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage II). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7432</td>
               <td rowspan="1">Stage II Lung Cancer<span class="subclass"> SubClassOf </span>Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage II Lung Cancer<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage II). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7433</td>
               <td rowspan="1">Stage II Non-Small Cell Lung Cancer<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage II. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage II Non-Small Cell Lung Cancer<span class="subclass"> EquivalentTo </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage II Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stage II Lung Cancer<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage II). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7434</td>
               <td rowspan="1">Stage II Non-Small Cell Lung Cancer<span class="subclass"> SubClassOf </span>Non-Small Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage II Non-Small Cell Lung Cancer<span class="subclass"> EquivalentTo </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage II Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7435</td>
               <td rowspan="1">Stage II Non-Small Cell Lung Cancer<span class="subclass"> SubClassOf </span>Stage II Lung Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage II Non-Small Cell Lung Cancer<span class="subclass"> EquivalentTo </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage II Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7436</td>
               <td rowspan="1">Stage II Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage II. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage II Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Limited Stage Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage II Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stage II Lung Cancer<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage II). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7437</td>
               <td rowspan="1">Stage II Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Limited Stage Small Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage II Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Limited Stage Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage II Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7438</td>
               <td rowspan="1">Stage II Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage II Lung Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage II Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Limited Stage Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage II Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7319</td>
               <td rowspan="1">Stage IIA Breast Cancer<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IIA. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIA Breast Cancer<span class="subclass"> EquivalentTo </span>Stage II Breast Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIA). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7320</td>
               <td rowspan="1">Stage IIA Breast Cancer<span class="subclass"> SubClassOf </span>Stage II Breast Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIA Breast Cancer<span class="subclass"> EquivalentTo </span>Stage II Breast Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIA). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7321</td>
               <td rowspan="1">Stage IIA Fallopian Tube Cancer<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IIA. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIA Fallopian Tube Cancer<span class="subclass"> EquivalentTo </span>Stage II Fallopian Tube Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIA). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7322</td>
               <td rowspan="1">Stage IIA Fallopian Tube Cancer<span class="subclass"> SubClassOf </span>Stage II Fallopian Tube Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIA Fallopian Tube Cancer<span class="subclass"> EquivalentTo </span>Stage II Fallopian Tube Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIA). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7323</td>
               <td rowspan="1">Stage IIA Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IIA. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIA Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage II Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIA). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stage IIA Non-Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIA Lung Carcinoma<br><span class="keyword"> and </span>Stage II Non-Small Cell Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Stage IIA Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIA Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage II Large Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7325</td>
               <td rowspan="1">Stage IIA Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage II Large Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIA Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIA Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage II Large Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7324</td>
               <td rowspan="1">Stage IIA Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage IIA Non-Small Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIA Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIA Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage II Large Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7326</td>
               <td rowspan="1">Stage IIA Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IIA. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIA Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage II Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIA). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stage IIA Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Stage IIA Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage II Lung Adenocarcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Stage IIA Non-Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIA Lung Carcinoma<br><span class="keyword"> and </span>Stage II Non-Small Cell Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7328</td>
               <td rowspan="1">Stage IIA Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Stage II Lung Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIA Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Stage IIA Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage II Lung Adenocarcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7327</td>
               <td rowspan="1">Stage IIA Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Stage IIA Non-Small Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIA Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Stage IIA Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage II Lung Adenocarcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7329</td>
               <td rowspan="1">Stage IIA Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IIA. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIA Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage II Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIA). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7330</td>
               <td rowspan="1">Stage IIA Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage II Lung Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIA Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage II Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIA). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7332</td>
               <td rowspan="1">Stage IIA Non-Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage II Non-Small Cell Lung Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIA Non-Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIA Lung Carcinoma<br><span class="keyword"> and </span>Stage II Non-Small Cell Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7331</td>
               <td rowspan="1">Stage IIA Non-Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage IIA Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIA Non-Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIA Lung Carcinoma<br><span class="keyword"> and </span>Stage II Non-Small Cell Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7333</td>
               <td rowspan="1">Stage IIA Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IIA. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIA Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIA Lung Carcinoma<br><span class="keyword"> and </span>Stage II Small Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stage IIA Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage II Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIA). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7335</td>
               <td rowspan="1">Stage IIA Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage II Small Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIA Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIA Lung Carcinoma<br><span class="keyword"> and </span>Stage II Small Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7334</td>
               <td rowspan="1">Stage IIA Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage IIA Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIA Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIA Lung Carcinoma<br><span class="keyword"> and </span>Stage II Small Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7336</td>
               <td rowspan="1">Stage IIB Breast Cancer<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IIB. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIB Breast Cancer<span class="subclass"> EquivalentTo </span>Stage II Breast Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIB). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7337</td>
               <td rowspan="1">Stage IIB Breast Cancer<span class="subclass"> SubClassOf </span>Stage II Breast Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIB Breast Cancer<span class="subclass"> EquivalentTo </span>Stage II Breast Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIB). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7338</td>
               <td rowspan="1">Stage IIB Fallopian Tube Cancer<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IIB. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIB Fallopian Tube Cancer<span class="subclass"> EquivalentTo </span>Stage II Fallopian Tube Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIB). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7339</td>
               <td rowspan="1">Stage IIB Fallopian Tube Cancer<span class="subclass"> SubClassOf </span>Stage II Fallopian Tube Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIB Fallopian Tube Cancer<span class="subclass"> EquivalentTo </span>Stage II Fallopian Tube Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIB). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7340</td>
               <td rowspan="1">Stage IIB Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IIB. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIB Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage II Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIB). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stage IIB Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIB Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage II Large Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Stage IIB Non-Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIB Lung Carcinoma<br><span class="keyword"> and </span>Stage II Non-Small Cell Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7342</td>
               <td rowspan="1">Stage IIB Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage II Large Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIB Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIB Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage II Large Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7341</td>
               <td rowspan="1">Stage IIB Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage IIB Non-Small Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIB Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIB Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage II Large Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7343</td>
               <td rowspan="1">Stage IIB Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IIB. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIB Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage II Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIB). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stage IIB Non-Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIB Lung Carcinoma<br><span class="keyword"> and </span>Stage II Non-Small Cell Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Stage IIB Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Stage IIB Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage II Lung Adenocarcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7345</td>
               <td rowspan="1">Stage IIB Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Stage II Lung Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIB Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Stage IIB Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage II Lung Adenocarcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7344</td>
               <td rowspan="1">Stage IIB Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Stage IIB Non-Small Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIB Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Stage IIB Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage II Lung Adenocarcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7346</td>
               <td rowspan="1">Stage IIB Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IIB. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIB Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage II Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIB). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7347</td>
               <td rowspan="1">Stage IIB Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage II Lung Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIB Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage II Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIB). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7349</td>
               <td rowspan="1">Stage IIB Non-Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage II Non-Small Cell Lung Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIB Non-Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIB Lung Carcinoma<br><span class="keyword"> and </span>Stage II Non-Small Cell Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7348</td>
               <td rowspan="1">Stage IIB Non-Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage IIB Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIB Non-Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIB Lung Carcinoma<br><span class="keyword"> and </span>Stage II Non-Small Cell Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7350</td>
               <td rowspan="1">Stage IIB Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IIB. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIB Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage II Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIB). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stage IIB Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIB Lung Carcinoma<br><span class="keyword"> and </span>Stage II Small Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7352</td>
               <td rowspan="1">Stage IIB Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage II Small Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIB Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIB Lung Carcinoma<br><span class="keyword"> and </span>Stage II Small Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7351</td>
               <td rowspan="1">Stage IIB Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage IIB Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIB Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIB Lung Carcinoma<br><span class="keyword"> and </span>Stage II Small Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7353</td>
               <td rowspan="1">Stage IIC Fallopian Tube Cancer<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IIC. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIC Fallopian Tube Cancer<span class="subclass"> EquivalentTo </span>Stage II Fallopian Tube Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIC). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7354</td>
               <td rowspan="1">Stage IIC Fallopian Tube Cancer<span class="subclass"> SubClassOf </span>Stage II Fallopian Tube Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIC Fallopian Tube Cancer<span class="subclass"> EquivalentTo </span>Stage II Fallopian Tube Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIC). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7403</td>
               <td rowspan="1">Stage III Breast Cancer<span class="subclass"> SubClassOf </span>Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage III Breast Cancer<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage III). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7404</td>
               <td rowspan="1">Stage III Breast Cancer<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage III. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage III Breast Cancer<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage III). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7405</td>
               <td rowspan="1">Stage III Fallopian Tube Cancer<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage III. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage III Fallopian Tube Cancer<span class="subclass"> EquivalentTo </span>Fallopian Tube Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage III). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7406</td>
               <td rowspan="1">Stage III Fallopian Tube Cancer<span class="subclass"> SubClassOf </span>Fallopian Tube Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage III Fallopian Tube Cancer<span class="subclass"> EquivalentTo </span>Fallopian Tube Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage III). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7407</td>
               <td rowspan="1">Stage III Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage III. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage III Lung Cancer<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage III). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stage III Non-Small Cell Lung Cancer<span class="subclass"> EquivalentTo </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage III Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Stage III Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Large Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage III Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7408</td>
               <td rowspan="1">Stage III Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Large Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage III Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Large Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage III Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7409</td>
               <td rowspan="1">Stage III Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage III Non-Small Cell Lung Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage III Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Large Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage III Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7410</td>
               <td rowspan="1">Stage III Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage III. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage III Lung Cancer<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage III). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stage III Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>Stage III Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Stage III Non-Small Cell Lung Cancer<span class="subclass"> EquivalentTo </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage III Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7411</td>
               <td rowspan="1">Stage III Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Lung Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage III Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>Stage III Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7412</td>
               <td rowspan="1">Stage III Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Stage III Non-Small Cell Lung Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage III Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>Stage III Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7413</td>
               <td rowspan="1">Stage III Lung Cancer<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage III. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage III Lung Cancer<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage III). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7414</td>
               <td rowspan="1">Stage III Lung Cancer<span class="subclass"> SubClassOf </span>Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage III Lung Cancer<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage III). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7415</td>
               <td rowspan="1">Stage III Non-Small Cell Lung Cancer<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage III. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage III Lung Cancer<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage III). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stage III Non-Small Cell Lung Cancer<span class="subclass"> EquivalentTo </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage III Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7416</td>
               <td rowspan="1">Stage III Non-Small Cell Lung Cancer<span class="subclass"> SubClassOf </span>Non-Small Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage III Non-Small Cell Lung Cancer<span class="subclass"> EquivalentTo </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage III Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7417</td>
               <td rowspan="1">Stage III Non-Small Cell Lung Cancer<span class="subclass"> SubClassOf </span>Stage III Lung Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage III Non-Small Cell Lung Cancer<span class="subclass"> EquivalentTo </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage III Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7418</td>
               <td rowspan="1">Stage III Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage III. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage III Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage III Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Coin Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hoarseness). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stage III Lung Cancer<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage III). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7419</td>
               <td rowspan="1">Stage III Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Small Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage III Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage III Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Coin Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hoarseness). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7420</td>
               <td rowspan="1">Stage III Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage III Lung Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage III Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage III Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Coin Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hoarseness). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7355</td>
               <td rowspan="1">Stage IIIA Breast Cancer<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IIIA. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIA Breast Cancer<span class="subclass"> EquivalentTo </span>Stage III Breast Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIIA). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7356</td>
               <td rowspan="1">Stage IIIA Breast Cancer<span class="subclass"> SubClassOf </span>Stage III Breast Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIA Breast Cancer<span class="subclass"> EquivalentTo </span>Stage III Breast Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIIA). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7357</td>
               <td rowspan="1">Stage IIIA Fallopian Tube Cancer<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IIIA. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIA Fallopian Tube Cancer<span class="subclass"> EquivalentTo </span>Stage III Fallopian Tube Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIIA). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7358</td>
               <td rowspan="1">Stage IIIA Fallopian Tube Cancer<span class="subclass"> SubClassOf </span>Stage III Fallopian Tube Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIA Fallopian Tube Cancer<span class="subclass"> EquivalentTo </span>Stage III Fallopian Tube Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIIA). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7359</td>
               <td rowspan="1">Stage IIIA Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IIIA. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIA Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIIA Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>Stage III Large Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stage IIIA Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage III Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIIA). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Stage IIIA Non-Small Cell Lung Cancer<span class="subclass"> EquivalentTo </span>Stage IIIA Lung Carcinoma<br><span class="keyword"> and </span>Stage III Non-Small Cell Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7361</td>
               <td rowspan="1">Stage IIIA Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage III Large Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIA Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIIA Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>Stage III Large Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7360</td>
               <td rowspan="1">Stage IIIA Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage IIIA Non-Small Cell Lung Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIA Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIIA Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>Stage III Large Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7362</td>
               <td rowspan="1">Stage IIIA Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IIIA. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIA Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage III Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIIA). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stage IIIA Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Stage IIIA Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>Stage III Lung Adenocarcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Stage IIIA Non-Small Cell Lung Cancer<span class="subclass"> EquivalentTo </span>Stage IIIA Lung Carcinoma<br><span class="keyword"> and </span>Stage III Non-Small Cell Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7364</td>
               <td rowspan="1">Stage IIIA Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Stage III Lung Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIA Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Stage IIIA Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>Stage III Lung Adenocarcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7363</td>
               <td rowspan="1">Stage IIIA Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Stage IIIA Non-Small Cell Lung Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIA Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Stage IIIA Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>Stage III Lung Adenocarcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7365</td>
               <td rowspan="1">Stage IIIA Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IIIA. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIA Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage III Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIIA). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7366</td>
               <td rowspan="1">Stage IIIA Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage III Lung Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIA Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage III Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIIA). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7368</td>
               <td rowspan="1">Stage IIIA Non-Small Cell Lung Cancer<span class="subclass"> SubClassOf </span>Stage III Non-Small Cell Lung Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIA Non-Small Cell Lung Cancer<span class="subclass"> EquivalentTo </span>Stage IIIA Lung Carcinoma<br><span class="keyword"> and </span>Stage III Non-Small Cell Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7367</td>
               <td rowspan="1">Stage IIIA Non-Small Cell Lung Cancer<span class="subclass"> SubClassOf </span>Stage IIIA Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIA Non-Small Cell Lung Cancer<span class="subclass"> EquivalentTo </span>Stage IIIA Lung Carcinoma<br><span class="keyword"> and </span>Stage III Non-Small Cell Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7369</td>
               <td rowspan="1">Stage IIIA Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IIIA. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIA Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage III Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIIA). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stage IIIA Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Limited Stage Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage IIIA Lung Carcinoma<br><span class="keyword"> and </span>Stage III Small Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7370</td>
               <td rowspan="1">Stage IIIA Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Limited Stage Small Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIA Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Limited Stage Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage IIIA Lung Carcinoma<br><span class="keyword"> and </span>Stage III Small Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7372</td>
               <td rowspan="1">Stage IIIA Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage III Small Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIA Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Limited Stage Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage IIIA Lung Carcinoma<br><span class="keyword"> and </span>Stage III Small Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7371</td>
               <td rowspan="1">Stage IIIA Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage IIIA Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIA Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Limited Stage Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage IIIA Lung Carcinoma<br><span class="keyword"> and </span>Stage III Small Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7373</td>
               <td rowspan="1">Stage IIIB Breast Cancer<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IIIB. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIB Breast Cancer<span class="subclass"> EquivalentTo </span>Stage III Breast Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIIB). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7374</td>
               <td rowspan="1">Stage IIIB Breast Cancer<span class="subclass"> SubClassOf </span>Stage III Breast Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIB Breast Cancer<span class="subclass"> EquivalentTo </span>Stage III Breast Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIIB). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7375</td>
               <td rowspan="1">Stage IIIB Fallopian Tube Cancer<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IIIB. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIB Fallopian Tube Cancer<span class="subclass"> EquivalentTo </span>Stage III Fallopian Tube Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIIB). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7376</td>
               <td rowspan="1">Stage IIIB Fallopian Tube Cancer<span class="subclass"> SubClassOf </span>Stage III Fallopian Tube Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIB Fallopian Tube Cancer<span class="subclass"> EquivalentTo </span>Stage III Fallopian Tube Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIIB). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7377</td>
               <td rowspan="1">Stage IIIB Inflammatory Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IIIB. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIB Inflammatory Breast Carcinoma<span class="subclass"> EquivalentTo </span>Inflammatory Breast Carcinoma<br><span class="keyword"> and </span>Stage IIIB Breast Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIIB). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7378</td>
               <td rowspan="1">Stage IIIB Inflammatory Breast Carcinoma<span class="subclass"> SubClassOf </span>Inflammatory Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIB Inflammatory Breast Carcinoma<span class="subclass"> EquivalentTo </span>Inflammatory Breast Carcinoma<br><span class="keyword"> and </span>Stage IIIB Breast Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIIB). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7379</td>
               <td rowspan="1">Stage IIIB Inflammatory Breast Carcinoma<span class="subclass"> SubClassOf </span>Stage IIIB Breast Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIB Inflammatory Breast Carcinoma<span class="subclass"> EquivalentTo </span>Inflammatory Breast Carcinoma<br><span class="keyword"> and </span>Stage IIIB Breast Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIIB). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7380</td>
               <td rowspan="1">Stage IIIB Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IIIB. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIB Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage III Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIIB). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stage IIIB Non-Small Cell Lung Cancer<span class="subclass"> EquivalentTo </span>Stage IIIB Lung Carcinoma<br><span class="keyword"> and </span>Stage III Non-Small Cell Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Stage IIIB Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIIB Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>Stage III Large Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7382</td>
               <td rowspan="1">Stage IIIB Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage III Large Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIB Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIIB Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>Stage III Large Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7381</td>
               <td rowspan="1">Stage IIIB Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage IIIB Non-Small Cell Lung Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIB Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIIB Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>Stage III Large Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7383</td>
               <td rowspan="1">Stage IIIB Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IIIB. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIB Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage III Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIIB). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stage IIIB Non-Small Cell Lung Cancer<span class="subclass"> EquivalentTo </span>Stage IIIB Lung Carcinoma<br><span class="keyword"> and </span>Stage III Non-Small Cell Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Stage IIIB Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Stage IIIB Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>Stage III Lung Adenocarcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7385</td>
               <td rowspan="1">Stage IIIB Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Stage III Lung Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIB Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Stage IIIB Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>Stage III Lung Adenocarcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7384</td>
               <td rowspan="1">Stage IIIB Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Stage IIIB Non-Small Cell Lung Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIB Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Stage IIIB Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>Stage III Lung Adenocarcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7386</td>
               <td rowspan="1">Stage IIIB Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IIIB. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIB Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage III Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIIB). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7387</td>
               <td rowspan="1">Stage IIIB Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage III Lung Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIB Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage III Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIIB). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7389</td>
               <td rowspan="1">Stage IIIB Non-Small Cell Lung Cancer<span class="subclass"> SubClassOf </span>Stage III Non-Small Cell Lung Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIB Non-Small Cell Lung Cancer<span class="subclass"> EquivalentTo </span>Stage IIIB Lung Carcinoma<br><span class="keyword"> and </span>Stage III Non-Small Cell Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7388</td>
               <td rowspan="1">Stage IIIB Non-Small Cell Lung Cancer<span class="subclass"> SubClassOf </span>Stage IIIB Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIB Non-Small Cell Lung Cancer<span class="subclass"> EquivalentTo </span>Stage IIIB Lung Carcinoma<br><span class="keyword"> and </span>Stage III Non-Small Cell Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7390</td>
               <td rowspan="1">Stage IIIB Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IIIB. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIB Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage III Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIIB). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stage IIIB Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIIB Lung Carcinoma<br><span class="keyword"> and </span>Stage III Small Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7392</td>
               <td rowspan="1">Stage IIIB Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage III Small Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIB Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIIB Lung Carcinoma<br><span class="keyword"> and </span>Stage III Small Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7391</td>
               <td rowspan="1">Stage IIIB Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage IIIB Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIB Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIIB Lung Carcinoma<br><span class="keyword"> and </span>Stage III Small Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7393</td>
               <td rowspan="1">Stage IIIB Small Cell Lung Carcinoma with Pleural Effusion<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IIIB. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIB Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage III Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIIB). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stage IIIB Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIIB Lung Carcinoma<br><span class="keyword"> and </span>Stage III Small Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Stage IIIB Small Cell Lung Carcinoma with Pleural Effusion<span class="subclass"> EquivalentTo </span>Extensive Stage Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage IIIB Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Pleural Effusion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7394</td>
               <td rowspan="1">Stage IIIB Small Cell Lung Carcinoma with Pleural Effusion<span class="subclass"> SubClassOf </span>Extensive Stage Small Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIB Small Cell Lung Carcinoma with Pleural Effusion<span class="subclass"> EquivalentTo </span>Extensive Stage Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage IIIB Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Pleural Effusion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7395</td>
               <td rowspan="1">Stage IIIB Small Cell Lung Carcinoma with Pleural Effusion<span class="subclass"> SubClassOf </span>Stage IIIB Small Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIB Small Cell Lung Carcinoma with Pleural Effusion<span class="subclass"> EquivalentTo </span>Extensive Stage Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage IIIB Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Pleural Effusion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7396</td>
               <td rowspan="1">Stage IIIB Small Cell Lung Carcinoma without Pleural Effusion<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IIIB. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIB Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage III Lung Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIIB). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stage IIIB Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Stage IIIB Lung Carcinoma<br><span class="keyword"> and </span>Stage III Small Cell Lung Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Stage IIIB Small Cell Lung Carcinoma without Pleural Effusion<span class="subclass"> EquivalentTo </span>Limited Stage Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage IIIB Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Pleural Effusion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7397</td>
               <td rowspan="1">Stage IIIB Small Cell Lung Carcinoma without Pleural Effusion<span class="subclass"> SubClassOf </span>Limited Stage Small Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIB Small Cell Lung Carcinoma without Pleural Effusion<span class="subclass"> EquivalentTo </span>Limited Stage Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage IIIB Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Pleural Effusion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7398</td>
               <td rowspan="1">Stage IIIB Small Cell Lung Carcinoma without Pleural Effusion<span class="subclass"> SubClassOf </span>Stage IIIB Small Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIB Small Cell Lung Carcinoma without Pleural Effusion<span class="subclass"> EquivalentTo </span>Limited Stage Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage IIIB Small Cell Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Pleural Effusion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7399</td>
               <td rowspan="1">Stage IIIC Breast Cancer<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IIIC. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIC Breast Cancer<span class="subclass"> EquivalentTo </span>Stage III Breast Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIIC). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7400</td>
               <td rowspan="1">Stage IIIC Breast Cancer<span class="subclass"> SubClassOf </span>Stage III Breast Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIC Breast Cancer<span class="subclass"> EquivalentTo </span>Stage III Breast Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIIC). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7401</td>
               <td rowspan="1">Stage IIIC Fallopian Tube Cancer<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IIIC. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIC Fallopian Tube Cancer<span class="subclass"> EquivalentTo </span>Stage III Fallopian Tube Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIIC). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7402</td>
               <td rowspan="1">Stage IIIC Fallopian Tube Cancer<span class="subclass"> SubClassOf </span>Stage III Fallopian Tube Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IIIC Fallopian Tube Cancer<span class="subclass"> EquivalentTo </span>Stage III Fallopian Tube Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IIIC). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7439</td>
               <td rowspan="1">Stage IV Breast Cancer<span class="subclass"> SubClassOf </span>Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IV Breast Cancer<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IV). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7440</td>
               <td rowspan="1">Stage IV Breast Cancer<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IV. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IV Breast Cancer<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IV). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7441</td>
               <td rowspan="1">Stage IV Fallopian Tube Cancer<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IV. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IV Fallopian Tube Cancer<span class="subclass"> EquivalentTo </span>Fallopian Tube Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IV). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7442</td>
               <td rowspan="1">Stage IV Fallopian Tube Cancer<span class="subclass"> SubClassOf </span>Fallopian Tube Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IV Fallopian Tube Cancer<span class="subclass"> EquivalentTo </span>Fallopian Tube Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IV). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7443</td>
               <td rowspan="1">Stage IV Inflammatory Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IV. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IV Inflammatory Breast Carcinoma<span class="subclass"> EquivalentTo </span>Inflammatory Breast Carcinoma<br><span class="keyword"> and </span>Stage IV Breast Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IV). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7444</td>
               <td rowspan="1">Stage IV Inflammatory Breast Carcinoma<span class="subclass"> SubClassOf </span>Inflammatory Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IV Inflammatory Breast Carcinoma<span class="subclass"> EquivalentTo </span>Inflammatory Breast Carcinoma<br><span class="keyword"> and </span>Stage IV Breast Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IV). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7445</td>
               <td rowspan="1">Stage IV Inflammatory Breast Carcinoma<span class="subclass"> SubClassOf </span>Stage IV Breast Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IV Inflammatory Breast Carcinoma<span class="subclass"> EquivalentTo </span>Inflammatory Breast Carcinoma<br><span class="keyword"> and </span>Stage IV Breast Cancer<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IV). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7446</td>
               <td rowspan="1">Stage IV Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IV. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IV Lung Cancer<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IV). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stage IV Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Large Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage IV Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Stage IV Non-Small Cell Lung Cancer<span class="subclass"> EquivalentTo </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage IV Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7447</td>
               <td rowspan="1">Stage IV Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Large Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IV Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Large Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage IV Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7448</td>
               <td rowspan="1">Stage IV Large Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage IV Non-Small Cell Lung Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IV Large Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Large Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage IV Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7449</td>
               <td rowspan="1">Stage IV Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IV. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IV Lung Cancer<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IV). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stage IV Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>Stage IV Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Stage IV Non-Small Cell Lung Cancer<span class="subclass"> EquivalentTo </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage IV Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7450</td>
               <td rowspan="1">Stage IV Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Lung Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IV Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>Stage IV Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7451</td>
               <td rowspan="1">Stage IV Lung Adenocarcinoma<span class="subclass"> SubClassOf </span>Stage IV Non-Small Cell Lung Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IV Lung Adenocarcinoma<span class="subclass"> EquivalentTo </span>Lung Adenocarcinoma<br><span class="keyword"> and </span>Stage IV Non-Small Cell Lung Cancer<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cough)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dyspnea)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemoptysis). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7452</td>
               <td rowspan="1">Stage IV Lung Cancer<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IV. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IV Lung Cancer<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IV). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7453</td>
               <td rowspan="1">Stage IV Lung Cancer<span class="subclass"> SubClassOf </span>Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IV Lung Cancer<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IV). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7454</td>
               <td rowspan="1">Stage IV Non-Small Cell Lung Cancer<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IV. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IV Lung Cancer<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IV). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stage IV Non-Small Cell Lung Cancer<span class="subclass"> EquivalentTo </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage IV Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7455</td>
               <td rowspan="1">Stage IV Non-Small Cell Lung Cancer<span class="subclass"> SubClassOf </span>Non-Small Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IV Non-Small Cell Lung Cancer<span class="subclass"> EquivalentTo </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage IV Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7456</td>
               <td rowspan="1">Stage IV Non-Small Cell Lung Cancer<span class="subclass"> SubClassOf </span>Stage IV Lung Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IV Non-Small Cell Lung Cancer<span class="subclass"> EquivalentTo </span>Non-Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage IV Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7457</td>
               <td rowspan="1">Stage IV Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Disease_Is_Stage<span class="some"> only </span>Stage IV. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IV Lung Cancer<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage IV). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stage IV Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Extensive Stage Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage IV Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7458</td>
               <td rowspan="1">Stage IV Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Extensive Stage Small Cell Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IV Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Extensive Stage Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage IV Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7459</td>
               <td rowspan="1">Stage IV Small Cell Lung Carcinoma<span class="subclass"> SubClassOf </span>Stage IV Lung Cancer. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Stage IV Small Cell Lung Carcinoma<span class="subclass"> EquivalentTo </span>Extensive Stage Small Cell Lung Carcinoma<br><span class="keyword"> and </span>Stage IV Lung Cancer. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7478</td>
               <td rowspan="1">Superior Sulcus Lung Carcinoma<span class="subclass"> SubClassOf </span>Malignant Superior Sulcus Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Superior Sulcus Lung Carcinoma<span class="subclass"> EquivalentTo </span>Bronchogenic Carcinoma<br><span class="keyword"> and </span>Malignant Superior Sulcus Neoplasm. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7479</td>
               <td rowspan="1">Synchronous Bilateral Breast Carcinoma<span class="subclass"> SubClassOf </span>Bilateral Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Synchronous Bilateral Breast Carcinoma<span class="subclass"> EquivalentTo </span>Bilateral Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Synchronous Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7480</td>
               <td rowspan="1">Synchronous Multifocal Osteosarcoma<span class="subclass"> SubClassOf </span>Multifocal Osteosarcoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Synchronous Multifocal Osteosarcoma<span class="subclass"> EquivalentTo </span>Multifocal Osteosarcoma<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Synchronous Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7481</td>
               <td rowspan="1">Tracheal Carcinoma<span class="subclass"> SubClassOf </span>Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Tracheal Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>Infrequent Neoplasm<br><span class="keyword"> and </span>Malignant Tracheal Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Tracheal Epithelium)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Trachea). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7482</td>
               <td rowspan="1">Tracheal Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Tracheal Epithelium. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Tracheal Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>Infrequent Neoplasm<br><span class="keyword"> and </span>Malignant Tracheal Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Tracheal Epithelium)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Trachea). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7483</td>
               <td rowspan="1">Tracheal Carcinoma<span class="subclass"> SubClassOf </span>Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Trachea. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Tracheal Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>Infrequent Neoplasm<br><span class="keyword"> and </span>Malignant Tracheal Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Tracheal Epithelium)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Trachea). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7484</td>
               <td rowspan="1">Tracheal Carcinoma<span class="subclass"> SubClassOf </span>Infrequent Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Tracheal Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>Infrequent Neoplasm<br><span class="keyword"> and </span>Malignant Tracheal Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Tracheal Epithelium)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Trachea). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7485</td>
               <td rowspan="1">Tracheal Carcinoma<span class="subclass"> SubClassOf </span>Malignant Tracheal Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Tracheal Carcinoma<span class="subclass"> EquivalentTo </span>Carcinoma<br><span class="keyword"> and </span>Infrequent Neoplasm<br><span class="keyword"> and </span>Malignant Tracheal Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Tracheal Epithelium)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Trachea). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7486</td>
               <td rowspan="1">Tracheal Neoplasm<span class="subclass"> SubClassOf </span>Respiratory Tract Neoplasm. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Tracheal Neoplasm<span class="subclass"> EquivalentTo </span>Respiratory Tract Neoplasm<br><span class="keyword"> and </span>Tracheal Disorder. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7487</td>
               <td rowspan="1">Tracheal Neoplasm<span class="subclass"> SubClassOf </span>Tracheal Disorder. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Tracheal Neoplasm<span class="subclass"> EquivalentTo </span>Respiratory Tract Neoplasm<br><span class="keyword"> and </span>Tracheal Disorder. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7488</td>
               <td rowspan="1">Transplant-Related Lung Carcinoma<span class="subclass"> SubClassOf </span>Lung Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Transplant-Related Lung Carcinoma<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>Transplant-Related Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7489</td>
               <td rowspan="1">Transplant-Related Lung Carcinoma<span class="subclass"> SubClassOf </span>Transplant-Related Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Transplant-Related Lung Carcinoma<span class="subclass"> EquivalentTo </span>Lung Carcinoma<br><span class="keyword"> and </span>Transplant-Related Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7490</td>
               <td rowspan="1">Tubular Breast Carcinoma<span class="subclass"> SubClassOf </span>Breast Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Tubular Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Tubular Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11q ATM Gene Locus)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p FHIT Gene Locus)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Calcification)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>High Mitotic Activity)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Nuclear Pleomorphism)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Desmoplastic Stroma Formation). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7491</td>
               <td rowspan="1">Tubular Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Tubular Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Tubular Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11q ATM Gene Locus)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p FHIT Gene Locus)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Calcification)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>High Mitotic Activity)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Nuclear Pleomorphism)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Desmoplastic Stroma Formation). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7492</td>
               <td rowspan="1">Tubular Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11q ATM Gene Locus. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Tubular Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Tubular Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11q ATM Gene Locus)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p FHIT Gene Locus)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Calcification)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>High Mitotic Activity)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Nuclear Pleomorphism)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Desmoplastic Stroma Formation). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7493</td>
               <td rowspan="1">Tubular Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Tubular Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Tubular Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11q ATM Gene Locus)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p FHIT Gene Locus)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Calcification)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>High Mitotic Activity)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Nuclear Pleomorphism)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Desmoplastic Stroma Formation). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7494</td>
               <td rowspan="1">Tubular Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p FHIT Gene Locus. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Tubular Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Tubular Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11q ATM Gene Locus)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p FHIT Gene Locus)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Calcification)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>High Mitotic Activity)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Nuclear Pleomorphism)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Desmoplastic Stroma Formation). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7495</td>
               <td rowspan="1">Tubular Breast Carcinoma<span class="subclass"> SubClassOf </span>Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Tubular Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Tubular Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11q ATM Gene Locus)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p FHIT Gene Locus)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Calcification)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>High Mitotic Activity)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Nuclear Pleomorphism)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Desmoplastic Stroma Formation). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7496</td>
               <td rowspan="1">Tubular Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Tubular Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Tubular Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11q ATM Gene Locus)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p FHIT Gene Locus)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Calcification)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>High Mitotic Activity)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Nuclear Pleomorphism)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Desmoplastic Stroma Formation). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7497</td>
               <td rowspan="1">Tubular Breast Carcinoma<span class="subclass"> SubClassOf </span>Tubular Adenocarcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Tubular Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Adenocarcinoma<br><span class="keyword"> and </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Tubular Adenocarcinoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 1q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11q ATM Gene Locus)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 16q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 3p FHIT Gene Locus)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8p)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Calcification)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>High Mitotic Activity)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Nuclear Pleomorphism)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Desmoplastic Stroma Formation). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7500</td>
               <td rowspan="1">Type I Pleuropulmonary Blastoma<span class="subclass"> SubClassOf </span>Pleuropulmonary Blastoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Type I Pleuropulmonary Blastoma<span class="subclass"> EquivalentTo </span>Pleuropulmonary Blastoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Small Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Cystic Change). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7499</td>
               <td rowspan="1">Type II Pleuropulmonary Blastoma<span class="subclass"> SubClassOf </span>Pleuropulmonary Blastoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Type II Pleuropulmonary Blastoma<span class="subclass"> EquivalentTo </span>Pleuropulmonary Blastoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Aggressive Clinical Course)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Small Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Sarcomatous Component Present). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7498</td>
               <td rowspan="1">Type III Pleuropulmonary Blastoma<span class="subclass"> SubClassOf </span>Pleuropulmonary Blastoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Type III Pleuropulmonary Blastoma<span class="subclass"> EquivalentTo </span>Pleuropulmonary Blastoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Aggressive Clinical Course)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Sarcomatous Component Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Solid Growth Pattern). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7501</td>
               <td rowspan="1">Undifferentiated Breast Carcinoma<span class="subclass"> SubClassOf </span>Invasive Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Undifferentiated Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Undifferentiated Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7502</td>
               <td rowspan="1">Undifferentiated Breast Carcinoma<span class="subclass"> SubClassOf </span>Undifferentiated Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Undifferentiated Breast Carcinoma<span class="subclass"> EquivalentTo </span>Invasive Breast Carcinoma<br><span class="keyword"> and </span>Undifferentiated Carcinoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="1">7503</td>
               <td rowspan="1">Unilateral Breast Carcinoma<span class="subclass"> SubClassOf </span>Breast Carcinoma. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Unilateral Breast Carcinoma<span class="subclass"> EquivalentTo </span>Breast Carcinoma<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Bilateral Disease). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
         </tbody>
         <tr class="withoutstyle">
            <td>&nbsp;</td>
         </tr>
      </table>
      <div id="shared" style="display:none" class="footnote">Shared axiom between Ontology 1 and 2.</div>
   </body>
</html>